Citrus Sinensis ID: 041576
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 714 | 2.2.26 [Sep-21-2011] | |||||||
| Q39202 | 832 | G-type lectin S-receptor- | yes | no | 0.969 | 0.831 | 0.403 | 1e-152 | |
| Q39203 | 797 | G-type lectin S-receptor- | no | no | 0.868 | 0.777 | 0.319 | 2e-73 | |
| Q9XID3 | 829 | G-type lectin S-receptor- | no | no | 0.404 | 0.348 | 0.451 | 5e-72 | |
| Q9FLV4 | 872 | G-type lectin S-receptor- | no | no | 0.467 | 0.383 | 0.422 | 8e-71 | |
| O64477 | 828 | G-type lectin S-receptor- | no | no | 0.408 | 0.352 | 0.459 | 2e-69 | |
| Q8RWZ5 | 821 | G-type lectin S-receptor- | no | no | 0.401 | 0.349 | 0.466 | 3e-69 | |
| Q9LFS4 | 638 | Protein NSP-INTERACTING K | no | no | 0.466 | 0.521 | 0.398 | 1e-62 | |
| Q8RY65 | 635 | Protein NSP-INTERACTING K | no | no | 0.466 | 0.524 | 0.404 | 1e-61 | |
| Q0WVM4 | 634 | Probable LRR receptor-lik | no | no | 0.453 | 0.511 | 0.388 | 7e-61 | |
| O65238 | 872 | G-type lectin S-receptor- | no | no | 0.518 | 0.424 | 0.367 | 8e-61 |
| >sp|Q39202|RLK1_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase RLK1 OS=Arabidopsis thaliana GN=RLK1 PE=2 SV=2 | Back alignment and function desciption |
|---|
Score = 540 bits (1391), Expect = e-152, Method: Compositional matrix adjust.
Identities = 333/825 (40%), Positives = 463/825 (56%), Gaps = 133/825 (16%)
Query: 5 ALSCLIL---LSLPLLPF------LSAANIPLGSTLSSTSN---NSSWISPSRDFAFGFR 52
+LSC I+ L L L F + ++P+G +L+++ + +SSW SPS DFAFGFR
Sbjct: 3 SLSCSIIHLVLILQLQTFFVFSQNIRNGSVPVGESLTASESQQISSSWRSPSGDFAFGFR 62
Query: 53 QLNNNSDLFLLAIWFNKMPERTIIWHANEDNHPV-LAPRGSTLELTATG-LLLKDPGGQA 110
++ N D F L+IWF+K+ ++TI+WHA N L P GS + LTA G L++ DP GQ
Sbjct: 63 KIQPN-DGFTLSIWFDKISDKTIVWHAQAVNTTTGLVPNGSKVTLTADGGLVIADPRGQE 121
Query: 111 IW-------------------------DEKPNKI---SFKSPTDTILPTQIFDLGSVLVS 142
+W E +++ SF++PTDT+LP Q ++G L S
Sbjct: 122 LWRALSGGSVSRGRFTDDGNFVLFRDGSEDSDEVLWSSFENPTDTLLPNQNIEVGRNLSS 181
Query: 143 RLTETNLSKGRFELHFSN-GSLQLIPVAWPTPSQ---YKSYYTSNTCSANS-------SE 191
R TET+ KGRF L + G+LQL + T S+ Y YY SNT N+ ++
Sbjct: 182 RRTETSFKKGRFSLRLEDDGNLQLHSLNAETASESDIYSQYYESNTNDPNNPGIQLVFNQ 241
Query: 192 SGINYLLFRATLDF------------------DGVFTEYAYPKNSAPNQSWFTIQRLPNN 233
SG Y+L R F G PK + + +N
Sbjct: 242 SGEIYVLQRNNSRFVVKDRDPDFSIAAPFYISTGFLLSTIIPKEARRIVGGCLLGLCRDN 301
Query: 234 ICTSISDEFGSGACGFNSYCLL-QNGRPFCECPPEYLFVDPTNRFSGCKPNY-WQGCGPD 291
+C S D G+ ACG+N+ C L N RP CECP ++ DP+N + C P++ Q C P+
Sbjct: 302 MC-SPDDALGNMACGYNNICSLGNNKRPKCECPERFVLKDPSNEYGDCLPDFEMQTCRPE 360
Query: 292 DGSRNAE-ELYEIRELADVNWPLGYYQ--------------------------------- 317
+ + N++ LYE L NWP G Y+
Sbjct: 361 NQTANSDVNLYEFITLEKTNWPFGDYESYANYDEERCKASCLSDCLCAAVIFGTNRDLKC 420
Query: 318 --KRFPLALGAYDYTRTGFTKALIKVRKGGF-RVDFDGNTGGKKGIPILRGALLLGSSVF 374
K+FPL+ G + + G + IKVR V GN K I+ ++LLG+S F
Sbjct: 421 WKKKFPLSHG--ERSPRGDSDTFIKVRNRSIADVPVTGNRAKKLDWLIIACSVLLGTSAF 478
Query: 375 FNGLLLLAISLLVFVWRKRKDGNKVQRSSISET---------NLRFFSLVELNEATNGFE 425
++ S +K K+ K Q I T NLR F+ EL EAT F
Sbjct: 479 ----VIFDTSCSYRKTKKSKNMMKNQARDIGRTTATTTANELNLRVFTYGELAEATRDFT 534
Query: 426 EELGRGSFGIVYKGVLKSASGN--AVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQL 483
EELGRG+FGIVYKG L+ A G+ VAVKKLD+L + E+EFK EV IG+ HHKNLV+L
Sbjct: 535 EELGRGAFGIVYKGYLEVAGGSEVTVAVKKLDRLDLDNEKEFKNEVKVIGQIHHKNLVRL 594
Query: 484 LGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPII 543
+GFC+EG ++++VYEF+ GTLAN LF PRP W R I++ IARG+LYLHEEC+ II
Sbjct: 595 IGFCNEGQSQMIVYEFLPQGTLANFLFRRPRPSWEDRKNIAVAIARGILYLHEECSEQII 654
Query: 544 HCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPVSAKV 603
HCDIKPQNILLD+ +T +ISDFGL+KLLL +Q+ T T IRGT+GYVAPEWF+N P+++KV
Sbjct: 655 HCDIKPQNILLDEYYTPRISDFGLAKLLLMNQTYTLTNIRGTKGYVAPEWFRNSPITSKV 714
Query: 604 DVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMADKSR 663
DVYS+GV+LL+I+CCK++V++ E + IL +WAYDC+ +G+L+ L ++D AM D
Sbjct: 715 DVYSYGVMLLEIVCCKKAVDL----EDNVILINWAYDCFRQGRLEDLTEDDSEAMNDMET 770
Query: 664 ACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLEVPSPPMPPLHS 708
+++ IA+WCIQE+ RP M+ + QMLEG ++V PP P +S
Sbjct: 771 VERYVKIAIWCIQEEHGMRPNMRNVTQMLEGVIQVFDPPNPSPYS 815
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q39203|SD22_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD2-2 OS=Arabidopsis thaliana GN=SD22 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 277 bits (709), Expect = 2e-73, Method: Compositional matrix adjust.
Identities = 233/729 (31%), Positives = 335/729 (45%), Gaps = 109/729 (14%)
Query: 47 FAFGFRQLNNNSDLFLLAIWFNKMPERTIIWHANEDNHPVLAPRGSTLELTATGLLL--- 103
F GF N S + L I + MP T +W AN PV P STLELT+TG L+
Sbjct: 40 FRLGFFSTTNGSSNWYLGISYASMPTPTHVWVANRI-RPVSDPDSSTLELTSTGYLIVSN 98
Query: 104 -----------KDPGGQAIWDEKPNKI-----------SFKSPTDTILPTQIFDLGSVLV 141
K PG + E N I SF +PTDT LP + +
Sbjct: 99 LRDGVVWQTDNKQPGTDFRFSETGNLILINDDGSPVWQSFDNPTDTWLPGMNVTGLTAMT 158
Query: 142 SRLTETNLSKGRFELHFSNG--SLQLIPVA----WPT----------------PSQYKSY 179
S + + S G + L S QL+ W T P Y+ +
Sbjct: 159 SWRSLFDPSPGFYSLRLSPSFNEFQLVYKGTTPYWSTGNWTGEAFVGVPEMTIPYIYRFH 218
Query: 180 YTSNTCSANSS--------ESGINYLLFRATLDFDGVFTEYAYPKNSAPNQSWFTIQRLP 231
+ N + +S +S L R + +G +Y + + QSW P
Sbjct: 219 FV-NPYTPTASFWYIVPPLDSVSEPRLTRFMVGANGQLKQYTWDPQT---QSWNMFWLQP 274
Query: 232 NNICTSISDEFGSGACGFNSYCLLQNGRPFCECPPEYLFVDPTNRFSGCKPNYWQGCGPD 291
+ C + CG +C + +P C C + P N + +Y GC +
Sbjct: 275 EDPCRVYN------LCGQLGFCSSELLKP-CACIRGF---RPRNDAAWRSDDYSDGCRRE 324
Query: 292 DGSRNAEELYEIRELADVNWPLGYYQKRFPLA--------------LGAYDYTRTGFTKA 337
+G + E+ + D+ + R ++ +G Y ++ K
Sbjct: 325 NGD-SGEKSDTFEAVGDLRYDGDVKMSRLQVSKSSCAKTCLGNSSCVGFYHKEKSNLCKI 383
Query: 338 LIKVRKGGFRVDFDGNTGGKKGIPILRGALLLGS---SVFFNGLLLLAISLLVFVWRKRK 394
L++ N KG I + ++L S S+ G LL +L+ RKRK
Sbjct: 384 LLESPN---------NLKNSKG-NISKSIIILCSVVGSISVLGFTLLVPLILLKRSRKRK 433
Query: 395 DGNKVQRSSISETNLRFFSLVELNEATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKL 454
K + NL+ FS EL ATNGF +++G G FG V+KG L +S VAVK+L
Sbjct: 434 KTRKQDEDGFAVLNLKVFSFKELQSATNGFSDKVGHGGFGAVFKGTLPGSS-TFVAVKRL 492
Query: 455 DKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEFMGNGTLANLLFAIPR 514
++ E EF+ EV IG H NLV+L GFC E L+RLLVY++M G+L++ L
Sbjct: 493 ERPGSG-ESEFRAEVCTIGNIQHVNLVRLRGFCSENLHRLLVYDYMPQGSLSSYLSRTSP 551
Query: 515 P--DWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLL 572
W R RI+L A+G+ YLHE C IIHCDIKP+NILLD D+ AK+SDFGL+KLL
Sbjct: 552 KLLSWETRFRIALGTAKGIAYLHEGCRDCIIHCDIKPENILLDSDYNAKVSDFGLAKLLG 611
Query: 573 SDQSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEME---LGEE 629
D SR +RGT GYVAPEW +P++ K DVYSFG+ LL++I +R+V + LGE+
Sbjct: 612 RDFSRVLATMRGTWGYVAPEWISGLPITTKADVYSFGMTLLELIGGRRNVIVNSDTLGEK 671
Query: 630 RSA----ILTDWAYDCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAM 685
+ WA ++G +D +VD+ + + +A+WCIQ++ RPAM
Sbjct: 672 ETEPEKWFFPPWAAREIIQGNVDSVVDSRLNGEYNTEEVTRMATVAIWCIQDNEEIRPAM 731
Query: 686 KMIVQMLEG 694
+V+MLEG
Sbjct: 732 GTVVKMLEG 740
|
Serine/threonine-protein kinase. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9XID3|Y1343_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g34300 OS=Arabidopsis thaliana GN=At1g34300 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 273 bits (697), Expect = 5e-72, Method: Compositional matrix adjust.
Identities = 135/299 (45%), Positives = 193/299 (64%), Gaps = 10/299 (3%)
Query: 412 FSLVELNEATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSA 471
F+ EL T F+E+LG G FG VY+GVL + + VAVK+L+ + Q E++F+ EV+
Sbjct: 474 FTYKELQRCTKSFKEKLGAGGFGTVYRGVLTNRT--VVAVKQLEGIEQG-EKQFRMEVAT 530
Query: 472 IGRTHHKNLVQLLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPD---WSLRVRISLEIA 528
I THH NLV+L+GFC +G +RLLVYEFM NG+L N LF W R I+L A
Sbjct: 531 ISSTHHLNLVRLIGFCSQGRHRLLVYEFMRNGSLDNFLFTTDSAKFLTWEYRFNIALGTA 590
Query: 529 RGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSR-TRTVIRGTRG 587
+G+ YLHEEC I+HCDIKP+NIL+D +F AK+SDFGL+KLL +R + +RGTRG
Sbjct: 591 KGITYLHEECRDCIVHCDIKPENILVDDNFAAKVSDFGLAKLLNPKDNRYNMSSVRGTRG 650
Query: 588 YVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKL 647
Y+APEW N+P+++K DVYS+G+VLL+++ KR+ ++ + WAY+ + +G
Sbjct: 651 YLAPEWLANLPITSKSDVYSYGMVLLELVSGKRNFDVSEKTNHKK-FSIWAYEEFEKGNT 709
Query: 648 DVLVDN--DKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLEVPSPPMP 704
++D + D + + + + WCIQE PL+RP M +VQMLEG E+ +P P
Sbjct: 710 KAILDTRLSEDQTVDMEQVMRMVKTSFWCIQEQPLQRPTMGKVVQMLEGITEIKNPLCP 768
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FLV4|Y5248_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At5g24080 OS=Arabidopsis thaliana GN=At5g24080 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 268 bits (686), Expect = 8e-71, Method: Compositional matrix adjust.
Identities = 148/350 (42%), Positives = 206/350 (58%), Gaps = 16/350 (4%)
Query: 360 IPILRGALLLGSSVFFNGLLLLAISLLVFVWRKRKDGNKVQRSSISETNLRFFSLVELNE 419
IPI+ G L+L + LL + L + RKR + S I + F+ +L
Sbjct: 476 IPIVVGMLVL--------VALLGMLLYYNLDRKRTLKRAAKNSLILCDSPVSFTYRDLQN 527
Query: 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKN 479
TN F + LG G FG VYKG + A VAVK+LD+ EREF TEV+ IG HH N
Sbjct: 528 CTNNFSQLLGSGGFGTVYKGTV--AGETLVAVKRLDRALSHGEREFITEVNTIGSMHHMN 585
Query: 480 LVQLLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRP----DWSLRVRISLEIARGLLYLH 535
LV+L G+C E +RLLVYE+M NG+L +F+ + DW R I++ A+G+ Y H
Sbjct: 586 LVRLCGYCSEDSHRLLVYEYMINGSLDKWIFSSEQTANLLDWRTRFEIAVATAQGIAYFH 645
Query: 536 EECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFK 595
E+C IIHCDIKP+NILLD +F K+SDFGL+K++ + S T+IRGTRGY+APEW
Sbjct: 646 EQCRNRIIHCDIKPENILLDDNFCPKVSDFGLAKMMGREHSHVVTMIRGTRGYLAPEWVS 705
Query: 596 NVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDK 655
N P++ K DVYS+G++LL+I+ +R+++M E WAY G VD
Sbjct: 706 NRPITVKADVYSYGMLLLEIVGGRRNLDMSYDAE-DFFYPGWAYKELTNGTSLKAVDKRL 764
Query: 656 AAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYL-EVPSPPMP 704
+A++ K L +A WCIQ++ RP+M +V++LEG E+ PPMP
Sbjct: 765 QGVAEEEEVVKALKVAFWCIQDEVSMRPSMGEVVKLLEGTSDEINLPPMP 814
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O64477|Y2913_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At2g19130 OS=Arabidopsis thaliana GN=At2g19130 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 264 bits (675), Expect = 2e-69, Method: Compositional matrix adjust.
Identities = 142/309 (45%), Positives = 194/309 (62%), Gaps = 17/309 (5%)
Query: 406 ETNLRFFSLVELNEATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREF 465
+ L FS EL AT F ++LG G FG V+KG L +S +AVK+L+ ++Q E++F
Sbjct: 477 DGTLSAFSYRELQNATKNFSDKLGGGGFGSVFKGALPDSSD--IAVKRLEGISQG-EKQF 533
Query: 466 KTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPD-----WSLR 520
+TEV IG H NLV+L GFC EG +LLVY++M NG+L + LF + W LR
Sbjct: 534 RTEVVTIGTIQHVNLVRLRGFCSEGSKKLLVYDYMPNGSLDSHLFLNQVEEKIVLGWKLR 593
Query: 521 VRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRT 580
+I+L ARGL YLH+EC IIHCDIKP+NILLD F K++DFGL+KL+ D SR T
Sbjct: 594 FQIALGTARGLAYLHDECRDCIIHCDIKPENILLDSQFCPKVADFGLAKLVGRDFSRVLT 653
Query: 581 VIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYD 640
+RGTRGY+APEW V ++AK DVYS+G++L +++ +R+ E + E+ WA
Sbjct: 654 TMRGTRGYLAPEWISGVAITAKADVYSYGMMLFELVSGRRNTE-QSENEKVRFFPSWAAT 712
Query: 641 CYV-EGKLDVLVD----NDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGY 695
+G + LVD D + + +RACK +A WCIQ++ RPAM +VQ+LEG
Sbjct: 713 ILTKDGDIRSLVDPRLEGDAVDIEEVTRACK---VACWCIQDEESHRPAMSQVVQILEGV 769
Query: 696 LEVPSPPMP 704
LEV PP P
Sbjct: 770 LEVNPPPFP 778
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8RWZ5|SD25_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD2-5 OS=Arabidopsis thaliana GN=SD25 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 263 bits (673), Expect = 3e-69, Method: Compositional matrix adjust.
Identities = 138/296 (46%), Positives = 186/296 (62%), Gaps = 9/296 (3%)
Query: 412 FSLVELNEATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSA 471
F+ +L ATN F +LG+G FG VY+G L G+ +AVKKL+ + Q + +EF+ EVS
Sbjct: 483 FAYKDLQSATNNFSVKLGQGGFGSVYEGTL--PDGSRLAVKKLEGIGQGK-KEFRAEVSI 539
Query: 472 IGRTHHKNLVQLLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPD----WSLRVRISLEI 527
IG HH +LV+L GFC EG +RLL YEF+ G+L +F D W R I+L
Sbjct: 540 IGSIHHLHLVRLRGFCAEGAHRLLAYEFLSKGSLERWIFRKKDGDVLLDWDTRFNIALGT 599
Query: 528 ARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRG 587
A+GL YLHE+C+ I+HCDIKP+NILLD +F AK+SDFGL+KL+ +QS T +RGTRG
Sbjct: 600 AKGLAYLHEDCDARIVHCDIKPENILLDDNFNAKVSDFGLAKLMTREQSHVFTTMRGTRG 659
Query: 588 YVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKL 647
Y+APEW N +S K DVYS+G+VLL++I +++ + E+ +A+ EGKL
Sbjct: 660 YLAPEWITNYAISEKSDVYSYGMVLLELIGGRKNYDPSETSEKCH-FPSFAFKKMEEGKL 718
Query: 648 DVLVDND-KAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLEVPSPP 702
+VD K R + + ALWCIQED RP+M +VQMLEG V PP
Sbjct: 719 MDIVDGKMKNVDVTDERVQRAMKTALWCIQEDMQTRPSMSKVVQMLEGVFPVVQPP 774
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LFS4|NIK1_ARATH Protein NSP-INTERACTING KINASE 1 OS=Arabidopsis thaliana GN=NIK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 242 bits (617), Expect = 1e-62, Method: Compositional matrix adjust.
Identities = 143/359 (39%), Positives = 207/359 (57%), Gaps = 26/359 (7%)
Query: 357 KKGIPILRG-------ALLLGSSVFFNGLLLLAISLLVFVWRKR---------KDGNKVQ 400
+ G+P+ G A+ +GSSV L+ +A+ L ++ WR+R KDGN
Sbjct: 232 QTGVPLYAGGSRNHKMAIAVGSSVGTVSLIFIAVGLFLW-WRQRHNQNTFFDVKDGN--H 288
Query: 401 RSSISETNLRFFSLVELNEATNGFEEE--LGRGSFGIVYKGVLKSASGNAVAVKKL-DKL 457
+S NLR F EL ATN F + LG+G +G VYKG+L ++ VAVK+L D
Sbjct: 289 HEEVSLGNLRRFGFRELQIATNNFSSKNLLGKGGYGNVYKGILGDST--VVAVKRLKDGG 346
Query: 458 AQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDW 517
A E +F+TEV I H+NL++L GFC +LLVY +M NG++A+ + A P DW
Sbjct: 347 ALGGEIQFQTEVEMISLAVHRNLLRLYGFCITQTEKLLVYPYMSNGSVASRMKAKPVLDW 406
Query: 518 SLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSR 577
S+R RI++ ARGL+YLHE+C+ IIH D+K NILLD A + DFGL+KLL S
Sbjct: 407 SIRKRIAIGAARGLVYLHEQCDPKIIHRDVKAANILLDDYCEAVVGDFGLAKLLDHQDSH 466
Query: 578 TRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDW 637
T +RGT G++APE+ S K DV+ FG++LL+++ +R+ E + ++ DW
Sbjct: 467 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELVTGQRAFEFGKAANQKGVMLDW 526
Query: 638 AYDCYVEGKLDVLVDND--KAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEG 694
+ E KL++LVD + K D+ + + +AL C Q P RP M +V+MLEG
Sbjct: 527 VKKIHQEKKLELLVDKELLKKKSYDEIELDEMVRVALLCTQYLPGHRPKMSEVVRMLEG 585
|
Involved in defense response to geminivirus infection via regulation of the nuclear trafficking of RPL10A. Phosphorylates RPL10A in vitro. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8RY65|NIK2_ARATH Protein NSP-INTERACTING KINASE 2 OS=Arabidopsis thaliana GN=NIK2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 238 bits (607), Expect = 1e-61, Method: Compositional matrix adjust.
Identities = 142/351 (40%), Positives = 203/351 (57%), Gaps = 18/351 (5%)
Query: 355 GGKKGIPILRGALLLGSSVFFNGLLLLAISLLVFVWRKRK-------DGNKVQRSSISET 407
GG K I A++ G S+ LL++ L++ WR+R D N+ + +
Sbjct: 240 GGTKNRKI---AVVFGVSLTCVCLLIIGFGFLLW-WRRRHNKQVLFFDINEQNKEEMCLG 295
Query: 408 NLRFFSLVELNEATNGFEEE--LGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQER-ERE 464
NLR F+ EL AT+ F + +G+G FG VYKG L G+ +AVK+L + E +
Sbjct: 296 NLRRFNFKELQSATSNFSSKNLVGKGGFGNVYKGCLHD--GSIIAVKRLKDINNGGGEVQ 353
Query: 465 FKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRIS 524
F+TE+ I H+NL++L GFC RLLVY +M NG++A+ L A P DW R RI+
Sbjct: 354 FQTELEMISLAVHRNLLRLYGFCTTSSERLLVYPYMSNGSVASRLKAKPVLDWGTRKRIA 413
Query: 525 LEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRG 584
L RGLLYLHE+C+ IIH D+K NILLD F A + DFGL+KLL ++S T +RG
Sbjct: 414 LGAGRGLLYLHEQCDPKIIHRDVKAANILLDDYFEAVVGDFGLAKLLDHEESHVTTAVRG 473
Query: 585 TRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEM-ELGEERSAILTDWAYDCYV 643
T G++APE+ S K DV+ FG++LL++I R++E + +R AIL DW
Sbjct: 474 TVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGLRALEFGKAANQRGAIL-DWVKKLQQ 532
Query: 644 EGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEG 694
E KL+ +VD D + D+ + + +AL C Q P+ RP M +V+MLEG
Sbjct: 533 EKKLEQIVDKDLKSNYDRIEVEEMVQVALLCTQYLPIHRPKMSEVVRMLEG 583
|
Involved in defense response to geminivirus infection (By similarity). Phosphorylates RPL10A in vitro. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q0WVM4|Y2239_ARATH Probable LRR receptor-like serine/threonine-protein kinase At2g23950 OS=Arabidopsis thaliana GN=At2g23950 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 236 bits (601), Expect = 7e-61, Method: Compositional matrix adjust.
Identities = 132/340 (38%), Positives = 195/340 (57%), Gaps = 16/340 (4%)
Query: 366 ALLLGSSVFFNGLLLLAISLLVFVWRKRKD--------GNKVQRSSISETNLRFFSLVEL 417
A+ LG S+ F ++L++ F+W ++K +K + + NLR F+ EL
Sbjct: 236 AVALGVSLGFAVSVILSLG---FIWYRKKQRRLTMLRISDKQEEGLLGLGNLRSFTFREL 292
Query: 418 NEATNGFEEE--LGRGSFGIVYKGVLKSASGNAVAVKKL-DKLAQEREREFKTEVSAIGR 474
+ AT+GF + LG G FG VY+G K G VAVK+L D +F+TE+ I
Sbjct: 293 HVATDGFSSKSILGAGGFGNVYRG--KFGDGTVVAVKRLKDVNGTSGNSQFRTELEMISL 350
Query: 475 THHKNLVQLLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYL 534
H+NL++L+G+C RLLVY +M NG++A+ L A P DW+ R +I++ ARGL YL
Sbjct: 351 AVHRNLLRLIGYCASSSERLLVYPYMSNGSVASRLKAKPALDWNTRKKIAIGAARGLFYL 410
Query: 535 HEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWF 594
HE+C+ IIH D+K NILLD+ F A + DFGL+KLL + S T +RGT G++APE+
Sbjct: 411 HEQCDPKIIHRDVKAANILLDEYFEAVVGDFGLAKLLNHEDSHVTTAVRGTVGHIAPEYL 470
Query: 595 KNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDND 654
S K DV+ FG++LL++I R++E + + +W + E K++ LVD +
Sbjct: 471 STGQSSEKTDVFGFGILLLELITGMRALEFGKSVSQKGAMLEWVRKLHKEMKVEELVDRE 530
Query: 655 KAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEG 694
D+ + L +AL C Q P RP M +VQMLEG
Sbjct: 531 LGTTYDRIEVGEMLQVALLCTQFLPAHRPKMSEVVQMLEG 570
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O65238|Y5537_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At5g35370 OS=Arabidopsis thaliana GN=At5g35370 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 235 bits (600), Expect = 8e-61, Method: Compositional matrix adjust.
Identities = 152/414 (36%), Positives = 214/414 (51%), Gaps = 44/414 (10%)
Query: 333 GFTKALIKVRKGGFRVDFDGNTGGKKGIPILRGALLLGSSVFFNGLLLLAISLL------ 386
G+ K + +RK + + N GG P++ +LL S FF LL+A+ LL
Sbjct: 418 GYVK--LSIRKTNAQPPGNNNRGGSS-FPVI-ALVLLPCSGFF---LLIALGLLWWRRCA 470
Query: 387 VFVWRKRKDGNKVQRSSISETNL---------RFFSLVELNEATNGFEEELGRGSFGIVY 437
V + ++ + S +L + F EL +AT F+ ++G G FG VY
Sbjct: 471 VMRYSSIREKQVTRPGSFESGDLGSFHIPGLPQKFEFEELEQATENFKMQIGSGGFGSVY 530
Query: 438 KGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVY 497
KG L + +AVKK+ +EF TE++ IG H NLV+L GFC G LLVY
Sbjct: 531 KGTLPDET--LIAVKKITNHGLHGRQEFCTEIAIIGNIRHTNLVKLRGFCARGRQLLLVY 588
Query: 498 EFMGNGTLANLLFAIPRP--DWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLD 555
E+M +G+L LF+ P +W R I+L ARGL YLH C+ IIHCD+KP+NILL
Sbjct: 589 EYMNHGSLEKTLFSGNGPVLEWQERFDIALGTARGLAYLHSGCDQKIIHCDVKPENILLH 648
Query: 556 QDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKI 615
F KISDFGLSKLL ++S T +RGTRGY+APEW N +S K DVYS+G+VLL++
Sbjct: 649 DHFQPKISDFGLSKLLNQEESSLFTTMRGTRGYLAPEWITNAAISEKADVYSYGMVLLEL 708
Query: 616 I-----CCKRSVEMELGEERS-------------AILTDWAYDCYVEGKLDVLVDNDKAA 657
+ C RS + E+ + +A D + +G+ L D
Sbjct: 709 VSGRKNCSFRSRSNSVTEDNNQNHSSTTTTSTGLVYFPLYALDMHEQGRYMELADPRLEG 768
Query: 658 MADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLEVPSPPMPPLHSLQL 711
A K + IAL C+ E+P RP M +V M EG + + +P M L+ L+
Sbjct: 769 RVTSQEAEKLVRIALCCVHEEPALRPTMAAVVGMFEGSIPLGNPRMESLNFLRF 822
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 714 | ||||||
| 224138692 | 776 | predicted protein [Populus trichocarpa] | 0.934 | 0.859 | 0.569 | 0.0 | |
| 255583185 | 787 | BRASSINOSTEROID INSENSITIVE 1-associated | 0.964 | 0.875 | 0.504 | 0.0 | |
| 357482135 | 803 | Kinase-like protein [Medicago truncatula | 0.964 | 0.858 | 0.486 | 0.0 | |
| 357482147 | 800 | Kinase-like protein [Medicago truncatula | 0.941 | 0.84 | 0.485 | 0.0 | |
| 356540555 | 802 | PREDICTED: G-type lectin S-receptor-like | 0.953 | 0.849 | 0.484 | 0.0 | |
| 356495583 | 809 | PREDICTED: G-type lectin S-receptor-like | 0.971 | 0.857 | 0.462 | 0.0 | |
| 356495581 | 801 | PREDICTED: G-type lectin S-receptor-like | 0.948 | 0.845 | 0.468 | 0.0 | |
| 224099309 | 801 | predicted protein [Populus trichocarpa] | 0.955 | 0.851 | 0.461 | 0.0 | |
| 359487487 | 808 | PREDICTED: G-type lectin S-receptor-like | 0.955 | 0.844 | 0.476 | 0.0 | |
| 224103119 | 799 | predicted protein [Populus trichocarpa] | 0.966 | 0.863 | 0.452 | 0.0 |
| >gi|224138692|ref|XP_002326666.1| predicted protein [Populus trichocarpa] gi|222833988|gb|EEE72465.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 827 bits (2137), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 439/771 (56%), Positives = 533/771 (69%), Gaps = 104/771 (13%)
Query: 32 SSTSNNSSWISPSRDFAFGFRQLNNNSDLFLLAIWFNKMPERTIIWHANEDNHPVLAPRG 91
S T+N ++W+SPS DFAFGFRQL N S+LFLLAIWF+ +P RTI+WH+N N+P+ PRG
Sbjct: 9 SLTTNGNTWLSPSGDFAFGFRQLGN-SNLFLLAIWFDIIPARTIVWHSN-GNNPL--PRG 64
Query: 92 STLELTATGLLLKDPGGQAIWDEKPNKI-------------------------SFKSPTD 126
S +ELT++ L+L +P G IW P +FK+PTD
Sbjct: 65 SKVELTSSNLVLTNPKGLIIWQANPATPVISAAMLDTGNFVLKGNDSSTYIWETFKNPTD 124
Query: 127 TILPTQIFDLGSVLVSRLTETNLSKGRFELHFSNGSLQLIPVAWPTPSQYKSYYTSNTCS 186
TILPTQ DLGS L SRLTETN SKGRFEL+FSNGSL+L P+AWP+ QY YY+SNT +
Sbjct: 125 TILPTQTLDLGSKLFSRLTETNYSKGRFELNFSNGSLELNPIAWPSEFQYDHYYSSNTYN 184
Query: 187 ANSSESG----------------------------INYL---LFRATLDFDGVFTEYAYP 215
A+ ESG INY +RATL FDGVFT+Y+ P
Sbjct: 185 ADPYESGYRLVFNESANVYIVKLNGEIAQFPDWNRINYTGDNYYRATLGFDGVFTQYSLP 244
Query: 216 KNSAPNQSWFTIQRLPNNICTSISDEFGSGACGFNSYCLLQ-NGRPFCECPPEYLFVDPT 274
KNS NQ W+ +Q +P ++CT+I ++ GSG CGFNSYC +Q N +P C+CPP Y+F+DP
Sbjct: 245 KNSTTNQGWWPVQSIPLDMCTAIFNDIGSGPCGFNSYCSIQENRKPTCDCPPGYVFLDPN 304
Query: 275 NRFSGCKPNYWQGCGPDDGSRNAEELYEIRELADVNWPLGYYQ----------------- 317
NR GCKP + QGCG DDG + EELYEIR+ +VNWPL Y+
Sbjct: 305 NRLGGCKPTFPQGCGLDDGRGDPEELYEIRQFDNVNWPLNDYERLSPYNQTQCEKSCLYD 364
Query: 318 ---------------KRFPLALGAYDYTRTGFTKALIKVRKGGFRVDFDG--NTGGKKGI 360
KR PL+ G Y RTGF+K L KVRK V G N G K
Sbjct: 365 CSCAVAIFDGRQCWKKRLPLSNGRY--MRTGFSKTLFKVRK---EVPPSGYCNVGSDKEK 419
Query: 361 PILRGALLLGSSVFFNGLLLLAISLLVFVWRKRKDGNKVQRSSISETNLRFFSLVELNEA 420
P+L GALL GSS F N +LL+ L++F R+RK SSI + LR F+ EL EA
Sbjct: 420 PVLLGALL-GSSAFLNVILLVVTFLILFRRRERKVKKAGPDSSIYFSTLRSFTYKELEEA 478
Query: 421 TNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNL 480
T+GF EELGRGSFGIVYKG ++S+SGNA+AVKKLDKLAQEREREF+TEVSAIG THHKNL
Sbjct: 479 TDGFMEELGRGSFGIVYKGFMRSSSGNAIAVKKLDKLAQEREREFRTEVSAIGETHHKNL 538
Query: 481 VQLLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNV 540
V+LLG+CDEG +RLL+YEFM NGTLAN LF +PRPDW RV+I+L +ARGLLYLH EC
Sbjct: 539 VRLLGYCDEGSHRLLIYEFMSNGTLANFLFTLPRPDWHQRVKIALGVARGLLYLHGECEF 598
Query: 541 PIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPVS 600
PIIHCDIKPQNILLD F+A+ISDFGL+KLLLS+Q+RTRT+IRGTRGYVAPEWFKNVPV+
Sbjct: 599 PIIHCDIKPQNILLDDSFSARISDFGLAKLLLSNQTRTRTMIRGTRGYVAPEWFKNVPVT 658
Query: 601 AKVDVYSFGVVLLKIICCKRSVEMEL--GEERSAILTDWAYDCYVEGKLDVLVDNDKAAM 658
AKVDVYSFGV+LL+IICC+RSV M+L GEE AILTDWAYDCY+ G++ LVDNDK AM
Sbjct: 659 AKVDVYSFGVLLLEIICCRRSVVMDLEEGEEERAILTDWAYDCYIGGRIYHLVDNDKVAM 718
Query: 659 ADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLEVPSPPMP-PLHS 708
DK R KW+ +++WCIQE+P KRP MKM+++MLEG+L+VP P PL S
Sbjct: 719 DDKERLKKWVEVSMWCIQEEPSKRPTMKMVLEMLEGFLDVPPLQSPFPLSS 769
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255583185|ref|XP_002532358.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] gi|223527945|gb|EEF30031.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 738 bits (1904), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 398/789 (50%), Positives = 513/789 (65%), Gaps = 100/789 (12%)
Query: 4 LALSCLILLSLPLLPFLSAA-NIPLGSTLSSTSNNSSWISPSRDFAFGFRQLNNNSDLFL 62
+ +S LI+L L LLP LSA NI L S+L + +N+ SW SPS DFAFGF +L N ++LFL
Sbjct: 1 MVVSKLIVLILFLLPPLSAQQNITLSSSLVANNNSPSWTSPSGDFAFGFHKLVN-TNLFL 59
Query: 63 LAIWFNKMPERTIIWHANEDNHPVLAPRGSTLELTATGLLLKDPGGQAIWDEKPNKIS-- 120
LAIWF+K+P++TI+W AN D A +GS LE++ GLLL DPGGQ IW+++ +S
Sbjct: 60 LAIWFDKIPDKTIVWDANGDKP---AQQGSKLEVSVNGLLLTDPGGQLIWEQQTATVSYA 116
Query: 121 ---------------------FKSPTDTILPTQIFDLGSVLVSRLTETNLSKGRFELHFS 159
FK+PTDTILP+Q + G+ L SRL ETN S+GRF+L+F
Sbjct: 117 AMLDTGNFVLVDNNSDYLWESFKNPTDTILPSQALEPGTFLFSRLAETNYSRGRFQLYFL 176
Query: 160 NGSLQLIPVAWPTPSQYKSYYTSNTCSANSSESGINYLL--------------------- 198
NG LQL PV WPT QY +Y++S T S++SS SG +
Sbjct: 177 NGDLQLSPVGWPTKVQYGAYFSSGTSSSDSSVSGYQLVFNQSDIYMVKTDGVTVRLPWQQ 236
Query: 199 -----------FRATLDFDGVFTEYAYPKNSAPNQSWFTIQRLPNNICTSISDEFGSGAC 247
+RATLD++GV T+Y PK S ++SW +Q +P +IC++I + GSGAC
Sbjct: 237 QDTAPSLAGNYYRATLDYNGVLTQYVCPKGSGSDRSWSIVQYIPQDICSAIFNGIGSGAC 296
Query: 248 GFNSYCLLQNGRPFCECPPEYLFVDPTNRFSGCKPNYWQGCGPDDGSRNAEELYEIRELA 307
G+NS C NGRP C CP Y F+D N F GCKP++ GCG D S N E+LYE REL
Sbjct: 297 GYNSICTEVNGRPNCACPLGYSFIDQNNLFGGCKPDFPLGCGVADASENMEDLYEFRELQ 356
Query: 308 DVNWPLGYYQ--------------------------------KRFPLALGAYDYTRTGFT 335
VNWPLG Y+ KR PLA G + G +
Sbjct: 357 YVNWPLGDYERLSPYSVEECKTSCLQDCMCAAAIYGSSICWKKRIPLANGRLE---KGNS 413
Query: 336 KALIKVRKGG--FRVDFDGNTGGKKGIPILRGALLLGSSVFFNGLLLLAISLLVFVWRKR 393
ALIKVRKG + K+ IL G+L G+S+ N L + L++F+ R
Sbjct: 414 LALIKVRKGAPLAQPGLTCIKKKKQDKTILFGSL--GTSLVLNAFFLFTVPLILFLKLNR 471
Query: 394 KDGNKVQRSSISETNLRFFSLVELNEATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKK 453
K +Q S++ ETNL FS EL EAT+ F+E++GRGS IVYKG+LK + N +AVKK
Sbjct: 472 KSNKVLQLSTLLETNLHMFSYKELEEATDNFKEQVGRGSSAIVYKGILKCSPNNVIAVKK 531
Query: 454 LDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEFMGNGTLANLLFAIP 513
LDKL+QE E+EF+TE+ IG+T HKNLV+LLGFC+EG +RLLVY+FM GTLAN L IP
Sbjct: 532 LDKLSQEAEKEFRTEMKVIGKTCHKNLVRLLGFCEEGSHRLLVYQFMTRGTLANFLLGIP 591
Query: 514 RPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLS 573
+P+W++R +I LEIARGLLYLHEEC PIIHCDIKP+NILLD+ FTAKISDFGLSKLLLS
Sbjct: 592 KPEWNIRAQIVLEIARGLLYLHEECEAPIIHCDIKPENILLDEYFTAKISDFGLSKLLLS 651
Query: 574 DQSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAI 633
+QSRT T+IRGTRGYVAPEWF+NV V+AKVDVYSFGVVLL+IICCK++V +L +E+ I
Sbjct: 652 NQSRTMTLIRGTRGYVAPEWFRNVAVTAKVDVYSFGVVLLEIICCKKNVS-KLEDEKDGI 710
Query: 634 LTDWAYDCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLE 693
LT+W YDC E +LD +++ D+ A+ADK R W+ +A+WC QEDP RP+MK ++QMLE
Sbjct: 711 LTEWVYDCLQEERLDAVIEFDEEAVADKERLNSWVRMAIWCTQEDPSTRPSMKTVLQMLE 770
Query: 694 GYLEVPSPP 702
G+ E+PS P
Sbjct: 771 GFTEIPSLP 779
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357482135|ref|XP_003611353.1| Kinase-like protein [Medicago truncatula] gi|355512688|gb|AES94311.1| Kinase-like protein [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 706 bits (1823), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 391/804 (48%), Positives = 520/804 (64%), Gaps = 115/804 (14%)
Query: 10 ILLSLPLLPFLSAANIPLGSTLSSTSNNSS-WISPSRDFAFGFRQLNNNSDLFLLAIWFN 68
I+ L L L+ N+ S LS+T+NN++ W+SPS +FAFGFR N ++ F+LAIW+N
Sbjct: 9 IIAILFLQLILAFGNVSPSSRLSTTNNNNNPWLSPSGEFAFGFR--NTTTNFFMLAIWYN 66
Query: 69 KMPERTIIWHA---NEDNHPVLAPRGSTLELTATGLLLKDPGGQAIWDEKPNKI------ 119
+ ++TI+W A N N+ VLAP GS ++LT+ GL L +P ++IW +PN I
Sbjct: 67 NIHDQTIVWSAKDMNNSNNLVLAPTGSQVQLTSGGLTLTNPQNESIWTAQPNDIVSYGTM 126
Query: 120 ------------------SFKSPTDTILPTQIFDLGSVLVSRLTETNLSKGRFELHFSNG 161
SFK PTDT+LP Q +LG+ L SR +ETN + GRF+L+F++
Sbjct: 127 LDNGNFVLVNNKSAIVWESFKFPTDTLLPNQSLELGATLTSRFSETNFTSGRFQLYFNDD 186
Query: 162 --SLQLIPVAWPTPSQYKSYY--TSNTCSANSS----ESGINYL---------------- 197
+L L P+AWPT +Y YY N SA+SS ESG Y+
Sbjct: 187 DHNLMLSPLAWPTQFRYNFYYRIEVNNNSASSSLVFDESGDIYVETNKNGTTRIKPQGTQ 246
Query: 198 -----------LFRATLDFDGVFTEYAYPKNSAPNQSWFTIQRLPNNICTSISDEFGSGA 246
+RA LD+ GV T+Y++P+++ Q W ++ +P+NIC +I +E GSG
Sbjct: 247 WKNLDLDPKLYYYRAILDYYGVLTQYSHPRDTKAKQGWTIMRYVPDNICIAIFNEMGSGT 306
Query: 247 CGFNSYCLLQNGRPFCECPPEYLFVDPTNRFSGCKPNYWQGCGPDDG---SRNAEELYEI 303
CG+NSYC ++N RP C+CP Y +DP+N+F GC+ N+ GCG D+G + E+LYE
Sbjct: 307 CGYNSYCSMENQRPTCKCPYGYSLIDPSNQFGGCQLNFTLGCGADNGEGLNVKPEDLYEF 366
Query: 304 RELADVNWPLGYYQ--------------------------------KRFPLALGAYDYTR 331
L +VNWPL Y+ KR PLA G +
Sbjct: 367 TVLTNVNWPLSDYERMQPYSQHDCQQSCLHDCMCSVVVFSNQNCWKKRSPLANGREE--- 423
Query: 332 TGFTKALIKVRKGGF-RVDFDGNTGGKKGI---PILRGALLLGSSVFFNGLLLLAISLLV 387
+G LIK R ++ +T KK PILRG LL+GS+VF N +LL A+ L+
Sbjct: 424 SGGNLVLIKTRVSPLGKIGASPSTNLKKDNQVNPILRG-LLIGSAVF-NSILLAAVVLVT 481
Query: 388 FVWRKRKDGNKVQRSSISETNLRFFSLVELNEATNGFEEELGRGSFGIVYKGVLKSA-SG 446
+ KR V +++ ETNL FS L EAT GF EELGRGSFGIV+KG LK+A S
Sbjct: 482 LLKPKRV----VVGTTLLETNLCSFSYDALKEATWGFIEELGRGSFGIVFKGELKAATSC 537
Query: 447 NAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEFMGNGTLA 506
N VAVK+LD+LAQ+RE+EFKTE+ AIG+T HKNLV+L+G+CDEG++R+LVYEFM NG+LA
Sbjct: 538 NVVAVKRLDRLAQDREKEFKTELRAIGKTCHKNLVKLIGYCDEGMHRMLVYEFMNNGSLA 597
Query: 507 NLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFG 566
N+LF +P W+ R+ +L IARGL+YLHEEC+ PIIHCDIKPQNIL+D+ FTAKISDFG
Sbjct: 598 NILFGQTKPTWNQRIGFALGIARGLVYLHEECDTPIIHCDIKPQNILIDEYFTAKISDFG 657
Query: 567 LSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVE-ME 625
L+KLLL+DQSRT+T+IRGTRGYVAPEWFKNVPV+AKVDVYSFG +LL+I+CC++SV ME
Sbjct: 658 LAKLLLADQSRTKTMIRGTRGYVAPEWFKNVPVTAKVDVYSFGAMLLEIVCCRKSVVLME 717
Query: 626 LGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAM 685
GEE AILTDWA DCY+EG++D LV+ND+ A+ D R KW+ IA+WCIQE P RP M
Sbjct: 718 SGEEEKAILTDWACDCYMEGRIDALVENDQEALDDIDRLEKWIKIAIWCIQEHPEMRPTM 777
Query: 686 KMIVQMLEGYLEVPSPPMPPLHSL 709
+M++QMLEG ++VP+PP P SL
Sbjct: 778 RMVMQMLEGVVQVPNPPSPFSFSL 801
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357482147|ref|XP_003611359.1| Kinase-like protein [Medicago truncatula] gi|355512694|gb|AES94317.1| Kinase-like protein [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 704 bits (1818), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 379/781 (48%), Positives = 501/781 (64%), Gaps = 109/781 (13%)
Query: 23 ANIPLGSTLSSTSNNSSWISPSRDFAFGFRQLNNNSDLFLLAIWFNKMPERTIIWHA--N 80
N+ STLS+T+ NS W+SPS +FAFGF+QL ++LF+LAIW+NK+PE+TI+W A
Sbjct: 23 GNVTRSSTLSTTNKNS-WLSPSGEFAFGFQQLGTATNLFMLAIWYNKIPEKTIVWSAKNT 81
Query: 81 EDNHPVLAPRGSTLELTATGLLLKDPGGQAIWDEKPNKI--------------------- 119
+N+ V AP GS ++LT+ GL L G++IW +PN
Sbjct: 82 NNNNLVQAPTGSQVQLTSGGLTLTTQQGESIWTAQPNTAVSYGIMHDTGNFVLVNKNSSI 141
Query: 120 ---SFKSPTDTILPTQIFDLGSVLVSRLTETNLSKGRFELHF--SNGSLQLIPVAWPTPS 174
SFK PTDT+LP Q +LG + SR +ETN + GRF+L+F + +L L P+AWPT
Sbjct: 142 VWESFKFPTDTLLPNQSLELGGNITSRFSETNYTSGRFQLYFRDDDHNLMLSPLAWPTQL 201
Query: 175 QYKSYYTSNTCSANSS-----ESGINYL---------------------------LFRAT 202
+YK YY + ++ SS ESG Y+ +RAT
Sbjct: 202 RYKFYYRIDVNNSASSSLVFDESGDIYVETNKNGTTRIIPQGTQWKNLDLDPKLYYYRAT 261
Query: 203 LDFDGVFTEYAYPKNSAPNQSWFTIQRLPNNICTSISDEFGSGACGFNSYCLLQNGRPFC 262
LD+ GV T+Y++P+++ Q W ++ +P+NIC +I +E GSG CG+NSYC ++N RP C
Sbjct: 262 LDYYGVLTQYSHPRDTKAKQGWTIMRYVPDNICIAIFNEMGSGTCGYNSYCSMENQRPTC 321
Query: 263 ECPPEYLFVDPTNRFSGCKPNYWQGCGPDDG---SRNAEELYEIRELADVNWPLGYYQK- 318
+CP Y +DP+N+F GC+ N+ GCG ++G + EELYE L DV+WPL Y+K
Sbjct: 322 KCPYGYSLIDPSNQFGGCQLNFTLGCGDNNGEGLNVKPEELYEFTVLRDVDWPLSDYEKM 381
Query: 319 -------------------------------RFPLALGAYDYTRTGFTKALIKVRKGGFR 347
R P+A G ++G L+K R F
Sbjct: 382 QPYSQQDCQQSCLHDCMCAVAVFNNNTCWKKRLPIANGR---AQSGGQLVLVKTRVSPFG 438
Query: 348 VDFDGNTGGK--KGIPILRGALLLGSSVFFNGLLLLAISLLVFVWRKRKDGNKVQRSSIS 405
+ K + PIL+G LL SS FN +LL A+ + + KR VQ +++
Sbjct: 439 PSSTTHDLKKDDRVKPILQG--LLISSTVFNSILLAAVVFMTLLKPKRV----VQAATLV 492
Query: 406 ETNLRFFSLVELNEATNGFEEELGRGSFGIVYKGVLKSASG-NAVAVKKLDKLAQERERE 464
ETNL FS L EAT GF EELGRGSFGIVYKG LK+ S N VAVK+LD+L ++RE+E
Sbjct: 493 ETNLCSFSYDALKEATWGFSEELGRGSFGIVYKGELKAGSTCNVVAVKRLDRLVEDREKE 552
Query: 465 FKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRIS 524
FKTE+ AIG+T HKNLV+L+GFCDEGL+R+LVYEFM NG+LAN+LF +P W+ RV +
Sbjct: 553 FKTELRAIGKTCHKNLVRLVGFCDEGLHRMLVYEFMSNGSLANILFGETKPIWNQRVGFA 612
Query: 525 LEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRG 584
L IARGL+YLHEEC+ PIIHCDIKPQNIL+D+ FTAKISDFGL+KLLL+DQSRT T++RG
Sbjct: 613 LGIARGLVYLHEECDTPIIHCDIKPQNILIDEYFTAKISDFGLAKLLLADQSRTNTMVRG 672
Query: 585 TRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVE-MELGEERSAILTDWAYDCYV 643
TRGYVAPEWFKNVPV+AKVDVYSFG +LL+I+CC++SV ME GEE AILTDWA DCY+
Sbjct: 673 TRGYVAPEWFKNVPVTAKVDVYSFGAMLLEIVCCRKSVVLMESGEEEKAILTDWACDCYM 732
Query: 644 EGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLEVPSPPM 703
EG++D LV+ND+ A+ D R KW+ IA+WCIQE P RP M+M++QMLE ++VP PP
Sbjct: 733 EGRIDALVENDQEALDDIDRLEKWIKIAIWCIQEHPEMRPTMRMVMQMLEDVVKVPDPPS 792
Query: 704 P 704
P
Sbjct: 793 P 793
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356540555|ref|XP_003538753.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RLK1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 690 bits (1781), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 381/786 (48%), Positives = 503/786 (63%), Gaps = 105/786 (13%)
Query: 23 ANIPLGSTLSSTSNNSSWISPSRDFAFGFRQLNNNSDLFLLAIWFNKMPERTIIWHANED 82
NI L STLS T++N +W+SPS +FAFGFRQLN+ ++LF++AIW++K+P +TI+W+A +
Sbjct: 22 GNITLSSTLS-TNDNDAWLSPSGEFAFGFRQLNS-TNLFVVAIWYDKIPAKTIVWNAKAN 79
Query: 83 NHPVLAPRGSTLELTATGLLLKDPGGQAIWDEKP------------------NK------ 118
AP GS ++LT GL L P G++IW +P NK
Sbjct: 80 ETLATAPAGSQVQLTLEGLTLTSPKGESIWKAQPSVPLSYGAMLDTGNFVLVNKNSTFEW 139
Query: 119 ISFKSPTDTILPTQIFDLGSVLVSRLTETNLSKGRFELHFSNGSLQLIPVAWPTPSQYKS 178
SFK+PTDT+LP Q +L L SRL +TN + GRF+L+F NG L L P+AWPT +Y+
Sbjct: 140 ESFKNPTDTLLPNQFLELDGKLTSRLQDTNYTTGRFQLYFQNGVLLLSPLAWPTQLRYRY 199
Query: 179 YYTSNTCSANS----SESGINYL-------------------------LFRATLDFDGVF 209
YY + + S E G Y+ +RATL+F+GVF
Sbjct: 200 YYRIDASHSASRLVFDELGNIYVERVNGTRIRPQGPTWGNSSLDPKEYYYRATLEFNGVF 259
Query: 210 TEYAYPKNSAPNQSWFTIQRLPNNICTSISDEFGSGACGFNSYCLLQNGRPFCECPPEYL 269
T+YA+P+ + Q W ++ +P NICT+I +E+GSG+CG+NSYC ++N RP C+CP Y
Sbjct: 260 TQYAHPRTNNAYQGWTIMRYVPGNICTAIFNEYGSGSCGYNSYCSMENDRPTCKCPYGYS 319
Query: 270 FVDPTNRFSGCKPNYWQGCGPDDGSRNAEELYEIRELADVNWPLGYYQK----------- 318
VDP+N F GC+PN+ CG D ++ EELYE+ E D N+PLG Y+K
Sbjct: 320 MVDPSNEFGGCQPNFTLACGVDVKAQ-PEELYEMHEFRDFNFPLGDYEKKQPYSQQECRQ 378
Query: 319 ---------------------RFPLALGAYDYTR-TGFTKALIKVRKG----GFRVDFDG 352
R PL+ G + F +VR+ G +
Sbjct: 379 SCLHDCICAMAVLGGNTCWMKRLPLSNGRVIHVNDQHFVYIKTRVRRDFYDPGANEELPP 438
Query: 353 NTGGKK---GIPILRGALLLGSSVFFN-GLLLLAISLLVFVWRKRKDGNKVQR-SSISET 407
KK PIL G+L+ GS VF + +LL A+S F+ K K V S+ ET
Sbjct: 439 GADSKKEDGAKPILLGSLI-GSLVFISISMLLCAVSW--FILLKPKLTRLVPAIPSLLET 495
Query: 408 NLRFFSLVELNEATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKT 467
NL F+ L +AT GF EE+GRGSFGIVYKG L++AS N +AVK+LD+LAQERE+EF+
Sbjct: 496 NLHSFTYETLEKATRGFCEEIGRGSFGIVYKGQLEAASCNVIAVKRLDRLAQEREKEFRA 555
Query: 468 EVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEFMGNGTLANLLFAIPR-PDWSLRVRISLE 526
E+SAIG+T HKNLV+L+GFCDEG+NRLLVYEFM NGTLA++LF + P W+ RV ++L
Sbjct: 556 ELSAIGKTCHKNLVRLIGFCDEGINRLLVYEFMSNGTLADILFGQSKAPIWNTRVGLALG 615
Query: 527 IARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTR 586
IARGLLYLHEEC+ IIHCDIKPQNIL+D+ F AKISDFGL+KLLL DQ+RT T+IRGTR
Sbjct: 616 IARGLLYLHEECDSAIIHCDIKPQNILIDEHFNAKISDFGLAKLLLFDQTRTNTMIRGTR 675
Query: 587 GYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSV-EMELGEERSAILTDWAYDCYVEG 645
GYVAPEWFKN+ V+ KVDVYSFGV+LL+IICC+R+V ME EE ILTDWAYDCY+EG
Sbjct: 676 GYVAPEWFKNIAVTVKVDVYSFGVMLLEIICCRRNVLTMEAEEEEKVILTDWAYDCYIEG 735
Query: 646 K-LDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLEVPSPPMP 704
+ +D LV+ND+ A++D R KW+ IA WCI E+P RP M M++ MLEG++EVP+PP P
Sbjct: 736 RNIDALVENDEEALSDNGRLEKWIKIAFWCINENPEVRPTMGMVMLMLEGFVEVPNPPPP 795
Query: 705 -PLHSL 709
+HS+
Sbjct: 796 FSMHSI 801
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356495583|ref|XP_003516654.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RLK1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 662 bits (1707), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 374/808 (46%), Positives = 500/808 (61%), Gaps = 114/808 (14%)
Query: 1 MDSLALSCLILLSLPLLPF-LSAANIPLGSTLSSTSNNSSWISPSRDFAFGFRQLNNN-S 58
M +L L+ LI+ + + L+ A + L S L T + +W+SPS +FAFGFRQLN+N +
Sbjct: 1 MAALNLNLLIVTLIYIHHVSLAFAKVTLNSPLF-TDTDDAWLSPSGEFAFGFRQLNDNDT 59
Query: 59 DLFLLAIWFNKMPE-RTIIWHANEDNHPVLAPRGSTLELTATGLLLKDPGGQAIWDEKPN 117
LF++AIW+N +P+ +T++W A +DN AP GS L++T GL L +P G IW
Sbjct: 60 KLFMVAIWYNMIPDDQTVVWSARKDNKLATAPAGSKLQITQEGLSLTNPKGDFIWTASSK 119
Query: 118 KI------------------------SFKSPTDTILPTQIFDLGSVLVSRLTETNLSKGR 153
SF+ PTDT+LP Q LG +L SRLT+TN + GR
Sbjct: 120 DFVSEGAMLDSGNFVLLNGSSANVWQSFEHPTDTLLPNQSLQLGGMLTSRLTDTNYTTGR 179
Query: 154 FELHFSNGSLQLIPVAWPTPSQYKSYYTSNTCSANSSE-----SGINYL----------- 197
F+L+F G+L L P+AWP+ +YKSY + S N+S SG Y+
Sbjct: 180 FQLYFDGGNLLLSPLAWPSQLRYKSYPVIDA-SGNASRLLFNISGDIYVETTNGNRIQPQ 238
Query: 198 -------------------LFRATLDFDGVFTEYAYPKNSAPNQSWFTIQRLPNNICTSI 238
+RATLD GVFT+YA+P+N+ Q W ++ +P++IC I
Sbjct: 239 GQKWVSNSSSSLDLNPEMNFYRATLDPSGVFTQYAHPRNNTARQGWIIMRYVPDDICNII 298
Query: 239 SDEFGSGACGFNSYCLLQNGRPFCECPPEYLFVDPTNRFSGCKPNYWQGCGPDDGSRNAE 298
D FGSG+CG+NSYC ++N RP C C Y VDP+N+F GC+PN+ CG D + E
Sbjct: 299 FDRFGSGSCGYNSYCDMENERPTCNCLDGYSLVDPSNQFGGCQPNFTLACGADVQAP-PE 357
Query: 299 ELYEIRELADVNWPLGYYQK--------------------------------RFPLALG- 325
+LY + + + N+P Y+K R PL+ G
Sbjct: 358 QLYHMLQSSRYNFPEADYEKIQPYTQQECLQFCLHDCMCAVAIFGLDTCWMKRLPLSNGR 417
Query: 326 AYDYTRTGFTKALIKVRKGGF---------RVDFDGNTGGKKGIPILRGALLLGSSVFFN 376
D F I+ + + D + G K PIL G+L+ S+ N
Sbjct: 418 VTDVNDHHFVYIKIRNSRDFYPGVNEELPPGADSNKEDGAK---PILMGSLI--GSLVVN 472
Query: 377 GLLLLAISLLVFVWRKRKDGNKVQRSSISETNLRFFSLVELNEATNGFEEELGRGSFGIV 436
G+LL ++LLV + K K V +S+ ETNL FS L EAT GF EELGRGS GIV
Sbjct: 473 GILLATVALLVLLKPKLKVAVPVAAASLLETNLHSFSYEALKEATWGFSEELGRGSCGIV 532
Query: 437 YKGVLKSA-SGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLL 495
YKG L++ S N +AVK+LD+LAQERE+EF+TE+SAIG+T HKNLV+L+GFCD+G+NRLL
Sbjct: 533 YKGKLEAEDSCNVIAVKRLDRLAQEREKEFRTELSAIGKTSHKNLVRLIGFCDQGINRLL 592
Query: 496 VYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLD 555
VYEFM NGTLA++LF +P+W+ RV +L IARGL+YLHEEC+ PIIHCDIKPQNIL+D
Sbjct: 593 VYEFMSNGTLADILFGHSKPNWNTRVGFALGIARGLVYLHEECDTPIIHCDIKPQNILID 652
Query: 556 QDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKI 615
+ F KISDFGL+KLLLSDQSRT T+IRGTRGYVAPEWFKNV V+ KVDVYSFG++LL+I
Sbjct: 653 EHFNTKISDFGLAKLLLSDQSRTNTMIRGTRGYVAPEWFKNVAVTVKVDVYSFGIMLLEI 712
Query: 616 ICCKRSVEMEL-GEERSAILTDWAYDCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWC 674
ICC+RSV ME GEE A+L DWA DCY+EG++D LV+N++ A++DK R KW+ IA+WC
Sbjct: 713 ICCRRSVVMEEPGEEEKAVLADWACDCYMEGRIDALVENEEEALSDKERLQKWIKIAIWC 772
Query: 675 IQEDPLKRPAMKMIVQMLEGYLEVPSPP 702
I E+P RP + M+VQMLEG+++V +PP
Sbjct: 773 IHENPEMRPTIGMVVQMLEGFVQVSNPP 800
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356495581|ref|XP_003516653.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RLK1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 656 bits (1693), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 369/788 (46%), Positives = 487/788 (61%), Gaps = 111/788 (14%)
Query: 20 LSAANIPLGSTLSSTSNNSSWISPSRDFAFGFRQLNN-NSDLFLLAIWFNKMPERTIIWH 78
L AN+ L S LS T N +W SPS +FAFGFRQL+N + LF++AIW++K+P++T++W
Sbjct: 18 LVFANVNLDSRLS-TDGNDAWRSPSGEFAFGFRQLSNFGTKLFMVAIWYDKIPDKTVVWS 76
Query: 79 ANEDNHPVLAPRGSTLELTATGLLLKDPGGQAIWDEKPNKI------------------- 119
A + AP GS +++T GL L P G +IW KP
Sbjct: 77 AKTEYKLATAPTGSHVQITKEGLSLTSPEGDSIWRAKPEATVSEGAMLNNGNFVLLNGGS 136
Query: 120 -------SFKSPTDTILPTQIFDLG--SVLVSRLTETNLSKGRFELHFSNGSLQLIPVAW 170
SF +PTDT+LP Q LG VL SR T+TN + GRF+L+F + ++ L P+A+
Sbjct: 137 EYENMWQSFDNPTDTLLPNQSLQLGLGGVLTSRFTDTNYTTGRFQLYFQDFNVMLSPLAF 196
Query: 171 PTPSQYKSYYTS-NTCSA-------------------------------NSSESGINYLL 198
P+ +Y YY + N S N+ ++ +NY
Sbjct: 197 PSQLRYNPYYHAINDASVGNASRLVFDKSGEIYVETTGGTRNRILPQVDNTLDTEVNY-- 254
Query: 199 FRATLDFDGVFTEYAYPKNSAPNQSWFTIQRLPNNICTSISDEFGSGACGFNSYCLLQNG 258
+RATLDF GVFT YA+P+N++ W + +P+NIC +I +++GSG+CG+NSYC ++N
Sbjct: 255 YRATLDFSGVFTLYAHPRNTSGQPRWRIMNYVPDNICDAIFNDYGSGSCGYNSYCSMEND 314
Query: 259 RPFCECPPEYLFVDPTNRFSGCKPNYWQGCGPDDGSRNAEELYEIRELADVNWPLGYYQK 318
RP C CP Y VDP+N GC+PN+ CG D + EELYE+ + N+PLG Y+K
Sbjct: 315 RPTCNCPYGYSLVDPSNESGGCQPNFTLACGAD-VQQPPEELYEMHVAKNFNFPLGDYEK 373
Query: 319 RFP--------------LALGAYDYTRTGFTKAL-------IKVRKGGF-----RVDFDG 352
P + A T + K L + +R F R+ D
Sbjct: 374 VEPYSQQECQQACLHDCMCAVAILEVDTCWMKRLPLGNGRQLPIRDQHFVYIKTRLSPDF 433
Query: 353 NTG-GKKGIP-------------ILRGALLLGSSVFFNGLLLLAISLLVFVWRKRKDGNK 398
G + +P I+ G+L+ +S+ N +LL A++L F K K
Sbjct: 434 YPGLANRELPAAPDSKKENRAKSIILGSLI--ASLVVNSILLAAVAL--FFLLKPKLKKV 489
Query: 399 VQRSSISETNLRFFSLVELNEATNGFEEELGRGSFGIVYKGVLKSA-SGNAVAVKKLDKL 457
+Q S++ ETNL FS L EAT F +ELGRGS GIVYKG L++A S N +AVK+LD+L
Sbjct: 490 IQASALLETNLHSFSFEALKEATEDFCKELGRGSCGIVYKGKLETADSCNVIAVKRLDRL 549
Query: 458 AQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDW 517
AQERE+EF+TE+SAIG+T HKNLV+L+GFCD+G+NRLLVYEFM NGTLA++LF +P W
Sbjct: 550 AQEREKEFRTELSAIGKTSHKNLVRLIGFCDQGINRLLVYEFMSNGTLADILFGHSKPIW 609
Query: 518 SLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSR 577
+LRV L IARGL+YLHEEC+ IIHCDIKPQNIL+D+ F AKISDFGL+KLLL DQSR
Sbjct: 610 NLRVGFVLGIARGLVYLHEECDSAIIHCDIKPQNILIDEHFNAKISDFGLAKLLLFDQSR 669
Query: 578 TRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSV-EMELGEERSAILTD 636
T T+IRGTRGYVAPEWFKNV V+ KVDVYSFGV+LL+ ICC+RSV ME EE AILTD
Sbjct: 670 TNTMIRGTRGYVAPEWFKNVAVTVKVDVYSFGVMLLENICCRRSVMTMEPEEEEKAILTD 729
Query: 637 WAYDCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYL 696
WAYDC VEG+L LV+ND+ A++D R +W+ IA+WCIQEDP RP M + QMLEG +
Sbjct: 730 WAYDCCVEGRLHALVENDREALSDIGRLQRWVKIAIWCIQEDPEMRPTMGKVNQMLEGLV 789
Query: 697 EVPSPPMP 704
EV +PP P
Sbjct: 790 EVANPPSP 797
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224099309|ref|XP_002334494.1| predicted protein [Populus trichocarpa] gi|222872794|gb|EEF09925.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 649 bits (1675), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 363/786 (46%), Positives = 477/786 (60%), Gaps = 104/786 (13%)
Query: 4 LALSCLILLSLPLLPFLSAANIPLGSTLSSTSNNSSWISPSRDFAFGFRQLNNNSDLFLL 63
L+ S LI+L P + NI +G++LS TS N+SW+SPS DFAFGF L N LFLL
Sbjct: 8 LSFSLLIMLP-PFAVSQTGGNITVGASLS-TSENTSWLSPSGDFAFGFHPLYGNKYLFLL 65
Query: 64 AIWFNKMPERTIIWHANEDNHPVLAPRGSTLELTAT-GLLLKDPGGQAIW---------- 112
AIW++K+PE+TI+W+AN D AP GS LTA G+ L DP G+ +W
Sbjct: 66 AIWYDKIPEKTIVWYANGDKP---APTGSKAVLTANRGISLTDPQGRELWRSETIIGVVA 122
Query: 113 -------------DEKPNKI--SFKSPTDTILPTQIFDLGSVLVSRLTETNLSKGRFELH 157
D +K+ SFK+P DT+LP+Q+ D G L SR +E N S GRF+L
Sbjct: 123 YGAMTDKGNFVLQDRVSDKLWESFKNPADTLLPSQVLDRGMTLSSRQSENNFSMGRFQLK 182
Query: 158 FSN-GSLQLIPVAWPTPSQYKSYYTSNTCSANSS----------ESGINYLLF------- 199
++ G+L+L + P+ + YY S T S ESG Y+L
Sbjct: 183 LTDDGNLELATINLPSDYTNEPYYKSGTDGGLDSSSPGYQVVFNESGYLYILRENDQIFS 242
Query: 200 --------------RATLDFDGVFTEYAYPKNSAPNQSWFTIQRLPNNICTSISDEFGSG 245
RATL+FDG+FT+Y +PK S N+ W I P+NIC + GSG
Sbjct: 243 LTQRVTASTGDFYRRATLNFDGLFTQYYHPKASTGNERWTPIWSQPDNICQASFVSSGSG 302
Query: 246 ACGFNSYCLLQNGR-PFCECPPEYLFVDPTNRFSGCKPNYWQGCGPDDGSRNAEELYEIR 304
CGFNS C L + R P CECP Y +DP++++ C+PNY Q C D+ + E+LY+
Sbjct: 303 TCGFNSVCRLNSDRRPICECPGGYSLLDPSDQYGSCRPNYTQSCEEDEVA-PVEDLYDFE 361
Query: 305 ELADVNWPLGYY---------------------------------QKRFPLALGAYDYTR 331
EL + +WP Y +K+ PL+ G
Sbjct: 362 ELTNTDWPTSDYALLKPFTEEKCRQSCLNDCMCAVAIFRSGDMCWKKKLPLSNGRVQTNL 421
Query: 332 TGFTKALIKVRKGGFRVD---FDGNTGGKKGIPILRGALLLGSSVFFNGLLLLAISLLVF 388
G KAL+KVR+ F N + G+ IL G++ LG SVF N LL+ AI + F
Sbjct: 422 DG--KALLKVRRSNVNPRSPYFPNNKKDRDGL-ILVGSVFLGCSVFVNFLLVCAIFMCFF 478
Query: 389 VWRKRKDGNKVQRSSISETNLRFFSLVELNEATNGFEEELGRGSFGIVYKGVLKSASGNA 448
+R+ Q+ ETNLR F+ EL EAT GF+EELGRG+FG+VYKGV+ S
Sbjct: 479 FIYRRRTKRIPQKDGAVETNLRCFTYQELAEATEGFKEELGRGAFGVVYKGVVHIGSSIV 538
Query: 449 VAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEFMGNGTLANL 508
VAVKKL+ +A++R REFKTEV+ IG+THHKNLV+LLGFC+EG RLLVYEFM NG+L++
Sbjct: 539 VAVKKLNNVAEDRVREFKTEVNVIGQTHHKNLVRLLGFCEEGDQRLLVYEFMSNGSLSSF 598
Query: 509 LFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLS 568
+F +P W +R++I+ +ARGLLYLHEEC+ IIHCDIKPQNILLD+ + A+ISDFGL+
Sbjct: 599 IFQDAKPGWKIRIQIAFGVARGLLYLHEECSNQIIHCDIKPQNILLDEYYNARISDFGLA 658
Query: 569 KLLLSDQSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGE 628
KLLL DQS+T T IRGT+GYVAPEWF+N+PV+ KVDVYS+GV+LL+IICC+R+V+ +
Sbjct: 659 KLLLLDQSQTHTAIRGTKGYVAPEWFRNLPVTVKVDVYSYGVLLLEIICCRRNVDSKATI 718
Query: 629 ERSAILTDWAYDCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMI 688
E AILTDWAYDCY EG LD LV +D A+ D + ++LMIA WCIQEDP RP M+ +
Sbjct: 719 EEQAILTDWAYDCYREGTLDALVGSDTGALDDIEKLERFLMIAFWCIQEDPSLRPTMRKV 778
Query: 689 VQMLEG 694
QMLEG
Sbjct: 779 TQMLEG 784
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359487487|ref|XP_002269067.2| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RLK1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 645 bits (1665), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 383/804 (47%), Positives = 490/804 (60%), Gaps = 122/804 (15%)
Query: 9 LILLSLPLLP-FLSAAN--IPLGSTLSSTSNNSSWISPSRDFAFGFRQLNNNSDLFLLAI 65
L+L LP P S AN I LGS+L ++ N+SSW SPS +FAFGF QL N +LFLLAI
Sbjct: 12 LLLFVLPSWPSVFSQANPEIRLGSSLIASDNSSSWRSPSGEFAFGFHQLGNQ-NLFLLAI 70
Query: 66 WFNKMPERTIIWHANEDNHPVLAPRGSTLELTATG-LLLKDPGGQAIW------------ 112
WF+K+PE+T+ W+AN DN AP GS +ELT+ G L+L DP G IW
Sbjct: 71 WFDKIPEKTLAWYANGDNP---APEGSKVELTSDGQLILNDPKGDEIWRPQTTLNGVTHA 127
Query: 113 -------------DEKPNKI--SFKSPTDTILPTQIFDLGSVLVSRLTETNLSKGRFELH 157
D+ + SFK+P DT+LPTQ+ ++G + SR E+N SKGRF+L
Sbjct: 128 YMLDAGNFALVNGDQNSTHVWESFKNPVDTVLPTQVLEIGGTVSSRQAESNYSKGRFQLR 187
Query: 158 F-SNGSLQLIPVAWPTPSQYKSYYTSNTCSA----NSSE---------------SGINYL 197
+G+L L T + Y +YY S T A NS E SG N
Sbjct: 188 LLPDGNLVLNTFDLQTNTAYDAYYWSKTYDAANRSNSGERVIFDELGHLYVVLQSGDNVT 247
Query: 198 L------------FRATLDFDGVFTEYAYPKNSAPNQSWFTIQRLPNNICTSISDEFGSG 245
L +RATLDFDGVF Y PK + N SW +P +IC+ I + G G
Sbjct: 248 LKSGSAESTGGYYYRATLDFDGVFRIYTRPKLQS-NGSWVPFWYVPKDICSEIGGDLGGG 306
Query: 246 ACGFNSYCLLQN-GRPFCECPPEYLFVDPTNRFSGCKPNYWQGCGPDDGSRNAEELYEIR 304
+CGFNSYC+ + GRP CEC P + DP N+ +GCK N Q C + G N E+LY+ R
Sbjct: 307 SCGFNSYCVPDSSGRPACECLPGFFPADPHNKLNGCKHNLTQKC--EAGGSNMEDLYQKR 364
Query: 305 ELADVNWPLGY---------------------------------YQKRFPLALGAYDYTR 331
E++++ WP +K+ PL+ G D++
Sbjct: 365 EVSNLFWPSSANFEKKESLSEDLCWTSCLYDCNCVVAVHKEGTCRKKKMPLSNGRVDWST 424
Query: 332 TGFTKALIKVRKGGFRVD-FDGNT---------GGKKGIPILRGALLLGSSVFFNGLLLL 381
G K L+KV R D F G T ++G IL G++LLGSSVF N LL+
Sbjct: 425 RG--KTLVKVP----RYDAFSGETPFRDPIREKKKEQGTFILVGSILLGSSVFLNFLLVA 478
Query: 382 AISLLVFVWRKRKDGNKVQRSSISETNLRFFSLVELNEATNGFEEELGRGSFGIVYKGVL 441
AISL V + +K + SSI ETN+R F+ EL +A +GF EELGRG+FG VYKGVL
Sbjct: 479 AISL-VRSYPSQKRRELTRASSILETNIRSFTYEELKQAADGFREELGRGAFGTVYKGVL 537
Query: 442 KSAS-GNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEFM 500
S+S G VAVKKLDKL QE EREFKTEV I THHKNLV+L+GFCDEG ++LLVYEFM
Sbjct: 538 SSSSSGTQVAVKKLDKLVQEGEREFKTEVRTIAMTHHKNLVRLIGFCDEGPHKLLVYEFM 597
Query: 501 GNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTA 560
NGTLA+ LF PDW +R +++ +ARGL+YLHEEC+ IIHCDIKPQN+LLD FTA
Sbjct: 598 CNGTLASFLFGSSAPDWKIRTQMAFGVARGLMYLHEECSTQIIHCDIKPQNVLLDDSFTA 657
Query: 561 KISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKR 620
+ISDFGL+KLL+SDQ+RT T IRGT+GYVAPEWF++ P++AKVDVYS+GV+LL+II C++
Sbjct: 658 RISDFGLAKLLMSDQTRTLTAIRGTKGYVAPEWFRSKPITAKVDVYSYGVMLLEIISCRK 717
Query: 621 SVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPL 680
++ + E AILTDWAYDCY +LD LV+ND A D R K +M+A+WCIQEDP
Sbjct: 718 CIDFQTENEEEAILTDWAYDCYRGHRLDKLVENDDDARNDMRRLEKLVMVAIWCIQEDPS 777
Query: 681 KRPAMKMIVQMLEGYLEVPSPPMP 704
RP+M+ + QMLEG +EVP PP P
Sbjct: 778 LRPSMRNVTQMLEGVVEVPMPPCP 801
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224103119|ref|XP_002334088.1| predicted protein [Populus trichocarpa] gi|222839594|gb|EEE77931.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 640 bits (1650), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 360/796 (45%), Positives = 483/796 (60%), Gaps = 106/796 (13%)
Query: 4 LALSCLILLSLPLLPFLSAANIPLGSTLSSTSNNSSWISPSRDFAFGFRQLNNNSDLFLL 63
L+ S LI+L P + NI +G++LS TS+N+SW+SPS DFAFGF QL N DLFLL
Sbjct: 8 LSFSLLIMLP-PFAVSQTGGNITVGASLS-TSDNTSWLSPSGDFAFGFYQLYGNKDLFLL 65
Query: 64 AIWFNKMPERTIIWHANEDNHPVLAPRGSTLELTAT-GLLLKDPGGQAIW---------- 112
AIW++K+P++TI+W+AN D AP GS LTA G+ L DP G+ +W
Sbjct: 66 AIWYDKIPDKTIVWYANGDKP---APTGSKAVLTANRGISLTDPQGRELWRSETIIGDVA 122
Query: 113 -------------DEKPNKI--SFKSPTDTILPTQIFDLGSVLVSRLTETNLSKGRFELH 157
D +K+ SFK+P DT+LP+Q+ D G L SR +ETN S GRF+L
Sbjct: 123 YGAMTDTGNFVLRDRVSDKLWESFKNPADTLLPSQVLDRGMTLSSRQSETNFSMGRFQLK 182
Query: 158 F-SNGSLQLIPVAWPTPSQYKSYYTSNTCSANSS----------ESGINYLL-------- 198
+G+L L + P+ + YY S T S ESG Y+L
Sbjct: 183 LRDDGNLVLATINLPSDYTNEPYYKSGTDGGLDSSSPGYQVVFNESGYLYILRKNDQIFS 242
Query: 199 -------------FRATLDFDGVFTEYAYPKNSAPNQSWFTIQRLPNNICTSISDEFGSG 245
RATL+FDGVFT+Y +PK S N+ W I P+NIC + S GSG
Sbjct: 243 LTQRVTASTGDFYHRATLNFDGVFTQYYHPKASTGNERWTPIWSQPDNICQASSVSAGSG 302
Query: 246 ACGFNSYCLLQ-NGRPFCECPPEYLFVDPTNRFSGCKPNYWQGCGPDDGSRNAEELYEIR 304
CGFNS C L +GRP CECP Y +DP++++ C+PNY Q C D+ + E+LY+
Sbjct: 303 TCGFNSVCRLNSDGRPICECPGGYSLLDPSDQYGSCRPNYTQSCEEDEVAP-VEDLYDFE 361
Query: 305 ELADVNWPLGYY---------------------------------QKRFPLALGAYDYTR 331
EL + +WP Y +K+ PL+ G
Sbjct: 362 ELTNTDWPTSDYALLQPFTEEKCRQSCLNDCMCAVAIFRSGDMCWKKKLPLSNGRVQTIV 421
Query: 332 TGFTKALIKVRKGGFRVD---FDGNTGGKKGIPILRGALLLGSSVFFNGLLLLAISLLVF 388
KAL+KVR+ F N + G+ IL G++ LG SVF N LL+ AI + F
Sbjct: 422 DA--KALLKVRRSNVNPRSPYFPNNKKDRDGL-ILVGSVFLGCSVFVNFLLVCAICMGFF 478
Query: 389 VWRKRKDGNKVQRSSISETNLRFFSLVELNEATNGFEEELGRGSFGIVYKGVLKSASGNA 448
+R+ Q+ ETNLR F+ EL EAT GF+EELGRG+FG+VY+GV+ S
Sbjct: 479 FIYRRRTKRIPQKDGAVETNLRCFTYQELAEATEGFKEELGRGAFGVVYRGVVHIGSSIV 538
Query: 449 VAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEFMGNGTLANL 508
VAVKKL+ +A++R REFKTEV+ IG+THHKNLV+LLGFC+EG RLLVYEFM NG+L++
Sbjct: 539 VAVKKLNNVAEDRVREFKTEVNVIGQTHHKNLVRLLGFCEEGDQRLLVYEFMSNGSLSSF 598
Query: 509 LFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLS 568
+F +P W +R++I+ +ARGLLYLHE+ IIHCDIKPQNILLD+ A+ISDFGL+
Sbjct: 599 IFQDAKPGWKIRIQIAFGVARGLLYLHEDSQ--IIHCDIKPQNILLDESLNARISDFGLA 656
Query: 569 KLLLSDQSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGE 628
KLL +DQ++T T IRGT+GYVAPEWFKN+PV+ KVD YSFG++LL+++CC+++ E+ +
Sbjct: 657 KLLKTDQTKTTTAIRGTKGYVAPEWFKNLPVTTKVDTYSFGILLLELVCCRKNFEINAMQ 716
Query: 629 ERSAILTDWAYDCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMI 688
E +L DWA DC EGKL++LV+ D+ AM D R +++M+A+WCIQEDP RP MK +
Sbjct: 717 EHQIVLADWACDCLKEGKLNLLVEEDEEAMEDMKRVERFVMVAIWCIQEDPSLRPGMKKV 776
Query: 689 VQMLEGYLEVPSPPMP 704
VQMLEG ++V PP P
Sbjct: 777 VQMLEGGVQVSVPPDP 792
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 714 | ||||||
| TAIR|locus:2059103 | 828 | AT2G19130 [Arabidopsis thalian | 0.460 | 0.397 | 0.428 | 7.1e-78 | |
| TAIR|locus:2116525 | 821 | SD2-5 "S-domain-2 5" [Arabidop | 0.401 | 0.349 | 0.466 | 1.4e-76 | |
| TAIR|locus:2026155 | 829 | AT1G34300 [Arabidopsis thalian | 0.404 | 0.348 | 0.451 | 1.8e-76 | |
| TAIR|locus:2182603 | 872 | AT5G35370 [Arabidopsis thalian | 0.291 | 0.238 | 0.485 | 7.1e-64 | |
| TAIR|locus:2197649 | 821 | AT1G61360 [Arabidopsis thalian | 0.413 | 0.359 | 0.375 | 1.5e-61 | |
| TAIR|locus:2137010 | 849 | AT4G11900 [Arabidopsis thalian | 0.408 | 0.343 | 0.383 | 1.7e-61 | |
| TAIR|locus:2141176 | 849 | B120 [Arabidopsis thaliana (ta | 0.424 | 0.356 | 0.399 | 2.5e-61 | |
| TAIR|locus:2125766 | 654 | CRK40 "cysteine-rich RLK (RECE | 0.474 | 0.518 | 0.396 | 4.2e-61 | |
| TAIR|locus:2131684 | 783 | AT4G27290 [Arabidopsis thalian | 0.673 | 0.614 | 0.310 | 4.8e-60 | |
| TAIR|locus:2197734 | 814 | AT1G61370 [Arabidopsis thalian | 0.432 | 0.379 | 0.373 | 1.2e-58 |
| TAIR|locus:2059103 AT2G19130 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 674 (242.3 bits), Expect = 7.1e-78, Sum P(3) = 7.1e-78
Identities = 149/348 (42%), Positives = 206/348 (59%)
Query: 367 LLLGSSVFFNGXXXXXXXXXVFVWRKRKDGNKVQRSSISETNLRFFSLVELNEATNGFEE 426
L+ G+ + G + + R R+ K R + L FS EL AT F +
Sbjct: 440 LIFGAVLGSLGVIVLVLLVVILILRYRR--RKRMRGEKGDGTLSAFSYRELQNATKNFSD 497
Query: 427 ELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGF 486
+LG G FG V+KG L +S +AVK+L+ ++Q E++F+TEV IG H NLV+L GF
Sbjct: 498 KLGGGGFGSVFKGALPDSSD--IAVKRLEGISQG-EKQFRTEVVTIGTIQHVNLVRLRGF 554
Query: 487 CDEGLNRLLVYEFMGNGTLANLLFAIPRPD-----WSLRVRISLEIARGLLYLHEECNVP 541
C EG +LLVY++M NG+L + LF + W LR +I+L ARGL YLH+EC
Sbjct: 555 CSEGSKKLLVYDYMPNGSLDSHLFLNQVEEKIVLGWKLRFQIALGTARGLAYLHDECRDC 614
Query: 542 IIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPVSA 601
IIHCDIKP+NILLD F K++DFGL+KL+ D SR T +RGTRGY+APEW V ++A
Sbjct: 615 IIHCDIKPENILLDSQFCPKVADFGLAKLVGRDFSRVLTTMRGTRGYLAPEWISGVAITA 674
Query: 602 KVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYV-EGKLDVLVD----NDKA 656
K DVYS+G++L +++ +R+ E E+ WA +G + LVD D
Sbjct: 675 KADVYSYGMMLFELVSGRRNTEQS-ENEKVRFFPSWAATILTKDGDIRSLVDPRLEGDAV 733
Query: 657 AMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLEVPSPPMP 704
+ + +RACK +A WCIQ++ RPAM +VQ+LEG LEV PP P
Sbjct: 734 DIEEVTRACK---VACWCIQDEESHRPAMSQVVQILEGVLEVNPPPFP 778
|
|
| TAIR|locus:2116525 SD2-5 "S-domain-2 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 659 (237.0 bits), Expect = 1.4e-76, Sum P(2) = 1.4e-76
Identities = 138/296 (46%), Positives = 186/296 (62%)
Query: 412 FSLVELNEATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSA 471
F+ +L ATN F +LG+G FG VY+G L G+ +AVKKL+ + Q + +EF+ EVS
Sbjct: 483 FAYKDLQSATNNFSVKLGQGGFGSVYEGTLPD--GSRLAVKKLEGIGQGK-KEFRAEVSI 539
Query: 472 IGRTHHKNLVQLLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPD----WSLRVRISLEI 527
IG HH +LV+L GFC EG +RLL YEF+ G+L +F D W R I+L
Sbjct: 540 IGSIHHLHLVRLRGFCAEGAHRLLAYEFLSKGSLERWIFRKKDGDVLLDWDTRFNIALGT 599
Query: 528 ARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRG 587
A+GL YLHE+C+ I+HCDIKP+NILLD +F AK+SDFGL+KL+ +QS T +RGTRG
Sbjct: 600 AKGLAYLHEDCDARIVHCDIKPENILLDDNFNAKVSDFGLAKLMTREQSHVFTTMRGTRG 659
Query: 588 YVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKL 647
Y+APEW N +S K DVYS+G+VLL++I +++ + E+ +A+ EGKL
Sbjct: 660 YLAPEWITNYAISEKSDVYSYGMVLLELIGGRKNYDPSETSEKCHF-PSFAFKKMEEGKL 718
Query: 648 DVLVDND-KAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLEVPSPP 702
+VD K R + + ALWCIQED RP+M +VQMLEG V PP
Sbjct: 719 MDIVDGKMKNVDVTDERVQRAMKTALWCIQEDMQTRPSMSKVVQMLEGVFPVVQPP 774
|
|
| TAIR|locus:2026155 AT1G34300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 682 (245.1 bits), Expect = 1.8e-76, Sum P(2) = 1.8e-76
Identities = 135/299 (45%), Positives = 193/299 (64%)
Query: 412 FSLVELNEATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSA 471
F+ EL T F+E+LG G FG VY+GVL + + VAVK+L+ + Q E++F+ EV+
Sbjct: 474 FTYKELQRCTKSFKEKLGAGGFGTVYRGVLTNRT--VVAVKQLEGIEQG-EKQFRMEVAT 530
Query: 472 IGRTHHKNLVQLLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPD---WSLRVRISLEIA 528
I THH NLV+L+GFC +G +RLLVYEFM NG+L N LF W R I+L A
Sbjct: 531 ISSTHHLNLVRLIGFCSQGRHRLLVYEFMRNGSLDNFLFTTDSAKFLTWEYRFNIALGTA 590
Query: 529 RGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSR-TRTVIRGTRG 587
+G+ YLHEEC I+HCDIKP+NIL+D +F AK+SDFGL+KLL +R + +RGTRG
Sbjct: 591 KGITYLHEECRDCIVHCDIKPENILVDDNFAAKVSDFGLAKLLNPKDNRYNMSSVRGTRG 650
Query: 588 YVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKL 647
Y+APEW N+P+++K DVYS+G+VLL+++ KR+ ++ + WAY+ + +G
Sbjct: 651 YLAPEWLANLPITSKSDVYSYGMVLLELVSGKRNFDVSEKTNHKKF-SIWAYEEFEKGNT 709
Query: 648 DVLVDN--DKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLEVPSPPMP 704
++D + D + + + + WCIQE PL+RP M +VQMLEG E+ +P P
Sbjct: 710 KAILDTRLSEDQTVDMEQVMRMVKTSFWCIQEQPLQRPTMGKVVQMLEGITEIKNPLCP 768
|
|
| TAIR|locus:2182603 AT5G35370 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 512 (185.3 bits), Expect = 7.1e-64, Sum P(3) = 7.1e-64
Identities = 103/212 (48%), Positives = 136/212 (64%)
Query: 412 FSLVELNEATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSA 471
F EL +AT F+ ++G G FG VYKG L + +AVKK+ +EF TE++
Sbjct: 505 FEFEELEQATENFKMQIGSGGFGSVYKGTLPDET--LIAVKKITNHGLHGRQEFCTEIAI 562
Query: 472 IGRTHHKNLVQLLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRP--DWSLRVRISLEIAR 529
IG H NLV+L GFC G LLVYE+M +G+L LF+ P +W R I+L AR
Sbjct: 563 IGNIRHTNLVKLRGFCARGRQLLLVYEYMNHGSLEKTLFSGNGPVLEWQERFDIALGTAR 622
Query: 530 GLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYV 589
GL YLH C+ IIHCD+KP+NILL F KISDFGLSKLL ++S T +RGTRGY+
Sbjct: 623 GLAYLHSGCDQKIIHCDVKPENILLHDHFQPKISDFGLSKLLNQEESSLFTTMRGTRGYL 682
Query: 590 APEWFKNVPVSAKVDVYSFGVVLLKIICCKRS 621
APEW N +S K DVYS+G+VLL+++ +++
Sbjct: 683 APEWITNAAISEKADVYSYGMVLLELVSGRKN 714
|
|
| TAIR|locus:2197649 AT1G61360 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 510 (184.6 bits), Expect = 1.5e-61, Sum P(3) = 1.5e-61
Identities = 115/306 (37%), Positives = 177/306 (57%)
Query: 407 TNLRFFSLVELNEATNGFE--EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQERERE 464
+ L FF + +L ATN F +LG+G FG VYKG L+ G +AVK+L + + E
Sbjct: 481 SGLNFFEIHDLQTATNNFSVLNKLGQGGFGTVYKGKLQD--GKEIAVKRLTSSSVQGTEE 538
Query: 465 FKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRP---DWSLRV 521
F E+ I + H+NL++LLG C +G +LLVYE+M N +L +F + + DW+ R
Sbjct: 539 FMNEIKLISKLQHRNLLRLLGCCIDGEEKLLVYEYMVNKSLDIFIFDLKKKLEIDWATRF 598
Query: 522 RISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRT- 580
I IARGLLYLH + + ++H D+K NILLD+ KISDFGL++L +Q + T
Sbjct: 599 NIIQGIARGLLYLHRDSFLRVVHRDLKVSNILLDEKMNPKISDFGLARLFHGNQHQDSTG 658
Query: 581 VIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYD 640
+ GT GY++PE+ S K D+YSFGV++L+II K G++ +L+ +A+D
Sbjct: 659 SVVGTLGYMSPEYAWTGTFSEKSDIYSFGVLMLEIITGKEISSFSYGKDNKNLLS-YAWD 717
Query: 641 CYVE-GKLDVL-VDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLEV 698
+ E G +++L D D + + A + + I L C+Q + RP +K ++ ML ++
Sbjct: 718 SWSENGGVNLLDQDLDDSDSVNSVEAGRCVHIGLLCVQHQAIDRPNIKQVMSMLTSTTDL 777
Query: 699 PSPPMP 704
P P P
Sbjct: 778 PKPTQP 783
|
|
| TAIR|locus:2137010 AT4G11900 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 505 (182.8 bits), Expect = 1.7e-61, Sum P(4) = 1.7e-61
Identities = 117/305 (38%), Positives = 174/305 (57%)
Query: 408 NLRFFSLVELNEATNGF--EEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREF 465
N+ + +L ++ ATN F +++LG G FG VYKG K +G VA+K+L K + + EF
Sbjct: 521 NMCYLNLHDIMVATNSFSRKKKLGEGGFGPVYKG--KLPNGMEVAIKRLSKKSSQGLTEF 578
Query: 466 KTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRP---DWSLRVR 522
K EV I + HKNLV+LLG+C EG +LL+YE+M N +L LLF + DW R++
Sbjct: 579 KNEVVLIIKLQHKNLVRLLGYCVEGDEKLLIYEYMSNKSLDGLLFDSLKSRELDWETRMK 638
Query: 523 ISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQ--SRTRT 580
I RGL YLHE + IIH D+K NILLD + KISDFG +++ Q T+
Sbjct: 639 IVNGTTRGLQYLHEYSRLRIIHRDLKASNILLDDEMNPKISDFGTARIFGCKQIDDSTQR 698
Query: 581 VIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILT-DWAY 639
++ GT GY++PE+ +S K D+YSFGV+LL+II K++ +++ +++ +W
Sbjct: 699 IV-GTFGYMSPEYALGGVISEKSDIYSFGVLLLEIISGKKATRFVHNDQKHSLIAYEWES 757
Query: 640 DCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLEVP 699
C +G ++D A + + IAL C+Q+ P RP + IV ML +P
Sbjct: 758 WCETKGVS--IIDEPMCCSYSLEEAMRCIHIALLCVQDHPKDRPMISQIVYMLSNDNTLP 815
Query: 700 SPPMP 704
P P
Sbjct: 816 IPKQP 820
|
|
| TAIR|locus:2141176 B120 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 543 (196.2 bits), Expect = 2.5e-61, Sum P(3) = 2.5e-61
Identities = 125/313 (39%), Positives = 180/313 (57%)
Query: 399 VQRSSISETNLRFFSLVELNEATNGF--EEELGRGSFGIVYKGVLKSASGNAVAVKKLDK 456
++ +++ + L FSL + ATN F E ELGRG FG VYKGVL+ G +AVK+L
Sbjct: 504 IEGKAVNTSELPVFSLNAIAIATNDFCKENELGRGGFGPVYKGVLED--GREIAVKRLSG 561
Query: 457 LAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRP- 515
+ + EFK E+ I + H+NLV+LLG C EG ++LVYE+M N +L LF +
Sbjct: 562 KSGQGVDEFKNEIILIAKLQHRNLVRLLGCCFEGEEKMLVYEYMPNKSLDFFLFDETKQA 621
Query: 516 --DWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLS 573
DW LR I IARGLLYLH + + IIH D+K N+LLD + KISDFG++++
Sbjct: 622 LIDWKLRFSIIEGIARGLLYLHRDSRLRIIHRDLKVSNVLLDAEMNPKISDFGMARIFGG 681
Query: 574 DQSRTRTV-IRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSA 632
+Q+ TV + GT GY++PE+ S K DVYSFGV+LL+I+ KR+ + E S
Sbjct: 682 NQNEANTVRVVGTYGYMSPEYAMEGLFSVKSDVYSFGVLLLEIVSGKRNTSLRSSEHGSL 741
Query: 633 ILTDWAYDCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQML 692
I +A+ Y G+ + LVD K A + + +A+ C+Q+ +RP M ++ ML
Sbjct: 742 I--GYAWYLYTHGRSEELVDPKIRVTCSKREALRCIHVAMLCVQDSAAERPNMASVLLML 799
Query: 693 EGYLEVPSPPMPP 705
E + P P
Sbjct: 800 ESDTATLAAPRQP 812
|
|
| TAIR|locus:2125766 CRK40 "cysteine-rich RLK (RECEPTOR-like protein kinase) 40" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 566 (204.3 bits), Expect = 4.2e-61, Sum P(3) = 4.2e-61
Identities = 142/358 (39%), Positives = 206/358 (57%)
Query: 357 KKGIPILRGALLLGSSVFFNGXXXXXXXXXVFVWRKRKDGNKVQRSSISETNLRF---FS 413
KKG I G ++ V F + V+ +R N V + S+++ +F F
Sbjct: 279 KKGKSIGYGGII-AIVVVFTFINLLVFIGFIKVYARRGKLNNVGSAEYSDSDGQFMLRFD 337
Query: 414 LVELNEATNGFEEE--LGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSA 471
L + AT+ F E LG+G FG VYKG + G VAVK+L K + + + EFK EVS
Sbjct: 338 LGMIVMATDDFSSENTLGQGGFGTVYKGTFPN--GQEVAVKRLTKGSGQGDMEFKNEVSL 395
Query: 472 IGRTHHKNLVQLLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPD---WSLRVRISLEIA 528
+ R HKNLV+LLGFC+EG +LVYEF+ N +L + +F + W +R RI IA
Sbjct: 396 LTRLQHKNLVKLLGFCNEGDEEILVYEFVPNSSLDHFIFDEDKRSLLTWEVRFRIIEGIA 455
Query: 529 RGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTV-IRGTRG 587
RGLLYLHE+ + IIH D+K NILLD + K++DFG ++L SD++R T I GTRG
Sbjct: 456 RGLLYLHEDSQLKIIHRDLKASNILLDAEMNPKVADFGTARLFDSDETRAETKRIAGTRG 515
Query: 588 YVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKL 647
Y+APE+ + +SAK DVYSFGV+LL++I +R+ E GE +A +A+ +VEGK
Sbjct: 516 YMAPEYLNHGQISAKSDVYSFGVMLLEMISGERNNSFE-GEGLAA----FAWKRWVEGKP 570
Query: 648 DVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGY-LEVPSPPMP 704
++++D ++ K + I L C+QE+ KRP M ++ L + +P P P
Sbjct: 571 EIIID-PFLIENPRNEIIKLIQIGLLCVQENSTKRPTMSSVIIWLGSETIIIPLPKAP 627
|
|
| TAIR|locus:2131684 AT4G27290 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 542 (195.9 bits), Expect = 4.8e-60, Sum P(2) = 4.8e-60
Identities = 162/521 (31%), Positives = 254/521 (48%)
Query: 197 LLFRATLDFDGVFTEYAYPKNSAPNQSW-FTIQRLPNNICTSISDEFGSGACGFNSYCLL 255
+L R L+ +G Y + N QSW F + + ++ C D++ CG C +
Sbjct: 256 VLTRMQLNPNGALQRYTWVDNL---QSWNFYLSAMMDS-C----DQYT--LCGSYGSCNI 305
Query: 256 QNGRPFCECPPEYLFVDPTNRFSGCKPNYWQGCGPD---DGSRNAEELYEIRELADVNWP 312
N P C C ++ P +G ++ +GC D + + +I +L +
Sbjct: 306 -NESPACRCLKGFVAKTPQAWVAG---DWSEGCVRRVKLDCGKGEDGFLKISKLKLPDTR 361
Query: 313 LGYYQKRFPLALGAYDYTRTGFTKALIKVRKGGFRVDFDGNTGGKKGIPILRGALLLGSS 372
+Y K L K ++ FD GGK G + G L+
Sbjct: 362 TSWYDKNMDL---------NECKKVCLRNCTCSAYSPFDIRDGGK-GCILWFGDLIDIRE 411
Query: 373 VFFNGXXXXXXXXXVFVWRKRKDGNKVQRSSISETNLR--FFSLVELNEATNGFE--EEL 428
NG + +++ ++V E +L F L ++EAT+GF +L
Sbjct: 412 YNENGQDLYVRLASSEIETLQRESSRVSSRKQEEEDLELPFLDLDTVSEATSGFSAGNKL 471
Query: 429 GRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCD 488
G+G FG VYKG L A G VAVK+L + +++ EFK E+ I + H+NLV++LG+C
Sbjct: 472 GQGGFGPVYKGTL--ACGQEVAVKRLSRTSRQGVEEFKNEIKLIAKLQHRNLVKILGYCV 529
Query: 489 EGLNRLLVYEFMGNGTLANLLFAIPRP---DWSLRVRISLEIARGLLYLHEECNVPIIHC 545
+ R+L+YE+ N +L + +F R DW RV I IARG+LYLHE+ + IIH
Sbjct: 530 DEEERMLIYEYQPNKSLDSFIFDKERRRELDWPKRVEIIKGIARGMLYLHEDSRLRIIHR 589
Query: 546 DIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTV-IRGTRGYVAPEWFKNVPVSAKVD 604
D+K N+LLD D AKISDFGL++ L D++ T + GT GY++PE+ + S K D
Sbjct: 590 DLKASNVLLDSDMNAKISDFGLARTLGGDETEANTTRVVGTYGYMSPEYQIDGYFSLKSD 649
Query: 605 VYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDND-KAAMADKSR 663
V+SFGV++L+I+ +R+ EE L A+ ++E K ++D + D S
Sbjct: 650 VFSFGVLVLEIVSGRRNRGFR-NEEHKLNLLGHAWRQFLEDKAYEIIDEAVNESCTDISE 708
Query: 664 ACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLEVPSPPMP 704
+ + I L C+Q+DP RP M ++V ML + + P P
Sbjct: 709 VLRVIHIGLLCVQQDPKDRPNMSVVVLMLSSEMLLLDPRQP 749
|
|
| TAIR|locus:2197734 AT1G61370 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 532 (192.3 bits), Expect = 1.2e-58, Sum P(2) = 1.2e-58
Identities = 120/321 (37%), Positives = 184/321 (57%)
Query: 401 RSSISETNLRFFSLVELNEATNGF--EEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA 458
R + ++ FF + + TN F E +LG+G FG VYKG L+ G +A+K+L +
Sbjct: 478 REQLKPQDVNFFDMQTILTITNNFSMENKLGQGGFGPVYKGNLQD--GKEIAIKRLSSTS 535
Query: 459 QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRP--- 515
+ EF E+ I + H+NLV+LLG C EG +LL+YEFM N +L +F +
Sbjct: 536 GQGLEEFMNEIILISKLQHRNLVRLLGCCIEGEEKLLIYEFMANKSLNTFIFDSTKKLEL 595
Query: 516 DWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLL--LS 573
DW R I IA GLLYLH + + ++H D+K NILLD++ KISDFGL+++
Sbjct: 596 DWPKRFEIIQGIACGLLYLHRDSCLRVVHRDMKVSNILLDEEMNPKISDFGLARMFQGTQ 655
Query: 574 DQSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAI 633
Q+ TR V+ GT GY++PE+ S K D+Y+FGV+LL+II KR +GEE +
Sbjct: 656 HQANTRRVV-GTLGYMSPEYAWTGMFSEKSDIYAFGVLLLEIITGKRISSFTIGEEGKTL 714
Query: 634 LTDWAYDCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLE 693
L ++A+D + E L+D D ++ +S + + I L CIQ+ RP + ++ ML
Sbjct: 715 L-EFAWDSWCESGGSDLLDQDISSSGSESEVARCVQIGLLCIQQQAGDRPNIAQVMSMLT 773
Query: 694 GYLEVPSPPMPPLHSLQLTES 714
+++P P P + ++Q+ ES
Sbjct: 774 TTMDLPKPKQP-VFAMQVQES 793
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q39202 | RLK1_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.4036 | 0.9691 | 0.8317 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.824 |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | fgenesh4_pg.C_scaffold_1505000001 | hypothetical protein (801 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 714 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-52 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-51 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 4e-50 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-44 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-43 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 4e-43 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-38 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 6e-38 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-33 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-31 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-30 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 7e-30 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-29 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-29 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 5e-29 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 7e-29 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-28 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 4e-28 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 6e-27 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-25 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 4e-25 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 8e-25 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 4e-24 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 4e-24 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-23 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-23 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-23 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-23 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-23 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-23 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-22 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-22 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-22 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-22 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 7e-22 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 8e-22 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 8e-22 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 9e-22 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-21 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-21 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-21 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 3e-21 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-21 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 4e-21 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 6e-21 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 6e-21 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 7e-21 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 9e-21 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-20 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-20 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-20 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-20 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-20 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-20 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-20 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 4e-20 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 5e-20 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 6e-20 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 7e-20 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 8e-20 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-19 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-19 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-19 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-19 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-19 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-19 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 3e-19 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 4e-19 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 4e-19 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 5e-19 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 8e-19 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-18 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-18 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-18 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-18 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-18 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-18 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 4e-18 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 6e-18 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 7e-18 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-17 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-17 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-17 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-17 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-17 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-17 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-17 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-17 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-17 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 4e-17 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 4e-17 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 4e-17 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 5e-17 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 6e-17 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 8e-17 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 8e-17 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 8e-17 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-16 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-16 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-16 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-16 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-16 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-16 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-16 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-16 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-16 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 4e-16 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 5e-16 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 6e-16 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 8e-16 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 8e-16 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 8e-16 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 9e-16 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-15 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-15 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-15 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-15 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-15 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-15 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-15 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-15 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 3e-15 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 3e-15 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 4e-15 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 4e-15 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 4e-15 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 4e-15 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 5e-15 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 5e-15 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 5e-15 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 6e-15 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 6e-15 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 9e-15 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-14 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-14 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-14 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-14 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-14 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-14 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-14 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-14 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-14 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-14 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 4e-14 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 5e-14 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 5e-14 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 6e-14 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 7e-14 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 8e-14 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-13 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-13 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-13 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-13 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-13 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-13 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-13 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 3e-13 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 4e-13 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 4e-13 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 4e-13 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 5e-13 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 6e-13 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 6e-13 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-12 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-12 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-12 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-12 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-12 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-12 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-12 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-12 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-12 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-12 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-12 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-12 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 3e-12 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-12 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-12 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-12 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 3e-12 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 3e-12 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 4e-12 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 4e-12 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 4e-12 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 4e-12 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 4e-12 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 5e-12 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 7e-12 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 7e-12 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 7e-12 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 7e-12 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 8e-12 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 9e-12 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-11 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-11 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-11 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-11 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-11 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-11 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-11 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-11 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-11 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-11 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-11 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-11 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 3e-11 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-11 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 3e-11 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 3e-11 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-11 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 6e-11 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 6e-11 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 8e-11 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 9e-11 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-10 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-10 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 3e-10 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 3e-10 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-10 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 3e-10 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 4e-10 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 5e-10 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 5e-10 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 7e-10 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 7e-10 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 7e-10 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 7e-10 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 9e-10 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-09 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-09 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-09 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-09 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-09 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-09 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-09 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-09 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-09 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-09 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-09 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-09 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-09 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 3e-09 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 3e-09 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-09 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 3e-09 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 3e-09 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 4e-09 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 6e-09 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-08 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-08 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-08 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-08 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-08 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-08 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-08 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-08 | |
| smart00108 | 114 | smart00108, B_lectin, Bulb-type mannose-specific l | 2e-08 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-08 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 3e-08 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 4e-08 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 5e-08 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 5e-08 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 5e-08 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 6e-08 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 6e-08 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 6e-08 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 7e-08 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 7e-08 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 9e-08 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 9e-08 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-07 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-07 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-07 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 3e-07 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 3e-07 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 4e-07 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 4e-07 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 5e-07 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 8e-07 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 9e-07 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-06 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-06 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-06 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-06 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 3e-06 | |
| cd00028 | 116 | cd00028, B_lectin, Bulb-type mannose-specific lect | 3e-06 | |
| pfam01453 | 109 | pfam01453, B_lectin, D-mannose binding lectin | 3e-06 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 4e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 5e-06 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 5e-06 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 6e-06 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 8e-06 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-05 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-05 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-05 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 3e-05 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 7e-05 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 7e-05 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-04 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-04 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 4e-04 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 5e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 7e-04 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 0.001 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 0.002 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 0.002 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 0.002 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 0.004 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 0.004 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 180 bits (460), Expect = 1e-52
Identities = 71/192 (36%), Positives = 100/192 (52%), Gaps = 9/192 (4%)
Query: 428 LGRGSFGIVYKGVLKSASGNAVAVKKLDK-LAQEREREFKTEVSAIGRTHHKNLVQLLGF 486
LG G FG VY K +G VA+K + K + E E+ + + +H N+V+L G
Sbjct: 1 LGEGGFGTVYLARDKK-TGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGV 59
Query: 487 CDEGLNRLLVYEFMGNGTLANLLFAIPRP-DWSLRVRISLEIARGLLYLHEECNVPIIHC 545
++ + LV E+ G+L +LL +RI L+I GL YLH IIH
Sbjct: 60 FEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSN---GIIHR 116
Query: 546 DIKPQNILLDQD-FTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPE-WFKNVPVSAKV 603
D+KP+NILLD D K++DFGLSK LL+ I GT Y+APE S K
Sbjct: 117 DLKPENILLDSDNGKVKLADFGLSK-LLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKS 175
Query: 604 DVYSFGVVLLKI 615
D++S GV+L ++
Sbjct: 176 DIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 179 bits (456), Expect = 1e-51
Identities = 88/270 (32%), Positives = 131/270 (48%), Gaps = 19/270 (7%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQ--EREREFKTEVSAIGRTHHKNLV 481
+LG GSFG VYK K +G VAVK L K ++ ++++ + E+ + R H N+V
Sbjct: 3 LLRKLGSGSFGTVYKAKHKG-TGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIV 61
Query: 482 QLLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVP 541
+L+ ++ + LV E+ G L + L +I+L+I RGL YLH
Sbjct: 62 RLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSN---G 118
Query: 542 IIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEW-FKNVPVS 600
IIH D+KP+NILLD++ KI+DFGL+K LL S T GT Y+APE
Sbjct: 119 IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSL-TTFVGTPWYMAPEVLLGGNGYG 177
Query: 601 AKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMAD 660
KVDV+S GV+L + + L + L ++ D+ +
Sbjct: 178 PKVDVWSLGVILY-ELLTGKPPFSGENILDQLQL--------IRRILGPPLEFDEPKWSS 228
Query: 661 KSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690
S K L+ C+ +DP KRP + I+Q
Sbjct: 229 GSEEAKDLI--KKCLNKDPSKRPTAEEILQ 256
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 175 bits (446), Expect = 4e-50
Identities = 67/197 (34%), Positives = 101/197 (51%), Gaps = 7/197 (3%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQERERE-FKTEVSAIGRTHHKNLVQ 482
E+LG GSFG VY K +G VA+K + K +++RE E+ + + H N+V+
Sbjct: 3 ILEKLGEGSFGKVYLARDKK-TGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVR 61
Query: 483 LLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPI 542
L ++ LV E+ G L +LL R +I L YLH + I
Sbjct: 62 LYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKG---I 118
Query: 543 IHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPVSAK 602
+H D+KP+NILLD+D K++DFGL++ L + T V GT Y+APE
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFV--GTPEYMAPEVLLGKGYGKA 176
Query: 603 VDVYSFGVVLLKIICCK 619
VD++S GV+L +++ K
Sbjct: 177 VDIWSLGVILYELLTGK 193
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 159 bits (405), Expect = 2e-44
Identities = 70/199 (35%), Positives = 107/199 (53%), Gaps = 17/199 (8%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNA---VAVKKLDKLAQERER-EFKTEVSAIGRTHHKN 479
++LG G+FG VYKG LK VAVK L + A E ER EF E S + + H N
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPN 62
Query: 480 LVQLLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRP-DWSLRVRISLEIARGLLYLHEEC 538
+V+LLG C +G +V E+M G L + L ++++L+IA+G+ YL
Sbjct: 63 IVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLES-- 120
Query: 539 NVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSD-----QSRTRTVIRGTRGYVAPEW 593
+H D+ +N L+ ++ KISDFGLS+ + D + + I+ ++APE
Sbjct: 121 -KNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIK----WMAPES 175
Query: 594 FKNVPVSAKVDVYSFGVVL 612
K+ ++K DV+SFGV+L
Sbjct: 176 LKDGKFTSKSDVWSFGVLL 194
|
Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 157 bits (399), Expect = 1e-43
Identities = 90/278 (32%), Positives = 131/278 (47%), Gaps = 32/278 (11%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNA---VAVKKLDKLAQERER-EFKTEVSAIGRTHHKN 479
++LG G+FG VYKG LK G VAVK L + A E++ EF E + + H N
Sbjct: 3 LGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62
Query: 480 LVQLLGFCDEGLNRLLVYEFMGNGTLAN-LLFAIPRPDWSLRVRISLEIARGLLYLHEEC 538
+V+LLG C E +V E+M G L + L P+ S + +L+IARG+ YL +
Sbjct: 63 VVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLESK- 121
Query: 539 NVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYV---APEWFK 595
IH D+ +N L+ ++ KISDFGLS+ L D RG + + APE K
Sbjct: 122 --NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY---YRKRGGKLPIRWMAPESLK 176
Query: 596 NVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEE-RSAILTDWAYDCYVEGKLDVLVDND 654
++K DV+SFGV+L +I LGE+ + + + G N
Sbjct: 177 EGKFTSKSDVWSFGVLLWEI--------FTLGEQPYPGMSNEEVLEYLKNGYRLPQPPNC 228
Query: 655 KAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQML 692
+ D + L C EDP RP +V++L
Sbjct: 229 PPELYD---------LMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 156 bits (396), Expect = 4e-43
Identities = 92/281 (32%), Positives = 135/281 (48%), Gaps = 37/281 (13%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNA---VAVKKLDKLAQERER-EFKTEVSAIGRTHHKN 479
++LG G+FG VYKG LK VAVK L + A E++ EF E + + H N
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62
Query: 480 LVQLLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPD---WSLRVRISLEIARGLLYLHE 536
+V+LLG C E ++V E+M G L + L RP S + +L+IARG+ YL
Sbjct: 63 IVKLLGVCTEEEPLMIVMEYMPGGDLLDYL-RKNRPKELSLSDLLSFALQIARGMEYLES 121
Query: 537 ECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYV---APEW 593
+ IH D+ +N L+ ++ KISDFGLS+ L D ++G + + APE
Sbjct: 122 K---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY---YKVKGGKLPIRWMAPES 175
Query: 594 FKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDN 653
K ++K DV+SFGV+L +I LGEE +++ +VL
Sbjct: 176 LKEGKFTSKSDVWSFGVLLWEI--------FTLGEEPYPGMSN----------AEVLEYL 217
Query: 654 DKAAMADKSRAC--KWLMIALWCIQEDPLKRPAMKMIVQML 692
K K C + + L C EDP RP +V++L
Sbjct: 218 KKGYRLPKPPNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 143 bits (363), Expect = 2e-38
Identities = 64/200 (32%), Positives = 103/200 (51%), Gaps = 9/200 (4%)
Query: 426 EELGRGSFGIVYKGVLKSASGNAVAVKK--LDKLAQEREREFKTEVSAIGRTHHKNLVQL 483
E LGRGSFG VY + K +G +AVK L ++E + E+ + H N+V+
Sbjct: 6 ELLGRGSFGSVYLALDKD-TGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRY 64
Query: 484 LGFC-DEGLNRLLVY-EFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVP 541
G DE N L ++ E++ G+L++LL + + + + +I GL YLH
Sbjct: 65 YGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNG--- 121
Query: 542 IIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTV-IRGTRGYVAPEWFKNVPVS 600
I+H DIK NIL+D D K++DFG +K L ++ T +RGT ++APE +
Sbjct: 122 IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYG 181
Query: 601 AKVDVYSFGVVLLKIICCKR 620
D++S G ++++ K
Sbjct: 182 RAADIWSLGCTVIEMATGKP 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 141 bits (359), Expect = 6e-38
Identities = 88/288 (30%), Positives = 129/288 (44%), Gaps = 46/288 (15%)
Query: 426 EELGRGSFGIVYKGVLKSASGN--AVAVKKLDKLAQERER-EFKTEVSAIGRTHHKNLVQ 482
++LG G+FG VYKG LK G VAVK L + A E ER +F E + + H N+V+
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 483 LLGFCDEGLNRLLVYEFMGNGTLANLL---------FAIPRPDWSLRVRISLEIARGLLY 533
LLG C E LV E+M G L + L + +++IA+G+ Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 534 LHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTV-----IRGTRGY 588
L +H D+ +N L+ +D KISDFGLS+ + D + IR +
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR----W 173
Query: 589 VAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEE-RSAILTDWAYDCYVEGKL 647
+APE K+ ++K DV+SFGV+L +I LG + + + +G
Sbjct: 174 MAPESLKDGIFTSKSDVWSFGVLLWEI--------FTLGATPYPGLSNEEVLEYLRKGY- 224
Query: 648 DVLVDNDKAAMADKSRAC--KWLMIALWCIQEDPLKRPAMKMIVQMLE 693
L K C + + L C Q DP RP +V+ LE
Sbjct: 225 -RL---------PKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 128 bits (325), Expect = 2e-33
Identities = 62/189 (32%), Positives = 98/189 (51%), Gaps = 7/189 (3%)
Query: 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLG 485
E++G+G FG VYK K +G VA+K + ++E++ + E+ + + H N+V+ G
Sbjct: 6 EKIGKGGFGEVYKARHKR-TGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYG 64
Query: 486 FCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVR-ISLEIARGLLYLHEECNVPIIH 544
+ +V EF G+L +LL + + ++ + E+ +GL YLH IIH
Sbjct: 65 SYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN---GIIH 121
Query: 545 CDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPVSAKVD 604
DIK NILL D K+ DFGLS L ++R V GT ++APE P K D
Sbjct: 122 RDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV--GTPYWMAPEVINGKPYDYKAD 179
Query: 605 VYSFGVVLL 613
++S G+ +
Sbjct: 180 IWSLGITAI 188
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 3e-31
Identities = 81/278 (29%), Positives = 128/278 (46%), Gaps = 41/278 (14%)
Query: 427 ELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQERER-EFKTEVSAIGRTHHKNLVQLLG 485
LG+GS G+VYK K +G A+KK+ E R + E+ + +V+ G
Sbjct: 8 VLGQGSSGVVYKVRHK-PTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYG 66
Query: 486 -FCDEGLNRLLVYEFMGNGTLANLL---FAIPRPDWSLRVRISLEIARGLLYLHEECNVP 541
F EG + V E+M G+LA+LL IP P + I+ +I +GL YLH + +
Sbjct: 67 AFYKEGEISI-VLEYMDGGSLADLLKKVGKIPEPVLAY---IARQILKGLDYLHTKRH-- 120
Query: 542 IIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPVSA 601
IIH DIKP N+L++ KI+DFG+SK+L + + T + GT Y++PE + S
Sbjct: 121 IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-GTVTYMSPERIQGESYSY 179
Query: 602 KVDVYSFGVVLLKIICCKRSVEMELGE---ERSAILTDWAYDCYVEGKLDVLVDNDKAAM 658
D++S G+ LL E LG+ + + + D
Sbjct: 180 AADIWSLGLTLL---------ECALGKFPFLPPGQPSFFELMQAI---------CDGPPP 221
Query: 659 ADKSRACKWLM---IALWCIQEDPLKRPAMKMIVQMLE 693
+ + I+ C+Q+DP KRP ++L+
Sbjct: 222 SLPAEEFSPEFRDFISA-CLQKDPKKRP---SAAELLQ 255
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 3e-30
Identities = 68/202 (33%), Positives = 103/202 (50%), Gaps = 13/202 (6%)
Query: 416 ELNEATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRT 475
+N +G+G FG V G + G VAVK L K + F E S +
Sbjct: 2 AINSKELKLGATIGKGEFGDVMLGDYR---GQKVAVKCL-KDDSTAAQAFLAEASVMTTL 57
Query: 476 HHKNLVQLLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRI--SLEIARGLLY 533
H NLVQLLG +G +V E+M G+L + L + R +L ++ +L++ G+ Y
Sbjct: 58 RHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEY 117
Query: 534 LHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEW 593
L EE N +H D+ +N+L+ +D AK+SDFGL+K Q + ++ T APE
Sbjct: 118 L-EEKN--FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWT----APEA 170
Query: 594 FKNVPVSAKVDVYSFGVVLLKI 615
+ S K DV+SFG++L +I
Sbjct: 171 LREKKFSTKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 7e-30
Identities = 74/191 (38%), Positives = 100/191 (52%), Gaps = 14/191 (7%)
Query: 428 LGRGSFGIVYKGVLKSASGNAVAVKKLDK--LAQEREREF-KTEVSAIGRTHHKNLVQLL 484
LG+GSFG V V K +G A+K L K + + +E E TE + + R +H +V+L
Sbjct: 1 LGKGSFGKVLL-VRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH 59
Query: 485 -GFCDEGLNRL-LVYEFMGNGTLANLLFAIPR-PDWSLRVRISLEIARGLLYLHEECNVP 541
F E +L LV E+ G L + L R + R + EI L YLH
Sbjct: 60 YAFQTE--EKLYLVLEYAPGGELFSHLSKEGRFSEERAR-FYAAEIVLALEYLHSL---G 113
Query: 542 IIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPVSA 601
II+ D+KP+NILLD D K++DFGL+K L S+ SRT T GT Y+APE
Sbjct: 114 IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC-GTPEYLAPEVLLGKGYGK 172
Query: 602 KVDVYSFGVVL 612
VD +S GV+L
Sbjct: 173 AVDWWSLGVLL 183
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 58/186 (31%), Positives = 101/186 (54%), Gaps = 7/186 (3%)
Query: 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLD--KLAQEREREFKTEVSAIGRTHHKNLVQL 483
+ +GRG+FG+VYKG L +G+ VA+K++ K+ +E + E+ + H N+V+
Sbjct: 6 DLIGRGAFGVVYKG-LNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKY 64
Query: 484 LGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPII 543
+G + + ++ E+ NG+L ++ SL ++ +GL YLHE+ +I
Sbjct: 65 IGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQ---GVI 121
Query: 544 HCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPVSAKV 603
H DIK NIL +D K++DFG++ L+D S+ + GT ++APE + S
Sbjct: 122 HRDIKAANILTTKDGVVKLADFGVA-TKLNDVSKDDASVVGTPYWMAPEVIEMSGASTAS 180
Query: 604 DVYSFG 609
D++S G
Sbjct: 181 DIWSLG 186
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 116 bits (294), Expect = 3e-29
Identities = 65/197 (32%), Positives = 102/197 (51%), Gaps = 19/197 (9%)
Query: 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLD-KLAQEREREF-KTEVSAIGRTHHKNLVQL 483
+++G+GSFG VY V + + G +K++D E+ERE EV + + +H N+++
Sbjct: 6 KQIGKGSFGKVYL-VRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKY 64
Query: 484 LGFCDEGLNRLLVYEFMGNGTLANLL-----FAIPRPD---WSLRVRISLEIARGLLYLH 535
+E +V E+ G L+ + P P+ V++ L L YLH
Sbjct: 65 YESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCL----ALKYLH 120
Query: 536 EECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFK 595
I+H DIKPQNI L + K+ DFG+SK+L S +TV+ GT Y++PE +
Sbjct: 121 SR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV-GTPYYLSPELCQ 176
Query: 596 NVPVSAKVDVYSFGVVL 612
N P + K D++S G VL
Sbjct: 177 NKPYNYKSDIWSLGCVL 193
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 5e-29
Identities = 64/220 (29%), Positives = 97/220 (44%), Gaps = 29/220 (13%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNAVAVKKLDK---LAQEREREFKTEVSAIGR-THHKN 479
F + +G GSF V K + A+K LDK + +++ + K E + R H
Sbjct: 5 FGKIIGEGSFSTVVLAKEKE-TNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPG 63
Query: 480 LVQLLG-FCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEEC 538
+++L F DE N V E+ NG L + D + EI L YLH
Sbjct: 64 IIKLYYTFQDEE-NLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLH--- 119
Query: 539 NVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQS-------------------RTR 579
+ IIH D+KP+NILLD+D KI+DFG +K+L + S R
Sbjct: 120 SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRF 179
Query: 580 TVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCK 619
GT YV+PE P D+++ G ++ +++ K
Sbjct: 180 ASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 7e-29
Identities = 59/197 (29%), Positives = 105/197 (53%), Gaps = 17/197 (8%)
Query: 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLG 485
E++G G+ G VYK A+G VA+KK+ +L ++ + E+ + H N+V
Sbjct: 25 EKIGEGASGEVYKAT-DRATGKEVAIKKM-RLRKQNKELIINEILIMKDCKHPNIVDYYD 82
Query: 486 --FCDEGLNRLLVYEFMGNGTLANLL----FAIPRPDWSLRVRISLEIARGLLYLHEECN 539
+ L +V E+M G+L +++ + P + + E+ +GL YLH +
Sbjct: 83 SYLVGDEL--WVVMEYMDGGSLTDIITQNFVRMNEPQIA---YVCREVLQGLEYLH---S 134
Query: 540 VPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPV 599
+IH DIK NILL +D + K++DFG + L ++S+ +V+ GT ++APE K
Sbjct: 135 QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVV-GTPYWMAPEVIKRKDY 193
Query: 600 SAKVDVYSFGVVLLKII 616
KVD++S G++ +++
Sbjct: 194 GPKVDIWSLGIMCIEMA 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 117 bits (293), Expect = 2e-28
Identities = 76/276 (27%), Positives = 118/276 (42%), Gaps = 28/276 (10%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNAVAVKKLDK---LAQEREREFKTEVSAIGR-THHKN 479
+LG GSFG VY + VA+K L K + F E+ + H N
Sbjct: 4 ILRKLGEGSFGEVYLARDRKL----VALKVLAKKLESKSKEVERFLREIQILASLNHPPN 59
Query: 480 LVQLLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRP---DWSLRVRISLEIARGLLYLHE 536
+V+L F + + LV E++ G+L +LL I R S + I +I L YLH
Sbjct: 60 IVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS 119
Query: 537 ECNVPIIHCDIKPQNILLDQD-FTAKISDFGLSKLLLSDQSRT-----RTVIRGTRGYVA 590
+ IIH DIKP+NILLD+D K+ DFGL+KLL S + + GT GY+A
Sbjct: 120 KG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMA 176
Query: 591 PEWFK---NVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKL 647
PE S+ D++S G+ L +++ E E ++ +
Sbjct: 177 PEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLA 236
Query: 648 DVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRP 683
L ++ ++ + + + +DP R
Sbjct: 237 SPLSPSNPELISKAASD-----LLKKLLAKDPKNRL 267
|
Length = 384 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 4e-28
Identities = 87/290 (30%), Positives = 138/290 (47%), Gaps = 49/290 (16%)
Query: 427 ELGRGSFGIVYKGVLKS-ASGNA---VAVKKLDKLAQERER-EFKTEVSAIGRTHHKNLV 481
ELG+GSFG+VY+G+ K G VA+K +++ A RER EF E S + + ++V
Sbjct: 13 ELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVV 72
Query: 482 QLLGFCDEGLNRLLVYEFMGNGTLANLLFA----------IPRPDWSLRVRISLEIARGL 531
+LLG G L+V E M G L + L + + P ++++ EIA G+
Sbjct: 73 RLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGM 132
Query: 532 LYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLL-SDQSRTRTVIRGTRG--- 587
YL + +H D+ +N ++ +D T KI DFG+++ + +D R +G +G
Sbjct: 133 AYLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYR-----KGGKGLLP 184
Query: 588 --YVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEG 645
++APE K+ + K DV+SFGVVL ++ L E+ L++ E
Sbjct: 185 VRWMAPESLKDGVFTTKSDVWSFGVVLWEMA--------TLAEQPYQGLSN-------EE 229
Query: 646 KLDVLVDNDKAAMADKSRAC--KWLMIALWCIQEDPLKRPAMKMIVQMLE 693
L ++D D C K L + C Q +P RP IV L+
Sbjct: 230 VLKFVIDGG---HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 110 bits (275), Expect = 6e-27
Identities = 88/290 (30%), Positives = 138/290 (47%), Gaps = 49/290 (16%)
Query: 414 LVELNEATNGFEEELGRGSFGIVYKGVLKSASGNAVAVK--KLDKLAQEREREFKTEVSA 471
L+ L + T G E +G G FG V +G +G VAVK K D AQ F E +
Sbjct: 2 LLNLQKLTLG--EIIGEGEFGAVLQG---EYTGQKVAVKNIKCDVTAQA----FLEETAV 52
Query: 472 IGRTHHKNLVQLLG-FCDEGLNRLLVYEFMGNGTLANLL-----FAIPRPDWSLRVRISL 525
+ + HHKNLV+LLG GL +V E M G L N L + ++ SL
Sbjct: 53 MTKLHHKNLVRLLGVILHNGLY--IVMELMSKGNLVNFLRTRGRALVSVIQL---LQFSL 107
Query: 526 EIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGT 585
++A G+ YL + ++H D+ +NIL+ +D AK+SDFGL+++ ++ ++ T
Sbjct: 108 DVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWT 164
Query: 586 RGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRS--VEMELGEERSAILTDWAYDCYV 643
APE K+ S+K DV+S+GV+L ++ R+ +M L E + + + +
Sbjct: 165 ----APEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPE 220
Query: 644 EGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLE 693
DV V LM + W + +P KRP+ + + LE
Sbjct: 221 GCPADVYV----------------LMTSCW--ETEPKKRPSFHKLREKLE 252
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 1e-25
Identities = 62/194 (31%), Positives = 103/194 (53%), Gaps = 9/194 (4%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQL 483
+E+G G FG+V+ G VA+K + + A E +F E + + H LVQL
Sbjct: 8 LVQEIGSGQFGLVWLGYWLEK--RKVAIKTIREGAMSEE-DFIEEAQVMMKLSHPKLVQL 64
Query: 484 LGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLR--VRISLEIARGLLYLHEECNVP 541
G C E LV+EFM +G L++ L A R +S + + L++ G+ YL
Sbjct: 65 YGVCTERSPICLVFEFMEHGCLSDYLRA-QRGKFSQETLLGMCLDVCEGMAYLESSN--- 120
Query: 542 IIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPVSA 601
+IH D+ +N L+ ++ K+SDFG+++ +L DQ + T + + +PE F S+
Sbjct: 121 VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSS 180
Query: 602 KVDVYSFGVVLLKI 615
K DV+SFGV++ ++
Sbjct: 181 KSDVWSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 4e-25
Identities = 69/232 (29%), Positives = 120/232 (51%), Gaps = 33/232 (14%)
Query: 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQERERE----------FKTEVSAIGRT 475
E +G+G++G VY L +G +AVK+++ A R ++E+ +
Sbjct: 7 ELIGKGTYGRVYLA-LNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL 65
Query: 476 HHKNLVQLLGFCDEGLNRLLVY-EFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYL 534
H N+VQ LGF + L ++ E++ G++ + L R + L + ++ GL YL
Sbjct: 66 DHLNIVQYLGF-ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYL 124
Query: 535 HEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSK----LLLSDQSRTRTVIRGTRGYVA 590
H + I+H D+K N+L+D D KISDFG+SK + +DQ+ + ++G+ ++A
Sbjct: 125 H---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMS---MQGSVFWMA 178
Query: 591 PEWFKN--VPVSAKVDVYSFGVVLLKIICCKR--------SVEMELGEERSA 632
PE + SAKVD++S G V+L++ +R + +LG +RSA
Sbjct: 179 PEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSA 230
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 8e-25
Identities = 87/289 (30%), Positives = 139/289 (48%), Gaps = 47/289 (16%)
Query: 427 ELGRGSFGIVYKGV----LKSASGNAVAVKKLDKLAQERER-EFKTEVSAIGRTHHKNLV 481
ELG+GSFG+VY+G +K + VAVK +++ A RER EF E S + ++V
Sbjct: 13 ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 72
Query: 482 QLLGFCDEGLNRLLVYEFMGNGTLANLLFAI----------PRPDWSLRVRISLEIARGL 531
+LLG +G L+V E M +G L + L ++ P P ++++ EIA G+
Sbjct: 73 RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 132
Query: 532 LYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRG---- 587
YL+ + +H D+ +N ++ DFT KI DFG+++ D T +G +G
Sbjct: 133 AYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR----DIYETDYYRKGGKGLLPV 185
Query: 588 -YVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGK 646
++APE K+ + D++SFGVVL +I L E+ L++ E
Sbjct: 186 RWMAPESLKDGVFTTSSDMWSFGVVLWEI--------TSLAEQPYQGLSN-------EQV 230
Query: 647 LDVLVDNDKAAMADKSRACKWLMIAL--WCIQEDPLKRPAMKMIVQMLE 693
L ++D D+ C + L C Q +P RP IV +L+
Sbjct: 231 LKFVMD---GGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 4e-24
Identities = 65/201 (32%), Positives = 100/201 (49%), Gaps = 17/201 (8%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQL 483
F +ELG G FG+V+ G + VA+K + + A E +F E + + H NLVQL
Sbjct: 8 FLKELGSGQFGVVHLGKWRGK--IDVAIKMIREGAMS-EDDFIEEAKVMMKLSHPNLVQL 64
Query: 484 LGFCDEGLNRLLVYEFMGNGTLANLLFAIP---RPDWSLRVRISLEIARGLLYLHEECNV 540
G C + +V E+M NG L N L +W L + ++ + YL
Sbjct: 65 YGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDM--CSDVCEAMEYLESNG-- 120
Query: 541 PIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTR---GYVAPEWFKNV 597
IH D+ +N L+ +D K+SDFGL++ +L DQ T +GT+ + PE F
Sbjct: 121 -FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY---TSSQGTKFPVKWAPPEVFDYS 176
Query: 598 PVSAKVDVYSFGVVLLKIICC 618
S+K DV+SFGV++ ++
Sbjct: 177 RFSSKSDVWSFGVLMWEVFSE 197
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 4e-24
Identities = 60/200 (30%), Positives = 104/200 (52%), Gaps = 16/200 (8%)
Query: 424 FEEELGRGSFGIVYKG---VLKSASGNAVAVKKLDKLAQERER-EFKTEVSAIGRTHHKN 479
F ++LG G FG V L +G VAVK L+ +E+ R +F+ E+ + H+N
Sbjct: 8 FIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHEN 67
Query: 480 LVQLLGFCDE--GLNRLLVYEFMGNGTLANLL-FAIPRPDWSLRVRISLEIARGLLYLHE 536
+V+ G C++ G + L+ E++ +G+L + L + + + S +I +G+ YL
Sbjct: 68 IVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGS 127
Query: 537 ECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRG----YVAPE 592
+ IH D+ +NIL++ + KISDFGL+K+L + + ++ + APE
Sbjct: 128 Q---RYIHRDLAARNILVESEDLVKISDFGLAKVL--PEDKDYYYVKEPGESPIFWYAPE 182
Query: 593 WFKNVPVSAKVDVYSFGVVL 612
+ S+ DV+SFGV L
Sbjct: 183 CLRTSKFSSASDVWSFGVTL 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 66/199 (33%), Positives = 107/199 (53%), Gaps = 20/199 (10%)
Query: 425 EEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLL 484
E +LG G FG V++G+ K+ VA+K L ++++F+ EV A+ R HK+L+ L
Sbjct: 11 ERKLGSGYFGEVWEGLWKNRV--RVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLF 68
Query: 485 GFCDEGLNRLLVYEFMGNGTLANLLFAIPRPD-WSLRVR----ISLEIARGLLYLHEECN 539
C G ++ E M G+L L + P+ L V ++ ++A G+ YL EE N
Sbjct: 69 AVCSVGEPVYIITELMEKGSLLAFLRS---PEGQVLPVASLIDMACQVAEGMAYL-EEQN 124
Query: 540 VPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSD---QSRTRTVIRGTRGYVAPEWFKN 596
IH D+ +NIL+ +D K++DFGL++L+ D S + + T APE +
Sbjct: 125 --SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWT----APEAASH 178
Query: 597 VPVSAKVDVYSFGVVLLKI 615
S K DV+SFG++L ++
Sbjct: 179 GTFSTKSDVWSFGILLYEM 197
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 66/205 (32%), Positives = 100/205 (48%), Gaps = 16/205 (7%)
Query: 425 EEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREF-KTEVSAIGRTHHKNLVQL 483
E +G+GSFG VYK + K + VA+K +D E E E + E+ + + + +
Sbjct: 6 LECIGKGSFGEVYKAIDKR-TNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKY 64
Query: 484 LGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPII 543
G +G ++ E+ G G+ +LL + + I E+ GL YLHEE I
Sbjct: 65 YGSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAF-ILREVLLGLEYLHEE---GKI 120
Query: 544 HCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPVSAKV 603
H DIK NILL ++ K++DFG+S L S S+ T + GT ++APE K K
Sbjct: 121 HRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV-GTPFWMAPEVIKQSGYDEKA 179
Query: 604 DVYSFGVVLLKIICCKRSVEMELGE 628
D++S G I +E+ GE
Sbjct: 180 DIWSLG------ITA---IELAKGE 195
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 65/218 (29%), Positives = 106/218 (48%), Gaps = 33/218 (15%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGN----AVAVKKLDKLAQERER-EFKTEVSAIGRTHHK 478
F EELG G+FG VYKG L + +VA+K L + A+ + + EF+ E + H
Sbjct: 9 FLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHP 68
Query: 479 NLVQLLGFCDEGLNRLLVYEFMGNGTLANLLF---------------AIPRPDWSLR-VR 522
N+V LLG C + +++E++ +G L L + +
Sbjct: 69 NIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLH 128
Query: 523 ISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSD-----QSR 577
I+++IA G+ YL +H D+ +N L+ + T KISDFGLS+ + S QS+
Sbjct: 129 IAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSK 185
Query: 578 TRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKI 615
+ +R ++ PE + + D++SFGVVL +I
Sbjct: 186 SLLPVR----WMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99.3 bits (248), Expect = 3e-23
Identities = 71/194 (36%), Positives = 101/194 (52%), Gaps = 13/194 (6%)
Query: 426 EELGRGSFGIVYKGVLKSASGN--AVAVKKL--DKLAQEREREFKTEVSAIGRTHHKNLV 481
+ELG G+FG V KGV SG VAVK L + +A ++EF E S + + H +V
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAG-KKEFLREASVMAQLDHPCIV 59
Query: 482 QLLGFCDEGLNRLLVYEFMGNGTLANLLFAIPR-PDWSLRVRISLEIARGLLYLHEECNV 540
+L+G C +G +LV E G L L P L+ ++ ++A G+ YL E +
Sbjct: 60 RLIGVC-KGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKE-LAHQVAMGMAYL-ESKH- 115
Query: 541 PIIHCDIKPQNILLDQDFTAKISDFGLSKLLL--SDQSRTRTVIRGTRGYVAPEWFKNVP 598
+H D+ +N+LL AKISDFG+S+ L SD R T R + APE
Sbjct: 116 -FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGK 174
Query: 599 VSAKVDVYSFGVVL 612
S+K DV+S+GV L
Sbjct: 175 FSSKSDVWSYGVTL 188
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 3e-23
Identities = 70/210 (33%), Positives = 113/210 (53%), Gaps = 29/210 (13%)
Query: 427 ELGRGSFGIVY----KGVLKSASGNAVAVKKLDKLAQERER-EFKTEVSAIGRTHHKNLV 481
ELG+GSFG+VY KGV+K VA+K +++ A RER EF E S + + ++V
Sbjct: 13 ELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 72
Query: 482 QLLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPD-----------WSLRVRISLEIARG 530
+LLG +G L++ E M G L + L ++ RP+ ++++ EIA G
Sbjct: 73 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSL-RPEMENNPVQAPPSLKKMIQMAGEIADG 131
Query: 531 LLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRG--- 587
+ YL+ +H D+ +N ++ +DFT KI DFG+++ D T +G +G
Sbjct: 132 MAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYYRKGGKGLLP 184
Query: 588 --YVAPEWFKNVPVSAKVDVYSFGVVLLKI 615
+++PE K+ + DV+SFGVVL +I
Sbjct: 185 VRWMSPESLKDGVFTTYSDVWSFGVVLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 4e-23
Identities = 79/337 (23%), Positives = 157/337 (46%), Gaps = 27/337 (8%)
Query: 375 FNGLLLLAISLLVFVWRKRKDGNKVQR----SSISET---NLRFFSLVELNEATNGFEEE 427
L+LA+ FV+ + ++ +++R E + + + +N+ + +EE
Sbjct: 636 LGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITINDILSSLKEE 695
Query: 428 --LGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLG 485
+ RG G YKG +G VK+++ + +E++ +G+ H N+V+L+G
Sbjct: 696 NVISRGKKGASYKGKSI-KNGMQFVVKEINDVNSIPS----SEIADMGKLQHPNIVKLIG 750
Query: 486 FCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHC 545
C L++E++ L+ +L + W R +I++ IA+ L +LH C+ ++
Sbjct: 751 LCRSEKGAYLIHEYIEGKNLSEVLRNL---SWERRRKIAIGIAKALRFLHCRCSPAVVVG 807
Query: 546 DIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPVSAKVDV 605
++ P+ I++D + L LL +D + YVAPE + ++ K D+
Sbjct: 808 NLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFIS-----SAYVAPETRETKDITEKSDI 861
Query: 606 YSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDN--DKAAMADKSR 663
Y FG++L++++ K + E G S + +WA CY + LD+ +D +++
Sbjct: 862 YGFGLILIELLTGKSPADAEFGVHGS--IVEWARYCYSDCHLDMWIDPSIRGDVSVNQNE 919
Query: 664 ACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLEVPS 700
+ + +AL C DP RP +++ LE S
Sbjct: 920 IVEVMNLALHCTATDPTARPCANDVLKTLESASRSSS 956
|
Length = 968 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 1e-22
Identities = 62/197 (31%), Positives = 97/197 (49%), Gaps = 15/197 (7%)
Query: 427 ELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLG- 485
ELG G+FG VYK K A A K + ++E +F E+ + H N+V L
Sbjct: 12 ELGDGAFGKVYKAQHKETGLFA-AAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEA 70
Query: 486 -FCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVR-ISLEIARGLLYLHEECNVPII 543
F + L L+ EF G L +++ + R ++R + ++ L +LH +I
Sbjct: 71 YFYENKLWILI--EFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSH---KVI 125
Query: 544 HCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAP-----EWFKNVP 598
H D+K NILL D K++DFG+S S + T I GT ++AP E FK+ P
Sbjct: 126 HRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI-GTPYWMAPEVVACETFKDNP 184
Query: 599 VSAKVDVYSFGVVLLKI 615
K D++S G+ L+++
Sbjct: 185 YDYKADIWSLGITLIEL 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.8 bits (244), Expect = 1e-22
Identities = 81/294 (27%), Positives = 130/294 (44%), Gaps = 58/294 (19%)
Query: 425 EEELGRGSFGIVYKGVLKSASGN--AVAVKKLDKLAQERER-EFKTEVSAIGRTHHKNLV 481
E+ +G G FG V +G LK VA+K L + +++R +F TE S +G+ H N++
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68
Query: 482 QLLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLR-----------VRISLEIARG 530
+L G + +++ E+M NG+L D LR V + IA G
Sbjct: 69 RLEGVVTKSRPVMIITEYMENGSL----------DKFLRENDGKFTVGQLVGMLRGIASG 118
Query: 531 LLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRG--- 587
+ YL E V H D+ +NIL++ + K+SDFGLS+ L D T T T+G
Sbjct: 119 MKYLSEMNYV---HRDLAARNILVNSNLVCKVSDFGLSR-RLEDSEATYT----TKGGKI 170
Query: 588 ---YVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVE 644
+ APE ++ DV+SFG+V+ ++ M GE +++
Sbjct: 171 PIRWTAPEAIAYRKFTSASDVWSFGIVMWEV--------MSYGERPYWDMSNQ------- 215
Query: 645 GKLDVLVDNDKAAMADKSRACKWLM--IALWCIQEDPLKRPAMKMIVQMLEGYL 696
DV+ + C + + L C Q+D +RP IV L+ +
Sbjct: 216 ---DVIKAVEDGYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKMI 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 96.9 bits (242), Expect = 2e-22
Identities = 60/201 (29%), Positives = 99/201 (49%), Gaps = 20/201 (9%)
Query: 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLD--KLAQEREREFKT-EVSAIGRTHHKNLVQ 482
E +G+GSFG V K KS G + K++D + E+E++ EV+ + H N+V+
Sbjct: 6 ETIGKGSFGTVRKVRRKS-DGKILVWKEIDYGNM-TEKEKQQLVSEVNILRELKHPNIVR 63
Query: 483 LLGFCDEGLNR-----LLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEE 537
+ D ++R +V E+ G LA L+ + + I LL E
Sbjct: 64 ---YYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYE 120
Query: 538 CNVP------IIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAP 591
C+ ++H D+KP NI LD + K+ DFGL+K+L D S +T + GT Y++P
Sbjct: 121 CHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV-GTPYYMSP 179
Query: 592 EWFKNVPVSAKVDVYSFGVVL 612
E ++ K D++S G ++
Sbjct: 180 EQLNHMSYDEKSDIWSLGCLI 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 97.0 bits (242), Expect = 3e-22
Identities = 57/193 (29%), Positives = 93/193 (48%), Gaps = 17/193 (8%)
Query: 428 LGRGSFGIVYKGVLKSASGNAVAVKKL------DKLAQEREREFKTEVSAIGRTHHKNLV 481
+G G+ GIV+K + +G VA+KK+ + + RE K A+ H +V
Sbjct: 8 IGEGAHGIVFKAKDR-ETGETVALKKVALRRLEGGIPNQALREIK----ALQACQHPYVV 62
Query: 482 QLLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVR-ISLEIARGLLYLHEECNV 540
+LL G +LV E+M L+ +L RP +V+ + +G+ Y+H
Sbjct: 63 KLLDVFPHGSGFVLVMEYMP-SDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHAN--- 118
Query: 541 PIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVP-V 599
I+H D+KP N+L+ D KI+DFGL++L ++ R + TR Y APE
Sbjct: 119 GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKY 178
Query: 600 SAKVDVYSFGVVL 612
VD+++ G +
Sbjct: 179 DPGVDLWAVGCIF 191
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 95.3 bits (237), Expect = 7e-22
Identities = 67/197 (34%), Positives = 98/197 (49%), Gaps = 19/197 (9%)
Query: 427 ELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGF 486
+LG G +G VY+GV K VAVK L + E E EF E + + H NLVQLLG
Sbjct: 13 KLGGGQYGEVYEGVWKK-YSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGV 70
Query: 487 CDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISL-----EIARGLLYLHEECNVP 541
C ++ EFM G NLL + + + L +I+ + YL ++
Sbjct: 71 CTREPPFYIITEFMTYG---NLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---N 124
Query: 542 IIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTR---GYVAPEWFKNVP 598
IH D+ +N L+ ++ K++DFGLS+L+ D T T G + + APE
Sbjct: 125 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD---TYTAHAGAKFPIKWTAPESLAYNK 181
Query: 599 VSAKVDVYSFGVVLLKI 615
S K DV++FGV+L +I
Sbjct: 182 FSIKSDVWAFGVLLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 8e-22
Identities = 64/216 (29%), Positives = 102/216 (47%), Gaps = 31/216 (14%)
Query: 424 FEEELGRGSFGIVYKGVLKSAS-GNA---VAVKKLDKLAQERERE-FKTEVSAIGRTHHK 478
+ ELG G+FG V+ G N VAVK L + A R+ F+ E + H+
Sbjct: 9 LKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHE 68
Query: 479 NLVQLLGFCDEGLNRLLVYEFMGNGTLANLL---------FAIPRPD-----WSLRVRIS 524
N+V+ G C EG ++V+E+M +G L L P S ++I+
Sbjct: 69 NIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIA 128
Query: 525 LEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLS-DQSRTRTVIR 583
++IA G++YL + +H D+ +N L+ D KI DFG+S+ + + D R +
Sbjct: 129 VQIASGMVYLASQ---HFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYR----VG 181
Query: 584 GTR----GYVAPEWFKNVPVSAKVDVYSFGVVLLKI 615
G ++ PE + + DV+SFGVVL +I
Sbjct: 182 GHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEI 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 8e-22
Identities = 72/279 (25%), Positives = 125/279 (44%), Gaps = 50/279 (17%)
Query: 428 LGRGSFGIVYKGVLKSASGNAVAVKKLD--KLAQEREREFKTEVSAIGRTHHKNLVQLLG 485
LG+GS+G VYK V + + A+K++D ++Q+ + E+ + +H N++
Sbjct: 8 LGKGSYGSVYK-VKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNII---S 63
Query: 486 FCDEGL--NRL-LVYEFMGNGTLANLL-----FAIPRPD---WSLRVRISLEIARGLLYL 534
+ + L N+L +V E+ G L+ + P+ W RI +++ RGL L
Sbjct: 64 YKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIW----RIFIQLLRGLQAL 119
Query: 535 HEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWF 594
HE+ I+H D+K NILL + KI D G+SK+L + ++T+ GT Y+APE +
Sbjct: 120 HEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQI---GTPHYMAPEVW 173
Query: 595 KNVPVSAKVDVYSFGVVLLKIICCKRSVEME---LGEERSAILTDWAYDCYVEGKLDVLV 651
K P S K D++S G +L ++ + E + + R + GK +
Sbjct: 174 KGRPYSYKSDIWSLGCLLYEM--ATFAPPFEARSMQDLRYKVQR---------GKYPPIP 222
Query: 652 DNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690
D + ++ P RP I+
Sbjct: 223 PIYS---QDLQNFIRSMLQV------KPKLRPNCDKILA 252
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 9e-22
Identities = 58/190 (30%), Positives = 100/190 (52%), Gaps = 6/190 (3%)
Query: 427 ELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGF 486
++G GS GIV KS +G VAVKK+D Q+R EV + H N+V++
Sbjct: 26 KIGEGSTGIVCIATDKS-TGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSS 84
Query: 487 CDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCD 546
G +V EF+ G L +++ R + + L + + L +LH + +IH D
Sbjct: 85 YLVGDELWVVMEFLEGGALTDIVTHT-RMNEEQIATVCLAVLKALSFLHAQ---GVIHRD 140
Query: 547 IKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVY 606
IK +ILL D K+SDFG + + R ++++ GT ++APE +P +VD++
Sbjct: 141 IKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLV-GTPYWMAPEVISRLPYGTEVDIW 199
Query: 607 SFGVVLLKII 616
S G+++++++
Sbjct: 200 SLGIMVIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 1e-21
Identities = 69/203 (33%), Positives = 106/203 (52%), Gaps = 23/203 (11%)
Query: 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLD--KLAQEREREFKTEVSAIGRTHHKNLVQL 483
++G+GSFG+V+K V K+ A+K++D K+ + E E + + +++
Sbjct: 6 NKIGKGSFGVVFKVVRKA-DKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRY 64
Query: 484 L-GFCDEG-LNRLLVYEFMGNGTLANLLFAI---PRPD---WSLRVRISLEIARGLLYLH 535
F D+G LN +V E+ NG L LL P P+ W ++I L GL +LH
Sbjct: 65 YESFLDKGKLN--IVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILL----GLAHLH 118
Query: 536 EECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFK 595
+ I+H DIK N+ LD KI D G++K LLSD + I GT Y++PE +
Sbjct: 119 SK---KILHRDIKSLNLFLDAYDNVKIGDLGVAK-LLSDNTNFANTIVGTPYYLSPELCE 174
Query: 596 NVPVSAKVDVYSFGVVLLKIICC 618
+ P + K DV++ GVVL + CC
Sbjct: 175 DKPYNEKSDVWALGVVLYE--CC 195
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 93.9 bits (234), Expect = 2e-21
Identities = 63/204 (30%), Positives = 107/204 (52%), Gaps = 30/204 (14%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQL 483
E+LG GS+G VYK + K +G VA+K + +E +E E+S + + +V+
Sbjct: 7 ILEKLGEGSYGSVYKAIHKE-TGQVVAIKVV--PVEEDLQEIIKEISILKQCDSPYIVKY 63
Query: 484 LG--FCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISL---EIA-------RGL 531
G F + L +V E+ G G++++++ +L EIA +GL
Sbjct: 64 YGSYFKNTDL--WIVMEYCGAGSVSDIMKIT---------NKTLTEEEIAAILYQTLKGL 112
Query: 532 LYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAP 591
YLH + IH DIK NILL+++ AK++DFG+S L ++ TVI GT ++AP
Sbjct: 113 EYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVI-GTPFWMAP 168
Query: 592 EWFKNVPVSAKVDVYSFGVVLLKI 615
E + + + K D++S G+ +++
Sbjct: 169 EVIQEIGYNNKADIWSLGITAIEM 192
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 2e-21
Identities = 81/275 (29%), Positives = 131/275 (47%), Gaps = 38/275 (13%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNAVAVKK--LDKLAQEREREFKTEVSAIGRTHHKNLV 481
E +G G+ +VY + + VA+K+ L+K + E + EV A+ + +H N+V
Sbjct: 5 LIEVIGVGATAVVYAAICL-PNNEKVAIKRIDLEKCQTSVD-ELRKEVQAMSQCNHPNVV 62
Query: 482 QLLGFCDEGLNRLLVYEFMGNGTLANLL-FAIPRP--DWSLRVRISLEIARGLLYLHEEC 538
+ G LV ++ G+L +++ + PR D ++ + E+ +GL YLH
Sbjct: 63 KYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG 122
Query: 539 NVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSD---QSRTRTVIRGTRGYVAPEWFK 595
IH DIK NILL +D + KI+DFG+S L + R GT ++APE +
Sbjct: 123 Q---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVME 179
Query: 596 NVP-VSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVL-VDN 653
V K D++SFG+ ++E+ G Y Y K+ +L + N
Sbjct: 180 QVHGYDFKADIWSFGIT---------AIELATGAA--------PYSKYPPMKVLMLTLQN 222
Query: 654 DKAAM---ADKSRACKWL--MIALWCIQEDPLKRP 683
D ++ AD + K MI+L C+Q+DP KRP
Sbjct: 223 DPPSLETGADYKKYSKSFRKMISL-CLQKDPSKRP 256
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 3e-21
Identities = 70/197 (35%), Positives = 102/197 (51%), Gaps = 19/197 (9%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNAVAVK--KLDKLAQEREREFKTEVSAIGRTHHKNLV 481
+ +G+G FG V G + GN VAVK K D AQ F E S + + H NLV
Sbjct: 10 LLQTIGKGEFGDVMLGDYR---GNKVAVKCIKNDATAQA----FLAEASVMTQLRHSNLV 62
Query: 482 QLLGFCDEGLNRL-LVYEFMGNGTLANLLFAIPRP--DWSLRVRISLEIARGLLYLHEEC 538
QLLG E L +V E+M G+L + L + R ++ SL++ + YL E
Sbjct: 63 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL--EA 120
Query: 539 NVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVP 598
N +H D+ +N+L+ +D AK+SDFGL+K S Q + ++ T APE +
Sbjct: 121 N-NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKK 175
Query: 599 VSAKVDVYSFGVVLLKI 615
S K DV+SFG++L +I
Sbjct: 176 FSTKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 3e-21
Identities = 62/199 (31%), Positives = 103/199 (51%), Gaps = 20/199 (10%)
Query: 426 EELGRGSFGIVYKGVLKSASGNAVAVKKL-DKLAQEREREFKTEVSAIGRTHHKNLVQLL 484
E++G+G+FG VYKGVLK VAVK L + +R+F E + + H N+V+L+
Sbjct: 1 EKIGKGNFGDVYKGVLK--GNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLI 58
Query: 485 GFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVR----ISLEIARGLLYLHEECNV 540
G C + +V E + G+L L + L V+ +SL+ A G+ YL +
Sbjct: 59 GVCVQKQPIYIVMELVPGGSLLTFL---RKKKNRLTVKKLLQMSLDAAAGMEYLESKN-- 113
Query: 541 PIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTR----GYVAPEWFKN 596
IH D+ +N L+ ++ KISDFG+S+ ++ TV G + + APE
Sbjct: 114 -CIHRDLAARNCLVGENNVLKISDFGMSR---EEEGGIYTVSDGLKQIPIKWTAPEALNY 169
Query: 597 VPVSAKVDVYSFGVVLLKI 615
+++ DV+S+G++L +
Sbjct: 170 GRYTSESDVWSYGILLWET 188
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 4e-21
Identities = 62/193 (32%), Positives = 95/193 (49%), Gaps = 7/193 (3%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQL 483
F +ELG G FG+V G K VA+K + K E EF E + + H+ LVQL
Sbjct: 8 FLKELGTGQFGVVKYG--KWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMKLSHEKLVQL 64
Query: 484 LGFCDEGLNRLLVYEFMGNGTLANLLFA-IPRPDWSLRVRISLEIARGLLYLHEECNVPI 542
G C + +V E+M NG L N L R S + + ++ G+ YL +
Sbjct: 65 YGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESK---QF 121
Query: 543 IHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPVSAK 602
IH D+ +N L+D K+SDFGLS+ +L D+ + + + PE S+K
Sbjct: 122 IHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSK 181
Query: 603 VDVYSFGVVLLKI 615
DV++FGV++ ++
Sbjct: 182 SDVWAFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.5 bits (233), Expect = 6e-21
Identities = 61/193 (31%), Positives = 98/193 (50%), Gaps = 14/193 (7%)
Query: 426 EELGRGSFGIVYKGVLKSA-SGNAVAVKKLDKLAQEREREFKT---EVSAIGRTHHKNLV 481
++G G++G+VYK + +G VA+KK+ KL E E KT E+ + +H N++
Sbjct: 5 GKIGEGTYGVVYKA--RDKLTGEIVAIKKI-KLRFESEGIPKTALREIKLLKELNHPNII 61
Query: 482 QLLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRP-DWSLRVRISLEIARGLLYLHEECNV 540
+LL + LV+EFM + L L+ R SL ++ +GL + H
Sbjct: 62 KLLDVFRHKGDLYLVFEFM-DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSH--- 117
Query: 541 PIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPV- 599
I+H D+KP+N+L++ + K++DFGL++ S R T TR Y APE
Sbjct: 118 GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RPYTHYVVTRWYRAPELLLGDKGY 176
Query: 600 SAKVDVYSFGVVL 612
S VD++S G +
Sbjct: 177 STPVDIWSVGCIF 189
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 6e-21
Identities = 70/208 (33%), Positives = 110/208 (52%), Gaps = 27/208 (12%)
Query: 428 LGRGSFGIVYKGVLKSASGNA----VAVKKLDKLA-QEREREFKTEVSAIGRTHHKNLVQ 482
LG G+FG VY+G+ + G+A VAVK L + ++ E +F E + + +H+N+V+
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73
Query: 483 LLGFCDEGLNRLLVYEFMGNGTLANLL-FAIPRPD--WSLRVR----ISLEIARGLLYLH 535
L+G E L R ++ E M G L + L PRP+ SL ++ + ++A+G YL
Sbjct: 74 LIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE 133
Query: 536 EECNVPIIHCDIKPQNILLDQ---DFTAKISDFGLSKLLLSDQSRTRTVIRGTRG----- 587
E IH DI +N LL AKI+DFG+++ D R +G R
Sbjct: 134 EN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMAR----DIYRASYYRKGGRAMLPIK 186
Query: 588 YVAPEWFKNVPVSAKVDVYSFGVVLLKI 615
++ PE F + ++K DV+SFGV+L +I
Sbjct: 187 WMPPEAFLDGIFTSKTDVWSFGVLLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 7e-21
Identities = 57/195 (29%), Positives = 95/195 (48%), Gaps = 8/195 (4%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQL 483
+LG G FG V++G+ + + VAVK L K ++F E + + H L+QL
Sbjct: 10 LLRKLGAGQFGEVWEGLWNNTT--PVAVKTL-KPGTMDPKDFLAEAQIMKKLRHPKLIQL 66
Query: 484 LGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSL--RVRISLEIARGLLYLHEECNVP 541
C +V E M G+L L L + ++ ++A G+ YL E N
Sbjct: 67 YAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYL-EAQN-- 123
Query: 542 IIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPVSA 601
IH D+ +N+L+ ++ K++DFGL++++ D R + + APE S
Sbjct: 124 YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSI 183
Query: 602 KVDVYSFGVVLLKII 616
K DV+SFG++L +I+
Sbjct: 184 KSDVWSFGILLTEIV 198
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 9e-21
Identities = 64/197 (32%), Positives = 101/197 (51%), Gaps = 18/197 (9%)
Query: 426 EELGRGSFGIVYKGVLKSASGNAVAVKKL-----DKLAQEREREFKTEVSAIGRTHHKNL 480
E LG GSFG VY+G L G+ AVK++ + QE ++ + E++ + + H N+
Sbjct: 6 ELLGSGSFGSVYEG-LNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNI 64
Query: 481 VQLLGFCDEGLNRLLVYEFMGNGTLANLLF---AIPRPDWSLRVRISLEIARGLLYLHEE 537
VQ LG E N + E + G+LA LL + P P L R +I GL YLH
Sbjct: 65 VQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTR---QILLGLEYLH-- 119
Query: 538 CNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNV 597
+ +H DIK NIL+D + K++DFG++K ++ S ++ +G+ ++APE
Sbjct: 120 -DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVE-FSFAKSF-KGSPYWMAPEVIAQQ 176
Query: 598 -PVSAKVDVYSFGVVLL 613
D++S G +L
Sbjct: 177 GGYGLAADIWSLGCTVL 193
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 91.6 bits (228), Expect = 2e-20
Identities = 62/204 (30%), Positives = 94/204 (46%), Gaps = 18/204 (8%)
Query: 428 LGRGSFGIVYKGVLKSASGNAVAVK--KLDKLAQEREREFKTEVSAIGRTHHKNLVQLLG 485
+G G+FG VY V +G +AVK ++ + +E E+ + H NLV+ G
Sbjct: 8 IGGGTFGKVYTAV-NLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYG 66
Query: 486 FCDEGLNRLLVYEFM---GNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPI 542
++R VY FM GTL LL D + +L++ GL YLH I
Sbjct: 67 V---EVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSH---GI 120
Query: 543 IHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRG---YVAPEWFKNVPV 599
+H DIKP NI LD + K+ DFG + L ++ + ++ G Y+APE
Sbjct: 121 VHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKG 180
Query: 600 SAK---VDVYSFGVVLLKIICCKR 620
D++S G V+L++ KR
Sbjct: 181 KGHGRAADIWSLGCVVLEMATGKR 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 2e-20
Identities = 81/279 (29%), Positives = 133/279 (47%), Gaps = 27/279 (9%)
Query: 425 EEELGRGSFGIVYKGVLKSA--SGNAVAVKKLDKLAQERER-EFKTEVSAIGRTHHKNLV 481
++ +G G FG V++G+LK AVA+K L E++R +F +E S +G+ H N++
Sbjct: 10 QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNII 69
Query: 482 QLLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLE-IARGLLYLHEECNV 540
+L G + +++ E+M NG L L S ++ L IA G+ YL ++
Sbjct: 70 RLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYL---SDM 126
Query: 541 PIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRG--YVAPEWFKNVP 598
+H D+ +NIL++ + K+SDFGLS++L D T T G + APE
Sbjct: 127 NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRK 186
Query: 599 VSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDK-AA 657
++ DV+SFG+V+ ++ M GE +D + + D + A
Sbjct: 187 FTSASDVWSFGIVMWEV--------MSFGERPY-------WDMSNHEVMKAINDGFRLPA 231
Query: 658 MADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYL 696
D A LM+ W Q+D +RP IV +L+ L
Sbjct: 232 PMDCPSAVYQLMLQCW--QQDRARRPRFVDIVNLLDKLL 268
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 96.5 bits (240), Expect = 2e-20
Identities = 63/196 (32%), Positives = 99/196 (50%), Gaps = 24/196 (12%)
Query: 445 SGNAVAVKKLDKLAQERERE---FKTEVSAIGRTHHKNLVQLL--GFCDEGLNRLLVYEF 499
+G+ VA+K L A E E + F+ E + R +H N+V LL G GL V+E+
Sbjct: 2 TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGL-LFAVFEY 60
Query: 500 MGNGTLANLLF---AIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQ 556
+ TL +L A+P + R+ L++ L H N I+H D+KPQNI++ Q
Sbjct: 61 VPGRTLREVLAADGALPAGE---TGRLMLQVLDALACAH---NQGIVHRDLKPQNIMVSQ 114
Query: 557 -DFT--AKISDFGLSKLL--LSDQSRTR----TVIRGTRGYVAPEWFKNVPVSAKVDVYS 607
AK+ DFG+ LL + D T + GT Y APE + PV+ D+Y+
Sbjct: 115 TGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYA 174
Query: 608 FGVVLLKIICCKRSVE 623
+G++ L+ + +R V+
Sbjct: 175 WGLIFLECLTGQRVVQ 190
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.2 bits (227), Expect = 2e-20
Identities = 67/191 (35%), Positives = 97/191 (50%), Gaps = 23/191 (12%)
Query: 417 LNEATNGFE--EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGR 474
L + T FE E +G G++G VYK K G VA+K +D + ++ E E K E + + +
Sbjct: 1 LPDPTGIFELVEVIGEGTYGKVYKARHKKT-GQLVAIKIMD-IIEDEEEEIKEEYNILRK 58
Query: 475 -THHKNLVQLLGF--------CDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLR----V 521
++H N+ G D+ L LV E G G++ +L+ + + L+
Sbjct: 59 YSNHPNIATFYGAFIKKNPPGNDDQL--WLVMELCGGGSVTDLVKGLRKKGKRLKEEWIA 116
Query: 522 RISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTV 581
I E RGL YLHE +IH DIK QNILL ++ K+ DFG+S L S R T
Sbjct: 117 YILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTF 173
Query: 582 IRGTRGYVAPE 592
I GT ++APE
Sbjct: 174 I-GTPYWMAPE 183
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.2 bits (227), Expect = 3e-20
Identities = 63/198 (31%), Positives = 101/198 (51%), Gaps = 15/198 (7%)
Query: 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKT---EVSAIGRTHHKNLVQ 482
+G G++G+V K K A+G VA+KK K +++ E KT EV + + H+N+V
Sbjct: 7 GVVGEGAYGVVLKCRNK-ATGEIVAIKKF-KESEDDEDVKKTALREVKVLRQLRHENIVN 64
Query: 483 LLGFCDEGLNRL-LVYEFMGNGTLANLLFAIPR--PDWSLRVRISLEIARGLLYLHEECN 539
L RL LV+E++ TL LL A P P ++R ++ + + Y H
Sbjct: 65 LKEAFRRK-GRLYLVFEYVER-TLLELLEASPGGLPPDAVR-SYIWQLLQAIAYCHSH-- 119
Query: 540 VPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWF-KNVP 598
IIH DIKP+NIL+ + K+ DFG ++ L + + T TR Y APE +
Sbjct: 120 -NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTN 178
Query: 599 VSAKVDVYSFGVVLLKII 616
VDV++ G ++ +++
Sbjct: 179 YGKPVDVWAIGCIMAELL 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 3e-20
Identities = 67/207 (32%), Positives = 110/207 (53%), Gaps = 26/207 (12%)
Query: 428 LGRGSFGIVYKGVLKSASGNAVAVKKL-----DKLAQERERE----FKTEVSAIGRTHHK 478
+G GSFG VY G + ++SG +AVK++ +++R+R E++ + H+
Sbjct: 8 IGSGSFGSVYLG-MNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 479 NLVQLLGFCDEGLNRLLVY-EFMGNGTLANLLF---AIPRPDWSLRVRISLEIARGLLYL 534
N+VQ LG + L ++ E++ G++A LL A VR +I +GL YL
Sbjct: 67 NIVQYLG-SSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVR---QILKGLNYL 122
Query: 535 HEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSK-----LLLSDQSRTRTVIRGTRGYV 589
H N IIH DIK NIL+D KISDFG+SK L + + R ++G+ ++
Sbjct: 123 H---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWM 179
Query: 590 APEWFKNVPVSAKVDVYSFGVVLLKII 616
APE K + K D++S G ++++++
Sbjct: 180 APEVVKQTSYTRKADIWSLGCLVVEML 206
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 3e-20
Identities = 84/286 (29%), Positives = 131/286 (45%), Gaps = 45/286 (15%)
Query: 425 EEELGRGSFGIVYKGVLKSASG--NAVAVKKLDKLAQERER-EFKTEVSAIGRTHHKNLV 481
EE +G G FG V +G LK VA+K L E++R +F +E S +G+ H N++
Sbjct: 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNII 68
Query: 482 QLLGFCDEGLNRLLVYEFMGNGTLANLL------FAIPRPDWSLRVRISLEIARGLLYLH 535
L G + +++ EFM NG L + L F + + LR IA G+ YL
Sbjct: 69 HLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLR-----GIAAGMKYLS 123
Query: 536 EECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSR-TRTVIRGTR---GYVAP 591
E + +H D+ +NIL++ + K+SDFGLS+ L D S T T G + + AP
Sbjct: 124 E---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAP 180
Query: 592 EWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVL- 650
E ++ DV+S+G+V+ ++ M GE +++ DV+
Sbjct: 181 EAIAYRKFTSASDVWSYGIVMWEV--------MSYGERPYWDMSNQ----------DVIN 222
Query: 651 -VDNDK--AAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLE 693
++ D D A LM+ W Q+D RP IV L+
Sbjct: 223 AIEQDYRLPPPMDCPTALHQLMLDCW--QKDRNARPKFGQIVSTLD 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 4e-20
Identities = 61/195 (31%), Positives = 97/195 (49%), Gaps = 11/195 (5%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQL 483
F +ELG G FG+V+ G K + VA+K +++ A E +F E + + H LVQL
Sbjct: 8 FMKELGSGQFGVVHLG--KWRAQIKVAIKAINEGAMS-EEDFIEEAKVMMKLSHPKLVQL 64
Query: 484 LGFCDEGLNRLLVYEFMGNGTLANLL---FAIPRPDWSLRVRISLEIARGLLYLHEECNV 540
G C + +V EFM NG L N L D L + ++ G+ YL
Sbjct: 65 YGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLL--SMCQDVCEGMEYLERN--- 119
Query: 541 PIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPVS 600
IH D+ +N L+ K+SDFG+++ +L D+ + + + + PE F S
Sbjct: 120 SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYS 179
Query: 601 AKVDVYSFGVVLLKI 615
+K DV+SFGV++ ++
Sbjct: 180 SKSDVWSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 90.1 bits (224), Expect = 5e-20
Identities = 64/210 (30%), Positives = 103/210 (49%), Gaps = 29/210 (13%)
Query: 427 ELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFK---TEVSAIGRTHHKNLVQL 483
ELG G+ G+V K VL +G +AVK + + E K E+ + + + +V
Sbjct: 8 ELGAGNSGVVSK-VLHRPTGKIMAVKTI--RLEINEAIQKQILRELDILHKCNSPYIVGF 64
Query: 484 LG-FCDEGLNRLLVYEFMGNGTLANLL----FAIPRPDWSLRVRISLEIARGLLYLHEEC 538
G F + G + + E+M G+L +L IP +I++ + +GL YLHE+
Sbjct: 65 YGAFYNNG-DISICMEYMDGGSLDKILKEVQGRIPERILG---KIAVAVLKGLTYLHEKH 120
Query: 539 NVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVP 598
IIH D+KP NIL++ K+ DFG+S L++ ++T GT Y+APE +
Sbjct: 121 K--IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFV---GTSSYMAPERIQGND 175
Query: 599 VSAKVDVYSFGVVLLKIICCKRSVEMELGE 628
S K D++S G+ L +E+ G
Sbjct: 176 YSVKSDIWSLGLSL---------IELATGR 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 6e-20
Identities = 70/278 (25%), Positives = 128/278 (46%), Gaps = 44/278 (15%)
Query: 428 LGRGSFG--IVYKGVLKSASGNAVAVKKLD--KLAQEREREFKTEVSAIGRTHHKNLVQL 483
LG+G+FG +Y+ ++ + V K+++ +L+++ R+ E+ + H N++
Sbjct: 8 LGKGAFGEATLYR---RTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAY 64
Query: 484 LG-FCDEGLNRLLV-YEFMGNGTLAN-------LLFAIPRPDWSLRVRISLEIARGLLYL 534
F D+ N LL+ E+ GTL + LF W L +I + Y+
Sbjct: 65 YNHFMDD--NTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYL-----FQIVSAVSYI 117
Query: 535 HEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWF 594
H+ I+H DIK NI L + K+ DFG+SK+L S+ S TV+ GT Y++PE
Sbjct: 118 HKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVV-GTPYYMSPELC 173
Query: 595 KNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDND 654
+ V + K D+++ G VL +++ KR+ + ++ V+G +V
Sbjct: 174 QGVKYNFKSDIWALGCVLYELLTLKRTFD---ATNPLNLVVK-----IVQGNYTPVVSVY 225
Query: 655 KAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQML 692
+ + + + +Q+DP KRP ++
Sbjct: 226 SSEL---------ISLVHSLLQQDPEKRPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 7e-20
Identities = 59/190 (31%), Positives = 101/190 (53%), Gaps = 6/190 (3%)
Query: 427 ELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGF 486
++G GS GIV +KS SG VAVKK+D Q+R EV + H+N+V++
Sbjct: 27 KIGEGSTGIVCIATVKS-SGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNS 85
Query: 487 CDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCD 546
G +V EF+ G L +++ R + + L + + L LH + +IH D
Sbjct: 86 YLVGDELWVVMEFLEGGALTDIV-THTRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRD 141
Query: 547 IKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVY 606
IK +ILL D K+SDFG + + R ++++ GT ++APE +P +VD++
Sbjct: 142 IKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV-GTPYWMAPELISRLPYGPEVDIW 200
Query: 607 SFGVVLLKII 616
S G+++++++
Sbjct: 201 SLGIMVIEMV 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.9 bits (224), Expect = 8e-20
Identities = 67/197 (34%), Positives = 99/197 (50%), Gaps = 14/197 (7%)
Query: 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKT---EVSAIGRTHHKNLVQ 482
E+LG G++G+VYK K +G VA+KK+ +L E E T E+S + H N+V+
Sbjct: 5 EKLGEGTYGVVYKARDK-KTGEIVALKKI-RLDNEEEGIPSTALREISLLKELKHPNIVK 62
Query: 483 LLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRP-DWSLRVRISLEIARGLLYLHEECNVP 541
LL LV+E+ L L P P +L I ++ RGL Y H
Sbjct: 63 LLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR--- 118
Query: 542 IIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSR-TRTVIRGTRGYVAPEWFKNVPV- 599
I+H D+KPQNIL+++D K++DFGL++ T V+ T Y APE
Sbjct: 119 ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV--TLWYRAPEILLGSKHY 176
Query: 600 SAKVDVYSFGVVLLKII 616
S VD++S G + ++I
Sbjct: 177 STAVDIWSVGCIFAEMI 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.6 bits (223), Expect = 1e-19
Identities = 61/200 (30%), Positives = 97/200 (48%), Gaps = 21/200 (10%)
Query: 426 EELGRGSFGIVYKGVLKSASGNAVAVKKL------DKLAQEREREFKTEVSAIGRTHHKN 479
E+G G++G VYK + +G VA+KK+ + + RE + + H N
Sbjct: 5 AEIGEGAYGTVYKARDLN-TGRFVALKKVRVPLSEEGIPLSTLREIAL-LKQLESFEHPN 62
Query: 480 LVQLLGFC-----DEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRV--RISLEIARGLL 532
+V+LL C D L LV+E + + LA L P+P + ++ RG+
Sbjct: 63 IVRLLDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPGLPPETIKDLMRQLLRGVD 121
Query: 533 YLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPE 592
+LH I+H D+KPQNIL+ D KI+DFGL+++ + + T V+ T Y APE
Sbjct: 122 FLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVV--TLWYRAPE 176
Query: 593 WFKNVPVSAKVDVYSFGVVL 612
+ VD++S G +
Sbjct: 177 VLLQSSYATPVDMWSVGCIF 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 1e-19
Identities = 63/190 (33%), Positives = 98/190 (51%), Gaps = 6/190 (3%)
Query: 427 ELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGF 486
++G GS GIV K +G VAVKK+D Q+R EV + HH+N+V +
Sbjct: 29 KIGEGSTGIVCIATEKH-TGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNS 87
Query: 487 CDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCD 546
G +V EF+ G L +++ R + + L + R L YLH N +IH D
Sbjct: 88 YLVGDELWVVMEFLEGGALTDIV-THTRMNEEQIATVCLSVLRALSYLH---NQGVIHRD 143
Query: 547 IKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVY 606
IK +ILL D K+SDFG + S + R + GT ++APE +P +VD++
Sbjct: 144 IKSDSILLTSDGRIKLSDFGFCAQV-SKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIW 202
Query: 607 SFGVVLLKII 616
S G++++++I
Sbjct: 203 SLGIMVIEMI 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 1e-19
Identities = 73/267 (27%), Positives = 133/267 (49%), Gaps = 26/267 (9%)
Query: 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQERERE-FKTEVSAIGRTHHKNLVQLL 484
E +G+GSFG V+KG+ + + VA+K +D E E E + E++ + + + +
Sbjct: 10 ERIGKGSFGEVFKGI-DNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYY 68
Query: 485 GFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIH 544
G +G ++ E++G G+ +LL A P ++ + + EI +GL YLH E IH
Sbjct: 69 GSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLK-EILKGLDYLHSEKK---IH 124
Query: 545 CDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPVSAKVD 604
DIK N+LL + K++DFG++ L Q + T + GT ++APE + +K D
Sbjct: 125 RDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIQQSAYDSKAD 183
Query: 605 VYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAM-ADKSR 663
++S G+ ++E+ GE ++ D + L ++ N+ + + S+
Sbjct: 184 IWSLGIT---------AIELAKGEPPNS-------DMHPMRVLFLIPKNNPPTLTGEFSK 227
Query: 664 ACKWLMIALWCIQEDPLKRPAMKMIVQ 690
K + A C+ +DP RP K +++
Sbjct: 228 PFKEFIDA--CLNKDPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.5 bits (220), Expect = 1e-19
Identities = 64/197 (32%), Positives = 96/197 (48%), Gaps = 14/197 (7%)
Query: 425 EEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLL 484
E +LG G FG V+ G + VAVK L K F E + + H LVQL
Sbjct: 11 ERKLGAGQFGEVWMGTWNGTT--KVAVKTL-KPGTMSPEAFLQEAQIMKKLRHDKLVQLY 67
Query: 485 GFCDEGLNRLLVYEFMGNGTLANLL-----FAIPRPDWSLRVRISLEIARGLLYLHEECN 539
C E +V E+M G+L + L + P V ++ +IA G+ YL E N
Sbjct: 68 AVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQL---VDMAAQIAEGMAYL-ESRN 123
Query: 540 VPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPV 599
IH D+ +NIL+ ++ KI+DFGL++L+ D+ R + + APE
Sbjct: 124 Y--IHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRF 181
Query: 600 SAKVDVYSFGVVLLKII 616
+ K DV+SFG++L +I+
Sbjct: 182 TIKSDVWSFGILLTEIV 198
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 2e-19
Identities = 62/208 (29%), Positives = 103/208 (49%), Gaps = 21/208 (10%)
Query: 428 LGRGSFGIVYKGVLKSASGNAVAVKKL--DKLAQEREREFKTEVSAIGRTHHKNLVQLLG 485
+GRG+FGIV+ + A V +K++ +++ ++ + E + H N+++
Sbjct: 8 VGRGAFGIVHL-CRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66
Query: 486 FCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLE-------IARGLLYLHEEC 538
E ++V E+ GTLA + R L+ + LL LH
Sbjct: 67 NFLEDKALMIVMEYAPGGTLAEYI--------QKRCNSLLDEDTILHFFVQILLALHHVH 118
Query: 539 NVPIIHCDIKPQNILLDQDFTA-KISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNV 597
I+H D+K QNILLD+ KI DFG+SK+L S +S+ TV+ GT Y++PE +
Sbjct: 119 TKLILHRDLKTQNILLDKHKMVVKIGDFGISKIL-SSKSKAYTVV-GTPCYISPELCEGK 176
Query: 598 PVSAKVDVYSFGVVLLKIICCKRSVEME 625
P + K D+++ G VL ++ KR+ E
Sbjct: 177 PYNQKSDIWALGCVLYELASLKRAFEAA 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 87.8 bits (218), Expect = 2e-19
Identities = 66/213 (30%), Positives = 95/213 (44%), Gaps = 17/213 (7%)
Query: 429 GRGSFGIVYKGVLKSASGNAVAVKKLDK---LAQEREREFKTEVSAIGRTHHKNLVQL-L 484
G+G+FG V V K + A+K ++K + + R E + +H LV L
Sbjct: 9 GKGAFGKVCI-VQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWY 67
Query: 485 GFCDEGLNRLLVYEFMGNGTLANLLFAIPR--PDWSLRVRISL-EIARGLLYLHEECNVP 541
F DE N LV + + G +L + + + +V+ + EI L YLH +
Sbjct: 68 SFQDEE-NMYLVVDLLLGG---DLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSK---G 120
Query: 542 IIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPVSA 601
IIH DIKP NILLD+ I+DF ++ + D T T GT GY+APE S
Sbjct: 121 IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTS--GTPGYMAPEVLCRQGYSV 178
Query: 602 KVDVYSFGVVLLKIICCKRSVEMELGEERSAIL 634
VD +S GV + + KR R I
Sbjct: 179 AVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIR 211
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 3e-19
Identities = 59/203 (29%), Positives = 102/203 (50%), Gaps = 20/203 (9%)
Query: 426 EELGRGSFGIVYKGVLKSASGNAVAVKKL-----DKLAQERE-REFKTEVSAIGRTHHKN 479
E LG+G++G VY G+ + G +AVK++ + LA E+E + + EV + H N
Sbjct: 6 EVLGKGAYGTVYCGL--TNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVN 63
Query: 480 LVQLLGFCDEGLNRLLVYEFMGNGTLANLL--FAIPRPDWSLRVRISLEIARGLLYLHEE 537
+VQ LG C + + EF+ G+++++L F P P+ + + +I G+ YLH
Sbjct: 64 IVQYLGTCLDDNTISIFMEFVPGGSISSILNRFG-PLPEPVFC-KYTKQILDGVAYLHNN 121
Query: 538 CNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLL-----SDQSRTRTVIRGTRGYVAPE 592
C ++H DIK N++L + K+ DFG ++ L S + GT ++APE
Sbjct: 122 C---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPE 178
Query: 593 WFKNVPVSAKVDVYSFGVVLLKI 615
K D++S G + ++
Sbjct: 179 VINESGYGRKSDIWSIGCTVFEM 201
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 87.3 bits (217), Expect = 4e-19
Identities = 61/201 (30%), Positives = 96/201 (47%), Gaps = 16/201 (7%)
Query: 428 LGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREF---KTEVSAIGRTHHKNLVQLL 484
+ +G++G V+ K ++G+ A+K + K R+ + TE + + +V+L
Sbjct: 1 ISKGAYGRVFL-AKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY 59
Query: 485 -GFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPII 543
F + N LV E++ G LA+LL + D + EI L YLH + II
Sbjct: 60 YSFQGKK-NLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLH---SNGII 115
Query: 544 HCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTV-------IRGTRGYVAPEWFKN 596
H D+KP NIL+D + K++DFGLSK+ L + I GT Y+APE
Sbjct: 116 HRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILG 175
Query: 597 VPVSAKVDVYSFGVVLLKIIC 617
S VD +S G +L + +
Sbjct: 176 QGHSKTVDWWSLGCILYEFLV 196
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 4e-19
Identities = 65/197 (32%), Positives = 99/197 (50%), Gaps = 11/197 (5%)
Query: 424 FEEELGRGSFGIVYK---GVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNL 480
F ++LG+G+FG V L+ +G VAVKKL E R+F+ E+ + H N+
Sbjct: 8 FIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNI 67
Query: 481 VQLLGFC-DEGLNRL-LVYEFMGNGTLANLLFA-IPRPDWSLRVRISLEIARGLLYLHEE 537
V+ G C G L LV E++ G+L + L R D + + +I +G+ YL +
Sbjct: 68 VKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSK 127
Query: 538 CNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRG--YVAPEWFK 595
+H D+ +NIL++ + KI DFGL+K+L D+ + G + APE
Sbjct: 128 ---RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLT 184
Query: 596 NVPVSAKVDVYSFGVVL 612
S DV+SFGVVL
Sbjct: 185 ESKFSVASDVWSFGVVL 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 5e-19
Identities = 61/196 (31%), Positives = 93/196 (47%), Gaps = 15/196 (7%)
Query: 426 EELGRGSFGIVYKGVLKSASGN--AVAVKKL--DKLAQEREREFKTEVSAIGRTHHKNLV 481
++LG GSFG+V +G ++ G VAVK L DKL + +F E + + H+NL+
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKL-SDIMDDFLKEAAIMHSLDHENLI 59
Query: 482 QLLGFC-DEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRV--RISLEIARGLLYLHEEC 538
+L G L ++V E G+L + L + + +++IA G+ YL +
Sbjct: 60 RLYGVVLTHPL--MMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK- 116
Query: 539 NVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLL--SDQSRTRTVIRGTRGYVAPEWFKN 596
IH D+ +NILL D KI DFGL + L D ++ + APE +
Sbjct: 117 --RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRT 174
Query: 597 VPVSAKVDVYSFGVVL 612
S DV+ FGV L
Sbjct: 175 RTFSHASDVWMFGVTL 190
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.6 bits (215), Expect = 8e-19
Identities = 59/192 (30%), Positives = 98/192 (51%), Gaps = 15/192 (7%)
Query: 426 EELGRGSFGIVYKGVLKSASGNAVAVK--KLDKLAQEREREFKTEVSAIGRTHHKNLVQL 483
+ +G G++G VYK A+G VA+K KL+ + + E+S + H N+V
Sbjct: 9 QRIGSGTYGDVYKARDI-ATGELVAIKVIKLE--PGDDFEIIQQEISMLKECRHPNIVAY 65
Query: 484 LGFCDEGLNRL-LVYEFMGNGTLANLLFAIPRPDWSLRVR-ISLEIARGLLYLHEECNVP 541
G ++L +V E+ G G+L ++ P L++ + E +GL YLHE
Sbjct: 66 FG-SYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHE---TG 121
Query: 542 IIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWF---KNVP 598
IH DIK NILL +D K++DFG+S L + ++ ++ I GT ++APE +
Sbjct: 122 KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFI-GTPYWMAPEVAAVERKGG 180
Query: 599 VSAKVDVYSFGV 610
K D+++ G+
Sbjct: 181 YDGKCDIWALGI 192
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 1e-18
Identities = 75/289 (25%), Positives = 128/289 (44%), Gaps = 53/289 (18%)
Query: 427 ELGRGSFGIVY----KGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQ 482
ELG G+FG V+ +L VAVK L + ++ ++F+ E + H+++V+
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71
Query: 483 LLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSL----------------RVRISLE 526
G C EG L+V+E+M +G L L + PD + + I+ +
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDLNRFLRS-HGPDAKILAGGEDVAPGQLTLGQMLAIASQ 130
Query: 527 IARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQ-----SRTRTV 581
IA G++YL ++ +H D+ +N L+ Q KI DFG+S+ + S RT
Sbjct: 131 IASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLP 187
Query: 582 IRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDC 641
IR ++ PE + + D++SFGVVL +I + +L A +C
Sbjct: 188 IR----WMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE-------AIEC 236
Query: 642 YVEGKLDVLVDNDKAAMADKSRACKWLMIALW--CIQEDPLKRPAMKMI 688
+G+ ++ R C + A+ C Q +P +R +K I
Sbjct: 237 ITQGR-----------ELERPRTCPPEVYAIMQGCWQREPQQRMVIKDI 274
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 1e-18
Identities = 74/273 (27%), Positives = 122/273 (44%), Gaps = 34/273 (12%)
Query: 428 LGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFC 487
LG+G++GIVY S +A+K++ + + E++ H+N+VQ LG
Sbjct: 16 LGKGTYGIVYAARDLSTQ-VRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSD 74
Query: 488 DEGLNRLLVYEFMGNGTLANLLFAIPRPDW-------SLRVRISLEIARGLLYLHEECNV 540
E + E + G+L+ LL R W + + +I GL YLH+
Sbjct: 75 SENGFFKIFMEQVPGGSLSALL----RSKWGPLKDNEQTIIFYTKQILEGLKYLHDN--- 127
Query: 541 PIIHCDIKPQNILLDQ-DFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVP- 598
I+H DIK N+L++ KISDFG SK L T T GT Y+APE P
Sbjct: 128 QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTET-FTGTLQYMAPEVIDKGPR 186
Query: 599 -VSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAA 657
A D++S G ++++ K +ELGE ++A+ + + E +
Sbjct: 187 GYGAPADIWSLGCTIVEMATGKPPF-IELGEPQAAMFKVGMFKIHPE---------IPES 236
Query: 658 MADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690
++ +++ L C + DP KR + ++Q
Sbjct: 237 LSAEAKN-----FILRCFEPDPDKRASAHDLLQ 264
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 2e-18
Identities = 61/205 (29%), Positives = 100/205 (48%), Gaps = 20/205 (9%)
Query: 428 LGRGSFGIVYKGVLKSASGNA--VAVK--KLDKLAQEREREFKTEVSAIGRTHHKNLVQL 483
LG G FG V +G L G+ VAVK KLD EF +E + + H N+++L
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 484 LGFCDEGLNR------LLVYEFMGNGTLANLLFAIPRPDWSLR------VRISLEIARGL 531
+G C E + +++ FM +G L + L + ++ ++IA G+
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126
Query: 532 LYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLS-DQSRTRTVIRGTRGYVA 590
YL N IH D+ +N +L +D T ++DFGLSK + S D R + + ++A
Sbjct: 127 EYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIA 183
Query: 591 PEWFKNVPVSAKVDVYSFGVVLLKI 615
E + ++K DV++FGV + +I
Sbjct: 184 IESLADRVYTSKSDVWAFGVTMWEI 208
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 2e-18
Identities = 82/288 (28%), Positives = 133/288 (46%), Gaps = 51/288 (17%)
Query: 425 EEELGRGSFGIVYKGVLKSASGN--AVAVKKLDKLAQERER-EFKTEVSAIGRTHHKNLV 481
E+ +G G FG V G LK VA+K L E++R +F +E S +G+ H N++
Sbjct: 9 EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNII 68
Query: 482 QLLGFCDEGLNRLLVYEFMGNGTLANLL------FAIPRPDWSLRVRISLEIARGLLYLH 535
L G + ++V E+M NG+L L F + + LR IA G+ YL
Sbjct: 69 HLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLR-----GIASGMKYL- 122
Query: 536 EECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRG------YV 589
++ +H D+ +NIL++ + K+SDFGLS++L D T TRG +
Sbjct: 123 --SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYT----TRGGKIPIRWT 176
Query: 590 APEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDV 649
APE ++ DV+S+G+V+ ++ M GE +++ DV
Sbjct: 177 APEAIAYRKFTSASDVWSYGIVMWEV--------MSYGERPYWEMSNQ----------DV 218
Query: 650 LVDNDKA----AMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLE 693
+ ++ A D A LM+ W Q+D +RP + IV +L+
Sbjct: 219 IKAIEEGYRLPAPMDCPAALHQLMLDCW--QKDRNERPKFEQIVSILD 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.0 bits (214), Expect = 2e-18
Identities = 60/207 (28%), Positives = 101/207 (48%), Gaps = 42/207 (20%)
Query: 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKT--------EVSAIGR-TH 476
++LG G+FG VY K +G VA+KK+ +++F + EV ++ +
Sbjct: 5 KQLGDGTFGSVYLARNKE-TGELVAIKKM-------KKKFYSWEECMNLREVKSLRKLNE 56
Query: 477 HKNLVQLLG-FCDEGLNRL-LVYEFMGNGTLANL-------LFAIPRPDWSLRVR-ISLE 526
H N+V+L F + + L V+E+M G L L F+ +R I +
Sbjct: 57 HPNIVKLKEVFREN--DELYFVFEYM-EGNLYQLMKDRKGKPFSESV------IRSIIYQ 107
Query: 527 IARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTR 586
I +GL ++H H D+KP+N+L+ KI+DFGL++ + S T V TR
Sbjct: 108 ILQGLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYV--STR 162
Query: 587 GYVAPEWF-KNVPVSAKVDVYSFGVVL 612
Y APE ++ S+ VD+++ G ++
Sbjct: 163 WYRAPEILLRSTSYSSPVDIWALGCIM 189
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 2e-18
Identities = 60/191 (31%), Positives = 100/191 (52%), Gaps = 7/191 (3%)
Query: 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQERERE-FKTEVSAIGRTHHKNLVQLL 484
E +G+GSFG VYKG+ + + VA+K +D E E E + E++ + + + +
Sbjct: 10 ERIGKGSFGEVYKGI-DNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYY 68
Query: 485 GFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIH 544
G +G ++ E++G G+ +LL P + + I EI +GL YLH E IH
Sbjct: 69 GSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYI-ATILREILKGLDYLHSERK---IH 124
Query: 545 CDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPVSAKVD 604
DIK N+LL + K++DFG++ L Q + T + GT ++APE K K D
Sbjct: 125 RDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAYDFKAD 183
Query: 605 VYSFGVVLLKI 615
++S G+ +++
Sbjct: 184 IWSLGITAIEL 194
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 4e-18
Identities = 59/197 (29%), Positives = 92/197 (46%), Gaps = 17/197 (8%)
Query: 428 LGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTH-----HKNLVQ 482
LG+G FG V A+G A KKLDK +R ++ K E A+ +
Sbjct: 1 LGKGGFGEVC-ACQVKATGKMYACKKLDK---KRLKKRKGEQMALNEKKILEKVSSRFIV 56
Query: 483 LLGFCDEGLNRL-LVYEFMGNGTLANLLFAIPRPDWSL-RVRI-SLEIARGLLYLHEECN 539
L + E + L LV M G L ++ + P + R + +I GL +LH+
Sbjct: 57 SLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR-- 114
Query: 540 VPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPV 599
I++ D+KP+N+LLD +ISD GL+ + L + + GT GY+APE +
Sbjct: 115 -RIVYRDLKPENVLLDDHGNVRISDLGLA-VELKGGKKIKGRA-GTPGYMAPEVLQGEVY 171
Query: 600 SAKVDVYSFGVVLLKII 616
VD ++ G L ++I
Sbjct: 172 DFSVDWFALGCTLYEMI 188
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 6e-18
Identities = 59/216 (27%), Positives = 102/216 (47%), Gaps = 24/216 (11%)
Query: 414 LVELNEATNGFEEELGRGSFGIVYKGVLKSASGNA---VAVKKL-DKLAQEREREFKTEV 469
L L E + LG G+FG VYKGV VA+K L ++ + + +E E
Sbjct: 1 LRILKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEA 60
Query: 470 SAIGRTHHKNLVQLLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRI----SL 525
+ H ++V+LLG C L+ + M L LL + ++ + +
Sbjct: 61 YVMASVDHPHVVRLLGIC-LSSQVQLITQLM---PLGCLLDYVRNHKDNIGSQYLLNWCV 116
Query: 526 EIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRT-----RT 580
+IA+G+ YL E ++H D+ +N+L+ KI+DFGL+KLL D+ +
Sbjct: 117 QIAKGMSYLEE---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKV 173
Query: 581 VIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKII 616
I+ ++A E + + K DV+S+GV + +++
Sbjct: 174 PIK----WMALESILHRIYTHKSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 7e-18
Identities = 54/198 (27%), Positives = 99/198 (50%), Gaps = 15/198 (7%)
Query: 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQERE-REFKTEVSAIGRTHH---KNLV 481
E +GRG++G VY+G +G VA+K ++ + + + + EV+ + + N+
Sbjct: 7 ELIGRGAYGAVYRGK-HVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNIT 65
Query: 482 QLLGFCDEGLNRLLVYEFMGNGTLANLLFA--IPRPDWSLRVRISLEIARGLLYLHEECN 539
+ G +G ++ E+ G++ L+ A I S+ +R E+ L Y+H+
Sbjct: 66 KYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIR---EVLVALKYIHK--- 119
Query: 540 VPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPV 599
V +IH DIK NIL+ K+ DFG++ LL + S+ R+ GT ++APE
Sbjct: 120 VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSK-RSTFVGTPYWMAPEVITEGKY 178
Query: 600 -SAKVDVYSFGVVLLKII 616
K D++S G+ + ++
Sbjct: 179 YDTKADIWSLGITIYEMA 196
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 1e-17
Identities = 80/277 (28%), Positives = 121/277 (43%), Gaps = 48/277 (17%)
Query: 428 LGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFK---TEVSAIGRTHHKNLVQLL 484
LG+G FG V ++ A+G A KKL+K ++ + ++ E + + H + +V L
Sbjct: 1 LGKGGFGEVSACQMR-ATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLA 59
Query: 485 GFCDEGLNRLLVYEFMGNGTL---------ANLLFAIPRPDWSLRVRISLEIARGLLYLH 535
+ LV M G L N F PR + +I GL +LH
Sbjct: 60 YAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRA-----CFYTAQIISGLEHLH 114
Query: 536 EECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFK 595
+ II+ D+KP+N+LLD D +ISD GL+ L QS+T+ GT G++APE +
Sbjct: 115 QR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYA-GTPGFMAPELLQ 170
Query: 596 NVPVSAKVDVYSFGVVLLKIICCK-----RSVEMELGEERSAILTDWAYDCYVEGKLDVL 650
VD ++ GV L ++I + R ++E E + IL
Sbjct: 171 GEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRIL---------------- 214
Query: 651 VDNDKAAMADK-SRACKWLMIALWCIQEDPLKRPAMK 686
ND DK S A K AL + +DP KR +
Sbjct: 215 --NDSVTYPDKFSPASKSFCEAL--LAKDPEKRLGFR 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 1e-17
Identities = 81/287 (28%), Positives = 129/287 (44%), Gaps = 42/287 (14%)
Query: 428 LGRGSFGIVYKGVLKSASGNA-----VAVKKLDKLAQERER-EFKTEVSAIGRTHHKNLV 481
LG G+FG VY+G G VAVK L K A ++E+ EF E + +H N+V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 482 QLLGFCDEGLNRLLVYEFMGNGTLANLLFA-----IPRPDWSLR--VRISLEIARGLLYL 534
+LLG C + ++ E M G L + L P +L+ + I L++A+G +YL
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122
Query: 535 HEECNVPIIHCDIKPQNILL-----DQDFTAKISDFGLSK-LLLSDQSRTRTVIRGTRGY 588
+ + IH D+ +N L+ D D KI DFGL++ + SD R +
Sbjct: 123 EQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRW 179
Query: 589 VAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLD 648
+APE + + + DV+SFGV++ +I + LG++ L + +
Sbjct: 180 MAPESLLDGKFTTQSDVWSFGVLMWEI--------LTLGQQPYPALNN----------QE 221
Query: 649 VLVDNDKAAMADKSRAC--KWLMIALWCIQEDPLKRPAMKMIVQMLE 693
VL K C K + C +DP +RP I ++L+
Sbjct: 222 VLQHVTAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 1e-17
Identities = 80/295 (27%), Positives = 130/295 (44%), Gaps = 54/295 (18%)
Query: 428 LGRGSFGIV----YKGVLKSASGNAVAVKKLDKLAQERE-REFKTEVS---AIGRTHHKN 479
LG G+FG V G+ + VAVK L A E++ + +E+ IG+ HKN
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK--HKN 77
Query: 480 LVQLLGFCDEGLNRLLVYEFMGNGTLANLLFA--------------IPRPDWSLR--VRI 523
++ LLG C + +V E+ +G L + L A P + + V
Sbjct: 78 IINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSF 137
Query: 524 SLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLS-DQSRTRTVI 582
+ ++ARG+ +L + IH D+ +N+L+ +D KI+DFGL++ + D R T
Sbjct: 138 AYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNG 194
Query: 583 RGTRGYVAPE-WFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMEL-GEERSAILTDWAYD 640
R ++APE F V + + DV+SFGV+L +I L G I + +
Sbjct: 195 RLPVKWMAPEALFDRV-YTHQSDVWSFGVLLWEI--------FTLGGSPYPGIPVEELFK 245
Query: 641 CYVEGKLDVLVDNDKAAMADKSRAC--KWLMIALWCIQEDPLKRPAMKMIVQMLE 693
EG +K + C + + C E P +RP K +V+ L+
Sbjct: 246 LLKEGY-----------RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLD 289
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 2e-17
Identities = 58/224 (25%), Positives = 105/224 (46%), Gaps = 39/224 (17%)
Query: 424 FEEELGRGSFGIVYK----GVLKSASGNAVAVKKL-DKLAQEREREFKTEVSAIGRTHHK 478
+ ++G+G+FG V++ G+L VAVK L ++ + + + +F+ E + + H
Sbjct: 9 YVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHP 68
Query: 479 NLVQLLGFCDEGLNRLLVYEFMGNGTLANLL--------------------FAIPRPDWS 518
N+V+LLG C G L++E+M G L L + S
Sbjct: 69 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLS 128
Query: 519 --LRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLS-KLLLSDQ 575
++ I+ ++A G+ YL E +H D+ +N L+ ++ KI+DFGLS + +D
Sbjct: 129 CTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY 185
Query: 576 SRTR----TVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKI 615
+ IR ++ PE + + DV+++GVVL +I
Sbjct: 186 YKASENDAIPIR----WMPPESIFYNRYTTESDVWAYGVVLWEI 225
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 2e-17
Identities = 65/203 (32%), Positives = 101/203 (49%), Gaps = 36/203 (17%)
Query: 428 LGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQERE-------REFKTEVSAIGRTHHKNL 480
+G G++GIVY+ + SG VA+KK+ ++ ER+ RE ++ + H N+
Sbjct: 15 IGEGTYGIVYRA-RDTTSGEIVALKKV-RMDNERDGIPISSLRE----ITLLLNLRHPNI 68
Query: 481 VQLL----GFCDEGLNRL----LVYEFMGNGTLANLLFAIPRPDWSLRVR-ISLEIARGL 531
V+L G L LV E+ LA+LL +P P +V+ + L++ RGL
Sbjct: 69 VELKEVVVG------KHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGL 121
Query: 532 LYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLL-LSDQSRTRTVIRGTRGYVA 590
YLHE IIH D+K N+LL KI+DFGL++ L + T V+ T Y A
Sbjct: 122 QYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV--TLWYRA 176
Query: 591 PE-WFKNVPVSAKVDVYSFGVVL 612
PE + +D+++ G +L
Sbjct: 177 PELLLGCTTYTTAIDMWAVGCIL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 2e-17
Identities = 57/191 (29%), Positives = 102/191 (53%), Gaps = 7/191 (3%)
Query: 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLD-KLAQEREREFKTEVSAIGRTHHKNLVQLL 484
E++G+GSFG V+KG+ + + VA+K +D + A++ + + E++ + + + +
Sbjct: 10 EKIGKGSFGEVFKGI-DNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYY 68
Query: 485 GFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIH 544
G + ++ E++G G+ +LL P D + I EI +GL YLH E IH
Sbjct: 69 GSYLKDTKLWIIMEYLGGGSALDLLEPGPL-DETQIATILREILKGLDYLHSEKK---IH 124
Query: 545 CDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPVSAKVD 604
DIK N+LL + K++DFG++ L+D R GT ++APE K +K D
Sbjct: 125 RDIKAANVLLSEHGEVKLADFGVAG-QLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKAD 183
Query: 605 VYSFGVVLLKI 615
++S G+ +++
Sbjct: 184 IWSLGITAIEL 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.9 bits (208), Expect = 2e-17
Identities = 64/220 (29%), Positives = 95/220 (43%), Gaps = 43/220 (19%)
Query: 428 LGRGSFGIVYKGVLKSASGNAVAVKKLDK---LAQEREREFKTEVSAIGRTHHKNLVQLL 484
+GRG+FG V+ V +G A+K L K + + + + E + +V+L
Sbjct: 9 IGRGAFGEVWL-VRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLY 67
Query: 485 -GFCDEGLNRL-LVYEFMGNGTLANLL--FAIPRPDWSLRVRISLEIARGLLYLHEECNV 540
F DE L LV E+M G L NLL + + + R I+ E+ L +H +
Sbjct: 68 YSFQDE--EHLYLVMEYMPGGDLMNLLIRKDVFPEETA-RFYIA-ELVLALDSVH---KL 120
Query: 541 PIIHCDIKPQNILLDQDFTAKISDFGLSK-------------LLLSDQSRTRTVIR---- 583
IH DIKP NIL+D D K++DFGL K + R ++R
Sbjct: 121 GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDH 180
Query: 584 -----------GTRGYVAPEWFKNVPVSAKVDVYSFGVVL 612
GT Y+APE + P + D +S GV+L
Sbjct: 181 KQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVIL 220
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 2e-17
Identities = 64/207 (30%), Positives = 99/207 (47%), Gaps = 24/207 (11%)
Query: 422 NGFEE--ELGRGSFGIVYKGVLKSASGNAVAVKKL-----DKLAQEREREFKTEVSAIGR 474
E LG G+ G V K LK +G A+K + L ++ RE + S
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLK-NTGMIFALKTITTDPNPDLQKQILRELEINKS---- 55
Query: 475 THHKNLVQLLG-FCDEGLNRL-LVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIA---- 528
+V+ G F DE + + + E+ G+L ++ + + + ++ +IA
Sbjct: 56 CKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVL 115
Query: 529 RGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGY 588
+GL YLH IIH DIKP NILL + K+ DFG+S L++ + T T GT Y
Sbjct: 116 KGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT---GTSFY 169
Query: 589 VAPEWFKNVPVSAKVDVYSFGVVLLKI 615
+APE + P S DV+S G+ LL++
Sbjct: 170 MAPERIQGKPYSITSDVWSLGLTLLEV 196
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 3e-17
Identities = 66/201 (32%), Positives = 100/201 (49%), Gaps = 23/201 (11%)
Query: 427 ELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLL-G 485
ELG G+FG VYK K +G A K +D ++E ++ E+ + H N+V+LL
Sbjct: 12 ELGDGAFGKVYKAQNKE-TGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 70
Query: 486 FCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISL-EIARGLLYLHEECNVPIIH 544
F E N ++ EF G + ++ + RP ++R+ + L YLHE IIH
Sbjct: 71 FYYEN-NLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHEN---KIIH 126
Query: 545 CDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIR-----GTRGYVAPEWF----- 594
D+K NIL D K++DFG+S TRT+ R GT ++APE
Sbjct: 127 RDLKAGNILFTLDGDIKLADFGVSA------KNTRTIQRRDSFIGTPYWMAPEVVMCETS 180
Query: 595 KNVPVSAKVDVYSFGVVLLKI 615
K+ P K DV+S G+ L+++
Sbjct: 181 KDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 4e-17
Identities = 60/194 (30%), Positives = 98/194 (50%), Gaps = 13/194 (6%)
Query: 428 LGRGSFGIVYKGVLKSASGNAV--AVKKLDKLAQERERE-FKTEVSAIGRTHHKNLVQLL 484
+G+G FG VY G L + G + AVK L+++ E E F E + H N++ LL
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 485 GFC--DEGLNRLLVYEFMGNGTLANLLFAIPR-PDWSLRVRISLEIARGLLYLHEECNVP 541
G C EG L+V +M +G L N + + P + L++A+G+ YL +
Sbjct: 63 GICLPSEGSP-LVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASK---K 118
Query: 542 IIHCDIKPQNILLDQDFTAKISDFGLSKLLLS---DQSRTRTVIRGTRGYVAPEWFKNVP 598
+H D+ +N +LD+ FT K++DFGL++ + T + ++A E +
Sbjct: 119 FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQK 178
Query: 599 VSAKVDVYSFGVVL 612
+ K DV+SFGV+L
Sbjct: 179 FTTKSDVWSFGVLL 192
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 4e-17
Identities = 63/210 (30%), Positives = 106/210 (50%), Gaps = 25/210 (11%)
Query: 426 EELGRGSFGIVYKGVL--KSASGNAVAVKKLD--KLAQEREREFKTEVSAIGRTHHKNLV 481
+++G GSFG K +L G +K+++ K++ + E + EV+ + H N+V
Sbjct: 6 KKIGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIV 62
Query: 482 QLLGFCDEGLNRLLVYEFMGNGTLANLLFA---IPRP-----DWSLRVRISLEIARGLLY 533
Q +E N +V ++ G L + A + P DW + +I L +
Sbjct: 63 QYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFV------QICLALKH 116
Query: 534 LHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEW 593
+H+ I+H DIK QNI L +D T K+ DFG++++L S RT I GT Y++PE
Sbjct: 117 VHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCI-GTPYYLSPEI 172
Query: 594 FKNVPVSAKVDVYSFGVVLLKIICCKRSVE 623
+N P + K D+++ G VL ++ K + E
Sbjct: 173 CENRPYNNKSDIWALGCVLYEMCTLKHAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 4e-17
Identities = 56/190 (29%), Positives = 97/190 (51%), Gaps = 6/190 (3%)
Query: 427 ELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGF 486
++G GS GIV K SG VAVK +D Q+R EV + H+N+V++
Sbjct: 28 KIGEGSTGIVCIAREKH-SGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKS 86
Query: 487 CDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCD 546
G ++ EF+ G L +++ R + + + + L YLH + +IH D
Sbjct: 87 YLVGEELWVLMEFLQGGALTDIVSQT-RLNEEQIATVCESVLQALCYLHSQ---GVIHRD 142
Query: 547 IKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVY 606
IK +ILL D K+SDFG + D + ++++ GT ++APE P +VD++
Sbjct: 143 IKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVISRTPYGTEVDIW 201
Query: 607 SFGVVLLKII 616
S G+++++++
Sbjct: 202 SLGIMVIEMV 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 5e-17
Identities = 71/217 (32%), Positives = 109/217 (50%), Gaps = 16/217 (7%)
Query: 428 LGRGSFGIVYKGVLKSASGNAVAVKKLDK--LAQEREREFK-TEVSAIGRTHHKNLVQLL 484
LG+GSFG V LK SG AVK L K + Q+ + E TE + + + L
Sbjct: 3 LGKGSFGKVMLARLKE-SGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61
Query: 485 GFCDEGLNRLL-VYEFMGNGTLANLLFAIP---RPDWSLRVRISLEIARGLLYLHEECNV 540
C + +RL V EF+ G +L+F I R D + + EI L++LH++
Sbjct: 62 YCCFQTPDRLFFVMEFVNGG---DLMFHIQKSRRFDEARARFYAAEITSALMFLHDK--- 115
Query: 541 PIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPVS 600
II+ D+K N+LLD + K++DFG+ K + + T T GT Y+APE + +
Sbjct: 116 GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFC-GTPDYIAPEILQEMLYG 174
Query: 601 AKVDVYSFGVVLLKIICCKRSVEMELGEER-SAILTD 636
VD ++ GV+L +++C E E ++ AIL D
Sbjct: 175 PSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND 211
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 6e-17
Identities = 63/189 (33%), Positives = 95/189 (50%), Gaps = 16/189 (8%)
Query: 428 LGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKT----EVSAIGRTHHKNLVQL 483
+G GS+G+V K K +G VA+KK L E ++ K E+ + + H+NLV L
Sbjct: 9 VGEGSYGMVMKCKHKE-TGQIVAIKKF--LESEDDKMVKKIAMREIRMLKQLRHENLVNL 65
Query: 484 LGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISL-EIARGLLYLHEECNVPI 542
+ LV+EF+ + T+ + L P RVR L +I RG+ + H + I
Sbjct: 66 IEVFRRKKRLYLVFEFVDH-TVLDDLEKYPNGLDESRVRKYLFQILRGIEFCH---SHNI 121
Query: 543 IHCDIKPQNILLDQDFTAKISDFGLSKLLLS-DQSRTRTVIRGTRGYVAPEWF-KNVPVS 600
IH DIKP+NIL+ Q K+ DFG ++ L + + T V TR Y APE +
Sbjct: 122 IHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYV--ATRWYRAPELLVGDTKYG 179
Query: 601 AKVDVYSFG 609
VD+++ G
Sbjct: 180 RAVDIWAVG 188
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 8e-17
Identities = 62/191 (32%), Positives = 96/191 (50%), Gaps = 9/191 (4%)
Query: 427 ELGRGSFGIVYKGVLKSASG-NAVAVKKLDKLAQER--EREFKTEVSAIGRTHHKNLVQL 483
ELG G+FG V KG+ K VAVK L + + E E + + + + +V++
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 484 LGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPII 543
+G C E + +LV E G L L + +++ G+ YL EE N +
Sbjct: 62 IGIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYL-EETN--FV 117
Query: 544 HCDIKPQNILLDQDFTAKISDFGLSKLLLSDQS--RTRTVIRGTRGYVAPEWFKNVPVSA 601
H D+ +N+LL AKISDFGLSK L +D++ + +T + + APE S+
Sbjct: 118 HRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSS 177
Query: 602 KVDVYSFGVVL 612
K DV+SFGV++
Sbjct: 178 KSDVWSFGVLM 188
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 81.1 bits (201), Expect = 8e-17
Identities = 60/197 (30%), Positives = 96/197 (48%), Gaps = 11/197 (5%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNAVAVKKLDK---LAQEREREFKTEVSAIGRTHHKNL 480
F + LG GSFG V K SG A+K L K + ++ E + H L
Sbjct: 5 FIKTLGTGSFGRVMLVRHKG-SGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFL 63
Query: 481 VQLLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNV 540
V L G + N LV E++ G L + L R + + ++ L YLH ++
Sbjct: 64 VNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLH---SL 120
Query: 541 PIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPVS 600
I++ D+KP+N+LLD D KI+DFG +K + + RT T + GT Y+APE +
Sbjct: 121 DIVYRDLKPENLLLDSDGYIKITDFGFAKRV---KGRTYT-LCGTPEYLAPEIILSKGYG 176
Query: 601 AKVDVYSFGVVLLKIIC 617
VD ++ G+++ +++
Sbjct: 177 KAVDWWALGILIYEMLA 193
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 8e-17
Identities = 55/206 (26%), Positives = 103/206 (50%), Gaps = 18/206 (8%)
Query: 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLD---KLAQERER---EFKTEVSAIGRTHHKN 479
++LG G+F Y +G +AVK++ + E+E + E+ + R +H +
Sbjct: 6 QQLGTGAFSSCY-QARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPH 64
Query: 480 LVQLLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECN 539
++++LG E + L E+M G++++LL ++ + + ++ RGL YLHE
Sbjct: 65 IIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHEN-- 122
Query: 540 VPIIHCDIKPQNILLD---QDFTAKISDFGLSKLLLSDQSRT---RTVIRGTRGYVAPEW 593
IIH D+K N+L+D Q +I+DFG + L + + + + GT ++APE
Sbjct: 123 -QIIHRDVKGANLLIDSTGQRL--RIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEV 179
Query: 594 FKNVPVSAKVDVYSFGVVLLKIICCK 619
+ DV+S G V++++ K
Sbjct: 180 LRGEQYGRSCDVWSVGCVIIEMATAK 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 1e-16
Identities = 61/194 (31%), Positives = 101/194 (52%), Gaps = 17/194 (8%)
Query: 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLG 485
E LG+G+FG V+KG LK + AV K D L QE + +F +E + + H N+V+L+G
Sbjct: 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKED-LPQELKIKFLSEARILKQYDHPNIVKLIG 59
Query: 486 FCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLR--VRISLEIARGLLYLH-EECNVPI 542
C + +V E + G + L + + + V+ +L+ A G+ YL + C
Sbjct: 60 VCTQRQPIYIVMELVPGGDFLSFLRK-KKDELKTKQLVKFALDAAAGMAYLESKNC---- 114
Query: 543 IHCDIKPQNILLDQDFTAKISDFGLSKL----LLSDQSRTRTVIRGTRGYVAPEWFKNVP 598
IH D+ +N L+ ++ KISDFG+S+ + S + I+ T APE
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWT----APEALNYGR 170
Query: 599 VSAKVDVYSFGVVL 612
S++ DV+S+G++L
Sbjct: 171 YSSESDVWSYGILL 184
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 1e-16
Identities = 65/218 (29%), Positives = 101/218 (46%), Gaps = 33/218 (15%)
Query: 424 FEEELGRGSFGIVYKGVL---KSASGNAVAVKKLDKLAQERE-REFKTEVSAIGRTHHKN 479
F EELG +FG +YKG L VA+K L + ++ EF+ E S + HH N
Sbjct: 9 FMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPN 68
Query: 480 LVQLLGFCDEGLNRLLVYEFMGNGTLAN-LLFAIPRPDWSLR----------------VR 522
+V LLG + +++E++ G L L+ P D +
Sbjct: 69 IVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLH 128
Query: 523 ISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSD-----QSR 577
I+++IA G+ YL +H D+ +NIL+ + KISD GLS+ + S Q +
Sbjct: 129 IAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPK 185
Query: 578 TRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKI 615
+ IR ++ PE S+ D++SFGVVL +I
Sbjct: 186 SLLPIR----WMPPEAIMYGKFSSDSDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 1e-16
Identities = 62/206 (30%), Positives = 96/206 (46%), Gaps = 27/206 (13%)
Query: 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLD-------KLAQEREREFKTEVSAIG----R 474
E LG G+FG VYK K+ N +A+K+++ K +ER++ VS + +
Sbjct: 6 EHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQ 65
Query: 475 THHKNLVQLLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPD--------WSLRVRISLE 526
H N+V+ E +V + + L ++ W++ V++ L
Sbjct: 66 LRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVL- 124
Query: 527 IARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTR 586
L YLH+E I+H D+ P NI+L +D I+DFGL+K + T V GT
Sbjct: 125 ---ALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVV--GTI 177
Query: 587 GYVAPEWFKNVPVSAKVDVYSFGVVL 612
Y PE KN P K DV++FG +L
Sbjct: 178 LYSCPEIVKNEPYGEKADVWAFGCIL 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 1e-16
Identities = 63/194 (32%), Positives = 95/194 (48%), Gaps = 15/194 (7%)
Query: 427 ELGRGSFGIVYKGVLKSASGNA-VAVKKLDKLAQERER-EFKTEVSAIGRTHHKNLVQLL 484
ELG G+FG V KGV K VA+K L ++ R E E + + + +V+++
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 485 GFCDEGLNRLLVYEFMGNGTLANLLFA----IPRPDWSLRVRISLEIARGLLYLHEECNV 540
G C E +LV E G L L I S V + +++ G+ YL E N
Sbjct: 62 GVC-EAEALMLVMEMASGGPLNKFLSGKKDEITV---SNVVELMHQVSMGMKYL-EGKN- 115
Query: 541 PIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQS--RTRTVIRGTRGYVAPEWFKNVP 598
+H D+ +N+LL AKISDFGLSK L +D S + R+ + + APE
Sbjct: 116 -FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRK 174
Query: 599 VSAKVDVYSFGVVL 612
S++ DV+S+G+ +
Sbjct: 175 FSSRSDVWSYGITM 188
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 80.7 bits (200), Expect = 1e-16
Identities = 67/210 (31%), Positives = 98/210 (46%), Gaps = 49/210 (23%)
Query: 428 LGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQERE----------REFK--TEVSAIGRT 475
LG G++ +VYK K +G VA+KK+ KL + +E RE K E+
Sbjct: 8 LGEGTYAVVYKARDKE-TGRIVAIKKI-KLGERKEAKDGINFTALREIKLLQEL------ 59
Query: 476 HHKNLVQLLG-FCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVR------ISLEIA 528
H N++ LL F + N LV+EFM L + + D S+ + L
Sbjct: 60 KHPNIIGLLDVFGHKS-NINLVFEFMETD-----LEKVIK-DKSIVLTPADIKSYMLMTL 112
Query: 529 RGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSR-TRTVIRGTRG 587
RGL YLH I+H D+KP N+L+ D K++DFGL++ S + T V+ TR
Sbjct: 113 RGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV--TRW 167
Query: 588 YVAPEWFKNVPVSAK-----VDVYSFGVVL 612
Y APE A+ VD++S G +
Sbjct: 168 YRAPELL----FGARHYGVGVDMWSVGCIF 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 2e-16
Identities = 61/217 (28%), Positives = 106/217 (48%), Gaps = 34/217 (15%)
Query: 424 FEEELGRGSFGIVYKG-VLKSASGNAVAVKKLDKLA-QEREREFKTEVSAIGRT-HHKNL 480
F++ +G G+FG V K + K A+K++ + A ++ R+F E+ + + HH N+
Sbjct: 11 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 70
Query: 481 VQLLGFCDEGLNRLLVYEFMGNGTLANLL-----------FAIPRPDWSLR-----VRIS 524
+ LLG C+ L E+ +G L + L FAI S + +
Sbjct: 71 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 130
Query: 525 LEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRG 584
++ARG+ YL ++ IH D+ +NIL+ +++ AKI+DFGLS+ ++
Sbjct: 131 ADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR-------GQEVYVKK 180
Query: 585 TRGYVAPEWFK----NVPV-SAKVDVYSFGVVLLKII 616
T G + W N V + DV+S+GV+L +I+
Sbjct: 181 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 217
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 2e-16
Identities = 78/287 (27%), Positives = 131/287 (45%), Gaps = 50/287 (17%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNAVAVKKLD-KLAQEREREFKTEVSAIGRTHHKNLVQ 482
+ELG+G++G VYK VL +G +A+K++ +L + + + E+ + + +V
Sbjct: 5 VLDELGKGNYGSVYK-VLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVD 63
Query: 483 LLG-FCDEGLNRLLVY---EFMGNGTLANLL---FAIPRPDWSLRVRISLEIARGLLYLH 535
G F EG VY E+M G+L L A + RI+ + +GL +L
Sbjct: 64 FYGAFFIEGA----VYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLK 119
Query: 536 EECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFK 595
EE N IIH D+KP N+L++ + K+ DFG+S L++ ++T G + Y+APE K
Sbjct: 120 EEHN--IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNI---GCQSYMAPERIK 174
Query: 596 ------NVPVSAKVDVYSFGVVLLKIICCKRSVEMELG------EERSAILTDWAYDCYV 643
N + + DV+S G+ +L EM LG E + I
Sbjct: 175 SGGPNQNPTYTVQSDVWSLGLSIL---------EMALGRYPYPPETYANIFA-------- 217
Query: 644 EGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690
+L +VD D + +A C+ + P +RP +++
Sbjct: 218 --QLSAIVDGDPPTLPSGYSDDAQDFVAK-CLNKIPNRRPTYAQLLE 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 3e-16
Identities = 61/201 (30%), Positives = 96/201 (47%), Gaps = 16/201 (7%)
Query: 426 EELGRGSFG--IVYK-GVLKSASGNAVAVKKLDK-LAQEREREFKTEVSAIGRTHHKNLV 481
LG G FG +Y +G VAVK L + Q+ +K E++ + +H+N+V
Sbjct: 10 RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIV 69
Query: 482 QLLGFCDEGLNR--LLVYEFMGNGTLANLLFAIPRPDWSLR--VRISLEIARGLLYLHEE 537
+ G C E + L+ E++ G+L + L P+ +L + + +I G+ YLH +
Sbjct: 70 KYKGCCSEQGGKGLQLIMEYVPLGSLRDYL---PKHKLNLAQLLLFAQQICEGMAYLHSQ 126
Query: 538 CNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRG--YVAPEWFK 595
IH D+ +N+LLD D KI DFGL+K + R G + A E K
Sbjct: 127 ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLK 183
Query: 596 NVPVSAKVDVYSFGVVLLKII 616
S DV+SFGV L +++
Sbjct: 184 ENKFSYASDVWSFGVTLYELL 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 3e-16
Identities = 66/194 (34%), Positives = 98/194 (50%), Gaps = 25/194 (12%)
Query: 414 LVELNEATNGFE--EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSA 471
L L + FE E +G G++G VYKG +G A+K +D + ++ E E K E++
Sbjct: 8 LSALRDPAGIFELVEVVGNGTYGQVYKG-RHVKTGQLAAIKVMD-VTEDEEEEIKLEINM 65
Query: 472 IGR-THHKNLVQLLGFC--------DEGLNRLLVYEFMGNGTLANLLFAIP----RPDWS 518
+ + +HH+N+ G D+ L LV EF G G++ +L+ + DW
Sbjct: 66 LKKYSHHRNIATYYGAFIKKSPPGHDDQL--WLVMEFCGAGSVTDLVKNTKGNALKEDWI 123
Query: 519 LRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRT 578
I EI RGL +LH +IH DIK QN+LL ++ K+ DFG+S L R
Sbjct: 124 --AYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRR 178
Query: 579 RTVIRGTRGYVAPE 592
T I GT ++APE
Sbjct: 179 NTFI-GTPYWMAPE 191
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 79.7 bits (197), Expect = 4e-16
Identities = 68/200 (34%), Positives = 98/200 (49%), Gaps = 21/200 (10%)
Query: 428 LGRGSFGIVYKGVLKSASGNAVAVKKLDK--LAQEREREF----KTEVSAIGRTHHKNLV 481
LG+GSFG V LK + AVK L K + Q+ + E K ++ G+ H L
Sbjct: 3 LGKGSFGKVLLAELKG-TDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGK--HPFLT 59
Query: 482 QLLGFCDEGLNRL-LVYEFMGNGTLANLLFAI---PRPDWSLRVRISLEIARGLLYLHEE 537
QL C + +RL V E++ G +L+F I R D + EI GL +LHE
Sbjct: 60 QLHS-CFQTKDRLFFVMEYVNGG---DLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHER 115
Query: 538 CNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNV 597
II+ D+K N+LLD + KI+DFG+ K + T T GT Y+APE
Sbjct: 116 ---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFC-GTPDYIAPEILSYQ 171
Query: 598 PVSAKVDVYSFGVVLLKIIC 617
P VD ++ GV+L +++
Sbjct: 172 PYGPAVDWWALGVLLYEMLA 191
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 79.0 bits (194), Expect = 5e-16
Identities = 52/191 (27%), Positives = 99/191 (51%), Gaps = 6/191 (3%)
Query: 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLG 485
E++G+G+ G VY + A+G VA+K+++ Q ++ E+ + + N+V L
Sbjct: 25 EKIGQGASGTVYTA-IDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLD 83
Query: 486 FCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHC 545
G +V E++ G+L +++ + + + E + L +LH +IH
Sbjct: 84 SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA-VCRECLQALDFLHSN---QVIHR 139
Query: 546 DIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPVSAKVDV 605
DIK NILL D + K++DFG + +QS+ T++ GT ++APE KVD+
Sbjct: 140 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDI 198
Query: 606 YSFGVVLLKII 616
+S G++ ++++
Sbjct: 199 WSLGIMAIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 6e-16
Identities = 70/222 (31%), Positives = 107/222 (48%), Gaps = 38/222 (17%)
Query: 412 FSLVELNEATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSA 471
F LVEL +G G++G VYKG +G A+K +D E E E K E++
Sbjct: 8 FELVEL----------VGNGTYGQVYKG-RHVKTGQLAAIKVMDVTGDEEE-EIKQEINM 55
Query: 472 IGR-THHKNLVQLLGF--------CDEGLNRLLVYEFMGNGTLANLLFAIP----RPDWS 518
+ + +HH+N+ G D+ L LV EF G G++ +L+ + +W
Sbjct: 56 LKKYSHHRNIATYYGAFIKKNPPGMDDQL--WLVMEFCGAGSVTDLIKNTKGNTLKEEWI 113
Query: 519 LRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRT 578
I EI RGL +LH+ +IH DIK QN+LL ++ K+ DFG+S L R
Sbjct: 114 --AYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRR 168
Query: 579 RTVIRGTRGYVAPEWFK-----NVPVSAKVDVYSFGVVLLKI 615
T I GT ++APE + K D++S G+ +++
Sbjct: 169 NTFI-GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEM 209
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 8e-16
Identities = 53/191 (27%), Positives = 99/191 (51%), Gaps = 6/191 (3%)
Query: 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLG 485
E++G+G+ G VY + A+G VA+K+++ Q ++ E+ + H N+V L
Sbjct: 25 EKIGQGASGTVYTAI-DVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLD 83
Query: 486 FCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHC 545
G +V E++ G+L +++ + + + E + L +LH +IH
Sbjct: 84 SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA-VCRECLQALEFLHSN---QVIHR 139
Query: 546 DIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPVSAKVDV 605
DIK NILL D + K++DFG + +QS+ R+ + GT ++APE KVD+
Sbjct: 140 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-RSTMVGTPYWMAPEVVTRKAYGPKVDI 198
Query: 606 YSFGVVLLKII 616
+S G++ ++++
Sbjct: 199 WSLGIMAIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 8e-16
Identities = 57/200 (28%), Positives = 97/200 (48%), Gaps = 13/200 (6%)
Query: 428 LGRGSFGIVYKGVLKSASGNAVAVKKL--DKLAQERERE---FKTEVSAIGRTHHKNLVQ 482
LG+G+FG VY +G +AVK++ D + E ++E + E+ + H+ +VQ
Sbjct: 10 LGQGAFGRVYLCY-DVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68
Query: 483 LLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPI 542
G + + E+M G++ + L A ++ + + +I G+ YLH I
Sbjct: 69 YYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSN---MI 125
Query: 543 IHCDIKPQNILLDQDFTAKISDFGLSKLL---LSDQSRTRTVIRGTRGYVAPEWFKNVPV 599
+H DIK NIL D K+ DFG SK L S + ++V GT +++PE
Sbjct: 126 VHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVT-GTPYWMSPEVISGEGY 184
Query: 600 SAKVDVYSFGVVLLKIICCK 619
K DV+S G +++++ K
Sbjct: 185 GRKADVWSVGCTVVEMLTEK 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 8e-16
Identities = 74/297 (24%), Positives = 127/297 (42%), Gaps = 54/297 (18%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNA----VAVKKLDKLAQEREREFKTEVSAIGRTHHKN 479
+ ELG G+FG V+ + S VAVK L ++F+ E + H++
Sbjct: 9 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 68
Query: 480 LVQLLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPD-----------------WSLRVR 522
+V+ G C +G ++V+E+M +G L L A PD S +
Sbjct: 69 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRA-HGPDAMILVDGQPRQAKGELGLSQMLH 127
Query: 523 ISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQ-----SR 577
I+ +IA G++YL + +H D+ +N L+ + KI DFG+S+ + S
Sbjct: 128 IASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGH 184
Query: 578 TRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDW 637
T IR ++ PE + + DV+SFGV+L +I + +L
Sbjct: 185 TMLPIR----WMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE------- 233
Query: 638 AYDCYVEGKLDVLVDNDKAAMADKSRACKWLM--IALWCIQEDPLKRPAMKMIVQML 692
+C +G++ ++ R C + I L C Q +P +R +K I ++L
Sbjct: 234 VIECITQGRV-----------LERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKIL 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 9e-16
Identities = 73/288 (25%), Positives = 118/288 (40%), Gaps = 42/288 (14%)
Query: 426 EELGRGSFGIVYKGVLKSASGNA-VAVKKLDKLAQERER-EFKTEVSAIGRTHHKNLVQL 483
+E+G G FG V G A V VK+L A E+ F EV +H N++Q
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60
Query: 484 LGFCDEGLNRLLVYEFMGNGTLANLLFA-------IPRPDWSLRVRISLEIARGLLYLHE 536
LG C E + LLV EF G L N L + + + D + R++ E+A GLL+LH+
Sbjct: 61 LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKD--VLQRMACEVASGLLWLHQ 118
Query: 537 ECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEW--- 593
IH D+ +N L D + KI D+GL+ +Q I V W
Sbjct: 119 ---ADFIHSDLALRNCQLTADLSVKIGDYGLA----LEQYPEDYYITKDCHAVPLRWLAP 171
Query: 594 ---------FKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVE 644
+ K +++S GV + ++ ++ L+D V
Sbjct: 172 ELVEIRGQDLLPKDQTKKSNIWSLGVTMWEL--------FTAADQPYPDLSDEQVLKQVV 223
Query: 645 GKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQML 692
+ D+ + + D + +W + +C DP RP + + ++L
Sbjct: 224 REQDIKLPKPQ---LDLKYSDRWYEVMQFCWL-DPETRPTAEEVHELL 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.0 bits (193), Expect = 1e-15
Identities = 54/182 (29%), Positives = 87/182 (47%), Gaps = 30/182 (16%)
Query: 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQERERE-----FKTEVSAIGRTHHKNL 480
++G G++G VYK K +G VA+KK+ E E+E E+ + + H N+
Sbjct: 5 AQIGEGTYGQVYKARNKK-TGELVALKKIRM---ENEKEGFPITAIREIKLLQKLRHPNI 60
Query: 481 VQLLGFC-DEGLNRL-LVYEFMG---NGTLAN--LLFAIPRPDWSLRVR-ISLEIARGLL 532
V+L +G + +V+E+M G L + + F + ++ ++ GL
Sbjct: 61 VRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQ------IKCYMKQLLEGLQ 114
Query: 533 YLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSR--TRTVIRGTRGYVA 590
YLH + I+H DIK NIL++ D K++DFGL++ S T VI T Y
Sbjct: 115 YLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI--TLWYRP 169
Query: 591 PE 592
PE
Sbjct: 170 PE 171
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 1e-15
Identities = 62/207 (29%), Positives = 100/207 (48%), Gaps = 22/207 (10%)
Query: 428 LGRGSFGIVYKGVLKSASGNAVAVKKLD--KLAQEREREFKTEVSAIGRTHHKNLVQLLG 485
+G GSFG +Y KS S + V +K++D K+ + + K EV + + H N+V
Sbjct: 8 IGEGSFGKIYLAKAKSDSEHCV-IKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFA 66
Query: 486 FCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRIS--------LEIARGLLYLHEE 537
E +V E+ G L + R + V S ++I+ GL ++H+
Sbjct: 67 SFQENGRLFIVMEYCDGGDL------MKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR 120
Query: 538 CNVPIIHCDIKPQNILLDQD-FTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKN 596
I+H DIK QNI L ++ AK+ DFG+++ L T + GT Y++PE +N
Sbjct: 121 ---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCV-GTPYYLSPEICQN 176
Query: 597 VPVSAKVDVYSFGVVLLKIICCKRSVE 623
P + K D++S G VL ++ K E
Sbjct: 177 RPYNNKTDIWSLGCVLYELCTLKHPFE 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 1e-15
Identities = 61/211 (28%), Positives = 98/211 (46%), Gaps = 36/211 (17%)
Query: 425 EEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQERE-REFKTEVSAIGRTHH-KNLVQ 482
E+GRG+FG V K +L SG +AVK++ E+E + ++ + R+ +V+
Sbjct: 9 LGEIGRGAFGTVNK-MLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVK 67
Query: 483 LLG---------FC----DEGLNRL--LVYEFMGNGTLANLLFAIPRPDWSLRVRISLEI 527
G C D L++ VYE + + + +I++
Sbjct: 68 FYGALFREGDCWICMELMDISLDKFYKYVYE-VLKSVIPEEILG----------KIAVAT 116
Query: 528 ARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRG 587
+ L YL EE IIH D+KP NILLD++ K+ DFG+S L+ ++TR G R
Sbjct: 117 VKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDA--GCRP 172
Query: 588 YVAPEW---FKNVPVSAKVDVYSFGVVLLKI 615
Y+APE + DV+S G+ L ++
Sbjct: 173 YMAPERIDPSARDGYDVRSDVWSLGITLYEV 203
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 1e-15
Identities = 59/196 (30%), Positives = 103/196 (52%), Gaps = 13/196 (6%)
Query: 427 ELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLG- 485
ELG G+FG VYK K +G A K ++ ++E ++ E+ + +H +V+LLG
Sbjct: 19 ELGDGAFGKVYKAKNKE-TGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGA 77
Query: 486 FCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVR-ISLEIARGLLYLHEECNVPIIH 544
F +G +++ EF G + ++ + R +++ I ++ L YLH ++ IIH
Sbjct: 78 FYWDGKLWIMI-EFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLH---SMKIIH 133
Query: 545 CDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAP-----EWFKNVPV 599
D+K N+LL D K++DFG+S + R + I GT ++AP E K+ P
Sbjct: 134 RDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI-GTPYWMAPEVVMCETMKDTPY 192
Query: 600 SAKVDVYSFGVVLLKI 615
K D++S G+ L+++
Sbjct: 193 DYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 1e-15
Identities = 76/305 (24%), Positives = 129/305 (42%), Gaps = 56/305 (18%)
Query: 424 FEEELGRGSFGIVY----KGVLK---------SASGNAVAVKKLDKLAQERER-EFKTEV 469
+E+LG G FG V+ +G+ + VAVK L + R +F E+
Sbjct: 9 LKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEI 68
Query: 470 SAIGRTHHKNLVQLLGFCDEGLNRLLVYEFMGNGTLANLL--------FA----IPRPDW 517
+ R + N+++LLG C ++ E+M NG L L F IP
Sbjct: 69 KIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSI 128
Query: 518 SLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSD--- 574
+ + ++++IA G+ YL ++ +H D+ +N L+ +T KI+DFG+S+ L S
Sbjct: 129 ANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYY 185
Query: 575 --QSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKI-ICCKRSVEMELGEERS 631
Q R IR ++A E + DV++FGV L ++ CK E+
Sbjct: 186 RIQGRAVLPIR----WMAWESILLGKFTTASDVWAFGVTLWEMFTLCK--------EQPY 233
Query: 632 AILTDWAYDCYVEGKLDVLVDNDKAAMADKSRACKW----LMIALWCIQEDPLKRPAMKM 687
++L+D + +E + + + ++ C LM+ W D RP
Sbjct: 234 SLLSD---EQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCW--SRDIKDRPTFNK 288
Query: 688 IVQML 692
I L
Sbjct: 289 IHHFL 293
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 1e-15
Identities = 61/203 (30%), Positives = 94/203 (46%), Gaps = 19/203 (9%)
Query: 428 LGRGSFGIVYKGVLK-SASGNA---VAVKKLDKLAQER-EREFKTEVSAIGRTHHKNLVQ 482
LGRG FG V+ K V VK L K E + EF+ E+ + HKN+V+
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72
Query: 483 LLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSL---------RVRISLEIARGLLY 533
LLG C E ++ E+ G L L A D L +V + +IA G+ +
Sbjct: 73 LLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDH 132
Query: 534 LHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQ-SRTRTVIRGTRGYVAPE 592
L N +H D+ +N L+ K+S LSK + + + + R + R ++APE
Sbjct: 133 LS---NARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLR-WLAPE 188
Query: 593 WFKNVPVSAKVDVYSFGVVLLKI 615
+ S K DV+SFGV++ ++
Sbjct: 189 AVQEDDFSTKSDVWSFGVLMWEV 211
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 77.5 bits (190), Expect = 2e-15
Identities = 52/191 (27%), Positives = 99/191 (51%), Gaps = 6/191 (3%)
Query: 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLG 485
E++G+G+ G VY + A+G VA+++++ Q ++ E+ + + N+V L
Sbjct: 26 EKIGQGASGTVYTA-MDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLD 84
Query: 486 FCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHC 545
G +V E++ G+L +++ + + + E + L +LH +IH
Sbjct: 85 SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA-VCRECLQALEFLHSN---QVIHR 140
Query: 546 DIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPVSAKVDV 605
DIK NILL D + K++DFG + +QS+ R+ + GT ++APE KVD+
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-RSTMVGTPYWMAPEVVTRKAYGPKVDI 199
Query: 606 YSFGVVLLKII 616
+S G++ +++I
Sbjct: 200 WSLGIMAIEMI 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 2e-15
Identities = 55/198 (27%), Positives = 99/198 (50%), Gaps = 9/198 (4%)
Query: 425 EEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLL 484
++LG G FG V+ G + VA+K L + + E F E + + + H LV+L
Sbjct: 11 VKKLGAGQFGEVWMGYYNGHT--KVAIKSLKQGSMSPE-AFLAEANLMKQLQHPRLVRLY 67
Query: 485 GFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLR--VRISLEIARGLLYLHEECNVPI 542
+ ++ E+M NG+L + L ++ + ++ +IA G+ ++ E N
Sbjct: 68 AVVTQE-PIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFI-ERKNY-- 123
Query: 543 IHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPVSAK 602
IH D++ NIL+ + KI+DFGL++L+ ++ R + + APE + K
Sbjct: 124 IHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK 183
Query: 603 VDVYSFGVVLLKIICCKR 620
DV+SFG++L +I+ R
Sbjct: 184 SDVWSFGILLTEIVTYGR 201
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 3e-15
Identities = 56/193 (29%), Positives = 92/193 (47%), Gaps = 13/193 (6%)
Query: 426 EELGRGSFGIVYKGVLKSASGNAVAVKKL-DKLAQEREREFKTEVSAIGRTHHKNLVQLL 484
E +GRG+FG V+ G L+ A VAVK + L + + +F E + + H N+V+L+
Sbjct: 1 ERIGRGNFGEVFSGRLR-ADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLI 59
Query: 485 GFCDEGLNRLLVYEFMGNGTLANLLFAI-PRPDWSLRVRISLEIARGLLYLHEECNVPII 543
G C + +V E + G L PR +++ A G+ YL + I
Sbjct: 60 GVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CI 116
Query: 544 HCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTR----GYVAPEWFKNVPV 599
H D+ +N L+ + KISDFG+S+ ++ G + + APE
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSR---EEEDGVYASTGGMKQIPVKWTAPEALNYGRY 173
Query: 600 SAKVDVYSFGVVL 612
S++ DV+SFG++L
Sbjct: 174 SSESDVWSFGILL 186
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 3e-15
Identities = 64/200 (32%), Positives = 109/200 (54%), Gaps = 18/200 (9%)
Query: 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKT---EVSAIGRTHHKNLVQ 482
E++G G++G+VYKG K +G VA+KK+ +L E E T E+S + H N+V
Sbjct: 6 EKIGEGTYGVVYKGRNKK-TGQIVAMKKI-RLESEEEGVPSTAIREISLLKELQHPNIVC 63
Query: 483 LLGFCDEGLNRL-LVYEFMGNGTLANLLFAIPRPDW--SLRVRISL-EIARGLLYLHEEC 538
L + +RL L++EF+ + L L ++P+ + + V+ L +I +G+L+ H
Sbjct: 64 LQDVLMQE-SRLYLIFEFL-SMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR- 120
Query: 539 NVPIIHCDIKPQNILLDQDFTAKISDFGLSKLL-LSDQSRTRTVIRGTRGYVAPEWFKNV 597
++H D+KPQN+L+D K++DFGL++ + + T V+ T Y APE
Sbjct: 121 --RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV--TLWYRAPEVLLGS 176
Query: 598 P-VSAKVDVYSFGVVLLKII 616
P S VD++S G + ++
Sbjct: 177 PRYSTPVDIWSIGTIFAEMA 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 76.3 bits (187), Expect = 4e-15
Identities = 76/297 (25%), Positives = 126/297 (42%), Gaps = 55/297 (18%)
Query: 424 FEEELGRGSFGIVY----KGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKN 479
+ ELG G+FG V+ + VAVK L + ++F E + H++
Sbjct: 9 LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEH 68
Query: 480 LVQLLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPD--------------WSLRVRISL 525
+V+ G C EG ++V+E+M +G L L A PD S + I+
Sbjct: 69 IVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRA-HGPDAVLMAEGNRPAELTQSQMLHIAQ 127
Query: 526 EIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLS-DQSR----TRT 580
+IA G++YL + +H D+ +N L+ ++ KI DFG+S+ + S D R T
Sbjct: 128 QIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTML 184
Query: 581 VIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYD 640
IR ++ PE + + DV+S GVVL +I + +L +
Sbjct: 185 PIR----WMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE-------VIE 233
Query: 641 CYVEGKLDVLVDNDKAAMADKSRACKW----LMIALWCIQEDPLKRPAMKMIVQMLE 693
C +G++ + R C LM+ W Q +P R +K I +L+
Sbjct: 234 CITQGRV-----------LQRPRTCPKEVYDLMLGCW--QREPHMRLNIKEIHSLLQ 277
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 4e-15
Identities = 58/211 (27%), Positives = 100/211 (47%), Gaps = 33/211 (15%)
Query: 425 EEELGRGSFGIVYKGVLKSASGNAVAVKKLDK------LAQEREREFKTEVSAIGRT-HH 477
E +G G++G+V + + SG VA+KK+ LA+ RE K I R H
Sbjct: 10 IENIGSGAYGVVCSAI-DTRSGKKVAIKKIPHAFDVPTLAKRTLRELK-----ILRHFKH 63
Query: 478 KNLVQLLGFC----DEGLNRLLVYEFMGNGTLANLLFAIPRPDWSL---RVRISL-EIAR 529
N++ + + + +V + M + L I D L +R L ++ R
Sbjct: 64 DNIIAIRDILRPPGADFKDVYVVMDLMESD-----LHHIIHSDQPLTEEHIRYFLYQLLR 118
Query: 530 GLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLS---DQSRTRTVIRGTR 586
GL Y+H +IH D+KP N+L+++D +I DFG+++ L S + T TR
Sbjct: 119 GLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATR 175
Query: 587 GYVAPEWFKNVP-VSAKVDVYSFGVVLLKII 616
Y APE ++P + +D++S G + +++
Sbjct: 176 WYRAPELLLSLPEYTTAIDMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 76.8 bits (190), Expect = 4e-15
Identities = 57/209 (27%), Positives = 93/209 (44%), Gaps = 43/209 (20%)
Query: 428 LGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSA---------IGRTHHK 478
+G G++G+V V K +G VA+KK+ F + A + H+
Sbjct: 8 IGSGAYGVVCSAVDKR-TGRKVAIKKI-------SNVFDDLIDAKRILREIKLLRHLRHE 59
Query: 479 NLVQLLG-FCDEGLNRL----LVYEFMGNGT-LANLLFAIPRPDWSLRVR-ISLEIARGL 531
N++ LL +V E M T L ++ + P+P ++ +I RGL
Sbjct: 60 NIIGLLDILRPPSPEDFNDVYIVTELME--TDLHKVIKS-PQPLTDDHIQYFLYQILRGL 116
Query: 532 LYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRT----VIRGTRG 587
YLH N +IH D+KP NIL++ + KI DFGL++ + D+ V+ TR
Sbjct: 117 KYLHS-AN--VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVV--TRW 171
Query: 588 YVAPE----WFKNVPVSAKVDVYSFGVVL 612
Y APE + + +D++S G +
Sbjct: 172 YRAPELLLSSSR---YTKAIDIWSVGCIF 197
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 4e-15
Identities = 87/286 (30%), Positives = 136/286 (47%), Gaps = 41/286 (14%)
Query: 424 FEEELGRGSFGIVYK----GVLKSASGNAVAVKKLDKLAQERERE-FKTEVSAIGRTH-- 476
F + LG G+FG V + G+ KS + VAVK L A ERE +E+ + +H
Sbjct: 39 FGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIM--SHLG 96
Query: 477 -HKNLVQLLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLR--VRISLEIARGLLY 533
H+N+V LLG C G L++ E+ G L N L +L + S ++A+G+ +
Sbjct: 97 NHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAF 156
Query: 534 L-HEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRG-TR---GY 588
L + C IH D+ +N+LL KI DFGL++ +++D + V++G R +
Sbjct: 157 LASKNC----IHRDLAARNVLLTHGKIVKICDFGLARDIMND---SNYVVKGNARLPVKW 209
Query: 589 VAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLD 648
+APE N + + DV+S+G++L +I LG + V+ K
Sbjct: 210 MAPESIFNCVYTFESDVWSYGILLWEI--------FSLG------SNPYP-GMPVDSKFY 254
Query: 649 VLVDNDKAAMADKSRACKWLM-IALWCIQEDPLKRPAMKMIVQMLE 693
L+ + MA A + I C DPLKRP K IVQ++
Sbjct: 255 KLI-KEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIG 299
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 5e-15
Identities = 63/197 (31%), Positives = 98/197 (49%), Gaps = 17/197 (8%)
Query: 428 LGRGSFGIVYKGVLKSASGN----AVAVKKLDKLAQERERE---FKTEVSAIGRTHHKNL 480
LG+GSFG K +L G A+ + K D + Q+ + E + V A+ L
Sbjct: 8 LGKGSFG---KVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPP-FL 63
Query: 481 VQLLGFCDEGLNRL-LVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECN 539
QL C + ++RL V E++ G L + + + V + EIA GL +LH +
Sbjct: 64 TQLHS-CFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSK-- 120
Query: 540 VPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPV 599
II+ D+K N++LD + KI+DFG+ K + TRT GT Y+APE P
Sbjct: 121 -GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFC-GTPDYIAPEIIAYQPY 178
Query: 600 SAKVDVYSFGVVLLKII 616
VD ++FGV+L +++
Sbjct: 179 GKSVDWWAFGVLLYEML 195
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 5e-15
Identities = 78/289 (26%), Positives = 131/289 (45%), Gaps = 37/289 (12%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNAVAVK--KLDKLAQEREREFKTEVSAIGRTHHKNLV 481
++E LG G+ G VYK + +AVK LD + E +++ +E+ + + ++
Sbjct: 5 YQEILGHGNGGTVYK-AYHLLTRRILAVKVIPLD-ITVELQKQIMSELEILYKCDSPYII 62
Query: 482 QLLG-FCDEGLNRL-LVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECN 539
G F E NR+ + EFM G+L ++ IP + RI++ + +GL YL +
Sbjct: 63 GFYGAFFVE--NRISICTEFMDGGSL-DVYRKIPEH---VLGRIAVAVVKGLTYL---WS 113
Query: 540 VPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPV 599
+ I+H D+KP N+L++ K+ DFG+S L++ ++T GT Y+APE
Sbjct: 114 LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYV---GTNAYMAPERISGEQY 170
Query: 600 SAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVE--GKLDVLVDNDKAA 657
DV+S G+ MEL R + L +VD D
Sbjct: 171 GIHSDVWSLGISF-----------MELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPV 219
Query: 658 MADKSRACKWLMIALWCIQEDPLKRPAMKM------IVQMLEGYLEVPS 700
+ + K++ C+++ P +RPA + IVQ +G EV S
Sbjct: 220 LPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQYNDGNAEVVS 268
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 5e-15
Identities = 58/152 (38%), Positives = 75/152 (49%), Gaps = 10/152 (6%)
Query: 426 EELGRGSFGIVYKGVLKSASGNA-VAVKKLDKLAQERE-REFKTEVSAIGRTHHKNLVQL 483
+E+G G FG V G + S A V VK+L A +E +F E H NL+Q
Sbjct: 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQC 60
Query: 484 LGFCDEGLNRLLVYEFMGNGTLANLLFAIPR-----PDWSLRVRISLEIARGLLYLHEEC 538
LG C E LLV EF G L L + + PD + R++ EIA GLL+LH+
Sbjct: 61 LGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN- 119
Query: 539 NVPIIHCDIKPQNILLDQDFTAKISDFGLSKL 570
IH D+ +N LL D T KI D+GLS
Sbjct: 120 --NFIHSDLALRNCLLTADLTVKIGDYGLSHN 149
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 6e-15
Identities = 76/298 (25%), Positives = 128/298 (42%), Gaps = 53/298 (17%)
Query: 428 LGRGSFGIVYKGVLKSASGNA----VAVKKLDKLAQERE-REFKTEVSAIGRTHHKNLVQ 482
LG G FG V K G A VAVK L + A E R+ +E + + + +H ++++
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 483 LLGFCDEGLNRLLVYEFMGNGTL----------------------ANLLFAIPRPDWSLR 520
L G C + LL+ E+ G+L ++ L ++
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 521 VRISL--EIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRT 578
IS +I+RG+ YL E + ++H D+ +N+L+ + KISDFGLS+ + + S
Sbjct: 128 DLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184
Query: 579 -RTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDW 637
R+ R ++A E + + + DV+SFGV+L +I+ + + ER L
Sbjct: 185 KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLLKT 244
Query: 638 AYDCYVEGKLDVLVDNDKAAMADKSRACKWLM--IALWCIQEDPLKRPAMKMIVQMLE 693
Y ++ C M + L C +++P KRP I + LE
Sbjct: 245 GY------------------RMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELE 284
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 6e-15
Identities = 58/207 (28%), Positives = 98/207 (47%), Gaps = 30/207 (14%)
Query: 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKT---EVSAIGRTHH-KNLV 481
EELGRG++G+V K + +G +AVK++ A +E K ++ R+ V
Sbjct: 7 EELGRGAYGVVDK-MRHVPTGTIMAVKRIR--ATVNSQEQKRLLMDLDISMRSVDCPYTV 63
Query: 482 QLLG---------FCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLL 532
G C E ++ L +F L IP +I++ I + L
Sbjct: 64 TFYGALFREGDVWICMEVMDTSL-DKFYKKVYDKGL--TIPEDILG---KIAVSIVKALE 117
Query: 533 YLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPE 592
YLH + +V IH D+KP N+L++++ K+ DFG+S L+ S +T+ G + Y+APE
Sbjct: 118 YLHSKLSV--IHRDVKPSNVLINRNGQVKLCDFGISGYLVD--SVAKTIDAGCKPYMAPE 173
Query: 593 WF----KNVPVSAKVDVYSFGVVLLKI 615
K DV+S G+ ++++
Sbjct: 174 RINPELNQKGYDVKSDVWSLGITMIEL 200
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.0 bits (185), Expect = 9e-15
Identities = 58/191 (30%), Positives = 99/191 (51%), Gaps = 15/191 (7%)
Query: 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKT---EVSAIGRTHHKNLVQ 482
E++G G++G+VYK K +G VA+KK+ +L E E T E+S + +H N+V+
Sbjct: 5 EKIGEGTYGVVYKARDK-LTGEIVALKKI-RLETEDEGVPSTAIREISLLKELNHPNIVR 62
Query: 483 LLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRV--RISLEIARGLLYLHEECNV 540
LL LV+EF+ + L + + P + ++ +G+ Y H
Sbjct: 63 LLDVVHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH--- 118
Query: 541 PIIHCDIKPQNILLDQDFTAKISDFGLSKLL-LSDQSRTRTVIRGTRGYVAPEWFKNVP- 598
++H D+KPQN+L+D++ K++DFGL++ + ++ T V+ T Y APE
Sbjct: 119 RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILLGSRQ 176
Query: 599 VSAKVDVYSFG 609
S VD++S G
Sbjct: 177 YSTPVDIWSIG 187
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 1e-14
Identities = 65/221 (29%), Positives = 109/221 (49%), Gaps = 42/221 (19%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNAV--AVKKLDKLAQERE-REFKTEVSAIGRT-HHKN 479
FE+ +G G+FG V + ++K G + A+K L + A E + R+F E+ + + HH N
Sbjct: 6 FEDVIGEGNFGQVIRAMIKK-DGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPN 64
Query: 480 LVQLLGFCDEGLNRLLVY---EFMGNGTLANLL-----------FAIPRPDWSLR----- 520
++ LLG C+ NR +Y E+ G L + L FA S
Sbjct: 65 IINLLGACE---NRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQL 121
Query: 521 VRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRT 580
++ + ++A G+ YL E+ IH D+ +N+L+ ++ +KI+DFGLS+
Sbjct: 122 LQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSR-------GEEV 171
Query: 581 VIRGTRGYVAPEWFK----NVPV-SAKVDVYSFGVVLLKII 616
++ T G + W N V + K DV+SFGV+L +I+
Sbjct: 172 YVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIV 212
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 1e-14
Identities = 62/207 (29%), Positives = 98/207 (47%), Gaps = 22/207 (10%)
Query: 428 LGRGSFGIVYKGVLKS--ASGNAVAVK--KLDKLAQEREREFKTEVSAIGRTHHKNLVQL 483
LG+G FG V + LKS S VAVK K D + EF E + + H N+++L
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66
Query: 484 LGFC--DEGLNRL----LVYEFMGNGTLANLLFA-------IPRPDWSLRVRISLEIARG 530
+G RL ++ FM +G L L P +L VR ++IA G
Sbjct: 67 IGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTL-VRFMIDIASG 125
Query: 531 LLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLS-DQSRTRTVIRGTRGYV 589
+ YL + IH D+ +N +L+++ T ++DFGLSK + S D R + ++
Sbjct: 126 MEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWL 182
Query: 590 APEWFKNVPVSAKVDVYSFGVVLLKII 616
A E + + DV++FGV + +I+
Sbjct: 183 ALESLADNVYTTHSDVWAFGVTMWEIM 209
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 1e-14
Identities = 54/197 (27%), Positives = 97/197 (49%), Gaps = 16/197 (8%)
Query: 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLG 485
++LG G FG V+ G +++ VAVK L K + F E + + H LV+L
Sbjct: 12 KKLGAGQFGEVWMGYYNNST--KVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRLYA 68
Query: 486 FCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRI------SLEIARGLLYLHEECN 539
+ ++ E+M G+L + L + D +V + S +IA G+ Y+ +
Sbjct: 69 VVTKEEPIYIITEYMAKGSLLDFL----KSDEGGKVLLPKLIDFSAQIAEGMAYIERK-- 122
Query: 540 VPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPV 599
IH D++ N+L+ + KI+DFGL++++ ++ R + + APE
Sbjct: 123 -NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSF 181
Query: 600 SAKVDVYSFGVVLLKII 616
+ K DV+SFG++L +I+
Sbjct: 182 TIKSDVWSFGILLYEIV 198
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 2e-14
Identities = 60/198 (30%), Positives = 104/198 (52%), Gaps = 15/198 (7%)
Query: 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKT---EVSAIGRTHHKNLVQ 482
E++G G++G+VYK K +G VA+KK+ +L E E T E+S + +H N+V+
Sbjct: 6 EKIGEGTYGVVYKARNKL-TGEVVALKKI-RLDTETEGVPSTAIREISLLKELNHPNIVK 63
Query: 483 LLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRIS--LEIARGLLYLHEECNV 540
LL LV+EF+ + L + A P L + S ++ +GL + H
Sbjct: 64 LLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH--- 119
Query: 541 PIIHCDIKPQNILLDQDFTAKISDFGLSKLL-LSDQSRTRTVIRGTRGYVAPEWFKNVPV 599
++H D+KPQN+L++ + K++DFGL++ + ++ T V+ T Y APE
Sbjct: 120 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILLGCKY 177
Query: 600 -SAKVDVYSFGVVLLKII 616
S VD++S G + +++
Sbjct: 178 YSTAVDIWSLGCIFAEMV 195
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 2e-14
Identities = 56/196 (28%), Positives = 96/196 (48%), Gaps = 15/196 (7%)
Query: 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDK---LAQEREREFKTEVSAI-GRTHHKNLV 481
+ + +G+FG VY K ++G+ A+K L K +A+ + K E + + + +
Sbjct: 2 KPISKGAFGSVYLAK-KRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVA 60
Query: 482 QLLGFCDEGLNRLLVYEFMGNGTLANLLFAI-PRPDWSLRVRISLEIARGLLYLHEECNV 540
+L LV E++ G A+L+ + P+ + I+ E+ G+ LH+
Sbjct: 61 KLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIA-EVVLGVEDLHQR--- 116
Query: 541 PIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPVS 600
IIH DIKP+N+L+DQ K++DFGLS+ L ++ GT Y+APE V
Sbjct: 117 GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKK-----FVGTPDYLAPETILGVGDD 171
Query: 601 AKVDVYSFGVVLLKII 616
D +S G V+ + +
Sbjct: 172 KMSDWWSLGCVIFEFL 187
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 75.0 bits (185), Expect = 2e-14
Identities = 68/231 (29%), Positives = 104/231 (45%), Gaps = 41/231 (17%)
Query: 412 FSLVELNEATNGFEEE------LGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREF 465
F ELN+ + +G G++G V +G VA+KKL R F
Sbjct: 1 FYRQELNKTVWEVPDRYQNLSPVGSGAYGQVCSAFDTK-TGRKVAIKKLS-------RPF 52
Query: 466 KTEVSAIGRT----------HHKNLVQLLG-FC-DEGLNRL----LVYEFMGNGTLANLL 509
++ + A RT H+N++ LL F L LV MG L N++
Sbjct: 53 QSAIHA-KRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMG-ADLNNIV 110
Query: 510 FAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSK 569
D ++ + +I RGL Y+H + IIH D+KP NI +++D KI DFGL++
Sbjct: 111 KCQKLSDDHIQF-LVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLAR 166
Query: 570 LLLSDQSRTRTVIRGTRGYVAPEWFKN-VPVSAKVDVYSFGVVLLKIICCK 619
D T V TR Y APE N + + VD++S G ++ +++ K
Sbjct: 167 HT--DDEMTGYV--ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 2e-14
Identities = 64/199 (32%), Positives = 100/199 (50%), Gaps = 20/199 (10%)
Query: 428 LGRGSFGIVYKGVLKSASGNAVAVKKLDK---LAQEREREFKTEVSAIGRTHHKNLVQLL 484
LG+G+FG V V + A+G A+K L K +A++ TE + T H L L
Sbjct: 3 LGKGTFGKVIL-VREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL- 60
Query: 485 GFCDEGLNRL-LVYEFMGNGTLANLL-----FAIPRPDWSLRVRISLEIARGLLYLHEEC 538
+ + +RL V E+ G L L F+ R + EI L YLH C
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-----YGAEIVSALGYLHS-C 114
Query: 539 NVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVP 598
+ +++ D+K +N++LD+D KI+DFGL K +SD + +T GT Y+APE ++
Sbjct: 115 D--VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPEVLEDND 171
Query: 599 VSAKVDVYSFGVVLLKIIC 617
VD + GVV+ +++C
Sbjct: 172 YGRAVDWWGLGVVMYEMMC 190
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 2e-14
Identities = 68/216 (31%), Positives = 106/216 (49%), Gaps = 36/216 (16%)
Query: 424 FEE--ELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEV-SAIGRT----H 476
FE+ ELG G+ G+V K VL SG +A +KL L E K + + I R H
Sbjct: 3 FEKLGELGAGNGGVVTK-VLHRPSGLIMA-RKLIHL------EIKPAIRNQIIRELKVLH 54
Query: 477 HKNLVQLLGF-----CDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGL 531
N ++GF D ++ + E M G+L +L R ++ +IS+ + RGL
Sbjct: 55 ECNSPYIVGFYGAFYSDGEISICM--EHMDGGSLDQVLKKAGRIPENILGKISIAVLRGL 112
Query: 532 LYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAP 591
YL E+ I+H D+KP NIL++ K+ DFG+S L+ + + GTR Y++P
Sbjct: 113 TYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS---FVGTRSYMSP 167
Query: 592 EWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELG 627
E + + + D++S G+ L VEM +G
Sbjct: 168 ERLQGTHYTVQSDIWSLGLSL---------VEMAIG 194
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 2e-14
Identities = 60/199 (30%), Positives = 99/199 (49%), Gaps = 19/199 (9%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQERE-REFKTEVSAIGRTHH-KNLV 481
E+G G+ G VYK K +G+ +AVK++ + + E + ++ + ++H +V
Sbjct: 19 NLGEIGSGTCGQVYKMRFKK-TGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIV 77
Query: 482 QLLGFCDEGLNRLLVYEFMGNGTLANLLFAI--PRPDWSLRVRISLEIARGLLYLHEECN 539
+ G+ + + E M L LL I P P+ L ++++ I + L YL E+
Sbjct: 78 KCYGYFITDSDVFICMELMST-CLDKLLKRIQGPIPEDILG-KMTVAIVKALHYLKEKHG 135
Query: 540 VPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPE------W 593
V IH D+KP NILLD K+ DFG+S L+ +++TR+ G Y+APE
Sbjct: 136 V--IHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSA--GCAAYMAPERIDPPDP 191
Query: 594 FKNVPVSAKVDVYSFGVVL 612
+ A DV+S G+ L
Sbjct: 192 NPKYDIRA--DVWSLGISL 208
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 3e-14
Identities = 56/194 (28%), Positives = 94/194 (48%), Gaps = 11/194 (5%)
Query: 428 LGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQER---EREFKTEVSAIGRTHHKNLVQLL 484
LG+G FG V V +G A KKLDK ++ E+ E + + + +V L
Sbjct: 1 LGKGGFGEVC-AVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLA 59
Query: 485 GFCDEGLNRLLVYEFMGNGTLANLLFAIPRP--DWSLRVRISLEIARGLLYLHEECNVPI 542
+ + LV M G L ++ + + + S +I G+L+LH + I
Sbjct: 60 YAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHS---MDI 116
Query: 543 IHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPVSAK 602
++ D+KP+N+LLD ++SD GL+ L ++ T+ GT GY+APE K P S
Sbjct: 117 VYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRA--GTNGYMAPEILKEEPYSYP 174
Query: 603 VDVYSFGVVLLKII 616
VD ++ G + +++
Sbjct: 175 VDWFAMGCSIYEMV 188
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 73.6 bits (180), Expect = 4e-14
Identities = 50/191 (26%), Positives = 99/191 (51%), Gaps = 6/191 (3%)
Query: 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLG 485
E++G+G+ G V+ + A+G VA+K+++ Q ++ E+ + + N+V L
Sbjct: 25 EKIGQGASGTVFTAI-DVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLD 83
Query: 486 FCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHC 545
G +V E++ G+L +++ + + + E + L +LH +IH
Sbjct: 84 SFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAA-VCRECLQALEFLHAN---QVIHR 139
Query: 546 DIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPVSAKVDV 605
DIK N+LL D + K++DFG + +QS+ T++ GT ++APE KVD+
Sbjct: 140 DIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDI 198
Query: 606 YSFGVVLLKII 616
+S G++ ++++
Sbjct: 199 WSLGIMAIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 5e-14
Identities = 55/215 (25%), Positives = 100/215 (46%), Gaps = 26/215 (12%)
Query: 425 EEELGRGSFGIVYKGVLKSASGNAVAVKKLDKL----AQEREREFKTEVSAIGRTHHKNL 480
E+++G+G F +VYK + G VA+KK+ A+ R+ K E+ + + H N+
Sbjct: 7 EKKIGKGQFSVVYKAICL-LDGRVVALKKVQIFEMMDAKARQDCLK-EIDLLKQLDHPNV 64
Query: 481 VQLL-GFCDEGLNRL-LVYEFMGNGTLANLL--FA-----IPRPD-WSLRVRISLEIARG 530
++ L F + N L +V E G L+ ++ F IP W V ++
Sbjct: 65 IKYLASFIEN--NELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFV----QLCSA 118
Query: 531 LLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVA 590
L ++H + I+H DIKP N+ + K+ D GL + S + +++ GT Y++
Sbjct: 119 LEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMS 174
Query: 591 PEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEME 625
PE + K D++S G +L ++ + +
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 5e-14
Identities = 69/230 (30%), Positives = 105/230 (45%), Gaps = 40/230 (17%)
Query: 424 FEEELGRGSFGIVY--------KGVLKSASGNA-------VAVKKLDKLAQERER-EFKT 467
F E+LG G FG V+ K+ + N VAVK L A + R +F
Sbjct: 9 FVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLK 68
Query: 468 EVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEFMGNGTLA-----------NLLFAIPRPD 516
EV + R N+ +LLG C ++ E+M NG L L
Sbjct: 69 EVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLS 128
Query: 517 WSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSK-LLLSDQ 575
+S + ++ +IA G+ YL E N +H D+ +N L+ +++T KI+DFG+S+ L SD
Sbjct: 129 FSTLLYMATQIASGMRYL-ESLN--FVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDY 185
Query: 576 SRT--RTV--IRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKR 620
R R IR ++A E + K DV++FGV L +I+ C+
Sbjct: 186 YRVQGRAPLPIR----WMAWESVLLGKFTTKSDVWAFGVTLWEILTLCRE 231
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 6e-14
Identities = 57/198 (28%), Positives = 95/198 (47%), Gaps = 15/198 (7%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQL 483
++LG G FG V+ G + AV K ++ E F E + + H LVQL
Sbjct: 10 LIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPE---SFLEEAQIMKKLRHDKLVQL 66
Query: 484 LGFCDEGLNRLLVYEFMGNGTLANLL-----FAIPRPDWSLRVRISLEIARGLLYLHEEC 538
E +V E+M G+L + L A+ P+ V ++ ++A G+ Y+ E
Sbjct: 67 YAVVSEE-PIYIVTEYMSKGSLLDFLKDGEGRALKLPNL---VDMAAQVAAGMAYI-ERM 121
Query: 539 NVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVP 598
N IH D++ NIL+ KI+DFGL++L+ ++ R + + APE
Sbjct: 122 NY--IHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 179
Query: 599 VSAKVDVYSFGVVLLKII 616
+ K DV+SFG++L +++
Sbjct: 180 FTIKSDVWSFGILLTELV 197
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 7e-14
Identities = 64/214 (29%), Positives = 103/214 (48%), Gaps = 36/214 (16%)
Query: 419 EATNGFEE--ELGRGSFGIVYKGVLKSASGNAVAVKKLDK------LAQEREREFKTEVS 470
E TN + + +G G+FG+V +G VA+KK+ K LA+ RE K
Sbjct: 7 EITNRYVDLQPVGMGAFGLVCSAR-DQLTGQNVAIKKIMKPFSTPVLAKRTYRELKL--- 62
Query: 471 AIGRTHHKNLVQLLGFCDEGLNRL----LVYEFMGNGTLANLLFAIPRPDWSLRVRISLE 526
+ H+N++ L D ++ L V E +G L LL + P ++ +
Sbjct: 63 -LKHLRHENIISL---SDIFISPLEDIYFVTELLGT-DLHRLLTSRPLEKQFIQY-FLYQ 116
Query: 527 IARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTR 586
I RGL Y+H + ++H D+KP NIL++++ KI DFGL+++ Q T TR
Sbjct: 117 ILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARI----QDPQMTGYVSTR 169
Query: 587 GYVAPE----WFKNVPVSAKVDVYSFGVVLLKII 616
Y APE W K +VD++S G + +++
Sbjct: 170 YYRAPEIMLTWQK---YDVEVDIWSAGCIFAEML 200
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 8e-14
Identities = 63/205 (30%), Positives = 100/205 (48%), Gaps = 7/205 (3%)
Query: 428 LGRGSFGIVYKGVLKSASG-NAVAVKKLDKLAQEREREFK-TEVSAIGRTHHKNLVQLLG 485
LG+GSFG V K A+ + K D + Q+ + E E + + + L
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLH 67
Query: 486 FCDEGLNRL-LVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIH 544
C + ++RL V E++ G L + + R V + EIA GL +LH + II+
Sbjct: 68 SCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSK---GIIY 124
Query: 545 CDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPVSAKVD 604
D+K N++LD + KI+DFG+ K + D T+T GT Y+APE P VD
Sbjct: 125 RDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFC-GTPDYIAPEIIAYQPYGKSVD 183
Query: 605 VYSFGVVLLKIICCKRSVEMELGEE 629
++FGV+L +++ + E E +E
Sbjct: 184 WWAFGVLLYEMLAGQAPFEGEDEDE 208
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 1e-13
Identities = 64/197 (32%), Positives = 97/197 (49%), Gaps = 16/197 (8%)
Query: 428 LGRGSFGIVYKGVLKSASGNAVAVKKLDK---LAQEREREFKTEVSAIGRTHHKNLVQLL 484
LG+G+FG V V + A+G A+K L K +A++ TE + T H L L
Sbjct: 3 LGKGTFGKVIL-VREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL- 60
Query: 485 GFCDEGLNRL-LVYEFMGNGTLANLLFAIPRPDWSLRVRISL---EIARGLLYLHEECNV 540
+ + +RL V E+ G L F + R R EI L YLH
Sbjct: 61 KYAFQTHDRLCFVMEYANGG---ELFFHLSRERVFTEERARFYGAEIVSALEYLHSR--- 114
Query: 541 PIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPVS 600
+++ DIK +N++LD+D KI+DFGL K +SD + +T GT Y+APE ++
Sbjct: 115 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPEVLEDNDYG 173
Query: 601 AKVDVYSFGVVLLKIIC 617
VD + GVV+ +++C
Sbjct: 174 RAVDWWGLGVVMYEMMC 190
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 1e-13
Identities = 60/207 (28%), Positives = 96/207 (46%), Gaps = 39/207 (18%)
Query: 428 LGRGSFGIVYKGVLKSASGNAVAVKKLD-KLAQEREREF-KTEVSAIGRTHHKNLVQ--- 482
+G+GS+G V V G +KKL+ + A RER+ + E + + H N+V
Sbjct: 8 VGKGSYGEV-SLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRE 66
Query: 483 -----------LLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGL 531
++GFC+ G + E G N + +W + +IA L
Sbjct: 67 SWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVV-----EWFV------QIAMAL 115
Query: 532 LYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAP 591
YLHE+ I+H D+K QN+ L + K+ D G++++L + T+I GT Y++P
Sbjct: 116 QYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLI-GTPYYMSP 171
Query: 592 EWFKNVPVSAKVDVYSFGVVLLKIICC 618
E F N P + K DV++ G CC
Sbjct: 172 ELFSNKPYNYKSDVWALG-------CC 191
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 1e-13
Identities = 54/198 (27%), Positives = 97/198 (48%), Gaps = 17/198 (8%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQL 483
E +LG+G FG V+ G + A+ K ++ E F E + + H+ LVQL
Sbjct: 10 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE---AFLQEAQVMKKLRHEKLVQL 66
Query: 484 LGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRI------SLEIARGLLYLHEE 537
E +V E+M G+L + L + + +R+ + +IA G+ Y+ E
Sbjct: 67 YAVVSEE-PIYIVTEYMSKGSLLDFL----KGEMGKYLRLPQLVDMAAQIASGMAYV-ER 120
Query: 538 CNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNV 597
N +H D++ NIL+ ++ K++DFGL++L+ ++ R + + APE
Sbjct: 121 MNY--VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 178
Query: 598 PVSAKVDVYSFGVVLLKI 615
+ K DV+SFG++L ++
Sbjct: 179 RFTIKSDVWSFGILLTEL 196
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 72.2 bits (178), Expect = 1e-13
Identities = 64/208 (30%), Positives = 109/208 (52%), Gaps = 28/208 (13%)
Query: 428 LGRGSFGIVYKGVLKSASGNAVAVKKL-DKL--AQEREREFKTEVSAIGR-THHKNLVQL 483
LG+G++GIV+K + + + VA+KK+ D A + +R F+ E+ + H N+V+L
Sbjct: 15 LGKGAYGIVWKAIDRR-TKEVVALKKIFDAFRNATDAQRTFR-EIMFLQELGDHPNIVKL 72
Query: 484 LGF--CDEGLNRLLVYEFM----GNGTLANLLFAIPRPDWSLRVR-ISLEIARGLLYLHE 536
L + + LV+E+M AN+L + + R I ++ + L Y+H
Sbjct: 73 LNVIKAENDKDIYLVFEYMETDLHAVIRANILEDVHK-------RYIMYQLLKALKYIHS 125
Query: 537 ECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLS-DQSRTRTVIR---GTRGYVAPE 592
NV IH D+KP NILL+ D K++DFGL++ L +++ V+ TR Y APE
Sbjct: 126 G-NV--IHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPE 182
Query: 593 -WFKNVPVSAKVDVYSFGVVLLKIICCK 619
+ + VD++S G +L +++ K
Sbjct: 183 ILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 2e-13
Identities = 63/199 (31%), Positives = 102/199 (51%), Gaps = 20/199 (10%)
Query: 428 LGRGSFGIVY--KGVLKSASGNAVAVKKLDKLA---QEREREFKTEVSAIGRTHHKNLVQ 482
LG+GSFG V+ + + +G A+K L K ++R R K E + +H +V+
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRT-KMERDILAEVNHPFIVK 62
Query: 483 L-LGFCDEGLNRLLVYEFMGNGTLANLL---FAIPRPDWSLRVRISL-EIARGLLYLHEE 537
L F EG L+ +F+ G L L D V+ L E+A L +LH
Sbjct: 63 LHYAFQTEG-KLYLILDFLRGGDLFTRLSKEVMFTEED----VKFYLAELALALDHLH-- 115
Query: 538 CNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNV 597
++ II+ D+KP+NILLD++ K++DFGLSK + + + + GT Y+APE
Sbjct: 116 -SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC-GTVEYMAPEVVNRR 173
Query: 598 PVSAKVDVYSFGVVLLKII 616
+ D +SFGV++ +++
Sbjct: 174 GHTQSADWWSFGVLMFEML 192
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 2e-13
Identities = 56/213 (26%), Positives = 97/213 (45%), Gaps = 23/213 (10%)
Query: 416 ELNEATNGFEEELGRGSFGIVYKGVLKSASGNA--VAVKKL-DKLAQEREREFKTEVSAI 472
EL+ + E LG G FG + +G LK S VA+ L + ++ R F E +
Sbjct: 1 ELDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTL 60
Query: 473 GRTHHKNLVQLLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLE----IA 528
G+ H N+V+L G G ++V E+M NG L + L + + L + +A
Sbjct: 61 GQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFL---RKHEGQLVAGQLMGMLPGLA 117
Query: 529 RGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRG- 587
G+ YL E + +H + +L++ D KIS F + + ++ + G
Sbjct: 118 SGMKYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFRRLQ-----EDKSEAIYTTMSGK 169
Query: 588 ----YVAPEWFKNVPVSAKVDVYSFGVVLLKII 616
+ APE + S+ DV+SFG+V+ +++
Sbjct: 170 SPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVM 202
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 64/197 (32%), Positives = 98/197 (49%), Gaps = 16/197 (8%)
Query: 428 LGRGSFGIVYKGVLKSASGNAVAVKKLDK---LAQEREREFKTEVSAIGRTHHKNLVQLL 484
LG+G+FG V V + ASG A+K L K +A++ TE + T H L L
Sbjct: 3 LGKGTFGKVIL-VREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL- 60
Query: 485 GFCDEGLNRL-LVYEFMGNGTLANLLFAIPRPDWSLRVRISL---EIARGLLYLHEECNV 540
+ + +RL V E++ G L F + R R EI L YLH
Sbjct: 61 KYSFQTKDRLCFVMEYVNGG---ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSG--- 114
Query: 541 PIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPVS 600
I++ D+K +N++LD+D KI+DFGL K ++D + +T GT Y+APE ++
Sbjct: 115 KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFC-GTPEYLAPEVLEDNDYG 173
Query: 601 AKVDVYSFGVVLLKIIC 617
VD + GVV+ +++C
Sbjct: 174 RAVDWWGLGVVMYEMMC 190
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 3e-13
Identities = 60/200 (30%), Positives = 95/200 (47%), Gaps = 9/200 (4%)
Query: 421 TNGFEEELGRGSFGIVYKGVLKSASGNAVAVK--KLDKLAQEREREFK-TEVSAIGRTHH 477
F LG+GSFG V K + A+K K D + Q+ + E E +
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERK-GTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDK 59
Query: 478 KNLVQLLGFCDEGLNRL-LVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHE 536
+ L C + ++RL V E++ G L + + + V + EI+ GL +LH
Sbjct: 60 PPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHR 119
Query: 537 ECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKN 596
II+ D+K N++LD + KI+DFG+ K + D TRT GT Y+APE
Sbjct: 120 R---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFC-GTPDYIAPEIIAY 175
Query: 597 VPVSAKVDVYSFGVVLLKII 616
P VD +++GV+L +++
Sbjct: 176 QPYGKSVDWWAYGVLLYEML 195
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 4e-13
Identities = 61/198 (30%), Positives = 93/198 (46%), Gaps = 19/198 (9%)
Query: 427 ELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKT--EVSAIGRTH---HKNLV 481
E+G G++G VYK SG+ VA+K + E T EV+ + R H N+V
Sbjct: 7 EIGVGAYGTVYKA-RDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIV 65
Query: 482 QLLGFC-----DEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISL--EIARGLLYL 534
+L+ C D LV+E + + L L +P P L + RGL +L
Sbjct: 66 RLMDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFL 124
Query: 535 HEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWF 594
H C I+H D+KP+NIL+ K++DFGL+++ + T V+ T Y APE
Sbjct: 125 HANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVV--TLWYRAPEVL 179
Query: 595 KNVPVSAKVDVYSFGVVL 612
+ VD++S G +
Sbjct: 180 LQSTYATPVDMWSVGCIF 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 69.6 bits (171), Expect = 4e-13
Identities = 59/197 (29%), Positives = 88/197 (44%), Gaps = 17/197 (8%)
Query: 428 LGRGSFGIVYKGVLKSASGNAVAVKKLDKL---AQEREREFKTEVSAIGRTHHKNLVQLL 484
LG G FG V +KS A+K + K ++ +E + +H +V+L
Sbjct: 1 LGVGGFGRVELVKVKS-KNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLY 59
Query: 485 -GFCDEGLNRLLVY---EFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNV 540
F D+ +Y E+ G L +L D + YLH N
Sbjct: 60 RTFKDK----KYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLH---NR 112
Query: 541 PIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPVS 600
II+ D+KP+N+LLD + K+ DFG +K L S Q +T T GT YVAPE N
Sbjct: 113 GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-KTWTFC-GTPEYVAPEIILNKGYD 170
Query: 601 AKVDVYSFGVVLLKIIC 617
VD +S G++L +++
Sbjct: 171 FSVDYWSLGILLYELLT 187
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 4e-13
Identities = 73/281 (25%), Positives = 120/281 (42%), Gaps = 39/281 (13%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQL 483
+ +LG+G FG V+ G + A+ K + E F E + + H LV L
Sbjct: 10 LDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPE---AFLQEAQIMKKLRHDKLVPL 66
Query: 484 LGFCDEGLNRLLVYEFMGNGTLANLL-------FAIPRPDWSLRVRISLEIARGLLYLHE 536
E +V EFMG G+L + L +P+ V ++ +IA G+ Y+ E
Sbjct: 67 YAVVSEE-PIYIVTEFMGKGSLLDFLKEGDGKYLKLPQ-----LVDMAAQIADGMAYI-E 119
Query: 537 ECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKN 596
N IH D++ NIL+ + KI+DFGL++L+ ++ R + + APE
Sbjct: 120 RMNY--IHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY 177
Query: 597 VPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKA 656
+ K DV+SFG++L +++ R Y V +VL ++
Sbjct: 178 GRFTIKSDVWSFGILLTELVTKGRV----------------PYPGMV--NREVLEQVERG 219
Query: 657 AMADKSRACKWLMIALW--CIQEDPLKRPAMKMIVQMLEGY 695
+ C + L C ++DP +RP + I LE Y
Sbjct: 220 YRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLEDY 260
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 5e-13
Identities = 58/204 (28%), Positives = 100/204 (49%), Gaps = 26/204 (12%)
Query: 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKT----EVSAIGRTHHKNLV 481
++G GS+G+V+K + +G VA+KK + E + K E+ + + H NLV
Sbjct: 7 SKIGEGSYGVVFKCRNRE-TGQIVAIKKF--VESEDDPVIKKIALREIRMLKQLKHPNLV 63
Query: 482 QLLGFCDEGLNRL----LVYEFMGNGTLANLLFAIPR--PDWSLRVRISLEIARGLLYLH 535
L+ E R LV+E+ + T+ N L PR P+ ++ +I + + + + H
Sbjct: 64 NLI----EVFRRKRKLHLVFEYCDH-TVLNELEKNPRGVPEHLIK-KIIWQTLQAVNFCH 117
Query: 536 EE-CNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWF 594
+ C IH D+KP+NIL+ + K+ DFG ++ +L+ T TR Y APE
Sbjct: 118 KHNC----IHRDVKPENILITKQGQIKLCDFGFAR-ILTGPGDDYTDYVATRWYRAPELL 172
Query: 595 -KNVPVSAKVDVYSFGVVLLKIIC 617
+ VDV++ G V +++
Sbjct: 173 VGDTQYGPPVDVWAIGCVFAELLT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 6e-13
Identities = 64/197 (32%), Positives = 98/197 (49%), Gaps = 15/197 (7%)
Query: 428 LGRGSFGIVYKGVLKSASGNAVAVKKLDK---LAQEREREFKTEVSAIGRTHHKNLVQLL 484
LG+G+FG V V + A+G A+K L K +A++ TE + + H L L
Sbjct: 3 LGKGTFGKVIL-VKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL- 60
Query: 485 GFCDEGLNRL-LVYEFMGNGTLANLLFAIPRPDWSLRVRISL---EIARGLLYLHEECNV 540
+ + +RL V E+ G L F + R R EI L YLH E NV
Sbjct: 61 KYSFQTHDRLCFVMEYANGG---ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNV 117
Query: 541 PIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPVS 600
++ D+K +N++LD+D KI+DFGL K + D + +T GT Y+APE ++
Sbjct: 118 --VYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC-GTPEYLAPEVLEDNDYG 174
Query: 601 AKVDVYSFGVVLLKIIC 617
VD + GVV+ +++C
Sbjct: 175 RAVDWWGLGVVMYEMMC 191
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 6e-13
Identities = 56/204 (27%), Positives = 97/204 (47%), Gaps = 19/204 (9%)
Query: 428 LGRGSFGIVYKGVL-KSASGNAVAVK--KLDKLAQEREREFKTEVSAIGRTHHKNLVQLL 484
LG G FG V +G L + S VAVK K+ + +F +E + H N+++L+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 485 GFCDEGLNR------LLVYEFMGNGTLANLLFAIPRPDWSLR------VRISLEIARGLL 532
G C + + +++ FM +G L + L D V+ +IA G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 533 YLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLS-DQSRTRTVIRGTRGYVAP 591
YL + IH D+ +N +L+++ ++DFGLSK + + D R + + ++A
Sbjct: 127 YLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183
Query: 592 EWFKNVPVSAKVDVYSFGVVLLKI 615
E + + K DV+SFGV + +I
Sbjct: 184 ESLADRVYTTKSDVWSFGVTMWEI 207
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 1e-12
Identities = 63/196 (32%), Positives = 94/196 (47%), Gaps = 15/196 (7%)
Query: 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDK---LAQEREREFKTEVSAIGRTHHKNLVQ 482
E LG GSFG V K +G A+K L K L ++ + E S + H +V
Sbjct: 24 ETLGTGSFGRVRIAKHK-GTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVN 82
Query: 483 LL-GFCDEGLNRL-LVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNV 540
++ F DE NR+ + EF+ G L L R + E+ YLH +
Sbjct: 83 MMCSFQDE--NRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHS-KD- 138
Query: 541 PIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPVS 600
II+ D+KP+N+LLD K++DFG +K + RT T+ GT Y+APE ++
Sbjct: 139 -IIYRDLKPENLLLDNKGHVKVTDFGFAKKV---PDRTFTLC-GTPEYLAPEVIQSKGHG 193
Query: 601 AKVDVYSFGVVLLKII 616
VD ++ GV+L + I
Sbjct: 194 KAVDWWTMGVLLYEFI 209
|
Length = 329 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 1e-12
Identities = 59/195 (30%), Positives = 91/195 (46%), Gaps = 13/195 (6%)
Query: 428 LGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRT------HHKNLV 481
LG+GSFG V+ LK + A+K L K + + E + + + H L
Sbjct: 3 LGKGSFGKVFLAELK-GTNQFFAIKALKKDVVLMDDD--VECTMVEKRVLSLAWEHPFLT 59
Query: 482 QLLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVP 541
L N V E++ G L + + + D + EI GL +LH +
Sbjct: 60 HLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSK---G 116
Query: 542 IIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPVSA 601
I++ D+K NILLD D KI+DFG+ K + ++T T GT Y+APE +
Sbjct: 117 IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFC-GTPDYIAPEILLGQKYNT 175
Query: 602 KVDVYSFGVVLLKII 616
VD +SFGV+L +++
Sbjct: 176 SVDWWSFGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 56/213 (26%), Positives = 98/213 (46%), Gaps = 21/213 (9%)
Query: 416 ELNEATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRT 475
E+ + E++LG G FG V+ + AV K ++ E F E + +
Sbjct: 2 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE---AFLAEANVMKTL 58
Query: 476 HHKNLVQLLGFCDEGLNRLLVY---EFMGNGTLANLLFA-----IPRPDWSLRVRISLEI 527
H LV+L + + +Y EFM G+L + L + P P + S +I
Sbjct: 59 QHDKLVKL----HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKL---IDFSAQI 111
Query: 528 ARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRG 587
A G+ ++ + IH D++ NIL+ KI+DFGL++++ ++ R +
Sbjct: 112 AEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIK 168
Query: 588 YVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKR 620
+ APE + K DV+SFG++L++I+ R
Sbjct: 169 WTAPEAINFGSFTIKSDVWSFGILLMEIVTYGR 201
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 1e-12
Identities = 50/165 (30%), Positives = 77/165 (46%), Gaps = 24/165 (14%)
Query: 531 LLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKL----LLSDQSRTRTVIRGTR 586
LL +H + +IH DIK NILL + K+ DFG SK+ + D RT GT
Sbjct: 153 LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRT---FCGTP 209
Query: 587 GYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGK 646
YVAPE ++ P S K D++S GV+L +++ KR + GE ++ + G+
Sbjct: 210 YYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFD---GENMEEVMHK-----TLAGR 261
Query: 647 LDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691
D L + M + I + DP +RP+ ++ M
Sbjct: 262 YDPLPPSISPEMQE---------IVTALLSSDPKRRPSSSKLLNM 297
|
Length = 496 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 1e-12
Identities = 66/209 (31%), Positives = 97/209 (46%), Gaps = 39/209 (18%)
Query: 428 LGRGSFGIV---YKGVLKSASGNAVAVKKLDK------LAQEREREFKTEVSAIGRTHHK 478
+G G+ GIV Y V G VA+KKL + A+ RE + +HK
Sbjct: 24 IGSGAQGIVCAAYDTVT----GQNVAIKKLSRPFQNVTHAKRAYRELVL----MKLVNHK 75
Query: 479 NLVQLLG-FC-----DEGLNRLLVYEFMGNGTLANLLFAIPRP-DWSLRVRISLEIAR-- 529
N++ LL F +E + LV E M ANL I D R+S + +
Sbjct: 76 NIIGLLNVFTPQKSLEEFQDVYLVMELMD----ANLCQVIQMDLDHE---RMSYLLYQML 128
Query: 530 -GLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGY 588
G+ +LH + IIH D+KP NI++ D T KI DFGL++ + T V+ TR Y
Sbjct: 129 CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRYY 183
Query: 589 VAPEWFKNVPVSAKVDVYSFGVVLLKIIC 617
APE + VD++S G ++ ++I
Sbjct: 184 RAPEVILGMGYKENVDIWSVGCIMGEMIR 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 60/198 (30%), Positives = 94/198 (47%), Gaps = 19/198 (9%)
Query: 428 LGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTH-----HKNLVQ 482
LG+G FG V ++ A+G A K+L+K +R ++ K E A+ + V
Sbjct: 8 LGKGGFGEVCACQVR-ATGKMYACKRLEK---KRIKKRKGESMALNEKQILEKVNSQFVV 63
Query: 483 LLGFCDEGLNRL-LVYEFMGNGTLANLLFAIPRPDWSLR--VRISLEIARGLLYLHEECN 539
L + E + L LV M G L ++ + P + + + EI GL LH E
Sbjct: 64 NLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE-- 121
Query: 540 VPIIHCDIKPQNILLDQDFTAKISDFGLS-KLLLSDQSRTRTVIRGTRGYVAPEWFKNVP 598
++ D+KP+NILLD +ISD GL+ K+ + R R GT GY+APE N
Sbjct: 122 -NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRV---GTVGYMAPEVLNNQR 177
Query: 599 VSAKVDVYSFGVVLLKII 616
+ D + G ++ ++I
Sbjct: 178 YTLSPDYWGLGCLIYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 2e-12
Identities = 61/214 (28%), Positives = 105/214 (49%), Gaps = 36/214 (16%)
Query: 428 LGRGSFGIVYKGVLKS--ASGNAVAVKKLDKLAQERE-REFKTEVSAIGRT-HHKNLVQL 483
+G G+FG V K +K +A A+K++ + A + + R+F E+ + + HH N++ L
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDA-AIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61
Query: 484 LGFCDEGLNRLLVYEFMGNGTLANLL-----------FAIPRPDWSLR-----VRISLEI 527
LG C+ L E+ +G L + L FAI S + + ++
Sbjct: 62 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121
Query: 528 ARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRG 587
ARG+ YL ++ IH D+ +NIL+ +++ AKI+DFGLS+ ++ T G
Sbjct: 122 ARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR-------GQEVYVKKTMG 171
Query: 588 YVAPEWFK----NVPV-SAKVDVYSFGVVLLKII 616
+ W N V + DV+S+GV+L +I+
Sbjct: 172 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 205
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 2e-12
Identities = 86/315 (27%), Positives = 135/315 (42%), Gaps = 54/315 (17%)
Query: 416 ELNEATNGFEEELGRGSFGIVYK----GVLKSASGNA--VAVKKLDKLAQERE-REFKTE 468
EL+ + LG G FG V G+ K VAVK L A +++ + +E
Sbjct: 8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSE 67
Query: 469 VSA---IGRTHHKNLVQLLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRP--DWSLR--- 520
+ IG+ HKN++ LLG C + ++ E+ G L L A P D+S
Sbjct: 68 MEMMKMIGK--HKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCK 125
Query: 521 -----------VRISLEIARGLLYL-HEECNVPIIHCDIKPQNILLDQDFTAKISDFGLS 568
V + ++ARG+ YL ++C IH D+ +N+L+ +D KI+DFGL+
Sbjct: 126 LPEEQLTFKDLVSCAYQVARGMEYLASQKC----IHRDLAARNVLVTEDNVMKIADFGLA 181
Query: 569 KLLLS-DQSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELG 627
+ + + D + T R ++APE + + + DV+SFGV+L +I G
Sbjct: 182 RDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLG-------G 234
Query: 628 EERSAILTDWAYDCYVEGKLDVLVDNDKAAMADKSRAC--KWLMIALWCIQEDPLKRPAM 685
I + + EG DK C + MI C P +RP
Sbjct: 235 SPYPGIPVEELFKLLKEGH-----------RMDKPANCTHELYMIMRECWHAVPSQRPTF 283
Query: 686 KMIVQMLEGYLEVPS 700
K +V+ L+ L V S
Sbjct: 284 KQLVEDLDRVLTVTS 298
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 2e-12
Identities = 58/200 (29%), Positives = 105/200 (52%), Gaps = 16/200 (8%)
Query: 425 EEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKT---EVSAIGRTHHKNLV 481
E++G G++G+VYK + + +A+KK+ +L QE E T E+S + H N+V
Sbjct: 7 VEKIGEGTYGVVYKARDR-VTNETIALKKI-RLEQEDEGVPSTAIREISLLKEMQHGNIV 64
Query: 482 QLLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISL--EIARGLLYLHEECN 539
+L LV+E++ + L + + P + R+ + +I RG+ Y H
Sbjct: 65 RLQDVVHSEKRLYLVFEYL-DLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH-- 121
Query: 540 VPIIHCDIKPQNILLDQDFTA-KISDFGLSKLL-LSDQSRTRTVIRGTRGYVAPE-WFKN 596
++H D+KPQN+L+D+ A K++DFGL++ + ++ T V+ T Y APE +
Sbjct: 122 -RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV--TLWYRAPEILLGS 178
Query: 597 VPVSAKVDVYSFGVVLLKII 616
S VD++S G + +++
Sbjct: 179 RHYSTPVDIWSVGCIFAEMV 198
|
Length = 294 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 2e-12
Identities = 63/197 (31%), Positives = 97/197 (49%), Gaps = 17/197 (8%)
Query: 428 LGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSA----IGRTHHKNLVQL 483
+G+GSFG V K+ G AVK L K A +++E K ++ + H LV L
Sbjct: 3 IGKGSFGKVLLAKHKA-DGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 484 LGFCDEGLNRL-LVYEFMGNGTLANLLFAIPRPDWSLRVR---ISLEIARGLLYLHEECN 539
+ + ++L V +++ G L F + R R + EIA L YLH
Sbjct: 62 -HYSFQTADKLYFVLDYVNGG---ELFFHLQRERSFPEPRARFYAAEIASALGYLHS--- 114
Query: 540 VPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPV 599
+ II+ D+KP+NILLD ++DFGL K + + S+T + GT Y+APE + P
Sbjct: 115 LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGI-EHSKTTSTFCGTPEYLAPEVLRKQPY 173
Query: 600 SAKVDVYSFGVVLLKII 616
VD + G VL +++
Sbjct: 174 DRTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 2e-12
Identities = 63/211 (29%), Positives = 95/211 (45%), Gaps = 28/211 (13%)
Query: 427 ELGRGSFGIVYKGVLKSASGNAVAVKKLD---KLAQEREREFKTEVSAIGRTHHKNLVQL 483
E+G GSFG VY + VA+KK+ K + E+ ++ EV + + H N ++
Sbjct: 22 EIGHGSFGAVYFAR-DVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEY 80
Query: 484 LGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVR-ISLEIARGLLYLHEECNVPI 542
G LV E+ G+ +++L +P + + I +GL YLH
Sbjct: 81 KGCYLREHTAWLVMEYC-LGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHER--- 136
Query: 543 IHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNV---PV 599
IH DIK NILL + T K++DFG + L+ S GT ++APE +
Sbjct: 137 IHRDIKAGNILLTEPGTVKLADFGSASLVSPANS-----FVGTPYWMAPEVILAMDEGQY 191
Query: 600 SAKVDVYSFGVVLLKIICCKRSVEMELGEER 630
KVDV+S G I C +EL E +
Sbjct: 192 DGKVDVWSLG-----ITC------IELAERK 211
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 3e-12
Identities = 63/197 (31%), Positives = 96/197 (48%), Gaps = 17/197 (8%)
Query: 428 LGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTH-----HKNLVQ 482
LG+G FG V ++ A+G A KKL+K +R ++ K E A+ + V
Sbjct: 8 LGKGGFGEVCACQVR-ATGKMYACKKLEK---KRIKKRKGESMALNEKQILEKVNSRFVV 63
Query: 483 LLGFCDEGLNRL-LVYEFMGNGTLANLLFAIPRP--DWSLRVRISLEIARGLLYLHEECN 539
L + E + L LV M G L ++ + + V + EI GL LH+E
Sbjct: 64 SLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE-- 121
Query: 540 VPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPV 599
I++ D+KP+NILLD +ISD GL+ + Q+ V GT GY+APE KN
Sbjct: 122 -RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV--GTVGYMAPEVVKNERY 178
Query: 600 SAKVDVYSFGVVLLKII 616
+ D ++ G +L ++I
Sbjct: 179 TFSPDWWALGCLLYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 3e-12
Identities = 73/265 (27%), Positives = 114/265 (43%), Gaps = 33/265 (12%)
Query: 427 ELGRGSFGIVYKGVLKSASGNAVAVKKLD---KLAQEREREFKTEVSAIGRTHHKNLVQL 483
E+G GSFG VY S + VAVKK+ K E+ ++ EV + + H N ++
Sbjct: 28 EIGHGSFGAVYFAT-NSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEY 86
Query: 484 LGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVR-ISLEIARGLLYLHEECNVPI 542
G + LV E+ G+ ++LL +P + + I+ +GL YLH +
Sbjct: 87 KGCYLKEHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---M 142
Query: 543 IHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNV---PV 599
IH DIK NILL + K++DFG + S GT ++APE +
Sbjct: 143 IHRDIKAGNILLTEPGQVKLADFGSASKSSPANS-----FVGTPYWMAPEVILAMDEGQY 197
Query: 600 SAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMA 659
KVDV+S G I C +EL E + + ++ L + ND +
Sbjct: 198 DGKVDVWSLG-----ITC------IELAERKPPL-----FNMNAMSALYHIAQNDSPTLQ 241
Query: 660 DKSRACKWLMIALWCIQEDPLKRPA 684
+ +C+Q+ P +RPA
Sbjct: 242 SNEWTDSFRGFVDYCLQKIPQERPA 266
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 3e-12
Identities = 63/210 (30%), Positives = 91/210 (43%), Gaps = 27/210 (12%)
Query: 428 LGRGSFGIVYKGVLKSASGNAVAVKKLDK---LAQEREREFKTE---VSAIGRTHHKNLV 481
LGRG FG V K +G A+K L K +A++ E H LV
Sbjct: 7 LGRGHFGKVLLAEYKK-TGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLV 65
Query: 482 QLLGFCDEGLNRL-LVYEFMGNGTLANLLFAIPRPDWSLR--VRISLEIARGLLYLHEEC 538
L C + + + V E+ G +L+ I +S V + + GL YLHE
Sbjct: 66 NLFA-CFQTEDHVCFVMEYAAGG---DLMMHIHTDVFSEPRAVFYAACVVLGLQYLHEN- 120
Query: 539 NVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVP 598
I++ D+K N+LLD + KI+DFGL K + RT T GT ++APE
Sbjct: 121 --KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFC-GTPEFLAPEVLTETS 177
Query: 599 VSAKVDVYSFGVVLLKIICCKRSVEMELGE 628
+ VD + GV++ EM +GE
Sbjct: 178 YTRAVDWWGLGVLIY---------EMLVGE 198
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 3e-12
Identities = 63/197 (31%), Positives = 96/197 (48%), Gaps = 17/197 (8%)
Query: 428 LGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGR------THHKNLV 481
LG+GSFG V LK + A+K L K + + E + + R H L
Sbjct: 3 LGKGSFGKVMLAELKGTN-EFFAIKALKKDVVLEDDD--VECTMVERRVLALAWEHPFLT 59
Query: 482 QLLGFCDEGLNRLL--VYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECN 539
L FC L V E++ G L + + R D + + EI GL +LH++
Sbjct: 60 HL--FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKK-- 115
Query: 540 VPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPV 599
II+ D+K N+LLD+D KI+DFG+ K ++ + + T GT Y+APE K
Sbjct: 116 -GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFC-GTPDYIAPEILKGQKY 173
Query: 600 SAKVDVYSFGVVLLKII 616
+ VD +SFGV+L +++
Sbjct: 174 NESVDWWSFGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 3e-12
Identities = 57/201 (28%), Positives = 97/201 (48%), Gaps = 16/201 (7%)
Query: 428 LGRGSFGIVYKGVLKSASGNAVAVKKLDK---LAQEREREFKTEVSAIGRTHHKNLVQLL 484
+GRG FG V + V + A+G+ A+K + K LAQE F+ E + ++ + QL
Sbjct: 9 VGRGHFGEV-QVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQ 67
Query: 485 GFCDEGLNRLLVYEFMGNGTLANLLFAIPRP-DWSLRVRISL-EIARGLLYLHEECNVPI 542
+ N LV E+ G L +LL D + + L E+ + +H+ +
Sbjct: 68 YAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDM-AQFYLAELVLAIHSVHQ---MGY 123
Query: 543 IHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPVSAK 602
+H DIKP+N+L+D+ K++DFG + L +++ + GT Y+APE + K
Sbjct: 124 VHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGK 183
Query: 603 ------VDVYSFGVVLLKIIC 617
D +S GV+ ++I
Sbjct: 184 GTYGVECDWWSLGVIAYEMIY 204
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 3e-12
Identities = 60/203 (29%), Positives = 103/203 (50%), Gaps = 26/203 (12%)
Query: 428 LGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQERE-REFKTEVS----AIGRTHHKNLVQ 482
LG G FG V+KG+ G+++ + K Q+R R+ E++ A+G H +V+
Sbjct: 15 LGSGVFGTVHKGIW-IPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVR 73
Query: 483 LLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISL----EIARGLLYLHEEC 538
LLG C G + LV + G+L L + + SL + L +IA+G+ YL E
Sbjct: 74 LLGIC-PGASLQLVTQLSPLGSL---LDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR 129
Query: 539 NVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQ-----SRTRTVIRGTRGYVAPEW 593
++H ++ +NILL D +I+DFG++ LL D S +T I+ ++A E
Sbjct: 130 ---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIK----WMALES 182
Query: 594 FKNVPVSAKVDVYSFGVVLLKII 616
+ + DV+S+GV + +++
Sbjct: 183 ILFGRYTHQSDVWSYGVTVWEMM 205
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 3e-12
Identities = 69/248 (27%), Positives = 113/248 (45%), Gaps = 48/248 (19%)
Query: 424 FEEELGRGSFGIVYKGVLKSA-------------SGNA--VAVKKLDKLAQERER-EFKT 467
F+E+LG G FG V+ + + G VAVK L A + R +F
Sbjct: 9 FKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLK 68
Query: 468 EVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEFMGNGTLANLLFA---------------- 511
EV + R N+++LLG C + ++ E+M NG L L +
Sbjct: 69 EVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPP 128
Query: 512 ---IPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLS 568
+P +S + ++L+IA G+ YL ++ +H D+ +N L+ ++ T KI+DFG+S
Sbjct: 129 AHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMS 185
Query: 569 KLLLSD-----QSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKII-CCKRSV 622
+ L + Q R IR ++A E + DV++FGV L +I+ CK
Sbjct: 186 RNLYAGDYYRIQGRAVLPIR----WMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241
Query: 623 EMELGEER 630
EL +E+
Sbjct: 242 YGELTDEQ 249
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 4e-12
Identities = 59/216 (27%), Positives = 95/216 (43%), Gaps = 31/216 (14%)
Query: 413 SLVELNEATNGFEEELGRGSFGIVYKGVLKSASGN--AVAVK--KLDKLAQEREREFKTE 468
+ L +G G FG VY+GV S AVAVK K RE+ F E
Sbjct: 6 EDITLGRC-------IGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREK-FLQE 57
Query: 469 VSAIGRTHHKNLVQLLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRI----S 524
+ + H ++V+L+G E +V E G L + L +SL + S
Sbjct: 58 AYIMRQFDHPHIVKLIGVITEN-PVWIVMELAPLGELRSYL---QVNKYSLDLASLILYS 113
Query: 525 LEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQ----SRTRT 580
+++ L YL + +H DI +N+L+ K+ DFGLS+ L + S+ +
Sbjct: 114 YQLSTALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKL 170
Query: 581 VIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKII 616
I+ ++APE ++ DV+ FGV + +I+
Sbjct: 171 PIK----WMAPESINFRRFTSASDVWMFGVCMWEIL 202
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 4e-12
Identities = 62/201 (30%), Positives = 90/201 (44%), Gaps = 22/201 (10%)
Query: 427 ELGRGSFGIVYKGVLKSAS-GNAVAVKKL----DK--LAQEREREFKTEVSAIGRTHHKN 479
ELG+G++GIV S VA+KK+ K LA+ RE K G HKN
Sbjct: 7 ELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRG---HKN 63
Query: 480 LVQLLGF---CDEGLNRLLVYEFMGNGTLANLLFA-IPRPDWSLRVRISLEIARGLLYLH 535
+ L N L +YE + L ++ + P D + I +I GL Y+H
Sbjct: 64 ITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFI-YQILCGLKYIH 122
Query: 536 EECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRG---TRGYVAPE 592
NV +H D+KP N+L++ D KI DFGL++ + + TR Y APE
Sbjct: 123 S-ANV--LHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPE 179
Query: 593 -WFKNVPVSAKVDVYSFGVVL 612
+ +DV+S G +L
Sbjct: 180 IMLSFQSYTKAIDVWSVGCIL 200
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 4e-12
Identities = 64/229 (27%), Positives = 99/229 (43%), Gaps = 39/229 (17%)
Query: 416 ELNEATNGFEEELGRGSFGIVYKG-VLKSASG---NAVAVKKL-DKLAQEREREFKTEVS 470
E+N +T F EELG FG VYKG + +A G AVA+K L DK EFK E
Sbjct: 1 EINLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAM 60
Query: 471 AIGRTHHKNLVQLLGFCDEGLNRLLVYEFMGNGTLANLLF-------------------A 511
R H N+V LLG + +++ + + L L
Sbjct: 61 MRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKST 120
Query: 512 IPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLL 571
+ D+ V I +IA G+ +L ++H D+ +N+L+ KISD GL + +
Sbjct: 121 LEPADF---VHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFREV 174
Query: 572 LSDQ-----SRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKI 615
+ + IR +++PE S D++S+GVVL ++
Sbjct: 175 YAADYYKLMGNSLLPIR----WMSPEAIMYGKFSIDSDIWSYGVVLWEV 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 4e-12
Identities = 52/192 (27%), Positives = 99/192 (51%), Gaps = 11/192 (5%)
Query: 428 LGRGSFGIVYKGVLKSASGNAVAVKKL---DKLAQEREREFKTEVSAIGRTHHKNLVQLL 484
+G G+FG V+ V S + A+K + + + ++E+ E + H +++L
Sbjct: 9 VGTGTFGRVHL-VRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLF 67
Query: 485 GFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIH 544
+ ++ E++ G L + L R S + + EI L YLH + I++
Sbjct: 68 WTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSK---EIVY 124
Query: 545 CDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPVSAKVD 604
D+KP+NILLD++ K++DFG +K L + RT T+ GT Y+APE ++ + VD
Sbjct: 125 RDLKPENILLDKEGHIKLTDFGFAKKL---RDRTWTLC-GTPEYLAPEVIQSKGHNKAVD 180
Query: 605 VYSFGVVLLKII 616
++ G+++ +++
Sbjct: 181 WWALGILIYEML 192
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 4e-12
Identities = 66/219 (30%), Positives = 105/219 (47%), Gaps = 40/219 (18%)
Query: 428 LGRGSFGIVYKGVLKSASG---------NAVAVKKLDKLAQERE-REFKTEVSA---IGR 474
LG G FG V V+ A G VAVK L A E++ + +E+ IG+
Sbjct: 26 LGEGCFGQV---VMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 82
Query: 475 THHKNLVQLLGFCDEGLNRLLVYEFMGNGTLANLLFA--------------IPRPDWSLR 520
HKN++ LLG C + ++ E+ G L L A +P S +
Sbjct: 83 --HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFK 140
Query: 521 --VRISLEIARGLLYL-HEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLS-DQS 576
V + ++ARG+ YL ++C IH D+ +N+L+ +D KI+DFGL++ + D
Sbjct: 141 DLVSCAYQVARGMEYLASKKC----IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 196
Query: 577 RTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKI 615
+ T R ++APE + + + DV+SFGV+L +I
Sbjct: 197 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 235
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 5e-12
Identities = 58/210 (27%), Positives = 102/210 (48%), Gaps = 9/210 (4%)
Query: 427 ELGRGSFGIVYKGVLKSASGNAVAVKKLD-KLAQEREREFKTEVSAIGRTHHKNLVQLLG 485
ELG G+ G+V K V SG +A K + ++ + E+ + + +V G
Sbjct: 12 ELGAGNGGVVTK-VQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 70
Query: 486 -FCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIH 544
F +G + + E M G+L +L R + ++S+ + RGL YL E+ I+H
Sbjct: 71 AFYSDGEISICM-EHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQ--IMH 127
Query: 545 CDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPVSAKVD 604
D+KP NIL++ K+ DFG+S L+ + + GTR Y++PE + S + D
Sbjct: 128 RDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS---FVGTRSYMSPERLQGTHYSVQSD 184
Query: 605 VYSFGVVLLKIICCKRSVEMELGEERSAIL 634
++S G+ L+++ + + +E AI
Sbjct: 185 IWSMGLSLVELAIGRYPIPPPDAKELEAIF 214
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 7e-12
Identities = 62/198 (31%), Positives = 97/198 (48%), Gaps = 14/198 (7%)
Query: 428 LGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFK---TEVSAIGRTHHKNLVQLL 484
+G+G+FG VY+ V K + A+K L K ++E E + + RT ++
Sbjct: 1 IGKGTFGQVYQ-VRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIV 59
Query: 485 G--FCDEGLNRL-LVYEFMGNGTLANLLFAIPR-PDWSLRVRISLEIARGLLYLHEECNV 540
G F + + L LV ++M G L L R + + I+ E+ L +LH+
Sbjct: 60 GLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIA-ELVLALEHLHKY--- 115
Query: 541 PIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPE-WFKNVPV 599
I++ D+KP+NILLD + DFGLSK L+D T T GT Y+APE
Sbjct: 116 DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFC-GTTEYLAPEVLLDEKGY 174
Query: 600 SAKVDVYSFGVVLLKIIC 617
+ VD +S GV++ ++ C
Sbjct: 175 TKHVDFWSLGVLVFEMCC 192
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 7e-12
Identities = 69/241 (28%), Positives = 115/241 (47%), Gaps = 42/241 (17%)
Query: 424 FEEELGRGSFGIVY----KGVLK--------SASGNA---VAVKKLDKLAQERER-EFKT 467
F+E+LG G FG V+ +G+ K SGN VAVK L + A + R +F
Sbjct: 9 FKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLK 68
Query: 468 EVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEFMGNGTLANLLFA-----------IPRPD 516
E+ + R N+++LL C ++ E+M NG L L +
Sbjct: 69 EIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTIS 128
Query: 517 WSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLS-DQ 575
+S + ++ +IA G+ YL ++ +H D+ +N L+ +++T KI+DFG+S+ L S D
Sbjct: 129 YSTLIFMATQIASGMKYLS---SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDY 185
Query: 576 SRTRTVIRGTRGYVAPEWFKNVPV-----SAKVDVYSFGVVLLKIIC-CKRSVEMELGEE 629
R I+G R + W + + DV++FGV L +I+ CK +L +E
Sbjct: 186 YR----IQG-RAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240
Query: 630 R 630
+
Sbjct: 241 Q 241
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 7e-12
Identities = 56/196 (28%), Positives = 94/196 (47%), Gaps = 10/196 (5%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFK---TEVSAIGRTHHKNL 480
F LG GSFG V K+ VA+K+ +K ++++ +E + +H
Sbjct: 34 FIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFC 93
Query: 481 VQLLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNV 540
V L G + LV EF+ G L R + + +I YL ++
Sbjct: 94 VNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQ---SL 150
Query: 541 PIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPVS 600
I++ D+KP+N+LLD+D K++DFG +K++ +RT T+ GT Y+APE NV
Sbjct: 151 NIVYRDLKPENLLLDKDGFIKMTDFGFAKVV---DTRTYTLC-GTPEYIAPEILLNVGHG 206
Query: 601 AKVDVYSFGVVLLKII 616
D ++ G+ + +I+
Sbjct: 207 KAADWWTLGIFIYEIL 222
|
Length = 340 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 7e-12
Identities = 61/209 (29%), Positives = 100/209 (47%), Gaps = 29/209 (13%)
Query: 428 LGRGSFGIVYKGVLKSASGNAVAVKKL--DKLAQERERE---FKTEVSAIGRTHHKNLVQ 482
LGRG+FG VY + +G +AVK++ D +QE +E + E+ + H +VQ
Sbjct: 10 LGRGAFGEVYL-CYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68
Query: 483 LLGFC--DEGLNRLLVY-EFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECN 539
G C D +L ++ E+M G++ + L A ++ R + +I +G+ YLH
Sbjct: 69 YYG-CLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNM- 126
Query: 540 VPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTV---------IRGTRGYVA 590
I+H DIK NIL D K+ DFG SK R +T+ + GT +++
Sbjct: 127 --IVHRDIKGANILRDSAGNVKLGDFGASK-------RIQTICMSGTGIKSVTGTPYWMS 177
Query: 591 PEWFKNVPVSAKVDVYSFGVVLLKIICCK 619
PE K DV+S +++++ K
Sbjct: 178 PEVISGEGYGRKADVWSVACTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 8e-12
Identities = 65/216 (30%), Positives = 107/216 (49%), Gaps = 34/216 (15%)
Query: 428 LGRGSFGIVYK----GVLKSASGNAV--AVKKLDKLAQERE-REFKTEVSA---IGRTHH 477
LG G FG V G+ K AV AVK L A E++ + +E+ IG+ H
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK--H 80
Query: 478 KNLVQLLGFCDEGLNRLLVYEFMGNGTLANLL-----------FAIPR-PDWSLR----V 521
KN++ LLG C + ++ E+ G L L + I R PD + V
Sbjct: 81 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLV 140
Query: 522 RISLEIARGLLYL-HEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLS-DQSRTR 579
+ ++ARG+ YL ++C IH D+ +N+L+ ++ KI+DFGL++ + + D +
Sbjct: 141 SCTYQVARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKT 196
Query: 580 TVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKI 615
T R ++APE + + + DV+SFGV++ +I
Sbjct: 197 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 232
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 9e-12
Identities = 58/197 (29%), Positives = 96/197 (48%), Gaps = 17/197 (8%)
Query: 428 LGRGSFGIVYKGVLKSASG-NAVAVKKLDKLAQERERE---FKTEVSAIGRTHHKNLVQL 483
LG+GSFG V LK A+ V K D + Q+ + + + + A+ H L L
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAA-KHPFLTAL 61
Query: 484 LGFCDEGLNRLL-VYEFMGNGTLANLLFAIPRP---DWSLRVRISLEIARGLLYLHEECN 539
C + +RL V E++ G +L+F I R D + E+ L++LH
Sbjct: 62 HC-CFQTKDRLFFVMEYVNGG---DLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRH-- 115
Query: 540 VPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPV 599
+I+ D+K NILLD + K++DFG+ K + + T T GT Y+APE + +
Sbjct: 116 -GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFC-GTPDYIAPEILQELEY 173
Query: 600 SAKVDVYSFGVVLLKII 616
VD ++ GV++ +++
Sbjct: 174 GPSVDWWALGVLMYEMM 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 57/201 (28%), Positives = 93/201 (46%), Gaps = 18/201 (8%)
Query: 427 ELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKT--EVSAIGRTH---HKNLV 481
E+G G++G V+K G VA+K++ E T EV+ + H N+V
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67
Query: 482 QLLGFC-----DEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRV--RISLEIARGLLYL 534
+L C D LV+E + + L L +P P + ++ RGL +L
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 126
Query: 535 HEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWF 594
H ++H D+KPQNIL+ K++DFGL++ + S Q +V+ T Y APE
Sbjct: 127 HSH---RVVHRDLKPQNILVTSSGQIKLADFGLAR-IYSFQMALTSVVV-TLWYRAPEVL 181
Query: 595 KNVPVSAKVDVYSFGVVLLKI 615
+ VD++S G + ++
Sbjct: 182 LQSSYATPVDLWSVGCIFAEM 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 68/222 (30%), Positives = 105/222 (47%), Gaps = 17/222 (7%)
Query: 408 NLRFFSLVELNEATNGFE--EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREF 465
N L L + T+ +E E +G+G++G VYK V G+ AVK LD ++ E E
Sbjct: 8 NSSMLGLESLGDPTDTWEIIETIGKGTYGKVYK-VTNKKDGSLAAVKILDPISDVDE-EI 65
Query: 466 KTEVSAI-GRTHHKNLVQLLGF---CDE--GLNRLLVYEFMGNGTLANLLFAIPRPDWSL 519
+ E + + +H N+V+ G D+ G LV E G++ L+ + L
Sbjct: 66 EAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRL 125
Query: 520 -RVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRT 578
IS + LL L N IIH D+K NILL + K+ DFG+S L S + R
Sbjct: 126 DEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRR 185
Query: 579 RTVIRGTRGYVAPEWFK-----NVPVSAKVDVYSFGVVLLKI 615
T + GT ++APE + A+ DV+S G+ +++
Sbjct: 186 NTSV-GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIEL 226
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 1e-11
Identities = 56/202 (27%), Positives = 90/202 (44%), Gaps = 29/202 (14%)
Query: 431 GSFGIVYKGVLKSASGN---AVAVKKL-DKLAQEREREFKTEVSAIGRTHHKNLVQLLGF 486
G+FG ++ G+L V VK + D ++ + E + H+N++ +L
Sbjct: 17 GTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHV 76
Query: 487 CDEGLNRLLV-YEFMGNGTLANLL----FAIPRPDWSLR----VRISLEIARGLLYLHEE 537
C E V Y +M G L L +L V ++++IA G+ YLH
Sbjct: 77 CIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH-- 134
Query: 538 CNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLL-------LSDQSRTRTVIRGTRGYVA 590
+IH DI +N ++D++ KI+D LS+ L L D + R V ++A
Sbjct: 135 -KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGD-NENRPV-----KWMA 187
Query: 591 PEWFKNVPVSAKVDVYSFGVVL 612
E N S+ DV+SFGV+L
Sbjct: 188 LESLVNKEYSSASDVWSFGVLL 209
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 1e-11
Identities = 55/196 (28%), Positives = 92/196 (46%), Gaps = 19/196 (9%)
Query: 427 ELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGF 486
+LG G+ G V K V +G +A K + A+ R K + + H ++ F
Sbjct: 12 DLGAGNGGSVSK-VKHIPTGTVMAKKVVHIGAKSSVR--KQILRELQIMHECRSPYIVSF 68
Query: 487 CDEGLNR---LLVYEFMGNGTLANLLFAIPRPDWSLRV----RISLEIARGLLYLHEECN 539
LN + EFM G+L I + + V +I++ + GL YL+
Sbjct: 69 YGAFLNENNICMCMEFMDCGSLD----RIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHR 124
Query: 540 VPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPV 599
I+H DIKP NIL++ K+ DFG+S L++ + T GT Y++PE +
Sbjct: 125 --IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADT---FVGTSTYMSPERIQGGKY 179
Query: 600 SAKVDVYSFGVVLLKI 615
+ K DV+S G+ ++++
Sbjct: 180 TVKSDVWSLGISIIEL 195
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 1e-11
Identities = 62/207 (29%), Positives = 104/207 (50%), Gaps = 27/207 (13%)
Query: 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQER---EREFKTEVSAIGRTHHKNLVQ 482
+++G G++G V L +G VA+KKL + Q +R ++ E+ + H+N++
Sbjct: 21 KQVGSGAYGTVCSA-LDRRTGAKVAIKKLYRPFQSELFAKRAYR-ELRLLKHMKHENVIG 78
Query: 483 LLGF--CDEGLNRL----LVYEFMGNGTLANLLFAIPRPDWSLRVRISL---EIARGLLY 533
LL D L+R LV FMG L + + + RI ++ +GL Y
Sbjct: 79 LLDVFTPDLSLDRFHDFYLVMPFMGTD-----LGKLMKHEKLSEDRIQFLVYQMLKGLKY 133
Query: 534 LHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEW 593
+H IIH D+KP N+ +++D KI DFGL++ +D T V+ TR Y APE
Sbjct: 134 IHA---AGIIHRDLKPGNLAVNEDCELKILDFGLAR--QTDSEMTGYVV--TRWYRAPEV 186
Query: 594 FKN-VPVSAKVDVYSFGVVLLKIICCK 619
N + + VD++S G ++ +++ K
Sbjct: 187 ILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 2e-11
Identities = 58/199 (29%), Positives = 98/199 (49%), Gaps = 18/199 (9%)
Query: 428 LGRGSFGIVYKGVLKSASGNA---VAVKKLDKLAQERER-EFKTEVSAIGRTHHKNLVQL 483
LG G+FG VYKG+ VA+K L++ + EF E + H +LV+L
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 484 LGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPD---WSLRVRISLEIARGLLYLHEECNV 540
LG C +L V + M +G L L + D L + ++IA+G++YL E
Sbjct: 75 LGVCLSPTIQL-VTQLMPHGCL--LDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEER--- 128
Query: 541 PIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTR---GYVAPEWFKNV 597
++H D+ +N+L+ KI+DFGL++LL D+ G + ++A E
Sbjct: 129 RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNA--DGGKMPIKWMALECIHYR 186
Query: 598 PVSAKVDVYSFGVVLLKII 616
+ + DV+S+GV + +++
Sbjct: 187 KFTHQSDVWSYGVTIWELM 205
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 2e-11
Identities = 55/205 (26%), Positives = 97/205 (47%), Gaps = 24/205 (11%)
Query: 427 ELGRGSFGIVY------KGVLKSASGNAVAVKKLD-KLAQEREREFKTEVSAIGRTHHKN 479
+LG G FG V +G +G VAVK L + + K E+ + +H+N
Sbjct: 11 DLGEGHFGKVELCRYDPEG---DNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHEN 67
Query: 480 LVQLLGFCDEGLNR--LLVYEFMGNGTLANLLFAIPRP----DWSLRVRISLEIARGLLY 533
+V+ G C E L+ EF+ +G+L L PR + +++ +++I +G+ Y
Sbjct: 68 IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL---PRNKNKINLKQQLKYAVQICKGMDY 124
Query: 534 LHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQS--RTRTVIRGTRGYVAP 591
L +H D+ +N+L++ + KI DFGL+K + +D+ + + + AP
Sbjct: 125 LGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAP 181
Query: 592 EWFKNVPVSAKVDVYSFGVVLLKII 616
E DV+SFGV L +++
Sbjct: 182 ECLIQSKFYIASDVWSFGVTLYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 2e-11
Identities = 64/198 (32%), Positives = 96/198 (48%), Gaps = 19/198 (9%)
Query: 428 LGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTH-----HKNLVQ 482
LG+G FG V ++ A+G A KKL+K +R ++ K E A+ + V
Sbjct: 8 LGKGGFGEVCACQVR-ATGKMYACKKLEK---KRIKKRKGEAMALNEKQILEKVNSRFVV 63
Query: 483 LLGFCDEGLNRL-LVYEFMGNGTLANLLFAIPRP--DWSLRVRISLEIARGLLYLHEECN 539
L + E + L LV M G L ++ + P D V + EI GL LH E
Sbjct: 64 SLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE-- 121
Query: 540 VPIIHCDIKPQNILLDQDFTAKISDFGLS-KLLLSDQSRTRTVIRGTRGYVAPEWFKNVP 598
I++ D+KP+NILLD +ISD GL+ ++ + R R GT GY+APE KN
Sbjct: 122 -RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRV---GTVGYMAPEVVKNER 177
Query: 599 VSAKVDVYSFGVVLLKII 616
+ D + G ++ ++I
Sbjct: 178 YTFSPDWWGLGCLIYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 62/197 (31%), Positives = 96/197 (48%), Gaps = 17/197 (8%)
Query: 428 LGRGSFGIVYKGVLKSASGNAVAVKKLDK---LAQEREREFKTEVSAIGRTHHKNLVQLL 484
+G+GSFG V K G AVK L K L ++ ++ E + + + + L
Sbjct: 3 IGKGSFGKVLLAKRK-LDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 485 GFCDEGLNRL-LVYEFMGNGTLANLLFAIPR----PDWSLRVRISLEIARGLLYLHEECN 539
+ + +L V +F+ G L F + R P+ R + EIA L YLH +
Sbjct: 62 HYSFQTTEKLYFVLDFVNGG---ELFFHLQRERSFPEPRARFYAA-EIASALGYLH---S 114
Query: 540 VPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPV 599
+ I++ D+KP+NILLD ++DFGL K ++ QS T T GT Y+APE + P
Sbjct: 115 INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIA-QSDTTTTFCGTPEYLAPEVIRKQPY 173
Query: 600 SAKVDVYSFGVVLLKII 616
VD + G VL +++
Sbjct: 174 DNTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 70/280 (25%), Positives = 129/280 (46%), Gaps = 26/280 (9%)
Query: 427 ELGRGSFGIVYKGVLKSASGNAVAVKKLD-KLAQEREREFKTEVSAIGRTHHKNLVQLLG 485
ELG G+ G+V+K V SG +A K + ++ + E+ + + +V G
Sbjct: 12 ELGAGNGGVVFK-VSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 70
Query: 486 -FCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIH 544
F +G + + E M G+L +L R + ++S+ + +GL YL E+ I+H
Sbjct: 71 AFYSDGEISICM-EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMH 127
Query: 545 CDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPVSAKVD 604
D+KP NIL++ K+ DFG+S L+ + + GTR Y++PE + S + D
Sbjct: 128 RDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS---FVGTRSYMSPERLQGTHYSVQSD 184
Query: 605 VYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMADKSRA 664
++S G+ L+++ + + +E + + C VEG D ++ + + R
Sbjct: 185 IWSMGLSLVEMAIGRYPIPPPDAKELELM-----FGCPVEG------DPAESETSPRPRP 233
Query: 665 CKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLEVPSPPMP 704
+ + P RP M I ++L+ + P P +P
Sbjct: 234 PGRPLSSY-----GPDSRPPMA-IFELLDYIVNEPPPKLP 267
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 2e-11
Identities = 59/202 (29%), Positives = 97/202 (48%), Gaps = 15/202 (7%)
Query: 428 LGRGSFGIVYKGVLKSASGNAVAVKKL--DKLAQERERE---FKTEVSAIGRTHHKNLVQ 482
LG+G+FG VY +G +A K++ D + E +E + E+ + H+ +VQ
Sbjct: 10 LGQGAFGRVYL-CYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68
Query: 483 LLG-FCDEGLNRLLVY-EFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNV 540
G D L ++ E+M G++ + L A S+ + + +I G+ YLH
Sbjct: 69 YYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNM-- 126
Query: 541 PIIHCDIKPQNILLDQDFTAKISDFGLSKLLLS---DQSRTRTVIRGTRGYVAPEWFKNV 597
I+H DIK NIL D K+ DFG SK L + + R+V GT +++PE
Sbjct: 127 -IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVT-GTPYWMSPEVISGE 184
Query: 598 PVSAKVDVYSFGVVLLKIICCK 619
K DV+S G +++++ K
Sbjct: 185 GYGRKADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 2e-11
Identities = 54/193 (27%), Positives = 88/193 (45%), Gaps = 15/193 (7%)
Query: 428 LGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRT-HHKNLVQLLGF 486
+G G+ G VYK V+ +G A+K + ++ R I R +H N+V+
Sbjct: 82 IGSGAGGTVYK-VIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDM 140
Query: 487 CDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCD 546
D ++ EFM G+L A D ++ +I G+ YLH I+H D
Sbjct: 141 FDHNGEIQVLLEFMDGGSLEGTHIA----DEQFLADVARQILSGIAYLHRR---HIVHRD 193
Query: 547 IKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPVSAKV--- 603
IKP N+L++ KI+DFG+S++L + + GT Y++PE
Sbjct: 194 IKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV-GTIAYMSPERINTDLNHGAYDGY 252
Query: 604 --DVYSFGVVLLK 614
D++S GV +L+
Sbjct: 253 AGDIWSLGVSILE 265
|
Length = 353 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 3e-11
Identities = 65/210 (30%), Positives = 93/210 (44%), Gaps = 43/210 (20%)
Query: 428 LGRGSFGIVYKGVLKSASGNAVAVKKLDK------------------LAQEREREFKTEV 469
LG+GSFG V LK G AVK L K LA E F T +
Sbjct: 3 LGKGSFGKVLLAELK-GKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHL 61
Query: 470 SAIGRTHHKNLVQLLGFCDEGLNRLLVYEFMGNGTLANLLFAIP---RPDWSLRVRISLE 526
+T + V EF+ G +L+F I R D + E
Sbjct: 62 YCTFQTKE--------------HLFFVMEFLNGG---DLMFHIQDKGRFDLYRATFYAAE 104
Query: 527 IARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTR 586
I GL +LH + II+ D+K N++LD+D KI+DFG+ K + +R T GT
Sbjct: 105 IVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFC-GTP 160
Query: 587 GYVAPEWFKNVPVSAKVDVYSFGVVLLKII 616
Y+APE + + + VD +SFGV+L +++
Sbjct: 161 DYIAPEILQGLKYTFSVDWWSFGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 3e-11
Identities = 60/205 (29%), Positives = 98/205 (47%), Gaps = 21/205 (10%)
Query: 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAI-GRTHHKNLVQLL 484
E +G+G++G V+K VL +G+ AVK LD + + + E + E + + + H N+V+
Sbjct: 24 ETIGKGTYGKVFK-VLNKKNGSKAAVKILDPI-HDIDEEIEAEYNILKALSDHPNVVKFY 81
Query: 485 GF-----CDEGLNRLLVYEFMGNGTLANLLFAI----PRPDWSLRVRISLEIARGLLYLH 535
G G LV E G++ +L+ R + + I E GL +LH
Sbjct: 82 GMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH 141
Query: 536 EECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFK 595
IH D+K NILL + K+ DFG+S L S + R T + GT ++APE
Sbjct: 142 VN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFWMAPEVIA 197
Query: 596 -----NVPVSAKVDVYSFGVVLLKI 615
+ A+ DV+S G+ +++
Sbjct: 198 CEQQLDSTYDARCDVWSLGITAIEL 222
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 3e-11
Identities = 61/199 (30%), Positives = 98/199 (49%), Gaps = 21/199 (10%)
Query: 428 LGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQER---EREFKTEVSAIGRTHHKNLVQLL 484
+G G+ GIV + G VAVKKL + Q + +R ++ E+ + +HKN++ LL
Sbjct: 29 IGSGAQGIVC-AAFDTVLGINVAVKKLSRPFQNQTHAKRAYR-ELVLLKCVNHKNIISLL 86
Query: 485 GF------CDEGLNRLLVYEFMGNGTLANLLFAIPRP-DWSLRVRISLEIARGLLYLHEE 537
+E + LV E M ANL I D + ++ G+ +LH
Sbjct: 87 NVFTPQKSLEEFQDVYLVMELMD----ANLCQVIHMELDHERMSYLLYQMLCGIKHLH-- 140
Query: 538 CNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNV 597
+ IIH D+KP NI++ D T KI DFGL++ ++ T V+ TR Y APE +
Sbjct: 141 -SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVV--TRYYRAPEVILGM 197
Query: 598 PVSAKVDVYSFGVVLLKII 616
VD++S G ++ +++
Sbjct: 198 GYKENVDIWSVGCIMGELV 216
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 3e-11
Identities = 54/198 (27%), Positives = 94/198 (47%), Gaps = 13/198 (6%)
Query: 428 LGRGSFGIVYKGVLKSASGNAVAVKKL--DKLAQERERE---FKTEVSAIGRTHHKNLVQ 482
LG+G+FG VY + +G +AVK++ D + E +E + E+ + H+ +VQ
Sbjct: 10 LGQGAFGRVYL-CYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68
Query: 483 LLGFCDEGLNRLL--VYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNV 540
G + + R L E M G++ + L + ++ + + +I G+ YLH
Sbjct: 69 YYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNM-- 126
Query: 541 PIIHCDIKPQNILLDQDFTAKISDFGLSKLL--LSDQSRTRTVIRGTRGYVAPEWFKNVP 598
I+H DIK NIL D K+ DFG SK L + + GT +++PE
Sbjct: 127 -IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEG 185
Query: 599 VSAKVDVYSFGVVLLKII 616
K D++S G +++++
Sbjct: 186 YGRKADIWSVGCTVVEML 203
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 3e-11
Identities = 60/199 (30%), Positives = 101/199 (50%), Gaps = 17/199 (8%)
Query: 428 LGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQER---EREFKTEVSAIGRTHHKNLVQLL 484
+G G+FG+V+ V G VA+KK+ + Q +R F+ E+ + H N++ L
Sbjct: 8 IGYGAFGVVW-SVTDPRDGKRVALKKMPNVFQNLVSCKRVFR-ELKMLCFFKHDNVLSAL 65
Query: 485 GFCDEGLNRL-----LVYEFMGNGTLANLLFAIPRPDWSLRVRISL-EIARGLLYLHEEC 538
+V E M L ++ + P+P S V++ L +I RGL YLH
Sbjct: 66 DILQPPHIDPFEEIYVVTELM-QSDLHKIIVS-PQPLSSDHVKVFLYQILRGLKYLH--- 120
Query: 539 NVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVP 598
+ I+H DIKP N+L++ + KI DFGL+++ D+S+ T T+ Y APE
Sbjct: 121 SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSR 180
Query: 599 -VSAKVDVYSFGVVLLKII 616
++ VD++S G + +++
Sbjct: 181 HYTSAVDIWSVGCIFAELL 199
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 6e-11
Identities = 61/196 (31%), Positives = 92/196 (46%), Gaps = 15/196 (7%)
Query: 428 LGRGSFGIVYKGVLKSASGNAVAVKKLDK---LAQEREREFKTEVSAIGRT-HHKNLVQL 483
+G+GSFG V KS G+ AVK L K L ++ + E + + + H LV L
Sbjct: 3 IGKGSFGKVLLAKRKS-DGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61
Query: 484 LGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRI---SLEIARGLLYLHEECNV 540
V +++ G L F + R L R + E+A + YLH ++
Sbjct: 62 HYSFQTAEKLYFVLDYVNGG---ELFFHLQRERCFLEPRARFYAAEVASAIGYLH---SL 115
Query: 541 PIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPVS 600
II+ D+KP+NILLD ++DFGL K + + T T GT Y+APE + P
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFC-GTPEYLAPEVLRKEPYD 174
Query: 601 AKVDVYSFGVVLLKII 616
VD + G VL +++
Sbjct: 175 RTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 6e-11
Identities = 63/216 (29%), Positives = 105/216 (48%), Gaps = 34/216 (15%)
Query: 428 LGRGSFGIVYK----GVLKSASGNA--VAVKKLDKLAQERE-REFKTEVS---AIGRTHH 477
LG G FG V + G+ KS VAVK L A +++ + +E+ IG+ H
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGK--H 77
Query: 478 KNLVQLLGFCDEGLNRLLVYEFMGNGTLANLLFA--IPRPDWSLR--------------V 521
KN++ LLG C + ++ E+ G L L A P PD++ V
Sbjct: 78 KNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLV 137
Query: 522 RISLEIARGLLYLH-EECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLS-DQSRTR 579
+ ++ARG+ YL C IH D+ +N+L+ +D KI+DFGL++ + D +
Sbjct: 138 SCAYQVARGMEYLESRRC----IHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKT 193
Query: 580 TVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKI 615
+ R ++APE + + + DV+SFG+++ +I
Sbjct: 194 SNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEI 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 8e-11
Identities = 60/198 (30%), Positives = 94/198 (47%), Gaps = 19/198 (9%)
Query: 428 LGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTH-----HKNLVQ 482
LG+G FG V ++ A+G A KKL+K +R ++ K E A+ + V
Sbjct: 8 LGKGGFGEVCACQVR-ATGKMYACKKLEK---KRIKKRKGEAMALNEKRILEKVNSRFVV 63
Query: 483 LLGFCDEGLNRL-LVYEFMGNGTLANLLFAIPRP--DWSLRVRISLEIARGLLYLHEECN 539
L + E + L LV M G L ++ + P D + + E+ GL L E
Sbjct: 64 SLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE-- 121
Query: 540 VPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQS-RTRTVIRGTRGYVAPEWFKNVP 598
I++ D+KP+NILLD +ISD GL+ + ++ R R GT GY+APE N
Sbjct: 122 -RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRV---GTVGYMAPEVINNEK 177
Query: 599 VSAKVDVYSFGVVLLKII 616
+ D + G ++ ++I
Sbjct: 178 YTFSPDWWGLGCLIYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 9e-11
Identities = 64/234 (27%), Positives = 97/234 (41%), Gaps = 48/234 (20%)
Query: 422 NGFE--EELGRGSFGIVYKGVLKSASGNAVAVKKLDK---LAQEREREFKTEVSAIGRTH 476
+ FE + +GRG+FG V + V K +G+ A+KKL K L +E+ + E +
Sbjct: 1 DDFESIKVIGRGAFGEV-RLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEAD 59
Query: 477 HKNLVQLL-GFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLH 535
+ +V+L F DE L+ E++ G + LL + D IA +L +
Sbjct: 60 NPWVVKLYYSFQDE-NYLYLIMEYLPGGDMMTLLM---KKDTFTEEETRFYIAETILAID 115
Query: 536 EECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLL--------------------LSDQ 575
+ IH DIKP N+LLD K+SDFGL L L
Sbjct: 116 SIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFI 175
Query: 576 SRTRTVIR-----------------GTRGYVAPEWFKNVPVSAKVDVYSFGVVL 612
S+ + R GT Y+APE F + + D +S GV++
Sbjct: 176 SKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIM 229
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 63.1 bits (154), Expect = 1e-10
Identities = 55/197 (27%), Positives = 80/197 (40%), Gaps = 40/197 (20%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQERERE-FKT----EVSAIGRTHHK 478
+LG G+FG VYK +G VA+KK+ E++ F E+ + + H
Sbjct: 12 ILGKLGEGTFGEVYKARQI-KTGRVVALKKI---LMHNEKDGFPITALREIKILKKLKHP 67
Query: 479 NLVQLLGFC-----DEGLNRLLVY---EFMG---NGTLANLLFAIPRPDWSLRVRISLEI 527
N+V L+ R VY +M +G L N + L++
Sbjct: 68 NVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKC---YMLQL 124
Query: 528 ARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLL------------LSDQ 575
G+ YLHE I+H DIK NIL+D KI+DFGL++ +
Sbjct: 125 LEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTR 181
Query: 576 SRTRTVIRGTRGYVAPE 592
T V+ TR Y PE
Sbjct: 182 KYTNLVV--TRWYRPPE 196
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 2e-10
Identities = 58/196 (29%), Positives = 97/196 (49%), Gaps = 16/196 (8%)
Query: 428 LGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQERER--EFKTEVSAIGR-THHKNLVQLL 484
+G G+F V K +G A+K + K + E+ + E+ A+ R + H N+++L+
Sbjct: 7 IGEGTFSEVLK-AQSRKTGKYYAIKCMKKHFKSLEQVNNLR-EIQALRRLSPHPNILRLI 64
Query: 485 GFC-DEGLNRL-LVYEFMGNGTLANLLFAIPRPDWSLRVRISL-EIARGLLYLHEECNVP 541
D RL LV+E M + L L+ RP RV+ + ++ + L ++H
Sbjct: 65 EVLFDRKTGRLALVFELM-DMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRN---G 120
Query: 542 IIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPE-WFKNVPVS 600
I H DIKP+NIL+ D K++DFG + + S T + TR Y APE +
Sbjct: 121 IFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPPYTEYI--STRWYRAPECLLTDGYYG 177
Query: 601 AKVDVYSFGVVLLKII 616
K+D+++ G V +I+
Sbjct: 178 PKMDIWAVGCVFFEIL 193
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 3e-10
Identities = 59/196 (30%), Positives = 92/196 (46%), Gaps = 15/196 (7%)
Query: 428 LGRGSFGIVYKGVLKSASGNAVAVKKLDK---LAQEREREFKTEVSAIGRTHHKNLVQLL 484
+G+GSFG V K+ AVK L K L ++ E+ +E + + + + L
Sbjct: 3 IGKGSFGKVLLARHKAEE-KFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 485 GFCDEGLNRL-LVYEFMGNGTLANLLFAIPRPDWSLRVRISL---EIARGLLYLHEECNV 540
F + ++L V +++ G L + + R L R EIA L YLH ++
Sbjct: 62 HFSFQTADKLYFVLDYINGG---ELFYHLQRERCFLEPRARFYAAEIASALGYLH---SL 115
Query: 541 PIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPVS 600
I++ D+KP+NILLD ++DFGL K + T T GT Y+APE P
Sbjct: 116 NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFC-GTPEYLAPEVLHKQPYD 174
Query: 601 AKVDVYSFGVVLLKII 616
VD + G VL +++
Sbjct: 175 RTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 3e-10
Identities = 61/208 (29%), Positives = 99/208 (47%), Gaps = 29/208 (13%)
Query: 428 LGRGSFGIVYKGVLKSASGNAVAVKKLDK-----LAQEREREFKTEVSAIGRTHHKNLVQ 482
+G G++G+V K +G VA+KK+ Q RE K + R H+N++
Sbjct: 13 IGEGAYGMVCSATHK-PTGVKVAIKKISPFEHQTFCQRTLREIKI----LRRFKHENIIG 67
Query: 483 LLGFCD-------EGLNRL-LVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYL 534
+L D E N + +V E M L L+ + ++ + +I RGL Y+
Sbjct: 68 IL---DIIRPPSFESFNDVYIVQELM-ETDLYKLIKTQHLSNDHIQYFL-YQILRGLKYI 122
Query: 535 HEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKL--LLSDQSRTRTVIRGTRGYVAPE 592
H NV +H D+KP N+LL+ + KI DFGL+++ D + T TR Y APE
Sbjct: 123 HS-ANV--LHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPE 179
Query: 593 WFKNVPVSAK-VDVYSFGVVLLKIICCK 619
N K +D++S G +L +++ +
Sbjct: 180 IMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 3e-10
Identities = 61/199 (30%), Positives = 101/199 (50%), Gaps = 21/199 (10%)
Query: 428 LGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQ---EREREFKTEVSAIGRTHHKNLVQLL 484
+G G++G V + +G VAVKKL + Q +R ++ E+ + H+N++ LL
Sbjct: 25 VGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLL 82
Query: 485 GF------CDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEEC 538
+E + LV MG L N++ D ++ I +I RGL Y+H
Sbjct: 83 DVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIH--- 137
Query: 539 NVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKN-V 597
+ IIH D+KP N+ +++D KI DFGL++ +D T V TR Y APE N +
Sbjct: 138 SADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYV--ATRWYRAPEIMLNWM 193
Query: 598 PVSAKVDVYSFGVVLLKII 616
+ VD++S G ++ +++
Sbjct: 194 HYNQTVDIWSVGCIMAELL 212
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.5 bits (150), Expect = 3e-10
Identities = 62/226 (27%), Positives = 88/226 (38%), Gaps = 49/226 (21%)
Query: 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFK---TEVSAIGRTHHKNLVQ 482
+ LG+G G V+ LK +G A+K LDK + + K TE + H L
Sbjct: 7 KLLGKGDVGRVFLVRLKG-TGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPT 65
Query: 483 LLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIAR--------GLLYL 534
L LV ++ G L LL P +S E+AR L YL
Sbjct: 66 LYASFQTETYLCLVMDYCPGGELFRLLQRQPGK------CLSEEVARFYAAEVLLALEYL 119
Query: 535 HEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLL----------LSDQSRTRTVIR- 583
H + I++ D+KP+NILL + +SDF LSK L SR +V
Sbjct: 120 H---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSI 176
Query: 584 -----------------GTRGYVAPEWFKNVPVSAKVDVYSFGVVL 612
GT Y+APE + VD ++ G++L
Sbjct: 177 PSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILL 222
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 4e-10
Identities = 58/196 (29%), Positives = 92/196 (46%), Gaps = 17/196 (8%)
Query: 427 ELGRGSFGIVYKGVLKSASGNAVAVKKLD---KLAQEREREFKTEVSAIGRTHHKNLVQL 483
E+G GSFG VY + VA+KK+ K + E+ ++ EV + R H N ++
Sbjct: 32 EIGHGSFGAVYFA-RDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEY 90
Query: 484 LGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVR-ISLEIARGLLYLHEECNVPI 542
G LV E+ G+ ++LL +P + + I+ +GL YLH +
Sbjct: 91 KGCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---NM 146
Query: 543 IHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNV---PV 599
IH DIK NILL + K++DFG + + S GT ++APE +
Sbjct: 147 IHRDIKAGNILLTEPGQVKLADFGSASIASPANS-----FVGTPYWMAPEVILAMDEGQY 201
Query: 600 SAKVDVYSFGVVLLKI 615
KVDV+S G+ +++
Sbjct: 202 DGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 5e-10
Identities = 65/227 (28%), Positives = 107/227 (47%), Gaps = 33/227 (14%)
Query: 412 FSLVELNEATNGFEEE------LGRGSFGIV---YKGVLKSASGNAVAVKKLDKLAQER- 461
F VE+ ++T + +G G+ GIV Y +L+ VA+KKL + Q +
Sbjct: 10 FYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILE----RNVAIKKLSRPFQNQT 65
Query: 462 --EREFKTEVSAIGRTHHKNLVQLLGF------CDEGLNRLLVYEFMGNGTLANLLFAIP 513
+R ++ E+ + +HKN++ LL +E + +V E M ANL I
Sbjct: 66 HAKRAYR-ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD----ANLCQVIQ 120
Query: 514 RP-DWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLL 572
D + ++ G+ +LH + IIH D+KP NI++ D T KI DFGL++
Sbjct: 121 MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 177
Query: 573 SDQSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCK 619
+ T V+ TR Y APE + VD++S G ++ ++I
Sbjct: 178 TSFMMTPYVV--TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 5e-10
Identities = 39/159 (24%), Positives = 73/159 (45%), Gaps = 32/159 (20%)
Query: 426 EELGRGSFGIVYKGVLKSASGNAVAVKK--LDKLAQEREREFKTEVSAIGRTHHKNLVQL 483
E++G G++G V+K + + VA+K+ LD + E+ + HKN+V+L
Sbjct: 6 EKIGEGTYGTVFKAKNRE-THEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRL 64
Query: 484 -------------LGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARG 530
+CD+ L + Y NG D + ++ +G
Sbjct: 65 YDVLHSDKKLTLVFEYCDQDLKK---YFDSCNGD----------IDPEIVKSFMFQLLKG 111
Query: 531 LLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSK 569
L + H ++H D+KPQN+L++++ K++DFGL++
Sbjct: 112 LAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 7e-10
Identities = 44/167 (26%), Positives = 78/167 (46%), Gaps = 29/167 (17%)
Query: 424 FEEELGRGSFGIVYKGVLKSAS-GNAVAVKKLDKLAQEREREFKTEVS-------AIGRT 475
E +GRG++G VYK K+ G A+KK + ++E T +S A+ R
Sbjct: 4 IEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKF-----KGDKEQYTGISQSACREIALLRE 58
Query: 476 -HHKNLVQLLGFCDEGLNRL--LVYEFMGNGTLANLLF-----AIPRPDWSLRVRISLEI 527
H+N+V L+ E ++ L++++ + + F + P ++ + +I
Sbjct: 59 LKHENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVK-SLLWQI 117
Query: 528 ARGLLYLHEECNVPIIHCDIKPQNILL----DQDFTAKISDFGLSKL 570
G+ YLH ++H D+KP NIL+ + KI D GL++L
Sbjct: 118 LNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARL 161
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 7e-10
Identities = 55/193 (28%), Positives = 94/193 (48%), Gaps = 18/193 (9%)
Query: 428 LGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKT---EVSAIGRTHHKNLVQLL 484
+G G++G+V K K + VA+KK K ++E E +T E+ + +N+V+L
Sbjct: 9 VGEGAYGVVLKCRHKE-TKEIVAIKKF-KDSEENEEVKETTLRELKMLRTLKQENIVEL- 65
Query: 485 GFCDEGLNR----LLVYEFMGNGTLANLLFAIPRPDWSLRVRISL-EIARGLLYLHEECN 539
E R LV+E++ L LL +P +VR + ++ + + + H+
Sbjct: 66 ---KEAFRRRGKLYLVFEYVEKNML-ELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKN-- 119
Query: 540 VPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPV 599
I+H DIKP+N+L+ + K+ DFG ++ L + T TR Y +PE P
Sbjct: 120 -DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPY 178
Query: 600 SAKVDVYSFGVVL 612
VD++S G +L
Sbjct: 179 GKAVDMWSVGCIL 191
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 7e-10
Identities = 66/209 (31%), Positives = 98/209 (46%), Gaps = 37/209 (17%)
Query: 427 ELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQERE-------REFKTEVSAIGRTHHKN 479
++G G++G VYK K +G VA+KK+ +L E+E RE K + + +H+N
Sbjct: 14 QIGEGTYGQVYKARDKD-TGELVALKKV-RLDNEKEGFPITAIREIKI----LRQLNHRN 67
Query: 480 LVQL----------LGFCDEGLNRLLVYEFMGN---GTLANLLFAIPRPDWSLRVRISLE 526
+V L L F + LV+E+M + G L + L ++ LE
Sbjct: 68 IVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLE 127
Query: 527 IARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSR--TRTVIRG 584
GL Y H +H DIK NILL+ K++DFGL++L S++SR T VI
Sbjct: 128 ---GLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI-- 179
Query: 585 TRGYVAPE-WFKNVPVSAKVDVYSFGVVL 612
T Y PE +DV+S G +L
Sbjct: 180 TLWYRPPELLLGEERYGPAIDVWSCGCIL 208
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 7e-10
Identities = 47/151 (31%), Positives = 75/151 (49%), Gaps = 15/151 (9%)
Query: 426 EELGRGSFGIVYKGVLKSASGNA-VAVKKLDKLAQERER-EFKTEVSAIGRTHHKNLVQL 483
+E+G G FG V + + +G A V VK+L A +E+ EF + H N++Q
Sbjct: 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQC 60
Query: 484 LGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLR-------VRISLEIARGLLYLHE 536
LG C E + LLV+E+ G L + L + W R R++ EIA G+ ++H+
Sbjct: 61 LGQCVEAIPYLLVFEYCELGDLKSYL---SQEQWHRRNSQLLLLQRMACEIAAGVTHMHK 117
Query: 537 ECNVPIIHCDIKPQNILLDQDFTAKISDFGL 567
+H D+ +N L D T K+ D+G+
Sbjct: 118 H---NFLHSDLALRNCFLTSDLTVKVGDYGI 145
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 9e-10
Identities = 66/271 (24%), Positives = 117/271 (43%), Gaps = 33/271 (12%)
Query: 427 ELGRGSFGIVYKGVLKSASGNAVAVKKLD---KLAQEREREFKTEVSAIGRTHHKNLVQL 483
E+G GSFG VY + VA+KK+ K + E+ ++ EV + + H N +Q
Sbjct: 22 EIGHGSFGAVYFA-RDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 484 LGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVR-ISLEIARGLLYLHEECNVPI 542
G LV E+ G+ ++LL +P + + ++ +GL YLH + +
Sbjct: 81 RGCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNM 136
Query: 543 IHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNV---PV 599
IH D+K NILL + K+ DFG + ++ GT ++APE +
Sbjct: 137 IHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX-----FVGTPYWMAPEVILAMDEGQY 191
Query: 600 SAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMA 659
KVDV+S G+ +EL E + + ++ L + N+ A+
Sbjct: 192 DGKVDVWSLGI-----------TCIELAERKPPL-----FNMNAMSALYHIAQNESPALQ 235
Query: 660 DKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690
+ + C+Q+ P RP +++++
Sbjct: 236 SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 1e-09
Identities = 33/95 (34%), Positives = 58/95 (61%), Gaps = 4/95 (4%)
Query: 525 LEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRG 584
+++ G+ ++HE+ ++H DIK +NI L Q+ K+ DFG ++LL S + T + G
Sbjct: 107 VQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-G 162
Query: 585 TRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCK 619
T YV PE ++N+P + K D++S G +L ++ K
Sbjct: 163 TPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLK 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 1e-09
Identities = 59/203 (29%), Positives = 94/203 (46%), Gaps = 28/203 (13%)
Query: 428 LGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFC 487
+GRG FG VY G K+ +G A+K LDK +R + + E A+ + + ++ L+
Sbjct: 2 IGRGGFGEVY-GCRKADTGKMYAMKCLDK---KRIKMKQGETLAL---NERIMLSLVSTG 54
Query: 488 DEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVR------------ISLEIARGLLYLH 535
D + Y F L +L + D + + EI GL ++H
Sbjct: 55 DCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMH 114
Query: 536 EECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRT-VIRGTRGYVAPEWF 594
N +++ D+KP NILLD+ +ISD GL+ D S+ + GT GY+APE
Sbjct: 115 ---NRFVVYRDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHASVGTHGYMAPEVL 167
Query: 595 -KNVPVSAKVDVYSFGVVLLKII 616
K + D +S G +L K++
Sbjct: 168 QKGTAYDSSADWFSLGCMLFKLL 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 1e-09
Identities = 62/202 (30%), Positives = 98/202 (48%), Gaps = 27/202 (13%)
Query: 428 LGRGSFGIV---YKGVLKSASGNAVAVKKLDKLAQER---EREFKTEVSAIGRTHHKNLV 481
+G G+ GIV Y VL VA+KKL + Q + +R ++ E+ + +HKN++
Sbjct: 25 IGSGAQGIVCAAYDAVLD----RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNII 79
Query: 482 QLLGF------CDEGLNRLLVYEFMGNGTLANLLFAIPRP-DWSLRVRISLEIARGLLYL 534
LL +E + LV E M ANL I D + ++ G+ +L
Sbjct: 80 SLLNVFTPQKSLEEFQDVYLVMELMD----ANLCQVIQMELDHERMSYLLYQMLCGIKHL 135
Query: 535 HEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWF 594
H + IIH D+KP NI++ D T KI DFGL++ + T V+ TR Y APE
Sbjct: 136 H---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRYYRAPEVI 190
Query: 595 KNVPVSAKVDVYSFGVVLLKII 616
+ VD++S G ++ +++
Sbjct: 191 LGMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 1e-09
Identities = 52/206 (25%), Positives = 100/206 (48%), Gaps = 31/206 (15%)
Query: 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKT-EVSAIGRTHHKNLVQLL 484
E+LG G++ VYKG +G VA+K++ A+E E+S + H+N+V+L
Sbjct: 6 EKLGEGTYATVYKG-RNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLH 64
Query: 485 GFCDEGLNRLLVYEFMGNGTLANLL--FAIPRP-DWSLRVRISLEIARGLLYLHEECNVP 541
+LV+E+M + L + + D + + ++ +G+ + HE
Sbjct: 65 DVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---R 120
Query: 542 IIHCDIKPQNILLDQDFTAKISDFGLSKLL------LSDQS-----RTRTVIRGTRGYVA 590
++H D+KPQN+L+++ K++DFGL++ S++ R V+ G+R Y
Sbjct: 121 VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTY-- 178
Query: 591 PEWFKNVPVSAKVDVYSFGVVLLKII 616
S +D++S G ++ ++I
Sbjct: 179 ---------STSIDIWSVGCIMAEMI 195
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 2e-09
Identities = 47/149 (31%), Positives = 78/149 (52%), Gaps = 13/149 (8%)
Query: 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKT--EVSAIGRTHHKNLVQL 483
++LG GS+ VYKG K +G VA+K++ +L E F E S + H N+V L
Sbjct: 11 DKLGEGSYATVYKGRSK-LTGQLVALKEI-RLEHEEGAPFTAIREASLLKDLKHANIVTL 68
Query: 484 --LGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISL-EIARGLLYLHEECNV 540
+ + L LV+E++ + L + VR+ L ++ RGL Y H+
Sbjct: 69 HDIIHTKKTLT--LVFEYL-DTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQR--- 122
Query: 541 PIIHCDIKPQNILLDQDFTAKISDFGLSK 569
++H D+KPQN+L+ + K++DFGL++
Sbjct: 123 RVLHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 2e-09
Identities = 60/198 (30%), Positives = 99/198 (50%), Gaps = 17/198 (8%)
Query: 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDK--LAQERE-REFKTEVSAIGRTHHKNLVQ 482
++G+G +G V+ K +G VA+K++ K L + E R TE + T + LV+
Sbjct: 7 TQVGQGGYGQVFLA-KKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVK 65
Query: 483 LL-GFCDEGLNRLLVYEFMGNGTLANLLFA--IPRPDWSLRVRISLEIARGLLYLHEECN 539
LL F D+ L E++ G LL + D R ++ E+ + LHE
Sbjct: 66 LLYAFQDDE-YLYLAMEYVPGGDFRTLLNNLGVLSED-HARFYMA-EMFEAVDALHE--- 119
Query: 540 VPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPV 599
+ IH D+KP+N L+D K++DFGLSK ++ + +V+ G+ Y+APE +
Sbjct: 120 LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIV---TYANSVV-GSPDYMAPEVLRGKGY 175
Query: 600 SAKVDVYSFGVVLLKIIC 617
VD +S G +L + +C
Sbjct: 176 DFTVDYWSLGCMLYEFLC 193
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 2e-09
Identities = 40/125 (32%), Positives = 65/125 (52%), Gaps = 7/125 (5%)
Query: 495 LVYEFMGNGTLANLLFAIPRPDWSLRVRISL-EIARGLLYLHEECNVPIIHCDIKPQNIL 553
L+ +++ G L L+ S VR+ + EI L +LH+ + II+ DIK +NIL
Sbjct: 82 LILDYVNGGELFTHLYQREHFTES-EVRVYIAEIVLALDHLHQ---LGIIYRDIKLENIL 137
Query: 554 LDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPV--SAKVDVYSFGVV 611
LD + ++DFGLSK L+++ GT Y+APE + VD +S GV+
Sbjct: 138 LDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVL 197
Query: 612 LLKII 616
+++
Sbjct: 198 TFELL 202
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 2e-09
Identities = 48/146 (32%), Positives = 71/146 (48%), Gaps = 7/146 (4%)
Query: 430 RGSFGIVYKGVLKSASGNAVAVK---KLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGF 486
RG+FG VY G K + AVK K D + + + + E A+ + +V L
Sbjct: 14 RGAFGKVYLG-RKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYS 72
Query: 487 CDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCD 546
N LV E++ G + +LL D + V+ E+A L YLH IIH D
Sbjct: 73 LQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRH---GIIHRD 129
Query: 547 IKPQNILLDQDFTAKISDFGLSKLLL 572
+KP N+L+ + K++DFGLSK+ L
Sbjct: 130 LKPDNMLISNEGHIKLTDFGLSKVTL 155
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 2e-09
Identities = 62/205 (30%), Positives = 97/205 (47%), Gaps = 32/205 (15%)
Query: 428 LGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFC 487
+GRG FG VY G K+ +G A+K LDK +R + + E A+ + + ++ L+
Sbjct: 2 IGRGGFGEVY-GCRKADTGKMYAMKCLDK---KRIKMKQGETLAL---NERIMLSLVSTG 54
Query: 488 DEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRIS--------------LEIARGLLY 533
D + Y F L+ +L + D L +S EI GL +
Sbjct: 55 DCPFIVCMSYAFHTPDKLSFILDLMNGGD--LHYHLSQHGVFSEAEMRFYAAEIILGLEH 112
Query: 534 LHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRT-VIRGTRGYVAPE 592
+H N +++ D+KP NILLD+ +ISD GL+ D S+ + GT GY+APE
Sbjct: 113 MH---NRFVVYRDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHASVGTHGYMAPE 165
Query: 593 WF-KNVPVSAKVDVYSFGVVLLKII 616
K V + D +S G +L K++
Sbjct: 166 VLQKGVAYDSSADWFSLGCMLFKLL 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 58.8 bits (143), Expect = 2e-09
Identities = 54/193 (27%), Positives = 96/193 (49%), Gaps = 28/193 (14%)
Query: 431 GSFGIVYKGVLKSASGNAVAVKKLDKLAQERE-------REFKTEVSAIGRTHHKNLVQL 483
G++G+VY+ K +G VA+KKL K+ +E+E RE + H N+V +
Sbjct: 16 GTYGVVYRARDKK-TGEIVALKKL-KMEKEKEGFPITSLREINILLKL----QHPNIVTV 69
Query: 484 ----LGFCDEGLNRL-LVYEFMGNGTLANLLFAIPRPDWSLRVR-ISLEIARGLLYLHEE 537
+G L+++ +V E++ + L +L+ + +P V+ + L++ G+ +LH+
Sbjct: 70 KEVVVG---SNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDN 125
Query: 538 CNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNV 597
I+H D+K N+LL+ KI DFGL++ + T + T Y APE
Sbjct: 126 W---ILHRDLKTSNLLLNNRGILKICDFGLAR-EYGSPLKPYTQLVVTLWYRAPELLLGA 181
Query: 598 PV-SAKVDVYSFG 609
S +D++S G
Sbjct: 182 KEYSTAIDMWSVG 194
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 2e-09
Identities = 49/157 (31%), Positives = 79/157 (50%), Gaps = 24/157 (15%)
Query: 428 LGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQERERE-FKT----EVSAIGRTHHKNLVQ 482
+G+G+FG V+K K + VA+KK+ E E+E F E+ + H+N+V
Sbjct: 20 IGQGTFGEVFKARHKK-TKQIVALKKV---LMENEKEGFPITALREIKILQLLKHENVVN 75
Query: 483 LLGFCD---EGLNR-----LLVYEFMGNGTLANLLFAIPRPDWSLRV--RISLEIARGLL 532
L+ C NR LV+EF + LA LL + ++L ++ + GL
Sbjct: 76 LIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLL-SNKNVKFTLSEIKKVMKMLLNGLY 133
Query: 533 YLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSK 569
Y+H I+H D+K NIL+ +D K++DFGL++
Sbjct: 134 YIHRN---KILHRDMKAANILITKDGILKLADFGLAR 167
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 3e-09
Identities = 59/198 (29%), Positives = 98/198 (49%), Gaps = 17/198 (8%)
Query: 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKT--EVSAIGRTHHKNLVQL 483
E+LG GS+ VYKG K +G VA+K + +L +E F E S + H N+V L
Sbjct: 11 EKLGEGSYATVYKGKSK-VNGKLVALKVI-RLQEEEGTPFTAIREASLLKGLKHANIVLL 68
Query: 484 LGFCDEGLNRLLVYEFMGNGTLANLLFAIP---RPDWSLRVRISL-EIARGLLYLHEECN 539
LV+E++ + L + P P+ V++ L ++ RGL Y+H+
Sbjct: 69 HDIIHTKETLTLVFEYV-HTDLCQYMDKHPGGLHPE---NVKLFLFQLLRGLSYIHQRY- 123
Query: 540 VPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPE-WFKNVP 598
I+H D+KPQN+L+ K++DFGL++ S S T + T Y P+ +
Sbjct: 124 --ILHRDLKPQNLLISDTGELKLADFGLAR-AKSVPSHTYSNEVVTLWYRPPDVLLGSTE 180
Query: 599 VSAKVDVYSFGVVLLKII 616
S +D++ G + +++I
Sbjct: 181 YSTCLDMWGVGCIFVEMI 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-09
Identities = 51/197 (25%), Positives = 98/197 (49%), Gaps = 16/197 (8%)
Query: 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREF-KTEVSAIGRTHHKNLVQLL 484
+ +G G++G VYK ++ +A K+ KL + + E+ + H N+V
Sbjct: 15 QRVGSGTYGDVYKA--RNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYF 72
Query: 485 G--FCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVR-ISLEIARGLLYLHEECNVP 541
G E L + E+ G G+L ++ + + P L++ + E +GL YLH +
Sbjct: 73 GSYLSREKL--WICMEYCGGGSLQDI-YHVTGPLSELQIAYVCRETLQGLAYLHSKGK-- 127
Query: 542 IIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWF---KNVP 598
+H DIK NILL + K++DFG++ + + ++ ++ I GT ++APE KN
Sbjct: 128 -MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFI-GTPYWMAPEVAAVEKNGG 185
Query: 599 VSAKVDVYSFGVVLLKI 615
+ D+++ G+ +++
Sbjct: 186 YNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 3e-09
Identities = 59/226 (26%), Positives = 94/226 (41%), Gaps = 41/226 (18%)
Query: 428 LGRGSFGIVYKGVLKSASGNAVAVK---KLDKLAQEREREFKTEVSAIGRTHHKNLVQLL 484
+GRG+FG V + V K +G+ A+K K D L +E+ + E + +V++
Sbjct: 9 IGRGAFGEV-RLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMF 67
Query: 485 GFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIH 544
+ LN L+ EF+ G + LL + D IA +L + + IH
Sbjct: 68 YSFQDKLNLYLIMEFLPGGDMMTLLM---KKDTLTEEETQFYIAETVLAIDSIHQLGFIH 124
Query: 545 CDIKPQNILLDQDFTAKISDFGLSKLL------------------------LSDQSRTRT 580
DIKP N+LLD K+SDFGL L ++ + + T
Sbjct: 125 RDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAET 184
Query: 581 VIR----------GTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKII 616
R GT Y+APE F + D +S GV++ +++
Sbjct: 185 WKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML 230
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 3e-09
Identities = 58/202 (28%), Positives = 95/202 (47%), Gaps = 24/202 (11%)
Query: 428 LGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKT--EVSAIGRTHHKNLVQLLG 485
+GRG++GIV S + VA+KK+ R +T E+ + H+N++ +
Sbjct: 13 IGRGAYGIVCSAK-NSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKD 71
Query: 486 F----CDEGLNRL-LVYEFMGNGTLANLLFAIPRPDWSL---RVRISL-EIARGLLYLHE 536
E N + +VYE M L I R +L + L ++ RGL Y+H
Sbjct: 72 IMPPPHREAFNDVYIVYELMDTD-----LHQIIRSSQTLSDDHCQYFLYQLLRGLKYIH- 125
Query: 537 ECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKL-LLSDQSRTRTVIRGTRGYVAPEWFK 595
+ ++H D+KP N+LL+ + KI DFGL++ T V+ TR Y APE
Sbjct: 126 --SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV--TRWYRAPELLL 181
Query: 596 NVP-VSAKVDVYSFGVVLLKII 616
N + +DV+S G + +++
Sbjct: 182 NCSEYTTAIDVWSVGCIFAELL 203
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 3e-09
Identities = 47/168 (27%), Positives = 82/168 (48%), Gaps = 7/168 (4%)
Query: 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLG 485
+ +G G++G VYK +G A+K + E + E+ + H N+V G
Sbjct: 15 QRIGSGTYGDVYKA-RNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFG 73
Query: 486 FCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVR-ISLEIARGLLYLHEECNVPIIH 544
+ EF G G+L ++ + + P ++ +S E +GL YLH + +H
Sbjct: 74 SYLRRDKLWICMEFCGGGSLQDI-YHVTGPLSESQIAYVSRETLQGLYYLHSKGK---MH 129
Query: 545 CDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPE 592
DIK NILL + K++DFG+S + + ++ ++ I GT ++APE
Sbjct: 130 RDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFI-GTPYWMAPE 176
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 3e-09
Identities = 59/198 (29%), Positives = 96/198 (48%), Gaps = 19/198 (9%)
Query: 428 LGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQE--REREFKTEVSAIGRTHHKNLVQLLG 485
+G G++G V + VAVKKL + Q R E+ + H+N++ LL
Sbjct: 23 VGSGAYGSVCSA-YDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLD 81
Query: 486 FCD-----EGLNRL-LVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECN 539
E N + LV MG L N++ D ++ I ++ RGL Y+H +
Sbjct: 82 VFTPATSIENFNEVYLVTNLMG-ADLNNIVKCQKLSDEHVQFLI-YQLLRGLKYIH---S 136
Query: 540 VPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKN-VP 598
IIH D+KP N+ +++D +I DFGL++ +D T V TR Y APE N +
Sbjct: 137 AGIIHRDLKPSNVAVNEDCELRILDFGLAR--QADDEMTGYV--ATRWYRAPEIMLNWMH 192
Query: 599 VSAKVDVYSFGVVLLKII 616
+ VD++S G ++ +++
Sbjct: 193 YNQTVDIWSVGCIMAELL 210
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 3e-09
Identities = 56/211 (26%), Positives = 96/211 (45%), Gaps = 41/211 (19%)
Query: 428 LGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQERERE------------------FKTEV 469
+G GSFG+VY+ + S VA+KK+ + Q + RE + TE
Sbjct: 74 IGNGSFGVVYEAICIDTS-EKVAIKKVLQDPQYKNRELLIMKNLNHINIIFLKDYYYTEC 132
Query: 470 SAIGRTHHKN--LVQLLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEI 527
+ + KN L ++ F + +++ + + N L L + S ++
Sbjct: 133 F---KKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKL----------YSYQL 179
Query: 528 ARGLLYLHEECNVPIIHCDIKPQNILLD-QDFTAKISDFGLSKLLLSDQSRTRTVIRGTR 586
R L Y+H + I H D+KPQN+L+D T K+ DFG +K LL+ Q + +R
Sbjct: 180 CRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYIC--SR 234
Query: 587 GYVAPE-WFKNVPVSAKVDVYSFGVVLLKII 616
Y APE + +D++S G ++ ++I
Sbjct: 235 FYRAPELMLGATNYTTHIDLWSLGCIIAEMI 265
|
Length = 440 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 4e-09
Identities = 58/193 (30%), Positives = 94/193 (48%), Gaps = 10/193 (5%)
Query: 428 LGRGSFGIVYKGVLKSASGNAVAVKKLDK---LAQEREREFKTEVSAIGRTHHKNLVQLL 484
+G+GSFG V + V K + A+K + K +++ E + + + + +V L
Sbjct: 1 IGKGSFGKVMQ-VRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPL- 58
Query: 485 GFCDEGLNRL-LVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPII 543
F + +L LV F+ G L + L R D S + E+ L LH+ +I
Sbjct: 59 KFSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHK---FNVI 115
Query: 544 HCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPVSAKV 603
+ D+KP+NILLD + DFGL KL + D +T T GT Y+APE + V
Sbjct: 116 YRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFC-GTPEYLAPELLLGHGYTKAV 174
Query: 604 DVYSFGVVLLKII 616
D ++ GV+L +++
Sbjct: 175 DWWTLGVLLYEML 187
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 6e-09
Identities = 55/196 (28%), Positives = 97/196 (49%), Gaps = 13/196 (6%)
Query: 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKT--EVSAIGRTHHKNLVQL 483
E+LG GS+ VYKG+ + +G VA+K + + E F E S + H N+V L
Sbjct: 11 EKLGEGSYATVYKGISR-INGQLVALKVI-SMKTEEGVPFTAIREASLLKGLKHANIVLL 68
Query: 484 LGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISL-EIARGLLYLHEECNVPI 542
V+E+M + LA + P VR+ + ++ RGL Y+H + I
Sbjct: 69 HDIIHTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQ---HI 124
Query: 543 IHCDIKPQNILLDQDFTAKISDFGLSKL-LLSDQSRTRTVIRGTRGYVAPE-WFKNVPVS 600
+H D+KPQN+L+ K++DFGL++ + Q+ + V+ T Y P+ S
Sbjct: 125 LHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWYRPPDVLLGATDYS 182
Query: 601 AKVDVYSFGVVLLKII 616
+ +D++ G + ++++
Sbjct: 183 SALDIWGAGCIFIEML 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 1e-08
Identities = 61/198 (30%), Positives = 96/198 (48%), Gaps = 19/198 (9%)
Query: 428 LGRGSFGIVYKGVLKSASGNAVAVKKLDK-LAQERER--EFKTEVSAIGR-THHKNLVQL 483
+GRGS+ V LK A+K + K L + E +TE ++H LV L
Sbjct: 3 IGRGSYAKVLLVELKKTR-RIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGL 61
Query: 484 LGFCDEGLNRL-LVYEFMGNGTLANLLFAIPR----PDWSLRVRISLEIARGLLYLHEEC 538
C + +RL V EF+ G +L+F + R P+ R S EI+ L +LHE
Sbjct: 62 HS-CFQTESRLFFVIEFVSGG---DLMFHMQRQRKLPEEHARF-YSAEISLALNFLHER- 115
Query: 539 NVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVP 598
II+ D+K N+LLD + K++D+G+ K + T T GT Y+APE +
Sbjct: 116 --GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFC-GTPNYIAPEILRGED 172
Query: 599 VSAKVDVYSFGVVLLKII 616
VD ++ GV++ +++
Sbjct: 173 YGFSVDWWALGVLMFEMM 190
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 54/203 (26%), Positives = 95/203 (46%), Gaps = 26/203 (12%)
Query: 428 LGRGSFGIVYKGVLKSASGNA---VAVKKLDKLAQER-EREFKTEVSAIGRTHHKNLVQL 483
LG G+FG VYKG+ VA+K+L + + +E E + + ++ +L
Sbjct: 15 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 74
Query: 484 LGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPD-----WSLRVRISLEIARGLLYLHEEC 538
LG C + L+ + M G L L + D + L ++IA+G+ YL E
Sbjct: 75 LGICLTSTVQ-LITQLMPFGCL--LDYVREHKDNIGSQYLL--NWCVQIAKGMNYLEER- 128
Query: 539 NVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVP 598
++H D+ +N+L+ KI+DFGL+KLL +D+ G V +W
Sbjct: 129 --RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKE----YHAEGGKVPIKWMALES 182
Query: 599 V-----SAKVDVYSFGVVLLKII 616
+ + + DV+S+GV + +++
Sbjct: 183 ILHRIYTHQSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 1e-08
Identities = 58/202 (28%), Positives = 102/202 (50%), Gaps = 22/202 (10%)
Query: 428 LGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQER---EREFKTEVSAIGRTHHKNLVQLL 484
+G G++G V + K +G VA+KKL + Q +R ++ E++ + H+N++ LL
Sbjct: 23 VGSGAYGSVCSAIDKR-TGEKVAIKKLSRPFQSEIFAKRAYR-ELTLLKHMQHENVIGLL 80
Query: 485 GF------CDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEEC 538
DE + LV +M T + P + ++ + ++ GL Y+H
Sbjct: 81 DVFTSAVSGDEFQDFYLVMPYMQ--TDLQKIMGHPLSEDKVQYLV-YQMLCGLKYIHS-- 135
Query: 539 NVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKN-V 597
IIH D+KP N+ +++D KI DFGL++ +D T V+ TR Y APE N +
Sbjct: 136 -AGIIHRDLKPGNLAVNEDCELKILDFGLAR--HADAEMTGYVV--TRWYRAPEVILNWM 190
Query: 598 PVSAKVDVYSFGVVLLKIICCK 619
+ VD++S G ++ +++ K
Sbjct: 191 HYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 2e-08
Identities = 70/289 (24%), Positives = 120/289 (41%), Gaps = 54/289 (18%)
Query: 426 EELGRGSFGIVYKGVLK------SASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKN 479
E LG+G+F ++KG+ + V +K LDK + F S + + HK+
Sbjct: 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKH 60
Query: 480 LVQLLGFCDEGLNRLLVYEFMGNGTLANLL----FAIPRPDWSLRVRISLEIARGLLYLH 535
LV G C G ++V E++ G+L L I W L V + ++A L +L
Sbjct: 61 LVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLIN-ISWKLEV--AKQLAWALHFLE 117
Query: 536 EECNVPIIHCDIKPQNILLDQDFTA--------KISDFGLSKLLLSDQSRTRTVIRGTRG 587
++ + H ++ +N+LL ++ K+SD G+S +L + ++
Sbjct: 118 DK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLP-----KEILLERIP 169
Query: 588 YVAPEWFKNVP-VSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGK 646
+V PE +N +S D +SFG L +I + L A D + K
Sbjct: 170 WVPPECIENPQNLSLAADKWSFGTTLWEIFS---GGDKPLS----------ALDS--QKK 214
Query: 647 LDVLVDNDKAAMADKSRACKWLMIALW---CIQEDPLKRPAMKMIVQML 692
L D + A KW +A C+ +P RP+ + I++ L
Sbjct: 215 LQFYEDRHQLP------APKWTELANLINQCMDYEPDFRPSFRAIIRDL 257
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 61/236 (25%), Positives = 101/236 (42%), Gaps = 38/236 (16%)
Query: 426 EELGRGSFGIVYKGVLKSASGNA---------VAVKKLDKLAQEREREFKTEVSAIGRTH 476
E LG+G+F +YKGVL+ S V +K L F S + +
Sbjct: 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGS-DHRDSLAFFETASLMSQLS 59
Query: 477 HKNLVQLLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDW-SLRVRISLEIARGLLYLH 535
HK+LV+L G C N ++V E++ G L L ++ ++ ++A L YL
Sbjct: 60 HKHLVKLYGVCVRDEN-IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLE 118
Query: 536 EECNVPIIHCDIKPQNILLDQDFT-------AKISDFGLSKLLLSDQSRTRTVIRGTRGY 588
++ ++H ++ +NIL+ + K+SD G+ +LS + R + +
Sbjct: 119 DK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERI-----PW 170
Query: 589 VAPEWFKNVPVSAKV--DVYSFGVVLLKIICC--------KRSVEMELGEERSAIL 634
+APE +N S + D +SFG LL+ IC S E E + L
Sbjct: 171 IAPECIRNGQASLTIAADKWSFGTTLLE-ICSNGEEPLSTLSSSEKERFYQDQHRL 225
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 63/216 (29%), Positives = 99/216 (45%), Gaps = 24/216 (11%)
Query: 428 LGRGSFGIVYKGVLKSASG-NAVAVKKLDKLAQEREREF-KTEVSAIGRTHHKNLVQLLG 485
+GRGS+ V LK A+ V K + + + + ++ +TE + + L
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62
Query: 486 FCDEGLNRL-LVYEFMGNGTLANLLFAIPR----PDWSLRVRISLEIARGLLYLHEECNV 540
C + +RL LV E++ G +L+F + R P+ R + EI L +LHE
Sbjct: 63 SCFQTTSRLFLVIEYVNGG---DLMFHMQRQRKLPEEHARF-YAAEICIALNFLHER--- 115
Query: 541 PIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPVS 600
II+ D+K N+LLD D K++D+G+ K L T T GT Y+APE +
Sbjct: 116 GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFC-GTPNYIAPEILRGEEYG 174
Query: 601 AKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTD 636
VD ++ GV++ EM G I+TD
Sbjct: 175 FSVDWWALGVLMF---------EMMAGRSPFDIITD 201
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 2e-08
Identities = 58/200 (29%), Positives = 97/200 (48%), Gaps = 20/200 (10%)
Query: 428 LGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQERERE---FKTEVSAIGRTHHKNLVQL- 483
+GRG+FG V + V +S A+K L K + + F E + + + +VQL
Sbjct: 51 IGRGAFGEV-QLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLH 109
Query: 484 LGFCDEGLNRLLVYEFMGNGTLANLL--FAIPRPDWSLRVRISLEIARGLLYLHEECNVP 541
F D+ +V E+M G L NL+ + IP W+ + E+ L +H ++
Sbjct: 110 YAFQDDKY-LYMVMEYMPGGDLVNLMSNYDIPE-KWA--RFYTAEVVLALDAIH---SMG 162
Query: 542 IIHCDIKPQNILLDQDFTAKISDFGLSKLLLSD-QSRTRTVIRGTRGYVAPEWFKNVPVS 600
IH D+KP N+LLD+ K++DFG + ++ R T + GT Y++PE K+
Sbjct: 163 FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAV-GTPDYISPEVLKSQGGD 221
Query: 601 A----KVDVYSFGVVLLKII 616
+ D +S GV L +++
Sbjct: 222 GYYGRECDWWSVGVFLYEML 241
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 2e-08
Identities = 58/199 (29%), Positives = 101/199 (50%), Gaps = 15/199 (7%)
Query: 428 LGRGSFGIVY--KGVLKSASGNAVAVKKLDKLA---QEREREF-KTEVSAIGRTHHKNLV 481
LG G++G V+ + V +G A+K L K A + + E +TE + + +
Sbjct: 8 LGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFL 67
Query: 482 QLLGFCDEGLNRL-LVYEFMGNGTLANLLFAIPRPDWS-LRVRI-SLEIARGLLYLHEEC 538
L + + +L L+ +++ G + L+ R ++S VR S EI L +LH+
Sbjct: 68 VTLHYAFQTEAKLHLILDYVSGGEMFTHLYQ--RDNFSEDEVRFYSGEIILALEHLHK-- 123
Query: 539 NVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVP 598
+ I++ DIK +NILLD + ++DFGLSK LS++ GT Y+APE +
Sbjct: 124 -LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKG 182
Query: 599 VSAK-VDVYSFGVVLLKII 616
K VD +S G+++ +++
Sbjct: 183 GHGKAVDWWSLGILIFELL 201
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|214519 smart00108, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 52.3 bits (126), Expect = 2e-08
Identities = 25/79 (31%), Positives = 37/79 (46%), Gaps = 7/79 (8%)
Query: 35 SNNSSWISPSRDFAFGFRQLNNNSDLFLLAIWFNKMPERTIIWHANEDNHPVLAPRGSTL 94
S+ + +S + F GF L +D L I + RT++W AN DN TL
Sbjct: 5 SSGQTLVSGNSLFELGFFTLIMQNDYNL--ILYKSSS-RTVVWVANRDNP---VSDSCTL 58
Query: 95 ELTATG-LLLKDPGGQAIW 112
L + G L+L D G+ +W
Sbjct: 59 TLQSDGNLVLYDGDGRVVW 77
|
Length = 114 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 52/205 (25%), Positives = 94/205 (45%), Gaps = 26/205 (12%)
Query: 425 EEELGRGSFGIVYKGVLKSASGNAVAVKKLDKL----AQEREREFKTEVSAIGRTHHKNL 480
E+++GRG F VY+ VA+KK+ A+ R+ K E+ + + +H N+
Sbjct: 7 EKKIGRGQFSEVYRATCL-LDRKPVALKKVQIFEMMDAKARQDCVK-EIDLLKQLNHPNV 64
Query: 481 VQLLG--FCDEGLNRLLVYEFMGNGTLANLLF-------AIP-RPDWSLRVRISLEIARG 530
++ L D LN +V E G L+ ++ IP R W V ++
Sbjct: 65 IKYLDSFIEDNELN--IVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFV----QLCSA 118
Query: 531 LLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVA 590
+ ++H ++H DIKP N+ + K+ D GL + S + +++ GT Y++
Sbjct: 119 VEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMS 174
Query: 591 PEWFKNVPVSAKVDVYSFGVVLLKI 615
PE + K D++S G +L ++
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 3e-08
Identities = 53/182 (29%), Positives = 83/182 (45%), Gaps = 23/182 (12%)
Query: 428 LGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFC 487
LG GS G+V+ V S VAVKK+ + + E+ I R H N+V++
Sbjct: 13 LGCGSNGLVFSAV-DSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVL 71
Query: 488 DEGLNRL--------------LVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLY 533
+ L +V E+M LAN+L P + R+ ++ RGL Y
Sbjct: 72 GPSGSDLTEDVGSLTELNSVYIVQEYM-ETDLANVLEQGPLSEEHARL-FMYQLLRGLKY 129
Query: 534 LHEECNVPIIHCDIKPQNILLDQ-DFTAKISDFGLSKLLLSDQSRTRTVIRG--TRGYVA 590
+H NV +H D+KP N+ ++ D KI DFGL++++ S + G T+ Y +
Sbjct: 130 IHS-ANV--LHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRS 186
Query: 591 PE 592
P
Sbjct: 187 PR 188
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 4e-08
Identities = 50/204 (24%), Positives = 95/204 (46%), Gaps = 24/204 (11%)
Query: 425 EEELGRGSFGIVYKGVLKSASGNAVAVKKL---DKLAQEREREFKTEVSAIGRTHHKNLV 481
E+++GRG F VY+ G VA+KK+ D + + + E+ + + +H N++
Sbjct: 7 EKKIGRGQFSEVYRATC-LLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVI 65
Query: 482 QLLG-FCDEGLNRL-LVYEFMGNGTLANLL-------FAIP-RPDWSLRVRISLEIARGL 531
+ F ++ N L +V E G L+ ++ IP + W V ++ L
Sbjct: 66 KYYASFIED--NELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFV----QLCSAL 119
Query: 532 LYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAP 591
++H ++H DIKP N+ + K+ D GL + S + +++ GT Y++P
Sbjct: 120 EHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSP 175
Query: 592 EWFKNVPVSAKVDVYSFGVVLLKI 615
E + K D++S G +L ++
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 5e-08
Identities = 48/175 (27%), Positives = 82/175 (46%), Gaps = 27/175 (15%)
Query: 524 SLEIARGLLYL-HEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVI 582
S ++A+G+ +L + C IH D+ +NILL KI DFGL++ + +D + V+
Sbjct: 220 SYQVAKGMSFLASKNC----IHRDLAARNILLTHGRITKICDFGLARDIRND---SNYVV 272
Query: 583 RGTR----GYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWA 638
+G ++APE N + + DV+S+G++L +I LG +
Sbjct: 273 KGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEI--------FSLGSSPYPGMP--- 321
Query: 639 YDCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLE 693
V+ K ++ ++ + + I C DPLKRP K IVQ++E
Sbjct: 322 ----VDSKFYKMIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIE 372
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 5e-08
Identities = 57/206 (27%), Positives = 97/206 (47%), Gaps = 32/206 (15%)
Query: 428 LGRGSFGIVYKGVLKSASGNA---VAVKKL-DKLAQEREREFKTEVSAIGRTHHKNLVQL 483
LG G+FG VYKG+ N VA+K L + + + +E E + + +L
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 484 LGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRIS--------LEIARGLLYLH 535
LG C +L V + M G L + + R + + RI ++IA+G+ YL
Sbjct: 75 LGICLTSTVQL-VTQLMPYGCLLDYV----REN---KDRIGSQDLLNWCVQIAKGMSYLE 126
Query: 536 EECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFK 595
E V ++H D+ +N+L+ KI+DFGL++LL D+ T G V +W
Sbjct: 127 E---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDE----TEYHADGGKVPIKWMA 179
Query: 596 NVPV-----SAKVDVYSFGVVLLKII 616
+ + + DV+S+GV + +++
Sbjct: 180 LESILHRRFTHQSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 5e-08
Identities = 46/147 (31%), Positives = 76/147 (51%), Gaps = 9/147 (6%)
Query: 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKT--EVSAIGRTHHKNLVQL 483
E+LG G++ V+KG K + N VA+K++ +L E EVS + H N+V L
Sbjct: 12 EKLGEGTYATVFKGRSK-LTENLVALKEI-RLEHEEGAPCTAIREVSLLKDLKHANIVTL 69
Query: 484 LGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISL-EIARGLLYLHEECNVPI 542
+ LV+E++ + L + V+I L +I RGL Y H +
Sbjct: 70 HDIVHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRR---KV 125
Query: 543 IHCDIKPQNILLDQDFTAKISDFGLSK 569
+H D+KPQN+L+++ K++DFGL++
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLAR 152
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 6e-08
Identities = 56/198 (28%), Positives = 92/198 (46%), Gaps = 16/198 (8%)
Query: 428 LGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQERERE---FKTEVSAIGRTHHKNLVQLL 484
+GRG+FG V + V +S A+K L K + + F E + + +VQL
Sbjct: 51 IGRGAFGEV-QLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 109
Query: 485 GFCDEGLNRLLVYEFMGNGTLANLLFAIPRPD-WSLRVRISLEIARGLLYLHEECNVPII 543
+ +V E+M G L NL+ P+ W+ A +L L ++ +I
Sbjct: 110 CAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWA-----KFYTAEVVLALDAIHSMGLI 164
Query: 544 HCDIKPQNILLDQDFTAKISDFGLS-KLLLSDQSRTRTVIRGTRGYVAPEWFKNVP---- 598
H D+KP N+LLD+ K++DFG K+ + R T + GT Y++PE K+
Sbjct: 165 HRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV-GTPDYISPEVLKSQGGDGY 223
Query: 599 VSAKVDVYSFGVVLLKII 616
+ D +S GV L +++
Sbjct: 224 YGRECDWWSVGVFLFEML 241
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 6e-08
Identities = 56/194 (28%), Positives = 89/194 (45%), Gaps = 16/194 (8%)
Query: 428 LGRGSFGIVY--KGVLKSASGNAVAVKKLDKLA----QEREREFKTEVSAIGRTHHKNLV 481
LG+G +G V+ + V + +G A+K L K Q+ K E + + H +V
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 482 QLLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISL---EIARGLLYLHEEC 538
L+ G L+ E++ G L + R + EI+ L +LH++
Sbjct: 64 DLIYAFQTGGKLYLILEYLSGG---ELFMHLEREGIFMEDTACFYLSEISLALEHLHQQ- 119
Query: 539 NVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVP 598
II+ D+KP+NILLD K++DFGL K + + + T T GT Y+APE
Sbjct: 120 --GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFC-GTIEYMAPEILMRSG 176
Query: 599 VSAKVDVYSFGVVL 612
VD +S G ++
Sbjct: 177 HGKAVDWWSLGALM 190
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 6e-08
Identities = 45/147 (30%), Positives = 76/147 (51%), Gaps = 9/147 (6%)
Query: 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKT--EVSAIGRTHHKNLVQL 483
++LG G++ V+KG K + N VA+K++ +L E EVS + H N+V L
Sbjct: 11 DKLGEGTYATVFKGRSK-LTENLVALKEI-RLEHEEGAPCTAIREVSLLKNLKHANIVTL 68
Query: 484 LGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISL-EIARGLLYLHEECNVPI 542
LV+E++ + L L V+I + ++ RGL Y H+ I
Sbjct: 69 HDIIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKR---KI 124
Query: 543 IHCDIKPQNILLDQDFTAKISDFGLSK 569
+H D+KPQN+L+++ K++DFGL++
Sbjct: 125 LHRDLKPQNLLINEKGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 7e-08
Identities = 58/216 (26%), Positives = 98/216 (45%), Gaps = 40/216 (18%)
Query: 426 EELGRGSFGIVYKGVLKSASGN-----------AVAVKKLDKLAQEREREFKTEVSAIGR 474
E LGRG+ +Y G+L + V +K LD ++ F S + +
Sbjct: 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQ 60
Query: 475 THHKNLVQLLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPD-----WSLRVRISLEIAR 529
HK++V L G C + ++V EF+ G L LF + D W +V + ++A
Sbjct: 61 VSHKHIVLLYGVCVRDVENIMVEEFVEFGPLD--LFMHRKSDVLTTPWKFKV--AKQLAS 116
Query: 530 GLLYLHEECNVPIIHCDIKPQNILLDQDFT-------AKISDFGLSKLLLSDQSRTRTVI 582
L YL ++ ++H ++ +NILL ++ K+SD G+ +LS Q +
Sbjct: 117 ALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQECVERI- 172
Query: 583 RGTRGYVAPEWF---KNVPVSAKVDVYSFGVVLLKI 615
++APE KN+ ++A D +SFG L +I
Sbjct: 173 ----PWIAPECVEDSKNLSIAA--DKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 7e-08
Identities = 56/200 (28%), Positives = 96/200 (48%), Gaps = 17/200 (8%)
Query: 428 LGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQERERE---FKTEVSAIGRTHHKNLVQL- 483
+GRG+FG V LK+A A+K L+K + E F+ E + ++ + L
Sbjct: 9 IGRGAFGEVAVVKLKNAD-KVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLH 67
Query: 484 LGFCDEGLNRLLVYEFMGNGTLANLL--FAIPRPDWSLRVRISLEIARGLLYLHEECNVP 541
F DE N LV ++ G L LL F P+ R ++ E+ + +H+ +
Sbjct: 68 YAFQDEN-NLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLA-EMVIAIDSVHQ---LH 122
Query: 542 IIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVP--- 598
+H DIKP NIL+D + +++DFG L+ D + +V GT Y++PE + +
Sbjct: 123 YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGK 182
Query: 599 --VSAKVDVYSFGVVLLKII 616
+ D +S GV + +++
Sbjct: 183 GKYGPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 9e-08
Identities = 31/88 (35%), Positives = 50/88 (56%), Gaps = 5/88 (5%)
Query: 530 GLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYV 589
G+ Y+H+ I+H D+K +NI L + KI DFG+S+LL+ T GT Y+
Sbjct: 118 GVHYMHQR---RILHRDLKAKNIFLKNNLL-KIGDFGVSRLLMG-SCDLATTFTGTPYYM 172
Query: 590 APEWFKNVPVSAKVDVYSFGVVLLKIIC 617
+PE K+ +K D++S G +L ++ C
Sbjct: 173 SPEALKHQGYDSKSDIWSLGCILYEMCC 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 9e-08
Identities = 42/158 (26%), Positives = 74/158 (46%), Gaps = 23/158 (14%)
Query: 428 LGRGSFGIVYKGVLKSASGNAVAVKK--LDKLAQERERE----------FKT--EVSAIG 473
LG G++G V K + +G VA+KK + +++ + ++ F T E+ +
Sbjct: 17 LGEGTYGKVEKA-YDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMN 75
Query: 474 RTHHKNLVQLLG-FCDEG-LNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGL 531
H+N++ L+ + + +N LV + M L ++ R S I L+I GL
Sbjct: 76 EIKHENIMGLVDVYVEGDFIN--LVMDIM-ASDLKKVVDRKIRLTESQVKCILLQILNGL 132
Query: 532 LYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSK 569
LH +H D+ P NI ++ KI+DFGL++
Sbjct: 133 NVLH---KWYFMHRDLSPANIFINSKGICKIADFGLAR 167
|
Length = 335 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 1e-07
Identities = 57/226 (25%), Positives = 93/226 (41%), Gaps = 41/226 (18%)
Query: 428 LGRGSFGIVYKGVLKSASGNAVAVK---KLDKLAQEREREFKTEVSAIGRTHHKNLVQLL 484
+GRG+FG V + V K +G+ A+K K D L +E+ + E + +V++
Sbjct: 9 IGRGAFGEV-RLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMF 67
Query: 485 GFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIH 544
+ N L+ EF+ G + LL + D IA +L + + IH
Sbjct: 68 YSFQDKRNLYLIMEFLPGGDMMTLLM---KKDTLSEEATQFYIAETVLAIDAIHQLGFIH 124
Query: 545 CDIKPQNILLDQDFTAKISDFGLSKLL------------------------LSDQSRTRT 580
DIKP N+LLD K+SDFGL L ++ + + T
Sbjct: 125 RDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAET 184
Query: 581 VIR----------GTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKII 616
+ GT Y+APE F + D +S GV++ +++
Sbjct: 185 WKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML 230
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 1e-07
Identities = 56/196 (28%), Positives = 96/196 (48%), Gaps = 15/196 (7%)
Query: 428 LGRGSFGIVYKGVLKSASG-NAVAVKKLDKLAQEREREF-KTEVSAIGRTHHKNLVQLLG 485
+GRGS+ V LK A+ V K + + + + ++ +TE + + + L
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62
Query: 486 FCDEGLNRLL-VYEFMGNGTLANLLFAIPR----PDWSLRVRISLEIARGLLYLHEECNV 540
C + +RL V E++ G +L+F + R P+ R S EI+ L YLHE
Sbjct: 63 SCFQTESRLFFVIEYVNGG---DLMFHMQRQRKLPEEHARF-YSAEISLALNYLHER--- 115
Query: 541 PIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPVS 600
II+ D+K N+LLD + K++D+G+ K L T + GT Y+APE +
Sbjct: 116 GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR-PGDTTSTFCGTPNYIAPEILRGEDYG 174
Query: 601 AKVDVYSFGVVLLKII 616
VD ++ GV++ +++
Sbjct: 175 FSVDWWALGVLMFEMM 190
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 45/156 (28%), Positives = 76/156 (48%), Gaps = 27/156 (17%)
Query: 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKT--EVSAIGRTHHKNLVQL 483
++LG G++ VYKG K + N VA+K++ +L E EVS + H N+V L
Sbjct: 12 DKLGEGTYATVYKGRSK-LTDNLVALKEI-RLEHEEGAPCTAIREVSLLKDLKHANIVTL 69
Query: 484 LGFCDEGLNRLLVYEFMGN---------GTLANLLFAIPRPDWSLRVRISL-EIARGLLY 533
+ LV+E++ G N+ V++ L ++ RGL Y
Sbjct: 70 HDIIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMH----------NVKLFLFQLLRGLNY 119
Query: 534 LHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSK 569
H ++H D+KPQN+L+++ K++DFGL++
Sbjct: 120 CHRR---KVLHRDLKPQNLLINERGELKLADFGLAR 152
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-07
Identities = 50/178 (28%), Positives = 82/178 (46%), Gaps = 25/178 (14%)
Query: 524 SLEIARGLLYL-HEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRT-V 581
S ++ARG+ +L +C IH D+ +NILL ++ KI DFGL++ + D R
Sbjct: 180 SFQVARGMEFLASRKC----IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGS 235
Query: 582 IRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVE--MELGEERSAILTDWAY 639
R ++APE + + + DV+SFGV+L +I S +++ EE L D
Sbjct: 236 ARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKD--- 292
Query: 640 DCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLE 697
A + + +M+A W Q DP +RP +V++L L+
Sbjct: 293 ------------GTRMRAPENATPEIYRIMLACW--QGDPKERPTFSALVEILGDLLQ 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 3e-07
Identities = 42/192 (21%), Positives = 88/192 (45%), Gaps = 20/192 (10%)
Query: 435 IVYKGVLKSASGNAVAVKKLDKLAQERE---REFKTEVSAIGRTHHKNLVQLLGF----C 487
+YKG+ + V ++ K + + + E+ + R N++++ GF
Sbjct: 35 SIYKGIF---NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIV 91
Query: 488 DEGLNRL-LVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCD 546
D+ L RL L+ E+ G L +L + ++ ++++ +GL L++ N P + +
Sbjct: 92 DD-LPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKP--YKN 148
Query: 547 IKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNV--PVSAKVD 604
+ + L+ +++ KI GL K+L S + + Y + + ++ + K D
Sbjct: 149 LTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFM----VYFSYKMLNDIFSEYTIKDD 204
Query: 605 VYSFGVVLLKII 616
+YS GVVL +I
Sbjct: 205 IYSLGVVLWEIF 216
|
Length = 283 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 4e-07
Identities = 55/221 (24%), Positives = 87/221 (39%), Gaps = 37/221 (16%)
Query: 428 LGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQERER---EFKTEVSAIGRTHHKNLVQLL 484
+G+G G VY VA+KK+ + E F E H +V +
Sbjct: 10 IGKGGMGEVYLAYDP-VCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68
Query: 485 GFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLR------------VRISLEIARGLL 532
C +G ++ TL +LL ++ + + SL + I +I +
Sbjct: 69 SICSDGDPVYYTMPYIEGYTLKSLLKSVWQKE-SLSKELAEKTSVGAFLSIFHKICATIE 127
Query: 533 YLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSK--------LLLSDQSRTRTV--- 581
Y+H + ++H D+KP NILL I D+G + LL D
Sbjct: 128 YVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSS 184
Query: 582 ------IRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKII 616
I GT Y+APE VP S D+Y+ GV+L +++
Sbjct: 185 MTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQML 225
|
Length = 932 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 4e-07
Identities = 56/206 (27%), Positives = 93/206 (45%), Gaps = 28/206 (13%)
Query: 428 LGRGSFGIVY--KGVLKSASGNAVAVKKLDK--LAQERE--REFKTEVSAIGRTHHKNLV 481
LG G++G V+ + V SG A+K L K + Q+ + +TE + +
Sbjct: 8 LGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 67
Query: 482 QLLGFCDEGLNRL-LVYEFMGNGTLANLLFAIPRPDWSLRVRISL--------EIARGLL 532
L + + +L L+ +++ G L L S R R EI L
Sbjct: 68 VTLHYAFQTDTKLHLILDYINGGELFTHL--------SQRERFKEQEVQIYSGEIVLALE 119
Query: 533 YLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPE 592
+LH+ + II+ DIK +NILLD + ++DFGLSK D+ GT Y+AP+
Sbjct: 120 HLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPD 176
Query: 593 WFK--NVPVSAKVDVYSFGVVLLKII 616
+ + VD +S GV++ +++
Sbjct: 177 IVRGGDGGHDKAVDWWSMGVLMYELL 202
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 5e-07
Identities = 57/216 (26%), Positives = 100/216 (46%), Gaps = 41/216 (18%)
Query: 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKT---EVSAIGRTHHKN-LV 481
E++G G++G VYK K+ +G VA+KK +L + E T E+S + +V
Sbjct: 7 EKIGEGTYGKVYKARDKN-TGKLVALKK-TRLEMDEEGIPPTALREISLLQMLSESIYIV 64
Query: 482 QLLGF----CDEGLNRL-LVYEFM-------------GNGTLANLLFAIPRPDWSLRVRI 523
+LL G L LV+E++ G G P P +++
Sbjct: 65 RLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGR--------PLPAKTIK-SF 115
Query: 524 SLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTA-KISDFGLSK-LLLSDQSRTRTV 581
++ +G+ + H+ ++H D+KPQN+L+D+ KI+D GL + + +S T +
Sbjct: 116 MYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEI 172
Query: 582 IRGTRGYVAPE-WFKNVPVSAKVDVYSFGVVLLKII 616
+ T Y APE + S VD++S G + ++
Sbjct: 173 V--TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMS 206
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 8e-07
Identities = 33/94 (35%), Positives = 53/94 (56%), Gaps = 6/94 (6%)
Query: 524 SLEIARGLLYL-HEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRT-V 581
S ++ARG+ +L +C IH D+ +NILL ++ KI DFGL++ + D R
Sbjct: 179 SFQVARGMEFLASRKC----IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD 234
Query: 582 IRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKI 615
R ++APE + + + DV+SFGV+L +I
Sbjct: 235 ARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEI 268
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 9e-07
Identities = 55/197 (27%), Positives = 91/197 (46%), Gaps = 14/197 (7%)
Query: 428 LGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQERERE---FKTEVSAIGRTHHKNLVQLL 484
+GRG+FG V + V ++ A+K L K + + F E + + +VQL
Sbjct: 51 IGRGAFGEV-QLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 109
Query: 485 GFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIH 544
+ +V E+M G L NL+ P+ R + E+ L +H ++ IH
Sbjct: 110 YAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTA-EVVLALDAIH---SMGFIH 165
Query: 545 CDIKPQNILLDQDFTAKISDFGLS-KLLLSDQSRTRTVIRGTRGYVAPEWFKNVP----V 599
D+KP N+LLD+ K++DFG K+ R T + GT Y++PE K+
Sbjct: 166 RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDGYY 224
Query: 600 SAKVDVYSFGVVLLKII 616
+ D +S GV L +++
Sbjct: 225 GRECDWWSVGVFLYEML 241
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 1e-06
Identities = 42/137 (30%), Positives = 63/137 (45%), Gaps = 19/137 (13%)
Query: 495 LVYEFMGNGTLANLLFAI-PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNIL 553
+V E++ G A LL I P R+ + E L YLH N I+H D+KP N+L
Sbjct: 78 MVMEYVEGGDCATLLKNIGALPVDMARMYFA-ETVLALEYLH---NYGIVHRDLKPDNLL 133
Query: 554 LDQDFTAKISDFGLSKLLL----------SDQSRTRTV----IRGTRGYVAPEWFKNVPV 599
+ K++DFGLSK+ L + TR + GT Y+APE
Sbjct: 134 ITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGY 193
Query: 600 SAKVDVYSFGVVLLKII 616
VD ++ G++L + +
Sbjct: 194 GKPVDWWAMGIILYEFL 210
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 2e-06
Identities = 28/94 (29%), Positives = 47/94 (50%), Gaps = 5/94 (5%)
Query: 523 ISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVI 582
I +I GL YLH + IIH D+K +NI ++ I D G ++ + + +
Sbjct: 162 IEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLG--L 216
Query: 583 RGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKII 616
GT APE ++K D++S G+VL +++
Sbjct: 217 AGTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 50.0 bits (120), Expect = 2e-06
Identities = 46/209 (22%), Positives = 83/209 (39%), Gaps = 29/209 (13%)
Query: 427 ELGRGSFGI----VYKGVLKSASGNAVAVKK--LDKLAQEREREFKTEVSAIGRTHHKNL 480
+G+ + + K + VAVKK LD ++E + + E+ + H N+
Sbjct: 5 LIGKCFEDLMIVHLAKHK---PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNI 61
Query: 481 VQLLGFCDEGLNRLLVYEFMGNGTLANLL---FAIPRPDWSLRVRISLEIARGLLYLHEE 537
+ + +V M G+ +LL F P+ ++ I ++ L Y+H +
Sbjct: 62 LPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAF-ILKDVLNALDYIHSK 120
Query: 538 CNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRG------YVAP 591
IH +K +ILL D +S S ++ R R V + +++P
Sbjct: 121 ---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSP 177
Query: 592 EWF-KNVP-VSAKVDVYSFGVVLLKIICC 618
E +N+ + K D+YS G I C
Sbjct: 178 EVLQQNLQGYNEKSDIYSVG-----ITAC 201
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 2e-06
Identities = 63/253 (24%), Positives = 95/253 (37%), Gaps = 81/253 (32%)
Query: 428 LGRGSFGIVYKGVLKSASGNAVAVKKL--------DKLAQER-EREFKTEVSAIGRTHHK 478
+G+G+FG V + V K +G A+K L D+LA + ER+ E +
Sbjct: 9 IGKGAFGEV-RLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAE------SDSP 61
Query: 479 NLVQLLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEEC 538
+V L + L+ EF+ G L +L + S ++ R Y+ EC
Sbjct: 62 WVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLI-----KYDT---FSEDVTR--FYM-AEC 110
Query: 539 NVPI--------IHCDIKPQNILLDQDFTAKISDFGLS-------------KLLLSDQSR 577
+ I IH DIKP NIL+D+ K+SDFGLS KLL ++
Sbjct: 111 VLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNK 170
Query: 578 TRTVIR---------------------------------GTRGYVAPEWFKNVPVSAKVD 604
R R GT Y+APE F + D
Sbjct: 171 NRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECD 230
Query: 605 VYSFGVVLLKIIC 617
+S G ++ + +
Sbjct: 231 WWSLGAIMFECLI 243
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 3e-06
Identities = 34/116 (29%), Positives = 63/116 (54%), Gaps = 16/116 (13%)
Query: 515 PDWSLRV----RISLEIARGLLYL-HEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSK 569
W L + R S ++A+G+ +L + C IH D+ +N+LL AKI DFGL++
Sbjct: 205 DSWPLDLDDLLRFSSQVAQGMDFLASKNC----IHRDVAARNVLLTDGRVAKICDFGLAR 260
Query: 570 LLLSDQSRTRTVIRGTR----GYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRS 621
+++D + V++G ++APE + + + DV+S+G++L +I +S
Sbjct: 261 DIMND---SNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKS 313
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|237995 cd00028, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 3e-06
Identities = 25/79 (31%), Positives = 37/79 (46%), Gaps = 6/79 (7%)
Query: 35 SNNSSWISPSRDFAFGFRQLNNNSDLFLLAIWFNKMPERTIIWHANEDNHPVLAPRGSTL 94
S+ + +S F GF +L S + L I + RT++W AN DN P TL
Sbjct: 5 SSGQTLVSSGSLFELGFFKLIMQSRDYNL-ILYKGSS-RTVVWVANRDN-PS--GSSCTL 59
Query: 95 ELTATG-LLLKDPGGQAIW 112
L + G L++ D G +W
Sbjct: 60 TLQSDGNLVIYDGSGTVVW 78
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. Length = 116 |
| >gnl|CDD|216511 pfam01453, B_lectin, D-mannose binding lectin | Back alignment and domain information |
|---|
Score = 45.8 bits (109), Expect = 3e-06
Identities = 29/111 (26%), Positives = 42/111 (37%), Gaps = 34/111 (30%)
Query: 72 ERTIIWHANEDNHPVLAPRGSTLELTATG-LLLKDPGGQAIWD----------------- 113
+T++W AN N L TL L + G L+L D G+ +W
Sbjct: 1 NQTVVWVANRLNP--LTDSSYTLILQSDGNLVLYDGNGRVVWSSNTSGKGSGCVAVLQDD 58
Query: 114 ------EKPNKI---SFKSPTDTILPTQIFDLGSV-----LVSRLTETNLS 150
+ K+ SF PTDT+LP Q + L S + T+ S
Sbjct: 59 GNLVLYDNSGKVLWQSFDHPTDTLLPGQKDGNVVIGGSRRLTSWKSNTDPS 109
|
These proteins include mannose-specific lectins from plants as well as bacteriocins from bacteria. Length = 109 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 4e-06
Identities = 34/101 (33%), Positives = 52/101 (51%), Gaps = 13/101 (12%)
Query: 526 EIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTR--TVIR 583
++ R L Y+H NV H D+KP+NIL + D KI DFGL+++ +D T
Sbjct: 111 QLLRALKYIHT-ANV--FHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYV 167
Query: 584 GTRGYVAPE-----WFKNVPVSAKVDVYSFGVVLLKIICCK 619
TR Y APE + K P +D++S G + +++ K
Sbjct: 168 ATRWYRAPELCGSFFSKYTPA---IDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 5e-06
Identities = 32/94 (34%), Positives = 53/94 (56%), Gaps = 6/94 (6%)
Query: 524 SLEIARGLLYL-HEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRT-V 581
S ++A+G+ +L +C IH D+ +NILL ++ KI DFGL++ + D R
Sbjct: 185 SFQVAKGMEFLASRKC----IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD 240
Query: 582 IRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKI 615
R ++APE + + + DV+SFGV+L +I
Sbjct: 241 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 274
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 5e-06
Identities = 56/201 (27%), Positives = 92/201 (45%), Gaps = 19/201 (9%)
Query: 428 LGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQERERE---FKTEVSAIGRTHHKNLVQL- 483
+GRG+FG V +K A+K L+K + E F+ E + + + + L
Sbjct: 9 IGRGAFGEVAVVKMKHTE-RIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLH 67
Query: 484 LGFCDEGLNRL-LVYEFMGNGTLANLL--FAIPRPDWSLRVRISLEIARGLLYLHEECNV 540
F DE N L LV ++ G L LL F P+ R IA +L +H +
Sbjct: 68 YAFQDE--NYLYLVMDYYVGGDLLTLLSKFEDRLPEDMAR----FYIAEMVLAIHSIHQL 121
Query: 541 PIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNV--- 597
+H DIKP N+LLD + +++DFG + D + +V GT Y++PE + +
Sbjct: 122 HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDG 181
Query: 598 --PVSAKVDVYSFGVVLLKII 616
+ D +S GV + +++
Sbjct: 182 MGKYGPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 6e-06
Identities = 34/100 (34%), Positives = 47/100 (47%), Gaps = 8/100 (8%)
Query: 527 IARGLL----YLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLS-KLLLSDQSRTRTV 581
I R LL YLH IIH D+K +NI LD+ A + DFG + KL +
Sbjct: 190 IQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYG 246
Query: 582 IRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRS 621
GT +PE P AK D++S G+VL ++ +
Sbjct: 247 WSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVT 286
|
Length = 392 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 8e-06
Identities = 52/171 (30%), Positives = 85/171 (49%), Gaps = 12/171 (7%)
Query: 428 LGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQERERE---FKTEVSAIGRTHHKNLVQL- 483
+GRG+FG V +K+ +G A+K L+K + E F+ E + + + L
Sbjct: 9 IGRGAFGEVAVVKMKN-TGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLH 67
Query: 484 LGFCDEGLNRLLVYEFMGNGTLANLL--FAIPRPDWSLRVRISLEIARGLLYLHEECNVP 541
F DE N LV ++ G L LL F P+ R ++ E+ + +H+ +
Sbjct: 68 YAFQDEN-NLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLA-EMVLAIDSVHQ---LG 122
Query: 542 IIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPE 592
+H DIKP N+LLD++ +++DFG LL+D + V GT Y++PE
Sbjct: 123 YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPE 173
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 1e-05
Identities = 34/92 (36%), Positives = 47/92 (51%), Gaps = 6/92 (6%)
Query: 424 FEEELGRGSFGIVYK----GVLKSASGNAVAVKKLDKLAQERERE-FKTEVSAIGRT-HH 477
F + LG G+FG V + G+ KS + VAVK L A ERE +E+ + +H
Sbjct: 39 FGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 98
Query: 478 KNLVQLLGFCDEGLNRLLVYEFMGNGTLANLL 509
N+V LLG C G L++ E+ G L N L
Sbjct: 99 INIVNLLGACTVGGPTLVITEYCCYGDLLNFL 130
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 2e-05
Identities = 38/95 (40%), Positives = 50/95 (52%), Gaps = 11/95 (11%)
Query: 424 FEEELGRGSFGIVYK----GVLKSASGNAVAVKKLDKLAQERE-REFKTEVSA---IGRT 475
+ LGRG+FG V + G+ KSAS VAVK L + A E + TE+ IG
Sbjct: 11 LGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIG-- 68
Query: 476 HHKNLVQLLGFCDEGLNRLLV-YEFMGNGTLANLL 509
HH N+V LLG C + L+V E+ G L+N L
Sbjct: 69 HHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYL 103
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 2e-05
Identities = 31/100 (31%), Positives = 46/100 (46%), Gaps = 3/100 (3%)
Query: 523 ISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVI 582
I + R + YLHE IIH DIK +NI ++ + DFG + + +
Sbjct: 187 IERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGW 243
Query: 583 RGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSV 622
GT APE P VD++S G+VL ++ C S+
Sbjct: 244 AGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSL 283
|
Length = 391 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 3e-05
Identities = 45/146 (30%), Positives = 72/146 (49%), Gaps = 13/146 (8%)
Query: 428 LGRGSFGIVYKGVLKSASGNAVAVKKLDK---LAQEREREFKTEVSAIGRTHHKNLVQLL 484
+G G+FG V V K + A+K L K L + + K E + ++ +V+L
Sbjct: 9 IGIGAFGEVCL-VRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLY 67
Query: 485 -GFCDEGLNRLLVYEFMGNGTLANLL--FAIPRPDWSLRVRISLEIARGLLYLHEECNVP 541
F D+ N V +++ G + +LL I D + R I+ E+ + +H +
Sbjct: 68 YSFQDKD-NLYFVMDYIPGGDMMSLLIRLGIFEEDLA-RFYIA-ELTCAIESVH---KMG 121
Query: 542 IIHCDIKPQNILLDQDFTAKISDFGL 567
IH DIKP NIL+D+D K++DFGL
Sbjct: 122 FIHRDIKPDNILIDRDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 7e-05
Identities = 36/94 (38%), Positives = 48/94 (51%), Gaps = 10/94 (10%)
Query: 424 FEEELGRGSFGIVYK----GVLKSASGNAVAVKKLDKLAQERERE-FKTEV---SAIGRT 475
F + LG G+FG V + G+ K + VAVK L A ERE +E+ S +G
Sbjct: 42 FGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLG-- 99
Query: 476 HHKNLVQLLGFCDEGLNRLLVYEFMGNGTLANLL 509
HKN+V LLG C G L++ E+ G L N L
Sbjct: 100 QHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFL 133
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 7e-05
Identities = 49/179 (27%), Positives = 84/179 (46%), Gaps = 23/179 (12%)
Query: 449 VAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEFMGNGTLANL 508
V +K LD ++ F S + + H +L + G C G ++V EF+ +G L
Sbjct: 47 VVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVC 106
Query: 509 L----FAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQ----DFTA 560
L +P W + V + ++A L YL ++ ++H ++ +NILL + + T+
Sbjct: 107 LRKEKGRVPV-AWKITV--AQQLASALSYLEDK---NLVHGNVCAKNILLARLGLAEGTS 160
Query: 561 ---KISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNV-PVSAKVDVYSFGVVLLKI 615
K+SD G+S LS + R + ++APE +S D +SFG LL+I
Sbjct: 161 PFIKLSDPGVSFTALSREERVERI-----PWIAPECVPGGNSLSTAADKWSFGTTLLEI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 44.1 bits (105), Expect = 1e-04
Identities = 51/204 (25%), Positives = 86/204 (42%), Gaps = 24/204 (11%)
Query: 431 GSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEG 490
G FG V VLK + V+K+ K E V + + + N ++L
Sbjct: 27 GKFGKVS--VLKHKPTQKLFVQKIIKAKNFNAIEPM--VHQLMK-DNPNFIKLYYSVTTL 81
Query: 491 LNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQ 550
+L+ +++ +G L +LL + + +I ++ L LH IIH DIK +
Sbjct: 82 KGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLH---KHNIIHNDIKLE 138
Query: 551 NILLDQDFTAK----ISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVY 606
N+L D+ AK + D+GL K+ T + GT Y +PE K D +
Sbjct: 139 NVLYDR---AKDRIYLCDYGLCKI-----IGTPSCYDGTLDYFSPEKIKGHNYDVSFDWW 190
Query: 607 SFGVVLLKIICC----KRSVEMEL 626
+ GV+ +++ K + EL
Sbjct: 191 AVGVLTYELLTGKHPFKEDEDEEL 214
|
Length = 267 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 2e-04
Identities = 30/96 (31%), Positives = 46/96 (47%), Gaps = 4/96 (4%)
Query: 526 EIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQS-RTRTVIRG 584
+I L +H ++H D+K NI L K+ DFG SK S + G
Sbjct: 177 QIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCG 233
Query: 585 TRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKR 620
T Y+APE ++ S K D++S GV+L +++ R
Sbjct: 234 TPYYLAPELWERKRYSKKADMWSLGVILYELLTLHR 269
|
Length = 478 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 4e-04
Identities = 35/89 (39%), Positives = 49/89 (55%), Gaps = 7/89 (7%)
Query: 428 LGRGSFGIVYK----GVLKSASGNAVAVKKLDKLAQERE-REFKTEVSA-IGRTHHKNLV 481
LGRG+FG V + G+ K+A+ VAVK L + A E R +E+ I HH N+V
Sbjct: 15 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 74
Query: 482 QLLGFCDE-GLNRLLVYEFMGNGTLANLL 509
LLG C + G +++ EF G L+N L
Sbjct: 75 NLLGACTKPGGPLMVIVEFCKFGNLSNYL 103
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.2 bits (101), Expect = 5e-04
Identities = 58/227 (25%), Positives = 100/227 (44%), Gaps = 46/227 (20%)
Query: 426 EELGRGSFGIVY----KGVLKSASGNAVAVKKLDKLAQERER-EFKTEVSAIGRTHHKNL 480
+++G G FG V+ K + A++ + L +ERE+ + EV+ + HKN+
Sbjct: 19 KKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGL----KEREKSQLVIEVNVMRELKHKNI 74
Query: 481 VQLLGFCDEGLNR-----LLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLL--- 532
V+ + D LN+ ++ EF G L+ + + + ++I R LL
Sbjct: 75 VR---YIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHAL 131
Query: 533 -YLHEECNVP----IIHCDIKPQNILLDQDF-----------------TAKISDFGLSKL 570
Y H + P ++H D+KPQNI L AKI DFGLSK
Sbjct: 132 AYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSK- 190
Query: 571 LLSDQSRTRTVIRGTRGYVAPEWFKNVPVS--AKVDVYSFGVVLLKI 615
+ +S + + GT Y +PE + S K D+++ G ++ ++
Sbjct: 191 NIGIESMAHSCV-GTPYYWSPELLLHETKSYDDKSDMWALGCIIYEL 236
|
Length = 1021 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 7e-04
Identities = 29/97 (29%), Positives = 55/97 (56%), Gaps = 12/97 (12%)
Query: 524 SLEIARGLLYL-HEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVI 582
+ ++ARG+ +L + C +H D+ +N+LL Q KI DFGL++ ++ D + V
Sbjct: 243 TYQVARGMEFLASKNC----VHRDLAARNVLLAQGKIVKICDFGLARDIMHDSN---YVS 295
Query: 583 RGTR----GYVAPEWFKNVPVSAKVDVYSFGVVLLKI 615
+G+ ++APE + + DV+S+G++L +I
Sbjct: 296 KGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEI 332
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.001
Identities = 39/118 (33%), Positives = 55/118 (46%), Gaps = 16/118 (13%)
Query: 428 LGRGSFGIVYK----GVLKSASGNAVAVKKLDKLAQERE-REFKTEVSA-IGRTHHKNLV 481
LG G+FG V + G+ K +S N VAVK L + A E + +E+ I +H N+V
Sbjct: 15 LGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVV 74
Query: 482 QLLGFCDEGLNRLLV-YEFMGNGTLANLL---------FAIPRPDWSLRVRISLEIAR 529
LLG C + L+V EF G L+N L + P R R +E +R
Sbjct: 75 NLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSR 132
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.002
Identities = 32/124 (25%), Positives = 59/124 (47%), Gaps = 10/124 (8%)
Query: 496 VYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYL-HEECNVPIIHCDIKPQNILL 554
+ L+ P + V S ++A G+ +L + C +H D+ +N+L+
Sbjct: 217 LPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNC----VHRDLAARNVLI 272
Query: 555 DQDFTAKISDFGLSKLLLSDQ---SRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVV 611
+ KI DFGL++ ++ D S+ T + ++APE N + DV+SFG++
Sbjct: 273 CEGKLVKICDFGLARDIMRDSNYISKGSTFL--PLKWMAPESIFNNLYTTLSDVWSFGIL 330
Query: 612 LLKI 615
L +I
Sbjct: 331 LWEI 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.002
Identities = 39/142 (27%), Positives = 66/142 (46%), Gaps = 5/142 (3%)
Query: 428 LGRGSFGIV--YKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLG 485
LG G+FG V + V A ++K D L + + K E + ++ +V+L
Sbjct: 9 LGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYY 68
Query: 486 FCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHC 545
+ N V +++ G + +LL + L E+ + +H+ + IH
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHK---MGFIHR 125
Query: 546 DIKPQNILLDQDFTAKISDFGL 567
DIKP NIL+D+D K++DFGL
Sbjct: 126 DIKPDNILIDRDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.002
Identities = 42/144 (29%), Positives = 69/144 (47%), Gaps = 9/144 (6%)
Query: 428 LGRGSFGIVYKGVLKSASGNAVAVKKL---DKLAQEREREFKTEVSAIGRTHHKNLVQLL 484
LG G+FG V K + A+K L D L + + K E + ++ +V+L
Sbjct: 9 LGIGAFGEVCLAC-KVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLY 67
Query: 485 GFCDEGLNRLLVYEFMGNGTLANLLFAIPR-PDWSLRVRISLEIARGLLYLHEECNVPII 543
+ N V +++ G + +LL + P+ R I+ E+ + +H+ + I
Sbjct: 68 YSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIA-ELTLAIESVHK---MGFI 123
Query: 544 HCDIKPQNILLDQDFTAKISDFGL 567
H DIKP NIL+D D K++DFGL
Sbjct: 124 HRDIKPDNILIDLDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.004
Identities = 31/95 (32%), Positives = 47/95 (49%), Gaps = 12/95 (12%)
Query: 527 IARGLL----YLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVI 582
+AR LL Y+H E IIH DIK +N+L++ + DFG + + S +
Sbjct: 265 VARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAA--CFARGSWSTPFH 319
Query: 583 RGTRGYV---APEWFKNVPVSAKVDVYSFGVVLLK 614
G G V APE P + VD++S G+V+ +
Sbjct: 320 YGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 40.1 bits (93), Expect = 0.004
Identities = 47/206 (22%), Positives = 81/206 (39%), Gaps = 31/206 (15%)
Query: 425 EEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLL 484
EE R +G K A VK + A + E E+ A+GR +H+N++++
Sbjct: 174 EEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLE----NEILALGRLNHENILKIE 229
Query: 485 GFCDEGLNRLLV--------YEFMGNGTLANLLFAIPRPDWSLRV------RISLEIARG 530
N ++ Y FM + DW R I ++
Sbjct: 230 EILRSEANTYMITQKYDFDLYSFMYDEAF----------DWKDRPLLKQTRAIMKQLLCA 279
Query: 531 LLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVA 590
+ Y+H++ +IH DIK +NI L+ D + DFG + ++ GT +
Sbjct: 280 VEYIHDK---KLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNS 336
Query: 591 PEWFKNVPVSAKVDVYSFGVVLLKII 616
PE D++S G++LL ++
Sbjct: 337 PEILAGDGYCEITDIWSCGLILLDML 362
|
Length = 501 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 714 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.98 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.98 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.98 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.98 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.98 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.98 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.96 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.94 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.94 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.94 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.93 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.92 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.92 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.91 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.89 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.88 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.86 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.85 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.85 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.82 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.81 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.8 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.8 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.79 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.79 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.78 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.75 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 99.75 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.73 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.73 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.73 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.71 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.7 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 99.7 | |
| PF00954 | 110 | S_locus_glycop: S-locus glycoprotein family; Inter | 99.69 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.68 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.67 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.66 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.66 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.63 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 99.62 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.61 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.56 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.55 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.54 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.51 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.44 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.38 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.29 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.27 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.25 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.21 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.19 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.1 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.08 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.06 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.98 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.96 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.92 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.83 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.81 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.75 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.63 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.6 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.6 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.57 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.51 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.37 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.36 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.2 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.15 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.07 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.04 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.92 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.77 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.75 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.68 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.67 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.66 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.58 | |
| PF08276 | 66 | PAN_2: PAN-like domain; InterPro: IPR013227 PAN do | 97.53 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.51 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.51 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.47 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.31 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.11 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 96.96 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.95 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.93 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.83 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 96.68 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.58 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.5 | |
| cd01098 | 84 | PAN_AP_plant Plant PAN/APPLE-like domain; present | 96.37 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.36 | |
| PLN02236 | 344 | choline kinase | 96.36 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.24 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.16 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 95.89 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 95.55 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 95.52 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 95.52 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 95.48 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 95.45 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 95.38 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 95.37 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 94.96 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-51 Score=436.13 Aligned_cols=287 Identities=47% Similarity=0.740 Sum_probs=249.8
Q ss_pred CccccCHHHHHHHhhhhh--hhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCcccccceec
Q 041576 408 NLRFFSLVELNEATNGFE--EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLG 485 (714)
Q Consensus 408 ~~~~~~~~el~~at~~~~--~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~ 485 (714)
..+.|++.|+..||.+|. ..||+|+||.||+|.+. +++.||||++........++|.+|++++.+++|||+|+++|
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~--~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlG 138 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLS--DGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLG 138 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEEC--CCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEE
Confidence 578899999999999998 58999999999999997 45899999887644321556999999999999999999999
Q ss_pred eEecCC-eeeEEEeecCCCchhhhhhcCC--CCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEE
Q 041576 486 FCDEGL-NRLLVYEFMGNGTLANLLFAIP--RPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKI 562 (714)
Q Consensus 486 ~~~~~~-~~~lv~E~~~~gsL~~~l~~~~--~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl 562 (714)
||.+.+ +.+||||||++|+|.++|+... .++|..|++|+.++|+||+|||+...++|||||||++|||+|+++++||
T Consensus 139 yC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKl 218 (361)
T KOG1187|consen 139 YCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKL 218 (361)
T ss_pred EEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEc
Confidence 999998 5999999999999999999765 7899999999999999999999999889999999999999999999999
Q ss_pred ecCCCccccccCcccceeee-cCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhh
Q 041576 563 SDFGLSKLLLSDQSRTRTVI-RGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDC 641 (714)
Q Consensus 563 ~Dfg~~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~ 641 (714)
+|||+++..... ....... .||.+|+|||++..+..+.|+|||||||+|+||+||+.+.+..... ....+..|+...
T Consensus 219 sDFGLa~~~~~~-~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~-~~~~l~~w~~~~ 296 (361)
T KOG1187|consen 219 SDFGLAKLGPEG-DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPR-GELSLVEWAKPL 296 (361)
T ss_pred cCccCcccCCcc-ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCc-ccccHHHHHHHH
Confidence 999999765441 1111122 7999999999999999999999999999999999999988765422 223377888888
Q ss_pred hhcCccceeecchhh-hccch-HHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCC
Q 041576 642 YVEGKLDVLVDNDKA-AMADK-SRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLEV 698 (714)
Q Consensus 642 ~~~~~~~~~~~~~~~-~~~~~-~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 698 (714)
+.++++..++|+.+. ..... ....++..++.+|++.+|.+||+|.||+++|+.+...
T Consensus 297 ~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 297 LEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred HHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 888899999999876 44443 6788899999999999999999999999999776554
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=369.49 Aligned_cols=255 Identities=27% Similarity=0.418 Sum_probs=213.7
Q ss_pred cCHHHHHHHhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecc-cchhhHHHHHHHHHHHhccCcccccceeceEecC
Q 041576 412 FSLVELNEATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDK-LAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEG 490 (714)
Q Consensus 412 ~~~~el~~at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 490 (714)
++..+++. .+.||+|..|+||+++++ .+++.+|+|.+.. ......+++.+|++++++.+||+||+++|.|..+
T Consensus 76 i~~~dle~-----~~~lG~G~gG~V~kv~Hk-~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~ 149 (364)
T KOG0581|consen 76 ISLSDLER-----LGVLGSGNGGTVYKVRHK-PTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSN 149 (364)
T ss_pred cCHHHhhh-----hhhcccCCCcEEEEEEEc-CCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeC
Confidence 45555543 478999999999999988 6889999999954 3455668999999999999999999999999998
Q ss_pred C-eeeEEEeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHh-cCCCCeEecCCCcCeEEECCCCceEEecCCCc
Q 041576 491 L-NRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHE-ECNVPIIHCDIKPQNILLDQDFTAKISDFGLS 568 (714)
Q Consensus 491 ~-~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~-~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~ 568 (714)
. ...++||||++|+|++++...+++++...-+|+.++++||.|||+ ++ ||||||||+||||+..|.+||+|||.+
T Consensus 150 ~~~isI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS 226 (364)
T KOG0581|consen 150 GEEISICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVS 226 (364)
T ss_pred CceEEeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEecccccc
Confidence 8 599999999999999999988999999999999999999999996 55 999999999999999999999999999
Q ss_pred cccccCcccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccc--hhhhhhhHHHhhhhhcCc
Q 041576 569 KLLLSDQSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGE--ERSAILTDWAYDCYVEGK 646 (714)
Q Consensus 569 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~--~~~~~l~~~~~~~~~~~~ 646 (714)
+.+.+. ......||..|||||.+.+..|+.++||||||+.++|+.+|+.|+...... .....+
T Consensus 227 ~~lvnS---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll------------ 291 (364)
T KOG0581|consen 227 GILVNS---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELL------------ 291 (364)
T ss_pred HHhhhh---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHH------------
Confidence 987554 445678999999999999999999999999999999999999999765111 111111
Q ss_pred cceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 647 LDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 647 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
..+.+...........+.++..++..||++||.+||+++|+++.
T Consensus 292 -~~Iv~~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 292 -CAIVDEPPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred -HHHhcCCCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 11222112111222467789999999999999999999999863
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-45 Score=386.44 Aligned_cols=254 Identities=37% Similarity=0.535 Sum_probs=210.4
Q ss_pred hhhhhhCcccceeEEEeEeeCCCCcE-EEEEEecccchh--hHHHHHHHHHHHhccCcccccceeceEecCC-eeeEEEe
Q 041576 423 GFEEELGRGSFGIVYKGVLKSASGNA-VAVKKLDKLAQE--REREFKTEVSAIGRTHHKNLVQLLGFCDEGL-NRLLVYE 498 (714)
Q Consensus 423 ~~~~~ig~G~~g~Vy~~~~~~~~~~~-vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-~~~lv~E 498 (714)
.+.+.||+|+||+||+|.++ |+. ||||++...... ..+.|.+|+.+|.+++|||||+++|+|.+.. ..++|||
T Consensus 44 ~~~~~iG~G~~g~V~~~~~~---g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtE 120 (362)
T KOG0192|consen 44 PIEEVLGSGSFGTVYKGKWR---GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTE 120 (362)
T ss_pred hhhhhcccCCceeEEEEEeC---CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEE
Confidence 34566999999999999996 555 999999764322 2569999999999999999999999999988 7899999
Q ss_pred ecCCCchhhhhhc--CCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCC-ceEEecCCCccccccCc
Q 041576 499 FMGNGTLANLLFA--IPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDF-TAKISDFGLSKLLLSDQ 575 (714)
Q Consensus 499 ~~~~gsL~~~l~~--~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~-~~kl~Dfg~~~~~~~~~ 575 (714)
|+++|+|.++++. ...+++..+++++.|||+||.|||+++. ||||||||+|||++.++ ++||+|||+++......
T Consensus 121 y~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~ 198 (362)
T KOG0192|consen 121 YMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK 198 (362)
T ss_pred eCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc
Confidence 9999999999988 5789999999999999999999999873 99999999999999997 99999999998764332
Q ss_pred ccceeeecCCCCccCccccc--CCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecc
Q 041576 576 SRTRTVIRGTRGYVAPEWFK--NVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDN 653 (714)
Q Consensus 576 ~~~~~~~~gt~~y~aPE~~~--~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 653 (714)
...+...||..|||||+++ ...++.|+||||||++||||+||+.||........ +......+...
T Consensus 199 -~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~-------~~~v~~~~~Rp----- 265 (362)
T KOG0192|consen 199 -TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQV-------ASAVVVGGLRP----- 265 (362)
T ss_pred -ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHH-------HHHHHhcCCCC-----
Confidence 2333367999999999999 56999999999999999999999999986544211 11111111111
Q ss_pred hhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCC
Q 041576 654 DKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLEV 698 (714)
Q Consensus 654 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 698 (714)
..+......+..++.+||+.||++||++.||+..|+.+...
T Consensus 266 ----~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~ 306 (362)
T KOG0192|consen 266 ----PIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSH 306 (362)
T ss_pred ----CCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHh
Confidence 12222556788899999999999999999999999876653
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=364.49 Aligned_cols=203 Identities=32% Similarity=0.478 Sum_probs=183.7
Q ss_pred hhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEeccc--chhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEe
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKL--AQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYE 498 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E 498 (714)
.|.+.++||+|+|++||+|+++. ++..||||.+.+. .....+.+..|+.+|+.++|||||++++++..++..|||||
T Consensus 11 ~y~~~~~iG~GsfavVykg~h~~-~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME 89 (429)
T KOG0595|consen 11 DYELSREIGSGSFAVVYKGRHKK-SGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME 89 (429)
T ss_pred cceehhhccCcceEEEEEeEecc-CCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence 35566789999999999999984 5699999999765 56667788999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCC------CceEEecCCCccccc
Q 041576 499 FMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQD------FTAKISDFGLSKLLL 572 (714)
Q Consensus 499 ~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~------~~~kl~Dfg~~~~~~ 572 (714)
||.+|+|.++++..+.+++..+..++.|||.||++||+++ ||||||||.||||+.. -.+||+|||+|+.+.
T Consensus 90 yC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~ 166 (429)
T KOG0595|consen 90 YCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQ 166 (429)
T ss_pred eCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchhhhCC
Confidence 9999999999999999999999999999999999999998 9999999999999765 468999999999885
Q ss_pred cCcccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccch
Q 041576 573 SDQSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEE 629 (714)
Q Consensus 573 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~ 629 (714)
. .......+|++-|||||+++..+|+.|+|+||+|+||||+++|+.||+.....+
T Consensus 167 ~--~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~e 221 (429)
T KOG0595|consen 167 P--GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKE 221 (429)
T ss_pred c--hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHH
Confidence 3 333445789999999999999999999999999999999999999998665443
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-44 Score=380.74 Aligned_cols=249 Identities=25% Similarity=0.364 Sum_probs=214.7
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecc---cchhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEE
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDK---LAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLV 496 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 496 (714)
.+|...+.||+|+|+.||.++.. .+|+.||+|++.+ ......+.+.+||++.++|+|||||+++++|++.++.|||
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~-~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYiv 96 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDL-DTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIV 96 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEc-CCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEE
Confidence 56777889999999999999874 4799999999976 2345567889999999999999999999999999999999
Q ss_pred EeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcc
Q 041576 497 YEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQS 576 (714)
Q Consensus 497 ~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 576 (714)
.|+|+.++|..+++.++.+++.+++.++.||+.||.|||+++ |+|||||..|++++++.++||+|||+|..+..+..
T Consensus 97 LELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~E 173 (592)
T KOG0575|consen 97 LELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGE 173 (592)
T ss_pred EEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCccc
Confidence 999999999999998899999999999999999999999998 99999999999999999999999999998866544
Q ss_pred cceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhh
Q 041576 577 RTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKA 656 (714)
Q Consensus 577 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 656 (714)
. ..+.+||+.|+|||++.....+..+||||+||++|.||.|++||+...-.+....+ ...+.
T Consensus 174 r-k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~I--------k~~~Y--------- 235 (592)
T KOG0575|consen 174 R-KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKI--------KLNEY--------- 235 (592)
T ss_pred c-cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHH--------HhcCc---------
Confidence 3 34567999999999999999999999999999999999999999866444322211 11110
Q ss_pred hccchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 657 AMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 657 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
..+...+.+..+||.++|++||.+|||+++|+..
T Consensus 236 -~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 236 -SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred -ccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0122344567789999999999999999999863
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-45 Score=368.31 Aligned_cols=254 Identities=27% Similarity=0.404 Sum_probs=211.3
Q ss_pred HHHhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc-------hhhHHHHHHHHHHHhccCcccccceeceEecC
Q 041576 418 NEATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA-------QEREREFKTEVSAIGRTHHKNLVQLLGFCDEG 490 (714)
Q Consensus 418 ~~at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 490 (714)
....|.+.+.||+|+||.|-+|..+ .+|+.||||++.+.. ......+++|+++|++++|||||+++++++..
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~-~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ 248 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEK-KTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVP 248 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEc-ccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecC
Confidence 4556778899999999999999876 689999999996521 11234568999999999999999999999999
Q ss_pred CeeeEEEeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCC---CceEEecCCC
Q 041576 491 LNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQD---FTAKISDFGL 567 (714)
Q Consensus 491 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~---~~~kl~Dfg~ 567 (714)
+..||||||++||.|.+.+-.++.+.+..-..++.|++.|+.|||++| |+||||||+|||+..+ ..+||+|||+
T Consensus 249 ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDFGl 325 (475)
T KOG0615|consen 249 DSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDFGL 325 (475)
T ss_pred CceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecccch
Confidence 999999999999999999999999999999999999999999999999 9999999999999766 7899999999
Q ss_pred ccccccCcccceeeecCCCCccCcccccCCCC---CchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhc
Q 041576 568 SKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPV---SAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVE 644 (714)
Q Consensus 568 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~ 644 (714)
|+... ......+.+||+.|.|||++.+... ..|.|+||+||+||-+++|.+||.....+.. ..+.+..
T Consensus 326 AK~~g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s-------l~eQI~~ 396 (475)
T KOG0615|consen 326 AKVSG--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS-------LKEQILK 396 (475)
T ss_pred hhccc--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc-------HHHHHhc
Confidence 99875 3344556789999999999976543 3488999999999999999999986654431 1112223
Q ss_pred CccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 645 GKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 645 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
++.... .....+..++..++|.+||..||++|||+.|+++
T Consensus 397 G~y~f~------p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 397 GRYAFG------PLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred Cccccc------ChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 322211 1223456678889999999999999999999986
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=379.59 Aligned_cols=265 Identities=27% Similarity=0.395 Sum_probs=224.9
Q ss_pred CHHHHHHHhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCcccccceeceEecCCe
Q 041576 413 SLVELNEATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLN 492 (714)
Q Consensus 413 ~~~el~~at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 492 (714)
...++......+.++||+|-||.||.|.++ ....||+|.++.. .-..+.|.+|+++|++|+|+|||+++++|..++.
T Consensus 199 d~wei~r~~l~l~~~LG~G~FG~V~~g~~~--~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~p 275 (468)
T KOG0197|consen 199 DPWEIPREELKLIRELGSGQFGEVWLGKWN--GSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEP 275 (468)
T ss_pred CCeeecHHHHHHHHHhcCCccceEEEEEEc--CCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCc
Confidence 345666677788899999999999999996 4559999999765 3345688899999999999999999999999999
Q ss_pred eeEEEeecCCCchhhhhhc--CCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccc
Q 041576 493 RLLVYEFMGNGTLANLLFA--IPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKL 570 (714)
Q Consensus 493 ~~lv~E~~~~gsL~~~l~~--~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~ 570 (714)
.+||||||+.|+|.++|+. ...++..+.+.++.|||+|++||++++ +|||||.++||||+++..+||+|||+|+.
T Consensus 276 iyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~ 352 (468)
T KOG0197|consen 276 IYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARL 352 (468)
T ss_pred eEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccc
Confidence 9999999999999999986 467899999999999999999999998 99999999999999999999999999997
Q ss_pred cccCcccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccchhhhhhhHHHhhhhhcCccce
Q 041576 571 LLSDQSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEERSAILTDWAYDCYVEGKLDV 649 (714)
Q Consensus 571 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 649 (714)
..++.........-...|.|||.+....++.|||||||||+||||+| |+.|+......+- ..
T Consensus 353 ~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev-----------------~~ 415 (468)
T KOG0197|consen 353 IGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEV-----------------LE 415 (468)
T ss_pred cCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHH-----------------HH
Confidence 66666555555667789999999999999999999999999999998 6777664433321 11
Q ss_pred eecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCCCC
Q 041576 650 LVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLEVPS 700 (714)
Q Consensus 650 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 700 (714)
.++...+...+..++..+.+++..||+.+|++|||++.+...|+.+.....
T Consensus 416 ~le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~~ 466 (468)
T KOG0197|consen 416 LLERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTSTE 466 (468)
T ss_pred HHhccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhccc
Confidence 122333344566677889999999999999999999999999998766543
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=338.17 Aligned_cols=261 Identities=25% Similarity=0.336 Sum_probs=212.0
Q ss_pred HHHHHhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecc--cchhhHHHHHHHHHHHhccCcccccceec-eEecCCe
Q 041576 416 ELNEATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDK--LAQEREREFKTEVSAIGRTHHKNLVQLLG-FCDEGLN 492 (714)
Q Consensus 416 el~~at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~nIv~l~~-~~~~~~~ 492 (714)
....+.|.+.++||+|.||.||++... .+|..+|.|.++- .+....+.+..|+.+|++|+|||||++++ .+.++.+
T Consensus 15 ~~~l~~y~Il~~IG~GsFg~vykv~~~-~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~e 93 (375)
T KOG0591|consen 15 QKTLADYQILKKIGRGSFGEVYKVQCL-LDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNE 93 (375)
T ss_pred cccHHHHHHHHHHcCCcchheEEeeec-cCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccch
Confidence 344567888999999999999999876 5799999999863 34556678999999999999999999999 4444444
Q ss_pred -eeEEEeecCCCchhhhhhc----CCCCChhhHHHHHHHHHHHHHHHHhcCC-CCeEecCCCcCeEEECCCCceEEecCC
Q 041576 493 -RLLVYEFMGNGTLANLLFA----IPRPDWSLRVRISLEIARGLLYLHEECN-VPIIHCDIKPQNILLDQDFTAKISDFG 566 (714)
Q Consensus 493 -~~lv~E~~~~gsL~~~l~~----~~~~~~~~~~~i~~qi~~~L~yLH~~~~-~~ivH~Dlk~~NIll~~~~~~kl~Dfg 566 (714)
.+||||+++.|+|...++. .+.+++..+++++.|++.||.++|+.-+ ..|+||||||.||+|+.+|.+||+|||
T Consensus 94 vlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfG 173 (375)
T KOG0591|consen 94 VLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFG 173 (375)
T ss_pred hhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccch
Confidence 8899999999999999863 4568999999999999999999999431 239999999999999999999999999
Q ss_pred CccccccCcccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCc
Q 041576 567 LSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGK 646 (714)
Q Consensus 567 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~ 646 (714)
+++.+....... ...+||+.||+||.+.+..|+.|+||||+||++|||..-++||....-.+.. ..+..++
T Consensus 174 L~r~l~s~~tfA-~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~--------~KI~qgd 244 (375)
T KOG0591|consen 174 LGRFLSSKTTFA-HSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLC--------KKIEQGD 244 (375)
T ss_pred hHhHhcchhHHH-HhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHH--------HHHHcCC
Confidence 999886554333 3467999999999999999999999999999999999999999866322211 1112221
Q ss_pred cceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 041576 647 LDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEG 694 (714)
Q Consensus 647 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 694 (714)
. .......++..+..+|..|+..||+.||+...+++.+..
T Consensus 245 ~--------~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 245 Y--------PPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred C--------CCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 1 112235677788999999999999999997666666544
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=377.38 Aligned_cols=264 Identities=30% Similarity=0.471 Sum_probs=220.5
Q ss_pred HHHHHhhhhhhhhCcccceeEEEeEeeC----CCCcEEEEEEecccchh-hHHHHHHHHHHHhccCcccccceeceEecC
Q 041576 416 ELNEATNGFEEELGRGSFGIVYKGVLKS----ASGNAVAVKKLDKLAQE-REREFKTEVSAIGRTHHKNLVQLLGFCDEG 490 (714)
Q Consensus 416 el~~at~~~~~~ig~G~~g~Vy~~~~~~----~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 490 (714)
++......+.++||+|+||.||+|+... .....||||.+++.... ..++|++|++++..++|||||+++|+|.++
T Consensus 482 ~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~ 561 (774)
T KOG1026|consen 482 EIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREG 561 (774)
T ss_pred EechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccC
Confidence 4444455567899999999999998642 23457999999887666 778999999999999999999999999999
Q ss_pred CeeeEEEeecCCCchhhhhhcC--------------CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECC
Q 041576 491 LNRLLVYEFMGNGTLANLLFAI--------------PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQ 556 (714)
Q Consensus 491 ~~~~lv~E~~~~gsL~~~l~~~--------------~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~ 556 (714)
+..++|+|||..|+|.++|... ..++..+.+.||.|||.|+.||-++. +|||||..+|+||.+
T Consensus 562 ~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge 638 (774)
T KOG1026|consen 562 DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGE 638 (774)
T ss_pred CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceecc
Confidence 9999999999999999999742 12678889999999999999999997 999999999999999
Q ss_pred CCceEEecCCCccccccCccccee-eecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccchhhhhh
Q 041576 557 DFTAKISDFGLSKLLLSDQSRTRT-VIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEERSAIL 634 (714)
Q Consensus 557 ~~~~kl~Dfg~~~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~l 634 (714)
+..+||+|||+++.+-..+..... .-.-..+|||||.+..+++|.+||||||||+|||+++ |+.|+.....++-
T Consensus 639 ~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EV---- 714 (774)
T KOG1026|consen 639 NLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEV---- 714 (774)
T ss_pred ceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHH----
Confidence 999999999999976554433322 3335679999999999999999999999999999998 8888876655442
Q ss_pred hHHHhhhhhcCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCCC
Q 041576 635 TDWAYDCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLEVP 699 (714)
Q Consensus 635 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 699 (714)
.+.+..+++ ...+...+.++..|+..||+.+|.+||+++||..+|+...+..
T Consensus 715 ----Ie~i~~g~l---------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s 766 (774)
T KOG1026|consen 715 ----IECIRAGQL---------LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQAS 766 (774)
T ss_pred ----HHHHHcCCc---------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcC
Confidence 222333333 2245567778999999999999999999999999999876654
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=340.13 Aligned_cols=247 Identities=28% Similarity=0.332 Sum_probs=207.8
Q ss_pred hhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEeccc---chhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEE
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKL---AQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVY 497 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 497 (714)
...+.++||+|+||.||.++.+ .+++.+|+|++++. .....+...+|..+|.+++||.||+++..|++++..|+|+
T Consensus 26 dF~~lkviGkG~fGkV~~Vrk~-dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVl 104 (357)
T KOG0598|consen 26 DFEILKVIGKGSFGKVFQVRKK-DTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVL 104 (357)
T ss_pred heeeeeeeeccCCceEEEEEEc-ccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEE
Confidence 3456789999999999999877 68999999999763 2334667899999999999999999999999999999999
Q ss_pred eecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCccc
Q 041576 498 EFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSR 577 (714)
Q Consensus 498 E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 577 (714)
||+.||.|..+|++...+++..+.-++.+|+.||.|||+.+ ||||||||+|||+|++|+++|+|||+++........
T Consensus 105 d~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~~ 181 (357)
T KOG0598|consen 105 DYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGDA 181 (357)
T ss_pred eccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhcccCCCc
Confidence 99999999999999999999999999999999999999998 999999999999999999999999999865444333
Q ss_pred ceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhh
Q 041576 578 TRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAA 657 (714)
Q Consensus 578 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 657 (714)
. ..++||+.|||||++.+..++..+|-||+|+++|||++|.+||...+.....+.+ ..+++ .
T Consensus 182 t-~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I--------~~~k~---------~ 243 (357)
T KOG0598|consen 182 T-RTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKI--------LKGKL---------P 243 (357)
T ss_pred c-ccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHH--------hcCcC---------C
Confidence 3 3478999999999999999999999999999999999999999876544322221 11110 1
Q ss_pred ccchHHHHHHHHHHHHccccCCCCCC----CHHHHH
Q 041576 658 MADKSRACKWLMIALWCIQEDPLKRP----AMKMIV 689 (714)
Q Consensus 658 ~~~~~~~~~l~~li~~cl~~dP~~RP----s~~evl 689 (714)
..+.-...+..+++..+|+.||++|. .+.+|-
T Consensus 244 ~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik 279 (357)
T KOG0598|consen 244 LPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIK 279 (357)
T ss_pred CCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhh
Confidence 11222345677799999999999995 555553
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=351.11 Aligned_cols=249 Identities=27% Similarity=0.357 Sum_probs=210.3
Q ss_pred hhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEeccc---chhhHHHHHHHHHHHhcc-CcccccceeceEecCCeeeEE
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKL---AQEREREFKTEVSAIGRT-HHKNLVQLLGFCDEGLNRLLV 496 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv 496 (714)
.+.|.+.||+|+|++|++|+.. .+++.+|||++.+. .+...+-+..|-++|.+| .||.|++|+-.|.++..+|+|
T Consensus 74 DF~Fg~~lGeGSYStV~~A~~~-~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFv 152 (604)
T KOG0592|consen 74 DFKFGKILGEGSYSTVVLAREK-ATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFV 152 (604)
T ss_pred hcchhheeccccceeEEEeeec-CCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEE
Confidence 4668899999999999999977 58999999999762 233345677888999999 899999999999999999999
Q ss_pred EeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcc
Q 041576 497 YEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQS 576 (714)
Q Consensus 497 ~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 576 (714)
+||+++|+|.++|+..+.+++..+..++.||+.||+|||+.| ||||||||+|||||.|+++||+|||.|+.+.....
T Consensus 153 Le~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~ 229 (604)
T KOG0592|consen 153 LEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKILSPSQK 229 (604)
T ss_pred EEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccCChhhc
Confidence 999999999999999999999999999999999999999999 99999999999999999999999999998754321
Q ss_pred c----------c--eeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhc
Q 041576 577 R----------T--RTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVE 644 (714)
Q Consensus 577 ~----------~--~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~ 644 (714)
. . ...++||..|.+||++.....+..+|||+||||||+|+.|++||....+-.....+....+
T Consensus 230 ~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y----- 304 (604)
T KOG0592|consen 230 SQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDY----- 304 (604)
T ss_pred cccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcc-----
Confidence 1 1 2457899999999999999999999999999999999999999986543322222211110
Q ss_pred CccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 645 GKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 645 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
..+...++...+|+.+.|..||.+|+|.++|.+.
T Consensus 305 -------------~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 305 -------------EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred -------------cCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 1122223566779999999999999999999874
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=326.08 Aligned_cols=264 Identities=21% Similarity=0.273 Sum_probs=207.3
Q ss_pred hhhhhhhCcccceeEEEeEeeCCCCcEEEEEEeccc--chhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEee
Q 041576 422 NGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKL--AQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEF 499 (714)
Q Consensus 422 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~ 499 (714)
|+..-++|+|+||+||+++.+ .+|+.||||++-.. ++.-.+-.++|+++|++++|+|+|.++++|......+||+||
T Consensus 4 YE~LgkvGEGSYGvV~KCrnk-~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~ 82 (396)
T KOG0593|consen 4 YEKLGKVGEGSYGVVMKCRNK-DTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEY 82 (396)
T ss_pred HhhhhccccCcceEEEEeccC-CcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeee
Confidence 444567999999999999988 58999999999653 344456789999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcccce
Q 041576 500 MGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTR 579 (714)
Q Consensus 500 ~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 579 (714)
++.--|+++-+....++.+...+++.|+++|+.|+|+++ +|||||||+||||+.++.+||+|||+|+.+.. .....
T Consensus 83 ~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-pgd~Y 158 (396)
T KOG0593|consen 83 CDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSA-PGDNY 158 (396)
T ss_pred cchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcC-Ccchh
Confidence 998666666656567899999999999999999999998 99999999999999999999999999998864 23334
Q ss_pred eeecCCCCccCcccccC-CCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHH-------hhhhhc-Ccccee
Q 041576 580 TVIRGTRGYVAPEWFKN-VPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWA-------YDCYVE-GKLDVL 650 (714)
Q Consensus 580 ~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~-------~~~~~~-~~~~~~ 650 (714)
+..+.|..|+|||.+-+ .+|....||||+||++.||++|.+.|...++-++.-.+.... ...+.. .....+
T Consensus 159 TDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv 238 (396)
T KOG0593|consen 159 TDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGV 238 (396)
T ss_pred hhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeee
Confidence 45668999999999977 789999999999999999999999998766544322221111 111111 111111
Q ss_pred ecchhhhc-----cchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 651 VDNDKAAM-----ADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 651 ~~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
.-+....+ .-.....-+++++..||+.||.+|++-+|++.
T Consensus 239 ~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 239 RLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred ecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 11111111 11223346889999999999999999999874
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=342.47 Aligned_cols=267 Identities=24% Similarity=0.276 Sum_probs=213.7
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc--hhhHHHHHHHHHHHhccCcccccceeceEecC--CeeeE
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA--QEREREFKTEVSAIGRTHHKNLVQLLGFCDEG--LNRLL 495 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~l 495 (714)
..|+..++||+|.||.||+|+.. .+|+.||+|+++... +.......+||.+|++|+||||+++.+...+. ...||
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~-~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDL-ETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeec-ccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 34556689999999999999976 689999999997644 44456778999999999999999999999776 68999
Q ss_pred EEeecCCCchhhhhhcC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccC
Q 041576 496 VYEFMGNGTLANLLFAI-PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSD 574 (714)
Q Consensus 496 v~E~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 574 (714)
|+|||++ +|.-++... -++++.++..++.||+.||.|+|++| |+|||||.+|||||.+|.+||+|||+|+.....
T Consensus 196 VFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~ 271 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYTPS 271 (560)
T ss_pred EEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeeccCC
Confidence 9999998 888888764 47899999999999999999999999 999999999999999999999999999988777
Q ss_pred cccceeeecCCCCccCcccccCC-CCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHh----hhhhcCccc-
Q 041576 575 QSRTRTVIRGTRGYVAPEWFKNV-PVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAY----DCYVEGKLD- 648 (714)
Q Consensus 575 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~----~~~~~~~~~- 648 (714)
.....+..+-|..|.|||++.+. .|+.+.|+||.||||.||++|++.+....+-++...+....- ..|...++.
T Consensus 272 ~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~ 351 (560)
T KOG0600|consen 272 GSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPH 351 (560)
T ss_pred CCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCc
Confidence 77777777889999999999865 699999999999999999999999988766655444433211 111111111
Q ss_pred -eeecchhh-----hccchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 649 -VLVDNDKA-----AMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 649 -~~~~~~~~-----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
..+.+... ...-...+...++|+..+|..||.+|.|+.++++-
T Consensus 352 ~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 352 ATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred ccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 11111000 00112233467789999999999999999999864
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=365.05 Aligned_cols=270 Identities=26% Similarity=0.408 Sum_probs=226.3
Q ss_pred cccCHHHHHHHhhhh-----------hhhhCcccceeEEEeEeeCCC--CcEEEEEEeccc-chhhHHHHHHHHHHHhcc
Q 041576 410 RFFSLVELNEATNGF-----------EEELGRGSFGIVYKGVLKSAS--GNAVAVKKLDKL-AQEREREFKTEVSAIGRT 475 (714)
Q Consensus 410 ~~~~~~el~~at~~~-----------~~~ig~G~~g~Vy~~~~~~~~--~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l 475 (714)
+.++|++-.+|-.+| +++||.|.||.|++|+++... ...||||.++.. .+....+|+.|+.+|.++
T Consensus 608 DP~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQF 687 (996)
T KOG0196|consen 608 DPHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQF 687 (996)
T ss_pred CCccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccC
Confidence 456676655555544 467999999999999998543 247999999864 455667999999999999
Q ss_pred CcccccceeceEecCCeeeEEEeecCCCchhhhhhcC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEE
Q 041576 476 HHKNLVQLLGFCDEGLNRLLVYEFMGNGTLANLLFAI-PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILL 554 (714)
Q Consensus 476 ~h~nIv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll 554 (714)
+||||++|.|+....+..+||.|||++|+|+.+|+.+ ..+++.+...++.+||.|+.||-+.+ +|||||..+||||
T Consensus 688 dHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILV 764 (996)
T KOG0196|consen 688 DHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILV 764 (996)
T ss_pred CCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheee
Confidence 9999999999999999999999999999999999866 56899999999999999999999988 9999999999999
Q ss_pred CCCCceEEecCCCccccccCcccceeee--cCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccchhh
Q 041576 555 DQDFTAKISDFGLSKLLLSDQSRTRTVI--RGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEERS 631 (714)
Q Consensus 555 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~--~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~ 631 (714)
+.+..+|++|||+++.+.++.....+.. .-..+|.|||.+....+|.++|||||||++||.++ |.+|+-....++.
T Consensus 765 NsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdV- 843 (996)
T KOG0196|consen 765 NSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV- 843 (996)
T ss_pred ccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHH-
Confidence 9999999999999998866653333333 33578999999999999999999999999999886 8888764433321
Q ss_pred hhhhHHHhhhhhcCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCCC
Q 041576 632 AILTDWAYDCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLEVP 699 (714)
Q Consensus 632 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 699 (714)
...++...+...+.+.+..|.+|++.|||+|-.+||.+.+|+..|++++..|
T Consensus 844 ----------------IkaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP 895 (996)
T KOG0196|consen 844 ----------------IKAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNP 895 (996)
T ss_pred ----------------HHHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCc
Confidence 1122334445567788889999999999999999999999999999987554
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=338.89 Aligned_cols=253 Identities=30% Similarity=0.427 Sum_probs=203.9
Q ss_pred hhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCcccccceeceEecCC--eeeEEEe
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGL--NRLLVYE 498 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~--~~~lv~E 498 (714)
+....+.||+|+||+||++... .+|...|||.+........+.+++|+.+|.+++|||||+.+|...... ..++.||
T Consensus 18 ~~~~~~~lG~Gs~G~V~l~~~~-~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 18 NWSKGKLLGRGSFGSVYLATNK-KTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred hhhhhccccCccceEEEEEEec-CCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 3455688999999999999986 358999999997654334677999999999999999999999854444 6889999
Q ss_pred ecCCCchhhhhhcCC-CCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECC-CCceEEecCCCcccccc--C
Q 041576 499 FMGNGTLANLLFAIP-RPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQ-DFTAKISDFGLSKLLLS--D 574 (714)
Q Consensus 499 ~~~~gsL~~~l~~~~-~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~-~~~~kl~Dfg~~~~~~~--~ 574 (714)
|+++|+|.+++...+ .+++..+..++.||++||+|||++| |+||||||+|||++. ++.+||+|||+++.... .
T Consensus 97 y~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~ 173 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGT 173 (313)
T ss_pred ccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccccccccc
Confidence 999999999999776 7999999999999999999999998 999999999999999 79999999999987763 2
Q ss_pred cccceeeecCCCCccCcccccCC-CCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecc
Q 041576 575 QSRTRTVIRGTRGYVAPEWFKNV-PVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDN 653 (714)
Q Consensus 575 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 653 (714)
.........||+.|||||++..+ ....++|||||||++.||+||+.||....... .+......+....
T Consensus 174 ~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~------~~~~~ig~~~~~P----- 242 (313)
T KOG0198|consen 174 KSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEA------EALLLIGREDSLP----- 242 (313)
T ss_pred cccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchH------HHHHHHhccCCCC-----
Confidence 22334457899999999999863 33459999999999999999999997531000 1111111111111
Q ss_pred hhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 041576 654 DKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQML 692 (714)
Q Consensus 654 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 692 (714)
..+...+....+++.+|++.||++||||.++++..
T Consensus 243 ----~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hp 277 (313)
T KOG0198|consen 243 ----EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHP 277 (313)
T ss_pred ----CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence 22333556778899999999999999999999865
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=340.22 Aligned_cols=266 Identities=25% Similarity=0.302 Sum_probs=211.8
Q ss_pred HHHhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc-hhhHHHHHHHHHHHhccC-cccccceeceEecCC-eee
Q 041576 418 NEATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA-QEREREFKTEVSAIGRTH-HKNLVQLLGFCDEGL-NRL 494 (714)
Q Consensus 418 ~~at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~-~~~ 494 (714)
...+|...++||.|.||.||+|+-. .++..||||++++.- .-++-.-.+|+..|++++ ||||+++.+++.+.+ ..+
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~-~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSK-ETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeec-CCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 3457888999999999999999976 578899999997532 233334578999999998 999999999998888 999
Q ss_pred EEEeecCCCchhhhhhcC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCcccccc
Q 041576 495 LVYEFMGNGTLANLLFAI-PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLS 573 (714)
Q Consensus 495 lv~E~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~ 573 (714)
+|||||+. +|.++++++ +.+++..+..|+.||++||+|+|.+| +.|||+||+|||+..+..+||+|||+|+.+..
T Consensus 87 fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~S 162 (538)
T KOG0661|consen 87 FVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVRS 162 (538)
T ss_pred eeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEeccccccccccc
Confidence 99999976 999999876 45799999999999999999999999 99999999999999999999999999997744
Q ss_pred CcccceeeecCCCCccCcccc-cCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHH----hhhhhcC---
Q 041576 574 DQSRTRTVIRGTRGYVAPEWF-KNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWA----YDCYVEG--- 645 (714)
Q Consensus 574 ~~~~~~~~~~gt~~y~aPE~~-~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~----~~~~~~~--- 645 (714)
. ...+..+.|..|+|||++ +...|+.+.|+||+|||++|+.+-++.|.+..+-++.-.+-+.. .+.+.++
T Consensus 163 k--pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~L 240 (538)
T KOG0661|consen 163 K--PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNL 240 (538)
T ss_pred C--CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHH
Confidence 3 344556789999999977 56789999999999999999999999998765544322111110 1111111
Q ss_pred ------ccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 646 ------KLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 646 ------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
+.............+. ...+..+++.+|++.||.+||||+|.++.
T Consensus 241 a~~mnf~~P~~~~~~l~~L~p~-~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 241 ASAMNFRFPQVKPSPLKDLLPN-ASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHhccCCCcCCCCChHHhCcc-cCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 1112222222222333 66788999999999999999999999985
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=331.06 Aligned_cols=260 Identities=24% Similarity=0.348 Sum_probs=208.2
Q ss_pred HHhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEeccc-chhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEE
Q 041576 419 EATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKL-AQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVY 497 (714)
Q Consensus 419 ~at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 497 (714)
...|++.++||.|..++||+|+.. ..+..||||++.-. .....+.+++|+..+..++||||++++..|..+...|+||
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~-p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVm 103 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCI-PTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVM 103 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeec-ccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEee
Confidence 346788899999999999999987 45699999999642 2334689999999999999999999999999999999999
Q ss_pred eecCCCchhhhhhcC--CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCc
Q 041576 498 EFMGNGTLANLLFAI--PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQ 575 (714)
Q Consensus 498 E~~~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 575 (714)
.||.+|++.+++... ..+++..+..|++++++||.|||++| .||||||+.||||+++|.+||+|||....+....
T Consensus 104 pfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G 180 (516)
T KOG0582|consen 104 PFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG 180 (516)
T ss_pred hhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence 999999999999864 45889999999999999999999999 9999999999999999999999999887665443
Q ss_pred ccc--e-eeecCCCCccCcccccC--CCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCcccee
Q 041576 576 SRT--R-TVIRGTRGYVAPEWFKN--VPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVL 650 (714)
Q Consensus 576 ~~~--~-~~~~gt~~y~aPE~~~~--~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 650 (714)
.+. . ....|++.|||||++.. ..|+.|+||||||+...||.+|..||........ .+.. ..+.....
T Consensus 181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkv--Ll~t------Lqn~pp~~ 252 (516)
T KOG0582|consen 181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKV--LLLT------LQNDPPTL 252 (516)
T ss_pred ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHH--HHHH------hcCCCCCc
Confidence 222 1 45689999999999643 4699999999999999999999999985543321 1111 11111111
Q ss_pred ecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 651 VDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 651 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
.-..............+.+++..||++||.+|||++++++
T Consensus 253 ~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 253 LTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred ccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 1111111122333447888999999999999999999986
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=351.28 Aligned_cols=261 Identities=28% Similarity=0.395 Sum_probs=204.3
Q ss_pred HHHhhhhhhhhCcccceeEEEeEee----CCCCcEEEEEEecccc-hhhHHHHHHHHHHHhcc-CcccccceeceEecCC
Q 041576 418 NEATNGFEEELGRGSFGIVYKGVLK----SASGNAVAVKKLDKLA-QEREREFKTEVSAIGRT-HHKNLVQLLGFCDEGL 491 (714)
Q Consensus 418 ~~at~~~~~~ig~G~~g~Vy~~~~~----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~ 491 (714)
...++.+.+.||+|+||.||+|.+. ...++.||||+++... ....+.+.+|+.++.++ +||||+++++++...+
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 3456778899999999999999752 2345689999997533 33456789999999999 8999999999987644
Q ss_pred -eeeEEEeecCCCchhhhhhcC----------------------------------------------------------
Q 041576 492 -NRLLVYEFMGNGTLANLLFAI---------------------------------------------------------- 512 (714)
Q Consensus 492 -~~~lv~E~~~~gsL~~~l~~~---------------------------------------------------------- 512 (714)
..++||||+++|+|.+++...
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 578999999999999998642
Q ss_pred ----CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCccc-ceeeecCCCC
Q 041576 513 ----PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSR-TRTVIRGTRG 587 (714)
Q Consensus 513 ----~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~ 587 (714)
..+++..+..++.||++||+|||+++ |+||||||+||++++++.+||+|||+++........ ......++..
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~ 241 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence 23567788899999999999999998 999999999999999999999999999865433221 1222345678
Q ss_pred ccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhhccchHHHHH
Q 041576 588 YVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMADKSRACK 666 (714)
Q Consensus 588 y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 666 (714)
|+|||.+.+..++.++||||||++||||++ |..||........ + ......+.... .+...+..
T Consensus 242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~---~----~~~~~~~~~~~---------~~~~~~~~ 305 (338)
T cd05102 242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE---F----CQRLKDGTRMR---------APENATPE 305 (338)
T ss_pred ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH---H----HHHHhcCCCCC---------CCCCCCHH
Confidence 999999999999999999999999999997 9999975432211 1 01111111100 11223456
Q ss_pred HHHHHHHccccCCCCCCCHHHHHHHHhcccC
Q 041576 667 WLMIALWCIQEDPLKRPAMKMIVQMLEGYLE 697 (714)
Q Consensus 667 l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 697 (714)
+.+++.+||+.||++|||+.||++.|+++++
T Consensus 306 l~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 306 IYRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 7889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=344.54 Aligned_cols=247 Identities=26% Similarity=0.359 Sum_probs=211.0
Q ss_pred hhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEeecCCC
Q 041576 424 FEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEFMGNG 503 (714)
Q Consensus 424 ~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~g 503 (714)
--++||+|+.|.||.|... .+++.||||++........+-+.+|+.+|+..+|+|||++++.+..+++.|+|||||++|
T Consensus 277 ~~~kigqgaSG~vy~A~~~-~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~gg 355 (550)
T KOG0578|consen 277 DFKKIGQGATGGVYVARKI-STKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGG 355 (550)
T ss_pred chhhhccccccceeeeeec-cCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCC
Confidence 3468999999999999865 578899999998877777888999999999999999999999999999999999999999
Q ss_pred chhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcccceeeec
Q 041576 504 TLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIR 583 (714)
Q Consensus 504 sL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 583 (714)
+|.+.+.. ..+++.++..|+.++++||+|||.++ |+|||||.+|||++.+|.+||+|||++..+..... .....+
T Consensus 356 sLTDvVt~-~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-KR~TmV 430 (550)
T KOG0578|consen 356 SLTDVVTK-TRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-KRSTMV 430 (550)
T ss_pred chhhhhhc-ccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccC-cccccc
Confidence 99999876 45899999999999999999999999 99999999999999999999999999988766554 455677
Q ss_pred CCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhhccchHH
Q 041576 584 GTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMADKSR 663 (714)
Q Consensus 584 gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 663 (714)
||+.|||||+.....|..|.||||||++++||+-|.+||-.+..-.- + ..+...- ..........
T Consensus 431 GTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrA---l-----yLIa~ng-------~P~lk~~~kl 495 (550)
T KOG0578|consen 431 GTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA---L-----YLIATNG-------TPKLKNPEKL 495 (550)
T ss_pred CCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHH---H-----HHHhhcC-------CCCcCCcccc
Confidence 99999999999999999999999999999999999999975432211 1 0111111 1111223445
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 664 ACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 664 ~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
+..+.+++.+||+.|+++|+++.|+|+.
T Consensus 496 S~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 496 SPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred CHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 5678899999999999999999999874
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=345.87 Aligned_cols=249 Identities=25% Similarity=0.352 Sum_probs=207.8
Q ss_pred HHHhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEeccc----ch-hhHHHHHHHHHHHhccC-cccccceeceEecCC
Q 041576 418 NEATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKL----AQ-EREREFKTEVSAIGRTH-HKNLVQLLGFCDEGL 491 (714)
Q Consensus 418 ~~at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~ 491 (714)
....|.+.+.||+|+||+|+.|.+. .+++.||+|.+.+. .. ...+.+.+|+.++++++ ||||+++++++....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~-~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHR-LTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeec-cCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 3456778899999999999999876 46799999977553 11 23456778999999998 999999999999999
Q ss_pred eeeEEEeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCC-CceEEecCCCccc
Q 041576 492 NRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQD-FTAKISDFGLSKL 570 (714)
Q Consensus 492 ~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~-~~~kl~Dfg~~~~ 570 (714)
..++||||+.+|+|.+++....++.+.++.+++.||+.|++|+|++| |+||||||+|||++.+ +++||+|||++..
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~s~~ 170 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGLSAI 170 (370)
T ss_pred eEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEeccccccc
Confidence 99999999999999999999889999999999999999999999998 9999999999999999 9999999999987
Q ss_pred cccCcccceeeecCCCCccCcccccCCC-CC-chhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccc
Q 041576 571 LLSDQSRTRTVIRGTRGYVAPEWFKNVP-VS-AKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLD 648 (714)
Q Consensus 571 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s-~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 648 (714)
.. ..........|++.|+|||++.+.. |+ .++||||+||+||.|++|+.||+........ ..+..+...
T Consensus 171 ~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~--------~ki~~~~~~ 241 (370)
T KOG0583|consen 171 SP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLY--------RKIRKGEFK 241 (370)
T ss_pred cC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHH--------HHHhcCCcc
Confidence 74 2334455678999999999999877 75 7899999999999999999999863322211 111121111
Q ss_pred eeecchhhhccchHH-HHHHHHHHHHccccCCCCCCCHHHHH
Q 041576 649 VLVDNDKAAMADKSR-ACKWLMIALWCIQEDPLKRPAMKMIV 689 (714)
Q Consensus 649 ~~~~~~~~~~~~~~~-~~~l~~li~~cl~~dP~~RPs~~evl 689 (714)
.+... ..++..++.+||+.||.+|+++.||+
T Consensus 242 ----------~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 242 ----------IPSYLLSPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred ----------CCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 01111 55777899999999999999999999
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=342.20 Aligned_cols=238 Identities=34% Similarity=0.475 Sum_probs=203.8
Q ss_pred hhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEeecCCCch
Q 041576 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEFMGNGTL 505 (714)
Q Consensus 426 ~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~gsL 505 (714)
+=||+|+.|.||+|+++ ++.||||+++... +.+|+-|++|+||||+.+.|+|.....++||||||..|.|
T Consensus 130 eWlGSGaQGAVF~Grl~---netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL 199 (904)
T KOG4721|consen 130 EWLGSGAQGAVFLGRLH---NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQL 199 (904)
T ss_pred hhhccCcccceeeeecc---CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccH
Confidence 56999999999999987 7899999996543 3467789999999999999999999999999999999999
Q ss_pred hhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcccceeeecCC
Q 041576 506 ANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGT 585 (714)
Q Consensus 506 ~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt 585 (714)
...|+..+.+.......|..+||.|+.|||.+. |||||||.-||||..+..+||+|||.++..... .....+.||
T Consensus 200 ~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~--STkMSFaGT 274 (904)
T KOG4721|consen 200 YEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDK--STKMSFAGT 274 (904)
T ss_pred HHHHhccCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhh--hhhhhhhhh
Confidence 999999999999999999999999999999998 999999999999999999999999999876433 444567899
Q ss_pred CCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhhccchHHHH
Q 041576 586 RGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMADKSRAC 665 (714)
Q Consensus 586 ~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 665 (714)
..|||||++++.+.++|.|||||||||||||||..|+..-.... ++ -| +=...+....+...+.
T Consensus 275 VaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA---II---------wG----VGsNsL~LpvPstcP~ 338 (904)
T KOG4721|consen 275 VAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA---II---------WG----VGSNSLHLPVPSTCPD 338 (904)
T ss_pred HhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe---eE---------Ee----ccCCcccccCcccCch
Confidence 99999999999999999999999999999999999986432221 00 00 0011122234555667
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 041576 666 KWLMIALWCIQEDPLKRPAMKMIVQMLEG 694 (714)
Q Consensus 666 ~l~~li~~cl~~dP~~RPs~~evl~~L~~ 694 (714)
.+..|+++||+-.|..||++++|+..|+-
T Consensus 339 GfklL~Kqcw~sKpRNRPSFrqil~HldI 367 (904)
T KOG4721|consen 339 GFKLLLKQCWNSKPRNRPSFRQILLHLDI 367 (904)
T ss_pred HHHHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence 78889999999999999999999999863
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=307.88 Aligned_cols=263 Identities=24% Similarity=0.286 Sum_probs=207.3
Q ss_pred hhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccch--hhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEe
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQ--EREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYE 498 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E 498 (714)
+|...++||+|.||.||+|++. .+|+.||||+++.... .-.....+|++.|+.++|+||+.++++|.+.....||+|
T Consensus 3 rY~~~~~lGEG~~gvVyka~d~-~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 3 RYEKLEKLGEGTYGVVYKARDT-ETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred hhhhhhhhcCcceEEEEEEEec-CCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 5666789999999999999976 6899999999975322 224577899999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcCC-CCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCccc
Q 041576 499 FMGNGTLANLLFAIP-RPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSR 577 (714)
Q Consensus 499 ~~~~gsL~~~l~~~~-~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 577 (714)
||+. +|+..+++.. .+....+..++.++++||+|||++. |+||||||.|+||+++|.+||+|||+++.+......
T Consensus 82 fm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~ 157 (318)
T KOG0659|consen 82 FMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI 157 (318)
T ss_pred eccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCCcc
Confidence 9987 9999998764 5789999999999999999999998 999999999999999999999999999987654432
Q ss_pred ceeeecCCCCccCcccccCC-CCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHh----hhhhcCccceeec
Q 041576 578 TRTVIRGTRGYVAPEWFKNV-PVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAY----DCYVEGKLDVLVD 652 (714)
Q Consensus 578 ~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~----~~~~~~~~~~~~~ 652 (714)
. +..+-|..|.|||.+.+. .|+...|+||.|||+.||+-|.+-|.+.++-++...+...-- +.++ .+..+.|
T Consensus 158 ~-~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP--~~~~lpd 234 (318)
T KOG0659|consen 158 Q-THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWP--EMTSLPD 234 (318)
T ss_pred c-ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCc--ccccccc
Confidence 2 233678899999998765 589999999999999999999988876655443322211100 0000 0111111
Q ss_pred chh--------hhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 653 NDK--------AAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 653 ~~~--------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
... ....-.......++++..|+..||.+|+++.|++++
T Consensus 235 Y~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 235 YVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred HHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 100 000112234466899999999999999999999876
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=341.45 Aligned_cols=270 Identities=27% Similarity=0.426 Sum_probs=212.2
Q ss_pred HHHHHHHhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecc--cchhhHHHHHHHHHHHhccCcccccceeceEecCC
Q 041576 414 LVELNEATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDK--LAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGL 491 (714)
Q Consensus 414 ~~el~~at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 491 (714)
..|+......+.+.||+|.||+||+|.+. -.||||.+.. ...+..+.|++|+.++++-+|.||+-+.|+|..+.
T Consensus 386 ~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh----GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~ 461 (678)
T KOG0193|consen 386 EWEIPPEEVLLGERIGSGSFGTVYRGRWH----GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP 461 (678)
T ss_pred ccccCHHHhhccceeccccccceeecccc----cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc
Confidence 34555555566789999999999999997 2799999864 44557789999999999999999999999999988
Q ss_pred eeeEEEeecCCCchhhhhhcC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccc
Q 041576 492 NRLLVYEFMGNGTLANLLFAI-PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKL 570 (714)
Q Consensus 492 ~~~lv~E~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~ 570 (714)
. .||+.+|+|.+|..+|+.. .+++....+.|+.||++|+.|||.++ |||||||..||++.+++++||+|||++..
T Consensus 462 ~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLatv 537 (678)
T KOG0193|consen 462 L-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLATV 537 (678)
T ss_pred e-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccceee
Confidence 7 9999999999999999865 47889999999999999999999998 99999999999999999999999999975
Q ss_pred cccC-cccceeeecCCCCccCcccccC---CCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCc
Q 041576 571 LLSD-QSRTRTVIRGTRGYVAPEWFKN---VPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGK 646 (714)
Q Consensus 571 ~~~~-~~~~~~~~~gt~~y~aPE~~~~---~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~ 646 (714)
-..- .........|..-|||||+++. .+|+..+||||||+++|||+||..|+.....+. ++ +.-|+
T Consensus 538 k~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dq---Ii-------fmVGr 607 (678)
T KOG0193|consen 538 KTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQ---II-------FMVGR 607 (678)
T ss_pred eeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhh---eE-------EEecc
Confidence 4321 1222223347788999999964 468999999999999999999999998332221 11 11111
Q ss_pred cceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCCCCCCCCC
Q 041576 647 LDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLEVPSPPMPP 705 (714)
Q Consensus 647 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~pp~p~ 705 (714)
-....+. .........++.+|+..||..++++||.+.+|+..|+.++.. .|...+
T Consensus 608 G~l~pd~---s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~-~pki~R 662 (678)
T KOG0193|consen 608 GYLMPDL---SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS-LPKINR 662 (678)
T ss_pred cccCccc---hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc-cccccc
Confidence 0000110 011223445778899999999999999999999999887763 334333
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=336.88 Aligned_cols=264 Identities=25% Similarity=0.366 Sum_probs=217.8
Q ss_pred hhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc--hhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEe
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA--QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYE 498 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E 498 (714)
.|.+.+.||+|+||.||+|+.+ .+.+.||+|.+.+.. +.+.+.+.+|++++++++||||+.+++.|+...+.++|.|
T Consensus 3 ~yhv~e~iG~Gsfg~VYKgrrK-~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 3 QYHVYEMIGEGSFGRVYKGRRK-YTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred chhHHHHhcCCccceeeecccc-cceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 4667799999999999999976 678999999997643 3446789999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcccc
Q 041576 499 FMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRT 578 (714)
Q Consensus 499 ~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 578 (714)
|+.+ +|..+|.....++++.+..|+.+++.||.|||+.+ |+|||+||.|||++..+.+|++|||+|+.+.. ....
T Consensus 82 ~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~-~t~v 156 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMST-NTSV 156 (808)
T ss_pred hhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhccc-Ccee
Confidence 9988 99999999999999999999999999999999998 99999999999999999999999999997654 3334
Q ss_pred eeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhhc
Q 041576 579 RTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAM 658 (714)
Q Consensus 579 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 658 (714)
.+...||+-|||||...+.+|+..+|.||+|||+||+++|++||.......- .... .. ++ . .
T Consensus 157 ltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~L-------v~~I-~~-------d~-v--~ 218 (808)
T KOG0597|consen 157 LTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQL-------VKSI-LK-------DP-V--K 218 (808)
T ss_pred eeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHH-------HHHH-hc-------CC-C--C
Confidence 4567899999999999999999999999999999999999999975432211 1100 00 11 0 1
Q ss_pred cchHHHHHHHHHHHHccccCCCCCCCHHHHHHH--Hhc-ccCCCCCCCCCCcc
Q 041576 659 ADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM--LEG-YLEVPSPPMPPLHS 708 (714)
Q Consensus 659 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~-~~~~~~pp~p~~~~ 708 (714)
.+......+..++...|++||.+|.+-.+++.. .++ +.....|.++...+
T Consensus 219 ~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~~~~~~~~~~~a~~s 271 (808)
T KOG0597|consen 219 PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGKINIAELPAQVAFDS 271 (808)
T ss_pred CcccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhhhhhhcccccccccC
Confidence 122455678889999999999999999999863 333 23334444444443
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=332.19 Aligned_cols=259 Identities=25% Similarity=0.345 Sum_probs=207.3
Q ss_pred HHHHhhhhhhhhCcccceeEEEeEeeC--CCCcEEEEEEecccc-hhhHHHHHHHHHHHhccCcccccceeceEecCCee
Q 041576 417 LNEATNGFEEELGRGSFGIVYKGVLKS--ASGNAVAVKKLDKLA-QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNR 493 (714)
Q Consensus 417 l~~at~~~~~~ig~G~~g~Vy~~~~~~--~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 493 (714)
+....+.+.+.||+|+||.||+|.+.. ..+..||+|.++... ......+.+|+..+++++||||+++++++..++..
T Consensus 2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 81 (266)
T cd05064 2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTM 81 (266)
T ss_pred CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCc
Confidence 345667788999999999999998653 345689999997643 33456789999999999999999999999999999
Q ss_pred eEEEeecCCCchhhhhhcC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccc
Q 041576 494 LLVYEFMGNGTLANLLFAI-PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLL 572 (714)
Q Consensus 494 ~lv~E~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~ 572 (714)
++||||+++++|.+++... ..+++..++.++.||+.||+|||+++ ++||||||+||+++.++.+|++|||.+....
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~ 158 (266)
T cd05064 82 MIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDK 158 (266)
T ss_pred EEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCccccccc
Confidence 9999999999999999764 46899999999999999999999998 9999999999999999999999999876543
Q ss_pred cCcccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccchhhhhhhHHHhhhhhcCccceee
Q 041576 573 SDQSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEERSAILTDWAYDCYVEGKLDVLV 651 (714)
Q Consensus 573 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 651 (714)
...........++..|+|||.+.+..++.++||||||+++||+++ |+.||........ +. ...++..
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~---~~-----~~~~~~~---- 226 (266)
T cd05064 159 SEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDV---IK-----AVEDGFR---- 226 (266)
T ss_pred ccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHH---HH-----HHHCCCC----
Confidence 222111222335678999999999999999999999999999875 9999975433221 11 1111110
Q ss_pred cchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 041576 652 DNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGY 695 (714)
Q Consensus 652 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 695 (714)
...+...+..+.+++.+||+.+|++||++++|++.|+++
T Consensus 227 -----~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 227 -----LPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred -----CCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 011223345678899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=335.39 Aligned_cols=260 Identities=19% Similarity=0.271 Sum_probs=206.4
Q ss_pred CccccCHHHHHHHhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhh---HHHHHHHHHHHhccCccccccee
Q 041576 408 NLRFFSLVELNEATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQER---EREFKTEVSAIGRTHHKNLVQLL 484 (714)
Q Consensus 408 ~~~~~~~~el~~at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~nIv~l~ 484 (714)
.++.+++.+++..+. ..|++|+++.||+|.+ +|+.||||.++...... .+.+.+|+.++.+++||||++++
T Consensus 11 ~~~~i~~~~i~~~~~---~~i~~g~~~~v~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~ 84 (283)
T PHA02988 11 DIKCIESDDIDKYTS---VLIKENDQNSIYKGIF---NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIY 84 (283)
T ss_pred cceecCHHHcCCCCC---eEEeeCCceEEEEEEE---CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEe
Confidence 345555666532211 4699999999999987 48899999997643322 46788999999999999999999
Q ss_pred ceEec----CCeeeEEEeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhc-CCCCeEecCCCcCeEEECCCCc
Q 041576 485 GFCDE----GLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEE-CNVPIIHCDIKPQNILLDQDFT 559 (714)
Q Consensus 485 ~~~~~----~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~-~~~~ivH~Dlk~~NIll~~~~~ 559 (714)
+++.+ ....++||||+++|+|.+++...+.+++...++++.|++.||+|||+. + ++||||||+||++++++.
T Consensus 85 g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~ 161 (283)
T PHA02988 85 GFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYK 161 (283)
T ss_pred eeEEecccCCCceEEEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCc
Confidence 99876 346789999999999999999888899999999999999999999985 5 789999999999999999
Q ss_pred eEEecCCCccccccCcccceeeecCCCCccCcccccC--CCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHH
Q 041576 560 AKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKN--VPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDW 637 (714)
Q Consensus 560 ~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~ 637 (714)
+||+|||+++...... ....++..|+|||++.+ ..++.++|||||||++|||++|+.||......+...
T Consensus 162 ~kl~dfg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~----- 232 (283)
T PHA02988 162 LKIICHGLEKILSSPP----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYD----- 232 (283)
T ss_pred EEEcccchHhhhcccc----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHH-----
Confidence 9999999988653321 22357889999999976 679999999999999999999999997543222111
Q ss_pred HhhhhhcCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 041576 638 AYDCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYL 696 (714)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 696 (714)
........ ...+...+..+.+++.+||+.||++|||++||++.|+.+.
T Consensus 233 ---~i~~~~~~--------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 233 ---LIINKNNS--------LKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred ---HHHhcCCC--------CCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 11000000 0111234557888999999999999999999999998753
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=334.33 Aligned_cols=248 Identities=27% Similarity=0.374 Sum_probs=214.0
Q ss_pred hhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEeccc-chhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEee
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKL-AQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEF 499 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~ 499 (714)
.|.-.+.||+|+||.||+|... .+++.||+|++.-. ......++++|+.+|.+++|+||.++++.+..+...+++|||
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~-~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDN-KTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred ccccchhccccccceeeeeeec-cccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 3444588999999999999976 67899999999753 345567899999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcccce
Q 041576 500 MGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTR 579 (714)
Q Consensus 500 ~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 579 (714)
+.+|++.+.+.....+++..+.-|+.+++.||.|||.++ .+|||||+.|||+..+|.+||+|||.+..+.......
T Consensus 93 ~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr- 168 (467)
T KOG0201|consen 93 CGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR- 168 (467)
T ss_pred hcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhhcc-
Confidence 999999999998888899999999999999999999998 9999999999999999999999999999887666555
Q ss_pred eeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhhcc
Q 041576 580 TVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMA 659 (714)
Q Consensus 580 ~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 659 (714)
..++||+.|||||++....|+.|+||||||++.+||.+|.+|+....+.. ...++........
T Consensus 169 ~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmr-----------------vlflIpk~~PP~L 231 (467)
T KOG0201|consen 169 KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMR-----------------VLFLIPKSAPPRL 231 (467)
T ss_pred ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcce-----------------EEEeccCCCCCcc
Confidence 66789999999999998899999999999999999999999987543321 1222222233333
Q ss_pred chHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 660 DKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 660 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
+......+.+++..||++||+.||+|.++++
T Consensus 232 ~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 232 DGDFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred ccccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 3456667889999999999999999999986
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=306.00 Aligned_cols=262 Identities=23% Similarity=0.279 Sum_probs=214.1
Q ss_pred HHHhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCcccccceeceEecCC-----e
Q 041576 418 NEATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGL-----N 492 (714)
Q Consensus 418 ~~at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-----~ 492 (714)
...+|.+.+.+|+|+|+-||++..- .++..+|+|++.....++.+..++|++..++++|||+++++++...+. .
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~-s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~ 97 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGL-STGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE 97 (302)
T ss_pred cCceEEEeeeecCCCceeeeeeccc-CcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence 3457888999999999999998844 468899999998887788889999999999999999999999985443 4
Q ss_pred eeEEEeecCCCchhhhhhcC----CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCc
Q 041576 493 RLLVYEFMGNGTLANLLFAI----PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLS 568 (714)
Q Consensus 493 ~~lv~E~~~~gsL~~~l~~~----~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~ 568 (714)
.|++++|+..|+|.+.+... ..+++.+.+.|+.+|.+||++||+.. ++++||||||.|||+.+.+.++|.|||.+
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~ 176 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSA 176 (302)
T ss_pred EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCc
Confidence 89999999999999998743 35799999999999999999999986 68999999999999999999999999999
Q ss_pred cccccCcc--------cceeeecCCCCccCccccc---CCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHH
Q 041576 569 KLLLSDQS--------RTRTVIRGTRGYVAPEWFK---NVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDW 637 (714)
Q Consensus 569 ~~~~~~~~--------~~~~~~~gt~~y~aPE~~~---~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~ 637 (714)
........ ........|..|+|||.+. +..+++++|||||||+||+|+.|..||+.......
T Consensus 177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~Gg------- 249 (302)
T KOG2345|consen 177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGG------- 249 (302)
T ss_pred cccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCC-------
Confidence 86532211 1122345789999999984 55689999999999999999999999985533211
Q ss_pred HhhhhhcCccce-eecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 041576 638 AYDCYVEGKLDV-LVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYL 696 (714)
Q Consensus 638 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 696 (714)
.+.. +.............++.+.+++.+||+.||.+||++.+++..++.++
T Consensus 250 --------SlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 250 --------SLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred --------eEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 1111 11112222223347778999999999999999999999999998764
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=332.54 Aligned_cols=268 Identities=22% Similarity=0.279 Sum_probs=217.9
Q ss_pred hhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEe
Q 041576 422 NGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA---QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYE 498 (714)
Q Consensus 422 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E 498 (714)
+.+.++||+|+||.||+|+-+ .+|..+|+|++++.. ..+.+.++.|-.+|...++|.||+++..|.+.+.+|||||
T Consensus 143 Fe~Lk~IgkGAfGeVrLarKk-~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiME 221 (550)
T KOG0605|consen 143 FELLKVIGKGAFGEVRLARKK-DTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIME 221 (550)
T ss_pred chhheeeccccceeEEEEEEc-cCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEE
Confidence 344578999999999999866 689999999998743 4455678899999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccC----
Q 041576 499 FMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSD---- 574 (714)
Q Consensus 499 ~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~---- 574 (714)
|++||++..+|.....+++..+...+.+++-|+..||+.| +|||||||+|+|||..|++||+|||++.-+...
T Consensus 222 ylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~ 298 (550)
T KOG0605|consen 222 YLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIE 298 (550)
T ss_pred ecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhhhhhhhh
Confidence 9999999999999999999999999999999999999999 999999999999999999999999998543210
Q ss_pred -----------------cccc-------------------------eeeecCCCCccCcccccCCCCCchhhhHHHHHHH
Q 041576 575 -----------------QSRT-------------------------RTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVL 612 (714)
Q Consensus 575 -----------------~~~~-------------------------~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil 612 (714)
.... ....+||+.|+|||++.+..|+..+|.||||||+
T Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~Im 378 (550)
T KOG0605|consen 299 SYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIM 378 (550)
T ss_pred hhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHHH
Confidence 0000 0113599999999999999999999999999999
Q ss_pred HHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCC---CHHHHH
Q 041576 613 LKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRP---AMKMIV 689 (714)
Q Consensus 613 ~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP---s~~evl 689 (714)
||||.|.+||..+...+....+..|....... .......+..+||.+||. ||++|. .++||.
T Consensus 379 yEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP--------------~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK 443 (550)
T KOG0605|consen 379 YEMLVGYPPFCSETPQETYRKIVNWRETLKFP--------------EEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIK 443 (550)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHHHhhhccCC--------------CcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHh
Confidence 99999999999988877766666664322111 112222567789999998 999996 577776
Q ss_pred HH-------HhcccCCCCCCCCCCcc
Q 041576 690 QM-------LEGYLEVPSPPMPPLHS 708 (714)
Q Consensus 690 ~~-------L~~~~~~~~pp~p~~~~ 708 (714)
+. .+.+.+.+.|=.|...+
T Consensus 444 ~HPfF~~v~W~~l~~~~apfvP~v~~ 469 (550)
T KOG0605|consen 444 KHPFFKGVDWDHLREMPAPFVPQVNS 469 (550)
T ss_pred cCCccccCCcchhhcCCCCCCCCCCC
Confidence 53 24455555444444443
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=347.05 Aligned_cols=263 Identities=29% Similarity=0.364 Sum_probs=213.0
Q ss_pred HHhhhhhhhhCcccceeEEEeEeeCCCC---cEEEEEEecc---cchhhHHHHHHHHHHHhccCcccccceeceEecCCe
Q 041576 419 EATNGFEEELGRGSFGIVYKGVLKSASG---NAVAVKKLDK---LAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLN 492 (714)
Q Consensus 419 ~at~~~~~~ig~G~~g~Vy~~~~~~~~~---~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 492 (714)
...-.+.++||+|+||.||+|.++..++ ..||||..+. .......+|++|++++++++|||||+++|++.....
T Consensus 156 H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~P 235 (474)
T KOG0194|consen 156 HSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEP 235 (474)
T ss_pred ccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCc
Confidence 3334455899999999999999986544 2389999874 456778899999999999999999999999999999
Q ss_pred eeEEEeecCCCchhhhhhcCC-CCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCcccc
Q 041576 493 RLLVYEFMGNGTLANLLFAIP-RPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLL 571 (714)
Q Consensus 493 ~~lv~E~~~~gsL~~~l~~~~-~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~ 571 (714)
.++|||+|.||+|.++|...+ .++..++++++.+.|.||+|||+++ ++||||..+|+|++.++.+||+|||+++..
T Consensus 236 l~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs~~~ 312 (474)
T KOG0194|consen 236 LMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLSRAG 312 (474)
T ss_pred cEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCccccccCC
Confidence 999999999999999999876 4999999999999999999999998 999999999999999999999999998754
Q ss_pred ccCcccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccchhhhhhhHHHhhhhhcCcccee
Q 041576 572 LSDQSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEERSAILTDWAYDCYVEGKLDVL 650 (714)
Q Consensus 572 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 650 (714)
.... .......-..+|+|||.+....++.++|||||||++||+++ |..|+......+....+. ..
T Consensus 313 ~~~~-~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~-------~~------ 378 (474)
T KOG0194|consen 313 SQYV-MKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIV-------KN------ 378 (474)
T ss_pred ccee-eccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHH-------hc------
Confidence 3111 11111235678999999999999999999999999999999 788887554332111110 11
Q ss_pred ecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCCCCC
Q 041576 651 VDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLEVPSP 701 (714)
Q Consensus 651 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~p 701 (714)
......+...+..+..++.+|++.+|++||+|.++.+.|+.+.....+
T Consensus 379 ---~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 379 ---GYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred ---CccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 111112224455677788899999999999999999999887766544
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=337.86 Aligned_cols=266 Identities=25% Similarity=0.368 Sum_probs=206.5
Q ss_pred HHhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEeccc-chhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEE
Q 041576 419 EATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKL-AQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVY 497 (714)
Q Consensus 419 ~at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 497 (714)
...|.+.+.||+|+||.||+++.. .++..+|+|.++.. .......+.+|++++++++||||+++++++..++..++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHK-PSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEEC-CCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEe
Confidence 345667789999999999999876 57889999998753 2334567999999999999999999999999999999999
Q ss_pred eecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCccc
Q 041576 498 EFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSR 577 (714)
Q Consensus 498 E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 577 (714)
||+++++|.+++.....+++..+..++.|++.||+|||+.+ .|+||||||+||+++.++.+||+|||++.......
T Consensus 83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 158 (331)
T cd06649 83 EHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-- 158 (331)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccccccc--
Confidence 99999999999988788899999999999999999999853 39999999999999999999999999987653321
Q ss_pred ceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCc-----------
Q 041576 578 TRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGK----------- 646 (714)
Q Consensus 578 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~----------- 646 (714)
.....|+..|+|||.+.+..++.++|||||||++|||++|+.||......+....+..-.... ..+.
T Consensus 159 -~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 236 (331)
T cd06649 159 -ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDG-EEGEPHSISPRPRPP 236 (331)
T ss_pred -cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccccccc-ccCCccccCcccccc
Confidence 223458999999999999999999999999999999999999996543222111110000000 0000
Q ss_pred --------------------cceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 647 --------------------LDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 647 --------------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
...+................+.+++.+||+.||++|||++||++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h 301 (331)
T cd06649 237 GRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH 301 (331)
T ss_pred cccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000000000000111245578899999999999999999999875
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=344.75 Aligned_cols=261 Identities=29% Similarity=0.413 Sum_probs=204.4
Q ss_pred HHHHHhhhhhhhhCcccceeEEEeEe----eCCCCcEEEEEEecccc-hhhHHHHHHHHHHHhcc-CcccccceeceEec
Q 041576 416 ELNEATNGFEEELGRGSFGIVYKGVL----KSASGNAVAVKKLDKLA-QEREREFKTEVSAIGRT-HHKNLVQLLGFCDE 489 (714)
Q Consensus 416 el~~at~~~~~~ig~G~~g~Vy~~~~----~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~ 489 (714)
++....+.+.+.||+|+||.||+|.. +..++..||||+++... ....+.+.+|++++..+ +||||+++++++.+
T Consensus 31 ~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~ 110 (375)
T cd05104 31 EFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTV 110 (375)
T ss_pred ccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeecc
Confidence 33455678889999999999999974 23356689999996532 33456788999999999 89999999999999
Q ss_pred CCeeeEEEeecCCCchhhhhhcCC--------------------------------------------------------
Q 041576 490 GLNRLLVYEFMGNGTLANLLFAIP-------------------------------------------------------- 513 (714)
Q Consensus 490 ~~~~~lv~E~~~~gsL~~~l~~~~-------------------------------------------------------- 513 (714)
+...++||||+++|+|.+++....
T Consensus 111 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (375)
T cd05104 111 GGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVR 190 (375)
T ss_pred CCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccc
Confidence 999999999999999999986421
Q ss_pred -------------------CCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccC
Q 041576 514 -------------------RPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSD 574 (714)
Q Consensus 514 -------------------~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 574 (714)
.+++..+++++.||++||+|||+.+ |+||||||+||++++++.+||+|||++......
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 267 (375)
T cd05104 191 SGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRND 267 (375)
T ss_pred cceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCc
Confidence 3577788999999999999999998 999999999999999999999999999866433
Q ss_pred cccc-eeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccchhhhhhhHHHhhhhhcCccceeec
Q 041576 575 QSRT-RTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVD 652 (714)
Q Consensus 575 ~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 652 (714)
.... .....++..|+|||.+.+..++.++||||||+++|||++ |..||........ +.. ....+...
T Consensus 268 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~---~~~----~~~~~~~~---- 336 (375)
T cd05104 268 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSK---FYK----MIKEGYRM---- 336 (375)
T ss_pred ccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHH---HHH----HHHhCccC----
Confidence 2211 112334567999999999999999999999999999998 8888864322211 111 11111000
Q ss_pred chhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 041576 653 NDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGY 695 (714)
Q Consensus 653 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 695 (714)
..+...+.++.+++.+||+.||++||++.||++.|++.
T Consensus 337 -----~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 337 -----LSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred -----CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 00111234678899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=367.06 Aligned_cols=260 Identities=27% Similarity=0.442 Sum_probs=214.2
Q ss_pred HHHHhhhhhhhhCcccceeEEEeEeeCCCCc----EEEEEEeccc-chhhHHHHHHHHHHHhccCcccccceeceEecCC
Q 041576 417 LNEATNGFEEELGRGSFGIVYKGVLKSASGN----AVAVKKLDKL-AQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGL 491 (714)
Q Consensus 417 l~~at~~~~~~ig~G~~g~Vy~~~~~~~~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 491 (714)
+....-.+.+.||+|+||.||.|...+.++. .||||.+++. +.+...+|.+|..+|+.++|||||+++|+|.+..
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~ 768 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG 768 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCC
Confidence 4445555667899999999999999877665 4899999775 4556779999999999999999999999999999
Q ss_pred eeeEEEeecCCCchhhhhhcC-------CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEec
Q 041576 492 NRLLVYEFMGNGTLANLLFAI-------PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISD 564 (714)
Q Consensus 492 ~~~lv~E~~~~gsL~~~l~~~-------~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D 564 (714)
..+|++|||++|+|..+|++. ..+.....+.++.|||+|+.|||+++ +|||||..+|+||+....+||+|
T Consensus 769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaD 845 (1025)
T KOG1095|consen 769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIAD 845 (1025)
T ss_pred CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcc
Confidence 999999999999999999865 35788999999999999999999998 99999999999999999999999
Q ss_pred CCCccccccCcccceeee-cCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccchhhhhhhHHHhhhh
Q 041576 565 FGLSKLLLSDQSRTRTVI-RGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEERSAILTDWAYDCY 642 (714)
Q Consensus 565 fg~~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~ 642 (714)
||+|+.+...+....... .-..+|||||.+..+.++.|+|||||||+|||++| |..||......+ .+.. ..
T Consensus 846 FGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~---v~~~----~~ 918 (1025)
T KOG1095|consen 846 FGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFE---VLLD----VL 918 (1025)
T ss_pred cchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHH---HHHH----HH
Confidence 999996544443332222 34578999999999999999999999999999998 677776443322 1111 11
Q ss_pred hcCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 041576 643 VEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYL 696 (714)
Q Consensus 643 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 696 (714)
..++ ...+..++..+.+++..||+.+|++||++..|++.+..+.
T Consensus 919 ~ggR----------L~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~ 962 (1025)
T KOG1095|consen 919 EGGR----------LDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAIS 962 (1025)
T ss_pred hCCc----------cCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhh
Confidence 1221 2235556778889999999999999999999999887655
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=330.80 Aligned_cols=266 Identities=20% Similarity=0.218 Sum_probs=204.5
Q ss_pred hhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc--hhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEe
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA--QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYE 498 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E 498 (714)
.|.+.+.||+|+||.||+|+.+ .+++.||+|+++... ....+.+.+|++++++++||||+++++++..++..++|||
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 2 KFEVLGVVGEGAYGVVLKCRHK-ETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CceEEEEecccCCEEEEEEEEC-CCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 3667789999999999999976 568899999986532 2334678899999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcccc
Q 041576 499 FMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRT 578 (714)
Q Consensus 499 ~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 578 (714)
|++++.+..+......+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++..........
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 157 (287)
T cd07848 81 YVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNAN 157 (287)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCccccccccccc
Confidence 9999888776655567899999999999999999999998 9999999999999999999999999998764433333
Q ss_pred eeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHH-------hhh-hhcCcccee
Q 041576 579 RTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWA-------YDC-YVEGKLDVL 650 (714)
Q Consensus 579 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~-------~~~-~~~~~~~~~ 650 (714)
.....++..|+|||++.+..++.++|||||||++|||++|+.||......+....+.... ... .........
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07848 158 YTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGL 237 (287)
T ss_pred ccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhccc
Confidence 334568999999999998889999999999999999999999997643322111111000 000 000000000
Q ss_pred ecchh------hhccchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 651 VDNDK------AAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 651 ~~~~~------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
..+.. ........+..+.+++.+||+.||++|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 238 RFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred ccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00000 00011123456889999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-39 Score=320.16 Aligned_cols=250 Identities=22% Similarity=0.348 Sum_probs=211.7
Q ss_pred HHHhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHHhccCcccccceeceEecCCeee
Q 041576 418 NEATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA---QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRL 494 (714)
Q Consensus 418 ~~at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 494 (714)
.+.+|+|.+.||+|.||.|-+|..+ ..|+.||||.+++.. +.+...+++|+++|..|+||||+.++++|++.+...
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~e~-~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIv 129 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAYEH-KSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIV 129 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehhhc-cCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEE
Confidence 4568899999999999999999865 579999999997643 444557899999999999999999999999999999
Q ss_pred EEEeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccC
Q 041576 495 LVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSD 574 (714)
Q Consensus 495 lv~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 574 (714)
|||||..+|.|.+++...+.+++.++..++.||..|+.|+|.++ ++|||||.+|||+|+++++||+|||++.+...
T Consensus 130 ivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~- 205 (668)
T KOG0611|consen 130 IVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYAD- 205 (668)
T ss_pred EEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhcc-
Confidence 99999999999999999999999999999999999999999998 99999999999999999999999999987643
Q ss_pred cccceeeecCCCCccCcccccCCCC-CchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecc
Q 041576 575 QSRTRTVIRGTRGYVAPEWFKNVPV-SAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDN 653 (714)
Q Consensus 575 ~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 653 (714)
.....+++|++-|.+||++.+.+| .+..|-|||||+||.|+.|..||+..+-...... +..|...
T Consensus 206 -~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQ--------Is~GaYr----- 271 (668)
T KOG0611|consen 206 -KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQ--------ISRGAYR----- 271 (668)
T ss_pred -ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHH--------hhccccc-----
Confidence 334456789999999999999998 5789999999999999999999986543321111 1111111
Q ss_pred hhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 041576 654 DKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQML 692 (714)
Q Consensus 654 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 692 (714)
..+.+....-||+|||..+|++|-|+.+|....
T Consensus 272 ------EP~~PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 272 ------EPETPSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred ------CCCCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 111222344599999999999999999998754
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=331.99 Aligned_cols=245 Identities=22% Similarity=0.234 Sum_probs=202.8
Q ss_pred hhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEE
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA---QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVY 497 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 497 (714)
.|.+.+.||+|+||.||+|... .+++.||+|.+.... ....+.+.+|++++++++||||+++++++.++...++||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 2 DLERIKTVGTGTFGRVHLVRDR-ISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CceeeeeeecCCCeEEEEEEEc-CCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 3566789999999999999876 468899999986432 233457889999999999999999999999999999999
Q ss_pred eecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCccc
Q 041576 498 EFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSR 577 (714)
Q Consensus 498 E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 577 (714)
||+++++|.+++.....+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~--- 154 (291)
T cd05612 81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR--- 154 (291)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCC---
Confidence 99999999999988888999999999999999999999998 999999999999999999999999999865332
Q ss_pred ceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhh
Q 041576 578 TRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAA 657 (714)
Q Consensus 578 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 657 (714)
.....|++.|+|||.+.+..++.++|||||||++|||++|+.||.......... ....+...
T Consensus 155 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~--------~i~~~~~~--------- 216 (291)
T cd05612 155 -TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYE--------KILAGKLE--------- 216 (291)
T ss_pred -cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH--------HHHhCCcC---------
Confidence 123458999999999999899999999999999999999999997543322111 11111110
Q ss_pred ccchHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 041576 658 MADKSRACKWLMIALWCIQEDPLKRPA-----MKMIVQM 691 (714)
Q Consensus 658 ~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~ 691 (714)
.+......+.+++.+||+.||.+||+ ++|+++.
T Consensus 217 -~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 217 -FPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred -CCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 11122446778999999999999995 8888764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=328.33 Aligned_cols=249 Identities=33% Similarity=0.503 Sum_probs=194.6
Q ss_pred hhhhhCcccceeEEEeEee---CCCCcEEEEEEeccc-chhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEee
Q 041576 424 FEEELGRGSFGIVYKGVLK---SASGNAVAVKKLDKL-AQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEF 499 (714)
Q Consensus 424 ~~~~ig~G~~g~Vy~~~~~---~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~ 499 (714)
+.+.||.|+||.||+|.+. ...+..|+||.++.. .....+.+.+|++.+++++||||++++|++...+..++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 4578999999999999987 234568999999653 334478999999999999999999999999988889999999
Q ss_pred cCCCchhhhhhcC--CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcc-
Q 041576 500 MGNGTLANLLFAI--PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQS- 576 (714)
Q Consensus 500 ~~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~- 576 (714)
+++|+|.++|... ..+++..+..|+.||++||+|||+++ ++|+||+++||++++++.+||+|||++........
T Consensus 83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred ccccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccc
Confidence 9999999999986 67899999999999999999999998 99999999999999999999999999987632221
Q ss_pred cceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccchhhhhhhHHHhhhhhcCccceeecchh
Q 041576 577 RTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDK 655 (714)
Q Consensus 577 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 655 (714)
...........|+|||.+....++.++||||||+++|||++ |+.|+......+. . ....++...
T Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~---~-----~~~~~~~~~------- 224 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEI---I-----EKLKQGQRL------- 224 (259)
T ss_dssp EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHH---H-----HHHHTTEET-------
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccc---c-----ccccccccc-------
Confidence 12222346778999999998889999999999999999999 6788764432221 1 111111111
Q ss_pred hhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 041576 656 AAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQML 692 (714)
Q Consensus 656 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 692 (714)
..+...+..+.+++.+||+.||++||++++|++.|
T Consensus 225 --~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 225 --PIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp --TSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred --eeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 11222345677899999999999999999999986
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=306.51 Aligned_cols=235 Identities=29% Similarity=0.321 Sum_probs=202.6
Q ss_pred hhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccch---hhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEe
Q 041576 422 NGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQ---EREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYE 498 (714)
Q Consensus 422 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E 498 (714)
+++.+.||.|+||.|.+++.+ .+|..+|+|++++..- .+.+...+|.++|+.+.||.++++.+.+.+....+||||
T Consensus 46 fe~~~tlGtGSFGrV~LVr~k-~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvme 124 (355)
T KOG0616|consen 46 FERLKTLGTGSFGRVHLVREK-HSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVME 124 (355)
T ss_pred hhheeeeccCccceEEEEEEc-cCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEe
Confidence 345688999999999999987 5689999999987443 334567899999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcccc
Q 041576 499 FMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRT 578 (714)
Q Consensus 499 ~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 578 (714)
|++||-|..+++..+++++..++-++.||+.||+|||+.+ |++|||||+|||+|.+|.+||+|||.|+.+.. .
T Consensus 125 yv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~----r 197 (355)
T KOG0616|consen 125 YVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSG----R 197 (355)
T ss_pred ccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecC----c
Confidence 9999999999999999999999999999999999999998 99999999999999999999999999997633 2
Q ss_pred eeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhhc
Q 041576 579 RTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAM 658 (714)
Q Consensus 579 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 658 (714)
..+.+||+.|+|||+++...+..++|-|||||++|||+.|.+||........ ++.+.++++.
T Consensus 198 T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~i--------Y~KI~~~~v~---------- 259 (355)
T KOG0616|consen 198 TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQI--------YEKILEGKVK---------- 259 (355)
T ss_pred EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHH--------HHHHHhCccc----------
Confidence 4567899999999999999999999999999999999999999987655332 2333333322
Q ss_pred cchHHHHHHHHHHHHccccCCCCC
Q 041576 659 ADKSRACKWLMIALWCIQEDPLKR 682 (714)
Q Consensus 659 ~~~~~~~~l~~li~~cl~~dP~~R 682 (714)
.+......+.+|+...|+.|-.+|
T Consensus 260 fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 260 FPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred CCcccCHHHHHHHHHHHhhhhHhh
Confidence 122334466778999999999999
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=336.11 Aligned_cols=242 Identities=26% Similarity=0.287 Sum_probs=199.6
Q ss_pred hhhCcccceeEEEeEeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEeecCC
Q 041576 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA---QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEFMGN 502 (714)
Q Consensus 426 ~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~ 502 (714)
+.||+|+||.||++..+ .+++.||+|+++... ......+.+|++++++++||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~ 79 (323)
T cd05571 1 KLLGKGTFGKVILVREK-ATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANG 79 (323)
T ss_pred CeeeeCCCeEEEEEEEC-CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCC
Confidence 46899999999999876 578999999997532 23445678999999999999999999999999999999999999
Q ss_pred CchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcccceeee
Q 041576 503 GTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVI 582 (714)
Q Consensus 503 gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 582 (714)
++|.+++.....+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++...... ......
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~-~~~~~~ 155 (323)
T cd05571 80 GELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKTF 155 (323)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC-Ccccce
Confidence 999999988888999999999999999999999998 9999999999999999999999999987532221 222345
Q ss_pred cCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhhccchH
Q 041576 583 RGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMADKS 662 (714)
Q Consensus 583 ~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 662 (714)
.|++.|+|||.+.+..++.++|||||||++|||++|+.||........... ...+.. ..+..
T Consensus 156 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~--------~~~~~~----------~~p~~ 217 (323)
T cd05571 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL--------ILMEEI----------RFPRT 217 (323)
T ss_pred ecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHH--------HHcCCC----------CCCCC
Confidence 689999999999999999999999999999999999999975432221110 111110 01122
Q ss_pred HHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 041576 663 RACKWLMIALWCIQEDPLKRP-----AMKMIVQ 690 (714)
Q Consensus 663 ~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 690 (714)
....+.+++.+||+.||++|| ++.++++
T Consensus 218 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 218 LSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred CCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 345678899999999999999 7999875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=337.71 Aligned_cols=252 Identities=23% Similarity=0.286 Sum_probs=205.7
Q ss_pred hhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEe
Q 041576 422 NGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA---QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYE 498 (714)
Q Consensus 422 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E 498 (714)
|.+.+.||+|+||.||+|+.. .+++.||+|+++... ......+.+|++++.+++||||+++++++.+++..++|||
T Consensus 3 y~~~~~ig~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e 81 (333)
T cd05600 3 FQILTQVGQGGYGQVFLAKKK-DTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAME 81 (333)
T ss_pred cEEEEEEeecCCeEEEEEEEC-CCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEe
Confidence 567789999999999999976 468899999997532 2344678899999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcccc
Q 041576 499 FMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRT 578 (714)
Q Consensus 499 ~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 578 (714)
|+++++|.+++.....+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++..... .
T Consensus 82 ~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~----~ 154 (333)
T cd05600 82 YVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT----Y 154 (333)
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc----c
Confidence 9999999999988888899999999999999999999998 99999999999999999999999999976533 2
Q ss_pred eeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhhc
Q 041576 579 RTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAM 658 (714)
Q Consensus 579 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 658 (714)
.....|++.|+|||.+.+..++.++|||||||++|||++|+.||......+....+..+. .... .+ ....
T Consensus 155 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~------~~~~---~~-~~~~ 224 (333)
T cd05600 155 ANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWK------ETLQ---RP-VYDD 224 (333)
T ss_pred cCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcc------cccc---CC-CCCc
Confidence 234568999999999999999999999999999999999999997654333211111110 0000 00 0000
Q ss_pred cchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 659 ADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 659 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
.....+..+.+++.+||+.+|.+||+++|+++.
T Consensus 225 ~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 225 PRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred cccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 012234567889999999999999999999975
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=330.48 Aligned_cols=263 Identities=25% Similarity=0.344 Sum_probs=201.1
Q ss_pred HHhhhhhhhhCcccceeEEEeEeeC---------------CCCcEEEEEEecccc-hhhHHHHHHHHHHHhccCcccccc
Q 041576 419 EATNGFEEELGRGSFGIVYKGVLKS---------------ASGNAVAVKKLDKLA-QEREREFKTEVSAIGRTHHKNLVQ 482 (714)
Q Consensus 419 ~at~~~~~~ig~G~~g~Vy~~~~~~---------------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~ 482 (714)
...+.+.++||+|+||.||+|.++. ..+..||+|.+.... .....++.+|++++.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 4567778999999999999998642 233479999987642 344568999999999999999999
Q ss_pred eeceEecCCeeeEEEeecCCCchhhhhhcCC-------------------CCChhhHHHHHHHHHHHHHHHHhcCCCCeE
Q 041576 483 LLGFCDEGLNRLLVYEFMGNGTLANLLFAIP-------------------RPDWSLRVRISLEIARGLLYLHEECNVPII 543 (714)
Q Consensus 483 l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~-------------------~~~~~~~~~i~~qi~~~L~yLH~~~~~~iv 543 (714)
+++++.+.+..++||||+++++|.+++.... .+++..+++++.||+.||+|||+.+ |+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence 9999999999999999999999999986431 3567788999999999999999998 99
Q ss_pred ecCCCcCeEEECCCCceEEecCCCccccccCccc-ceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh--cCC
Q 041576 544 HCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSR-TRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC--CKR 620 (714)
Q Consensus 544 H~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt--G~~ 620 (714)
||||||+||++++++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ +..
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence 9999999999999999999999999865332221 1122345778999999988899999999999999999987 456
Q ss_pred CCcccccchhhhhhhHHHhhhhhcCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 041576 621 SVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEG 694 (714)
Q Consensus 621 p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 694 (714)
||........... .............. ..+...+..+.+++.+||+.||++|||+.||.+.|++
T Consensus 241 p~~~~~~~~~~~~----~~~~~~~~~~~~~~------~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 241 PYGELTDEQVIEN----AGEFFRDQGRQVYL------FRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCCcCCHHHHHHH----HHHHhhhccccccc------cCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 6654332221111 11111111000000 0112234578889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=322.79 Aligned_cols=255 Identities=27% Similarity=0.376 Sum_probs=205.9
Q ss_pred HHhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEe
Q 041576 419 EATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYE 498 (714)
Q Consensus 419 ~at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E 498 (714)
...+.+.+.||+|++|.||+|..+ ..++.|++|.+... ......+.+|++.+++++||||+++++++..+...+++||
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (263)
T cd05052 5 RTDITMKHKLGGGQYGEVYEGVWK-KYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 82 (263)
T ss_pred hHHeEEeeecCCcccceEEEEEEe-cCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEE
Confidence 344667789999999999999976 46789999998753 3345678999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcC--CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcc
Q 041576 499 FMGNGTLANLLFAI--PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQS 576 (714)
Q Consensus 499 ~~~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 576 (714)
|+++++|.+++... ..+++..++.++.|+++||+|||+.+ ++||||||+||++++++.+||+|||++........
T Consensus 83 ~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~ 159 (263)
T cd05052 83 FMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 159 (263)
T ss_pred eCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCcccccccccee
Confidence 99999999999754 35788999999999999999999998 99999999999999999999999999987644322
Q ss_pred cceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccchhhhhhhHHHhhhhhcCccceeecchh
Q 041576 577 RTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDK 655 (714)
Q Consensus 577 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 655 (714)
.......++..|+|||.+.+..++.++||||||+++|||++ |..|+......+.... ...+.
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~--------~~~~~--------- 222 (263)
T cd05052 160 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL--------LEKGY--------- 222 (263)
T ss_pred eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH--------HHCCC---------
Confidence 22222234567999999999999999999999999999998 8899865432221111 11110
Q ss_pred hhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 041576 656 AAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGY 695 (714)
Q Consensus 656 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 695 (714)
....+...+..+.+++.+||+.||++||++.+++++|+.+
T Consensus 223 ~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 223 RMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 0011222345788899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=347.58 Aligned_cols=257 Identities=21% Similarity=0.290 Sum_probs=211.4
Q ss_pred hhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccC-cccccceece-Eec------CCe
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTH-HKNLVQLLGF-CDE------GLN 492 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~-~~~------~~~ 492 (714)
+..+.+.|.+|+|+.||.|... ..+..||+|++-..++...+.+.+|+++|++|+ |+|||.+++. ... .-+
T Consensus 38 ~v~V~~vLAEGGFa~VYla~~~-~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E 116 (738)
T KOG1989|consen 38 RVTVEKVLAEGGFAQVYLAQDV-KGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE 116 (738)
T ss_pred EEEEEEEEccCCcEEEEEEEec-CCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence 4456789999999999999986 344899999997778888999999999999996 9999999993 211 235
Q ss_pred eeEEEeecCCCchhhhhhcC--CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccc
Q 041576 493 RLLVYEFMGNGTLANLLFAI--PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKL 570 (714)
Q Consensus 493 ~~lv~E~~~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~ 570 (714)
.+|.||||++|.|-+++..+ ..+++.++++|+.|+++|+++||... +||||||||.+||||+.++..||||||.+.-
T Consensus 117 vllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFGSatt 195 (738)
T KOG1989|consen 117 VLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDFGSATT 195 (738)
T ss_pred EEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCccccccc
Confidence 68999999999999999854 46899999999999999999999985 8899999999999999999999999999875
Q ss_pred cccCccc--------ceeeecCCCCccCcccc---cCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHh
Q 041576 571 LLSDQSR--------TRTVIRGTRGYVAPEWF---KNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAY 639 (714)
Q Consensus 571 ~~~~~~~--------~~~~~~gt~~y~aPE~~---~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~ 639 (714)
....... ......-|+.|+|||.+ .+..+++|+|||+|||+||-|+....||+....
T Consensus 196 ~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~------------ 263 (738)
T KOG1989|consen 196 KILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK------------ 263 (738)
T ss_pred ccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc------------
Confidence 3222110 01112368999999977 678899999999999999999999999974321
Q ss_pred hhhhcCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCCC
Q 041576 640 DCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLEVP 699 (714)
Q Consensus 640 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 699 (714)
..+++..........+...+..||..||++||++||++-+|++.+.++...+
T Consensus 264 --------laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~ 315 (738)
T KOG1989|consen 264 --------LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKP 315 (738)
T ss_pred --------eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCC
Confidence 1223333333334578889999999999999999999999999998877654
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-38 Score=326.29 Aligned_cols=249 Identities=24% Similarity=0.282 Sum_probs=200.0
Q ss_pred hhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEe
Q 041576 422 NGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA---QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYE 498 (714)
Q Consensus 422 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E 498 (714)
|...+.||+|+||.||+|... .+++.||+|.+.... ......+.+|+.++.+++|+||+++++++.+++..++|||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVR-ATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEe-cCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 455688999999999999876 478999999986532 2233467899999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcC--CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcc
Q 041576 499 FMGNGTLANLLFAI--PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQS 576 (714)
Q Consensus 499 ~~~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 576 (714)
|+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||++.......
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~- 156 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE- 156 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC-
Confidence 99999999888643 35789999999999999999999998 9999999999999999999999999998653322
Q ss_pred cceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhh
Q 041576 577 RTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKA 656 (714)
Q Consensus 577 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 656 (714)
......|+..|+|||.+.+..++.++|||||||++|||++|+.||...........+.. ......
T Consensus 157 -~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~----~~~~~~---------- 221 (285)
T cd05631 157 -TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDR----RVKEDQ---------- 221 (285)
T ss_pred -eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHH----Hhhccc----------
Confidence 12234689999999999999999999999999999999999999975433221111110 000100
Q ss_pred hccchHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 041576 657 AMADKSRACKWLMIALWCIQEDPLKRPA-----MKMIVQ 690 (714)
Q Consensus 657 ~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 690 (714)
.......+..+.+|+.+||+.||++||+ ++|+++
T Consensus 222 ~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 222 EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 0112223456778999999999999997 888886
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=341.36 Aligned_cols=261 Identities=27% Similarity=0.391 Sum_probs=204.5
Q ss_pred HHHHhhhhhhhhCcccceeEEEeEee----CCCCcEEEEEEecccc-hhhHHHHHHHHHHHhcc-CcccccceeceEecC
Q 041576 417 LNEATNGFEEELGRGSFGIVYKGVLK----SASGNAVAVKKLDKLA-QEREREFKTEVSAIGRT-HHKNLVQLLGFCDEG 490 (714)
Q Consensus 417 l~~at~~~~~~ig~G~~g~Vy~~~~~----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~ 490 (714)
+....+.+.+.||+|+||.||+|+.. ..++..||+|+++... ......+.+|+++++.+ +|+||+++++++...
T Consensus 35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~ 114 (374)
T cd05106 35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHG 114 (374)
T ss_pred ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC
Confidence 44556778899999999999999853 2234589999997533 33456788999999999 899999999999999
Q ss_pred CeeeEEEeecCCCchhhhhhcC----------------------------------------------------------
Q 041576 491 LNRLLVYEFMGNGTLANLLFAI---------------------------------------------------------- 512 (714)
Q Consensus 491 ~~~~lv~E~~~~gsL~~~l~~~---------------------------------------------------------- 512 (714)
...++||||+++|+|.++++..
T Consensus 115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (374)
T cd05106 115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS 194 (374)
T ss_pred CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence 9999999999999999988532
Q ss_pred ------------CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcccc-e
Q 041576 513 ------------PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRT-R 579 (714)
Q Consensus 513 ------------~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~-~ 579 (714)
..+++.++++++.||++||+|||+++ |+||||||+||++++++.+||+|||++.......... .
T Consensus 195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~ 271 (374)
T cd05106 195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVK 271 (374)
T ss_pred ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeec
Confidence 13567788999999999999999998 9999999999999999999999999997654332211 1
Q ss_pred eeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhhc
Q 041576 580 TVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAM 658 (714)
Q Consensus 580 ~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 658 (714)
....++..|+|||++.+..++.++|||||||++|||++ |+.||........ +.. ....+ .. ..
T Consensus 272 ~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~---~~~----~~~~~-~~--------~~ 335 (374)
T cd05106 272 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK---FYK----MVKRG-YQ--------MS 335 (374)
T ss_pred cCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH---HHH----HHHcc-cC--------cc
Confidence 12234567999999998899999999999999999997 9999975432211 100 00110 00 00
Q ss_pred cchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 041576 659 ADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYL 696 (714)
Q Consensus 659 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 696 (714)
.+...+..+.+++.+||+.||++|||+.+|+++|++++
T Consensus 336 ~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 336 RPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 01112356788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=336.61 Aligned_cols=253 Identities=24% Similarity=0.339 Sum_probs=212.6
Q ss_pred hhhhhhhCcccceeEEEeEeeCCCCcEEEEEEeccc---chhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEe
Q 041576 422 NGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKL---AQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYE 498 (714)
Q Consensus 422 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E 498 (714)
+.+.+.||.|+-|.|-+|++. .+|+.+|||++.+. .......+++|+-+|+.+.|||++++++++++..+.|+|.|
T Consensus 14 wkLgkTLG~Gstg~vrlakh~-~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE 92 (786)
T KOG0588|consen 14 WKLGKTLGKGSTGCVRLAKHA-ETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE 92 (786)
T ss_pred eeccccccCCCCceehhhhcc-cccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence 456789999999999999987 68999999999654 22334578999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcccc
Q 041576 499 FMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRT 578 (714)
Q Consensus 499 ~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 578 (714)
|+++|-|.+++...+++.+.++.+++.||+.|+.|+|..+ |+||||||+|+|+|..+++||+|||+|.+-.. ...
T Consensus 93 yv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~--gkl 167 (786)
T KOG0588|consen 93 YVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVP--GKL 167 (786)
T ss_pred ecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccC--Ccc
Confidence 9999999999999999999999999999999999999998 99999999999999999999999999986433 333
Q ss_pred eeeecCCCCccCcccccCCCC-CchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhh
Q 041576 579 RTVIRGTRGYVAPEWFKNVPV-SAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAA 657 (714)
Q Consensus 579 ~~~~~gt~~y~aPE~~~~~~~-s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 657 (714)
..+.+|++.|.|||++.+.+| ..++||||.|||||.||||+.||+..... ..+ .++..|..+
T Consensus 168 LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir---~LL-----lKV~~G~f~--------- 230 (786)
T KOG0588|consen 168 LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIR---VLL-----LKVQRGVFE--------- 230 (786)
T ss_pred ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHH---HHH-----HHHHcCccc---------
Confidence 455679999999999999998 56999999999999999999999843322 111 122222221
Q ss_pred ccchHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HhcccCC
Q 041576 658 MADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM--LEGYLEV 698 (714)
Q Consensus 658 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~~~~ 698 (714)
.+...+.+..+|+.+||..||++|.|++||++. |.+....
T Consensus 231 -MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~ 272 (786)
T KOG0588|consen 231 -MPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTSL 272 (786)
T ss_pred -CCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCCC
Confidence 123345577789999999999999999999985 4554444
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=328.21 Aligned_cols=267 Identities=26% Similarity=0.367 Sum_probs=215.2
Q ss_pred HHHHHHHhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhh-HHHHHHHHHHHhccCcccccceeceEecCCe
Q 041576 414 LVELNEATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQER-EREFKTEVSAIGRTHHKNLVQLLGFCDEGLN 492 (714)
Q Consensus 414 ~~el~~at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 492 (714)
..|..+....|.|+||+|.||.|.++... .+..||||+++...... .++|.+|+++|.+++||||++++|+|..++.
T Consensus 532 l~EfPRs~L~~~ekiGeGqFGEVhLCeve--g~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DeP 609 (807)
T KOG1094|consen 532 LVEFPRSRLRFKEKIGEGQFGEVHLCEVE--GPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDP 609 (807)
T ss_pred hhhcchhheehhhhhcCcccceeEEEEec--CceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCc
Confidence 44666666678899999999999999876 46899999998765544 4899999999999999999999999999999
Q ss_pred eeEEEeecCCCchhhhhhcCC--CCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccc
Q 041576 493 RLLVYEFMGNGTLANLLFAIP--RPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKL 570 (714)
Q Consensus 493 ~~lv~E~~~~gsL~~~l~~~~--~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~ 570 (714)
.++|+|||++|+|.+++..+. ....+...+|+.||+.||+||.+-+ +|||||.++|+|++.++++||+|||+++.
T Consensus 610 icmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~ 686 (807)
T KOG1094|consen 610 LCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRN 686 (807)
T ss_pred hHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccc
Confidence 999999999999999998763 3355667889999999999999988 99999999999999999999999999997
Q ss_pred cccCccc-ceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh--cCCCCcccccchhhhhhhHHHhhhhhcCcc
Q 041576 571 LLSDQSR-TRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC--CKRSVEMELGEERSAILTDWAYDCYVEGKL 647 (714)
Q Consensus 571 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt--G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~ 647 (714)
+-..... .....+-..+|||||.+..+++|.++|||+||+.+||+++ ...|+.....+...+.. ...+..+..
T Consensus 687 lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~----~~~~~~~~~ 762 (807)
T KOG1094|consen 687 LYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENA----GEFFRDQGR 762 (807)
T ss_pred cccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhh----hhhcCCCCc
Confidence 6554433 3333456789999999999999999999999999999864 67788655443321111 111111111
Q ss_pred ceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 041576 648 DVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGY 695 (714)
Q Consensus 648 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 695 (714)
... ...+.-.+..+.+++.+||..|-++||+++++...|++.
T Consensus 763 ~~~------l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 763 QVV------LSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred cee------ccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 111 112344556788999999999999999999999988764
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=322.08 Aligned_cols=256 Identities=26% Similarity=0.393 Sum_probs=206.5
Q ss_pred HHHHhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEE
Q 041576 417 LNEATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLV 496 (714)
Q Consensus 417 l~~at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 496 (714)
+...++.+.+.||+|++|.||+|... +++.||+|.++... ...+++.+|++++++++||||+++++++...+..++|
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~--~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 79 (261)
T cd05068 3 IDRTSIQLLRKLGAGQFGEVWEGLWN--NTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIV 79 (261)
T ss_pred cchhheeeEEEecccCCccEEEEEec--CCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeee
Confidence 44566778899999999999999864 45789999987533 3456789999999999999999999999999999999
Q ss_pred EeecCCCchhhhhhcCC--CCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccC
Q 041576 497 YEFMGNGTLANLLFAIP--RPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSD 574 (714)
Q Consensus 497 ~E~~~~gsL~~~l~~~~--~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 574 (714)
|||+++++|.+++.... .+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||++......
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05068 80 TELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKED 156 (261)
T ss_pred eecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCC
Confidence 99999999999997654 6899999999999999999999998 999999999999999999999999999876532
Q ss_pred cccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccchhhhhhhHHHhhhhhcCccceeecc
Q 041576 575 QSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDN 653 (714)
Q Consensus 575 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 653 (714)
..........+..|+|||.+.+..++.++||||||+++|||++ |+.||....... .+. .......
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~-----~~~~~~~------ 222 (261)
T cd05068 157 IYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE---VLQ-----QVDQGYR------ 222 (261)
T ss_pred cccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH---HHH-----HHHcCCC------
Confidence 2222222223457999999999899999999999999999999 998986443221 111 1111100
Q ss_pred hhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 041576 654 DKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGY 695 (714)
Q Consensus 654 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 695 (714)
...+...+..+.+++.+|++.+|++||++.++++.|+.+
T Consensus 223 ---~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 223 ---MPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred ---CCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 001122345688899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=322.29 Aligned_cols=255 Identities=24% Similarity=0.286 Sum_probs=202.7
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccch--------------hhHHHHHHHHHHHhccCcccccceec
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQ--------------EREREFKTEVSAIGRTHHKNLVQLLG 485 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~--------------~~~~~~~~E~~~l~~l~h~nIv~l~~ 485 (714)
..|.+.+.||+|.||.|-+|+.. .+++.||||++.+... ...+.+.+|+.+|++++|||||+|++
T Consensus 97 Nqy~l~~eiG~G~yGkVkLar~~-~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiE 175 (576)
T KOG0585|consen 97 NQYELIKEIGSGQYGKVKLARDE-VDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIE 175 (576)
T ss_pred hheehhhhhcCCccceEEEEeec-CCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEE
Confidence 45777899999999999999876 5789999999965221 11257899999999999999999999
Q ss_pred eEecC--CeeeEEEeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEe
Q 041576 486 FCDEG--LNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKIS 563 (714)
Q Consensus 486 ~~~~~--~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~ 563 (714)
+..+. +..|||+|||..|.+...-.....+++.++++++.++..||+|||.+| ||||||||+|+||+++|++||+
T Consensus 176 vLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g~VKIs 252 (576)
T KOG0585|consen 176 VLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDGTVKIS 252 (576)
T ss_pred eecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCCcEEee
Confidence 99664 578999999998887766555455899999999999999999999999 9999999999999999999999
Q ss_pred cCCCccccccCc----ccceeeecCCCCccCcccccCCC----CCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhh
Q 041576 564 DFGLSKLLLSDQ----SRTRTVIRGTRGYVAPEWFKNVP----VSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILT 635 (714)
Q Consensus 564 Dfg~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~----~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~ 635 (714)
|||.+....... ........||+.|+|||...++. .+.+.||||+||.||.|+.|+.||-.+...+....
T Consensus 253 DFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~K-- 330 (576)
T KOG0585|consen 253 DFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDK-- 330 (576)
T ss_pred ccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHH--
Confidence 999998662211 11122357999999999987632 36689999999999999999999976544332111
Q ss_pred HHHhhhhhcCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 041576 636 DWAYDCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEG 694 (714)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 694 (714)
++...+......+..+.+.+||+++|++||++|.+..+|....--
T Consensus 331 --------------Ivn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwv 375 (576)
T KOG0585|consen 331 --------------IVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWV 375 (576)
T ss_pred --------------HhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheeccee
Confidence 111222222233456678889999999999999999999876543
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=373.17 Aligned_cols=272 Identities=26% Similarity=0.512 Sum_probs=210.9
Q ss_pred cCHHHHHHHhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCcccccceeceEecCC
Q 041576 412 FSLVELNEATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGL 491 (714)
Q Consensus 412 ~~~~el~~at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 491 (714)
+++.++..+ +...+.||+|+||.||+|... .++..||||+++..... ..+|++.+++++||||++++++|.+++
T Consensus 683 ~~~~~~~~~-~~~~~~ig~G~~g~Vy~~~~~-~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~ 756 (968)
T PLN00113 683 ITINDILSS-LKEENVISRGKKGASYKGKSI-KNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEK 756 (968)
T ss_pred hhHHHHHhh-CCcccEEccCCCeeEEEEEEC-CCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCC
Confidence 444554433 334568999999999999875 46889999998653322 234688899999999999999999999
Q ss_pred eeeEEEeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCcccc
Q 041576 492 NRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLL 571 (714)
Q Consensus 492 ~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~ 571 (714)
..++||||+++|+|.++++. ++|..+.+|+.||++||+|||+.+.++|+||||||+||+++.++.+++. |+.....
T Consensus 757 ~~~lv~Ey~~~g~L~~~l~~---l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~ 832 (968)
T PLN00113 757 GAYLIHEYIEGKNLSEVLRN---LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLL 832 (968)
T ss_pred CCEEEEeCCCCCcHHHHHhc---CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccc
Confidence 99999999999999999963 7899999999999999999997655669999999999999999988876 6655432
Q ss_pred ccCcccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceee
Q 041576 572 LSDQSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLV 651 (714)
Q Consensus 572 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 651 (714)
... ....++..|+|||++.+..++.|+|||||||++|||+||+.|++...... ..+..|.............+
T Consensus 833 ~~~-----~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 905 (968)
T PLN00113 833 CTD-----TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVH--GSIVEWARYCYSDCHLDMWI 905 (968)
T ss_pred ccC-----CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCC--CcHHHHHHHhcCccchhhee
Confidence 211 12357889999999999999999999999999999999999996433221 22334443333333333344
Q ss_pred cchhhh--ccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCCCC
Q 041576 652 DNDKAA--MADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLEVPS 700 (714)
Q Consensus 652 ~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 700 (714)
++.... ..+.....++.+++.+||+.||++||+|+||+++|+++.+...
T Consensus 906 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~~ 956 (968)
T PLN00113 906 DPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSSS 956 (968)
T ss_pred CccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcccc
Confidence 433321 2234556678899999999999999999999999998876543
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=335.46 Aligned_cols=246 Identities=25% Similarity=0.290 Sum_probs=203.1
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEE
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA---QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLV 496 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 496 (714)
..|.+.+.||+|+||.||+|+.+ .+++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+++..++|
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 96 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHK-GTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL 96 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEEC-CCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence 34677889999999999999976 468899999996532 23345788999999999999999999999999999999
Q ss_pred EeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcc
Q 041576 497 YEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQS 576 (714)
Q Consensus 497 ~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 576 (714)
|||+++++|.+++.....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 97 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~- 172 (329)
T PTZ00263 97 LEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT- 172 (329)
T ss_pred EcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCCc-
Confidence 999999999999998888899999999999999999999998 9999999999999999999999999998653322
Q ss_pred cceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhh
Q 041576 577 RTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKA 656 (714)
Q Consensus 577 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 656 (714)
....|++.|+|||.+.+..++.++|||||||++|||++|+.||........ .....++...
T Consensus 173 ---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~--------~~~i~~~~~~-------- 233 (329)
T PTZ00263 173 ---FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRI--------YEKILAGRLK-------- 233 (329)
T ss_pred ---ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHH--------HHHHhcCCcC--------
Confidence 234689999999999999999999999999999999999999975432211 1111122111
Q ss_pred hccchHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 041576 657 AMADKSRACKWLMIALWCIQEDPLKRPA-----MKMIVQM 691 (714)
Q Consensus 657 ~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~ 691 (714)
.+......+.+++.+||+.||.+||+ ++++++.
T Consensus 234 --~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 234 --FPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred --CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 01112345778999999999999996 6887743
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=331.99 Aligned_cols=240 Identities=25% Similarity=0.276 Sum_probs=196.4
Q ss_pred hCcccceeEEEeEeeCCCCcEEEEEEeccc---chhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEeecCCCc
Q 041576 428 LGRGSFGIVYKGVLKSASGNAVAVKKLDKL---AQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEFMGNGT 504 (714)
Q Consensus 428 ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~gs 504 (714)
||+|+||.||+|... .+++.||+|.++.. .......+.+|++++++++||||+++++++.+++..++||||+++|+
T Consensus 1 lg~G~~g~Vy~~~~~-~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 79 (312)
T cd05585 1 IGKGSFGKVMQVRKR-DTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGE 79 (312)
T ss_pred CCcCCCeEEEEEEEC-CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCc
Confidence 799999999999876 46889999998653 23345678899999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcccceeeecC
Q 041576 505 LANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRG 584 (714)
Q Consensus 505 L~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g 584 (714)
|.+++.....+++..+..++.||++||+|||+.+ |+||||||+||+++.++.+||+|||+++...... .......|
T Consensus 80 L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~g 155 (312)
T cd05585 80 LFHHLQREGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNTFCG 155 (312)
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC-CccccccC
Confidence 9999988788999999999999999999999998 9999999999999999999999999987543222 12234568
Q ss_pred CCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhhccchHHH
Q 041576 585 TRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMADKSRA 664 (714)
Q Consensus 585 t~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 664 (714)
++.|+|||.+.+..++.++|||||||++|||++|+.||........ . ........ ..+....
T Consensus 156 t~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~---~-----~~~~~~~~----------~~~~~~~ 217 (312)
T cd05585 156 TPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEM---Y-----RKILQEPL----------RFPDGFD 217 (312)
T ss_pred CcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHH---H-----HHHHcCCC----------CCCCcCC
Confidence 9999999999999999999999999999999999999975432211 1 01111110 0112234
Q ss_pred HHHHHHHHHccccCCCCCCC---HHHHHH
Q 041576 665 CKWLMIALWCIQEDPLKRPA---MKMIVQ 690 (714)
Q Consensus 665 ~~l~~li~~cl~~dP~~RPs---~~evl~ 690 (714)
..+.+++.+||+.||++||+ +.|+++
T Consensus 218 ~~~~~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 218 RDAKDLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred HHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 56778999999999999985 566654
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=332.38 Aligned_cols=203 Identities=26% Similarity=0.393 Sum_probs=177.6
Q ss_pred HHHHhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEeccc-chhhHHHHHHHHHHHhccCcccccceeceEecCCeeeE
Q 041576 417 LNEATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKL-AQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLL 495 (714)
Q Consensus 417 l~~at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 495 (714)
+....|.+.+.||+|+||.||++.++ .++..+|+|.++.. .......+.+|++++++++||||+++++++.+++..++
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~-~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHK-PSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 80 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEEC-CCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEE
Confidence 34566788899999999999999876 56788999988653 33345678999999999999999999999999999999
Q ss_pred EEeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCc
Q 041576 496 VYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQ 575 (714)
Q Consensus 496 v~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 575 (714)
||||+++++|.+++.....+++..+..++.|+++||+|||+.+ +++|+||||+||++++++.+||+|||++......
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~- 157 (333)
T cd06650 81 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 157 (333)
T ss_pred EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh-
Confidence 9999999999999988778899999999999999999999752 3999999999999999999999999998755322
Q ss_pred ccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCccc
Q 041576 576 SRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEME 625 (714)
Q Consensus 576 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~ 625 (714)
......++..|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus 158 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 158 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred --ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 112345889999999999989999999999999999999999999754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=324.83 Aligned_cols=255 Identities=29% Similarity=0.455 Sum_probs=204.9
Q ss_pred hhhhhhhhCcccceeEEEeEeeCCC----CcEEEEEEecccc-hhhHHHHHHHHHHHhccCcccccceeceEecCCeeeE
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSAS----GNAVAVKKLDKLA-QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLL 495 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 495 (714)
.+.+.+.||+|+||.||+|...... ...|++|.++... ......+.+|++.+.+++||||+++++++......++
T Consensus 6 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 85 (283)
T cd05048 6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCM 85 (283)
T ss_pred HcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEE
Confidence 4667899999999999999875322 2579999986533 3345678999999999999999999999999999999
Q ss_pred EEeecCCCchhhhhhcC----------------CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCc
Q 041576 496 VYEFMGNGTLANLLFAI----------------PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFT 559 (714)
Q Consensus 496 v~E~~~~gsL~~~l~~~----------------~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~ 559 (714)
+|||+++++|.+++... ..+++..++.++.|+++||+|||+.+ ++|+||||+||++++++.
T Consensus 86 ~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05048 86 LFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGLT 162 (283)
T ss_pred EEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCCc
Confidence 99999999999999754 34677888999999999999999998 999999999999999999
Q ss_pred eEEecCCCccccccCcc-cceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccchhhhhhhHH
Q 041576 560 AKISDFGLSKLLLSDQS-RTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEERSAILTDW 637 (714)
Q Consensus 560 ~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~l~~~ 637 (714)
+||+|||++........ .......++..|+|||.+.+..++.++|||||||++|||++ |..||......+...
T Consensus 163 ~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~----- 237 (283)
T cd05048 163 VKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIE----- 237 (283)
T ss_pred EEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH-----
Confidence 99999999976533221 12223346788999999998899999999999999999998 999987543322111
Q ss_pred HhhhhhcCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 041576 638 AYDCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGY 695 (714)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 695 (714)
.+..+... ..+...+.++.+++.+||+.||++||+++||++.|+.+
T Consensus 238 ---~i~~~~~~---------~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 238 ---MIRSRQLL---------PCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred ---HHHcCCcC---------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 11111111 11233456788999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=335.74 Aligned_cols=249 Identities=24% Similarity=0.283 Sum_probs=205.1
Q ss_pred HHHhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHHhccCcccccceeceEecCCeee
Q 041576 418 NEATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA---QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRL 494 (714)
Q Consensus 418 ~~at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 494 (714)
....|.+.+.||+|+||.||+|.++...+..||+|.+.... ......+.+|+++++.++||||+++++++.++...+
T Consensus 28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 107 (340)
T PTZ00426 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLY 107 (340)
T ss_pred ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEE
Confidence 34457788999999999999998775555789999986532 233457889999999999999999999999999999
Q ss_pred EEEeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccC
Q 041576 495 LVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSD 574 (714)
Q Consensus 495 lv~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 574 (714)
+||||+++|+|.+++.....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 108 lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~ 184 (340)
T PTZ00426 108 LVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR 184 (340)
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecCCC
Confidence 99999999999999998888999999999999999999999998 999999999999999999999999999865322
Q ss_pred cccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecch
Q 041576 575 QSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDND 654 (714)
Q Consensus 575 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 654 (714)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||........ ......+...
T Consensus 185 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~--------~~~i~~~~~~------ 246 (340)
T PTZ00426 185 ----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLI--------YQKILEGIIY------ 246 (340)
T ss_pred ----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHH--------HHHHhcCCCC------
Confidence 2345689999999999998899999999999999999999999975432211 1111111110
Q ss_pred hhhccchHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 041576 655 KAAMADKSRACKWLMIALWCIQEDPLKRP-----AMKMIVQM 691 (714)
Q Consensus 655 ~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 691 (714)
.+......+.+++.+||+.||++|+ +++|+++.
T Consensus 247 ----~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 247 ----FPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred ----CCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 1112234567899999999999995 89998764
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=331.55 Aligned_cols=242 Identities=26% Similarity=0.296 Sum_probs=198.7
Q ss_pred hhhCcccceeEEEeEeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEeecCC
Q 041576 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA---QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEFMGN 502 (714)
Q Consensus 426 ~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~ 502 (714)
+.||+|+||.||++... .+++.||+|.++... ......+.+|++++++++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~ 79 (323)
T cd05595 1 KLLGKGTFGKVILVREK-ATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANG 79 (323)
T ss_pred CeeeeCCCEEEEEEEEC-CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCC
Confidence 46899999999999875 578999999997532 23445678899999999999999999999999999999999999
Q ss_pred CchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcccceeee
Q 041576 503 GTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVI 582 (714)
Q Consensus 503 gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 582 (714)
++|.+++.....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++....... ......
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~~~ 155 (323)
T cd05595 80 GELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKTF 155 (323)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCC-Cccccc
Confidence 999999988788999999999999999999999998 9999999999999999999999999987532221 122335
Q ss_pred cCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhhccchH
Q 041576 583 RGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMADKS 662 (714)
Q Consensus 583 ~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 662 (714)
.|+..|+|||.+.+..++.++|||||||++|||++|+.||...........+ ..... ..+..
T Consensus 156 ~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~--------~~~~~----------~~p~~ 217 (323)
T cd05595 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI--------LMEEI----------RFPRT 217 (323)
T ss_pred cCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH--------hcCCC----------CCCCC
Confidence 6899999999999999999999999999999999999999754332211110 01100 01122
Q ss_pred HHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 041576 663 RACKWLMIALWCIQEDPLKRP-----AMKMIVQ 690 (714)
Q Consensus 663 ~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 690 (714)
....+.+++.+||+.||++|| ++.++++
T Consensus 218 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 218 LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred CCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 345677899999999999998 8888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=318.54 Aligned_cols=250 Identities=27% Similarity=0.421 Sum_probs=201.3
Q ss_pred hhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEeec
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEFM 500 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~ 500 (714)
.+.+.+.||+|+||.||+|.++ .+..+|+|.+... ......+.+|++++++++||||+++++++......++||||+
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~--~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~ 81 (256)
T cd05114 5 ELTFMKELGSGQFGVVHLGKWR--AQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFM 81 (256)
T ss_pred HcEEeeEecCCcCceEEEEEec--cCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcC
Confidence 4566788999999999999875 4568999988643 233467889999999999999999999999999999999999
Q ss_pred CCCchhhhhhcC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcccce
Q 041576 501 GNGTLANLLFAI-PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTR 579 (714)
Q Consensus 501 ~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 579 (714)
++++|.+++... ..+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||.+...........
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~ 158 (256)
T cd05114 82 ENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSS 158 (256)
T ss_pred CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCceecc
Confidence 999999999754 45789999999999999999999998 99999999999999999999999999886543332222
Q ss_pred eeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhhc
Q 041576 580 TVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAM 658 (714)
Q Consensus 580 ~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 658 (714)
....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+....+ ..+... .
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i--------~~~~~~--~------- 221 (256)
T cd05114 159 SGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMI--------SRGFRL--Y------- 221 (256)
T ss_pred CCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH--------HCCCCC--C-------
Confidence 22335668999999998889999999999999999999 89998754332211111 111100 0
Q ss_pred cchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 041576 659 ADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLE 693 (714)
Q Consensus 659 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 693 (714)
.+......+.+++.+||+.+|++||+++|+++.|.
T Consensus 222 ~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 222 RPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 01112346788999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=331.62 Aligned_cols=243 Identities=28% Similarity=0.296 Sum_probs=199.6
Q ss_pred hhhCcccceeEEEeEeeCCCCcEEEEEEeccc---chhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEeecCC
Q 041576 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDKL---AQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEFMGN 502 (714)
Q Consensus 426 ~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~ 502 (714)
+.||+|+||.||++... .+++.||+|++... .......+.+|++++++++||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~ 79 (328)
T cd05593 1 KLLGKGTFGKVILVREK-ASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNG 79 (328)
T ss_pred CeeeeCCCEEEEEEEEC-CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCC
Confidence 46899999999999875 57899999999753 233456788999999999999999999999999999999999999
Q ss_pred CchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcccceeee
Q 041576 503 GTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVI 582 (714)
Q Consensus 503 gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 582 (714)
++|.+++.....+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...... ......
T Consensus 80 g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~~~ 155 (328)
T cd05593 80 GELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA-ATMKTF 155 (328)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCcc-cccccc
Confidence 999999988788999999999999999999999998 9999999999999999999999999987532221 122335
Q ss_pred cCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhhccchH
Q 041576 583 RGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMADKS 662 (714)
Q Consensus 583 ~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 662 (714)
.|++.|+|||.+.+..++.++|||||||++|||++|+.||........... ...... ..+..
T Consensus 156 ~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~--------~~~~~~----------~~p~~ 217 (328)
T cd05593 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL--------ILMEDI----------KFPRT 217 (328)
T ss_pred cCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHH--------hccCCc----------cCCCC
Confidence 689999999999998999999999999999999999999975432211100 000000 01122
Q ss_pred HHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 041576 663 RACKWLMIALWCIQEDPLKRP-----AMKMIVQM 691 (714)
Q Consensus 663 ~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 691 (714)
....+.+++.+||+.||++|| ++.|+++.
T Consensus 218 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 218 LSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 345677899999999999997 89998864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=322.52 Aligned_cols=256 Identities=29% Similarity=0.460 Sum_probs=206.6
Q ss_pred HHhhhhhhhhCcccceeEEEeEeeC----CCCcEEEEEEecccchh-hHHHHHHHHHHHhccCcccccceeceEecCCee
Q 041576 419 EATNGFEEELGRGSFGIVYKGVLKS----ASGNAVAVKKLDKLAQE-REREFKTEVSAIGRTHHKNLVQLLGFCDEGLNR 493 (714)
Q Consensus 419 ~at~~~~~~ig~G~~g~Vy~~~~~~----~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 493 (714)
..++.+.+.||+|+||.||+|.... ..++.||+|.++..... ..+.+.+|++++++++|+||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 4567888999999999999998642 23578999999765443 467899999999999999999999999999999
Q ss_pred eEEEeecCCCchhhhhhcC--------------CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCc
Q 041576 494 LLVYEFMGNGTLANLLFAI--------------PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFT 559 (714)
Q Consensus 494 ~lv~E~~~~gsL~~~l~~~--------------~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~ 559 (714)
++||||+++++|.+++... ..+++..+..++.||+.||+|||+++ ++||||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCe
Confidence 9999999999999999753 23678889999999999999999998 999999999999999999
Q ss_pred eEEecCCCccccccCcc-cceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccchhhhhhhHH
Q 041576 560 AKISDFGLSKLLLSDQS-RTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEERSAILTDW 637 (714)
Q Consensus 560 ~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~l~~~ 637 (714)
+||+|||++........ .......++..|+|||.+.+..++.++||||||+++|||++ |+.||..........
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~----- 235 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIE----- 235 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHH-----
Confidence 99999999976533221 11222335678999999999999999999999999999998 999986543322111
Q ss_pred HhhhhhcCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 041576 638 AYDCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEG 694 (714)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 694 (714)
....+.... .+...+..+.+++.+||+.||++||++.||++.|++
T Consensus 236 ---~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 236 ---CITQGRLLQ---------RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred ---HHHcCCcCC---------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 111111111 112234567889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=324.36 Aligned_cols=264 Identities=20% Similarity=0.229 Sum_probs=198.9
Q ss_pred hhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc-hhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEee
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA-QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEF 499 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~ 499 (714)
.|.+.+.||+|+||.||+|..+ .+++.||+|.++... ......+.+|++++++++||||+++++++..++..++||||
T Consensus 6 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 6 TYVKLDKLGEGTYATVFKGRSK-LTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred cceEeeEEecCCCEEEEEEEEC-CCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 4667789999999999999876 578899999986532 22345678999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcccc
Q 041576 500 MGNGTLANLLFAI-PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRT 578 (714)
Q Consensus 500 ~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 578 (714)
+++ +|.+++... ..+++..+..++.||++||+|||+++ |+||||||+||++++++.+||+|||++........ .
T Consensus 85 ~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~-~ 159 (288)
T cd07871 85 LDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK-T 159 (288)
T ss_pred CCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCCc-c
Confidence 985 898888654 35788999999999999999999998 99999999999999999999999999976432221 2
Q ss_pred eeeecCCCCccCcccccC-CCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHh----hhhhc----Cccce
Q 041576 579 RTVIRGTRGYVAPEWFKN-VPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAY----DCYVE----GKLDV 649 (714)
Q Consensus 579 ~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~----~~~~~----~~~~~ 649 (714)
.....++..|+|||.+.+ ..++.++||||+||++|||++|+.||......+....+..... ..+.. .....
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (288)
T cd07871 160 YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRS 239 (288)
T ss_pred ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhc
Confidence 223457889999998865 5689999999999999999999999976543322111111000 00000 00000
Q ss_pred eecchh----hhccchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 650 LVDNDK----AAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 650 ~~~~~~----~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
...+.. ..........++.+++.+||+.||.+|||++|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 240 YLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred cccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 000000 00001122346788999999999999999999985
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=319.41 Aligned_cols=254 Identities=23% Similarity=0.369 Sum_probs=204.4
Q ss_pred HHhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEe
Q 041576 419 EATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYE 498 (714)
Q Consensus 419 ~at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E 498 (714)
...+.+.++||+|++|.||+|... ++..|++|.+.... ...+.+.+|+.++++++|+||+++++.+...+..+++||
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~--~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYN--NSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITE 81 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEec--CCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEe
Confidence 345667799999999999999865 56789999986533 235688999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcC--CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcc
Q 041576 499 FMGNGTLANLLFAI--PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQS 576 (714)
Q Consensus 499 ~~~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 576 (714)
|+++++|.+++... ..+++..+..++.|+++||+|||+.+ ++|+||||+||++++++.++|+|||++........
T Consensus 82 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05072 82 YMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY 158 (261)
T ss_pred cCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCce
Confidence 99999999999753 45788899999999999999999988 99999999999999999999999999987644332
Q ss_pred cceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccchhhhhhhHHHhhhhhcCccceeecchh
Q 041576 577 RTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDK 655 (714)
Q Consensus 577 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 655 (714)
.......++..|+|||.+....++.++||||||+++|||++ |+.||........ ... .......
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~---~~~-----~~~~~~~------- 223 (261)
T cd05072 159 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDV---MSA-----LQRGYRM------- 223 (261)
T ss_pred eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHH---HHH-----HHcCCCC-------
Confidence 22222345678999999998889999999999999999998 9999864432221 111 0111000
Q ss_pred hhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 041576 656 AAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGY 695 (714)
Q Consensus 656 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 695 (714)
......+..+.+++.+||+.+|++||+++++.+.|+++
T Consensus 224 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 224 --PRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred --CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 01112334678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=323.55 Aligned_cols=260 Identities=26% Similarity=0.418 Sum_probs=208.6
Q ss_pred HHhhhhhhhhCcccceeEEEeEeeC----CCCcEEEEEEecccchhhHHHHHHHHHHHhccCcccccceeceEecCCeee
Q 041576 419 EATNGFEEELGRGSFGIVYKGVLKS----ASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRL 494 (714)
Q Consensus 419 ~at~~~~~~ig~G~~g~Vy~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 494 (714)
...+.+.+.||+|+||.||++.... .++..+++|.+..........+.+|++++++++||||+++++++...+..+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 3456677899999999999997532 345579999998766666778999999999999999999999999999999
Q ss_pred EEEeecCCCchhhhhhcCC-------------CCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceE
Q 041576 495 LVYEFMGNGTLANLLFAIP-------------RPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAK 561 (714)
Q Consensus 495 lv~E~~~~gsL~~~l~~~~-------------~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~k 561 (714)
+||||+++++|.+++.... .+++..++.++.|++.||+|||+++ ++||||||+||++++++.+|
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEE
Confidence 9999999999999986432 4789999999999999999999998 99999999999999999999
Q ss_pred EecCCCccccccCcc-cceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccchhhhhhhHHHh
Q 041576 562 ISDFGLSKLLLSDQS-RTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEERSAILTDWAY 639 (714)
Q Consensus 562 l~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~l~~~~~ 639 (714)
|+|||++........ .......++..|+|||.+.+..++.++||||||+++|||++ |+.||........ +
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~---~----- 232 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEV---I----- 232 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH---H-----
Confidence 999999986543221 11122335678999999998899999999999999999998 8988864432221 1
Q ss_pred hhhhcCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCC
Q 041576 640 DCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLEV 698 (714)
Q Consensus 640 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 698 (714)
.....+..... +...+..+.+++.+||+.||.+|||+.||++.|+.+...
T Consensus 233 ~~i~~~~~~~~---------~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 233 ECITQGRVLQR---------PRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred HHHHcCCcCCC---------CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 11111111110 112234688899999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=317.72 Aligned_cols=254 Identities=27% Similarity=0.425 Sum_probs=208.7
Q ss_pred HHhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEe
Q 041576 419 EATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYE 498 (714)
Q Consensus 419 ~at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E 498 (714)
...|.+.++||+|++|.||+|.... ++.+++|.+..........+.+|+.++++++|+||+++++++.+....++|||
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~--~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 82 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN--RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE 82 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC--CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence 3457778999999999999999863 78999999987666566789999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcC--CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcc
Q 041576 499 FMGNGTLANLLFAI--PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQS 576 (714)
Q Consensus 499 ~~~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 576 (714)
|+++++|.+++... ..+++..+..++.||+.||+|||+++ ++|+||||+||++++++.+||+|||.+........
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 83 LMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY 159 (261)
T ss_pred ecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence 99999999999754 45789999999999999999999998 99999999999999999999999999976643222
Q ss_pred cceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccchhhhhhhHHHhhhhhcCccceeecchh
Q 041576 577 RTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDK 655 (714)
Q Consensus 577 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 655 (714)
. .....++..|+|||.+.+..++.++||||||+++|+|++ |+.||......+. +.. ...+.
T Consensus 160 ~-~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~---~~~-----~~~~~--------- 221 (261)
T cd05148 160 L-SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEV---YDQ-----ITAGY--------- 221 (261)
T ss_pred c-ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHH---HHH-----HHhCC---------
Confidence 1 123345678999999998899999999999999999998 8999865432221 111 00100
Q ss_pred hhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 041576 656 AAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGY 695 (714)
Q Consensus 656 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 695 (714)
....+...+..+.+++.+||+.||.+|||++++++.|+.+
T Consensus 222 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 222 RMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 0011223345678899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=294.86 Aligned_cols=245 Identities=27% Similarity=0.345 Sum_probs=207.9
Q ss_pred hhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEe
Q 041576 422 NGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA---QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYE 498 (714)
Q Consensus 422 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E 498 (714)
.++.+.||+|.||.||.|+.+ .++..||+|++.+.. .....++.+|+++-..|+||||++++++|.+....||++|
T Consensus 24 feigr~LgkgkFG~vYlarek-ks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilE 102 (281)
T KOG0580|consen 24 FEIGRPLGKGKFGNVYLAREK-KSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILE 102 (281)
T ss_pred ccccccccCCccccEeEeeec-cCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEE
Confidence 456789999999999999977 578899999996532 2335689999999999999999999999999999999999
Q ss_pred ecCCCchhhhhh--cCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcc
Q 041576 499 FMGNGTLANLLF--AIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQS 576 (714)
Q Consensus 499 ~~~~gsL~~~l~--~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 576 (714)
|...|.|...|+ ...++++.....++.|+|.||.|+|..+ ++||||||+|+|++.++.+||+|||-+.... .
T Consensus 103 ya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p---~ 176 (281)
T KOG0580|consen 103 YAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP---S 176 (281)
T ss_pred ecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC---C
Confidence 999999999999 5567899999999999999999999988 9999999999999999999999999987543 4
Q ss_pred cceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhh
Q 041576 577 RTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKA 656 (714)
Q Consensus 577 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 656 (714)
......+||..|.|||...+...+.+.|+|++|++.||++.|.+||+.....+....+. .-+ +.
T Consensus 177 ~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~--------k~~---~~----- 240 (281)
T KOG0580|consen 177 NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIR--------KVD---LK----- 240 (281)
T ss_pred CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHH--------Hcc---cc-----
Confidence 45566789999999999999999999999999999999999999998765333222111 111 00
Q ss_pred hccchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 657 AMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 657 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
.+........++|.+|+..+|.+|.+..|+++.
T Consensus 241 --~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 241 --FPSTISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred --CCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 122334466779999999999999999999864
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=333.50 Aligned_cols=260 Identities=20% Similarity=0.225 Sum_probs=198.9
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEee
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEF 499 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~ 499 (714)
..|.+.+.||+|+||.||++... .+++.||+|.... ..+.+|++++++++||||+++++++..+...++|+|+
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~-~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDN-KTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEEC-CCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 45778899999999999999876 5788999997532 3567899999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcccce
Q 041576 500 MGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTR 579 (714)
Q Consensus 500 ~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 579 (714)
+. ++|.+++.....+++..++.++.||++||+|||+++ |+||||||+||+++.++.+||+|||++...........
T Consensus 165 ~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~ 240 (391)
T PHA03212 165 YK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKY 240 (391)
T ss_pred CC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCccccccccccccc
Confidence 96 689888887778899999999999999999999998 99999999999999999999999999975433222233
Q ss_pred eeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchh----hhhhhHHHhhh------hhc---Cc
Q 041576 580 TVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEER----SAILTDWAYDC------YVE---GK 646 (714)
Q Consensus 580 ~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~----~~~l~~~~~~~------~~~---~~ 646 (714)
....||+.|+|||++.+..++.++|||||||++|||++|+.|+........ ...+....... +.. ..
T Consensus 241 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~ 320 (391)
T PHA03212 241 YGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQAN 320 (391)
T ss_pred ccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHH
Confidence 345699999999999998999999999999999999999988753221100 00000000000 000 00
Q ss_pred cceee---------cc--hhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 647 LDVLV---------DN--DKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 647 ~~~~~---------~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
..... .+ ..........+..+.+++.+||+.||++|||++|+++
T Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 321 LDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred HHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00000 00 0000001123457888999999999999999999986
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=318.35 Aligned_cols=257 Identities=27% Similarity=0.385 Sum_probs=205.9
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCC--CCcEEEEEEecccc-hhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEE
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSA--SGNAVAVKKLDKLA-QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLV 496 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~--~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 496 (714)
..+.+.+.||+|+||.||+|.+... +...|+||.++... ......+.+|+.++++++||||+++++++.+.+..+++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 4566788999999999999988633 24589999987543 34456789999999999999999999999999999999
Q ss_pred EeecCCCchhhhhhcC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCc
Q 041576 497 YEFMGNGTLANLLFAI-PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQ 575 (714)
Q Consensus 497 ~E~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 575 (714)
|||+++++|.+++... ..+++..+.+++.|++.||+|||+.+ |+|+||||+||++++++.++|+|||++.......
T Consensus 84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~ 160 (266)
T cd05033 84 TEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE 160 (266)
T ss_pred EEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhcccccc
Confidence 9999999999999764 46899999999999999999999988 9999999999999999999999999998775222
Q ss_pred c-cceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccchhhhhhhHHHhhhhhcCccceeecc
Q 041576 576 S-RTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDN 653 (714)
Q Consensus 576 ~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 653 (714)
. .......++..|+|||.+.+..++.++||||||+++|||++ |..||......... . ....+...
T Consensus 161 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~----~----~~~~~~~~----- 227 (266)
T cd05033 161 ATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVI----K----AVEDGYRL----- 227 (266)
T ss_pred cceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHH----H----HHHcCCCC-----
Confidence 1 11112334678999999998899999999999999999998 99998643322111 1 11111000
Q ss_pred hhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 041576 654 DKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYL 696 (714)
Q Consensus 654 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 696 (714)
..+...+..+.+++.+||+.+|++||++.||++.|++++
T Consensus 228 ----~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~~ 266 (266)
T cd05033 228 ----PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKMI 266 (266)
T ss_pred ----CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence 011223456788999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=322.77 Aligned_cols=258 Identities=26% Similarity=0.414 Sum_probs=208.1
Q ss_pred HhhhhhhhhCcccceeEEEeEeeC----CCCcEEEEEEecccchhhHHHHHHHHHHHhccCcccccceeceEecCCeeeE
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKS----ASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLL 495 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 495 (714)
..+.+.+.||+|+||.||+|.... .++..+++|.+........+.+.+|++++++++|+||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 345667899999999999997542 2345789999987666666789999999999999999999999999999999
Q ss_pred EEeecCCCchhhhhhcC----------------CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCc
Q 041576 496 VYEFMGNGTLANLLFAI----------------PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFT 559 (714)
Q Consensus 496 v~E~~~~gsL~~~l~~~----------------~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~ 559 (714)
||||+++++|.+++... ..+++..++.++.||+.||+|||+++ ++||||||+||+++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 99999999999999653 23688899999999999999999998 999999999999999999
Q ss_pred eEEecCCCccccccCcc-cceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccchhhhhhhHH
Q 041576 560 AKISDFGLSKLLLSDQS-RTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEERSAILTDW 637 (714)
Q Consensus 560 ~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~l~~~ 637 (714)
++|+|||++........ .......++..|+|||.+.+..++.++||||||+++|||++ |+.||.........
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~------ 235 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVI------ 235 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH------
Confidence 99999999976543221 11223346788999999999899999999999999999999 99998654332211
Q ss_pred HhhhhhcCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccC
Q 041576 638 AYDCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLE 697 (714)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 697 (714)
.....+..... ....+..+.+++.+||+.+|++||++++|+++|+++..
T Consensus 236 --~~~~~~~~~~~---------~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 236 --ECITQGRVLER---------PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred --HHHhCCCCCCC---------CccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 11111111111 11234567889999999999999999999999998855
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=322.07 Aligned_cols=264 Identities=23% Similarity=0.283 Sum_probs=194.8
Q ss_pred hhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc--hhhHHHHHHHHHHHhcc---CcccccceeceEe-----cC
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA--QEREREFKTEVSAIGRT---HHKNLVQLLGFCD-----EG 490 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~nIv~l~~~~~-----~~ 490 (714)
+|.+.+.||+|+||.||+|.....+++.||+|.++... ......+.+|+.+++++ +||||+++++++. ..
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~ 81 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 81 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence 46778899999999999998754567899999986432 22234556677766655 7999999999985 34
Q ss_pred CeeeEEEeecCCCchhhhhhcC--CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCc
Q 041576 491 LNRLLVYEFMGNGTLANLLFAI--PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLS 568 (714)
Q Consensus 491 ~~~~lv~E~~~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~ 568 (714)
...++||||++ ++|.+++... ..+++..+..++.||++||+|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 82 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg~~ 157 (290)
T cd07862 82 TKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLA 157 (290)
T ss_pred CcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEccccce
Confidence 56789999997 5899888653 35788999999999999999999998 999999999999999999999999999
Q ss_pred cccccCcccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcC---
Q 041576 569 KLLLSDQSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEG--- 645 (714)
Q Consensus 569 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~--- 645 (714)
...... .......++..|+|||.+.+..++.++|||||||++|||++|+.||......+....+...........
T Consensus 158 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~ 235 (290)
T cd07862 158 RIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR 235 (290)
T ss_pred EeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchh
Confidence 765432 222344589999999999988999999999999999999999999986543332211111100000000
Q ss_pred --cc-ceeecchh---hhccchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 646 --KL-DVLVDNDK---AAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 646 --~~-~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
.. ........ ........+..+.+++.+||+.||++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 236 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 00 00000000 00011123456778999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=329.99 Aligned_cols=260 Identities=29% Similarity=0.396 Sum_probs=203.8
Q ss_pred HHhhhhhhhhCcccceeEEEeEeeC----CCCcEEEEEEecccc-hhhHHHHHHHHHHHhcc-CcccccceeceEec-CC
Q 041576 419 EATNGFEEELGRGSFGIVYKGVLKS----ASGNAVAVKKLDKLA-QEREREFKTEVSAIGRT-HHKNLVQLLGFCDE-GL 491 (714)
Q Consensus 419 ~at~~~~~~ig~G~~g~Vy~~~~~~----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~-~~ 491 (714)
..++.+.+.||+|+||.||+|.... .+++.||+|+++... ....+.+.+|+.++.++ +|+||++++++|.. +.
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 4568888999999999999997532 235789999987532 33446788999999999 89999999998864 45
Q ss_pred eeeEEEeecCCCchhhhhhcC-----------------------------------------------------------
Q 041576 492 NRLLVYEFMGNGTLANLLFAI----------------------------------------------------------- 512 (714)
Q Consensus 492 ~~~lv~E~~~~gsL~~~l~~~----------------------------------------------------------- 512 (714)
..++++||+++++|.+++...
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 678999999999999998532
Q ss_pred --CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcc-cceeeecCCCCcc
Q 041576 513 --PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQS-RTRTVIRGTRGYV 589 (714)
Q Consensus 513 --~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~ 589 (714)
..+++..+..++.||+.||+|||+.+ |+||||||+||++++++.+||+|||++..+..... .......++..|+
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence 25678889999999999999999998 99999999999999999999999999987643322 1222334567899
Q ss_pred CcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhhccchHHHHHHH
Q 041576 590 APEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMADKSRACKWL 668 (714)
Q Consensus 590 aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 668 (714)
|||++.+..++.++|||||||++|||++ |..||......+. +.. ....+... ..+......+.
T Consensus 243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~---~~~----~~~~~~~~---------~~~~~~~~~~~ 306 (337)
T cd05054 243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE---FCR----RLKEGTRM---------RAPEYATPEIY 306 (337)
T ss_pred CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH---HHH----HHhccCCC---------CCCccCCHHHH
Confidence 9999999999999999999999999998 9999864322211 100 11111100 01122345678
Q ss_pred HHHHHccccCCCCCCCHHHHHHHHhcccC
Q 041576 669 MIALWCIQEDPLKRPAMKMIVQMLEGYLE 697 (714)
Q Consensus 669 ~li~~cl~~dP~~RPs~~evl~~L~~~~~ 697 (714)
+++.+||+.+|++||++.||++.|+++++
T Consensus 307 ~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 307 SIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 89999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=335.54 Aligned_cols=252 Identities=25% Similarity=0.316 Sum_probs=205.6
Q ss_pred hhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEE
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA---QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVY 497 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 497 (714)
.|.+.+.||+|+||+||+|... .+++.||+|+++... ......+.+|++++..++||||+++++++.+++..++||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 2 DFEVIKVIGRGAFGEVWLVRDK-DTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CceEEEEEEeCCcEEEEEEEEC-CCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 3567789999999999999876 468999999997532 234567899999999999999999999999999999999
Q ss_pred eecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCc--
Q 041576 498 EFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQ-- 575 (714)
Q Consensus 498 E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~-- 575 (714)
||+++++|.+++.....+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~ 157 (350)
T cd05573 81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDR 157 (350)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCcccCcc
Confidence 99999999999988788999999999999999999999988 9999999999999999999999999998664432
Q ss_pred --------------------------ccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccch
Q 041576 576 --------------------------SRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEE 629 (714)
Q Consensus 576 --------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~ 629 (714)
........|+..|+|||.+.+..++.++|||||||++|||++|+.||.......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~ 237 (350)
T cd05573 158 EYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQE 237 (350)
T ss_pred cccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHH
Confidence 112233468999999999999999999999999999999999999997654322
Q ss_pred hhhhhhHHHhhhhhcCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCC-HHHHHHH
Q 041576 630 RSAILTDWAYDCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPA-MKMIVQM 691 (714)
Q Consensus 630 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~~ 691 (714)
....+..+. .... .......+..+.+++.+||+ ||.+||+ ++|+++.
T Consensus 238 ~~~~i~~~~------~~~~--------~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 238 TYNKIINWK------ESLR--------FPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred HHHHHhccC------Cccc--------CCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 111111100 0000 00011134567789999997 9999999 9999874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=313.72 Aligned_cols=247 Identities=25% Similarity=0.376 Sum_probs=197.7
Q ss_pred hhhCcccceeEEEeEeeCCCCcEEEEEEeccc-chhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEeecCCCc
Q 041576 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDKL-AQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEFMGNGT 504 (714)
Q Consensus 426 ~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~gs 504 (714)
+.||+|+||.||+|.+. .+++.+|+|.+... .......+.+|++++++++||||+++++++......++||||+++++
T Consensus 1 ~~lg~g~~g~vy~~~~~-~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (252)
T cd05084 1 ERIGRGNFGEVFSGRLR-ADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGD 79 (252)
T ss_pred CccCcccCccEEEEEEe-cCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCc
Confidence 46999999999999986 46889999988643 33445679999999999999999999999999999999999999999
Q ss_pred hhhhhhcC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcccce-eee
Q 041576 505 LANLLFAI-PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTR-TVI 582 (714)
Q Consensus 505 L~~~l~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~-~~~ 582 (714)
|.+++... ..+++..++.++.|+++||+|||+.+ ++||||||+||+++.++.+||+|||++........... ...
T Consensus 80 L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 156 (252)
T cd05084 80 FLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMK 156 (252)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCCC
Confidence 99999754 45789999999999999999999998 99999999999999999999999999876432211111 111
Q ss_pred cCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhhccch
Q 041576 583 RGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMADK 661 (714)
Q Consensus 583 ~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 661 (714)
..+..|+|||.+.+..++.++||||||+++|||++ |..|+...........+ ..... ...+.
T Consensus 157 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~--------~~~~~---------~~~~~ 219 (252)
T cd05084 157 QIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAI--------EQGVR---------LPCPE 219 (252)
T ss_pred CCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHH--------HcCCC---------CCCcc
Confidence 23456999999998899999999999999999998 88888643322111100 00000 01112
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 041576 662 SRACKWLMIALWCIQEDPLKRPAMKMIVQMLE 693 (714)
Q Consensus 662 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 693 (714)
..+..+.+++.+||+.+|++|||+.||+++|+
T Consensus 220 ~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 220 LCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 23457888999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=331.86 Aligned_cols=201 Identities=27% Similarity=0.330 Sum_probs=175.9
Q ss_pred hhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEe
Q 041576 422 NGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA---QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYE 498 (714)
Q Consensus 422 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E 498 (714)
+.+.+.||+|+||+||+|... .+++.||+|+++... ......+.+|+.++.+++||||+++++.+.++...++|||
T Consensus 3 y~~~~~LG~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E 81 (363)
T cd05628 3 FESLKVIGRGAFGEVRLVQKK-DTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIME 81 (363)
T ss_pred ceEeEEEEeCCCEEEEEEEEC-CCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEc
Confidence 456789999999999999876 468899999997532 2334578899999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcc--
Q 041576 499 FMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQS-- 576 (714)
Q Consensus 499 ~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~-- 576 (714)
|+++|+|.+++.....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.+.....
T Consensus 82 ~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~ 158 (363)
T cd05628 82 FLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTE 158 (363)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccccccc
Confidence 9999999999988888999999999999999999999998 99999999999999999999999999875432110
Q ss_pred --------------------------------cceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcc
Q 041576 577 --------------------------------RTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEM 624 (714)
Q Consensus 577 --------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~ 624 (714)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~ 238 (363)
T cd05628 159 FYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS 238 (363)
T ss_pred ccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCC
Confidence 001234689999999999999999999999999999999999999975
Q ss_pred cc
Q 041576 625 EL 626 (714)
Q Consensus 625 ~~ 626 (714)
..
T Consensus 239 ~~ 240 (363)
T cd05628 239 ET 240 (363)
T ss_pred CC
Confidence 54
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=344.48 Aligned_cols=249 Identities=20% Similarity=0.233 Sum_probs=203.1
Q ss_pred hhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEeecC
Q 041576 422 NGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEFMG 501 (714)
Q Consensus 422 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~ 501 (714)
|.+.+.||+|++|.||+|......++.||+|.+..........+.+|+.+++.++||||+++++++..++..++||||++
T Consensus 69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~ 148 (478)
T PTZ00267 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGS 148 (478)
T ss_pred EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCC
Confidence 77789999999999999987654477899998766555556678899999999999999999999999999999999999
Q ss_pred CCchhhhhhc----CCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcc-
Q 041576 502 NGTLANLLFA----IPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQS- 576 (714)
Q Consensus 502 ~gsL~~~l~~----~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~- 576 (714)
+|+|.+++.. ...+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 149 gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~ 225 (478)
T PTZ00267 149 GGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSL 225 (478)
T ss_pred CCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCcccc
Confidence 9999988753 345788899999999999999999998 99999999999999999999999999987643322
Q ss_pred cceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhh
Q 041576 577 RTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKA 656 (714)
Q Consensus 577 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 656 (714)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||....... .+. ....+....
T Consensus 226 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~---~~~-----~~~~~~~~~------- 290 (478)
T PTZ00267 226 DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQRE---IMQ-----QVLYGKYDP------- 290 (478)
T ss_pred ccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH---HHH-----HHHhCCCCC-------
Confidence 12334568999999999999999999999999999999999999997543221 111 111111110
Q ss_pred hccchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 657 AMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 657 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
.+......+.+++.+||+.||++||+++++++
T Consensus 291 --~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 291 --FPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred --CCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 11123346788999999999999999999864
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=335.26 Aligned_cols=250 Identities=23% Similarity=0.264 Sum_probs=200.3
Q ss_pred hhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEe
Q 041576 422 NGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA---QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYE 498 (714)
Q Consensus 422 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E 498 (714)
|.+.+.||+|+||.||+|+.. .+++.||||++.... ......+.+|++++..++||||+++++++.+++..++|||
T Consensus 3 y~~~~~lG~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (364)
T cd05599 3 FESIKVIGRGAFGEVRLVQKK-DTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIME 81 (364)
T ss_pred ceEEEEEEecCCEEEEEEEEC-CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEEC
Confidence 556789999999999999976 468899999997532 2344568899999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCccc-
Q 041576 499 FMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSR- 577 (714)
Q Consensus 499 ~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~- 577 (714)
|+++|+|.+++.....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+......
T Consensus 82 ~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~ 158 (364)
T cd05599 82 YLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTE 158 (364)
T ss_pred CCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecccccccc
Confidence 9999999999988888999999999999999999999998 999999999999999999999999998754321100
Q ss_pred ------------------------------------ceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCC
Q 041576 578 ------------------------------------TRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRS 621 (714)
Q Consensus 578 ------------------------------------~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p 621 (714)
......||+.|+|||++.+..++.++|||||||++|||++|..|
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~P 238 (364)
T cd05599 159 FYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPP 238 (364)
T ss_pred ccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCC
Confidence 01123589999999999999999999999999999999999999
Q ss_pred CcccccchhhhhhhHHHhhhhhcCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCC---HHHHHH
Q 041576 622 VEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPA---MKMIVQ 690 (714)
Q Consensus 622 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl~ 690 (714)
|...........+..+ ....... ........+.+++.+|+. +|.+|++ ++|+++
T Consensus 239 f~~~~~~~~~~~i~~~--------~~~~~~~------~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 239 FCSDNPQETYRKIINW--------KETLQFP------DEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred CCCCCHHHHHHHHHcC--------CCccCCC------CCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 9755432211111110 0000000 011223466778888996 9999998 988877
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=335.39 Aligned_cols=252 Identities=23% Similarity=0.279 Sum_probs=198.8
Q ss_pred hhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEe
Q 041576 422 NGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA---QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYE 498 (714)
Q Consensus 422 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E 498 (714)
+.+.+.||+|+||+||+|+.. .+++.||+|++.... ......+.+|++++++++||||+++++++.+.+..++|||
T Consensus 3 f~~~~~LG~G~~g~Vy~~~~~-~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 3 FVKIKTLGIGAFGEVCLACKV-DTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred ceEEEEEeecCCEEEEEEEEC-CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 456788999999999999876 578899999996532 3345678999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcc--
Q 041576 499 FMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQS-- 576 (714)
Q Consensus 499 ~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~-- 576 (714)
|+++|+|.+++.....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++++||+|||++........
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~ 158 (381)
T cd05626 82 YIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSK 158 (381)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCcccccccccc
Confidence 9999999999988888899999999999999999999998 99999999999999999999999999764311000
Q ss_pred --------------------------------------------cceeeecCCCCccCcccccCCCCCchhhhHHHHHHH
Q 041576 577 --------------------------------------------RTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVL 612 (714)
Q Consensus 577 --------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil 612 (714)
.......||..|+|||.+.+..++.++|||||||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il 238 (381)
T cd05626 159 YYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVIL 238 (381)
T ss_pred cccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHH
Confidence 001234689999999999988899999999999999
Q ss_pred HHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhhccchHHHHHHHHHHHH--ccccCCCCCCCHHHHHH
Q 041576 613 LKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMADKSRACKWLMIALW--CIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 613 ~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~--cl~~dP~~RPs~~evl~ 690 (714)
|||++|+.||...........+..+ ..... .........++.+++.+ |+..+|..||+++|+++
T Consensus 239 ~elltG~~Pf~~~~~~~~~~~i~~~------~~~~~--------~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~ 304 (381)
T cd05626 239 FEMLVGQPPFLAPTPTETQLKVINW------ENTLH--------IPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKA 304 (381)
T ss_pred HHHHhCCCCCcCCCHHHHHHHHHcc------ccccC--------CCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhc
Confidence 9999999999765433211111110 00000 00011123456667776 55667777999999987
Q ss_pred H
Q 041576 691 M 691 (714)
Q Consensus 691 ~ 691 (714)
.
T Consensus 305 h 305 (381)
T cd05626 305 H 305 (381)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=313.88 Aligned_cols=248 Identities=27% Similarity=0.387 Sum_probs=199.5
Q ss_pred hhCcccceeEEEeEee-CCCCcEEEEEEecccc--hhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEeecCCC
Q 041576 427 ELGRGSFGIVYKGVLK-SASGNAVAVKKLDKLA--QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEFMGNG 503 (714)
Q Consensus 427 ~ig~G~~g~Vy~~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~g 503 (714)
+||+|+||.||+|.++ ..++..+|+|+++... ....+++.+|+.++++++||||+++++++. .+..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 6899999999999764 3457789999986432 334568899999999999999999999885 45678999999999
Q ss_pred chhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcccce--ee
Q 041576 504 TLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTR--TV 581 (714)
Q Consensus 504 sL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~--~~ 581 (714)
+|.+++.....+++..+..++.|++.||+|||+++ ++||||||+||++++++.+||+|||++........... ..
T Consensus 81 ~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05116 81 PLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTH 157 (257)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCC
Confidence 99999987778899999999999999999999998 99999999999999999999999999987644332211 12
Q ss_pred ecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhhccc
Q 041576 582 IRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMAD 660 (714)
Q Consensus 582 ~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 660 (714)
..++..|+|||.+....++.++||||||+++|||++ |+.||.......... ....+... ..+
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~--------~i~~~~~~---------~~~ 220 (257)
T cd05116 158 GKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQ--------MIESGERM---------ECP 220 (257)
T ss_pred CCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH--------HHHCCCCC---------CCC
Confidence 234578999999988889999999999999999998 999997543322111 11111110 112
Q ss_pred hHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 041576 661 KSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGY 695 (714)
Q Consensus 661 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 695 (714)
...+..+.+++.+||+.||++||++.+|.+.|++.
T Consensus 221 ~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 221 QRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred CCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 22345778899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=316.03 Aligned_cols=251 Identities=28% Similarity=0.400 Sum_probs=201.6
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEee
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEF 499 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~ 499 (714)
..+.+.+.||+|++|.||+|... .+..+|+|.+.... .....+.+|+.++++++||||+++++++.+....++||||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~--~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWR--GQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEY 80 (256)
T ss_pred HHeEEeeEecCcccceEEEEEec--CCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEc
Confidence 34667789999999999999865 35579999987532 3346789999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcccc
Q 041576 500 MGNGTLANLLFAI-PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRT 578 (714)
Q Consensus 500 ~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 578 (714)
+++++|.+++... ..+++..++.++.||+.||+|||+.+ ++|+||||+||++++++.+||+|||.++.........
T Consensus 81 ~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05113 81 MSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS 157 (256)
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCceee
Confidence 9999999999764 46799999999999999999999998 9999999999999999999999999988654433222
Q ss_pred eeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhh
Q 041576 579 RTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAA 657 (714)
Q Consensus 579 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 657 (714)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||.......... ....+...
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~--------~~~~~~~~--------- 220 (256)
T cd05113 158 SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVE--------KVSQGLRL--------- 220 (256)
T ss_pred cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHH--------HHhcCCCC---------
Confidence 222335678999999988889999999999999999998 999986443221111 11111110
Q ss_pred ccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 041576 658 MADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLE 693 (714)
Q Consensus 658 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 693 (714)
..+...+..+.+++.+||+.+|.+||++.+|++.|+
T Consensus 221 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 221 YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 001122457788999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=334.63 Aligned_cols=262 Identities=24% Similarity=0.340 Sum_probs=204.9
Q ss_pred HHHHhhhhhhhhCcccceeEEEeEeeC----CCCcEEEEEEecccc-hhhHHHHHHHHHHHhccC-cccccceeceEecC
Q 041576 417 LNEATNGFEEELGRGSFGIVYKGVLKS----ASGNAVAVKKLDKLA-QEREREFKTEVSAIGRTH-HKNLVQLLGFCDEG 490 (714)
Q Consensus 417 l~~at~~~~~~ig~G~~g~Vy~~~~~~----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~ 490 (714)
.....+.+.+.||+|+||.||+|+... ..+..||||+++... ....+.+.+|+++++++. ||||+++++++.+.
T Consensus 34 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~ 113 (400)
T cd05105 34 FPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKS 113 (400)
T ss_pred ccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC
Confidence 344566778999999999999998632 223479999997533 333467999999999995 99999999999999
Q ss_pred CeeeEEEeecCCCchhhhhhcC----------------------------------------------------------
Q 041576 491 LNRLLVYEFMGNGTLANLLFAI---------------------------------------------------------- 512 (714)
Q Consensus 491 ~~~~lv~E~~~~gsL~~~l~~~---------------------------------------------------------- 512 (714)
...++||||+++|+|.++++..
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (400)
T cd05105 114 GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLE 193 (400)
T ss_pred CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhh
Confidence 9999999999999999988642
Q ss_pred --------------------------------------CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEE
Q 041576 513 --------------------------------------PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILL 554 (714)
Q Consensus 513 --------------------------------------~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll 554 (714)
..+++..++.++.||++||+|||+.+ |+|+||||+||++
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill 270 (400)
T cd05105 194 IKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLL 270 (400)
T ss_pred hhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEE
Confidence 13566778899999999999999998 9999999999999
Q ss_pred CCCCceEEecCCCccccccCccc-ceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccchhhh
Q 041576 555 DQDFTAKISDFGLSKLLLSDQSR-TRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEERSA 632 (714)
Q Consensus 555 ~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~ 632 (714)
++++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..||........
T Consensus 271 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~-- 348 (400)
T cd05105 271 AQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST-- 348 (400)
T ss_pred eCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH--
Confidence 99999999999999865433221 1222346778999999998899999999999999999997 8899864322211
Q ss_pred hhhHHHhhhhhcCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccC
Q 041576 633 ILTDWAYDCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLE 697 (714)
Q Consensus 633 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 697 (714)
+ ......+.. ...+...+..+.+++.+||+.||++||++.+|.++|+++++
T Consensus 349 -~----~~~~~~~~~---------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 349 -F----YNKIKSGYR---------MAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred -H----HHHHhcCCC---------CCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 0 001111100 00112234567889999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=329.51 Aligned_cols=271 Identities=21% Similarity=0.313 Sum_probs=200.8
Q ss_pred hhhhhhhCcccceeEEEeEeeCCCCcEEEEEEeccc--chhhHHHHHHHHHHHhccCcccccceeceEecC-----Ceee
Q 041576 422 NGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKL--AQEREREFKTEVSAIGRTHHKNLVQLLGFCDEG-----LNRL 494 (714)
Q Consensus 422 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-----~~~~ 494 (714)
|.+.+.||+|+||.||+|+.. .+++.||||++... .......+.+|++++++++||||+++++++... ...+
T Consensus 2 y~i~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 2 YKIQEVIGKGSYGVVCSAIDT-HTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred eEEEEEEeecCCeEEEEEEEC-CCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 567789999999999999875 57899999998642 223345788999999999999999999988543 2479
Q ss_pred EEEeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccC
Q 041576 495 LVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSD 574 (714)
Q Consensus 495 lv~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 574 (714)
+||||+. ++|.+++.....+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 156 (338)
T cd07859 81 VVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFND 156 (338)
T ss_pred EEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCccccccccc
Confidence 9999996 589999988788999999999999999999999998 999999999999999999999999999865332
Q ss_pred cc--cceeeecCCCCccCcccccC--CCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHH-------hhhhh
Q 041576 575 QS--RTRTVIRGTRGYVAPEWFKN--VPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWA-------YDCYV 643 (714)
Q Consensus 575 ~~--~~~~~~~gt~~y~aPE~~~~--~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~-------~~~~~ 643 (714)
.. .......++..|+|||++.+ ..++.++|||||||++|||++|+.||...........+.... .....
T Consensus 157 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 236 (338)
T cd07859 157 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVR 236 (338)
T ss_pred cCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhh
Confidence 21 11233568999999999875 678999999999999999999999997543221111110000 00000
Q ss_pred cCccceeec---chhh---hccchHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HhcccC
Q 041576 644 EGKLDVLVD---NDKA---AMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM--LEGYLE 697 (714)
Q Consensus 644 ~~~~~~~~~---~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~~~ 697 (714)
......... .... ...-......+.+++.+||+.||++|||++|+++. ++++..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~ 298 (338)
T cd07859 237 NEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAK 298 (338)
T ss_pred hhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCc
Confidence 000000000 0000 00001123467789999999999999999999974 544443
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=328.58 Aligned_cols=252 Identities=23% Similarity=0.256 Sum_probs=200.7
Q ss_pred hhhhhhhCcccceeEEEeEeeC--CCCcEEEEEEecccc----hhhHHHHHHHHHHHhcc-CcccccceeceEecCCeee
Q 041576 422 NGFEEELGRGSFGIVYKGVLKS--ASGNAVAVKKLDKLA----QEREREFKTEVSAIGRT-HHKNLVQLLGFCDEGLNRL 494 (714)
Q Consensus 422 ~~~~~~ig~G~~g~Vy~~~~~~--~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~ 494 (714)
|.+.+.||+|+||.||+++... .+++.||+|.+.+.. ....+.+.+|+.++.++ +||||+++++++..++..+
T Consensus 2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (332)
T cd05614 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLH 81 (332)
T ss_pred ceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEE
Confidence 5567899999999999987632 367899999986532 22345678899999999 5999999999999999999
Q ss_pred EEEeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccC
Q 041576 495 LVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSD 574 (714)
Q Consensus 495 lv~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 574 (714)
+||||+++|+|.+++.....+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 82 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~ 158 (332)
T cd05614 82 LILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSE 158 (332)
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcccccc
Confidence 99999999999999988888999999999999999999999998 999999999999999999999999999865443
Q ss_pred cccceeeecCCCCccCcccccCC-CCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecc
Q 041576 575 QSRTRTVIRGTRGYVAPEWFKNV-PVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDN 653 (714)
Q Consensus 575 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 653 (714)
.........|+..|+|||.+.+. .++.++|||||||++|||++|+.||...........+.. ...... .
T Consensus 159 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~----~~~~~~------~ 228 (332)
T cd05614 159 EKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSR----RILKCD------P 228 (332)
T ss_pred CCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHH----HHhcCC------C
Confidence 33333345689999999999865 478999999999999999999999975432221111111 011100 0
Q ss_pred hhhhccchHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 041576 654 DKAAMADKSRACKWLMIALWCIQEDPLKRP-----AMKMIVQ 690 (714)
Q Consensus 654 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 690 (714)
..+......+.+++.+||+.||++|| +++++++
T Consensus 229 ----~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 229 ----PFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred ----CCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 01122344677899999999999999 7778875
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=329.49 Aligned_cols=243 Identities=26% Similarity=0.293 Sum_probs=198.2
Q ss_pred hhhCcccceeEEEeEeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEeecCC
Q 041576 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA---QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEFMGN 502 (714)
Q Consensus 426 ~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~ 502 (714)
+.||+|+||.||++... .+++.||+|.++... ......+.+|+++++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~-~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 79 (325)
T cd05594 1 KLLGKGTFGKVILVKEK-ATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANG 79 (325)
T ss_pred CeeeeCCCEEEEEEEEC-CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46899999999999875 578999999997532 23345678899999999999999999999999999999999999
Q ss_pred CchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHh-cCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcccceee
Q 041576 503 GTLANLLFAIPRPDWSLRVRISLEIARGLLYLHE-ECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTV 581 (714)
Q Consensus 503 gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~-~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 581 (714)
++|.+++.....+++..+..++.||+.||+|||+ .+ |+||||||+|||++.++.+||+|||+++....... ....
T Consensus 80 ~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~~~ 155 (325)
T cd05594 80 GELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-TMKT 155 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc-cccc
Confidence 9999999887889999999999999999999997 56 99999999999999999999999999875432221 2223
Q ss_pred ecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhhccch
Q 041576 582 IRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMADK 661 (714)
Q Consensus 582 ~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 661 (714)
..|+..|+|||.+.+..++.++|||||||++|||++|+.||...........+ ..... ..+.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i--------~~~~~----------~~p~ 217 (325)
T cd05594 156 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI--------LMEEI----------RFPR 217 (325)
T ss_pred ccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHH--------hcCCC----------CCCC
Confidence 46899999999999999999999999999999999999999754332211110 00000 0111
Q ss_pred HHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 041576 662 SRACKWLMIALWCIQEDPLKRP-----AMKMIVQM 691 (714)
Q Consensus 662 ~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 691 (714)
.....+.+++.+||+.||++|+ ++.++++.
T Consensus 218 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 218 TLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 2344677899999999999996 89999753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=324.73 Aligned_cols=242 Identities=27% Similarity=0.338 Sum_probs=193.5
Q ss_pred hhhCcccceeEEEeEeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHHhcc-CcccccceeceEecCCeeeEEEeecC
Q 041576 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA---QEREREFKTEVSAIGRT-HHKNLVQLLGFCDEGLNRLLVYEFMG 501 (714)
Q Consensus 426 ~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~E~~~ 501 (714)
+.||+|+||.||+|... .+++.||+|.++... ....+.+..|..++... +||||+++++++..+...++||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~ 79 (316)
T cd05592 1 KVLGKGSFGKVMLAELK-GTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLN 79 (316)
T ss_pred CeeeeCCCeEEEEEEEC-CCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCC
Confidence 46999999999999876 468899999997532 22334556677777654 89999999999999999999999999
Q ss_pred CCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcccceee
Q 041576 502 NGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTV 581 (714)
Q Consensus 502 ~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 581 (714)
+|+|.+++.....+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++....... .....
T Consensus 80 gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~~~ 155 (316)
T cd05592 80 GGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKAST 155 (316)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Ccccc
Confidence 9999999988788999999999999999999999998 9999999999999999999999999997543222 22234
Q ss_pred ecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhhccch
Q 041576 582 IRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMADK 661 (714)
Q Consensus 582 ~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 661 (714)
..|+..|+|||.+.+..++.++|||||||++|||++|+.||........ ... ..... ...+.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~---~~~-----i~~~~----------~~~~~ 217 (316)
T cd05592 156 FCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDEL---FDS-----ILNDR----------PHFPR 217 (316)
T ss_pred ccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHH---HHH-----HHcCC----------CCCCC
Confidence 5689999999999998999999999999999999999999975433221 111 01100 00111
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHH-HHHH
Q 041576 662 SRACKWLMIALWCIQEDPLKRPAMK-MIVQ 690 (714)
Q Consensus 662 ~~~~~l~~li~~cl~~dP~~RPs~~-evl~ 690 (714)
.....+.+++.+||+.||++||++. ++++
T Consensus 218 ~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 218 WISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred CCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 2334567899999999999999875 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=318.54 Aligned_cols=268 Identities=25% Similarity=0.336 Sum_probs=202.5
Q ss_pred hhhhhhCcccceeEEEeEee---CCCCcEEEEEEecccc-hhhHHHHHHHHHHHhccCcccccceeceEecC--CeeeEE
Q 041576 423 GFEEELGRGSFGIVYKGVLK---SASGNAVAVKKLDKLA-QEREREFKTEVSAIGRTHHKNLVQLLGFCDEG--LNRLLV 496 (714)
Q Consensus 423 ~~~~~ig~G~~g~Vy~~~~~---~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~lv 496 (714)
.+.+.||+|+||+||++..+ ..++..||+|.++... ......+.+|++++++++||||+++++++... ...+++
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence 67789999999999887632 2467789999987543 23456788999999999999999999988653 457899
Q ss_pred EeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcc
Q 041576 497 YEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQS 576 (714)
Q Consensus 497 ~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 576 (714)
|||+++++|.+++.. ..+++.++..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||++........
T Consensus 87 ~e~~~~~~l~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 162 (283)
T cd05080 87 MEYVPLGSLRDYLPK-HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE 162 (283)
T ss_pred ecCCCCCCHHHHHHH-cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccCCcch
Confidence 999999999999976 45899999999999999999999998 99999999999999999999999999986643322
Q ss_pred cc--eeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecch
Q 041576 577 RT--RTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDND 654 (714)
Q Consensus 577 ~~--~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 654 (714)
.. .....++..|+|||.+.+..++.++||||||+++|||++|..|+......... ..................+..
T Consensus 163 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 240 (283)
T cd05080 163 YYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEE--MIGPKQGQMTVVRLIELLERG 240 (283)
T ss_pred hhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhh--hhcccccccchhhhhhhhhcC
Confidence 11 11223566799999999888999999999999999999999998643221100 000000000000011111111
Q ss_pred hhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 041576 655 KAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYL 696 (714)
Q Consensus 655 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 696 (714)
.....+...+..+.+++.+||+.+|++|||+++|+++|+.+.
T Consensus 241 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 241 MRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred CCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 111122334567888999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=327.07 Aligned_cols=247 Identities=23% Similarity=0.369 Sum_probs=193.4
Q ss_pred hhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc-hhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEeec
Q 041576 422 NGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA-QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEFM 500 (714)
Q Consensus 422 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~ 500 (714)
+.+.++||+|+||.||+|++. .+++.||||.+.... ......+.+|++++++++|+||+++++++..++..++||||+
T Consensus 76 ~~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 154 (353)
T PLN00034 76 LERVNRIGSGAGGTVYKVIHR-PTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFM 154 (353)
T ss_pred HhhhhhccCCCCeEEEEEEEC-CCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecC
Confidence 345688999999999999876 568899999986532 334567899999999999999999999999999999999999
Q ss_pred CCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCccccee
Q 041576 501 GNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRT 580 (714)
Q Consensus 501 ~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 580 (714)
++++|.+. ...++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||++..+..... ...
T Consensus 155 ~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-~~~ 226 (353)
T PLN00034 155 DGGSLEGT----HIADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD-PCN 226 (353)
T ss_pred CCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceecccccc-ccc
Confidence 99998654 23467778899999999999999998 99999999999999999999999999986643221 122
Q ss_pred eecCCCCccCcccccC-----CCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchh
Q 041576 581 VIRGTRGYVAPEWFKN-----VPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDK 655 (714)
Q Consensus 581 ~~~gt~~y~aPE~~~~-----~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 655 (714)
...|+..|+|||.+.. ...+.++|||||||++|||++|+.||............... ....
T Consensus 227 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~-----~~~~--------- 292 (353)
T PLN00034 227 SSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAI-----CMSQ--------- 292 (353)
T ss_pred ccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHH-----hccC---------
Confidence 3468999999998843 23456899999999999999999999733222111111000 0000
Q ss_pred hhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 656 AAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 656 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
..........++.+++.+||+.||++||++.|+++.
T Consensus 293 ~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 293 PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 001122334578889999999999999999999985
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=326.84 Aligned_cols=250 Identities=23% Similarity=0.333 Sum_probs=211.3
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecc--cchhhHHHHHHHHHHHhccCcccccceeceEecCCe-eeEE
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDK--LAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLN-RLLV 496 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~-~~lv 496 (714)
..|.+.+++|+|+||.++..+++ .++..+++|++.- ......+..++|+.++++++|||||.+.+.+.+++. .+||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk-~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHK-SDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred chhhhhhhcCccccchhhhhhhc-cCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 35778899999999999998877 4667999998854 334445578999999999999999999999998888 8999
Q ss_pred EeecCCCchhhhhhcCC--CCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccC
Q 041576 497 YEFMGNGTLANLLFAIP--RPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSD 574 (714)
Q Consensus 497 ~E~~~~gsL~~~l~~~~--~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 574 (714)
|+|++||+|.+.+...+ .++++.+.+++.||+.|++|||++. |+|||||+.||+++.+..+||+|||+|+.+..+
T Consensus 83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 99999999999998654 5789999999999999999999887 999999999999999999999999999988765
Q ss_pred cccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecch
Q 041576 575 QSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDND 654 (714)
Q Consensus 575 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 654 (714)
.. ......||+.|+.||.+.+.+|..|+|||||||++|||++-+++|...+-......+ ....
T Consensus 160 ~~-~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki------------~~~~---- 222 (426)
T KOG0589|consen 160 DS-LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKI------------NRGL---- 222 (426)
T ss_pred hh-hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHH------------hhcc----
Confidence 53 334567999999999999999999999999999999999999999865433211111 0111
Q ss_pred hhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 655 KAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 655 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
....+..+..++..++..||+.+|..||++.+++.+
T Consensus 223 -~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 223 -YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred -CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 122445566788889999999999999999999875
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=325.77 Aligned_cols=237 Identities=27% Similarity=0.354 Sum_probs=193.7
Q ss_pred hhhCcccceeEEEeEeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHHhcc-CcccccceeceEecCCeeeEEEeecC
Q 041576 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA---QEREREFKTEVSAIGRT-HHKNLVQLLGFCDEGLNRLLVYEFMG 501 (714)
Q Consensus 426 ~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~E~~~ 501 (714)
+.||+|+||.||+|..+ .+++.||+|.++... ......+..|..++..+ +||||+++++++...+..++||||++
T Consensus 1 ~~lg~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~ 79 (320)
T cd05590 1 RVLGKGSFGKVMLARLK-ESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVN 79 (320)
T ss_pred CeeeeCCCeEEEEEEEc-CCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCC
Confidence 46899999999999876 468899999997532 23445677888888876 79999999999999999999999999
Q ss_pred CCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcccceee
Q 041576 502 NGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTV 581 (714)
Q Consensus 502 ~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 581 (714)
+++|.+++.....+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++...... .....
T Consensus 80 ~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-~~~~~ 155 (320)
T cd05590 80 GGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG-KTTST 155 (320)
T ss_pred CchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-Ccccc
Confidence 9999999988888999999999999999999999998 9999999999999999999999999987542221 12233
Q ss_pred ecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhhccch
Q 041576 582 IRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMADK 661 (714)
Q Consensus 582 ~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 661 (714)
..|++.|+|||.+.+..++.++|||||||++|||++|+.||.......... ....+... .+.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~--------~i~~~~~~----------~~~ 217 (320)
T cd05590 156 FCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFE--------AILNDEVV----------YPT 217 (320)
T ss_pred cccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHH--------HHhcCCCC----------CCC
Confidence 568999999999999999999999999999999999999997543322111 11111110 111
Q ss_pred HHHHHHHHHHHHccccCCCCCCCH
Q 041576 662 SRACKWLMIALWCIQEDPLKRPAM 685 (714)
Q Consensus 662 ~~~~~l~~li~~cl~~dP~~RPs~ 685 (714)
.....+.+++.+||+.||++||++
T Consensus 218 ~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 218 WLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred CCCHHHHHHHHHHcccCHHHCCCC
Confidence 233467789999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=321.48 Aligned_cols=262 Identities=21% Similarity=0.236 Sum_probs=195.4
Q ss_pred hhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccch-hhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEee
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQ-EREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEF 499 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~ 499 (714)
.|.+.+.||+|+||.||+|..+ .+++.||||+++.... .....+.+|++++++++||||+++++++.++...++||||
T Consensus 6 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (303)
T cd07869 6 SYEKLEKLGEGSYATVYKGKSK-VNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEY 84 (303)
T ss_pred cceEeeeEEecCCEEEEEEEEC-CCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEEC
Confidence 4667889999999999999876 4688999999875332 2334678899999999999999999999999999999999
Q ss_pred cCCCchhhhhhcC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcccc
Q 041576 500 MGNGTLANLLFAI-PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRT 578 (714)
Q Consensus 500 ~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 578 (714)
++ ++|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+||++++++.+||+|||++....... ..
T Consensus 85 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~ 159 (303)
T cd07869 85 VH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS-HT 159 (303)
T ss_pred CC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCC-cc
Confidence 96 5777776543 56788999999999999999999998 9999999999999999999999999987543221 12
Q ss_pred eeeecCCCCccCcccccC-CCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhh-------hhhc------
Q 041576 579 RTVIRGTRGYVAPEWFKN-VPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYD-------CYVE------ 644 (714)
Q Consensus 579 ~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~-------~~~~------ 644 (714)
.....++..|+|||.+.+ ..++.++||||+||++|||++|+.||........ .+...... .+..
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (303)
T cd07869 160 YSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQD--QLERIFLVLGTPNEDTWPGVHSLPH 237 (303)
T ss_pred CCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH--HHHHHHHHhCCCChhhccchhhccc
Confidence 223457899999998865 4588999999999999999999999975422111 11000000 0000
Q ss_pred ---Cccceeecchhhh-ccchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 645 ---GKLDVLVDNDKAA-MADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 645 ---~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
............. .........+.+++.+||+.||++|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 238 FKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred cccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 0000000000000 000012245778999999999999999999986
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=330.54 Aligned_cols=263 Identities=22% Similarity=0.284 Sum_probs=201.0
Q ss_pred hhhhhhCcccceeEEEeEeeCCCCcEEEEEEeccc--chhhHHHHHHHHHHHhccCcccccceeceEecCC-----eeeE
Q 041576 423 GFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKL--AQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGL-----NRLL 495 (714)
Q Consensus 423 ~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-----~~~l 495 (714)
.+.+.||+|+||.||+|... .+++.||||++... .....+.+.+|+++++.++||||+++++++.... ..++
T Consensus 3 ~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 81 (372)
T cd07853 3 EPDRPIGYGAFGVVWSVTDP-RDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYV 81 (372)
T ss_pred cccceeeeCCCEEEEEEEEC-CCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEE
Confidence 45688999999999999875 57899999998653 2334567889999999999999999999998776 7899
Q ss_pred EEeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCc
Q 041576 496 VYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQ 575 (714)
Q Consensus 496 v~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 575 (714)
|+||+. ++|.+.+.....+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 82 v~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~ 157 (372)
T cd07853 82 VTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDE 157 (372)
T ss_pred Eeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeecccCc
Confidence 999997 588888887788999999999999999999999998 9999999999999999999999999998654433
Q ss_pred ccceeeecCCCCccCcccccCC-CCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHH---------------h
Q 041576 576 SRTRTVIRGTRGYVAPEWFKNV-PVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWA---------------Y 639 (714)
Q Consensus 576 ~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~---------------~ 639 (714)
........++..|+|||.+.+. .++.++|||||||++|||++|+.||...........+.... .
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 237 (372)
T cd07853 158 SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGAR 237 (372)
T ss_pred cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHH
Confidence 3333344578899999998774 47999999999999999999999997654332211111100 0
Q ss_pred hhhhcCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 640 DCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 640 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
......... .................+.+++.+||+.||++|||+.|+++.
T Consensus 238 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 238 AHILRGPHK-PPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHhCCCC-CCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 000000000 000000000111224577889999999999999999999874
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=325.47 Aligned_cols=243 Identities=25% Similarity=0.305 Sum_probs=197.7
Q ss_pred hhhCcccceeEEEeEee--CCCCcEEEEEEecccc----hhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEee
Q 041576 426 EELGRGSFGIVYKGVLK--SASGNAVAVKKLDKLA----QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEF 499 (714)
Q Consensus 426 ~~ig~G~~g~Vy~~~~~--~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~ 499 (714)
+.||+|+||.||++... ...++.||+|.++... ......+.+|++++++++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 57999999999999763 2467899999997532 22345678999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcccce
Q 041576 500 MGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTR 579 (714)
Q Consensus 500 ~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 579 (714)
+++++|.+++.....+.+..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++....... ..
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~ 157 (323)
T cd05584 82 LSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT-VT 157 (323)
T ss_pred CCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC-cc
Confidence 999999999988788889999999999999999999998 99999999999999999999999999875432221 22
Q ss_pred eeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhhcc
Q 041576 580 TVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMA 659 (714)
Q Consensus 580 ~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 659 (714)
....|+..|+|||++.+..++.++||||||+++|||++|+.||........ + .....+... .
T Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~---~-----~~~~~~~~~----------~ 219 (323)
T cd05584 158 HTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKT---I-----DKILKGKLN----------L 219 (323)
T ss_pred cccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHH---H-----HHHHcCCCC----------C
Confidence 334689999999999988899999999999999999999999975432211 1 111111110 1
Q ss_pred chHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 041576 660 DKSRACKWLMIALWCIQEDPLKRP-----AMKMIVQ 690 (714)
Q Consensus 660 ~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 690 (714)
+......+.+++.+||+.||++|| +++++++
T Consensus 220 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 220 PPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred CCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 112234677899999999999999 7888876
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=318.92 Aligned_cols=255 Identities=29% Similarity=0.417 Sum_probs=201.8
Q ss_pred HhhhhhhhhCcccceeEEEeEee---CCCCcEEEEEEeccc-chhhHHHHHHHHHHHhccCcccccceeceEecCCeeeE
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLK---SASGNAVAVKKLDKL-AQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLL 495 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~---~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 495 (714)
..+.+.+.||+|+||.||+|... ...++.|++|.+... .......+.+|++++++++||||+++++++..+...++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 44567789999999999999853 234578999999753 33445678999999999999999999999999999999
Q ss_pred EEeecCCCchhhhhhcC-----------------CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCC
Q 041576 496 VYEFMGNGTLANLLFAI-----------------PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDF 558 (714)
Q Consensus 496 v~E~~~~gsL~~~l~~~-----------------~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~ 558 (714)
||||+++++|.+++... ..+++...+.++.|++.||+|||+++ ++||||||+||++++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence 99999999999998532 23678888999999999999999998 99999999999999999
Q ss_pred ceEEecCCCccccccCcc-cceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccchhhhhhhH
Q 041576 559 TAKISDFGLSKLLLSDQS-RTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEERSAILTD 636 (714)
Q Consensus 559 ~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~l~~ 636 (714)
.+||+|||++........ .......++..|+|||.+.+..++.++||||||+++|||++ |..||..........
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~---- 237 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIE---- 237 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHH----
Confidence 999999999986543321 11222335678999999988889999999999999999998 888886433221111
Q ss_pred HHhhhhhcCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 041576 637 WAYDCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEG 694 (714)
Q Consensus 637 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 694 (714)
........ ..+...+..+.+++.+||+.||++||++.+|++.|..
T Consensus 238 ----~~~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 238 ----MVRKRQLL---------PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred ----HHHcCCcC---------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 11111110 0112234567889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-38 Score=312.92 Aligned_cols=256 Identities=26% Similarity=0.304 Sum_probs=197.5
Q ss_pred hhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCcccccceeceEecCC-----eeeEEEee
Q 041576 425 EEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGL-----NRLLVYEF 499 (714)
Q Consensus 425 ~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-----~~~lv~E~ 499 (714)
.+.+|+|+||.||+|++.. +++.||||+.-...+ .-.+|+.+|+.++|||||+++-+|.... ...+||||
T Consensus 29 ~~liG~GsFg~Vyq~~~~e-~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVley 103 (364)
T KOG0658|consen 29 VRLIGSGSFGVVYQAKLRE-TEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEY 103 (364)
T ss_pred eEEEeecccceEEEEEEcC-CCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHh
Confidence 4789999999999999884 588999999854322 2357899999999999999999884332 23589999
Q ss_pred cCCCchhhhhhc----CCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCC-CceEEecCCCccccccC
Q 041576 500 MGNGTLANLLFA----IPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQD-FTAKISDFGLSKLLLSD 574 (714)
Q Consensus 500 ~~~gsL~~~l~~----~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~-~~~kl~Dfg~~~~~~~~ 574 (714)
|+. +|.+.++. +.+++...+.-+..||.+||+|||+.+ |+||||||.|+|+|.+ |.+||+|||.|+.+...
T Consensus 104 mP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~ 179 (364)
T KOG0658|consen 104 MPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKG 179 (364)
T ss_pred chH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceeeccC
Confidence 997 89888874 567888888999999999999999988 9999999999999977 89999999999988665
Q ss_pred cccceeeecCCCCccCcccccCC-CCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHh----hhhh------
Q 041576 575 QSRTRTVIRGTRGYVAPEWFKNV-PVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAY----DCYV------ 643 (714)
Q Consensus 575 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~----~~~~------ 643 (714)
+.. .....|..|+|||.+.+. .|+.+.||||.||++.||+-|++.|.+++..++...+..... +.+.
T Consensus 180 epn--iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y 257 (364)
T KOG0658|consen 180 EPN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNY 257 (364)
T ss_pred CCc--eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCccc
Confidence 544 334468899999998765 699999999999999999999999988765554333322110 0000
Q ss_pred -cCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 644 -EGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 644 -~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
+.+...+...............++++++.++|+++|.+|.++.|++..
T Consensus 258 ~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 258 TEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred ccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 111111111111112334455688899999999999999999999863
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=299.79 Aligned_cols=251 Identities=25% Similarity=0.332 Sum_probs=207.0
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEec--ccchhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEE
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLD--KLAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVY 497 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 497 (714)
..|.+.++||+|.|+.||+.... .+|+.+|+|++. +......+++.+|+++-+.++||||+++++.+.+....|||+
T Consensus 11 d~y~l~e~igkG~FSvVrRc~~~-~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 11 DNYDVKEELGKGAFSVVRRCVHK-TTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred hhhhHHHHHccCchHHHHHHHhc-cchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 45777899999999999998766 689999999874 344456788999999999999999999999999999999999
Q ss_pred eecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECC---CCceEEecCCCccccccC
Q 041576 498 EFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQ---DFTAKISDFGLSKLLLSD 574 (714)
Q Consensus 498 E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~---~~~~kl~Dfg~~~~~~~~ 574 (714)
|+|.|+.|..-+-.+...++..+-..+.||++||+|+|.++ |||||+||+|+++.. .--+||+|||+|..+.
T Consensus 90 e~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~-- 164 (355)
T KOG0033|consen 90 DLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN-- 164 (355)
T ss_pred ecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEeC--
Confidence 99999999877776666788899999999999999999998 999999999999954 3458999999999876
Q ss_pred cccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecch
Q 041576 575 QSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDND 654 (714)
Q Consensus 575 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 654 (714)
.........||++|||||+++..+++..+|||+.|||||-|+.|..||..+...... +.+..+..+. +
T Consensus 165 ~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rly--------e~I~~g~yd~--~-- 232 (355)
T KOG0033|consen 165 DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLY--------EQIKAGAYDY--P-- 232 (355)
T ss_pred CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHH--------HHHhccccCC--C--
Confidence 233334567999999999999999999999999999999999999999875544322 2222222221 1
Q ss_pred hhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 655 KAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 655 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
...-....++..+|+.+||..||.+|.|+.|.++
T Consensus 233 --~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 233 --SPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred --CcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 1111223456677999999999999999999875
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=324.60 Aligned_cols=259 Identities=24% Similarity=0.347 Sum_probs=203.6
Q ss_pred HHHhhhhhhhhCcccceeEEEeEeeCCCCc----EEEEEEecccc-hhhHHHHHHHHHHHhccCcccccceeceEecCCe
Q 041576 418 NEATNGFEEELGRGSFGIVYKGVLKSASGN----AVAVKKLDKLA-QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLN 492 (714)
Q Consensus 418 ~~at~~~~~~ig~G~~g~Vy~~~~~~~~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 492 (714)
....+...+.||+|+||.||+|++.. ++. .||+|.++... ....+++.+|+.+++.++||||+++++++... .
T Consensus 5 ~~~~f~~~~~lg~G~~g~Vy~~~~~~-~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~ 82 (316)
T cd05108 5 KETEFKKIKVLGSGAFGTVYKGLWIP-EGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-T 82 (316)
T ss_pred chhhceeeeeeecCCCceEEEEEEec-CCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-C
Confidence 34556777899999999999998753 233 48999987533 34556889999999999999999999999765 5
Q ss_pred eeEEEeecCCCchhhhhhcC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCcccc
Q 041576 493 RLLVYEFMGNGTLANLLFAI-PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLL 571 (714)
Q Consensus 493 ~~lv~E~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~ 571 (714)
.++++||+++|+|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+||++++++.+||+|||+++..
T Consensus 83 ~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~ 159 (316)
T cd05108 83 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (316)
T ss_pred ceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEccccccccc
Confidence 67999999999999999864 45788999999999999999999998 999999999999999999999999999876
Q ss_pred ccCcccc-eeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccchhhhhhhHHHhhhhhcCccce
Q 041576 572 LSDQSRT-RTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEERSAILTDWAYDCYVEGKLDV 649 (714)
Q Consensus 572 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 649 (714)
....... ......+..|+|||.+.+..++.++||||||+++|||++ |+.||........... ...+...
T Consensus 160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~--------~~~~~~~- 230 (316)
T cd05108 160 GADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI--------LEKGERL- 230 (316)
T ss_pred cCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHH--------HhCCCCC-
Confidence 5433211 112234568999999999999999999999999999998 9999875432221110 0111000
Q ss_pred eecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCC
Q 041576 650 LVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLEV 698 (714)
Q Consensus 650 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 698 (714)
..+......+.+++.+||+.+|++||++.++++.|..+...
T Consensus 231 --------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~ 271 (316)
T cd05108 231 --------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 271 (316)
T ss_pred --------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcC
Confidence 00112234677899999999999999999999999876643
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=325.66 Aligned_cols=243 Identities=24% Similarity=0.300 Sum_probs=197.9
Q ss_pred hhhCcccceeEEEeEeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHHhcc-CcccccceeceEecCCeeeEEEeecC
Q 041576 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA---QEREREFKTEVSAIGRT-HHKNLVQLLGFCDEGLNRLLVYEFMG 501 (714)
Q Consensus 426 ~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~E~~~ 501 (714)
+.||+|+||.||+|..+ .+++.||+|.++... ......+..|.+++..+ +||||+++++++..++..++||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~ 79 (321)
T cd05591 1 KVLGKGSFGKVMLAELK-GTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVN 79 (321)
T ss_pred CccccCCCeEEEEEEEC-CCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCC
Confidence 46999999999999876 568899999997532 23345677888888866 89999999999999999999999999
Q ss_pred CCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcccceee
Q 041576 502 NGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTV 581 (714)
Q Consensus 502 ~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 581 (714)
+++|...+.....+++..+..++.||++||+|||+.+ |+||||||+||+++.++.+||+|||++....... .....
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~~~~ 155 (321)
T cd05591 80 GGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG-VTTTT 155 (321)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCC-ccccc
Confidence 9999999988888999999999999999999999998 9999999999999999999999999987543222 22234
Q ss_pred ecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhhccch
Q 041576 582 IRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMADK 661 (714)
Q Consensus 582 ~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 661 (714)
..|+..|+|||++.+..++.++|||||||++|||++|+.||........... ...+... .+.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~--------i~~~~~~----------~p~ 217 (321)
T cd05591 156 FCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFES--------ILHDDVL----------YPV 217 (321)
T ss_pred cccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHH--------HHcCCCC----------CCC
Confidence 5689999999999998999999999999999999999999975543321111 1111100 111
Q ss_pred HHHHHHHHHHHHccccCCCCCC-------CHHHHHHH
Q 041576 662 SRACKWLMIALWCIQEDPLKRP-------AMKMIVQM 691 (714)
Q Consensus 662 ~~~~~l~~li~~cl~~dP~~RP-------s~~evl~~ 691 (714)
.....+.+++.+||+.||++|| +++++++.
T Consensus 218 ~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 218 WLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred CCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 1234677899999999999999 88888753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=312.58 Aligned_cols=249 Identities=30% Similarity=0.431 Sum_probs=200.1
Q ss_pred hhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEeec
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEFM 500 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~ 500 (714)
.+.+.+.||+|++|.||+|.++ .+..+++|.+.... .....+.+|++++++++||||+++++++......++||||+
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~--~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWR--GKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYM 81 (256)
T ss_pred HcchhhhhccCCCceEEEeEec--CCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecC
Confidence 4567889999999999999875 46689999986432 23456888999999999999999999999999999999999
Q ss_pred CCCchhhhhhcC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcccce
Q 041576 501 GNGTLANLLFAI-PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTR 579 (714)
Q Consensus 501 ~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 579 (714)
++++|.+++... ..+++..++.++.||++||+|||+.+ ++||||||+||++++++.+||+|||+++..........
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (256)
T cd05059 82 ANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSS 158 (256)
T ss_pred CCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceeccccccccc
Confidence 999999999754 46789999999999999999999998 99999999999999999999999999876543222222
Q ss_pred eeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhhc
Q 041576 580 TVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAM 658 (714)
Q Consensus 580 ~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 658 (714)
....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+... ....+. ...
T Consensus 159 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~--------~~~~~~---------~~~ 221 (256)
T cd05059 159 QGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVE--------SVSAGY---------RLY 221 (256)
T ss_pred CCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHH--------HHHcCC---------cCC
Confidence 22223457999999998899999999999999999999 788886543222111 011110 001
Q ss_pred cchHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 041576 659 ADKSRACKWLMIALWCIQEDPLKRPAMKMIVQML 692 (714)
Q Consensus 659 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 692 (714)
.+...+..+.+++.+||+.+|++|||+.|+++.|
T Consensus 222 ~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 222 RPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 1122455788899999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=316.49 Aligned_cols=256 Identities=23% Similarity=0.334 Sum_probs=200.4
Q ss_pred hhhhhhhhCcccceeEEEeEeeCCCCc----EEEEEEecccc-hhhHHHHHHHHHHHhccCcccccceeceEecCCeeeE
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSASGN----AVAVKKLDKLA-QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLL 495 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 495 (714)
.+.+.+.||+|+||+||+|.+.. +++ .+++|.+.... .....++..|+..+++++||||+++++++.. ...++
T Consensus 8 ~~~~~~~lg~G~~~~vy~~~~~~-~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~ 85 (279)
T cd05111 8 ELRKLKLLGSGVFGTVHKGIWIP-EGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL 85 (279)
T ss_pred hceeccccCccCCcceEEEEEcC-CCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence 34566899999999999998753 333 57888876432 2334678889999999999999999998864 45789
Q ss_pred EEeecCCCchhhhhhcC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccC
Q 041576 496 VYEFMGNGTLANLLFAI-PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSD 574 (714)
Q Consensus 496 v~E~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 574 (714)
++||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ ++|+||||+||++++++.+||+|||+++.....
T Consensus 86 i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPD 162 (279)
T ss_pred EEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceeccCC
Confidence 99999999999999764 56899999999999999999999998 999999999999999999999999999865433
Q ss_pred cc-cceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccchhhhhhhHHHhhhhhcCccceeec
Q 041576 575 QS-RTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVD 652 (714)
Q Consensus 575 ~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 652 (714)
.. .......++..|+|||.+.+..++.++||||||+++||+++ |+.||........... ...+....
T Consensus 163 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~--------~~~~~~~~--- 231 (279)
T cd05111 163 DKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDL--------LEKGERLA--- 231 (279)
T ss_pred CcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH--------HHCCCcCC---
Confidence 22 22233456778999999998899999999999999999998 9999865432221111 11111100
Q ss_pred chhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCC
Q 041576 653 NDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLEV 698 (714)
Q Consensus 653 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 698 (714)
.+......+.+++.+|++.||++|||+.|+++.|+.+.+.
T Consensus 232 ------~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~ 271 (279)
T cd05111 232 ------QPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARD 271 (279)
T ss_pred ------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence 0111223567789999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=330.85 Aligned_cols=250 Identities=22% Similarity=0.268 Sum_probs=202.1
Q ss_pred hhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEe
Q 041576 422 NGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA---QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYE 498 (714)
Q Consensus 422 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E 498 (714)
|.+.+.||+|+||.||++... .+++.||+|+++... ....+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (330)
T cd05601 3 FDVKSLVGRGHFGEVQVVREK-ATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVME 81 (330)
T ss_pred ceEEEEEEeccCEEEEEEEEC-CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEEC
Confidence 567789999999999999876 578899999997532 2345678899999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCccc
Q 041576 499 FMGNGTLANLLFAI-PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSR 577 (714)
Q Consensus 499 ~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 577 (714)
|+++++|.+++... ..+++..+..++.||++||+|||+.+ |+||||||+||+++.++.+||+|||++..+......
T Consensus 82 ~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~ 158 (330)
T cd05601 82 YQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV 158 (330)
T ss_pred CCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCCCce
Confidence 99999999999876 67899999999999999999999998 999999999999999999999999999876544433
Q ss_pred ceeeecCCCCccCccccc------CCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceee
Q 041576 578 TRTVIRGTRGYVAPEWFK------NVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLV 651 (714)
Q Consensus 578 ~~~~~~gt~~y~aPE~~~------~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 651 (714)
......|+..|+|||++. ...++.++|||||||++|||++|+.||...........+ .... ...
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i--------~~~~--~~~ 228 (330)
T cd05601 159 NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNI--------MNFQ--RFL 228 (330)
T ss_pred eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHH--------HcCC--Ccc
Confidence 334456899999999986 456789999999999999999999999754332211111 1100 000
Q ss_pred cchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 652 DNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 652 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
. .......+..+.+++..||+ +|.+||+++++++
T Consensus 229 ~----~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 229 K----FPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred C----CCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 0 00111234567789999998 9999999999986
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=312.16 Aligned_cols=253 Identities=25% Similarity=0.383 Sum_probs=202.2
Q ss_pred HHHhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEE
Q 041576 418 NEATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVY 497 (714)
Q Consensus 418 ~~at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 497 (714)
....+.+.++||+|++|.||+|... .+..+++|.++.... ....+.+|+.++++++|+||+++++++. ....+++|
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~--~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~ 79 (260)
T cd05070 4 PRESLQLIKKLGNGQFGEVWMGTWN--GNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVT 79 (260)
T ss_pred chHHhhhhheeccccCceEEEEEec--CCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEE
Confidence 3456778899999999999999765 567899999875332 3457899999999999999999999885 45678999
Q ss_pred eecCCCchhhhhhcC--CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCc
Q 041576 498 EFMGNGTLANLLFAI--PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQ 575 (714)
Q Consensus 498 E~~~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 575 (714)
||+++++|.+++... ..+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||++.......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05070 80 EYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNE 156 (260)
T ss_pred EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCcc
Confidence 999999999999753 35789999999999999999999998 9999999999999999999999999998764433
Q ss_pred ccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccchhhhhhhHHHhhhhhcCccceeecch
Q 041576 576 SRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDND 654 (714)
Q Consensus 576 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 654 (714)
........++..|+|||.+.+..++.++||||||+++|||++ |+.||......+. +.. ...+.
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~---~~~-----~~~~~-------- 220 (260)
T cd05070 157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREV---LEQ-----VERGY-------- 220 (260)
T ss_pred cccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHH---HHH-----HHcCC--------
Confidence 222222335668999999988889999999999999999999 8888865432211 111 11100
Q ss_pred hhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 041576 655 KAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEG 694 (714)
Q Consensus 655 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 694 (714)
....+...+..+.+++.+||+.+|++|||++++.+.|++
T Consensus 221 -~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 221 -RMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred -CCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 001122334568889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=317.42 Aligned_cols=257 Identities=28% Similarity=0.440 Sum_probs=201.4
Q ss_pred HHHhhhhhhhhCcccceeEEEeEee----CCCCcEEEEEEecccc-hhhHHHHHHHHHHHhccCcccccceeceEecCCe
Q 041576 418 NEATNGFEEELGRGSFGIVYKGVLK----SASGNAVAVKKLDKLA-QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLN 492 (714)
Q Consensus 418 ~~at~~~~~~ig~G~~g~Vy~~~~~----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 492 (714)
....+.+.+.||+|++|.||+|.++ ...+..||+|.+.... .....++.+|+.++++++||||+++++++..+..
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 3456777899999999999999764 2345689999986432 2345578899999999999999999999999999
Q ss_pred eeEEEeecCCCchhhhhhcCC----------CCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEE
Q 041576 493 RLLVYEFMGNGTLANLLFAIP----------RPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKI 562 (714)
Q Consensus 493 ~~lv~E~~~~gsL~~~l~~~~----------~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl 562 (714)
.++||||+++++|.+++.... .+++..++.++.|+++||+|||+.+ ++|+||||+||++++++.++|
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence 999999999999999986532 2467788999999999999999988 999999999999999999999
Q ss_pred ecCCCccccccCcccc-eeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccchhhhhhhHHHhh
Q 041576 563 SDFGLSKLLLSDQSRT-RTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEERSAILTDWAYD 640 (714)
Q Consensus 563 ~Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~l~~~~~~ 640 (714)
+|||++.......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||........ +.
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~---~~----- 232 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQV---LR----- 232 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH---HH-----
Confidence 9999987654322211 112234678999999998899999999999999999999 6888864432211 10
Q ss_pred hhhcCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 041576 641 CYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEG 694 (714)
Q Consensus 641 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 694 (714)
....+.... .+...+..+.+++.+||+.+|++|||+.|+++.|++
T Consensus 233 ~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 233 FVMEGGLLD---------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred HHHcCCcCC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 111111110 111223467889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=313.90 Aligned_cols=255 Identities=25% Similarity=0.384 Sum_probs=202.9
Q ss_pred HHHhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEE
Q 041576 418 NEATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVY 497 (714)
Q Consensus 418 ~~at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 497 (714)
....|.+.++||+|++|.||+|.+. ....|++|+++... ...+.+.+|++++++++||||+++++++.+ ...++||
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~--~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~ 79 (262)
T cd05071 4 PRESLRLEVKLGQGCFGEVWMGTWN--GTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT 79 (262)
T ss_pred ChHHeeEeeecCCCCCCcEEEEEec--CCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEE
Confidence 3456888899999999999999875 34579999997532 234578999999999999999999998754 5679999
Q ss_pred eecCCCchhhhhhcC--CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCc
Q 041576 498 EFMGNGTLANLLFAI--PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQ 575 (714)
Q Consensus 498 E~~~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 575 (714)
||+++++|.+++... ..+++..+..++.|+++||+|||+.+ ++|+||||+||++++++.+||+|||.+.......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~ 156 (262)
T cd05071 80 EYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE 156 (262)
T ss_pred EcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccccc
Confidence 999999999999753 35788999999999999999999998 9999999999999999999999999998664433
Q ss_pred ccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccchhhhhhhHHHhhhhhcCccceeecch
Q 041576 576 SRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDND 654 (714)
Q Consensus 576 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 654 (714)
........++..|+|||...+..++.++||||||+++|||++ |+.||........ .. ....+..
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~---~~-----~~~~~~~------- 221 (262)
T cd05071 157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV---LD-----QVERGYR------- 221 (262)
T ss_pred cccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHH---HH-----HHhcCCC-------
Confidence 222223345678999999988899999999999999999999 7888864432211 10 0111100
Q ss_pred hhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 041576 655 KAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYL 696 (714)
Q Consensus 655 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 696 (714)
.......+..+.+++.+|++.||++||++.++++.|++..
T Consensus 222 --~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 222 --MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred --CCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 0112234456788999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=311.08 Aligned_cols=250 Identities=30% Similarity=0.384 Sum_probs=200.8
Q ss_pred hhhCcccceeEEEeEeeCCC--CcEEEEEEecccch-hhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEeecCC
Q 041576 426 EELGRGSFGIVYKGVLKSAS--GNAVAVKKLDKLAQ-EREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEFMGN 502 (714)
Q Consensus 426 ~~ig~G~~g~Vy~~~~~~~~--~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~ 502 (714)
++||+|+||.||+|++...+ +..+++|.+..... ...+.+.+|+.++++++||||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 47999999999999876443 36899999875443 35568899999999999999999999876 4567999999999
Q ss_pred CchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcccce--e
Q 041576 503 GTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTR--T 580 (714)
Q Consensus 503 gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~--~ 580 (714)
++|.+++.....+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++........... .
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~ 156 (257)
T cd05060 80 GPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATT 156 (257)
T ss_pred CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCccccccc
Confidence 999999988778999999999999999999999998 99999999999999999999999999987644332211 1
Q ss_pred eecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhhcc
Q 041576 581 VIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMA 659 (714)
Q Consensus 581 ~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 659 (714)
...++..|+|||.+.+..++.++||||||+++||+++ |+.||......... .. ...... ...
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~----~~----~~~~~~---------~~~ 219 (257)
T cd05060 157 AGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVI----AM----LESGER---------LPR 219 (257)
T ss_pred CccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHH----HH----HHcCCc---------CCC
Confidence 1223467999999998899999999999999999998 99998754332211 11 111110 011
Q ss_pred chHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 041576 660 DKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYL 696 (714)
Q Consensus 660 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 696 (714)
+...+..+.+++.+||+.+|++||++.+|++.|+++.
T Consensus 220 ~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 220 PEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 1223457788999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=313.59 Aligned_cols=256 Identities=20% Similarity=0.312 Sum_probs=205.2
Q ss_pred hhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecc---cchhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEE
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDK---LAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVY 497 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 497 (714)
.|.+.+.||+|+||.||+|+.. .+++.||||.++. ........+.+|++++++++||||+++++++...+..++++
T Consensus 3 ~~~i~~~l~~g~~~~v~~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 3 NFQIEKKIGRGQFSEVYRATCL-LDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred ceeeeeeeccCCCeeEEEEEEe-CCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 4567789999999999999976 4688999998754 22344567899999999999999999999999999999999
Q ss_pred eecCCCchhhhhhc----CCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCcccccc
Q 041576 498 EFMGNGTLANLLFA----IPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLS 573 (714)
Q Consensus 498 E~~~~gsL~~~l~~----~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~ 573 (714)
||+++++|.+++.. ...+++..+..++.||++||+|||+++ ++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 99999999988853 234788899999999999999999998 99999999999999999999999999886643
Q ss_pred CcccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecc
Q 041576 574 DQSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDN 653 (714)
Q Consensus 574 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 653 (714)
... ......++..|+|||.+.+..++.++||||||+++|||++|+.||........ ... . .......
T Consensus 159 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~-~~~-~----~~~~~~~------ 225 (267)
T cd08228 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLF-SLC-Q----KIEQCDY------ 225 (267)
T ss_pred hhH-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHH-HHH-H----HHhcCCC------
Confidence 222 11234578899999999988899999999999999999999999864322110 000 0 0111000
Q ss_pred hhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 041576 654 DKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGY 695 (714)
Q Consensus 654 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 695 (714)
...........+.+++.+||+.+|++||++.||++.|+++
T Consensus 226 --~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 226 --PPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred --CCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 0111223445688899999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=312.35 Aligned_cols=267 Identities=28% Similarity=0.393 Sum_probs=200.9
Q ss_pred hhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhc--cCcccccceeceEecCC----eeeEE
Q 041576 423 GFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGR--THHKNLVQLLGFCDEGL----NRLLV 496 (714)
Q Consensus 423 ~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~nIv~l~~~~~~~~----~~~lv 496 (714)
.+.+.||+|.||.||+|.+. ++.||||++.. ...+.|++|-++.+. ++|+||+++++.-.... +.+||
T Consensus 213 ~l~eli~~Grfg~V~KaqL~---~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLV 286 (534)
T KOG3653|consen 213 QLLELIGRGRFGCVWKAQLD---NRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLV 286 (534)
T ss_pred hhHHHhhcCccceeehhhcc---CceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEE
Confidence 45689999999999999985 68999999964 455677777777665 58999999999876555 88999
Q ss_pred EeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcC------CCCeEecCCCcCeEEECCCCceEEecCCCccc
Q 041576 497 YEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEEC------NVPIIHCDIKPQNILLDQDFTAKISDFGLSKL 570 (714)
Q Consensus 497 ~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~------~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~ 570 (714)
+||.+.|+|.++|.. ...+|....+|+..+++||+|||+.- +++|+|||||++||||..|+++.|+|||+|..
T Consensus 287 t~fh~kGsL~dyL~~-ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~ 365 (534)
T KOG3653|consen 287 TEFHPKGSLCDYLKA-NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALR 365 (534)
T ss_pred eeeccCCcHHHHHHh-ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEE
Confidence 999999999999987 57899999999999999999999863 57899999999999999999999999999998
Q ss_pred cccCcccce-eeecCCCCccCcccccCCC-CC-----chhhhHHHHHHHHHHHhcCCCCcccccchhh----------hh
Q 041576 571 LLSDQSRTR-TVIRGTRGYVAPEWFKNVP-VS-----AKVDVYSFGVVLLKIICCKRSVEMELGEERS----------AI 633 (714)
Q Consensus 571 ~~~~~~~~~-~~~~gt~~y~aPE~~~~~~-~s-----~ksDVwSlGvil~elltG~~p~~~~~~~~~~----------~~ 633 (714)
+........ ...+||.+|||||++.+.. +. .+.||||+|.|||||++.-.-+......+.+ ..
T Consensus 366 ~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt 445 (534)
T KOG3653|consen 366 LEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPT 445 (534)
T ss_pred ecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCC
Confidence 875544332 3368999999999997642 22 3799999999999999865443211000000 00
Q ss_pred hhHHHhhhhhcCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCCCC
Q 041576 634 LTDWAYDCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLEVPS 700 (714)
Q Consensus 634 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 700 (714)
+.+.......+.....+.+.-. ......-+.+.+..||..||+.|.|+.=|.+++.++.....
T Consensus 446 ~e~mq~~VV~kK~RP~~p~~W~----~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~ 508 (534)
T KOG3653|consen 446 LEEMQELVVRKKQRPKIPDAWR----KHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWE 508 (534)
T ss_pred HHHHHHHHHhhccCCCChhhhh----cCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCC
Confidence 1111001111111111111111 11344567889999999999999999999999888766543
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=322.96 Aligned_cols=242 Identities=28% Similarity=0.323 Sum_probs=197.5
Q ss_pred hhhCcccceeEEEeEeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHHhcc-CcccccceeceEecCCeeeEEEeecC
Q 041576 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA---QEREREFKTEVSAIGRT-HHKNLVQLLGFCDEGLNRLLVYEFMG 501 (714)
Q Consensus 426 ~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~E~~~ 501 (714)
+.||+|+||.||+|.+. .+++.||+|.++... ......+..|.+++..+ +||||+++++++...+..++||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~ 79 (318)
T cd05570 1 KVLGKGSFGKVLLAELK-GTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVN 79 (318)
T ss_pred CeeeeCCCeEEEEEEEC-CCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCC
Confidence 46899999999999876 467899999997532 23345677888888887 79999999999999999999999999
Q ss_pred CCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcccceee
Q 041576 502 NGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTV 581 (714)
Q Consensus 502 ~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 581 (714)
+++|.+++.....+++..+..++.||+.||+|||+.+ |+||||||+||++++++.+||+|||+++...... .....
T Consensus 80 ~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 155 (318)
T cd05570 80 GGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG-VTTST 155 (318)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCC-Ccccc
Confidence 9999999988888999999999999999999999998 9999999999999999999999999987532221 12223
Q ss_pred ecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhhccch
Q 041576 582 IRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMADK 661 (714)
Q Consensus 582 ~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 661 (714)
..|+..|+|||.+.+..++.++|||||||++|||++|+.||.......... ....... ..+.
T Consensus 156 ~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~--------~i~~~~~----------~~~~ 217 (318)
T cd05570 156 FCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQ--------SILEDEV----------RYPR 217 (318)
T ss_pred eecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHH--------HHHcCCC----------CCCC
Confidence 458999999999999999999999999999999999999997543222111 1111110 0112
Q ss_pred HHHHHHHHHHHHccccCCCCCCCH-----HHHHH
Q 041576 662 SRACKWLMIALWCIQEDPLKRPAM-----KMIVQ 690 (714)
Q Consensus 662 ~~~~~l~~li~~cl~~dP~~RPs~-----~evl~ 690 (714)
..+..+.+++.+||+.||++||++ .++++
T Consensus 218 ~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 218 WLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred cCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 234567889999999999999999 88865
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=315.34 Aligned_cols=254 Identities=27% Similarity=0.410 Sum_probs=203.2
Q ss_pred hhhhhhhhCcccceeEEEeEee----CCCCcEEEEEEecccchhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEE
Q 041576 421 TNGFEEELGRGSFGIVYKGVLK----SASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLV 496 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 496 (714)
.+.+.++||+|+||.||++... ..++..+++|.+..........+.+|++++++++|+||+++++++.++...+++
T Consensus 6 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (280)
T cd05092 6 DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMV 85 (280)
T ss_pred hceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEE
Confidence 4456789999999999999642 234668999999877666777899999999999999999999999999999999
Q ss_pred EeecCCCchhhhhhcCC---------------CCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceE
Q 041576 497 YEFMGNGTLANLLFAIP---------------RPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAK 561 (714)
Q Consensus 497 ~E~~~~gsL~~~l~~~~---------------~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~k 561 (714)
|||+++++|.+++.... .+++..++.++.||+.||+|||+.+ ++||||||+||++++++.+|
T Consensus 86 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~k 162 (280)
T cd05092 86 FEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVVK 162 (280)
T ss_pred EecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCEE
Confidence 99999999999987542 4678899999999999999999998 99999999999999999999
Q ss_pred EecCCCccccccCcc-cceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccchhhhhhhHHHh
Q 041576 562 ISDFGLSKLLLSDQS-RTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEERSAILTDWAY 639 (714)
Q Consensus 562 l~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~l~~~~~ 639 (714)
|+|||++........ .......++..|+|||.+.+..++.++|||||||++|||++ |+.||..........
T Consensus 163 L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~------- 235 (280)
T cd05092 163 IGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIE------- 235 (280)
T ss_pred ECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHH-------
Confidence 999999875533221 11122234678999999999899999999999999999998 898886433222110
Q ss_pred hhhhcCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 041576 640 DCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEG 694 (714)
Q Consensus 640 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 694 (714)
....+... ..+...+..+.+++.+||+.||++||+++||++.|++
T Consensus 236 -~~~~~~~~---------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 236 -CITQGREL---------ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred -HHHcCccC---------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 01111100 0111233467789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=317.78 Aligned_cols=271 Identities=27% Similarity=0.380 Sum_probs=202.8
Q ss_pred hhhhhhhhCcccceeEEEeEee---CCCCcEEEEEEecccchhhHHHHHHHHHHHhccCcccccceeceEec--CCeeeE
Q 041576 421 TNGFEEELGRGSFGIVYKGVLK---SASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCDE--GLNRLL 495 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--~~~~~l 495 (714)
.+.+.+.||+|+||.||++..+ ..+++.|++|++........+.+.+|++++++++||||+++++++.. ....++
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 84 (284)
T cd05081 5 HLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRL 84 (284)
T ss_pred cceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEE
Confidence 4567789999999999999753 34678999999987666667789999999999999999999998743 346789
Q ss_pred EEeecCCCchhhhhhcC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccC
Q 041576 496 VYEFMGNGTLANLLFAI-PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSD 574 (714)
Q Consensus 496 v~E~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 574 (714)
|+||+++++|.+++... ..+++..+..++.|++.||+|||+++ ++||||||+||++++++.+||+|||++......
T Consensus 85 v~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 161 (284)
T cd05081 85 VMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVLPQD 161 (284)
T ss_pred EEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccccCC
Confidence 99999999999999754 46899999999999999999999998 999999999999999999999999999876443
Q ss_pred cccce--eeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeec
Q 041576 575 QSRTR--TVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVD 652 (714)
Q Consensus 575 ~~~~~--~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 652 (714)
..... ....++..|+|||.+.+..++.++||||||+++|||++|..++.......... .............+.....
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd05081 162 KEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRM-MGNDKQGQMIVYHLIELLK 240 (284)
T ss_pred CcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhh-cccccccccchHHHHHHHh
Confidence 22111 11223456999999998889999999999999999999887654322110000 0000000000000000000
Q ss_pred chhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 041576 653 NDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGY 695 (714)
Q Consensus 653 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 695 (714)
...........+..+.+++.+||+.+|++|||++||++.|+.+
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 241 NNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred cCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 0000111223345788899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=308.31 Aligned_cols=272 Identities=24% Similarity=0.299 Sum_probs=209.9
Q ss_pred hhhhCcccceeEEEeEeeCCCCcEEEEEEecc--cchhhHHHHHHHHHHHhccCcccccceeceEec-----CCeeeEEE
Q 041576 425 EEELGRGSFGIVYKGVLKSASGNAVAVKKLDK--LAQEREREFKTEVSAIGRTHHKNLVQLLGFCDE-----GLNRLLVY 497 (714)
Q Consensus 425 ~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-----~~~~~lv~ 497 (714)
.+.||+|+||.|..|..+ .+|+.||||++.+ ......++..+|++.|+.++|+||+.+++.+.. -+..|+|+
T Consensus 27 ~~~iG~GAyGvVcsA~~~-~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~ 105 (359)
T KOG0660|consen 27 IEPIGRGAYGVVCSAKDK-RTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVF 105 (359)
T ss_pred cccccCcceeeEEEEEEc-CCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEeh
Confidence 578999999999999977 5789999999974 445556788999999999999999999999854 45679999
Q ss_pred eecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCc-c
Q 041576 498 EFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQ-S 576 (714)
Q Consensus 498 E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~-~ 576 (714)
|+|+. +|...++..+.++.....-++.||++||.|+|+.+ |+||||||+|++++.+..+||+|||+|+...... .
T Consensus 106 elMet-DL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~ 181 (359)
T KOG0660|consen 106 ELMET-DLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFED 181 (359)
T ss_pred hHHhh-HHHHHHHcCccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccceeeccccCcc
Confidence 99954 99999999888999999999999999999999998 9999999999999999999999999999875431 2
Q ss_pred cceeeecCCCCccCccccc-CCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHh-------hhhhcCcc-
Q 041576 577 RTRTVIRGTRGYVAPEWFK-NVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAY-------DCYVEGKL- 647 (714)
Q Consensus 577 ~~~~~~~gt~~y~aPE~~~-~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~-------~~~~~~~~- 647 (714)
...+..+-|..|.|||++. ...||.+.||||.|||+.||++|++.|.+...-.+...+..... ........
T Consensus 182 ~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar 261 (359)
T KOG0660|consen 182 GFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKAR 261 (359)
T ss_pred cchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHH
Confidence 2335566799999999875 56799999999999999999999999986654333222221110 00000000
Q ss_pred ------ceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HhcccCCCCCC
Q 041576 648 ------DVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM--LEGYLEVPSPP 702 (714)
Q Consensus 648 ------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~~~~~~pp 702 (714)
............ ....+..++++.+||..||.+|+|++|+++. |...-+....|
T Consensus 262 ~yi~slp~~p~~~f~~~f-p~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP 323 (359)
T KOG0660|consen 262 PYIKSLPQIPKQPFSSIF-PNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEP 323 (359)
T ss_pred HHHHhCCCCCCCCHHHHc-CCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCC
Confidence 000000111111 1344577889999999999999999999874 56655544333
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=324.17 Aligned_cols=250 Identities=24% Similarity=0.319 Sum_probs=197.1
Q ss_pred hhhCcccceeEEEeEeeCCCCcEEEEEEeccc---chhhHHHHHHHHHHHhcc-CcccccceeceEecCCeeeEEEeecC
Q 041576 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDKL---AQEREREFKTEVSAIGRT-HHKNLVQLLGFCDEGLNRLLVYEFMG 501 (714)
Q Consensus 426 ~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~E~~~ 501 (714)
+.||+|+||.||+|... .+++.||+|.++.. .......+.+|+.++.++ +||||+++++++..++..++||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~ 79 (329)
T cd05618 1 RVIGRGSYAKVLLVRLK-KTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVN 79 (329)
T ss_pred CeeeeCCCeEEEEEEEC-CCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCC
Confidence 46899999999999876 56889999999753 223445678898888876 89999999999999999999999999
Q ss_pred CCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcccceee
Q 041576 502 NGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTV 581 (714)
Q Consensus 502 ~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 581 (714)
+++|..++.....+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+++...... .....
T Consensus 80 ~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~-~~~~~ 155 (329)
T cd05618 80 GGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-DTTST 155 (329)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCC-Ccccc
Confidence 9999999988788999999999999999999999998 9999999999999999999999999987532221 12234
Q ss_pred ecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchh-hhhhhHHHhhhhhcCccceeecchhhhccc
Q 041576 582 IRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEER-SAILTDWAYDCYVEGKLDVLVDNDKAAMAD 660 (714)
Q Consensus 582 ~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 660 (714)
..|+..|+|||++.+..++.++|||||||++|||++|+.||........ ......+.......... ..+
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~----------~~p 225 (329)
T cd05618 156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI----------RIP 225 (329)
T ss_pred ccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC----------CCC
Confidence 5689999999999999999999999999999999999999963221110 00111111111111111 012
Q ss_pred hHHHHHHHHHHHHccccCCCCCCC------HHHHHH
Q 041576 661 KSRACKWLMIALWCIQEDPLKRPA------MKMIVQ 690 (714)
Q Consensus 661 ~~~~~~l~~li~~cl~~dP~~RPs------~~evl~ 690 (714)
......+.+++.+||+.||++||+ +.++++
T Consensus 226 ~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05618 226 RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 261 (329)
T ss_pred CCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhc
Confidence 223456778999999999999998 466654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=323.86 Aligned_cols=250 Identities=24% Similarity=0.312 Sum_probs=198.3
Q ss_pred hhhCcccceeEEEeEeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHHhcc-CcccccceeceEecCCeeeEEEeecC
Q 041576 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA---QEREREFKTEVSAIGRT-HHKNLVQLLGFCDEGLNRLLVYEFMG 501 (714)
Q Consensus 426 ~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~E~~~ 501 (714)
+.||+|+||.||+|... .+++.||+|.++... ......+..|..++.++ +||||+++++++.+....++||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~-~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~ 79 (329)
T cd05588 1 RVIGRGSYAKVLLVELK-KTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVS 79 (329)
T ss_pred CeEeeCCCeEEEEEEEC-CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCC
Confidence 46899999999999876 578899999997532 23345688899999988 79999999999999999999999999
Q ss_pred CCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcccceee
Q 041576 502 NGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTV 581 (714)
Q Consensus 502 ~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 581 (714)
+++|.+++.....+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+++...... .....
T Consensus 80 ~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-~~~~~ 155 (329)
T cd05588 80 GGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG-DTTST 155 (329)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccCC-Ccccc
Confidence 9999999988788999999999999999999999998 9999999999999999999999999987432211 12234
Q ss_pred ecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccch-hhhhhhHHHhhhhhcCccceeecchhhhccc
Q 041576 582 IRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEE-RSAILTDWAYDCYVEGKLDVLVDNDKAAMAD 660 (714)
Q Consensus 582 ~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~-~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 660 (714)
..|+..|+|||++.+..++.++|||||||++|||++|+.||....... .......+........... .+
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~p 225 (329)
T cd05588 156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIR----------IP 225 (329)
T ss_pred ccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCC----------CC
Confidence 568999999999999999999999999999999999999996432111 0011111111111111110 11
Q ss_pred hHHHHHHHHHHHHccccCCCCCCC------HHHHHH
Q 041576 661 KSRACKWLMIALWCIQEDPLKRPA------MKMIVQ 690 (714)
Q Consensus 661 ~~~~~~l~~li~~cl~~dP~~RPs------~~evl~ 690 (714)
...+..+.+++.+||+.||.+||+ ++++++
T Consensus 226 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 226 RSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred CCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 223456788999999999999997 677764
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=330.96 Aligned_cols=254 Identities=22% Similarity=0.230 Sum_probs=202.2
Q ss_pred HHhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHHhccCcccccceeceEecCCeeeE
Q 041576 419 EATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA---QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLL 495 (714)
Q Consensus 419 ~at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 495 (714)
...|.+.+.||+|+||.||+|... .+++.||+|.+.... ......+.+|+.+++.++||||+++++++.++...++
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHK-SSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEEC-CCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 345677789999999999999876 578899999996532 2334567899999999999999999999999999999
Q ss_pred EEeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCc
Q 041576 496 VYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQ 575 (714)
Q Consensus 496 v~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 575 (714)
||||+++|+|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 121 v~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~ 196 (370)
T cd05596 121 VMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANG 196 (370)
T ss_pred EEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeeccCCC
Confidence 9999999999999876 35788889999999999999999998 9999999999999999999999999998764433
Q ss_pred ccceeeecCCCCccCcccccCC----CCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceee
Q 041576 576 SRTRTVIRGTRGYVAPEWFKNV----PVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLV 651 (714)
Q Consensus 576 ~~~~~~~~gt~~y~aPE~~~~~----~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 651 (714)
........|++.|+|||.+.+. .++.++|||||||++|||++|+.||......... ..........
T Consensus 197 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~--------~~i~~~~~~~-- 266 (370)
T cd05596 197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTY--------SKIMDHKNSL-- 266 (370)
T ss_pred cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHH--------HHHHcCCCcC--
Confidence 3233345689999999998653 4789999999999999999999999754332211 1111110000
Q ss_pred cchhhhccchHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 041576 652 DNDKAAMADKSRACKWLMIALWCIQEDPLK--RPAMKMIVQM 691 (714)
Q Consensus 652 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~ 691 (714)
........+..+.+++.+||+.+|.+ ||++.|+++.
T Consensus 267 ----~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 267 ----TFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred ----CCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 00011123457778999999999988 9999999764
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=313.42 Aligned_cols=257 Identities=28% Similarity=0.411 Sum_probs=204.1
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCC--cEEEEEEeccc-chhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEE
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASG--NAVAVKKLDKL-AQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLV 496 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~--~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 496 (714)
..+...+.||+|++|.||+|++....+ ..+++|.++.. .....+.+.+|++++++++||||+++++++...+..++|
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII 84 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence 345567899999999999999863222 37999998754 334456789999999999999999999999999999999
Q ss_pred EeecCCCchhhhhhcC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCc
Q 041576 497 YEFMGNGTLANLLFAI-PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQ 575 (714)
Q Consensus 497 ~E~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 575 (714)
|||+++++|.+++... ..+++.++..++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||++.......
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~ 161 (268)
T cd05063 85 TEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDP 161 (268)
T ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceeccccc
Confidence 9999999999999764 56789999999999999999999998 9999999999999999999999999998664332
Q ss_pred ccceee--ecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccchhhhhhhHHHhhhhhcCccceeec
Q 041576 576 SRTRTV--IRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVD 652 (714)
Q Consensus 576 ~~~~~~--~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 652 (714)
...... ...+..|+|||.+....++.++||||||+++||+++ |+.||.......... ....+.
T Consensus 162 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~--------~i~~~~------ 227 (268)
T cd05063 162 EGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMK--------AINDGF------ 227 (268)
T ss_pred ccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHH--------HHhcCC------
Confidence 221111 123457999999998889999999999999999997 999986543221111 111110
Q ss_pred chhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 041576 653 NDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYL 696 (714)
Q Consensus 653 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 696 (714)
........+..+.+++.+|++.+|++||++.+|++.|++++
T Consensus 228 ---~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~~ 268 (268)
T cd05063 228 ---RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKLL 268 (268)
T ss_pred ---CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence 00011123456788999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=323.24 Aligned_cols=245 Identities=24% Similarity=0.304 Sum_probs=194.6
Q ss_pred hhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHH---hccCcccccceeceEecCCeeeE
Q 041576 422 NGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA---QEREREFKTEVSAI---GRTHHKNLVQLLGFCDEGLNRLL 495 (714)
Q Consensus 422 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~h~nIv~l~~~~~~~~~~~l 495 (714)
|.+.+.||+|+||.||+|... .+++.||||.++... ....+.+.+|++++ ++++||||+++++++..++..++
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~l 79 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYK-KTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCF 79 (324)
T ss_pred CeEEEEEeecCCEEEEEEEEC-CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEE
Confidence 345688999999999999876 578899999997532 22334566666554 56789999999999999999999
Q ss_pred EEeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCc
Q 041576 496 VYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQ 575 (714)
Q Consensus 496 v~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 575 (714)
||||+++++|...+.. ..+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 80 v~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05589 80 VMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG 155 (324)
T ss_pred EEcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCCCC
Confidence 9999999999988865 56899999999999999999999998 9999999999999999999999999987532222
Q ss_pred ccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchh
Q 041576 576 SRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDK 655 (714)
Q Consensus 576 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 655 (714)
.......|+..|+|||.+.+..++.++|||||||++|||++|+.||........ +.. ...+...
T Consensus 156 -~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~---~~~-----i~~~~~~------- 219 (324)
T cd05589 156 -DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEV---FDS-----IVNDEVR------- 219 (324)
T ss_pred -CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHH---HHH-----HHhCCCC-------
Confidence 222345689999999999999999999999999999999999999975433221 111 1111100
Q ss_pred hhccchHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 041576 656 AAMADKSRACKWLMIALWCIQEDPLKRP-----AMKMIVQ 690 (714)
Q Consensus 656 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 690 (714)
.+...+..+.+++.+||+.||.+|| ++.++++
T Consensus 220 ---~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 220 ---YPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred ---CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 1112345677899999999999999 5777765
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=321.07 Aligned_cols=242 Identities=27% Similarity=0.324 Sum_probs=194.4
Q ss_pred hhhCcccceeEEEeEeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHHhcc-CcccccceeceEecCCeeeEEEeecC
Q 041576 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA---QEREREFKTEVSAIGRT-HHKNLVQLLGFCDEGLNRLLVYEFMG 501 (714)
Q Consensus 426 ~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~E~~~ 501 (714)
+.||+|+||.||+|... .+++.||||.++... ......+..|..++... +||||+++++++.+.+..++||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~ 79 (316)
T cd05619 1 KMLGKGSFGKVFLAELK-GTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLN 79 (316)
T ss_pred CeeeeCCCEEEEEEEEC-CCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCC
Confidence 46899999999999876 467899999997532 23345566777888764 99999999999999999999999999
Q ss_pred CCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcccceee
Q 041576 502 NGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTV 581 (714)
Q Consensus 502 ~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 581 (714)
+|+|.+++.....+++.++..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||++....... .....
T Consensus 80 ~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 155 (316)
T cd05619 80 GGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD-AKTCT 155 (316)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCC-Cceee
Confidence 9999999988778899999999999999999999998 9999999999999999999999999987532211 12234
Q ss_pred ecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhhccch
Q 041576 582 IRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMADK 661 (714)
Q Consensus 582 ~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 661 (714)
..|+..|+|||.+.+..++.++|||||||++|||++|+.||........ ... ...... ..+.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~---~~~-----i~~~~~----------~~~~ 217 (316)
T cd05619 156 FCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEEL---FQS-----IRMDNP----------CYPR 217 (316)
T ss_pred ecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHH---HHH-----HHhCCC----------CCCc
Confidence 5689999999999998999999999999999999999999975432221 111 000000 0111
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHH-HHHH
Q 041576 662 SRACKWLMIALWCIQEDPLKRPAMK-MIVQ 690 (714)
Q Consensus 662 ~~~~~l~~li~~cl~~dP~~RPs~~-evl~ 690 (714)
.....+.+++.+||+.||++||++. ++++
T Consensus 218 ~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 218 WLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred cCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 2234577899999999999999997 6654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=322.11 Aligned_cols=241 Identities=27% Similarity=0.305 Sum_probs=194.3
Q ss_pred hhhCcccceeEEEeEeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHHhcc-CcccccceeceEecCCeeeEEEeecC
Q 041576 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA---QEREREFKTEVSAIGRT-HHKNLVQLLGFCDEGLNRLLVYEFMG 501 (714)
Q Consensus 426 ~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~E~~~ 501 (714)
+.||+|+||.||+|..+ .+++.||+|.++... ......+..|..++... +||||+++++++.+++..++||||++
T Consensus 1 ~~lg~G~~g~V~~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~ 79 (316)
T cd05620 1 KVLGKGSFGKVLLAELK-GKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLN 79 (316)
T ss_pred CeeeeCCCeEEEEEEEC-CCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCC
Confidence 46999999999999976 578899999997532 23345667788887764 89999999999999999999999999
Q ss_pred CCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcccceee
Q 041576 502 NGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTV 581 (714)
Q Consensus 502 ~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 581 (714)
+++|.+++.....+++..+..++.||++||+|||+++ |+||||||+||+++.++.+||+|||+++..... ......
T Consensus 80 ~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~ 155 (316)
T cd05620 80 GGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG-DNRAST 155 (316)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccC-CCceec
Confidence 9999999988788899999999999999999999998 999999999999999999999999998743211 122334
Q ss_pred ecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhhccch
Q 041576 582 IRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMADK 661 (714)
Q Consensus 582 ~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 661 (714)
..|+..|+|||.+.+..++.++|||||||++|||++|+.||........... ...... ..+.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~--------~~~~~~----------~~~~ 217 (316)
T cd05620 156 FCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFES--------IRVDTP----------HYPR 217 (316)
T ss_pred cCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHH--------HHhCCC----------CCCC
Confidence 5689999999999999999999999999999999999999975433221110 011000 0111
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHH-HHH
Q 041576 662 SRACKWLMIALWCIQEDPLKRPAMK-MIV 689 (714)
Q Consensus 662 ~~~~~l~~li~~cl~~dP~~RPs~~-evl 689 (714)
.....+.+++.+||+.||++||++. +++
T Consensus 218 ~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 218 WITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 1234677899999999999999985 565
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=310.78 Aligned_cols=256 Identities=20% Similarity=0.315 Sum_probs=205.8
Q ss_pred hhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEeccc---chhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEE
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKL---AQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVY 497 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 497 (714)
.|.+.+.||+|++|.||+|... .+++.++||.+... ......++.+|+.+++.++||||+++++++.+++..+++|
T Consensus 3 ~y~~~~~ig~g~~g~v~~~~~~-~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 3 NFRIEKKIGRGQFSEVYRATCL-LDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred hhhhhhhhcccCCeEEEEEeec-CCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4667889999999999999875 46889999988642 2334467889999999999999999999999999999999
Q ss_pred eecCCCchhhhhhc----CCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCcccccc
Q 041576 498 EFMGNGTLANLLFA----IPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLS 573 (714)
Q Consensus 498 E~~~~gsL~~~l~~----~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~ 573 (714)
||+++++|.+++.. ...+++..+..++.||++||+|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 99999999998863 345789999999999999999999998 99999999999999999999999999876543
Q ss_pred CcccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecc
Q 041576 574 DQSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDN 653 (714)
Q Consensus 574 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 653 (714)
... ......++..|+|||.+.+..++.++||||||+++|||++|..||........ .... ......
T Consensus 159 ~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~~~-----~~~~~~------- 224 (267)
T cd08229 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY-SLCK-----KIEQCD------- 224 (267)
T ss_pred CCc-ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHH-HHhh-----hhhcCC-------
Confidence 222 12234578899999999988899999999999999999999999864322110 0000 000000
Q ss_pred hhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 041576 654 DKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGY 695 (714)
Q Consensus 654 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 695 (714)
............+.+++.+||+.||++||||.+|+++++++
T Consensus 225 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 225 -YPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred -CCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 00111123455788899999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=314.69 Aligned_cols=245 Identities=26% Similarity=0.316 Sum_probs=195.3
Q ss_pred hCcccceeEEEeEeeCCCCcEEEEEEecccch---hhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEeecCCCc
Q 041576 428 LGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQ---EREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEFMGNGT 504 (714)
Q Consensus 428 ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~gs 504 (714)
||+|+||+||++..+ .+++.||+|.+..... ...+.+..|++++++++|+||+++.+++..+...++||||+++|+
T Consensus 1 lg~G~~g~Vy~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~ 79 (280)
T cd05608 1 LGKGGFGEVSACQMR-ATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGD 79 (280)
T ss_pred CCCCCceeEEEEEEc-cCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCC
Confidence 699999999999876 4788999999865322 233567889999999999999999999999999999999999999
Q ss_pred hhhhhhc----CCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCccccee
Q 041576 505 LANLLFA----IPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRT 580 (714)
Q Consensus 505 L~~~l~~----~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 580 (714)
|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+||++++++.+||+|||++........ ...
T Consensus 80 L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~ 155 (280)
T cd05608 80 LRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTK 155 (280)
T ss_pred HHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-ccc
Confidence 9988743 346889999999999999999999998 99999999999999999999999999976543322 122
Q ss_pred eecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhhccc
Q 041576 581 VIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMAD 660 (714)
Q Consensus 581 ~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 660 (714)
...|+..|+|||.+.+..++.++||||||+++|||++|+.||...........+.. ...... ...+
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~----~~~~~~----------~~~~ 221 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQ----RILNDS----------VTYP 221 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHH----hhcccC----------CCCc
Confidence 34688999999999999999999999999999999999999975432211111100 000000 0112
Q ss_pred hHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 041576 661 KSRACKWLMIALWCIQEDPLKRP-----AMKMIVQM 691 (714)
Q Consensus 661 ~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 691 (714)
...+..+.+++.+||+.||++|| +++++++.
T Consensus 222 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 222 DKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 23445678899999999999999 77888863
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=312.56 Aligned_cols=256 Identities=24% Similarity=0.386 Sum_probs=205.2
Q ss_pred HHHHHhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCcccccceeceEecCCeeeE
Q 041576 416 ELNEATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLL 495 (714)
Q Consensus 416 el~~at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 495 (714)
++...++++.++||+|+||.||+|..+ +++.||+|.+.... .....+.+|+.++++++|+||+++++++. .+..++
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~--~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~ 77 (260)
T cd05067 2 EVPRETLKLVKKLGAGQFGEVWMGYYN--GHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYI 77 (260)
T ss_pred ccchHHceeeeeeccCccceEEeeecC--CCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEE
Confidence 355678888999999999999999865 57889999987543 23467899999999999999999999874 456899
Q ss_pred EEeecCCCchhhhhhcC--CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCcccccc
Q 041576 496 VYEFMGNGTLANLLFAI--PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLS 573 (714)
Q Consensus 496 v~E~~~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~ 573 (714)
+|||+++++|.+++... ..+++.++..++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||++.....
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05067 78 ITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIED 154 (260)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCC
Confidence 99999999999998653 35788999999999999999999988 99999999999999999999999999976653
Q ss_pred CcccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccchhhhhhhHHHhhhhhcCccceeec
Q 041576 574 DQSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVD 652 (714)
Q Consensus 574 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 652 (714)
..........++..|+|||.+....++.++||||||+++||+++ |+.||........... ...+...
T Consensus 155 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~--------~~~~~~~---- 222 (260)
T cd05067 155 NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQN--------LERGYRM---- 222 (260)
T ss_pred CCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHH--------HHcCCCC----
Confidence 33222223345678999999998889999999999999999999 9999975432221110 0111000
Q ss_pred chhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 041576 653 NDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGY 695 (714)
Q Consensus 653 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 695 (714)
..+...+.++.+++.+||+.+|++||+++++++.|+.+
T Consensus 223 -----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 260 (260)
T cd05067 223 -----PRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLEDF 260 (260)
T ss_pred -----CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhcC
Confidence 01112334688899999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=312.38 Aligned_cols=255 Identities=20% Similarity=0.284 Sum_probs=203.7
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEee
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEF 499 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~ 499 (714)
..|.+.+.||+|+||.||+|+.. .+++.||+|++..........+.+|+.++++++||||+++++.+..++..++||||
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~-~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNL-HTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhcchhheeecCCCeEEEEEEEC-CCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 45778899999999999999875 46889999999765445556788999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcccce
Q 041576 500 MGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTR 579 (714)
Q Consensus 500 ~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 579 (714)
+++++|.+++.....+++..+..++.|+++||+|||+.+ |+||||+|+||+++.++.+||+|||++........ ..
T Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~-~~ 163 (267)
T cd06646 88 CGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATIA-KR 163 (267)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeeccccc-cc
Confidence 999999999987778899999999999999999999998 99999999999999999999999999986533221 12
Q ss_pred eeecCCCCccCccccc---CCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhh
Q 041576 580 TVIRGTRGYVAPEWFK---NVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKA 656 (714)
Q Consensus 580 ~~~~gt~~y~aPE~~~---~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 656 (714)
....++..|+|||.+. ...++.++||||||+++|||++|+.|+...........+ ..... ..+...
T Consensus 164 ~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~--------~~~~~---~~~~~~ 232 (267)
T cd06646 164 KSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM--------SKSNF---QPPKLK 232 (267)
T ss_pred CccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheee--------ecCCC---CCCCCc
Confidence 2345788999999884 445788999999999999999999998643222110000 00000 000000
Q ss_pred hccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 041576 657 AMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQML 692 (714)
Q Consensus 657 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 692 (714)
.....+..+.+++.+||+.+|++||++++|++.|
T Consensus 233 --~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 233 --DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred --cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 0112345788899999999999999999998753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=316.66 Aligned_cols=256 Identities=26% Similarity=0.335 Sum_probs=202.8
Q ss_pred HHhhhhhhhhCcccceeEEEeEeeC----CCCcEEEEEEecccch-hhHHHHHHHHHHHhccCcccccceeceEecCCee
Q 041576 419 EATNGFEEELGRGSFGIVYKGVLKS----ASGNAVAVKKLDKLAQ-EREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNR 493 (714)
Q Consensus 419 ~at~~~~~~ig~G~~g~Vy~~~~~~----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 493 (714)
-..+.+.++||+|+||.||+|.... ..++.||+|.++.... .....+.+|+.++.+++||||+++++++......
T Consensus 4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~ 83 (283)
T cd05091 4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPL 83 (283)
T ss_pred HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCce
Confidence 3457788999999999999998642 2357899999975433 2346788999999999999999999999999999
Q ss_pred eEEEeecCCCchhhhhhcC----------------CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCC
Q 041576 494 LLVYEFMGNGTLANLLFAI----------------PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQD 557 (714)
Q Consensus 494 ~lv~E~~~~gsL~~~l~~~----------------~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~ 557 (714)
++++||+++++|.+++... ..+++..+..++.|+++||+|||+.+ ++||||||+||+++++
T Consensus 84 ~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~ 160 (283)
T cd05091 84 SMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDK 160 (283)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCC
Confidence 9999999999999998531 23677888999999999999999998 9999999999999999
Q ss_pred CceEEecCCCccccccCccc-ceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccchhhhhhh
Q 041576 558 FTAKISDFGLSKLLLSDQSR-TRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEERSAILT 635 (714)
Q Consensus 558 ~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~l~ 635 (714)
+.+||+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |..||......+. +
T Consensus 161 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~---~- 236 (283)
T cd05091 161 LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV---I- 236 (283)
T ss_pred CceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHH---H-
Confidence 99999999998865432221 1122345678999999988889999999999999999998 7788764432211 1
Q ss_pred HHHhhhhhcCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 041576 636 DWAYDCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEG 694 (714)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 694 (714)
.....+... ..+...+..+.+++.+||+.+|++||++++|++.|+.
T Consensus 237 ----~~i~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 237 ----EMIRNRQVL---------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred ----HHHHcCCcC---------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 111111111 1122344567889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=331.81 Aligned_cols=251 Identities=23% Similarity=0.276 Sum_probs=198.5
Q ss_pred hhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEe
Q 041576 422 NGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA---QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYE 498 (714)
Q Consensus 422 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E 498 (714)
|.+.+.||+|+||.||++... .+++.||||++.... ....+.+.+|++++++++||||+++++++.++...++|||
T Consensus 3 y~~~~~lG~G~~g~Vy~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E 81 (377)
T cd05629 3 FHTVKVIGKGAFGEVRLVQKK-DTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIME 81 (377)
T ss_pred ceEeEEEeecCCEEEEEEEEC-CCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEe
Confidence 556789999999999999876 578899999986532 2344678899999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcc--
Q 041576 499 FMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQS-- 576 (714)
Q Consensus 499 ~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~-- 576 (714)
|+++|+|.+++.....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 158 (377)
T cd05629 82 FLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSA 158 (377)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccccccccc
Confidence 9999999999988888899999999999999999999998 99999999999999999999999999863321000
Q ss_pred -----------c---------------------------------ceeeecCCCCccCcccccCCCCCchhhhHHHHHHH
Q 041576 577 -----------R---------------------------------TRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVL 612 (714)
Q Consensus 577 -----------~---------------------------------~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil 612 (714)
. ......||+.|+|||++.+..++.++|||||||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 238 (377)
T cd05629 159 YYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIM 238 (377)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhh
Confidence 0 00124589999999999998999999999999999
Q ss_pred HHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhhccchHHHHHHHHHHHHccccCCCCC---CCHHHHH
Q 041576 613 LKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKR---PAMKMIV 689 (714)
Q Consensus 613 ~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R---Ps~~evl 689 (714)
|||++|+.||......+....+..+. ..+ .+ + ........+.+++.+||+ +|.+| +++.|++
T Consensus 239 ~elltG~~Pf~~~~~~~~~~~i~~~~------~~~-~~--p-----~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l 303 (377)
T cd05629 239 FECLIGWPPFCSENSHETYRKIINWR------ETL-YF--P-----DDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIK 303 (377)
T ss_pred hhhhcCCCCCCCCCHHHHHHHHHccC------Ccc-CC--C-----CCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHh
Confidence 99999999997554322211111110 000 00 0 011123467779999997 67665 5999988
Q ss_pred HH
Q 041576 690 QM 691 (714)
Q Consensus 690 ~~ 691 (714)
+.
T Consensus 304 ~h 305 (377)
T cd05629 304 SH 305 (377)
T ss_pred cC
Confidence 75
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=323.42 Aligned_cols=246 Identities=27% Similarity=0.325 Sum_probs=198.3
Q ss_pred hhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHHhccCc-ccccceeceEecCCeeeEEE
Q 041576 422 NGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA---QEREREFKTEVSAIGRTHH-KNLVQLLGFCDEGLNRLLVY 497 (714)
Q Consensus 422 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h-~nIv~l~~~~~~~~~~~lv~ 497 (714)
|.+.+.||+|+||.||+|..+ .+++.||||+++... ....+.+..|.+++..++| ++|+++++++.+.+..++||
T Consensus 2 y~~~~~lg~G~~g~Vy~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 2 FNFLMVLGKGSFGKVMLAERK-GTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred ceEEEEEeeccCeEEEEEEEC-CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 456789999999999999876 567899999997532 2345677889999999966 56888999999999999999
Q ss_pred eecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCccc
Q 041576 498 EFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSR 577 (714)
Q Consensus 498 E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 577 (714)
||+++|+|.+++.....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++...... ..
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~-~~ 156 (324)
T cd05587 81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG-GK 156 (324)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCC-CC
Confidence 99999999999988888899999999999999999999998 999999999999999999999999998743221 12
Q ss_pred ceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhh
Q 041576 578 TRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAA 657 (714)
Q Consensus 578 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 657 (714)
......|+..|+|||++.+..++.++|||||||++|||++|+.||...........+ .....
T Consensus 157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i--------~~~~~---------- 218 (324)
T cd05587 157 TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSI--------MEHNV---------- 218 (324)
T ss_pred ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH--------HcCCC----------
Confidence 233456899999999999999999999999999999999999999754332211111 11110
Q ss_pred ccchHHHHHHHHHHHHccccCCCCCCCH-----HHHHH
Q 041576 658 MADKSRACKWLMIALWCIQEDPLKRPAM-----KMIVQ 690 (714)
Q Consensus 658 ~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~ 690 (714)
..+......+.+++.+||+.||.+|++. +++++
T Consensus 219 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 256 (324)
T cd05587 219 SYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIRE 256 (324)
T ss_pred CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 0111234467789999999999999976 56654
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=299.68 Aligned_cols=264 Identities=21% Similarity=0.219 Sum_probs=201.8
Q ss_pred hhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchh--hHHHHHHHHHHHhccCcccccceeceEe--cCCeeeEEE
Q 041576 422 NGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQE--REREFKTEVSAIGRTHHKNLVQLLGFCD--EGLNRLLVY 497 (714)
Q Consensus 422 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~--~~~~~~lv~ 497 (714)
|+..+.|++|.||.||+|+++ .+++.||+|+++-..+. ---.-.+||.+|.+++|||||.+.++.. +-+..||||
T Consensus 78 fe~lnrI~EGtyGiVYRakdk-~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VM 156 (419)
T KOG0663|consen 78 FEKLNRIEEGTYGVVYRAKDK-KTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVM 156 (419)
T ss_pred HHHHhhcccCcceeEEEeccC-CcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeH
Confidence 344578999999999999977 67899999999753221 1134689999999999999999999874 345689999
Q ss_pred eecCCCchhhhhhcCC-CCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcc
Q 041576 498 EFMGNGTLANLLFAIP-RPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQS 576 (714)
Q Consensus 498 E~~~~gsL~~~l~~~~-~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 576 (714)
||++. +|..++...+ ++...++..+..|+++|++|||.+. |+|||||++|+|+++.|.+||+|||+|+..... .
T Consensus 157 e~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp-~ 231 (419)
T KOG0663|consen 157 EYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYGSP-L 231 (419)
T ss_pred HHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhcCC-c
Confidence 99998 9999998765 7899999999999999999999998 999999999999999999999999999987554 3
Q ss_pred cceeeecCCCCccCcccccCC-CCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHH---hhhhhcC----c--
Q 041576 577 RTRTVIRGTRGYVAPEWFKNV-PVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWA---YDCYVEG----K-- 646 (714)
Q Consensus 577 ~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~---~~~~~~~----~-- 646 (714)
...+..+-|..|.|||.+.+. .|+.+.|+||+|||+.||+++++.|......++...+...- .+....+ .
T Consensus 232 k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~ 311 (419)
T KOG0663|consen 232 KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAV 311 (419)
T ss_pred ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchh
Confidence 344556679999999998765 58999999999999999999999998766554332222110 0000000 0
Q ss_pred ----cceeecchhhhccchH-HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 647 ----LDVLVDNDKAAMADKS-RACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 647 ----~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
.....-..+...+... ....-.+++..+|..||.+|.|+.|.|+.
T Consensus 312 k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 312 KKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred hccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 0000000011111111 33566778899999999999999999874
|
|
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=318.87 Aligned_cols=259 Identities=27% Similarity=0.393 Sum_probs=205.3
Q ss_pred HHHhhhhhhhhCcccceeEEEeEee----CCCCcEEEEEEecccc-hhhHHHHHHHHHHHhcc-CcccccceeceEecCC
Q 041576 418 NEATNGFEEELGRGSFGIVYKGVLK----SASGNAVAVKKLDKLA-QEREREFKTEVSAIGRT-HHKNLVQLLGFCDEGL 491 (714)
Q Consensus 418 ~~at~~~~~~ig~G~~g~Vy~~~~~----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~ 491 (714)
....+.+.+.||+|+||.||+|... ...+..||+|.++... ....+.+.+|+++++++ +||||+++++++...+
T Consensus 33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 112 (302)
T cd05055 33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGG 112 (302)
T ss_pred cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence 3345677889999999999999752 2345589999987543 33456789999999999 8999999999999999
Q ss_pred eeeEEEeecCCCchhhhhhcCC--CCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCcc
Q 041576 492 NRLLVYEFMGNGTLANLLFAIP--RPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSK 569 (714)
Q Consensus 492 ~~~lv~E~~~~gsL~~~l~~~~--~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~ 569 (714)
..++||||+++++|.+++.... .+++.++..++.||+.||+|||+++ ++|+||||+||+++.++.++|+|||++.
T Consensus 113 ~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~~ 189 (302)
T cd05055 113 PILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLAR 189 (302)
T ss_pred ceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCcccc
Confidence 9999999999999999997543 3789999999999999999999998 9999999999999999999999999998
Q ss_pred ccccCccc-ceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccchhhhhhhHHHhhhhhcCcc
Q 041576 570 LLLSDQSR-TRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEERSAILTDWAYDCYVEGKL 647 (714)
Q Consensus 570 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~ 647 (714)
........ ......++..|+|||.+.+..++.++||||||+++|||++ |+.||........ +.. ....+..
T Consensus 190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~---~~~----~~~~~~~ 262 (302)
T cd05055 190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK---FYK----LIKEGYR 262 (302)
T ss_pred cccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH---HHH----HHHcCCc
Confidence 65433221 1112345678999999999899999999999999999998 9999865432211 101 0111100
Q ss_pred ceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 041576 648 DVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGY 695 (714)
Q Consensus 648 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 695 (714)
...+...+..+.+++.+||+.+|++||++.|+++.|+++
T Consensus 263 ---------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 263 ---------MAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred ---------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 001112235688899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=332.92 Aligned_cols=250 Identities=22% Similarity=0.249 Sum_probs=196.4
Q ss_pred hhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEe
Q 041576 422 NGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA---QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYE 498 (714)
Q Consensus 422 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E 498 (714)
+.+.++||+|+||.||+|+.. .+++.||+|.+.... ......+.+|++++++++||||+++++.+.+++..++|||
T Consensus 3 f~~~~~LG~G~~g~Vy~a~~~-~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 3 FVKIKTLGIGAFGEVCLARKV-DTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred cEEEEEEEeCCCEEEEEEEEC-CCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 456789999999999999876 578899999997532 2345678899999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCc---
Q 041576 499 FMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQ--- 575 (714)
Q Consensus 499 ~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~--- 575 (714)
|+++|+|.+++.....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~ 158 (382)
T cd05625 82 YIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 158 (382)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCcccccccccc
Confidence 9999999999988778899999999999999999999998 9999999999999999999999999975321000
Q ss_pred -------------------------------------------ccceeeecCCCCccCcccccCCCCCchhhhHHHHHHH
Q 041576 576 -------------------------------------------SRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVL 612 (714)
Q Consensus 576 -------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil 612 (714)
........||+.|+|||++.+..++.++|||||||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil 238 (382)
T cd05625 159 YYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 238 (382)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHH
Confidence 0001124689999999999999999999999999999
Q ss_pred HHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCC---HHHHH
Q 041576 613 LKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPA---MKMIV 689 (714)
Q Consensus 613 ~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl 689 (714)
|||++|+.||......+....+..+ ... ............+.+++.+|+ .+|.+|++ +.|++
T Consensus 239 ~elltG~~Pf~~~~~~~~~~~i~~~------~~~--------~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~ 303 (382)
T cd05625 239 YEMLVGQPPFLAQTPLETQMKVINW------QTS--------LHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIK 303 (382)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHcc------CCC--------cCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHh
Confidence 9999999999754332211111110 000 000011122345566777766 49999987 88877
Q ss_pred H
Q 041576 690 Q 690 (714)
Q Consensus 690 ~ 690 (714)
+
T Consensus 304 ~ 304 (382)
T cd05625 304 A 304 (382)
T ss_pred c
Confidence 5
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=310.51 Aligned_cols=249 Identities=29% Similarity=0.398 Sum_probs=204.5
Q ss_pred HHhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEe
Q 041576 419 EATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYE 498 (714)
Q Consensus 419 ~at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E 498 (714)
...+.+.+.||+|++|.||+|... ++.|++|.++.... ..+++.+|+.++++++|+||+++++++.+....++|||
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~---~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 80 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR---GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTE 80 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec---CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEE
Confidence 345677889999999999999864 78999999976544 56789999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcCC--CCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcc
Q 041576 499 FMGNGTLANLLFAIP--RPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQS 576 (714)
Q Consensus 499 ~~~~gsL~~~l~~~~--~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 576 (714)
|+++++|.+++.... .+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||.+........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~ 157 (256)
T cd05039 81 YMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD 157 (256)
T ss_pred ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccccc
Confidence 999999999997655 6899999999999999999999998 99999999999999999999999999986632211
Q ss_pred cceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccchhhhhhhHHHhhhhhcCccceeecchh
Q 041576 577 RTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDK 655 (714)
Q Consensus 577 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 655 (714)
....+..|+|||.+....++.++||||||+++||+++ |+.||......... . ....+...
T Consensus 158 ----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~----~----~~~~~~~~------- 218 (256)
T cd05039 158 ----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV----P----HVEKGYRM------- 218 (256)
T ss_pred ----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHH----H----HHhcCCCC-------
Confidence 2234567999999998889999999999999999997 99998644322110 1 00111000
Q ss_pred hhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 041576 656 AAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGY 695 (714)
Q Consensus 656 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 695 (714)
..+...+..+.+++.+||+.+|++||+++|++++|+.+
T Consensus 219 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 219 --EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred --CCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 01122345778899999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=316.91 Aligned_cols=264 Identities=22% Similarity=0.312 Sum_probs=201.6
Q ss_pred HHHhhhhhhhhCcccceeEEEeEeeCC-------------CCcEEEEEEeccc-chhhHHHHHHHHHHHhccCcccccce
Q 041576 418 NEATNGFEEELGRGSFGIVYKGVLKSA-------------SGNAVAVKKLDKL-AQEREREFKTEVSAIGRTHHKNLVQL 483 (714)
Q Consensus 418 ~~at~~~~~~ig~G~~g~Vy~~~~~~~-------------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l 483 (714)
....+.+.+.||+|+||.||++..... ....||+|.++.. .......+.+|++++++++|+||+++
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~ 82 (295)
T cd05097 3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRL 82 (295)
T ss_pred chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeE
Confidence 345678889999999999999876421 1235899998753 33445679999999999999999999
Q ss_pred eceEecCCeeeEEEeecCCCchhhhhhcCC------------CCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCe
Q 041576 484 LGFCDEGLNRLLVYEFMGNGTLANLLFAIP------------RPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQN 551 (714)
Q Consensus 484 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~------------~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~N 551 (714)
++++......++||||+++++|.+++.... .+++..++.++.|++.||+|||+.+ ++|+||||+|
T Consensus 83 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~N 159 (295)
T cd05097 83 LGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRN 159 (295)
T ss_pred EEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhh
Confidence 999999999999999999999999986432 3578888999999999999999998 9999999999
Q ss_pred EEECCCCceEEecCCCccccccCccc-ceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh--cCCCCcccccc
Q 041576 552 ILLDQDFTAKISDFGLSKLLLSDQSR-TRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC--CKRSVEMELGE 628 (714)
Q Consensus 552 Ill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt--G~~p~~~~~~~ 628 (714)
|++++++.+||+|||++......... ......++..|+|||.+.+..++.++||||||+++|||++ +..||......
T Consensus 160 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~ 239 (295)
T cd05097 160 CLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE 239 (295)
T ss_pred EEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChH
Confidence 99999999999999999765332211 1122234678999999998889999999999999999998 55676644322
Q ss_pred hhhhhhhHHHhhhhhcCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 041576 629 ERSAILTDWAYDCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEG 694 (714)
Q Consensus 629 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 694 (714)
....... ......... .. ...+...+..+.+++.+||+.||++||++.+|++.|++
T Consensus 240 ~~~~~~~----~~~~~~~~~-~~-----~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 240 QVIENTG----EFFRNQGRQ-IY-----LSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred HHHHHHH----Hhhhhcccc-cc-----CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 2111110 000000000 00 00111234578899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=326.83 Aligned_cols=241 Identities=25% Similarity=0.322 Sum_probs=202.3
Q ss_pred hhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEeccc---chhhHHHHHHHHHHHhcc-CcccccceeceEecCCeeeEE
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKL---AQEREREFKTEVSAIGRT-HHKNLVQLLGFCDEGLNRLLV 496 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv 496 (714)
...+.++||+|.||+|+++.++ .+++.+|||.+++. ..++.+..+.|.+++... +||.+++++.+|...++.++|
T Consensus 369 ~F~~l~vLGkGsFGkV~lae~k-~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fv 447 (694)
T KOG0694|consen 369 DFRLLAVLGRGSFGKVLLAELK-GTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFV 447 (694)
T ss_pred ceEEEEEeccCcCceEEEEEEc-CCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEE
Confidence 3456789999999999999988 56789999999873 345567788888888877 699999999999999999999
Q ss_pred EeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcc
Q 041576 497 YEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQS 576 (714)
Q Consensus 497 ~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 576 (714)
|||+.||++..++ ....+++..+.-++..|+.||+|||+++ ||+||||.+|||+|.+|++||+|||+++......
T Consensus 448 mey~~Ggdm~~~~-~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g- 522 (694)
T KOG0694|consen 448 MEYVAGGDLMHHI-HTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQG- 522 (694)
T ss_pred EEecCCCcEEEEE-ecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccccccCCCC-
Confidence 9999999944443 4478999999999999999999999998 9999999999999999999999999998643222
Q ss_pred cceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhh
Q 041576 577 RTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKA 656 (714)
Q Consensus 577 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 656 (714)
....++.||+.|||||++.+..|+.+.|-|||||+||||+.|..||..+++++....+.. .+
T Consensus 523 ~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~----------------d~-- 584 (694)
T KOG0694|consen 523 DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVN----------------DE-- 584 (694)
T ss_pred CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhc----------------CC--
Confidence 345668899999999999999999999999999999999999999997766653322211 00
Q ss_pred hccchHHHHHHHHHHHHccccCCCCCCCH
Q 041576 657 AMADKSRACKWLMIALWCIQEDPLKRPAM 685 (714)
Q Consensus 657 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 685 (714)
...+.-.+.+.+.++.++|..+|++|.-+
T Consensus 585 ~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 585 VRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred CCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 11233445577789999999999999755
|
|
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=318.30 Aligned_cols=261 Identities=25% Similarity=0.382 Sum_probs=203.7
Q ss_pred hhhhhhhCcccceeEEEeEeeCCC-CcEEEEEEeccc-chhhHHHHHHHHHHHhcc-CcccccceeceEecCCeeeEEEe
Q 041576 422 NGFEEELGRGSFGIVYKGVLKSAS-GNAVAVKKLDKL-AQEREREFKTEVSAIGRT-HHKNLVQLLGFCDEGLNRLLVYE 498 (714)
Q Consensus 422 ~~~~~~ig~G~~g~Vy~~~~~~~~-~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~E 498 (714)
+.+.+.||+|+||.||+|..+... ...+++|.++.. .....+.+.+|++++.++ +||||+++++++......++++|
T Consensus 4 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e 83 (297)
T cd05089 4 IKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIE 83 (297)
T ss_pred ceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEE
Confidence 566789999999999999876322 235788888753 334456789999999999 79999999999999999999999
Q ss_pred ecCCCchhhhhhcCC----------------CCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEE
Q 041576 499 FMGNGTLANLLFAIP----------------RPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKI 562 (714)
Q Consensus 499 ~~~~gsL~~~l~~~~----------------~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl 562 (714)
|+++++|.+++.... .+++..++.++.||+.||+|||+.+ ++||||||+||++++++.+||
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl 160 (297)
T cd05089 84 YAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLASKI 160 (297)
T ss_pred ecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeEEE
Confidence 999999999996532 3678889999999999999999988 999999999999999999999
Q ss_pred ecCCCccccccCcccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccchhhhhhhHHHhhh
Q 041576 563 SDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEERSAILTDWAYDC 641 (714)
Q Consensus 563 ~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~l~~~~~~~ 641 (714)
+|||++...... ........+..|+|||.+....++.++|||||||++|||++ |..||........ . ..
T Consensus 161 ~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~---~-----~~ 230 (297)
T cd05089 161 ADFGLSRGEEVY--VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAEL---Y-----EK 230 (297)
T ss_pred CCcCCCccccce--eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH---H-----HH
Confidence 999998643211 11111223457999999998889999999999999999997 9999965432221 1 11
Q ss_pred hhcCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCCCCCCCC
Q 041576 642 YVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLEVPSPPMP 704 (714)
Q Consensus 642 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~pp~p 704 (714)
...+.. ...+...+..+.+++.+||+.+|.+||+++++++.|+++++...+..+
T Consensus 231 ~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~~~~ 284 (297)
T cd05089 231 LPQGYR---------MEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKAYVN 284 (297)
T ss_pred HhcCCC---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhccccc
Confidence 111100 001122345678899999999999999999999999998876544443
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=309.43 Aligned_cols=253 Identities=25% Similarity=0.377 Sum_probs=201.0
Q ss_pred HHHhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEE
Q 041576 418 NEATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVY 497 (714)
Q Consensus 418 ~~at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 497 (714)
....+.+.+.||+|++|.||+|.+. .+..+++|.+.... ...+.+.+|++++++++|+|++++++++. .+..+++|
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~--~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~ 79 (260)
T cd05069 4 PRESLRLDVKLGQGCFGEVWMGTWN--GTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVT 79 (260)
T ss_pred ChHHeeeeeeecCcCCCeEEEEEEc--CCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEE
Confidence 3456778889999999999999875 34579999886432 23467889999999999999999999875 45688999
Q ss_pred eecCCCchhhhhhcC--CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCc
Q 041576 498 EFMGNGTLANLLFAI--PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQ 575 (714)
Q Consensus 498 E~~~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 575 (714)
||+++++|.+++... ..+++..+..++.|+++||+|||+.+ ++|+||||+||++++++.++|+|||++.......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05069 80 EFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNE 156 (260)
T ss_pred EcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCc
Confidence 999999999999754 34788999999999999999999998 9999999999999999999999999997664332
Q ss_pred ccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccchhhhhhhHHHhhhhhcCccceeecch
Q 041576 576 SRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDND 654 (714)
Q Consensus 576 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 654 (714)
........++..|+|||.+.+..++.++||||||+++|||++ |+.||.......... ....+..
T Consensus 157 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~--------~~~~~~~------- 221 (260)
T cd05069 157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLE--------QVERGYR------- 221 (260)
T ss_pred ccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH--------HHHcCCC-------
Confidence 222222345678999999998899999999999999999999 888987543222110 0111100
Q ss_pred hhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 041576 655 KAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEG 694 (714)
Q Consensus 655 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 694 (714)
...+...+..+.+++.+||+.||++||++++|++.|+.
T Consensus 222 --~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 222 --MPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred --CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 01112334578889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=311.10 Aligned_cols=253 Identities=29% Similarity=0.446 Sum_probs=202.6
Q ss_pred hhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhH--HHHHHHHHHHhccCcccccceeceEecCCeeeEEEee
Q 041576 422 NGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQERE--REFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEF 499 (714)
Q Consensus 422 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~ 499 (714)
|.+.+.||+|+||+||++... .+++.+|+|.+........ ....+|+.++++++||||+++++++.+....++||||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~-~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~ 79 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNK-KNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEY 79 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEET-TTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEEC-CCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccccccccccccc
Confidence 456789999999999999976 5677999999976544333 2345699999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcccce
Q 041576 500 MGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTR 579 (714)
Q Consensus 500 ~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 579 (714)
+++++|.+++.....+++..+..++.||++||++||+.+ ++|+||||+||++++++.++|+|||.+... .......
T Consensus 80 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~-~~~~~~~ 155 (260)
T PF00069_consen 80 CPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKL-SENNENF 155 (260)
T ss_dssp ETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEES-TSTTSEB
T ss_pred ccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccc-ccccccc
Confidence 999999999997788899999999999999999999998 999999999999999999999999999764 1222233
Q ss_pred eeecCCCCccCccccc-CCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhhc
Q 041576 580 TVIRGTRGYVAPEWFK-NVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAM 658 (714)
Q Consensus 580 ~~~~gt~~y~aPE~~~-~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 658 (714)
....++..|+|||.+. +...+.++||||+|+++++|++|..|+...........+...... .... ...
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~-----~~~~------~~~ 224 (260)
T PF00069_consen 156 NPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKR-----PLPS------SSQ 224 (260)
T ss_dssp SSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHT-----HHHH------HTT
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccc-----cccc------ccc
Confidence 3456889999999998 888999999999999999999999999865222211111111000 0000 000
Q ss_pred cchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 659 ADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 659 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
........+.+++.+||+.||++||++.++++
T Consensus 225 ~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 225 QSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred ccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00111267888999999999999999999985
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=311.89 Aligned_cols=253 Identities=25% Similarity=0.393 Sum_probs=199.9
Q ss_pred hhhhhhCcccceeEEEeEeeCCC--CcEEEEEEeccc--chhhHHHHHHHHHHHhccCcccccceeceEecCCe------
Q 041576 423 GFEEELGRGSFGIVYKGVLKSAS--GNAVAVKKLDKL--AQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLN------ 492 (714)
Q Consensus 423 ~~~~~ig~G~~g~Vy~~~~~~~~--~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~------ 492 (714)
.+.+.||+|+||.||+|.+.... +..||+|+++.. .......+.+|++.++.++||||+++++++.....
T Consensus 2 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 81 (273)
T cd05035 2 KLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPK 81 (273)
T ss_pred ccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcc
Confidence 45688999999999999876432 468999998743 23445688999999999999999999999866554
Q ss_pred eeEEEeecCCCchhhhhhcC------CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCC
Q 041576 493 RLLVYEFMGNGTLANLLFAI------PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFG 566 (714)
Q Consensus 493 ~~lv~E~~~~gsL~~~l~~~------~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg 566 (714)
.++++||+++++|..++... ..+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||
T Consensus 82 ~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg 158 (273)
T cd05035 82 PMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADFG 158 (273)
T ss_pred cEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCcc
Confidence 78999999999999998532 35788899999999999999999998 9999999999999999999999999
Q ss_pred CccccccCcccc-eeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccchhhhhhhHHHhhhhhc
Q 041576 567 LSKLLLSDQSRT-RTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEERSAILTDWAYDCYVE 644 (714)
Q Consensus 567 ~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~ 644 (714)
+++......... ......+..|+|||.+.+..++.++||||||+++|||++ |..||........ . . ....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~---~-~----~~~~ 230 (273)
T cd05035 159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEI---Y-D----YLRH 230 (273)
T ss_pred ceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHH---H-H----HHHc
Confidence 998664332211 112234678999999998899999999999999999999 8888864332211 1 1 1111
Q ss_pred CccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 041576 645 GKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGY 695 (714)
Q Consensus 645 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 695 (714)
+.... .+......+.+++.+||+.||++||++.|+++.|+++
T Consensus 231 ~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 231 GNRLK---------QPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CCCCC---------CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 11110 1123345788899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=309.09 Aligned_cols=248 Identities=26% Similarity=0.368 Sum_probs=196.8
Q ss_pred hhCcccceeEEEeEeeCC-CCcEEEEEEecccc-hhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEeecCCCc
Q 041576 427 ELGRGSFGIVYKGVLKSA-SGNAVAVKKLDKLA-QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEFMGNGT 504 (714)
Q Consensus 427 ~ig~G~~g~Vy~~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~gs 504 (714)
.||+|+||.||+|.++.. .+..||+|.+.... ....+.+.+|+.++++++||||+++++++.. ...++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence 489999999999987533 34579999987543 3334679999999999999999999998854 57899999999999
Q ss_pred hhhhhhc-CCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcccce--ee
Q 041576 505 LANLLFA-IPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTR--TV 581 (714)
Q Consensus 505 L~~~l~~-~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~--~~ 581 (714)
|.+++.. ...+++..+++++.||++||+|||+++ ++||||||+||+++.++.+||+|||++........... ..
T Consensus 81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05115 81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSA 157 (257)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceeccCC
Confidence 9999975 356899999999999999999999998 99999999999999999999999999986543322211 11
Q ss_pred ecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhhccc
Q 041576 582 IRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMAD 660 (714)
Q Consensus 582 ~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 660 (714)
..++..|+|||.+....++.++||||||+++||+++ |..||.......... ....+.. ...+
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~--------~~~~~~~---------~~~~ 220 (257)
T cd05115 158 GKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMS--------FIEQGKR---------LDCP 220 (257)
T ss_pred CCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHH--------HHHCCCC---------CCCC
Confidence 223568999999988889999999999999999996 999997543322111 1111111 0112
Q ss_pred hHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 041576 661 KSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGY 695 (714)
Q Consensus 661 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 695 (714)
......+.+++.+||+.+|++||++.+|.+.|+.+
T Consensus 221 ~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 221 AECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 23345778899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=313.24 Aligned_cols=259 Identities=25% Similarity=0.344 Sum_probs=203.5
Q ss_pred HHhhhhhhhhCcccceeEEEeEeeCCCCc----EEEEEEeccc-chhhHHHHHHHHHHHhccCcccccceeceEecCCee
Q 041576 419 EATNGFEEELGRGSFGIVYKGVLKSASGN----AVAVKKLDKL-AQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNR 493 (714)
Q Consensus 419 ~at~~~~~~ig~G~~g~Vy~~~~~~~~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 493 (714)
...+.+.+.||+|+||+||+|.+.. +++ +||+|.++.. .......+.+|+.+++.++||||+++++++... ..
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~-~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~ 83 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIP-DGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TV 83 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEec-CCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-Cc
Confidence 3445667899999999999998753 333 5899998653 344466889999999999999999999999754 56
Q ss_pred eEEEeecCCCchhhhhhcC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccc
Q 041576 494 LLVYEFMGNGTLANLLFAI-PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLL 572 (714)
Q Consensus 494 ~lv~E~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~ 572 (714)
++++||+++|+|.+++... ..+++..++.++.||+.||+|||+.+ ++||||||+||++++++.+||+|||+++...
T Consensus 84 ~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~ 160 (279)
T cd05109 84 QLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLD 160 (279)
T ss_pred EEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeecc
Confidence 7999999999999999764 46899999999999999999999998 9999999999999999999999999998764
Q ss_pred cCcccc-eeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccchhhhhhhHHHhhhhhcCcccee
Q 041576 573 SDQSRT-RTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEERSAILTDWAYDCYVEGKLDVL 650 (714)
Q Consensus 573 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 650 (714)
...... .....++..|+|||.+.+..++.++||||||+++|||++ |..||........ ... ...+...
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~----~~~----~~~~~~~-- 230 (279)
T cd05109 161 IDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREI----PDL----LEKGERL-- 230 (279)
T ss_pred cccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH----HHH----HHCCCcC--
Confidence 332211 111234678999999998899999999999999999998 8899864332211 111 1111100
Q ss_pred ecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCCC
Q 041576 651 VDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLEVP 699 (714)
Q Consensus 651 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 699 (714)
..+...+..+.+++.+||+.||++||++.|+++.|+.+...+
T Consensus 231 -------~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 231 -------PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred -------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 011123346778999999999999999999999998876654
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=324.47 Aligned_cols=238 Identities=28% Similarity=0.312 Sum_probs=191.0
Q ss_pred hhhCcccceeEEEeEeeCCCCcEEEEEEecccc---hhhHHHHHHHHH-HHhccCcccccceeceEecCCeeeEEEeecC
Q 041576 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA---QEREREFKTEVS-AIGRTHHKNLVQLLGFCDEGLNRLLVYEFMG 501 (714)
Q Consensus 426 ~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~ 501 (714)
+.||+|+||+||+|... .+++.||+|++.... ......+..|.. +++.++||||+++++.+.+++..++||||++
T Consensus 1 ~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 79 (323)
T cd05575 1 KVIGKGSFGKVLLAKHK-ADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVN 79 (323)
T ss_pred CeeeeCCCeEEEEEEEC-CCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCC
Confidence 46899999999999976 578999999996532 222344555554 5677899999999999999999999999999
Q ss_pred CCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcccceee
Q 041576 502 NGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTV 581 (714)
Q Consensus 502 ~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 581 (714)
+++|.+++.....+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||++...... ......
T Consensus 80 ~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~~~~ 155 (323)
T cd05575 80 GGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH-SKTTST 155 (323)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccC-CCcccc
Confidence 9999999988888999999999999999999999998 999999999999999999999999998753222 122334
Q ss_pred ecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhhccch
Q 041576 582 IRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMADK 661 (714)
Q Consensus 582 ~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 661 (714)
..|+..|+|||.+.+..++.++|||||||++|||++|+.||.......... ....+... ...
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~--------~i~~~~~~----------~~~ 217 (323)
T cd05575 156 FCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYD--------NILNKPLR----------LKP 217 (323)
T ss_pred ccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHH--------HHHcCCCC----------CCC
Confidence 568999999999999999999999999999999999999997543222110 11111110 011
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHH
Q 041576 662 SRACKWLMIALWCIQEDPLKRPAMK 686 (714)
Q Consensus 662 ~~~~~l~~li~~cl~~dP~~RPs~~ 686 (714)
.....+.+++.+||+.||.+||+++
T Consensus 218 ~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 218 NISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 2245677899999999999999984
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=326.34 Aligned_cols=240 Identities=25% Similarity=0.270 Sum_probs=195.2
Q ss_pred hhhCcccceeEEEeEee--CCCCcEEEEEEecccc--hhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEeecC
Q 041576 426 EELGRGSFGIVYKGVLK--SASGNAVAVKKLDKLA--QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEFMG 501 (714)
Q Consensus 426 ~~ig~G~~g~Vy~~~~~--~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~ 501 (714)
+.||+|+||.||++... ..+++.||+|+++... ......+.+|++++++++||||+++++++.++...++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 57999999999998753 2467899999997532 2234567889999999999999999999999999999999999
Q ss_pred CCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcccceee
Q 041576 502 NGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTV 581 (714)
Q Consensus 502 ~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 581 (714)
+++|.+++.....+++..+..++.||++||+|||+.+ |+||||||+||++++++.+||+|||++....... .....
T Consensus 82 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~~~~~ 157 (318)
T cd05582 82 GGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-KKAYS 157 (318)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-Cceec
Confidence 9999999988778999999999999999999999998 9999999999999999999999999987653322 22234
Q ss_pred ecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhhccch
Q 041576 582 IRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMADK 661 (714)
Q Consensus 582 ~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 661 (714)
..|+..|+|||.+.+..++.++||||||+++|||++|+.||.......... ........ .+.
T Consensus 158 ~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~--------~i~~~~~~----------~p~ 219 (318)
T cd05582 158 FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMT--------MILKAKLG----------MPQ 219 (318)
T ss_pred ccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHH--------HHHcCCCC----------CCC
Confidence 568999999999998889999999999999999999999997543222111 01111110 111
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHH
Q 041576 662 SRACKWLMIALWCIQEDPLKRPAMKM 687 (714)
Q Consensus 662 ~~~~~l~~li~~cl~~dP~~RPs~~e 687 (714)
.....+.+++.+||+.||++||++.+
T Consensus 220 ~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 220 FLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 23346778999999999999999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=310.19 Aligned_cols=250 Identities=23% Similarity=0.279 Sum_probs=201.9
Q ss_pred hhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc-----hhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEE
Q 041576 422 NGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA-----QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLV 496 (714)
Q Consensus 422 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 496 (714)
+...+.||+|++|.||+|... .++++|++|.+.... ....+.+.+|++++++++||||+++++++.+++..++|
T Consensus 4 ~~~~~~lg~g~~~~vy~~~~~-~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 82 (263)
T cd06625 4 WRRGKLLGQGAFGRVYLCYDV-DTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIF 82 (263)
T ss_pred ccccceecCCCceEEEEEEEc-CCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEE
Confidence 556789999999999999865 468899999886421 22345788999999999999999999999999999999
Q ss_pred EeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcc
Q 041576 497 YEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQS 576 (714)
Q Consensus 497 ~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 576 (714)
+||+++++|.+++.....+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++........
T Consensus 83 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~ 159 (263)
T cd06625 83 MEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICS 159 (263)
T ss_pred EEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecccccc
Confidence 999999999999988778899999999999999999999998 99999999999999999999999999876543222
Q ss_pred cce--eeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecch
Q 041576 577 RTR--TVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDND 654 (714)
Q Consensus 577 ~~~--~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 654 (714)
... ....++..|+|||.+.+..++.++||||||+++|||++|+.||........ .... .....
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~---~~~~-----~~~~~------- 224 (263)
T cd06625 160 SGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAA---IFKI-----ATQPT------- 224 (263)
T ss_pred ccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHH---HHHH-----hccCC-------
Confidence 111 234577899999999998899999999999999999999999864322211 0000 00000
Q ss_pred hhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 655 KAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 655 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
....+......+.+++.+||+.+|++|||+.|+++.
T Consensus 225 -~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 225 -NPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred -CCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 001122334567789999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=318.42 Aligned_cols=260 Identities=27% Similarity=0.350 Sum_probs=205.4
Q ss_pred HHHHhhhhhhhhCcccceeEEEeEeeC----CCCcEEEEEEeccc-chhhHHHHHHHHHHHhcc-CcccccceeceEecC
Q 041576 417 LNEATNGFEEELGRGSFGIVYKGVLKS----ASGNAVAVKKLDKL-AQEREREFKTEVSAIGRT-HHKNLVQLLGFCDEG 490 (714)
Q Consensus 417 l~~at~~~~~~ig~G~~g~Vy~~~~~~----~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~ 490 (714)
+....+.+.+.||+|+||.||++.... .....+|+|.+... .......+.+|++++.++ +|+||+++++++..+
T Consensus 9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (293)
T cd05053 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE 88 (293)
T ss_pred cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence 334456677899999999999998753 23368999998753 233456788999999999 899999999999999
Q ss_pred CeeeEEEeecCCCchhhhhhcC----------------CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEE
Q 041576 491 LNRLLVYEFMGNGTLANLLFAI----------------PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILL 554 (714)
Q Consensus 491 ~~~~lv~E~~~~gsL~~~l~~~----------------~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll 554 (714)
...+++|||+++++|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+||++
T Consensus 89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~ 165 (293)
T cd05053 89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLV 165 (293)
T ss_pred CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEE
Confidence 9999999999999999998542 35788899999999999999999988 9999999999999
Q ss_pred CCCCceEEecCCCccccccCcccc-eeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccchhhh
Q 041576 555 DQDFTAKISDFGLSKLLLSDQSRT-RTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEERSA 632 (714)
Q Consensus 555 ~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~ 632 (714)
++++.+||+|||+++......... .....++..|+|||.+.+..++.++|||||||++|||++ |..||..........
T Consensus 166 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~ 245 (293)
T cd05053 166 TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK 245 (293)
T ss_pred cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHH
Confidence 999999999999998764332211 122234578999999998899999999999999999997 888886443222111
Q ss_pred hhhHHHhhhhhcCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 041576 633 ILTDWAYDCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYL 696 (714)
Q Consensus 633 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 696 (714)
....+... ..+......+.+++.+||+.||++|||+.|+++.|++++
T Consensus 246 --------~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 246 --------LLKEGYRM---------EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred --------HHHcCCcC---------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 11111100 011223456788999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=332.84 Aligned_cols=251 Identities=21% Similarity=0.256 Sum_probs=198.3
Q ss_pred hhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEe
Q 041576 422 NGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA---QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYE 498 (714)
Q Consensus 422 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E 498 (714)
|.+.+.||+|+||.||+|+.. .+++.||||.+.+.. ......+.+|++++++++||||+++++.+.+++..++|||
T Consensus 3 y~~~~~lG~G~~g~V~~a~~~-~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 3 FVKIKTIGIGAFGEVCLVRKV-DTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred ceEEEEEEeCCCeEEEEEEEC-CCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 567789999999999999876 468999999996532 2334578899999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCc---
Q 041576 499 FMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQ--- 575 (714)
Q Consensus 499 ~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~--- 575 (714)
|+++|+|.+++.....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+....
T Consensus 82 ~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~ 158 (376)
T cd05598 82 YIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 158 (376)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccc
Confidence 9999999999988888899999999999999999999998 9999999999999999999999999975321000
Q ss_pred ---------------------------------------ccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHH
Q 041576 576 ---------------------------------------SRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKII 616 (714)
Q Consensus 576 ---------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ell 616 (714)
........||+.|+|||++.+..++.++|||||||++|||+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell 238 (376)
T cd05598 159 YYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 238 (376)
T ss_pred ccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehh
Confidence 00011246899999999999999999999999999999999
Q ss_pred hcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCC---CHHHHHHH
Q 041576 617 CCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRP---AMKMIVQM 691 (714)
Q Consensus 617 tG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP---s~~evl~~ 691 (714)
+|+.||......+....+..+ .....+ .........+.+++.+|+ .+|.+|+ ++.|+++.
T Consensus 239 ~G~~Pf~~~~~~~~~~~i~~~--------~~~~~~------~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 239 VGQPPFLADTPAETQLKVINW--------ETTLHI------PSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred hCCCCCCCCCHHHHHHHHhcc--------CccccC------CCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 999999765433211111111 000000 001112345566777766 5999999 89999864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=309.59 Aligned_cols=255 Identities=28% Similarity=0.435 Sum_probs=205.7
Q ss_pred HHHHhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEE
Q 041576 417 LNEATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLV 496 (714)
Q Consensus 417 l~~at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 496 (714)
+....+.+.++||+|++|.||+|..+ +++.++||.+.... ...+++.+|+.++++++|+||+++++++......++|
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~--~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 79 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWN--GTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIV 79 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEc--CCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEE
Confidence 44556778899999999999999865 45789999987533 3456789999999999999999999999998999999
Q ss_pred EeecCCCchhhhhhcC--CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccC
Q 041576 497 YEFMGNGTLANLLFAI--PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSD 574 (714)
Q Consensus 497 ~E~~~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 574 (714)
|||+++++|.+++... ..+++..+..++.|++.||+|||+++ ++|+||||+||++++++.+||+|||.+......
T Consensus 80 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~ 156 (261)
T cd05034 80 TEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDD 156 (261)
T ss_pred EeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccch
Confidence 9999999999999765 36789999999999999999999998 999999999999999999999999999876543
Q ss_pred cccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccchhhhhhhHHHhhhhhcCccceeecc
Q 041576 575 QSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDN 653 (714)
Q Consensus 575 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 653 (714)
..........+..|+|||.+.+..++.++||||||+++||+++ |+.||....... .+.. ...+. .
T Consensus 157 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~---~~~~-----~~~~~-~----- 222 (261)
T cd05034 157 EYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE---VLEQ-----VERGY-R----- 222 (261)
T ss_pred hhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHH-----HHcCC-C-----
Confidence 2222222334568999999998889999999999999999998 999986433221 1111 01100 0
Q ss_pred hhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 041576 654 DKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEG 694 (714)
Q Consensus 654 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 694 (714)
...+...+..+.+++.+||+.+|++||+++++++.|+.
T Consensus 223 ---~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 223 ---MPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred ---CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 00111124567889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=322.67 Aligned_cols=262 Identities=27% Similarity=0.374 Sum_probs=220.8
Q ss_pred CHHHHHHHhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCcccccceeceEecCCe
Q 041576 413 SLVELNEATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLN 492 (714)
Q Consensus 413 ~~~el~~at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 492 (714)
...|+++....+..+||-|.||.||.|+|+. -.-.||||.++... -..++|++|..+|+.++|||+|+++|+|..+..
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKk-yslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpP 337 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKK-YSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPP 337 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeec-cceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCC
Confidence 4456666666677899999999999999984 45689999997654 346799999999999999999999999999999
Q ss_pred eeEEEeecCCCchhhhhhcCC--CCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccc
Q 041576 493 RLLVYEFMGNGTLANLLFAIP--RPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKL 570 (714)
Q Consensus 493 ~~lv~E~~~~gsL~~~l~~~~--~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~ 570 (714)
.|||.|||..|+|.++|+... .++....+.++.||+.|+.||..++ +|||||..+|.|+.++..+||+|||++++
T Consensus 338 FYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRl 414 (1157)
T KOG4278|consen 338 FYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRL 414 (1157)
T ss_pred eEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhh
Confidence 999999999999999998653 4567778899999999999999998 99999999999999999999999999999
Q ss_pred cccCcccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccchhhhhhhHHHhhhhhcCccce
Q 041576 571 LLSDQSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEERSAILTDWAYDCYVEGKLDV 649 (714)
Q Consensus 571 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 649 (714)
+..+.............|.|||.+.-..++.|+|||+|||+|||+.| |..|+..-.... ++..
T Consensus 415 MtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSq--------VY~L-------- 478 (1157)
T KOG4278|consen 415 MTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--------VYGL-------- 478 (1157)
T ss_pred hcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHH--------HHHH--------
Confidence 87776555555556789999999999999999999999999999987 677775432222 1221
Q ss_pred eecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 041576 650 LVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYL 696 (714)
Q Consensus 650 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 696 (714)
++.......+..+++.+.+|++.||+..|.+||+++|+.+.+|.+.
T Consensus 479 -LEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf 524 (1157)
T KOG4278|consen 479 -LEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMF 524 (1157)
T ss_pred -HhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHh
Confidence 2222333345567778999999999999999999999999998765
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=306.69 Aligned_cols=246 Identities=25% Similarity=0.355 Sum_probs=197.8
Q ss_pred hhhCcccceeEEEeEeeCCCCcEEEEEEecccc-hhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEeecCCCc
Q 041576 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA-QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEFMGNGT 504 (714)
Q Consensus 426 ~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~gs 504 (714)
+.||+|+||.||+|... +++.+|+|.++... ......+.+|++++++++||||+++++++......++||||+++++
T Consensus 1 ~~ig~g~~g~vy~~~~~--~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 78 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK--DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGD 78 (250)
T ss_pred CccCCCCCceEEEEEec--CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCc
Confidence 46899999999999864 57899999987543 3334578999999999999999999999999999999999999999
Q ss_pred hhhhhhcC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcccceeeec
Q 041576 505 LANLLFAI-PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIR 583 (714)
Q Consensus 505 L~~~l~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 583 (714)
|.+++... ..+++..+..++.|+++||.|||+++ ++||||||+||++++++.+||+|||++...............
T Consensus 79 L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (250)
T cd05085 79 FLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQ 155 (250)
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccccCCCCC
Confidence 99998754 45789999999999999999999998 999999999999999999999999998754332222222223
Q ss_pred CCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhhccchH
Q 041576 584 GTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMADKS 662 (714)
Q Consensus 584 gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 662 (714)
++..|+|||++.+..++.++||||||+++||+++ |..||.......... ....+... ..+..
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~--------~~~~~~~~---------~~~~~ 218 (250)
T cd05085 156 IPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQARE--------QVEKGYRM---------SCPQK 218 (250)
T ss_pred CcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH--------HHHcCCCC---------CCCCC
Confidence 4567999999998889999999999999999998 899986443221110 01111000 01122
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 041576 663 RACKWLMIALWCIQEDPLKRPAMKMIVQMLE 693 (714)
Q Consensus 663 ~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 693 (714)
.+..+.+++.+|++.+|++||++.|+++.|.
T Consensus 219 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 219 CPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 3457888999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=318.49 Aligned_cols=265 Identities=26% Similarity=0.340 Sum_probs=208.5
Q ss_pred HHHHHhhhhhhhhCcccceeEEEeEee------CCCCcEEEEEEecccc-hhhHHHHHHHHHHHhcc-CcccccceeceE
Q 041576 416 ELNEATNGFEEELGRGSFGIVYKGVLK------SASGNAVAVKKLDKLA-QEREREFKTEVSAIGRT-HHKNLVQLLGFC 487 (714)
Q Consensus 416 el~~at~~~~~~ig~G~~g~Vy~~~~~------~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~ 487 (714)
++....+.+.+.||+|+||.||+|... ...+..|++|.++... ....+.+.+|+.+++.+ +||||+++++++
T Consensus 11 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 90 (304)
T cd05101 11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 90 (304)
T ss_pred cccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEE
Confidence 345566778899999999999999752 1234579999987532 34456889999999999 899999999999
Q ss_pred ecCCeeeEEEeecCCCchhhhhhcC----------------CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCe
Q 041576 488 DEGLNRLLVYEFMGNGTLANLLFAI----------------PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQN 551 (714)
Q Consensus 488 ~~~~~~~lv~E~~~~gsL~~~l~~~----------------~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~N 551 (714)
......++||||+++++|.+++... ..+++..+..++.||++||+|||+++ ++||||||+|
T Consensus 91 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~N 167 (304)
T cd05101 91 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARN 167 (304)
T ss_pred ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccce
Confidence 9999999999999999999999753 23567788999999999999999998 9999999999
Q ss_pred EEECCCCceEEecCCCccccccCcccc-eeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccch
Q 041576 552 ILLDQDFTAKISDFGLSKLLLSDQSRT-RTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEE 629 (714)
Q Consensus 552 Ill~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~ 629 (714)
|++++++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..|+......+
T Consensus 168 ili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~ 247 (304)
T cd05101 168 VLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 247 (304)
T ss_pred EEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH
Confidence 999999999999999998764332221 122335678999999998889999999999999999998 777875432222
Q ss_pred hhhhhhHHHhhhhhcCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCCCC
Q 041576 630 RSAILTDWAYDCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLEVPS 700 (714)
Q Consensus 630 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 700 (714)
... ....+... ..+...+..+.+++.+||+.+|++||++.||++.|++++....
T Consensus 248 ~~~--------~~~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~~ 301 (304)
T cd05101 248 LFK--------LLKEGHRM---------DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLTT 301 (304)
T ss_pred HHH--------HHHcCCcC---------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhhh
Confidence 111 11111100 0112234567889999999999999999999999999876643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=312.05 Aligned_cols=256 Identities=28% Similarity=0.396 Sum_probs=203.3
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCC--CcEEEEEEeccc-chhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEE
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSAS--GNAVAVKKLDKL-AQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLV 496 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~--~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 496 (714)
+.+.+.+.||+|+||.||+|.+.... +..|+||.+... .......+..|+.++++++||||+++++++.++...++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 45677899999999999999976432 236999998754 344567899999999999999999999999999999999
Q ss_pred EeecCCCchhhhhhcC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCc
Q 041576 497 YEFMGNGTLANLLFAI-PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQ 575 (714)
Q Consensus 497 ~E~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 575 (714)
|||+++++|.+++... ..+++.+++.++.|++.||+|||+++ ++|+||||+||+++.++.+||+|||++.......
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 84 TEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 160 (269)
T ss_pred EecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccccccCc
Confidence 9999999999999754 46789999999999999999999998 9999999999999999999999999987654322
Q ss_pred ccce-ee-ec--CCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccchhhhhhhHHHhhhhhcCcccee
Q 041576 576 SRTR-TV-IR--GTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEERSAILTDWAYDCYVEGKLDVL 650 (714)
Q Consensus 576 ~~~~-~~-~~--gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 650 (714)
.... .. .. .+..|+|||.+.+..++.++||||||+++||+++ |..||......... ... ... .
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~----~~i----~~~-~--- 228 (269)
T cd05065 161 SDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVI----NAI----EQD-Y--- 228 (269)
T ss_pred cccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHH----HHH----HcC-C---
Confidence 2111 11 11 2357999999999899999999999999999886 99998644322111 110 000 0
Q ss_pred ecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 041576 651 VDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGY 695 (714)
Q Consensus 651 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 695 (714)
....+...+..+.+++.+||+.+|++||++++|++.|+++
T Consensus 229 -----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 229 -----RLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred -----cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0001122345677899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=315.22 Aligned_cols=256 Identities=26% Similarity=0.356 Sum_probs=202.0
Q ss_pred hhhhhhhCcccceeEEEeEeeCC----CCcEEEEEEecccc-hhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEE
Q 041576 422 NGFEEELGRGSFGIVYKGVLKSA----SGNAVAVKKLDKLA-QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLV 496 (714)
Q Consensus 422 ~~~~~~ig~G~~g~Vy~~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 496 (714)
+.+.+.||+|+||.||+|..... ....+++|.+.... ......+.+|+.++++++||||+++++.+...+..+++
T Consensus 2 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (290)
T cd05045 2 LVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLI 81 (290)
T ss_pred ccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEE
Confidence 35668899999999999986421 23468888886533 33456789999999999999999999999999999999
Q ss_pred EeecCCCchhhhhhcC------------------------CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeE
Q 041576 497 YEFMGNGTLANLLFAI------------------------PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNI 552 (714)
Q Consensus 497 ~E~~~~gsL~~~l~~~------------------------~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NI 552 (714)
+||+.+++|.+++... ..+++..++.++.|++.||+|||+.+ ++||||||+||
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~ni 158 (290)
T cd05045 82 VEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARNV 158 (290)
T ss_pred EEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhheE
Confidence 9999999999998642 23678888999999999999999988 99999999999
Q ss_pred EECCCCceEEecCCCccccccCccc-ceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccchh
Q 041576 553 LLDQDFTAKISDFGLSKLLLSDQSR-TRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEER 630 (714)
Q Consensus 553 ll~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~ 630 (714)
++++++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |+.||........
T Consensus 159 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~ 238 (290)
T cd05045 159 LVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERL 238 (290)
T ss_pred EEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHH
Confidence 9999999999999999865433221 1122345678999999988889999999999999999998 9999864432221
Q ss_pred hhhhhHHHhhhhhcCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccC
Q 041576 631 SAILTDWAYDCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLE 697 (714)
Q Consensus 631 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 697 (714)
. . ...... ....+...+..+.+++.+||+.+|++||+++|+++.|++++.
T Consensus 239 ~----~----~~~~~~---------~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 239 F----N----LLKTGY---------RMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred H----H----HHhCCC---------CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 1 1 111110 000112233567889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=328.71 Aligned_cols=263 Identities=24% Similarity=0.335 Sum_probs=205.3
Q ss_pred HHHHHHhhhhhhhhCcccceeEEEeEeeC----CCCcEEEEEEecccc-hhhHHHHHHHHHHHhccC-cccccceeceEe
Q 041576 415 VELNEATNGFEEELGRGSFGIVYKGVLKS----ASGNAVAVKKLDKLA-QEREREFKTEVSAIGRTH-HKNLVQLLGFCD 488 (714)
Q Consensus 415 ~el~~at~~~~~~ig~G~~g~Vy~~~~~~----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~ 488 (714)
.++....+.+.+.||+|+||.||+|+++. ..+..||+|+++... ....+.+.+|++++.++. ||||+++++++.
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~ 111 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT 111 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence 44555667778999999999999998642 245689999997543 233457889999999997 999999999999
Q ss_pred cCCeeeEEEeecCCCchhhhhhcCC-------------------------------------------------------
Q 041576 489 EGLNRLLVYEFMGNGTLANLLFAIP------------------------------------------------------- 513 (714)
Q Consensus 489 ~~~~~~lv~E~~~~gsL~~~l~~~~------------------------------------------------------- 513 (714)
.....++||||+++|+|.++++..+
T Consensus 112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (401)
T cd05107 112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP 191 (401)
T ss_pred cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence 9999999999999999999986431
Q ss_pred -------------------------------------------CCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcC
Q 041576 514 -------------------------------------------RPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQ 550 (714)
Q Consensus 514 -------------------------------------------~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~ 550 (714)
.+++..++.++.||+.||+|||+.+ ++||||||+
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~ 268 (401)
T cd05107 192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAAR 268 (401)
T ss_pred hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcc
Confidence 2455667889999999999999987 999999999
Q ss_pred eEEECCCCceEEecCCCccccccCcc-cceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccc
Q 041576 551 NILLDQDFTAKISDFGLSKLLLSDQS-RTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGE 628 (714)
Q Consensus 551 NIll~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~ 628 (714)
||++++++.+||+|||+++....... .......++..|+|||.+.+..++.++||||||+++|||++ |+.||......
T Consensus 269 NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~ 348 (401)
T cd05107 269 NVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN 348 (401)
T ss_pred eEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch
Confidence 99999999999999999986533221 11222346788999999998889999999999999999998 88888643221
Q ss_pred hhhhhhhHHHhhhhhcCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 041576 629 ERSAILTDWAYDCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYL 696 (714)
Q Consensus 629 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 696 (714)
+. +. .....+.. ...+......+.+++.+||+.+|.+||+++||++.|++++
T Consensus 349 ~~---~~----~~~~~~~~---------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 349 EQ---FY----NAIKRGYR---------MAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred HH---HH----HHHHcCCC---------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 11 10 00111100 0011223457888999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=314.60 Aligned_cols=251 Identities=26% Similarity=0.280 Sum_probs=200.5
Q ss_pred hhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEE
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA---QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVY 497 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 497 (714)
+|+..+.||+|+||.||++... .+++.||+|++.... ......+.+|+.++++++||||+++++.+..++..++||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVR-ATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVL 79 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEc-CCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEE
Confidence 3556788999999999999875 468899999996532 222356788999999999999999999999999999999
Q ss_pred eecCCCchhhhhhcC--CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCc
Q 041576 498 EFMGNGTLANLLFAI--PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQ 575 (714)
Q Consensus 498 E~~~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 575 (714)
||+++++|.+++... ..+++..+..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||++.......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 80 TLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE 156 (285)
T ss_pred eccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence 999999999888643 45889999999999999999999998 9999999999999999999999999998653322
Q ss_pred ccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchh
Q 041576 576 SRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDK 655 (714)
Q Consensus 576 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 655 (714)
. .....|+..|+|||.+.+..++.++||||+|+++|||++|+.||...........+.. ......
T Consensus 157 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~----~~~~~~--------- 221 (285)
T cd05605 157 T--IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVER----RVKEDQ--------- 221 (285)
T ss_pred c--cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHH----Hhhhcc---------
Confidence 2 1234588999999999988999999999999999999999999975433221111110 000000
Q ss_pred hhccchHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 041576 656 AAMADKSRACKWLMIALWCIQEDPLKRP-----AMKMIVQM 691 (714)
Q Consensus 656 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 691 (714)
...+...+..+.+++.+||+.||++|| +++++++.
T Consensus 222 -~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 222 -EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred -cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 011223445678899999999999999 88898653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=310.91 Aligned_cols=256 Identities=28% Similarity=0.393 Sum_probs=204.2
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCC--CcEEEEEEecccc-hhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEE
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSAS--GNAVAVKKLDKLA-QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLV 496 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~--~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 496 (714)
..+.+.+.||+|+||.||+|.+...+ +..+|+|.++... ....+.+.+|+.++++++||||+++++++.+++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 45677899999999999999875332 3379999986532 33456889999999999999999999999999999999
Q ss_pred EeecCCCchhhhhhcC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCc
Q 041576 497 YEFMGNGTLANLLFAI-PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQ 575 (714)
Q Consensus 497 ~E~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 575 (714)
|||+++++|.+++... ..+++.++..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++.......
T Consensus 84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd05066 84 TEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 160 (267)
T ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence 9999999999999764 45788999999999999999999998 9999999999999999999999999998764433
Q ss_pred cccee--eecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccchhhhhhhHHHhhhhhcCccceeec
Q 041576 576 SRTRT--VIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVD 652 (714)
Q Consensus 576 ~~~~~--~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 652 (714)
..... ...++..|+|||.+.+..++.++||||||+++||+++ |+.||......+.... ..++..
T Consensus 161 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~--------~~~~~~----- 227 (267)
T cd05066 161 EAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKA--------IEEGYR----- 227 (267)
T ss_pred ceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHH--------HhCCCc-----
Confidence 22111 1223567999999998889999999999999999886 9999865432221110 111100
Q ss_pred chhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 041576 653 NDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGY 695 (714)
Q Consensus 653 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 695 (714)
.......+..+.+++.+|++.+|.+||++.++++.|+++
T Consensus 228 ----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 228 ----LPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred ----CCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 001112345677899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=323.28 Aligned_cols=242 Identities=27% Similarity=0.274 Sum_probs=192.3
Q ss_pred hhhCcccceeEEEeEeeCCCCcEEEEEEecccc---hhhHHHHHHHH-HHHhccCcccccceeceEecCCeeeEEEeecC
Q 041576 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA---QEREREFKTEV-SAIGRTHHKNLVQLLGFCDEGLNRLLVYEFMG 501 (714)
Q Consensus 426 ~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~-~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~ 501 (714)
+.||+|+||.||+|+.. .+++.||+|.+.... ......+..|. .+++.++||||+++++++...+..++||||++
T Consensus 1 ~~lg~G~fg~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~ 79 (325)
T cd05602 1 KVIGKGSFGKVLLARHK-AEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYIN 79 (325)
T ss_pred CeeeeCCCeEEEEEEEC-CCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCC
Confidence 46999999999999876 467899999996532 12233444444 45677899999999999999999999999999
Q ss_pred CCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcccceee
Q 041576 502 NGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTV 581 (714)
Q Consensus 502 ~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 581 (714)
+++|.+++.....+.+..+..++.||++||+|||+.+ |+||||||+||+++.++.+||+|||+++...... .....
T Consensus 80 ~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~-~~~~~ 155 (325)
T cd05602 80 GGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-GTTST 155 (325)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCC-CCccc
Confidence 9999999988788888999999999999999999998 9999999999999999999999999987542222 22334
Q ss_pred ecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhhccch
Q 041576 582 IRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMADK 661 (714)
Q Consensus 582 ~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 661 (714)
..|++.|+|||++.+..++.++|||||||++|||++|+.||...........+ ...... ...
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i--------~~~~~~----------~~~ 217 (325)
T cd05602 156 FCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNI--------LNKPLQ----------LKP 217 (325)
T ss_pred ccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHH--------HhCCcC----------CCC
Confidence 56899999999999999999999999999999999999999754332211111 111100 111
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 662 SRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 662 ~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
.....+.+++.+||+.||.+||++.+.+.
T Consensus 218 ~~~~~~~~li~~~l~~~p~~R~~~~~~~~ 246 (325)
T cd05602 218 NITNSARHLLEGLLQKDRTKRLGAKDDFM 246 (325)
T ss_pred CCCHHHHHHHHHHcccCHHHCCCCCCCHH
Confidence 23446778999999999999998875443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=321.49 Aligned_cols=246 Identities=28% Similarity=0.324 Sum_probs=198.1
Q ss_pred hhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHHhcc-CcccccceeceEecCCeeeEEE
Q 041576 422 NGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA---QEREREFKTEVSAIGRT-HHKNLVQLLGFCDEGLNRLLVY 497 (714)
Q Consensus 422 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~ 497 (714)
|.+.+.||+|+||.||+|..+ .+++.||+|.+++.. ......+..|..++..+ +|++|+++++++...+..++||
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 2 FNFLMVLGKGSFGKVMLAERK-GTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred ceEEEEEeeCCCeEEEEEEEC-CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 456788999999999999876 567899999997532 22334567788888777 6899999999999999999999
Q ss_pred eecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCccc
Q 041576 498 EFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSR 577 (714)
Q Consensus 498 E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 577 (714)
||+++|+|.+.+.....+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++...... .
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~-~ 156 (323)
T cd05616 81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG-V 156 (323)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCCC-C
Confidence 99999999999988788999999999999999999999998 9999999999999999999999999987543221 1
Q ss_pred ceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhh
Q 041576 578 TRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAA 657 (714)
Q Consensus 578 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 657 (714)
......|++.|+|||++.+..++.++|||||||++|||++|+.||........... ......
T Consensus 157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~--------i~~~~~---------- 218 (323)
T cd05616 157 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQS--------IMEHNV---------- 218 (323)
T ss_pred ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHH--------HHhCCC----------
Confidence 22345689999999999999999999999999999999999999975443221111 111111
Q ss_pred ccchHHHHHHHHHHHHccccCCCCCCCH-----HHHHH
Q 041576 658 MADKSRACKWLMIALWCIQEDPLKRPAM-----KMIVQ 690 (714)
Q Consensus 658 ~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~ 690 (714)
..+.....++.+++.+||+.||++|++. .++++
T Consensus 219 ~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~ 256 (323)
T cd05616 219 AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 256 (323)
T ss_pred CCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhc
Confidence 0112234567789999999999999984 56653
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=311.01 Aligned_cols=249 Identities=27% Similarity=0.406 Sum_probs=196.1
Q ss_pred hhhCcccceeEEEeEeeCCCCc--EEEEEEeccc-chhhHHHHHHHHHHHhcc-CcccccceeceEecCCeeeEEEeecC
Q 041576 426 EELGRGSFGIVYKGVLKSASGN--AVAVKKLDKL-AQEREREFKTEVSAIGRT-HHKNLVQLLGFCDEGLNRLLVYEFMG 501 (714)
Q Consensus 426 ~~ig~G~~g~Vy~~~~~~~~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~E~~~ 501 (714)
+.||+|+||.||+|.++. ++. .+++|.++.. .....+.+.+|++++.++ +||||+++++++......++||||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~ 79 (270)
T cd05047 1 DVIGEGNFGQVLKARIKK-DGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 79 (270)
T ss_pred CcCCCCCCceEEEEEEcC-CCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCC
Confidence 468999999999999863 343 5788888753 344556889999999999 89999999999999999999999999
Q ss_pred CCchhhhhhcCC----------------CCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecC
Q 041576 502 NGTLANLLFAIP----------------RPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDF 565 (714)
Q Consensus 502 ~gsL~~~l~~~~----------------~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Df 565 (714)
+++|.+++.... .+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.+||+||
T Consensus 80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~df 156 (270)
T cd05047 80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADF 156 (270)
T ss_pred CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCC
Confidence 999999987532 3678889999999999999999988 999999999999999999999999
Q ss_pred CCccccccCcccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccchhhhhhhHHHhhhhhc
Q 041576 566 GLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEERSAILTDWAYDCYVE 644 (714)
Q Consensus 566 g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~ 644 (714)
|++...... ........+..|+|||++....++.++||||||+++|||++ |..||......... .....
T Consensus 157 gl~~~~~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~--------~~~~~ 226 (270)
T cd05047 157 GLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY--------EKLPQ 226 (270)
T ss_pred CCccccchh--hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHH--------HHHhC
Confidence 998632211 11111223567999999988889999999999999999997 99998643322111 01111
Q ss_pred CccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccC
Q 041576 645 GKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLE 697 (714)
Q Consensus 645 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 697 (714)
+... ..+......+.+++.+|++.+|.+|||+.|+++.|+++++
T Consensus 227 ~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~~ 270 (270)
T cd05047 227 GYRL---------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 270 (270)
T ss_pred CCCC---------CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhhC
Confidence 1000 0111223467789999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=310.63 Aligned_cols=252 Identities=24% Similarity=0.381 Sum_probs=196.2
Q ss_pred hhhhhCcccceeEEEeEeeCCCC-cEEEEEEeccc--chhhHHHHHHHHHHHhccCcccccceeceEecC------Ceee
Q 041576 424 FEEELGRGSFGIVYKGVLKSASG-NAVAVKKLDKL--AQEREREFKTEVSAIGRTHHKNLVQLLGFCDEG------LNRL 494 (714)
Q Consensus 424 ~~~~ig~G~~g~Vy~~~~~~~~~-~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~------~~~~ 494 (714)
+.+.||+|+||.||+|.+..... ..+|+|.++.. .....+.+.+|++++++++|+||+++++++... ...+
T Consensus 3 i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 82 (272)
T cd05075 3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPV 82 (272)
T ss_pred cccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcE
Confidence 56889999999999998763322 26899988643 344467889999999999999999999987432 2468
Q ss_pred EEEeecCCCchhhhhhc------CCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCc
Q 041576 495 LVYEFMGNGTLANLLFA------IPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLS 568 (714)
Q Consensus 495 lv~E~~~~gsL~~~l~~------~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~ 568 (714)
+++||+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+||++++++.+||+|||++
T Consensus 83 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 159 (272)
T cd05075 83 VILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGLS 159 (272)
T ss_pred EEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCCcc
Confidence 99999999999988742 234688999999999999999999988 999999999999999999999999999
Q ss_pred cccccCccc-ceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccchhhhhhhHHHhhhhhcCc
Q 041576 569 KLLLSDQSR-TRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEERSAILTDWAYDCYVEGK 646 (714)
Q Consensus 569 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~ 646 (714)
+........ ......++..|+|||.+.+..++.++||||||+++|||++ |+.||........ ......+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~--------~~~~~~~~ 231 (272)
T cd05075 160 KKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEI--------YDYLRQGN 231 (272)
T ss_pred cccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH--------HHHHHcCC
Confidence 876433221 1122235678999999999999999999999999999999 7888864322211 11111111
Q ss_pred cceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 041576 647 LDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGY 695 (714)
Q Consensus 647 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 695 (714)
... ........+.+++.+||+.||++|||+.||++.|+++
T Consensus 232 ~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 232 RLK---------QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CCC---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 100 1112334678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=306.86 Aligned_cols=248 Identities=25% Similarity=0.349 Sum_probs=203.4
Q ss_pred hhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecc--cchhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEee
Q 041576 422 NGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDK--LAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEF 499 (714)
Q Consensus 422 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~ 499 (714)
|.+.+.||+|++|.||+|..+ .+++.|++|.+.. ........+.+|++++++++||||+++++++.+.+..++||||
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~-~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 2 FEILNKIGKGSFGVVFKVVRK-ADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred ceEeEEecCCCCeEEEEEEEc-CCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 456688999999999999876 4688999999864 2344567889999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcC--CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCccc
Q 041576 500 MGNGTLANLLFAI--PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSR 577 (714)
Q Consensus 500 ~~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 577 (714)
+++++|.+++... ..+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++.........
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~ 157 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF 157 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccch
Confidence 9999999999764 56788999999999999999999988 999999999999999999999999998866443222
Q ss_pred ceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhh
Q 041576 578 TRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAA 657 (714)
Q Consensus 578 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 657 (714)
.....++..|+|||++.+..++.++||||||++++||++|+.||........ . .....+....
T Consensus 158 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~-----~~~~~~~~~~-------- 220 (256)
T cd08529 158 -ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGAL---I-----LKIIRGVFPP-------- 220 (256)
T ss_pred -hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH---H-----HHHHcCCCCC--------
Confidence 2234578899999999998999999999999999999999999975542211 1 1111111111
Q ss_pred ccchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 658 MADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 658 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
........+.+++.+||+.+|++||++.++++.
T Consensus 221 -~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 221 -VSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred -CccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 111334568889999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=313.57 Aligned_cols=254 Identities=28% Similarity=0.392 Sum_probs=200.1
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCC----CCcEEEEEEecccc-hhhHHHHHHHHHHHhccCcccccceeceEecCCeee
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSA----SGNAVAVKKLDKLA-QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRL 494 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 494 (714)
..+.+.+.||+|++|.||+|.+... .+..|++|.+.... ......+.+|+.++++++|+||+++++++.+....+
T Consensus 6 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 85 (277)
T cd05036 6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRF 85 (277)
T ss_pred HHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcE
Confidence 3455678999999999999998631 45789999886533 334567899999999999999999999999999999
Q ss_pred EEEeecCCCchhhhhhcCC-------CCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCC---ceEEec
Q 041576 495 LVYEFMGNGTLANLLFAIP-------RPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDF---TAKISD 564 (714)
Q Consensus 495 lv~E~~~~gsL~~~l~~~~-------~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~---~~kl~D 564 (714)
+||||+++++|.+++.... .+++..+++++.||+.||+|||+.+ ++|+||||+||+++.++ .+||+|
T Consensus 86 lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl~d 162 (277)
T cd05036 86 ILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIAD 162 (277)
T ss_pred EEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEecc
Confidence 9999999999999987543 4788999999999999999999998 99999999999998765 599999
Q ss_pred CCCccccccCcccc-eeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccchhhhhhhHHHhhhh
Q 041576 565 FGLSKLLLSDQSRT-RTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEERSAILTDWAYDCY 642 (714)
Q Consensus 565 fg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~ 642 (714)
||+++......... ......+..|+|||.+.+..++.++|||||||++|||++ |..||...........+.
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~------- 235 (277)
T cd05036 163 FGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVT------- 235 (277)
T ss_pred CccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-------
Confidence 99998763322111 111223567999999998899999999999999999997 999987543322111100
Q ss_pred hcCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 041576 643 VEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLE 693 (714)
Q Consensus 643 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 693 (714)
..... ..+...+..+.+++.+||+.+|++||++.+|++.|+
T Consensus 236 ~~~~~----------~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 236 GGGRL----------DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred cCCcC----------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 00000 011223456788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=320.11 Aligned_cols=256 Identities=26% Similarity=0.399 Sum_probs=200.8
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCc--EEEEEEeccc-chhhHHHHHHHHHHHhcc-CcccccceeceEecCCeeeE
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGN--AVAVKKLDKL-AQEREREFKTEVSAIGRT-HHKNLVQLLGFCDEGLNRLL 495 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~l 495 (714)
..+.+.+.||+|+||.||+|.++. ++. .+++|.++.. .......+.+|++++.++ +||||+++++++..++..++
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~-~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKK-DGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEcc-CCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 345677899999999999999763 443 5688877653 334456888999999999 89999999999999999999
Q ss_pred EEeecCCCchhhhhhcCC----------------CCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCc
Q 041576 496 VYEFMGNGTLANLLFAIP----------------RPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFT 559 (714)
Q Consensus 496 v~E~~~~gsL~~~l~~~~----------------~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~ 559 (714)
||||+++++|.+++.... .+++..++.++.||++||+|||+.+ ++||||||+||++++++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCc
Confidence 999999999999997432 4678899999999999999999998 999999999999999999
Q ss_pred eEEecCCCccccccCcccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccchhhhhhhHHH
Q 041576 560 AKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEERSAILTDWA 638 (714)
Q Consensus 560 ~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~l~~~~ 638 (714)
+||+|||++....... .......+..|+|||.+.+..++.++||||||+++|||+| |..||......+...
T Consensus 163 ~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~------ 234 (303)
T cd05088 163 AKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE------ 234 (303)
T ss_pred EEeCccccCcccchhh--hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHH------
Confidence 9999999986432111 1111224567999999988889999999999999999998 999986443222111
Q ss_pred hhhhhcCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCC
Q 041576 639 YDCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLEV 698 (714)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 698 (714)
....+.. ...+...+..+.+++.+||+.+|++||++.++++.|+++++.
T Consensus 235 --~~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~ 283 (303)
T cd05088 235 --KLPQGYR---------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 283 (303)
T ss_pred --HHhcCCc---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 0111100 001112234678899999999999999999999999886644
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=302.28 Aligned_cols=264 Identities=25% Similarity=0.305 Sum_probs=202.8
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccch--hhHHHHHHHHHHHhccCccc-ccceeceEecCC-----
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQ--EREREFKTEVSAIGRTHHKN-LVQLLGFCDEGL----- 491 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~n-Iv~l~~~~~~~~----- 491 (714)
..+...++||+|+||+||+|+.+ .+|+.||+|+++-... ..-....+|+.++++++|+| |+++++++...+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~-~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSK-RTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEe-cCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 34555678999999999999987 5789999999975433 23356789999999999999 999999998877
Q ss_pred -eeeEEEeecCCCchhhhhhcCC----CCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCC
Q 041576 492 -NRLLVYEFMGNGTLANLLFAIP----RPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFG 566 (714)
Q Consensus 492 -~~~lv~E~~~~gsL~~~l~~~~----~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg 566 (714)
..++|+||++. +|..++.... .++...+..++.||++||+|||+++ |+||||||.||||+++|.+||+|||
T Consensus 90 ~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFG 165 (323)
T KOG0594|consen 90 GKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFG 165 (323)
T ss_pred ceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccc
Confidence 78899999976 9999998655 4667789999999999999999998 9999999999999999999999999
Q ss_pred CccccccCcccceeeecCCCCccCcccccCC-CCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHh----hh
Q 041576 567 LSKLLLSDQSRTRTVIRGTRGYVAPEWFKNV-PVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAY----DC 641 (714)
Q Consensus 567 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~----~~ 641 (714)
+|+...-. ....+..+.|..|.|||++.+. .|+...||||+|||+.||++++..|....+.++...+..... +.
T Consensus 166 lAra~~ip-~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~ 244 (323)
T KOG0594|consen 166 LARAFSIP-MRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKD 244 (323)
T ss_pred hHHHhcCC-cccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccC
Confidence 99965422 2234455688899999999876 699999999999999999999999987665433222211100 00
Q ss_pred hhcCccceeecch----------hhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 642 YVEGKLDVLVDND----------KAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 642 ~~~~~~~~~~~~~----------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
++. ...+.+.. ..............+++.+||+.+|.+|.|++.+++.
T Consensus 245 Wp~--v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 245 WPG--VSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCC--ccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 000 00000000 0000011112467889999999999999999999986
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=328.39 Aligned_cols=253 Identities=22% Similarity=0.239 Sum_probs=199.4
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEeccc---chhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEE
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKL---AQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLV 496 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 496 (714)
..|.+.+.||+|+||.||++..+ .+++.+|+|.+.+. .......+.+|+.+++.++||||+++++++.++...++|
T Consensus 43 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv 121 (370)
T cd05621 43 EDYDVVKVIGRGAFGEVQLVRHK-SSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMV 121 (370)
T ss_pred HHCeEEEEEEecCCeEEEEEEEC-CCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence 45677789999999999999976 46889999998652 223345688999999999999999999999999999999
Q ss_pred EeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcc
Q 041576 497 YEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQS 576 (714)
Q Consensus 497 ~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 576 (714)
|||+++|+|.+++... .+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++........
T Consensus 122 ~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~ 197 (370)
T cd05621 122 MEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGM 197 (370)
T ss_pred EcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceecccCCc
Confidence 9999999999999754 5788899999999999999999998 99999999999999999999999999987644333
Q ss_pred cceeeecCCCCccCcccccCC----CCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeec
Q 041576 577 RTRTVIRGTRGYVAPEWFKNV----PVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVD 652 (714)
Q Consensus 577 ~~~~~~~gt~~y~aPE~~~~~----~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 652 (714)
.......||+.|+|||++.+. .++.++||||+||++|||++|+.||........... .......
T Consensus 198 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~--------i~~~~~~---- 265 (370)
T cd05621 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSK--------IMDHKNS---- 265 (370)
T ss_pred eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHH--------HHhCCcc----
Confidence 233445699999999998754 378899999999999999999999975433221111 1110000
Q ss_pred chhhhccchHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 041576 653 NDKAAMADKSRACKWLMIALWCIQEDPLK--RPAMKMIVQM 691 (714)
Q Consensus 653 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~ 691 (714)
............+.+++.+||+.+|.+ ||++.|+++.
T Consensus 266 --~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 266 --LNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred --cCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 000011123445677888999855543 8999999885
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=315.43 Aligned_cols=263 Identities=26% Similarity=0.362 Sum_probs=204.4
Q ss_pred HHhhhhhhhhCcccceeEEEeEeeCCC---------------CcEEEEEEecccc-hhhHHHHHHHHHHHhccCcccccc
Q 041576 419 EATNGFEEELGRGSFGIVYKGVLKSAS---------------GNAVAVKKLDKLA-QEREREFKTEVSAIGRTHHKNLVQ 482 (714)
Q Consensus 419 ~at~~~~~~ig~G~~g~Vy~~~~~~~~---------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~ 482 (714)
...+.+.++||+|+||.||+|...... +..||+|.+.... ....+.+.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 346778899999999999999865322 2458999987543 345678999999999999999999
Q ss_pred eeceEecCCeeeEEEeecCCCchhhhhhcCC-----------CCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCe
Q 041576 483 LLGFCDEGLNRLLVYEFMGNGTLANLLFAIP-----------RPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQN 551 (714)
Q Consensus 483 l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~-----------~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~N 551 (714)
+++++..+...++++||+++++|.+++.... .+++..++.++.|+++||+|||+.+ ++|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence 9999999999999999999999999997654 6789999999999999999999998 9999999999
Q ss_pred EEECCCCceEEecCCCccccccCcc-cceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh--cCCCCcccccc
Q 041576 552 ILLDQDFTAKISDFGLSKLLLSDQS-RTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC--CKRSVEMELGE 628 (714)
Q Consensus 552 Ill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt--G~~p~~~~~~~ 628 (714)
|+++.++.++|+|||++........ .......++..|+|||.+.+..++.++||||||+++|||++ +..|+......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ 240 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence 9999999999999999876533221 11223345778999999988889999999999999999998 66777543222
Q ss_pred hhhhhhhHHHhhhhhcCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 041576 629 ERSAILTDWAYDCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEG 694 (714)
Q Consensus 629 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 694 (714)
.. + ......+.......... .+...+.++.+++.+||+.||++|||+.||++.|+.
T Consensus 241 ~~---~-~~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 241 QV---I-ENAGHFFRDDGRQIYLP------RPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred HH---H-HHHHhccccccccccCC------CccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 11 1 11111111111110000 111233578899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=313.79 Aligned_cols=262 Identities=28% Similarity=0.439 Sum_probs=204.2
Q ss_pred HHHHhhhhhhhhCcccceeEEEeEeeC----CCCcEEEEEEecccc-hhhHHHHHHHHHHHhccCcccccceeceEecCC
Q 041576 417 LNEATNGFEEELGRGSFGIVYKGVLKS----ASGNAVAVKKLDKLA-QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGL 491 (714)
Q Consensus 417 l~~at~~~~~~ig~G~~g~Vy~~~~~~----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 491 (714)
+...++.+.+.||+|+||.||+|..++ ..+..||+|.+.... ......+.+|+..+++++||||+++++++.+..
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ 82 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 345667788999999999999997642 235589999886433 233456889999999999999999999999999
Q ss_pred eeeEEEeecCCCchhhhhhcC----------CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceE
Q 041576 492 NRLLVYEFMGNGTLANLLFAI----------PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAK 561 (714)
Q Consensus 492 ~~~lv~E~~~~gsL~~~l~~~----------~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~k 561 (714)
..++||||+++|+|.+++... ...++..+..++.|++.||+|||+++ |+||||||+||++++++.++
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~ 159 (288)
T cd05061 83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVK 159 (288)
T ss_pred CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEE
Confidence 999999999999999999642 23456778899999999999999998 99999999999999999999
Q ss_pred EecCCCccccccCccc-ceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccchhhhhhhHHHh
Q 041576 562 ISDFGLSKLLLSDQSR-TRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEERSAILTDWAY 639 (714)
Q Consensus 562 l~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~l~~~~~ 639 (714)
|+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||......+. . .
T Consensus 160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~---~-~--- 232 (288)
T cd05061 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQV---L-K--- 232 (288)
T ss_pred ECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHH---H-H---
Confidence 9999998865432221 1122234678999999998899999999999999999998 7888864332221 1 0
Q ss_pred hhhhcCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCC
Q 041576 640 DCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLEV 698 (714)
Q Consensus 640 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 698 (714)
....+.... .+...+..+.+++.+||+.||++|||+.++++.|+..+..
T Consensus 233 -~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~ 281 (288)
T cd05061 233 -FVMDGGYLD---------QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHP 281 (288)
T ss_pred -HHHcCCCCC---------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCC
Confidence 111111100 1112235788899999999999999999999999886543
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=313.38 Aligned_cols=258 Identities=29% Similarity=0.435 Sum_probs=205.1
Q ss_pred HHHHhhhhhhhhCcccceeEEEeEeeC----CCCcEEEEEEecccc-hhhHHHHHHHHHHHhccCcccccceeceEecCC
Q 041576 417 LNEATNGFEEELGRGSFGIVYKGVLKS----ASGNAVAVKKLDKLA-QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGL 491 (714)
Q Consensus 417 l~~at~~~~~~ig~G~~g~Vy~~~~~~----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 491 (714)
+....+.+.+.||+|+||.||+|.... ..+..|++|.+.... ......+.+|+.++++++||||+++++++....
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 82 (277)
T cd05032 3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQ 82 (277)
T ss_pred cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCC
Confidence 344566777899999999999998753 234689999986543 344567889999999999999999999999999
Q ss_pred eeeEEEeecCCCchhhhhhcC----------CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceE
Q 041576 492 NRLLVYEFMGNGTLANLLFAI----------PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAK 561 (714)
Q Consensus 492 ~~~lv~E~~~~gsL~~~l~~~----------~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~k 561 (714)
..++||||+++++|.+++... ..+++..++.++.||+.||+|||+.+ ++|+||||+||+++.++.+|
T Consensus 83 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~k 159 (277)
T cd05032 83 PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVK 159 (277)
T ss_pred CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEE
Confidence 999999999999999998643 23577889999999999999999988 99999999999999999999
Q ss_pred EecCCCccccccCcc-cceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccchhhhhhhHHHh
Q 041576 562 ISDFGLSKLLLSDQS-RTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEERSAILTDWAY 639 (714)
Q Consensus 562 l~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~l~~~~~ 639 (714)
|+|||+++.+..... .......++..|+|||.+.+..++.++||||||+++||+++ |+.||..........
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~------- 232 (277)
T cd05032 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLK------- 232 (277)
T ss_pred ECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHH-------
Confidence 999999986544322 12223346778999999988889999999999999999998 888886443322111
Q ss_pred hhhhcCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 041576 640 DCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEG 694 (714)
Q Consensus 640 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 694 (714)
....+.... .+...+..+.+++.+||+.+|++|||+.++++.|++
T Consensus 233 -~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 233 -FVIDGGHLD---------LPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred -HHhcCCCCC---------CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 111111111 111224578889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=319.12 Aligned_cols=263 Identities=27% Similarity=0.344 Sum_probs=206.3
Q ss_pred HHHHHhhhhhhhhCcccceeEEEeEeeC------CCCcEEEEEEecccc-hhhHHHHHHHHHHHhcc-CcccccceeceE
Q 041576 416 ELNEATNGFEEELGRGSFGIVYKGVLKS------ASGNAVAVKKLDKLA-QEREREFKTEVSAIGRT-HHKNLVQLLGFC 487 (714)
Q Consensus 416 el~~at~~~~~~ig~G~~g~Vy~~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~ 487 (714)
++....|.+.+.||+|+||.||+|.... .....+|+|.++... ......+.+|+++++++ +||||+++++++
T Consensus 14 ~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (307)
T cd05098 14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 93 (307)
T ss_pred eeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 4445678888999999999999997642 123479999997532 34456788999999999 799999999999
Q ss_pred ecCCeeeEEEeecCCCchhhhhhcCC----------------CCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCe
Q 041576 488 DEGLNRLLVYEFMGNGTLANLLFAIP----------------RPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQN 551 (714)
Q Consensus 488 ~~~~~~~lv~E~~~~gsL~~~l~~~~----------------~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~N 551 (714)
......++||||+++++|.+++.... .+++.++++++.|++.||+|||+.+ ++||||||+|
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~N 170 (307)
T cd05098 94 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARN 170 (307)
T ss_pred ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHh
Confidence 99999999999999999999997532 3678899999999999999999988 9999999999
Q ss_pred EEECCCCceEEecCCCccccccCcccc-eeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccch
Q 041576 552 ILLDQDFTAKISDFGLSKLLLSDQSRT-RTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEE 629 (714)
Q Consensus 552 Ill~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~ 629 (714)
|+++.++.+||+|||.+.......... .....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+
T Consensus 171 ill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~ 250 (307)
T cd05098 171 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 250 (307)
T ss_pred eEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHH
Confidence 999999999999999987654322111 111224568999999998889999999999999999998 888886433221
Q ss_pred hhhhhhHHHhhhhhcCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCC
Q 041576 630 RSAILTDWAYDCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLEV 698 (714)
Q Consensus 630 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 698 (714)
.... ...+... ..+......+.+++.+||+.+|++||++.||++.|+++++.
T Consensus 251 ~~~~--------~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~ 302 (307)
T cd05098 251 LFKL--------LKEGHRM---------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL 302 (307)
T ss_pred HHHH--------HHcCCCC---------CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence 1110 1111100 11122345777899999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=316.00 Aligned_cols=262 Identities=23% Similarity=0.336 Sum_probs=202.2
Q ss_pred hhhhhhhCcccceeEEEeEeeCCCCcEEEEEEeccc-chhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEeec
Q 041576 422 NGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKL-AQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEFM 500 (714)
Q Consensus 422 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~ 500 (714)
+.+.+.||+|+||.||++... .++..+++|.+... ......++.+|++++++++||||+++++++.+++..++||||+
T Consensus 3 ~~~~~~lg~G~~g~v~~~~~~-~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~ 81 (308)
T cd06615 3 FEKLGELGAGNGGVVTKVLHR-PSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHM 81 (308)
T ss_pred ceEEeeccCCCCeEEEEEEEc-CCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeecc
Confidence 556788999999999999876 46788999988653 2334567889999999999999999999999999999999999
Q ss_pred CCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhc-CCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcccce
Q 041576 501 GNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEE-CNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTR 579 (714)
Q Consensus 501 ~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~-~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 579 (714)
++++|.+++.....+++..+..++.|+++||+|||+. + ++|+||||+||+++.++.+||+|||++....... .
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~---~ 155 (308)
T cd06615 82 DGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---A 155 (308)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCcccccccc---c
Confidence 9999999998878889999999999999999999984 5 9999999999999999999999999987553221 1
Q ss_pred eeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCc-------------
Q 041576 580 TVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGK------------- 646 (714)
Q Consensus 580 ~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~------------- 646 (714)
....++..|+|||.+.+..++.++||||||+++|||++|+.||...........+... ........
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 234 (308)
T cd06615 156 NSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRP-VSEGEAKESHRPVSGHPPDSP 234 (308)
T ss_pred ccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCc-cccccccCCcccccCCCCCcc
Confidence 2345788999999998888999999999999999999999998644322211111000 00000000
Q ss_pred --------cceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 647 --------LDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 647 --------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
....................+.+++.+||+.+|++||+++||++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 235 RPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred chhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000000000011234568899999999999999999999876
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=323.28 Aligned_cols=241 Identities=27% Similarity=0.293 Sum_probs=192.5
Q ss_pred hhhCcccceeEEEeEeeCCCCcEEEEEEecccc---hhhHHHHHHHHH-HHhccCcccccceeceEecCCeeeEEEeecC
Q 041576 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA---QEREREFKTEVS-AIGRTHHKNLVQLLGFCDEGLNRLLVYEFMG 501 (714)
Q Consensus 426 ~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~ 501 (714)
+.||+|+||.||+|... .+++.||+|++.... ......+..|.. +++.++||||+++++.+..++..++||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~ 79 (325)
T cd05604 1 KVIGKGSFGKVLLAKRK-LDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVN 79 (325)
T ss_pred CceeeCCCeEEEEEEEC-CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCC
Confidence 46999999999999876 578999999996532 223345555554 4677899999999999999999999999999
Q ss_pred CCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcccceee
Q 041576 502 NGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTV 581 (714)
Q Consensus 502 ~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 581 (714)
+++|..++.....+++..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++..... ......
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~-~~~~~~ 155 (325)
T cd05604 80 GGELFFHLQRERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ-SDTTTT 155 (325)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCC-CCCccc
Confidence 9999999988888999999999999999999999998 999999999999999999999999998753221 122234
Q ss_pred ecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhhccch
Q 041576 582 IRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMADK 661 (714)
Q Consensus 582 ~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 661 (714)
..|+..|+|||.+.+..++.++|||||||++|||++|+.||......... ......... ...
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~--------~~~~~~~~~----------~~~ 217 (325)
T cd05604 156 FCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMY--------DNILHKPLV----------LRP 217 (325)
T ss_pred ccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHH--------HHHHcCCcc----------CCC
Confidence 56899999999999999999999999999999999999999754322211 111111110 011
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHH
Q 041576 662 SRACKWLMIALWCIQEDPLKRPAMKMIV 689 (714)
Q Consensus 662 ~~~~~l~~li~~cl~~dP~~RPs~~evl 689 (714)
.....+.+++.+||+.+|.+||++++.+
T Consensus 218 ~~~~~~~~ll~~ll~~~p~~R~~~~~~~ 245 (325)
T cd05604 218 GASLTAWSILEELLEKDRQRRLGAKEDF 245 (325)
T ss_pred CCCHHHHHHHHHHhccCHHhcCCCCCCH
Confidence 2334667899999999999999886433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=309.82 Aligned_cols=245 Identities=25% Similarity=0.340 Sum_probs=193.2
Q ss_pred hCcccceeEEEeEeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEeecCCCc
Q 041576 428 LGRGSFGIVYKGVLKSASGNAVAVKKLDKLA---QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEFMGNGT 504 (714)
Q Consensus 428 ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~gs 504 (714)
||+|+||.||++..+ .+++.||+|.+.... ......+..|++++++++||||+++++++.++...++||||+++++
T Consensus 1 lg~G~~g~Vy~~~~~-~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~ 79 (277)
T cd05607 1 LGKGGFGEVCAVQVK-NTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGD 79 (277)
T ss_pred CCCCCceEEEEEEEc-cCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCC
Confidence 799999999999876 468999999986422 1223456679999999999999999999999999999999999999
Q ss_pred hhhhhhcC--CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcccceeee
Q 041576 505 LANLLFAI--PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVI 582 (714)
Q Consensus 505 L~~~l~~~--~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 582 (714)
|.+++... ..+++..+..++.||+.||+|||+.+ ++||||||+||++++++.++|+|||++....... .....
T Consensus 80 L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~~ 154 (277)
T cd05607 80 LKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQR 154 (277)
T ss_pred HHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeecc
Confidence 99888644 35788889999999999999999998 9999999999999999999999999987654322 22234
Q ss_pred cCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhhccchH
Q 041576 583 RGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMADKS 662 (714)
Q Consensus 583 ~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 662 (714)
.++..|+|||++.+..++.++||||+||++|||++|+.||...........+. .......... ....
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~----~~~~~~~~~~---------~~~~ 221 (277)
T cd05607 155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELK----RRTLEDEVKF---------EHQN 221 (277)
T ss_pred CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHH----HHhhcccccc---------cccc
Confidence 58899999999998889999999999999999999999997432211111110 0001111100 0112
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 663 RACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 663 ~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
...++.+++.+||+.||++||+++|+++.
T Consensus 222 ~~~~~~~li~~~L~~~P~~R~~~~~~~~~ 250 (277)
T cd05607 222 FTEESKDICRLFLAKKPEDRLGSREKNDD 250 (277)
T ss_pred CCHHHHHHHHHHhccCHhhCCCCccchhh
Confidence 34467889999999999999999776643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=312.73 Aligned_cols=260 Identities=24% Similarity=0.358 Sum_probs=206.2
Q ss_pred HHHhhhhhhhhCcccceeEEEeEeeCC---CCcEEEEEEeccc-chhhHHHHHHHHHHHhccCcccccceeceEec-CCe
Q 041576 418 NEATNGFEEELGRGSFGIVYKGVLKSA---SGNAVAVKKLDKL-AQEREREFKTEVSAIGRTHHKNLVQLLGFCDE-GLN 492 (714)
Q Consensus 418 ~~at~~~~~~ig~G~~g~Vy~~~~~~~---~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-~~~ 492 (714)
...++.+.+.||+|+||.||+|.+... .+..|++|.+... .......+.+|+.++++++||||+++++++.. +..
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 455677889999999999999998742 2678999998753 34446678999999999999999999998766 567
Q ss_pred eeEEEeecCCCchhhhhhcC--------CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEec
Q 041576 493 RLLVYEFMGNGTLANLLFAI--------PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISD 564 (714)
Q Consensus 493 ~~lv~E~~~~gsL~~~l~~~--------~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D 564 (714)
.++++||+++++|.+++... ..+++..++.++.||+.||+|||+.+ ++|+||||+||++++++.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECC
Confidence 89999999999999998653 34788999999999999999999988 99999999999999999999999
Q ss_pred CCCccccccCccc-ceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccchhhhhhhHHHhhhh
Q 041576 565 FGLSKLLLSDQSR-TRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEERSAILTDWAYDCY 642 (714)
Q Consensus 565 fg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~ 642 (714)
||+++.+...... ......++..|+|||.+.+..++.++||||||+++||+++ |+.||......+ +..+ .
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~----~~~~----~ 232 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE----MAAY----L 232 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH----HHHH----H
Confidence 9999865433221 1122345678999999998889999999999999999999 999987543222 1111 1
Q ss_pred hcCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccC
Q 041576 643 VEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLE 697 (714)
Q Consensus 643 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 697 (714)
..+.. . ......+..+.+++.+||+.||++|||+.|+++.|+.+.+
T Consensus 233 ~~~~~--~-------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 233 KDGYR--L-------AQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred HcCCC--C-------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 11100 0 0011123467889999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=313.29 Aligned_cols=264 Identities=23% Similarity=0.353 Sum_probs=204.0
Q ss_pred HHhhhhhhhhCcccceeEEEeEee---CCCCcEEEEEEecccc-hhhHHHHHHHHHHHhccCcccccceeceEecC--Ce
Q 041576 419 EATNGFEEELGRGSFGIVYKGVLK---SASGNAVAVKKLDKLA-QEREREFKTEVSAIGRTHHKNLVQLLGFCDEG--LN 492 (714)
Q Consensus 419 ~at~~~~~~ig~G~~g~Vy~~~~~---~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~ 492 (714)
..++.+.+.||+|+||.||++.++ ..++..|++|.++... ......+.+|++++++++||||+++++++... ..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (284)
T cd05079 3 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 82 (284)
T ss_pred hhhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence 345667789999999999999753 2457899999987543 34456799999999999999999999998775 56
Q ss_pred eeEEEeecCCCchhhhhhcC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCcccc
Q 041576 493 RLLVYEFMGNGTLANLLFAI-PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLL 571 (714)
Q Consensus 493 ~~lv~E~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~ 571 (714)
.++||||+++++|.+++... ..+++..+..++.||+.||+|||+++ ++||||||+||+++.++.+||+|||++..+
T Consensus 83 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05079 83 IKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAI 159 (284)
T ss_pred eEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCcccccc
Confidence 78999999999999999754 35799999999999999999999998 999999999999999999999999999876
Q ss_pred ccCccc--ceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchh--------hhhhhHHHhhh
Q 041576 572 LSDQSR--TRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEER--------SAILTDWAYDC 641 (714)
Q Consensus 572 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~--------~~~l~~~~~~~ 641 (714)
...... ......++..|+|||.+.+..++.++||||||+++|||++++.|......... ....... ...
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 238 (284)
T cd05079 160 ETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRL-VRV 238 (284)
T ss_pred ccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHH-HHH
Confidence 443221 11234466789999999888899999999999999999998776532211000 0000000 000
Q ss_pred hhcCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 041576 642 YVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGY 695 (714)
Q Consensus 642 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 695 (714)
...+. ....+...+..+.+++.+||+.+|++||+++++++.|+++
T Consensus 239 ~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 239 LEEGK---------RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHcCc---------cCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 00110 0011222456788899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=324.99 Aligned_cols=255 Identities=21% Similarity=0.233 Sum_probs=200.2
Q ss_pred HHHhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHHhccCcccccceeceEecCCeee
Q 041576 418 NEATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA---QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRL 494 (714)
Q Consensus 418 ~~at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 494 (714)
....|.+.+.||+|+||.||++..+ .+++.+|+|.+.... ......+.+|+.+++.++||||+++++.+.++...+
T Consensus 41 ~~~~y~i~~~lG~G~fg~Vy~~~~~-~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (371)
T cd05622 41 KAEDYEVVKVIGRGAFGEVQLVRHK-STRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLY 119 (371)
T ss_pred chhhcEEEEEEeecCCeEEEEEEEC-CCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEE
Confidence 3456777889999999999999876 578899999986422 233456789999999999999999999999999999
Q ss_pred EEEeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccC
Q 041576 495 LVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSD 574 (714)
Q Consensus 495 lv~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 574 (714)
+||||+++|+|.+++... .+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||++......
T Consensus 120 lv~Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~ 195 (371)
T cd05622 120 MVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE 195 (371)
T ss_pred EEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCceeEcCcC
Confidence 999999999999998763 5788889999999999999999998 999999999999999999999999999876543
Q ss_pred cccceeeecCCCCccCcccccCC----CCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCcccee
Q 041576 575 QSRTRTVIRGTRGYVAPEWFKNV----PVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVL 650 (714)
Q Consensus 575 ~~~~~~~~~gt~~y~aPE~~~~~----~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 650 (714)
.........||+.|+|||++.+. .++.++|||||||++|||++|+.||.......... ........
T Consensus 196 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~--------~i~~~~~~-- 265 (371)
T cd05622 196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYS--------KIMNHKNS-- 265 (371)
T ss_pred CcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHH--------HHHcCCCc--
Confidence 33333455699999999998754 37899999999999999999999997543322111 11111000
Q ss_pred ecchhhhccchHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 041576 651 VDNDKAAMADKSRACKWLMIALWCIQEDPLK--RPAMKMIVQM 691 (714)
Q Consensus 651 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~ 691 (714)
.........+..+.+++.+||+.++.+ ||+++|+++.
T Consensus 266 ----~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 266 ----LTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred ----ccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 000011223456777999999844433 7899999874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=306.84 Aligned_cols=248 Identities=27% Similarity=0.393 Sum_probs=200.7
Q ss_pred hhhCcccceeEEEeEeeCCCCc--EEEEEEecccch-hhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEeecCC
Q 041576 426 EELGRGSFGIVYKGVLKSASGN--AVAVKKLDKLAQ-EREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEFMGN 502 (714)
Q Consensus 426 ~~ig~G~~g~Vy~~~~~~~~~~--~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~ 502 (714)
+.||+|++|.||+|.+....++ .||+|.++.... ...+.+.+|+..+++++||||+++++.+.. ...++|+||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 4689999999999998643444 699999987555 566789999999999999999999999988 889999999999
Q ss_pred CchhhhhhcCC--CCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCccc--c
Q 041576 503 GTLANLLFAIP--RPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSR--T 578 (714)
Q Consensus 503 gsL~~~l~~~~--~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~--~ 578 (714)
++|.+++.... .+++..+..++.|+++||+|||+.+ ++|+||||+||+++.++.+||+|||++......... .
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 156 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM 156 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence 99999997654 6789999999999999999999998 999999999999999999999999999876443221 1
Q ss_pred eeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhh
Q 041576 579 RTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAA 657 (714)
Q Consensus 579 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 657 (714)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+....+. .... ..
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~-------~~~~--~~------- 220 (257)
T cd05040 157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKID-------KEGE--RL------- 220 (257)
T ss_pred ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-------hcCC--cC-------
Confidence 122346788999999999899999999999999999999 999986443322111110 0000 00
Q ss_pred ccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 041576 658 MADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLE 693 (714)
Q Consensus 658 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 693 (714)
..+...+..+.+++.+||+.+|++||++.||++.|.
T Consensus 221 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 221 ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 011123456888999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=308.46 Aligned_cols=256 Identities=24% Similarity=0.392 Sum_probs=204.2
Q ss_pred HHHHHhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCcccccceeceEecCCeeeE
Q 041576 416 ELNEATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLL 495 (714)
Q Consensus 416 el~~at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 495 (714)
++...++.+.+.||+|+||.||+|.+. .+..+++|.+... ......+.+|++++++++|+||+++++++.+ ...++
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~vy~~~~~--~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~ 77 (260)
T cd05073 2 EIPRESLKLEKKLGAGQFGEVWMATYN--KHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYI 77 (260)
T ss_pred cccccceeEEeEecCccceEEEEEEec--CCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEE
Confidence 345567888899999999999999864 4567999988753 2345678899999999999999999999887 77899
Q ss_pred EEeecCCCchhhhhhcC--CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCcccccc
Q 041576 496 VYEFMGNGTLANLLFAI--PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLS 573 (714)
Q Consensus 496 v~E~~~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~ 573 (714)
+|||+++++|.+++... ..+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||.+.....
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 154 (260)
T cd05073 78 ITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIED 154 (260)
T ss_pred EEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccC
Confidence 99999999999999753 35688889999999999999999988 99999999999999999999999999976643
Q ss_pred CcccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccchhhhhhhHHHhhhhhcCccceeec
Q 041576 574 DQSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVD 652 (714)
Q Consensus 574 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 652 (714)
..........++..|+|||.+....++.++||||||+++|++++ |+.||.......... ....+...
T Consensus 155 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~--------~~~~~~~~---- 222 (260)
T cd05073 155 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIR--------ALERGYRM---- 222 (260)
T ss_pred CCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHH--------HHhCCCCC----
Confidence 32222222335677999999998889999999999999999999 898986543221111 00111000
Q ss_pred chhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 041576 653 NDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGY 695 (714)
Q Consensus 653 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 695 (714)
......+..+.+++.+|++.+|++||++.++++.|+.+
T Consensus 223 -----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~~ 260 (260)
T cd05073 223 -----PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 260 (260)
T ss_pred -----CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhcC
Confidence 01122345688899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=319.04 Aligned_cols=241 Identities=27% Similarity=0.321 Sum_probs=194.8
Q ss_pred hhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHHhccC-cccccceeceEecCCeeeEEE
Q 041576 422 NGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA---QEREREFKTEVSAIGRTH-HKNLVQLLGFCDEGLNRLLVY 497 (714)
Q Consensus 422 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~ 497 (714)
+++.+.||+|+||.||+|..+ .+++.||+|+++... ....+.+..|..++..+. |++|+++++++.+.+..++||
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 2 FNFLMVLGKGSFGKVMLAERK-GTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred ceEEEEEEecCCeEEEEEEEC-CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 456789999999999999876 578899999997532 233456778888888885 678889999999999999999
Q ss_pred eecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCccc
Q 041576 498 EFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSR 577 (714)
Q Consensus 498 E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 577 (714)
||+++|+|.+++.....+++.++..++.||+.||+|||+++ |+||||||+||++++++.+||+|||+++...... .
T Consensus 81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~-~ 156 (323)
T cd05615 81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG-V 156 (323)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCCC-c
Confidence 99999999999988888999999999999999999999998 9999999999999999999999999987543222 1
Q ss_pred ceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhh
Q 041576 578 TRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAA 657 (714)
Q Consensus 578 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 657 (714)
......|+..|+|||++.+..++.++|||||||++|||++|+.||........... .......
T Consensus 157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~--------i~~~~~~--------- 219 (323)
T cd05615 157 TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQS--------IMEHNVS--------- 219 (323)
T ss_pred cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHH--------HHhCCCC---------
Confidence 22334589999999999998999999999999999999999999975433221111 1111110
Q ss_pred ccchHHHHHHHHHHHHccccCCCCCCCH
Q 041576 658 MADKSRACKWLMIALWCIQEDPLKRPAM 685 (714)
Q Consensus 658 ~~~~~~~~~l~~li~~cl~~dP~~RPs~ 685 (714)
.+......+.+++.+||+.+|.+|++.
T Consensus 220 -~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 220 -YPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred -CCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 111233467789999999999999974
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=318.15 Aligned_cols=254 Identities=28% Similarity=0.336 Sum_probs=214.0
Q ss_pred HHHHhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchh---hHHHHHHHHHHHhccC-cccccceeceEecCCe
Q 041576 417 LNEATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQE---REREFKTEVSAIGRTH-HKNLVQLLGFCDEGLN 492 (714)
Q Consensus 417 l~~at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~ 492 (714)
-....|.+.+.||+|.||.||+++.+ .+|+.+|+|.+.+.... ....+.+|+.+|+++. ||||+.+.+.+++...
T Consensus 32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~-~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~ 110 (382)
T KOG0032|consen 32 DIKEKYELGRELGRGQFGVVYLCREK-STGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDS 110 (382)
T ss_pred cccccEEehhhhCCCCceEEEEEEec-CCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCe
Confidence 34456788899999999999999977 56999999999764332 3468999999999998 9999999999999999
Q ss_pred eeEEEeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCC----CceEEecCCCc
Q 041576 493 RLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQD----FTAKISDFGLS 568 (714)
Q Consensus 493 ~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~----~~~kl~Dfg~~ 568 (714)
.++|||++.||.|.+.+... .+++..+..++.||+.+++|||+.| |+||||||+|+|+... +.+|++|||++
T Consensus 111 ~~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGla 186 (382)
T KOG0032|consen 111 VYLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGLA 186 (382)
T ss_pred EEEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCCc
Confidence 99999999999999999876 4999999999999999999999998 9999999999999543 57999999999
Q ss_pred cccccCcccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccc
Q 041576 569 KLLLSDQSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLD 648 (714)
Q Consensus 569 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 648 (714)
..... .......+||+.|+|||++....++..+||||+|+++|.|++|..||.......... ....++.
T Consensus 187 ~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~--------~i~~~~~- 255 (382)
T KOG0032|consen 187 KFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL--------AILRGDF- 255 (382)
T ss_pred eEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH--------HHHcCCC-
Confidence 98766 455667789999999999999999999999999999999999999998765443222 1122222
Q ss_pred eeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 649 VLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 649 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
......-......+.+++..||..||.+|+|+.++++.
T Consensus 256 -----~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 256 -----DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred -----CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 11111223345677889999999999999999999994
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=316.55 Aligned_cols=261 Identities=25% Similarity=0.365 Sum_probs=219.6
Q ss_pred HHHHHhhhhhhhhCcccceeEEEeEeeCC-CCc--EEEEEEecc-cchhhHHHHHHHHHHHhccCcccccceeceEecCC
Q 041576 416 ELNEATNGFEEELGRGSFGIVYKGVLKSA-SGN--AVAVKKLDK-LAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGL 491 (714)
Q Consensus 416 el~~at~~~~~~ig~G~~g~Vy~~~~~~~-~~~--~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 491 (714)
++.++...+.+.||.|-||.||+|++.+. .|. .||||..+. ...+..+.|+.|..+++.++||||++++|+|.+.
T Consensus 385 el~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~- 463 (974)
T KOG4257|consen 385 ELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ- 463 (974)
T ss_pred eeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-
Confidence 34444445668899999999999997644 233 689999876 4556678899999999999999999999999764
Q ss_pred eeeEEEeecCCCchhhhhhcC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccc
Q 041576 492 NRLLVYEFMGNGTLANLLFAI-PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKL 570 (714)
Q Consensus 492 ~~~lv~E~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~ 570 (714)
..|+|||.++.|-|+.+|+.+ ..++......++.||..||+|||+.. +|||||..+|||+.....+||+|||+++.
T Consensus 464 P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~ 540 (974)
T KOG4257|consen 464 PMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRY 540 (974)
T ss_pred ceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhh
Confidence 679999999999999999865 46888889999999999999999997 99999999999999999999999999999
Q ss_pred cccCcccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccchhhhhhhHHHhhhhhcCccce
Q 041576 571 LLSDQSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEERSAILTDWAYDCYVEGKLDV 649 (714)
Q Consensus 571 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 649 (714)
+..+.....+...-...|||||.+.-..++.++|||-|||.+||+++ |..||..-...+ +..
T Consensus 541 ~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsD-----------------VI~ 603 (974)
T KOG4257|consen 541 LEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSD-----------------VIG 603 (974)
T ss_pred ccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccc-----------------eEE
Confidence 98777766666667889999999999999999999999999999875 899997543222 222
Q ss_pred eecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccC
Q 041576 650 LVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLE 697 (714)
Q Consensus 650 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 697 (714)
.++...+...+..+++.+..++.+||++||.+||++.|+...|+++++
T Consensus 604 ~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 604 HIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred EecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 233334445567778889999999999999999999999988876654
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=321.44 Aligned_cols=261 Identities=28% Similarity=0.371 Sum_probs=201.5
Q ss_pred HHHhhhhhhhhCcccceeEEEeEee----CCCCcEEEEEEecccc-hhhHHHHHHHHHHHhcc-CcccccceeceEecC-
Q 041576 418 NEATNGFEEELGRGSFGIVYKGVLK----SASGNAVAVKKLDKLA-QEREREFKTEVSAIGRT-HHKNLVQLLGFCDEG- 490 (714)
Q Consensus 418 ~~at~~~~~~ig~G~~g~Vy~~~~~----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~- 490 (714)
...++.+.+.||+|+||.||+|... ..+++.||||+++... ......+.+|+.++.++ +||||+++++++...
T Consensus 5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (343)
T cd05103 5 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 84 (343)
T ss_pred chhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence 3457888999999999999999742 2356799999997533 33456788999999999 789999999988654
Q ss_pred CeeeEEEeecCCCchhhhhhcCC---------------------------------------------------------
Q 041576 491 LNRLLVYEFMGNGTLANLLFAIP--------------------------------------------------------- 513 (714)
Q Consensus 491 ~~~~lv~E~~~~gsL~~~l~~~~--------------------------------------------------------- 513 (714)
...+++|||+++|+|.+++....
T Consensus 85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (343)
T cd05103 85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 164 (343)
T ss_pred CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence 46789999999999999986421
Q ss_pred ----------CCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCccc-ceeee
Q 041576 514 ----------RPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSR-TRTVI 582 (714)
Q Consensus 514 ----------~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~ 582 (714)
.+++..+..++.||++||+|||+++ |+||||||+||++++++.+||+|||++......... .....
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 241 (343)
T cd05103 165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 241 (343)
T ss_pred hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCC
Confidence 2467778899999999999999998 999999999999999999999999999865332221 11223
Q ss_pred cCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhhccch
Q 041576 583 RGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMADK 661 (714)
Q Consensus 583 ~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 661 (714)
.++..|+|||.+.+..++.++||||||+++|||++ |..|+........ +. .....+.... .+.
T Consensus 242 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~---~~----~~~~~~~~~~---------~~~ 305 (343)
T cd05103 242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---FC----RRLKEGTRMR---------APD 305 (343)
T ss_pred CCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH---HH----HHHhccCCCC---------CCC
Confidence 35678999999998899999999999999999997 8888864322111 00 0111111100 011
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccC
Q 041576 662 SRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLE 697 (714)
Q Consensus 662 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 697 (714)
.....+.+++.+||+.||++|||+.||++.|+.+++
T Consensus 306 ~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 306 YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 123467889999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=313.19 Aligned_cols=250 Identities=25% Similarity=0.347 Sum_probs=203.3
Q ss_pred hhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEeec
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEFM 500 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~ 500 (714)
+|.+.+.||+|++|.||+|+.. .+++.|++|.+..........+.+|+.++++++|+||+++++.+..+...++||||+
T Consensus 21 ~y~~~~~lg~g~~~~v~~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 21 KYTRFEKIGQGASGTVYTAMDV-ATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred ceeeEEEecCCCCeEEEEEEEC-CCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 5666788999999999999865 568899999997655555678899999999999999999999999999999999999
Q ss_pred CCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCccccee
Q 041576 501 GNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRT 580 (714)
Q Consensus 501 ~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 580 (714)
++++|.+++.. ..+++.++..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++........ ...
T Consensus 100 ~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~-~~~ 174 (296)
T cd06654 100 AGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRS 174 (296)
T ss_pred CCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhcccccc-ccC
Confidence 99999999865 45788999999999999999999998 99999999999999999999999999876533221 122
Q ss_pred eecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhhccc
Q 041576 581 VIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMAD 660 (714)
Q Consensus 581 ~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 660 (714)
...++..|+|||.+.+..++.++|||||||++|||++|+.||........ +.. ....+. .. ...+
T Consensus 175 ~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~---~~~----~~~~~~-~~-------~~~~ 239 (296)
T cd06654 175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA---LYL----IATNGT-PE-------LQNP 239 (296)
T ss_pred cccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh---HHH----HhcCCC-CC-------CCCc
Confidence 34578899999999988899999999999999999999999975432211 100 000000 00 0011
Q ss_pred hHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 661 KSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 661 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
......+.+++.+||+.+|++||++.||++.
T Consensus 240 ~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 240 EKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred cccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 2234567889999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=320.35 Aligned_cols=238 Identities=25% Similarity=0.291 Sum_probs=190.5
Q ss_pred hhhCcccceeEEEeEeeCCCCcEEEEEEecccc---hhhHHHHHHHHH-HHhccCcccccceeceEecCCeeeEEEeecC
Q 041576 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA---QEREREFKTEVS-AIGRTHHKNLVQLLGFCDEGLNRLLVYEFMG 501 (714)
Q Consensus 426 ~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~ 501 (714)
+.||+|+||.||+|+.. .+++.||+|.+.... ......+..|.. +++.++||||+++++++.+.+..++||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~ 79 (321)
T cd05603 1 KVIGKGSFGKVLLAKRK-SDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVN 79 (321)
T ss_pred CeeeeCCCEEEEEEEEC-CCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCC
Confidence 46999999999999876 568899999986532 222344555554 5788999999999999999999999999999
Q ss_pred CCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcccceee
Q 041576 502 NGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTV 581 (714)
Q Consensus 502 ~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 581 (714)
+++|...+.....+.+..+..++.||++||+|||+.+ |+||||||+||+++.++.+||+|||++....... .....
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 155 (321)
T cd05603 80 GGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ETTST 155 (321)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-Ccccc
Confidence 9999999988778899999999999999999999998 9999999999999999999999999987532221 22234
Q ss_pred ecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhhccch
Q 041576 582 IRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMADK 661 (714)
Q Consensus 582 ~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 661 (714)
..|++.|+|||.+.+..++.++|||||||++|||++|+.||......... ........ ..+.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--------~~i~~~~~----------~~~~ 217 (321)
T cd05603 156 FCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMY--------DNILHKPL----------QLPG 217 (321)
T ss_pred ccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHH--------HHHhcCCC----------CCCC
Confidence 56899999999999989999999999999999999999999754322111 11111110 0112
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHH
Q 041576 662 SRACKWLMIALWCIQEDPLKRPAMK 686 (714)
Q Consensus 662 ~~~~~l~~li~~cl~~dP~~RPs~~ 686 (714)
.....+.+++.+||+.||.+||++.
T Consensus 218 ~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 218 GKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCHHHHHHHHHHccCCHhhcCCCC
Confidence 2345677899999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=308.17 Aligned_cols=259 Identities=24% Similarity=0.313 Sum_probs=205.2
Q ss_pred HHHhhhhhhhhCcccceeEEEeEeeCC--CCcEEEEEEecccc-hhhHHHHHHHHHHHhccCcccccceeceEecCCeee
Q 041576 418 NEATNGFEEELGRGSFGIVYKGVLKSA--SGNAVAVKKLDKLA-QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRL 494 (714)
Q Consensus 418 ~~at~~~~~~ig~G~~g~Vy~~~~~~~--~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 494 (714)
...++.+.+.||+|+||.||+|.+... ....|++|...... ....+.+.+|+.++++++||||+++++++.+ ...+
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~ 82 (270)
T cd05056 4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVW 82 (270)
T ss_pred chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcE
Confidence 345566788999999999999987533 23478999887544 4456689999999999999999999998875 4578
Q ss_pred EEEeecCCCchhhhhhcC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCcccccc
Q 041576 495 LVYEFMGNGTLANLLFAI-PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLS 573 (714)
Q Consensus 495 lv~E~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~ 573 (714)
+||||+++++|.+++... ..+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++.....
T Consensus 83 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 159 (270)
T cd05056 83 IVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLED 159 (270)
T ss_pred EEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeeccc
Confidence 999999999999999764 35799999999999999999999988 99999999999999999999999999986644
Q ss_pred CcccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccchhhhhhhHHHhhhhhcCccceeec
Q 041576 574 DQSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVD 652 (714)
Q Consensus 574 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 652 (714)
..........++..|+|||.+....++.++||||||+++||+++ |..||......+... . ...+...
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~---~-----~~~~~~~---- 227 (270)
T cd05056 160 ESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIG---R-----IENGERL---- 227 (270)
T ss_pred ccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHH---H-----HHcCCcC----
Confidence 33222222334568999999988889999999999999999986 999997543322111 1 1111100
Q ss_pred chhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccC
Q 041576 653 NDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLE 697 (714)
Q Consensus 653 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 697 (714)
..+...+..+.+++.+|+..+|++|||+.++++.|+++..
T Consensus 228 -----~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 228 -----PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred -----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 0112234578889999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=309.14 Aligned_cols=240 Identities=24% Similarity=0.352 Sum_probs=189.6
Q ss_pred hhCcccceeEEEeEeeCC-----------------------CCcEEEEEEecccchhhHHHHHHHHHHHhccCcccccce
Q 041576 427 ELGRGSFGIVYKGVLKSA-----------------------SGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQL 483 (714)
Q Consensus 427 ~ig~G~~g~Vy~~~~~~~-----------------------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l 483 (714)
.||+|+||.||+|.+... ....|++|.+..........+.+|+.++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 589999999999986321 123689999876555556678899999999999999999
Q ss_pred eceEecCCeeeEEEeecCCCchhhhhhc-CCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCC----
Q 041576 484 LGFCDEGLNRLLVYEFMGNGTLANLLFA-IPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDF---- 558 (714)
Q Consensus 484 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~-~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~---- 558 (714)
++++.+....++||||+++++|..++.. ...+++..+..++.||++||+|||+++ |+||||||+||+++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcccC
Confidence 9999999999999999999999999875 456889999999999999999999988 99999999999997643
Q ss_pred ---ceEEecCCCccccccCcccceeeecCCCCccCcccccC-CCCCchhhhHHHHHHHHHHH-hcCCCCcccccchhhhh
Q 041576 559 ---TAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKN-VPVSAKVDVYSFGVVLLKII-CCKRSVEMELGEERSAI 633 (714)
Q Consensus 559 ---~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvil~ell-tG~~p~~~~~~~~~~~~ 633 (714)
.+|++|||.+...... ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.||...........
T Consensus 159 ~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~ 233 (274)
T cd05076 159 TSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERF 233 (274)
T ss_pred ccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHH
Confidence 4899999987643221 12246788999998865 56899999999999999994 78988875433221110
Q ss_pred hhHHHhhhhhcCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 041576 634 LTDWAYDCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLE 693 (714)
Q Consensus 634 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 693 (714)
+ ... . . .+......+.+++.+||+.+|++||++.+|++.|+
T Consensus 234 ~--------~~~-~-~---------~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 234 Y--------EKK-H-R---------LPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred H--------Hhc-c-C---------CCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 0 000 0 0 01112235788999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=306.31 Aligned_cols=256 Identities=21% Similarity=0.337 Sum_probs=206.2
Q ss_pred hhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecc---cchhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEE
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDK---LAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVY 497 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 497 (714)
.|.+.+.||+|++|.||+|... .+++.|++|.++. ......+.+.+|++++++++|+||+++++++...+..++||
T Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 3 NFKIEKKIGKGQFSVVYKAICL-LDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred ceeeeeeeccCCceEEEEEEEc-CCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 4667889999999999999986 5788999998863 22334568899999999999999999999999999999999
Q ss_pred eecCCCchhhhhhc----CCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCcccccc
Q 041576 498 EFMGNGTLANLLFA----IPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLS 573 (714)
Q Consensus 498 E~~~~gsL~~~l~~----~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~ 573 (714)
||+++++|.+++.. ...+++..+..++.|+++||+|||+.+ ++||||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 99999999999864 245788999999999999999999998 99999999999999999999999999876543
Q ss_pred CcccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecc
Q 041576 574 DQSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDN 653 (714)
Q Consensus 574 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 653 (714)
... ......++..|+|||.+.+..++.++||||||+++|+|++|+.||....... ... ......+...
T Consensus 159 ~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----~~~-~~~~~~~~~~----- 226 (267)
T cd08224 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-----YSL-CKKIEKCDYP----- 226 (267)
T ss_pred CCc-ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccH-----HHH-HhhhhcCCCC-----
Confidence 221 1223457889999999998889999999999999999999999986432111 000 0011111110
Q ss_pred hhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 041576 654 DKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGY 695 (714)
Q Consensus 654 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 695 (714)
..........+.+++.+||+.+|++||++.+|+++|+++
T Consensus 227 ---~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 227 ---PLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred ---CCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 011123445778899999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=335.25 Aligned_cols=251 Identities=25% Similarity=0.308 Sum_probs=201.2
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEeccc--chhhHHHHHHHHHHHhccCcccccceeceEecCC------
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKL--AQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGL------ 491 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~------ 491 (714)
.+|.+.+.||+|+||+||+|... .+++.||||.++.. .......+.+|+..+..++|+||+++++.+...+
T Consensus 32 ~rY~i~~~LG~G~fG~Vy~a~~~-~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~ 110 (496)
T PTZ00283 32 KKYWISRVLGSGATGTVLCAKRV-SDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPEN 110 (496)
T ss_pred CCEEEEEEEecCCCEEEEEEEEc-CCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCccc
Confidence 46788899999999999999875 46899999998643 3445567889999999999999999988774432
Q ss_pred --eeeEEEeecCCCchhhhhhcC----CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecC
Q 041576 492 --NRLLVYEFMGNGTLANLLFAI----PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDF 565 (714)
Q Consensus 492 --~~~lv~E~~~~gsL~~~l~~~----~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Df 565 (714)
..++||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+||
T Consensus 111 ~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL~DF 187 (496)
T PTZ00283 111 VLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKLGDF 187 (496)
T ss_pred ceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEEEec
Confidence 357999999999999998643 45788999999999999999999998 999999999999999999999999
Q ss_pred CCccccccCcc-cceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhc
Q 041576 566 GLSKLLLSDQS-RTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVE 644 (714)
Q Consensus 566 g~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~ 644 (714)
|+++....... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||........ + .....
T Consensus 188 Gls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~---~-----~~~~~ 259 (496)
T PTZ00283 188 GFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEV---M-----HKTLA 259 (496)
T ss_pred ccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH---H-----HHHhc
Confidence 99986543221 222345689999999999999999999999999999999999999975432211 1 11111
Q ss_pred CccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 645 GKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 645 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
+.... .+...+..+.+++.+||+.||.+||++.++++.
T Consensus 260 ~~~~~---------~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 260 GRYDP---------LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred CCCCC---------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 11111 122334568889999999999999999999863
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=309.47 Aligned_cols=250 Identities=23% Similarity=0.359 Sum_probs=197.5
Q ss_pred hhhhhhhCcccceeEEEeEeeCCCCcEEEEEEeccc-chhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEeec
Q 041576 422 NGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKL-AQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEFM 500 (714)
Q Consensus 422 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~ 500 (714)
+.+.+.||+|+||.||+|+.. .+++.||+|.+... .....+.+.+|++++++++||||+++++++...+..++||||+
T Consensus 3 ~~~~~~lg~g~~~~v~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (279)
T cd06619 3 IQYQEILGHGNGGTVYKAYHL-LTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM 81 (279)
T ss_pred chheeeeccCCCeEEEEEEEc-CCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence 456688999999999999876 46889999998653 3344567999999999999999999999999999999999999
Q ss_pred CCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCccccee
Q 041576 501 GNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRT 580 (714)
Q Consensus 501 ~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 580 (714)
++++|..+ ..+++..+..++.|++.||+|||+.+ |+|+||||+||+++.++.++|+|||++...... ...
T Consensus 82 ~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~---~~~ 151 (279)
T cd06619 82 DGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS---IAK 151 (279)
T ss_pred CCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccc---ccc
Confidence 99998765 34678888999999999999999998 999999999999999999999999999765332 122
Q ss_pred eecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhhccc
Q 041576 581 VIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMAD 660 (714)
Q Consensus 581 ~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 660 (714)
...++..|+|||.+.+..++.++||||||+++|+|++|+.||............... ........ ......
T Consensus 152 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~--------~~~~~~ 222 (279)
T cd06619 152 TYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQL-LQCIVDED--------PPVLPV 222 (279)
T ss_pred CCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHH-HHHHhccC--------CCCCCC
Confidence 346889999999999989999999999999999999999999753322211100000 00000000 000111
Q ss_pred hHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 661 KSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 661 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
......+.+++.+||+.+|++||+++|+++.
T Consensus 223 ~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 223 GQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred CcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 2234567889999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=305.85 Aligned_cols=253 Identities=22% Similarity=0.296 Sum_probs=202.8
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEee
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEF 499 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~ 499 (714)
..|.+.+.||+|+||.||+|... .+++.||+|.++.........+.+|+.+++.++||||+++++.+...+..++|+||
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~ 87 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNV-NTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF 87 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEc-CCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence 46778899999999999999875 56889999998765555556788999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcccce
Q 041576 500 MGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTR 579 (714)
Q Consensus 500 ~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 579 (714)
+++++|.+++.....+++.+++.++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++....... ...
T Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~-~~~ 163 (267)
T cd06645 88 CGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATI-AKR 163 (267)
T ss_pred cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCcc-ccc
Confidence 999999999988888999999999999999999999998 9999999999999999999999999987653321 122
Q ss_pred eeecCCCCccCccccc---CCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhh
Q 041576 580 TVIRGTRGYVAPEWFK---NVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKA 656 (714)
Q Consensus 580 ~~~~gt~~y~aPE~~~---~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 656 (714)
....|+..|+|||.+. ...++.++|||||||++|||++|+.|+........ +... ...... .+...
T Consensus 164 ~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~---~~~~-----~~~~~~---~~~~~ 232 (267)
T cd06645 164 KSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA---LFLM-----TKSNFQ---PPKLK 232 (267)
T ss_pred ccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh---HHhh-----hccCCC---CCccc
Confidence 3345889999999874 45688999999999999999999999864332111 0000 000000 00000
Q ss_pred hccchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 657 AMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 657 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
.....+..+.+++.+||+.+|++||++++|++
T Consensus 233 --~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 233 --DKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred --ccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 01112345778999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=305.35 Aligned_cols=248 Identities=33% Similarity=0.476 Sum_probs=203.3
Q ss_pred hhhCcccceeEEEeEeeC--CCCcEEEEEEecccchh-hHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEeecCC
Q 041576 426 EELGRGSFGIVYKGVLKS--ASGNAVAVKKLDKLAQE-REREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEFMGN 502 (714)
Q Consensus 426 ~~ig~G~~g~Vy~~~~~~--~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~ 502 (714)
+.||+|+||.||+|.... ..+..|++|.+...... ..+.+.+|++.+.+++|+||+++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999999863 12778999999764433 367899999999999999999999999999999999999999
Q ss_pred CchhhhhhcC---------CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCcccccc
Q 041576 503 GTLANLLFAI---------PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLS 573 (714)
Q Consensus 503 gsL~~~l~~~---------~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~ 573 (714)
++|.+++... ..+++..+..++.|+++||+|||+++ ++|+||+|+||++++++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999875 67899999999999999999999998 99999999999999999999999999987654
Q ss_pred Ccc-cceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccchhhhhhhHHHhhhhhcCccceee
Q 041576 574 DQS-RTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEERSAILTDWAYDCYVEGKLDVLV 651 (714)
Q Consensus 574 ~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 651 (714)
... .......++..|+|||.+....++.++||||+|+++|||++ |..||.......... ....+..
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~--------~~~~~~~---- 225 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLE--------YLRKGYR---- 225 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHH--------HHHcCCC----
Confidence 332 22233457889999999988889999999999999999999 589987553222111 1111100
Q ss_pred cchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 041576 652 DNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLE 693 (714)
Q Consensus 652 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 693 (714)
...+...+..+.+++.+||+.+|++|||+.|+++.|+
T Consensus 226 -----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 226 -----LPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred -----CCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 0111222457888999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=312.18 Aligned_cols=263 Identities=26% Similarity=0.409 Sum_probs=205.9
Q ss_pred HhhhhhhhhCcccceeEEEeEee---CCCCcEEEEEEecccchh-hHHHHHHHHHHHhccCcccccceeceEec--CCee
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLK---SASGNAVAVKKLDKLAQE-REREFKTEVSAIGRTHHKNLVQLLGFCDE--GLNR 493 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~---~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--~~~~ 493 (714)
..+.+.+.||+|+||.||+|.+. ..++..+|||.+...... ..+.+.+|++.+++++||||+++++++.. +...
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 44566789999999999999864 235779999999765443 56789999999999999999999999877 5678
Q ss_pred eEEEeecCCCchhhhhhcCC-CCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccc
Q 041576 494 LLVYEFMGNGTLANLLFAIP-RPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLL 572 (714)
Q Consensus 494 ~lv~E~~~~gsL~~~l~~~~-~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~ 572 (714)
+++|||+++++|.+++.... .+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||.+....
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKVLP 160 (284)
T ss_pred EEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence 99999999999999997654 6899999999999999999999998 9999999999999999999999999998765
Q ss_pred cCcccc--eeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhh--------hhhhHHHhhhh
Q 041576 573 SDQSRT--RTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERS--------AILTDWAYDCY 642 (714)
Q Consensus 573 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~--------~~l~~~~~~~~ 642 (714)
...... .....++..|+|||.+.+..++.++||||||++++||++|+.|+......... ...... ....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 239 (284)
T cd05038 161 EDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRL-LELL 239 (284)
T ss_pred cCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHH-HHHH
Confidence 332211 11223456799999998889999999999999999999999998643222100 000000 0000
Q ss_pred hcCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 041576 643 VEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGY 695 (714)
Q Consensus 643 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 695 (714)
.. ......+...+.++.+++.+||+.+|++||+|.||+++|+.+
T Consensus 240 ~~---------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 240 KE---------GERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred Hc---------CCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 00 000111122335788899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=316.35 Aligned_cols=263 Identities=17% Similarity=0.195 Sum_probs=195.2
Q ss_pred hhhhhCcc--cceeEEEeEeeCCCCcEEEEEEeccc--chhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEee
Q 041576 424 FEEELGRG--SFGIVYKGVLKSASGNAVAVKKLDKL--AQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEF 499 (714)
Q Consensus 424 ~~~~ig~G--~~g~Vy~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~ 499 (714)
+.++||+| +|++||++..+ .+++.||+|+++.. .....+.+.+|+++++.++||||+++++++..++..++||||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 80 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYK-PTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF 80 (327)
T ss_pred hhhhccccccceEEEEEEeec-ccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence 56789999 78999999876 57899999999753 233456788899999999999999999999999999999999
Q ss_pred cCCCchhhhhhcC--CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCccc
Q 041576 500 MGNGTLANLLFAI--PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSR 577 (714)
Q Consensus 500 ~~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 577 (714)
+++++|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+||+++.++.++++||+...........
T Consensus 81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence 9999999999653 45889999999999999999999998 999999999999999999999999865543221110
Q ss_pred ------ceeeecCCCCccCcccccC--CCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhh-hhHHHh---------
Q 041576 578 ------TRTVIRGTRGYVAPEWFKN--VPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAI-LTDWAY--------- 639 (714)
Q Consensus 578 ------~~~~~~gt~~y~aPE~~~~--~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~-l~~~~~--------- 639 (714)
......++..|+|||++.+ ..++.++|||||||++|||++|+.||........... ......
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIP 237 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchh
Confidence 1112246678999999976 4589999999999999999999999974322110000 000000
Q ss_pred -hhhh--------cCccce---------eecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 640 -DCYV--------EGKLDV---------LVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 640 -~~~~--------~~~~~~---------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
.... +..... .................+.+++.+||+.||++|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 238 AEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred hhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 0000 000000 00000000112233457889999999999999999999987
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=311.39 Aligned_cols=263 Identities=23% Similarity=0.319 Sum_probs=200.8
Q ss_pred HHhhhhhhhhCcccceeEEEeEee---------------CCCCcEEEEEEeccc-chhhHHHHHHHHHHHhccCcccccc
Q 041576 419 EATNGFEEELGRGSFGIVYKGVLK---------------SASGNAVAVKKLDKL-AQEREREFKTEVSAIGRTHHKNLVQ 482 (714)
Q Consensus 419 ~at~~~~~~ig~G~~g~Vy~~~~~---------------~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~ 482 (714)
...+.+.+.||+|+||.||++... ..+...+|+|.++.. .......+.+|++++++++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 345778899999999999998532 123447899999754 3344568999999999999999999
Q ss_pred eeceEecCCeeeEEEeecCCCchhhhhhcCC-----------CCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCe
Q 041576 483 LLGFCDEGLNRLLVYEFMGNGTLANLLFAIP-----------RPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQN 551 (714)
Q Consensus 483 l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~-----------~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~N 551 (714)
+++++...+..++||||+++++|.+++.... .+++..+..++.||+.||+|||+.+ ++|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhe
Confidence 9999999999999999999999999987542 2556789999999999999999998 9999999999
Q ss_pred EEECCCCceEEecCCCccccccCcccc-eeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh--cCCCCcccccc
Q 041576 552 ILLDQDFTAKISDFGLSKLLLSDQSRT-RTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC--CKRSVEMELGE 628 (714)
Q Consensus 552 Ill~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt--G~~p~~~~~~~ 628 (714)
|++++++.++|+|||++..+....... .....++..|+|||......++.++|||||||++|||++ |..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence 999999999999999998654322211 112234578999999888889999999999999999998 67787643322
Q ss_pred hhhhhhhHHHhhhhhcCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 041576 629 ERSAILTDWAYDCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEG 694 (714)
Q Consensus 629 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 694 (714)
....... ..+......... ..+...+..+.+++.+||+.||++||++.||++.|++
T Consensus 241 ~~~~~~~----~~~~~~~~~~~~------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 241 QVIENTG----EFFRDQGRQVYL------PKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred HHHHHHH----HHHhhccccccC------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 2111110 001110000000 0111233577889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=317.20 Aligned_cols=244 Identities=24% Similarity=0.305 Sum_probs=194.2
Q ss_pred hhhCcccceeEEEeEeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHHhcc-CcccccceeceEecCCeeeEEEeecC
Q 041576 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA---QEREREFKTEVSAIGRT-HHKNLVQLLGFCDEGLNRLLVYEFMG 501 (714)
Q Consensus 426 ~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~E~~~ 501 (714)
+.||+|+||.||+|... .+++.||+|+++... ....+.+.+|+.++.++ +||||+++++++...+..++||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 79 (327)
T cd05617 1 RVIGRGSYAKVLLVRLK-KNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVN 79 (327)
T ss_pred CeeeeCCCeEEEEEEEC-CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCC
Confidence 36999999999999876 468899999997532 23345688999999888 69999999999999999999999999
Q ss_pred CCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcccceee
Q 041576 502 NGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTV 581 (714)
Q Consensus 502 ~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 581 (714)
+++|..++.....+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||++....... .....
T Consensus 80 ~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 155 (327)
T cd05617 80 GGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG-DTTST 155 (327)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCC-Cceec
Confidence 9999999988788999999999999999999999998 9999999999999999999999999987532211 22234
Q ss_pred ecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhhccch
Q 041576 582 IRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMADK 661 (714)
Q Consensus 582 ~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 661 (714)
..|+..|+|||++.+..++.++|||||||++|||++|+.||.......... .............. ..+.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~----------~~p~ 224 (327)
T cd05617 156 FCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMN-TEDYLFQVILEKPI----------RIPR 224 (327)
T ss_pred ccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccc-cHHHHHHHHHhCCC----------CCCC
Confidence 568999999999999999999999999999999999999996432211100 00111111111111 0112
Q ss_pred HHHHHHHHHHHHccccCCCCCCCH
Q 041576 662 SRACKWLMIALWCIQEDPLKRPAM 685 (714)
Q Consensus 662 ~~~~~l~~li~~cl~~dP~~RPs~ 685 (714)
..+..+.+++.+||+.||++||++
T Consensus 225 ~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 225 FLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred CCCHHHHHHHHHHhccCHHHcCCC
Confidence 233456789999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=314.76 Aligned_cols=263 Identities=20% Similarity=0.245 Sum_probs=197.6
Q ss_pred hhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc-hhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEee
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA-QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEF 499 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~ 499 (714)
+|.+.+.||+|+||.||+|..+ .+++.||+|.++... ......+.+|++++++++||||+++++++..++..++||||
T Consensus 7 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 7 TYIKLEKLGEGTYATVFKGRSK-LTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred ceEEEEEecccCCEEEEEEEec-CCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 4667789999999999999876 467899999986432 22344678899999999999999999999999999999999
Q ss_pred cCCCchhhhhhcC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcccc
Q 041576 500 MGNGTLANLLFAI-PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRT 578 (714)
Q Consensus 500 ~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 578 (714)
+++ +|.+++... ..+++..+..++.||++||+|||+++ |+||||||+||+++.++.+||+|||++........ .
T Consensus 86 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~ 160 (309)
T cd07872 86 LDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTK-T 160 (309)
T ss_pred CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCcc-c
Confidence 986 788777654 45788999999999999999999998 99999999999999999999999999875433221 1
Q ss_pred eeeecCCCCccCcccccC-CCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHH-------hhhhhcC-----
Q 041576 579 RTVIRGTRGYVAPEWFKN-VPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWA-------YDCYVEG----- 645 (714)
Q Consensus 579 ~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~-------~~~~~~~----- 645 (714)
.....++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+....+.... +......
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (309)
T cd07872 161 YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKN 240 (309)
T ss_pred cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhh
Confidence 223357889999998865 468999999999999999999999997654332211111100 0000000
Q ss_pred -ccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 646 -KLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 646 -~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
........... ......+..+.+++.+||+.||.+|||++|+++
T Consensus 241 ~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 241 YNFPKYKPQPLI-NHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhcCccCCCchh-hhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 00000000000 001123446788999999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=320.32 Aligned_cols=245 Identities=26% Similarity=0.354 Sum_probs=204.2
Q ss_pred hhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEeecCCCchh
Q 041576 427 ELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEFMGNGTLA 506 (714)
Q Consensus 427 ~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~gsL~ 506 (714)
+||+|.||+||.|++. .+...+|||.+...+....+-+.+|+...++++|.|||+++|.+.+++..-|.||.++||+|.
T Consensus 582 VLGKGTYG~VYA~RD~-~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDM-DTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EeecCceeEEEeeccc-cceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 5999999999999976 567899999998877777788999999999999999999999999999999999999999999
Q ss_pred hhhhcC-CCC--ChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECC-CCceEEecCCCccccccCcccceeee
Q 041576 507 NLLFAI-PRP--DWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQ-DFTAKISDFGLSKLLLSDQSRTRTVI 582 (714)
Q Consensus 507 ~~l~~~-~~~--~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~ 582 (714)
++|+.. +++ ++...-.+.+||++||.|||++. |||||||-+||||+. .|.+||+|||.++.+..-. ....++
T Consensus 661 sLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin-P~TETF 736 (1226)
T KOG4279|consen 661 SLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN-PCTETF 736 (1226)
T ss_pred HHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccCC-cccccc
Confidence 999865 444 78888889999999999999998 999999999999975 7899999999998774432 333456
Q ss_pred cCCCCccCcccccCC--CCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhhccc
Q 041576 583 RGTRGYVAPEWFKNV--PVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMAD 660 (714)
Q Consensus 583 ~gt~~y~aPE~~~~~--~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 660 (714)
.||..|||||++..+ .|..++|||||||.+.||.||++||.......-.. +.-|- .. .-...+
T Consensus 737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAM---------FkVGm----yK--vHP~iP 801 (1226)
T KOG4279|consen 737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAM---------FKVGM----YK--VHPPIP 801 (1226)
T ss_pred ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhh---------hhhcc----ee--cCCCCc
Confidence 799999999999765 48899999999999999999999996432221110 01110 00 112245
Q ss_pred hHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 661 KSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 661 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
.+...+...+|.+|+.+||.+||+++++++.
T Consensus 802 eelsaeak~FilrcFepd~~~R~sA~~LL~D 832 (1226)
T KOG4279|consen 802 EELSAEAKNFILRCFEPDPCDRPSAKDLLQD 832 (1226)
T ss_pred HHHHHHHHHHHHHHcCCCcccCccHHHhccC
Confidence 6677788899999999999999999999873
|
|
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=311.78 Aligned_cols=256 Identities=25% Similarity=0.397 Sum_probs=201.9
Q ss_pred HHhhhhhhhhCcccceeEEEeEeeC----CCCcEEEEEEecccc-hhhHHHHHHHHHHHhccCcccccceeceEecCCee
Q 041576 419 EATNGFEEELGRGSFGIVYKGVLKS----ASGNAVAVKKLDKLA-QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNR 493 (714)
Q Consensus 419 ~at~~~~~~ig~G~~g~Vy~~~~~~----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 493 (714)
...+.+.+.||+|+||.||+|.... .++..||+|.+.... ......+.+|+.++++++||||+++++++.++...
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 3456677899999999999998642 256789999987543 34456799999999999999999999999999999
Q ss_pred eEEEeecCCCchhhhhhcCC----------------------CCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCe
Q 041576 494 LLVYEFMGNGTLANLLFAIP----------------------RPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQN 551 (714)
Q Consensus 494 ~lv~E~~~~gsL~~~l~~~~----------------------~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~N 551 (714)
++||||+++++|.+++.... .+++..++.++.||+.||+|||+.+ ++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence 99999999999999996431 3567788999999999999999998 9999999999
Q ss_pred EEECCCCceEEecCCCccccccCcc-cceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccch
Q 041576 552 ILLDQDFTAKISDFGLSKLLLSDQS-RTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEE 629 (714)
Q Consensus 552 Ill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~ 629 (714)
|++++++.++|+|||++........ ........+..|+|||.+.+..++.++|||||||++|||++ |..||......+
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~ 240 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE 240 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999999876533221 11112234567999999998899999999999999999997 888885432221
Q ss_pred hhhhhhHHHhhhhhcCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 041576 630 RSAILTDWAYDCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEG 694 (714)
Q Consensus 630 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 694 (714)
. . .....+.... .+...+.++.+++.+||+.+|++|||+.|+++.|++
T Consensus 241 ~---~-----~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 241 V---I-----YYVRDGNVLS---------CPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred H---H-----HHHhcCCCCC---------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 1 1 1111111110 111234578889999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=307.05 Aligned_cols=249 Identities=25% Similarity=0.370 Sum_probs=202.6
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc-hhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEe
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA-QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYE 498 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E 498 (714)
+.|...+.||+|+||.||+|.+. .+++.||+|.+.... ....+.+.+|++++++++||||+++++++..+...++|+|
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDN-RTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIME 82 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEc-CCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEE
Confidence 45667789999999999999876 467899999987432 3445678999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcccc
Q 041576 499 FMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRT 578 (714)
Q Consensus 499 ~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 578 (714)
|+++++|.+++.. ..+++..+..++.||++||+|||+++ ++|+||+|+||++++++.++|+|||++..+..... .
T Consensus 83 ~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~ 157 (277)
T cd06642 83 YLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-K 157 (277)
T ss_pred ccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcch-h
Confidence 9999999998865 56788999999999999999999988 99999999999999999999999999976543221 2
Q ss_pred eeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhhc
Q 041576 579 RTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAM 658 (714)
Q Consensus 579 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 658 (714)
.....++..|+|||.+.+..++.++||||||+++|||++|+.|+.......... ...... ...
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~--------~~~~~~---------~~~ 220 (277)
T cd06642 158 RNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLF--------LIPKNS---------PPT 220 (277)
T ss_pred hhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHh--------hhhcCC---------CCC
Confidence 223457889999999999899999999999999999999999986432221100 000110 001
Q ss_pred cchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 659 ADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 659 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
.....+..+.+++.+||+.+|++||++.+|++.
T Consensus 221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 221 LEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred CCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 112234567889999999999999999999983
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=306.24 Aligned_cols=250 Identities=25% Similarity=0.320 Sum_probs=200.8
Q ss_pred hhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEeecC
Q 041576 422 NGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEFMG 501 (714)
Q Consensus 422 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~ 501 (714)
|.+.+.||+|+||.||+|... .++..+++|.+........+.+.+|+++++.++||||+++++++..+...++|+||++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~-~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~ 85 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNK-ETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA 85 (282)
T ss_pred HHHHhhcccCCCeEEEEEEEC-CCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence 566788999999999999876 4678899999976665666788999999999999999999999999999999999999
Q ss_pred CCchhhhhhc-CCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCccccee
Q 041576 502 NGTLANLLFA-IPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRT 580 (714)
Q Consensus 502 ~gsL~~~l~~-~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 580 (714)
+++|..++.. ...+++..+..++.|+++||+|||+.+ ++||||||+||+++.++.+||+|||++....... ....
T Consensus 86 ~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-~~~~ 161 (282)
T cd06643 86 GGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QRRD 161 (282)
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccccc-cccc
Confidence 9999998765 456899999999999999999999998 9999999999999999999999999987653322 1222
Q ss_pred eecCCCCccCccccc-----CCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchh
Q 041576 581 VIRGTRGYVAPEWFK-----NVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDK 655 (714)
Q Consensus 581 ~~~gt~~y~aPE~~~-----~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 655 (714)
...++..|+|||.+. +..++.++|||||||++|||++|+.||........ .... ........
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~---~~~~-----~~~~~~~~----- 228 (282)
T cd06643 162 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRV---LLKI-----AKSEPPTL----- 228 (282)
T ss_pred cccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHH---HHHH-----hhcCCCCC-----
Confidence 345888999999983 45578899999999999999999999875432211 1110 00000000
Q ss_pred hhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 656 AAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 656 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
..+...+..+.+++.+||+.||.+||++.++++.
T Consensus 229 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 229 --AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred --CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0112234567889999999999999999998764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=305.22 Aligned_cols=247 Identities=28% Similarity=0.370 Sum_probs=197.6
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCcccccceeceEe-cCCeeeEEEe
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCD-EGLNRLLVYE 498 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~-~~~~~~lv~E 498 (714)
..+.+.+.||+|+||.||++..+ +..+++|.++... ..+.+.+|+.++++++|+|++++++++. .+...++++|
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~---~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR---GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 80 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc---CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEE
Confidence 45667789999999999999764 7889999986532 3467899999999999999999999764 5567899999
Q ss_pred ecCCCchhhhhhcCC--CCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcc
Q 041576 499 FMGNGTLANLLFAIP--RPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQS 576 (714)
Q Consensus 499 ~~~~gsL~~~l~~~~--~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 576 (714)
|+++++|.+++.... .+++..++.++.|++.||+|||+++ ++||||||+||++++++.+||+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~- 156 (256)
T cd05082 81 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ- 156 (256)
T ss_pred CCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC-
Confidence 999999999997643 4788999999999999999999998 9999999999999999999999999987543322
Q ss_pred cceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccchhhhhhhHHHhhhhhcCccceeecchh
Q 041576 577 RTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDK 655 (714)
Q Consensus 577 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 655 (714)
.....+..|+|||.+.+..++.++||||||+++|||++ |+.||........ . . ....+..
T Consensus 157 ---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~---~-~----~~~~~~~-------- 217 (256)
T cd05082 157 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV---V-P----RVEKGYK-------- 217 (256)
T ss_pred ---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHH---H-H----HHhcCCC--------
Confidence 12234567999999998899999999999999999998 8988864322111 0 0 0001100
Q ss_pred hhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 041576 656 AAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGY 695 (714)
Q Consensus 656 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 695 (714)
.......+..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus 218 -~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 218 -MDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred -CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 011122345678899999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=302.62 Aligned_cols=249 Identities=25% Similarity=0.365 Sum_probs=203.5
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEee
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEF 499 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~ 499 (714)
..|.+.+.||+|++|.||+|... .+++.+++|.+..... .+++.+|++++++++||||+++++++.++...++++||
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~-~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~ 79 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHK-ETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY 79 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEc-CCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence 35677889999999999999987 3578999999975433 67899999999999999999999999999999999999
Q ss_pred cCCCchhhhhhc-CCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcccc
Q 041576 500 MGNGTLANLLFA-IPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRT 578 (714)
Q Consensus 500 ~~~gsL~~~l~~-~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 578 (714)
+++++|.+++.. ...+++..+..++.|+++||+|||+.+ ++|+||+|+||+++.++.+||+|||++........ .
T Consensus 80 ~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-~ 155 (256)
T cd06612 80 CGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-K 155 (256)
T ss_pred CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc-c
Confidence 999999999975 356799999999999999999999998 99999999999999999999999999987644321 2
Q ss_pred eeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhhc
Q 041576 579 RTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAM 658 (714)
Q Consensus 579 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 658 (714)
.....++..|+|||.+.+..++.++||||||+++|||++|+.|+............ ...... ...
T Consensus 156 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~--------~~~~~~-------~~~ 220 (256)
T cd06612 156 RNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMI--------PNKPPP-------TLS 220 (256)
T ss_pred cccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhh--------ccCCCC-------CCC
Confidence 22344788999999999989999999999999999999999999754322111000 000000 000
Q ss_pred cchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 659 ADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 659 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
.+......+.+++.+||+.||++|||+.||++
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 221 DPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred chhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 12223456888999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=304.27 Aligned_cols=241 Identities=25% Similarity=0.389 Sum_probs=191.2
Q ss_pred hhhCcccceeEEEeEeeCC-----------CCcEEEEEEecccchhhHHHHHHHHHHHhccCcccccceeceEecCCeee
Q 041576 426 EELGRGSFGIVYKGVLKSA-----------SGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRL 494 (714)
Q Consensus 426 ~~ig~G~~g~Vy~~~~~~~-----------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 494 (714)
+.||+|+||.||+|.+... ....|++|.+..........+.+|+.++.+++||||+++++++..+...+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 4689999999999986422 12368999887665556668899999999999999999999999999999
Q ss_pred EEEeecCCCchhhhhhcC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCc-------eEEecCC
Q 041576 495 LVYEFMGNGTLANLLFAI-PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFT-------AKISDFG 566 (714)
Q Consensus 495 lv~E~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~-------~kl~Dfg 566 (714)
+||||+++++|..++... ..+++..++.++.||++||+|||+.+ |+||||||+||+++.++. ++++|||
T Consensus 81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157 (262)
T ss_pred EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence 999999999999998754 56899999999999999999999998 999999999999987664 8999999
Q ss_pred CccccccCcccceeeecCCCCccCccccc-CCCCCchhhhHHHHHHHHHHH-hcCCCCcccccchhhhhhhHHHhhhhhc
Q 041576 567 LSKLLLSDQSRTRTVIRGTRGYVAPEWFK-NVPVSAKVDVYSFGVVLLKII-CCKRSVEMELGEERSAILTDWAYDCYVE 644 (714)
Q Consensus 567 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~ksDVwSlGvil~ell-tG~~p~~~~~~~~~~~~l~~~~~~~~~~ 644 (714)
++...... ....++..|+|||.+. +..++.++||||||+++|||+ +|+.|+......+.. ....
T Consensus 158 ~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~---------~~~~ 223 (262)
T cd05077 158 IPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE---------RFYE 223 (262)
T ss_pred CCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH---------HHHh
Confidence 98754322 2234678899999886 466899999999999999998 577777543221110 0011
Q ss_pred CccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 041576 645 GKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLE 693 (714)
Q Consensus 645 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 693 (714)
+... . .......+.+++.+||+.||++||++.+|++.|+
T Consensus 224 ~~~~-~---------~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 224 GQCM-L---------VTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred cCcc-C---------CCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 1100 0 1112346778999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=305.71 Aligned_cols=248 Identities=27% Similarity=0.352 Sum_probs=200.7
Q ss_pred hhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccch---------hhHHHHHHHHHHHhccCcccccceeceEecCCe
Q 041576 422 NGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQ---------EREREFKTEVSAIGRTHHKNLVQLLGFCDEGLN 492 (714)
Q Consensus 422 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 492 (714)
+.+.+.||+|++|.||+|... .+++.+++|.+..... ...+.+.+|+.++++++||||+++++++.+...
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~-~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNA-SSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred ccccceeecCCCeEEEEEEec-CCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 456678999999999999875 4678999998864221 123568899999999999999999999999999
Q ss_pred eeEEEeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccc
Q 041576 493 RLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLL 572 (714)
Q Consensus 493 ~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~ 572 (714)
.++|+||+++++|.+++.....+++..+..++.|++.||+|||+.+ ++||||+|+||++++++.++|+|||.++...
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKKLE 157 (267)
T ss_pred cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCcccc
Confidence 9999999999999999988788899999999999999999999998 9999999999999999999999999998765
Q ss_pred cCcc-----cceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCcc
Q 041576 573 SDQS-----RTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKL 647 (714)
Q Consensus 573 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~ 647 (714)
.... .......++..|+|||.+.+..++.++||||||+++|+|++|+.||........ +.. ......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~---~~~-----~~~~~~ 229 (267)
T cd06628 158 ANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQA---IFK-----IGENAS 229 (267)
T ss_pred cccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHH---HHH-----HhccCC
Confidence 3211 111223578899999999988899999999999999999999999975422111 000 000000
Q ss_pred ceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 648 DVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 648 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
...+...+..+.+++.+||+.||++||++.||++
T Consensus 230 ---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 230 ---------PEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred ---------CcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 0112233456778999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=304.52 Aligned_cols=252 Identities=29% Similarity=0.410 Sum_probs=191.0
Q ss_pred hhhCcccceeEEEeEeeC-CCCcEEEEEEecccc-hhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEeecCCC
Q 041576 426 EELGRGSFGIVYKGVLKS-ASGNAVAVKKLDKLA-QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEFMGNG 503 (714)
Q Consensus 426 ~~ig~G~~g~Vy~~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~g 503 (714)
+.||+|+||.||+|.... ..+..+++|.++... ......+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 368999999999998642 345679999987543 334457899999999999999999999999999999999999999
Q ss_pred chhhhhhcCC-----CCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcc-c
Q 041576 504 TLANLLFAIP-----RPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQS-R 577 (714)
Q Consensus 504 sL~~~l~~~~-----~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~-~ 577 (714)
+|.+++.... ..++..+..++.|+++||+|||+.+ ++|+||||+||+++.++.+||+|||++........ .
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 9999997532 3466778899999999999999998 99999999999999999999999999875433222 1
Q ss_pred ceeeecCCCCccCcccccCC-------CCCchhhhHHHHHHHHHHHh-cCCCCcccccchhhhhhhHHHhhhhhcCccce
Q 041576 578 TRTVIRGTRGYVAPEWFKNV-------PVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEERSAILTDWAYDCYVEGKLDV 649 (714)
Q Consensus 578 ~~~~~~gt~~y~aPE~~~~~-------~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 649 (714)
......++..|+|||++.+. .++.++||||||+++|||++ |+.||......+... .. ... ....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~----~~---~~~-~~~~ 229 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLT----YT---VRE-QQLK 229 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHH----HH---hhc-ccCC
Confidence 12233467889999998642 35789999999999999996 999996543222110 00 000 0011
Q ss_pred eecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 041576 650 LVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLE 693 (714)
Q Consensus 650 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 693 (714)
..++.. .......+.+++..|+ .+|++|||++||+..|+
T Consensus 230 ~~~~~~----~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 230 LPKPRL----KLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCCcc----CCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 111111 1112335667888998 68999999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=317.26 Aligned_cols=264 Identities=28% Similarity=0.350 Sum_probs=206.6
Q ss_pred HHHHHhhhhhhhhCcccceeEEEeEeeCC------CCcEEEEEEecccc-hhhHHHHHHHHHHHhcc-CcccccceeceE
Q 041576 416 ELNEATNGFEEELGRGSFGIVYKGVLKSA------SGNAVAVKKLDKLA-QEREREFKTEVSAIGRT-HHKNLVQLLGFC 487 (714)
Q Consensus 416 el~~at~~~~~~ig~G~~g~Vy~~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~ 487 (714)
++...++.+.+.||+|+||.||+|..... ....||+|.++... ....+++.+|+++++++ +||||+++++++
T Consensus 8 ~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (334)
T cd05100 8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGAC 87 (334)
T ss_pred ccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEE
Confidence 45556788899999999999999975321 22368999887532 33456889999999999 899999999999
Q ss_pred ecCCeeeEEEeecCCCchhhhhhcC----------------CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCe
Q 041576 488 DEGLNRLLVYEFMGNGTLANLLFAI----------------PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQN 551 (714)
Q Consensus 488 ~~~~~~~lv~E~~~~gsL~~~l~~~----------------~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~N 551 (714)
..+...++++||+++++|.+++... ..+++..++.++.||++||+|||+.+ ++||||||+|
T Consensus 88 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~N 164 (334)
T cd05100 88 TQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARN 164 (334)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccce
Confidence 9999999999999999999998653 23677888999999999999999998 9999999999
Q ss_pred EEECCCCceEEecCCCccccccCccc-ceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccch
Q 041576 552 ILLDQDFTAKISDFGLSKLLLSDQSR-TRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEE 629 (714)
Q Consensus 552 Ill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~ 629 (714)
|++++++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..||.......
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~ 244 (334)
T cd05100 165 VLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE 244 (334)
T ss_pred EEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 99999999999999999765432211 1112234567999999999999999999999999999998 888886443222
Q ss_pred hhhhhhHHHhhhhhcCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCCC
Q 041576 630 RSAILTDWAYDCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLEVP 699 (714)
Q Consensus 630 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 699 (714)
... ....+... ..+......+.+++.+||+.+|++||++.|+++.|+.+....
T Consensus 245 ~~~--------~~~~~~~~---------~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~ 297 (334)
T cd05100 245 LFK--------LLKEGHRM---------DKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT 297 (334)
T ss_pred HHH--------HHHcCCCC---------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence 111 11111100 011223446788999999999999999999999999877443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=314.49 Aligned_cols=260 Identities=25% Similarity=0.350 Sum_probs=203.5
Q ss_pred HHHhhhhhhhhCcccceeEEEeEee------CCCCcEEEEEEeccc-chhhHHHHHHHHHHHhcc-CcccccceeceEec
Q 041576 418 NEATNGFEEELGRGSFGIVYKGVLK------SASGNAVAVKKLDKL-AQEREREFKTEVSAIGRT-HHKNLVQLLGFCDE 489 (714)
Q Consensus 418 ~~at~~~~~~ig~G~~g~Vy~~~~~------~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~ 489 (714)
...++.+.+.||+|+||.||+|... ......+|+|.++.. .......+.+|+++++++ +||||+++++++..
T Consensus 10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (314)
T cd05099 10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQ 89 (314)
T ss_pred cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence 3456677899999999999999752 123457899998753 234456788999999999 69999999999999
Q ss_pred CCeeeEEEeecCCCchhhhhhcC----------------CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEE
Q 041576 490 GLNRLLVYEFMGNGTLANLLFAI----------------PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNIL 553 (714)
Q Consensus 490 ~~~~~lv~E~~~~gsL~~~l~~~----------------~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIl 553 (714)
....+++|||+++++|.+++... ..+++.++.+++.||+.||+|||+++ ++||||||+||+
T Consensus 90 ~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nil 166 (314)
T cd05099 90 EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVL 166 (314)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEE
Confidence 99999999999999999999653 23678888999999999999999998 999999999999
Q ss_pred ECCCCceEEecCCCccccccCcccc-eeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccchhh
Q 041576 554 LDQDFTAKISDFGLSKLLLSDQSRT-RTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEERS 631 (714)
Q Consensus 554 l~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~ 631 (714)
+++++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||.........
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~ 246 (314)
T cd05099 167 VTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELF 246 (314)
T ss_pred EcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 9999999999999998654322111 111224467999999998899999999999999999999 88888644322211
Q ss_pred hhhhHHHhhhhhcCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccC
Q 041576 632 AILTDWAYDCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLE 697 (714)
Q Consensus 632 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 697 (714)
.. ...+... ..+......+.+++.+||+.+|++||++.|+++.|+++..
T Consensus 247 ~~--------~~~~~~~---------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~ 295 (314)
T cd05099 247 KL--------LREGHRM---------DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA 295 (314)
T ss_pred HH--------HHcCCCC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 11 1111100 0112233467789999999999999999999999988664
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=317.01 Aligned_cols=254 Identities=22% Similarity=0.245 Sum_probs=196.9
Q ss_pred hhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEeccc---chhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEE
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKL---AQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVY 497 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 497 (714)
.|.+.+.||+|+||.||++... .+++.||+|.+.+. .....+.+.+|+.++..++|+||+++++++.+++..++||
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 2 DFEILKVIGRGAFGEVAVVKMK-NTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CceEEEEEEecCCeEEEEEEEC-CCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 3567789999999999999876 46889999999652 2233456889999999999999999999999999999999
Q ss_pred eecCCCchhhhhhc-CCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcc
Q 041576 498 EFMGNGTLANLLFA-IPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQS 576 (714)
Q Consensus 498 E~~~~gsL~~~l~~-~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 576 (714)
||+++++|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++........
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 157 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT 157 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCCCC
Confidence 99999999999976 457889999999999999999999998 99999999999999999999999999876544333
Q ss_pred cceeeecCCCCccCcccccC-----CCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceee
Q 041576 577 RTRTVIRGTRGYVAPEWFKN-----VPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLV 651 (714)
Q Consensus 577 ~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 651 (714)
.......|++.|+|||++.. ..++.++|||||||++|||++|+.||......+....+. .......+
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~-------~~~~~~~~- 229 (331)
T cd05597 158 VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM-------NHKEHFQF- 229 (331)
T ss_pred ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHH-------cCCCcccC-
Confidence 33333468999999999863 457889999999999999999999997543222111110 00000000
Q ss_pred cchhhhccchHHHHHHHHHHHHccccCC--CCCCCHHHHHHH
Q 041576 652 DNDKAAMADKSRACKWLMIALWCIQEDP--LKRPAMKMIVQM 691 (714)
Q Consensus 652 ~~~~~~~~~~~~~~~l~~li~~cl~~dP--~~RPs~~evl~~ 691 (714)
.. .....+..+.+++.+||..++ ..||+++++++.
T Consensus 230 ~~-----~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 230 PP-----DVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred CC-----ccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 00 011134456678888775433 347899999875
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=310.23 Aligned_cols=262 Identities=24% Similarity=0.306 Sum_probs=192.6
Q ss_pred hhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc--hhhHHHHHHHHHHHhcc---CcccccceeceEec-----CC
Q 041576 422 NGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA--QEREREFKTEVSAIGRT---HHKNLVQLLGFCDE-----GL 491 (714)
Q Consensus 422 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~nIv~l~~~~~~-----~~ 491 (714)
|.+.+.||+|+||.||+|..+ .+++.||+|.++... ......+.+|+++++++ +||||+++++++.. ..
T Consensus 2 y~~~~~lg~g~~g~v~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 2 YEPVAEIGVGAYGTVYKARDP-HSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred ceEeeEEeecCCeEEEEEEEC-CCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 566789999999999999876 568899999986432 12233456677766655 79999999998854 34
Q ss_pred eeeEEEeecCCCchhhhhhcC--CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCcc
Q 041576 492 NRLLVYEFMGNGTLANLLFAI--PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSK 569 (714)
Q Consensus 492 ~~~lv~E~~~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~ 569 (714)
..++||||+++ +|.+++... ..+++..+..++.||+.||+|||+.+ ++||||||+||+++.++.+||+|||++.
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~~ 156 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLAR 156 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCccc
Confidence 57899999985 888888754 34789999999999999999999998 9999999999999999999999999998
Q ss_pred ccccCcccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHh----hhhhcC
Q 041576 570 LLLSDQSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAY----DCYVEG 645 (714)
Q Consensus 570 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~----~~~~~~ 645 (714)
...... ......++..|+|||.+.+..++.++|||||||++|||++|++||...........+..... ..+...
T Consensus 157 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07863 157 IYSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRD 234 (288)
T ss_pred cccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccc
Confidence 654322 12234578899999999988999999999999999999999999975433322111111000 000000
Q ss_pred -cc-ceeecc---hhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 646 -KL-DVLVDN---DKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 646 -~~-~~~~~~---~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
.. .....+ .............+.+++.+||+.||++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 235 VTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred ccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00 000000 0000111223456788999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=309.30 Aligned_cols=259 Identities=22% Similarity=0.290 Sum_probs=206.0
Q ss_pred HHHhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc-hhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEE
Q 041576 418 NEATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA-QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLV 496 (714)
Q Consensus 418 ~~at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 496 (714)
....+.+.+.||+|++|+||++... .+++.||+|.+.... ....+.+.+|+++++.++||||+++++++......++|
T Consensus 3 ~~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (284)
T cd06620 3 RNEDLETISDLGAGNGGSVSKVKHI-PTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMC 81 (284)
T ss_pred cHHHHHHHHHcCCCCCeEEEEEEEc-CCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEE
Confidence 3456778899999999999999876 468899999886532 34457889999999999999999999999999999999
Q ss_pred EeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhc-CCCCeEecCCCcCeEEECCCCceEEecCCCccccccCc
Q 041576 497 YEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEE-CNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQ 575 (714)
Q Consensus 497 ~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~-~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 575 (714)
|||+++++|.+++...+.+++.....++.+++.||.|||+. + ++|+||+|+||++++++.++|+|||++.......
T Consensus 82 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~ 158 (284)
T cd06620 82 MEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI 158 (284)
T ss_pred EecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchhhhc
Confidence 99999999999998877889999999999999999999974 5 9999999999999999999999999986542221
Q ss_pred ccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhh----hhhhHHHhhhhhcCccceee
Q 041576 576 SRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERS----AILTDWAYDCYVEGKLDVLV 651 (714)
Q Consensus 576 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~----~~l~~~~~~~~~~~~~~~~~ 651 (714)
.....++..|+|||.+.+..++.++|||||||++|||++|+.||......... ..+..........
T Consensus 159 ---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~------- 228 (284)
T cd06620 159 ---ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQE------- 228 (284)
T ss_pred ---cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhc-------
Confidence 12345889999999998889999999999999999999999999855432110 0011111110000
Q ss_pred cchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 041576 652 DNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQML 692 (714)
Q Consensus 652 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 692 (714)
..........+..+.+++.+||+.||++|||+.|++++.
T Consensus 229 --~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 229 --PPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred --cCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 000011112345688899999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=302.68 Aligned_cols=252 Identities=24% Similarity=0.319 Sum_probs=205.3
Q ss_pred hhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEeec
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEFM 500 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~ 500 (714)
.+.+.+.||.|++|.||+|... .+++.+++|.+........+.+.+|++++++++||||+++++++.++...+++|||+
T Consensus 4 ~~~~~~~l~~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 4 DYELIQRIGSGTYGDVYKARDI-ATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred ceEEEEEecCCCceEEEEeEec-CCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 4667789999999999999876 467889999997665556788999999999999999999999999999999999999
Q ss_pred CCCchhhhhhcC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcccce
Q 041576 501 GNGTLANLLFAI-PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTR 579 (714)
Q Consensus 501 ~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 579 (714)
++++|.+++... ..+++.++..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||.+........ ..
T Consensus 83 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~~ 158 (262)
T cd06613 83 GGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA-KR 158 (262)
T ss_pred CCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhhh-cc
Confidence 999999999876 67899999999999999999999998 99999999999999999999999999876543221 22
Q ss_pred eeecCCCCccCcccccCC---CCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhh
Q 041576 580 TVIRGTRGYVAPEWFKNV---PVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKA 656 (714)
Q Consensus 580 ~~~~gt~~y~aPE~~~~~---~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 656 (714)
....++..|+|||.+.+. .++.++||||||+++|||++|+.|+.......... .. ...... ...
T Consensus 159 ~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~---~~-----~~~~~~---~~~-- 225 (262)
T cd06613 159 KSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALF---LI-----SKSNFP---PPK-- 225 (262)
T ss_pred ccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH---HH-----HhccCC---Ccc--
Confidence 234578889999999776 88999999999999999999999997543222110 00 000000 000
Q ss_pred hccchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 657 AMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 657 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
.......+..+.+++.+||+.+|.+|||+.+|+.
T Consensus 226 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 226 LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0112234567889999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=324.37 Aligned_cols=251 Identities=24% Similarity=0.261 Sum_probs=197.8
Q ss_pred hhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEe
Q 041576 422 NGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA---QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYE 498 (714)
Q Consensus 422 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E 498 (714)
+.+.+.||+|+||.||++..+ .+++.||+|+++... ......+.+|+.++.+++||||+++++.+.+++..++|||
T Consensus 3 f~~~~~lG~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E 81 (360)
T cd05627 3 FESLKVIGRGAFGEVRLVQKK-DTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIME 81 (360)
T ss_pred ceEEEEEeeCCCEEEEEEEEC-CCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence 456688999999999999876 478899999997532 2345678899999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcc--
Q 041576 499 FMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQS-- 576 (714)
Q Consensus 499 ~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~-- 576 (714)
|+++|+|.+++.....+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++..+.....
T Consensus 82 ~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~ 158 (360)
T cd05627 82 FLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTE 158 (360)
T ss_pred CCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccccccc
Confidence 9999999999988888999999999999999999999998 99999999999999999999999999875432110
Q ss_pred --------------------------------cceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcc
Q 041576 577 --------------------------------RTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEM 624 (714)
Q Consensus 577 --------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~ 624 (714)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~ 238 (360)
T cd05627 159 FYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS 238 (360)
T ss_pred cccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCC
Confidence 001134689999999999999999999999999999999999999975
Q ss_pred cccchhhhhhhHHHhhhhhcCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCC---HHHHHHH
Q 041576 625 ELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPA---MKMIVQM 691 (714)
Q Consensus 625 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl~~ 691 (714)
.........+. .......+.+ .......+.+++.+++. ||.+|++ +.|+++.
T Consensus 239 ~~~~~~~~~i~--------~~~~~~~~p~------~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 239 ETPQETYRKVM--------NWKETLVFPP------EVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSH 293 (360)
T ss_pred CCHHHHHHHHH--------cCCCceecCC------CCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcC
Confidence 54332111111 1000000110 11123456667777764 9999985 6676654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=288.56 Aligned_cols=250 Identities=27% Similarity=0.355 Sum_probs=205.2
Q ss_pred hhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEeccc--------chhhHHHHHHHHHHHhcc-CcccccceeceEecCC
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKL--------AQEREREFKTEVSAIGRT-HHKNLVQLLGFCDEGL 491 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~--------~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~ 491 (714)
.|.-.+.||+|..++|-+..++ .++...|+|++... ..+-.+.-.+|+.+|+++ .||+|+++.++++.+.
T Consensus 18 ~y~pkeilgrgvss~vrRci~k-~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s 96 (411)
T KOG0599|consen 18 KYEPKEILGRGVSSVVRRCIHK-ETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA 96 (411)
T ss_pred hcChHHHhcccchhhhhhhhhc-ccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence 3444678999999999998887 57888999988531 112234567899999998 7999999999999999
Q ss_pred eeeEEEeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCcccc
Q 041576 492 NRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLL 571 (714)
Q Consensus 492 ~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~ 571 (714)
-.++|+|.|+.|-|.|+|...-.+++++..+|+.|+.+|+.|||..+ ||||||||+|||+|++.++||+|||++..+
T Consensus 97 F~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFGFa~~l 173 (411)
T KOG0599|consen 97 FVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFGFACQL 173 (411)
T ss_pred hhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEeccceeecc
Confidence 99999999999999999999889999999999999999999999998 999999999999999999999999999987
Q ss_pred ccCcccceeeecCCCCccCccccc------CCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcC
Q 041576 572 LSDQSRTRTVIRGTRGYVAPEWFK------NVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEG 645 (714)
Q Consensus 572 ~~~~~~~~~~~~gt~~y~aPE~~~------~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~ 645 (714)
.... .....+||++|+|||.+. ...|+...|+|++|||+|.|+.|.+||.-...... ...+.+|
T Consensus 174 ~~Ge--kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlM--------LR~ImeG 243 (411)
T KOG0599|consen 174 EPGE--KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLM--------LRMIMEG 243 (411)
T ss_pred CCch--hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHH--------HHHHHhc
Confidence 5543 344578999999999884 34688999999999999999999999974322211 1222333
Q ss_pred ccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 646 KLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 646 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
+...- ...-.+......++|.+||+.||.+|.|++|+++
T Consensus 244 kyqF~------speWadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 244 KYQFR------SPEWADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred ccccC------CcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 32211 1122344556788999999999999999999986
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=303.68 Aligned_cols=251 Identities=26% Similarity=0.429 Sum_probs=193.3
Q ss_pred hhhCcccceeEEEeEeeCC--CCcEEEEEEeccc-chhhHHHHHHHHHHHhccCcccccceeceEe-cCCeeeEEEeecC
Q 041576 426 EELGRGSFGIVYKGVLKSA--SGNAVAVKKLDKL-AQEREREFKTEVSAIGRTHHKNLVQLLGFCD-EGLNRLLVYEFMG 501 (714)
Q Consensus 426 ~~ig~G~~g~Vy~~~~~~~--~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~-~~~~~~lv~E~~~ 501 (714)
+.||+|+||.||+|.+... ....||+|.+... .....+.+.+|+.+++.++||||+++++++. .+...++++||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 4689999999999986532 3457999998643 3344568889999999999999999999875 4556789999999
Q ss_pred CCchhhhhhcC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCccc---
Q 041576 502 NGTLANLLFAI-PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSR--- 577 (714)
Q Consensus 502 ~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~--- 577 (714)
+++|.+++... ...++..+..++.||++||+|||+.+ ++||||||+||++++++.+||+|||++.........
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 157 (262)
T cd05058 81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH 157 (262)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence 99999999764 34677888999999999999999987 999999999999999999999999999765332211
Q ss_pred ceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcC-CCCcccccchhhhhhhHHHhhhhhcCccceeecchhh
Q 041576 578 TRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCK-RSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKA 656 (714)
Q Consensus 578 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~-~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 656 (714)
......++..|+|||.+.+..++.++||||||+++|||++|. .|+....... +... ...+...
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~----~~~~----~~~~~~~-------- 221 (262)
T cd05058 158 NHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFD----ITVY----LLQGRRL-------- 221 (262)
T ss_pred ccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHH----HHHH----HhcCCCC--------
Confidence 111234567899999998889999999999999999999964 4554322111 1110 1111000
Q ss_pred hccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 041576 657 AMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYL 696 (714)
Q Consensus 657 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 696 (714)
..+...+..+.+++.+||+.+|++||++.||++.|+++.
T Consensus 222 -~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 222 -LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred -CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 001112346788999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=339.10 Aligned_cols=259 Identities=23% Similarity=0.323 Sum_probs=202.8
Q ss_pred hhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEE
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA---QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVY 497 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 497 (714)
.|.+.++||+|+||.||+|... .+++.||+|+++... ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus 3 rYeIi~~LGkGgfG~VYlA~d~-~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 3 RYDIIRLIGKGGMGEVYLAYDP-VCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CeEEEEEEecCCCEEEEEEEEC-CCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 4667789999999999999875 468899999997532 233567899999999999999999999999999999999
Q ss_pred eecCCCchhhhhhcC-----------CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCC
Q 041576 498 EFMGNGTLANLLFAI-----------PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFG 566 (714)
Q Consensus 498 E~~~~gsL~~~l~~~-----------~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg 566 (714)
||+++++|.+++... ...++..+++++.||++||+|||+.+ |+||||||+||+++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 999999999998642 23456678899999999999999998 9999999999999999999999999
Q ss_pred CccccccCcc-----------------cceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccch
Q 041576 567 LSKLLLSDQS-----------------RTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEE 629 (714)
Q Consensus 567 ~~~~~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~ 629 (714)
+++....... .......||+.|+|||.+.+..++.++|||||||++|||+||+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9986621110 01112458999999999999999999999999999999999999997532221
Q ss_pred hhhhhhHHHhhhhhcCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHhcccCC
Q 041576 630 RSAILTDWAYDCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRP-AMKMIVQMLEGYLEV 698 (714)
Q Consensus 630 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~~~~~ 698 (714)
. . ... .. ..+.. .......+..+.+++.+||+.||++|| +++++++.|+..++.
T Consensus 239 i---~----~~~----~i---~~P~~-~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~ 293 (932)
T PRK13184 239 I---S----YRD----VI---LSPIE-VAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG 293 (932)
T ss_pred h---h----hhh----hc---cChhh-ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 1 0 000 00 00000 000112334677899999999999995 678888888876654
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=303.29 Aligned_cols=250 Identities=28% Similarity=0.459 Sum_probs=200.4
Q ss_pred hhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEeec
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEFM 500 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~ 500 (714)
.+.+.+.||+|+||.||+|.+. .+..+++|.++... .....+.+|++++++++||||+++++++......++||||+
T Consensus 5 ~~~~~~~ig~g~~g~v~~~~~~--~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (256)
T cd05112 5 ELTLVQEIGSGQFGLVWLGYWL--EKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFM 81 (256)
T ss_pred HeEEEeeecCcccceEEEEEEe--CCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcC
Confidence 4566789999999999999875 46789999986532 23457889999999999999999999999999999999999
Q ss_pred CCCchhhhhhcC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcccce
Q 041576 501 GNGTLANLLFAI-PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTR 579 (714)
Q Consensus 501 ~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 579 (714)
++++|.+++... ..++++.+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++...........
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~ 158 (256)
T cd05112 82 EHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSS 158 (256)
T ss_pred CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCccccc
Confidence 999999999764 45789999999999999999999998 99999999999999999999999999876543322222
Q ss_pred eeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhhc
Q 041576 580 TVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAM 658 (714)
Q Consensus 580 ~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 658 (714)
....++.+|+|||.+.+..++.++||||||+++|||++ |+.||........... ...+. ....
T Consensus 159 ~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~--------~~~~~--~~~~------ 222 (256)
T cd05112 159 TGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVET--------INAGF--RLYK------ 222 (256)
T ss_pred CCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHH--------HhCCC--CCCC------
Confidence 22334678999999998889999999999999999998 8999864432221110 11110 0000
Q ss_pred cchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 041576 659 ADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLE 693 (714)
Q Consensus 659 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 693 (714)
+...+..+.+++.+||+.+|++||++.|+++.|.
T Consensus 223 -~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 223 -PRLASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred -CCCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 1112356888999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=305.76 Aligned_cols=241 Identities=24% Similarity=0.397 Sum_probs=190.8
Q ss_pred hhhCcccceeEEEeEeeCC------CCcEEEEEEecccchhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEee
Q 041576 426 EELGRGSFGIVYKGVLKSA------SGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEF 499 (714)
Q Consensus 426 ~~ig~G~~g~Vy~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~ 499 (714)
+.||+|+||.||+|..+.. ....|++|.+........+.+.+|+.++++++||||+++++++..+...++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 4699999999999987522 1235888888765555567889999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCC-CCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCc--------eEEecCCCccc
Q 041576 500 MGNGTLANLLFAIP-RPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFT--------AKISDFGLSKL 570 (714)
Q Consensus 500 ~~~gsL~~~l~~~~-~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~--------~kl~Dfg~~~~ 570 (714)
+++|+|.+++.... .+++..++.++.||+.||+|||+.+ |+||||||+||+++.++. ++++|||++..
T Consensus 81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 99999999997654 5789999999999999999999998 999999999999987765 69999998865
Q ss_pred cccCcccceeeecCCCCccCcccccCC-CCCchhhhHHHHHHHHHHHhcC-CCCcccccchhhhhhhHHHhhhhhcCccc
Q 041576 571 LLSDQSRTRTVIRGTRGYVAPEWFKNV-PVSAKVDVYSFGVVLLKIICCK-RSVEMELGEERSAILTDWAYDCYVEGKLD 648 (714)
Q Consensus 571 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~-~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 648 (714)
.... ....++..|+|||.+.+. .++.++||||||+++|||++|. .|+.......... ......
T Consensus 158 ~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~---------~~~~~~- 222 (258)
T cd05078 158 VLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ---------FYEDRH- 222 (258)
T ss_pred cCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH---------HHHccc-
Confidence 4321 224577889999999864 5799999999999999999995 5544322211100 000000
Q ss_pred eeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 041576 649 VLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLE 693 (714)
Q Consensus 649 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 693 (714)
..+.....++.+++.+||+.||++|||++++++.|+
T Consensus 223 ---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 223 ---------QLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred ---------cCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 011122346788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=305.90 Aligned_cols=255 Identities=27% Similarity=0.375 Sum_probs=202.6
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCC----CCcEEEEEEecccchh-hHHHHHHHHHHHhccCcccccceeceEecCCeee
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSA----SGNAVAVKKLDKLAQE-REREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRL 494 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 494 (714)
..+...+.||+|+||.||+|+.+.. ..+.|++|.+...... ....+.+|++++++++|+||+++++++.+....+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 3445567899999999999987532 3467999988654433 4568999999999999999999999999999999
Q ss_pred EEEeecCCCchhhhhhcCC---------CCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecC
Q 041576 495 LVYEFMGNGTLANLLFAIP---------RPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDF 565 (714)
Q Consensus 495 lv~E~~~~gsL~~~l~~~~---------~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Df 565 (714)
+||||+++++|.+++.... .+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.++|+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 9999999999999997655 6889999999999999999999998 999999999999999999999999
Q ss_pred CCccccccCcccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccchhhhhhhHHHhhhhhc
Q 041576 566 GLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEERSAILTDWAYDCYVE 644 (714)
Q Consensus 566 g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~ 644 (714)
|++...............++..|+|||.+.+...+.++||||||+++|+|++ |..||....... ... ....
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~---~~~-----~~~~ 233 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE---VLN-----RLQA 233 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH---HHH-----HHHc
Confidence 9987543332222223345678999999988889999999999999999999 778885432221 111 1111
Q ss_pred CccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 041576 645 GKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLE 693 (714)
Q Consensus 645 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 693 (714)
+..... .....+..+.+++.+||+.+|++||++.|+++.|.
T Consensus 234 ~~~~~~--------~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 234 GKLELP--------VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CCcCCC--------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 111110 11123357888999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=316.86 Aligned_cols=254 Identities=19% Similarity=0.218 Sum_probs=197.9
Q ss_pred hhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEeccc---chhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEE
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKL---AQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVY 497 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 497 (714)
.|.+.+.||+|+||.||+++.. .+++.||+|.+.+. .......+.+|..++..++|+||+++++++.+++..++||
T Consensus 2 ~y~i~~~lG~G~fg~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 2 DFEIIKVIGRGAFGEVAVVKMK-HTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CceEEEEEeeCCCeEEEEEEEC-CCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 3567789999999999999876 56889999998652 2233456888999999999999999999999999999999
Q ss_pred eecCCCchhhhhhc-CCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcc
Q 041576 498 EFMGNGTLANLLFA-IPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQS 576 (714)
Q Consensus 498 E~~~~gsL~~~l~~-~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 576 (714)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++........
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 157 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT 157 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCCCc
Confidence 99999999999986 457889999999999999999999998 99999999999999999999999999987654433
Q ss_pred cceeeecCCCCccCcccccC-----CCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceee
Q 041576 577 RTRTVIRGTRGYVAPEWFKN-----VPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLV 651 (714)
Q Consensus 577 ~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 651 (714)
.......|+..|+|||.+.+ ..++.++||||||+++|||++|+.||......+....+ ........+
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i--------~~~~~~~~~ 229 (331)
T cd05624 158 VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI--------MNHEERFQF 229 (331)
T ss_pred eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHH--------HcCCCcccC
Confidence 33334568999999999875 46788999999999999999999999754322211111 010000000
Q ss_pred cchhhhccchHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 041576 652 DNDKAAMADKSRACKWLMIALWCIQEDPLK--RPAMKMIVQM 691 (714)
Q Consensus 652 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~ 691 (714)
... ....+..+.+++.+||..++++ |++++++++.
T Consensus 230 p~~-----~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 230 PSH-----ITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred CCc-----cccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 000 0112356777888988866544 4688888754
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=327.83 Aligned_cols=260 Identities=23% Similarity=0.308 Sum_probs=191.3
Q ss_pred hhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCcccccceeceEecC--------Ce
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEG--------LN 492 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--------~~ 492 (714)
.|.+.+.||+|+||.||+|+.. .+++.||||++.... ....+|+.++++++||||+++++++... ..
T Consensus 67 ~y~~~~~LG~G~fg~Vy~~~~~-~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 141 (440)
T PTZ00036 67 SYKLGNIIGNGSFGVVYEAICI-DTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIF 141 (440)
T ss_pred eEEEeEEEEeCCCEEEEEEEEC-CCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceE
Confidence 4677889999999999999876 468899999885432 2345799999999999999999876332 23
Q ss_pred eeEEEeecCCCchhhhhh----cCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCC-ceEEecCCC
Q 041576 493 RLLVYEFMGNGTLANLLF----AIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDF-TAKISDFGL 567 (714)
Q Consensus 493 ~~lv~E~~~~gsL~~~l~----~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~-~~kl~Dfg~ 567 (714)
.++||||+++ +|.+++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||+
T Consensus 142 l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DFGl 217 (440)
T PTZ00036 142 LNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGS 217 (440)
T ss_pred EEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeecccc
Confidence 5689999986 6766654 3456889999999999999999999998 99999999999999665 799999999
Q ss_pred ccccccCcccceeeecCCCCccCcccccCC-CCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHH----hhh-
Q 041576 568 SKLLLSDQSRTRTVIRGTRGYVAPEWFKNV-PVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWA----YDC- 641 (714)
Q Consensus 568 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~----~~~- 641 (714)
++.+..... .....+++.|+|||++.+. .++.++|||||||++|||++|.+||......+....+.... ...
T Consensus 218 a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~ 295 (440)
T PTZ00036 218 AKNLLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQL 295 (440)
T ss_pred chhccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 986643222 2234578999999998654 68999999999999999999999997654332211111100 000
Q ss_pred ------hhcCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 642 ------YVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 642 ------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
+..-..............+...+.++.+++.+||+.||.+|||+.|+++.
T Consensus 296 ~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 296 KEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred HHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 00000011111111111222334578899999999999999999999853
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=301.78 Aligned_cols=239 Identities=26% Similarity=0.411 Sum_probs=190.8
Q ss_pred hhhCcccceeEEEeEeeCCCC---------cEEEEEEecccchhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEE
Q 041576 426 EELGRGSFGIVYKGVLKSASG---------NAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLV 496 (714)
Q Consensus 426 ~~ig~G~~g~Vy~~~~~~~~~---------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 496 (714)
+.||+|+||.||+|.+..... ..+++|.+...... ...+.+|+.++++++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 468999999999999874321 35788877654333 6788999999999999999999999988 778999
Q ss_pred EeecCCCchhhhhhcCC-CCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCC-------ceEEecCCCc
Q 041576 497 YEFMGNGTLANLLFAIP-RPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDF-------TAKISDFGLS 568 (714)
Q Consensus 497 ~E~~~~gsL~~~l~~~~-~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~-------~~kl~Dfg~~ 568 (714)
|||+++++|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+||+++.++ .+||+|||++
T Consensus 79 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 79 EEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred EEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence 99999999999998765 7899999999999999999999988 99999999999999888 7999999999
Q ss_pred cccccCcccceeeecCCCCccCcccccCC--CCCchhhhHHHHHHHHHHHh-cCCCCcccccchhhhhhhHHHhhhhhcC
Q 041576 569 KLLLSDQSRTRTVIRGTRGYVAPEWFKNV--PVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEERSAILTDWAYDCYVEG 645 (714)
Q Consensus 569 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~ 645 (714)
..... .....++..|+|||.+.+. .++.++||||||+++|||++ |..|+.......... .+ ...
T Consensus 156 ~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~---~~-----~~~ 222 (259)
T cd05037 156 ITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKER---FY-----QDQ 222 (259)
T ss_pred ccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHH---HH-----hcC
Confidence 86533 1223466789999999876 78999999999999999999 466665443211100 00 000
Q ss_pred ccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 041576 646 KLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLE 693 (714)
Q Consensus 646 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 693 (714)
. . .+......+.+++.+||+.+|.+|||+.||++.|+
T Consensus 223 ~--~---------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 223 H--R---------LPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred C--C---------CCCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0 0 00111157788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=301.00 Aligned_cols=247 Identities=27% Similarity=0.389 Sum_probs=198.2
Q ss_pred hhhCcccceeEEEeEeeCCCCcEEEEEEecccchh-hHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEeecCCCc
Q 041576 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQE-REREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEFMGNGT 504 (714)
Q Consensus 426 ~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~gs 504 (714)
++||+|++|.||++... .++.|++|.++..... ....+.+|++++++++|+||+++++++.+....++||||+++++
T Consensus 1 ~~lg~g~~g~v~~~~~~--~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~ 78 (251)
T cd05041 1 EKIGKGNFGDVYKGVLK--GNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGS 78 (251)
T ss_pred CccccCCCceEEEEEEe--CCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCc
Confidence 46999999999999876 2889999998764433 55689999999999999999999999999999999999999999
Q ss_pred hhhhhhcC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcccce-eee
Q 041576 505 LANLLFAI-PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTR-TVI 582 (714)
Q Consensus 505 L~~~l~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~-~~~ 582 (714)
|.+++... ..+++.....++.+++.||+|||+++ ++||||+|+||+++.++.+||+|||++........... ...
T Consensus 79 l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (251)
T cd05041 79 LLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK 155 (251)
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence 99999653 45788899999999999999999998 99999999999999999999999999976542211111 112
Q ss_pred cCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhhccch
Q 041576 583 RGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMADK 661 (714)
Q Consensus 583 ~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 661 (714)
..+..|+|||.+.+..++.++||||||+++|||++ |..||...........+ .... ....+.
T Consensus 156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~--------~~~~---------~~~~~~ 218 (251)
T cd05041 156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERI--------ESGY---------RMPAPQ 218 (251)
T ss_pred cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHH--------hcCC---------CCCCCc
Confidence 23567999999998899999999999999999999 78888654322211110 0000 000112
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 041576 662 SRACKWLMIALWCIQEDPLKRPAMKMIVQMLEG 694 (714)
Q Consensus 662 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 694 (714)
..+..+.+++.+||+.+|++||++.||++.|+.
T Consensus 219 ~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~ 251 (251)
T cd05041 219 LCPEEIYRLMLQCWAYDPENRPSFSEIYNELQI 251 (251)
T ss_pred cCCHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence 234578889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=308.43 Aligned_cols=264 Identities=23% Similarity=0.276 Sum_probs=199.7
Q ss_pred hhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchh-----hHHHHHHHHHHHhccCcccccceeceEecCCeeeEE
Q 041576 422 NGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQE-----REREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLV 496 (714)
Q Consensus 422 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 496 (714)
|.+.+.||+|++|.||+|... .+++.|++|.++..... ....+.+|++++++++|+||+++++++.+.+..++|
T Consensus 2 y~~~~~lg~g~~~~vy~~~~~-~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 2 YEKGKKLGEGTYAVVYKARDK-ETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred ceeeeeeeeccccEEEEEEEC-CCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 456688999999999999976 45889999999754322 345678899999999999999999999999999999
Q ss_pred EeecCCCchhhhhhcCC-CCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCc
Q 041576 497 YEFMGNGTLANLLFAIP-RPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQ 575 (714)
Q Consensus 497 ~E~~~~gsL~~~l~~~~-~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 575 (714)
|||+ +++|.+++.... .+++..+..++.||++||+|||+++ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 156 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN 156 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccCCC
Confidence 9999 889999998765 7899999999999999999999998 9999999999999999999999999998764432
Q ss_pred ccceeeecCCCCccCcccccC-CCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHh----hhhhc-Cccce
Q 041576 576 SRTRTVIRGTRGYVAPEWFKN-VPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAY----DCYVE-GKLDV 649 (714)
Q Consensus 576 ~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~----~~~~~-~~~~~ 649 (714)
. ......++..|+|||.+.+ ..++.++||||||+++|||++|..+|...........+..... ..+.. .....
T Consensus 157 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (298)
T cd07841 157 R-KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPD 235 (298)
T ss_pred c-cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccc
Confidence 2 1122345778999998854 4678999999999999999999887765433221111100000 00000 00000
Q ss_pred eec-----chhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 650 LVD-----NDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 650 ~~~-----~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
... ..............+.+++.+||+.||++|||++||++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 236 YVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred cccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 000 000000112234678899999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=309.43 Aligned_cols=250 Identities=24% Similarity=0.352 Sum_probs=203.4
Q ss_pred hhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEeec
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEFM 500 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~ 500 (714)
+|.+.+.||.|++|.||+|+.. .+++.|++|.+........+.+.+|+.+++.++||||+++++++..++..++|+||+
T Consensus 20 ~y~~~~~lg~g~~g~vy~~~~~-~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 20 KYTRYEKIGQGASGTVFTAIDV-ATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred eEEEEEEEecCCCeEEEEEEEc-CCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 3556688999999999999865 578899999997655555678899999999999999999999999999999999999
Q ss_pred CCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCccccee
Q 041576 501 GNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRT 580 (714)
Q Consensus 501 ~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 580 (714)
++++|.+++.. ..+++.++..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++......... ..
T Consensus 99 ~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~-~~ 173 (296)
T cd06655 99 AGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK-RS 173 (296)
T ss_pred CCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhccccccc-CC
Confidence 99999999875 46899999999999999999999998 999999999999999999999999998765433221 22
Q ss_pred eecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhhccc
Q 041576 581 VIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMAD 660 (714)
Q Consensus 581 ~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 660 (714)
...++..|+|||.+.+..++.++|||||||++|+|++|+.||...........+ ........ ..+
T Consensus 174 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~--------~~~~~~~~-------~~~ 238 (296)
T cd06655 174 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI--------ATNGTPEL-------QNP 238 (296)
T ss_pred CcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--------HhcCCccc-------CCc
Confidence 345788999999999888999999999999999999999999754332211000 00000000 011
Q ss_pred hHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 661 KSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 661 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
......+.+++.+||+.||++||++.+|++.
T Consensus 239 ~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 239 EKLSPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred ccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 2233467789999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=305.84 Aligned_cols=259 Identities=25% Similarity=0.331 Sum_probs=204.9
Q ss_pred HHhhhhhhhhCcccceeEEEeEeeCCCC---cEEEEEEecccc-hhhHHHHHHHHHHHhccCcccccceeceEecCCeee
Q 041576 419 EATNGFEEELGRGSFGIVYKGVLKSASG---NAVAVKKLDKLA-QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRL 494 (714)
Q Consensus 419 ~at~~~~~~ig~G~~g~Vy~~~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 494 (714)
...+.+.+.||+|+||.||+|..+.... ..+++|.+.... ......+.+|+..+++++||||+++++++.. ...+
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 84 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ 84 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence 3456777999999999999998763221 268999886543 3445688999999999999999999999987 7889
Q ss_pred EEEeecCCCchhhhhhcC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCcccccc
Q 041576 495 LVYEFMGNGTLANLLFAI-PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLS 573 (714)
Q Consensus 495 lv~E~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~ 573 (714)
+|+||+++|+|.+++... ..+++..++.++.||+.||+|||+.+ ++|+||||+||++++++.+||+|||+++....
T Consensus 85 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~ 161 (279)
T cd05057 85 LITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLDV 161 (279)
T ss_pred EEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCcccccccC
Confidence 999999999999999764 46899999999999999999999987 99999999999999999999999999987653
Q ss_pred Ccccc-eeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccchhhhhhhHHHhhhhhcCccceee
Q 041576 574 DQSRT-RTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEERSAILTDWAYDCYVEGKLDVLV 651 (714)
Q Consensus 574 ~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 651 (714)
..... .....++..|+|||.+....++.++||||||+++||+++ |+.||......+... ....+...
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~--------~~~~~~~~--- 230 (279)
T cd05057 162 DEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPD--------LLEKGERL--- 230 (279)
T ss_pred cccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHH--------HHhCCCCC---
Confidence 32211 111223568999999988889999999999999999998 999997543322111 11111100
Q ss_pred cchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCC
Q 041576 652 DNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLEV 698 (714)
Q Consensus 652 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 698 (714)
..+......+.+++.+||..+|++||++.++++.|+.+...
T Consensus 231 ------~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05057 231 ------PQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD 271 (279)
T ss_pred ------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence 01111234577899999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=304.98 Aligned_cols=248 Identities=27% Similarity=0.386 Sum_probs=202.9
Q ss_pred hhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc-hhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEee
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA-QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEF 499 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~ 499 (714)
+|.+.+.||.|++|.||+|+.. .+++.|++|.+.... ......+.+|++++++++|+||+++++++.++...++|+||
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDK-RTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEEC-CCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 4667789999999999999976 468899999986543 34456788999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcccce
Q 041576 500 MGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTR 579 (714)
Q Consensus 500 ~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 579 (714)
+++++|.+++... .+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++....... ...
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~~ 155 (274)
T cd06609 81 CGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM-SKR 155 (274)
T ss_pred eCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeecccc-ccc
Confidence 9999999999865 7899999999999999999999998 9999999999999999999999999998765432 122
Q ss_pred eeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhhcc
Q 041576 580 TVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMA 659 (714)
Q Consensus 580 ~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 659 (714)
....++..|+|||.+.+..++.++||||||+++|||++|+.||........ .. .........+.
T Consensus 156 ~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~---~~-----~~~~~~~~~~~-------- 219 (274)
T cd06609 156 NTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRV---LF-----LIPKNNPPSLE-------- 219 (274)
T ss_pred ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHH---HH-----HhhhcCCCCCc--------
Confidence 234578889999999988899999999999999999999999965432211 00 00111111000
Q ss_pred chHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 660 DKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 660 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
....+..+.+++.+||+.+|++||+++++++
T Consensus 220 ~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 220 GNKFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred ccccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 1113456788999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=305.52 Aligned_cols=252 Identities=23% Similarity=0.329 Sum_probs=202.3
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEee
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEF 499 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~ 499 (714)
..|.+.++||+|+||.||+|... .+++.+++|.+........+.+.+|+.++++++||||+++++.+..+...++||||
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~-~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 90 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNK-ETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF 90 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEEC-CCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence 45778899999999999999876 46889999999876666678899999999999999999999999999999999999
Q ss_pred cCCCchhhhhhc-CCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcccc
Q 041576 500 MGNGTLANLLFA-IPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRT 578 (714)
Q Consensus 500 ~~~gsL~~~l~~-~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 578 (714)
+++++|..++.. ...+++..+..++.|+++||+|||+.+ ++||||||+||+++.++.+||+|||++....... ..
T Consensus 91 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~-~~ 166 (292)
T cd06644 91 CPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL-QR 166 (292)
T ss_pred CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceeccccc-cc
Confidence 999999988764 356899999999999999999999988 9999999999999999999999999987543221 12
Q ss_pred eeeecCCCCccCccccc-----CCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecc
Q 041576 579 RTVIRGTRGYVAPEWFK-----NVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDN 653 (714)
Q Consensus 579 ~~~~~gt~~y~aPE~~~-----~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 653 (714)
.....++..|+|||.+. ...++.++||||||+++|||++|+.||........ ... .........
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~---~~~-----~~~~~~~~~--- 235 (292)
T cd06644 167 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV---LLK-----IAKSEPPTL--- 235 (292)
T ss_pred cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHH---HHH-----HhcCCCccC---
Confidence 23345788999999984 34578899999999999999999999865432111 111 111100000
Q ss_pred hhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 654 DKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 654 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
..+......+.+++.+||+.+|++||+++|+++.
T Consensus 236 ----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 236 ----SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred ----CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 0112234467889999999999999999999863
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=305.06 Aligned_cols=251 Identities=24% Similarity=0.340 Sum_probs=203.4
Q ss_pred hhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEeec
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEFM 500 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~ 500 (714)
.|.+.+.||.|++|.||+|... .++..+++|.++.......+.+.+|++++++++||||+++++.+..+...++||||+
T Consensus 6 ~~~i~~~l~~g~~~~v~~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (280)
T cd06611 6 IWEIIGELGDGAFGKVYKAQHK-ETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFC 84 (280)
T ss_pred HHHHHHHhcCCCCceEEEEEEc-CCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeecc
Confidence 4778899999999999999876 468899999997666666778999999999999999999999999999999999999
Q ss_pred CCCchhhhhhcC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcccce
Q 041576 501 GNGTLANLLFAI-PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTR 579 (714)
Q Consensus 501 ~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 579 (714)
++++|.+++... ..+++..+..++.|++.||+|||+.+ |+|+||+|+||+++.++.++|+|||++........ ..
T Consensus 85 ~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~ 160 (280)
T cd06611 85 DGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ-KR 160 (280)
T ss_pred CCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhccccc-cc
Confidence 999999998764 46899999999999999999999998 99999999999999999999999999876533222 22
Q ss_pred eeecCCCCccCccccc-----CCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecch
Q 041576 580 TVIRGTRGYVAPEWFK-----NVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDND 654 (714)
Q Consensus 580 ~~~~gt~~y~aPE~~~-----~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 654 (714)
....++..|+|||.+. ...++.++||||||+++|||++|+.||....... .+... ..+....+
T Consensus 161 ~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~---~~~~~-----~~~~~~~~---- 228 (280)
T cd06611 161 DTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR---VLLKI-----LKSEPPTL---- 228 (280)
T ss_pred ceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH---HHHHH-----hcCCCCCc----
Confidence 3345888999999874 3457889999999999999999999997543221 11111 11110000
Q ss_pred hhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 655 KAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 655 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
..+......+.+++.+||+.+|.+||++.+|++.
T Consensus 229 ---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 229 ---DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred ---CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 0111233467789999999999999999999874
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=308.58 Aligned_cols=250 Identities=24% Similarity=0.355 Sum_probs=203.2
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEee
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEF 499 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~ 499 (714)
.+|.+.+.||+|++|.||+|+.. .+++.||+|.+........+.+.+|+.+++.++|+||+++++++..++..++||||
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDI-ATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEEC-CCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 45667789999999999999865 46889999999765555567789999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcccce
Q 041576 500 MGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTR 579 (714)
Q Consensus 500 ~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 579 (714)
+++++|.+++.. ..+++.++..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++........ ..
T Consensus 98 ~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~-~~ 172 (297)
T cd06656 98 LAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KR 172 (297)
T ss_pred cCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCcc-Cc
Confidence 999999999865 45788899999999999999999998 99999999999999999999999999876543322 12
Q ss_pred eeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhhcc
Q 041576 580 TVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMA 659 (714)
Q Consensus 580 ~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 659 (714)
....++..|+|||.+.+..++.++||||||+++|++++|+.||............ ...+ ......
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~-------~~~~--------~~~~~~ 237 (297)
T cd06656 173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI-------ATNG--------TPELQN 237 (297)
T ss_pred CcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeee-------ccCC--------CCCCCC
Confidence 2345788999999999988999999999999999999999999654322110000 0000 000001
Q ss_pred chHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 660 DKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 660 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
+......+.+++.+||+.+|++||++++|++
T Consensus 238 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 238 PERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1223345778999999999999999999998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=303.35 Aligned_cols=246 Identities=26% Similarity=0.337 Sum_probs=195.8
Q ss_pred hhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEeecCCCch
Q 041576 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEFMGNGTL 505 (714)
Q Consensus 426 ~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~gsL 505 (714)
..||+|+||.||+|.+. .++..|++|.+........+.+.+|++++++++|+||+++++++..++..++|+||+++++|
T Consensus 14 ~~lg~g~~g~v~~~~~~-~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 92 (268)
T cd06624 14 VVLGKGTYGIVYAARDL-STQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSL 92 (268)
T ss_pred EEEecCCceEEEEeEec-CCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCH
Confidence 47999999999999876 46789999999876666677899999999999999999999999999999999999999999
Q ss_pred hhhhhcC-CCC--ChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECC-CCceEEecCCCccccccCcccceee
Q 041576 506 ANLLFAI-PRP--DWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQ-DFTAKISDFGLSKLLLSDQSRTRTV 581 (714)
Q Consensus 506 ~~~l~~~-~~~--~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~-~~~~kl~Dfg~~~~~~~~~~~~~~~ 581 (714)
.+++... ..+ ++..+..++.||++||+|||+.+ |+||||||+||+++. ++.++|+|||++........ ....
T Consensus 93 ~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~-~~~~ 168 (268)
T cd06624 93 SALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP-CTET 168 (268)
T ss_pred HHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheecccCCC-cccc
Confidence 9999764 344 78888899999999999999998 999999999999976 67999999999876533221 1222
Q ss_pred ecCCCCccCcccccCCC--CCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhhcc
Q 041576 582 IRGTRGYVAPEWFKNVP--VSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMA 659 (714)
Q Consensus 582 ~~gt~~y~aPE~~~~~~--~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 659 (714)
..++..|+|||.+.+.. ++.++||||||+++|+|++|+.||......... .+... ... .....
T Consensus 169 ~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~----~~~~~--~~~---------~~~~~ 233 (268)
T cd06624 169 FTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAA----MFKVG--MFK---------IHPEI 233 (268)
T ss_pred CCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhh----Hhhhh--hhc---------cCCCC
Confidence 34788999999986543 789999999999999999999998643211100 00000 000 00011
Q ss_pred chHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 660 DKSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 660 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
+......+.+++.+||+.+|++|||+.|+++.
T Consensus 234 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 234 PESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred CcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 22334567889999999999999999999863
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=307.56 Aligned_cols=249 Identities=25% Similarity=0.298 Sum_probs=198.2
Q ss_pred hhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEe
Q 041576 422 NGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA---QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYE 498 (714)
Q Consensus 422 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E 498 (714)
+...+.||+|+||.||++... .+++.||+|.+.... ......+.+|+.++++++|+||+++++.+.+++..++|||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVR-ATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEc-CCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 445678999999999999876 578899999986432 2233567789999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcC--CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcc
Q 041576 499 FMGNGTLANLLFAI--PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQS 576 (714)
Q Consensus 499 ~~~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 576 (714)
|+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++........
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT 157 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc
Confidence 99999999998643 35788999999999999999999988 99999999999999999999999999876533222
Q ss_pred cceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhh
Q 041576 577 RTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKA 656 (714)
Q Consensus 577 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 656 (714)
.....|+..|+|||.+.+..++.++||||||+++|||++|+.||............... ... ..
T Consensus 158 --~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~-----~~~-~~-------- 221 (285)
T cd05630 158 --IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERL-----VKE-VQ-------- 221 (285)
T ss_pred --ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhh-----hhh-hh--------
Confidence 12235899999999999999999999999999999999999999754322111111000 000 00
Q ss_pred hccchHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 041576 657 AMADKSRACKWLMIALWCIQEDPLKRPA-----MKMIVQ 690 (714)
Q Consensus 657 ~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 690 (714)
..........+.+++.+||+.||++||| ++|+++
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 222 EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred hhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 0011223346778999999999999999 889987
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=314.74 Aligned_cols=254 Identities=21% Similarity=0.236 Sum_probs=197.1
Q ss_pred hhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEeccc---chhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEE
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKL---AQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVY 497 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 497 (714)
.|.+.++||+|+||.||+++.+ .+++.+|+|.+.+. .......+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 2 ~y~~~~~lG~G~fg~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 2 DFEILKVIGRGAFGEVAVVKLK-NADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CceEEEEEEeCCCeEEEEEEEC-CCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 3566789999999999999876 46789999998642 2233445889999999999999999999999999999999
Q ss_pred eecCCCchhhhhhc-CCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcc
Q 041576 498 EFMGNGTLANLLFA-IPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQS 576 (714)
Q Consensus 498 E~~~~gsL~~~l~~-~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 576 (714)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++........
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~ 157 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT 157 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccCCc
Confidence 99999999999976 356889999999999999999999998 99999999999999999999999999976544333
Q ss_pred cceeeecCCCCccCccccc-----CCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceee
Q 041576 577 RTRTVIRGTRGYVAPEWFK-----NVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLV 651 (714)
Q Consensus 577 ~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 651 (714)
.......|++.|+|||++. ...++.++|||||||++|||++|+.||...........+ ........+
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i--------~~~~~~~~~ 229 (332)
T cd05623 158 VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI--------MNHKERFQF 229 (332)
T ss_pred ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHH--------hCCCccccC
Confidence 3333456899999999986 346789999999999999999999999754322211111 111000000
Q ss_pred cchhhhccchHHHHHHHHHHHHccccCCC--CCCCHHHHHHH
Q 041576 652 DNDKAAMADKSRACKWLMIALWCIQEDPL--KRPAMKMIVQM 691 (714)
Q Consensus 652 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~--~RPs~~evl~~ 691 (714)
.. ........+.+++.+|+..+++ .|++++|+++.
T Consensus 230 p~-----~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 230 PA-----QVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred CC-----ccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 00 0112244667788888865444 46899999876
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=306.25 Aligned_cols=265 Identities=22% Similarity=0.298 Sum_probs=202.0
Q ss_pred hhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc--hhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEe
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA--QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYE 498 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E 498 (714)
.|.+.+.||+|++|.||+|..+ .+++.||+|++.... ....+.+.+|++++++++||||+++++++..+...++|||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 2 KYEKLSKIGEGSYGVVFKCRNR-ETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred ceeeeeeecccCCeEEEEEEEC-CCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 3566788999999999999976 468899999886432 2234568899999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcccc
Q 041576 499 FMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRT 578 (714)
Q Consensus 499 ~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 578 (714)
|+++++|..++.....+++..++.++.||++||+|||+.+ ++|+||||+||+++.++.+||+|||++........ .
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-~ 156 (286)
T cd07847 81 YCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPGD-D 156 (286)
T ss_pred ccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCcc-c
Confidence 9999999988877778899999999999999999999988 99999999999999999999999999987644322 1
Q ss_pred eeeecCCCCccCcccccC-CCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhh-------hhcCc-cce
Q 041576 579 RTVIRGTRGYVAPEWFKN-VPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDC-------YVEGK-LDV 649 (714)
Q Consensus 579 ~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~-------~~~~~-~~~ 649 (714)
.....++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+....+....... +.... ...
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T cd07847 157 YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKG 236 (286)
T ss_pred ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccccc
Confidence 222346788999999876 457899999999999999999999997544332211111100000 00000 000
Q ss_pred eecchhhhcc-----chHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 650 LVDNDKAAMA-----DKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 650 ~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
...+...... .......+.+++.+||+.+|++||++.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 237 LSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred ccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 0000000000 0122457888999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=301.99 Aligned_cols=249 Identities=24% Similarity=0.359 Sum_probs=203.5
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc-hhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEe
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA-QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYE 498 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E 498 (714)
..|...+.||.|+||.||+|... .++..||+|.+.... ......+.+|+.++++++||||+++++++.++...++|||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDN-RTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIME 82 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEc-cCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEe
Confidence 45666788999999999999876 467899999986432 3456788999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcccc
Q 041576 499 FMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRT 578 (714)
Q Consensus 499 ~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 578 (714)
|+++++|.+++.. ..+++.+...++.|+++||+|||+.+ ++|+||+|+||+++.++.++|+|||++........ .
T Consensus 83 ~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-~ 157 (277)
T cd06640 83 YLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-K 157 (277)
T ss_pred cCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCcc-c
Confidence 9999999999875 46788899999999999999999988 99999999999999999999999999976643322 2
Q ss_pred eeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhhc
Q 041576 579 RTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAM 658 (714)
Q Consensus 579 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 658 (714)
.....++..|+|||.+.+..++.++||||||+++|||++|+.|+........... .... ....
T Consensus 158 ~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~--------~~~~---------~~~~ 220 (277)
T cd06640 158 RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFL--------IPKN---------NPPT 220 (277)
T ss_pred cccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhh--------hhcC---------CCCC
Confidence 2234578889999999988899999999999999999999999874432211000 0000 0111
Q ss_pred cchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 659 ADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 659 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
.....+..+.+++.+||+.+|++||++.++++.
T Consensus 221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 221 LTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred CchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 223455678889999999999999999999765
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=301.66 Aligned_cols=249 Identities=34% Similarity=0.482 Sum_probs=201.8
Q ss_pred hhhhhCcccceeEEEeEeeCCC---CcEEEEEEecccchh-hHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEee
Q 041576 424 FEEELGRGSFGIVYKGVLKSAS---GNAVAVKKLDKLAQE-REREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEF 499 (714)
Q Consensus 424 ~~~~ig~G~~g~Vy~~~~~~~~---~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~ 499 (714)
+.+.||.|+||.||++...... +..||+|.+...... ..+.+.+|++.+.+++|+||+++++++.+.+..+++|||
T Consensus 3 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~ 82 (258)
T smart00219 3 LGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEY 82 (258)
T ss_pred ccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEec
Confidence 5678999999999999986432 488999999765433 567899999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCC--CChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCccc
Q 041576 500 MGNGTLANLLFAIPR--PDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSR 577 (714)
Q Consensus 500 ~~~gsL~~~l~~~~~--~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 577 (714)
+++++|.+++..... +++..+..++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||++.........
T Consensus 83 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (258)
T smart00219 83 MEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYY 159 (258)
T ss_pred cCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceeccccccc
Confidence 999999999986544 899999999999999999999998 999999999999999999999999999876544322
Q ss_pred ceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhh
Q 041576 578 TRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKA 656 (714)
Q Consensus 578 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 656 (714)
......++..|+|||.+.+..++.++||||+|++++||++ |..||.......... ....+...
T Consensus 160 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~--------~~~~~~~~-------- 223 (258)
T smart00219 160 KKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLE--------YLKKGYRL-------- 223 (258)
T ss_pred ccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH--------HHhcCCCC--------
Confidence 2222336789999999988889999999999999999998 788876432221110 11111110
Q ss_pred hccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 041576 657 AMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQML 692 (714)
Q Consensus 657 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 692 (714)
......+..+.+++.+||+.||++|||+.|+++.|
T Consensus 224 -~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 224 -PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred -CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 01112345688899999999999999999999865
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=301.57 Aligned_cols=248 Identities=21% Similarity=0.304 Sum_probs=201.1
Q ss_pred hhhhhhhCcccceeEEEeEeeCCCCcEEEEEEeccc-chhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEeec
Q 041576 422 NGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKL-AQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEFM 500 (714)
Q Consensus 422 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~ 500 (714)
|.+.+.||+|+||.||++... .+++.+++|.++.. .....+.+.+|+.++++++|+||+++++.+..+...+++|||+
T Consensus 2 y~~~~~lg~g~~g~v~~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 2 YNVLRVVGEGSFGRALLVQHV-NSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred ceEEEEeeccCCeEEEEEEEc-CCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 456789999999999999876 46889999998642 2344567889999999999999999999999999999999999
Q ss_pred CCCchhhhhhcC--CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcccc
Q 041576 501 GNGTLANLLFAI--PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRT 578 (714)
Q Consensus 501 ~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 578 (714)
++++|.+++... ..+++..+..++.||+.||+|||+++ ++|+||||+||++++++.++|+|||.+........ .
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-~ 156 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA-Y 156 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeeccccc-c
Confidence 999999988643 35788999999999999999999998 99999999999999999999999999876543222 2
Q ss_pred eeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhhc
Q 041576 579 RTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAM 658 (714)
Q Consensus 579 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 658 (714)
.....++..|+|||.+.+..++.++||||||+++|+|++|+.||........ .. ....+....
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~---~~-----~~~~~~~~~--------- 219 (255)
T cd08219 157 ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNL---IL-----KVCQGSYKP--------- 219 (255)
T ss_pred cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHH---HH-----HHhcCCCCC---------
Confidence 2234588899999999988899999999999999999999999975432211 10 111111111
Q ss_pred cchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 659 ADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 659 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
.+......+.+++.+||+.||++||++.||+..
T Consensus 220 ~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 220 LPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 112233467789999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=304.77 Aligned_cols=248 Identities=24% Similarity=0.368 Sum_probs=210.1
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEeccc--chhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEE
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKL--AQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVY 497 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 497 (714)
.-|.+.+.||+|.|..|-+|++- -+|..||||++.+. +......+.+|++.|+.++|||||+++++.......|||+
T Consensus 18 GLYDLekTlG~GHFAVVKLArHV-FTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL 96 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHV-FTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL 96 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhh-cccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence 45777899999999999999876 68999999999763 3445568899999999999999999999999999999999
Q ss_pred eecCCCchhhhhhcC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEE-CCCCceEEecCCCccccccCc
Q 041576 498 EFMGNGTLANLLFAI-PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILL-DQDFTAKISDFGLSKLLLSDQ 575 (714)
Q Consensus 498 E~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll-~~~~~~kl~Dfg~~~~~~~~~ 575 (714)
|.-++|+|.++|-.. ..+.+..+.+++.||+.|+.|+|+.. +|||||||+||.+ ..-|-+||.|||++..+.+..
T Consensus 97 ELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~ 173 (864)
T KOG4717|consen 97 ELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK 173 (864)
T ss_pred EecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCCcc
Confidence 999999999999765 56899999999999999999999988 9999999999866 667899999999998765433
Q ss_pred ccceeeecCCCCccCcccccCCCCC-chhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecch
Q 041576 576 SRTRTVIRGTRGYVAPEWFKNVPVS-AKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDND 654 (714)
Q Consensus 576 ~~~~~~~~gt~~y~aPE~~~~~~~s-~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 654 (714)
.....+|+..|.|||++.+..|+ ++.||||||||||.|++|+.||+.....+....+ +|-.
T Consensus 174 --kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmI----------------mDCK 235 (864)
T KOG4717|consen 174 --KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMI----------------MDCK 235 (864)
T ss_pred --hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhh----------------hccc
Confidence 34566799999999999999886 5899999999999999999999866555432222 2211
Q ss_pred hhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 655 KAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 655 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
. ..+.....++.+||..||..||.+|-+.+||+..
T Consensus 236 Y--tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 236 Y--TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred c--cCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence 1 1344556678889999999999999999999864
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=307.67 Aligned_cols=266 Identities=21% Similarity=0.264 Sum_probs=205.1
Q ss_pred hhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEeccc--chhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEe
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKL--AQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYE 498 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E 498 (714)
+|.+.+.||+|++|.||+|..+ .+++.|++|.++.. .....+.+.+|++++++++|+||+++++++..++..++|||
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~-~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNK-ATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeC-CCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 4667789999999999999876 46789999998653 23345688999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcccc
Q 041576 499 FMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRT 578 (714)
Q Consensus 499 ~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 578 (714)
|++++.+..+......+++.++..++.||+.||+|||+.+ ++|+||+|+||++++++.+||+|||++..........
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~ 157 (288)
T cd07833 81 YVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARPASP 157 (288)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCcccc
Confidence 9999888877776677899999999999999999999998 9999999999999999999999999998765544323
Q ss_pred eeeecCCCCccCcccccCC-CCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHh--------hhhhcCc---
Q 041576 579 RTVIRGTRGYVAPEWFKNV-PVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAY--------DCYVEGK--- 646 (714)
Q Consensus 579 ~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~--------~~~~~~~--- 646 (714)
.....++..|+|||++.+. .++.++||||||+++|+|++|+.||......+....+..... .......
T Consensus 158 ~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd07833 158 LTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAG 237 (288)
T ss_pred ccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccc
Confidence 3345578899999999887 789999999999999999999999875433221111100000 0000000
Q ss_pred --cceeecch-hhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 647 --LDVLVDND-KAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 647 --~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
........ .....+...+..+.+++.+||+.+|++||+++++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 238 VAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred cccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 00000000 001112223567889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=306.44 Aligned_cols=246 Identities=27% Similarity=0.391 Sum_probs=199.4
Q ss_pred hhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEeecCCCc
Q 041576 425 EEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEFMGNGT 504 (714)
Q Consensus 425 ~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~gs 504 (714)
...||+|+||.||++... .++..||||.+........+.+.+|+..+++++|+||+++++.+..++..++||||+++++
T Consensus 27 ~~~lg~g~~g~v~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~ 105 (292)
T cd06658 27 FIKIGEGSTGIVCIATEK-HTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGA 105 (292)
T ss_pred hhcccCCCCeEEEEEEEC-CCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCc
Confidence 367999999999999875 4688999999876555666788999999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcccceeeecC
Q 041576 505 LANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRG 584 (714)
Q Consensus 505 L~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g 584 (714)
|.+++.. ..+++.++..++.||+.||+|||+++ |+||||||+||++++++.++|+|||++........ ......+
T Consensus 106 L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~~~~~ 180 (292)
T cd06658 106 LTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-KRKSLVG 180 (292)
T ss_pred HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-cCceeec
Confidence 9998865 46889999999999999999999998 99999999999999999999999999876533222 1223457
Q ss_pred CCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhhccchHHH
Q 041576 585 TRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMADKSRA 664 (714)
Q Consensus 585 t~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 664 (714)
+..|+|||.+.+..++.++||||||+++|||++|+.||........ +.. ... .....+. ......
T Consensus 181 ~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~---~~~-----~~~-~~~~~~~------~~~~~~ 245 (292)
T cd06658 181 TPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQA---MRR-----IRD-NLPPRVK------DSHKVS 245 (292)
T ss_pred CccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHH-----HHh-cCCCccc------cccccC
Confidence 8899999999888899999999999999999999999975432211 100 000 0000000 011223
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 665 CKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 665 ~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
..+..++.+||+.||++|||++|+++.
T Consensus 246 ~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 246 SVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 457779999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=321.36 Aligned_cols=267 Identities=19% Similarity=0.197 Sum_probs=203.1
Q ss_pred HHHHHHhhhhhhhhCcccceeEEEeEeeC-CCCcEEEEEEecccchhhHHHHHHHHHHHhccCcccccceeceEecCCee
Q 041576 415 VELNEATNGFEEELGRGSFGIVYKGVLKS-ASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNR 493 (714)
Q Consensus 415 ~el~~at~~~~~~ig~G~~g~Vy~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 493 (714)
..+...+|.+.+.||+|+||.||++.... ..++.|++|.+... ....+|++++++++||||+++++++......
T Consensus 87 ~~~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~ 161 (392)
T PHA03207 87 ASVVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTV 161 (392)
T ss_pred chhccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEE
Confidence 34445678888999999999999997542 34678999988643 2456899999999999999999999999999
Q ss_pred eEEEeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCcccccc
Q 041576 494 LLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLS 573 (714)
Q Consensus 494 ~lv~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~ 573 (714)
++|||++. ++|.+++.....+++.+++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 162 ~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~ 237 (392)
T PHA03207 162 CMVMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDA 237 (392)
T ss_pred EEEehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCc
Confidence 99999996 588888877778999999999999999999999998 99999999999999999999999999976544
Q ss_pred Ccc-cceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccc----
Q 041576 574 DQS-RTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLD---- 648 (714)
Q Consensus 574 ~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~---- 648 (714)
... .......||..|+|||++.+..++.++|||||||++|||++|+.||...........+..... ........
T Consensus 238 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~-~~~~~~~~~~~~ 316 (392)
T PHA03207 238 HPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIR-CMQVHPLEFPQN 316 (392)
T ss_pred ccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHH-HhccCccccCCc
Confidence 322 222345689999999999999999999999999999999999999975433221111111100 00000000
Q ss_pred -------------eeecchhh---hccchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 649 -------------VLVDNDKA---AMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 649 -------------~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
....+... ..........+.+++.+||+.||++|||+.|++..
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 317 GSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred cchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000000 00001123467789999999999999999999875
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=316.01 Aligned_cols=263 Identities=25% Similarity=0.289 Sum_probs=195.6
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEeccc--chhhHHHHHHHHHHHhccCcccccceeceEecCC------
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKL--AQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGL------ 491 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~------ 491 (714)
..|.+.+.||+|+||.||++... .+++.||+|++... .......+.+|+.+++.++||||+++++++....
T Consensus 21 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 21 KRYQQLKPIGSGAQGIVCAAFDT-VLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hceEEEEEeecCCCEEEEEEEEc-CCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 56777899999999999999875 56889999998643 2344567889999999999999999999986543
Q ss_pred eeeEEEeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCcccc
Q 041576 492 NRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLL 571 (714)
Q Consensus 492 ~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~ 571 (714)
..++||||+++ +|.+.+. ..+++..+..++.||++||+|||+++ |+||||||+||+++.++.+||+|||+++..
T Consensus 100 ~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~ 173 (359)
T cd07876 100 DVYLVMELMDA-NLCQVIH--MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA 173 (359)
T ss_pred eeEEEEeCCCc-CHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCCcccc
Confidence 46899999976 5666554 34788889999999999999999998 999999999999999999999999999754
Q ss_pred ccCcccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHH--------------
Q 041576 572 LSDQSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDW-------------- 637 (714)
Q Consensus 572 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~-------------- 637 (714)
.... ......++..|+|||.+.+..++.++|||||||++|||++|+.||...........+...
T Consensus 174 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (359)
T cd07876 174 CTNF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQP 251 (359)
T ss_pred ccCc--cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHH
Confidence 3222 222345789999999999999999999999999999999999999754322110000000
Q ss_pred HhhhhhcC--cc-----ceeecchh---hhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 638 AYDCYVEG--KL-----DVLVDNDK---AAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 638 ~~~~~~~~--~~-----~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
....+... .. ........ ...........+.+++.+||+.||++|||+.|+++.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 252 TVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00000000 00 00000000 000111223567889999999999999999999984
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=301.99 Aligned_cols=252 Identities=25% Similarity=0.352 Sum_probs=200.8
Q ss_pred hhhhhhhCcccceeEEEeEeeCCCCcEEEEEEeccc----------chhhHHHHHHHHHHHhc-cCcccccceeceEecC
Q 041576 422 NGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKL----------AQEREREFKTEVSAIGR-THHKNLVQLLGFCDEG 490 (714)
Q Consensus 422 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~----------~~~~~~~~~~E~~~l~~-l~h~nIv~l~~~~~~~ 490 (714)
|.+.+.||+|+||.||+|.++..+++.+|+|.+... ......++.+|+.++.+ ++||||+++++++.++
T Consensus 2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 81 (269)
T cd08528 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEN 81 (269)
T ss_pred chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccC
Confidence 556789999999999999987546789999987531 22234567788888875 7999999999999999
Q ss_pred CeeeEEEeecCCCchhhhhhc----CCCCChhhHHHHHHHHHHHHHHHHh-cCCCCeEecCCCcCeEEECCCCceEEecC
Q 041576 491 LNRLLVYEFMGNGTLANLLFA----IPRPDWSLRVRISLEIARGLLYLHE-ECNVPIIHCDIKPQNILLDQDFTAKISDF 565 (714)
Q Consensus 491 ~~~~lv~E~~~~gsL~~~l~~----~~~~~~~~~~~i~~qi~~~L~yLH~-~~~~~ivH~Dlk~~NIll~~~~~~kl~Df 565 (714)
+..+++|||+++++|.+++.. ...+++..++.++.|++.||.|||+ .+ ++|+||+|+||+++.++.+||+||
T Consensus 82 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 82 DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEecc
Confidence 999999999999999988743 3467889999999999999999996 55 999999999999999999999999
Q ss_pred CCccccccCcccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcC
Q 041576 566 GLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEG 645 (714)
Q Consensus 566 g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~ 645 (714)
|.+....... ......++..|+|||.+.+..++.++||||||+++|||++|+.||.......... ...++
T Consensus 159 g~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~--------~~~~~ 228 (269)
T cd08528 159 GLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLAT--------KIVEA 228 (269)
T ss_pred cceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHH--------HHhhc
Confidence 9998654432 2234558889999999998889999999999999999999999986442221110 11111
Q ss_pred ccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 041576 646 KLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEG 694 (714)
Q Consensus 646 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 694 (714)
.... .........+.+++.+||+.||++||++.|+.+++++
T Consensus 229 ~~~~--------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~ 269 (269)
T cd08528 229 VYEP--------LPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD 269 (269)
T ss_pred cCCc--------CCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence 1110 0111234568889999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=308.73 Aligned_cols=265 Identities=24% Similarity=0.316 Sum_probs=201.6
Q ss_pred hhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccch--hhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEe
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQ--EREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYE 498 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E 498 (714)
+|.+.+.||+|++|.||+|.++ .+++.||+|++..... ...+.+.+|++++++++||||+++++++..+...++|+|
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 2 KYENLGLVGEGSYGMVMKCKHK-ETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred ceeEeeeeccCCCeEEEEEEEC-CCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 4567789999999999999976 4688999998864322 234578899999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcccc
Q 041576 499 FMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRT 578 (714)
Q Consensus 499 ~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 578 (714)
|+++++|.++......+++.+++.++.||++||+|||+.+ ++|+||+|+||++++++.++|+|||++........ .
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-~ 156 (286)
T cd07846 81 FVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE-V 156 (286)
T ss_pred cCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc-c
Confidence 9999999988877667899999999999999999999998 99999999999999999999999999886544332 2
Q ss_pred eeeecCCCCccCcccccC-CCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhh-------hhcCc----
Q 041576 579 RTVIRGTRGYVAPEWFKN-VPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDC-------YVEGK---- 646 (714)
Q Consensus 579 ~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~-------~~~~~---- 646 (714)
.....++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+....+....... .....
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T cd07846 157 YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAG 236 (286)
T ss_pred cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhc
Confidence 223457889999999875 457889999999999999999999987543322111111100000 00000
Q ss_pred --cceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 647 --LDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 647 --~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
.................+..+.+++.+||+.+|++||++.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 237 MRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred cccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 00000000000011223467888999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=303.85 Aligned_cols=249 Identities=28% Similarity=0.421 Sum_probs=196.7
Q ss_pred hhhCcccceeEEEeEeeC-----CCCcEEEEEEecccc-hhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEee
Q 041576 426 EELGRGSFGIVYKGVLKS-----ASGNAVAVKKLDKLA-QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEF 499 (714)
Q Consensus 426 ~~ig~G~~g~Vy~~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~ 499 (714)
+.||+|+||.||+|.... ..++.+++|.+.... ......+.+|+.++++++||||+++++++......++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 368999999999998752 123679999886533 34456889999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcC-------CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCC-----ceEEecCCC
Q 041576 500 MGNGTLANLLFAI-------PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDF-----TAKISDFGL 567 (714)
Q Consensus 500 ~~~gsL~~~l~~~-------~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~-----~~kl~Dfg~ 567 (714)
+++++|.+++... ..+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++ .++|+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence 9999999999642 33678899999999999999999988 99999999999999887 899999999
Q ss_pred ccccccCcc-cceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccchhhhhhhHHHhhhhhcC
Q 041576 568 SKLLLSDQS-RTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEERSAILTDWAYDCYVEG 645 (714)
Q Consensus 568 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~ 645 (714)
+........ .......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+.... ...+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~--------~~~~ 229 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQH--------VTAG 229 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHH--------HhcC
Confidence 976533221 11122335678999999999999999999999999999998 9999864332211100 0010
Q ss_pred ccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 041576 646 KLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEG 694 (714)
Q Consensus 646 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 694 (714)
. ....+...+..+.+++.+||+.+|++||++++|++.|++
T Consensus 230 ~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 230 G---------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred C---------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 0 001122234577889999999999999999999999864
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=305.41 Aligned_cols=250 Identities=23% Similarity=0.273 Sum_probs=198.0
Q ss_pred hhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEe
Q 041576 422 NGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA---QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYE 498 (714)
Q Consensus 422 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E 498 (714)
+...+.||+|+||+||+|... .+++.||+|.+.... ......+.+|++++++++|+||+++.+.+..++..++|||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVR-ATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred ceEEEEEecCCCeEEEEEEEC-CCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 344578999999999999876 478899999986532 2233467889999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcC--CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcc
Q 041576 499 FMGNGTLANLLFAI--PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQS 576 (714)
Q Consensus 499 ~~~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 576 (714)
|+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~- 156 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE- 156 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCC-
Confidence 99999999888643 36899999999999999999999998 9999999999999999999999999987653222
Q ss_pred cceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhh
Q 041576 577 RTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKA 656 (714)
Q Consensus 577 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 656 (714)
......|+..|+|||.+.+..++.++||||||+++|||++|+.||...........+. ........
T Consensus 157 -~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~----~~~~~~~~--------- 222 (285)
T cd05632 157 -SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVD----RRVLETEE--------- 222 (285)
T ss_pred -cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH----Hhhhcccc---------
Confidence 1123458999999999998899999999999999999999999997543221111110 00111100
Q ss_pred hccchHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 041576 657 AMADKSRACKWLMIALWCIQEDPLKRPA-----MKMIVQM 691 (714)
Q Consensus 657 ~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~ 691 (714)
.........+.+++..||+.||++||+ +.++++.
T Consensus 223 -~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 223 -VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred -ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 011123345678999999999999999 6777663
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=301.28 Aligned_cols=252 Identities=28% Similarity=0.420 Sum_probs=188.2
Q ss_pred hhhCcccceeEEEeEeeCC-CCcEEEEEEecccc-hhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEeecCCC
Q 041576 426 EELGRGSFGIVYKGVLKSA-SGNAVAVKKLDKLA-QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEFMGNG 503 (714)
Q Consensus 426 ~~ig~G~~g~Vy~~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~g 503 (714)
++||+|+||.||+|..... ....+++|.+.... ......+.+|++.++.++||||+++++.+.+....++||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 3699999999999975422 34578899876432 334567889999999999999999999999999999999999999
Q ss_pred chhhhhhcCC-----CCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCccc-
Q 041576 504 TLANLLFAIP-----RPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSR- 577 (714)
Q Consensus 504 sL~~~l~~~~-----~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~- 577 (714)
+|.+++.... ..++.....++.||+.||+|||+.+ |+||||||+||++++++.+||+|||++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 9999997643 2357778899999999999999998 999999999999999999999999998754332211
Q ss_pred ceeeecCCCCccCcccccC-------CCCCchhhhHHHHHHHHHHHh-cCCCCcccccchhhhhhhHHHhhhhhcCccce
Q 041576 578 TRTVIRGTRGYVAPEWFKN-------VPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEERSAILTDWAYDCYVEGKLDV 649 (714)
Q Consensus 578 ~~~~~~gt~~y~aPE~~~~-------~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 649 (714)
......++..|+|||++.. ..++.++||||||+++|||++ |..||......+ .+.. ...... ..
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~---~~~~----~~~~~~-~~ 229 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ---VLKQ----VVREQD-IK 229 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH---HHHH----HhhccC-cc
Confidence 1122335677999998743 356889999999999999999 777876432221 1111 011111 11
Q ss_pred eecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 041576 650 LVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLE 693 (714)
Q Consensus 650 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 693 (714)
+..+. ........+.+++..|+ .||++|||++||++.|.
T Consensus 230 ~~~~~----~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 230 LPKPQ----LDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCCCc----ccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 11111 11223345566778887 59999999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=301.70 Aligned_cols=249 Identities=24% Similarity=0.371 Sum_probs=199.3
Q ss_pred hhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc------hhhHHHHHHHHHHHhccCcccccceeceEecCCeeeE
Q 041576 422 NGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA------QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLL 495 (714)
Q Consensus 422 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 495 (714)
+...+.||+|+||.||+|... +++.+|+|.++... ......+.+|++++++++|+||+++++++.+....++
T Consensus 2 ~~~~~~ig~g~~~~v~~~~~~--~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (265)
T cd06631 2 WTKGEVLGKGAYGTVYCGLTN--QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI 79 (265)
T ss_pred ccccceEeccCCeEEEEEEEc--CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence 345678999999999999764 68899999886321 2234568899999999999999999999999999999
Q ss_pred EEeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCc
Q 041576 496 VYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQ 575 (714)
Q Consensus 496 v~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 575 (714)
++||+++++|.+++.....+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 156 (265)
T cd06631 80 FMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVG 156 (265)
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhhcc
Confidence 9999999999999988778889999999999999999999988 9999999999999999999999999987653211
Q ss_pred -----ccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCcccee
Q 041576 576 -----SRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVL 650 (714)
Q Consensus 576 -----~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 650 (714)
........++..|+|||.+.+..++.++||||||+++|||++|+.||............ ........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~------~~~~~~~~-- 228 (265)
T cd06631 157 LHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYI------GAHRGLMP-- 228 (265)
T ss_pred ccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHh------hhccCCCC--
Confidence 11122345788999999999988999999999999999999999999643221110000 00000000
Q ss_pred ecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 651 VDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 651 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
..+......+.+++.+||+.+|++||++.|+++
T Consensus 229 -------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 229 -------RLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred -------CCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 112234456788999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=318.59 Aligned_cols=241 Identities=26% Similarity=0.282 Sum_probs=189.4
Q ss_pred hCcccceeEEEeEeeCCCCcEEEEEEecccch---hhHHHHHHHHHHHhcc---CcccccceeceEecCCeeeEEEeecC
Q 041576 428 LGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQ---EREREFKTEVSAIGRT---HHKNLVQLLGFCDEGLNRLLVYEFMG 501 (714)
Q Consensus 428 ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l---~h~nIv~l~~~~~~~~~~~lv~E~~~ 501 (714)
||+|+||+||+|+.. .+++.||||++..... .....+..|..++.+. +||||+++++.+.+....++||||++
T Consensus 1 lG~G~~g~Vy~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~ 79 (330)
T cd05586 1 IGKGTFGQVYQVRKK-DTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMS 79 (330)
T ss_pred CCCCCceEEEEEEEC-CCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCC
Confidence 799999999999876 5688999999965322 2233455666666655 79999999999999999999999999
Q ss_pred CCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcccceee
Q 041576 502 NGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTV 581 (714)
Q Consensus 502 ~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 581 (714)
+++|.+++.....+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||++....... .....
T Consensus 80 ~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~-~~~~~ 155 (330)
T cd05586 80 GGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDN-KTTNT 155 (330)
T ss_pred CChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-CCccC
Confidence 9999999988888999999999999999999999998 9999999999999999999999999987543222 12234
Q ss_pred ecCCCCccCcccccCC-CCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhhccc
Q 041576 582 IRGTRGYVAPEWFKNV-PVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMAD 660 (714)
Q Consensus 582 ~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 660 (714)
..|+..|+|||.+.+. .++.++|||||||++|||++|+.||......... .....+... + ..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~--------~~i~~~~~~-~--------~~ 218 (330)
T cd05586 156 FCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMY--------RNIAFGKVR-F--------PK 218 (330)
T ss_pred ccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHH--------HHHHcCCCC-C--------CC
Confidence 5689999999998764 4799999999999999999999999754322211 111111110 0 01
Q ss_pred hHHHHHHHHHHHHccccCCCCCC----CHHHHHH
Q 041576 661 KSRACKWLMIALWCIQEDPLKRP----AMKMIVQ 690 (714)
Q Consensus 661 ~~~~~~l~~li~~cl~~dP~~RP----s~~evl~ 690 (714)
......+.+++.+||+.||.+|| ++.++++
T Consensus 219 ~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 219 NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 11234667799999999999998 5666655
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=303.11 Aligned_cols=249 Identities=26% Similarity=0.376 Sum_probs=196.3
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhcc-CcccccceeceEecC------Ce
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRT-HHKNLVQLLGFCDEG------LN 492 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~------~~ 492 (714)
..|.+.+.||+|+||.||+|... .+++.||+|.+.... .....+..|+.++.++ +|+||+++++++... ..
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~-~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~ 83 (272)
T cd06637 6 GIFELVELVGNGTYGQVYKGRHV-KTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ 83 (272)
T ss_pred hhhhHHHheeecCCeEEEEEEEc-CCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcE
Confidence 45667789999999999999876 568899999986533 3446788999999998 799999999998653 45
Q ss_pred eeEEEeecCCCchhhhhhcC--CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccc
Q 041576 493 RLLVYEFMGNGTLANLLFAI--PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKL 570 (714)
Q Consensus 493 ~~lv~E~~~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~ 570 (714)
.+++|||+++++|.+++... ..+++..+..++.|++.||+|||+++ |+|+||||+||++++++.++|+|||++..
T Consensus 84 ~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~~~~ 160 (272)
T cd06637 84 LWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQ 160 (272)
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCCcee
Confidence 78999999999999999864 35788999999999999999999998 99999999999999999999999999876
Q ss_pred cccCcccceeeecCCCCccCccccc-----CCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcC
Q 041576 571 LLSDQSRTRTVIRGTRGYVAPEWFK-----NVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEG 645 (714)
Q Consensus 571 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~ 645 (714)
..... .......|+..|+|||++. +..++.++|||||||++|||++|+.||........... ....
T Consensus 161 ~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~--------~~~~ 231 (272)
T cd06637 161 LDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFL--------IPRN 231 (272)
T ss_pred ccccc-ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHH--------HhcC
Confidence 53322 2223456888999999986 34578899999999999999999999964322211100 0000
Q ss_pred ccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 646 KLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 646 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
.... ......+..+.+++.+||+.+|.+|||+.|+++
T Consensus 232 ~~~~--------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 232 PAPR--------LKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred CCCC--------CCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 0000 011123346788999999999999999999975
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=309.71 Aligned_cols=195 Identities=21% Similarity=0.357 Sum_probs=159.9
Q ss_pred hhhhCcccceeEEEeEeeC-CCCcEEEEEEecccchhhHHHHHHHHHHHhccCcccccceeceEec--CCeeeEEEeecC
Q 041576 425 EEELGRGSFGIVYKGVLKS-ASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCDE--GLNRLLVYEFMG 501 (714)
Q Consensus 425 ~~~ig~G~~g~Vy~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--~~~~~lv~E~~~ 501 (714)
.++||+|+||.||+|+.+. .+++.||+|.+.... ....+.+|++++++++||||+++++++.. +...+++|||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 3689999999999998753 356789999986532 23457889999999999999999998854 456789999987
Q ss_pred CCchhhhhhcC---------CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEE----CCCCceEEecCCCc
Q 041576 502 NGTLANLLFAI---------PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILL----DQDFTAKISDFGLS 568 (714)
Q Consensus 502 ~gsL~~~l~~~---------~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll----~~~~~~kl~Dfg~~ 568 (714)
+ +|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||+ +.++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 5 787776421 24788889999999999999999998 9999999999999 45678999999999
Q ss_pred cccccCcc--cceeeecCCCCccCcccccCC-CCCchhhhHHHHHHHHHHHhcCCCCccc
Q 041576 569 KLLLSDQS--RTRTVIRGTRGYVAPEWFKNV-PVSAKVDVYSFGVVLLKIICCKRSVEME 625 (714)
Q Consensus 569 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~p~~~~ 625 (714)
+....... .......+|..|+|||++.+. .++.++||||+||++|||++|+.||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 87643321 122345689999999998764 5899999999999999999999999643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=316.99 Aligned_cols=246 Identities=26% Similarity=0.371 Sum_probs=201.0
Q ss_pred hhhhhCcccceeEEEeEeeCCCCcEEEEEEec--c--cchhhHHHHHHHHHHHhccCcccccceeceEecCCe--eeEEE
Q 041576 424 FEEELGRGSFGIVYKGVLKSASGNAVAVKKLD--K--LAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLN--RLLVY 497 (714)
Q Consensus 424 ~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~--~--~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~--~~lv~ 497 (714)
|.++||+|+|-+||+|.+. ..|..||--.++ + ......+.|..|+++|+.|+||||++++.++.+... .-+|+
T Consensus 44 ~~evLGrGafKtVYka~De-~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDE-EEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred hhhhcccccceeeeecccc-ccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 5678999999999999875 577788754432 2 234445889999999999999999999999977665 67899
Q ss_pred eecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECC-CCceEEecCCCccccccCcc
Q 041576 498 EFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQ-DFTAKISDFGLSKLLLSDQS 576 (714)
Q Consensus 498 E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~-~~~~kl~Dfg~~~~~~~~~~ 576 (714)
|.+..|+|..++...++.+.+....|+.||++||.|||++. +||||||||.+||+|+. .|.+||+|+|+|........
T Consensus 123 EL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~a 201 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSHA 201 (632)
T ss_pred ecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhcccc
Confidence 99999999999999999999999999999999999999985 89999999999999976 48999999999998754333
Q ss_pred cceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhh
Q 041576 577 RTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKA 656 (714)
Q Consensus 577 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 656 (714)
..+.||+.|||||.+. ..|++..||||||++++||+|+..|+..-.... ..+.....|.....+
T Consensus 202 ---ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~A-------QIYKKV~SGiKP~sl----- 265 (632)
T KOG0584|consen 202 ---KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPA-------QIYKKVTSGIKPAAL----- 265 (632)
T ss_pred ---ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHH-------HHHHHHHcCCCHHHh-----
Confidence 3378999999999998 689999999999999999999999996432221 123333333322222
Q ss_pred hccchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 657 AMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 657 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
..-..+++.++|.+||.. .++|||+.|+|+.
T Consensus 266 ---~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 266 ---SKVKDPEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred ---hccCCHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 122245677899999999 9999999999973
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=316.09 Aligned_cols=263 Identities=24% Similarity=0.260 Sum_probs=196.2
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEeccc--chhhHHHHHHHHHHHhccCcccccceeceEecC------C
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKL--AQEREREFKTEVSAIGRTHHKNLVQLLGFCDEG------L 491 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~------~ 491 (714)
.+|.+.+.||+|+||.||+|... ..++.||||++... .......+.+|+.+++.++||||+++++++... .
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 24 KRYQNLKPIGSGAQGIVCAAYDA-ILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred cceeEEEEeecCCCeEEEEEEEC-CCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 46777889999999999999865 46889999999753 233456788999999999999999999987543 3
Q ss_pred eeeEEEeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCcccc
Q 041576 492 NRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLL 571 (714)
Q Consensus 492 ~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~ 571 (714)
..++||||+++ +|.+.+.. .+++..+..++.|+++||+|||+++ |+||||||+||+++.++.+||+|||+++..
T Consensus 103 ~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 176 (364)
T cd07875 103 DVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA 176 (364)
T ss_pred eEEEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCCcccc
Confidence 56999999976 67766643 4778889999999999999999998 999999999999999999999999999865
Q ss_pred ccCcccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHH-------------
Q 041576 572 LSDQSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWA------------- 638 (714)
Q Consensus 572 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~------------- 638 (714)
.... ......++..|+|||++.+..++.++|||||||++|||++|+.||...........+....
T Consensus 177 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (364)
T cd07875 177 GTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP 254 (364)
T ss_pred CCCC--cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhH
Confidence 3321 2233468999999999999999999999999999999999999997543322111110000
Q ss_pred -hhhhhcCcc-------ceeecchh---hhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 639 -YDCYVEGKL-------DVLVDNDK---AAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 639 -~~~~~~~~~-------~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
...+.+... ........ ...........+.+++.+||+.||++|||+.|+++.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 255 TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 000000000 00000000 000111123467889999999999999999999884
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=314.27 Aligned_cols=190 Identities=22% Similarity=0.269 Sum_probs=163.2
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEee
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEF 499 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~ 499 (714)
..|.+.+.||+|+||.||+|... .+++.||+|..... ....|+.++++++||||+++++++..+...++|+|+
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 138 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKP-GQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPH 138 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEEC-CCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEc
Confidence 45777899999999999999976 46789999986432 235689999999999999999999999999999999
Q ss_pred cCCCchhhhhhc-CCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcccc
Q 041576 500 MGNGTLANLLFA-IPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRT 578 (714)
Q Consensus 500 ~~~gsL~~~l~~-~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 578 (714)
+. ++|.+++.. ...+++..+..|+.||+.||+|||+++ |+||||||+||+++.++.+||+|||++...... ..
T Consensus 139 ~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--~~ 212 (357)
T PHA03209 139 YS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA--PA 212 (357)
T ss_pred cC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccC--cc
Confidence 96 578877764 456899999999999999999999998 999999999999999999999999998753222 12
Q ss_pred eeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCC
Q 041576 579 RTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSV 622 (714)
Q Consensus 579 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~ 622 (714)
.....|+..|+|||++.+..++.++|||||||++|||+++..++
T Consensus 213 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 213 FLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred cccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 22345899999999999999999999999999999999876655
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=320.73 Aligned_cols=192 Identities=24% Similarity=0.236 Sum_probs=165.8
Q ss_pred hhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEeec
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEFM 500 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~ 500 (714)
.|.+.+.||+|+||.||+|.+. ..++.||||.... ..+.+|++++++++|+||+++++++..+...++|||++
T Consensus 170 gy~i~~~Lg~G~~G~Vy~a~~~-~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~ 242 (461)
T PHA03211 170 GFAIHRALTPGSEGCVFESSHP-DYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY 242 (461)
T ss_pred CeEEEEEEccCCCeEEEEEEEC-CCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc
Confidence 4667789999999999999876 4678999996432 24578999999999999999999999999999999999
Q ss_pred CCCchhhhhhcC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCccc-c
Q 041576 501 GNGTLANLLFAI-PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSR-T 578 (714)
Q Consensus 501 ~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~-~ 578 (714)
. ++|.+++... ..+++.+++.|+.||++||+|||+++ |+||||||+||||+.++.+||+|||+++........ .
T Consensus 243 ~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 318 (461)
T PHA03211 243 R-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPF 318 (461)
T ss_pred C-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceeccccccccc
Confidence 5 6888887654 46899999999999999999999998 999999999999999999999999999865433221 2
Q ss_pred eeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCc
Q 041576 579 RTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVE 623 (714)
Q Consensus 579 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~ 623 (714)
.....||..|+|||++.+..++.++|||||||+||||++|..++.
T Consensus 319 ~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf 363 (461)
T PHA03211 319 HYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLF 363 (461)
T ss_pred ccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcc
Confidence 223568999999999999999999999999999999999887653
|
|
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=298.43 Aligned_cols=248 Identities=23% Similarity=0.334 Sum_probs=203.3
Q ss_pred hhhhhhhCcccceeEEEeEeeCCCCcEEEEEEeccc--chhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEee
Q 041576 422 NGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKL--AQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEF 499 (714)
Q Consensus 422 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~ 499 (714)
|.+.+.||.|+||.||.+... .+++.+++|.+... .....+.+.+|++++++++|+||+++++++.+.+..+++|||
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~-~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 2 YIPIRVLGKGAFGEATLYRRT-EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred ceEeeEecccCCceEEEEEEc-CCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 566789999999999998866 56889999987643 345566789999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcC--CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCccc
Q 041576 500 MGNGTLANLLFAI--PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSR 577 (714)
Q Consensus 500 ~~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 577 (714)
+++++|.+++... ..+++.++..++.|+++||+|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~- 156 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS- 156 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence 9999999999765 45789999999999999999999998 99999999999999999999999999986644332
Q ss_pred ceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhh
Q 041576 578 TRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAA 657 (714)
Q Consensus 578 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 657 (714)
......++..|+|||.+.+..++.++||||||++++||++|+.||......+. .. ....+....
T Consensus 157 ~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~---~~-----~~~~~~~~~-------- 220 (256)
T cd08221 157 MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNL---VV-----KIVQGNYTP-------- 220 (256)
T ss_pred cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHH---HH-----HHHcCCCCC--------
Confidence 22334588999999999888899999999999999999999999975432211 11 111111111
Q ss_pred ccchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 658 MADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 658 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
........+.+++.+||+.+|++||++.|+++.
T Consensus 221 -~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 221 -VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred -CccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 112234567789999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-35 Score=303.33 Aligned_cols=265 Identities=23% Similarity=0.295 Sum_probs=201.7
Q ss_pred hhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc--hhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEee
Q 041576 422 NGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA--QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEF 499 (714)
Q Consensus 422 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~ 499 (714)
|.+.+.||+|++|.||+|... .+++.|++|++.... ......+.+|+.++++++||||+++++++..+...++|+||
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~-~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 2 YKILGRIGEGAHGIVFKAKDR-ETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred ceEEeecccCCCcEEEEEEEC-CCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 567789999999999999876 468899999987543 33456889999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcccc
Q 041576 500 MGNGTLANLLFAI-PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRT 578 (714)
Q Consensus 500 ~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 578 (714)
+ +++|.+++... ..+++.+++.++.||++||+|||+.+ ++|+||||+||++++++.++|+|||++..........
T Consensus 81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 156 (286)
T cd07832 81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRL 156 (286)
T ss_pred c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCc
Confidence 9 99999998653 56899999999999999999999998 9999999999999999999999999998765443323
Q ss_pred eeeecCCCCccCcccccCC-CCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHH-------hhhhhc-Cccce
Q 041576 579 RTVIRGTRGYVAPEWFKNV-PVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWA-------YDCYVE-GKLDV 649 (714)
Q Consensus 579 ~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~-------~~~~~~-~~~~~ 649 (714)
.....++..|+|||.+.+. .++.++||||+|++++||++|+++|...........+.... +....+ .....
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T cd07832 157 YSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNK 236 (286)
T ss_pred cccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhc
Confidence 3345688899999998654 46899999999999999999988876543222111111000 000000 00000
Q ss_pred ee-c--ch-hhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 650 LV-D--ND-KAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 650 ~~-~--~~-~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
+. . .. ............+.+++.+||+.+|++||+++++++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 237 ITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred ccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00 0 00 0000111234678899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=297.93 Aligned_cols=248 Identities=25% Similarity=0.362 Sum_probs=199.8
Q ss_pred hhhhhhhCcccceeEEEeEeeCCCCcEEEEEEeccc--chhhHHHHHHHHHHHhccCcccccceeceEec-CCeeeEEEe
Q 041576 422 NGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKL--AQEREREFKTEVSAIGRTHHKNLVQLLGFCDE-GLNRLLVYE 498 (714)
Q Consensus 422 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-~~~~~lv~E 498 (714)
|.+.+.||+|++|.||++..+ .+++.+++|++... .....+.+.+|++++++++|+|++++++.+.. ....+++||
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~-~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 2 YCFVRVVGKGSYGEVSLVRHR-TDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred ceEEEEecCCCCeEEEEEEEc-CCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 567789999999999999976 46789999998643 23445678999999999999999999998764 445789999
Q ss_pred ecCCCchhhhhhcC--CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcc
Q 041576 499 FMGNGTLANLLFAI--PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQS 576 (714)
Q Consensus 499 ~~~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 576 (714)
|+++++|.+++... ..+++.++..++.|++.||++||+.+ ++|+||||+||+++.++.++|+|||++........
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~ 157 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD 157 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccCC
Confidence 99999999999763 45789999999999999999999998 99999999999999999999999999986643322
Q ss_pred cceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhh
Q 041576 577 RTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKA 656 (714)
Q Consensus 577 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 656 (714)
......++..|+|||.+.+..++.++||||||++++||++|+.||........ . . ....+...
T Consensus 158 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~---~----~-~~~~~~~~-------- 220 (257)
T cd08223 158 -MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSL---V----Y-RIIEGKLP-------- 220 (257)
T ss_pred -ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHH---H----H-HHHhcCCC--------
Confidence 22334578899999999999999999999999999999999999874332211 0 0 11111111
Q ss_pred hccchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 657 AMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 657 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
..+......+.+++.+|++.+|++||++.++++.
T Consensus 221 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 221 -PMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred -CCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 1122344578889999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=294.28 Aligned_cols=250 Identities=24% Similarity=0.278 Sum_probs=205.1
Q ss_pred hhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEE
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA---QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVY 497 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 497 (714)
..++.+.||.|.-|+||++.++ .++..+|+|++.+.. +....+.+.|-++|+.++||.++.++..++.++..+++|
T Consensus 78 ~f~llk~LG~GdiG~VyL~~l~-~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 78 HFRLLKRLGCGDIGTVYLVELR-GTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHcCCCCceeEEEEEec-CCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 4456689999999999999987 466899999998743 344567788999999999999999999999999999999
Q ss_pred eecCCCchhhhhhcC--CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCcccccc--
Q 041576 498 EFMGNGTLANLLFAI--PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLS-- 573 (714)
Q Consensus 498 E~~~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~-- 573 (714)
|||+||+|..+++.+ +.+++..+.-++.+++-||+|||..| ||.|||||+||||.++|++-|+||.++.....
T Consensus 157 eyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~P 233 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVSP 233 (459)
T ss_pred ecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCCCC
Confidence 999999999999865 46899999999999999999999998 99999999999999999999999998754311
Q ss_pred ------C------------------------c-c----------------------cceeeecCCCCccCcccccCCCCC
Q 041576 574 ------D------------------------Q-S----------------------RTRTVIRGTRGYVAPEWFKNVPVS 600 (714)
Q Consensus 574 ------~------------------------~-~----------------------~~~~~~~gt~~y~aPE~~~~~~~s 600 (714)
. . . .....++||-.|+|||++++...+
T Consensus 234 t~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHg 313 (459)
T KOG0610|consen 234 TLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHG 313 (459)
T ss_pred eeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCC
Confidence 0 0 0 011124689999999999999999
Q ss_pred chhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhhccchHHHHHHHHHHHHccccCCC
Q 041576 601 AKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPL 680 (714)
Q Consensus 601 ~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~ 680 (714)
.+.|-|+|||+||||+.|+.||......+. +.. ++...+........+..+.+||++.|.+||+
T Consensus 314 sAVDWWtfGIflYEmLyG~TPFKG~~~~~T---l~N-------------Iv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~ 377 (459)
T KOG0610|consen 314 SAVDWWTFGIFLYEMLYGTTPFKGSNNKET---LRN-------------IVGQPLKFPEEPEVSSAAKDLIRKLLVKDPS 377 (459)
T ss_pred chhhHHHHHHHHHHHHhCCCCcCCCCchhh---HHH-------------HhcCCCcCCCCCcchhHHHHHHHHHhccChh
Confidence 999999999999999999999987655432 211 1111121112224556788899999999999
Q ss_pred CCCC----HHHHHH
Q 041576 681 KRPA----MKMIVQ 690 (714)
Q Consensus 681 ~RPs----~~evl~ 690 (714)
+|.. +.||.+
T Consensus 378 kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 378 KRLGSKRGAAEIKR 391 (459)
T ss_pred hhhccccchHHhhc
Confidence 9998 888876
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=299.45 Aligned_cols=247 Identities=28% Similarity=0.372 Sum_probs=201.0
Q ss_pred hhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc-----hhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEE
Q 041576 422 NGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA-----QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLV 496 (714)
Q Consensus 422 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 496 (714)
+...+.||+|++|.||+|... .+++.|++|.+.... ....+.+.+|+.++++++|+||+++++++.++...+++
T Consensus 2 ~~~~~~ig~g~~~~vy~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 2 WRKGELLGSGSFGSVYEGLNL-DDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred ccccceeeecCCceEEEEEEc-CCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 445688999999999999876 468899999886432 23456889999999999999999999999999999999
Q ss_pred EeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcc
Q 041576 497 YEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQS 576 (714)
Q Consensus 497 ~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 576 (714)
+||+++++|.+++.....+++..+..++.||++||+|||+.+ ++|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~- 156 (258)
T cd06632 81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS- 156 (258)
T ss_pred EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccccc-
Confidence 999999999999988777899999999999999999999998 9999999999999999999999999987654332
Q ss_pred cceeeecCCCCccCcccccCCC-CCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchh
Q 041576 577 RTRTVIRGTRGYVAPEWFKNVP-VSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDK 655 (714)
Q Consensus 577 ~~~~~~~gt~~y~aPE~~~~~~-~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 655 (714)
......++..|+|||.+.... ++.++|+||||+++|+|++|+.||....... ...... ......
T Consensus 157 -~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~---~~~~~~----~~~~~~------- 221 (258)
T cd06632 157 -FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVA---AVFKIG----RSKELP------- 221 (258)
T ss_pred -cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHH---HHHHHH----hcccCC-------
Confidence 223345788999999987766 8999999999999999999999996543111 111100 000111
Q ss_pred hhccchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 656 AAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 656 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
..+......+.+++.+||+.+|++||++.++++
T Consensus 222 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 222 --PIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred --CcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 011223456778999999999999999999985
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=306.07 Aligned_cols=246 Identities=25% Similarity=0.347 Sum_probs=199.2
Q ss_pred hhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEeecCCCc
Q 041576 425 EEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEFMGNGT 504 (714)
Q Consensus 425 ~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~gs 504 (714)
...||+|+||.||+|... .+++.||+|.+........+.+.+|+.++..++||||+++++++..++..++|+||+++++
T Consensus 26 ~~~ig~g~~g~v~~~~~~-~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~ 104 (297)
T cd06659 26 YIKIGEGSTGIVCIAREK-HSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA 104 (297)
T ss_pred hhhcCCCCceeEEEEEEc-CCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCC
Confidence 357999999999999875 4688999999876544556678899999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcccceeeecC
Q 041576 505 LANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRG 584 (714)
Q Consensus 505 L~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g 584 (714)
|.+++.. ..+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++........ ......+
T Consensus 105 L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~~~~~ 179 (297)
T cd06659 105 LTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-KRKSLVG 179 (297)
T ss_pred HHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhcccccc-cccceec
Confidence 9998755 56889999999999999999999998 99999999999999999999999999875543222 2233458
Q ss_pred CCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhhccchHHH
Q 041576 585 TRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMADKSRA 664 (714)
Q Consensus 585 t~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 664 (714)
+..|+|||.+.+..++.++||||||+++|||++|+.||...........+ ........ .......
T Consensus 180 ~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~--------~~~~~~~~-------~~~~~~~ 244 (297)
T cd06659 180 TPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRL--------RDSPPPKL-------KNAHKIS 244 (297)
T ss_pred CccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--------hccCCCCc-------cccCCCC
Confidence 89999999999889999999999999999999999999754322211100 00000000 0011223
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 665 CKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 665 ~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
..+.+++.+||+.+|++||++.|+++.
T Consensus 245 ~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 245 PVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred HHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 457789999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=298.94 Aligned_cols=251 Identities=27% Similarity=0.383 Sum_probs=202.3
Q ss_pred hhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccch--hhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEee
Q 041576 422 NGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQ--EREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEF 499 (714)
Q Consensus 422 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~ 499 (714)
|...+.||+|++|.||+|... .+++.|++|.++.... ...+.+.+|++++++++|+||+++++++...+..++|+||
T Consensus 2 y~~~~~lg~G~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 2 WQRGNKIGGGTFGKVYTAVNL-DTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred ceeeeEeecCCCcEEEEEEEC-CCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 556789999999999999875 4678999999875433 3667899999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcccce
Q 041576 500 MGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTR 579 (714)
Q Consensus 500 ~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 579 (714)
+++++|.+++.....+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||++...........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~ 157 (264)
T cd06626 81 CSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMG 157 (264)
T ss_pred CCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCCccc
Confidence 999999999988777899999999999999999999998 99999999999999999999999999987654332221
Q ss_pred e---eecCCCCccCcccccCCC---CCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecc
Q 041576 580 T---VIRGTRGYVAPEWFKNVP---VSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDN 653 (714)
Q Consensus 580 ~---~~~gt~~y~aPE~~~~~~---~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 653 (714)
. ...++..|+|||.+.+.. .+.++||||||++++|+++|+.||........ .. . . ...+....+
T Consensus 158 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~--~~--~--~-~~~~~~~~~--- 227 (264)
T cd06626 158 EEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQ--IM--F--H-VGAGHKPPI--- 227 (264)
T ss_pred ccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHH--HH--H--H-HhcCCCCCC---
Confidence 1 345788999999998766 88999999999999999999999964321111 00 0 0 000100000
Q ss_pred hhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 654 DKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 654 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
.........+.+++.+||+.+|++||++.|++.
T Consensus 228 ----~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 228 ----PDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred ----CcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 011112456678999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=307.14 Aligned_cols=263 Identities=21% Similarity=0.233 Sum_probs=197.8
Q ss_pred hhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc-hhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEee
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA-QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEF 499 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~ 499 (714)
.|.+.+.||+|+||.||+|..+ .+++.||+|.++... ......+.+|+.++++++||||+++++++..++..++||||
T Consensus 7 ~y~~~~~lg~g~~g~vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 7 TYIKLDKLGEGTYATVYKGRSK-LTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred ceEEeeEeccCcCEEEEEEEEc-CCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 4667789999999999999876 467899999986432 23345678899999999999999999999999999999999
Q ss_pred cCCCchhhhhhcC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcccc
Q 041576 500 MGNGTLANLLFAI-PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRT 578 (714)
Q Consensus 500 ~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 578 (714)
++ ++|.+++... ..+++..+..++.||++||+|||+.+ ++|+||||+||++++++.+||+|||++........ .
T Consensus 86 ~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~-~ 160 (301)
T cd07873 86 LD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK-T 160 (301)
T ss_pred cc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC-c
Confidence 98 4888888654 46788999999999999999999998 99999999999999999999999999975432221 1
Q ss_pred eeeecCCCCccCcccccC-CCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHH-------hhhhhcC-c---
Q 041576 579 RTVIRGTRGYVAPEWFKN-VPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWA-------YDCYVEG-K--- 646 (714)
Q Consensus 579 ~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~-------~~~~~~~-~--- 646 (714)
.....++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+....+.... +...... .
T Consensus 161 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (301)
T cd07873 161 YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKS 240 (301)
T ss_pred ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccc
Confidence 122346889999998865 457889999999999999999999997654332211111100 0000000 0
Q ss_pred --cceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 647 --LDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 647 --~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
......... .......+..+.+++.+||+.||.+|||++|+++
T Consensus 241 ~~~~~~~~~~~-~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 241 YNYPKYRADCL-HNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred cccCccccccH-HhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 000000000 0011123446788999999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=315.40 Aligned_cols=263 Identities=25% Similarity=0.280 Sum_probs=195.7
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEeccc--chhhHHHHHHHHHHHhccCcccccceeceEecC------C
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKL--AQEREREFKTEVSAIGRTHHKNLVQLLGFCDEG------L 491 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~------~ 491 (714)
..|.+.+.||+|+||.||++... ..++.||||++... .......+.+|+.+++.++||||+++++++... .
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 95 (355)
T cd07874 17 KRYQNLKPIGSGAQGIVCAAYDA-VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQ 95 (355)
T ss_pred hceeEEEEeeecCCEEEEEEEec-CCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccc
Confidence 45677789999999999999865 46889999999753 233456788999999999999999999988543 3
Q ss_pred eeeEEEeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCcccc
Q 041576 492 NRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLL 571 (714)
Q Consensus 492 ~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~ 571 (714)
..++||||+++ +|.+.+.. .+++..+..++.||++||+|||+++ |+||||||+||+++.++.+||+|||+++..
T Consensus 96 ~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~~~~~ 169 (355)
T cd07874 96 DVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA 169 (355)
T ss_pred eeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcccccC
Confidence 46899999976 66666643 4788889999999999999999998 999999999999999999999999999765
Q ss_pred ccCcccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHH-------------
Q 041576 572 LSDQSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWA------------- 638 (714)
Q Consensus 572 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~------------- 638 (714)
... .......++..|+|||.+.+..++.++|||||||++|||++|+.||................
T Consensus 170 ~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (355)
T cd07874 170 GTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 247 (355)
T ss_pred CCc--cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcH
Confidence 332 12233468999999999999999999999999999999999999997543221110000000
Q ss_pred -hhhhhcC--ccc-----eeecchh---hhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 639 -YDCYVEG--KLD-----VLVDNDK---AAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 639 -~~~~~~~--~~~-----~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
...+.+. ... ....... ...........+.+++.+||+.||++|||+.|+++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 0000000 000 0000000 000111234567889999999999999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=325.04 Aligned_cols=261 Identities=20% Similarity=0.261 Sum_probs=190.1
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccC------cccccceeceEecC-Ce
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTH------HKNLVQLLGFCDEG-LN 492 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------h~nIv~l~~~~~~~-~~ 492 (714)
.+|.+.+.||+|+||+||+|.+. ..++.||||+++... .....+..|+.++++++ |.+++++++++..+ .+
T Consensus 129 ~~y~i~~~lG~G~fg~V~~a~~~-~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~ 206 (467)
T PTZ00284 129 QRFKILSLLGEGTFGKVVEAWDR-KRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGH 206 (467)
T ss_pred CcEEEEEEEEeccCEEEEEEEEc-CCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCce
Confidence 45777889999999999999876 467899999996532 22334455666666554 45688999988665 46
Q ss_pred eeEEEeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhc-CCCCeEecCCCcCeEEECCCC-------------
Q 041576 493 RLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEE-CNVPIIHCDIKPQNILLDQDF------------- 558 (714)
Q Consensus 493 ~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~-~~~~ivH~Dlk~~NIll~~~~------------- 558 (714)
.++|||++ +++|.+++.....+++..+..|+.||+.||+|||++ + |+||||||+|||++.++
T Consensus 207 ~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~~~~~~~~~ 282 (467)
T PTZ00284 207 MCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDPVTNRALPP 282 (467)
T ss_pred EEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCcccccccccccCC
Confidence 78999987 668999888778899999999999999999999984 6 99999999999998765
Q ss_pred ---ceEEecCCCccccccCcccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhh
Q 041576 559 ---TAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILT 635 (714)
Q Consensus 559 ---~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~ 635 (714)
.+||+|||.+.... .......||..|+|||++.+..++.++|||||||++|||++|+.||......+....+.
T Consensus 283 ~~~~vkl~DfG~~~~~~----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~ 358 (467)
T PTZ00284 283 DPCRVRICDLGGCCDER----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLME 358 (467)
T ss_pred CCceEEECCCCccccCc----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 49999999875322 22334568999999999999999999999999999999999999997544322111111
Q ss_pred H--------HHhh--------hhh-cCccceeecchhh-------hccchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 636 D--------WAYD--------CYV-EGKLDVLVDNDKA-------AMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 636 ~--------~~~~--------~~~-~~~~~~~~~~~~~-------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
. |... .+. .+.+....++... ..........+.+|+.+||+.||++|||++|+++
T Consensus 359 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~ 437 (467)
T PTZ00284 359 KTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTT 437 (467)
T ss_pred HHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhc
Confidence 1 0000 000 0000000000000 0001112346779999999999999999999997
|
|
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=301.68 Aligned_cols=250 Identities=24% Similarity=0.361 Sum_probs=199.0
Q ss_pred hhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEeccc-chhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEee
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKL-AQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEF 499 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~ 499 (714)
.+++.+.||+|+||.||++... .+++.||+|.++.. .......+.+|++++++++||||+++++.+...+..++||||
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~-~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHR-PTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEc-CCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 4667899999999999999876 46889999988653 334456889999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcC---CCCChhhHHHHHHHHHHHHHHHHhc-CCCCeEecCCCcCeEEECCCCceEEecCCCccccccCc
Q 041576 500 MGNGTLANLLFAI---PRPDWSLRVRISLEIARGLLYLHEE-CNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQ 575 (714)
Q Consensus 500 ~~~gsL~~~l~~~---~~~~~~~~~~i~~qi~~~L~yLH~~-~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 575 (714)
+++++|..++... ..+++..+..++.||+.||.|||++ + ++|+||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL 157 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccCCc
Confidence 9999999998763 3689999999999999999999974 5 9999999999999999999999999987653221
Q ss_pred ccceeeecCCCCccCcccccCCC------CCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccce
Q 041576 576 SRTRTVIRGTRGYVAPEWFKNVP------VSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDV 649 (714)
Q Consensus 576 ~~~~~~~~gt~~y~aPE~~~~~~------~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 649 (714)
.....++..|+|||.+.+.. ++.++|||||||++|||++|+.||...........+. ....+...
T Consensus 158 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~-----~~~~~~~~- 228 (286)
T cd06622 158 ---AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLS-----AIVDGDPP- 228 (286)
T ss_pred ---cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHH-----HHhhcCCC-
Confidence 12234778999999986543 5889999999999999999999996432221111100 00111110
Q ss_pred eecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 650 LVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 650 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
..+......+.+++.+||+.+|++||+++++++.
T Consensus 229 --------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 229 --------TLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred --------CCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 1122245567789999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=303.31 Aligned_cols=262 Identities=25% Similarity=0.294 Sum_probs=195.4
Q ss_pred hhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc--hhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEee
Q 041576 422 NGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA--QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEF 499 (714)
Q Consensus 422 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~ 499 (714)
|.+.+.||+|++|.||+|..+ .+++.||+|+++... ......+.+|+.++++++||||+++++++.++...++||||
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 2 YTKIEKIGEGTYGVVYKGRNK-KTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred ceEeeEecccCceEEEEEEEC-CCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 456688999999999999876 468899999986432 23346788999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcC---CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcc
Q 041576 500 MGNGTLANLLFAI---PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQS 576 (714)
Q Consensus 500 ~~~gsL~~~l~~~---~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 576 (714)
++ ++|.+++... ..+++..+..++.||++||+|||+.+ ++|+||||+||++++++.+||+|||++........
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR 156 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence 98 5888887643 45789999999999999999999998 99999999999999999999999999876533221
Q ss_pred cceeeecCCCCccCcccccCC-CCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhh-hHHH---hhhhhc-------
Q 041576 577 RTRTVIRGTRGYVAPEWFKNV-PVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAIL-TDWA---YDCYVE------- 644 (714)
Q Consensus 577 ~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l-~~~~---~~~~~~------- 644 (714)
......++..|+|||.+.+. .++.++||||||+++|||++|+.||............ ..+. ...+..
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (285)
T cd07861 157 -VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDY 235 (285)
T ss_pred -cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHH
Confidence 11223467889999988654 5789999999999999999999999754322111000 0000 000000
Q ss_pred -CccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 645 -GKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 645 -~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
........... .........++.+++.+||+.||++|||+.+|++
T Consensus 236 ~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 236 KNTFPKWKKGSL-RSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HhhccccCcchh-HHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00000000000 0011123456778999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=299.28 Aligned_cols=248 Identities=23% Similarity=0.292 Sum_probs=193.7
Q ss_pred hhhhhhhCcccceeEEEeEeeCCCCcEEEEEEeccc-----chhhHHHHHHHHHHHhccCcccccceeceEec--CCeee
Q 041576 422 NGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKL-----AQEREREFKTEVSAIGRTHHKNLVQLLGFCDE--GLNRL 494 (714)
Q Consensus 422 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--~~~~~ 494 (714)
+...+.||+|+||.||+|... .++..|++|++... .......+.+|+.++++++||||+++++++.+ ....+
T Consensus 4 ~~~~~~lg~g~~g~vy~~~~~-~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (266)
T cd06651 4 WRRGKLLGQGAFGRVYLCYDV-DTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT 82 (266)
T ss_pred ccccceecCCCCEEEEEEEEc-CCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence 455689999999999999875 46889999988532 12334578899999999999999999998865 35678
Q ss_pred EEEeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccC
Q 041576 495 LVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSD 574 (714)
Q Consensus 495 lv~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 574 (714)
+++||+++++|.+++.....+++...+.++.|++.||+|||+.+ ++||||+|+||+++.++.+||+|||++......
T Consensus 83 l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd06651 83 IFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTI 159 (266)
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccccccc
Confidence 99999999999999988777899999999999999999999988 999999999999999999999999998765332
Q ss_pred c--ccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeec
Q 041576 575 Q--SRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVD 652 (714)
Q Consensus 575 ~--~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 652 (714)
. ........++..|+|||.+.+..++.++||||||+++|||++|+.||........ +.. ...... .
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~---~~~----~~~~~~-----~ 227 (266)
T cd06651 160 CMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAA---IFK----IATQPT-----N 227 (266)
T ss_pred cccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHH---HHH----HhcCCC-----C
Confidence 1 1112234578899999999998899999999999999999999999974322111 000 000000 0
Q ss_pred chhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 653 NDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 653 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
+ ..+......+..++ +||..+|++||+++||++
T Consensus 228 ~----~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 228 P----QLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred C----CCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 0 11122233455566 688899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=306.86 Aligned_cols=255 Identities=25% Similarity=0.384 Sum_probs=198.7
Q ss_pred hhhhhhhCcccceeEEEeEeeCCCCc----EEEEEEecccc-hhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEE
Q 041576 422 NGFEEELGRGSFGIVYKGVLKSASGN----AVAVKKLDKLA-QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLV 496 (714)
Q Consensus 422 ~~~~~~ig~G~~g~Vy~~~~~~~~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 496 (714)
+...+.||+|+||.||+|.+.. ++. .||+|.+.... .....++.+|+.++++++||||+++++++... ..+++
T Consensus 9 ~~~~~~lg~G~~g~vy~~~~~~-~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v 86 (303)
T cd05110 9 LKRVKVLGSGAFGTVYKGIWVP-EGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLV 86 (303)
T ss_pred ceeccccccCCCccEEEEEEec-CCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cceee
Confidence 4456789999999999998763 333 57889886533 23345788999999999999999999998764 46799
Q ss_pred EeecCCCchhhhhhcCC-CCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCc
Q 041576 497 YEFMGNGTLANLLFAIP-RPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQ 575 (714)
Q Consensus 497 ~E~~~~gsL~~~l~~~~-~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 575 (714)
+||+++|+|.+++.... .+++..+..++.|++.||+|||+++ |+|+||||+||++++++.+||+|||+++......
T Consensus 87 ~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~ 163 (303)
T cd05110 87 TQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDE 163 (303)
T ss_pred ehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccccccCcc
Confidence 99999999999987653 5788999999999999999999998 9999999999999999999999999998664332
Q ss_pred cc-ceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccchhhhhhhHHHhhhhhcCccceeecc
Q 041576 576 SR-TRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDN 653 (714)
Q Consensus 576 ~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 653 (714)
.. ......++..|+|||.+.+..++.++||||||+++|||++ |+.||......... .+ ...+...
T Consensus 164 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~----~~----~~~~~~~----- 230 (303)
T cd05110 164 KEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIP----DL----LEKGERL----- 230 (303)
T ss_pred cccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH----HH----HHCCCCC-----
Confidence 21 1112335678999999998899999999999999999997 88998644322111 11 0111000
Q ss_pred hhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCC
Q 041576 654 DKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLEV 698 (714)
Q Consensus 654 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 698 (714)
..+......+.+++..|+..+|++||+++++++.|+.+.+.
T Consensus 231 ----~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 231 ----PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred ----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 00111234677899999999999999999999999876544
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=307.47 Aligned_cols=249 Identities=24% Similarity=0.267 Sum_probs=199.9
Q ss_pred hhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccch---hhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEe
Q 041576 422 NGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQ---EREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYE 498 (714)
Q Consensus 422 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E 498 (714)
|.+.+.||+|++|.||+|... .+++.+|+|.+..... ...+.+.+|++++++++||||+++++.+.+....++|||
T Consensus 3 y~~~~~ig~g~~g~vy~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (316)
T cd05574 3 FKKIKLLGKGDVGRVFLVRLK-GTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMD 81 (316)
T ss_pred eEEeeeecCCccEEEEEEEEc-CCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEE
Confidence 556688999999999999876 4688999999865322 245678999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcC--CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcc
Q 041576 499 FMGNGTLANLLFAI--PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQS 576 (714)
Q Consensus 499 ~~~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 576 (714)
|+.+++|.+++... ..+++..+..++.|+++||+|||+.+ ++|+||||+||+++.++.++|+|||++........
T Consensus 82 ~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 158 (316)
T cd05574 82 YCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPP 158 (316)
T ss_pred ecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccccccc
Confidence 99999999998754 46789999999999999999999998 99999999999999999999999999875432111
Q ss_pred ----------------------------cceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccc
Q 041576 577 ----------------------------RTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGE 628 (714)
Q Consensus 577 ----------------------------~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~ 628 (714)
.......|+..|+|||.+.+..++.++||||||+++|+|++|+.||......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~ 238 (316)
T cd05574 159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRD 238 (316)
T ss_pred ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchH
Confidence 0111235788999999999888999999999999999999999999754332
Q ss_pred hhhhhhhHHHhhhhhcCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCC----HHHHHH
Q 041576 629 ERSAILTDWAYDCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPA----MKMIVQ 690 (714)
Q Consensus 629 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs----~~evl~ 690 (714)
.. +.. ....... .......+..+.+++.+||+.||++||+ ++|+++
T Consensus 239 ~~---~~~-----~~~~~~~--------~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 239 ET---FSN-----ILKKEVT--------FPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred HH---HHH-----HhcCCcc--------CCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 21 110 0011100 0011114567888999999999999999 777776
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=298.38 Aligned_cols=252 Identities=24% Similarity=0.380 Sum_probs=201.5
Q ss_pred hhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc------hhhHHHHHHHHHHHhccCcccccceeceEecCCeeeE
Q 041576 422 NGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA------QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLL 495 (714)
Q Consensus 422 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 495 (714)
|...+.||+|++|.||+|... .+++.||+|.+.... ....+.+.+|++.+++++|+||+++++++.+.+..++
T Consensus 2 ~~~~~~lg~g~~~~v~~~~~~-~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 2 WLKGQQLGTGAFSSCYQARDV-KTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred ccccceecCcCceEEEEEEEc-CCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 445678999999999999865 578899999986422 2235688999999999999999999999999999999
Q ss_pred EEeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCC-ceEEecCCCccccccC
Q 041576 496 VYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDF-TAKISDFGLSKLLLSD 574 (714)
Q Consensus 496 v~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~-~~kl~Dfg~~~~~~~~ 574 (714)
|+||+++++|.+++.....+++..+..++.||+.||+|||+.+ ++|+||+|+||+++.++ .+||+|||.+......
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~ 157 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAK 157 (268)
T ss_pred EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEcccccccccccc
Confidence 9999999999999988778899999999999999999999998 99999999999998776 5999999998776443
Q ss_pred cc---cceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceee
Q 041576 575 QS---RTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLV 651 (714)
Q Consensus 575 ~~---~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 651 (714)
.. .......++..|+|||.+.+..++.++||||+|+++++|++|+.||............... ....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~----~~~~------ 227 (268)
T cd06630 158 GTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKI----ASAT------ 227 (268)
T ss_pred cccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHH----hccC------
Confidence 21 1122345788999999998888999999999999999999999999644322111111000 0000
Q ss_pred cchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 652 DNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 652 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
.....+......+.+++.+||+.+|++||++.|+++
T Consensus 228 ---~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 228 ---TAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred ---CCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 001122334567888999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=300.00 Aligned_cols=254 Identities=26% Similarity=0.366 Sum_probs=199.1
Q ss_pred hhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccch----------hhHHHHHHHHHHHhccCcccccceeceEecCC
Q 041576 422 NGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQ----------EREREFKTEVSAIGRTHHKNLVQLLGFCDEGL 491 (714)
Q Consensus 422 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~----------~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 491 (714)
|...+.||+|++|.||+|... .+++.||+|.++.... ...+.+.+|+.++++++||||+++++++...+
T Consensus 3 ~~~~~~lg~g~~~~vy~~~~~-~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 3 WVKGELIGKGTYGRVYLALNV-TTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred eeecceecccCceEEEEEeec-CCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 445678999999999999865 4688999998853211 11346788999999999999999999999999
Q ss_pred eeeEEEeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCcccc
Q 041576 492 NRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLL 571 (714)
Q Consensus 492 ~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~ 571 (714)
..++||||+++++|.+++.....+++..+..++.||+.||+|||+.+ ++||||+|+||+++.++.++|+|||++...
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~~~~ 158 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKS 158 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeeccccccc
Confidence 99999999999999999988788899999999999999999999988 999999999999999999999999999765
Q ss_pred ccCcc-cceeeecCCCCccCcccccCCC--CCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccc
Q 041576 572 LSDQS-RTRTVIRGTRGYVAPEWFKNVP--VSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLD 648 (714)
Q Consensus 572 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~--~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 648 (714)
..... .......++..|+|||.+.... ++.++||||||+++||+++|+.|+........ +.. .......
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~---~~~-----~~~~~~~ 230 (272)
T cd06629 159 DDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAA---MFK-----LGNKRSA 230 (272)
T ss_pred cccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHH---HHH-----hhccccC
Confidence 43221 1223345788999999987654 88999999999999999999999864322110 100 0000000
Q ss_pred eeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 649 VLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 649 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
..+.. .........+.+++.+||+.+|++||++++|++.
T Consensus 231 ~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 231 PPIPP----DVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred CcCCc----cccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 00111 1112234578889999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=305.88 Aligned_cols=254 Identities=21% Similarity=0.281 Sum_probs=201.1
Q ss_pred hhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEe
Q 041576 422 NGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA---QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYE 498 (714)
Q Consensus 422 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E 498 (714)
|.+.+.||+|+||.||++... ..++.|++|.+.... ......+.+|+++++.++||||+++++.+..++..++|||
T Consensus 3 y~~~~~l~~g~~~~v~~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (305)
T cd05609 3 FETIKLISNGAYGAVYLVRHK-ETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVME 81 (305)
T ss_pred ceEeeEeecCCCeeEEEEEEC-CCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEe
Confidence 556788999999999999876 568899999987543 2334578899999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCc---
Q 041576 499 FMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQ--- 575 (714)
Q Consensus 499 ~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~--- 575 (714)
|+++++|.+++.....+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~ 158 (305)
T cd05609 82 YVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTN 158 (305)
T ss_pred cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcCcccc
Confidence 9999999999988788899999999999999999999998 9999999999999999999999999986421100
Q ss_pred -----------ccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhc
Q 041576 576 -----------SRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVE 644 (714)
Q Consensus 576 -----------~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~ 644 (714)
........++..|+|||.+.+..++.++||||||+++|||++|+.||......+ .... ...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~---~~~~-----~~~ 230 (305)
T cd05609 159 LYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE---LFGQ-----VIS 230 (305)
T ss_pred ccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHH-----HHh
Confidence 001112346788999999988889999999999999999999999996432221 1111 111
Q ss_pred CccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 041576 645 GKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEG 694 (714)
Q Consensus 645 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 694 (714)
+.... +. .....+..+.+++.+||+.||++||++.++.+.|+.
T Consensus 231 ~~~~~---~~----~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 231 DDIEW---PE----GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred cccCC---CC----ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 11000 00 011234467889999999999999997767666655
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=299.90 Aligned_cols=252 Identities=25% Similarity=0.409 Sum_probs=202.3
Q ss_pred hhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc-hhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEeec
Q 041576 422 NGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA-QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEFM 500 (714)
Q Consensus 422 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~ 500 (714)
+.+.+.||+|++|.||++.++ .+++.+++|.+.... ......+.+|++++++++||||+++++.+..+...++++||+
T Consensus 3 ~~~~~~ig~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (265)
T cd06605 3 LEYLGELGAGNSGVVSKVLHR-PTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM 81 (265)
T ss_pred chHHHHhcCCCCeEEEEEEEc-CCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence 456789999999999999876 468899999987643 345567899999999999999999999999999999999999
Q ss_pred CCCchhhhhhcC-CCCChhhHHHHHHHHHHHHHHHHh-cCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcccc
Q 041576 501 GNGTLANLLFAI-PRPDWSLRVRISLEIARGLLYLHE-ECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRT 578 (714)
Q Consensus 501 ~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~L~yLH~-~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 578 (714)
++++|.+++... ..+++..+..++.|+++||+|||+ .+ ++|+||||+||++++++.++|+|||.+..........
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~ 158 (265)
T cd06605 82 DGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKT 158 (265)
T ss_pred CCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHHhhc
Confidence 999999999876 678899999999999999999999 77 9999999999999999999999999987653322211
Q ss_pred eeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhhc
Q 041576 579 RTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAM 658 (714)
Q Consensus 579 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 658 (714)
..++..|+|||.+.+..++.++||||||+++|+|++|+.||........ . .... .......... ..
T Consensus 159 ---~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-~-~~~~-~~~~~~~~~~--------~~ 224 (265)
T cd06605 159 ---FVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPD-G-IFEL-LQYIVNEPPP--------RL 224 (265)
T ss_pred ---ccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccc-c-HHHH-HHHHhcCCCC--------CC
Confidence 5578899999999998999999999999999999999999965422110 0 0000 0001111000 00
Q ss_pred cchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 659 ADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 659 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
........+.+++.+||+.||++|||+.++++.
T Consensus 225 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 225 PSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred ChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 111145568889999999999999999999853
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=298.03 Aligned_cols=245 Identities=29% Similarity=0.440 Sum_probs=196.5
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEee
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEF 499 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~ 499 (714)
..+.+.+.||+|+||.||++.. .++.||+|.++... ....+.+|+.++++++||||+++++++..+ ..+++|||
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~---~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~ 79 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY---TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMEL 79 (254)
T ss_pred HHceeeeeeccCCCCceEeccc---CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEEC
Confidence 4567788999999999999874 57889999986532 345788999999999999999999998664 47999999
Q ss_pred cCCCchhhhhhcCC--CCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCccc
Q 041576 500 MGNGTLANLLFAIP--RPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSR 577 (714)
Q Consensus 500 ~~~gsL~~~l~~~~--~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 577 (714)
+++++|.+++.... .+++..++.++.|+++||+|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 80 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~-- 154 (254)
T cd05083 80 MSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV-- 154 (254)
T ss_pred CCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceeccccC--
Confidence 99999999997543 4788899999999999999999988 9999999999999999999999999987543211
Q ss_pred ceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhh
Q 041576 578 TRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKA 656 (714)
Q Consensus 578 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 656 (714)
.....+..|+|||.+.+..++.++||||||+++|||++ |+.||......+... ....+..
T Consensus 155 --~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~--------~~~~~~~--------- 215 (254)
T cd05083 155 --DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKE--------CVEKGYR--------- 215 (254)
T ss_pred --CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHH--------HHhCCCC---------
Confidence 11224567999999998899999999999999999998 899986443222111 1111100
Q ss_pred hccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 041576 657 AMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEG 694 (714)
Q Consensus 657 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 694 (714)
.......+..+.+++.+||+.+|++||+++++++.|++
T Consensus 216 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 216 MEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 00112234567889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=292.01 Aligned_cols=247 Identities=23% Similarity=0.345 Sum_probs=209.1
Q ss_pred hhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEeec
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEFM 500 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~ 500 (714)
-..+.++||+|+||.||+|+++ .+|+.+|+|++.- ..+.+++.+|+.++++.+.|++|+++|.+......++|||||
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~-EsG~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYC 110 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHR-ESGHVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYC 110 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHh-ccCcEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhc
Confidence 3556789999999999999988 6899999999854 345778999999999999999999999999999999999999
Q ss_pred CCCchhhhhhcC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcccce
Q 041576 501 GNGTLANLLFAI-PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTR 579 (714)
Q Consensus 501 ~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 579 (714)
..|+..+.++.+ +.+.+.++..++...++||+|||... -+|||||..|||++.+|.+||+|||.+..+..... ..
T Consensus 111 GAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA-KR 186 (502)
T KOG0574|consen 111 GAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA-KR 186 (502)
T ss_pred CCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhhHH-hh
Confidence 999999999855 67899999999999999999999876 89999999999999999999999999987754333 33
Q ss_pred eeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCcccee-ecchhhhc
Q 041576 580 TVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVL-VDNDKAAM 658 (714)
Q Consensus 580 ~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~-~~~~~~~~ 658 (714)
..+.||+-|||||+++.-.|+.++||||||+...||.-|++|+..-.... .+..+ ..+.....
T Consensus 187 NTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMR----------------AIFMIPT~PPPTF~ 250 (502)
T KOG0574|consen 187 NTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMR----------------AIFMIPTKPPPTFK 250 (502)
T ss_pred CccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccc----------------eeEeccCCCCCCCC
Confidence 45679999999999999999999999999999999999999986332111 00111 11112222
Q ss_pred cchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 659 ADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 659 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
.+...+.++.++++.||-+.|++|-|+-++++
T Consensus 251 KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 251 KPEEWSSEFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred ChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 35667778999999999999999999988876
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=311.86 Aligned_cols=261 Identities=22% Similarity=0.240 Sum_probs=194.1
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc--hhhHHHHHHHHHHHhccCcccccceeceEecC------C
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA--QEREREFKTEVSAIGRTHHKNLVQLLGFCDEG------L 491 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~------~ 491 (714)
.+|.+.+.||+|+||.||+|... .+++.||||++.... ....+.+.+|++++++++||||+++++++... .
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07878 15 ERYQNLTPVGSGAYGSVCSAYDT-RLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFN 93 (343)
T ss_pred hhhhhheecccCCCeEEEEEEEC-CCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccC
Confidence 45677789999999999999875 468899999987532 23345678999999999999999999988543 3
Q ss_pred eeeEEEeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCcccc
Q 041576 492 NRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLL 571 (714)
Q Consensus 492 ~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~ 571 (714)
..++++|++ +++|.+++.. ..+++..+..++.||++||+|||+++ |+||||||+||++++++.+||+|||++...
T Consensus 94 ~~~~~~~~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~ 168 (343)
T cd07878 94 EVYLVTNLM-GADLNNIVKC-QKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQA 168 (343)
T ss_pred cEEEEeecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCccceec
Confidence 468999987 6789887754 56899999999999999999999998 999999999999999999999999999865
Q ss_pred ccCcccceeeecCCCCccCcccccC-CCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHh-------hhhh
Q 041576 572 LSDQSRTRTVIRGTRGYVAPEWFKN-VPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAY-------DCYV 643 (714)
Q Consensus 572 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~-------~~~~ 643 (714)
... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...........+..... ....
T Consensus 169 ~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (343)
T cd07878 169 DDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKIS 244 (343)
T ss_pred CCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence 332 223458899999999876 5689999999999999999999999965432211111100000 0000
Q ss_pred cC-------ccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 644 EG-------KLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 644 ~~-------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
.. .+.......... ........+.+++.+||+.||++|||+.|+++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 245 SEHARKYIQSLPHMPQQDLKK-IFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred hhhHHHHhhccccccchhHHH-hccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00 000000000000 000122356789999999999999999999964
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=300.05 Aligned_cols=253 Identities=25% Similarity=0.365 Sum_probs=196.8
Q ss_pred hhhhhhCcccceeEEEeEeeC--CCCcEEEEEEeccc--chhhHHHHHHHHHHHhccCcccccceeceEecCC------e
Q 041576 423 GFEEELGRGSFGIVYKGVLKS--ASGNAVAVKKLDKL--AQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGL------N 492 (714)
Q Consensus 423 ~~~~~ig~G~~g~Vy~~~~~~--~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~------~ 492 (714)
.+.+.||+|+||.||+|.++. .+++.||||.+... .....+++.+|++++++++||||+++++++.... .
T Consensus 2 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 81 (273)
T cd05074 2 TLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPI 81 (273)
T ss_pred cchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccc
Confidence 456889999999999998753 34679999998653 3344567899999999999999999999886543 2
Q ss_pred eeEEEeecCCCchhhhhhcC------CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCC
Q 041576 493 RLLVYEFMGNGTLANLLFAI------PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFG 566 (714)
Q Consensus 493 ~~lv~E~~~~gsL~~~l~~~------~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg 566 (714)
.++++||+++++|.+++... ..+++...+.++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||
T Consensus 82 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 158 (273)
T cd05074 82 PMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADFG 158 (273)
T ss_pred eEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECccc
Confidence 37889999999999887532 24678889999999999999999998 9999999999999999999999999
Q ss_pred CccccccCcc-cceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccchhhhhhhHHHhhhhhc
Q 041576 567 LSKLLLSDQS-RTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEERSAILTDWAYDCYVE 644 (714)
Q Consensus 567 ~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~ 644 (714)
.++....... .......++..|++||.+....++.++||||||+++|||++ |+.||........ ... ...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~----~~~----~~~ 230 (273)
T cd05074 159 LSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEI----YNY----LIK 230 (273)
T ss_pred ccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHH----HHH----HHc
Confidence 9986543321 11122335678999999998889999999999999999999 8888864432211 110 111
Q ss_pred CccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 041576 645 GKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGY 695 (714)
Q Consensus 645 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 695 (714)
.... ..+......+.+++.+||+.+|++||++.|+++.|+++
T Consensus 231 ~~~~---------~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 231 GNRL---------KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CCcC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1000 00112345788899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=321.45 Aligned_cols=254 Identities=25% Similarity=0.357 Sum_probs=210.5
Q ss_pred hhhhhCcccceeEEEeEeeCCCC---cEEEEEEeccc-chhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEee
Q 041576 424 FEEELGRGSFGIVYKGVLKSASG---NAVAVKKLDKL-AQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEF 499 (714)
Q Consensus 424 ~~~~ig~G~~g~Vy~~~~~~~~~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~ 499 (714)
-.++||+|+||+||+|.+-.+.. .+||+|++... ......++.+|+-+|.+++|||++|++++|.... ..||++|
T Consensus 700 k~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~ 778 (1177)
T KOG1025|consen 700 KDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQL 778 (1177)
T ss_pred hhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHh
Confidence 35789999999999999874422 27899988654 3445678999999999999999999999998876 7899999
Q ss_pred cCCCchhhhhhcC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcccc
Q 041576 500 MGNGTLANLLFAI-PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRT 578 (714)
Q Consensus 500 ~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 578 (714)
++.|+|.++++.. ..+..+..+.|..|||+||.|||++. ++||||..+||||.+-..+||.|||+++.+..+....
T Consensus 779 mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey 855 (1177)
T KOG1025|consen 779 MPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEY 855 (1177)
T ss_pred cccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCcccccc
Confidence 9999999999864 57888999999999999999999987 9999999999999999999999999999987765433
Q ss_pred ee-eecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhh
Q 041576 579 RT-VIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKA 656 (714)
Q Consensus 579 ~~-~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 656 (714)
.. ...-.+.|||-|.+....++.++|||||||.+||++| |..|+.....++.... ++...+
T Consensus 856 ~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dl-----------------le~geR 918 (1177)
T KOG1025|consen 856 SAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDL-----------------LEKGER 918 (1177)
T ss_pred cccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHH-----------------Hhcccc
Confidence 33 3345678999999999999999999999999999998 8888876554442222 122222
Q ss_pred hccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCC
Q 041576 657 AMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLEV 698 (714)
Q Consensus 657 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 698 (714)
...+......+..++.+||..|++.||+++++.+.+.+++..
T Consensus 919 LsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ard 960 (1177)
T KOG1025|consen 919 LSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARD 960 (1177)
T ss_pred CCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence 223455666788899999999999999999999998876654
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=312.66 Aligned_cols=261 Identities=25% Similarity=0.336 Sum_probs=203.6
Q ss_pred hhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccC-c-----ccccceeceEecCCeee
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTH-H-----KNLVQLLGFCDEGLNRL 494 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-----~nIv~l~~~~~~~~~~~ 494 (714)
+|.+.+.||+|+||.|.+|... .+++.||||++++.. .-..+-..|+.+|.+|+ | -|+|+++++|...++.|
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~-~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlc 264 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDH-KTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLC 264 (586)
T ss_pred EEEEEEEecccccceeEEEEec-CCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccccee
Confidence 7888999999999999999876 689999999998643 34556688999999986 3 57999999999999999
Q ss_pred EEEeecCCCchhhhhhcC--CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCC--ceEEecCCCccc
Q 041576 495 LVYEFMGNGTLANLLFAI--PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDF--TAKISDFGLSKL 570 (714)
Q Consensus 495 lv~E~~~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~--~~kl~Dfg~~~~ 570 (714)
||+|.+.. +|.++|+.+ ..++...+..++.||+.||..||+.+ |||+||||+||||.+.. .+||+|||.+..
T Consensus 265 iVfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 265 IVFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSCF 340 (586)
T ss_pred eeehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccccc
Confidence 99999975 999999876 45789999999999999999999998 99999999999997643 799999999986
Q ss_pred cccCcccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHH-------h----
Q 041576 571 LLSDQSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWA-------Y---- 639 (714)
Q Consensus 571 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~-------~---- 639 (714)
... .......+..|+|||++.+.+|+.+.||||||||+.||++|.+.|.+++..++...+.+.. .
T Consensus 341 ~~q----~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~ 416 (586)
T KOG0667|consen 341 ESQ----RVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAK 416 (586)
T ss_pred cCC----cceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence 432 2224557889999999999999999999999999999999998887765544333322210 0
Q ss_pred ---hhhhc--Cccc-----e-----------------eec---c----hhhhccchHHHHHHHHHHHHccccCCCCCCCH
Q 041576 640 ---DCYVE--GKLD-----V-----------------LVD---N----DKAAMADKSRACKWLMIALWCIQEDPLKRPAM 685 (714)
Q Consensus 640 ---~~~~~--~~~~-----~-----------------~~~---~----~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 685 (714)
..+.. +... . ..+ + .............+++++++||+.||.+|+|.
T Consensus 417 ~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp 496 (586)
T KOG0667|consen 417 KAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITP 496 (586)
T ss_pred ccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCH
Confidence 00000 0000 0 000 0 00011112334568999999999999999999
Q ss_pred HHHHHH
Q 041576 686 KMIVQM 691 (714)
Q Consensus 686 ~evl~~ 691 (714)
.|+++.
T Consensus 497 ~qal~H 502 (586)
T KOG0667|consen 497 AQALNH 502 (586)
T ss_pred HHHhcC
Confidence 999974
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=295.32 Aligned_cols=252 Identities=24% Similarity=0.376 Sum_probs=187.2
Q ss_pred hhhCcccceeEEEeEeeCC-CCcEEEEEEecccc-hhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEeecCCC
Q 041576 426 EELGRGSFGIVYKGVLKSA-SGNAVAVKKLDKLA-QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEFMGNG 503 (714)
Q Consensus 426 ~~ig~G~~g~Vy~~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~g 503 (714)
++||+|+||.||+|..... ....+++|.++... ....+.+.+|+..++.++||||+++++.+......++||||++++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 3699999999999976432 23356777776433 344578999999999999999999999999999999999999999
Q ss_pred chhhhhhcC----CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCc-ccc
Q 041576 504 TLANLLFAI----PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQ-SRT 578 (714)
Q Consensus 504 sL~~~l~~~----~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~ 578 (714)
+|.+++... ...++..+..++.||++||+|||+.+ ++||||||+||+++.++.+||+|||++....... ...
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 999999754 23456677899999999999999988 9999999999999999999999999986432211 112
Q ss_pred eeeecCCCCccCcccccC-------CCCCchhhhHHHHHHHHHHHhc-CCCCcccccchhhhhhhHHHhhhhhcCcccee
Q 041576 579 RTVIRGTRGYVAPEWFKN-------VPVSAKVDVYSFGVVLLKIICC-KRSVEMELGEERSAILTDWAYDCYVEGKLDVL 650 (714)
Q Consensus 579 ~~~~~gt~~y~aPE~~~~-------~~~s~ksDVwSlGvil~elltG-~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 650 (714)
.....++..|+|||++.. ..++.++||||||+++|||+++ ..||......+ .+.. ...+....+
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~---~~~~-----~~~~~~~~~ 229 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDRE---VLNH-----VIKDQQVKL 229 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHH---HHHH-----HHhhccccc
Confidence 223457889999998753 2457899999999999999975 66775332211 1111 011111111
Q ss_pred ecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 041576 651 VDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLE 693 (714)
Q Consensus 651 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 693 (714)
.++... ......+.+++..|+ .+|++||+++||++.|.
T Consensus 230 ~~~~~~----~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 230 FKPQLE----LPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCCccC----CCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 221111 123356777888899 67999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=302.98 Aligned_cols=263 Identities=18% Similarity=0.236 Sum_probs=194.7
Q ss_pred hhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc--hhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEee
Q 041576 422 NGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA--QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEF 499 (714)
Q Consensus 422 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~ 499 (714)
|.+.+.||+|++|.||+|+.. .+|+.|++|.++... ......+.+|++++++++||||+++++++.+....++|+||
T Consensus 2 y~~~~~l~~g~~~~vy~~~~~-~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 2 YEKLEKIGEGTYGTVFKAKNR-ETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred ceeEEEecccCCeEEEEEEEC-CCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 566788999999999999976 468899999986432 22335678899999999999999999999999999999999
Q ss_pred cCCCchhhhhhc-CCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcccc
Q 041576 500 MGNGTLANLLFA-IPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRT 578 (714)
Q Consensus 500 ~~~gsL~~~l~~-~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 578 (714)
+++ +|.+++.. ...+++..++.++.||++||+|||+.+ ++||||||+||+++.++.+||+|||++........ .
T Consensus 81 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~-~ 155 (284)
T cd07839 81 CDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR-C 155 (284)
T ss_pred CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCCC-C
Confidence 975 77777654 456899999999999999999999998 99999999999999999999999999976533221 1
Q ss_pred eeeecCCCCccCcccccCC-CCCchhhhHHHHHHHHHHHhcCCCCcccccc-hhhhhhhHH-------Hhhhh---hcCc
Q 041576 579 RTVIRGTRGYVAPEWFKNV-PVSAKVDVYSFGVVLLKIICCKRSVEMELGE-ERSAILTDW-------AYDCY---VEGK 646 (714)
Q Consensus 579 ~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~-~~~~~l~~~-------~~~~~---~~~~ 646 (714)
.....++..|+|||.+.+. .++.++||||||+++|||++|+.|+...... .....+... .+... ....
T Consensus 156 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd07839 156 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYK 235 (284)
T ss_pred cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccccc
Confidence 2233468899999998764 4789999999999999999999986432221 111111000 00000 0000
Q ss_pred cceeecchhh-hccchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 647 LDVLVDNDKA-AMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 647 ~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
.......... ..........+.+++.+||+.||.+|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 236 PYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred ccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 0000000000 0111123457788999999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=312.31 Aligned_cols=249 Identities=26% Similarity=0.348 Sum_probs=207.7
Q ss_pred hhhhhhCcccceeEEEeEeeCCCCc--EEEEEEecccchh-hHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEee
Q 041576 423 GFEEELGRGSFGIVYKGVLKSASGN--AVAVKKLDKLAQE-REREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEF 499 (714)
Q Consensus 423 ~~~~~ig~G~~g~Vy~~~~~~~~~~--~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~ 499 (714)
.+.|+||+|.||.|++|.|...+|+ .||||.++..... ...+|++|+.+|.+|+|||+++++|+..+ ....||+|.
T Consensus 113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~EL 191 (1039)
T KOG0199|consen 113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFEL 191 (1039)
T ss_pred HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhh
Confidence 4568999999999999999877776 6899999875544 66899999999999999999999999988 788999999
Q ss_pred cCCCchhhhhhcC--CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCccc
Q 041576 500 MGNGTLANLLFAI--PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSR 577 (714)
Q Consensus 500 ~~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 577 (714)
++.|+|.+.|++. ..+-......++.|||+||+||.+++ +|||||..+|+|+-....+||+|||+.+.+...+..
T Consensus 192 aplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~ 268 (1039)
T KOG0199|consen 192 APLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGENEDM 268 (1039)
T ss_pred cccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCCCcc
Confidence 9999999999873 34667788899999999999999998 999999999999999999999999999988665443
Q ss_pred cee--eecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccchhhhhhhHHHhhhhhcCccceeecch
Q 041576 578 TRT--VIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDND 654 (714)
Q Consensus 578 ~~~--~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 654 (714)
... ...-...|.|||.++...++.++|||+|||.||||+| |..||-....... + ..+|..
T Consensus 269 Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qI---L--------------~~iD~~ 331 (1039)
T KOG0199|consen 269 YVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQI---L--------------KNIDAG 331 (1039)
T ss_pred eEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHH---H--------------Hhcccc
Confidence 321 1234567999999999999999999999999999998 6778765433321 1 112233
Q ss_pred hhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 041576 655 KAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQML 692 (714)
Q Consensus 655 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 692 (714)
.....++.+++.++++++.||..+|++|||+..|.+.+
T Consensus 332 erLpRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 332 ERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred ccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 33345677888999999999999999999999997543
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=302.40 Aligned_cols=243 Identities=27% Similarity=0.287 Sum_probs=201.2
Q ss_pred hhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEe
Q 041576 422 NGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA---QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYE 498 (714)
Q Consensus 422 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E 498 (714)
|.+.+.||+|++|.||++... .+++.+|+|.+.... ......+.+|++++++++||||+++++++.+++..++|||
T Consensus 3 y~~~~~ig~g~~~~vy~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (290)
T cd05580 3 FEFIKTLGTGSFGRVMLVRHK-GSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVME 81 (290)
T ss_pred eEEEEEeecCCCeEEEEEEEc-CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEe
Confidence 566789999999999999876 468899999986532 2345678899999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcccc
Q 041576 499 FMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRT 578 (714)
Q Consensus 499 ~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 578 (714)
|+++++|.+++.....+++..+..++.||++||+|||+.+ ++|+||+|+||++++++.+||+|||++......
T Consensus 82 ~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~---- 154 (290)
T cd05580 82 YVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR---- 154 (290)
T ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC----
Confidence 9999999999988888999999999999999999999988 999999999999999999999999999876443
Q ss_pred eeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhhc
Q 041576 579 RTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAM 658 (714)
Q Consensus 579 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 658 (714)
.....++..|+|||.+.+...+.++||||||+++|+|++|+.||......... .....+.. .
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~--------~~~~~~~~----------~ 216 (290)
T cd05580 155 TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIY--------EKILEGKV----------R 216 (290)
T ss_pred CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHH--------HHHhcCCc----------c
Confidence 22345788999999998888999999999999999999999999754321110 01111111 0
Q ss_pred cchHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 041576 659 ADKSRACKWLMIALWCIQEDPLKRP-----AMKMIVQ 690 (714)
Q Consensus 659 ~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 690 (714)
.+......+.+++.+||+.||.+|| +++|+++
T Consensus 217 ~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 217 FPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred CCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 1112245777899999999999999 7777764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=297.11 Aligned_cols=248 Identities=21% Similarity=0.262 Sum_probs=195.7
Q ss_pred hhhhhhhCcccceeEEEeEeeCCCCcEEEEEEeccc-----chhhHHHHHHHHHHHhccCcccccceeceEecC--Ceee
Q 041576 422 NGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKL-----AQEREREFKTEVSAIGRTHHKNLVQLLGFCDEG--LNRL 494 (714)
Q Consensus 422 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~ 494 (714)
+.+.+.||+|+||.||+|... .+++.|++|.+... .....+.+.+|+.++++++||||+++++++.+. ...+
T Consensus 4 ~~~~~~l~~g~~g~v~~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (265)
T cd06652 4 WRLGKLLGQGAFGRVYLCYDA-DTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLS 82 (265)
T ss_pred ceEeeEEecCCceEEEEEEEc-CCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEE
Confidence 455688999999999999876 56889999988532 123346788999999999999999999988664 4678
Q ss_pred EEEeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccC
Q 041576 495 LVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSD 574 (714)
Q Consensus 495 lv~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 574 (714)
++|||+++++|.+++.....+++...++++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 83 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~ 159 (265)
T cd06652 83 IFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTI 159 (265)
T ss_pred EEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccccccc
Confidence 99999999999999987777889999999999999999999998 999999999999999999999999998765322
Q ss_pred cc--cceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeec
Q 041576 575 QS--RTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVD 652 (714)
Q Consensus 575 ~~--~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 652 (714)
.. .......++..|+|||.+.+..++.++||||||+++|||++|+.||........ +.. .....
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~---~~~----~~~~~------- 225 (265)
T cd06652 160 CLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAA---IFK----IATQP------- 225 (265)
T ss_pred cccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHH---HHH----HhcCC-------
Confidence 11 112234578899999999888899999999999999999999999964322111 100 00000
Q ss_pred chhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 653 NDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 653 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
.....+......+.+++.+|+. +|++||+++||++
T Consensus 226 --~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 226 --TNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred --CCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 0011223344567778888985 9999999999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=305.54 Aligned_cols=194 Identities=22% Similarity=0.362 Sum_probs=158.8
Q ss_pred hhhCcccceeEEEeEeeC-CCCcEEEEEEecccchhhHHHHHHHHHHHhccCcccccceeceEe--cCCeeeEEEeecCC
Q 041576 426 EELGRGSFGIVYKGVLKS-ASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCD--EGLNRLLVYEFMGN 502 (714)
Q Consensus 426 ~~ig~G~~g~Vy~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~--~~~~~~lv~E~~~~ 502 (714)
.+||+|+||.||+|..+. ..+..||+|.+.... ....+.+|++++++++||||+++++++. .+...++|+||+++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH 84 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence 579999999999998753 356789999986532 2346788999999999999999999884 45677899999875
Q ss_pred CchhhhhhcC---------CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEE----CCCCceEEecCCCcc
Q 041576 503 GTLANLLFAI---------PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILL----DQDFTAKISDFGLSK 569 (714)
Q Consensus 503 gsL~~~l~~~---------~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll----~~~~~~kl~Dfg~~~ 569 (714)
+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+||++ ++++.+||+|||+++
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 777766421 24678889999999999999999998 9999999999999 566799999999998
Q ss_pred ccccCcc--cceeeecCCCCccCcccccCC-CCCchhhhHHHHHHHHHHHhcCCCCccc
Q 041576 570 LLLSDQS--RTRTVIRGTRGYVAPEWFKNV-PVSAKVDVYSFGVVLLKIICCKRSVEME 625 (714)
Q Consensus 570 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~p~~~~ 625 (714)
....... .......++..|+|||.+.+. .++.++|||||||++|||+||+.||...
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 7643322 122334678999999998764 5899999999999999999999999743
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=296.14 Aligned_cols=248 Identities=24% Similarity=0.331 Sum_probs=201.4
Q ss_pred hhhhhhhCcccceeEEEeEeeCCCCcEEEEEEeccc--chhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEee
Q 041576 422 NGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKL--AQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEF 499 (714)
Q Consensus 422 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~ 499 (714)
|.+.+.||+|+||.||++... .+++.|++|.+... .....+++.+|+.++++++||||+++++++...+..++|+||
T Consensus 2 y~~~~~lg~g~~g~~~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 2 YVKVKKIGEGSFGKAILVKSK-EDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred ceEEEEeccCCceEEEEEEEc-CCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 566789999999999999876 47889999998642 234456889999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCC--CCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCccc
Q 041576 500 MGNGTLANLLFAIP--RPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSR 577 (714)
Q Consensus 500 ~~~gsL~~~l~~~~--~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 577 (714)
+++++|.+++.... .+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~- 156 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE- 156 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchh-
Confidence 99999999987543 5688899999999999999999998 99999999999999999999999999976543222
Q ss_pred ceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhh
Q 041576 578 TRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAA 657 (714)
Q Consensus 578 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 657 (714)
......++..|+|||.+.+...+.++||||||+++++|++|+.|+......+. .. ....+...
T Consensus 157 ~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~---~~-----~~~~~~~~--------- 219 (256)
T cd08218 157 LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNL---VL-----KIIRGSYP--------- 219 (256)
T ss_pred hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHH---HH-----HHhcCCCC---------
Confidence 11233578889999999988999999999999999999999999874422211 10 01111111
Q ss_pred ccchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 658 MADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 658 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
..+......+.+++.+||+.+|++||++.||++.
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 220 PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 0122334567889999999999999999999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=299.55 Aligned_cols=245 Identities=25% Similarity=0.357 Sum_probs=199.9
Q ss_pred hhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEeecCCCc
Q 041576 425 EEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEFMGNGT 504 (714)
Q Consensus 425 ~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~gs 504 (714)
.+.||+|++|.||++... .+++.+++|+++.......+.+.+|+.++++++||||+++++++..++..++++||+++++
T Consensus 24 ~~~lg~g~~g~v~~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~ 102 (285)
T cd06648 24 FVKIGEGSTGIVCIATDK-STGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGA 102 (285)
T ss_pred ceEeccCCCeEEEEEEEC-CCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCC
Confidence 468999999999999865 4678999999876555556678999999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcccceeeecC
Q 041576 505 LANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRG 584 (714)
Q Consensus 505 L~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g 584 (714)
|.+++.. ..+++..+..++.|++.||+|||+++ ++||||+|+||+++.++.++|+|||.+........ ......+
T Consensus 103 L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~ 177 (285)
T cd06648 103 LTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-RRKSLVG 177 (285)
T ss_pred HHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCc-ccccccC
Confidence 9999987 67889999999999999999999998 99999999999999999999999998876543222 1223457
Q ss_pred CCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhhccchHHH
Q 041576 585 TRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMADKSRA 664 (714)
Q Consensus 585 t~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 664 (714)
+..|+|||.+.+..++.++||||||+++|||++|+.||.......... ........... ......
T Consensus 178 ~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~--------~~~~~~~~~~~-------~~~~~~ 242 (285)
T cd06648 178 TPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMK--------RIRDNLPPKLK-------NLHKVS 242 (285)
T ss_pred CccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHH--------HHHhcCCCCCc-------ccccCC
Confidence 889999999988889999999999999999999999986533221110 01111000000 011234
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 665 CKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 665 ~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
..+.+++.+||+.+|++||++.++++
T Consensus 243 ~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 243 PRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred HHHHHHHHHHcccChhhCcCHHHHcc
Confidence 57888999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=295.36 Aligned_cols=251 Identities=28% Similarity=0.380 Sum_probs=206.5
Q ss_pred hhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccch-hhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEeec
Q 041576 422 NGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQ-EREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEFM 500 (714)
Q Consensus 422 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~ 500 (714)
+++.+.||+|++|.||+|+.+ .+++.|++|++..... .....+.+|++.+.+++|+||+++++++..+...++|+||+
T Consensus 3 ~~~~~~i~~g~~~~v~~~~~~-~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (264)
T cd06623 3 LERVKVLGQGSSGVVYKVRHK-PTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYM 81 (264)
T ss_pred ceeeeeeeecCCeEEEEEEEc-CCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEec
Confidence 456789999999999999987 4688999999876443 45678999999999999999999999999999999999999
Q ss_pred CCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHh-cCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcccce
Q 041576 501 GNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHE-ECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTR 579 (714)
Q Consensus 501 ~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~-~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 579 (714)
++++|.+++.....+++..++.++.|+++||+|||+ .+ ++|+||+|+||+++.++.++|+|||.+..........
T Consensus 82 ~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~- 157 (264)
T cd06623 82 DGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQC- 157 (264)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCCCcc-
Confidence 999999999887889999999999999999999999 87 9999999999999999999999999998764433222
Q ss_pred eeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhhcc
Q 041576 580 TVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMA 659 (714)
Q Consensus 580 ~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 659 (714)
....++..|+|||.+.+..++.++||||||+++|||++|+.|+.............. ....... ..
T Consensus 158 ~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~-----~~~~~~~---------~~ 223 (264)
T cd06623 158 NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQA-----ICDGPPP---------SL 223 (264)
T ss_pred cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHH-----HhcCCCC---------CC
Confidence 234578899999999998999999999999999999999999975532111111111 0111110 01
Q ss_pred chH-HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 660 DKS-RACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 660 ~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
+.. .+..+.+++.+||+.+|++||++.|+++.
T Consensus 224 ~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 224 PAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred CcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 111 44678889999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=296.67 Aligned_cols=254 Identities=27% Similarity=0.401 Sum_probs=203.0
Q ss_pred hhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc-hhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEee
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA-QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEF 499 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~ 499 (714)
.|.+.+.||.|++|+||+|... .++..+++|++.... ....+.+.+|++.++.++|+||+++++.+..++..++|+|+
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 2 DYELIEVIGVGATAVVYAAICL-PNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred cceeeeeecCCCCeEEEEEEEc-CCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 3567789999999999999876 468899999986432 23567899999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcC---CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcc
Q 041576 500 MGNGTLANLLFAI---PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQS 576 (714)
Q Consensus 500 ~~~gsL~~~l~~~---~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 576 (714)
+++++|.+++... ..+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 9999999999764 45789999999999999999999998 99999999999999999999999999887654332
Q ss_pred c---ceeeecCCCCccCcccccCC-CCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeec
Q 041576 577 R---TRTVIRGTRGYVAPEWFKNV-PVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVD 652 (714)
Q Consensus 577 ~---~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 652 (714)
. ......++..|+|||.+... .++.++||||||+++|||++|+.||........ .... ....... ..
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~---~~~~-----~~~~~~~-~~ 228 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV---LMLT-----LQNDPPS-LE 228 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhh---HHHH-----hcCCCCC-cC
Confidence 2 22334588899999998776 789999999999999999999999975433211 1110 0000000 00
Q ss_pred chhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 653 NDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 653 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
. .......+..+.+++.+||+.||++||++++|++
T Consensus 229 ~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 229 T---GADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred C---ccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0 0001233467788999999999999999999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=293.24 Aligned_cols=261 Identities=24% Similarity=0.317 Sum_probs=199.3
Q ss_pred hhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhc--cCcccccceeceEecCC----eeeEEE
Q 041576 424 FEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGR--THHKNLVQLLGFCDEGL----NRLLVY 497 (714)
Q Consensus 424 ~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~nIv~l~~~~~~~~----~~~lv~ 497 (714)
+.+.||+|.||.||+|.++ |+.||||++.. .+++.+.+|.++.+. |+|+||+.+++.-..++ +.+||.
T Consensus 215 L~e~IGkGRyGEVwrG~wr---Ge~VAVKiF~s---rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvT 288 (513)
T KOG2052|consen 215 LQEIIGKGRFGEVWRGRWR---GEDVAVKIFSS---RDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVT 288 (513)
T ss_pred EEEEecCccccceeecccc---CCceEEEEecc---cchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEee
Confidence 5678999999999999997 88999999954 345677788888876 49999999999875544 468999
Q ss_pred eecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhc-----CCCCeEecCCCcCeEEECCCCceEEecCCCccccc
Q 041576 498 EFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEE-----CNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLL 572 (714)
Q Consensus 498 E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~-----~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~ 572 (714)
+|.+.|||.|+|.. ..++.+..++++..+|.||++||.+ |++.|.|||||+.||||..++...|+|+|+|....
T Consensus 289 dYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~ 367 (513)
T KOG2052|consen 289 DYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD 367 (513)
T ss_pred ecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEec
Confidence 99999999999988 7789999999999999999999964 67889999999999999999999999999998765
Q ss_pred cCc---ccceeeecCCCCccCcccccCCC----C--CchhhhHHHHHHHHHHHhc----------CCCCcccccchhhhh
Q 041576 573 SDQ---SRTRTVIRGTRGYVAPEWFKNVP----V--SAKVDVYSFGVVLLKIICC----------KRSVEMELGEERSAI 633 (714)
Q Consensus 573 ~~~---~~~~~~~~gt~~y~aPE~~~~~~----~--s~ksDVwSlGvil~elltG----------~~p~~~~~~~~~~~~ 633 (714)
.+. .......+||.+|||||++...- + =..+||||||.|+||+... +.||....+.+..
T Consensus 368 ~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs-- 445 (513)
T KOG2052|consen 368 SDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPS-- 445 (513)
T ss_pred ccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCC--
Confidence 543 23344567999999999995431 2 2369999999999999742 2344432222110
Q ss_pred hhHHHhhhhhcCccceeecchh-hhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCC
Q 041576 634 LTDWAYDCYVEGKLDVLVDNDK-AAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLEV 698 (714)
Q Consensus 634 l~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 698 (714)
.+...+-.-..-+.+.. ..-...+....+.++++.||..+|.-|-|+-.|.+.|.++.+.
T Consensus 446 -----~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~~ 506 (513)
T KOG2052|consen 446 -----FEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSNS 506 (513)
T ss_pred -----HHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhcC
Confidence 00011100000011111 1112345667888999999999999999999999999887754
|
|
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=295.41 Aligned_cols=251 Identities=25% Similarity=0.378 Sum_probs=199.8
Q ss_pred hhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecc--cchhhHHHHHHHHHHHhccCcccccceeceEec--CCeeeEEE
Q 041576 422 NGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDK--LAQEREREFKTEVSAIGRTHHKNLVQLLGFCDE--GLNRLLVY 497 (714)
Q Consensus 422 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--~~~~~lv~ 497 (714)
|.+.+.||.|++|.||++... .+++.+++|.+.. ......+.+.+|++++++++||||+++++++.. +...+++|
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~-~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 2 YEVLETIGKGSFGTVRKVRRK-SDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred ceeeeeeccCCCeEEEEeeec-CCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 456788999999999999876 4678999998864 234445678899999999999999999998754 45678999
Q ss_pred eecCCCchhhhhhc----CCCCChhhHHHHHHHHHHHHHHHHhcC--CCCeEecCCCcCeEEECCCCceEEecCCCcccc
Q 041576 498 EFMGNGTLANLLFA----IPRPDWSLRVRISLEIARGLLYLHEEC--NVPIIHCDIKPQNILLDQDFTAKISDFGLSKLL 571 (714)
Q Consensus 498 E~~~~gsL~~~l~~----~~~~~~~~~~~i~~qi~~~L~yLH~~~--~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~ 571 (714)
||+++++|.+++.. ...+++..++.++.||++||+|||..+ ..+++|+||+|+||++++++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 99999999999865 356889999999999999999999322 233999999999999999999999999999876
Q ss_pred ccCcccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceee
Q 041576 572 LSDQSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLV 651 (714)
Q Consensus 572 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 651 (714)
...... .....++..|+|||.+.+..++.++||||||+++++|++|+.||....... +.. ....+...
T Consensus 161 ~~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~----~~~----~~~~~~~~--- 228 (265)
T cd08217 161 GHDSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQ----LAS----KIKEGKFR--- 228 (265)
T ss_pred cCCccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHH----HHH----HHhcCCCC---
Confidence 543321 223458899999999998889999999999999999999999997543221 111 11111111
Q ss_pred cchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 652 DNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 652 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
..+...+..+.+++.+||+.+|++||++++|++.
T Consensus 229 ------~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 229 ------RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred ------CCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 1122344578889999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=299.46 Aligned_cols=251 Identities=27% Similarity=0.341 Sum_probs=194.6
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhcc-CcccccceeceEe-----cCCee
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRT-HHKNLVQLLGFCD-----EGLNR 493 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~-----~~~~~ 493 (714)
.++.+.+.||+|+||.||+|... .+++.+++|.++... .....+.+|+.+++++ +||||+++++++. .+...
T Consensus 18 ~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~ 95 (286)
T cd06638 18 DTWEIIETIGKGTYGKVFKVLNK-KNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQL 95 (286)
T ss_pred cceeeeeeeccCCCcEEEEEEEC-CCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeE
Confidence 35566789999999999999876 467899999886532 2345678899999999 7999999999884 44568
Q ss_pred eEEEeecCCCchhhhhhc----CCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCcc
Q 041576 494 LLVYEFMGNGTLANLLFA----IPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSK 569 (714)
Q Consensus 494 ~lv~E~~~~gsL~~~l~~----~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~ 569 (714)
++||||+++++|.+++.. ...+++..+..++.|+++||.|||+.+ ++||||||+||++++++.+||+|||++.
T Consensus 96 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~ 172 (286)
T cd06638 96 WLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKLVDFGVSA 172 (286)
T ss_pred EEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEEccCCcee
Confidence 999999999999998753 345788889999999999999999988 9999999999999999999999999987
Q ss_pred ccccCcccceeeecCCCCccCcccccC-----CCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhc
Q 041576 570 LLLSDQSRTRTVIRGTRGYVAPEWFKN-----VPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVE 644 (714)
Q Consensus 570 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~ 644 (714)
....... ......|+..|+|||.+.. ..++.++|||||||++|||++|+.|+........ +.. ...
T Consensus 173 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~---~~~-----~~~ 243 (286)
T cd06638 173 QLTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA---LFK-----IPR 243 (286)
T ss_pred ecccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH---Hhh-----ccc
Confidence 6543221 2223458899999998853 4578899999999999999999999875432111 100 000
Q ss_pred CccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 645 GKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 645 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
....... .+......+.+++.+||+.||++|||+.||++.
T Consensus 244 ~~~~~~~-------~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 244 NPPPTLH-------QPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred cCCCccc-------CCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 0000000 111123467889999999999999999999875
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=297.14 Aligned_cols=248 Identities=23% Similarity=0.339 Sum_probs=199.2
Q ss_pred hhhhhhhCcccceeEEEeEeeCCCCcEEEEEEeccc-chhhHHHHHHHHHHHhccC---cccccceeceEecCCeeeEEE
Q 041576 422 NGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKL-AQEREREFKTEVSAIGRTH---HKNLVQLLGFCDEGLNRLLVY 497 (714)
Q Consensus 422 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~---h~nIv~l~~~~~~~~~~~lv~ 497 (714)
|.+.+.||+|+||.||+|.+. .+++.|++|.++.. ......++.+|+.++++++ |||++++++++..+...++||
T Consensus 3 y~~~~~l~~g~~g~v~~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 3 YQRLELIGRGAYGAVYRGKHV-PTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhheeccCCceEEEEEEc-CCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 556788999999999999975 46889999998653 3344567889999999986 999999999999999999999
Q ss_pred eecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCccc
Q 041576 498 EFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSR 577 (714)
Q Consensus 498 E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 577 (714)
||+++++|.+++.. ..+++..++.++.|+++||+|||+.+ ++|+||+|+||++++++.++|+|||++........
T Consensus 82 e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06917 82 EYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS- 156 (277)
T ss_pred ecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc-
Confidence 99999999999876 47889999999999999999999998 99999999999999999999999999987654332
Q ss_pred ceeeecCCCCccCcccccCC-CCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhh
Q 041576 578 TRTVIRGTRGYVAPEWFKNV-PVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKA 656 (714)
Q Consensus 578 ~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 656 (714)
......|+..|+|||.+.+. .++.++||||||+++|+|++|+.||.......... .........+
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~--------~~~~~~~~~~------ 222 (277)
T cd06917 157 KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMM--------LIPKSKPPRL------ 222 (277)
T ss_pred ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhh--------ccccCCCCCC------
Confidence 22334588899999988754 57899999999999999999999997443221100 0000000000
Q ss_pred hccchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 657 AMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 657 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
........+.+++.+||+.||++||++.|+++.
T Consensus 223 --~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 223 --EDNGYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred --CcccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 011134567889999999999999999999873
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=293.08 Aligned_cols=247 Identities=27% Similarity=0.373 Sum_probs=199.6
Q ss_pred hhhhhhhCcccceeEEEeEeeCCCCcEEEEEEeccc--chhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEee
Q 041576 422 NGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKL--AQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEF 499 (714)
Q Consensus 422 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~ 499 (714)
|.+.+.||+|++|.||++... .+++.+++|.+... .......+.+|++++++++||||+++++.+..++..++||||
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 2 YEKIRVVGRGAFGIVHLCRRK-ADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred ceEEEEecccCceEEEEEEEc-CCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 556789999999999999876 47889999998643 334456889999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcC--CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCC-CceEEecCCCccccccCcc
Q 041576 500 MGNGTLANLLFAI--PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQD-FTAKISDFGLSKLLLSDQS 576 (714)
Q Consensus 500 ~~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~-~~~kl~Dfg~~~~~~~~~~ 576 (714)
+++++|.+++... ..+++..+..++.|+++||+|||+++ ++|+||+|+||+++++ +.+||+|||.+........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK 157 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc
Confidence 9999999999764 34788999999999999999999998 9999999999999865 4689999999987643321
Q ss_pred cceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhh
Q 041576 577 RTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKA 656 (714)
Q Consensus 577 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 656 (714)
.....++..|+|||.+.+..++.++||||||+++|+|++|+.||........ ... ...+....
T Consensus 158 --~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~---~~~-----~~~~~~~~------- 220 (256)
T cd08220 158 --AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPAL---VLK-----IMSGTFAP------- 220 (256)
T ss_pred --ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHH---HHH-----HHhcCCCC-------
Confidence 2234578899999999988899999999999999999999999865432211 100 01111110
Q ss_pred hccchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 657 AMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 657 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
.+......+.+++.+||+.+|++|||+.|+++.
T Consensus 221 --~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 221 --ISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred --CCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 111234567889999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=333.09 Aligned_cols=256 Identities=21% Similarity=0.278 Sum_probs=198.5
Q ss_pred HHHHHHhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEeccc--chhhHHHHHHHHHHHhccCcccccceeceEec--C
Q 041576 415 VELNEATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKL--AQEREREFKTEVSAIGRTHHKNLVQLLGFCDE--G 490 (714)
Q Consensus 415 ~el~~at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--~ 490 (714)
.+.....|.+.+.||+|+||+||+|.+. .++..+|+|.+... .......+..|+.++++++||||+++++++.+ .
T Consensus 8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk-~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~ 86 (1021)
T PTZ00266 8 GESRLNEYEVIKKIGNGRFGEVFLVKHK-RTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKAN 86 (1021)
T ss_pred CccccCCEEEEEEEecCCCeEEEEEEEC-CCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCC
Confidence 3444456888899999999999999976 46789999988642 33445678999999999999999999998854 4
Q ss_pred CeeeEEEeecCCCchhhhhhcC----CCCChhhHHHHHHHHHHHHHHHHhcCC----CCeEecCCCcCeEEECC------
Q 041576 491 LNRLLVYEFMGNGTLANLLFAI----PRPDWSLRVRISLEIARGLLYLHEECN----VPIIHCDIKPQNILLDQ------ 556 (714)
Q Consensus 491 ~~~~lv~E~~~~gsL~~~l~~~----~~~~~~~~~~i~~qi~~~L~yLH~~~~----~~ivH~Dlk~~NIll~~------ 556 (714)
...+|||||+++++|.++|... ..+++..++.|+.||+.||+|||+.+. .+||||||||+||||+.
T Consensus 87 ~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg 166 (1021)
T PTZ00266 87 QKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIG 166 (1021)
T ss_pred CEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccc
Confidence 5689999999999999998752 468999999999999999999998542 34999999999999964
Q ss_pred -----------CCceEEecCCCccccccCcccceeeecCCCCccCcccccC--CCCCchhhhHHHHHHHHHHHhcCCCCc
Q 041576 557 -----------DFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKN--VPVSAKVDVYSFGVVLLKIICCKRSVE 623 (714)
Q Consensus 557 -----------~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~ksDVwSlGvil~elltG~~p~~ 623 (714)
...+||+|||++..+.... ......||+.|+|||++.+ ..++.++|||||||+||||++|+.||.
T Consensus 167 ~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~ 244 (1021)
T PTZ00266 167 KITAQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFH 244 (1021)
T ss_pred cccccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCC
Confidence 2358999999998653322 1223468999999999854 458999999999999999999999996
Q ss_pred ccccchhhhhhhHHHhhhhhcCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 624 MELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 624 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
...... ..+. .+.... . ......+..+.+||..||+.+|.+||++.|+++
T Consensus 245 ~~~~~~--qli~-----~lk~~p--~--------lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 245 KANNFS--QLIS-----ELKRGP--D--------LPIKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred cCCcHH--HHHH-----HHhcCC--C--------CCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 432211 1110 011100 0 001112456788999999999999999999984
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=299.02 Aligned_cols=264 Identities=20% Similarity=0.227 Sum_probs=198.0
Q ss_pred hhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccch--hhHHHHHHHHHHHhccCcccccceeceEecC--CeeeEE
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQ--EREREFKTEVSAIGRTHHKNLVQLLGFCDEG--LNRLLV 496 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~lv 496 (714)
.|.+.+.||+|++|.||+|... .+++.+++|.++.... .....+.+|+.++++++||||+++++++... ...++|
T Consensus 6 ~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 6 EYEKLNRIEEGTYGVVYRARDK-KTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhcCCCCeEEEEEEEC-CCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 4667789999999999999876 4688999999965332 2234677899999999999999999998777 889999
Q ss_pred EeecCCCchhhhhhcCC-CCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCc
Q 041576 497 YEFMGNGTLANLLFAIP-RPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQ 575 (714)
Q Consensus 497 ~E~~~~gsL~~~l~~~~-~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 575 (714)
+||+++ +|.+++.... .+++..++.++.||++||+|||+.+ ++|+||||+||++++++.+||+|||++.......
T Consensus 85 ~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 160 (293)
T cd07843 85 MEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL 160 (293)
T ss_pred ehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence 999985 9998887643 5899999999999999999999998 9999999999999999999999999998664432
Q ss_pred ccceeeecCCCCccCcccccCC-CCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHH-------hhhh---hc
Q 041576 576 SRTRTVIRGTRGYVAPEWFKNV-PVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWA-------YDCY---VE 644 (714)
Q Consensus 576 ~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~-------~~~~---~~ 644 (714)
. ......++..|+|||.+.+. .++.++||||||+++|||++|+.||...........+.... +..+ ..
T Consensus 161 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (293)
T cd07843 161 K-PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPG 239 (293)
T ss_pred c-ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccch
Confidence 1 12233467889999998754 46899999999999999999999997554322111111000 0000 00
Q ss_pred ---CccceeecchhhhccchH-HHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 645 ---GKLDVLVDNDKAAMADKS-RACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 645 ---~~~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
...............+.. ....+.+++.+||+.||++|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 240 AKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred hcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 000000000011111111 3456788999999999999999999986
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=298.46 Aligned_cols=263 Identities=24% Similarity=0.254 Sum_probs=199.9
Q ss_pred hhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc--hhhHHHHHHHHHHHhccCcccccceeceEecC--CeeeEEEe
Q 041576 423 GFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA--QEREREFKTEVSAIGRTHHKNLVQLLGFCDEG--LNRLLVYE 498 (714)
Q Consensus 423 ~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~lv~E 498 (714)
.+.+.||+|++|.||+|+.. .+++.+++|++.... ......+.+|++++++++|+|++++++++... ...++|+|
T Consensus 2 ~~~~~l~~g~~~~vy~~~~~-~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 2 EKIAQIGEGTYGQVYKARNK-KTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred eeeEEeccCCCeEEEEEEEC-CCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 45678999999999999876 467899999997643 33446788999999999999999999999888 88999999
Q ss_pred ecCCCchhhhhhcC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCccc
Q 041576 499 FMGNGTLANLLFAI-PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSR 577 (714)
Q Consensus 499 ~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 577 (714)
|+++ +|.+++... ..+++..++.++.||++||+|||+.+ ++|+||+|+||++++++.+||+|||++.........
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~ 156 (287)
T cd07840 81 YMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSA 156 (287)
T ss_pred cccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCCcc
Confidence 9985 888888765 57899999999999999999999998 999999999999999999999999999876544322
Q ss_pred ceeeecCCCCccCcccccC-CCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhh----hhhc--------
Q 041576 578 TRTVIRGTRGYVAPEWFKN-VPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYD----CYVE-------- 644 (714)
Q Consensus 578 ~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~----~~~~-------- 644 (714)
......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...........+...... .+..
T Consensus 157 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (287)
T cd07840 157 DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFE 236 (287)
T ss_pred cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhh
Confidence 2333456788999998764 45789999999999999999999999765433221111110000 0000
Q ss_pred -CccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 645 -GKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 645 -~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
...................+..+.+++.+||+.+|.+||+++++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 237 NLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred hccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0000000000011111112567889999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=296.53 Aligned_cols=247 Identities=26% Similarity=0.273 Sum_probs=202.2
Q ss_pred hhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEe
Q 041576 422 NGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA---QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYE 498 (714)
Q Consensus 422 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E 498 (714)
|.+.+.||.|+||.||+|... .+++.|++|.+.... ....+.+.+|++++++++||||+++++.+.++...++|+|
T Consensus 2 y~~~~~i~~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 2 FELLRVIGKGAFGKVCIVQKR-DTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred ceEEEEeccCCCceEEEEEEc-cCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 566789999999999999875 568899999996532 2446789999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcccc
Q 041576 499 FMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRT 578 (714)
Q Consensus 499 ~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 578 (714)
|+++++|.+++.....+++..+..++.||++||+|||+.+ ++|+||+|+||++++++.++|+|||.+....... .
T Consensus 81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--~ 155 (258)
T cd05578 81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--L 155 (258)
T ss_pred CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc--c
Confidence 9999999999987778899999999999999999999998 9999999999999999999999999988764432 2
Q ss_pred eeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhhc
Q 041576 579 RTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAM 658 (714)
Q Consensus 579 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 658 (714)
.....++..|+|||.+.+..++.++||||||+++|+|++|+.||............ ..... ....
T Consensus 156 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~-----~~~~~----------~~~~ 220 (258)
T cd05578 156 TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIR-----AKQET----------ADVL 220 (258)
T ss_pred ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHH-----HHhcc----------cccc
Confidence 23345788999999998888999999999999999999999999865432111111 00000 0011
Q ss_pred cchHHHHHHHHHHHHccccCCCCCCCH--HHHH
Q 041576 659 ADKSRACKWLMIALWCIQEDPLKRPAM--KMIV 689 (714)
Q Consensus 659 ~~~~~~~~l~~li~~cl~~dP~~RPs~--~evl 689 (714)
.+...+..+.+++.+||+.||.+||++ +|++
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 221 YPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred CcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 122234678889999999999999999 5554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=296.31 Aligned_cols=249 Identities=24% Similarity=0.351 Sum_probs=201.6
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc-hhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEe
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA-QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYE 498 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E 498 (714)
..+.+.+.||+|+||.||+|... .+++.||+|.+.... ......+.+|+..+.+++||||+++++++..+...++|||
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 82 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDN-RTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 82 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEEC-CCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEE
Confidence 45667788999999999999865 467899999886432 3445678999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcccc
Q 041576 499 FMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRT 578 (714)
Q Consensus 499 ~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 578 (714)
|+++++|.+++.. ..+++..+..++.|++.|++|||+.+ ++|+||+|+||+++.++.++|+|||++..+..... .
T Consensus 83 ~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~-~ 157 (277)
T cd06641 83 YLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-K 157 (277)
T ss_pred eCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccchh-h
Confidence 9999999999865 46789999999999999999999998 99999999999999999999999999876543221 2
Q ss_pred eeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhhc
Q 041576 579 RTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAM 658 (714)
Q Consensus 579 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 658 (714)
.....++..|+|||.+.+..++.++||||||+++|+|++|..|+.......... ........ .
T Consensus 158 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~--------~~~~~~~~---------~ 220 (277)
T cd06641 158 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLF--------LIPKNNPP---------T 220 (277)
T ss_pred hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHH--------HHhcCCCC---------C
Confidence 223457889999999988889999999999999999999999986432211100 00111100 1
Q ss_pred cchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 659 ADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 659 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
.....+..+.+++.+||+.+|.+||++.++++.
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 221 LEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 112234567789999999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=297.41 Aligned_cols=250 Identities=27% Similarity=0.391 Sum_probs=203.2
Q ss_pred hhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEeec
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEFM 500 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~ 500 (714)
.+.+.+.||+|++|.||+|.+. .++..+++|.+..... ....+.+|++.+++++|+||+++++.+..+...++++||+
T Consensus 20 ~~~~~~~l~~g~~~~v~~~~~~-~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 97 (286)
T cd06614 20 LYKNLEKIGEGASGEVYKATDR-ATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYM 97 (286)
T ss_pred cchHhHhccCCCCeEEEEEEEc-cCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEecc
Confidence 3556688999999999999976 4678999999976444 5667899999999999999999999999999999999999
Q ss_pred CCCchhhhhhcCC-CCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcccce
Q 041576 501 GNGTLANLLFAIP-RPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTR 579 (714)
Q Consensus 501 ~~gsL~~~l~~~~-~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 579 (714)
++++|.+++.... .+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++........ ..
T Consensus 98 ~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~ 173 (286)
T cd06614 98 DGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS-KR 173 (286)
T ss_pred CCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccchh-hh
Confidence 9999999998876 8899999999999999999999988 99999999999999999999999998876543221 22
Q ss_pred eeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhhcc
Q 041576 580 TVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMA 659 (714)
Q Consensus 580 ~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 659 (714)
....++..|+|||.+.+..++.++||||||+++|+|++|+.|+...........+ ........ ..
T Consensus 174 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~--------~~~~~~~~-------~~ 238 (286)
T cd06614 174 NSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLI--------TTKGIPPL-------KN 238 (286)
T ss_pred ccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--------HhcCCCCC-------cc
Confidence 2334778999999999888999999999999999999999998754322111100 00001000 01
Q ss_pred chHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 660 DKSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 660 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
.......+.+++.+||+.+|.+||++.+|++.
T Consensus 239 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 239 PEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred hhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 11134567889999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=299.57 Aligned_cols=251 Identities=25% Similarity=0.363 Sum_probs=203.1
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEee
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEF 499 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~ 499 (714)
.+|.+.+.||+|+||.||++... .++..|++|.+........+.+.+|+.++++++||||+++++.+...+..++|+||
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~-~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~ 97 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDV-ATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY 97 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEc-CCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence 45667789999999999999865 46789999998755555567789999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcccce
Q 041576 500 MGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTR 579 (714)
Q Consensus 500 ~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 579 (714)
+++++|.+++.. ..+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++........ ..
T Consensus 98 ~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~-~~ 172 (293)
T cd06647 98 LAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KR 172 (293)
T ss_pred CCCCcHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccccc-cc
Confidence 999999999875 35788899999999999999999998 99999999999999999999999998876543322 22
Q ss_pred eeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhhcc
Q 041576 580 TVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMA 659 (714)
Q Consensus 580 ~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 659 (714)
....++..|+|||.+.+..++.++||||||+++||+++|+.||...........+ ...+. .....
T Consensus 173 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~-------~~~~~--------~~~~~ 237 (293)
T cd06647 173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI-------ATNGT--------PELQN 237 (293)
T ss_pred ccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeeh-------hcCCC--------CCCCC
Confidence 2345788899999998888999999999999999999999999754322110000 00000 00011
Q ss_pred chHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 660 DKSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 660 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
.......+.+++.+||+.+|++||++.+++..
T Consensus 238 ~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 238 PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 12234467789999999999999999999976
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=290.55 Aligned_cols=248 Identities=28% Similarity=0.406 Sum_probs=204.0
Q ss_pred hhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEeecC
Q 041576 422 NGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEFMG 501 (714)
Q Consensus 422 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~ 501 (714)
|...+.||+|++|.||++... .+++.+++|++..........+.+|++.+++++|+||+++++++......++++||++
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~-~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 2 FEILEKIGKGGFGEVYKARHK-RTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred ceeeeeeccCCceEEEEEEEC-CCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 345678999999999999976 3688999999977655567789999999999999999999999999999999999999
Q ss_pred CCchhhhhhcC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCccccee
Q 041576 502 NGTLANLLFAI-PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRT 580 (714)
Q Consensus 502 ~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 580 (714)
+++|.+++... ..+++..+..++.|+++||+|||+.+ ++||||+|+||++++++.++|+|||.+........ ..
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~ 155 (253)
T cd05122 81 GGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--RN 155 (253)
T ss_pred CCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc--cc
Confidence 99999999876 57899999999999999999999987 99999999999999999999999999987654332 23
Q ss_pred eecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhhccc
Q 041576 581 VIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMAD 660 (714)
Q Consensus 581 ~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 660 (714)
...++..|+|||.+.+...+.++||||||+++++|++|+.|+.......... .. ......... ..
T Consensus 156 ~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~---~~-----~~~~~~~~~-------~~ 220 (253)
T cd05122 156 TMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALF---KI-----ATNGPPGLR-------NP 220 (253)
T ss_pred ceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHH---HH-----HhcCCCCcC-------cc
Confidence 4457889999999998889999999999999999999999987543221100 00 000001110 01
Q ss_pred hHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 661 KSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 661 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
......+.+++.+||+.||++|||+.|+++
T Consensus 221 ~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 221 EKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred cccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 112456888999999999999999999986
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=297.02 Aligned_cols=261 Identities=24% Similarity=0.306 Sum_probs=196.5
Q ss_pred hhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc--hhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEeec
Q 041576 423 GFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA--QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEFM 500 (714)
Q Consensus 423 ~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~ 500 (714)
.+.+.||.|++|.||+|... .++..|++|++.... ......+.+|++.+++++||||+++++++.+++..+++|||+
T Consensus 2 ~~~~~l~~g~~~~vy~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 2 QKVEKIGEGTYGVVYKARDK-LTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred chheEecCCCCeEEEEEEEc-CCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 45678999999999999876 478999999986432 223457889999999999999999999999999999999999
Q ss_pred CCCchhhhhhcCC--CCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcccc
Q 041576 501 GNGTLANLLFAIP--RPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRT 578 (714)
Q Consensus 501 ~~gsL~~~l~~~~--~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 578 (714)
+ ++|.+++.... .+++..+..++.|+++||+|||+.+ ++||||+|+||++++++.++|+|||++........ .
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-~ 155 (283)
T cd07835 81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR-T 155 (283)
T ss_pred C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc-c
Confidence 5 68999987665 6899999999999999999999987 99999999999999999999999999976533221 1
Q ss_pred eeeecCCCCccCcccccCC-CCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHH-------hh---hhhcC--
Q 041576 579 RTVIRGTRGYVAPEWFKNV-PVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWA-------YD---CYVEG-- 645 (714)
Q Consensus 579 ~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~-------~~---~~~~~-- 645 (714)
.....++..|+|||.+.+. .++.++||||||+++|||++|+.||...........+.... +. ...+.
T Consensus 156 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd07835 156 YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKP 235 (283)
T ss_pred cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhh
Confidence 1222467889999988654 57899999999999999999999997543322111110000 00 00000
Q ss_pred ccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 646 KLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 646 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
........ ............+.+++.+||+.||++|||++|+++
T Consensus 236 ~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 236 TFPKWARQ-DLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hccccccc-chhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 00000000 000111223356788999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=297.26 Aligned_cols=262 Identities=23% Similarity=0.284 Sum_probs=195.1
Q ss_pred hhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc--hhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEee
Q 041576 422 NGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA--QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEF 499 (714)
Q Consensus 422 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~ 499 (714)
|...+.||.|++|.||+|+.. .+++.|+||+++... ......+.+|++++++++||||+++++++.+++..++||||
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 2 FQKVEKIGEGTYGVVYKARNK-LTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred ceeeeeecCCCceEEEEEEEC-CCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 455678999999999999876 468899999986432 22345788999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcC--CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCccc
Q 041576 500 MGNGTLANLLFAI--PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSR 577 (714)
Q Consensus 500 ~~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 577 (714)
+. ++|.+++... ..+++..+..++.|+++||+|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~- 155 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR- 155 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCcc-
Confidence 96 5888888653 46789999999999999999999998 99999999999999999999999999876533221
Q ss_pred ceeeecCCCCccCcccccCCC-CCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhh----------hhhc--
Q 041576 578 TRTVIRGTRGYVAPEWFKNVP-VSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYD----------CYVE-- 644 (714)
Q Consensus 578 ~~~~~~gt~~y~aPE~~~~~~-~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~----------~~~~-- 644 (714)
......++..|+|||.+.+.. ++.++||||||+++|||+||+.||...........+...... ....
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd07860 156 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYK 235 (284)
T ss_pred ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHH
Confidence 112234678899999887644 688999999999999999999999754322211110000000 0000
Q ss_pred CccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 645 GKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 645 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
............. ........+.+++.+||+.||++|||++|+++
T Consensus 236 ~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 236 PSFPKWARQDFSK-VVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred hhcccccccCHHH-HcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 0000000000000 01122346778999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=321.81 Aligned_cols=270 Identities=18% Similarity=0.247 Sum_probs=189.8
Q ss_pred HHHhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEe--------------c---ccchhhHHHHHHHHHHHhccCcccc
Q 041576 418 NEATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKL--------------D---KLAQEREREFKTEVSAIGRTHHKNL 480 (714)
Q Consensus 418 ~~at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~--------------~---~~~~~~~~~~~~E~~~l~~l~h~nI 480 (714)
....|.+.+.||+|+||+||++.++...+...+.|.+ . .........+.+|++++++++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 3457888899999999999998876444433333311 0 1112234568899999999999999
Q ss_pred cceeceEecCCeeeEEEeecCCCchhhhhhcC-----CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEEC
Q 041576 481 VQLLGFCDEGLNRLLVYEFMGNGTLANLLFAI-----PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLD 555 (714)
Q Consensus 481 v~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~-----~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~ 555 (714)
+++++++...+..++|+|++.. +|.+++... .......+..|+.||+.||+|||+++ |+||||||+|||++
T Consensus 226 v~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl~ 301 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFLN 301 (501)
T ss_pred CcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEC
Confidence 9999999999999999999865 666665432 22345667889999999999999998 99999999999999
Q ss_pred CCCceEEecCCCccccccCcccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhh
Q 041576 556 QDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILT 635 (714)
Q Consensus 556 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~ 635 (714)
.++.+||+|||++..+............|+..|+|||++.+..++.++|||||||++|||++|..++...........+.
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~ 381 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLL 381 (501)
T ss_pred CCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHH
Confidence 99999999999998765443333344578999999999999999999999999999999999886543222111111111
Q ss_pred HHHh------hhhhc-----------CccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 636 DWAY------DCYVE-----------GKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 636 ~~~~------~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
.... ..+.. ......................+.+++.+||+.||++|||+.|+++.
T Consensus 382 ~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 382 KIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 1000 00000 00000000000000001122356678999999999999999999863
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=304.00 Aligned_cols=241 Identities=25% Similarity=0.326 Sum_probs=201.0
Q ss_pred hhhhCcccceeEEEeEeeCCCCcEEEEEEecc---cchhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEeecC
Q 041576 425 EEELGRGSFGIVYKGVLKSASGNAVAVKKLDK---LAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEFMG 501 (714)
Q Consensus 425 ~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~ 501 (714)
.+.||.|+||.||.|+.. .+.+.||||++.- ...+...++.+|++.|.+++|||++.+.|++..+...|||||||-
T Consensus 31 LrEIGHGSFGAVYfArd~-~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYCl 109 (948)
T KOG0577|consen 31 LREIGHGSFGAVYFARDV-RNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYCL 109 (948)
T ss_pred HHHhcCCccceeEEeecc-CccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHHh
Confidence 367999999999999876 5788999999964 444566799999999999999999999999999999999999996
Q ss_pred CCchhhhhhc-CCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCccccee
Q 041576 502 NGTLANLLFA-IPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRT 580 (714)
Q Consensus 502 ~gsL~~~l~~-~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 580 (714)
| +-.|++.- .+++.+.++..|..+.+.||+|||+.+ .||||||..|||+++.|.+||+|||.|....+. .
T Consensus 110 G-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA-----n 180 (948)
T KOG0577|consen 110 G-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAPA-----N 180 (948)
T ss_pred c-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCch-----h
Confidence 5 88888763 467889999999999999999999998 999999999999999999999999999765433 3
Q ss_pred eecCCCCccCccccc---CCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhh
Q 041576 581 VIRGTRGYVAPEWFK---NVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAA 657 (714)
Q Consensus 581 ~~~gt~~y~aPE~~~---~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 657 (714)
.++||+.|||||++. .+.|+-|+|||||||...||.-.++|........- +.. +.... .+.
T Consensus 181 sFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSA---LYH-----IAQNe--------sPt 244 (948)
T KOG0577|consen 181 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA---LYH-----IAQNE--------SPT 244 (948)
T ss_pred cccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHH---HHH-----HHhcC--------CCC
Confidence 467999999999884 56899999999999999999999999764433221 111 11111 112
Q ss_pred ccchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 658 MADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 658 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
....+.+..+..++..||++-|.+|||.++++..
T Consensus 245 Lqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 245 LQSNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred CCCchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 2355677888999999999999999999998864
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=294.94 Aligned_cols=255 Identities=25% Similarity=0.316 Sum_probs=197.6
Q ss_pred hhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc-hhhHHHHHHHHHHHhccCcccccceeceEecC--CeeeEEEe
Q 041576 422 NGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA-QEREREFKTEVSAIGRTHHKNLVQLLGFCDEG--LNRLLVYE 498 (714)
Q Consensus 422 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~lv~E 498 (714)
+.+.+.||.|++|.||++... .+++.+|+|.+.... ......+.+|++++++++||||+++++++.+. ...++|||
T Consensus 3 ~~~~~~lg~g~~~~v~~~~~~-~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 81 (287)
T cd06621 3 IVELSRLGEGAGGSVTKCRLK-NTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAME 81 (287)
T ss_pred eEEEEEeccCCceEEEEEEEC-CCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEE
Confidence 445678999999999999986 467899999987532 34556789999999999999999999998553 46799999
Q ss_pred ecCCCchhhhhhc----CCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccC
Q 041576 499 FMGNGTLANLLFA----IPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSD 574 (714)
Q Consensus 499 ~~~~gsL~~~l~~----~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 574 (714)
|+++++|.+++.. ...+++..+..++.||++||+|||+.+ ++|+||+|+||++++++.++|+|||++......
T Consensus 82 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 158 (287)
T cd06621 82 YCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS 158 (287)
T ss_pred ecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeecccccccccc
Confidence 9999999988753 345788899999999999999999998 999999999999999999999999998754322
Q ss_pred cccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchh-hhhhhHHHhhhhhcCccceeecc
Q 041576 575 QSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEER-SAILTDWAYDCYVEGKLDVLVDN 653 (714)
Q Consensus 575 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~-~~~l~~~~~~~~~~~~~~~~~~~ 653 (714)
.. ....++..|+|||.+.+..++.++||||||+++|||++|+.||........ ......+ ........+.+.
T Consensus 159 ~~---~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~ 231 (287)
T cd06621 159 LA---GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSY----IVNMPNPELKDE 231 (287)
T ss_pred cc---ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHH----HhcCCchhhccC
Confidence 21 233467889999999998999999999999999999999999975532100 0001111 011011111000
Q ss_pred hhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 654 DKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 654 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
..........+.+++.+||+.+|++|||+.||++
T Consensus 232 ---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 232 ---PGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred ---CCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 0001224567889999999999999999999988
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=299.98 Aligned_cols=246 Identities=25% Similarity=0.301 Sum_probs=196.0
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEeccc---chhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEE
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKL---AQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLV 496 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 496 (714)
..|.+.+.||+|+||.||+|... .+++.|++|.+... .....+.+.+|++++++++||||+++++++.+++..++|
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~-~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDV-RTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEc-CCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence 34777789999999999999876 46889999988642 233446788999999999999999999999999999999
Q ss_pred EeecCCCchhhhhhc-CCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCc
Q 041576 497 YEFMGNGTLANLLFA-IPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQ 575 (714)
Q Consensus 497 ~E~~~~gsL~~~l~~-~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 575 (714)
+||+++ +|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++......
T Consensus 94 ~e~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~- 168 (307)
T cd06607 94 MEYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPA- 168 (307)
T ss_pred HHhhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCCC-
Confidence 999974 67666653 456899999999999999999999998 999999999999999999999999998755322
Q ss_pred ccceeeecCCCCccCccccc---CCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeec
Q 041576 576 SRTRTVIRGTRGYVAPEWFK---NVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVD 652 (714)
Q Consensus 576 ~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 652 (714)
....++..|+|||.+. ...++.++||||||+++|||++|+.||........ +.. ......
T Consensus 169 ----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~---~~~-----~~~~~~----- 231 (307)
T cd06607 169 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA---LYH-----IAQNDS----- 231 (307)
T ss_pred ----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHH---HHH-----HhcCCC-----
Confidence 2235778999999874 45688999999999999999999999864432211 000 000000
Q ss_pred chhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 653 NDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 653 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
...........+.+++.+||+.+|++||++.+|++.
T Consensus 232 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 232 ---PTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred ---CCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 011122245578889999999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=294.06 Aligned_cols=243 Identities=24% Similarity=0.264 Sum_probs=197.6
Q ss_pred hCcccceeEEEeEeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEeecCCCc
Q 041576 428 LGRGSFGIVYKGVLKSASGNAVAVKKLDKLA---QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEFMGNGT 504 (714)
Q Consensus 428 ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~gs 504 (714)
||.|++|.||+|+.. .+++.+++|.+.... ....+.+.+|+.++++++||||+++++.+.++...++++||+++++
T Consensus 1 lg~g~~~~v~~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (262)
T cd05572 1 LGVGGFGRVELVKVK-SKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGE 79 (262)
T ss_pred CCCCCceEEEEEEEC-CCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCc
Confidence 689999999999976 468899999986532 2345689999999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcccceeeecC
Q 041576 505 LANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRG 584 (714)
Q Consensus 505 L~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g 584 (714)
|.+++.....+++..+..++.||+.||+|||+++ ++|+||+|+||+++.++.++|+|||++....... ......+
T Consensus 80 L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~~~ 154 (262)
T cd05572 80 LWTILRDRGLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTFCG 154 (262)
T ss_pred HHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--ccccccC
Confidence 9999988778899999999999999999999988 9999999999999999999999999998764432 1223457
Q ss_pred CCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhhccchHHH
Q 041576 585 TRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMADKSRA 664 (714)
Q Consensus 585 t~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 664 (714)
+..|+|||.+.+..++.++|+||||+++|||++|+.||.....+.. ... .....+.. ....+....
T Consensus 155 ~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~-----~~~~~~~~--------~~~~~~~~~ 220 (262)
T cd05572 155 TPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPM-EIY-----NDILKGNG--------KLEFPNYID 220 (262)
T ss_pred CcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHH-HHH-----HHHhccCC--------CCCCCcccC
Confidence 8899999999888899999999999999999999999975542110 011 00110000 001111224
Q ss_pred HHHHHHHHHccccCCCCCCC-----HHHHHH
Q 041576 665 CKWLMIALWCIQEDPLKRPA-----MKMIVQ 690 (714)
Q Consensus 665 ~~l~~li~~cl~~dP~~RPs-----~~evl~ 690 (714)
..+.+++.+||+.+|++||+ ++|+++
T Consensus 221 ~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 221 KAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred HHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 57888999999999999999 777765
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=294.27 Aligned_cols=243 Identities=23% Similarity=0.260 Sum_probs=189.0
Q ss_pred hhCcccceeEEEeEeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHH---hccCcccccceeceEecCCeeeEEEeec
Q 041576 427 ELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA---QEREREFKTEVSAI---GRTHHKNLVQLLGFCDEGLNRLLVYEFM 500 (714)
Q Consensus 427 ~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~h~nIv~l~~~~~~~~~~~lv~E~~ 500 (714)
.||+|+||.||++... .+++.+|+|.+.... ......+.+|..++ ...+||||+.+++++..++..++||||+
T Consensus 1 ~lg~G~~g~Vy~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 79 (279)
T cd05633 1 IIGRGGFGEVYGCRKA-DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLM 79 (279)
T ss_pred CcccCCCeEEEEEEEC-CCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecC
Confidence 4899999999999875 468899999886432 12223334444333 3347999999999999999999999999
Q ss_pred CCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCccccee
Q 041576 501 GNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRT 580 (714)
Q Consensus 501 ~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 580 (714)
++++|.+++.....+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||++....... ..
T Consensus 80 ~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~---~~ 153 (279)
T cd05633 80 NGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PH 153 (279)
T ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC---cc
Confidence 99999999988788999999999999999999999998 9999999999999999999999999987543221 12
Q ss_pred eecCCCCccCccccc-CCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhhcc
Q 041576 581 VIRGTRGYVAPEWFK-NVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMA 659 (714)
Q Consensus 581 ~~~gt~~y~aPE~~~-~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 659 (714)
...++..|+|||.+. +..++.++|||||||++|||++|+.||......... .+... ... .. ...
T Consensus 154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-~~~~~----~~~------~~----~~~ 218 (279)
T cd05633 154 ASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRM----TLT------VN----VEL 218 (279)
T ss_pred CcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH-HHHHH----hhc------CC----cCC
Confidence 235899999999886 456899999999999999999999999754322111 11000 000 00 011
Q ss_pred chHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 041576 660 DKSRACKWLMIALWCIQEDPLKRP-----AMKMIVQM 691 (714)
Q Consensus 660 ~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 691 (714)
+...+..+.+++.+||+.||++|| +++|+++.
T Consensus 219 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 219 PDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred ccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 223445778899999999999999 69999884
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=295.09 Aligned_cols=250 Identities=28% Similarity=0.377 Sum_probs=197.3
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhcc-CcccccceeceEecCC------e
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRT-HHKNLVQLLGFCDEGL------N 492 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~------~ 492 (714)
.+|.+.+.||+|++|.||+|..+ .+++.+++|.+..... ....+.+|+++++++ +|+||+++++++.... .
T Consensus 6 ~~y~~~~~l~~g~~~~v~~~~~~-~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~ 83 (275)
T cd06608 6 GIFELVEVIGEGTYGKVYKARHK-KTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQ 83 (275)
T ss_pred hheeheeeecCCCCeEEEEEEEC-CCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceE
Confidence 45677899999999999999976 4678999999875433 346789999999999 7999999999996644 4
Q ss_pred eeEEEeecCCCchhhhhhc----CCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCc
Q 041576 493 RLLVYEFMGNGTLANLLFA----IPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLS 568 (714)
Q Consensus 493 ~~lv~E~~~~gsL~~~l~~----~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~ 568 (714)
.++||||+++++|.+++.. ...+++..+..++.|+++||+|||+.+ ++|+||+|+||++++++.+||+|||++
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~~~ 160 (275)
T cd06608 84 LWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGVS 160 (275)
T ss_pred EEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCccc
Confidence 8999999999999999865 246889999999999999999999998 999999999999999999999999998
Q ss_pred cccccCcccceeeecCCCCccCcccccC-----CCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhh
Q 041576 569 KLLLSDQSRTRTVIRGTRGYVAPEWFKN-----VPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYV 643 (714)
Q Consensus 569 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~ 643 (714)
........ ......++..|+|||.+.. ..++.++||||||+++|+|++|+.||....... .+.. ..
T Consensus 161 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~~~-----~~ 231 (275)
T cd06608 161 AQLDSTLG-RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR---ALFK-----IP 231 (275)
T ss_pred eecccchh-hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH---HHHH-----hh
Confidence 76533222 2223457889999998753 346789999999999999999999996432211 1111 11
Q ss_pred cCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 644 EGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 644 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
...... ..........+.+++.+||+.||++|||+.|+++
T Consensus 232 ~~~~~~-------~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 232 RNPPPT-------LKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred ccCCCC-------CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 111110 0111224457888999999999999999999986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=294.72 Aligned_cols=246 Identities=29% Similarity=0.374 Sum_probs=199.3
Q ss_pred hCcccceeEEEeEeeCCCCcEEEEEEecccch---hhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEeecCCCc
Q 041576 428 LGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQ---EREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEFMGNGT 504 (714)
Q Consensus 428 ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~gs 504 (714)
||+|+||.||++... .+++.+++|.+..... .....+.+|++++++++||||+++++.+..+...++++||+++++
T Consensus 1 lg~g~~~~vy~~~~~-~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (265)
T cd05579 1 ISKGAYGRVFLAKKK-STGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGD 79 (265)
T ss_pred CCCCCceEEEEEEEC-CCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCc
Confidence 689999999999976 4688999999865433 455678999999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcc-------c
Q 041576 505 LANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQS-------R 577 (714)
Q Consensus 505 L~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~-------~ 577 (714)
|.+++.....+++..+..++.||++||+|||+.+ ++|+||+|+||++++++.++|+|||++........ .
T Consensus 80 L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 156 (265)
T cd05579 80 LASLLENVGSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEK 156 (265)
T ss_pred HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccc
Confidence 9999988778899999999999999999999998 99999999999999999999999999876533221 1
Q ss_pred ceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhh
Q 041576 578 TRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAA 657 (714)
Q Consensus 578 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 657 (714)
......++..|+|||.+.....+.++||||||+++|||++|+.||.......... ....+....
T Consensus 157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~--------~~~~~~~~~-------- 220 (265)
T cd05579 157 EDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQ--------NILNGKIEW-------- 220 (265)
T ss_pred cccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHH--------HHhcCCcCC--------
Confidence 2233457889999999988889999999999999999999999997544322111 011111100
Q ss_pred ccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 041576 658 MADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLE 693 (714)
Q Consensus 658 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 693 (714)
......+..+.+++.+||+.+|++|||+.++.+.|+
T Consensus 221 ~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 221 PEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred CccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 000012456788999999999999999977766665
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=296.95 Aligned_cols=249 Identities=26% Similarity=0.379 Sum_probs=195.1
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhcc-CcccccceeceEec------CCe
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRT-HHKNLVQLLGFCDE------GLN 492 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~------~~~ 492 (714)
..+.+.+.||+|+||.||+|... .+++.+|+|.+.... .....+..|+.+++++ +|+||+++++++.. ...
T Consensus 16 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~ 93 (282)
T cd06636 16 GIFELVEVVGNGTYGQVYKGRHV-KTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQ 93 (282)
T ss_pred hhhhhheeeccCCCeEEEEEEEc-CCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCE
Confidence 45667789999999999999986 468899999986533 3345788899999998 79999999999853 457
Q ss_pred eeEEEeecCCCchhhhhhcC--CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccc
Q 041576 493 RLLVYEFMGNGTLANLLFAI--PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKL 570 (714)
Q Consensus 493 ~~lv~E~~~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~ 570 (714)
.+++|||+++++|.+++... ..+++..+..++.||++||+|||+.+ ++|+||+|+||++++++.++|+|||++..
T Consensus 94 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~l~dfg~~~~ 170 (282)
T cd06636 94 LWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQ 170 (282)
T ss_pred EEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCcchhh
Confidence 79999999999999999753 34778888999999999999999998 99999999999999999999999999876
Q ss_pred cccCcccceeeecCCCCccCccccc-----CCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcC
Q 041576 571 LLSDQSRTRTVIRGTRGYVAPEWFK-----NVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEG 645 (714)
Q Consensus 571 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~ 645 (714)
...... ......++..|+|||.+. ...++.++||||||+++|||++|+.||.......... . ....
T Consensus 171 ~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~---~-----~~~~ 241 (282)
T cd06636 171 LDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF---L-----IPRN 241 (282)
T ss_pred hhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhh---h-----HhhC
Confidence 532221 222345888999999885 3467889999999999999999999996432211100 0 0000
Q ss_pred ccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 646 KLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 646 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
. .........+..+.+++.+||+.||.+||++.||++
T Consensus 242 ~--------~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 242 P--------PPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred C--------CCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 0 001111223457888999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=298.19 Aligned_cols=264 Identities=21% Similarity=0.248 Sum_probs=194.4
Q ss_pred hhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccch-hhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEee
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQ-EREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEF 499 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~ 499 (714)
.|.+.+.||+|++|.||+|..+ .+++.||+|.+..... .....+.+|++++++++|+||+++++++.+++..++||||
T Consensus 6 ~y~~~~~lg~g~~~~vy~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 6 TYKKLDKLGEGSYATVYKGRSK-LTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred ceeEEEEEeecCCeEEEEEEEc-CCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 4566789999999999999875 4678999999865332 2234567899999999999999999999999999999999
Q ss_pred cCCCchhhhhhcC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcccc
Q 041576 500 MGNGTLANLLFAI-PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRT 578 (714)
Q Consensus 500 ~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 578 (714)
+++ +|.+++... ..+++..+..++.|+++||+|||+.+ ++|+||||+||++++++.+||+|||+++....... .
T Consensus 85 ~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~-~ 159 (291)
T cd07844 85 LDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSK-T 159 (291)
T ss_pred CCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCCc-c
Confidence 985 899988754 46789999999999999999999998 99999999999999999999999999875432211 1
Q ss_pred eeeecCCCCccCcccccC-CCCCchhhhHHHHHHHHHHHhcCCCCcccccchh-hhhhhHHH----hhhhhc--------
Q 041576 579 RTVIRGTRGYVAPEWFKN-VPVSAKVDVYSFGVVLLKIICCKRSVEMELGEER-SAILTDWA----YDCYVE-------- 644 (714)
Q Consensus 579 ~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~-~~~l~~~~----~~~~~~-------- 644 (714)
.....++..|+|||.+.+ ..++.++||||+|+++|||++|+.||........ ...+.... ...+..
T Consensus 160 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (291)
T cd07844 160 YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFK 239 (291)
T ss_pred ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccc
Confidence 122236788999998875 4588999999999999999999999964431111 00000000 000000
Q ss_pred -Cccceeecchhhh-ccchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 645 -GKLDVLVDNDKAA-MADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 645 -~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
............. .........+.+++.+||+.+|++|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 240 PYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred cccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 0000000000000 001111256778999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=298.93 Aligned_cols=253 Identities=25% Similarity=0.290 Sum_probs=198.9
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEeccc---chhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEE
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKL---AQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLV 496 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 496 (714)
..+...+.||+|+||.||+|+.. .++..|++|.+... .......+.+|++++++++|||++++++++.++...++|
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~-~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 103 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDV-RTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLV 103 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEc-CCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEE
Confidence 44666788999999999999876 46789999998642 223445788999999999999999999999999999999
Q ss_pred EeecCCCchhhhhhc-CCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCc
Q 041576 497 YEFMGNGTLANLLFA-IPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQ 575 (714)
Q Consensus 497 ~E~~~~gsL~~~l~~-~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 575 (714)
|||+.+ +|.+.+.. ...+++.++..++.||+.||.|||+.+ ++||||+|+||+++.++.+||+|||++......
T Consensus 104 ~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~- 178 (317)
T cd06635 104 MEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPA- 178 (317)
T ss_pred EeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCCc-
Confidence 999975 77777653 456899999999999999999999998 999999999999999999999999998754322
Q ss_pred ccceeeecCCCCccCccccc---CCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeec
Q 041576 576 SRTRTVIRGTRGYVAPEWFK---NVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVD 652 (714)
Q Consensus 576 ~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 652 (714)
....++..|+|||.+. ...++.++||||||+++|||++|+.||........ +... .....
T Consensus 179 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~---~~~~-----~~~~~----- 241 (317)
T cd06635 179 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA---LYHI-----AQNES----- 241 (317)
T ss_pred ----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH---HHHH-----HhccC-----
Confidence 2235788999999873 45689999999999999999999999864322211 1111 00000
Q ss_pred chhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCC
Q 041576 653 NDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLEV 698 (714)
Q Consensus 653 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 698 (714)
...........+.+++.+||+.+|.+||++.+|++.+.-....
T Consensus 242 ---~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 284 (317)
T cd06635 242 ---PTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRER 284 (317)
T ss_pred ---CCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccC
Confidence 0011122345678899999999999999999999876544433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=296.56 Aligned_cols=250 Identities=27% Similarity=0.350 Sum_probs=194.3
Q ss_pred hhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhcc-CcccccceeceEecC-----Ceee
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRT-HHKNLVQLLGFCDEG-----LNRL 494 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~-----~~~~ 494 (714)
.|.+.+.||+|+||.||+|... .+++.+|+|.+.... .....+.+|+.++.++ +||||+++++++... ...+
T Consensus 23 ~y~~~~~l~~g~~~~vy~~~~~-~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~ 100 (291)
T cd06639 23 TWEIIETIGKGTYGKVYKVTNK-KDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLW 100 (291)
T ss_pred CeEEEEEeecCCCeEEEEEEEC-CCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeE
Confidence 3556688999999999999876 468899999986532 2345678899999998 899999999998654 3579
Q ss_pred EEEeecCCCchhhhhhc----CCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccc
Q 041576 495 LVYEFMGNGTLANLLFA----IPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKL 570 (714)
Q Consensus 495 lv~E~~~~gsL~~~l~~----~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~ 570 (714)
+|+||+++++|.++++. ...+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||++..
T Consensus 101 lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~kl~dfg~~~~ 177 (291)
T cd06639 101 LVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVKLVDFGVSAQ 177 (291)
T ss_pred EEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEeecccchh
Confidence 99999999999998863 356789999999999999999999998 99999999999999999999999999886
Q ss_pred cccCcccceeeecCCCCccCcccccCC-----CCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcC
Q 041576 571 LLSDQSRTRTVIRGTRGYVAPEWFKNV-----PVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEG 645 (714)
Q Consensus 571 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~ 645 (714)
....... .....++..|+|||.+... .++.++|||||||++|||++|+.||........ +.. ....
T Consensus 178 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~---~~~-----~~~~ 248 (291)
T cd06639 178 LTSTRLR-RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT---LFK-----IPRN 248 (291)
T ss_pred ccccccc-ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH---HHH-----HhcC
Confidence 5432211 1234578899999998643 368899999999999999999999875432211 111 1111
Q ss_pred ccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 646 KLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 646 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
....+. ........+.+++.+||+.+|++||++.|+++.
T Consensus 249 ~~~~~~-------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 249 PPPTLL-------HPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred CCCCCC-------cccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 111111 111233468889999999999999999999863
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-34 Score=291.75 Aligned_cols=245 Identities=23% Similarity=0.302 Sum_probs=192.1
Q ss_pred hhhCcccceeEEEeEeeCCCCcEEEEEEecccc---hhhHHHHHHHHHH-HhccCcccccceeceEecCCeeeEEEeecC
Q 041576 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA---QEREREFKTEVSA-IGRTHHKNLVQLLGFCDEGLNRLLVYEFMG 501 (714)
Q Consensus 426 ~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~-l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~ 501 (714)
+.||+|++|.||+|... .+++.||+|.++... ......+..|..+ ....+|+||+++++++..++..++|+||++
T Consensus 2 ~~l~~g~~~~v~~a~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (260)
T cd05611 2 KPISKGAFGSVYLAKKR-STGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLN 80 (260)
T ss_pred ccCCcCCCeeEEEEEec-CCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccC
Confidence 56999999999999875 468899999986532 2222344455444 445589999999999999999999999999
Q ss_pred CCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcccceee
Q 041576 502 NGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTV 581 (714)
Q Consensus 502 ~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 581 (714)
+++|.+++.....+++..+..++.||++||.|||+.+ ++|+||+|+||++++++.+||+|||++..... ...
T Consensus 81 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~~~ 152 (260)
T cd05611 81 GGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----NKK 152 (260)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc-----ccc
Confidence 9999999988788899999999999999999999998 99999999999999999999999999875432 223
Q ss_pred ecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhhccch
Q 041576 582 IRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMADK 661 (714)
Q Consensus 582 ~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 661 (714)
..++..|+|||.+.+..++.++||||||+++|||++|..||........ .. ....+.... ......
T Consensus 153 ~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~---~~-----~~~~~~~~~------~~~~~~ 218 (260)
T cd05611 153 FVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAV---FD-----NILSRRINW------PEEVKE 218 (260)
T ss_pred CCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHH---HH-----HHHhcccCC------CCcccc
Confidence 3578899999999888899999999999999999999999975432221 11 111111100 000111
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 041576 662 SRACKWLMIALWCIQEDPLKRPAMKMIVQMLE 693 (714)
Q Consensus 662 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 693 (714)
..+..+.+++.+||+.+|++||++.++.+.|+
T Consensus 219 ~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 219 FCSPEAVDLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred cCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence 23456788999999999999998876666553
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=293.95 Aligned_cols=243 Identities=26% Similarity=0.325 Sum_probs=193.8
Q ss_pred hCcccceeEEEeEeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEeecCCCc
Q 041576 428 LGRGSFGIVYKGVLKSASGNAVAVKKLDKLA---QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEFMGNGT 504 (714)
Q Consensus 428 ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~gs 504 (714)
||+|+||+||++... .+++.+++|.+.... ......+.+|++++++++||||+++++.+...+..++||||+++++
T Consensus 1 lg~g~~g~vy~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (277)
T cd05577 1 LGKGGFGEVCACQVK-ATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGD 79 (277)
T ss_pred CCCCCceeEEEEEEc-CCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCc
Confidence 689999999999865 468899999986432 2234567789999999999999999999999999999999999999
Q ss_pred hhhhhhcCC--CCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcccceeee
Q 041576 505 LANLLFAIP--RPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVI 582 (714)
Q Consensus 505 L~~~l~~~~--~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 582 (714)
|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||.+....... .....
T Consensus 80 L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~ 154 (277)
T cd05577 80 LKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK--KIKGR 154 (277)
T ss_pred HHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccCC--ccccc
Confidence 999997655 6889999999999999999999998 9999999999999999999999999987654321 22233
Q ss_pred cCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhhccchH
Q 041576 583 RGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMADKS 662 (714)
Q Consensus 583 ~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 662 (714)
.++..|+|||.+.+..++.++||||||+++|+|++|+.||...........+.. ..... ....+..
T Consensus 155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--------~~~~~------~~~~~~~ 220 (277)
T cd05577 155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKR--------RTLEM------AVEYPDK 220 (277)
T ss_pred cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHh--------ccccc------cccCCcc
Confidence 577899999999888899999999999999999999999975433211111100 00000 0011122
Q ss_pred HHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 041576 663 RACKWLMIALWCIQEDPLKRP-----AMKMIVQ 690 (714)
Q Consensus 663 ~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 690 (714)
....+.+++.+||+.||++|| ++.++++
T Consensus 221 ~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 221 FSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred CCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 355678899999999999999 7777765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=294.85 Aligned_cols=245 Identities=26% Similarity=0.369 Sum_probs=198.5
Q ss_pred hhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEeecCCCc
Q 041576 425 EEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEFMGNGT 504 (714)
Q Consensus 425 ~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~gs 504 (714)
..+||+|+||.||++..+ .+++.||+|++..........+.+|+.++++++|+||+++++.+..++..++||||+++++
T Consensus 25 ~~~lg~g~~g~v~~~~~~-~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 103 (292)
T cd06657 25 FIKIGEGSTGIVCIATVK-SSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA 103 (292)
T ss_pred HHHcCCCCCeEEEEEEEc-CCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCc
Confidence 368999999999999876 4688999999876555566789999999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcccceeeecC
Q 041576 505 LANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRG 584 (714)
Q Consensus 505 L~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g 584 (714)
|.+++.. ..+++.....++.|++.||+|||+.+ ++||||+|+||+++.++.++|+|||++........ ......+
T Consensus 104 L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~ 178 (292)
T cd06657 104 LTDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKSLVG 178 (292)
T ss_pred HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceecccccc-ccccccc
Confidence 9998754 46788999999999999999999998 99999999999999999999999999876543221 2223457
Q ss_pred CCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhhccchHHH
Q 041576 585 TRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMADKSRA 664 (714)
Q Consensus 585 t~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 664 (714)
+..|+|||.+.+..++.++||||||+++|||++|+.||...........+. .. .... .. ......
T Consensus 179 ~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~--------~~-~~~~----~~--~~~~~~ 243 (292)
T cd06657 179 TPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIR--------DN-LPPK----LK--NLHKVS 243 (292)
T ss_pred CccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--------hh-CCcc----cC--CcccCC
Confidence 889999999988889999999999999999999999987543222111110 00 0000 00 001123
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 665 CKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 665 ~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
..+.+++.+||+.+|.+||++.++++
T Consensus 244 ~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 244 PSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred HHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 45677999999999999999999988
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=304.28 Aligned_cols=264 Identities=25% Similarity=0.293 Sum_probs=197.8
Q ss_pred HHhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEeccc--chhhHHHHHHHHHHHhccCcccccceeceEecC------
Q 041576 419 EATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKL--AQEREREFKTEVSAIGRTHHKNLVQLLGFCDEG------ 490 (714)
Q Consensus 419 ~at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~------ 490 (714)
...|...+.||+|+||.||+|... .+++.||+|.+... .......+.+|+.++++++||||+++++++...
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDT-VTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEEC-CCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 355777789999999999999876 46889999998642 233445678899999999999999999988543
Q ss_pred CeeeEEEeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccc
Q 041576 491 LNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKL 570 (714)
Q Consensus 491 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~ 570 (714)
...++||||+.+ +|.+.+... +++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++..
T Consensus 94 ~~~~lv~e~~~~-~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~ 167 (353)
T cd07850 94 QDVYLVMELMDA-NLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART 167 (353)
T ss_pred CcEEEEEeccCC-CHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCcccee
Confidence 356999999965 888877653 888899999999999999999998 99999999999999999999999999986
Q ss_pred cccCcccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhH--------H-----
Q 041576 571 LLSDQSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTD--------W----- 637 (714)
Q Consensus 571 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~--------~----- 637 (714)
...... .....++..|+|||.+.+..++.++|||||||++|+|++|+.||...........+.. +
T Consensus 168 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (353)
T cd07850 168 AGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQ 245 (353)
T ss_pred CCCCCC--CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhh
Confidence 543221 2233578899999999999999999999999999999999999975432211111000 0
Q ss_pred -HhhhhhcCc-------cceeecc----hhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 638 -AYDCYVEGK-------LDVLVDN----DKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 638 -~~~~~~~~~-------~~~~~~~----~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
......... ...+... .............+.+++.+||+.||++|||+.|+++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 246 PTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred hhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000000000 0000000 00001122345567889999999999999999999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=299.55 Aligned_cols=262 Identities=21% Similarity=0.276 Sum_probs=193.6
Q ss_pred hhhhCcc--cceeEEEeEeeCCCCcEEEEEEeccc--chhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEeec
Q 041576 425 EEELGRG--SFGIVYKGVLKSASGNAVAVKKLDKL--AQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEFM 500 (714)
Q Consensus 425 ~~~ig~G--~~g~Vy~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~ 500 (714)
.+.||+| +|++||+|.+. .+++.||+|.+... .....+.+.+|+.+++.++||||+++++++..++..++|+||+
T Consensus 3 ~~~ig~g~~~~~~v~~a~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~ 81 (328)
T cd08226 3 QVEIGRGFCNLTSVYLARHT-PTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFM 81 (328)
T ss_pred HHHhCCcccCceeEEEEEEc-CCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecc
Confidence 3567777 99999999875 57899999998642 2334578899999999999999999999999999999999999
Q ss_pred CCCchhhhhhcC--CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcccc
Q 041576 501 GNGTLANLLFAI--PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRT 578 (714)
Q Consensus 501 ~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 578 (714)
.+++|.+++... ..+++..+..++.||++||+|||+.+ ++||||||+||+++.++.++++||+.+..........
T Consensus 82 ~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~ 158 (328)
T cd08226 82 AYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA 158 (328)
T ss_pred cCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence 999999998764 35788889999999999999999988 9999999999999999999999998654332211110
Q ss_pred ------eeeecCCCCccCcccccCC--CCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHH------------
Q 041576 579 ------RTVIRGTRGYVAPEWFKNV--PVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWA------------ 638 (714)
Q Consensus 579 ------~~~~~gt~~y~aPE~~~~~--~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~------------ 638 (714)
.....++..|+|||++.+. .++.++|||||||++|||++|+.||................
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (328)
T cd08226 159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPC 238 (328)
T ss_pred cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccch
Confidence 0112245679999999764 47899999999999999999999997543221100000000
Q ss_pred -hhh-------hh----cCcc-----ceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 639 -YDC-------YV----EGKL-----DVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 639 -~~~-------~~----~~~~-----~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
... .. +... ...................+.+++.+||+.||++|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 239 EESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred hhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 000 00 0000 0000111111123345567899999999999999999999975
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=292.99 Aligned_cols=261 Identities=22% Similarity=0.240 Sum_probs=193.5
Q ss_pred hhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc-hhhHHHHHHHHHHHhccC-cccccceeceEecC--CeeeEEE
Q 041576 422 NGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA-QEREREFKTEVSAIGRTH-HKNLVQLLGFCDEG--LNRLLVY 497 (714)
Q Consensus 422 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~--~~~~lv~ 497 (714)
|.+.+.||+|+||.||+|... .+++.||+|+++... ........+|+..+.++. |+||+++++++.++ +..++|+
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~-~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~ 79 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSR-KTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVF 79 (282)
T ss_pred CceEeeccccccceEEEEEEc-CCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEE
Confidence 345678999999999999876 468899999987532 222334567888999885 99999999999887 8899999
Q ss_pred eecCCCchhhhhhcC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcc
Q 041576 498 EFMGNGTLANLLFAI-PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQS 576 (714)
Q Consensus 498 E~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 576 (714)
||+++ +|.+.+... ..+++..+..++.||+.||+|||+.+ ++||||+|+||+++. +.+||+|||++........
T Consensus 80 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~ 154 (282)
T cd07831 80 ELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP 154 (282)
T ss_pred ecCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCCC
Confidence 99975 777777653 56899999999999999999999998 999999999999999 9999999999986643322
Q ss_pred cceeeecCCCCccCccccc-CCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHH-------hhhhhcCccc
Q 041576 577 RTRTVIRGTRGYVAPEWFK-NVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWA-------YDCYVEGKLD 648 (714)
Q Consensus 577 ~~~~~~~gt~~y~aPE~~~-~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~-------~~~~~~~~~~ 648 (714)
. ....++..|+|||.+. +..++.++|||||||++|||++|+.||......+....+.... ..........
T Consensus 155 ~--~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
T cd07831 155 Y--TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHM 232 (282)
T ss_pred c--CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccc
Confidence 1 2234788999999764 4567899999999999999999999997554322111111100 0000000000
Q ss_pred ee-ecchh---hhccchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 649 VL-VDNDK---AAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 649 ~~-~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
.. ..... ........+..+.+++.+||+++|++||+++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 233 NYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred cccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 00 00000 00011234578899999999999999999999986
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=296.65 Aligned_cols=267 Identities=23% Similarity=0.250 Sum_probs=197.9
Q ss_pred HHHhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc--hhhHHHHHHHHHHHhccCcccccceeceEecCC----
Q 041576 418 NEATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA--QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGL---- 491 (714)
Q Consensus 418 ~~at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~---- 491 (714)
....|.+.+.||+|++|.||+|... .+++.|++|.++... ......+.+|++++++++||||+++++++.+..
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDK-DTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEEC-CCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 3455677889999999999999986 467899999986532 223456788999999999999999999987655
Q ss_pred ------eeeEEEeecCCCchhhhhhcC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEec
Q 041576 492 ------NRLLVYEFMGNGTLANLLFAI-PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISD 564 (714)
Q Consensus 492 ------~~~lv~E~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D 564 (714)
..++|+||+++ +|.+.+... ..+++..+..++.||+.||+|||+.+ |+|+||||+||++++++.+||+|
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl~d 159 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLAD 159 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEeCc
Confidence 78999999987 666666543 46899999999999999999999998 99999999999999999999999
Q ss_pred CCCccccccCcccceeeecCCCCccCcccccC-CCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhh
Q 041576 565 FGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKN-VPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYV 643 (714)
Q Consensus 565 fg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~ 643 (714)
||++...............++..|+|||.+.+ ..++.++||||||++++||++|+.||...........+.........
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (302)
T cd07864 160 FGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCP 239 (302)
T ss_pred ccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence 99998765433222222345778999998865 35789999999999999999999999754432222111111000000
Q ss_pred cC--cccee-----ec------chhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 644 EG--KLDVL-----VD------NDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 644 ~~--~~~~~-----~~------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
.. .+... .+ ..... .....+..+.+++.+||+.||.+||+++++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 240 AVWPDVIKLPYFNTMKPKKQYRRRLRE-EFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred hhcccccccccccccccccccccchhh-hcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 00 00000 00 00000 00112457888999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=300.75 Aligned_cols=253 Identities=21% Similarity=0.303 Sum_probs=198.5
Q ss_pred HHHHhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecc--cchhhHHHHHHHHHHHhcc-CcccccceeceEecCCee
Q 041576 417 LNEATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDK--LAQEREREFKTEVSAIGRT-HHKNLVQLLGFCDEGLNR 493 (714)
Q Consensus 417 l~~at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~ 493 (714)
+....|.+.++||+|+.+.||++... +.+.+|+|++.. .+......|.+|+..|.+| .|.+|+++++|-..++..
T Consensus 358 Vkg~~Yeilk~iG~GGSSkV~kV~~s--~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~l 435 (677)
T KOG0596|consen 358 VKGREYEILKQIGSGGSSKVFKVLNS--DKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYL 435 (677)
T ss_pred ECcchhhHHHhhcCCCcceeeeeecC--CCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceE
Confidence 34456778899999999999998754 456788887643 4455667899999999999 699999999999999999
Q ss_pred eEEEeecCCCchhhhhhcCCCCCh-hhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccc
Q 041576 494 LLVYEFMGNGTLANLLFAIPRPDW-SLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLL 572 (714)
Q Consensus 494 ~lv~E~~~~gsL~~~l~~~~~~~~-~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~ 572 (714)
||||||=+ .+|..+|+....... -.+..+..||+.|+.++|++| |||.||||.|+|+-. |.+||+|||+|..+.
T Consensus 436 YmvmE~Gd-~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVk-G~LKLIDFGIA~aI~ 510 (677)
T KOG0596|consen 436 YMVMECGD-IDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVK-GRLKLIDFGIANAIQ 510 (677)
T ss_pred EEEeeccc-ccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEe-eeEEeeeechhcccC
Confidence 99999864 499999987654322 377889999999999999998 999999999999975 599999999999887
Q ss_pred cCcc-cceeeecCCCCccCcccccCC-----------CCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhh
Q 041576 573 SDQS-RTRTVIRGTRGYVAPEWFKNV-----------PVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYD 640 (714)
Q Consensus 573 ~~~~-~~~~~~~gt~~y~aPE~~~~~-----------~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~ 640 (714)
.+.. ......+||..||+||.+... .++.++||||+|||||+|+.|+.||..... .++
T Consensus 511 ~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n--------~~a-- 580 (677)
T KOG0596|consen 511 PDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN--------QIA-- 580 (677)
T ss_pred ccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH--------HHH--
Confidence 6553 344567899999999998532 256799999999999999999999963211 111
Q ss_pred hhhcCccceeecchhhhccc-hHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 641 CYVEGKLDVLVDNDKAAMAD-KSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 641 ~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
++..+.++.....++ .....+++++++.||+.||++||++.|+|+.
T Consensus 581 -----Kl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 581 -----KLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred -----HHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 122333332211111 1112238899999999999999999999874
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=287.81 Aligned_cols=250 Identities=28% Similarity=0.386 Sum_probs=204.6
Q ss_pred hhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc--hhhHHHHHHHHHHHhccCcccccceeceEecC--CeeeEEE
Q 041576 422 NGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA--QEREREFKTEVSAIGRTHHKNLVQLLGFCDEG--LNRLLVY 497 (714)
Q Consensus 422 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~lv~ 497 (714)
+...+.||+|++|.||+|... .+++.|++|.+.... ....+.+.+|++.+++++||||+++++.+... ...++++
T Consensus 2 ~~~~~~i~~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 2 WTRGELLGRGSFGSVYLALDK-DTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred ceeeeEeeecCceEEEEEEEC-CCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 345578999999999999876 468899999986543 24567899999999999999999999999988 8899999
Q ss_pred eecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCccc
Q 041576 498 EFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSR 577 (714)
Q Consensus 498 E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 577 (714)
||+++++|.+++.....+++..+..++.|+++||+|||+.+ ++|+||+|+||+++.++.++|+|||.+.........
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 157 (260)
T cd06606 81 EYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG 157 (260)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEeccccccc
Confidence 99999999999988778999999999999999999999988 999999999999999999999999999876544321
Q ss_pred -ceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhh
Q 041576 578 -TRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKA 656 (714)
Q Consensus 578 -~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 656 (714)
......++..|+|||.+.+...+.++||||||+++++|++|+.||....... ... .........
T Consensus 158 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~~----~~~~~~~~~--------- 222 (260)
T cd06606 158 EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPM--AAL----YKIGSSGEP--------- 222 (260)
T ss_pred ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH--HHH----HhccccCCC---------
Confidence 1233457889999999998889999999999999999999999997554111 000 000000000
Q ss_pred hccchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 657 AMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 657 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
...+......+.+++.+|++.+|++||++.|+++
T Consensus 223 ~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 223 PEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred cCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 1112223567888999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=295.64 Aligned_cols=262 Identities=22% Similarity=0.229 Sum_probs=192.9
Q ss_pred hhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccch-hhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEee
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQ-EREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEF 499 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~ 499 (714)
.|.+.+.||+|+||.||+|... .+++.|++|.+..... .....+.+|+.++++++|+||+++++++..+...++|+||
T Consensus 6 ~y~~~~~ig~g~~~~v~~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07870 6 SYLNLEKLGEGSYATVYKGISR-INGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEY 84 (291)
T ss_pred eeEEEEEEEecCCEEEEEEEEc-CCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEec
Confidence 4566789999999999999876 4678999999865332 2234678899999999999999999999999999999999
Q ss_pred cCCCchhhhhhc-CCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcccc
Q 041576 500 MGNGTLANLLFA-IPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRT 578 (714)
Q Consensus 500 ~~~gsL~~~l~~-~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 578 (714)
+. ++|.+.+.. ...+.+..+..++.||+.||+|||+.+ |+|+||||+||+++.++.+||+|||+++....... .
T Consensus 85 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-~ 159 (291)
T cd07870 85 MH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ-T 159 (291)
T ss_pred cc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCCCC-C
Confidence 96 566666544 345778888999999999999999998 99999999999999999999999999876433221 1
Q ss_pred eeeecCCCCccCcccccCC-CCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhH-HHhhhhh-----------cC
Q 041576 579 RTVIRGTRGYVAPEWFKNV-PVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTD-WAYDCYV-----------EG 645 (714)
Q Consensus 579 ~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~-~~~~~~~-----------~~ 645 (714)
.....++..|+|||.+.+. .++.++||||||+++|||++|+.||....... ..+.. +...... ..
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (291)
T cd07870 160 YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVF--EQLEKIWTVLGVPTEDTWPGVSKLPN 237 (291)
T ss_pred CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHH--HHHHHHHHHcCCCChhhhhhhhhccc
Confidence 1223468899999998754 57889999999999999999999997543211 11110 0000000 00
Q ss_pred ccceeec----chhhh-ccchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 646 KLDVLVD----NDKAA-MADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 646 ~~~~~~~----~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
....... ..... .........+.+++.+|++.||++|||++|++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 238 YKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred ccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 0000000 00000 000112456778999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=294.67 Aligned_cols=256 Identities=23% Similarity=0.258 Sum_probs=201.5
Q ss_pred hhhhhhhCcccceeEEEeEee--CCCCcEEEEEEecccc----hhhHHHHHHHHHHHhcc-CcccccceeceEecCCeee
Q 041576 422 NGFEEELGRGSFGIVYKGVLK--SASGNAVAVKKLDKLA----QEREREFKTEVSAIGRT-HHKNLVQLLGFCDEGLNRL 494 (714)
Q Consensus 422 ~~~~~~ig~G~~g~Vy~~~~~--~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~ 494 (714)
|.+.+.||+|++|.||+++.. ..+++.||||.+++.. ....+.+.+|+.++.++ +||||+++++.+..+...+
T Consensus 2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~ 81 (288)
T cd05583 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLH 81 (288)
T ss_pred ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEE
Confidence 456688999999999998754 2356789999987532 22345688999999999 6999999999999999999
Q ss_pred EEEeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccC
Q 041576 495 LVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSD 574 (714)
Q Consensus 495 lv~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 574 (714)
+||||+++++|.+++.....+++..+..++.|+++||+|||+.+ ++||||+|+||+++.++.++|+|||++......
T Consensus 82 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 158 (288)
T cd05583 82 LILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAE 158 (288)
T ss_pred EEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccccccc
Confidence 99999999999999987777899999999999999999999988 999999999999999999999999998876544
Q ss_pred cccceeeecCCCCccCcccccCCC--CCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeec
Q 041576 575 QSRTRTVIRGTRGYVAPEWFKNVP--VSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVD 652 (714)
Q Consensus 575 ~~~~~~~~~gt~~y~aPE~~~~~~--~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 652 (714)
.........++..|+|||.+.+.. .+.++||||||+++|||++|..||...........+.. .. ....
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~---~~-~~~~------ 228 (288)
T cd05583 159 EEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISR---RI-LKSK------ 228 (288)
T ss_pred cccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHH---HH-HccC------
Confidence 333333345788999999987655 78899999999999999999999864322111111110 00 0000
Q ss_pred chhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 041576 653 NDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEG 694 (714)
Q Consensus 653 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 694 (714)
...+......+.+++.+||+.||++|||+.++.+.|+.
T Consensus 229 ----~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 229 ----PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred ----CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 00111233467789999999999999999888877754
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=289.82 Aligned_cols=248 Identities=24% Similarity=0.347 Sum_probs=199.0
Q ss_pred hhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc--hhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEee
Q 041576 422 NGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA--QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEF 499 (714)
Q Consensus 422 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~ 499 (714)
|.+.+.||+|+||.||+|... .++..+|+|.+.... ....+.+.+|++++++++|+||+++++.+......++|+||
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 2 YEIIKKIGEGSFGKIYLAKAK-SDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred ceEEEEecCCCcceEEEEEEc-CCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 456788999999999999986 467889999986532 23456788999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCC--CCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCC-ceEEecCCCccccccCcc
Q 041576 500 MGNGTLANLLFAIP--RPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDF-TAKISDFGLSKLLLSDQS 576 (714)
Q Consensus 500 ~~~gsL~~~l~~~~--~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~-~~kl~Dfg~~~~~~~~~~ 576 (714)
+++++|.+++.... .+++..+..++.|+++||+|||+.+ ++|+||||+||++++++ .+||+|||.+........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME 157 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence 99999999987543 4689999999999999999999998 99999999999999886 469999999986643322
Q ss_pred cceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhh
Q 041576 577 RTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKA 656 (714)
Q Consensus 577 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 656 (714)
......|+..|+|||.+.+..++.++||||||++++||++|+.||........ .. . ...+....
T Consensus 158 -~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~---~~----~-~~~~~~~~------- 221 (257)
T cd08225 158 -LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQL---VL----K-ICQGYFAP------- 221 (257)
T ss_pred -cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHH---HH----H-HhcccCCC-------
Confidence 22234578899999999888899999999999999999999999864432211 10 0 01111110
Q ss_pred hccchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 657 AMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 657 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
........+.+++.+|++.+|++|||+.|+++.
T Consensus 222 --~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 222 --ISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred --CCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 111233467889999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=294.92 Aligned_cols=247 Identities=23% Similarity=0.346 Sum_probs=189.9
Q ss_pred hhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc-hhhHHHHHHHHHH-HhccCcccccceeceEecCCeeeEEEee
Q 041576 422 NGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA-QEREREFKTEVSA-IGRTHHKNLVQLLGFCDEGLNRLLVYEF 499 (714)
Q Consensus 422 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~-l~~l~h~nIv~l~~~~~~~~~~~lv~E~ 499 (714)
+.+.+.||+|+||.||+|+.. .+++.||+|+++... ......+..|+.. ++.++||||+++++++..+...+++|||
T Consensus 3 ~~~~~~ig~g~~g~v~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~ 81 (283)
T cd06617 3 LEVIEELGRGAYGVVDKMRHV-PTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEV 81 (283)
T ss_pred ceEEEEecccCCeEEEEEEEc-CCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhh
Confidence 456788999999999999876 568999999987532 2334455566665 5567999999999999999999999999
Q ss_pred cCCCchhhhhhc----CCCCChhhHHHHHHHHHHHHHHHHhc-CCCCeEecCCCcCeEEECCCCceEEecCCCccccccC
Q 041576 500 MGNGTLANLLFA----IPRPDWSLRVRISLEIARGLLYLHEE-CNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSD 574 (714)
Q Consensus 500 ~~~gsL~~~l~~----~~~~~~~~~~~i~~qi~~~L~yLH~~-~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 574 (714)
++ ++|.+++.. ...+++..++.++.||+.||+|||++ + ++||||||+||+++.++.+||+|||++......
T Consensus 82 ~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 82 MD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 97 588777653 24678999999999999999999987 6 999999999999999999999999998865332
Q ss_pred cccceeeecCCCCccCcccccC----CCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCcccee
Q 041576 575 QSRTRTVIRGTRGYVAPEWFKN----VPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVL 650 (714)
Q Consensus 575 ~~~~~~~~~gt~~y~aPE~~~~----~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 650 (714)
. ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||....... ..+... ..+....+
T Consensus 158 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--~~~~~~-----~~~~~~~~ 228 (283)
T cd06617 158 V--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPF--QQLKQV-----VEEPSPQL 228 (283)
T ss_pred c--ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCH--HHHHHH-----HhcCCCCC
Confidence 1 1222457889999998864 456889999999999999999999986422111 111100 01100000
Q ss_pred ecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 651 VDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 651 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
.....+..+.+++.+||+.+|++||+++++++
T Consensus 229 --------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 229 --------PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred --------CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11123456888999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=289.13 Aligned_cols=246 Identities=26% Similarity=0.320 Sum_probs=201.8
Q ss_pred hhhhhhhCcccceeEEEeEeeCCCCcEEEEEEeccc--chhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEee
Q 041576 422 NGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKL--AQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEF 499 (714)
Q Consensus 422 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~ 499 (714)
|.+.+.||+|++|.||++... .+++.+++|.+... .......+.+|++++++++|+||+++++++.+....++|+||
T Consensus 2 y~~~~~i~~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 2 FKVLKKLGKGSYGSVYKVKRL-SDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred ceEeeeecCCCceeEEEEEEC-CCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 456788999999999999865 57889999998653 234456788999999999999999999999999999999999
Q ss_pred cCCCchhhhhhc----CCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCc
Q 041576 500 MGNGTLANLLFA----IPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQ 575 (714)
Q Consensus 500 ~~~gsL~~~l~~----~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 575 (714)
+++++|.+++.. ...+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 999999999876 356788999999999999999999998 999999999999999999999999999876543
Q ss_pred ccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchh
Q 041576 576 SRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDK 655 (714)
Q Consensus 576 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 655 (714)
......++..|+|||.+.+..++.++|+||||+++|||++|+.||......... . ....+....
T Consensus 157 --~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~----~----~~~~~~~~~------ 220 (256)
T cd08530 157 --MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLR----Y----KVQRGKYPP------ 220 (256)
T ss_pred --CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH----H----HHhcCCCCC------
Confidence 122234788999999999989999999999999999999999999754322110 0 111111111
Q ss_pred hhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 656 AAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 656 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
.+......+.+++.+||+.+|++||++.|+++.
T Consensus 221 ---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 221 ---IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred ---CchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 122344568889999999999999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-34 Score=276.78 Aligned_cols=255 Identities=24% Similarity=0.318 Sum_probs=202.9
Q ss_pred hhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhcc-CcccccceeceEecCCeeeEEEeecCCCc
Q 041576 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRT-HHKNLVQLLGFCDEGLNRLLVYEFMGNGT 504 (714)
Q Consensus 426 ~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~E~~~~gs 504 (714)
+.||+|+++.|-.++.- .++..+|||++.+........+.+|++++.+. .|+||++++++|+++...|||||.|.||+
T Consensus 84 e~LGeGAyasVqtcv~i-~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGp 162 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSI-QTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGP 162 (463)
T ss_pred HHhcCccceeeeeeeee-ccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCch
Confidence 78999999999988754 58999999999998888888999999999998 69999999999999999999999999999
Q ss_pred hhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCC---ceEEecCCCccccccCc------
Q 041576 505 LANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDF---TAKISDFGLSKLLLSDQ------ 575 (714)
Q Consensus 505 L~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~---~~kl~Dfg~~~~~~~~~------ 575 (714)
|..+|+++..+++.++.++..+|+.||.+||.+| |.||||||+|||-.+-. -+||+||.+..-+....
T Consensus 163 lLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spas 239 (463)
T KOG0607|consen 163 LLSHIQKRKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPAS 239 (463)
T ss_pred HHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCC
Confidence 9999999999999999999999999999999998 99999999999997654 48999998876543221
Q ss_pred ccceeeecCCCCccCccccc-----CCCCCchhhhHHHHHHHHHHHhcCCCCcccccchh----h---hhhhHHHhhhhh
Q 041576 576 SRTRTVIRGTRGYVAPEWFK-----NVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEER----S---AILTDWAYDCYV 643 (714)
Q Consensus 576 ~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~----~---~~l~~~~~~~~~ 643 (714)
.......+|+..|||||+.. ...|+.++|.||||||||-|++|.+||...-+.+- . ..-...-...+.
T Consensus 240 tP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQ 319 (463)
T KOG0607|consen 240 TPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQ 319 (463)
T ss_pred CccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHh
Confidence 12233457889999999763 34589999999999999999999999976533221 0 000111112222
Q ss_pred cCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 644 EGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 644 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
+|.... .+. .-...+.+..+++...|..|+.+|.++.++++
T Consensus 320 EGkYeF-Pdk-----dWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 320 EGKYEF-PDK-----DWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred ccCCcC-Chh-----hhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 332211 111 11233456677888899999999999999987
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=299.17 Aligned_cols=267 Identities=24% Similarity=0.289 Sum_probs=198.5
Q ss_pred HHhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEeccc--chhhHHHHHHHHHHHhcc-CcccccceeceEecC--Cee
Q 041576 419 EATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKL--AQEREREFKTEVSAIGRT-HHKNLVQLLGFCDEG--LNR 493 (714)
Q Consensus 419 ~at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~--~~~ 493 (714)
...|.+.+.||+|+||.||+|... .+++.+++|++... .......+.+|+.+++++ +||||+++++++... ...
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDR-RTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEc-CCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 356778899999999999999876 46789999988542 233345677899999999 999999999998643 467
Q ss_pred eEEEeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCcccccc
Q 041576 494 LLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLS 573 (714)
Q Consensus 494 ~lv~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~ 573 (714)
++||||++ ++|..++... .+++..+..++.||+.||+|||+.+ |+|+||||+||+++.++.+||+|||++.....
T Consensus 85 ~lv~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~ 159 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSLSE 159 (337)
T ss_pred EEEecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhcccc
Confidence 99999998 4999988765 7788899999999999999999988 99999999999999999999999999986644
Q ss_pred Ccc----cceeeecCCCCccCcccccC-CCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHh-------hh
Q 041576 574 DQS----RTRTVIRGTRGYVAPEWFKN-VPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAY-------DC 641 (714)
Q Consensus 574 ~~~----~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~-------~~ 641 (714)
... .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...........+..... ..
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (337)
T cd07852 160 LEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIES 239 (337)
T ss_pred ccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 322 12233457889999998754 4578999999999999999999999965433221111100000 00
Q ss_pred h----hcCccceeecch--hhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 642 Y----VEGKLDVLVDND--KAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 642 ~----~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
. ............ .........+..+.+++.+||+.||++|||+.++++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 240 IKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 0 000000000000 0000111135678889999999999999999999975
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=301.87 Aligned_cols=269 Identities=21% Similarity=0.253 Sum_probs=201.5
Q ss_pred hhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEeccc--chhhHHHHHHHHHHHhccCcccccceeceEecC-----Cee
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKL--AQEREREFKTEVSAIGRTHHKNLVQLLGFCDEG-----LNR 493 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-----~~~ 493 (714)
.|.+.+.||+|+||.||+|+.. .+++.||||.++.. .......+.+|+.+++.++|+||+++++++... ...
T Consensus 6 ~y~~~~~lg~G~~~~vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 84 (337)
T cd07858 6 KYVPIKPIGRGAYGIVCSAKNS-ETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV 84 (337)
T ss_pred ceeEEEEeccCCCeEEEEEEec-CCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence 4666789999999999999875 57899999998653 233345678899999999999999999988654 347
Q ss_pred eEEEeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCcccccc
Q 041576 494 LLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLS 573 (714)
Q Consensus 494 ~lv~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~ 573 (714)
++|+||+. ++|.+++.....+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++.....
T Consensus 85 ~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 160 (337)
T cd07858 85 YIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLARTTSE 160 (337)
T ss_pred EEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCccccccCC
Confidence 99999996 689999988788999999999999999999999998 99999999999999999999999999986643
Q ss_pred CcccceeeecCCCCccCcccccC-CCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHh-------hhhhcC
Q 041576 574 DQSRTRTVIRGTRGYVAPEWFKN-VPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAY-------DCYVEG 645 (714)
Q Consensus 574 ~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~-------~~~~~~ 645 (714)
.. .......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...........+..... ......
T Consensus 161 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (337)
T cd07858 161 KG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNE 239 (337)
T ss_pred Cc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCch
Confidence 32 12223457889999998865 4689999999999999999999999975432221111111000 000000
Q ss_pred cc-------ceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHH--Hhccc
Q 041576 646 KL-------DVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM--LEGYL 696 (714)
Q Consensus 646 ~~-------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~~ 696 (714)
.. ......... ......+..+.+++.+||+.+|++|||++|+++. ++.+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~ 298 (337)
T cd07858 240 KARRYIRSLPYTPRQSFA-RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLH 298 (337)
T ss_pred hhhHHHHhcCcccccCHH-HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhc
Confidence 00 000000000 0112244678899999999999999999999976 65543
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=293.28 Aligned_cols=251 Identities=26% Similarity=0.379 Sum_probs=193.1
Q ss_pred hhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc-hhhHHHHHHHHHHHhccC-cccccceeceEecCCeeeEEEee
Q 041576 422 NGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA-QEREREFKTEVSAIGRTH-HKNLVQLLGFCDEGLNRLLVYEF 499 (714)
Q Consensus 422 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~E~ 499 (714)
+.+.+.||+|+||.||++... .+++.+|+|.+.... ......+.+|+.++.++. |+||+++++++..+...+++|||
T Consensus 6 ~~~~~~lg~G~~g~vy~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 6 LKDLGEIGRGAFGTVNKMLHK-PSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred hHHHHHhCCCCceEEEEEEEC-CCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 345678999999999999876 568999999986532 344567899999999996 99999999999999999999999
Q ss_pred cCCCchhhhh---h--cCCCCChhhHHHHHHHHHHHHHHHHhc-CCCCeEecCCCcCeEEECCCCceEEecCCCcccccc
Q 041576 500 MGNGTLANLL---F--AIPRPDWSLRVRISLEIARGLLYLHEE-CNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLS 573 (714)
Q Consensus 500 ~~~gsL~~~l---~--~~~~~~~~~~~~i~~qi~~~L~yLH~~-~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~ 573 (714)
+.. +|.++. . ....+++..+..++.|+++||+|||+. + ++||||||+||+++.++.+||+|||++.....
T Consensus 85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 874 554433 2 235688999999999999999999975 5 99999999999999999999999999876533
Q ss_pred CcccceeeecCCCCccCcccccCC---CCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCcccee
Q 041576 574 DQSRTRTVIRGTRGYVAPEWFKNV---PVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVL 650 (714)
Q Consensus 574 ~~~~~~~~~~gt~~y~aPE~~~~~---~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 650 (714)
... .....++..|+|||.+.+. .++.++||||||+++|||++|+.||...... ...+. ....+....
T Consensus 161 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~~-----~~~~~~~~~- 230 (288)
T cd06616 161 SIA--KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSV--FDQLT-----QVVKGDPPI- 230 (288)
T ss_pred CCc--cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchH--HHHHh-----hhcCCCCCc-
Confidence 221 1223578899999999766 6899999999999999999999999643210 00000 000111111
Q ss_pred ecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 651 VDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 651 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
.........+..+.+++.+||+.+|++|||++||++.
T Consensus 231 ----~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 231 ----LSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred ----CCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1111112345578889999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=286.72 Aligned_cols=247 Identities=26% Similarity=0.393 Sum_probs=203.2
Q ss_pred hhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccch--hhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEee
Q 041576 422 NGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQ--EREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEF 499 (714)
Q Consensus 422 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~ 499 (714)
|.+.+.||+|++|.||+|+.. .+++.|++|.+..... .....+.+|++++.+++|||++++++++.+++..++++||
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 2 YQLGDLIGRGAFGVVYKGLNL-ETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred ceeeeEEcccCCeEEEEEEEc-CCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 456789999999999999876 4678999999976543 4557899999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcccce
Q 041576 500 MGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTR 579 (714)
Q Consensus 500 ~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 579 (714)
+++++|.+++.....+++..+..++.|++.||+|||+.+ ++||||+|+||+++.++.++|+|||.+......... .
T Consensus 81 ~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-~ 156 (254)
T cd06627 81 AENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD-D 156 (254)
T ss_pred CCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCccc-c
Confidence 999999999988788999999999999999999999998 999999999999999999999999999876543321 2
Q ss_pred eeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhhcc
Q 041576 580 TVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMA 659 (714)
Q Consensus 580 ~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 659 (714)
....++..|+|||.+.+..++.++||||+|+++++|++|+.|+........ ... ....... ..
T Consensus 157 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~---~~~-----~~~~~~~---------~~ 219 (254)
T cd06627 157 ASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAA---LFR-----IVQDDHP---------PL 219 (254)
T ss_pred cccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHH---HHH-----HhccCCC---------CC
Confidence 334578899999999888889999999999999999999999874432110 100 0001111 01
Q ss_pred chHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 660 DKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 660 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
+......+.+++.+||+.+|++||++.+++.
T Consensus 220 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 220 PEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 1223456778999999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=297.62 Aligned_cols=265 Identities=22% Similarity=0.275 Sum_probs=195.5
Q ss_pred hhhhhhhCcccceeEEEeEeeCC-CCcEEEEEEecccc---hhhHHHHHHHHHHHhccCcccccceeceEecC--CeeeE
Q 041576 422 NGFEEELGRGSFGIVYKGVLKSA-SGNAVAVKKLDKLA---QEREREFKTEVSAIGRTHHKNLVQLLGFCDEG--LNRLL 495 (714)
Q Consensus 422 ~~~~~~ig~G~~g~Vy~~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~l 495 (714)
|.+.+.||+|++|.||+|..... .++.||+|.+.... ......+.+|+.++++++||||+++++++.+. ...++
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 81 (316)
T cd07842 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYL 81 (316)
T ss_pred ceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEE
Confidence 55678899999999999998642 67899999997632 33346778899999999999999999999888 88999
Q ss_pred EEeecCCCchhhhhhcC-----CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECC----CCceEEecCC
Q 041576 496 VYEFMGNGTLANLLFAI-----PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQ----DFTAKISDFG 566 (714)
Q Consensus 496 v~E~~~~gsL~~~l~~~-----~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~----~~~~kl~Dfg 566 (714)
||||+++ +|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+||+++. ++.+||+|||
T Consensus 82 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg 157 (316)
T cd07842 82 LFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLG 157 (316)
T ss_pred EEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence 9999986 666665422 25788899999999999999999998 999999999999999 9999999999
Q ss_pred CccccccCcc--cceeeecCCCCccCcccccCC-CCCchhhhHHHHHHHHHHHhcCCCCcccccchhh------hhhhHH
Q 041576 567 LSKLLLSDQS--RTRTVIRGTRGYVAPEWFKNV-PVSAKVDVYSFGVVLLKIICCKRSVEMELGEERS------AILTDW 637 (714)
Q Consensus 567 ~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~------~~l~~~ 637 (714)
++........ .......++..|+|||.+.+. .++.++||||||++++||++|+.||......... ..+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (316)
T cd07842 158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERI 237 (316)
T ss_pred cccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHH
Confidence 9987643322 122234578889999988664 5799999999999999999999999754433200 000000
Q ss_pred Hhh----------h---hhc-------Cccceeecchhhhccch--HHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 638 AYD----------C---YVE-------GKLDVLVDNDKAAMADK--SRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 638 ~~~----------~---~~~-------~~~~~~~~~~~~~~~~~--~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
... . ..+ ...............+. ....++.+++.+||+.||++|||+.|+++
T Consensus 238 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 238 FEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 000 0 000 00000000000010111 33456888999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=292.51 Aligned_cols=262 Identities=21% Similarity=0.276 Sum_probs=197.5
Q ss_pred hhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccch-hhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEeec
Q 041576 422 NGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQ-EREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEFM 500 (714)
Q Consensus 422 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~ 500 (714)
|.+.+.||.|++|.||+|+.. .+++.||||.++.... .....+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 2 FKQLEKLGEGTYATVYKGRNR-TTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred ceEeeeeccCCceEEEEEEEC-CCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 456789999999999999976 4688999999875432 23456788999999999999999999999999999999999
Q ss_pred CCCchhhhhhcC---CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCccc
Q 041576 501 GNGTLANLLFAI---PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSR 577 (714)
Q Consensus 501 ~~gsL~~~l~~~---~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 577 (714)
++ +|.+++... ..+++..+..++.||++||+|||+.+ ++||||||+||++++++.++|+|||++........
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~- 155 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN- 155 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence 85 888887653 35789999999999999999999998 99999999999999999999999999976533221
Q ss_pred ceeeecCCCCccCcccccCC-CCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHH-------hhhhhc-----
Q 041576 578 TRTVIRGTRGYVAPEWFKNV-PVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWA-------YDCYVE----- 644 (714)
Q Consensus 578 ~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~-------~~~~~~----- 644 (714)
......++..|+|||.+.+. .++.++||||||+++|||++|+.||......+....+.... +.....
T Consensus 156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd07836 156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYK 235 (284)
T ss_pred ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhc
Confidence 11223467889999988654 57899999999999999999999997554332211111100 000000
Q ss_pred CccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 645 GKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 645 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
.......+... .......+..+.+++.+||+.||.+||++.|+++
T Consensus 236 ~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 236 PTFPRYPPQDL-QQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred ccccCCChHHH-HHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00000000000 0111123456788999999999999999999985
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=301.05 Aligned_cols=270 Identities=22% Similarity=0.278 Sum_probs=206.3
Q ss_pred hhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc--hhhHHHHHHHHHHHhccCcccccceeceEecCC-----eee
Q 041576 422 NGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA--QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGL-----NRL 494 (714)
Q Consensus 422 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-----~~~ 494 (714)
|.+.+.||+|++|.||+|+.. .+++.|++|++.... ....+.+.+|++++++++|+||+++++++.... ..+
T Consensus 2 y~i~~~ig~g~~~~v~~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 2 YELLKPIGSGAYGVVCSAVDK-RTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred ceeeeeecCCCCeEEEEEEeC-CCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 567789999999999999875 468899999987643 445568999999999999999999999998775 789
Q ss_pred EEEeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccC
Q 041576 495 LVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSD 574 (714)
Q Consensus 495 lv~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 574 (714)
++|||+++ +|.+++.....+++..++.++.||++||+|||+.+ |+||||||+||+++.++.++|+|||++......
T Consensus 81 lv~e~~~~-~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~ 156 (330)
T cd07834 81 IVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPD 156 (330)
T ss_pred EEecchhh-hHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEeeccc
Confidence 99999984 89999988778999999999999999999999998 999999999999999999999999999876443
Q ss_pred cc--cceeeecCCCCccCcccccCC-CCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHh----hh---hhc
Q 041576 575 QS--RTRTVIRGTRGYVAPEWFKNV-PVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAY----DC---YVE 644 (714)
Q Consensus 575 ~~--~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~----~~---~~~ 644 (714)
.. .......++..|+|||.+.+. .++.++||||||+++|+|++|+.||......+....+..... .. ...
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 236 (330)
T cd07834 157 EDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITS 236 (330)
T ss_pred ccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccc
Confidence 21 122334578889999999887 789999999999999999999999976543322111111000 00 000
Q ss_pred Cccceeec------chhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHH--Hhccc
Q 041576 645 GKLDVLVD------NDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM--LEGYL 696 (714)
Q Consensus 645 ~~~~~~~~------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~~ 696 (714)
......+. ..............+.+++.+||+.+|++||+++++++. +++..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~ 296 (330)
T cd07834 237 EKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLH 296 (330)
T ss_pred cchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhc
Confidence 00000000 000000111234567889999999999999999999984 55543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=288.24 Aligned_cols=248 Identities=22% Similarity=0.289 Sum_probs=197.2
Q ss_pred hhhhhhhCcccceeEEEeEeeCCCCcEEEEEEeccc-----chhhHHHHHHHHHHHhccCcccccceeceEecC--Ceee
Q 041576 422 NGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKL-----AQEREREFKTEVSAIGRTHHKNLVQLLGFCDEG--LNRL 494 (714)
Q Consensus 422 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~ 494 (714)
|.+.+.||+|++|.||+|... .+++.|++|.+... .......+.+|++++++++|+||+++++++.+. ...+
T Consensus 4 ~~~~~~lg~g~~g~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (264)
T cd06653 4 WRLGKLLGRGAFGEVYLCYDA-DTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLS 82 (264)
T ss_pred eeeeeeEccCCCeEEEEEEEc-CCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEE
Confidence 566789999999999999876 57889999987421 223456789999999999999999999998664 4578
Q ss_pred EEEeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccC
Q 041576 495 LVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSD 574 (714)
Q Consensus 495 lv~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 574 (714)
+++||+++++|.+++.....+++.....++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 83 ~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 159 (264)
T cd06653 83 IFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTI 159 (264)
T ss_pred EEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccccccc
Confidence 99999999999999987777889999999999999999999998 999999999999999999999999999865321
Q ss_pred c--ccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeec
Q 041576 575 Q--SRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVD 652 (714)
Q Consensus 575 ~--~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 652 (714)
. ........++..|+|||.+.+..++.++||||||+++|||++|+.||....... .+... ....
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~----~~~~------- 225 (264)
T cd06653 160 CMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMA---AIFKI----ATQP------- 225 (264)
T ss_pred cccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHH---HHHHH----HcCC-------
Confidence 1 111223457889999999998889999999999999999999999996432211 11110 0000
Q ss_pred chhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 653 NDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 653 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
.....+......+.+++.+||+ +|.+||++.++++
T Consensus 226 --~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 226 --TKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred --CCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 0111233344568889999999 5799999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=294.16 Aligned_cols=265 Identities=23% Similarity=0.269 Sum_probs=194.0
Q ss_pred hhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc--hhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEe
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA--QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYE 498 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E 498 (714)
.|.+.+.||+|++|.||+|... .+++.|++|.++... ......+.+|++++++++||||+++++++.++...++|||
T Consensus 3 ~y~~~~~l~~g~~~~v~~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 3 QYEKVEKIGEGTYGVVYKARDR-VTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred ceEEEEEecCCCCEEEEEEEec-CCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 3566789999999999999876 468899999986532 2334578899999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcCCC--CChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECC-CCceEEecCCCccccccCc
Q 041576 499 FMGNGTLANLLFAIPR--PDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQ-DFTAKISDFGLSKLLLSDQ 575 (714)
Q Consensus 499 ~~~~gsL~~~l~~~~~--~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~-~~~~kl~Dfg~~~~~~~~~ 575 (714)
|+++ +|.+++..... .++..+..++.||+.||+|||+++ ++|+||+|+||+++. ++.+||+|||++.......
T Consensus 82 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~ 157 (294)
T PLN00009 82 YLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (294)
T ss_pred cccc-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence 9964 78777765433 477888899999999999999998 999999999999985 5679999999997653321
Q ss_pred ccceeeecCCCCccCcccccCC-CCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhh---hhcC--ccce
Q 041576 576 SRTRTVIRGTRGYVAPEWFKNV-PVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDC---YVEG--KLDV 649 (714)
Q Consensus 576 ~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~---~~~~--~~~~ 649 (714)
. ......++..|+|||.+.+. .++.++||||||+++|+|+||+.||......+....+....... ...+ .+..
T Consensus 158 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (294)
T PLN00009 158 R-TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPD 236 (294)
T ss_pred c-ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchh
Confidence 1 11223467899999988664 57899999999999999999999997543322111100000000 0000 0000
Q ss_pred ------eecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 650 ------LVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 650 ------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
.................+.+++.+||+.+|++||++.++++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 237 YKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred hhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000001112234567889999999999999999999863
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=301.17 Aligned_cols=249 Identities=24% Similarity=0.369 Sum_probs=205.8
Q ss_pred hhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEeecC
Q 041576 422 NGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEFMG 501 (714)
Q Consensus 422 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~ 501 (714)
.++.-.||.|+||.||+|+.+ .++...|.|.+.....+...+++-|+++|..++||+||++++.|..++.++|+.|||.
T Consensus 34 WeIiGELGDGAFGKVyKA~nk-et~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~ 112 (1187)
T KOG0579|consen 34 WEIIGELGDGAFGKVYKAVNK-ETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCG 112 (1187)
T ss_pred HHHHhhhcCccchhhhhhhcc-cchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecC
Confidence 445667999999999999977 4666778899988888888999999999999999999999999999999999999999
Q ss_pred CCchhhhhhcC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCccccee
Q 041576 502 NGTLANLLFAI-PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRT 580 (714)
Q Consensus 502 ~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 580 (714)
||-.+.++-.. ..+.+.++.-+++|++.||.|||++. |||||||..|||++-+|.++|+|||.+...... .....
T Consensus 113 GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t-~qkRD 188 (1187)
T KOG0579|consen 113 GGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKST-RQKRD 188 (1187)
T ss_pred CchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchhH-Hhhhc
Confidence 99999988755 56899999999999999999999998 999999999999999999999999998654322 23345
Q ss_pred eecCCCCccCcccc-----cCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchh
Q 041576 581 VIRGTRGYVAPEWF-----KNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDK 655 (714)
Q Consensus 581 ~~~gt~~y~aPE~~-----~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 655 (714)
.+.||+.|||||+. ...+|+.++||||||+.|.||..+.+|-....... .+.. +.......+
T Consensus 189 sFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMR---VllK-----iaKSePPTL----- 255 (1187)
T KOG0579|consen 189 SFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMR---VLLK-----IAKSEPPTL----- 255 (1187)
T ss_pred cccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHH---HHHH-----HhhcCCCcc-----
Confidence 57799999999986 46789999999999999999999998865332221 1111 111111111
Q ss_pred hhccchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 656 AAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 656 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
..+......+.+++.+||..||..||++.++++
T Consensus 256 --lqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 256 --LQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred --cCcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 123445667888999999999999999999986
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=291.36 Aligned_cols=262 Identities=23% Similarity=0.289 Sum_probs=199.6
Q ss_pred hhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccch--hhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEeec
Q 041576 423 GFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQ--EREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEFM 500 (714)
Q Consensus 423 ~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~ 500 (714)
.+.+.||+|++|.||+|... .+++.+++|.+..... .....+.+|++++++++|+||+++++++..+...++|+||+
T Consensus 2 ~~~~~i~~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 2 QKLGKIGEGTYGVVYKARDK-LTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred ccceeeecCCCceEEEEEcC-CCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 45678999999999999875 4688999999865332 34567889999999999999999999999999999999999
Q ss_pred CCCchhhhhhcC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcccce
Q 041576 501 GNGTLANLLFAI-PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTR 579 (714)
Q Consensus 501 ~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 579 (714)
++ +|.+++... ..+++..+..++.||++||+|||+.+ ++|+||||+||++++++.++|+|||.+....... ...
T Consensus 81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~~~ 155 (283)
T cd05118 81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RPY 155 (283)
T ss_pred CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-ccc
Confidence 86 888877663 57899999999999999999999998 9999999999999999999999999998765433 122
Q ss_pred eeecCCCCccCcccccCC-CCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHH-------Hhhhhhc---Cccc
Q 041576 580 TVIRGTRGYVAPEWFKNV-PVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDW-------AYDCYVE---GKLD 648 (714)
Q Consensus 580 ~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~-------~~~~~~~---~~~~ 648 (714)
....++..|+|||.+.+. .++.++||||||+++|+|++|+.||......+....+... .+..... ....
T Consensus 156 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd05118 156 THYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKF 235 (283)
T ss_pred cCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhh
Confidence 234577889999998776 7899999999999999999999999754432211111000 0000000 0000
Q ss_pred eeecc--hhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 649 VLVDN--DKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 649 ~~~~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
...+. ..........+..+.+++.+||+.||.+||++.+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 236 SFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 00000 0001112234568889999999999999999999986
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=295.65 Aligned_cols=265 Identities=24% Similarity=0.274 Sum_probs=195.5
Q ss_pred hhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccch--hhHHHHHHHHHHHhccCcccccceeceEecC--CeeeEE
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQ--EREREFKTEVSAIGRTHHKNLVQLLGFCDEG--LNRLLV 496 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~lv 496 (714)
.|.+.+.||+|+||.||+|... .+++.||+|.++.... .....+.+|+.++++++|+||+++++++.+. +..++|
T Consensus 8 ~y~~~~~ig~g~~~~v~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (309)
T cd07845 8 EFEKLNRIGEGTYGIVYRARDT-TSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLV 86 (309)
T ss_pred ceeEeeeeeecCCEEEEEEEEC-CCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEE
Confidence 4666788999999999999976 5788999999864322 2233567899999999999999999998655 467999
Q ss_pred EeecCCCchhhhhhcC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCc
Q 041576 497 YEFMGNGTLANLLFAI-PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQ 575 (714)
Q Consensus 497 ~E~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 575 (714)
|||+.+ +|.+++... ..+++.++..++.||++||+|||+.+ ++||||||+||++++++.+||+|||++.......
T Consensus 87 ~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~ 162 (309)
T cd07845 87 MEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA 162 (309)
T ss_pred EecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecCCcc
Confidence 999975 788887653 56899999999999999999999998 9999999999999999999999999998764332
Q ss_pred ccceeeecCCCCccCcccccC-CCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHh-------hhhhcCcc
Q 041576 576 SRTRTVIRGTRGYVAPEWFKN-VPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAY-------DCYVEGKL 647 (714)
Q Consensus 576 ~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~-------~~~~~~~~ 647 (714)
. ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...........+..... ........
T Consensus 163 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (309)
T cd07845 163 K-PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPL 241 (309)
T ss_pred C-CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccc
Confidence 1 1222335778999999865 4579999999999999999999999975543322111111000 00000000
Q ss_pred -cee-ecchh-h--hccchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 648 -DVL-VDNDK-A--AMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 648 -~~~-~~~~~-~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
... ..... . ..........+.+++.+||+.||++|||+.|+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 242 VGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred cccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 000 00000 0 00001124567789999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=293.71 Aligned_cols=262 Identities=21% Similarity=0.216 Sum_probs=192.7
Q ss_pred hhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc--hhhHHHHHHHHHHHhcc-CcccccceeceEecCCe-----
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA--QEREREFKTEVSAIGRT-HHKNLVQLLGFCDEGLN----- 492 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~----- 492 (714)
.|.+.+.||+|+||.||+|... .+++.||+|.++... ......+.+|+.+++++ +||||+++++++...+.
T Consensus 2 ~y~~~~~lg~g~~g~vy~~~~~-~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 2 AYEKLEKIGEGTYGKVYKARDK-NTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CceEeeEecccCCeEEEEEEEC-CCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 3556788999999999999976 468899999886532 22345788899999999 56999999999977665
Q ss_pred eeEEEeecCCCchhhhhhcC-----CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECC-CCceEEecCC
Q 041576 493 RLLVYEFMGNGTLANLLFAI-----PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQ-DFTAKISDFG 566 (714)
Q Consensus 493 ~~lv~E~~~~gsL~~~l~~~-----~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~-~~~~kl~Dfg 566 (714)
.++||||+++ +|.+++... ..+++..++.++.||++||+|||+.+ ++||||+|+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999986 788887542 34689999999999999999999998 999999999999998 8999999999
Q ss_pred CccccccCcccceeeecCCCCccCcccccC-CCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcC
Q 041576 567 LSKLLLSDQSRTRTVIRGTRGYVAPEWFKN-VPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEG 645 (714)
Q Consensus 567 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~ 645 (714)
++......... .....+++.|+|||.+.+ ..++.++||||||+++|||++|..||...........+.... .....
T Consensus 157 ~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~--~~~~~ 233 (295)
T cd07837 157 LGRAFSIPVKS-YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLL--GTPTE 233 (295)
T ss_pred cceecCCCccc-cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh--CCCCh
Confidence 98765332211 112246788999998865 457999999999999999999999997543222111110000 00000
Q ss_pred cc-cee--------e---cchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 646 KL-DVL--------V---DNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 646 ~~-~~~--------~---~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
.. ... . .+.............+.+++.+||++||.+||+++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 234 QVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred hhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 00 000 0 000000011224557888999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=300.30 Aligned_cols=270 Identities=23% Similarity=0.299 Sum_probs=198.3
Q ss_pred hhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc-hhhHHHHHHHHHHHhccCcccccceeceEecC-----Ceee
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA-QEREREFKTEVSAIGRTHHKNLVQLLGFCDEG-----LNRL 494 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-----~~~~ 494 (714)
.|.+.+.||+|++|.||+|+.. .+++.||+|.+.... ......+.+|+.++++++||||+++++++... ...+
T Consensus 6 ~y~i~~~lg~G~~g~vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 84 (336)
T cd07849 6 RYQNLSYIGEGAYGMVCSATHK-PTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVY 84 (336)
T ss_pred ceEEEEEEEecCCeEEEEEEEc-CCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEE
Confidence 4667789999999999999876 578899999986432 23445688899999999999999999987554 3579
Q ss_pred EEEeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccC
Q 041576 495 LVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSD 574 (714)
Q Consensus 495 lv~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 574 (714)
+|+||+.+ +|.+++.. ..+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 85 lv~e~~~~-~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~ 159 (336)
T cd07849 85 IVQELMET-DLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIADPE 159 (336)
T ss_pred EEehhccc-CHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceeecccc
Confidence 99999975 78777754 56889999999999999999999998 999999999999999999999999998765432
Q ss_pred ccc--ceeeecCCCCccCcccccC-CCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceee
Q 041576 575 QSR--TRTVIRGTRGYVAPEWFKN-VPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLV 651 (714)
Q Consensus 575 ~~~--~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 651 (714)
... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...........+....... .......+.
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 238 (336)
T cd07849 160 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTP-SQEDLNCII 238 (336)
T ss_pred ccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCC-CHHHHHHhh
Confidence 211 1123457889999998754 568999999999999999999999996543211110000000000 000000000
Q ss_pred cc-----------hh---hhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HhcccC
Q 041576 652 DN-----------DK---AAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM--LEGYLE 697 (714)
Q Consensus 652 ~~-----------~~---~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~~~ 697 (714)
.. .. ...........+.+++.+||+.||++|||+.|+++. ++....
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~ 300 (336)
T cd07849 239 SLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHD 300 (336)
T ss_pred chhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCC
Confidence 00 00 000011224568899999999999999999999986 666553
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=286.59 Aligned_cols=248 Identities=27% Similarity=0.378 Sum_probs=203.0
Q ss_pred hhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc--hhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEee
Q 041576 422 NGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA--QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEF 499 (714)
Q Consensus 422 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~ 499 (714)
|.+.+.||+|++|.||++... .+++.+++|++.... ......+.+|++.+++++|||++++++.+..+...++|+||
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 2 YEIIKQIGKGSFGKVYLVRRK-SDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred ceEEeeeccCCCeEEEEEEEc-CCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 456688999999999999976 468899999987543 35567889999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcC----CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCc
Q 041576 500 MGNGTLANLLFAI----PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQ 575 (714)
Q Consensus 500 ~~~gsL~~~l~~~----~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 575 (714)
+++++|.+++... ..+++..+..++.++++||+|||+.+ ++|+||+|+||++++++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 9999999999764 66899999999999999999999998 9999999999999999999999999998764433
Q ss_pred ccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchh
Q 041576 576 SRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDK 655 (714)
Q Consensus 576 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 655 (714)
. ......++..|+|||.+.+..++.++||||+|+++++|++|+.|+........ .. .........
T Consensus 158 ~-~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~---~~-----~~~~~~~~~------ 222 (258)
T cd08215 158 D-LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLEL---AL-----KILKGQYPP------ 222 (258)
T ss_pred c-eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHH---HH-----HHhcCCCCC------
Confidence 1 22234578899999999988899999999999999999999999865432211 11 011111111
Q ss_pred hhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 656 AAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 656 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
.+......+.+++.+||+.+|++||++.|+++.
T Consensus 223 ---~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 223 ---IPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred ---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 111234567889999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=289.39 Aligned_cols=262 Identities=26% Similarity=0.341 Sum_probs=196.9
Q ss_pred hhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccch-hhHHHHHHHHHHHhccC-cccccceeceEecCCeeeEEEee
Q 041576 422 NGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQ-EREREFKTEVSAIGRTH-HKNLVQLLGFCDEGLNRLLVYEF 499 (714)
Q Consensus 422 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~E~ 499 (714)
|.+.+.||+|++|+||+|+.. .+++.|++|++..... .......+|+..+++++ |+||+++++++..++..++||||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~ 79 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNK-ETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEY 79 (283)
T ss_pred CeeheeeccCCceEEEEEEEC-CCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEec
Confidence 346688999999999999976 4578999999865322 23334567999999998 99999999999999999999999
Q ss_pred cCCCchhhhhhcCC--CCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCccc
Q 041576 500 MGNGTLANLLFAIP--RPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSR 577 (714)
Q Consensus 500 ~~~gsL~~~l~~~~--~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 577 (714)
+ +++|.+++.... .+++..+..++.|++.+|.|||+++ ++|+||+|+||++++++.++|+|||++........
T Consensus 80 ~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~- 154 (283)
T cd07830 80 M-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP- 154 (283)
T ss_pred C-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCCC-
Confidence 9 789999887654 6799999999999999999999998 99999999999999999999999999986543222
Q ss_pred ceeeecCCCCccCccccc-CCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhH---------HHhhhhhcCcc
Q 041576 578 TRTVIRGTRGYVAPEWFK-NVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTD---------WAYDCYVEGKL 647 (714)
Q Consensus 578 ~~~~~~gt~~y~aPE~~~-~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~---------~~~~~~~~~~~ 647 (714)
.....++..|+|||.+. ...++.++||||||++++||++|+.||......+....... |..........
T Consensus 155 -~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd07830 155 -YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKL 233 (283)
T ss_pred -cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccc
Confidence 12345788999999885 44579999999999999999999999965543221111100 00000000001
Q ss_pred ceeec----chhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 648 DVLVD----NDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 648 ~~~~~----~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
...+. .......+ .....+.+++.+||+.+|++||+++|+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~-~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 234 GFRFPQFAPTSLHQLIP-NASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred cccccccccccHHHHcc-cCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 10000 00111111 114578899999999999999999999763
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=290.91 Aligned_cols=253 Identities=25% Similarity=0.242 Sum_probs=198.5
Q ss_pred hhhhhhhCcccceeEEEeEeeC--CCCcEEEEEEecccch----hhHHHHHHHHHHHhcc-CcccccceeceEecCCeee
Q 041576 422 NGFEEELGRGSFGIVYKGVLKS--ASGNAVAVKKLDKLAQ----EREREFKTEVSAIGRT-HHKNLVQLLGFCDEGLNRL 494 (714)
Q Consensus 422 ~~~~~~ig~G~~g~Vy~~~~~~--~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~ 494 (714)
|.+.+.||+|+||.||+|.... .+|+.||+|.+..... ...+.+.+|++++.++ +|+||+++++++..+...+
T Consensus 2 y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (290)
T cd05613 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLH 81 (290)
T ss_pred ceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEE
Confidence 4566889999999999998642 3678999999875322 2345678899999999 6999999999999999999
Q ss_pred EEEeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccC
Q 041576 495 LVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSD 574 (714)
Q Consensus 495 lv~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 574 (714)
+|+||+++++|.+++.....+++..+..++.|+++||+|||+.+ ++||||+|+||++++++.+||+|||++......
T Consensus 82 lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 158 (290)
T cd05613 82 LILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFHED 158 (290)
T ss_pred EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCccceecccc
Confidence 99999999999999988788899999999999999999999998 999999999999999999999999999876443
Q ss_pred cccceeeecCCCCccCcccccCC--CCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeec
Q 041576 575 QSRTRTVIRGTRGYVAPEWFKNV--PVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVD 652 (714)
Q Consensus 575 ~~~~~~~~~gt~~y~aPE~~~~~--~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 652 (714)
.........++..|+|||.+.+. .++.++||||||+++|+|++|+.||...........+. .......
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~---~~~~~~~------- 228 (290)
T cd05613 159 EVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEIS---RRILKSE------- 228 (290)
T ss_pred cccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHH---HHhhccC-------
Confidence 33333345588899999998753 46889999999999999999999986432211111111 1000000
Q ss_pred chhhhccchHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 041576 653 NDKAAMADKSRACKWLMIALWCIQEDPLKRP-----AMKMIVQM 691 (714)
Q Consensus 653 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 691 (714)
...+......+.+++.+||+.||++|| ++.++++.
T Consensus 229 ----~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 229 ----PPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred ----CCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 001122345677899999999999997 77777663
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=291.53 Aligned_cols=263 Identities=19% Similarity=0.208 Sum_probs=188.0
Q ss_pred HHHHHhhhhhhhhCcccceeEEEeEeeCCC--CcEEEEEEecccchhh-----------HHHHHHHHHHHhccCcccccc
Q 041576 416 ELNEATNGFEEELGRGSFGIVYKGVLKSAS--GNAVAVKKLDKLAQER-----------EREFKTEVSAIGRTHHKNLVQ 482 (714)
Q Consensus 416 el~~at~~~~~~ig~G~~g~Vy~~~~~~~~--~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~h~nIv~ 482 (714)
++....|.+.+.||+|+||.||+|...... +..+++|......... ......+...+..++|+||++
T Consensus 8 ~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~ 87 (294)
T PHA02882 8 DITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPK 87 (294)
T ss_pred ccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCc
Confidence 444557888899999999999999876321 4456666543211110 112233445566779999999
Q ss_pred eeceEecCC----eeeEEEeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCC
Q 041576 483 LLGFCDEGL----NRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDF 558 (714)
Q Consensus 483 l~~~~~~~~----~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~ 558 (714)
+++++.... ..++++|++.. ++.+.+......++..+..|+.|+++||+|||+.+ |+||||||+|||++.++
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~ 163 (294)
T PHA02882 88 YYGCGSFKRCRMYYRFILLEKLVE-NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNN 163 (294)
T ss_pred EEEeeeEecCCceEEEEEEehhcc-CHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCC
Confidence 999775543 34677887654 66666665555678888999999999999999998 99999999999999999
Q ss_pred ceEEecCCCccccccCcc------cceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhh
Q 041576 559 TAKISDFGLSKLLLSDQS------RTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSA 632 (714)
Q Consensus 559 ~~kl~Dfg~~~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~ 632 (714)
.++|+|||+++....... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||..........
T Consensus 164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~ 243 (294)
T PHA02882 164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLI 243 (294)
T ss_pred cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHH
Confidence 999999999987643221 11123468999999999999999999999999999999999999997653222110
Q ss_pred hhhHH-HhhhhhcCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 041576 633 ILTDW-AYDCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLE 693 (714)
Q Consensus 633 ~l~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 693 (714)
..... .......+.. .....+..+.+++..|++.+|++||++.++++.|+
T Consensus 244 ~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 244 HAAKCDFIKRLHEGKI-----------KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HHhHHHHHHHhhhhhh-----------ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 00000 0011111111 01112356788999999999999999999998863
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=293.89 Aligned_cols=265 Identities=22% Similarity=0.268 Sum_probs=193.4
Q ss_pred hhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc--hhhHHHHHHHHHHHhccCcccccceeceEecCC-------
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA--QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGL------- 491 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~------- 491 (714)
.|.+.+.||+|+||.||+|... .+++.||||.+.... ......+.+|++++++++||||+++++++....
T Consensus 13 ~y~~~~~lg~g~~~~v~~~~~~-~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 91 (310)
T cd07865 13 KYEKLAKIGQGTFGEVFKARHK-KTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK 91 (310)
T ss_pred heEEEEEeecCCCEEEEEEEEC-CCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence 4677789999999999999876 478899999886432 222345678999999999999999999986654
Q ss_pred -eeeEEEeecCCCchhhhhhcC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCcc
Q 041576 492 -NRLLVYEFMGNGTLANLLFAI-PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSK 569 (714)
Q Consensus 492 -~~~lv~E~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~ 569 (714)
..++||||+.+ +|.+.+... ..+++.+++.++.||++||+|||+++ ++|+||||+||+++.++.+||+|||++.
T Consensus 92 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~ 167 (310)
T cd07865 92 GSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGLAR 167 (310)
T ss_pred ceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCCCcc
Confidence 34999999975 787777654 36899999999999999999999998 9999999999999999999999999998
Q ss_pred ccccCccc---ceeeecCCCCccCcccccCC-CCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHh----hh
Q 041576 570 LLLSDQSR---TRTVIRGTRGYVAPEWFKNV-PVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAY----DC 641 (714)
Q Consensus 570 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~----~~ 641 (714)
........ ......++..|+|||.+.+. .++.++||||||+++|||++|+.||...........+..... ..
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (310)
T cd07865 168 AFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEV 247 (310)
T ss_pred cccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence 66432221 11233467889999988664 478899999999999999999999975543322111111100 00
Q ss_pred hhcCccce------eecc----hhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 642 YVEGKLDV------LVDN----DKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 642 ~~~~~~~~------~~~~----~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
+....... .... .............+.+++.+||+.||++|||++|+++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 248 WPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred cccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 00000000 0000 0000000112345678999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=299.15 Aligned_cols=267 Identities=20% Similarity=0.282 Sum_probs=199.4
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc--hhhHHHHHHHHHHHhccCcccccceeceEec----CCee
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA--QEREREFKTEVSAIGRTHHKNLVQLLGFCDE----GLNR 493 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~----~~~~ 493 (714)
..|.+.+.||+|++|.||+|... .+++.|++|++.... ......+.+|+.++++++||||+++++++.. ....
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~-~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDT-RSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEc-CCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 45666788999999999999876 568899999986532 2345677889999999999999999998753 3567
Q ss_pred eEEEeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCcccccc
Q 041576 494 LLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLS 573 (714)
Q Consensus 494 ~lv~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~ 573 (714)
++||||+. ++|.+++.....+++..+..++.||++||+|||+.+ |+||||||+||++++++.+||+|||++.....
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 159 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSS 159 (334)
T ss_pred EEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccceeecc
Confidence 99999996 589999987778999999999999999999999998 99999999999999999999999999976543
Q ss_pred Cccc---ceeeecCCCCccCcccccC-CCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHH-------hhhh
Q 041576 574 DQSR---TRTVIRGTRGYVAPEWFKN-VPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWA-------YDCY 642 (714)
Q Consensus 574 ~~~~---~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~-------~~~~ 642 (714)
.... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...........+.... ....
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~ 239 (334)
T cd07855 160 SPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRI 239 (334)
T ss_pred cCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhh
Confidence 2221 1123467889999999865 458999999999999999999999997543222111100000 0000
Q ss_pred hcCccceeecc---h---hhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 643 VEGKLDVLVDN---D---KAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 643 ~~~~~~~~~~~---~---~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
....+....+. . .........+..+.+++.+||+.+|++||+++++++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 240 GSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred chhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 00000000000 0 0000112235678899999999999999999999874
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=290.45 Aligned_cols=247 Identities=26% Similarity=0.337 Sum_probs=202.1
Q ss_pred hhhhhhhCcccceeEEEeEeeCCCCcEEEEEEeccc---chhhHHHHHHHHHHHhccC-cccccceeceEecCCeeeEEE
Q 041576 422 NGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKL---AQEREREFKTEVSAIGRTH-HKNLVQLLGFCDEGLNRLLVY 497 (714)
Q Consensus 422 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~ 497 (714)
|.+.+.||+|++|.||+|..+ .+++.|++|.+... .....+.+.+|++++++++ ||||+++++++..++..++||
T Consensus 3 y~~~~~lg~g~~~~vy~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~ 81 (280)
T cd05581 3 FKFGKIIGEGSFSTVVLAKEK-ETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVL 81 (280)
T ss_pred ceEeeeecCCCceEEEEEEEc-CCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEE
Confidence 566788999999999999976 47889999998652 2334567889999999998 999999999999999999999
Q ss_pred eecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcc-
Q 041576 498 EFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQS- 576 (714)
Q Consensus 498 E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~- 576 (714)
|++++++|.+++.....+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 82 e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~ 158 (280)
T cd05581 82 EYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSP 158 (280)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCCcccc
Confidence 99999999999998888999999999999999999999998 99999999999999999999999999986643321
Q ss_pred ------------------cceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHH
Q 041576 577 ------------------RTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWA 638 (714)
Q Consensus 577 ------------------~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~ 638 (714)
.......++..|+|||.+....++.++||||||++++++++|+.||........ +..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~---~~~-- 233 (280)
T cd05581 159 ESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLT---FQK-- 233 (280)
T ss_pred ccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHH---HHH--
Confidence 122234578899999999888899999999999999999999999975432111 100
Q ss_pred hhhhhcCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCH----HHHHH
Q 041576 639 YDCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAM----KMIVQ 690 (714)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~----~evl~ 690 (714)
.... ....+...+..+.+++.+||+.+|++||++ +++++
T Consensus 234 ---~~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 234 ---ILKL----------EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred ---HHhc----------CCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 0000 001112224567889999999999999999 77664
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=297.21 Aligned_cols=262 Identities=23% Similarity=0.238 Sum_probs=196.4
Q ss_pred hhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhh--------------HHHHHHHHHHHhccCcccccceeceEec
Q 041576 424 FEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQER--------------EREFKTEVSAIGRTHHKNLVQLLGFCDE 489 (714)
Q Consensus 424 ~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~h~nIv~l~~~~~~ 489 (714)
+.+.||+|+||.||+|... .+++.||||.++...... ...+.+|++++++++|+||+++++++..
T Consensus 13 ~~~~ig~G~~g~vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 91 (335)
T PTZ00024 13 KGAHLGEGTYGKVEKAYDT-LTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVE 91 (335)
T ss_pred hhhcccCCCceeEEEEEEC-CCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEec
Confidence 3467999999999999876 468899999986432211 1257899999999999999999999999
Q ss_pred CCeeeEEEeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCcc
Q 041576 490 GLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSK 569 (714)
Q Consensus 490 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~ 569 (714)
++..++||||+. ++|.+++.....+++.....++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++.
T Consensus 92 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl~dfg~~~ 167 (335)
T PTZ00024 92 GDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLAR 167 (335)
T ss_pred CCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEECCcccee
Confidence 999999999997 599999988778899999999999999999999998 9999999999999999999999999997
Q ss_pred ccccCc-------------ccceeeecCCCCccCcccccCC-CCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhh
Q 041576 570 LLLSDQ-------------SRTRTVIRGTRGYVAPEWFKNV-PVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILT 635 (714)
Q Consensus 570 ~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~ 635 (714)
...... ........++..|+|||.+.+. .++.++||||||+++|||++|+.||......+....+.
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i~ 247 (335)
T PTZ00024 168 RYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIF 247 (335)
T ss_pred ecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 654111 1111123467789999998764 46899999999999999999999997654332211111
Q ss_pred HHHhhh----hhcCc-------cceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 636 DWAYDC----YVEGK-------LDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 636 ~~~~~~----~~~~~-------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
...... +.... .......... .........+.+++.+||+.+|++||+++|++..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 248 ELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLK-TIFPNASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred HHhCCCchhhCcchhhcccccccCcCCcccHH-HhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 100000 00000 0000000000 0111224567889999999999999999999974
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=287.26 Aligned_cols=243 Identities=23% Similarity=0.246 Sum_probs=188.9
Q ss_pred hhCcccceeEEEeEeeCCCCcEEEEEEecccc---hhhHHHHHHHH---HHHhccCcccccceeceEecCCeeeEEEeec
Q 041576 427 ELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA---QEREREFKTEV---SAIGRTHHKNLVQLLGFCDEGLNRLLVYEFM 500 (714)
Q Consensus 427 ~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~---~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~ 500 (714)
.||+|+||.||+|... .+++.||+|.+.... ......+.+|. ..+...+||||+++++++..++..++||||+
T Consensus 1 ~ig~g~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 79 (278)
T cd05606 1 IIGRGGFGEVYGCRKA-DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLM 79 (278)
T ss_pred CcccCCCeEEEEEEEe-cCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecC
Confidence 4899999999999875 468899999886422 11122233343 3444568999999999999999999999999
Q ss_pred CCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCccccee
Q 041576 501 GNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRT 580 (714)
Q Consensus 501 ~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 580 (714)
++++|.+++.....+++..+..++.|+++||+|||+.+ ++||||||+||+++.++.+||+|||++....... ..
T Consensus 80 ~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~---~~ 153 (278)
T cd05606 80 NGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PH 153 (278)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccC---Cc
Confidence 99999999987778999999999999999999999998 9999999999999999999999999987553222 12
Q ss_pred eecCCCCccCcccccCC-CCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhhcc
Q 041576 581 VIRGTRGYVAPEWFKNV-PVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMA 659 (714)
Q Consensus 581 ~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 659 (714)
...|+..|+|||.+.+. .++.++||||+|+++|||++|+.||............ ...... . ...
T Consensus 154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~-----~~~~~~------~----~~~ 218 (278)
T cd05606 154 ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID-----RMTLTM------A----VEL 218 (278)
T ss_pred CcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHH-----HHhhcc------C----CCC
Confidence 34588999999998754 6899999999999999999999999754222111000 000000 0 001
Q ss_pred chHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 041576 660 DKSRACKWLMIALWCIQEDPLKRP-----AMKMIVQM 691 (714)
Q Consensus 660 ~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 691 (714)
+...+..+.+++.+||+.+|.+|| ++.|+++.
T Consensus 219 ~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 219 PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred CCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 112345788899999999999999 99999863
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-33 Score=293.11 Aligned_cols=249 Identities=25% Similarity=0.317 Sum_probs=196.6
Q ss_pred HHHhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEeccc---chhhHHHHHHHHHHHhccCcccccceeceEecCCeee
Q 041576 418 NEATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKL---AQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRL 494 (714)
Q Consensus 418 ~~at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 494 (714)
...++...+.||+|++|.||+|+.. .++..+++|.+... ......++.+|+++++.++|+|++++++++......+
T Consensus 13 ~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 91 (308)
T cd06634 13 PEKLFSDLREIGHGSFGAVYFARDV-RNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAW 91 (308)
T ss_pred cHHHHHHHHheeeCCCEEEEEEEEc-CCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeE
Confidence 3445666788999999999999976 46789999998642 2334457889999999999999999999999999999
Q ss_pred EEEeecCCCchhhhhhc-CCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCcccccc
Q 041576 495 LVYEFMGNGTLANLLFA-IPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLS 573 (714)
Q Consensus 495 lv~E~~~~gsL~~~l~~-~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~ 573 (714)
+||||+. ++|.+.+.. ...+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++.....
T Consensus 92 lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 167 (308)
T cd06634 92 LVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (308)
T ss_pred EEEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecC
Confidence 9999997 577777653 456789999999999999999999998 99999999999999999999999999876533
Q ss_pred CcccceeeecCCCCccCccccc---CCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCcccee
Q 041576 574 DQSRTRTVIRGTRGYVAPEWFK---NVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVL 650 (714)
Q Consensus 574 ~~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 650 (714)
. ....++..|+|||.+. ...++.++||||||+++|||++|+.|+........ +... ..+...
T Consensus 168 ~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~---~~~~-----~~~~~~-- 232 (308)
T cd06634 168 A-----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA---LYHI-----AQNESP-- 232 (308)
T ss_pred c-----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHH---HHHH-----hhcCCC--
Confidence 2 2234788999999874 35678899999999999999999999864322211 1010 111100
Q ss_pred ecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 041576 651 VDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQML 692 (714)
Q Consensus 651 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 692 (714)
..........+.+++.+||+.+|++||++.++++.-
T Consensus 233 ------~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~ 268 (308)
T cd06634 233 ------ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 268 (308)
T ss_pred ------CcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence 011223445678899999999999999999999764
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=287.97 Aligned_cols=261 Identities=24% Similarity=0.268 Sum_probs=194.0
Q ss_pred hhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc--hhhHHHHHHHHHHHhcc---CcccccceeceEecCCe-----
Q 041576 423 GFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA--QEREREFKTEVSAIGRT---HHKNLVQLLGFCDEGLN----- 492 (714)
Q Consensus 423 ~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~nIv~l~~~~~~~~~----- 492 (714)
.+.+.||+|++|.||+|+.+ .+++.||+|.++... ......+.+|+.+++++ +||||+++++++...+.
T Consensus 2 ~~~~~l~~g~~~~v~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 2 EELAEIGEGAYGTVYKARDL-NTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred eEEEEecccCceEEEEEEEC-CCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 45678999999999999986 368899999996422 22234566777776665 69999999999988776
Q ss_pred eeEEEeecCCCchhhhhhcCC--CCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccc
Q 041576 493 RLLVYEFMGNGTLANLLFAIP--RPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKL 570 (714)
Q Consensus 493 ~~lv~E~~~~gsL~~~l~~~~--~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~ 570 (714)
.+++|||+.+ +|.+++.... .+++..+..++.|+++||+|||+.+ ++|+||+|+||+++.++.+||+|||++..
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~~ 156 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARI 156 (287)
T ss_pred eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCccee
Confidence 8999999975 8888887543 5889999999999999999999998 99999999999999999999999999977
Q ss_pred cccCcccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhh----hhhcCc
Q 041576 571 LLSDQSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYD----CYVEGK 646 (714)
Q Consensus 571 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~----~~~~~~ 646 (714)
...... .....++..|+|||.+.+..++.++||||||+++|||++|+.||......+....+...... .+....
T Consensus 157 ~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07838 157 YSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNV 234 (287)
T ss_pred ccCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCc
Confidence 643322 12234688899999999989999999999999999999999998765433221111110000 000000
Q ss_pred c--ceeecc---hhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 647 L--DVLVDN---DKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 647 ~--~~~~~~---~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
. ...... .............+.+++.+||+.||++||+++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 235 SLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred ccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 0 000000 0001111233467788999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=299.20 Aligned_cols=248 Identities=25% Similarity=0.328 Sum_probs=207.1
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEeccc--chhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEE
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKL--AQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVY 497 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 497 (714)
.-|.+.+.||+|.|++|.+|++. .++..||+|.+++. +....+.+.+|+++|+.++|||||+++.+.......|+||
T Consensus 56 g~y~i~~tig~g~f~~V~La~~~-~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ 134 (596)
T KOG0586|consen 56 GLYVIIKTIGKGNFAKVKLARHI-LTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM 134 (596)
T ss_pred cceeeeeeeccceeEEEEeeEec-CCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence 34667789999999999999987 57899999999763 2333456899999999999999999999999999999999
Q ss_pred eecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCccc
Q 041576 498 EFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSR 577 (714)
Q Consensus 498 E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 577 (714)
||+.+|.+.+++....+..+..+..++.|+..|++|||+++ |+|||||++||||+.+.++||+|||++..+. ...
T Consensus 135 eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~--~~~ 209 (596)
T KOG0586|consen 135 EYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFD--YGL 209 (596)
T ss_pred EeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeec--ccc
Confidence 99999999999999999988999999999999999999998 9999999999999999999999999998774 333
Q ss_pred ceeeecCCCCccCcccccCCCC-CchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhh
Q 041576 578 TRTVIRGTRGYVAPEWFKNVPV-SAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKA 656 (714)
Q Consensus 578 ~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 656 (714)
......|++.|.|||++.+..+ .+++|+||+|++||-|+.|..||+...-.+.. +..+.. ..
T Consensus 210 ~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr------------~rvl~g----k~- 272 (596)
T KOG0586|consen 210 MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELR------------PRVLRG----KY- 272 (596)
T ss_pred cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccccc------------chheee----ee-
Confidence 4456779999999999998876 67999999999999999999999854322210 000000 00
Q ss_pred hccchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 657 AMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 657 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
..+.....++.++++++|-.+|.+|++++++.+.
T Consensus 273 -rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 273 -RIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred -cccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 1122233456679999999999999999999764
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=284.33 Aligned_cols=241 Identities=21% Similarity=0.204 Sum_probs=187.2
Q ss_pred hhhhhh--hCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhcc-CcccccceeceEecCCeeeEEEe
Q 041576 422 NGFEEE--LGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRT-HHKNLVQLLGFCDEGLNRLLVYE 498 (714)
Q Consensus 422 ~~~~~~--ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~E 498 (714)
+.+.+. ||+|+||.||++..+ .+++.+++|.+........ |+.....+ +||||+++++.+...+..++|||
T Consensus 16 ~~~~~~~~lg~g~~g~v~~~~~~-~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e 89 (267)
T PHA03390 16 CEIVKKLKLIDGKFGKVSVLKHK-PTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMD 89 (267)
T ss_pred hccccceeecCCCceEEEEEEEc-CCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCeeEEEEE
Confidence 344455 499999999999876 4688999999865321111 22222222 79999999999999999999999
Q ss_pred ecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCC-ceEEecCCCccccccCccc
Q 041576 499 FMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDF-TAKISDFGLSKLLLSDQSR 577 (714)
Q Consensus 499 ~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~-~~kl~Dfg~~~~~~~~~~~ 577 (714)
|+++++|.+++.....+++.++..++.||++||+|||+.+ ++||||||+||+++.++ .++|+|||++.......
T Consensus 90 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~-- 164 (267)
T PHA03390 90 YIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPS-- 164 (267)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccceecCCCc--
Confidence 9999999999988778999999999999999999999998 99999999999999998 99999999987653322
Q ss_pred ceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhh
Q 041576 578 TRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAA 657 (714)
Q Consensus 578 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 657 (714)
...++..|+|||.+.+..++.++||||||+++|||++|+.||........ ....+.... ....
T Consensus 165 ---~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~--~~~~~~~~~--~~~~---------- 227 (267)
T PHA03390 165 ---CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEEL--DLESLLKRQ--QKKL---------- 227 (267)
T ss_pred ---cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchh--hHHHHHHhh--cccC----------
Confidence 23478899999999998999999999999999999999999974432221 011111100 0000
Q ss_pred ccchHHHHHHHHHHHHccccCCCCCCC-HHHHHH
Q 041576 658 MADKSRACKWLMIALWCIQEDPLKRPA-MKMIVQ 690 (714)
Q Consensus 658 ~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~ 690 (714)
......+..+.+++.+||+.+|.+||+ ++|+++
T Consensus 228 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 228 PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred CcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 011134457888999999999999996 688874
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=290.26 Aligned_cols=259 Identities=17% Similarity=0.168 Sum_probs=191.8
Q ss_pred hhhhCcccceeEEEeEeeCCCCcEEEEEEeccc--chhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEeecCC
Q 041576 425 EEELGRGSFGIVYKGVLKSASGNAVAVKKLDKL--AQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEFMGN 502 (714)
Q Consensus 425 ~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~ 502 (714)
.+.+|.|+++.|+++. .+++.||||++... .....+.+.+|++++++++|+||+++++++.+.+..+++|||+++
T Consensus 7 ~~~~~~~~~v~~~~~~---~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~ 83 (314)
T cd08216 7 GKCFEDLMIVHLAKHK---PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAY 83 (314)
T ss_pred hHhhcCCceEEEEEec---CCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCC
Confidence 3445555555555544 26899999998653 345567899999999999999999999999999999999999999
Q ss_pred CchhhhhhcC--CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcc----
Q 041576 503 GTLANLLFAI--PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQS---- 576 (714)
Q Consensus 503 gsL~~~l~~~--~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~---- 576 (714)
++|.+++... ..+++..+..++.|+++||+|||+++ |+||||||+||+++.++.+||+|||.+........
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~ 160 (314)
T cd08216 84 GSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV 160 (314)
T ss_pred CCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeeccccccccc
Confidence 9999999753 45788889999999999999999998 99999999999999999999999998875532211
Q ss_pred --cceeeecCCCCccCcccccC--CCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHH---hhhhh------
Q 041576 577 --RTRTVIRGTRGYVAPEWFKN--VPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWA---YDCYV------ 643 (714)
Q Consensus 577 --~~~~~~~gt~~y~aPE~~~~--~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~---~~~~~------ 643 (714)
.......++..|+|||.+.. ..++.++||||||+++|||++|+.||........ .+.... .....
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 238 (314)
T cd08216 161 VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM--LLEKVRGTVPCLLDKSTYPL 238 (314)
T ss_pred cccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHhccCccccccCchhh
Confidence 11123346778999999875 3588999999999999999999999975432211 000000 00000
Q ss_pred -cCccc--------eeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 644 -EGKLD--------VLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 644 -~~~~~--------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
..... ..................+.+++.+||+.||++|||++++++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 239 YEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred hcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 00000 0000011111223345678889999999999999999999874
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-33 Score=287.76 Aligned_cols=261 Identities=26% Similarity=0.296 Sum_probs=199.4
Q ss_pred hhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc--hhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEeec
Q 041576 423 GFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA--QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEFM 500 (714)
Q Consensus 423 ~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~ 500 (714)
.+.+.||+|.+|.||+|+.. .+++.+++|.+.... ....+.+.+|+.++++++|+||+++++++.+....++|+||+
T Consensus 2 ~~~~~ig~g~~~~vy~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 2 EKLEKLGEGTYGVVYKARDK-KTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred eeehcccccCcceEEEeeec-CCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 34578999999999999976 468899999997643 333467889999999999999999999999999999999999
Q ss_pred CCCchhhhhhcC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcccce
Q 041576 501 GNGTLANLLFAI-PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTR 579 (714)
Q Consensus 501 ~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 579 (714)
+ ++|.+++... ..+++..+..++.|+++||+|||+++ ++||||+|+||++++++.++|+|||.+........ ..
T Consensus 81 ~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-~~ 155 (282)
T cd07829 81 D-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-TY 155 (282)
T ss_pred C-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcc-cc
Confidence 8 4899999876 57899999999999999999999998 99999999999999999999999999976543322 12
Q ss_pred eeecCCCCccCcccccCC-CCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHH-------hhhh-----hcCc
Q 041576 580 TVIRGTRGYVAPEWFKNV-PVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWA-------YDCY-----VEGK 646 (714)
Q Consensus 580 ~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~-------~~~~-----~~~~ 646 (714)
....++..|+|||.+.+. .++.++||||||++++||++|+.||...........+.... +... ....
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (282)
T cd07829 156 THEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPT 235 (282)
T ss_pred CccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccccc
Confidence 223456789999998766 78999999999999999999999997654322111111000 0000 0000
Q ss_pred cceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 647 LDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 647 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
........... ........+.+++.+||+.||++||++++++.
T Consensus 236 ~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 236 FPKFPPKDLEK-VLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred ccccCccchHH-hcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 00000000000 01112557889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=290.09 Aligned_cols=244 Identities=25% Similarity=0.301 Sum_probs=191.7
Q ss_pred hhhhhhhCcccceeEEEeEeeCCCCcEEEEEEeccc---chhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEe
Q 041576 422 NGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKL---AQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYE 498 (714)
Q Consensus 422 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E 498 (714)
+...++||+|+||.||+|+.. .+++.|++|.+... .......+.+|++++++++|||++++++++.+....++|||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 101 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNS-HTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVME 101 (313)
T ss_pred hhcceeeccCCCeEEEEEEEC-CCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEe
Confidence 334567999999999999865 46889999998642 22334578899999999999999999999999999999999
Q ss_pred ecCCCchhhhhhc-CCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCccc
Q 041576 499 FMGNGTLANLLFA-IPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSR 577 (714)
Q Consensus 499 ~~~~gsL~~~l~~-~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 577 (714)
|+.+ +|.+++.. ...+++.++..++.||+.||+|||+.+ ++|+||+|+||++++++.+||+|||++.....
T Consensus 102 ~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~---- 173 (313)
T cd06633 102 YCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP---- 173 (313)
T ss_pred cCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCC----
Confidence 9964 77776654 456889999999999999999999998 99999999999999999999999998864322
Q ss_pred ceeeecCCCCccCccccc---CCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecch
Q 041576 578 TRTVIRGTRGYVAPEWFK---NVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDND 654 (714)
Q Consensus 578 ~~~~~~gt~~y~aPE~~~---~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 654 (714)
.....++..|+|||.+. ...++.++||||||+++|||++|..|+.......... .. .......
T Consensus 174 -~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~---~~-----~~~~~~~----- 239 (313)
T cd06633 174 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY---HI-----AQNDSPT----- 239 (313)
T ss_pred -CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH---HH-----HhcCCCC-----
Confidence 12345788999999984 4568899999999999999999999986543221110 00 0000000
Q ss_pred hhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 655 KAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 655 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
.........+.+++.+||+.+|.+||++.++++.
T Consensus 240 ---~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 240 ---LQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred ---CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0111223457789999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-33 Score=292.50 Aligned_cols=265 Identities=23% Similarity=0.270 Sum_probs=192.9
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccch--hhHHHHHHHHHHHhccCcccccceeceEecCC------
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQ--EREREFKTEVSAIGRTHHKNLVQLLGFCDEGL------ 491 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~------ 491 (714)
..|.+.+.||+|++|.||+|... .+++.+++|++..... .....+.+|++++++++||||+++++++.+..
T Consensus 8 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 8 RDYEILGKLGEGTFGEVYKARQI-KTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred ccEEEEEEeccCCCEEEEEEEEC-CCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 35667789999999999999976 4688999998864322 22346788999999999999999999875443
Q ss_pred --eeeEEEeecCCCchhhhhhc-CCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCc
Q 041576 492 --NRLLVYEFMGNGTLANLLFA-IPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLS 568 (714)
Q Consensus 492 --~~~lv~E~~~~gsL~~~l~~-~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~ 568 (714)
..++|+||+.+ +|...+.. ...+++..+..++.||++||+|||+.+ ++|+||||+||++++++.++|+|||++
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~ 162 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGLA 162 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCccc
Confidence 45899999976 66666654 457899999999999999999999998 999999999999999999999999999
Q ss_pred cccccCccc----------ceeeecCCCCccCcccccCC-CCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHH
Q 041576 569 KLLLSDQSR----------TRTVIRGTRGYVAPEWFKNV-PVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDW 637 (714)
Q Consensus 569 ~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~ 637 (714)
......... ......++..|+|||.+.+. .++.++||||||+++|||++|+.||...........+...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~ 242 (311)
T cd07866 163 RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKL 242 (311)
T ss_pred hhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 865432211 11223567889999988654 5899999999999999999999999754433221111110
Q ss_pred Hhhh----hhc-Ccccee--------ecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 638 AYDC----YVE-GKLDVL--------VDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 638 ~~~~----~~~-~~~~~~--------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
.... +.. ..+... ....... ........+.+++.+||+.||++|||+.|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 243 CGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEE-RFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred hCCCChhhchhhhhcccccccccCCCCCccHHH-HcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 0000 000 000000 0000000 00112256788999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=295.30 Aligned_cols=267 Identities=21% Similarity=0.265 Sum_probs=194.7
Q ss_pred hhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc--hhhHHHHHHHHHHHhccCcccccceeceEecCC------e
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA--QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGL------N 492 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~------~ 492 (714)
.|.+.+.||+|++|.||+|+.. .+++.||+|++.... ......+.+|+.++++++||||+++++++.... .
T Consensus 16 ~y~~~~~ig~g~~g~v~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 94 (342)
T cd07879 16 RYTSLKQVGSGAYGSVCSAIDK-RTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD 94 (342)
T ss_pred ceEEEEEeeecCCeEEEEEEeC-CCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence 4555678999999999999875 468899999986532 223456889999999999999999999986543 4
Q ss_pred eeEEEeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccc
Q 041576 493 RLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLL 572 (714)
Q Consensus 493 ~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~ 572 (714)
.++|+||+.. +|.+++. ..+++..+..++.|+++||+|||+.+ ++||||||+||+++.++.+||+|||+++...
T Consensus 95 ~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~ 168 (342)
T cd07879 95 FYLVMPYMQT-DLQKIMG--HPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARHAD 168 (342)
T ss_pred EEEEeccccc-CHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCCcCCC
Confidence 5899999974 6766653 35788999999999999999999998 9999999999999999999999999987643
Q ss_pred cCcccceeeecCCCCccCcccccC-CCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHH-------hhhhhc
Q 041576 573 SDQSRTRTVIRGTRGYVAPEWFKN-VPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWA-------YDCYVE 644 (714)
Q Consensus 573 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~-------~~~~~~ 644 (714)
.. .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...........+.... ......
T Consensus 169 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (342)
T cd07879 169 AE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLED 244 (342)
T ss_pred CC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcc
Confidence 22 122346788999999876 468999999999999999999999997543221111100000 000000
Q ss_pred Ccc-------ceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HhcccCCC
Q 041576 645 GKL-------DVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM--LEGYLEVP 699 (714)
Q Consensus 645 ~~~-------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~~~~~ 699 (714)
... .......... ........+.+++.+||+.||++||+++|+++. +++..+..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~~ 307 (342)
T cd07879 245 KAAKSYIKSLPKYPRKDFST-LFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDAD 307 (342)
T ss_pred cchHHHHhhcCCcccchHHH-HhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccccc
Confidence 000 0000000000 001123467889999999999999999999954 77665543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=313.11 Aligned_cols=273 Identities=23% Similarity=0.240 Sum_probs=222.6
Q ss_pred HHhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecc---cchhhHHHHHHHHHHHhccCcccccceeceEecCCeeeE
Q 041576 419 EATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDK---LAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLL 495 (714)
Q Consensus 419 ~at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 495 (714)
...+.+.++||+|+||.|..++++ .+++.||+|++.+ ..+....-|.+|-.+|..-+.+-|++++..|.++++.|+
T Consensus 74 ~~DfeilKvIGrGaFGEV~lVr~k-~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYl 152 (1317)
T KOG0612|consen 74 AEDFEILKVIGRGAFGEVALVRHK-STEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYL 152 (1317)
T ss_pred HHhhHHHHHhcccccceeEEEEee-ccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEE
Confidence 345667899999999999999987 5789999999987 334456679999999999999999999999999999999
Q ss_pred EEeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCc
Q 041576 496 VYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQ 575 (714)
Q Consensus 496 v~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 575 (714)
|||||+||+|-.++....++++..+..++..|..||.-||+.| +|||||||+|||||..|++||+|||.+..+..+.
T Consensus 153 VMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFGsClkm~~dG 229 (1317)
T KOG0612|consen 153 VMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADG 229 (1317)
T ss_pred EEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccchhHHhcCCCC
Confidence 9999999999999998888999999999999999999999998 9999999999999999999999999999988877
Q ss_pred ccceeeecCCCCccCccccc----C-CCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCcccee
Q 041576 576 SRTRTVIRGTRGYVAPEWFK----N-VPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVL 650 (714)
Q Consensus 576 ~~~~~~~~gt~~y~aPE~~~----~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 650 (714)
.......+|||.|++||+++ + +.|...+|-||+||++|||+.|..||+.+.--+....+... ...
T Consensus 230 ~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~h-------k~~--- 299 (1317)
T KOG0612|consen 230 TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNH-------KES--- 299 (1317)
T ss_pred cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhch-------hhh---
Confidence 77777778999999999995 3 56899999999999999999999999866544333222221 000
Q ss_pred ecchhhhccchHHHHHHHHHHHHccccCCCCCCC---HHHHHHH-------HhcccCCCCCCCCCCccCC
Q 041576 651 VDNDKAAMADKSRACKWLMIALWCIQEDPLKRPA---MKMIVQM-------LEGYLEVPSPPMPPLHSLQ 710 (714)
Q Consensus 651 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl~~-------L~~~~~~~~pp~p~~~~~~ 710 (714)
+..+.....++...+||.+.+ -+|+.|.. ++++... ..++-+...|-.|-..|..
T Consensus 300 ----l~FP~~~~VSeeakdLI~~ll-~~~e~RLgrngiedik~HpFF~g~~W~~iR~~~pP~vPevssd~ 364 (1317)
T KOG0612|consen 300 ----LSFPDETDVSEEAKDLIEALL-CDREVRLGRNGIEDIKNHPFFEGIDWDNIRESVPPVVPEVSSDD 364 (1317)
T ss_pred ----cCCCcccccCHHHHHHHHHHh-cChhhhcccccHHHHHhCccccCCChhhhhhcCCCCCCcCCCCC
Confidence 111112235566777888766 48889987 8888653 2445566666666555543
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=267.46 Aligned_cols=247 Identities=24% Similarity=0.398 Sum_probs=194.5
Q ss_pred hhhhhCcccceeEEEeEeeCCCCcEEEEEEecc-cchhhHHHHHHHHHHHhcc-CcccccceeceEecCCeeeEEEeecC
Q 041576 424 FEEELGRGSFGIVYKGVLKSASGNAVAVKKLDK-LAQEREREFKTEVSAIGRT-HHKNLVQLLGFCDEGLNRLLVYEFMG 501 (714)
Q Consensus 424 ~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~E~~~ 501 (714)
+...||+|..|+|++++.+ .+|..+|||.+.+ .+.+..++++..+.++..- +.|.||+.+|+|..+...++.||.|.
T Consensus 96 ~l~dlGsGtcG~V~k~~~r-s~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs 174 (391)
T KOG0983|consen 96 NLGDLGSGTCGQVWKMRFR-STGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS 174 (391)
T ss_pred hHHhhcCCCccceEEEEEc-ccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH
Confidence 4577999999999999988 4788999999976 4455567788888877766 48999999999999999999999986
Q ss_pred CCchhhhhhcC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCccccee
Q 041576 502 NGTLANLLFAI-PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRT 580 (714)
Q Consensus 502 ~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 580 (714)
. .++.++... .++++..+-++...+++||.||.++. +|+|||+||+|||+|+.|++||+|||++..+..... .+
T Consensus 175 ~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA--ht 249 (391)
T KOG0983|consen 175 T-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA--HT 249 (391)
T ss_pred H-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecccc--cc
Confidence 4 566666543 45677777889999999999999876 699999999999999999999999999987754433 33
Q ss_pred eecCCCCccCccccc---CCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhh
Q 041576 581 VIRGTRGYVAPEWFK---NVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAA 657 (714)
Q Consensus 581 ~~~gt~~y~aPE~~~---~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 657 (714)
...|-+.|||||.+. ...|+.++||||||+.|+||.||+.||.....+-. .+... ..... ..++
T Consensus 250 rsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe--~ltkv-----ln~eP-P~L~----- 316 (391)
T KOG0983|consen 250 RSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFE--VLTKV-----LNEEP-PLLP----- 316 (391)
T ss_pred cccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHH--HHHHH-----HhcCC-CCCC-----
Confidence 445889999999985 34688999999999999999999999986543321 11111 11111 1111
Q ss_pred ccchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 658 MADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 658 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
.....+..+.+++..||++|+.+||...++++
T Consensus 317 -~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 317 -GHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred -cccCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 11125567888999999999999999999876
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-32 Score=278.18 Aligned_cols=237 Identities=31% Similarity=0.317 Sum_probs=194.5
Q ss_pred hCcccceeEEEeEeeCCCCcEEEEEEecccch---hhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEeecCCCc
Q 041576 428 LGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQ---EREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEFMGNGT 504 (714)
Q Consensus 428 ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~gs 504 (714)
||+|++|.||++... .+++.+++|.++.... .....+.+|+.++++++||||+++++.+..+...++||||+++++
T Consensus 1 lg~G~~~~v~~~~~~-~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~ 79 (250)
T cd05123 1 LGKGSFGKVLLVRKK-DTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGE 79 (250)
T ss_pred CCCCCceEEEEEEEC-CCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCc
Confidence 689999999999876 4688999999865332 245678999999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcccceeeecC
Q 041576 505 LANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRG 584 (714)
Q Consensus 505 L~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g 584 (714)
|.+++.....+++..+..++.|+++||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... .......+
T Consensus 80 L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~ 155 (250)
T cd05123 80 LFSHLSKEGRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTFCG 155 (250)
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccCCcC
Confidence 9999988778899999999999999999999988 9999999999999999999999999997654332 12233457
Q ss_pred CCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhhccchHHH
Q 041576 585 TRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMADKSRA 664 (714)
Q Consensus 585 t~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 664 (714)
+..|+|||.+.+...+.++|+||||+++||+++|+.||....... .... ...... ..+....
T Consensus 156 ~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~---~~~~-----~~~~~~----------~~~~~~~ 217 (250)
T cd05123 156 TPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKE---IYEK-----ILKDPL----------RFPEFLS 217 (250)
T ss_pred CccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH---HHHH-----HhcCCC----------CCCCCCC
Confidence 889999999988889999999999999999999999996543211 1100 011000 0111224
Q ss_pred HHHHHHHHHccccCCCCCCCHHH
Q 041576 665 CKWLMIALWCIQEDPLKRPAMKM 687 (714)
Q Consensus 665 ~~l~~li~~cl~~dP~~RPs~~e 687 (714)
..+.+++.+||..||++||++.+
T Consensus 218 ~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 218 PEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred HHHHHHHHHHhcCCHhhCCCccc
Confidence 56788999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-33 Score=314.61 Aligned_cols=264 Identities=25% Similarity=0.341 Sum_probs=210.5
Q ss_pred HHHHHHHhhhhhhhhCcccceeEEEeEeeCCC------CcEEEEEEecccc-hhhHHHHHHHHHHHhcc-Ccccccceec
Q 041576 414 LVELNEATNGFEEELGRGSFGIVYKGVLKSAS------GNAVAVKKLDKLA-QEREREFKTEVSAIGRT-HHKNLVQLLG 485 (714)
Q Consensus 414 ~~el~~at~~~~~~ig~G~~g~Vy~~~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~ 485 (714)
.-|+......+.+.||+|+||.|++|...... ...||||.++... ..+.+.+..|+++++.+ +|+||+.++|
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 34555555566779999999999999865222 4579999998643 35667899999999999 7999999999
Q ss_pred eEecCCeeeEEEeecCCCchhhhhhcCC----------------CCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCc
Q 041576 486 FCDEGLNRLLVYEFMGNGTLANLLFAIP----------------RPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKP 549 (714)
Q Consensus 486 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~----------------~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~ 549 (714)
+|..+...++|+||+..|+|.++|+..+ .+.....+.++.|||.|++||++.. +|||||..
T Consensus 370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAa 446 (609)
T KOG0200|consen 370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAA 446 (609)
T ss_pred eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhh
Confidence 9999999999999999999999998765 3778889999999999999999987 99999999
Q ss_pred CeEEECCCCceEEecCCCccccccCcccceeeec--CCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccc
Q 041576 550 QNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIR--GTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMEL 626 (714)
Q Consensus 550 ~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~ 626 (714)
+|||+.++..+||+|||+++.............. -...|||||.+....++.|+|||||||+|||++| |..|+..-.
T Consensus 447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~ 526 (609)
T KOG0200|consen 447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP 526 (609)
T ss_pred hhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC
Confidence 9999999999999999999976555444333222 2456999999999999999999999999999998 566665311
Q ss_pred cchhhhhhhHHHhhhhhcCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 041576 627 GEERSAILTDWAYDCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYL 696 (714)
Q Consensus 627 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 696 (714)
... +. .+...+|.. ...+.....++.++++.||+.+|++||++.|+.+.++..+
T Consensus 527 ~~~------~l-~~~l~~G~r---------~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l 580 (609)
T KOG0200|consen 527 PTE------EL-LEFLKEGNR---------MEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHL 580 (609)
T ss_pred cHH------HH-HHHHhcCCC---------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence 011 11 112233322 1223344567888999999999999999999999998843
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-32 Score=285.22 Aligned_cols=250 Identities=25% Similarity=0.398 Sum_probs=191.7
Q ss_pred hhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc-hhhHHHHHHHHHHHhcc-CcccccceeceEecCCeeeEEEe
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA-QEREREFKTEVSAIGRT-HHKNLVQLLGFCDEGLNRLLVYE 498 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~E 498 (714)
.+.+.+.||+|++|.||+|.+. .+++.||||.++... ......+..|+.++.+. .||||+++++++.++...+++||
T Consensus 16 ~~~~~~~lg~g~~~~v~~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 94 (296)
T cd06618 16 DLENLGEIGSGTCGQVYKMRFK-KTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME 94 (296)
T ss_pred hheeeeEeeccCCeEEEEEEEC-CCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence 3566789999999999999976 358899999997532 23445667777777666 59999999999999999999999
Q ss_pred ecCCCchhhhhhc-CCCCChhhHHHHHHHHHHHHHHHHhc-CCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcc
Q 041576 499 FMGNGTLANLLFA-IPRPDWSLRVRISLEIARGLLYLHEE-CNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQS 576 (714)
Q Consensus 499 ~~~~gsL~~~l~~-~~~~~~~~~~~i~~qi~~~L~yLH~~-~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 576 (714)
|+.+ +|.+++.. ...+++..+..++.||++||+|||+. + |+||||+|+||++++++.+||+|||++..+.....
T Consensus 95 ~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~ 170 (296)
T cd06618 95 LMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA 170 (296)
T ss_pred ccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhccCCCc
Confidence 9864 77777654 34678899999999999999999974 5 99999999999999999999999999876543222
Q ss_pred cceeeecCCCCccCcccccCCC----CCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeec
Q 041576 577 RTRTVIRGTRGYVAPEWFKNVP----VSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVD 652 (714)
Q Consensus 577 ~~~~~~~gt~~y~aPE~~~~~~----~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 652 (714)
. ....++..|+|||.+.+.. ++.++||||||+++|||++|+.||....... ..+.. ..........
T Consensus 171 ~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~~~~~-----~~~~~~~~~~- 240 (296)
T cd06618 171 K--TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF--EVLTK-----ILQEEPPSLP- 240 (296)
T ss_pred c--cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHH--HHHHH-----HhcCCCCCCC-
Confidence 1 2234678899999987553 7899999999999999999999996432211 11111 0111100000
Q ss_pred chhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 653 NDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 653 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
.......++.+++.+||+.||++||++.++++.
T Consensus 241 ------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 241 ------PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred ------CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 011234568889999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=273.85 Aligned_cols=281 Identities=22% Similarity=0.314 Sum_probs=201.1
Q ss_pred hhhhhhhhCcccceeEEEeEeeCCCC---cEEEEEEecccch--hhHHHHHHHHHHHhccCcccccceeceEec-CCeee
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSASG---NAVAVKKLDKLAQ--EREREFKTEVSAIGRTHHKNLVQLLGFCDE-GLNRL 494 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~~~---~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-~~~~~ 494 (714)
.|+....||+|.||.||+|+..+.++ ..+|+|+++.... .-.....+|+..++.++||||+.+..++.+ +...+
T Consensus 25 ~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~ 104 (438)
T KOG0666|consen 25 EYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVW 104 (438)
T ss_pred HhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEE
Confidence 46667889999999999997654443 2689999975321 223466789999999999999999999977 88899
Q ss_pred EEEeecCCCchhhhhhcC-----CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCC----CceEEecC
Q 041576 495 LVYEFMGNGTLANLLFAI-----PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQD----FTAKISDF 565 (714)
Q Consensus 495 lv~E~~~~gsL~~~l~~~-----~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~----~~~kl~Df 565 (714)
+++||.+. +|.+.|+.. +.++......|+.||+.|+.|||++- |+||||||.||||..+ |.+||+||
T Consensus 105 l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIaDl 180 (438)
T KOG0666|consen 105 LLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIADL 180 (438)
T ss_pred EEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEeecc
Confidence 99999988 888888632 35678889999999999999999998 9999999999999877 89999999
Q ss_pred CCccccccCcc--cceeeecCCCCccCcccccCC-CCCchhhhHHHHHHHHHHHhcCCCCcccccchhhh--h---hhHH
Q 041576 566 GLSKLLLSDQS--RTRTVIRGTRGYVAPEWFKNV-PVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSA--I---LTDW 637 (714)
Q Consensus 566 g~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~--~---l~~~ 637 (714)
|+++.+...-. .....++-|..|.|||.+.+. .||.+.|||+.|||..||+|-++.|.......... . ....
T Consensus 181 GlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~r 260 (438)
T KOG0666|consen 181 GLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDR 260 (438)
T ss_pred cHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHH
Confidence 99998765432 233456678999999999875 58999999999999999999998886542221110 0 0000
Q ss_pred HhhhhhcC---c---cceeec--------------ch-hhhc--cchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 041576 638 AYDCYVEG---K---LDVLVD--------------ND-KAAM--ADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEG 694 (714)
Q Consensus 638 ~~~~~~~~---~---~~~~~~--------------~~-~~~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 694 (714)
....+-.. + +....+ .. +..- .....+....+|+.++|+.||.+|.|+++.++.. -
T Consensus 261 If~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~-y 339 (438)
T KOG0666|consen 261 IFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHP-Y 339 (438)
T ss_pred HHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccc-c
Confidence 00000000 0 000000 00 0000 0001122367799999999999999999988753 2
Q ss_pred ccCCCCCCCCCC
Q 041576 695 YLEVPSPPMPPL 706 (714)
Q Consensus 695 ~~~~~~pp~p~~ 706 (714)
..+.+.||.|..
T Consensus 340 F~~d~lpp~pt~ 351 (438)
T KOG0666|consen 340 FTEDPLPPLPTS 351 (438)
T ss_pred cccCCCCCCccc
Confidence 344555665543
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=293.78 Aligned_cols=265 Identities=20% Similarity=0.242 Sum_probs=194.2
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCcccccceeceEecC---------
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEG--------- 490 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--------- 490 (714)
.+|.+.+.||.|+||.||+|... .+++.|++|++........+.+.+|++++++++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~-~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDS-DCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEEC-CCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 45677889999999999999876 57889999998765555667889999999999999999999876543
Q ss_pred -----CeeeEEEeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEEC-CCCceEEec
Q 041576 491 -----LNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLD-QDFTAKISD 564 (714)
Q Consensus 491 -----~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~-~~~~~kl~D 564 (714)
...++||||++ ++|.+++.. ..+++..+..++.||++||+|||+.+ ++||||||+||+++ +++.+||+|
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~kl~d 158 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGD 158 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEEECC
Confidence 35789999997 488888864 46789999999999999999999998 99999999999997 456789999
Q ss_pred CCCccccccCccc--ceeeecCCCCccCcccccC-CCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhH-HH--
Q 041576 565 FGLSKLLLSDQSR--TRTVIRGTRGYVAPEWFKN-VPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTD-WA-- 638 (714)
Q Consensus 565 fg~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~-~~-- 638 (714)
||++..+...... ......++..|+|||.+.. ..++.++|||||||++|||++|+.||...........+.. ..
T Consensus 159 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 238 (342)
T cd07854 159 FGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVV 238 (342)
T ss_pred cccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 9999765332111 1122346888999998754 5688899999999999999999999975432221111000 00
Q ss_pred ----hhhhhcCccceee-----cchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 639 ----YDCYVEGKLDVLV-----DNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 639 ----~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
............. ..............++.+++.+||+.||++|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 239 REEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred ChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 0000000000000 000000001123456788999999999999999999985
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=280.72 Aligned_cols=247 Identities=24% Similarity=0.328 Sum_probs=193.2
Q ss_pred hhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEeccc-----chhhHHHHHHHHHHHhccCcccccceeceEecCCeeeE
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKL-----AQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLL 495 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 495 (714)
+|.+.+.||+|+||.||++.... .+..+++|.++.. .......+..|+.++++++||||+++++++.+....++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 79 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKK-AVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCI 79 (260)
T ss_pred CceeeeeecCCCCceEEEEEecC-CCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEE
Confidence 36677899999999999998753 3455666655431 22234467789999999999999999999999999999
Q ss_pred EEeecCCCchhhhhhc----CCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCcccc
Q 041576 496 VYEFMGNGTLANLLFA----IPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLL 571 (714)
Q Consensus 496 v~E~~~~gsL~~~l~~----~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~ 571 (714)
|+||+++++|.+++.. ...+++..++.++.|+++||+|||+.+ ++|+||+|+||++++ +.++|+|||.+...
T Consensus 80 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~ 155 (260)
T cd08222 80 ITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLL 155 (260)
T ss_pred EEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeec
Confidence 9999999999998863 356889999999999999999999998 999999999999975 56999999998765
Q ss_pred ccCcccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceee
Q 041576 572 LSDQSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLV 651 (714)
Q Consensus 572 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 651 (714)
..... ......++..|+|||.+.+..++.++||||||+++|+|++|..||....... ... ....+...
T Consensus 156 ~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~---~~~-----~~~~~~~~--- 223 (260)
T cd08222 156 MGSCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLS---VVL-----RIVEGPTP--- 223 (260)
T ss_pred CCCcc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH---HHH-----HHHcCCCC---
Confidence 43222 2223457889999999988889999999999999999999999986432111 110 01111111
Q ss_pred cchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 652 DNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 652 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
..+......+.+++.+||+.+|++||++.|+++
T Consensus 224 ------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 224 ------SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred ------CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 112334457888999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=323.39 Aligned_cols=246 Identities=26% Similarity=0.347 Sum_probs=201.8
Q ss_pred hhhCcccceeEEEeEeeCCCCcEEEEEEecccc--hhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEeecCCC
Q 041576 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA--QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEFMGNG 503 (714)
Q Consensus 426 ~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~g 503 (714)
..||.|.||.||.|+.- .+|.-.|+|.++-.. ....+...+|+.++..++|||+|+++|+-.+.+..+|.||||++|
T Consensus 1241 ~~Ig~G~fG~VYtavN~-~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~G 1319 (1509)
T KOG4645|consen 1241 NFIGGGTFGKVYTAVNL-DTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGG 1319 (1509)
T ss_pred cccCCcceeeeEEeecC-CccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccC
Confidence 46999999999999865 578999999886432 334467889999999999999999999999999999999999999
Q ss_pred chhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcc---ccee
Q 041576 504 TLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQS---RTRT 580 (714)
Q Consensus 504 sL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~---~~~~ 580 (714)
+|.+++...+..++.....+..|++.|++|||++| ||||||||.||+++.+|.+|++|||.|..+..... ....
T Consensus 1320 sLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el~ 1396 (1509)
T KOG4645|consen 1320 SLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGELQ 1396 (1509)
T ss_pred cHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecCchhcCCHHHH
Confidence 99999999888888888899999999999999999 99999999999999999999999999998865431 2223
Q ss_pred eecCCCCccCcccccCC---CCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhh
Q 041576 581 VIRGTRGYVAPEWFKNV---PVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAA 657 (714)
Q Consensus 581 ~~~gt~~y~aPE~~~~~---~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 657 (714)
...||+.|||||++.+. .-..++||||+|||++||+||++||...+.+-. +. .+...+....
T Consensus 1397 ~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~a--IM-----y~V~~gh~Pq-------- 1461 (1509)
T KOG4645|consen 1397 SMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWA--IM-----YHVAAGHKPQ-------- 1461 (1509)
T ss_pred hhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhH--HH-----hHHhccCCCC--------
Confidence 46799999999999754 346689999999999999999999975433221 11 1112222222
Q ss_pred ccchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 658 MADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 658 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
.+.....+-.+++.+||+.||++|-++.|+++.
T Consensus 1462 -~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1462 -IPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred -CchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 233355567789999999999999888888765
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=293.40 Aligned_cols=277 Identities=23% Similarity=0.288 Sum_probs=202.3
Q ss_pred hhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEeccc--chhhHHHHHHHHHHHhccCcccccceeceEecCCe------
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKL--AQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLN------ 492 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~------ 492 (714)
.|.+.+.||+|++|.||+|... .+++.||+|++... .......+.+|+.++++++||||+++++++...+.
T Consensus 16 ~y~~~~~ig~g~~g~vy~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 94 (343)
T cd07851 16 RYQNLSPVGSGAYGQVCSAFDT-KTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQD 94 (343)
T ss_pred ceEEEEEeccCCceEEEEEEEC-CCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccccc
Confidence 4566788999999999999976 46789999998653 23344567889999999999999999998866654
Q ss_pred eeEEEeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccc
Q 041576 493 RLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLL 572 (714)
Q Consensus 493 ~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~ 572 (714)
.++|+||+ +++|.+++.. ..+++..+..++.||++||+|||+.+ |+||||||+||++++++.+||+|||++....
T Consensus 95 ~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~~~~~~ 169 (343)
T cd07851 95 VYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLARHTD 169 (343)
T ss_pred EEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEcccccccccc
Confidence 89999998 5699998876 56899999999999999999999998 9999999999999999999999999998653
Q ss_pred cCcccceeeecCCCCccCcccccC-CCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHH-------hhhhhc
Q 041576 573 SDQSRTRTVIRGTRGYVAPEWFKN-VPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWA-------YDCYVE 644 (714)
Q Consensus 573 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~-------~~~~~~ 644 (714)
.. .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...........+.... ...+..
T Consensus 170 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 245 (343)
T cd07851 170 DE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISS 245 (343)
T ss_pred cc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccc
Confidence 32 223357888999998865 467899999999999999999999997543322111111100 000000
Q ss_pred Cccceee-------cchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HhcccCCCCCCCCCCcc
Q 041576 645 GKLDVLV-------DNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM--LEGYLEVPSPPMPPLHS 708 (714)
Q Consensus 645 ~~~~~~~-------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~~~~~~pp~p~~~~ 708 (714)
....... ...... .....+..+.+++.+||+.||++|||+.||++. ++........+.++...
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~-~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~~~~~~~~~~~ 317 (343)
T cd07851 246 ESARNYIQSLPQMPKKDFKE-VFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDPEDEPVAPPYD 317 (343)
T ss_pred hhHHHHHHhccccCCCCHHH-HhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCCcccccccccC
Confidence 0000000 000000 001125678899999999999999999999873 44444443334333333
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=296.58 Aligned_cols=198 Identities=30% Similarity=0.457 Sum_probs=172.0
Q ss_pred hhhhCcccceeEEEeEeeCCCCcEEEEEEecccc-hhhHHHHHHHHHHHhccCcccccceeceEecCC------eeeEEE
Q 041576 425 EEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA-QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGL------NRLLVY 497 (714)
Q Consensus 425 ~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~------~~~lv~ 497 (714)
.+.||+|+||.||+|+.+ .+|+.||||.++... ....+...+|+++|++++|+|||+++++-++.. ...+||
T Consensus 18 ~e~LG~Ga~g~V~rgrnk-etG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvm 96 (732)
T KOG4250|consen 18 DERLGKGAFGNVYRGRNK-ETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVM 96 (732)
T ss_pred hhhhcCCccceeeeeccc-ccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEE
Confidence 578999999999999977 689999999997633 334556789999999999999999999875544 568999
Q ss_pred eecCCCchhhhhhcC---CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEEC--CCC--ceEEecCCCccc
Q 041576 498 EFMGNGTLANLLFAI---PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLD--QDF--TAKISDFGLSKL 570 (714)
Q Consensus 498 E~~~~gsL~~~l~~~---~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~--~~~--~~kl~Dfg~~~~ 570 (714)
|||.+|+|+..|+.. ..+++.+.+.++.++..||.|||+++ |+||||||.||++- .+| .-||+|||.|+.
T Consensus 97 EyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Are 173 (732)
T KOG4250|consen 97 EYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARE 173 (732)
T ss_pred eecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeeccccccc
Confidence 999999999999864 46899999999999999999999998 99999999999983 334 479999999998
Q ss_pred cccCcccceeeecCCCCccCccccc-CCCCCchhhhHHHHHHHHHHHhcCCCCcccccc
Q 041576 571 LLSDQSRTRTVIRGTRGYVAPEWFK-NVPVSAKVDVYSFGVVLLKIICCKRSVEMELGE 628 (714)
Q Consensus 571 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~ 628 (714)
+..+. ......||..|++||.+. .+.|+..+|.|||||++||..||..||......
T Consensus 174 l~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p 230 (732)
T KOG4250|consen 174 LDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGP 230 (732)
T ss_pred CCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCc
Confidence 75544 556778999999999998 488999999999999999999999999865444
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-32 Score=290.83 Aligned_cols=268 Identities=22% Similarity=0.268 Sum_probs=197.7
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEeccc--chhhHHHHHHHHHHHhccCcccccceeceEecCC------
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKL--AQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGL------ 491 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~------ 491 (714)
.+|.+.+.||+|++|.||+|... .++..||||++... .......+.+|++++++++||||+++++++..+.
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07880 15 DRYRDLKQVGSGAYGTVCSALDR-RTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFH 93 (343)
T ss_pred cceEEEEEeeecCCeEEEEEEEC-CCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccc
Confidence 35667789999999999999865 56889999998542 2233456889999999999999999999986554
Q ss_pred eeeEEEeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCcccc
Q 041576 492 NRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLL 571 (714)
Q Consensus 492 ~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~ 571 (714)
..++||||+ +++|.+++.. ..+++..++.++.||++||+|||+.+ |+||||||+||+++.++.+||+|||++...
T Consensus 94 ~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg~~~~~ 168 (343)
T cd07880 94 DFYLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQT 168 (343)
T ss_pred eEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeccccccc
Confidence 358999998 6789888865 56889999999999999999999998 999999999999999999999999999765
Q ss_pred ccCcccceeeecCCCCccCcccccC-CCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHH-------hhhhh
Q 041576 572 LSDQSRTRTVIRGTRGYVAPEWFKN-VPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWA-------YDCYV 643 (714)
Q Consensus 572 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~-------~~~~~ 643 (714)
.... ....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...........+.... .....
T Consensus 169 ~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (343)
T cd07880 169 DSEM----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQ 244 (343)
T ss_pred ccCc----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhc
Confidence 3321 23356889999999876 458899999999999999999999997543221111110000 00000
Q ss_pred cCc-------cceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHH--HHhcccCC
Q 041576 644 EGK-------LDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ--MLEGYLEV 698 (714)
Q Consensus 644 ~~~-------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~~~~ 698 (714)
... +........ ..........+.+++.+||+.||++|||+.++++ .++...+.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~ 307 (343)
T cd07880 245 SEDAKNYVKKLPRFRKKDF-RSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDP 307 (343)
T ss_pred chhHHHHHHhccccCcchH-HHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCc
Confidence 000 000000000 0011123346788999999999999999999994 45555444
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-32 Score=289.29 Aligned_cols=263 Identities=22% Similarity=0.239 Sum_probs=193.0
Q ss_pred hhhhhhhCcccceeEEEeEeeCCC--CcEEEEEEeccc--chhhHHHHHHHHHHHhcc-CcccccceeceEecC----Ce
Q 041576 422 NGFEEELGRGSFGIVYKGVLKSAS--GNAVAVKKLDKL--AQEREREFKTEVSAIGRT-HHKNLVQLLGFCDEG----LN 492 (714)
Q Consensus 422 ~~~~~~ig~G~~g~Vy~~~~~~~~--~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~----~~ 492 (714)
|.+.+.||+|+||.||++... .. +..||+|++... .....+.+.+|+++++++ +||||+++++.+... ..
T Consensus 2 y~~~~~lg~G~~g~vy~~~~~-~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 2 YELIKELGQGAYGIVCSARNA-ETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred ceEEEEccccCCeEEEEEEeC-CCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 456788999999999999976 34 778999998652 222356788899999999 599999999975432 45
Q ss_pred eeEEEeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccc
Q 041576 493 RLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLL 572 (714)
Q Consensus 493 ~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~ 572 (714)
.++++||+. ++|.+++.....+++..+..++.||+.||+|||+.+ ++||||||+||++++++.+||+|||++....
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~~~~ 156 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFS 156 (332)
T ss_pred EEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCceecc
Confidence 678888886 589999988788999999999999999999999998 9999999999999999999999999998654
Q ss_pred cCccc---ceeeecCCCCccCcccccC-CCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHH-------Hhhh
Q 041576 573 SDQSR---TRTVIRGTRGYVAPEWFKN-VPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDW-------AYDC 641 (714)
Q Consensus 573 ~~~~~---~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~-------~~~~ 641 (714)
..... ......|+..|+|||.+.+ ..++.++||||+|+++|+|++|+.||...........+... ....
T Consensus 157 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (332)
T cd07857 157 ENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSR 236 (332)
T ss_pred cccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 32211 1223468899999998765 46899999999999999999999998754322110000000 0000
Q ss_pred hhcCc-------cceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 642 YVEGK-------LDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 642 ~~~~~-------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
..... .......... .........+.+++.+||+.||++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 237 IGSPKAQNYIRSLPNIPKKPFE-SIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred hhhhhHHHHHHhccccCCcchH-hhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00000 0000000000 001112456888999999999999999999975
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-32 Score=309.60 Aligned_cols=245 Identities=31% Similarity=0.437 Sum_probs=186.6
Q ss_pred hhhCcccceeEEEeEeeCCCCcEEEEEEeccc-chhhHHHHHHHHHHHhccCcccccceeceEecC--------------
Q 041576 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDKL-AQEREREFKTEVSAIGRTHHKNLVQLLGFCDEG-------------- 490 (714)
Q Consensus 426 ~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-------------- 490 (714)
+.||+|+||.||+++.+ -+|+.||||++.-. .......+.+|+..|++|+|||||+++..+.+.
T Consensus 485 ~lLGkGGFG~VvkVRNK-lDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~~~~~ 563 (1351)
T KOG1035|consen 485 ELLGKGGFGSVVKVRNK-LDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIVASDS 563 (1351)
T ss_pred HHhcCCCCceEEEEeec-ccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccccccch
Confidence 57999999999999987 58999999999654 334456788999999999999999987632100
Q ss_pred --------------------------------------------------------------------------------
Q 041576 491 -------------------------------------------------------------------------------- 490 (714)
Q Consensus 491 -------------------------------------------------------------------------------- 490 (714)
T Consensus 564 ~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~~~d 643 (1351)
T KOG1035|consen 564 ESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSVILD 643 (1351)
T ss_pred hhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCccccC
Confidence
Q ss_pred -------------------------CeeeEEEeecCCCchhhhhhcCCCC-ChhhHHHHHHHHHHHHHHHHhcCCCCeEe
Q 041576 491 -------------------------LNRLLVYEFMGNGTLANLLFAIPRP-DWSLRVRISLEIARGLLYLHEECNVPIIH 544 (714)
Q Consensus 491 -------------------------~~~~lv~E~~~~gsL~~~l~~~~~~-~~~~~~~i~~qi~~~L~yLH~~~~~~ivH 544 (714)
...||-||||+..+|.++++.+... .....++++.+|++||+|+|++| |||
T Consensus 644 ~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~g---iIH 720 (1351)
T KOG1035|consen 644 DTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQG---IIH 720 (1351)
T ss_pred cchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCc---eee
Confidence 1136889999998888888765444 57788999999999999999998 999
Q ss_pred cCCCcCeEEECCCCceEEecCCCccccc-----------------cCcccceeeecCCCCccCcccccCC---CCCchhh
Q 041576 545 CDIKPQNILLDQDFTAKISDFGLSKLLL-----------------SDQSRTRTVIRGTRGYVAPEWFKNV---PVSAKVD 604 (714)
Q Consensus 545 ~Dlk~~NIll~~~~~~kl~Dfg~~~~~~-----------------~~~~~~~~~~~gt~~y~aPE~~~~~---~~s~ksD 604 (714)
|||||.||+++++..+||+|||+|.... .......+..+||.-|+|||++.+. .|+.|+|
T Consensus 721 RDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiD 800 (1351)
T KOG1035|consen 721 RDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKID 800 (1351)
T ss_pred ccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhh
Confidence 9999999999999999999999998721 0112244567899999999999755 4999999
Q ss_pred hHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCC
Q 041576 605 VYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPA 684 (714)
Q Consensus 605 VwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs 684 (714)
+||+|||++||+. ||.. ..++...+.. ++.+.+..- .....+....-..+|.+|++.||++|||
T Consensus 801 mYSLGIVlFEM~y---PF~T--sMERa~iL~~-----LR~g~iP~~------~~f~~~~~~~e~slI~~Ll~hdP~kRPt 864 (1351)
T KOG1035|consen 801 MYSLGIVLFEMLY---PFGT--SMERASILTN-----LRKGSIPEP------ADFFDPEHPEEASLIRWLLSHDPSKRPT 864 (1351)
T ss_pred hHHHHHHHHHHhc---cCCc--hHHHHHHHHh-----cccCCCCCC------cccccccchHHHHHHHHHhcCCCccCCC
Confidence 9999999999984 4432 2233223322 222222211 1112233344556999999999999999
Q ss_pred HHHHHH
Q 041576 685 MKMIVQ 690 (714)
Q Consensus 685 ~~evl~ 690 (714)
|.|+|+
T Consensus 865 A~eLL~ 870 (1351)
T KOG1035|consen 865 ATELLN 870 (1351)
T ss_pred HHHHhh
Confidence 999986
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=6e-33 Score=282.87 Aligned_cols=247 Identities=25% Similarity=0.275 Sum_probs=201.4
Q ss_pred hhhhhCcccceeEEEeEeeCCCCcEEEEEEeccc---chhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEeec
Q 041576 424 FEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKL---AQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEFM 500 (714)
Q Consensus 424 ~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~ 500 (714)
.-++||+|+||.||-.+.+ .+|+.+|.|++.+. .+..+...++|-.+|.+++.+.||.+-..++..+..++|+..|
T Consensus 189 ~~RvlGkGGFGEV~acqvr-aTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlM 267 (591)
T KOG0986|consen 189 VYRVLGKGGFGEVCACQVR-ATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLM 267 (591)
T ss_pred eeEEEecccccceeEEEEe-cchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEee
Confidence 3478999999999998877 58999999998652 3344567789999999999999999999999999999999999
Q ss_pred CCCchhhhhhcCC--CCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcccc
Q 041576 501 GNGTLANLLFAIP--RPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRT 578 (714)
Q Consensus 501 ~~gsL~~~l~~~~--~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 578 (714)
.||+|.-+|.+.. .++++.++-++.+|+-||++||++. ||.|||||+|||+|+.|+++|+|+|+|..+......
T Consensus 268 NGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~~- 343 (591)
T KOG0986|consen 268 NGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKPI- 343 (591)
T ss_pred cCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCCCCcc-
Confidence 9999999998664 7899999999999999999999998 999999999999999999999999999977554433
Q ss_pred eeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhhc
Q 041576 579 RTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAM 658 (714)
Q Consensus 579 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 658 (714)
...+||.+|||||++.+..|+...|-||+||+||||+.|+.||.........+.+... +... ...
T Consensus 344 -~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr-------------~~~~-~~e 408 (591)
T KOG0986|consen 344 -RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRR-------------TLED-PEE 408 (591)
T ss_pred -ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHH-------------Hhcc-hhh
Confidence 3347999999999999999999999999999999999999999754333221111111 0000 111
Q ss_pred cchHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 041576 659 ADKSRACKWLMIALWCIQEDPLKRP-----AMKMIVQ 690 (714)
Q Consensus 659 ~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 690 (714)
.+...+++...+....|+.||++|. .++||.+
T Consensus 409 y~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~ 445 (591)
T KOG0986|consen 409 YSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKE 445 (591)
T ss_pred cccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhh
Confidence 2334455667788888999999996 4556643
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=285.90 Aligned_cols=261 Identities=23% Similarity=0.279 Sum_probs=193.5
Q ss_pred hhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEeccc--chhhHHHHHHHHHHHhccCcccccceeceEec-CCeeeEEE
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKL--AQEREREFKTEVSAIGRTHHKNLVQLLGFCDE-GLNRLLVY 497 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-~~~~~lv~ 497 (714)
.|.+.+.||+|+||.||+|... .+++.||+|++... .....+.+.+|++++++++||||+++++++.. ....++++
T Consensus 11 ~y~~~~~ig~g~~g~v~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~ 89 (328)
T cd07856 11 RYVDLQPVGMGAFGLVCSARDQ-LTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVT 89 (328)
T ss_pred ceEEEEeecccCCeEEEEEEEC-CCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEe
Confidence 4566789999999999999865 57889999988642 22334678899999999999999999999865 56788999
Q ss_pred eecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCccc
Q 041576 498 EFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSR 577 (714)
Q Consensus 498 E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 577 (714)
||+. ++|.+++.. ..+++..+..++.||++||+|||+.+ ++|+||+|+||++++++.++|+|||.+......
T Consensus 90 e~~~-~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~--- 161 (328)
T cd07856 90 ELLG-TDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQDPQ--- 161 (328)
T ss_pred ehhc-cCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccccccCCC---
Confidence 9984 589888865 45678888899999999999999998 999999999999999999999999998754221
Q ss_pred ceeeecCCCCccCcccccC-CCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHH-------hhhhhcCccce
Q 041576 578 TRTVIRGTRGYVAPEWFKN-VPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWA-------YDCYVEGKLDV 649 (714)
Q Consensus 578 ~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~-------~~~~~~~~~~~ 649 (714)
.....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...........+.+.. ...........
T Consensus 162 -~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (328)
T cd07856 162 -MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLR 240 (328)
T ss_pred -cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHH
Confidence 122346788999998866 568999999999999999999999996543322111111100 00000000000
Q ss_pred eecc-h-----hhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 650 LVDN-D-----KAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 650 ~~~~-~-----~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
+... . ............+.+++.+||+.+|++||++.+++..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 241 FVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred HHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000 0 0000001234578889999999999999999999775
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-32 Score=268.02 Aligned_cols=246 Identities=27% Similarity=0.283 Sum_probs=203.5
Q ss_pred hhhhhhhCcccceeEEEeEeeCCCCcEEEEEEeccc---chhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEe
Q 041576 422 NGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKL---AQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYE 498 (714)
Q Consensus 422 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E 498 (714)
..|.++||+|.||.|-+++-+ .+++.+|+|++++. ..+....-..|-++|+..+||.+..+...|...+..++|||
T Consensus 170 FdfLKvLGkGTFGKVIL~rEK-at~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMe 248 (516)
T KOG0690|consen 170 FDFLKVLGKGTFGKVILCREK-ATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVME 248 (516)
T ss_pred hhHHHHhcCCccceEEEEeec-ccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEE
Confidence 457799999999999998866 68999999999873 34445566788999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcccc
Q 041576 499 FMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRT 578 (714)
Q Consensus 499 ~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 578 (714)
|..||.|.-+|...+.+++....-...+|+.||.|||+++ ||.||||.+|+|+|.+|++||+|||+++.--. ....
T Consensus 249 yanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~-~g~t 324 (516)
T KOG0690|consen 249 YANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEIK-YGDT 324 (516)
T ss_pred EccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhccc-ccce
Confidence 9999999999999889999999999999999999999998 99999999999999999999999999985322 2334
Q ss_pred eeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhhc
Q 041576 579 RTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAM 658 (714)
Q Consensus 579 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 658 (714)
...++||+.|+|||++....|..+.|-|.+||++|||++|+.||.....+...+.+.. .+- .
T Consensus 325 ~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~------ed~------------k 386 (516)
T KOG0690|consen 325 TKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILM------EDL------------K 386 (516)
T ss_pred eccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHh------hhc------------c
Confidence 4567899999999999999999999999999999999999999986554432222110 010 1
Q ss_pred cchHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 041576 659 ADKSRACKWLMIALWCIQEDPLKRP-----AMKMIVQ 690 (714)
Q Consensus 659 ~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 690 (714)
.+.....+...|+...|.+||.+|. .++||.+
T Consensus 387 FPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~ 423 (516)
T KOG0690|consen 387 FPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMR 423 (516)
T ss_pred CCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHh
Confidence 1222334555688889999999994 4566654
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-32 Score=266.45 Aligned_cols=245 Identities=22% Similarity=0.230 Sum_probs=194.4
Q ss_pred hhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhcc-CcccccceeceEec----CCeeeEEEeec
Q 041576 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRT-HHKNLVQLLGFCDE----GLNRLLVYEFM 500 (714)
Q Consensus 426 ~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~----~~~~~lv~E~~ 500 (714)
++||-|-.|.|-...++ .+++.+|+|++... ...++|++..-.. .|||||.+++++.+ ...+++|||.|
T Consensus 68 qvLG~GinGkV~~C~~k-~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~m 141 (400)
T KOG0604|consen 68 QVLGAGINGKVVQCVHK-RTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECM 141 (400)
T ss_pred hhhccccCCceEEEEec-cchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecc
Confidence 68999999999998877 68899999999653 2346777766655 79999999999854 45568999999
Q ss_pred CCCchhhhhhcCCC--CChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECC---CCceEEecCCCccccccCc
Q 041576 501 GNGTLANLLFAIPR--PDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQ---DFTAKISDFGLSKLLLSDQ 575 (714)
Q Consensus 501 ~~gsL~~~l~~~~~--~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~---~~~~kl~Dfg~~~~~~~~~ 575 (714)
+||.|...+++++. +++.++..|+.||+.|++|||+.+ |.||||||+|+|... |-.+||+|||+|+....
T Consensus 142 eGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~-- 216 (400)
T KOG0604|consen 142 EGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQE-- 216 (400)
T ss_pred cchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccccccccCC--
Confidence 99999999987754 899999999999999999999998 999999999999964 45799999999986543
Q ss_pred ccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchh
Q 041576 576 SRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDK 655 (714)
Q Consensus 576 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 655 (714)
........-|+.|.|||++....|+..+|+||+||++|-|++|.+||....+.....-. ...+..+... .
T Consensus 217 ~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgM----k~rI~~gqy~------F 286 (400)
T KOG0604|consen 217 PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM----KRRIRTGQYE------F 286 (400)
T ss_pred CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhH----HhHhhccCcc------C
Confidence 23344556799999999999999999999999999999999999999866443211111 1111222111 1
Q ss_pred hhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 656 AAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 656 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
....-...++...++|+.+|..+|.+|.|+.|+++.
T Consensus 287 P~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 287 PEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred CChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 111123345577889999999999999999999875
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-32 Score=292.51 Aligned_cols=240 Identities=25% Similarity=0.266 Sum_probs=196.8
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhcc-CcccccceeceEecCCeeeEEEe
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRT-HHKNLVQLLGFCDEGLNRLLVYE 498 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~E 498 (714)
..|.+...+|.|+|+.|-.+.+. .+++..+||++.+. ..+..+|+.++.+. +||||+++.+.+.++.+.|+|||
T Consensus 322 ~~y~~~~~~~~gs~s~~~~~~~~-~t~~~~~vkii~~~----~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 322 ESYEFREELGEGSFSAVKYCESS-PTDQEPAVKIISKR----ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred hhhccccccCCCCccceeeeecc-ccccchhheecccc----ccccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 34666778999999999999876 57889999999764 23446677666666 89999999999999999999999
Q ss_pred ecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEE-CCCCceEEecCCCccccccCccc
Q 041576 499 FMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILL-DQDFTAKISDFGLSKLLLSDQSR 577 (714)
Q Consensus 499 ~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll-~~~~~~kl~Dfg~~~~~~~~~~~ 577 (714)
.+.++-|.+.+...+... .++..|+.+|+.|+.|||++| +|||||||+|||+ ++.++++|+|||.++.....
T Consensus 397 ~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~--- 469 (612)
T KOG0603|consen 397 LLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS--- 469 (612)
T ss_pred hccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchh---
Confidence 999998888887766655 788889999999999999998 9999999999999 68999999999999877554
Q ss_pred ceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhh
Q 041576 578 TRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAA 657 (714)
Q Consensus 578 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 657 (714)
....+-|..|.|||++....+++++|+||||++||+|++|+.||.....+. ... ..+..+.
T Consensus 470 -~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~--ei~-----~~i~~~~----------- 530 (612)
T KOG0603|consen 470 -CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGI--EIH-----TRIQMPK----------- 530 (612)
T ss_pred -hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchH--HHH-----HhhcCCc-----------
Confidence 223346889999999999999999999999999999999999998654441 111 1111111
Q ss_pred ccchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 658 MADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 658 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
.....+....+|+.+||+.||.+||+|.++...
T Consensus 531 -~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 531 -FSECVSDEAKDLLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred -cccccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence 113445567789999999999999999999764
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=287.96 Aligned_cols=260 Identities=22% Similarity=0.251 Sum_probs=191.5
Q ss_pred hhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc--hhhHHHHHHHHHHHhccCcccccceeceEecC------Ce
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA--QEREREFKTEVSAIGRTHHKNLVQLLGFCDEG------LN 492 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~------~~ 492 (714)
+|.+.+.||+|+||.||+|... .+++.||+|++.... ....+.+.+|++++++++||||+++++++... ..
T Consensus 18 ~y~~~~~lg~G~~g~v~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (345)
T cd07877 18 RYQNLSPVGSGAYGSVCAAFDT-KTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 96 (345)
T ss_pred ceEEEEEeeecCCeEEEEEEEc-CCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccccc
Confidence 4455678999999999999865 468899999997532 23345788899999999999999999988543 34
Q ss_pred eeEEEeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccc
Q 041576 493 RLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLL 572 (714)
Q Consensus 493 ~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~ 572 (714)
.+++++++ +++|.+++.. ..+++..+..++.||++||+|||+.+ |+||||||+||++++++.+||+|||++....
T Consensus 97 ~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~ 171 (345)
T cd07877 97 VYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTD 171 (345)
T ss_pred EEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEEEeccccccccc
Confidence 67788876 6799888765 46889999999999999999999998 9999999999999999999999999987543
Q ss_pred cCcccceeeecCCCCccCcccccC-CCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHH-------hhhhhc
Q 041576 573 SDQSRTRTVIRGTRGYVAPEWFKN-VPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWA-------YDCYVE 644 (714)
Q Consensus 573 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~-------~~~~~~ 644 (714)
.. .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...........+.... ......
T Consensus 172 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (345)
T cd07877 172 DE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 247 (345)
T ss_pred cc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhccc
Confidence 22 223457889999998866 568899999999999999999999996543222111110000 000000
Q ss_pred Cc-------cceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 645 GK-------LDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 645 ~~-------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
.. +......... .........+.+++.+||+.||.+||++.++++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 248 ESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred HhHHHHHHHhcccCCcchh-hhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 00 0000000000 0001124467889999999999999999999874
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=272.74 Aligned_cols=222 Identities=20% Similarity=0.136 Sum_probs=178.5
Q ss_pred ccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEeecCCCchhhhhh
Q 041576 431 GSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEFMGNGTLANLLF 510 (714)
Q Consensus 431 G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~ 510 (714)
|.++.||++... .+++.+|+|+++... .+.+|...+....||||+++++++.+.+..++||||+++++|.+++.
T Consensus 4 g~~~~v~~~~~~-~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 77 (237)
T cd05576 4 GVIDKVLLVMDT-RTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHIS 77 (237)
T ss_pred cccceEEEEEEc-cCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHH
Confidence 889999999876 578899999997643 23345555556679999999999999999999999999999999998
Q ss_pred cCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcccceeeecCCCCccC
Q 041576 511 AIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVA 590 (714)
Q Consensus 511 ~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~a 590 (714)
....+++..+..++.|+++||+|||+.+ ++||||||+||+++.++.++++|||.+....... ....++..|+|
T Consensus 78 ~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~y~a 150 (237)
T cd05576 78 KFLNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC----DGEAVENMYCA 150 (237)
T ss_pred HhcCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhcccccc----ccCCcCccccC
Confidence 7778899999999999999999999998 9999999999999999999999999876553321 22335677999
Q ss_pred cccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhhccchHHHHHHHHH
Q 041576 591 PEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMADKSRACKWLMI 670 (714)
Q Consensus 591 PE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 670 (714)
||.+.+..++.++||||+|+++|||++|+.|+........ .. .. ...+......+.++
T Consensus 151 PE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~-------------~~-~~--------~~~~~~~~~~~~~l 208 (237)
T cd05576 151 PEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN-------------TH-TT--------LNIPEWVSEEARSL 208 (237)
T ss_pred CcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc-------------cc-cc--------cCCcccCCHHHHHH
Confidence 9999888899999999999999999999988653211100 00 00 00111234567789
Q ss_pred HHHccccCCCCCCCHHH
Q 041576 671 ALWCIQEDPLKRPAMKM 687 (714)
Q Consensus 671 i~~cl~~dP~~RPs~~e 687 (714)
+.+||+.||++||++.+
T Consensus 209 i~~~l~~dp~~R~~~~~ 225 (237)
T cd05576 209 LQQLLQFNPTERLGAGV 225 (237)
T ss_pred HHHHccCCHHHhcCCCc
Confidence 99999999999999743
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-33 Score=267.41 Aligned_cols=261 Identities=26% Similarity=0.347 Sum_probs=200.3
Q ss_pred ccccCHHHHHHHhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccch-hhHHHHHHHHHHHhcc-Ccccccceece
Q 041576 409 LRFFSLVELNEATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQ-EREREFKTEVSAIGRT-HHKNLVQLLGF 486 (714)
Q Consensus 409 ~~~~~~~el~~at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~l~~~ 486 (714)
+..|+-+.++. ...||.|+||+|++-.++ ..|+.+|||+++.... .+.++++.|.+...+- +.||||+++|.
T Consensus 58 ~~~F~~~~Lqd-----lg~iG~G~fG~V~KM~hk-~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa 131 (361)
T KOG1006|consen 58 LHTFTSDNLQD-----LGEIGNGAFGTVNKMLHK-PSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGA 131 (361)
T ss_pred ccccccchHHH-----HHHhcCCcchhhhhhhcC-ccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhh
Confidence 34455444433 367999999999998876 6899999999986443 5567888888876665 79999999999
Q ss_pred EecCCeeeEEEeecCCCchhhhhh-----cCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceE
Q 041576 487 CDEGLNRLLVYEFMGNGTLANLLF-----AIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAK 561 (714)
Q Consensus 487 ~~~~~~~~lv~E~~~~gsL~~~l~-----~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~k 561 (714)
+..++..|+-||.|+- ||+.+-. ....+++...-.|..-...||.||.+.- .|||||+||+|||++..|.+|
T Consensus 132 ~F~EGdcWiCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vK 208 (361)
T KOG1006|consen 132 LFSEGDCWICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVK 208 (361)
T ss_pred hhcCCceeeeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEe
Confidence 9999999999999964 7766543 2356788888889999999999999864 699999999999999999999
Q ss_pred EecCCCccccccCcccceeeecCCCCccCccccc--CCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHh
Q 041576 562 ISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFK--NVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAY 639 (714)
Q Consensus 562 l~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~ 639 (714)
|+|||++..+.... ..+.-.|-..|||||.+. +..++-++||||||+.|||+.||+.|+......- +.+
T Consensus 209 LCDFGIcGqLv~Si--AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svf--eql----- 279 (361)
T KOG1006|consen 209 LCDFGICGQLVDSI--AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVF--EQL----- 279 (361)
T ss_pred eecccchHhHHHHH--HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHH--HHH-----
Confidence 99999998764433 233345788999999985 3358999999999999999999999997543311 111
Q ss_pred hhhhcCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 640 DCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 640 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
.....+....+..+. ........+..++.-||.+|-++||...++++.
T Consensus 280 ~~Vv~gdpp~l~~~~----~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 280 CQVVIGDPPILLFDK----ECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred HHHHcCCCCeecCcc----cccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 112233333322211 123355678889999999999999999998763
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=306.19 Aligned_cols=145 Identities=32% Similarity=0.425 Sum_probs=131.3
Q ss_pred hhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEE
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA---QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVY 497 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 497 (714)
.|.+.+.||+|+||.||+|.+. .+++.||||+++... ......+..|+.+++.++||||+++++++......++||
T Consensus 5 ~y~i~~~LG~G~fg~Vy~a~~~-~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 5 EFVIVKPISRGAFGKVYLGRKK-NNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CEEEEEEEecCCCeEEEEEEEC-CCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 4567789999999999999876 468899999996532 333467889999999999999999999999999999999
Q ss_pred eecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCcc
Q 041576 498 EFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSK 569 (714)
Q Consensus 498 E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~ 569 (714)
||+.+++|.+++.....+++..++.|+.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999999987778899999999999999999999998 9999999999999999999999999885
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-32 Score=280.60 Aligned_cols=243 Identities=25% Similarity=0.386 Sum_probs=196.7
Q ss_pred hhhhCcccceeEEEeEeeCCCCcEEEEEEecc--cchhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEeecCC
Q 041576 425 EEELGRGSFGIVYKGVLKSASGNAVAVKKLDK--LAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEFMGN 502 (714)
Q Consensus 425 ~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~ 502 (714)
.|+||+|.||+||-|+++ .+|+.||||.+.+ .....+.++++|+.+|++++||.||.+...|+..+..++|||.+.|
T Consensus 569 devLGSGQFG~VYgg~hR-ktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHR-KTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG 647 (888)
T ss_pred HhhccCCcceeeecceec-ccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc
Confidence 478999999999999988 6899999999976 3445567899999999999999999999999999999999999976
Q ss_pred Cchhhhhh-cCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCC---CceEEecCCCccccccCcccc
Q 041576 503 GTLANLLF-AIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQD---FTAKISDFGLSKLLLSDQSRT 578 (714)
Q Consensus 503 gsL~~~l~-~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~---~~~kl~Dfg~~~~~~~~~~~~ 578 (714)
.=|+-+|. +..++++.....++.||+.||.|||.++ |+|+||||+|||+.+. -.+||+|||+|+.+.... .
T Consensus 648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks--F 722 (888)
T KOG4236|consen 648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS--F 722 (888)
T ss_pred hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhh--h
Confidence 44544444 3467888888899999999999999998 9999999999999654 479999999999885533 3
Q ss_pred eeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhhc
Q 041576 579 RTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAM 658 (714)
Q Consensus 579 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 658 (714)
...++||+.|+|||+++++.|...-|+||.|||+|--++|..||....+- ...+.. ...+..+.
T Consensus 723 RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdI--ndQIQN----------AaFMyPp~---- 786 (888)
T KOG4236|consen 723 RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDI--NDQIQN----------AAFMYPPN---- 786 (888)
T ss_pred hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccch--hHHhhc----------cccccCCC----
Confidence 44577999999999999999999999999999999999999999743211 111111 01111111
Q ss_pred cchHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 041576 659 ADKSRACKWLMIALWCIQEDPLKRPAMKMIV 689 (714)
Q Consensus 659 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl 689 (714)
.-.+.....+++|...||..-.+|-|...-+
T Consensus 787 PW~eis~~AidlIn~LLqVkm~kRysvdk~l 817 (888)
T KOG4236|consen 787 PWSEISPEAIDLINNLLQVKMRKRYSVDKSL 817 (888)
T ss_pred chhhcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence 1234455778899999999999999887654
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=264.56 Aligned_cols=239 Identities=29% Similarity=0.338 Sum_probs=194.6
Q ss_pred cceeEEEeEeeCCCCcEEEEEEecccchhh-HHHHHHHHHHHhccCcccccceeceEecCCeeeEEEeecCCCchhhhhh
Q 041576 432 SFGIVYKGVLKSASGNAVAVKKLDKLAQER-EREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEFMGNGTLANLLF 510 (714)
Q Consensus 432 ~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~ 510 (714)
+||.||+|+.. .+++.+++|++....... .+.+.+|++.+++++|+||+++++++......++++||+++++|.+++.
T Consensus 1 ~~g~v~~~~~~-~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~ 79 (244)
T smart00220 1 SFGKVYLARDK-KTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLK 79 (244)
T ss_pred CceEEEEEEEC-CCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHH
Confidence 58999999986 467899999997655444 6789999999999999999999999999999999999999999999998
Q ss_pred cCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcccceeeecCCCCccC
Q 041576 511 AIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVA 590 (714)
Q Consensus 511 ~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~a 590 (714)
....+++..+..++.+++++++|||+.+ ++|+||+|+||++++++.++|+|||.+....... ......++..|+|
T Consensus 80 ~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~ 154 (244)
T smart00220 80 KRGRLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEYMA 154 (244)
T ss_pred hccCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCCCC
Confidence 7666899999999999999999999998 9999999999999999999999999998765432 2233457889999
Q ss_pred cccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhhccchHHHHHHHHH
Q 041576 591 PEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMADKSRACKWLMI 670 (714)
Q Consensus 591 PE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 670 (714)
||.+.+..++.++||||||++++++++|..|+....... .+.. .......... .........+.++
T Consensus 155 pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~---~~~~----~~~~~~~~~~-------~~~~~~~~~~~~~ 220 (244)
T smart00220 155 PEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLL---ELFK----KIGKPKPPFP-------PPEWKISPEAKDL 220 (244)
T ss_pred HHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH---HHHH----HHhccCCCCc-------cccccCCHHHHHH
Confidence 999998889999999999999999999999987531111 1111 1111111000 0000033578889
Q ss_pred HHHccccCCCCCCCHHHHHH
Q 041576 671 ALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 671 i~~cl~~dP~~RPs~~evl~ 690 (714)
+.+|+..+|++||++.++++
T Consensus 221 i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 221 IRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHccCCchhccCHHHHhh
Confidence 99999999999999999987
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.7e-32 Score=271.09 Aligned_cols=245 Identities=27% Similarity=0.325 Sum_probs=204.0
Q ss_pred HHHHHhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHHhcc-CcccccceeceEecCC
Q 041576 416 ELNEATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA---QEREREFKTEVSAIGRT-HHKNLVQLLGFCDEGL 491 (714)
Q Consensus 416 el~~at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~ 491 (714)
.+..+..+|..+||+|+||.|.+|..+ .+.+.+|||++++.. .++.+--+.|-++|+.. +-|.+++++.++..-+
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerk-gtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmD 423 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERK-GTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMD 423 (683)
T ss_pred ceeecccceEEEeccCccceeeeeccc-CcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhh
Confidence 455566789999999999999999866 577899999998632 22334446677777776 6789999999999999
Q ss_pred eeeEEEeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCcccc
Q 041576 492 NRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLL 571 (714)
Q Consensus 492 ~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~ 571 (714)
.+|+||||+.||+|--++++-.++.+..+.-++.+||-||-+||++| |+.||||.+||++|.+|++||+|||+++.-
T Consensus 424 RLyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEn 500 (683)
T KOG0696|consen 424 RLYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 500 (683)
T ss_pred heeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeeccccccc
Confidence 99999999999999999999999999999999999999999999999 999999999999999999999999999743
Q ss_pred ccCcccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceee
Q 041576 572 LSDQSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLV 651 (714)
Q Consensus 572 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 651 (714)
-- ......++.||+.|+|||++.-.+|...+|-|||||+||||+.|++||+.+++++....+.+.
T Consensus 501 i~-~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~eh-------------- 565 (683)
T KOG0696|consen 501 IF-DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEH-------------- 565 (683)
T ss_pred cc-CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHc--------------
Confidence 21 233445678999999999999999999999999999999999999999987766543332221
Q ss_pred cchhhhccchHHHHHHHHHHHHccccCCCCCC
Q 041576 652 DNDKAAMADKSRACKWLMIALWCIQEDPLKRP 683 (714)
Q Consensus 652 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 683 (714)
....++..+.+...+....|.+.|.+|.
T Consensus 566 ----nvsyPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 566 ----NVSYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred ----cCcCcccccHHHHHHHHHHhhcCCcccc
Confidence 1123445556677788889999999994
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=269.68 Aligned_cols=257 Identities=25% Similarity=0.274 Sum_probs=198.1
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEeccc-------chhhHHHHHHHHHHHhccCcccccceeceE-ecCC
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKL-------AQEREREFKTEVSAIGRTHHKNLVQLLGFC-DEGL 491 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~-------~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~-~~~~ 491 (714)
.+|-+...||+|+|+.||+|.+- ...+.||||+-.-. .....+...+|.++.+.|+||.||++++++ .+.+
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl-~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDL-TEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHHHhccccHHHHHHhccc-chhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence 35556678999999999999865 45788999975321 112235677899999999999999999999 4566
Q ss_pred eeeEEEeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECC---CCceEEecCCCc
Q 041576 492 NRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQ---DFTAKISDFGLS 568 (714)
Q Consensus 492 ~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~---~~~~kl~Dfg~~ 568 (714)
..+-|+|||+|.+|+-+|...+.++++++..|+.||+.||.||.+.. +||||-||||.|||+.+ -|.+||.|||++
T Consensus 542 sFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITDFGLS 620 (775)
T KOG1151|consen 542 SFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITDFGLS 620 (775)
T ss_pred cceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeeecchh
Confidence 78899999999999999999999999999999999999999999985 88999999999999954 578999999999
Q ss_pred cccccCccc------ceeeecCCCCccCcccccC----CCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHH
Q 041576 569 KLLLSDQSR------TRTVIRGTRGYVAPEWFKN----VPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWA 638 (714)
Q Consensus 569 ~~~~~~~~~------~~~~~~gt~~y~aPE~~~~----~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~ 638 (714)
+.+..+... ......||..|++||.+-- ..++.|.||||.|||+|+.+.|+.||....... .++.
T Consensus 621 KIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQ--dILq--- 695 (775)
T KOG1151|consen 621 KIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQ--DILQ--- 695 (775)
T ss_pred hhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHH--HHHh---
Confidence 998665432 2233579999999998843 247899999999999999999999997543221 1111
Q ss_pred hhhhhcCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 639 YDCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
+..+....+ ......+....+...+|++||++.-++|....++..
T Consensus 696 -----eNTIlkAtE--VqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 696 -----ENTILKATE--VQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred -----hhchhccee--ccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 111111111 011112223345667999999999999988877754
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=268.06 Aligned_cols=271 Identities=20% Similarity=0.295 Sum_probs=206.2
Q ss_pred cccCHHHHHHHhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccC-c-cc----ccce
Q 041576 410 RFFSLVELNEATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTH-H-KN----LVQL 483 (714)
Q Consensus 410 ~~~~~~el~~at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-~n----Iv~l 483 (714)
-.+...+....+|.+...+|+|.||.|-...++. .+..||||+++..... .+..+-|+++|+++. + |+ ++.+
T Consensus 79 ~v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~-~~~~vAlKIik~V~kY-reAa~iEi~vLqki~~~DP~g~~rcv~m 156 (415)
T KOG0671|consen 79 YVYQVGDILTNRYEIVDLLGEGTFGKVVECWDRE-TKEHVALKIIKNVDKY-REAALIEIEVLQKINESDPNGKFRCVQM 156 (415)
T ss_pred EEEEeccccccceehhhhhcCCcccceEEEeecC-CCceehHHHHHHHHHH-hhHHHHHHHHHHHHHhcCCCCceEEEee
Confidence 3455667778899999999999999999988774 4889999999865433 345577999999993 2 33 7889
Q ss_pred eceEecCCeeeEEEeecCCCchhhhhhcCC--CCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECC-----
Q 041576 484 LGFCDEGLNRLLVYEFMGNGTLANLLFAIP--RPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQ----- 556 (714)
Q Consensus 484 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~--~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~----- 556 (714)
.++|+-.++.++|+|.+ |.|+.++|..+. +++...+..|+.|+++++++||+.+ ++|.||||+|||+.+
T Consensus 157 ~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~ 232 (415)
T KOG0671|consen 157 RDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFK 232 (415)
T ss_pred ehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEE
Confidence 99999999999999988 449999998764 5788999999999999999999998 999999999999932
Q ss_pred ---------------CCceEEecCCCccccccCcccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCC
Q 041576 557 ---------------DFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRS 621 (714)
Q Consensus 557 ---------------~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p 621 (714)
+..++|+|||.|....... ...+.|..|.|||++.+-.++.++||||+||||+||.||...
T Consensus 233 ~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~L 308 (415)
T KOG0671|consen 233 TYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETL 308 (415)
T ss_pred EeccCCccceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeecccee
Confidence 2358999999998653322 456689999999999999999999999999999999999999
Q ss_pred Ccccccchhh----hhhhHHH---------hhhhhcCccc-----------eeecc----hhhhccchHHHHHHHHHHHH
Q 041576 622 VEMELGEERS----AILTDWA---------YDCYVEGKLD-----------VLVDN----DKAAMADKSRACKWLMIALW 673 (714)
Q Consensus 622 ~~~~~~~~~~----~~l~~~~---------~~~~~~~~~~-----------~~~~~----~~~~~~~~~~~~~l~~li~~ 673 (714)
|......+.. ..+.... ...+..++++ ...+. .........+..+|.+|+.+
T Consensus 309 FqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~ 388 (415)
T KOG0671|consen 309 FQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRR 388 (415)
T ss_pred cccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHH
Confidence 9765433311 1111000 1111111111 00000 00111233455689999999
Q ss_pred ccccCCCCCCCHHHHHH
Q 041576 674 CIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 674 cl~~dP~~RPs~~evl~ 690 (714)
||..||.+|+|+.|++.
T Consensus 389 mL~fDP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 389 MLEFDPARRITLREALS 405 (415)
T ss_pred HHccCccccccHHHHhc
Confidence 99999999999999986
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.3e-32 Score=254.95 Aligned_cols=267 Identities=22% Similarity=0.307 Sum_probs=197.8
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecc--cchhhHHHHHHHHHHHhccCcccccceeceEecC-------
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDK--LAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEG------- 490 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~------- 490 (714)
.+|.-..+||+|.||.||+|+.+ .+|+.||+|++-- ....--....+|+.+|..++|+|++.+++.|...
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~-n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~ 95 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSK-NTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRD 95 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhc-CccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccc
Confidence 44555678999999999999987 4677889886532 1122224568899999999999999999998432
Q ss_pred -CeeeEEEeecCCCchhhhhhcC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCc
Q 041576 491 -LNRLLVYEFMGNGTLANLLFAI-PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLS 568 (714)
Q Consensus 491 -~~~~lv~E~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~ 568 (714)
...|+||.+|+. +|.-+|... .+++..++.+++.++..||.|+|... |+|||+|++|+||+.++.+||+|||++
T Consensus 96 r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGla 171 (376)
T KOG0669|consen 96 RATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGLA 171 (376)
T ss_pred cceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeeccccc
Confidence 346899999987 888888776 57899999999999999999999987 999999999999999999999999999
Q ss_pred cccccCc---ccceeeecCCCCccCcccccCC-CCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHh----h
Q 041576 569 KLLLSDQ---SRTRTVIRGTRGYVAPEWFKNV-PVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAY----D 640 (714)
Q Consensus 569 ~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~----~ 640 (714)
+.+.... ....+..+-|..|++||.+.+. .++++.|||..|||+.||.|+.+.+...........+....- +
T Consensus 172 r~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tke 251 (376)
T KOG0669|consen 172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKE 251 (376)
T ss_pred cceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcc
Confidence 7654322 1223344568999999988764 689999999999999999999999987665544333332211 1
Q ss_pred hhhcCc---c------ceeecchhh----hccchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 641 CYVEGK---L------DVLVDNDKA----AMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 641 ~~~~~~---~------~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
.+++-. + +.+...... ...+.......++++..+|..||.+|+.+.+++..
T Consensus 252 vWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 252 VWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred cCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 111100 0 000000000 00011122366789999999999999999999864
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-30 Score=232.70 Aligned_cols=263 Identities=19% Similarity=0.260 Sum_probs=195.3
Q ss_pred hhhhhhhCcccceeEEEeEeeCCCCcEEEEEEeccc--chhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEee
Q 041576 422 NGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKL--AQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEF 499 (714)
Q Consensus 422 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~ 499 (714)
|.-.|+||+|.||+||+|+.+ .+++.||+|+++-. ++.--....+|+-+++.++|.|||+++++...++..-+|+||
T Consensus 4 ydkmekigegtygtvfkarn~-~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 4 YDKMEKIGEGTYGTVFKARNR-ETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred hHHHHhhcCCcceeeEecccC-CccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 344588999999999999977 57889999998643 333345778999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcccc
Q 041576 500 MGNGTLANLLFAI-PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRT 578 (714)
Q Consensus 500 ~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 578 (714)
|.. +|..+.... +.++.+....++.|+++||.++|+++ +.||||||.|.+|+.+|.+|++|||+++.+..... .
T Consensus 83 cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipvr-c 157 (292)
T KOG0662|consen 83 CDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR-C 157 (292)
T ss_pred hhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCceE-e
Confidence 975 777777643 56889999999999999999999998 99999999999999999999999999997654332 2
Q ss_pred eeeecCCCCccCcccccCCC-CCchhhhHHHHHHHHHHHh-cCCCCcccccchhhhhhhHHHhhhhhcCc---cceeecc
Q 041576 579 RTVIRGTRGYVAPEWFKNVP-VSAKVDVYSFGVVLLKIIC-CKRSVEMELGEERSAILTDWAYDCYVEGK---LDVLVDN 653 (714)
Q Consensus 579 ~~~~~gt~~y~aPE~~~~~~-~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~---~~~~~~~ 653 (714)
....+-|..|.+|.++.+.. |+...|+||.|||+.|+.. |++.|...+..++...+.. ......+.. +..+.|.
T Consensus 158 ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~-~lg~p~ed~wps~t~lpdy 236 (292)
T KOG0662|consen 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFR-LLGTPTEDQWPSMTKLPDY 236 (292)
T ss_pred eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHH-HhCCCccccCCccccCCCC
Confidence 23344688999999998764 7999999999999999986 5555554443333222111 111111111 1111221
Q ss_pred hhhhccc---------hHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 654 DKAAMAD---------KSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 654 ~~~~~~~---------~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
......+ +.....-.+++...|.-+|.+|.++++.++.
T Consensus 237 k~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 237 KPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred cccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 1111111 1112234567778888899999999988763
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=286.79 Aligned_cols=258 Identities=21% Similarity=0.240 Sum_probs=168.4
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCC----CcEEEEEEecccchhhHHHHHHHHHHHhccCcccccceece------Eec
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSAS----GNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGF------CDE 489 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~------~~~ 489 (714)
..|.+.+.||+|+||.||+|.+. .+ +..||||++...... +...+| .+.+..+.++..++.. ...
T Consensus 132 ~~y~l~~~LG~G~FG~VYka~~~-~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~ 206 (566)
T PLN03225 132 DDFVLGKKLGEGAFGVVYKASLV-NKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSKK 206 (566)
T ss_pred CCeEEeEEEeeCCCeEEEEEEEc-CCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhccccccc
Confidence 34667789999999999999986 34 789999998643221 111111 1222223333322222 245
Q ss_pred CCeeeEEEeecCCCchhhhhhcCCC--------------------CChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCc
Q 041576 490 GLNRLLVYEFMGNGTLANLLFAIPR--------------------PDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKP 549 (714)
Q Consensus 490 ~~~~~lv~E~~~~gsL~~~l~~~~~--------------------~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~ 549 (714)
+...++|+||+++++|.+++..... .....+..++.||+.||+|||+++ |+||||||
T Consensus 207 ~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLKP 283 (566)
T PLN03225 207 EDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVKP 283 (566)
T ss_pred CCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCCH
Confidence 6778999999999999999875321 112345679999999999999998 99999999
Q ss_pred CeEEECC-CCceEEecCCCccccccCcccceeeecCCCCccCcccccCC----------------------CCCchhhhH
Q 041576 550 QNILLDQ-DFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNV----------------------PVSAKVDVY 606 (714)
Q Consensus 550 ~NIll~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~s~ksDVw 606 (714)
+|||+++ ++.+||+|||+++.+............+++.|+|||.+... .++.++|||
T Consensus 284 ~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVw 363 (566)
T PLN03225 284 QNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIY 363 (566)
T ss_pred HHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccH
Confidence 9999986 57999999999986654444444456789999999965321 234567999
Q ss_pred HHHHHHHHHHhcCCCCcccccchhh------hhhhHHHhhhhhcCccceeecchhhh--ccchHHHHHHHHHHHHccccC
Q 041576 607 SFGVVLLKIICCKRSVEMELGEERS------AILTDWAYDCYVEGKLDVLVDNDKAA--MADKSRACKWLMIALWCIQED 678 (714)
Q Consensus 607 SlGvil~elltG~~p~~~~~~~~~~------~~l~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~d 678 (714)
||||+||||+++..+.+........ ..+..|.. ..... ....... ...........+|+.+||+.|
T Consensus 364 SlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~--~~~~~----~~~~~~~~~~~~d~~~~~~~dLi~~mL~~d 437 (566)
T PLN03225 364 SAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRK--LVEPR----ASPDLRRGFEVLDLDGGAGWELLKSMMRFK 437 (566)
T ss_pred HHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHH--hhccc----cchhhhhhhhhccccchHHHHHHHHHccCC
Confidence 9999999999977665422111000 00001100 00000 0000000 000011223457999999999
Q ss_pred CCCCCCHHHHHHH
Q 041576 679 PLKRPAMKMIVQM 691 (714)
Q Consensus 679 P~~RPs~~evl~~ 691 (714)
|++|||++|+++.
T Consensus 438 P~kR~ta~e~L~H 450 (566)
T PLN03225 438 GRQRISAKAALAH 450 (566)
T ss_pred cccCCCHHHHhCC
Confidence 9999999999984
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-29 Score=276.93 Aligned_cols=259 Identities=21% Similarity=0.250 Sum_probs=177.7
Q ss_pred HhhhhhhhhCcccceeEEEeEee---------------CCCCcEEEEEEecccchhhHHH--------------HHHHHH
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLK---------------SASGNAVAVKKLDKLAQERERE--------------FKTEVS 470 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~---------------~~~~~~vavK~~~~~~~~~~~~--------------~~~E~~ 470 (714)
..+.+.++||+|+||+||+|.+. ...++.||||++........++ ...|+.
T Consensus 145 d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~ 224 (507)
T PLN03224 145 DDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAY 224 (507)
T ss_pred cCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHH
Confidence 34666789999999999999742 1245689999986543332223 334666
Q ss_pred HHhccCcccc-----cceeceEec--------CCeeeEEEeecCCCchhhhhhcCC------------------------
Q 041576 471 AIGRTHHKNL-----VQLLGFCDE--------GLNRLLVYEFMGNGTLANLLFAIP------------------------ 513 (714)
Q Consensus 471 ~l~~l~h~nI-----v~l~~~~~~--------~~~~~lv~E~~~~gsL~~~l~~~~------------------------ 513 (714)
++.+++|.++ ++++++|.. +...++||||+++++|.++++...
T Consensus 225 ~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~ 304 (507)
T PLN03224 225 MCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQD 304 (507)
T ss_pred HHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccc
Confidence 7777766554 677887753 356799999999999999986421
Q ss_pred CCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcccceeeecCCCCccCccc
Q 041576 514 RPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEW 593 (714)
Q Consensus 514 ~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~ 593 (714)
.+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||++...............+++.|+|||.
T Consensus 305 ~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~ 381 (507)
T PLN03224 305 KRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEE 381 (507)
T ss_pred cCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhh
Confidence 2346678889999999999999998 9999999999999999999999999997654332222222335789999998
Q ss_pred ccCCCC----------------------CchhhhHHHHHHHHHHHhcCC-CCcccccchh-----hhhhhHHHhhhhhcC
Q 041576 594 FKNVPV----------------------SAKVDVYSFGVVLLKIICCKR-SVEMELGEER-----SAILTDWAYDCYVEG 645 (714)
Q Consensus 594 ~~~~~~----------------------s~ksDVwSlGvil~elltG~~-p~~~~~~~~~-----~~~l~~~~~~~~~~~ 645 (714)
+..... ..+.||||+||++|||++|.. |+.....-.. ...+..| ......
T Consensus 382 l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~--r~~~~~ 459 (507)
T PLN03224 382 LVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRW--RMYKGQ 459 (507)
T ss_pred hcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHH--Hhhccc
Confidence 854321 235799999999999999875 6542211000 0111111 111111
Q ss_pred ccceeecchhhhccchHHHHHHHHHHHHccccCC---CCCCCHHHHHHH
Q 041576 646 KLDVLVDNDKAAMADKSRACKWLMIALWCIQEDP---LKRPAMKMIVQM 691 (714)
Q Consensus 646 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP---~~RPs~~evl~~ 691 (714)
.... ...........+++.++|..+| .+|+|++|+++.
T Consensus 460 ~~~~--------~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 460 KYDF--------SLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred CCCc--------ccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 1110 0111234567789999999766 689999999863
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-30 Score=252.15 Aligned_cols=246 Identities=24% Similarity=0.308 Sum_probs=199.8
Q ss_pred hhhhhhCcccceeEEEeEeeCCCCcEEEEEEeccc---chhhHHHHHHHHHHHhcc-CcccccceeceEecCCeeeEEEe
Q 041576 423 GFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKL---AQEREREFKTEVSAIGRT-HHKNLVQLLGFCDEGLNRLLVYE 498 (714)
Q Consensus 423 ~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~E 498 (714)
.+..+||+|+|..|..++++ .+.+.+|+|++++. +.++..-++.|-.+..+- +||.+|.++.+|..+...++|.|
T Consensus 253 ~ll~vigrgsyakvl~~~~~-~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvie 331 (593)
T KOG0695|consen 253 DLLRVIGRGSYAKVLLVRLK-KTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIE 331 (593)
T ss_pred eeeeeecCcchhhhhheehc-ccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEE
Confidence 45678999999999999987 57789999999762 333444566777777766 89999999999999999999999
Q ss_pred ecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcccc
Q 041576 499 FMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRT 578 (714)
Q Consensus 499 ~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 578 (714)
|+++|+|--+++..++++++.+.-+..+|.-||.|||++| |+.||||.+|+|+|..|++||.|+|+++.-..+. ..
T Consensus 332 yv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l~~g-d~ 407 (593)
T KOG0695|consen 332 YVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPG-DT 407 (593)
T ss_pred EecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCCCCC-cc
Confidence 9999999999999999999999999999999999999999 9999999999999999999999999998643333 33
Q ss_pred eeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhhc
Q 041576 579 RTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAM 658 (714)
Q Consensus 579 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 658 (714)
..++.||+.|+|||++++..|....|-|++||+++||+.|+.||+.-..+.....-.++..+.+.+..+.
T Consensus 408 tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqir---------- 477 (593)
T KOG0695|consen 408 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIR---------- 477 (593)
T ss_pred cccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhccc----------
Confidence 4567899999999999999999999999999999999999999986543333333333333333333221
Q ss_pred cchHHHHHHHHHHHHccccCCCCCC
Q 041576 659 ADKSRACKWLMIALWCIQEDPLKRP 683 (714)
Q Consensus 659 ~~~~~~~~l~~li~~cl~~dP~~RP 683 (714)
.+...+.+...+++..|.+||.+|.
T Consensus 478 iprslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 478 IPRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred ccceeehhhHHHHHHhhcCCcHHhc
Confidence 1222233445588889999999994
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8e-30 Score=255.49 Aligned_cols=255 Identities=22% Similarity=0.289 Sum_probs=200.0
Q ss_pred hhhhhhhhCcccceeEEEeEeeCC----CCcEEEEEEeccc-chhhHHHHHHHHHHHhccCcccccceeceEec-CCeee
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSA----SGNAVAVKKLDKL-AQEREREFKTEVSAIGRTHHKNLVQLLGFCDE-GLNRL 494 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-~~~~~ 494 (714)
+......+-+|.||.||+|++++. +.+.|.||.++.. ++-+...+..|-..+..+.|||+..+.+++.+ ....+
T Consensus 285 Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~ 364 (563)
T KOG1024|consen 285 RVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPF 364 (563)
T ss_pred heechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcce
Confidence 333455789999999999988633 2345777777653 34455678899999999999999999999855 45678
Q ss_pred EEEeecCCCchhhhhhcC--------CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCC
Q 041576 495 LVYEFMGNGTLANLLFAI--------PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFG 566 (714)
Q Consensus 495 lv~E~~~~gsL~~~l~~~--------~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg 566 (714)
++|.++.-|+|..+|... +.++..+...++.|++.|++|||+++ +||.||..+|.+||+..++||+|=.
T Consensus 365 V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~LqVkltDsa 441 (563)
T KOG1024|consen 365 VLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQLQVKLTDSA 441 (563)
T ss_pred EEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhheeEEeccch
Confidence 999999999999999721 23566778889999999999999998 9999999999999999999999999
Q ss_pred CccccccCcccce-eeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccchhhhhhhHHHhhhhhc
Q 041576 567 LSKLLLSDQSRTR-TVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEERSAILTDWAYDCYVE 644 (714)
Q Consensus 567 ~~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~ 644 (714)
+++.+.+...... ........||+||.+.+..|+.++|||||||+||||+| |+.|+..-++.+....+ .+
T Consensus 442 LSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~yl--------kd 513 (563)
T KOG1024|consen 442 LSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYL--------KD 513 (563)
T ss_pred hccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHH--------hc
Confidence 9987654433222 22235678999999999999999999999999999998 77887644443322222 11
Q ss_pred CccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 041576 645 GKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGY 695 (714)
Q Consensus 645 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 695 (714)
| .+...+...+.++..++.-||+.+|++||++++++.-|.+.
T Consensus 514 G---------yRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF 555 (563)
T KOG1024|consen 514 G---------YRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEF 555 (563)
T ss_pred c---------ceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence 1 11223455677889999999999999999999999988763
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=277.57 Aligned_cols=249 Identities=27% Similarity=0.380 Sum_probs=203.9
Q ss_pred hhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhcc-CcccccceeceEe-----cCCeee
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRT-HHKNLVQLLGFCD-----EGLNRL 494 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~-----~~~~~~ 494 (714)
+..|.++||.|.+|.||+++.+ .+++.+|+|++... .+..++++.|.++++.. +|||++.++|++. .++.+|
T Consensus 20 ~~ei~evig~Gtygkv~k~k~~-~~~~~aa~kI~~~~-~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLW 97 (953)
T KOG0587|consen 20 IFEIIEVIGNGTYGKVYKGRHV-KTGQLAAIKIMDPT-EDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLW 97 (953)
T ss_pred ccEEEEEEeeccceeEEEEeee-ecCceeeeEeecCC-ccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEE
Confidence 4567799999999999999877 57889999988653 34456778899999988 7999999999984 356889
Q ss_pred EEEeecCCCchhhhhhcC--CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccc
Q 041576 495 LVYEFMGNGTLANLLFAI--PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLL 572 (714)
Q Consensus 495 lv~E~~~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~ 572 (714)
||||||.+|+..|+++.. .++.|..+.-|+..++.||++||.+. ++|||||-.|||++.++.+||.|||.+..+.
T Consensus 98 LVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLvDFGvSaQld 174 (953)
T KOG0587|consen 98 LVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 174 (953)
T ss_pred EEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEeeeeeeeeee
Confidence 999999999999999754 56789999999999999999999997 9999999999999999999999999998775
Q ss_pred cCcccceeeecCCCCccCccccc-----CCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCcc
Q 041576 573 SDQSRTRTVIRGTRGYVAPEWFK-----NVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKL 647 (714)
Q Consensus 573 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~ 647 (714)
...... ....||+.|||||++. ...|+..+|+||||++..||--|.+|+....... .+ .
T Consensus 175 sT~grR-nT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmr---aL------------F 238 (953)
T KOG0587|consen 175 STVGRR-NTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMR---AL------------F 238 (953)
T ss_pred cccccc-cCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhh---hh------------c
Confidence 544333 3456999999999985 3357789999999999999999999986432211 00 0
Q ss_pred ceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 648 DVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 648 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
.....+.+....+.....++.++|..||..|-++||++.++++
T Consensus 239 ~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 239 LIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred cCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 1111223333446778889999999999999999999998875
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.7e-31 Score=251.56 Aligned_cols=262 Identities=23% Similarity=0.300 Sum_probs=201.8
Q ss_pred hhhCcccceeEEEeEeeCCCCcEEEEEEecccch--hhHHHHHHHHHHHhccCcccccceeceEecC-----CeeeEEEe
Q 041576 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQ--EREREFKTEVSAIGRTHHKNLVQLLGFCDEG-----LNRLLVYE 498 (714)
Q Consensus 426 ~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-----~~~~lv~E 498 (714)
+.||.|+||.||.+.+. .+|+.|++|++...-. ...+.+-+|+.+|.-++|.|++..++...-. ++.|++.|
T Consensus 59 RPIGYGAFGVVWsVTDP-RdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TE 137 (449)
T KOG0664|consen 59 RPIGYGAFGVVWSVTDP-RSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTE 137 (449)
T ss_pred CcccccceeEEEeccCC-CCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHH
Confidence 67999999999998865 6899999999976322 3456788999999999999999998876544 24678899
Q ss_pred ecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcccc
Q 041576 499 FMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRT 578 (714)
Q Consensus 499 ~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 578 (714)
.|.. +|..++-....++...+.-+..||++||.|||+.+ |.||||||.|.|++.|..+||+|||+++.-..++...
T Consensus 138 LmQS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~h 213 (449)
T KOG0664|consen 138 LMQS-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRLN 213 (449)
T ss_pred HHHh-hhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccchhhhhh
Confidence 8865 89999988888999999999999999999999998 9999999999999999999999999999887777777
Q ss_pred eeeecCCCCccCcccccCC-CCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHH---------------hhhh
Q 041576 579 RTVIRGTRGYVAPEWFKNV-PVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWA---------------YDCY 642 (714)
Q Consensus 579 ~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~---------------~~~~ 642 (714)
.+..+-|..|.|||++.+. .|+.+.||||.|||+.||+..+..|.....-+..+.+.+.. ....
T Consensus 214 MTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~ 293 (449)
T KOG0664|consen 214 MTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHV 293 (449)
T ss_pred hHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHh
Confidence 7777789999999999875 58999999999999999999888887654443333332211 0111
Q ss_pred hcCccceeecchhh-hccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 041576 643 VEGKLDVLVDNDKA-AMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQML 692 (714)
Q Consensus 643 ~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 692 (714)
..+....-.-+.+. ...+.....+...+...++..||++|.+..+.+..+
T Consensus 294 LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 294 LRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred hccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 11100000000000 011122334566678889999999999999988754
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-30 Score=281.80 Aligned_cols=238 Identities=29% Similarity=0.395 Sum_probs=186.1
Q ss_pred hhhCccccee-EEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhcc-CcccccceeceEecCCeeeEEEeecCCC
Q 041576 426 EELGRGSFGI-VYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRT-HHKNLVQLLGFCDEGLNRLLVYEFMGNG 503 (714)
Q Consensus 426 ~~ig~G~~g~-Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~E~~~~g 503 (714)
+++|.|+.|+ ||+|..+ ++.||||++-. +...-.++|+..|+.- +|||||++++.-.+.+..||..|.|..
T Consensus 515 eilG~Gs~Gt~Vf~G~ye---~R~VAVKrll~---e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~- 587 (903)
T KOG1027|consen 515 EILGYGSNGTVVFRGVYE---GREVAVKRLLE---EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCAC- 587 (903)
T ss_pred HHcccCCCCcEEEEEeeC---CceehHHHHhh---HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhh-
Confidence 6789998865 7899985 88999999843 3345668999999988 799999999999999999999999976
Q ss_pred chhhhhhcC-CCC---ChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECC---C--CceEEecCCCccccccC
Q 041576 504 TLANLLFAI-PRP---DWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQ---D--FTAKISDFGLSKLLLSD 574 (714)
Q Consensus 504 sL~~~l~~~-~~~---~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~---~--~~~kl~Dfg~~~~~~~~ 574 (714)
+|.+++... ... .....+.+..|+++||++||+-+ ||||||||.||||+. + .+++|+|||+++.+..+
T Consensus 588 sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~ 664 (903)
T KOG1027|consen 588 SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGG 664 (903)
T ss_pred hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccCCC
Confidence 999999874 111 12445788999999999999987 999999999999975 3 57999999999998765
Q ss_pred cc--cceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhc-CCCCcccccchhhhhhhHHHhhhhhcCccceee
Q 041576 575 QS--RTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICC-KRSVEMELGEERSAILTDWAYDCYVEGKLDVLV 651 (714)
Q Consensus 575 ~~--~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG-~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 651 (714)
.. .......||.+|+|||.+....-+.++||||+||++|+.++| .+||......+. .+ ..+...
T Consensus 665 ~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~--NI--------l~~~~~--- 731 (903)
T KOG1027|consen 665 KSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA--NI--------LTGNYT--- 731 (903)
T ss_pred cchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh--hh--------hcCccc---
Confidence 53 234456799999999999998889999999999999999997 899975432211 11 111100
Q ss_pred cchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 652 DNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 652 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
+....+... .+..+||.+|++++|..||++.+|+.
T Consensus 732 ---L~~L~~~~d-~eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 732 ---LVHLEPLPD-CEAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred ---eeeeccCch-HHHHHHHHHhcCCCcccCCCHHHHhC
Confidence 000111111 16778999999999999999999973
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-30 Score=267.31 Aligned_cols=244 Identities=21% Similarity=0.232 Sum_probs=201.8
Q ss_pred hhhhCcccceeEEEeEeeCCCCcEEEEEEecc---cchhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEeecC
Q 041576 425 EEELGRGSFGIVYKGVLKSASGNAVAVKKLDK---LAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEFMG 501 (714)
Q Consensus 425 ~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~ 501 (714)
...||-|+||.|=++.... ....+|+|.+++ .+..+++.+..|-++|...+.|.||+++.-|.+....|+.||-|-
T Consensus 425 iaTLGvGgFGRVELV~~~~-~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaCl 503 (732)
T KOG0614|consen 425 IATLGVGGFGRVELVKVNS-QKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACL 503 (732)
T ss_pred hhhcccCccceEEEEEecc-cchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhc
Confidence 4569999999999988752 222478888865 344556678899999999999999999999999999999999999
Q ss_pred CCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcccceee
Q 041576 502 NGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTV 581 (714)
Q Consensus 502 ~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 581 (714)
||.|...|++++.++...+..++..+++|++|||+++ ||.|||||+|.+++.+|-+||.|||+|+.+.... ..-+
T Consensus 504 GGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~--KTwT 578 (732)
T KOG0614|consen 504 GGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR--KTWT 578 (732)
T ss_pred CchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccCC--ceee
Confidence 9999999999999999999999999999999999998 9999999999999999999999999999875433 3345
Q ss_pred ecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhhccch
Q 041576 582 IRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMADK 661 (714)
Q Consensus 582 ~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 661 (714)
++||+.|.|||++.+...+.++|.||||+++|||++|.+||...++......+ ..|. .....+.
T Consensus 579 FcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~I--------LkGi--------d~i~~Pr 642 (732)
T KOG0614|consen 579 FCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLI--------LKGI--------DKIEFPR 642 (732)
T ss_pred ecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHH--------Hhhh--------hhhhccc
Confidence 78999999999999999999999999999999999999999876554322221 1111 0111223
Q ss_pred HHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 041576 662 SRACKWLMIALWCIQEDPLKRPA-----MKMIVQ 690 (714)
Q Consensus 662 ~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 690 (714)
.......+++++.+..+|.+|.. +.+|.+
T Consensus 643 ~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkk 676 (732)
T KOG0614|consen 643 RITKTATDLIKKLCRDNPTERLGYQKGGINDIKK 676 (732)
T ss_pred ccchhHHHHHHHHHhcCcHhhhccccCChHHHHh
Confidence 33445667889999999999975 666654
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-29 Score=231.24 Aligned_cols=196 Identities=28% Similarity=0.414 Sum_probs=165.7
Q ss_pred hhhhCcccceeEEEeEeeCCCCcEEEEEEecc-cchhhHHHHHHHHHHHhcc-CcccccceeceEecCCeeeEEEeecCC
Q 041576 425 EEELGRGSFGIVYKGVLKSASGNAVAVKKLDK-LAQEREREFKTEVSAIGRT-HHKNLVQLLGFCDEGLNRLLVYEFMGN 502 (714)
Q Consensus 425 ~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~E~~~~ 502 (714)
.+.||+|++|.|-+-++. .+|...|+|+++. ......++...|+.+..+. .+|.+|.++|........++.||.|+.
T Consensus 51 i~elGrGayG~vekmrh~-~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~t 129 (282)
T KOG0984|consen 51 IEELGRGAYGVVEKMRHI-QSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMDT 129 (282)
T ss_pred hhhhcCCccchhhheeec-cCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhhh
Confidence 478999999999888776 6899999999975 3344556788899887776 899999999999999999999999975
Q ss_pred Cchhhhhh----cCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcccc
Q 041576 503 GTLANLLF----AIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRT 578 (714)
Q Consensus 503 gsL~~~l~----~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 578 (714)
||+.+-. .....++...-+|+..+.+||.|||++- .++|||+||+||||+.+|++|++|||++..+.+.....
T Consensus 130 -Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiAkt 206 (282)
T KOG0984|consen 130 -SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIAKT 206 (282)
T ss_pred -hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceeehhhhHHH
Confidence 7766643 4567788889999999999999999974 79999999999999999999999999998775543332
Q ss_pred eeeecCCCCccCccccc----CCCCCchhhhHHHHHHHHHHHhcCCCCcccc
Q 041576 579 RTVIRGTRGYVAPEWFK----NVPVSAKVDVYSFGVVLLKIICCKRSVEMEL 626 (714)
Q Consensus 579 ~~~~~gt~~y~aPE~~~----~~~~s~ksDVwSlGvil~elltG~~p~~~~~ 626 (714)
...|-..|+|||.+. ...|+-|+||||||+.+.||.+++.|++...
T Consensus 207 --~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~ 256 (282)
T KOG0984|consen 207 --MDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG 256 (282)
T ss_pred --HhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence 234778999999884 3468999999999999999999999997543
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-29 Score=263.19 Aligned_cols=208 Identities=24% Similarity=0.340 Sum_probs=178.8
Q ss_pred hhhCcccceeEEEeEeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEeecCC
Q 041576 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA---QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEFMGN 502 (714)
Q Consensus 426 ~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~ 502 (714)
+.||-|+||.|.++.-- ++...+|+|.+++.+ +.....+..|-.||..-+.+-||+|+..|.+++.+|+||+|++|
T Consensus 635 k~iGvGAFGeV~Lv~Kv-DT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPG 713 (1034)
T KOG0608|consen 635 KTIGVGAFGEVCLVRKV-DTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPG 713 (1034)
T ss_pred eeecccccceeEEEeec-chhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCC
Confidence 56999999999998743 467789999997643 34456788999999999999999999999999999999999999
Q ss_pred CchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccc---------c
Q 041576 503 GTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLL---------S 573 (714)
Q Consensus 503 gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~---------~ 573 (714)
|++-.+|-..+.+.+..+..++.++..|+++.|..| +|||||||+|||||.+|++||.|||++.-+. .
T Consensus 714 GDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq~ 790 (1034)
T KOG0608|consen 714 GDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQE 790 (1034)
T ss_pred ccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccceeccccccccC
Confidence 999999999999999999999999999999999998 9999999999999999999999999986541 0
Q ss_pred C----------------c----------------ccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCC
Q 041576 574 D----------------Q----------------SRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRS 621 (714)
Q Consensus 574 ~----------------~----------------~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p 621 (714)
. . .......+||+.|+|||++....++..+|-||.|||||||+.|+.|
T Consensus 791 gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~~p 870 (1034)
T KOG0608|consen 791 GDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQPP 870 (1034)
T ss_pred CCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCCCC
Confidence 0 0 0001124599999999999999999999999999999999999999
Q ss_pred CcccccchhhhhhhHH
Q 041576 622 VEMELGEERSAILTDW 637 (714)
Q Consensus 622 ~~~~~~~~~~~~l~~~ 637 (714)
|-.....+.+..+..|
T Consensus 871 f~~~tp~~tq~kv~nw 886 (1034)
T KOG0608|consen 871 FLADTPGETQYKVINW 886 (1034)
T ss_pred ccCCCCCcceeeeeeh
Confidence 9877666554444444
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-27 Score=234.66 Aligned_cols=210 Identities=39% Similarity=0.559 Sum_probs=183.6
Q ss_pred hCcccceeEEEeEeeCCCCcEEEEEEecccchh-hHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEeecCCCchh
Q 041576 428 LGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQE-REREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEFMGNGTLA 506 (714)
Q Consensus 428 ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~gsL~ 506 (714)
||+|.+|.||++... .+++.+++|.+...... ....+.+|++.+++++|++|+++++++......++++|++++++|.
T Consensus 1 l~~g~~~~v~~~~~~-~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~ 79 (215)
T cd00180 1 LGEGGFGTVYLARDK-KTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLK 79 (215)
T ss_pred CCcCCceEEEEEEec-CCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHH
Confidence 689999999999875 35889999999764432 4568999999999999999999999999999999999999999999
Q ss_pred hhhhcC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECC-CCceEEecCCCccccccCcccceeeecC
Q 041576 507 NLLFAI-PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQ-DFTAKISDFGLSKLLLSDQSRTRTVIRG 584 (714)
Q Consensus 507 ~~l~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~g 584 (714)
+++... ..+++..+..++.+++++|++||+.+ ++|+||+|.||+++. ++.++|+|||.+........ ......+
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~ 155 (215)
T cd00180 80 DLLKENEGKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIVG 155 (215)
T ss_pred HHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcccC
Confidence 999875 46889999999999999999999998 999999999999999 89999999999986644321 1223447
Q ss_pred CCCccCcccccCC-CCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhhccchHH
Q 041576 585 TRGYVAPEWFKNV-PVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMADKSR 663 (714)
Q Consensus 585 t~~y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 663 (714)
...|++||.+... ..+.+.|+|++|++++++
T Consensus 156 ~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------------ 187 (215)
T cd00180 156 TPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------------ 187 (215)
T ss_pred CCCccChhHhcccCCCCchhhhHHHHHHHHHH------------------------------------------------
Confidence 7889999999887 889999999999999998
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 664 ACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 664 ~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
..+.+++..|++.+|++||++.++++.
T Consensus 188 -~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 -PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred -HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 356669999999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-28 Score=257.52 Aligned_cols=193 Identities=25% Similarity=0.364 Sum_probs=168.3
Q ss_pred hhhhhCcccceeEEEeEeeCCCCcEEEEEEecccch--------hhHHHHHHHHHHHhccC---cccccceeceEecCCe
Q 041576 424 FEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQ--------EREREFKTEVSAIGRTH---HKNLVQLLGFCDEGLN 492 (714)
Q Consensus 424 ~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~---h~nIv~l~~~~~~~~~ 492 (714)
-.+.+|+|+||.|+.|+++. +...|+||.+.+..- .....+-.|+.+|..++ |+||++++++|++++.
T Consensus 565 tlq~lG~GAyGkV~lai~K~-n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd~ 643 (772)
T KOG1152|consen 565 TLQPLGEGAYGKVNLAIHKE-NNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDDY 643 (772)
T ss_pred eeeeccccccceEEEeeecc-cceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCCe
Confidence 34679999999999999984 477899998865211 11224567999999997 9999999999999999
Q ss_pred eeEEEeecC-CCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCcccc
Q 041576 493 RLLVYEFMG-NGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLL 571 (714)
Q Consensus 493 ~~lv~E~~~-~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~ 571 (714)
.||+||-.. +.+|.+++.-.+.+++.++.-|+.|++.|+++||+++ |||||||-+|+.++.+|-+||+|||.+...
T Consensus 644 yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidfgsaa~~ 720 (772)
T KOG1152|consen 644 YYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDFGSAAYT 720 (772)
T ss_pred eEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeeccchhhh
Confidence 999999764 6699999999999999999999999999999999999 999999999999999999999999999765
Q ss_pred ccCcccceeeecCCCCccCcccccCCCC-CchhhhHHHHHHHHHHHhcCCCCc
Q 041576 572 LSDQSRTRTVIRGTRGYVAPEWFKNVPV-SAKVDVYSFGVVLLKIICCKRSVE 623 (714)
Q Consensus 572 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwSlGvil~elltG~~p~~ 623 (714)
. +.....++||..|.|||++.+..| ...-|||++|++||.++....||.
T Consensus 721 k---sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 721 K---SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred c---CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 3 344556789999999999999887 567899999999999999888875
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-26 Score=231.19 Aligned_cols=198 Identities=32% Similarity=0.467 Sum_probs=174.1
Q ss_pred hhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchh-hHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEeecC
Q 041576 423 GFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQE-REREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEFMG 501 (714)
Q Consensus 423 ~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~ 501 (714)
.+.+.||+|++|.||++... .+++.+++|.+...... ..+.+.+|++.+++++|+|++++++++......++++|+++
T Consensus 2 ~~~~~i~~g~~~~v~~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 2 ELGKKLGEGAFGKVYLARDK-GTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred ceeeEeecCCCeEEEEEEEc-CCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 45678999999999999986 35789999999865544 56789999999999999999999999999999999999999
Q ss_pred CCchhhhhhcCCC-CChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCccccee
Q 041576 502 NGTLANLLFAIPR-PDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRT 580 (714)
Q Consensus 502 ~gsL~~~l~~~~~-~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 580 (714)
+++|.+++..... +++.....++.+++.+|.+||+.+ ++|+||+|+||+++.++.++|+|||.+............
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~ 157 (225)
T smart00221 81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLK 157 (225)
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccccc
Confidence 9999999987666 899999999999999999999997 999999999999999999999999999876544311223
Q ss_pred eecCCCCccCcccc-cCCCCCchhhhHHHHHHHHHHHhcCCCCcc
Q 041576 581 VIRGTRGYVAPEWF-KNVPVSAKVDVYSFGVVLLKIICCKRSVEM 624 (714)
Q Consensus 581 ~~~gt~~y~aPE~~-~~~~~s~ksDVwSlGvil~elltG~~p~~~ 624 (714)
...++..|++||.+ ....++.++|||+||++++||++|+.||..
T Consensus 158 ~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 158 TVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 34577889999998 667788899999999999999999999964
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-26 Score=239.75 Aligned_cols=130 Identities=31% Similarity=0.446 Sum_probs=111.0
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccC-----c---ccccceeceEe---
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTH-----H---KNLVQLLGFCD--- 488 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h---~nIv~l~~~~~--- 488 (714)
++|.+.++||.|.|++||++.+. ...+.||+|+.+. .+...+..+.||++|++++ | .+||+|+++|.
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDt-q~~r~VAlKVvKS-AqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG 155 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDT-QNKRYVALKVVKS-AQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG 155 (590)
T ss_pred ceEEEEEeccccccceeEEEeec-cCCeEEEEEEEeh-hhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence 77888999999999999999765 5778999999864 3445567789999999983 3 35999999994
Q ss_pred -cCCeeeEEEeecCCCchhhhhhcC--CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEE
Q 041576 489 -EGLNRLLVYEFMGNGTLANLLFAI--PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILL 554 (714)
Q Consensus 489 -~~~~~~lv~E~~~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll 554 (714)
++.+.+||+|++. .+|..+|... +.++...+.+|+.||+.||.|||.++ +|||.||||+|||+
T Consensus 156 pNG~HVCMVfEvLG-dnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 156 PNGQHVCMVFEVLG-DNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred CCCcEEEEEehhhh-hHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 5678999999985 4888888644 57889999999999999999999997 79999999999999
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-27 Score=234.56 Aligned_cols=256 Identities=25% Similarity=0.273 Sum_probs=189.7
Q ss_pred hhhCcccceeEEEeEeeCCCCcEEEEEEecc--cchhhHHHHHHHHHHHhccCcccccceeceEecC------CeeeEEE
Q 041576 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDK--LAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEG------LNRLLVY 497 (714)
Q Consensus 426 ~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~------~~~~lv~ 497 (714)
..++.|+- .|-.|.+ .-.+++|++|++.. ......+...+|+..+..++|+||++++.++.-. ...|+||
T Consensus 23 ~p~~~g~~-~v~~a~D-~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~ 100 (369)
T KOG0665|consen 23 KPIGSGAQ-IVVAAFD-QVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVM 100 (369)
T ss_pred cccCCCCc-eEEecch-hhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHH
Confidence 56777877 5555543 35688999998854 2234456778999999999999999999998443 4569999
Q ss_pred eecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCccc
Q 041576 498 EFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSR 577 (714)
Q Consensus 498 E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 577 (714)
|+|.. +|...+. -.++-+....|+.|++.|++|||+.+ |+||||||+||++..+..+||.|||+++....+ .
T Consensus 101 e~m~~-nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~--~ 172 (369)
T KOG0665|consen 101 ELMDA-NLCQVIL--MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD--F 172 (369)
T ss_pred Hhhhh-HHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhcccCcc--c
Confidence 99975 8888887 46778889999999999999999998 999999999999999999999999999865433 4
Q ss_pred ceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhH---------------HHhhhh
Q 041576 578 TRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTD---------------WAYDCY 642 (714)
Q Consensus 578 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~---------------~~~~~~ 642 (714)
..+..+.+..|.|||++.+..+.+.+||||.||++.||++|+..|.+...-++...+.+ .+....
T Consensus 173 ~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv 252 (369)
T KOG0665|consen 173 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYV 252 (369)
T ss_pred ccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHh
Confidence 55566788999999999988899999999999999999999998875432221111100 000000
Q ss_pred h------cCccceee-cchhhh--ccchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 643 V------EGKLDVLV-DNDKAA--MADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 643 ~------~~~~~~~~-~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
. .-....++ |..... ..+......+.+++.+||-.||++|.|++++|+.
T Consensus 253 ~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 253 ENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred hcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 0 00011111 111111 1112334456779999999999999999999985
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=217.82 Aligned_cols=259 Identities=17% Similarity=0.303 Sum_probs=191.0
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccC-cccccceeceEecCC--eeeEE
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTH-HKNLVQLLGFCDEGL--NRLLV 496 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~--~~~lv 496 (714)
..|++.+++|+|.++.||.|+.- .+++.++||+++. ...+.+.+|+.+|..+. ||||+++++...+.. ...||
T Consensus 38 ddYeivrk~GRGKYSEVFeg~~~-~~~eK~ViKiLKP---VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 38 DDYEIVRKVGRGKYSEVFEGINI-TNNEKCVIKILKP---VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred chHHHHHHHcCccHhhHhccccc-CCCceEEEeeech---HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 45778899999999999999854 4678999999975 44568899999999996 999999999997654 45799
Q ss_pred EeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCC-CceEEecCCCccccccCc
Q 041576 497 YEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQD-FTAKISDFGLSKLLLSDQ 575 (714)
Q Consensus 497 ~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~-~~~kl~Dfg~~~~~~~~~ 575 (714)
+||+.+.+...+- +.++...+...+.++++||.|+|+.| |.|||+||.|++||.. -.++|+|.|+|.......
T Consensus 114 FE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~ 187 (338)
T KOG0668|consen 114 FEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 187 (338)
T ss_pred hhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcCCCc
Confidence 9999997776665 45677788899999999999999999 9999999999999975 569999999998775544
Q ss_pred ccceeeecCCCCccCcccccCC-CCCchhhhHHHHHHHHHHHhcCCCCcccccc-hhhhhhhH---------HH--hhhh
Q 041576 576 SRTRTVIRGTRGYVAPEWFKNV-PVSAKVDVYSFGVVLLKIICCKRSVEMELGE-ERSAILTD---------WA--YDCY 642 (714)
Q Consensus 576 ~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~-~~~~~l~~---------~~--~~~~ 642 (714)
.... .+.+..|.-||.+-.. .++..-|+|||||+|..|+..+.||-..... ++...+.. +. +...
T Consensus 188 eYnV--RVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~ 265 (338)
T KOG0668|consen 188 EYNV--RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQID 265 (338)
T ss_pred eeee--eeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccC
Confidence 3322 2356678899998654 5788999999999999999999998643221 11111111 00 0000
Q ss_pred hcCccceeecc----hhhhc----cchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 643 VEGKLDVLVDN----DKAAM----ADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 643 ~~~~~~~~~~~----~~~~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
.+.+...++.. ..... ...-..++.++++...|..|-.+|||++|.+.
T Consensus 266 Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 266 LDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred CChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 01111111110 00000 01112357788999999999999999999875
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=223.08 Aligned_cols=265 Identities=18% Similarity=0.273 Sum_probs=197.2
Q ss_pred ccccCCccccCHHHHHHHhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhcc-Cccccc
Q 041576 403 SISETNLRFFSLVELNEATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRT-HHKNLV 481 (714)
Q Consensus 403 ~~~~~~~~~~~~~el~~at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv 481 (714)
.+....++..++.+ .|.+.+.+|+|.||.+-++.++ .+++.+++|.+... ....++|.+|...--.| .|.||+
T Consensus 11 ~I~~~el~kv~l~d----~y~I~k~lgeG~FgkIlL~eHr-~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi 84 (378)
T KOG1345|consen 11 LIPMEELKKVDLED----VYTINKQLGEGRFGKILLAEHR-QSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHII 84 (378)
T ss_pred ccccccccccchhh----hhhHHHHhcccceeeEEeeecc-CCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhh
Confidence 34444455555444 4778899999999999999988 57889999999763 34567899998866666 699999
Q ss_pred ceece-EecCCeeeEEEeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEE--CCCC
Q 041576 482 QLLGF-CDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILL--DQDF 558 (714)
Q Consensus 482 ~l~~~-~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll--~~~~ 558 (714)
..++. |+..+..++++||++.|+|..-+.. ..+.+....+++.|++.||.|||+++ +||||||.+|||| .+..
T Consensus 85 ~tY~vaFqt~d~YvF~qE~aP~gdL~snv~~-~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~ 160 (378)
T KOG1345|consen 85 DTYEVAFQTSDAYVFVQEFAPRGDLRSNVEA-AGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFY 160 (378)
T ss_pred HHHHHHhhcCceEEEeeccCccchhhhhcCc-ccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCcc
Confidence 88775 5667778899999999999998876 45677788899999999999999998 9999999999999 3445
Q ss_pred ceEEecCCCccccccCcccceeeecCCCCccCcccccCC-----CCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhh
Q 041576 559 TAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNV-----PVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAI 633 (714)
Q Consensus 559 ~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~ 633 (714)
++||+|||..+....... ...-+..|.+||..... ...+.+|||.||+++|.++||+.||......+
T Consensus 161 rvKlcDFG~t~k~g~tV~----~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d---- 232 (378)
T KOG1345|consen 161 RVKLCDFGLTRKVGTTVK----YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMD---- 232 (378)
T ss_pred EEEeeecccccccCceeh----hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccC----
Confidence 899999999876533222 22346689999977432 34678999999999999999999998543332
Q ss_pred hhHHHhhhhhcCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 634 LTDWAYDCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 634 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
...|.+..+..+....+.+. -....+++..+.++-|.++|++|=-..++.++
T Consensus 233 ~~Y~~~~~w~~rk~~~~P~~------F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~ 284 (378)
T KOG1345|consen 233 KPYWEWEQWLKRKNPALPKK------FNPFSEKALRLFKKSLTPRFKDRCKIWTAKKM 284 (378)
T ss_pred chHHHHHHHhcccCccCchh------hcccCHHHHHHHHHhcCCcccccchhHHHHHH
Confidence 23455555555544432221 11223456677888899999999555444443
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.7e-27 Score=244.86 Aligned_cols=274 Identities=19% Similarity=0.205 Sum_probs=208.8
Q ss_pred CccccCHHHHHHHhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccC------ccccc
Q 041576 408 NLRFFSLVELNEATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTH------HKNLV 481 (714)
Q Consensus 408 ~~~~~~~~el~~at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------h~nIv 481 (714)
..-.+.+.|+...+|.+.-..|+|-|++|.+|... ..|+.||||+++.. +.-.+.=+.|+++|++|+ --|++
T Consensus 420 GYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~-~r~~~vAiKIIRnN-E~M~KtGl~EleiLkKL~~AD~Edk~Hcl 497 (752)
T KOG0670|consen 420 GYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQ-ARGQEVAIKIIRNN-EVMHKTGLKELEILKKLNDADPEDKFHCL 497 (752)
T ss_pred ceEEEehhhhhcceeEEEeccccceeeeeeecccc-CCCCeeEEEEeecc-hHHhhhhhHHHHHHHHhhccCchhhhHHH
Confidence 34556788999999999999999999999999876 45779999999864 333455578999999994 46799
Q ss_pred ceeceEecCCeeeEEEeecCCCchhhhhhcCC---CCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCC-
Q 041576 482 QLLGFCDEGLNRLLVYEFMGNGTLANLLFAIP---RPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQD- 557 (714)
Q Consensus 482 ~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~---~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~- 557 (714)
+++-.|...+++|||+|-+.- +|.++|...+ .+....+..++.|+.-||..|...+ |+|.||||+|||+++.
T Consensus 498 rl~r~F~hknHLClVFE~Lsl-NLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k 573 (752)
T KOG0670|consen 498 RLFRHFKHKNHLCLVFEPLSL-NLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESK 573 (752)
T ss_pred HHHHHhhhcceeEEEehhhhc-hHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCc
Confidence 999999999999999998754 8999998653 4678889999999999999999998 9999999999999875
Q ss_pred CceEEecCCCccccccCcccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHH
Q 041576 558 FTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDW 637 (714)
Q Consensus 558 ~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~ 637 (714)
..+||||||.|.....++- +...-+..|.|||++.+.+|+...|+||.||.||||.||+..|.+...........+.
T Consensus 574 ~iLKLCDfGSA~~~~enei---tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~ 650 (752)
T KOG0670|consen 574 NILKLCDFGSASFASENEI---TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMEL 650 (752)
T ss_pred ceeeeccCccccccccccc---cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHh
Confidence 5689999999986644332 2233456799999999999999999999999999999999999865443332222211
Q ss_pred ----HhhhhhcC------------------------cc---ceeecc------hh-----hhccchHHHHHHHHHHHHcc
Q 041576 638 ----AYDCYVEG------------------------KL---DVLVDN------DK-----AAMADKSRACKWLMIALWCI 675 (714)
Q Consensus 638 ----~~~~~~~~------------------------~~---~~~~~~------~~-----~~~~~~~~~~~l~~li~~cl 675 (714)
....+..+ .. ...+.+ .+ ...........+.+|+..||
T Consensus 651 KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml 730 (752)
T KOG0670|consen 651 KGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKML 730 (752)
T ss_pred cCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHh
Confidence 00000000 00 000011 00 00112334557888999999
Q ss_pred ccCCCCCCCHHHHHH
Q 041576 676 QEDPLKRPAMKMIVQ 690 (714)
Q Consensus 676 ~~dP~~RPs~~evl~ 690 (714)
..||++|.|..++|+
T Consensus 731 ~LdP~KRit~nqAL~ 745 (752)
T KOG0670|consen 731 ILDPEKRITVNQALK 745 (752)
T ss_pred ccChhhcCCHHHHhc
Confidence 999999999999875
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.1e-27 Score=250.49 Aligned_cols=252 Identities=22% Similarity=0.291 Sum_probs=204.2
Q ss_pred hhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEeec
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEFM 500 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~ 500 (714)
.|.+.+.+|+|.+|.||+|++. .+++..|+|.++-.......-+++|+-+++..+||||+.+++.+...+..++.|||+
T Consensus 16 dyellqrvgsgTygdvyKaRd~-~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEyc 94 (829)
T KOG0576|consen 16 DYELLQRVGSGTYGDVYKARDK-RSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYC 94 (829)
T ss_pred chhheeeecCCcccchhhhccc-ccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEec
Confidence 4566789999999999999977 578999999998877778888999999999999999999999999999999999999
Q ss_pred CCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCccccee
Q 041576 501 GNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRT 580 (714)
Q Consensus 501 ~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 580 (714)
.+|+|.+.-+....+++.++..+.++.++||+|||+.+ =+|||||-.||++++.|.+|++|||.+..+..... ...
T Consensus 95 gggslQdiy~~TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitati~-Krk 170 (829)
T KOG0576|consen 95 GGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITATIA-KRK 170 (829)
T ss_pred CCCcccceeeecccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhhhh-hhh
Confidence 99999999999899999999999999999999999998 89999999999999999999999999876644322 233
Q ss_pred eecCCCCccCcccc---cCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhh
Q 041576 581 VIRGTRGYVAPEWF---KNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAA 657 (714)
Q Consensus 581 ~~~gt~~y~aPE~~---~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 657 (714)
.+.||+.|||||+. +.+.|.+++|||+.|+...|+---++|........ ...+. .. ..+++. ..
T Consensus 171 sfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr-~l~Lm-------Tk----S~~qpp-~l 237 (829)
T KOG0576|consen 171 SFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMR-ALFLM-------TK----SGFQPP-TL 237 (829)
T ss_pred cccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHH-HHHHh-------hc----cCCCCC-cc
Confidence 46799999999987 46679999999999999999977666643221111 00000 00 001110 01
Q ss_pred ccchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 658 MADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 658 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
.......+.+-++++.||..+|++||+++.+++
T Consensus 238 kDk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 238 KDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred cCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 112334556777999999999999999988764
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.9e-25 Score=227.98 Aligned_cols=197 Identities=23% Similarity=0.334 Sum_probs=163.9
Q ss_pred hhhhhhhCcccceeEEEeEeeCC--CCcEEEEEEecccchhhHHHHHHHHHHHhcc-CcccccceeceEecCCeeeEEEe
Q 041576 422 NGFEEELGRGSFGIVYKGVLKSA--SGNAVAVKKLDKLAQEREREFKTEVSAIGRT-HHKNLVQLLGFCDEGLNRLLVYE 498 (714)
Q Consensus 422 ~~~~~~ig~G~~g~Vy~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~E 498 (714)
+...++||+|.|++||+|.+... ..+.||+|.+.... .-..+.+|++.|.++ -+.||+++.+++..++...+|+|
T Consensus 38 ~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp 115 (418)
T KOG1167|consen 38 YKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLP 115 (418)
T ss_pred hhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEec
Confidence 44567899999999999987642 56799999996532 334689999999999 69999999999999999999999
Q ss_pred ecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCC-CceEEecCCCccccccC---
Q 041576 499 FMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQD-FTAKISDFGLSKLLLSD--- 574 (714)
Q Consensus 499 ~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~-~~~kl~Dfg~~~~~~~~--- 574 (714)
|++.....++... ++..++...+..++.||+++|.+| ||||||||+|+|.+.. ++-.|.|||+|......
T Consensus 116 ~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~ 189 (418)
T KOG1167|consen 116 YFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQT 189 (418)
T ss_pred ccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechhHHHHHhhhhh
Confidence 9999999988865 568889999999999999999999 9999999999999864 67899999999721000
Q ss_pred ----------------------------------------cccceeeecCCCCccCcccccCC-CCCchhhhHHHHHHHH
Q 041576 575 ----------------------------------------QSRTRTVIRGTRGYVAPEWFKNV-PVSAKVDVYSFGVVLL 613 (714)
Q Consensus 575 ----------------------------------------~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvil~ 613 (714)
.........||++|.|||++... .-+.+.||||.|||++
T Consensus 190 ~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~L 269 (418)
T KOG1167|consen 190 EHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILL 269 (418)
T ss_pred hhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceee
Confidence 00011224599999999998765 4688999999999999
Q ss_pred HHHhcCCCCcccc
Q 041576 614 KIICCKRSVEMEL 626 (714)
Q Consensus 614 elltG~~p~~~~~ 626 (714)
-+++++.||-...
T Consensus 270 slls~~~PFf~a~ 282 (418)
T KOG1167|consen 270 SLLSRRYPFFKAK 282 (418)
T ss_pred hhhccccccccCc
Confidence 9999999997543
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.9e-25 Score=264.97 Aligned_cols=196 Identities=19% Similarity=0.200 Sum_probs=139.2
Q ss_pred hccCc-ccccceeceE-------ecCCeeeEEEeecCCCchhhhhhcC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeE
Q 041576 473 GRTHH-KNLVQLLGFC-------DEGLNRLLVYEFMGNGTLANLLFAI-PRPDWSLRVRISLEIARGLLYLHEECNVPII 543 (714)
Q Consensus 473 ~~l~h-~nIv~l~~~~-------~~~~~~~lv~E~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~iv 543 (714)
++++| +||.+++++| .+....++++|++ +++|.++|... ..+++.+++.++.||++||+|||+++ |+
T Consensus 27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g---Iv 102 (793)
T PLN00181 27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQG---IV 102 (793)
T ss_pred chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence 34556 6888888887 2334567788887 55999999753 45899999999999999999999998 99
Q ss_pred ecCCCcCeEEECC-------------------CCceEEecCCCccccccCcc---------------cceeeecCCCCcc
Q 041576 544 HCDIKPQNILLDQ-------------------DFTAKISDFGLSKLLLSDQS---------------RTRTVIRGTRGYV 589 (714)
Q Consensus 544 H~Dlk~~NIll~~-------------------~~~~kl~Dfg~~~~~~~~~~---------------~~~~~~~gt~~y~ 589 (714)
||||||+||||+. ++.+|++|||+++....... .......||+.|+
T Consensus 103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 182 (793)
T PLN00181 103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT 182 (793)
T ss_pred eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence 9999999999965 44566666666653211000 0011134788899
Q ss_pred CcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhhccchHHHHHHHH
Q 041576 590 APEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMADKSRACKWLM 669 (714)
Q Consensus 590 aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 669 (714)
|||++.+..++.++|||||||+||||++|..|+..... .+...... ...+.. .........
T Consensus 183 APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~-----~~~~~~~~---------~~~~~~-----~~~~~~~~~ 243 (793)
T PLN00181 183 SPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR-----TMSSLRHR---------VLPPQI-----LLNWPKEAS 243 (793)
T ss_pred ChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH-----HHHHHHHh---------hcChhh-----hhcCHHHHH
Confidence 99999999999999999999999999999888652211 11111000 000000 011233456
Q ss_pred HHHHccccCCCCCCCHHHHHHH
Q 041576 670 IALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 670 li~~cl~~dP~~RPs~~evl~~ 691 (714)
++.+||+++|.+||+|.||++.
T Consensus 244 ~~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 244 FCLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred HHHHhCCCChhhCcChHHHhhc
Confidence 8889999999999999999863
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.3e-24 Score=206.21 Aligned_cols=166 Identities=22% Similarity=0.202 Sum_probs=125.4
Q ss_pred CchhhhhhcC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcccceee
Q 041576 503 GTLANLLFAI-PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTV 581 (714)
Q Consensus 503 gsL~~~l~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 581 (714)
|+|.+++... ..+++.+++.|+.||++||+|||+++ ||+||+++.++.+|+ ||++.......
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~------ 63 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ------ 63 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc------
Confidence 6899999864 46899999999999999999999975 999999999999999 99987654322
Q ss_pred ecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhhccch
Q 041576 582 IRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMADK 661 (714)
Q Consensus 582 ~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 661 (714)
..|++.|+|||++.+..++.++|||||||++|||++|+.||....... ..+...... ..... ... .....
T Consensus 64 ~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~--~~~~~~~~~-~~~~~-----~~~--~~~~~ 133 (176)
T smart00750 64 SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS--AILEILLNG-MPADD-----PRD--RSNLE 133 (176)
T ss_pred CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc--HHHHHHHHH-hccCC-----ccc--cccHH
Confidence 257899999999999999999999999999999999999996443211 111111100 00000 000 00111
Q ss_pred HHH--HHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 041576 662 SRA--CKWLMIALWCIQEDPLKRPAMKMIVQMLEGY 695 (714)
Q Consensus 662 ~~~--~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 695 (714)
... ..+.+++.+||+.+|++||++.|+++.+...
T Consensus 134 ~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 134 SVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred HHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 222 2688899999999999999999999988654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.1e-24 Score=202.68 Aligned_cols=251 Identities=25% Similarity=0.391 Sum_probs=193.5
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEec--ccchhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEE
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLD--KLAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVY 497 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 497 (714)
...++..+|.+...|..|+|+++ |..+++|++. .......++|.+|.-.|+-+.||||+.+++.|....+..++.
T Consensus 190 ~~lnl~tkl~e~hsgelwrgrwq---gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~is 266 (448)
T KOG0195|consen 190 SSLNLITKLAESHSGELWRGRWQ---GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIIS 266 (448)
T ss_pred hhhhhhhhhccCCCccccccccc---CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEee
Confidence 34456678999999999999996 6678888774 334445578999999999999999999999999999999999
Q ss_pred eecCCCchhhhhhcCCC--CChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCc
Q 041576 498 EFMGNGTLANLLFAIPR--PDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQ 575 (714)
Q Consensus 498 E~~~~gsL~~~l~~~~~--~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 575 (714)
.||+.|+|...|+.... .+..++.+++.+||+|++|||+.. +-|.---|.+..++||++.+++|+= +-++.
T Consensus 267 q~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarism-ad~kf----- 339 (448)
T KOG0195|consen 267 QYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISM-ADTKF----- 339 (448)
T ss_pred eeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheec-cccee-----
Confidence 99999999999998654 578899999999999999999985 2233446899999999999888752 11111
Q ss_pred ccceeeecCCCCccCcccccCCCC---CchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeec
Q 041576 576 SRTRTVIRGTRGYVAPEWFKNVPV---SAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVD 652 (714)
Q Consensus 576 ~~~~~~~~gt~~y~aPE~~~~~~~---s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 652 (714)
+.......-.+.|++||.++..+- -.++|+|||.++||||.|...||......+....+. .+
T Consensus 340 sfqe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkia-------le-------- 404 (448)
T KOG0195|consen 340 SFQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIA-------LE-------- 404 (448)
T ss_pred eeeccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhh-------hc--------
Confidence 111111224678999999987654 348999999999999999999998665444322211 01
Q ss_pred chhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 041576 653 NDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYL 696 (714)
Q Consensus 653 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 696 (714)
.+....++..+..+.+++.-|+..||.+||.+..|+-+||++.
T Consensus 405 -glrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 405 -GLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred -cccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 1222234445566777899999999999999999999999864
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.3e-22 Score=214.61 Aligned_cols=175 Identities=21% Similarity=0.142 Sum_probs=133.9
Q ss_pred HHhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEeccc-----chhhHHHHHHHHHHHhccCcccccceeceEecCCee
Q 041576 419 EATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKL-----AQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNR 493 (714)
Q Consensus 419 ~at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 493 (714)
...|.+.+.||+|+||+||+|.++..+++.||||++... .......+.+|+++|++++|+|+++.+.. ....
T Consensus 17 ~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~~~ 93 (365)
T PRK09188 17 SARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TGKD 93 (365)
T ss_pred cCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cCCc
Confidence 345778899999999999999887556788999987532 12235679999999999999999853322 2457
Q ss_pred eEEEeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCC-CcCeEEECCCCceEEecCCCccccc
Q 041576 494 LLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDI-KPQNILLDQDFTAKISDFGLSKLLL 572 (714)
Q Consensus 494 ~lv~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dl-k~~NIll~~~~~~kl~Dfg~~~~~~ 572 (714)
++||||+++++|... .. . ....++.|+++||+|||+++ |+|||| ||+|||++.++.+||+|||+++.+.
T Consensus 94 ~LVmE~~~G~~L~~~-~~---~---~~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~ 163 (365)
T PRK09188 94 GLVRGWTEGVPLHLA-RP---H---GDPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQLASVFR 163 (365)
T ss_pred EEEEEccCCCCHHHh-Cc---c---chHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECccceecc
Confidence 999999999999732 11 1 12568899999999999998 999999 9999999999999999999999765
Q ss_pred cCccc-------ceeeecCCCCccCcccccCCC------CCchhhhH
Q 041576 573 SDQSR-------TRTVIRGTRGYVAPEWFKNVP------VSAKVDVY 606 (714)
Q Consensus 573 ~~~~~-------~~~~~~gt~~y~aPE~~~~~~------~s~ksDVw 606 (714)
..... ......++..|+|||.+.-.+ .+..+|-|
T Consensus 164 ~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 164 RRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred cCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 43211 113456788899999985332 23446666
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.5e-21 Score=205.37 Aligned_cols=261 Identities=21% Similarity=0.263 Sum_probs=192.3
Q ss_pred hhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCc----ccccceeceE-ecCCeeeE
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHH----KNLVQLLGFC-DEGLNRLL 495 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h----~nIv~l~~~~-~~~~~~~l 495 (714)
.+.+.+.||+|+||.||++.........+|+|............+..|+.++..+.+ +++.++++.. ..+...++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 577889999999999999987643345788887765433322367788888888863 6889999988 57788899
Q ss_pred EEeecCCCchhhhhhcC--CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCC-----CceEEecCCCc
Q 041576 496 VYEFMGNGTLANLLFAI--PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQD-----FTAKISDFGLS 568 (714)
Q Consensus 496 v~E~~~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~-----~~~kl~Dfg~~ 568 (714)
||+.+ |.+|.++.... +.++..+.++|+.|++.+|.+||+.| ++||||||+|+++... ..+.|.|||++
T Consensus 99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99987 66999988544 57899999999999999999999998 9999999999999765 46999999999
Q ss_pred c--ccccCcc------cc-eeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHh
Q 041576 569 K--LLLSDQS------RT-RTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAY 639 (714)
Q Consensus 569 ~--~~~~~~~------~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~ 639 (714)
+ ....... .. ....+||.+|.+++...+.+.+.+.|+||++.++.|++.|..||...........+.....
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~ 254 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPR 254 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhh
Confidence 8 4322211 11 2345699999999999999999999999999999999999999965433221111111100
Q ss_pred hhhhcCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCC
Q 041576 640 DCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLEV 698 (714)
Q Consensus 640 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 698 (714)
...... .....+..+..+...+-..+..++|....+.+.|++....
T Consensus 255 --------~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~ 300 (322)
T KOG1164|consen 255 --------KLLTDR-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDS 300 (322)
T ss_pred --------hhcccc-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHh
Confidence 000000 1111223344444444558999999999999998776544
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.3e-22 Score=226.53 Aligned_cols=253 Identities=20% Similarity=0.226 Sum_probs=190.8
Q ss_pred hhhhCcccceeEEEeEeeCCCCcEEEEEEec----c-cchhh-HHHHHHHHHHHhccCcccccceeceEecCCeeeEEEe
Q 041576 425 EEELGRGSFGIVYKGVLKSASGNAVAVKKLD----K-LAQER-EREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYE 498 (714)
Q Consensus 425 ~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~----~-~~~~~-~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E 498 (714)
...+|.|++|.|+...... .....+.|..+ . ..... ...+..|+-+-..++|||++..+..+.+.....-+||
T Consensus 323 ~~~~g~ga~g~~~~~~~~~-~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 323 GRVLGSGAYGSVRIAKRRS-DLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred cceeeecccCceEEEEecC-CCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 4679999999777766442 33334444332 1 11111 1236778888888999999999888888777777799
Q ss_pred ecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcc--
Q 041576 499 FMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQS-- 576 (714)
Q Consensus 499 ~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~-- 576 (714)
|++. +|..++.....+...++..++.|++.|++|||+.| |.|||+|++|+++..+|.+||+|||.+........
T Consensus 402 ~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~ 477 (601)
T KOG0590|consen 402 YCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKN 477 (601)
T ss_pred cccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccCcchh
Confidence 9999 99999998778999999999999999999999999 99999999999999999999999999987654433
Q ss_pred -cceeeecCCCCccCcccccCCCCCc-hhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecch
Q 041576 577 -RTRTVIRGTRGYVAPEWFKNVPVSA-KVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDND 654 (714)
Q Consensus 577 -~~~~~~~gt~~y~aPE~~~~~~~s~-ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 654 (714)
.......|+..|+|||.+.+..|.+ ..||||.|+++..|++|+.||......+..- ......... ....
T Consensus 478 ~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~------~~~~~~~~~---~~~~ 548 (601)
T KOG0590|consen 478 IHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF------KTNNYSDQR---NIFE 548 (601)
T ss_pred hhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch------hhhcccccc---cccc
Confidence 4455678999999999999999876 6999999999999999999998654443211 000000000 0011
Q ss_pred hhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 655 KAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 655 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
-........+.+...++.+||+.||.+|.|+++|++.
T Consensus 549 ~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d 585 (601)
T KOG0590|consen 549 GPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND 585 (601)
T ss_pred ChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence 1111223344566779999999999999999999873
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.5e-20 Score=195.83 Aligned_cols=258 Identities=29% Similarity=0.368 Sum_probs=196.7
Q ss_pred hhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchh---hHHHHHHHHHHHhccCcc-cccceeceEecCCeeeEEE
Q 041576 422 NGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQE---REREFKTEVSAIGRTHHK-NLVQLLGFCDEGLNRLLVY 497 (714)
Q Consensus 422 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~-nIv~l~~~~~~~~~~~lv~ 497 (714)
+.+.+.||.|+|+.||++... ..+++|.+...... ....+.+|+..+..+.|+ +|+++.+++......++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~----~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 77 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR----KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVM 77 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec----cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEE
Confidence 445678999999999999865 78999998764332 367899999999999888 7999999997777789999
Q ss_pred eecCCCchhhhhhcCC---CCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCC-ceEEecCCCcccccc
Q 041576 498 EFMGNGTLANLLFAIP---RPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDF-TAKISDFGLSKLLLS 573 (714)
Q Consensus 498 E~~~~gsL~~~l~~~~---~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~-~~kl~Dfg~~~~~~~ 573 (714)
|++.++++.+++.... .+.......++.|++.++.|+|+.+ ++|||+||+||+++..+ .++++|||.+.....
T Consensus 78 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~ 154 (384)
T COG0515 78 EYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPD 154 (384)
T ss_pred ecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCC
Confidence 9999999998877664 6889999999999999999999998 99999999999999998 799999999986544
Q ss_pred Cccc-----ceeeecCCCCccCcccccC---CCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcC
Q 041576 574 DQSR-----TRTVIRGTRGYVAPEWFKN---VPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEG 645 (714)
Q Consensus 574 ~~~~-----~~~~~~gt~~y~aPE~~~~---~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~ 645 (714)
.... ......++..|+|||.+.+ ...+...|+||+|++++++++|..|+......................
T Consensus 155 ~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~- 233 (384)
T COG0515 155 PGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP- 233 (384)
T ss_pred CCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc-
Confidence 3322 2355679999999999987 578999999999999999999999976544310000011100000000
Q ss_pred ccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 646 KLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 646 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
.......... .......+.+++..++..+|..|.++.+....
T Consensus 234 ~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 234 SLASPLSPSN----PELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred ccccccCccc----cchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 0000000000 02223467778999999999999998887764
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.4e-22 Score=223.79 Aligned_cols=249 Identities=24% Similarity=0.282 Sum_probs=182.9
Q ss_pred hhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc-hhhHHHHHHHHHH--HhccCcccccceeceEecCCeeeEEE
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA-QEREREFKTEVSA--IGRTHHKNLVQLLGFCDEGLNRLLVY 497 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~--l~~l~h~nIv~l~~~~~~~~~~~lv~ 497 (714)
.+.+.+.||++.|=.|.+|+++ .|. |+||++-+.. .-..+.+.++++. ...++|||.+++.-.-......|||-
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~--eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvR 100 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDR--EGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVR 100 (1431)
T ss_pred ceeeecccCchhhhhhhhccCC--Cce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHH
Confidence 4556789999999999999876 454 9999885433 3334444444333 44569999999999888888889999
Q ss_pred eecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccc--cccCc
Q 041576 498 EFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKL--LLSDQ 575 (714)
Q Consensus 498 E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~--~~~~~ 575 (714)
+|..+ +|.|.|..++-+...+...|+.|++.||..+|..| |+|||||.+||||+.-.-+.|+||..-+. +..+.
T Consensus 101 qyvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDN 176 (1431)
T KOG1240|consen 101 QYVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDN 176 (1431)
T ss_pred HHHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCCC
Confidence 99987 99999999888899999999999999999999998 99999999999999999999999987653 23333
Q ss_pred ccceeee----cCCCCccCcccccC----------CC-CCchhhhHHHHHHHHHHHh-cCCCCcccccchhhhhhhHHHh
Q 041576 576 SRTRTVI----RGTRGYVAPEWFKN----------VP-VSAKVDVYSFGVVLLKIIC-CKRSVEMELGEERSAILTDWAY 639 (714)
Q Consensus 576 ~~~~~~~----~gt~~y~aPE~~~~----------~~-~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~l~~~~~ 639 (714)
......+ +.-..|+|||.+-. .. .+++.||||+||++.||++ |+++|.... .+ +
T Consensus 177 Padf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ------L~---a- 246 (1431)
T KOG1240|consen 177 PADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ------LL---A- 246 (1431)
T ss_pred cccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH------HH---h-
Confidence 2222222 23346999998743 12 6889999999999999988 577776321 11 0
Q ss_pred hhhhcCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 041576 640 DCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLE 693 (714)
Q Consensus 640 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 693 (714)
++.+. ....+ .....-+...+..++..|++.||++|.++++.|+.-.
T Consensus 247 --Yr~~~-~~~~e----~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~yr 293 (1431)
T KOG1240|consen 247 --YRSGN-ADDPE----QLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQKYR 293 (1431)
T ss_pred --HhccC-ccCHH----HHHHhCcCccHHHHHHHHHccCchhccCHHHHHHhhh
Confidence 11111 00000 0011112225677999999999999999999998743
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.7e-20 Score=183.23 Aligned_cols=175 Identities=12% Similarity=0.084 Sum_probs=135.0
Q ss_pred HHHHHHHhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHH---H------HHHHHHHHhccCccccccee
Q 041576 414 LVELNEATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQERER---E------FKTEVSAIGRTHHKNLVQLL 484 (714)
Q Consensus 414 ~~el~~at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~---~------~~~E~~~l~~l~h~nIv~l~ 484 (714)
..++...+|...+.+|.|+||.||++.. ++..+|+|.++.......+ . +++|+..+.+++|++|..+.
T Consensus 25 ~~~~l~~~y~~~~~l~~~~f~~v~l~~~---~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~ 101 (232)
T PRK10359 25 FDDFLSYNIKTIKVFRNIDDTKVSLIDT---DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLN 101 (232)
T ss_pred HHHHhhCceEEEEEecCCCceEEEEEec---CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcce
Confidence 3466777888899999999999998543 4668999999754332222 2 68999999999999999999
Q ss_pred ceEecC--------CeeeEEEeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECC
Q 041576 485 GFCDEG--------LNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQ 556 (714)
Q Consensus 485 ~~~~~~--------~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~ 556 (714)
+++... ...+++|||++|.+|.++.. .+. ....+++.+|..+|+.| ++|||+||+||+++.
T Consensus 102 d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~----~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~ 170 (232)
T PRK10359 102 DFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE----ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSK 170 (232)
T ss_pred EeeeecccccccccCCeEEEEEEECCccHHHhhh----ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeC
Confidence 886533 35789999999999988742 222 34669999999999998 999999999999999
Q ss_pred CCceEEecCCCccccccCcccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHH
Q 041576 557 DFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKII 616 (714)
Q Consensus 557 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ell 616 (714)
++ ++|+|||.......+.... .+.....+..++|||+||+.+..+.
T Consensus 171 ~g-i~liDfg~~~~~~e~~a~d-------------~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 171 NG-LRIIDLSGKRCTAQRKAKD-------------RIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CC-EEEEECCCcccccchhhHH-------------HHHHHhHhcccccccceeEeehHHH
Confidence 88 9999999887543222111 1333445667999999999987654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=6.4e-20 Score=178.63 Aligned_cols=139 Identities=18% Similarity=0.142 Sum_probs=109.6
Q ss_pred hhhhCcccceeEEEeEeeCCCCcEEEEEEecccchh--h------------------------HHHHHHHHHHHhccCcc
Q 041576 425 EEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQE--R------------------------EREFKTEVSAIGRTHHK 478 (714)
Q Consensus 425 ~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~--~------------------------~~~~~~E~~~l~~l~h~ 478 (714)
.+.||+|++|.||+|... +|++||||+++..... . ......|++.+.++.++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~--~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 79 (190)
T cd05147 2 NGCISTGKEANVYHATTA--NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTA 79 (190)
T ss_pred CCccccccceEEEEEECC--CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHC
Confidence 367999999999999875 7899999999653211 0 11234599999999888
Q ss_pred cccceeceEecCCeeeEEEeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHH-HhcCCCCeEecCCCcCeEEECCC
Q 041576 479 NLVQLLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYL-HEECNVPIIHCDIKPQNILLDQD 557 (714)
Q Consensus 479 nIv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yL-H~~~~~~ivH~Dlk~~NIll~~~ 557 (714)
++.....+.. ...+|||||++++++...+.....++......++.|++.+|.|| |+.+ |+||||||+||+++ +
T Consensus 80 ~v~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~-~ 153 (190)
T cd05147 80 GIPCPEPILL--KSHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH-D 153 (190)
T ss_pred CCCCCcEEEe--cCCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-C
Confidence 7744433322 22389999999988776544446788899999999999999999 6777 99999999999998 4
Q ss_pred CceEEecCCCcccc
Q 041576 558 FTAKISDFGLSKLL 571 (714)
Q Consensus 558 ~~~kl~Dfg~~~~~ 571 (714)
+.++|+|||++...
T Consensus 154 ~~v~LiDFG~a~~~ 167 (190)
T cd05147 154 GKLYIIDVSQSVEH 167 (190)
T ss_pred CcEEEEEccccccC
Confidence 78999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.2e-19 Score=171.93 Aligned_cols=206 Identities=22% Similarity=0.259 Sum_probs=172.3
Q ss_pred HHHHHhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCc-ccccceeceEecCCeee
Q 041576 416 ELNEATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHH-KNLVQLLGFCDEGLNRL 494 (714)
Q Consensus 416 el~~at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~nIv~l~~~~~~~~~~~ 494 (714)
.+....|.+.++||+|+||.+|.|..- .+|..||||.-+.... ..++..|..+...++| ..|..+.-+..++..-.
T Consensus 11 ~iv~gky~lvrkiGsGSFGdIy~~~~i-~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynv 87 (341)
T KOG1163|consen 11 LIVGGKYKLVRKIGSGSFGDIYLGISI-TSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNV 87 (341)
T ss_pred heeccceEEEEeecCCchhheeeeeec-cCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccce
Confidence 445567888999999999999999865 6899999998765332 3467778888888865 67888888889999999
Q ss_pred EEEeecCCCchhhhhhc-CCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECC---CCceEEecCCCccc
Q 041576 495 LVYEFMGNGTLANLLFA-IPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQ---DFTAKISDFGLSKL 570 (714)
Q Consensus 495 lv~E~~~~gsL~~~l~~-~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~---~~~~kl~Dfg~~~~ 570 (714)
+||+.. |.+|+++..- .+.++.++.+-++-|++.-++|+|.++ ++||||||+|+|+.- ...+.|+|||+++.
T Consensus 88 lVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKk 163 (341)
T KOG1163|consen 88 LVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKK 163 (341)
T ss_pred eeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhh
Confidence 999988 6699999874 367899999999999999999999998 999999999999964 35799999999998
Q ss_pred cccCcc------cceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccc
Q 041576 571 LLSDQS------RTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGE 628 (714)
Q Consensus 571 ~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~ 628 (714)
..+... .......||.+|.+-....+.+-+.+.|+=|+|.+|..+.-|..||......
T Consensus 164 y~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~ 227 (341)
T KOG1163|consen 164 YRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAA 227 (341)
T ss_pred hccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchh
Confidence 754322 2334456999999999888888899999999999999999999999876544
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=6.3e-19 Score=172.21 Aligned_cols=141 Identities=17% Similarity=0.114 Sum_probs=111.9
Q ss_pred hhhhCcccceeEEEeEeeCCCCcEEEEEEecccchh--------------------------hHHHHHHHHHHHhccCcc
Q 041576 425 EEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQE--------------------------REREFKTEVSAIGRTHHK 478 (714)
Q Consensus 425 ~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~--------------------------~~~~~~~E~~~l~~l~h~ 478 (714)
...||+|++|.||+|... +|+.||||+++..... ....+..|.+.+.++.|+
T Consensus 2 ~~~ig~G~~~~Vy~a~~~--~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 79 (190)
T cd05145 2 NGCISTGKEANVYHARTG--DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA 79 (190)
T ss_pred CceeecCCCcEEEEEEcC--CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence 467999999999999875 7899999998753210 012346789999999999
Q ss_pred cccceeceEecCCeeeEEEeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHh-cCCCCeEecCCCcCeEEECCC
Q 041576 479 NLVQLLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHE-ECNVPIIHCDIKPQNILLDQD 557 (714)
Q Consensus 479 nIv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~-~~~~~ivH~Dlk~~NIll~~~ 557 (714)
++.....+... ..++||||++++++.........++......++.|++.+|.+||+ .| |+||||||+||+++ +
T Consensus 80 ~i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~-~ 153 (190)
T cd05145 80 GVPVPEPILLK--KNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH-D 153 (190)
T ss_pred CCCCceEEEec--CCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-C
Confidence 88555444333 248999999988654443333567788899999999999999999 87 99999999999999 8
Q ss_pred CceEEecCCCcccccc
Q 041576 558 FTAKISDFGLSKLLLS 573 (714)
Q Consensus 558 ~~~kl~Dfg~~~~~~~ 573 (714)
+.++|+|||++.....
T Consensus 154 ~~~~liDFG~a~~~~~ 169 (190)
T cd05145 154 GKPYIIDVSQAVELDH 169 (190)
T ss_pred CCEEEEEcccceecCC
Confidence 8999999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=3.1e-19 Score=192.08 Aligned_cols=218 Identities=23% Similarity=0.383 Sum_probs=164.6
Q ss_pred HhccCcccccceeceEecCCeeeEEEeecCCCchhhhhhc-CCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcC
Q 041576 472 IGRTHHKNLVQLLGFCDEGLNRLLVYEFMGNGTLANLLFA-IPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQ 550 (714)
Q Consensus 472 l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~-~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~ 550 (714)
|+.+.|.|+.+++|.+.++...++|.+|+..|+|.+.+.. ...+++.....++++|++||+|||+.. -..|+.+++.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~s~ 78 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALKSS 78 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeeccc
Confidence 4578999999999999999999999999999999999987 457899999999999999999999975 2299999999
Q ss_pred eEEECCCCceEEecCCCccccccCc-ccceeeecCCCCccCcccccCC-------CCCchhhhHHHHHHHHHHHhcCCCC
Q 041576 551 NILLDQDFTAKISDFGLSKLLLSDQ-SRTRTVIRGTRGYVAPEWFKNV-------PVSAKVDVYSFGVVLLKIICCKRSV 622 (714)
Q Consensus 551 NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-------~~s~ksDVwSlGvil~elltG~~p~ 622 (714)
|.++|....+||+|||+........ ........-..-|.|||.++.. ..+.++||||||++++|+++.+.||
T Consensus 79 nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~ 158 (484)
T KOG1023|consen 79 NCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF 158 (484)
T ss_pred cceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence 9999999999999999988764311 1111112234569999999763 2577899999999999999999999
Q ss_pred cccccchhhhhhhHHHhhhhhcCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCC
Q 041576 623 EMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLEV 698 (714)
Q Consensus 623 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 698 (714)
...........+.... ..+ -...+.+..... .+....+..++..||..+|++||++++|-..++.+...
T Consensus 159 ~~~~~~~~~~eii~~~----~~~-~~~~~rP~i~~~--~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~ 227 (484)
T KOG1023|consen 159 DLRNLVEDPDEIILRV----KKG-GSNPFRPSIELL--NELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG 227 (484)
T ss_pred ccccccCChHHHHHHH----Hhc-CCCCcCcchhhh--hhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence 8654333221121111 110 011111111111 13333688899999999999999999999998876654
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.79 E-value=6.2e-19 Score=178.79 Aligned_cols=228 Identities=22% Similarity=0.290 Sum_probs=146.8
Q ss_pred hhhhhCcccceeEEEeEeeCCCCcEEEEEEecc---cchhhHHHHHHHHHHHhccC----------cccccceeceEe--
Q 041576 424 FEEELGRGSFGIVYKGVLKSASGNAVAVKKLDK---LAQEREREFKTEVSAIGRTH----------HKNLVQLLGFCD-- 488 (714)
Q Consensus 424 ~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~----------h~nIv~l~~~~~-- 488 (714)
..+.||.|+++.||.+++. .++++++||.+.- ......+++++|.-....+. |-.++-.++...
T Consensus 16 ~~~~i~~g~~~~v~~v~d~-~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~ 94 (288)
T PF14531_consen 16 RGRIIGKGGFSIVFEVTDV-ETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIP 94 (288)
T ss_dssp EEEEEEEETTEEEEEEEET-TTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEET
T ss_pred EccccccCCceEEEEEEEc-cCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEc
Confidence 3468999999999999976 5789999998743 23344567777776555532 222332233221
Q ss_pred -------cC---C-----eeeEEEeecCCCchhhhhhc---CCC----CChhhHHHHHHHHHHHHHHHHhcCCCCeEecC
Q 041576 489 -------EG---L-----NRLLVYEFMGNGTLANLLFA---IPR----PDWSLRVRISLEIARGLLYLHEECNVPIIHCD 546 (714)
Q Consensus 489 -------~~---~-----~~~lv~E~~~~gsL~~~l~~---~~~----~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~D 546 (714)
.. . ..+++|+-+. ++|.+++.. ... +....++.+..|+++.+++||+.| ++|+|
T Consensus 95 ~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVHgd 170 (288)
T PF14531_consen 95 GKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVHGD 170 (288)
T ss_dssp TS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEEST
T ss_pred CCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEecc
Confidence 11 1 2356777774 588877642 211 234455677799999999999999 99999
Q ss_pred CCcCeEEECCCCceEEecCCCccccccCcccceeeecCCCCccCcccccC--------CCCCchhhhHHHHHHHHHHHhc
Q 041576 547 IKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKN--------VPVSAKVDVYSFGVVLLKIICC 618 (714)
Q Consensus 547 lk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~s~ksDVwSlGvil~elltG 618 (714)
|+|+|++++.+|.++|+||+........... ...+..|.+||.... ..++.+.|.|++|+++|.|.++
T Consensus 171 i~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~ 246 (288)
T PF14531_consen 171 IKPENFLLDQDGGVFLGDFSSLVRAGTRYRC----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCG 246 (288)
T ss_dssp -SGGGEEE-TTS-EEE--GGGEEETTEEEEG----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHS
T ss_pred cceeeEEEcCCCCEEEcChHHHeecCceeec----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHc
Confidence 9999999999999999999877654322111 234578999997743 2578899999999999999999
Q ss_pred CCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhhccchHHHHHHHHHHHHccccCCCCC
Q 041576 619 KRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKR 682 (714)
Q Consensus 619 ~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 682 (714)
+.||........... .-..+. ..++.+..+|..+|+++|.+|
T Consensus 247 ~lPf~~~~~~~~~~~---------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 247 RLPFGLSSPEADPEW---------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp S-STCCCGGGSTSGG---------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred cCCCCCCCccccccc---------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 999986543321110 111233 566778889999999999988
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.5e-18 Score=170.31 Aligned_cols=202 Identities=21% Similarity=0.300 Sum_probs=170.7
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhcc-CcccccceeceEecCCeeeEEEe
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRT-HHKNLVQLLGFCDEGLNRLLVYE 498 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~E 498 (714)
-.|.+.++||+|.||.++.|..- -++++||||.-... ...-++..|.+..+.| ..++|...+.+-.++.+-.||+|
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl-~nne~VAIKfEPrk--S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVid 104 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNL-YNNEPVAIKFEPRK--SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVID 104 (449)
T ss_pred ccceeccccccCcceeeeccccc-ccCceEEEEecccc--CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhh
Confidence 45778899999999999999854 57899999986432 2334778888888888 57999999999899999999999
Q ss_pred ecCCCchhhhhhc-CCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECC-----CCceEEecCCCccccc
Q 041576 499 FMGNGTLANLLFA-IPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQ-----DFTAKISDFGLSKLLL 572 (714)
Q Consensus 499 ~~~~gsL~~~l~~-~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~-----~~~~kl~Dfg~~~~~~ 572 (714)
.+ |-+|+|+..- .++++.+.+.-||.|++.-++|+|++. +|.|||||+|+||.. ...+.|+|||+|+...
T Consensus 105 LL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Yr 180 (449)
T KOG1165|consen 105 LL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYR 180 (449)
T ss_pred hh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhhhc
Confidence 88 5699998864 367999999999999999999999998 999999999999964 3468999999999875
Q ss_pred cCcc------cceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccc
Q 041576 573 SDQS------RTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGE 628 (714)
Q Consensus 573 ~~~~------~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~ 628 (714)
+... .......||.+||+-....+.+-+.+.|.=|+|-++...|-|..||......
T Consensus 181 Dp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~ 242 (449)
T KOG1165|consen 181 DPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAD 242 (449)
T ss_pred CccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCc
Confidence 4332 2233456999999999999999999999999999999999999999876544
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=6.9e-18 Score=162.57 Aligned_cols=184 Identities=15% Similarity=0.072 Sum_probs=138.7
Q ss_pred hhhhCcccceeEEEeEeeCCCCcEEEEEEecccchh----hHHHHHHHHHHHhccC-cccccceeceEecCCeeeEEEee
Q 041576 425 EEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQE----REREFKTEVSAIGRTH-HKNLVQLLGFCDEGLNRLLVYEF 499 (714)
Q Consensus 425 ~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~E~ 499 (714)
...|++|+||+||.+. .++.+++.+.+.....- ....+.+|+++|++++ |+++++++++ +..+++|||
T Consensus 7 ~~~l~~~~f~~v~~~~---~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 7 NEPLKSDTFGRILLVR---GGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ceeecCCCcceEEEee---cCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 4679999999999754 36788888887654331 1235889999999994 5889999886 456999999
Q ss_pred cCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCC-CcCeEEECCCCceEEecCCCccccccCccc-
Q 041576 500 MGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDI-KPQNILLDQDFTAKISDFGLSKLLLSDQSR- 577 (714)
Q Consensus 500 ~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dl-k~~NIll~~~~~~kl~Dfg~~~~~~~~~~~- 577 (714)
+.|.+|...+.. ....++.|++++|.++|++| |+|||| ||+|||++.++.++|+|||++.........
T Consensus 80 I~G~~L~~~~~~-------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~ 149 (218)
T PRK12274 80 LAGAAMYQRPPR-------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWM 149 (218)
T ss_pred ecCccHHhhhhh-------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHH
Confidence 999998754321 12457889999999999998 999999 799999999999999999999855432210
Q ss_pred ---c--------eeeecCCCCccCcccccCC-CCC-chhhhHHHHHHHHHHHhcCCCCccc
Q 041576 578 ---T--------RTVIRGTRGYVAPEWFKNV-PVS-AKVDVYSFGVVLLKIICCKRSVEME 625 (714)
Q Consensus 578 ---~--------~~~~~gt~~y~aPE~~~~~-~~s-~ksDVwSlGvil~elltG~~p~~~~ 625 (714)
. ......++.|++|+...-. ..+ ...+-++-|.-+|.++|++.+.-..
T Consensus 150 r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 150 RLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred HHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 0 0012256778888755432 233 5678889999999999999886543
|
|
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=99.75 E-value=2e-19 Score=158.72 Aligned_cols=79 Identities=37% Similarity=0.541 Sum_probs=51.2
Q ss_pred CCeeEEeeCCCCCCcccCCccEEEEcccc-eEEeCCCCCeEEec-CC---------------------------Cccccc
Q 041576 72 ERTIIWHANEDNHPVLAPRGSTLELTATG-LLLKDPGGQAIWDE-KP---------------------------NKISFK 122 (714)
Q Consensus 72 ~~t~vW~Anr~~p~~~~~~~~~l~~~~~g-lvl~d~~~~~vWst-~~---------------------------~~qSFd 122 (714)
++||||+|||++|+.......+|.|+.|| |||.|.+|+++|+| +. .|||||
T Consensus 1 ~~tvvW~an~~~p~~~~s~~~~L~l~~dGnLvl~~~~~~~iWss~~t~~~~~~~~~~~L~~~GNlvl~d~~~~~lW~Sf~ 80 (114)
T PF01453_consen 1 PRTVVWVANRNSPLTSSSGNYTLILQSDGNLVLYDSNGSVIWSSNNTSGRGNSGCYLVLQDDGNLVLYDSSGNVLWQSFD 80 (114)
T ss_dssp ---------TTEEEEECETTEEEEEETTSEEEEEETTTEEEEE--S-TTSS-SSEEEEEETTSEEEEEETTSEEEEESTT
T ss_pred CcccccccccccccccccccccceECCCCeEEEEcCCCCEEEEecccCCccccCeEEEEeCCCCEEEEeecceEEEeecC
Confidence 48999999999973211245899999999 99999999999999 31 199999
Q ss_pred CCCCCcCCcceeccC------ceEEecCCCCCCC
Q 041576 123 SPTDTILPTQIFDLG------SVLVSRLTETNLS 150 (714)
Q Consensus 123 ~PtDTlLp~~~l~~~------~~l~S~~s~~dps 150 (714)
|||||+||+|+|+.+ ..++||++.+|||
T Consensus 81 ~ptdt~L~~q~l~~~~~~~~~~~~~sw~s~~dps 114 (114)
T PF01453_consen 81 YPTDTLLPGQKLGDGNVTGKNDSLTSWSSNTDPS 114 (114)
T ss_dssp SSS-EEEEEET--TSEEEEESTSSEEEESS----
T ss_pred CCccEEEeccCcccCCCccccceEEeECCCCCCC
Confidence 999999999999873 3499999999997
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.8e-17 Score=190.44 Aligned_cols=202 Identities=23% Similarity=0.231 Sum_probs=161.5
Q ss_pred cCHHHHHHHhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccC---cccccceeceEe
Q 041576 412 FSLVELNEATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTH---HKNLVQLLGFCD 488 (714)
Q Consensus 412 ~~~~el~~at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~nIv~l~~~~~ 488 (714)
.+.-++....+.+.+.||+|+||+||+|... +|+.||+|+-+....- +|---.+++.||+ -+-|..+...+.
T Consensus 690 ~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~--~~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~ 764 (974)
T KOG1166|consen 690 NTEFEVGGEKFCISKEIGEGSYGSVYVATHS--NGKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHV 764 (974)
T ss_pred cceeeecceeEEEEeeeccccceEEEEeecC--CCcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHc
Confidence 3445666677778899999999999999986 4999999988653321 1111222333333 244556666666
Q ss_pred cCCeeeEEEeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEEC-------CCCceE
Q 041576 489 EGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLD-------QDFTAK 561 (714)
Q Consensus 489 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~-------~~~~~k 561 (714)
-.+..+||+||.+.|+|.++++..+.+++.....++.|+++.+.+||..+ ||||||||+|+||. ++..++
T Consensus 765 ~~~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~ 841 (974)
T KOG1166|consen 765 FQNASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLY 841 (974)
T ss_pred cCCcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceE
Confidence 77788999999999999999999899999999999999999999999998 99999999999993 245699
Q ss_pred EecCCCccccccC-cccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCC
Q 041576 562 ISDFGLSKLLLSD-QSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRS 621 (714)
Q Consensus 562 l~Dfg~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p 621 (714)
|+|||.+-.+.-- .........+|-.+-.+|...+.+++..+|.|.++.+++-||.|+.-
T Consensus 842 lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 842 LIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred EEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 9999998755321 12345566789999999999999999999999999999999999764
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=3.2e-17 Score=161.09 Aligned_cols=133 Identities=18% Similarity=0.242 Sum_probs=105.3
Q ss_pred hhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhcc-----CcccccceeceEecCC---e-eeEE
Q 041576 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRT-----HHKNLVQLLGFCDEGL---N-RLLV 496 (714)
Q Consensus 426 ~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~nIv~l~~~~~~~~---~-~~lv 496 (714)
+.||+|+++.||. +. .++.. +||++........+.+.+|+.+++++ +||||++++|++.++. . ..+|
T Consensus 8 ~~LG~G~~~~Vy~--hp-~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I 83 (210)
T PRK10345 8 SPLGTGRHRKCYA--HP-EDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVI 83 (210)
T ss_pred ceecCCCceEEEE--CC-CCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEE
Confidence 6799999999996 33 24444 69988764444567899999999999 5799999999998874 3 3378
Q ss_pred Eee--cCCCchhhhhhcCCCCChhhHHHHHHHHHHHH-HHHHhcCCCCeEecCCCcCeEEECC----CCceEEecCCCc
Q 041576 497 YEF--MGNGTLANLLFAIPRPDWSLRVRISLEIARGL-LYLHEECNVPIIHCDIKPQNILLDQ----DFTAKISDFGLS 568 (714)
Q Consensus 497 ~E~--~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L-~yLH~~~~~~ivH~Dlk~~NIll~~----~~~~kl~Dfg~~ 568 (714)
+|| +++++|.+++... .+++. ..++.|++.++ +|||+++ |+||||||+||+++. +..++|+||+.+
T Consensus 84 ~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 84 ADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred ecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 999 5579999999763 44444 45678888887 9999998 999999999999974 348999995444
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.1e-17 Score=167.13 Aligned_cols=196 Identities=22% Similarity=0.271 Sum_probs=139.4
Q ss_pred CcccccceeceEec---------------------------CCeeeEEEeecCCCchhhhhhcCCCCChhhHHHHHHHHH
Q 041576 476 HHKNLVQLLGFCDE---------------------------GLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIA 528 (714)
Q Consensus 476 ~h~nIv~l~~~~~~---------------------------~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~ 528 (714)
+|||||++.++|.+ +...|+||..++. +|+.++..+ ..+.....-|+.|++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~-~~s~r~~~~~laQlL 351 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTR-HRSYRTGRVILAQLL 351 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcC-CCchHHHHHHHHHHH
Confidence 59999999988743 2345899988876 999999764 445666777899999
Q ss_pred HHHHHHHhcCCCCeEecCCCcCeEEE--CCCC--ceEEecCCCccccccCc-----ccceeeecCCCCccCcccccCCC-
Q 041576 529 RGLLYLHEECNVPIIHCDIKPQNILL--DQDF--TAKISDFGLSKLLLSDQ-----SRTRTVIRGTRGYVAPEWFKNVP- 598 (714)
Q Consensus 529 ~~L~yLH~~~~~~ivH~Dlk~~NIll--~~~~--~~kl~Dfg~~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~- 598 (714)
+|+.|||.+| |.|||+|++|||+ |+|+ .+.|+|||.+..-.... ........|...-||||+....+
T Consensus 352 Eav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PG 428 (598)
T KOG4158|consen 352 EAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPG 428 (598)
T ss_pred HHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCC
Confidence 9999999999 9999999999999 3443 57899999886433211 11122234677899999986432
Q ss_pred ----C-CchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhhccchHHHHHHHHHHHH
Q 041576 599 ----V-SAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMADKSRACKWLMIALW 673 (714)
Q Consensus 599 ----~-s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 673 (714)
+ -.|+|.|+.|.+.||+++...||....+. .+... .+.+..+..+ +...+..+.+++..
T Consensus 429 p~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem----~L~~r---~Yqe~qLPal---------p~~vpp~~rqlV~~ 492 (598)
T KOG4158|consen 429 PNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEM----LLDTR---TYQESQLPAL---------PSRVPPVARQLVFD 492 (598)
T ss_pred CceeeccchhhhhhhhhhHHHHhccCCcccccchh----eechh---hhhhhhCCCC---------cccCChHHHHHHHH
Confidence 1 24899999999999999999999862211 11111 1222222222 22334466778999
Q ss_pred ccccCCCCCCCHHHHHHHH
Q 041576 674 CIQEDPLKRPAMKMIVQML 692 (714)
Q Consensus 674 cl~~dP~~RPs~~evl~~L 692 (714)
.|+.||++|++..-....|
T Consensus 493 lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 493 LLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred HhcCCccccCCccHHHhHH
Confidence 9999999999887665554
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.71 E-value=7.2e-17 Score=162.58 Aligned_cols=143 Identities=22% Similarity=0.215 Sum_probs=111.5
Q ss_pred hhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchh------------------------hHHHHHHHHHHHhccCc
Q 041576 422 NGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQE------------------------REREFKTEVSAIGRTHH 477 (714)
Q Consensus 422 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~h 477 (714)
+.+.+.||+|++|.||+|.+...+|+.||+|.++..... ....+..|++.+.++.+
T Consensus 30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~ 109 (237)
T smart00090 30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE 109 (237)
T ss_pred HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence 556789999999999999833357899999998643210 11246789999999975
Q ss_pred cc--ccceeceEecCCeeeEEEeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEEC
Q 041576 478 KN--LVQLLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLD 555 (714)
Q Consensus 478 ~n--Iv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~ 555 (714)
.. +.++++. ...++||||+++.+|.............+...++.||+.+|++||+.+ .++||||||+||+++
T Consensus 110 ~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dikp~NIli~ 183 (237)
T smart00090 110 AGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLSEYNILVH 183 (237)
T ss_pred cCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCChhhEEEE
Confidence 33 3444432 235899999999888776644455566677899999999999999986 499999999999999
Q ss_pred CCCceEEecCCCcccc
Q 041576 556 QDFTAKISDFGLSKLL 571 (714)
Q Consensus 556 ~~~~~kl~Dfg~~~~~ 571 (714)
++.++|+|||.+...
T Consensus 184 -~~~i~LiDFg~a~~~ 198 (237)
T smart00090 184 -DGKVVIIDVSQSVEL 198 (237)
T ss_pred -CCCEEEEEChhhhcc
Confidence 889999999998754
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.70 E-value=2.4e-18 Score=184.82 Aligned_cols=227 Identities=24% Similarity=0.227 Sum_probs=177.9
Q ss_pred hhCcccceeEEEeEe--eCCCCcEEEEEEecccchh--hHHHHHHHHHHHhccC-cccccceeceEecCCeeeEEEeecC
Q 041576 427 ELGRGSFGIVYKGVL--KSASGNAVAVKKLDKLAQE--REREFKTEVSAIGRTH-HKNLVQLLGFCDEGLNRLLVYEFMG 501 (714)
Q Consensus 427 ~ig~G~~g~Vy~~~~--~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~E~~~ 501 (714)
.+|+|++|.|+++.- ....+..+++|.+++.... .......|-.++...+ ||.++++...+..+...+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 368999999987532 1124567888887652211 1114556777788886 9999999999999999999999999
Q ss_pred CCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcccceee
Q 041576 502 NGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTV 581 (714)
Q Consensus 502 ~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 581 (714)
+|.|...+.....+++.........++-+++++|+.+ ++|||+|++||+++.+|++++.|||+.+..-.....
T Consensus 81 gg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~---- 153 (612)
T KOG0603|consen 81 GGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA---- 153 (612)
T ss_pred cchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhhc----
Confidence 9999999998888888888889999999999999998 999999999999999999999999999865433322
Q ss_pred ecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhhccch
Q 041576 582 IRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMADK 661 (714)
Q Consensus 582 ~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 661 (714)
+||..|||||++. ....++|-||||++++||+||..||..+ ....+ .. .....+.
T Consensus 154 -cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~~----~~~~I----------------l~--~~~~~p~ 208 (612)
T KOG0603|consen 154 -CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGGD----TMKRI----------------LK--AELEMPR 208 (612)
T ss_pred -ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCchH----HHHHH----------------hh--hccCCch
Confidence 6899999999998 5688999999999999999999999751 10011 00 1112344
Q ss_pred HHHHHHHHHHHHccccCCCCCCCH
Q 041576 662 SRACKWLMIALWCIQEDPLKRPAM 685 (714)
Q Consensus 662 ~~~~~l~~li~~cl~~dP~~RPs~ 685 (714)
........++..++..+|..|--.
T Consensus 209 ~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 209 ELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred hhhHHHHHHHHHHHhhCHHHHhcc
Confidence 455566667888888888888644
|
|
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.70 E-value=7.2e-17 Score=143.73 Aligned_cols=76 Identities=29% Similarity=0.511 Sum_probs=67.9
Q ss_pred CCCeEeeCCCeeeeeeecCCCCCCceEEEEEeecCCCCeeEEeeCCCCCCcccCCccEEEEcccc-eEEeCCCCCeEEec
Q 041576 36 NNSSWISPSRDFAFGFRQLNNNSDLFLLAIWFNKMPERTIIWHANEDNHPVLAPRGSTLELTATG-LLLKDPGGQAIWDE 114 (714)
Q Consensus 36 ~~~~l~S~~g~F~lgFf~~~~~~~~~ylgIw~~~~~~~t~vW~Anr~~p~~~~~~~~~l~~~~~g-lvl~d~~~~~vWst 114 (714)
++++|+|+++.|++|||++..+. .++.+|||.+++ +++||.|||+.| ....+.|.|+.|| |+|.|.+|.+||+|
T Consensus 6 ~~~~l~s~~~~f~~G~~~~~~q~-~dgnlv~~~~~~-~~~vW~snt~~~---~~~~~~l~l~~dGnLvl~~~~g~~vW~S 80 (116)
T cd00028 6 SGQTLVSSGSLFELGFFKLIMQS-RDYNLILYKGSS-RTVVWVANRDNP---SGSSCTLTLQSDGNLVIYDGSGTVVWSS 80 (116)
T ss_pred CCCEEEeCCCcEEEecccCCCCC-CeEEEEEEeCCC-CeEEEECCCCCC---CCCCEEEEEecCCCeEEEcCCCcEEEEe
Confidence 57899999999999999997654 389999999887 899999999986 3667889999999 99999999999999
Q ss_pred CC
Q 041576 115 KP 116 (714)
Q Consensus 115 ~~ 116 (714)
+.
T Consensus 81 ~~ 82 (116)
T cd00028 81 NT 82 (116)
T ss_pred cc
Confidence 84
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >PF00954 S_locus_glycop: S-locus glycoprotein family; InterPro: IPR000858 In Brassicaceae, self-incompatible plants have a self/non-self recognition system, which involves the inability of flowering plants to achieve self-fertilisation | Back alignment and domain information |
|---|
Probab=99.69 E-value=5.1e-17 Score=143.07 Aligned_cols=79 Identities=32% Similarity=0.611 Sum_probs=66.3
Q ss_pred ccccCCCcceeeE------EEEeeeeeccceEEEEeecCCCCCCCCeEEEeecCcccccccccCCCcCccCCCcccccCC
Q 041576 184 TCSANSSESGINY------LLFRATLDFDGVFTEYAYPKNSAPNQSWFTIQRLPNNICTSISDEFGSGACGFNSYCLLQN 257 (714)
Q Consensus 184 ~~~~~~~~~~~~~------~~~~~~~~~~G~~~~~~~~~~~~~~~~w~~~~~~p~d~Cd~y~~~~~~~~CG~~g~C~~~~ 257 (714)
.++.+..+.+++| .++|++||.+|++|+|.| .+.+++|...|.+|.|+||+| +.||+||+|+. +
T Consensus 26 ~fv~~~~e~~~t~~~~~~s~~~r~~ld~~G~l~~~~w---~~~~~~W~~~~~~p~d~Cd~y------~~CG~~g~C~~-~ 95 (110)
T PF00954_consen 26 SFVSNNEEVYYTYSLSNSSVLSRLVLDSDGQLQRYIW---NESTQSWSVFWSAPKDQCDVY------GFCGPNGICNS-N 95 (110)
T ss_pred EEEECCCeEEEEEecCCCceEEEEEEeeeeEEEEEEE---ecCCCcEEEEEEecccCCCCc------cccCCccEeCC-C
Confidence 3344555555555 467999999999999999 555789999999999999996 99999999975 4
Q ss_pred CCCcccCCCCCcccC
Q 041576 258 GRPFCECPPEYLFVD 272 (714)
Q Consensus 258 ~~~~C~C~~gf~~~~ 272 (714)
..|.|+||+||+|++
T Consensus 96 ~~~~C~Cl~GF~P~n 110 (110)
T PF00954_consen 96 NSPKCSCLPGFEPKN 110 (110)
T ss_pred CCCceECCCCcCCCc
Confidence 688999999999874
|
This is sporophytically controlled by multiple alleles at a single locus (S). There are a total of 50 different S alleles in Brassica oleracea. S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles []. Most of the proteins within this family contain apple-like domain (IPR003609 from INTERPRO), which is predicted to possess protein- and/or carbohydrate-binding functions.; GO: 0048544 recognition of pollen |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.6e-16 Score=156.61 Aligned_cols=134 Identities=22% Similarity=0.289 Sum_probs=114.0
Q ss_pred hhhCcccceeEEEeEeeCCCCcEEEEEEecccc--------hhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEE
Q 041576 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA--------QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVY 497 (714)
Q Consensus 426 ~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 497 (714)
+.||+|++|.||+|.. .+..+++|+..... ......+.+|++++..++|++|.....++......+++|
T Consensus 2 ~~l~~G~~~~vy~~~~---~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~ 78 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF---LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVM 78 (211)
T ss_pred cccccCceEEEEEEee---CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEE
Confidence 5789999999999986 47789999765321 112346789999999999999988888887778889999
Q ss_pred eecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccc
Q 041576 498 EFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKL 570 (714)
Q Consensus 498 E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~ 570 (714)
||+++++|.+++..... .+..++.+++.+|.+||+.+ ++|+|++|+||+++ ++.++|+|||.+..
T Consensus 79 e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 79 EYIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999999865332 78899999999999999998 99999999999999 78999999998864
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.67 E-value=2.1e-17 Score=174.41 Aligned_cols=170 Identities=25% Similarity=0.330 Sum_probs=128.2
Q ss_pred eeeEEEeecCCCchhhhhhcCC---CCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCc
Q 041576 492 NRLLVYEFMGNGTLANLLFAIP---RPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLS 568 (714)
Q Consensus 492 ~~~lv~E~~~~gsL~~~l~~~~---~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~ 568 (714)
..++.|+++...+|.++|..++ ..++...+.++.|++.|+.| ++ .+|+|+||.||++..+..+||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhe
Confidence 4689999999999999997654 45778889999999999999 65 999999999999999999999999999
Q ss_pred cccccCc-----ccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccchhhhhhhHHHhhhh
Q 041576 569 KLLLSDQ-----SRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEERSAILTDWAYDCY 642 (714)
Q Consensus 569 ~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~ 642 (714)
....... ....+...||..||+||.+.+..|+.|+||||||++|+||+. -...++- .. ....+
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er------~~-----t~~d~ 472 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER------IA-----TLTDI 472 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH------HH-----hhhhh
Confidence 8775544 334455679999999999999999999999999999999986 2222211 01 11122
Q ss_pred hcCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHH
Q 041576 643 VEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKM 687 (714)
Q Consensus 643 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e 687 (714)
.++.+. +......+ .-..++.+++.+.|.+||++.+
T Consensus 473 r~g~ip----~~~~~d~p-----~e~~ll~~lls~~p~~RP~~~~ 508 (516)
T KOG1033|consen 473 RDGIIP----PEFLQDYP-----EEYTLLQQLLSPSPEERPSAIE 508 (516)
T ss_pred hcCCCC----hHHhhcCc-----HHHHHHHHhcCCCcccCchHHH
Confidence 222222 11111111 2234888999999999995444
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.66 E-value=7.7e-16 Score=151.60 Aligned_cols=137 Identities=20% Similarity=0.158 Sum_probs=108.7
Q ss_pred hhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccch----------------------hhHHHHHHHHHHHhccCccc
Q 041576 422 NGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQ----------------------EREREFKTEVSAIGRTHHKN 479 (714)
Q Consensus 422 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~E~~~l~~l~h~n 479 (714)
+.+.+.||+|+||.||++..+ +|+.||||+++.... ........|+..+..+.|++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 94 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDP--DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG 94 (198)
T ss_pred hhcCCccccCcceEEEEEEcC--CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence 667789999999999999875 689999998753210 01123678899999998874
Q ss_pred --ccceeceEecCCeeeEEEeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCC
Q 041576 480 --LVQLLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQD 557 (714)
Q Consensus 480 --Iv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~ 557 (714)
+.+.++ ....++||||+++++|...... .....++.++++++.++|+.+ ++||||||+||+++++
T Consensus 95 i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p~Nill~~~ 161 (198)
T cd05144 95 FPVPKPID----WNRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHG---IIHGDLSEFNILVDDD 161 (198)
T ss_pred CCCCceee----cCCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCC---CCcCCCCcccEEEcCC
Confidence 444443 2345899999999998876431 345788999999999999988 9999999999999999
Q ss_pred CceEEecCCCcccccc
Q 041576 558 FTAKISDFGLSKLLLS 573 (714)
Q Consensus 558 ~~~kl~Dfg~~~~~~~ 573 (714)
+.++|+|||++.....
T Consensus 162 ~~~~liDfg~~~~~~~ 177 (198)
T cd05144 162 EKIYIIDWPQMVSTDH 177 (198)
T ss_pred CcEEEEECCccccCCC
Confidence 9999999999975533
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.66 E-value=6e-16 Score=152.50 Aligned_cols=130 Identities=22% Similarity=0.325 Sum_probs=107.5
Q ss_pred hhCcccceeEEEeEeeCCCCcEEEEEEecccc--------hhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEe
Q 041576 427 ELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA--------QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYE 498 (714)
Q Consensus 427 ~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E 498 (714)
.||+|++|.||+|.+ .+..+++|...... ......+.+|++++..++|+++.....++......++|||
T Consensus 1 ~ig~G~~~~vy~~~~---~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e 77 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF---LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVME 77 (199)
T ss_pred CCCCCceEEEEEeec---CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEE
Confidence 389999999999985 46789999864321 1123567899999999998887666666666777899999
Q ss_pred ecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccc
Q 041576 499 FMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKL 570 (714)
Q Consensus 499 ~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~ 570 (714)
|+++++|.+++..... .++.+++++|++||+.+ ++|+|++|+||+++ ++.++++|||++..
T Consensus 78 ~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 78 YIEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred EECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999999998755321 88999999999999998 99999999999999 88999999999864
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.63 E-value=2.3e-15 Score=170.71 Aligned_cols=133 Identities=20% Similarity=0.292 Sum_probs=109.8
Q ss_pred hhhhhhCcccceeEEEeEeeCCCCcEEEEEEe-ccc-------chhhHHHHHHHHHHHhccCcccccceeceEecCCeee
Q 041576 423 GFEEELGRGSFGIVYKGVLKSASGNAVAVKKL-DKL-------AQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRL 494 (714)
Q Consensus 423 ~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~-~~~-------~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 494 (714)
...+.||+|+||+||+|.+. +..+++|+. .+. .....+.+.+|++++.+++|++++....++......+
T Consensus 336 ~~~~~iG~G~~g~Vy~~~~~---~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~ 412 (535)
T PRK09605 336 IPDHLIGKGAEADIKKGEYL---GRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKT 412 (535)
T ss_pred CccceeccCCcEEEEEEeec---CccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCE
Confidence 34678999999999999875 334444432 211 1122356889999999999999998888888777889
Q ss_pred EEEeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccc
Q 041576 495 LVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKL 570 (714)
Q Consensus 495 lv~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~ 570 (714)
+||||+++++|.+++. ....++.+++++|+|||+.+ ++||||||+||++ +++.++|+|||+++.
T Consensus 413 lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 413 IVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred EEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 9999999999999885 45789999999999999998 9999999999999 678999999999975
|
|
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.62 E-value=1.6e-15 Score=134.76 Aligned_cols=75 Identities=29% Similarity=0.503 Sum_probs=66.2
Q ss_pred CCCeEeeCCCeeeeeeecCCCCCCceEEEEEeecCCCCeeEEeeCCCCCCcccCCccEEEEcccc-eEEeCCCCCeEEec
Q 041576 36 NNSSWISPSRDFAFGFRQLNNNSDLFLLAIWFNKMPERTIIWHANEDNHPVLAPRGSTLELTATG-LLLKDPGGQAIWDE 114 (714)
Q Consensus 36 ~~~~l~S~~g~F~lgFf~~~~~~~~~ylgIw~~~~~~~t~vW~Anr~~p~~~~~~~~~l~~~~~g-lvl~d~~~~~vWst 114 (714)
++++|+|+++.|++|||++... .++.+|||++.+ +++||+|||+.|. ..+..|.+.+|| |+|.|.+|.+||+|
T Consensus 6 ~~~~l~s~~~~f~~G~~~~~~q--~dgnlV~~~~~~-~~~vW~snt~~~~---~~~~~l~l~~dGnLvl~~~~g~~vW~S 79 (114)
T smart00108 6 SGQTLVSGNSLFELGFFTLIMQ--NDYNLILYKSSS-RTVVWVANRDNPV---SDSCTLTLQSDGNLVLYDGDGRVVWSS 79 (114)
T ss_pred CCCEEecCCCcEeeeccccCCC--CCEEEEEEECCC-CcEEEECCCCCCC---CCCEEEEEeCCCCEEEEeCCCCEEEEe
Confidence 5789999999999999999765 389999999887 8999999999872 334789999999 99999999999998
Q ss_pred CC
Q 041576 115 KP 116 (714)
Q Consensus 115 ~~ 116 (714)
+.
T Consensus 80 ~t 81 (114)
T smart00108 80 NT 81 (114)
T ss_pred cc
Confidence 75
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.61 E-value=3.8e-16 Score=175.78 Aligned_cols=203 Identities=24% Similarity=0.281 Sum_probs=141.1
Q ss_pred hhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEeecCCCc
Q 041576 425 EEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEFMGNGT 504 (714)
Q Consensus 425 ~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~gs 504 (714)
.+.|..|++|.||..+++ .+.+++|+| +.+.+- -+++ ++.....|.+| |+
T Consensus 88 IklisngAygavylvrh~-~trqrfa~k-iNkq~l----ilRn---ilt~a~npfvv---------------------gD 137 (1205)
T KOG0606|consen 88 IKLISNGAYGAVYLVRHK-ETRQRFAMK-INKQNL----ILRN---ILTFAGNPFVV---------------------GD 137 (1205)
T ss_pred eEeeccCCCCceeeeecc-ccccchhhc-ccccch----hhhc---cccccCCccee---------------------ch
Confidence 478999999999999876 456788884 332111 0011 22222333332 44
Q ss_pred hhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccC----------
Q 041576 505 LANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSD---------- 574 (714)
Q Consensus 505 L~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~---------- 574 (714)
=.+.+...+.+.... +.+++|||+.+ |+|||+||+|.+|+.-|++|+.|||+.+.....
T Consensus 138 c~tllk~~g~lPvdm--------vla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I 206 (1205)
T KOG0606|consen 138 CATLLKNIGPLPVDM--------VLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHI 206 (1205)
T ss_pred hhhhcccCCCCcchh--------hHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcch
Confidence 455555444443332 78999999998 999999999999999999999999998764221
Q ss_pred ----cccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCcccee
Q 041576 575 ----QSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVL 650 (714)
Q Consensus 575 ----~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 650 (714)
.......++||+.|+|||++....|....|-|++|+|+||.+-|..||..+..++....+... ...+.+
T Consensus 207 ~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd-~i~wpE------ 279 (1205)
T KOG0606|consen 207 EKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISD-DIEWPE------ 279 (1205)
T ss_pred HHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhh-hccccc------
Confidence 112223457999999999999999999999999999999999999999987665532222110 000111
Q ss_pred ecchhhhccchHHHHHHHHHHHHccccCCCCCC
Q 041576 651 VDNDKAAMADKSRACKWLMIALWCIQEDPLKRP 683 (714)
Q Consensus 651 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 683 (714)
.+.....+..+++.+.|+.+|..|-
T Consensus 280 --------~dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 280 --------EDEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred --------cCcCCCHHHHHHHHHHHHhChHhhc
Confidence 1223344677789999999999994
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.56 E-value=4.8e-16 Score=175.58 Aligned_cols=255 Identities=22% Similarity=0.299 Sum_probs=193.9
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc--hhhHHHHHHHHHHHhccC-cccccceeceEecCCeeeEE
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA--QEREREFKTEVSAIGRTH-HKNLVQLLGFCDEGLNRLLV 496 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lv 496 (714)
..+.+.+.||+|+++.|-...........+|+|.+.... .........|..+-+.+. |+|++++++...+.+..+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 345666789999999999887655566678888776533 333345556777777776 99999999999999999999
Q ss_pred EeecCCCchhhhh-hcCC-CCChhhHHHHHHHHHHHHHHHH-hcCCCCeEecCCCcCeEEECCCC-ceEEecCCCccccc
Q 041576 497 YEFMGNGTLANLL-FAIP-RPDWSLRVRISLEIARGLLYLH-EECNVPIIHCDIKPQNILLDQDF-TAKISDFGLSKLLL 572 (714)
Q Consensus 497 ~E~~~~gsL~~~l-~~~~-~~~~~~~~~i~~qi~~~L~yLH-~~~~~~ivH~Dlk~~NIll~~~~-~~kl~Dfg~~~~~~ 572 (714)
.||..++++.+.+ .... ..+...+...+.|+..++.|+| ..+ +.|+|+||+|.+++..+ ..+++|||+|....
T Consensus 100 ~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~ 176 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATAYR 176 (601)
T ss_pred cCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhcccc
Confidence 9999999999999 5443 5677888899999999999999 877 99999999999999999 99999999998876
Q ss_pred c--CcccceeeecC-CCCccCcccccCC-CCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccc
Q 041576 573 S--DQSRTRTVIRG-TRGYVAPEWFKNV-PVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLD 648 (714)
Q Consensus 573 ~--~~~~~~~~~~g-t~~y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 648 (714)
. ..........| ++.|+|||...+. ...+..|+||.|+++.-+++|..|+......... ...| .+....
T Consensus 177 ~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~--~~~~-----~~~~~~ 249 (601)
T KOG0590|consen 177 NKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR--YSSW-----KSNKGR 249 (601)
T ss_pred ccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc--ceee-----cccccc
Confidence 6 23344445567 9999999999885 4577899999999999999999999765433210 0011 111100
Q ss_pred eeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 649 VLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 649 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
..............+++.+++..+|..|.+.+++..
T Consensus 250 ------~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 250 ------FTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred ------cccCccccCChhhhhcccccccCCchhccccccccc
Confidence 001112223335566888889899999999988754
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.55 E-value=2.2e-14 Score=139.78 Aligned_cols=135 Identities=21% Similarity=0.244 Sum_probs=96.8
Q ss_pred hhhhCcccceeEEEeEeeCCCCcEEEEEEecccchh--hHHH----------------------HHHHHHHHhccCccc-
Q 041576 425 EEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQE--RERE----------------------FKTEVSAIGRTHHKN- 479 (714)
Q Consensus 425 ~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~--~~~~----------------------~~~E~~~l~~l~h~n- 479 (714)
.+.||+|+||.||+|... +++.||||+++..... .... ...|.+.+.++.+..
T Consensus 2 ~~~lg~G~~g~Vy~a~~~--~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~ 79 (187)
T cd05119 2 GGPIGTGKEADVYLALDG--DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGV 79 (187)
T ss_pred CcccccccceeEEEEECC--CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCC
Confidence 467999999999999865 6889999988643211 1111 135566666654432
Q ss_pred -ccceeceEecCCeeeEEEeecCCCchhhh-hhcCCCCChhhHHHHHHHHHHHHHHHHh-cCCCCeEecCCCcCeEEECC
Q 041576 480 -LVQLLGFCDEGLNRLLVYEFMGNGTLANL-LFAIPRPDWSLRVRISLEIARGLLYLHE-ECNVPIIHCDIKPQNILLDQ 556 (714)
Q Consensus 480 -Iv~l~~~~~~~~~~~lv~E~~~~gsL~~~-l~~~~~~~~~~~~~i~~qi~~~L~yLH~-~~~~~ivH~Dlk~~NIll~~ 556 (714)
+.+.+++ ...++||||++++.+... +... .. ...+..++.+++.++.++|. .+ |+|+||||+||+++
T Consensus 80 ~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~-~~-~~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~- 149 (187)
T cd05119 80 PVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDV-RL-LEDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD- 149 (187)
T ss_pred CCCceEec----CCCEEEEEEeCCCCccChhhhhh-hh-cccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-
Confidence 3444432 245899999999543321 1111 11 16678999999999999999 77 99999999999999
Q ss_pred CCceEEecCCCcccc
Q 041576 557 DFTAKISDFGLSKLL 571 (714)
Q Consensus 557 ~~~~kl~Dfg~~~~~ 571 (714)
++.++|+|||.+...
T Consensus 150 ~~~~~liDfg~a~~~ 164 (187)
T cd05119 150 DGKVYIIDVPQAVEI 164 (187)
T ss_pred CCcEEEEECcccccc
Confidence 899999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.54 E-value=4.3e-14 Score=131.97 Aligned_cols=134 Identities=20% Similarity=0.171 Sum_probs=114.2
Q ss_pred hhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCc--ccccceeceEecCCeeeEEEeecCC
Q 041576 425 EEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHH--KNLVQLLGFCDEGLNRLLVYEFMGN 502 (714)
Q Consensus 425 ~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~nIv~l~~~~~~~~~~~lv~E~~~~ 502 (714)
.+.||+|.++.||++... +..+++|....... ...+.+|+..+..++| .++++++.+....+..++++||+++
T Consensus 3 ~~~i~~g~~~~v~~~~~~---~~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g 77 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTK---DEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEG 77 (155)
T ss_pred ceecccccccceEEEEec---CCeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCC
Confidence 367999999999999874 47899999865433 5678899999999976 5899999988888889999999998
Q ss_pred CchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccc
Q 041576 503 GTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKL 570 (714)
Q Consensus 503 gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~ 570 (714)
+.+..+ +......++.+++++|++||.....+++|+|++|+||++++.+.++++|||.+..
T Consensus 78 ~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 78 ETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred eecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 877655 4566778899999999999996444599999999999999999999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.51 E-value=9.6e-14 Score=140.22 Aligned_cols=134 Identities=16% Similarity=0.131 Sum_probs=104.1
Q ss_pred hhhC-cccceeEEEeEeeCCCCcEEEEEEecccc-------------hhhHHHHHHHHHHHhccCcccc--cceeceEec
Q 041576 426 EELG-RGSFGIVYKGVLKSASGNAVAVKKLDKLA-------------QEREREFKTEVSAIGRTHHKNL--VQLLGFCDE 489 (714)
Q Consensus 426 ~~ig-~G~~g~Vy~~~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~h~nI--v~l~~~~~~ 489 (714)
..|| .|+.|+||++... +..++||++.... ......+.+|++++.+++|++| ++.+++...
T Consensus 37 ~~lg~~~g~gtv~~v~~~---~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~ 113 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP---GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVV 113 (239)
T ss_pred ceeecCCCCccEEEEEeC---CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeee
Confidence 4677 8888899987753 6789999875311 1233567889999999998875 677776543
Q ss_pred CCe----eeEEEeecCC-CchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEec
Q 041576 490 GLN----RLLVYEFMGN-GTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISD 564 (714)
Q Consensus 490 ~~~----~~lv~E~~~~-gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D 564 (714)
... .++|+|++++ .+|.+++... .++. ..+.+|+++|.+||+.| |+|+||||+|||++.++.++|+|
T Consensus 114 ~~~~~~~~~lV~e~l~G~~~L~~~l~~~-~l~~----~~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LID 185 (239)
T PRK01723 114 RHGLFYRADILIERIEGARDLVALLQEA-PLSE----EQWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLID 185 (239)
T ss_pred ecCcceeeeEEEEecCCCCCHHHHHhcC-CCCH----HHHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEEE
Confidence 322 2599999997 6899888653 3333 34678999999999998 99999999999999999999999
Q ss_pred CCCccc
Q 041576 565 FGLSKL 570 (714)
Q Consensus 565 fg~~~~ 570 (714)
||.+..
T Consensus 186 fg~~~~ 191 (239)
T PRK01723 186 FDRGEL 191 (239)
T ss_pred CCCccc
Confidence 998864
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.44 E-value=2.7e-13 Score=134.75 Aligned_cols=205 Identities=19% Similarity=0.262 Sum_probs=142.5
Q ss_pred HHHHHHHHHhccCcccccceeceEecCC-----eeeEEEeecCCCchhhhhhcC----CCCChhhHHHHHHHHHHHHHHH
Q 041576 464 EFKTEVSAIGRTHHKNLVQLLGFCDEGL-----NRLLVYEFMGNGTLANLLFAI----PRPDWSLRVRISLEIARGLLYL 534 (714)
Q Consensus 464 ~~~~E~~~l~~l~h~nIv~l~~~~~~~~-----~~~lv~E~~~~gsL~~~l~~~----~~~~~~~~~~i~~qi~~~L~yL 534 (714)
....-...|-++.|.||++++.|+.+.+ ...++.|||..|+|..+|+.. ..+......+|+.||+.||.||
T Consensus 113 k~~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yL 192 (458)
T KOG1266|consen 113 KRRAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYL 192 (458)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhh
Confidence 3344455667778999999999986544 357899999999999999754 3467778889999999999999
Q ss_pred HhcCCCCeEecCCCcCeEEECCCCceEEecCCCcccccc----CcccceeeecCCCCccCcccccCCCCCchhhhHHHHH
Q 041576 535 HEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLS----DQSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGV 610 (714)
Q Consensus 535 H~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~----~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGv 610 (714)
|+. .++|+|+++..+.|++..++-+|+.--.-. .... ..........+-++|.|||.=.....+.++|||+||+
T Consensus 193 hs~-~PpiihgnlTc~tifiq~ngLIkig~~ap~-s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgm 270 (458)
T KOG1266|consen 193 HSC-DPPIIHGNLTCDTIFIQHNGLIKIGSVAPD-STHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGM 270 (458)
T ss_pred hcc-CCccccCCcchhheeecCCceEEecccCcc-ccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhH
Confidence 997 488999999999999999998888532111 1110 0111112234678999999888878889999999999
Q ss_pred HHHHHHhcCCCC-cccccchhhhhhhHHHhhhhhcCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 041576 611 VLLKIICCKRSV-EMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIV 689 (714)
Q Consensus 611 il~elltG~~p~-~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl 689 (714)
..+||.-+..-. .....-.....+.. .+..+-+.. -..++..|++.+|+.||+|++++
T Consensus 271 cAlemailEiq~tnseS~~~~ee~ia~---------~i~~len~l------------qr~~i~kcl~~eP~~rp~ar~ll 329 (458)
T KOG1266|consen 271 CALEMAILEIQSTNSESKVEVEENIAN---------VIIGLENGL------------QRGSITKCLEGEPNGRPDARLLL 329 (458)
T ss_pred HHHHHHHheeccCCCcceeehhhhhhh---------heeeccCcc------------ccCcCcccccCCCCCCcchhhhh
Confidence 999998765432 11111111111110 011111111 11267789999999999999986
Q ss_pred HH
Q 041576 690 QM 691 (714)
Q Consensus 690 ~~ 691 (714)
..
T Consensus 330 fH 331 (458)
T KOG1266|consen 330 FH 331 (458)
T ss_pred cC
Confidence 53
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.38 E-value=1.8e-12 Score=142.31 Aligned_cols=139 Identities=22% Similarity=0.259 Sum_probs=99.4
Q ss_pred hhhCcccceeEEEeEeeCCCCcEEEEEEecccchhh----------------------------------------HHHH
Q 041576 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQER----------------------------------------EREF 465 (714)
Q Consensus 426 ~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~----------------------------------------~~~~ 465 (714)
+.||.|++|.||+|+++ +|+.||||+.+...... +-+|
T Consensus 123 ~plasaSigQVh~A~l~--~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf 200 (437)
T TIGR01982 123 KPLAAASIAQVHRARLV--DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL 200 (437)
T ss_pred cceeeeehhheEEEEec--CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence 46999999999999986 68999999986432110 0124
Q ss_pred HHHHHHHhccC-----cccccceeceE-ecCCeeeEEEeecCCCchhhhhhcCCCCChhhHHHHHHHHHH-HHHHHHhcC
Q 041576 466 KTEVSAIGRTH-----HKNLVQLLGFC-DEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIAR-GLLYLHEEC 538 (714)
Q Consensus 466 ~~E~~~l~~l~-----h~nIv~l~~~~-~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~-~L~yLH~~~ 538 (714)
.+|.+.+.++. +++| .+-.++ ......+|||||++|++|.++...... . ..+.+++.++++ .+..+|..|
T Consensus 201 ~~Ea~n~~~~~~~~~~~~~v-~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~-~-~~~~~ia~~~~~~~l~ql~~~g 277 (437)
T TIGR01982 201 RREAANASELGENFKNDPGV-YVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA-G-LDRKALAENLARSFLNQVLRDG 277 (437)
T ss_pred HHHHHHHHHHHHhcCCCCCE-EeCCEehhhcCCceEEEEeECCcccccHHHHHhc-C-CCHHHHHHHHHHHHHHHHHhCC
Confidence 55666555552 2332 222222 223457899999999999988653211 1 134567777766 478899988
Q ss_pred CCCeEecCCCcCeEEECCCCceEEecCCCccccc
Q 041576 539 NVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLL 572 (714)
Q Consensus 539 ~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~ 572 (714)
++|+|+||.||++++++.++++|||++..+.
T Consensus 278 ---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 278 ---FFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred ---ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 9999999999999999999999999998764
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.29 E-value=3.5e-12 Score=137.93 Aligned_cols=255 Identities=20% Similarity=0.210 Sum_probs=186.3
Q ss_pred CHHHHHHHhhhhhhhhCc--ccceeEEEeEe--eCCCCcEEEEEEecccch--hhHHHHHHHHHHHhcc-Ccccccceec
Q 041576 413 SLVELNEATNGFEEELGR--GSFGIVYKGVL--KSASGNAVAVKKLDKLAQ--EREREFKTEVSAIGRT-HHKNLVQLLG 485 (714)
Q Consensus 413 ~~~el~~at~~~~~~ig~--G~~g~Vy~~~~--~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l-~h~nIv~l~~ 485 (714)
...+....+..+.+.+|. |.+|.||.+.. . .++..+|+|+-+.... .....-.+|+...+++ .|+|.++...
T Consensus 107 ~~~s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~-~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~ 185 (524)
T KOG0601|consen 107 PFDSFFDQRFPISSRTGSLPGSKGSVFKSRCTNS-ESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSP 185 (524)
T ss_pred CccchhhhhcccccccccCCCCCceeecccCCcc-cCCcccccccccCCCCCccccccccchhhcccccCccccccccCc
Confidence 344555666777889999 99999999886 4 4677899998543222 2333445677777777 5999999999
Q ss_pred eEecCCeeeEEEeecCCCchhhhhhcCCC-CChhhHHHHHHHHHH----HHHHHHhcCCCCeEecCCCcCeEEECCC-Cc
Q 041576 486 FCDEGLNRLLVYEFMGNGTLANLLFAIPR-PDWSLRVRISLEIAR----GLLYLHEECNVPIIHCDIKPQNILLDQD-FT 559 (714)
Q Consensus 486 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~-~~~~~~~~i~~qi~~----~L~yLH~~~~~~ivH~Dlk~~NIll~~~-~~ 559 (714)
.+...+..++-+|++. .+|.++.+.... +.....+.+..+..+ ||.++|+.. ++|-|+||.||++..+ ..
T Consensus 186 ~~e~~~~lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s 261 (524)
T KOG0601|consen 186 AWEGSGILFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTS 261 (524)
T ss_pred ccccCCcceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccce
Confidence 9999999999999987 588888876544 677888888888888 999999998 9999999999999999 88
Q ss_pred eEEecCCCccccccCcccc----eeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhh
Q 041576 560 AKISDFGLSKLLLSDQSRT----RTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILT 635 (714)
Q Consensus 560 ~kl~Dfg~~~~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~ 635 (714)
.+++|||+...+....... .....+...|++||..++ .++.+.|||++|.++.+..++..+.......
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~------- 333 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNS------- 333 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCC-------
Confidence 9999999998876544211 122257889999998865 5788999999999999999887765432111
Q ss_pred HHHhhhhhcCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 636 DWAYDCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
.| .....+.+ .+. .-.....++...+..|++.+|..|++.+++..
T Consensus 334 ~W--~~~r~~~i---p~e-----~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 334 SW--SQLRQGYI---PLE-----FCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred Cc--cccccccC---chh-----hhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 11 11111110 000 00111123334788899999999999988765
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.27 E-value=5.7e-11 Score=129.57 Aligned_cols=169 Identities=17% Similarity=0.225 Sum_probs=128.9
Q ss_pred eEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEeecCCCchhhhhhcCCCCChh
Q 041576 439 GVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWS 518 (714)
Q Consensus 439 ~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~ 518 (714)
|..+ .++.+|.|...+...........+-++.|+.++||||++++...+.+...|||+|.+. .|..++.... ..
T Consensus 31 ~t~k-~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~---~~ 104 (690)
T KOG1243|consen 31 GTRK-ADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG---KE 104 (690)
T ss_pred ccee-ccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH---HH
Confidence 4433 4678898888876555445667888999999999999999999999999999999874 6777775533 55
Q ss_pred hHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcccceeeecCCCCccCcccccCCC
Q 041576 519 LRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVP 598 (714)
Q Consensus 519 ~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 598 (714)
...-.+.||+.||.+||+.+ .++|++|..+.|+|+..|..||++|.++........ .......-..|..|+.+....
T Consensus 105 ~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~ 181 (690)
T KOG1243|consen 105 EVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE 181 (690)
T ss_pred HHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc
Confidence 66677899999999999776 599999999999999999999999988865432211 111111223466666543222
Q ss_pred CCchhhhHHHHHHHHHHHhc
Q 041576 599 VSAKVDVYSFGVVLLKIICC 618 (714)
Q Consensus 599 ~s~ksDVwSlGvil~elltG 618 (714)
-..|.|-||++++|++.|
T Consensus 182 --~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 182 --WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred --cchhhhhHHHHHHHHhCc
Confidence 456999999999999999
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.25 E-value=2.3e-11 Score=116.42 Aligned_cols=129 Identities=19% Similarity=0.125 Sum_probs=97.2
Q ss_pred hhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCccccc-ceeceEecCCeeeEEEeecCCCc
Q 041576 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLV-QLLGFCDEGLNRLLVYEFMGNGT 504 (714)
Q Consensus 426 ~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv-~l~~~~~~~~~~~lv~E~~~~gs 504 (714)
+.|+.|..+.||++... +..+++|....... ....+.+|+.+++.+.+.+++ +++.+. ....++||||+++.+
T Consensus 4 ~~l~~G~~~~vy~~~~~---~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~ 77 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA---NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSE 77 (170)
T ss_pred eecCCcccCceEEEEEC---CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCc
Confidence 56889999999998753 77899999865432 223567899999988665554 444433 334589999999988
Q ss_pred hhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcC--CCCeEecCCCcCeEEECCCCceEEecCCCcc
Q 041576 505 LANLLFAIPRPDWSLRVRISLEIARGLLYLHEEC--NVPIIHCDIKPQNILLDQDFTAKISDFGLSK 569 (714)
Q Consensus 505 L~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~--~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~ 569 (714)
+.+. ......++.+++++|+.||+.+ ...++|+|++|.||+++ ++.++++||+.+.
T Consensus 78 l~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 78 LLTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred cccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 7653 1112356789999999999986 23369999999999999 6689999999886
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.21 E-value=1.8e-10 Score=111.28 Aligned_cols=139 Identities=14% Similarity=0.138 Sum_probs=99.9
Q ss_pred hhhCcccceeEEEeEeeCC-----CCcEEEEEEeccc-------------c---------hhhHHHHH----HHHHHHhc
Q 041576 426 EELGRGSFGIVYKGVLKSA-----SGNAVAVKKLDKL-------------A---------QEREREFK----TEVSAIGR 474 (714)
Q Consensus 426 ~~ig~G~~g~Vy~~~~~~~-----~~~~vavK~~~~~-------------~---------~~~~~~~~----~E~~~l~~ 474 (714)
..||.|.-+.||.|...+. .+..+|||+.+.. + ....+.+. +|++.|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 4689999999999975421 3579999976420 0 01122333 89999999
Q ss_pred cCc--ccccceeceEecCCeeeEEEeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHH-HhcCCCCeEecCCCcCe
Q 041576 475 THH--KNLVQLLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYL-HEECNVPIIHCDIKPQN 551 (714)
Q Consensus 475 l~h--~nIv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yL-H~~~~~~ivH~Dlk~~N 551 (714)
+.. -++.+++++ ...++||||+.+..+..-.-....++.++...+..+++.+|..| |+.+ ++||||++.|
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDLs~~N 155 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADLSEYN 155 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHH
Confidence 853 556666654 45689999998754432211112344556678889999999999 7777 9999999999
Q ss_pred EEECCCCceEEecCCCccccc
Q 041576 552 ILLDQDFTAKISDFGLSKLLL 572 (714)
Q Consensus 552 Ill~~~~~~kl~Dfg~~~~~~ 572 (714)
|+++ ++.+.|+|||.+....
T Consensus 156 IL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 156 MLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred EEEE-CCcEEEEECCCceeCC
Confidence 9997 4689999999987653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.19 E-value=3.3e-11 Score=133.78 Aligned_cols=140 Identities=19% Similarity=0.181 Sum_probs=88.5
Q ss_pred hhhCcccceeEEEeEeeCCCCcEEEEEEecccchh----------------------------------hHH------HH
Q 041576 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQE----------------------------------RER------EF 465 (714)
Q Consensus 426 ~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~----------------------------------~~~------~~ 465 (714)
+.||+|++|+||+|++++ +|+.||||+++..... -.+ ++
T Consensus 125 ~PlasaSiaQVh~A~l~~-~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~ 203 (537)
T PRK04750 125 KPLASASIAQVHFARLKD-NGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDL 203 (537)
T ss_pred hhhcCCCccEEEEEEECC-CCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCH
Confidence 469999999999999872 4899999999743211 011 23
Q ss_pred HHHHHHHhccC----cccccceeceEe-cCCeeeEEEeecCCCchhhhh--hcCCCCChhhHHHHHHHHHHH-HHHHHhc
Q 041576 466 KTEVSAIGRTH----HKNLVQLLGFCD-EGLNRLLVYEFMGNGTLANLL--FAIPRPDWSLRVRISLEIARG-LLYLHEE 537 (714)
Q Consensus 466 ~~E~~~l~~l~----h~nIv~l~~~~~-~~~~~~lv~E~~~~gsL~~~l--~~~~~~~~~~~~~i~~qi~~~-L~yLH~~ 537 (714)
.+|+..+.+++ +.+.+.+-.++. -....+|||||++|+.+.++- ... ..+ +..++...++. +..++..
T Consensus 204 ~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~-g~d---~~~la~~~v~~~~~Qif~~ 279 (537)
T PRK04750 204 MREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAA-GTD---MKLLAERGVEVFFTQVFRD 279 (537)
T ss_pred HHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhc-CCC---HHHHHHHHHHHHHHHHHhC
Confidence 34444444432 222222222221 134567999999999998752 221 111 11222222221 2334456
Q ss_pred CCCCeEecCCCcCeEEECCCC----ceEEecCCCcccccc
Q 041576 538 CNVPIIHCDIKPQNILLDQDF----TAKISDFGLSKLLLS 573 (714)
Q Consensus 538 ~~~~ivH~Dlk~~NIll~~~~----~~kl~Dfg~~~~~~~ 573 (714)
| ++|+|+||.||+++.++ .+++.|||++..+..
T Consensus 280 G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 280 G---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred C---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 6 99999999999999988 999999999987754
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.10 E-value=9.3e-10 Score=102.53 Aligned_cols=131 Identities=23% Similarity=0.324 Sum_probs=104.3
Q ss_pred hhhCcccceeEEEeEeeCCCCcEEEEEE-ecccc-------hhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEE
Q 041576 426 EELGRGSFGIVYKGVLKSASGNAVAVKK-LDKLA-------QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVY 497 (714)
Q Consensus 426 ~~ig~G~~g~Vy~~~~~~~~~~~vavK~-~~~~~-------~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 497 (714)
..+++|+-+.+|.+.+. |.++++|. +.+.- .-....-.+|++++.+++--.|...+-+..+.+...|+|
T Consensus 2 ~~i~~GAEa~i~~~~~~---g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~m 78 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL---GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVM 78 (204)
T ss_pred chhhCCcceeEEeeecc---CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEE
Confidence 35789999999998664 55666664 32211 112345778999999987767766666778888889999
Q ss_pred eecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccc
Q 041576 498 EFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKL 570 (714)
Q Consensus 498 E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~ 570 (714)
||++|..|.+.+... ...++..+-.-+.-||..| |+||||.++||++..+. +.++|||++..
T Consensus 79 e~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 79 EYIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred EEeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 999999999998764 3667788888899999998 99999999999998875 99999999874
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.08 E-value=8e-11 Score=127.48 Aligned_cols=245 Identities=21% Similarity=0.209 Sum_probs=174.2
Q ss_pred hhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHH--HHHHHHHHHhcc-CcccccceeceEecCCeeeEEEe
Q 041576 422 NGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQERER--EFKTEVSAIGRT-HHKNLVQLLGFCDEGLNRLLVYE 498 (714)
Q Consensus 422 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~--~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~E 498 (714)
..+...||.|.|+.|+....+..++..+++|.+.+....... .-..|+-+...+ .|.++++....+......++--|
T Consensus 267 f~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e 346 (524)
T KOG0601|consen 267 FGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLE 346 (524)
T ss_pred cceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchh
Confidence 344567999999999998766577889999988653322222 223455555555 68889998888888888889999
Q ss_pred ecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCC-CceEEecCCCccccccCccc
Q 041576 499 FMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQD-FTAKISDFGLSKLLLSDQSR 577 (714)
Q Consensus 499 ~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~-~~~kl~Dfg~~~~~~~~~~~ 577 (714)
|++++++...+.-...+++..++++..|++.++.++|+.. ++|+|++|+||++..+ +..++.|||.+..+.-..
T Consensus 347 ~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~-- 421 (524)
T KOG0601|consen 347 FCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSS-- 421 (524)
T ss_pred hhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhccccccccccceec--
Confidence 9999998888755566788899999999999999999887 9999999999999886 788999999986421111
Q ss_pred ceeeecCCCCc-cCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhh
Q 041576 578 TRTVIRGTRGY-VAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKA 656 (714)
Q Consensus 578 ~~~~~~gt~~y-~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 656 (714)
......+..| .+|+......+-.+.|++|||.-+.|.+++...-...... .....+.....
T Consensus 422 -~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~-----------~~i~~~~~p~~------ 483 (524)
T KOG0601|consen 422 -GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQS-----------LTIRSGDTPNL------ 483 (524)
T ss_pred -ccccccccccccchhhccccccccccccccccccccccccCcccCcccccc-----------eeeecccccCC------
Confidence 1111123334 3666667778899999999999999999887644321110 01111111111
Q ss_pred hccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 041576 657 AMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLE 693 (714)
Q Consensus 657 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 693 (714)
+. ....+..+...++.+++..||.+.++....+
T Consensus 484 ---~~-~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~ 516 (524)
T KOG0601|consen 484 ---PG-LKLQLQVLLKVMINPDRKRRPSAVELSLHSE 516 (524)
T ss_pred ---Cc-hHHhhhhhhhhhcCCccccchhhhhhcccch
Confidence 11 1134455777788999999999988876554
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.06 E-value=1.1e-09 Score=109.54 Aligned_cols=142 Identities=18% Similarity=0.252 Sum_probs=110.9
Q ss_pred hhhCcccceeEEEeEeeCCCCcEEEEEEecccch-hhHHHHHHHHHHHhccCc--ccccceeceEecCC---eeeEEEee
Q 041576 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQ-EREREFKTEVSAIGRTHH--KNLVQLLGFCDEGL---NRLLVYEF 499 (714)
Q Consensus 426 ~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h--~nIv~l~~~~~~~~---~~~lv~E~ 499 (714)
+.|+.|..+.||++... +|+.+++|....... .....+..|+++++.+++ .++.+++.+..... ..++||||
T Consensus 4 ~~l~~G~~n~~~~v~~~--~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~ 81 (223)
T cd05154 4 RQLSGGQSNLTYLLTAG--GGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMER 81 (223)
T ss_pred eecCCCccceEEEEEec--CCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEE
Confidence 56899999999998864 357899999865332 134578999999999965 44677787776543 56899999
Q ss_pred cCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcC-----------------------------------------
Q 041576 500 MGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEEC----------------------------------------- 538 (714)
Q Consensus 500 ~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~----------------------------------------- 538 (714)
+++.++.+.+.. ..++......++.+++++|++||+..
T Consensus 82 i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (223)
T cd05154 82 VDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL 160 (223)
T ss_pred eCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence 999988887643 45677788888999999999998531
Q ss_pred ------------CCCeEecCCCcCeEEECC--CCceEEecCCCccc
Q 041576 539 ------------NVPIIHCDIKPQNILLDQ--DFTAKISDFGLSKL 570 (714)
Q Consensus 539 ------------~~~ivH~Dlk~~NIll~~--~~~~kl~Dfg~~~~ 570 (714)
...++|+|+++.||+++. ++.+.|+||+.+..
T Consensus 161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 234799999999999998 66789999998763
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.98 E-value=4.5e-09 Score=97.43 Aligned_cols=140 Identities=22% Similarity=0.285 Sum_probs=107.1
Q ss_pred hhhhCcccceeEEEeEeeCCCCcEEEEEE-ecc-------cchhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEE
Q 041576 425 EEELGRGSFGIVYKGVLKSASGNAVAVKK-LDK-------LAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLV 496 (714)
Q Consensus 425 ~~~ig~G~~g~Vy~~~~~~~~~~~vavK~-~~~-------~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 496 (714)
.+.|-+|+-+.|+++.+. |+..+||. +.+ ...-..+...+|++.|.+++--.|.-..-++.+...-.|+
T Consensus 12 l~likQGAEArv~~~~~~---Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ 88 (229)
T KOG3087|consen 12 LELIKQGAEARVPRGSFS---GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY 88 (229)
T ss_pred ceeeeccceeeEeeeccC---CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence 367889999999999874 88877774 322 1122345778999999998766666666667777778899
Q ss_pred EeecCC-CchhhhhhcCC-CCChhh-HHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCC---ceEEecCCCccc
Q 041576 497 YEFMGN-GTLANLLFAIP-RPDWSL-RVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDF---TAKISDFGLSKL 570 (714)
Q Consensus 497 ~E~~~~-gsL~~~l~~~~-~~~~~~-~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~---~~kl~Dfg~~~~ 570 (714)
|||+++ .++.+++...- ...... ...++..|-+.+.-||..+ |+||||..+||++..++ .+.++|||++..
T Consensus 89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence 999987 47888886542 222333 3788999999999999998 99999999999997655 458999999864
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.96 E-value=1.4e-08 Score=107.60 Aligned_cols=167 Identities=21% Similarity=0.277 Sum_probs=129.5
Q ss_pred ceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCcccccceeceEe----cCCeeeEEEeecCC-Cchhh
Q 041576 433 FGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCD----EGLNRLLVYEFMGN-GTLAN 507 (714)
Q Consensus 433 ~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~----~~~~~~lv~E~~~~-gsL~~ 507 (714)
-.+.|++... .+|..|++|+++............-+++++++.|+|||++.+++. .+...++||+|+++ ++|.+
T Consensus 289 ~~Ttyk~~s~-~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 289 SITTYKATSN-VDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred cceeEeeeec-cCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 4577888765 689999999995433222334456688999999999999999885 45567899999986 46766
Q ss_pred hhhcC---------------CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccc
Q 041576 508 LLFAI---------------PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLL 572 (714)
Q Consensus 508 ~l~~~---------------~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~ 572 (714)
+-... .+.++...+.++.|+..||.++|+.| +.-+-|.+.+|+++.+.+++|+..|+...+.
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeec
Confidence 65422 23467889999999999999999999 8889999999999999999999999887665
Q ss_pred cCcccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCC
Q 041576 573 SDQSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRS 621 (714)
Q Consensus 573 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p 621 (714)
.+.. |-+ +--.+-|.=.||.+++.|.||...
T Consensus 445 ~d~~---------------~~l---e~~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 445 EDPT---------------EPL---ESQQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCCC---------------cch---hHHhhhhHHHHHHHHHHHhhcccc
Confidence 4431 111 113467899999999999999654
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.92 E-value=2.7e-10 Score=129.35 Aligned_cols=242 Identities=17% Similarity=0.177 Sum_probs=164.3
Q ss_pred hhhCcccceeEEEeEeeCCCCcEEEEEEecc---cchhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEeecCC
Q 041576 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDK---LAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEFMGN 502 (714)
Q Consensus 426 ~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~ 502 (714)
+-+-+|+++.++.+.-. ..+...+.|.... ....+.+....+-.++-..+||-+++...-+.-....+|+++|+.+
T Consensus 810 ~p~qS~sp~ss~p~~pa-~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~~~~ 888 (1205)
T KOG0606|consen 810 KPSQSGSPSSSFPASPA-GSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHYLNG 888 (1205)
T ss_pred ccccCCCCcccccCCcc-ccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhHHhcc
Confidence 35677888888766532 2332223332221 1111222223333333334456666655555667778999999999
Q ss_pred CchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCcccccc---------
Q 041576 503 GTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLS--------- 573 (714)
Q Consensus 503 gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~--------- 573 (714)
++|...|+..+..+.+-....+..+.++++|||... +.|+|++|.|+++..++..+++||+.......
T Consensus 889 ~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~~sg 965 (1205)
T KOG0606|consen 889 GDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTDLSG 965 (1205)
T ss_pred CCchhhhhcCCCcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCccccccccccccCcCCccc
Confidence 999999998887887888888888999999999986 89999999999999999999999984332210
Q ss_pred ------------C---------cccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhh
Q 041576 574 ------------D---------QSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSA 632 (714)
Q Consensus 574 ------------~---------~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~ 632 (714)
. .........+|+.|.+||.+.+......+|.|++|++++|.++|..||.....+...+
T Consensus 966 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~~f~ 1045 (1205)
T KOG0606|consen 966 PSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQQIFE 1045 (1205)
T ss_pred ccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcchhhhhh
Confidence 0 0011233568999999999999999999999999999999999999998765544321
Q ss_pred hhhHHHhhhhhcCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHH
Q 041576 633 ILTDWAYDCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMK 686 (714)
Q Consensus 633 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 686 (714)
.+. .+.+. ....+.....+...++...+..+|.+|-.|.
T Consensus 1046 ni~--------~~~~~-------~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1046 NIL--------NRDIP-------WPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred ccc--------cCCCC-------CCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 111 11111 0111222334455577777889999997766
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.83 E-value=3.3e-08 Score=101.06 Aligned_cols=129 Identities=18% Similarity=0.146 Sum_probs=96.1
Q ss_pred eEEEeEeeCCCCcEEEEEEecccchh-----------hHHHHHHHHHHHhccCcccc--cceeceEec-----CCeeeEE
Q 041576 435 IVYKGVLKSASGNAVAVKKLDKLAQE-----------REREFKTEVSAIGRTHHKNL--VQLLGFCDE-----GLNRLLV 496 (714)
Q Consensus 435 ~Vy~~~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~nI--v~l~~~~~~-----~~~~~lv 496 (714)
.|.+..+ +|+.+.||+....... ....+.+|.+.+.++...+| .+++++... ....++|
T Consensus 37 rvvr~~~---~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LV 113 (268)
T PRK15123 37 RTLRFEL---AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFII 113 (268)
T ss_pred eEEEEEE---CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEE
Confidence 3556554 4778999977442211 11247899999988854443 445556543 2346899
Q ss_pred EeecCCC-chhhhhhc--CCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECC-------CCceEEecCC
Q 041576 497 YEFMGNG-TLANLLFA--IPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQ-------DFTAKISDFG 566 (714)
Q Consensus 497 ~E~~~~g-sL~~~l~~--~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~-------~~~~kl~Dfg 566 (714)
+|++++- +|.+++.. ....+...+..++.++++.++-||..| |+|+|++++|||++. +..+.|+||+
T Consensus 114 te~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~ 190 (268)
T PRK15123 114 TEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLKLSVIDLH 190 (268)
T ss_pred EeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCceEEEEECC
Confidence 9999986 89999853 234556777899999999999999999 999999999999975 4689999999
Q ss_pred Ccc
Q 041576 567 LSK 569 (714)
Q Consensus 567 ~~~ 569 (714)
.+.
T Consensus 191 r~~ 193 (268)
T PRK15123 191 RAQ 193 (268)
T ss_pred ccc
Confidence 875
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.81 E-value=4.6e-08 Score=94.32 Aligned_cols=125 Identities=24% Similarity=0.249 Sum_probs=83.5
Q ss_pred eEEEeEeeCCCCcEEEEEEeccc--------------ch------------hhHHHHHHHHHHHhccCcc--cccceece
Q 041576 435 IVYKGVLKSASGNAVAVKKLDKL--------------AQ------------EREREFKTEVSAIGRTHHK--NLVQLLGF 486 (714)
Q Consensus 435 ~Vy~~~~~~~~~~~vavK~~~~~--------------~~------------~~~~~~~~E~~~l~~l~h~--nIv~l~~~ 486 (714)
.||.|... ++..+|||..+.. .+ ......++|.+.|.++..- ++.+++++
T Consensus 1 ~Vy~~~~~--~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~ 78 (188)
T PF01163_consen 1 DVYHAIDP--DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY 78 (188)
T ss_dssp EEEEEEEC--TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE
T ss_pred CEEEEECC--CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE
Confidence 48888764 6789999976421 00 1123567899999999755 56666654
Q ss_pred EecCCeeeEEEeecC--CCchhhhhhcCCCCChhhHHHHHHHHHHHHHH-HHhcCCCCeEecCCCcCeEEECCCCceEEe
Q 041576 487 CDEGLNRLLVYEFMG--NGTLANLLFAIPRPDWSLRVRISLEIARGLLY-LHEECNVPIIHCDIKPQNILLDQDFTAKIS 563 (714)
Q Consensus 487 ~~~~~~~~lv~E~~~--~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~y-LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~ 563 (714)
- ..+|||||++ +..+..+.... ++......++.++++.+.. +|..| |+||||.+.||+++++ .+.|+
T Consensus 79 ~----~~~ivME~I~~~G~~~~~l~~~~--~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~iI 148 (188)
T PF01163_consen 79 N----RNVIVMEYIGEDGVPLPRLKDVD--LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYII 148 (188)
T ss_dssp E----TTEEEEE--EETTEEGGCHHHCG--GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE-
T ss_pred e----CCEEEEEecCCCccchhhHHhcc--ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEEE
Confidence 3 3479999999 65555443321 1245667788888886666 56777 9999999999999988 99999
Q ss_pred cCCCcccc
Q 041576 564 DFGLSKLL 571 (714)
Q Consensus 564 Dfg~~~~~ 571 (714)
|||.+...
T Consensus 149 Df~qav~~ 156 (188)
T PF01163_consen 149 DFGQAVDS 156 (188)
T ss_dssp -GTTEEET
T ss_pred ecCcceec
Confidence 99988754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.75 E-value=2.4e-07 Score=96.08 Aligned_cols=188 Identities=13% Similarity=0.171 Sum_probs=127.4
Q ss_pred hhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhcc-CcccccceeceE------ecC-CeeeEE
Q 041576 425 EEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRT-HHKNLVQLLGFC------DEG-LNRLLV 496 (714)
Q Consensus 425 ~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~------~~~-~~~~lv 496 (714)
...||+|+-+.+|..- .-...+.|+..........+.. ..|... .||-+..-+.+= -++ ...-+.
T Consensus 16 gr~LgqGgea~ly~l~----e~~d~VAKIYh~Pppa~~aqk~---a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl 88 (637)
T COG4248 16 GRPLGQGGEADLYTLG----EVRDQVAKIYHAPPPAAQAQKV---AELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL 88 (637)
T ss_pred CccccCCccceeeecc----hhhchhheeecCCCchHHHHHH---HHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence 4679999999999632 1223455777654443333322 333333 566544311111 111 224467
Q ss_pred EeecCCC-chhhhhh------cCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCcc
Q 041576 497 YEFMGNG-TLANLLF------AIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSK 569 (714)
Q Consensus 497 ~E~~~~g-sL~~~l~------~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~ 569 (714)
|..+++. ....++. ..+..+|...++.+..++.+.+-||+.| .+-||++++|+|+++++.+.|.|-..-.
T Consensus 89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfq 165 (637)
T COG4248 89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQ 165 (637)
T ss_pred cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEccccee
Confidence 7776654 2333332 2245689999999999999999999999 8899999999999999999999865443
Q ss_pred ccccCcccceeeecCCCCccCccccc-----CCCCCchhhhHHHHHHHHHHHhc-CCCCcc
Q 041576 570 LLLSDQSRTRTVIRGTRGYVAPEWFK-----NVPVSAKVDVYSFGVVLLKIICC-KRSVEM 624 (714)
Q Consensus 570 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVwSlGvil~elltG-~~p~~~ 624 (714)
.. .......-.+|...|.+||.-. +..-+...|-|.||+++++|+.| ++||..
T Consensus 166 i~--~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysG 224 (637)
T COG4248 166 IN--ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSG 224 (637)
T ss_pred ec--cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCc
Confidence 32 2222233346889999999754 44567789999999999999987 999975
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.63 E-value=2.4e-07 Score=91.53 Aligned_cols=123 Identities=24% Similarity=0.266 Sum_probs=94.2
Q ss_pred CCcEEEEEEecc-cch------hhHHHHHHHHHHHhccCc--ccccceeceEecCC----eeeEEEeecCC-Cchhhhhh
Q 041576 445 SGNAVAVKKLDK-LAQ------EREREFKTEVSAIGRTHH--KNLVQLLGFCDEGL----NRLLVYEFMGN-GTLANLLF 510 (714)
Q Consensus 445 ~~~~vavK~~~~-~~~------~~~~~~~~E~~~l~~l~h--~nIv~l~~~~~~~~----~~~lv~E~~~~-gsL~~~l~ 510 (714)
.++.+.+|.... ... -......+|.+.+.++.. -...+.+++..... ..++|+|++++ .+|.+++.
T Consensus 31 ~~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~ 110 (206)
T PF06293_consen 31 VGRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQ 110 (206)
T ss_pred cceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHH
Confidence 455666665422 111 234467888888888853 33556677665532 34899999998 48999998
Q ss_pred cCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCC---ceEEecCCCccc
Q 041576 511 AIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDF---TAKISDFGLSKL 570 (714)
Q Consensus 511 ~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~---~~kl~Dfg~~~~ 570 (714)
.....+......++.++++.++-||+.| |+|+|+++.|||++.+. .+.++||+.++.
T Consensus 111 ~~~~~~~~~~~~ll~~l~~~i~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 111 QWEQLDPSQRRELLRALARLIAKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred hhcccchhhHHHHHHHHHHHHHHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 7555777888999999999999999999 99999999999999887 899999998764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.60 E-value=5.3e-07 Score=87.42 Aligned_cols=137 Identities=16% Similarity=0.047 Sum_probs=104.0
Q ss_pred hCcccceeEEEeEeeCCCCcEEEEEEecccc------hhhHHHHHHHHHHHhccCc--ccccceeceEec----CCeeeE
Q 041576 428 LGRGSFGIVYKGVLKSASGNAVAVKKLDKLA------QEREREFKTEVSAIGRTHH--KNLVQLLGFCDE----GLNRLL 495 (714)
Q Consensus 428 ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h--~nIv~l~~~~~~----~~~~~l 495 (714)
-++|+.+.|++-.+. |+.+-+|+-.... +.....|.+|+..|.++.. -.+.+++..... ....+|
T Consensus 26 ~~rgG~SgV~r~~~~---g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~L 102 (216)
T PRK09902 26 YRRNGMSGVQCVERN---GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALL 102 (216)
T ss_pred cCCCCcceEEEEEeC---CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEE
Confidence 466999999997664 5578999875211 3356789999999999853 234555522212 123579
Q ss_pred EEeecCC-CchhhhhhcC--CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCc--eEEecCCCccc
Q 041576 496 VYEFMGN-GTLANLLFAI--PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFT--AKISDFGLSKL 570 (714)
Q Consensus 496 v~E~~~~-gsL~~~l~~~--~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~--~kl~Dfg~~~~ 570 (714)
|+|-+++ .+|.+++.+. .+.+...+..++.++++.++-||+.| +.|+|+.+.||+++.++. ++++||.-++.
T Consensus 103 VTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 103 VTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 9997764 5899988663 45677888999999999999999998 999999999999987677 99999987653
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.60 E-value=4.3e-07 Score=89.98 Aligned_cols=135 Identities=20% Similarity=0.180 Sum_probs=98.5
Q ss_pred hhhhhhhCcccceeEEEeEeeCCCCcEEEEEEeccc--------------------c--hhhHHHHHHHHHHHhccCcc-
Q 041576 422 NGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKL--------------------A--QEREREFKTEVSAIGRTHHK- 478 (714)
Q Consensus 422 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~--------------------~--~~~~~~~~~E~~~l~~l~h~- 478 (714)
+.+.++||-|.-+.||.|... .|.++|||.=+.. + .......++|.++|.++...
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~--~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G 170 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP--KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEG 170 (304)
T ss_pred HhhccccccCccceEEEEECC--CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcC
Confidence 446689999999999999875 6899999953210 0 01123567899999998654
Q ss_pred -cccceeceEecCCeeeEEEeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCC
Q 041576 479 -NLVQLLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQD 557 (714)
Q Consensus 479 -nIv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~ 557 (714)
.+.+.+++ +...+|||++++-.|...-- +.+....|+..|++-+.-+-..| |||||+++-||+++++
T Consensus 171 ~~VP~P~~~----nRHaVvMe~ieG~eL~~~r~-----~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~d 238 (304)
T COG0478 171 VKVPKPIAW----NRHAVVMEYIEGVELYRLRL-----DVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTED 238 (304)
T ss_pred CCCCCcccc----ccceeeeehcccceeecccC-----cccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEecC
Confidence 66776654 34579999999866655431 34444555666666665555666 9999999999999999
Q ss_pred CceEEecCCCccc
Q 041576 558 FTAKISDFGLSKL 570 (714)
Q Consensus 558 ~~~kl~Dfg~~~~ 570 (714)
|.+.++||--+..
T Consensus 239 g~~~vIDwPQ~v~ 251 (304)
T COG0478 239 GDIVVIDWPQAVP 251 (304)
T ss_pred CCEEEEeCccccc
Confidence 9999999976654
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.57 E-value=1.5e-08 Score=111.45 Aligned_cols=150 Identities=18% Similarity=0.278 Sum_probs=102.8
Q ss_pred HHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcccce--------eeecCCCCccCcccccC
Q 041576 525 LEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTR--------TVIRGTRGYVAPEWFKN 596 (714)
Q Consensus 525 ~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~--------~~~~gt~~y~aPE~~~~ 596 (714)
.+++.||.|+|... .+||++|.|++|.++.++..||+.|+.+........... .-......|.|||++.+
T Consensus 106 ~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 34559999999875 799999999999999999999999998876544221111 01124567999999999
Q ss_pred CCCCchhhhHHHHHHHHHHHh-cCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhhccchHHHHHHHHHHHHcc
Q 041576 597 VPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCI 675 (714)
Q Consensus 597 ~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 675 (714)
...+.++|+||+|+++|.+.. |+.-+.......... . ....+...........+.++.+=+.+++
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~----~----------~~~~~~~~~~~~s~~~p~el~~~l~k~l 249 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYS----F----------SRNLLNAGAFGYSNNLPSELRESLKKLL 249 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCcchhh----h----------hhcccccccccccccCcHHHHHHHHHHh
Confidence 888999999999999999994 444443332211100 0 0000111111122344556777778889
Q ss_pred ccCCCCCCCHHHHHH
Q 041576 676 QEDPLKRPAMKMIVQ 690 (714)
Q Consensus 676 ~~dP~~RPs~~evl~ 690 (714)
..++.-||++.++..
T Consensus 250 ~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 250 NGDSAVRPTLDLLLS 264 (700)
T ss_pred cCCcccCcchhhhhc
Confidence 999999998877754
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.51 E-value=5.3e-07 Score=99.81 Aligned_cols=140 Identities=25% Similarity=0.316 Sum_probs=93.2
Q ss_pred hhhCcccceeEEEeEeeCCCCcEEEEEEecccchhh----------------------------------------HHHH
Q 041576 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQER----------------------------------------EREF 465 (714)
Q Consensus 426 ~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~----------------------------------------~~~~ 465 (714)
+.|+.++-|.||+|+++ +|+.||||+.+..-... +-++
T Consensus 131 ~PiAsASIaQVH~A~L~--sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy 208 (517)
T COG0661 131 EPIASASIAQVHRAVLK--SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDY 208 (517)
T ss_pred CchhhhhHhhheeEEec--CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCH
Confidence 45899999999999997 59999999986422211 1123
Q ss_pred HHHHHHHhccC-----cccccceeceEecCCeeeEEEeecCCCchhhhhhc-CCCCChhhHHHHHHHHHHH-HHHHHhcC
Q 041576 466 KTEVSAIGRTH-----HKNLVQLLGFCDEGLNRLLVYEFMGNGTLANLLFA-IPRPDWSLRVRISLEIARG-LLYLHEEC 538 (714)
Q Consensus 466 ~~E~~~l~~l~-----h~nIv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~-~~~~~~~~~~~i~~qi~~~-L~yLH~~~ 538 (714)
.+|...+.+++ .++|.=..=+.+-.....|+|||++|-.+.+...- ....+. ..++..++++ +..+-..|
T Consensus 209 ~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~---k~ia~~~~~~f~~q~~~dg 285 (517)
T COG0661 209 RREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDR---KELAELLVRAFLRQLLRDG 285 (517)
T ss_pred HHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCH---HHHHHHHHHHHHHHHHhcC
Confidence 45555555442 23332222222334567899999999999888532 133442 3333333333 23334455
Q ss_pred CCCeEecCCCcCeEEECCCCceEEecCCCcccccc
Q 041576 539 NVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLS 573 (714)
Q Consensus 539 ~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~ 573 (714)
++|.|.+|.||+++.++++.+.|||+...+..
T Consensus 286 ---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 286 ---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred ---ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 99999999999999999999999999987654
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.37 E-value=4.1e-06 Score=82.36 Aligned_cols=136 Identities=22% Similarity=0.226 Sum_probs=94.5
Q ss_pred hhCcccceeEEEeEeeCCCCcEEEEEEecccchhhH------------------------HHHHHHHHHHhccC--cccc
Q 041576 427 ELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQERE------------------------REFKTEVSAIGRTH--HKNL 480 (714)
Q Consensus 427 ~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~------------------------~~~~~E~~~l~~l~--h~nI 480 (714)
.|++|.-+.||+|... ++..+|||+.+....... .=..+|+..|.++. +-.+
T Consensus 55 ~istGKEA~Vy~a~~~--~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrv 132 (268)
T COG1718 55 CISTGKEANVYLAETG--DGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRV 132 (268)
T ss_pred eecCCcceEEEeeccC--CCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCC
Confidence 5889999999999753 688999999864221110 11346777777773 4555
Q ss_pred cceeceEecCCeeeEEEeecCCCch-hhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCc
Q 041576 481 VQLLGFCDEGLNRLLVYEFMGNGTL-ANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFT 559 (714)
Q Consensus 481 v~l~~~~~~~~~~~lv~E~~~~gsL-~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~ 559 (714)
.+.+++..+ .|||||+....+ .-.|.. -.+...+...+..++++.+.-|-..+ ++||+||+.-|||+. ++.
T Consensus 133 P~Pi~~~~n----VLvMEfIg~~g~pAP~LkD-v~~e~~e~~~~~~~~v~~~~~l~~~a--~LVHgDLSEyNiL~~-~~~ 204 (268)
T COG1718 133 PEPIAFRNN----VLVMEFIGDDGLPAPRLKD-VPLELEEAEGLYEDVVEYMRRLYKEA--GLVHGDLSEYNILVH-DGE 204 (268)
T ss_pred CCceeecCC----eEEEEeccCCCCCCCCccc-CCcCchhHHHHHHHHHHHHHHHHHhc--CcccccchhhheEEE-CCe
Confidence 566655433 699999976421 111211 12223367888889999998888833 399999999999999 889
Q ss_pred eEEecCCCccccc
Q 041576 560 AKISDFGLSKLLL 572 (714)
Q Consensus 560 ~kl~Dfg~~~~~~ 572 (714)
+.|+|++-+....
T Consensus 205 p~iID~~QaV~~~ 217 (268)
T COG1718 205 PYIIDVSQAVTID 217 (268)
T ss_pred EEEEECccccccC
Confidence 9999999987654
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.36 E-value=2.8e-06 Score=82.66 Aligned_cols=140 Identities=14% Similarity=0.170 Sum_probs=90.1
Q ss_pred HHHHHhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHH---------HHHHHHHhccCcc---cccce
Q 041576 416 ELNEATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREF---------KTEVSAIGRTHHK---NLVQL 483 (714)
Q Consensus 416 el~~at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~---------~~E~~~l~~l~h~---nIv~l 483 (714)
++....+...+++-......|.+-.. ++..+++|..+......++.| .+++..+.+++.. ..+.+
T Consensus 27 ~i~~~~~~~~kv~k~~~r~~ValIei---~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~ 103 (229)
T PF06176_consen 27 KILDNNYKIIKVFKNTKRNYVALIEI---DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADP 103 (229)
T ss_pred HHHhCCceEEEeecCCCccEEEEEEE---CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccc
Confidence 34444555556666666666666543 578899998876443333322 3444444444322 22232
Q ss_pred eceEe-----cCCeeeEEEeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCC
Q 041576 484 LGFCD-----EGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDF 558 (714)
Q Consensus 484 ~~~~~-----~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~ 558 (714)
+.+.. -....+++|||++|..|.+... +++ .++..|++++.-||+.| ++|||.+|+|++++++
T Consensus 104 yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~- 171 (229)
T PF06176_consen 104 YLAAEKKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNN- 171 (229)
T ss_pred eeeeeeeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECC-
Confidence 32222 2234568999999988776642 121 35567888899999999 9999999999999965
Q ss_pred ceEEecCCCccc
Q 041576 559 TAKISDFGLSKL 570 (714)
Q Consensus 559 ~~kl~Dfg~~~~ 570 (714)
.++++||+..+.
T Consensus 172 ~i~iID~~~k~~ 183 (229)
T PF06176_consen 172 GIRIIDTQGKRM 183 (229)
T ss_pred cEEEEECccccc
Confidence 499999987653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.20 E-value=1.5e-05 Score=79.82 Aligned_cols=132 Identities=16% Similarity=0.155 Sum_probs=85.7
Q ss_pred hhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCccc--ccceeceEecCCeeeEEEeecCCC
Q 041576 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKN--LVQLLGFCDEGLNRLLVYEFMGNG 503 (714)
Q Consensus 426 ~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--Iv~l~~~~~~~~~~~lv~E~~~~g 503 (714)
+.||+|..+.||+. .+..+++|...... ......+|.+++..+..-. +.+.+++....+...+|||+++|.
T Consensus 7 ~~i~~G~t~~~y~~-----~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~ 79 (226)
T TIGR02172 7 TQTGEGGNGESYTH-----KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGK 79 (226)
T ss_pred eeecCCCCcceeEe-----cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCc
Confidence 57899999999983 24467888876532 3345688999999886443 467788887777788999999996
Q ss_pred c-hhhhhhcCCCCChhhHHHHHHHHHHHH---------------------------------------HHHHhc-CCCCe
Q 041576 504 T-LANLLFAIPRPDWSLRVRISLEIARGL---------------------------------------LYLHEE-CNVPI 542 (714)
Q Consensus 504 s-L~~~l~~~~~~~~~~~~~i~~qi~~~L---------------------------------------~yLH~~-~~~~i 542 (714)
+ +...+.. +......++.++++.+ .+|... ....+
T Consensus 80 ~~~~~~~~~----~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~ 155 (226)
T TIGR02172 80 RSFSRIISD----NPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTC 155 (226)
T ss_pred cchhhhhcC----CHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCce
Confidence 3 2211110 0011111111111111 222211 12357
Q ss_pred EecCCCcCeEEECCCCceEEecCCCcc
Q 041576 543 IHCDIKPQNILLDQDFTAKISDFGLSK 569 (714)
Q Consensus 543 vH~Dlk~~NIll~~~~~~kl~Dfg~~~ 569 (714)
+|+|++|.||++++++ +.|+||+.+.
T Consensus 156 ~HgD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 156 LHGDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred EecCCCCCcEEEcCCC-cEEEechhcC
Confidence 8999999999999988 9999999875
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.15 E-value=1.7e-05 Score=80.60 Aligned_cols=137 Identities=15% Similarity=0.110 Sum_probs=84.4
Q ss_pred hhCcccc-eeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccC-cccccceeceEecCCeeeEEEeecCCCc
Q 041576 427 ELGRGSF-GIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTH-HKNLVQLLGFCDEGLNRLLVYEFMGNGT 504 (714)
Q Consensus 427 ~ig~G~~-g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~E~~~~gs 504 (714)
.|..|.. ..||+... .+..++||+..... ...+.+|+++++.+. +--+.+++++...++..++|||+++|.+
T Consensus 5 ~~~~g~~~~~v~~~~~---~~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~ 78 (244)
T cd05150 5 RVTEGQSGATVYRLDG---KNPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVP 78 (244)
T ss_pred ecCCCCCcCeEEEEcC---CCCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCcc
Confidence 3445555 78898754 24688888886542 345677888888873 4446677887777667899999999987
Q ss_pred hhhhhh-------------------cCCC--CChh----hHHHHHH--------------------HHHHHHHHHHhc--
Q 041576 505 LANLLF-------------------AIPR--PDWS----LRVRISL--------------------EIARGLLYLHEE-- 537 (714)
Q Consensus 505 L~~~l~-------------------~~~~--~~~~----~~~~i~~--------------------qi~~~L~yLH~~-- 537 (714)
|..... ..+. .... ....... .+.+.+..|-..
T Consensus 79 l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 158 (244)
T cd05150 79 AAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRP 158 (244)
T ss_pred HhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCC
Confidence 764421 1100 0000 0000000 011112222111
Q ss_pred --CCCCeEecCCCcCeEEECCCCceEEecCCCcc
Q 041576 538 --CNVPIIHCDIKPQNILLDQDFTAKISDFGLSK 569 (714)
Q Consensus 538 --~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~ 569 (714)
..+.++|+|+.|.||+++++....|+||+.+.
T Consensus 159 ~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 159 AEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred CcCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 12458999999999999998778999998875
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.07 E-value=1.8e-05 Score=87.47 Aligned_cols=138 Identities=22% Similarity=0.242 Sum_probs=89.3
Q ss_pred hhhCcccceeEEEeEeeCCCCcEEEEEEecccchhh-------------------------------------HHHHHHH
Q 041576 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQER-------------------------------------EREFKTE 468 (714)
Q Consensus 426 ~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~-------------------------------------~~~~~~E 468 (714)
+.||..+.+.||+|+++ +|+.||||+-+..-+.. +-+|.+|
T Consensus 167 ~piaaASlaQVhrA~L~--~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~E 244 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLK--NGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKE 244 (538)
T ss_pred chhhhcchhheEEEEec--CCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHH
Confidence 46999999999999998 59999999876422110 1134455
Q ss_pred HHHHhcc----Cccc------ccceeceEecCCeeeEEEeecCCCchhhhhh-cCCCCChhhHHHHHHHHHHHH-HHHHh
Q 041576 469 VSAIGRT----HHKN------LVQLLGFCDEGLNRLLVYEFMGNGTLANLLF-AIPRPDWSLRVRISLEIARGL-LYLHE 536 (714)
Q Consensus 469 ~~~l~~l----~h~n------Iv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~-~~~~~~~~~~~~i~~qi~~~L-~yLH~ 536 (714)
.+...+. .|-+ |.+++- .-...+.|+|||++|..+.+.-. .....+.. .|+..+.++. ..+=.
T Consensus 245 A~Nae~~~~~f~~~~~~~~V~VP~Vy~--~~st~RVLtME~~~G~~i~Dl~~i~~~gi~~~---~i~~~l~~~~~~qIf~ 319 (538)
T KOG1235|consen 245 AKNAERFRENFKDFSLLTYVLVPKVYW--DLSTKRVLTMEYVDGIKINDLDAIDKRGISPH---DILNKLVEAYLEQIFK 319 (538)
T ss_pred HHhHHHHHHHHHhcccccceeCCeehh--hcCcceEEEEEecCCccCCCHHHHHHcCCCHH---HHHHHHHHHHHHHHHh
Confidence 5544443 3444 223222 22346789999999998877643 12334444 3333333332 22223
Q ss_pred cCCCCeEecCCCcCeEEECC----CCceEEecCCCcccccc
Q 041576 537 ECNVPIIHCDIKPQNILLDQ----DFTAKISDFGLSKLLLS 573 (714)
Q Consensus 537 ~~~~~ivH~Dlk~~NIll~~----~~~~kl~Dfg~~~~~~~ 573 (714)
.| ++|+|-+|.||+++. ++.+.+-|||+...+..
T Consensus 320 ~G---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 320 TG---FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred cC---CccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 34 999999999999984 67899999999986644
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.04 E-value=4.8e-05 Score=76.46 Aligned_cols=139 Identities=20% Similarity=0.209 Sum_probs=82.7
Q ss_pred hhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCcc--cccceeceEec---CCeeeEEEeec
Q 041576 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHK--NLVQLLGFCDE---GLNRLLVYEFM 500 (714)
Q Consensus 426 ~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--nIv~l~~~~~~---~~~~~lv~E~~ 500 (714)
+.|+.|..+.||+.... +..+++|..... .....+.+|..++..+... .+.+++..... ....+++|+++
T Consensus 3 ~~l~~G~~n~~~~v~~~---~~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i 77 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTD---DGRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYI 77 (239)
T ss_dssp EEEEESSSSEEEEEEET---TSEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEE
T ss_pred ccCCCCCeeeEEEEEEC---CcEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEe
Confidence 56888999999998764 359999998654 4556778888888888533 35566664422 23468999999
Q ss_pred CCCchhh----------------hh---hcC--C--CCCh-h--------hHHHH------------HHHHHH-HHHHHH
Q 041576 501 GNGTLAN----------------LL---FAI--P--RPDW-S--------LRVRI------------SLEIAR-GLLYLH 535 (714)
Q Consensus 501 ~~gsL~~----------------~l---~~~--~--~~~~-~--------~~~~i------------~~qi~~-~L~yLH 535 (714)
++..+.. .+ +.. . .... . ..... ...+.+ .++.++
T Consensus 78 ~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (239)
T PF01636_consen 78 PGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELE 157 (239)
T ss_dssp SSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHH
Confidence 9988877 11 111 0 0000 0 00000 112222 333333
Q ss_pred hc----CCCCeEecCCCcCeEEEC-CCCceEEecCCCcc
Q 041576 536 EE----CNVPIIHCDIKPQNILLD-QDFTAKISDFGLSK 569 (714)
Q Consensus 536 ~~----~~~~ivH~Dlk~~NIll~-~~~~~kl~Dfg~~~ 569 (714)
+. ....++|+|+.|.||+++ +++.+.|+||+.+.
T Consensus 158 ~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 158 ALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred hhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 21 234599999999999999 66666899998875
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.00 E-value=2.3e-05 Score=75.95 Aligned_cols=102 Identities=25% Similarity=0.369 Sum_probs=83.7
Q ss_pred HHHHHHHhccCc-ccccceeceEecCCeeeEEEeecCCCchhhh---hhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCC
Q 041576 466 KTEVSAIGRTHH-KNLVQLLGFCDEGLNRLLVYEFMGNGTLANL---LFAIPRPDWSLRVRISLEIARGLLYLHEECNVP 541 (714)
Q Consensus 466 ~~E~~~l~~l~h-~nIv~l~~~~~~~~~~~lv~E~~~~gsL~~~---l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ 541 (714)
.+|.-+++.+++ +++.+++|+| ..++|.||...+++... +..-...+|..+.+|+.++++.+.+|++.-...
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 458888888866 6999999999 34789999987766432 222234689999999999999999999965556
Q ss_pred eEecCCCcCeEEECCCCceEEecCCCcccc
Q 041576 542 IIHCDIKPQNILLDQDFTAKISDFGLSKLL 571 (714)
Q Consensus 542 ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~ 571 (714)
+...|++++|+-+++++++|++|...+...
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 888999999999999999999999877654
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.92 E-value=2.2e-06 Score=93.52 Aligned_cols=183 Identities=16% Similarity=0.104 Sum_probs=131.6
Q ss_pred hhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCccc-ccceeceEecCCeeeEEEeecCC
Q 041576 424 FEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKN-LVQLLGFCDEGLNRLLVYEFMGN 502 (714)
Q Consensus 424 ~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-Iv~l~~~~~~~~~~~lv~E~~~~ 502 (714)
+-..+++++++.++|.+.. ..+...++.+... ....-++++|.+++||| .++.++-++.+...+++++++..
T Consensus 246 ~fh~fvK~altknpKkRpt--aeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~ 318 (829)
T KOG0576|consen 246 FFHNFVKGALTKNPKKRPT--AEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICST 318 (829)
T ss_pred HHHHHHHHHhcCCCccCCC--hhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcC
Confidence 3456788999999987532 2223334444321 45566889999999999 77778878888889999999988
Q ss_pred C-chhhhhh-cCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCccccee
Q 041576 503 G-TLANLLF-AIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRT 580 (714)
Q Consensus 503 g-sL~~~l~-~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 580 (714)
+ +-..... ..-.+...+...+...-++++++||+.- =+|+| ||+..+ +..+..||+....+.... ...
T Consensus 319 ~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~--~~~ 388 (829)
T KOG0576|consen 319 GRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM--KPR 388 (829)
T ss_pred CccccccCChhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCccc--ccc
Confidence 7 2222221 1122334445566677788999999863 48888 776665 688999999987765433 344
Q ss_pred eecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCc
Q 041576 581 VIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVE 623 (714)
Q Consensus 581 ~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~ 623 (714)
...+++.++|||......+..+.|+|++|+--.++--|-+|-.
T Consensus 389 t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 389 TAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred cCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 5568999999999999999999999999987777776766654
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.77 E-value=0.00029 Score=73.73 Aligned_cols=75 Identities=8% Similarity=0.051 Sum_probs=54.7
Q ss_pred hhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCc---ccccceeceEecC---CeeeEEEee
Q 041576 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHH---KNLVQLLGFCDEG---LNRLLVYEF 499 (714)
Q Consensus 426 ~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---~nIv~l~~~~~~~---~~~~lv~E~ 499 (714)
+.||.|..+.||+.... ++ .+++|..+.. .....+..|.+.|+.+.- ..+.++++++..+ +..++|||+
T Consensus 20 ~~i~~G~~~~vy~~~~~--~~-~~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~ 94 (297)
T PRK10593 20 ECISEQPYAALWALYDS--QG-NPMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLER 94 (297)
T ss_pred eecCCccceeEEEEEcC--CC-CEEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEec
Confidence 56999999999987542 23 5677775431 123578899999988842 4678888887543 568999999
Q ss_pred cCCCch
Q 041576 500 MGNGTL 505 (714)
Q Consensus 500 ~~~gsL 505 (714)
+++.++
T Consensus 95 i~G~~~ 100 (297)
T PRK10593 95 LRGVSV 100 (297)
T ss_pred cCCEec
Confidence 998765
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.75 E-value=0.00022 Score=72.14 Aligned_cols=74 Identities=16% Similarity=0.219 Sum_probs=45.8
Q ss_pred hhhCcccce-eEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCcc---cccceeceEecC---CeeeEEEe
Q 041576 426 EELGRGSFG-IVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHK---NLVQLLGFCDEG---LNRLLVYE 498 (714)
Q Consensus 426 ~~ig~G~~g-~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---nIv~l~~~~~~~---~~~~lv~E 498 (714)
+.|+.|+.. .||+. +..+++|..+.. .....+.+|.+.+..+... -+.++++..... ...+++||
T Consensus 3 ~~~~~gG~~n~vy~~------~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~ 74 (235)
T cd05155 3 EPVDSGGTDNATFRL------GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYR 74 (235)
T ss_pred eeccCCCcccceEEc------CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEE
Confidence 456766665 58874 235777876542 2345788899998887532 344445444332 23488999
Q ss_pred ecCCCchhh
Q 041576 499 FMGNGTLAN 507 (714)
Q Consensus 499 ~~~~gsL~~ 507 (714)
+++|.++.+
T Consensus 75 ~i~G~~l~~ 83 (235)
T cd05155 75 WLEGETATA 83 (235)
T ss_pred eecCCCCCc
Confidence 999977743
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.68 E-value=0.00059 Score=66.47 Aligned_cols=127 Identities=18% Similarity=0.237 Sum_probs=89.9
Q ss_pred hhhCcccceeEEEeEeeCCCCcEEEEEEecccc----------------hhhHHHHHHHHHHHhccC------cccccce
Q 041576 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA----------------QEREREFKTEVSAIGRTH------HKNLVQL 483 (714)
Q Consensus 426 ~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~E~~~l~~l~------h~nIv~l 483 (714)
..||+|+.-.||. +. .....+||+..... ....++..+|+....++. +.+|.++
T Consensus 7 ~~i~~G~~R~cy~--HP--~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 7 DLIAQGGERDCYQ--HP--DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred cccccCCCceEEE--CC--CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 5799999999996 22 45577888886544 123456667766665555 8899999
Q ss_pred eceEecCCeeeEEEeecCC------CchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCC
Q 041576 484 LGFCDEGLNRLLVYEFMGN------GTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQD 557 (714)
Q Consensus 484 ~~~~~~~~~~~lv~E~~~~------gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~ 557 (714)
+|+.+.+...-+|+|.+.+ .+|.+++... .++. . +...+-+-..||-+.+ |+.+|++|.||++..+
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~-~~~~-~---~~~~L~~f~~~l~~~~---Iv~~dl~~~NIv~~~~ 154 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKEG-GLTE-E---LRQALDEFKRYLLDHH---IVIRDLNPHNIVVQRR 154 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHHcC-CccH-H---HHHHHHHHHHHHHHcC---CeecCCCcccEEEEec
Confidence 9999999999999998754 2677777543 3443 3 3333334456677766 9999999999999543
Q ss_pred C----ceEEec
Q 041576 558 F----TAKISD 564 (714)
Q Consensus 558 ~----~~kl~D 564 (714)
. .+.|+|
T Consensus 155 ~~~~~~lvlID 165 (199)
T PF10707_consen 155 DSGEFRLVLID 165 (199)
T ss_pred CCCceEEEEEe
Confidence 2 577776
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.67 E-value=0.00037 Score=83.41 Aligned_cols=80 Identities=9% Similarity=0.220 Sum_probs=56.5
Q ss_pred hhhCcccceeEEEeEeeCCCC-cEEEEEEecccc-hhhHHHHHHHHHHHhccC-cccc--cceeceEecC---CeeeEEE
Q 041576 426 EELGRGSFGIVYKGVLKSASG-NAVAVKKLDKLA-QEREREFKTEVSAIGRTH-HKNL--VQLLGFCDEG---LNRLLVY 497 (714)
Q Consensus 426 ~~ig~G~~g~Vy~~~~~~~~~-~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~nI--v~l~~~~~~~---~~~~lv~ 497 (714)
+.++.|.+..+|+........ ..+++|+..... ......+.+|+++++.+. |.++ .+++.+|.+. ...++||
T Consensus 44 ~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVM 123 (822)
T PLN02876 44 SQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIM 123 (822)
T ss_pred EEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEE
Confidence 568899999999876542111 467777764322 123357889999999995 6665 7888888664 4578999
Q ss_pred eecCCCch
Q 041576 498 EFMGNGTL 505 (714)
Q Consensus 498 E~~~~gsL 505 (714)
||+++..+
T Consensus 124 E~v~G~~~ 131 (822)
T PLN02876 124 EYLEGRIF 131 (822)
T ss_pred EecCCccc
Confidence 99998654
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.66 E-value=0.00032 Score=65.51 Aligned_cols=129 Identities=22% Similarity=0.317 Sum_probs=89.2
Q ss_pred hhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEeecCCC
Q 041576 424 FEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEFMGNG 503 (714)
Q Consensus 424 ~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~g 503 (714)
..+.|++|.+|.||++.+. |..+|+|+-+..+ ....++.|+++|..++-.++.+=+-.+.. -++.|||+.|.
T Consensus 26 v~~~L~KG~~s~Vyl~~~~---~~~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~yg~---~~i~me~i~G~ 97 (201)
T COG2112 26 VEKELAKGTTSVVYLGEWR---GGEVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFYGE---DFIRMEYIDGR 97 (201)
T ss_pred hhhhhhcccccEEEEeecc---CceEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEech---hhhhhhhhcCc
Confidence 4578999999999999985 6699999886543 35678999999998887766543322222 23459999998
Q ss_pred chhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCC-cCeEEECCCCceEEecCCCccc
Q 041576 504 TLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIK-PQNILLDQDFTAKISDFGLSKL 570 (714)
Q Consensus 504 sL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk-~~NIll~~~~~~kl~Dfg~~~~ 570 (714)
.|.+.-... + .+-...+++.---|...| |-|+.|+ |...+|-.+..+.|+||.-|..
T Consensus 98 ~L~~~~~~~---~----rk~l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 98 PLGKLEIGG---D----RKHLLRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred chhhhhhcc---c----HHHHHHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 877765431 1 223344555544555555 9999987 4444444445999999998873
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.58 E-value=0.00026 Score=82.98 Aligned_cols=198 Identities=20% Similarity=0.206 Sum_probs=139.8
Q ss_pred HHHHHHHHHHhccCcccccceeceEecCCee----eEEEeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcC
Q 041576 463 REFKTEVSAIGRTHHKNLVQLLGFCDEGLNR----LLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEEC 538 (714)
Q Consensus 463 ~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~----~lv~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~ 538 (714)
...+.|++.+.++.|+|++.++.+-.+.... .+..|++..-++...+......+....+.+..++.+||+|+|+..
T Consensus 227 ~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~ 306 (1351)
T KOG1035|consen 227 QTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLS 306 (1351)
T ss_pred HHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhc
Confidence 3456678888899999999999987554433 355678888899999988888899999999999999999999985
Q ss_pred CCCeEecCCCcC---eEEECCCCceEEe--cCCCccccccCcccceeeecCCCCccCcccccCCCCCc--hhhhHHHHHH
Q 041576 539 NVPIIHCDIKPQ---NILLDQDFTAKIS--DFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPVSA--KVDVYSFGVV 611 (714)
Q Consensus 539 ~~~ivH~Dlk~~---NIll~~~~~~kl~--Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~--ksDVwSlGvi 611 (714)
..|.-|..+ +-..+.++...++ ||+..+.......... ...+..+.+||.......+. ..|+|.+|..
T Consensus 307 ---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~--~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll 381 (1351)
T KOG1035|consen 307 ---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFS--DLLAEIRNADEDLKENTAKKSRLTDLWCLGLL 381 (1351)
T ss_pred ---cceeEEecccccccccCccceeecchhhhcccccCCCcccchh--hcCccccccccccccccchhhhhhHHHHHHHH
Confidence 555544444 4455666777777 8888876644332211 12355688888887766555 4799999999
Q ss_pred HHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 612 LLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 612 l~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
+..+..|..+-....... .+.+ .... ..+.+....|+..++++|+++.+++..
T Consensus 382 ~~~~~~~~~i~~~~~~~~-------------------~~l~----~~~~----~~~~d~~~~~~~~~~~~Rl~~~~ll~~ 434 (1351)
T KOG1035|consen 382 LLQLSQGEDISEKSAVPV-------------------SLLD----VLST----SELLDALPKCLDEDSEERLSALELLTH 434 (1351)
T ss_pred HhhhhhcCcccccccchh-------------------hhhc----cccc----hhhhhhhhhhcchhhhhccchhhhhhc
Confidence 999988876543221110 0000 0000 034457778999999999999999886
Q ss_pred H
Q 041576 692 L 692 (714)
Q Consensus 692 L 692 (714)
.
T Consensus 435 ~ 435 (1351)
T KOG1035|consen 435 P 435 (1351)
T ss_pred h
Confidence 4
|
|
| >PF08276 PAN_2: PAN-like domain; InterPro: IPR013227 PAN domains have significant functional versatility fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions [] | Back alignment and domain information |
|---|
Probab=97.53 E-value=4.4e-05 Score=60.11 Aligned_cols=56 Identities=9% Similarity=-0.145 Sum_probs=43.2
Q ss_pred ceeEEeccccCCCCCcccccccccccccccChhhHHHHhhhcCCCCccccc----cCCCCCCCCCcc
Q 041576 300 LYEIRELADVNWPLGYYQKRFPLALGAYDYTRTGFTKALIKVRKGGFRVDF----DGNTGGKKGIPI 362 (714)
Q Consensus 300 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~C~~~cl~~c~c~~~~~~----~~~~c~~~~~~l 362 (714)
.++|+++++|++|++..... ..+.+.++|++.|+++|+|. ++.+ ++++|..|...+
T Consensus 4 ~d~F~~l~~~~~p~~~~~~~------~~~~s~~~C~~~Cl~nCsC~-Ayay~~~~~~~~C~lW~~~L 63 (66)
T PF08276_consen 4 GDGFLKLPNMKLPDFDNAIV------DSSVSLEECEKACLSNCSCT-AYAYSNLSGGGGCLLWYGDL 63 (66)
T ss_pred CCEEEEECCeeCCCCcceee------ecCCCHHHHHhhcCCCCCEe-eEEeeccCCCCEEEEEcCEe
Confidence 36899999999999866543 24588999999999999998 4444 357887775543
|
These domains contain a hair-pin loop like structure, similar to knottins, but the pattern of disulphide bonds differs |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.51 E-value=0.00065 Score=65.64 Aligned_cols=135 Identities=30% Similarity=0.402 Sum_probs=95.4
Q ss_pred CCccccCHHHHHHHhhhhhhhhCcccc-eeEEEeEeeCCCCcEEEEEEecc------------cch---------hhHHH
Q 041576 407 TNLRFFSLVELNEATNGFEEELGRGSF-GIVYKGVLKSASGNAVAVKKLDK------------LAQ---------ERERE 464 (714)
Q Consensus 407 ~~~~~~~~~el~~at~~~~~~ig~G~~-g~Vy~~~~~~~~~~~vavK~~~~------------~~~---------~~~~~ 464 (714)
..++.|+.. .+..+|.+.||.|.. |.||++... |+.+|+|.++. ... .....
T Consensus 27 PKL~~F~~h---~~~I~flefLg~g~~~~~V~kv~I~---g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~P 100 (207)
T PF13095_consen 27 PKLEPFTHH---GDDIEFLEFLGHGSHDGYVFKVEID---GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADP 100 (207)
T ss_pred CCcCCcCCC---CCcEeeeeecCCCCceeEEEEEEEC---CeEEEEEEeeccccCCCccccccccccccccchhhhhcCh
Confidence 345566662 267778899999999 999999874 88999999421 000 11235
Q ss_pred HHHHHHHHhccC---cccc--cceeceEecCC------------------eeeEEEeecCCCchhhhhhcCCCCChhhHH
Q 041576 465 FKTEVSAIGRTH---HKNL--VQLLGFCDEGL------------------NRLLVYEFMGNGTLANLLFAIPRPDWSLRV 521 (714)
Q Consensus 465 ~~~E~~~l~~l~---h~nI--v~l~~~~~~~~------------------~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~ 521 (714)
|..|++...+|+ +.++ ++.+|+..-.. ...||.||++... ....
T Consensus 101 F~~ECRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------------~~~~ 167 (207)
T PF13095_consen 101 FNCECRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------------PLQI 167 (207)
T ss_pred HHHHHHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------------ccch
Confidence 889999988884 4456 88888872220 1246777765422 2234
Q ss_pred HHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCc
Q 041576 522 RISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLS 568 (714)
Q Consensus 522 ~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~ 568 (714)
+-+.+|.+-|..+|..| |+-+|+++.|.. .-||+|||.+
T Consensus 168 ~~~~~~~~dl~~~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 168 RDIPQMLRDLKILHKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred hHHHHHHHHHHHHHHCC---eeeccCcccccc-----CCEEEecccC
Confidence 45667888889999998 999999999985 4588999864
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.51 E-value=0.00086 Score=67.65 Aligned_cols=76 Identities=20% Similarity=0.181 Sum_probs=47.3
Q ss_pred hhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCcccc-cceeceEecCCeeeEEEeecCCCc
Q 041576 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNL-VQLLGFCDEGLNRLLVYEFMGNGT 504 (714)
Q Consensus 426 ~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~l~~~~~~~~~~~lv~E~~~~gs 504 (714)
+.|..|-...+|+......++..+++|....... ......+|+.+++.+....+ .++++... ..++|||++|.+
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~-~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~ 78 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE-LIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT 78 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc-ceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence 4577788889998764311256888997754322 12234578888888854334 34443332 248999999877
Q ss_pred hh
Q 041576 505 LA 506 (714)
Q Consensus 505 L~ 506 (714)
+.
T Consensus 79 l~ 80 (235)
T cd05157 79 LE 80 (235)
T ss_pred CC
Confidence 63
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.47 E-value=0.00066 Score=69.58 Aligned_cols=136 Identities=13% Similarity=0.118 Sum_probs=77.8
Q ss_pred hhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCcccc-cceeceEecCCeeeEEEeecCCCch
Q 041576 427 ELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNL-VQLLGFCDEGLNRLLVYEFMGNGTL 505 (714)
Q Consensus 427 ~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~l~~~~~~~~~~~lv~E~~~~gsL 505 (714)
.+..|-...+|+... ++..+++|........-.....+|.++++.+....+ .+++.... .++|+||++|..+
T Consensus 3 ~~~~G~tn~~y~~~~---~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~ 75 (256)
T TIGR02721 3 TLSGGLTNRSWRIEH---PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVI 75 (256)
T ss_pred cCCCcCcCCeEEEEe---CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccc
Confidence 356677889998752 467888887654322211235778888888854333 34444332 3689999998765
Q ss_pred hhh-----------------hhcCCC----CChhh-HHHHHHH---------HHHHHHHHHhc-----CCCCeEecCCCc
Q 041576 506 ANL-----------------LFAIPR----PDWSL-RVRISLE---------IARGLLYLHEE-----CNVPIIHCDIKP 549 (714)
Q Consensus 506 ~~~-----------------l~~~~~----~~~~~-~~~i~~q---------i~~~L~yLH~~-----~~~~ivH~Dlk~ 549 (714)
... ++..+. ++... ......+ +.+.+..+... ....++|+|+.|
T Consensus 76 ~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~ 155 (256)
T TIGR02721 76 TLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHA 155 (256)
T ss_pred ccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCc
Confidence 431 111111 11111 1111111 11112222221 123489999999
Q ss_pred CeEEECCCCceEEecCCCccc
Q 041576 550 QNILLDQDFTAKISDFGLSKL 570 (714)
Q Consensus 550 ~NIll~~~~~~kl~Dfg~~~~ 570 (714)
.||++++++ +.|+||..+..
T Consensus 156 ~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 156 YNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred CcEEEeCCC-CEEEeccccCc
Confidence 999999877 78999988753
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.31 E-value=0.0012 Score=69.29 Aligned_cols=138 Identities=14% Similarity=0.140 Sum_probs=83.7
Q ss_pred hhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCccc--ccceece------EecCCeeeEEE
Q 041576 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKN--LVQLLGF------CDEGLNRLLVY 497 (714)
Q Consensus 426 ~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--Iv~l~~~------~~~~~~~~lv~ 497 (714)
+.|..|....+|+.... +..+++|+... .....+..|++++..+.+.. +.+++.. ...++..++|+
T Consensus 20 ~~i~~G~~n~~y~v~~~---~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~ 93 (296)
T cd05153 20 EGISAGIENTNYFVTTD---SGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALV 93 (296)
T ss_pred ecccCccccceEEEEeC---CCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEE
Confidence 45778888899987543 45788898764 23345677788777774332 4454442 12334568999
Q ss_pred eecCCCchhh----hh----------hcC-CC----------CChhhH----------HHHHHHHHHHHHHHHhc----C
Q 041576 498 EFMGNGTLAN----LL----------FAI-PR----------PDWSLR----------VRISLEIARGLLYLHEE----C 538 (714)
Q Consensus 498 E~~~~gsL~~----~l----------~~~-~~----------~~~~~~----------~~i~~qi~~~L~yLH~~----~ 538 (714)
++++|..+.. .. +.. .. ..|... ......+..++.++... -
T Consensus 94 ~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~ 173 (296)
T cd05153 94 EFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDL 173 (296)
T ss_pred EeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence 9999876532 00 100 00 011110 01112234445555541 1
Q ss_pred CCCeEecCCCcCeEEECCCCceEEecCCCcc
Q 041576 539 NVPIIHCDIKPQNILLDQDFTAKISDFGLSK 569 (714)
Q Consensus 539 ~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~ 569 (714)
...++|+|+.|.||+++++..+.|+||+.+.
T Consensus 174 ~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 174 PRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 2359999999999999998778999998875
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.11 E-value=0.0061 Score=65.89 Aligned_cols=74 Identities=16% Similarity=0.213 Sum_probs=51.4
Q ss_pred hhhCcccceeEEEeEeeCCCC-cEEEEEEecccc-------hhhHHHHHHHHHHHhccC---cccccceeceEecCCeee
Q 041576 426 EELGRGSFGIVYKGVLKSASG-NAVAVKKLDKLA-------QEREREFKTEVSAIGRTH---HKNLVQLLGFCDEGLNRL 494 (714)
Q Consensus 426 ~~ig~G~~g~Vy~~~~~~~~~-~~vavK~~~~~~-------~~~~~~~~~E~~~l~~l~---h~nIv~l~~~~~~~~~~~ 494 (714)
+.||.|.+..||++... +| +.++||.-.... .-.......|.+.|..+. -.++.+++.+ +....+
T Consensus 32 ~elggGn~N~VyrV~~~--~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~ 107 (401)
T PRK09550 32 REIGDGNLNLVFRVSDT--EGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAV 107 (401)
T ss_pred eEcCCCceEEEEEEEeC--CCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCE
Confidence 57999999999999875 34 589999854211 123456677888887762 2446666665 445678
Q ss_pred EEEeecCCC
Q 041576 495 LVYEFMGNG 503 (714)
Q Consensus 495 lv~E~~~~g 503 (714)
+|||++++.
T Consensus 108 lVME~L~~~ 116 (401)
T PRK09550 108 TVMEDLSDH 116 (401)
T ss_pred EEEecCCCc
Confidence 999999864
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=96.96 E-value=0.006 Score=64.32 Aligned_cols=139 Identities=15% Similarity=0.203 Sum_probs=79.8
Q ss_pred hhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCcc--cccceeceE------ecCCeeeEEE
Q 041576 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHK--NLVQLLGFC------DEGLNRLLVY 497 (714)
Q Consensus 426 ~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--nIv~l~~~~------~~~~~~~lv~ 497 (714)
+.++.|....+|+.... +..+++|+.+... ....+..|++++..|... .+.+++... ...+..++++
T Consensus 28 ~~~~~G~~n~~y~v~t~---~~~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~ 102 (307)
T TIGR00938 28 KGIAEGVENSNYLLTTD---VGRYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLV 102 (307)
T ss_pred cccCCccccceEEEEeC---CCcEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEE
Confidence 45777877899987532 3367788775421 123445666666666322 234444321 2234568999
Q ss_pred eecCCCchhhh--------------hhcC-CCC-----------ChhhHH------------HHHHHHHHHHHHHHh---
Q 041576 498 EFMGNGTLANL--------------LFAI-PRP-----------DWSLRV------------RISLEIARGLLYLHE--- 536 (714)
Q Consensus 498 E~~~~gsL~~~--------------l~~~-~~~-----------~~~~~~------------~i~~qi~~~L~yLH~--- 536 (714)
||++|..+... ++.. ..+ .|.... .....+.+.++++..
T Consensus 103 e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~ 182 (307)
T TIGR00938 103 EFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWP 182 (307)
T ss_pred EeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhh
Confidence 99998654211 1110 000 111100 011223345555543
Q ss_pred -cCCCCeEecCCCcCeEEECCCCceEEecCCCcc
Q 041576 537 -ECNVPIIHCDIKPQNILLDQDFTAKISDFGLSK 569 (714)
Q Consensus 537 -~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~ 569 (714)
.....++|+|+++.||++++++...|+||+.+.
T Consensus 183 ~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 183 RDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred hcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 123469999999999999998877899999874
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.95 E-value=0.0071 Score=63.10 Aligned_cols=137 Identities=20% Similarity=0.251 Sum_probs=84.3
Q ss_pred hhCcccceeEEEeEeeCCCCcEEEEEEec-ccchhhHHHHHHHHHHHhccCc--ccccceeceEecCC--eeeEEEeecC
Q 041576 427 ELGRGSFGIVYKGVLKSASGNAVAVKKLD-KLAQEREREFKTEVSAIGRTHH--KNLVQLLGFCDEGL--NRLLVYEFMG 501 (714)
Q Consensus 427 ~ig~G~~g~Vy~~~~~~~~~~~vavK~~~-~~~~~~~~~~~~E~~~l~~l~h--~nIv~l~~~~~~~~--~~~lv~E~~~ 501 (714)
++..|..-.+|.... +++++++.+-. ...........+|+++++.+.- .-+.+.+++|.++. ..+.||+|++
T Consensus 32 ~~~~G~sn~t~~~~~---~~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~ve 108 (321)
T COG3173 32 EISGGWSNDTFRLGD---TGQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVE 108 (321)
T ss_pred eccCCcccceEEEec---CCceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEec
Confidence 344444445555432 36778888221 1223344566778888887743 33456677776666 6699999999
Q ss_pred CCchhhhhhcCCCCChhhHHHHH-HHHHHHHHHHHh--------------------------------------------
Q 041576 502 NGTLANLLFAIPRPDWSLRVRIS-LEIARGLLYLHE-------------------------------------------- 536 (714)
Q Consensus 502 ~gsL~~~l~~~~~~~~~~~~~i~-~qi~~~L~yLH~-------------------------------------------- 536 (714)
|..+.+.+..... . .+.+ ..+++.|+-||+
T Consensus 109 Ge~~~~~~~~~~~---~--~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~ 183 (321)
T COG3173 109 GEVVWSALPPESL---G--RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRL 183 (321)
T ss_pred ceeccCcCCcccc---h--HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHH
Confidence 8544333321110 0 1112 244444444443
Q ss_pred ------cC-----CCCeEecCCCcCeEEECCCCceEEecCCCcccc
Q 041576 537 ------EC-----NVPIIHCDIKPQNILLDQDFTAKISDFGLSKLL 571 (714)
Q Consensus 537 ------~~-----~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~ 571 (714)
+- .+.++|||+++.||+++.+.-+-|.||+++..-
T Consensus 184 ~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 184 IKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred HHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 21 356999999999999999988999999998754
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.93 E-value=0.0041 Score=65.42 Aligned_cols=139 Identities=24% Similarity=0.280 Sum_probs=81.5
Q ss_pred hhhCcccceeEEEeEeeC-----CCCcEEEEEEecccchhhHHHHHHHHHHHhccCcccc-cceeceEecCCeeeEEEee
Q 041576 426 EELGRGSFGIVYKGVLKS-----ASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNL-VQLLGFCDEGLNRLLVYEF 499 (714)
Q Consensus 426 ~~ig~G~~g~Vy~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~l~~~~~~~~~~~lv~E~ 499 (714)
+.+..|-...+|+..... ..++.+++|...... .......+|.+++..+....+ .++++++.. .+|+||
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence 345667777889876531 125789999876533 223456778888887743333 345555432 358999
Q ss_pred cCCCchhhh-h----------------hcCC-CC------C----hhhHHH--------------------------HHH
Q 041576 500 MGNGTLANL-L----------------FAIP-RP------D----WSLRVR--------------------------ISL 525 (714)
Q Consensus 500 ~~~gsL~~~-l----------------~~~~-~~------~----~~~~~~--------------------------i~~ 525 (714)
++|..+... + +... .. . +..... +..
T Consensus 79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (302)
T cd05156 79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE 158 (302)
T ss_pred eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence 998776431 0 1110 00 0 000000 111
Q ss_pred HHHHHHHHHHh------cCCCCeEecCCCcCeEEECCC----CceEEecCCCcc
Q 041576 526 EIARGLLYLHE------ECNVPIIHCDIKPQNILLDQD----FTAKISDFGLSK 569 (714)
Q Consensus 526 qi~~~L~yLH~------~~~~~ivH~Dlk~~NIll~~~----~~~kl~Dfg~~~ 569 (714)
++.+.++.|.. .....++|+|+.+.||+++++ +.++++||..+.
T Consensus 159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 22233344432 124568999999999999985 889999999885
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.83 E-value=0.0018 Score=66.23 Aligned_cols=134 Identities=14% Similarity=0.119 Sum_probs=92.1
Q ss_pred hhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecc---------cch-------------hhHHHHHHHHHHHhccCc--
Q 041576 422 NGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDK---------LAQ-------------EREREFKTEVSAIGRTHH-- 477 (714)
Q Consensus 422 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~---------~~~-------------~~~~~~~~E~~~l~~l~h-- 477 (714)
+.+.++||-|.-+.||.+... .|++.++|.=+- ..+ -..-...+|+..|+.+..
T Consensus 94 ~svGnqIGVGKESDIY~v~d~--~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g 171 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADE--EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG 171 (465)
T ss_pred hhhccccccccccceEEEecC--CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence 456789999999999999875 688888884221 000 001234578888887742
Q ss_pred ccccceeceEecCCeeeEEEeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCC
Q 041576 478 KNLVQLLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQD 557 (714)
Q Consensus 478 ~nIv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~ 557 (714)
--+.+.+++ +..++|||++.+-.|...-+- ...-.+...+..-+.-|-.+| +||+|..-=||+++++
T Consensus 172 fpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v------~d~~~ly~~lm~~Iv~la~~G---lIHgDFNEFNimv~dd 238 (465)
T KOG2268|consen 172 FPVPKPIDH----NRHCVVMELVDGYPLRQVRHV------EDPPTLYDDLMGLIVRLANHG---LIHGDFNEFNIMVKDD 238 (465)
T ss_pred CCCCCcccc----cceeeHHHhhcccceeeeeec------CChHHHHHHHHHHHHHHHHcC---ceecccchheeEEecC
Confidence 224444544 345799999998777665432 122334445555566677777 9999999999999999
Q ss_pred CceEEecCCCccc
Q 041576 558 FTAKISDFGLSKL 570 (714)
Q Consensus 558 ~~~kl~Dfg~~~~ 570 (714)
+.++++||--...
T Consensus 239 ~~i~vIDFPQmvS 251 (465)
T KOG2268|consen 239 DKIVVIDFPQMVS 251 (465)
T ss_pred CCEEEeechHhhc
Confidence 9999999965543
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.68 E-value=0.02 Score=60.62 Aligned_cols=138 Identities=12% Similarity=0.160 Sum_probs=74.7
Q ss_pred hhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCccc--ccceec------eEecCCeeeEEE
Q 041576 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKN--LVQLLG------FCDEGLNRLLVY 497 (714)
Q Consensus 426 ~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--Iv~l~~------~~~~~~~~~lv~ 497 (714)
+.|+.|....+|+.... +..+++|+.... ....+..|+..+..+.... +.+++. +....+..++++
T Consensus 28 ~~l~~G~~n~~y~v~t~---~g~~vLK~~~~~---~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~ 101 (319)
T PRK05231 28 KGIAEGIENSNFFLTTT---QGEYVLTLFERL---TAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIV 101 (319)
T ss_pred chhccccccceEEEEeC---CCcEEEEEeccC---ChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEE
Confidence 45777888899987643 336888987522 2233344555555542211 333332 112345678999
Q ss_pred eecCCCchhh-----------hh---hcC-CCC--------C--h-hhHHH------------HH-HHHHHHHHHHHhc-
Q 041576 498 EFMGNGTLAN-----------LL---FAI-PRP--------D--W-SLRVR------------IS-LEIARGLLYLHEE- 537 (714)
Q Consensus 498 E~~~~gsL~~-----------~l---~~~-~~~--------~--~-~~~~~------------i~-~qi~~~L~yLH~~- 537 (714)
||++|..+.. .+ +.. ..+ . + ..... .. ..+...++.+...
T Consensus 102 ~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 181 (319)
T PRK05231 102 TFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAA 181 (319)
T ss_pred EecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhccc
Confidence 9999875421 11 100 000 0 1 11100 11 1111222333211
Q ss_pred ---CCCCeEecCCCcCeEEECCCCceEEecCCCcc
Q 041576 538 ---CNVPIIHCDIKPQNILLDQDFTAKISDFGLSK 569 (714)
Q Consensus 538 ---~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~ 569 (714)
-...++|+|+++.||+++.+...-|+||+.+.
T Consensus 182 ~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 182 WPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 13459999999999999977666899999875
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.58 E-value=0.014 Score=60.43 Aligned_cols=72 Identities=17% Similarity=0.272 Sum_probs=46.7
Q ss_pred hhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccC---cccccceeceEecCCeeeEEEeecCC
Q 041576 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTH---HKNLVQLLGFCDEGLNRLLVYEFMGN 502 (714)
Q Consensus 426 ~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~nIv~l~~~~~~~~~~~lv~E~~~~ 502 (714)
+.++-|....+|+.. .+++.+.||.-.. .....|..|.+-|+.|. --.+.+++++....+..+||+||++.
T Consensus 23 ~~v~GG~i~~a~~~~---~~~~~~FvK~~~~---~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~ 96 (288)
T PF03881_consen 23 EPVSGGDINEAYRLD---TDGGSYFVKVNSE---SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEM 96 (288)
T ss_dssp EEE--SSSSEEEEEE---TTS-EEEEEEEEG---GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE----
T ss_pred EecCCCChhheEEEE---CCCccEEEEecCh---hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecC
Confidence 458888889999865 4678999998762 33456788888888773 45577889888877788999999987
Q ss_pred C
Q 041576 503 G 503 (714)
Q Consensus 503 g 503 (714)
+
T Consensus 97 ~ 97 (288)
T PF03881_consen 97 G 97 (288)
T ss_dssp -
T ss_pred C
Confidence 6
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.50 E-value=0.00027 Score=84.48 Aligned_cols=159 Identities=11% Similarity=-0.033 Sum_probs=113.9
Q ss_pred HHHHHHHHHhccCcccccceeceE--ecCCeeeEEEeecCCCchhhhhhcC----CCCChhhHHHHHHHHHHHHHHHHhc
Q 041576 464 EFKTEVSAIGRTHHKNLVQLLGFC--DEGLNRLLVYEFMGNGTLANLLFAI----PRPDWSLRVRISLEIARGLLYLHEE 537 (714)
Q Consensus 464 ~~~~E~~~l~~l~h~nIv~l~~~~--~~~~~~~lv~E~~~~gsL~~~l~~~----~~~~~~~~~~i~~qi~~~L~yLH~~ 537 (714)
....|...++...|+++.....-. .+..+.+.+++|+..|.+.+.|-+. +.++.........+...+..-.|+.
T Consensus 1275 mll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~ 1354 (2724)
T KOG1826|consen 1275 MLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSL 1354 (2724)
T ss_pred hhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhc
Confidence 344455555666888887655544 2344568999999999999998643 2333443444444435555555554
Q ss_pred C--CCCeEecCCCcCeEEECCCCceEEecCCCccccccCcccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHH
Q 041576 538 C--NVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKI 615 (714)
Q Consensus 538 ~--~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~el 615 (714)
. ..-.+|++||+-|.+|..+..+|+.++|+.+...+. ........+++.|++|+......++.++|+|..|+.+|++
T Consensus 1355 tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~-~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~r 1433 (2724)
T KOG1826|consen 1355 TNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPV-LSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLR 1433 (2724)
T ss_pred ccCCccchhhhhhhhccceecCCcccccccccccccCch-HhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHH
Confidence 3 234789999999999999999999999999843322 2222334577889999999999999999999999999999
Q ss_pred HhcCCCCc
Q 041576 616 ICCKRSVE 623 (714)
Q Consensus 616 ltG~~p~~ 623 (714)
--|..+|-
T Consensus 1434 s~~n~~fi 1441 (2724)
T KOG1826|consen 1434 SDGNAYFI 1441 (2724)
T ss_pred hcccHHHH
Confidence 88877764
|
|
| >cd01098 PAN_AP_plant Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Probab=96.37 E-value=0.0039 Score=51.58 Aligned_cols=55 Identities=9% Similarity=-0.109 Sum_probs=41.3
Q ss_pred ceeEEeccccCCCCCcccccccccccccccChhhHHHHhhhcCCCCccccc--cCCCCCCCCCccc
Q 041576 300 LYEIRELADVNWPLGYYQKRFPLALGAYDYTRTGFTKALIKVRKGGFRVDF--DGNTGGKKGIPIL 363 (714)
Q Consensus 300 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~C~~~cl~~c~c~~~~~~--~~~~c~~~~~~l~ 363 (714)
.++|+.+.++++|+..+.. ...+.++|++.|+++|+|. ++.+ ++++|..|..++.
T Consensus 11 ~~~f~~~~~~~~~~~~~~~--------~~~s~~~C~~~Cl~nCsC~-a~~~~~~~~~C~~~~~~~~ 67 (84)
T cd01098 11 TDGFLKLPDVKLPDNASAI--------TAISLEECREACLSNCSCT-AYAYNNGSGGCLLWNGLLN 67 (84)
T ss_pred CCEEEEeCCeeCCCchhhh--------ccCCHHHHHHHHhcCCCcc-eeeecCCCCeEEEEeceec
Confidence 3579999999999775532 4568899999999999997 4444 3678877765543
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.36 E-value=0.039 Score=57.10 Aligned_cols=31 Identities=29% Similarity=0.586 Sum_probs=25.8
Q ss_pred CCeEecCCCcCeEEECCCCc-eEEecCCCccc
Q 041576 540 VPIIHCDIKPQNILLDQDFT-AKISDFGLSKL 570 (714)
Q Consensus 540 ~~ivH~Dlk~~NIll~~~~~-~kl~Dfg~~~~ 570 (714)
..++|+|+++.||+++++++ .-|+||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 34899999999999997555 56999998864
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.36 E-value=0.022 Score=61.01 Aligned_cols=139 Identities=18% Similarity=0.203 Sum_probs=80.3
Q ss_pred hhCcccceeEEEeEeeCC---CCcEEEEEEecccchhhHHHHHHHHHHHhccCccccc-ceeceEecCCeeeEEEeecCC
Q 041576 427 ELGRGSFGIVYKGVLKSA---SGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLV-QLLGFCDEGLNRLLVYEFMGN 502 (714)
Q Consensus 427 ~ig~G~~g~Vy~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv-~l~~~~~~~~~~~lv~E~~~~ 502 (714)
.+..|-...+|+...... .++.|++|....... ..-...+|..+++.+...++. ++++.+..+ .|.||+++
T Consensus 43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~-~~idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~g 117 (344)
T PLN02236 43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVE-LFFDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIHA 117 (344)
T ss_pred EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCC-eeechHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeCC
Confidence 455577778888764321 246888998765432 222336788888888554443 455555333 58999987
Q ss_pred Cchhhh-----------------hhcCCC-----CC-hhhHHHHHHH-----------------HHHHHHHHH----h-c
Q 041576 503 GTLANL-----------------LFAIPR-----PD-WSLRVRISLE-----------------IARGLLYLH----E-E 537 (714)
Q Consensus 503 gsL~~~-----------------l~~~~~-----~~-~~~~~~i~~q-----------------i~~~L~yLH----~-~ 537 (714)
.+|... +|.... .. +....++..+ +...+..|. . .
T Consensus 118 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~ 197 (344)
T PLN02236 118 RTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDD 197 (344)
T ss_pred CCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccC
Confidence 776421 111110 11 2222222211 111222222 1 1
Q ss_pred CCCCeEecCCCcCeEEECC-CCceEEecCCCccc
Q 041576 538 CNVPIIHCDIKPQNILLDQ-DFTAKISDFGLSKL 570 (714)
Q Consensus 538 ~~~~ivH~Dlk~~NIll~~-~~~~kl~Dfg~~~~ 570 (714)
....++|+|+++.||++++ ++.+.++||..+..
T Consensus 198 ~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 198 QEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred CCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 1345899999999999986 47899999988753
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.24 E-value=0.039 Score=59.59 Aligned_cols=79 Identities=18% Similarity=0.212 Sum_probs=51.5
Q ss_pred hhhCcccceeEEEeEeeCCCCcEEEEEEecccch-------hhHHHHHHHHHHHhccC---cccccceeceEecCCeeeE
Q 041576 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQ-------EREREFKTEVSAIGRTH---HKNLVQLLGFCDEGLNRLL 495 (714)
Q Consensus 426 ~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~---h~nIv~l~~~~~~~~~~~l 495 (714)
+.||.|....||+... .+..++||+-..... .....-..|.+.|+.+. ..++.+++.++. +..++
T Consensus 38 ~eiggGn~N~VyrV~~---~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vl 112 (418)
T PLN02756 38 KEVGDGNLNFVYIVVS---SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALI 112 (418)
T ss_pred EEcCCCceeeEEEEEc---CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEE
Confidence 6789999999999764 345799997652111 12333444566666553 246778888777 44678
Q ss_pred EEeecCC--Cchhhhh
Q 041576 496 VYEFMGN--GTLANLL 509 (714)
Q Consensus 496 v~E~~~~--gsL~~~l 509 (714)
+||++++ ..+.+-+
T Consensus 113 vME~L~~~~~ilr~~L 128 (418)
T PLN02756 113 GMRYLEPPHIILRKGL 128 (418)
T ss_pred EEeecCCcceehhhhh
Confidence 9999976 3454444
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.16 E-value=0.049 Score=56.97 Aligned_cols=140 Identities=19% Similarity=0.175 Sum_probs=93.9
Q ss_pred hhhCcccceeEEEeEeeCCCCcEEEEEEeccc-----ch-----------------hhHH----HHHHHHHHHhccCccc
Q 041576 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDKL-----AQ-----------------ERER----EFKTEVSAIGRTHHKN 479 (714)
Q Consensus 426 ~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~-----~~-----------------~~~~----~~~~E~~~l~~l~h~n 479 (714)
-.|..|.-+.||.|.-. +|..+|||+.+.. ++ ...+ -.++|++.|++++...
T Consensus 150 GCiSTGKEANVYHat~~--dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG 227 (520)
T KOG2270|consen 150 GCISTGKEANVYHATEE--DGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG 227 (520)
T ss_pred cccccCccceeEeeecC--CCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence 35889999999998764 7888999987420 00 0011 1357888888886555
Q ss_pred ccceeceEecCCeeeEEEeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCc
Q 041576 480 LVQLLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFT 559 (714)
Q Consensus 480 Iv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~ 559 (714)
|.-.--+.. ....|||+|+....-..-.-..-.++...+..+-.|++.-+.-|.+.+ ++||.||+--|+|+-+ |.
T Consensus 228 IP~PePIlL--k~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Lyhd-G~ 302 (520)
T KOG2270|consen 228 IPCPEPILL--KNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLYHD-GK 302 (520)
T ss_pred CCCCCceee--ecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheEEC-CE
Confidence 432211111 134699999864222211112234566678888889999999998887 6999999999998864 58
Q ss_pred eEEecCCCccccc
Q 041576 560 AKISDFGLSKLLL 572 (714)
Q Consensus 560 ~kl~Dfg~~~~~~ 572 (714)
+.|+|-+-+....
T Consensus 303 lyiIDVSQSVE~D 315 (520)
T KOG2270|consen 303 LYIIDVSQSVEHD 315 (520)
T ss_pred EEEEEccccccCC
Confidence 9999988776543
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=95.89 E-value=0.016 Score=57.30 Aligned_cols=30 Identities=33% Similarity=0.557 Sum_probs=21.4
Q ss_pred CeEecCCCcCeEEE-CCCCceEEecCCCccc
Q 041576 541 PIIHCDIKPQNILL-DQDFTAKISDFGLSKL 570 (714)
Q Consensus 541 ~ivH~Dlk~~NIll-~~~~~~kl~Dfg~~~~ 570 (714)
.+.|+|+.+.||++ +.++.++++||..+..
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 48899999999999 8889999999998853
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=95.55 E-value=0.073 Score=56.66 Aligned_cols=140 Identities=19% Similarity=0.265 Sum_probs=78.5
Q ss_pred hhhCcccceeEEEeEeeCCC--CcEEEEEEecccchhhHHHHHHHHHHHhccCccccc-ceeceEecCCeeeEEEeecCC
Q 041576 426 EELGRGSFGIVYKGVLKSAS--GNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLV-QLLGFCDEGLNRLLVYEFMGN 502 (714)
Q Consensus 426 ~~ig~G~~g~Vy~~~~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv-~l~~~~~~~~~~~lv~E~~~~ 502 (714)
+.|..|-...+|+......+ +..|++|+...... ..-.-.+|..+++.+..-++. ++++++..+ +|.+|+++
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~-~~IdR~~E~~il~~l~~~gl~P~~l~~~~~G----~i~~fi~g 94 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD-YVIDRERELQAIKYLSAAGFGAKLLGVFGNG----MIQSFINA 94 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC-eEechHHHHHHHHHHHhcCCCCceeEEeCCc----EeehhhcC
Confidence 34555777788887654221 34788898765332 222346788888888655553 555555322 58999987
Q ss_pred Cchhhh-------h----------hcCCC-----C-ChhhHHHHHHH----------------------HHHHHHHHH--
Q 041576 503 GTLANL-------L----------FAIPR-----P-DWSLRVRISLE----------------------IARGLLYLH-- 535 (714)
Q Consensus 503 gsL~~~-------l----------~~~~~-----~-~~~~~~~i~~q----------------------i~~~L~yLH-- 535 (714)
..|..- + |..+. . -+....++..+ +.+-+..+.
T Consensus 95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~ 174 (330)
T PLN02421 95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI 174 (330)
T ss_pred CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence 665321 1 11110 1 11222122111 111122211
Q ss_pred --hcC-CCCeEecCCCcCeEEECC-CCceEEecCCCccc
Q 041576 536 --EEC-NVPIIHCDIKPQNILLDQ-DFTAKISDFGLSKL 570 (714)
Q Consensus 536 --~~~-~~~ivH~Dlk~~NIll~~-~~~~kl~Dfg~~~~ 570 (714)
..+ +..++|.|+.+.||++++ ++.++++||..+..
T Consensus 175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 111 234799999999999975 57899999998853
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=95.52 E-value=0.099 Score=55.49 Aligned_cols=82 Identities=20% Similarity=0.129 Sum_probs=49.1
Q ss_pred hhhCcccceeEEEeEeeCCCCcEEEEEEecccc-------hhhHHHHHHHHHHHhccC--cccccceeceEecCCeeeEE
Q 041576 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA-------QEREREFKTEVSAIGRTH--HKNLVQLLGFCDEGLNRLLV 496 (714)
Q Consensus 426 ~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~E~~~l~~l~--h~nIv~l~~~~~~~~~~~lv 496 (714)
++||.|....||++... ..++.|+||.-.... +-...+..-|.+.|+... -|..++-+- +.++....+|
T Consensus 1 ~EigdGnlN~VfrV~~~-~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy-~~D~e~~~~v 78 (370)
T TIGR01767 1 QEVGDGNLNLVFHVYDQ-EGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIF-HFDTEMAVTV 78 (370)
T ss_pred CcCCCCceEEEEEEEcC-CCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEE-EEccccceeh
Confidence 35899999999999864 223689999764211 222344556677776652 343333322 3355556799
Q ss_pred EeecCCC-chhhhh
Q 041576 497 YEFMGNG-TLANLL 509 (714)
Q Consensus 497 ~E~~~~g-sL~~~l 509 (714)
||+++.. .|++.|
T Consensus 79 MEdL~~~~ilR~~L 92 (370)
T TIGR01767 79 MEDLSHHKIARKGL 92 (370)
T ss_pred HhhCccchHHHHHH
Confidence 9998543 344444
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=95.52 E-value=0.023 Score=50.21 Aligned_cols=43 Identities=28% Similarity=0.604 Sum_probs=34.9
Q ss_pred CCCeeEEeeCCCCCCcccCCccEEEEcccc-eEEeCCCCCeEEecCCCcccccC
Q 041576 71 PERTIIWHANEDNHPVLAPRGSTLELTATG-LLLKDPGGQAIWDEKPNKISFKS 123 (714)
Q Consensus 71 ~~~t~vW~Anr~~p~~~~~~~~~l~~~~~g-lvl~d~~~~~vWst~~~~qSFd~ 123 (714)
+...+||.++... ......++|.+|| |||.|..|++||+ ||||
T Consensus 71 ~~g~~vW~S~t~~----~~~~~~~~L~ddGnlvl~~~~~~~~W~------Sf~~ 114 (114)
T smart00108 71 GDGRVVWSSNTTG----ANGNYVLVLLDDGNLVIYDSDGNFLWQ------SFDY 114 (114)
T ss_pred CCCCEEEEecccC----CCCceEEEEeCCCCEEEECCCCCEEeC------CCCC
Confidence 3367899998872 1344678999999 9999999999999 9986
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=95.48 E-value=0.13 Score=54.16 Aligned_cols=31 Identities=13% Similarity=0.268 Sum_probs=27.8
Q ss_pred CCeEecCCCcCeEEECCCCceEEecCCCccc
Q 041576 540 VPIIHCDIKPQNILLDQDFTAKISDFGLSKL 570 (714)
Q Consensus 540 ~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~ 570 (714)
..++|+|+.+.||+++.++.+.++||..+..
T Consensus 196 ~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 196 TVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 4599999999999999999999999988763
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=95.45 E-value=0.14 Score=50.20 Aligned_cols=74 Identities=16% Similarity=0.239 Sum_probs=52.9
Q ss_pred hhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhcc---CcccccceeceEecCCeeeEEEeecCCC
Q 041576 427 ELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRT---HHKNLVQLLGFCDEGLNRLLVYEFMGNG 503 (714)
Q Consensus 427 ~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l---~h~nIv~l~~~~~~~~~~~lv~E~~~~g 503 (714)
.+.-|.--..|+.. ....++.||.-. ......|..|+.-|..| +.-++.+++.+-.+..+.|+|+||.+-+
T Consensus 23 ~v~gG~inea~~v~---dg~~~~FvK~n~---~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~ 96 (286)
T COG3001 23 EVSGGDINEAWRLR---DGTDPFFVKCNQ---REQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTG 96 (286)
T ss_pred ccCCccccceeEee---cCCcceEEEecc---hhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCC
Confidence 35555555555543 346688888753 34456778887777666 4466888898889999999999999987
Q ss_pred chh
Q 041576 504 TLA 506 (714)
Q Consensus 504 sL~ 506 (714)
.+.
T Consensus 97 ~~d 99 (286)
T COG3001 97 PLD 99 (286)
T ss_pred CCC
Confidence 665
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=95.38 E-value=0.11 Score=54.87 Aligned_cols=29 Identities=28% Similarity=0.311 Sum_probs=25.3
Q ss_pred CCeEecCCCcCeEEECCCCceEEecCCCcc
Q 041576 540 VPIIHCDIKPQNILLDQDFTAKISDFGLSK 569 (714)
Q Consensus 540 ~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~ 569 (714)
..++|||+++.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 45899999999999988 678999998764
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=95.37 E-value=0.055 Score=47.71 Aligned_cols=67 Identities=25% Similarity=0.548 Sum_probs=44.3
Q ss_pred CeEeeCCCeeeeeeecCCCCCCceEEEEEeecCCCCeeEEeeCC-CCCCcccCCccEEEEcccc-eEEeCCCCCeEEecC
Q 041576 38 SSWISPSRDFAFGFRQLNNNSDLFLLAIWFNKMPERTIIWHANE-DNHPVLAPRGSTLELTATG-LLLKDPGGQAIWDEK 115 (714)
Q Consensus 38 ~~l~S~~g~F~lgFf~~~~~~~~~ylgIw~~~~~~~t~vW~Anr-~~p~~~~~~~~~l~~~~~g-lvl~d~~~~~vWst~ 115 (714)
+++.+.+|.+.|-|-.-++ |-| |+ ...++||..+. ... ......|.|.++| |||.|.++.+||+|.
T Consensus 12 ~p~~~~s~~~~L~l~~dGn------Lvl-~~--~~~~~iWss~~t~~~---~~~~~~~~L~~~GNlvl~d~~~~~lW~Sf 79 (114)
T PF01453_consen 12 SPLTSSSGNYTLILQSDGN------LVL-YD--SNGSVIWSSNNTSGR---GNSGCYLVLQDDGNLVLYDSSGNVLWQSF 79 (114)
T ss_dssp EEEEECETTEEEEEETTSE------EEE-EE--TTTEEEEE--S-TTS---S-SSEEEEEETTSEEEEEETTSEEEEEST
T ss_pred cccccccccccceECCCCe------EEE-Ec--CCCCEEEEecccCCc---cccCeEEEEeCCCCEEEEeecceEEEeec
Confidence 3454545778887765322 334 43 33677999943 332 1156789999999 999999999999996
Q ss_pred C
Q 041576 116 P 116 (714)
Q Consensus 116 ~ 116 (714)
.
T Consensus 80 ~ 80 (114)
T PF01453_consen 80 D 80 (114)
T ss_dssp T
T ss_pred C
Confidence 3
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.96 E-value=0.052 Score=59.06 Aligned_cols=164 Identities=22% Similarity=0.263 Sum_probs=90.8
Q ss_pred HHHHHHHHHHhccCcccccceeceEecCCee-eEEEeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCC
Q 041576 463 REFKTEVSAIGRTHHKNLVQLLGFCDEGLNR-LLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVP 541 (714)
Q Consensus 463 ~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~-~lv~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ 541 (714)
.++.-...+++.+.|+|+...+.+......+ .+|+|++. -+|++.+..+. +...... -| +
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~-~Sled~~~~~~-l~~~s~~------------~~--~--- 87 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHYT-MSLEDILKTGN-LKDESLL------------AH--G--- 87 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhhc-cchHHHHHhcc-cchhhhc------------cc--c---
Confidence 3556667888899999999999988665544 57888885 48988887644 2111100 11 1
Q ss_pred eEecCCCcCeEEECCCCceEEecCCCccccccCcccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCC
Q 041576 542 IIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRS 621 (714)
Q Consensus 542 ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p 621 (714)
+.|- |+ .+.+| .++. .| | ....+|+||||+|.++.|+.-|...
T Consensus 88 ~~~~-----~~-------~~~td-~~~t-----------------~~--~-----~~~~pKsdVwsl~~i~~el~L~~~l 130 (725)
T KOG1093|consen 88 VLHL-----NI-------IYITD-HFLT-----------------KY--P-----SPIGPKSDVWSLGFIILELYLGISL 130 (725)
T ss_pred ccee-----hh-------hhccc-cccc-----------------cC--C-----CCCCcchhhhhHHHHHHHHHHhhHH
Confidence 2221 11 22222 0000 00 1 0122499999999999999988776
Q ss_pred CcccccchhhhhhhHHHhhhhhcCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHH
Q 041576 622 VEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMI 688 (714)
Q Consensus 622 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev 688 (714)
+......+....+..+. ..++....+. .......+.....+++...|+-..|..||...+.
T Consensus 131 ~~~~~~s~~l~~i~k~~---~~d~~~~~~a---~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~ 191 (725)
T KOG1093|consen 131 EAELTESEYLEILLKYY---TDDQELLSTA---MEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMEL 191 (725)
T ss_pred HHHHHHHHHHHHHHHhc---cCchhHHHHH---HHHHHHHhhhHhHHHHhccCCccccccccchhHH
Confidence 65433333222222110 0000000000 0112233455577788899999999988865444
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 714 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-56 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-55 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 3e-42 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-41 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-40 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-40 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-39 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-36 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-26 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 4e-26 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 9e-23 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 9e-23 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-22 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-22 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-22 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-22 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 4e-22 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 5e-22 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 5e-22 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 5e-22 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-21 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-21 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-21 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-21 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-21 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-21 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-21 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-21 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-21 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 3e-21 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 3e-21 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 4e-21 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 7e-21 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-20 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-20 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-20 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-20 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-20 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 7e-20 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 7e-20 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-19 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-19 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 4e-19 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 4e-19 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 4e-19 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 4e-19 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 5e-19 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 5e-19 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 5e-19 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 6e-19 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 7e-19 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-19 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 8e-19 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 8e-19 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 8e-19 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 9e-19 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 9e-19 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-18 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-18 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-18 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-18 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-18 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-18 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-18 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-18 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 3e-18 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 4e-18 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-18 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 5e-18 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 6e-18 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 6e-18 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 6e-18 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 7e-18 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-18 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-18 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 7e-18 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 8e-18 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-18 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 8e-18 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-17 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-17 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-17 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-17 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-17 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-17 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-17 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-17 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-17 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-17 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-17 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-17 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-17 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-17 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-17 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-17 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-17 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-17 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-17 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-17 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-17 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-17 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-17 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-17 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-17 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-17 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-17 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-17 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 3e-17 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 3e-17 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-17 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 3e-17 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 3e-17 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-17 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-17 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 3e-17 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 3e-17 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 3e-17 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 4e-17 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 4e-17 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 4e-17 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 4e-17 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 4e-17 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 4e-17 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 4e-17 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-17 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-17 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 4e-17 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-17 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 4e-17 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 4e-17 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 4e-17 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 4e-17 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-17 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 4e-17 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 4e-17 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 4e-17 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 5e-17 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 5e-17 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 5e-17 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 5e-17 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 5e-17 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 5e-17 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-17 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-17 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 5e-17 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-17 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 5e-17 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 5e-17 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 7e-17 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 7e-17 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 8e-17 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 9e-17 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 9e-17 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-17 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 9e-17 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-16 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-16 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-16 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-16 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-16 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-16 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-16 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-16 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-16 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-16 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-16 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-16 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-16 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 3e-16 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-16 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-16 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-16 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 7e-16 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 8e-16 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 8e-16 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 9e-16 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 9e-16 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 9e-16 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-15 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-15 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-15 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-15 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-15 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-15 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-15 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-15 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-15 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-15 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-15 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-15 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-15 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-15 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-15 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-15 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-15 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-15 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-15 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-15 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-15 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-15 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-15 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 3e-15 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 3e-15 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-15 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 3e-15 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 3e-15 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-15 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 3e-15 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 3e-15 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-15 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 3e-15 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 3e-15 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 3e-15 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-15 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 4e-15 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 4e-15 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-15 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-15 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 4e-15 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 4e-15 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 4e-15 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 5e-15 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 5e-15 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 5e-15 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-15 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 5e-15 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 5e-15 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 5e-15 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 6e-15 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 6e-15 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 6e-15 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 6e-15 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 7e-15 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 7e-15 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 7e-15 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 7e-15 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 7e-15 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 7e-15 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 8e-15 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 8e-15 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 8e-15 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 9e-15 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 9e-15 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 9e-15 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 9e-15 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 9e-15 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-14 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-14 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-14 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-14 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-14 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-14 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-14 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-14 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-14 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-14 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 3e-14 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 3e-14 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 3e-14 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 3e-14 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 4e-14 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 4e-14 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 4e-14 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 4e-14 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 4e-14 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 4e-14 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 4e-14 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 4e-14 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 4e-14 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 4e-14 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 4e-14 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-14 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 5e-14 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 5e-14 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 5e-14 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 5e-14 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-14 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-14 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 5e-14 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 5e-14 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 6e-14 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 6e-14 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 6e-14 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-14 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 6e-14 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 7e-14 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 7e-14 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 7e-14 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 7e-14 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 8e-14 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 8e-14 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 9e-14 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 9e-14 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-13 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-13 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-13 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-13 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-13 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-13 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-13 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-13 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-13 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-13 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-13 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-13 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-13 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-13 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-13 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-13 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-13 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-13 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 3e-13 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-13 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-13 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-13 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-13 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 3e-13 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 3e-13 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-13 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-13 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-13 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 3e-13 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-13 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-13 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 3e-13 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 3e-13 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-13 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 3e-13 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 3e-13 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 4e-13 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 4e-13 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 4e-13 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 4e-13 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 4e-13 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 5e-13 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 5e-13 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 5e-13 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 5e-13 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 5e-13 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 5e-13 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 5e-13 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 5e-13 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-13 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 5e-13 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-13 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 6e-13 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 6e-13 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 6e-13 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 6e-13 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-13 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 6e-13 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 6e-13 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 6e-13 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 6e-13 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 6e-13 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 6e-13 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 7e-13 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 7e-13 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 7e-13 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 7e-13 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 8e-13 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 8e-13 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 8e-13 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 8e-13 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 8e-13 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 8e-13 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 8e-13 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 8e-13 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 9e-13 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 9e-13 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 9e-13 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 9e-13 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-12 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-12 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-12 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-12 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-12 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-12 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-12 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-12 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-12 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-12 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-12 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-12 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-12 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-12 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-12 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-12 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-12 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-12 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-12 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-12 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-12 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-12 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-12 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-12 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-12 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-12 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-12 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-12 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-12 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-12 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-12 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-12 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-12 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-12 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-12 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-12 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-12 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-12 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 3e-12 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 3e-12 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-12 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-12 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-12 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 3e-12 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-12 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 3e-12 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-12 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 3e-12 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-12 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 3e-12 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 3e-12 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 3e-12 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-12 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 3e-12 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 3e-12 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 3e-12 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-12 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-12 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 3e-12 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 3e-12 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-12 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 4e-12 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 4e-12 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-12 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 4e-12 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 4e-12 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 4e-12 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 4e-12 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 4e-12 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-12 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 5e-12 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 5e-12 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 5e-12 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 5e-12 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 5e-12 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 5e-12 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 5e-12 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 5e-12 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-12 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-12 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 5e-12 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 5e-12 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-12 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 5e-12 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 5e-12 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 5e-12 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 5e-12 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 5e-12 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 5e-12 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 6e-12 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 6e-12 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 6e-12 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 6e-12 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 6e-12 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 6e-12 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 6e-12 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-12 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 6e-12 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 7e-12 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 7e-12 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 7e-12 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 7e-12 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 7e-12 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 8e-12 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 8e-12 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 8e-12 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 8e-12 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 8e-12 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 8e-12 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 9e-12 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 9e-12 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 9e-12 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 9e-12 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 9e-12 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 9e-12 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-11 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-11 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-11 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-11 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-11 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-11 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-11 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-11 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-11 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-11 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-11 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-11 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-11 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-11 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-11 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-11 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-11 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-11 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-11 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-11 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-11 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-11 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-11 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-11 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-11 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-11 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-11 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-11 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-11 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-11 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-11 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-11 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-11 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-11 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-11 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-11 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-11 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-11 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-11 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-11 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-11 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-11 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-11 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-11 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-11 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-11 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-11 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 3e-11 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-11 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-11 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 3e-11 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-11 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-11 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-11 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 3e-11 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 3e-11 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-11 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 3e-11 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 3e-11 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-11 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-11 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 3e-11 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-11 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 3e-11 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 4e-11 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 4e-11 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 4e-11 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-11 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-11 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 4e-11 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 4e-11 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-11 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 4e-11 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 4e-11 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 4e-11 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-11 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 4e-11 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 4e-11 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 4e-11 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 4e-11 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 4e-11 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 5e-11 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-11 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 5e-11 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 5e-11 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 5e-11 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 5e-11 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 5e-11 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 5e-11 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-11 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 5e-11 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 5e-11 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 5e-11 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 6e-11 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 6e-11 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 6e-11 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 6e-11 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 6e-11 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 6e-11 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 6e-11 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 6e-11 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 6e-11 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 6e-11 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 6e-11 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-11 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 6e-11 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 6e-11 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 6e-11 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 7e-11 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 7e-11 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 7e-11 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 7e-11 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 7e-11 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 7e-11 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 7e-11 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 7e-11 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 7e-11 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 7e-11 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 7e-11 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 7e-11 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 7e-11 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 7e-11 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 8e-11 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-11 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 8e-11 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-11 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 8e-11 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 8e-11 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 9e-11 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 9e-11 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 9e-11 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 9e-11 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 9e-11 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-11 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 9e-11 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 9e-11 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 9e-11 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 9e-11 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-10 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-10 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-10 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-10 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-10 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-10 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-10 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-10 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-10 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-10 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-10 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-10 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-10 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-10 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-10 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-10 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-10 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-10 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-10 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-10 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-10 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-10 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-10 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-10 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-10 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-10 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-10 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-10 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-10 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-10 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-10 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-10 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-10 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-10 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-10 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-10 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-10 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-10 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-10 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-10 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-10 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-10 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-10 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-10 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-10 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-10 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-10 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-10 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-10 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-10 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-10 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-10 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-10 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-10 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-10 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-10 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-10 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-10 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-10 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-10 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-10 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-10 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-10 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 3e-10 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-10 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 3e-10 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-10 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 3e-10 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-10 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-10 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 3e-10 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-10 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-10 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 3e-10 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-10 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 3e-10 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 4e-10 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 4e-10 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 4e-10 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 4e-10 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 6e-10 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 6e-10 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 7e-10 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 7e-10 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 8e-10 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 8e-10 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 8e-10 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 8e-10 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 8e-10 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 8e-10 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 9e-10 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 9e-10 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 9e-10 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 9e-10 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 9e-10 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-09 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-09 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-09 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-09 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 1e-09 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-09 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-09 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-09 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-09 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-09 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-09 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-09 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-09 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-09 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-09 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-09 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-09 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-09 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-09 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-09 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 3e-09 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-09 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 3e-09 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 3e-09 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 3e-09 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 3e-09 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 3e-09 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 3e-09 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-09 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 3e-09 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 3e-09 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 3e-09 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 3e-09 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 3e-09 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 3e-09 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-09 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-09 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 3e-09 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 3e-09 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 3e-09 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-09 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 3e-09 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-09 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 3e-09 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-09 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 4e-09 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 4e-09 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-09 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-09 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 4e-09 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-09 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 4e-09 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-09 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 4e-09 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 4e-09 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 4e-09 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-09 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 4e-09 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 4e-09 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 4e-09 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 5e-09 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 5e-09 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 5e-09 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 6e-09 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 6e-09 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 6e-09 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 6e-09 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 7e-09 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 7e-09 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 8e-09 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 8e-09 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 8e-09 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 8e-09 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 8e-09 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 9e-09 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 9e-09 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-08 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-08 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-08 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-08 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-08 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-08 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-08 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 1e-08 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-08 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-08 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-08 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-08 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-08 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-08 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-08 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-08 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-08 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-08 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-08 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-08 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-08 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-08 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-08 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-08 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-08 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-08 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-08 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-08 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-08 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-08 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-08 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-08 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-08 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-08 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-08 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-08 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-08 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 3e-08 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 3e-08 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 3e-08 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 3e-08 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 3e-08 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 3e-08 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 3e-08 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 3e-08 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 3e-08 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-08 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-08 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 3e-08 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 3e-08 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-08 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-08 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 4e-08 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 4e-08 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 4e-08 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-08 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 4e-08 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 4e-08 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 4e-08 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 4e-08 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-08 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 4e-08 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 4e-08 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 4e-08 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 4e-08 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 4e-08 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 4e-08 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 4e-08 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 4e-08 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-08 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 4e-08 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 5e-08 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 5e-08 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 5e-08 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 5e-08 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 5e-08 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-08 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 5e-08 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 5e-08 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 5e-08 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 5e-08 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 5e-08 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 5e-08 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 5e-08 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-08 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 5e-08 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 5e-08 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 6e-08 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 6e-08 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-08 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 6e-08 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 7e-08 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 7e-08 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 8e-08 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 8e-08 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 8e-08 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 9e-08 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 9e-08 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 9e-08 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 9e-08 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 9e-08 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-07 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-07 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-07 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-07 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-07 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-07 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-07 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 2e-07 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-07 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-07 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-07 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-07 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 3e-07 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-07 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 3e-07 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 3e-07 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 3e-07 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 3e-07 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-07 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-07 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 3e-07 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 3e-07 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 3e-07 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-07 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 4e-07 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 4e-07 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 4e-07 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 4e-07 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-07 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 4e-07 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-07 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 4e-07 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 4e-07 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 4e-07 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 4e-07 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 5e-07 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 5e-07 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 6e-07 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 8e-07 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 9e-07 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 9e-07 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 1e-06 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-06 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-06 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-06 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 2e-06 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 2e-06 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 2e-06 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-06 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-06 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-06 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-06 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-06 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-06 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-06 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-06 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-06 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-06 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-06 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 3e-06 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 3e-06 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 3e-06 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 4e-06 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 4e-06 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 5e-06 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 9e-06 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-05 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-05 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 1e-05 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-05 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-05 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 1e-05 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-05 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-05 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-05 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-05 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-05 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-05 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 2e-05 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 2e-05 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 2e-05 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-05 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-05 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-05 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-05 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-05 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-05 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-05 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-05 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-05 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-05 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-05 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 2e-05 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-05 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 2e-05 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 2e-05 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-05 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-05 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-05 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-05 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-05 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-05 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-05 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 373 bits (961), Expect = e-125
Identities = 124/295 (42%), Positives = 173/295 (58%), Gaps = 10/295 (3%)
Query: 408 NLRFFSLVELNEATNGFEEE--LGRGSFGIVYKGVLKSASGNAVAVKKL-DKLAQERERE 464
L+ FSL EL A++ F + LGRG FG VYKG L G VAVK+L ++ Q E +
Sbjct: 16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLAD--GTLVAVKRLKEERTQGGELQ 73
Query: 465 FKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRP----DWSLR 520
F+TEV I H+NL++L GFC RLLVY +M NG++A+ L P DW R
Sbjct: 74 FQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKR 133
Query: 521 VRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRT 580
RI+L ARGL YLH+ C+ IIH D+K NILLD++F A + DFGL+KL+ + T
Sbjct: 134 QRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT 193
Query: 581 VIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEM-ELGEERSAILTDWAY 639
+RGT G++APE+ S K DV+ +GV+LL++I +R+ ++ L + +L DW
Sbjct: 194 AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 253
Query: 640 DCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEG 694
E KL+ LVD D + + +AL C Q P++RP M +V+MLEG
Sbjct: 254 GLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 344 bits (884), Expect = e-113
Identities = 113/304 (37%), Positives = 167/304 (54%), Gaps = 13/304 (4%)
Query: 402 SSISETNLRFFSLVELNEATNGFEEE--LGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQ 459
S + LV+L EATN F+ + +G G FG VYKGVL+ G VA+K+ +
Sbjct: 19 SYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRD--GAKVALKRRTPESS 76
Query: 460 EREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRP---- 515
+ EF+TE+ + H +LV L+GFCDE +L+Y++M NG L L+ P
Sbjct: 77 QGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSM 136
Query: 516 DWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLS-D 574
W R+ I + ARGL YLH IIH D+K NILLD++F KI+DFG+SK D
Sbjct: 137 SWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELD 193
Query: 575 QSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAIL 634
Q+ TV++GT GY+ PE+F ++ K DVYSFGVVL +++C + ++ L E L
Sbjct: 194 QTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMV-NL 252
Query: 635 TDWAYDCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEG 694
+WA + + G+L+ +VD + A K+ A+ C+ RP+M ++ LE
Sbjct: 253 AEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEY 312
Query: 695 YLEV 698
L +
Sbjct: 313 ALRL 316
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 326 bits (839), Expect = e-107
Identities = 107/313 (34%), Positives = 158/313 (50%), Gaps = 32/313 (10%)
Query: 403 SISETNLRFFSLVELNEATNGFEEE--------LGRGSFGIVYKGVLKSASGNAVAVKKL 454
+S+T FS EL TN F+E +G G FG+VYKG + VAVKKL
Sbjct: 6 EVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN---NTTVAVKKL 62
Query: 455 DKLAQER----EREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEFMGNGTLANLLF 510
+ +++F E+ + + H+NLV+LLGF +G + LVY +M NG+L + L
Sbjct: 63 AAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLS 122
Query: 511 AIPRP---DWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGL 567
+ W +R +I+ A G+ +LHE IH DIK NILLD+ FTAKISDFGL
Sbjct: 123 CLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGL 179
Query: 568 SKLLLS-DQSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMEL 626
++ Q+ + I GT Y+APE + ++ K D+YSFGVVLL+II +V+
Sbjct: 180 ARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHR 238
Query: 627 GEERSAILTDWAYDCYVE-GKLDVLVDNDKAAMADKSR--ACKWLMIALWCIQEDPLKRP 683
+ +L D + E ++ +D M D +A C+ E KRP
Sbjct: 239 EPQ---LLLDIKEEIEDEEKTIEDYID---KKMNDADSTSVEAMYSVASQCLHEKKNKRP 292
Query: 684 AMKMIVQMLEGYL 696
+K + Q+L+
Sbjct: 293 DIKKVQQLLQEMT 305
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 238 bits (610), Expect = 5e-73
Identities = 71/320 (22%), Positives = 125/320 (39%), Gaps = 31/320 (9%)
Query: 399 VQRSSISETNLRFFSLVELNEATNGFE--EELGRGSFGIVYKGVLKSASGNAVAVKKLDK 456
+ ++ L + + E RG FG V+K L VAVK
Sbjct: 1 MGHHHHHHSSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL---NEYVAVKIFPI 57
Query: 457 LAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLN----RLLVYEFMGNGTLANLLFAI 512
++ + + EV ++ H+N++Q +G G + L+ F G+L++ L A
Sbjct: 58 -QDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA- 115
Query: 513 PRPDWSLRVRISLEIARGLLYLHEE-------CNVPIIHCDIKPQNILLDQDFTAKISDF 565
W+ I+ +ARGL YLHE+ I H DIK +N+LL + TA I+DF
Sbjct: 116 NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADF 175
Query: 566 GLSKLLLSDQSRTRTVIR-GTRGYVAPE-----WFKNVPVSAKVDVYSFGVVLLKIICCK 619
GL+ + +S T + GTR Y+APE ++D+Y+ G+VL ++
Sbjct: 176 GLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRC 235
Query: 620 RSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKA------AMADKSRACKWLMIALW 673
+ + + +E + + +V + K +
Sbjct: 236 TAADGPV-DEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEE 294
Query: 674 CIQEDPLKRPAMKMIVQMLE 693
C D R + + + +
Sbjct: 295 CWDHDAEARLSAGCVGERIT 314
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 221 bits (564), Expect = 1e-66
Identities = 82/286 (28%), Positives = 141/286 (49%), Gaps = 30/286 (10%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNAVAVKKL--DKLAQEREREFKTEVSAIGRTHHKNLV 481
+E++G GSFG V++ G+ VAVK L ER EF EV+ + R H N+V
Sbjct: 41 IKEKIGAGSFGTVHRAEWH---GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIV 97
Query: 482 QLLGFCDEGLNRLLVYEFMGNGTLANLL---FAIPRPDWSLRVRISLEIARGLLYLHEEC 538
+G + N +V E++ G+L LL A + D R+ ++ ++A+G+ YLH
Sbjct: 98 LFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-R 156
Query: 539 NVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVP 598
N PI+H ++K N+L+D+ +T K+ DFGLS+ L + + GT ++APE ++ P
Sbjct: 157 NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSR-LKASTFLSSKSAAGTPEWMAPEVLRDEP 215
Query: 599 VSAKVDVYSFGVVLLKIICCKR-SVEMELGEERSAILTDWAYDCYVEGK-LDVLVDNDKA 656
+ K DVYSFGV+L ++ ++ + + K L++ + +
Sbjct: 216 SNEKSDVYSFGVILWELATLQQPWGNLN--------PAQVVAAVGFKCKRLEIPRNLNP- 266
Query: 657 AMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLEVPSPP 702
+A ++ C +P KRP+ I+ +L ++ PP
Sbjct: 267 QVAA-------IIEG--CWTNEPWKRPSFATIMDLLRPLIKSAVPP 303
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 218 bits (557), Expect = 2e-65
Identities = 84/301 (27%), Positives = 139/301 (46%), Gaps = 39/301 (12%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQL 483
EE +GRG+FG+V K + VA+K+++ + + F E+ + R +H N+V+L
Sbjct: 12 VEEVVGRGAFGVVCKAKWR---AKDVAIKQIES--ESERKAFIVELRQLSRVNHPNIVKL 66
Query: 484 LGFCDEGLNRLLVYEFMGNGTLANLLFA---IPRPDWSLRVRISLEIARGLLYLHEECNV 540
G C + LV E+ G+L N+L +P + + L+ ++G+ YLH
Sbjct: 67 YGACLNPV--CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPK 124
Query: 541 PIIHCDIKPQNILLDQDFT-AKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPV 599
+IH D+KP N+LL T KI DFG + D T +G+ ++APE F+
Sbjct: 125 ALIHRDLKPPNLLLVAGGTVLKICDFGTAC----DIQTHMTNNKGSAAWMAPEVFEGSNY 180
Query: 600 SAKVDVYSFGVVLLKIICCKR-SVEMELGEERSAILTDWAYDCYV-EGKLDVLVDNDKAA 657
S K DV+S+G++L ++I ++ E+ + V G L+ N
Sbjct: 181 SEKCDVFSWGIILWEVITRRKPFDEIG--------GPAFRIMWAVHNGTRPPLIKNLPKP 232
Query: 658 MADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLEVPSPPMPPL-----HSLQLT 712
+ LM W +DP +RP+M+ IV+++ + PL HSL
Sbjct: 233 IES-------LMTRCW--SKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPCQHSLPPG 283
Query: 713 E 713
E
Sbjct: 284 E 284
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 215 bits (549), Expect = 2e-64
Identities = 75/307 (24%), Positives = 130/307 (42%), Gaps = 37/307 (12%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQL 483
E LG+G FG K + +G + +K+L + +E +R F EV + H N+++
Sbjct: 14 HGEVLGKGCFGQAIKVTHRE-TGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKF 72
Query: 484 LGFCDEGLNRLLVYEFMGNGTLANLLFAIPRP-DWSLRVRISLEIARGLLYLHEECNVPI 542
+G + + E++ GTL ++ ++ WS RV + +IA G+ YLH N I
Sbjct: 73 IGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH-SMN--I 129
Query: 543 IHCDIKPQNILLDQDFTAKISDFGLSKLLLSD-------------QSRTRTVIRGTRGYV 589
IH D+ N L+ ++ ++DFGL++L++ + + R + G ++
Sbjct: 130 IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWM 189
Query: 590 APEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDV 649
APE KVDV+SFG+VL +II A Y+ +D
Sbjct: 190 APEMINGRSYDEKVDVFSFGIVLCEIIGRVN-----------------ADPDYLPRTMDF 232
Query: 650 LVDNDKAAMADKSRAC--KWLMIALWCIQEDPLKRPAMKMIVQMLEGYLEVPSPPMPPLH 707
++ C + I + C DP KRP+ + LE + +P
Sbjct: 233 GLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPLGP 292
Query: 708 SLQLTES 714
L+ +
Sbjct: 293 QLEQLDR 299
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 203 bits (519), Expect = 2e-60
Identities = 77/284 (27%), Positives = 118/284 (41%), Gaps = 39/284 (13%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNAVAVKKL----DKLAQEREREFKTEVSAIGRTHHKN 479
EE +G G FG VY+ G+ VAVK D+ + + E H N
Sbjct: 11 LEEIIGIGGFGKVYRAFWI---GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPN 67
Query: 480 LVQLLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECN 539
++ L G C + N LV EF G L +L + R + V +++IARG+ YLH+E
Sbjct: 68 IIALRGVCLKEPNLCLVMEFARGGPLNRVL-SGKRIPPDILVNWAVQIARGMNYLHDEAI 126
Query: 540 VPIIHCDIKPQNILLDQDF--------TAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAP 591
VPIIH D+K NIL+ Q KI+DFGL++ + G ++AP
Sbjct: 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAA---GAYAWMAP 183
Query: 592 EWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLV 651
E + S DV+S+GV+L +++ + + + V
Sbjct: 184 EVIRASMFSKGSDVWSYGVLLWELLTGEV-----------------PFRGIDGLAVAYGV 226
Query: 652 DNDKAAMADKSRAC--KWLMIALWCIQEDPLKRPAMKMIVQMLE 693
+K A+ C + + C DP RP+ I+ L
Sbjct: 227 AMNKLAL-PIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLT 269
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 203 bits (519), Expect = 2e-60
Identities = 78/293 (26%), Positives = 131/293 (44%), Gaps = 53/293 (18%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNAVAVKKL-------DKLAQEREREFKTEVSAIGRTH 476
+E+++G+G FG+V+KG L + VA+K L + E+ +EF+ EV + +
Sbjct: 23 YEKQIGKGGFGLVHKGRLVK-DKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81
Query: 477 HKNLVQLLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRP-DWSLRVRISLEIARGLLYLH 535
H N+V+L G +V EF+ G L + L P WS+++R+ L+IA G+ Y+
Sbjct: 82 HPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ 139
Query: 536 EECNVPIIHCDIKPQNILLDQ-----DFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVA 590
N PI+H D++ NI L AK++DFGLS+ + + + G ++A
Sbjct: 140 -NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ----QSVHSVSGLLGNFQWMA 194
Query: 591 PEWF--KNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLD 648
PE + + K D YSF ++L I+ + +D Y GK+
Sbjct: 195 PETIGAEEESYTEKADTYSFAMILYTILTGEG-----------------PFDEYSYGKIK 237
Query: 649 VLVDNDKAAMADKS------RAC--KWLMIALWCIQEDPLKRPAMKMIVQMLE 693
+ + ++ C + + C DP KRP IV+ L
Sbjct: 238 FI-----NMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELS 285
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 203 bits (517), Expect = 2e-59
Identities = 76/323 (23%), Positives = 113/323 (34%), Gaps = 45/323 (13%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTE--VSAIGRTHHKNLV 481
E +GRG +G VYKG L VAVK + F E + + H N+
Sbjct: 17 LLELIGRGRYGAVYKGSLD---ERPVAVKVFSF---ANRQNFINEKNIYRVPLMEHDNIA 70
Query: 482 QLLGFCDEG-----LNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHE 536
+ + + + LLV E+ NG+L L DW R++ + RGL YLH
Sbjct: 71 RFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL-HTSDWVSSCRLAHSVTRGLAYLHT 129
Query: 537 E------CNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSD-------QSRTRTVIR 583
E I H D+ +N+L+ D T ISDFGLS L + +
Sbjct: 130 ELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEV 189
Query: 584 GTRGYVAPEWFKNV-------PVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEERSAILT 635
GT Y+APE + +VD+Y+ G++ +I C E E
Sbjct: 190 GTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQ 249
Query: 636 DWAYDCYVEGKLDVLVDNDK-------AAMADKSRACKWLMIALWCIQEDPLKRPAMKMI 688
+ + VLV +K A + C +D R +
Sbjct: 250 TEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXA 309
Query: 689 VQMLEG---YLEVPSPPMPPLHS 708
+ + E P H
Sbjct: 310 EERMAELMMIWERNKSVSPTAHH 332
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 200 bits (512), Expect = 2e-59
Identities = 68/281 (24%), Positives = 117/281 (41%), Gaps = 39/281 (13%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNAVAVKKL--DKLAQEREREFKTEVSAIGRTHHKNLV 481
F +L G ++KG + GN + VK L + + R+F E + H N++
Sbjct: 14 FLTKLNENHSGELWKGRWQ---GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVL 70
Query: 482 QLLGFCDE--GLNRLLVYEFMGNGTLANLLFAIPRP--DWSLRVRISLEIARGLLYLHEE 537
+LG C + L+ +M G+L N+L D S V+ +L++ARG+ +LH
Sbjct: 71 PVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT- 129
Query: 538 CNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNV 597
I + +++++D+D TA+IS + S +VAPE +
Sbjct: 130 LEPLIPRHALNSRSVMIDEDMTARISMADVKF------SFQSPGRMYAPAWVAPEALQKK 183
Query: 598 PVSA---KVDVYSFGVVLLKIICCKR-SVEMELGEERSAILTDWAYDCYVEGK-LDVLVD 652
P D++SF V+L +++ + ++ E + EG +
Sbjct: 184 PEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVAL--------EGLRPTIPPG 235
Query: 653 NDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLE 693
++ LM C+ EDP KRP MIV +LE
Sbjct: 236 ISP-HVSK-------LMKI--CMNEDPAKRPKFDMIVPILE 266
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 200 bits (511), Expect = 8e-59
Identities = 64/300 (21%), Positives = 123/300 (41%), Gaps = 40/300 (13%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNAVAVKKL--DKLAQEREREFKTEVSAIGRTHHKNLV 481
E +G+G FG VY G VA++ + ++ +++ + FK EV A +T H+N+V
Sbjct: 37 IGELIGKGRFGQVYHGRWH----GEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVV 92
Query: 482 QLLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRP-DWSLRVRISLEIARGLLYLHEECNV 540
+G C + ++ TL +++ D + +I+ EI +G+ YLH +
Sbjct: 93 LFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAK--- 149
Query: 541 PIIHCDIKPQNILLDQDFTAKISDFGLSKL----LLSDQSRTRTVIRGTRGYVAPEWFKN 596
I+H D+K +N+ D + I+DFGL + + + G ++APE +
Sbjct: 150 GILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQ 208
Query: 597 V---------PVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKL 647
+ P S DV++ G + ++ + + + AI +
Sbjct: 209 LSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFK---TQPAEAI-------------I 252
Query: 648 DVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLEVPSPPMPPLH 707
+ K ++ + I L+C + +RP ++ MLE + P H
Sbjct: 253 WQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSHPGH 312
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 192 bits (490), Expect = 3e-56
Identities = 72/280 (25%), Positives = 123/280 (43%), Gaps = 33/280 (11%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNAVAVKKL--DKLAQEREREFKTEVSAIGRTHHKNLV 481
+ +G GSFG VYKG VAVK L ++ + FK EV + +T H N++
Sbjct: 28 VGQRIGSGSFGTVYKGKWH----GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 83
Query: 482 QLLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRP-DWSLRVRISLEIARGLLYLHEECNV 540
+G+ +V ++ +L + L A + + I+ + ARG+ YLH +
Sbjct: 84 LFMGYSTAP-QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAK--- 139
Query: 541 PIIHCDIKPQNILLDQDFTAKISDFGLSKLL-LSDQSRTRTVIRGTRGYVAPEWFKN--- 596
IIH D+K NI L +D T KI DFGL+ S + G+ ++APE +
Sbjct: 140 SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDS 199
Query: 597 VPVSAKVDVYSFGVVLLKIICCKRSVE-MELGEERSAILTDWAYDCYVEGKLDVLVDNDK 655
P S + DVY+FG+VL +++ + + R I+ V +
Sbjct: 200 NPYSFQSDVYAFGIVLYELMTGQLPYSNI---NNRDQII--EM----------VGRGSLS 244
Query: 656 AAMADKSRAC--KWLMIALWCIQEDPLKRPAMKMIVQMLE 693
++ C + + C+++ +RP+ I+ +E
Sbjct: 245 PDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIE 284
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 183 bits (465), Expect = 4e-52
Identities = 59/292 (20%), Positives = 113/292 (38%), Gaps = 27/292 (9%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQL 483
+++G+G +G V+ G + G VAVK +E +TE+ H+N++
Sbjct: 41 MVKQIGKGRYGEVWMGKWR---GEKVAVKVFFT-TEEASWFRETEIYQTVLMRHENILGF 96
Query: 484 LGFCDEGLNR----LLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEE-- 537
+ +G L+ ++ NG+L + L D ++++ GL +LH E
Sbjct: 97 IAADIKGTGSWTQLYLITDYHENGSLYDYL-KSTTLDAKSMLKLAYSSVSGLCHLHTEIF 155
Query: 538 ---CNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRT---RTVIRGTRGYVAP 591
I H D+K +NIL+ ++ T I+D GL+ +SD + GT+ Y+ P
Sbjct: 156 STQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPP 215
Query: 592 E------WFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEG 645
E + D+YSFG++L ++ S + + + Y +
Sbjct: 216 EVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDM 275
Query: 646 KLDVLVDND----KAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLE 693
+ V + + + + C +P R + + L
Sbjct: 276 REIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLA 327
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 9e-51
Identities = 63/292 (21%), Positives = 115/292 (39%), Gaps = 27/292 (9%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQL 483
+E +G+G FG V++G + G VAVK +ER + E+ H+N++
Sbjct: 46 LQESIGKGRFGEVWRGKWR---GEEVAVKIFSS-REERSWFREAEIYQTVMLRHENILGF 101
Query: 484 LGFC----DEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEE-- 537
+ LV ++ +G+L + L ++++L A GL +LH E
Sbjct: 102 IAADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEGMIKLALSTASGLAHLHMEIV 160
Query: 538 ---CNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVI---RGTRGYVAP 591
I H D+K +NIL+ ++ T I+D GL+ S GT+ Y+AP
Sbjct: 161 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 220
Query: 592 E------WFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEG 645
E K+ + D+Y+ G+V +I + + + E
Sbjct: 221 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 280
Query: 646 KLDVLVDNDKAAMADKSRACKWL--MIAL--WCIQEDPLKRPAMKMIVQMLE 693
+ V + + ++ ++C+ L M + C + R I + L
Sbjct: 281 RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 332
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 1e-50
Identities = 64/301 (21%), Positives = 114/301 (37%), Gaps = 45/301 (14%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQL 483
E +G+G +G V++G + G VAVK E+ +TE+ H+N++
Sbjct: 12 LLECVGKGRYGEVWRGSWQ---GENVAVKIFSS-RDEKSWFRETELYNTVMLRHENILGF 67
Query: 484 LGFCDEGLNR----LLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEE-- 537
+ + L+ + G+L + L + D +RI L IA GL +LH E
Sbjct: 68 IASDMTSRHSSTQLWLITHYHEMGSLYDYL-QLTTLDTVSCLRIVLSIASGLAHLHIEIF 126
Query: 538 ---CNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSR---TRTVIRGTRGYVAP 591
I H D+K +NIL+ ++ I+D GL+ + ++ GT+ Y+AP
Sbjct: 127 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAP 186
Query: 592 EWFKNVPVSA------KVDVYSFGVVLLKIICCKRSV----EMEL---GEERSAILTDWA 638
E +VD+++FG+VL ++ S + + + +
Sbjct: 187 EVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDM 246
Query: 639 YDCYVEGKL------DVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQML 692
+ D ++A LM W ++P R I + L
Sbjct: 247 RKVVCVDQQRPNIPNRWFSDPTLTSLAK-------LMKECW--YQNPSARLTALRIKKTL 297
Query: 693 E 693
Sbjct: 298 T 298
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 4e-41
Identities = 63/212 (29%), Positives = 96/212 (45%), Gaps = 22/212 (10%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNAVAVK--KLDKLAQEREREFKTEVSAIGRTHHKNLV 481
F+ E+GRGSF VYKG L + + VA + KL + + FK E + H N+V
Sbjct: 30 FDIEIGRGSFKTVYKG-LDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIV 88
Query: 482 QLLGFC---DEGLNRLLVY-EFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEE 537
+ +G +++ E M +GTL L + +I +GL +LH
Sbjct: 89 RFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH-T 147
Query: 538 CNVPIIHCDIKPQNILLD-QDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKN 596
PIIH D+K NI + + KI D GL+ L + ++ + GT ++APE ++
Sbjct: 148 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA---VIGTPEFMAPEMYEE 204
Query: 597 VPVSAKVDVYSFGVVLLKIICCKRSVEMELGE 628
VDVY+FG C +EM E
Sbjct: 205 -KYDESVDVYAFG-------MC--MLEMATSE 226
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 3e-39
Identities = 65/311 (20%), Positives = 117/311 (37%), Gaps = 53/311 (17%)
Query: 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQERERE-FKTEVSAIGRTHHKNLVQLL 484
+ LGRG FG+V++ A+K++ +E RE EV A+ + H +V+
Sbjct: 11 QCLGRGGFGVVFE-AKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYF 69
Query: 485 GFCDEGLN---------RLLVY---EFMGNGTLANLLFA---IPRPDWSLRVRISLEIAR 529
E ++ +Y + L + + I + S+ + I L+IA
Sbjct: 70 NAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAE 129
Query: 530 GLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIR------ 583
+ +LH + ++H D+KP NI D K+ DFGL + D+ +
Sbjct: 130 AVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYAR 186
Query: 584 -----GTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWA 638
GT+ Y++PE S KVD++S G++L ++ S +ME + +
Sbjct: 187 HTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFEL-LYPFSTQMERVRTLTDV----- 240
Query: 639 YDCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYL-E 697
K L M+ + P++RP I++ +
Sbjct: 241 ----RNLKFPPLFTQKYPCEYV--------MVQ-DMLSPSPMERPEAINIIEN--AVFED 285
Query: 698 VPSPPMPPLHS 708
+ P L
Sbjct: 286 LDFPGKTVLRQ 296
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 9e-39
Identities = 78/282 (27%), Positives = 123/282 (43%), Gaps = 27/282 (9%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQL 483
+ +LG G +G VY+GV K VAVK L + E E EF E + + H NLVQL
Sbjct: 224 MKHKLGGGQYGEVYEGVWKK-YSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQL 281
Query: 484 LGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLR--VRISLEIARGLLYLHEECNVP 541
LG C ++ EFM G L + L R + S + ++ +I+ + YL ++
Sbjct: 282 LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--- 338
Query: 542 IIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPVSA 601
IH ++ +N L+ ++ K++DFGLS+L+ D + + APE S
Sbjct: 339 FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 398
Query: 602 KVDVYSFGVVLLKIICCKRSV--EMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMA 659
K DV++FGV+L +I S ++L + + D +++
Sbjct: 399 KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD--------YRME--------RPE 442
Query: 660 DKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLEVPSP 701
LM A W Q +P RP+ I Q E + S
Sbjct: 443 GCPEKVYELMRACW--QWNPSDRPSFAEIHQAFETMFQESSI 482
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 146 bits (369), Expect = 6e-38
Identities = 72/290 (24%), Positives = 122/290 (42%), Gaps = 29/290 (10%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQL 483
E +LG+G FG V+ G + VA+K L E F E + + H+ LVQL
Sbjct: 188 LEVKLGQGCFGEVWMGTWNGTT--RVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQL 244
Query: 484 LGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLR--VRISLEIARGLLYLHEECNVP 541
E +V E+M G+L + L L V ++ +IA G+ Y+ E N
Sbjct: 245 YAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV-ERMN-- 300
Query: 542 IIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPVSA 601
+H D++ NIL+ ++ K++DFGL++L+ ++ R + + APE +
Sbjct: 301 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 360
Query: 602 KVDVYSFGVVLLKIICCKRS--VEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMA 659
K DV+SFG++L ++ R M E + ++
Sbjct: 361 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG--------YRMP--------CPP 404
Query: 660 DKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLEVPSPPMPPLHSL 709
+ + LM W +++P +RP + + LE Y P P +L
Sbjct: 405 ECPESLHDLMCQCW--RKEPEERPTFEYLQAFLEDYFTSTEPQYQPGENL 452
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 9e-38
Identities = 53/197 (26%), Positives = 96/197 (48%), Gaps = 12/197 (6%)
Query: 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQ-EREREF-KTEVSAIGRTHHKNLVQL 483
+G GS+G K + + + G + K+LD + E E++ +EV+ + H N+V+
Sbjct: 12 YTIGTGSYGRCQK-IRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRY 70
Query: 484 LG-FCDEGLNRL-LVYEFMGNGTLANLLFAIPRPDWSLR----VRISLEIARGLLYLHEE 537
D L +V E+ G LA+++ + L +R+ ++ L H
Sbjct: 71 YDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR 130
Query: 538 CNVP--IIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFK 595
+ ++H D+KP N+ LD K+ DFGL+++L D S +T + GT Y++PE
Sbjct: 131 SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPYYMSPEQMN 189
Query: 596 NVPVSAKVDVYSFGVVL 612
+ + K D++S G +L
Sbjct: 190 RMSYNEKSDIWSLGCLL 206
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-37
Identities = 45/203 (22%), Positives = 90/203 (44%), Gaps = 14/203 (6%)
Query: 426 EELGRGSFGIVYKGVLKSASGNAVAVKK--LDKLAQEREREF-KTEVSAIGRTHHKNLVQ 482
+++GRG F VY+ G VA+KK + L + R E+ + + +H N+++
Sbjct: 38 KKIGRGQFSEVYR-AACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIK 96
Query: 483 LLGFCDEGLNRLLVY-EFMGNGTLANLLFAIPRPDWSLR----VRISLEIARGLLYLHEE 537
E N L + E G L+ ++ + + + +++ L ++H
Sbjct: 97 YYASFIED-NELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR 155
Query: 538 CNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNV 597
++H DIKP N+ + K+ D GL + S + +++ GT Y++PE
Sbjct: 156 R---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIHEN 211
Query: 598 PVSAKVDVYSFGVVLLKIICCKR 620
+ K D++S G +L ++ +
Sbjct: 212 GYNFKSDIWSLGCLLYEMAALQS 234
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 4e-37
Identities = 53/196 (27%), Positives = 90/196 (45%), Gaps = 15/196 (7%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQERER-EFKTEVSAIGRTHHKNLVQ 482
E++GRG+FG V+ G L++ + VAVK + + +F E + + H N+V+
Sbjct: 118 LGEQIGRGNFGEVFSGRLRADNTL-VAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVR 176
Query: 483 LLGFCDEGLNRLLVYEFMGNGTLANLLFA-IPRPDWSLRVRISLEIARGLLYLHEECNVP 541
L+G C + +V E + G L R +++ + A G+ YL +
Sbjct: 177 LIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESK---C 233
Query: 542 IIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTV-----IRGTRGYVAPEWFKN 596
IH D+ +N L+ + KISDFG+S+ ++ T APE
Sbjct: 234 CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWT----APEALNY 289
Query: 597 VPVSAKVDVYSFGVVL 612
S++ DV+SFG++L
Sbjct: 290 GRYSSESDVWSFGILL 305
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 4e-37
Identities = 72/290 (24%), Positives = 122/290 (42%), Gaps = 29/290 (10%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQL 483
E +LG+G FG V+ G + VA+K L E F E + + H+ LVQL
Sbjct: 271 LEVKLGQGCFGEVWMGTWNGTT--RVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQL 327
Query: 484 LGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLR--VRISLEIARGLLYLHEECNVP 541
E +V E+M G+L + L L V ++ +IA G+ Y+ E N
Sbjct: 328 YAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV-ERMN-- 383
Query: 542 IIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPVSA 601
+H D++ NIL+ ++ K++DFGL++L+ ++ R + + APE +
Sbjct: 384 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 443
Query: 602 KVDVYSFGVVLLKIICCKRS--VEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMA 659
K DV+SFG++L ++ R M E + ++
Sbjct: 444 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG--------YRMP--------CPP 487
Query: 660 DKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLEVPSPPMPPLHSL 709
+ + LM W +++P +RP + + LE Y P P +L
Sbjct: 488 ECPESLHDLMCQCW--RKEPEERPTFEYLQAFLEDYFTSTEPQYQPGENL 535
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 2e-36
Identities = 70/295 (23%), Positives = 112/295 (37%), Gaps = 49/295 (16%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQL 483
LG+G+FG V K A+KK+ +E+ +EV + +H+ +V+
Sbjct: 10 EIAVLGQGAFGQVVKARNAL-DSRYYAIKKIRH-TEEKLSTILSEVMLLASLNHQYVVRY 67
Query: 484 LGFCDEGLNRL-------------LVYEFMGNGTLANLLFAIPRP-DWSLRVRISLEIAR 529
E N + + E+ NGTL +L+ + R+ +I
Sbjct: 68 YAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILE 127
Query: 530 GLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLL-------------LSDQS 576
L Y+H + IIH D+KP NI +D+ KI DFGL+K + L S
Sbjct: 128 ALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSS 184
Query: 577 RTRTVIRGTRGYVAPEWFKNVPV-SAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILT 635
T GT YVA E + K+D+YS G++ + S ME +
Sbjct: 185 DNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFF-EMIYPFSTGMERVNILKKLR- 242
Query: 636 DWAYDCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690
++ +K + K + I I DP KRP + ++
Sbjct: 243 --------SVS----IEFPPDFDDNKMKVEKKI-IR-LLIDHDPNKRPGARTLLN 283
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 6e-36
Identities = 55/206 (26%), Positives = 91/206 (44%), Gaps = 26/206 (12%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNA------VAVKKLDKLAQEREREFKTEVSAIGRTHH 477
F E LG+G+F ++KGV + V +K LDK + F S + + H
Sbjct: 12 FNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSH 71
Query: 478 KNLVQLLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLR--VRISLEIARGLLYLH 535
K+LV G C G +LV EF+ G+L L + ++ + ++ ++A + +L
Sbjct: 72 KHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKK-NKNCINILWKLEVAKQLAAAMHFL- 129
Query: 536 EECNVPIIHCDIKPQNILLDQDFT--------AKISDFGLSKLLLSDQSRTRTVIRGTRG 587
EE + IH ++ +NILL ++ K+SD G+S +L + I
Sbjct: 130 EENTL--IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDI-LQERIPWV-- 184
Query: 588 YVAPEWFKNVPV-SAKVDVYSFGVVL 612
PE +N + D +SFG L
Sbjct: 185 --PPECIENPKNLNLATDKWSFGTTL 208
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 8e-36
Identities = 63/200 (31%), Positives = 98/200 (49%), Gaps = 19/200 (9%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGN--AVAVKKLDKLAQERER-EFKTEVSAIGRTHHKNL 480
E+ +G G G V G L+ VA+K L ER+R +F +E S +G+ H N+
Sbjct: 53 IEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNI 112
Query: 481 VQLLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLR--VRISLEIARGLLYLHEEC 538
++L G G ++V E+M NG+L L +++ V + + G+ YL +
Sbjct: 113 IRLEGVVTRGRLAMIVTEYMENGSLDTFLRT-HDGQFTIMQLVGMLRGVGAGMRYL-SDL 170
Query: 539 NVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTV------IRGTRGYVAPE 592
+H D+ +N+L+D + K+SDFGLS++L D T IR T APE
Sbjct: 171 GY--VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWT----APE 224
Query: 593 WFKNVPVSAKVDVYSFGVVL 612
S+ DV+SFGVV+
Sbjct: 225 AIAFRTFSSASDVWSFGVVM 244
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 1e-35
Identities = 70/324 (21%), Positives = 118/324 (36%), Gaps = 54/324 (16%)
Query: 413 SLVELNEATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAI 472
+V ++ F ++LG G F V V G+ A+K++ Q+ E + E
Sbjct: 22 HMVIIDNKHYLFIQKLGEGGFSYVDL-VEGLHDGHFYALKRILCHEQQDREEAQREADMH 80
Query: 473 GRTHHKNLVQLLGFCDEGLNR----LLVYEFMGNGTLANLLFAIPRPDWSLR----VRIS 524
+H N+++L+ +C L+ F GTL N + + L + +
Sbjct: 81 RLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLL 140
Query: 525 LEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIR- 583
L I RGL +H + H D+KP NILL + + D G +R +
Sbjct: 141 LGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTL 197
Query: 584 -------GTRGYVAPEWF---KNVPVSAKVDVYSFGVVLLKIICCK---RSVEMELGEER 630
T Y APE F + + + DV+S G VL ++ + V +
Sbjct: 198 QDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVA 257
Query: 631 SAILTDW---AYDCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKM 687
A+ + S A L+ + DP +RP + +
Sbjct: 258 LAVQNQLSIPQSPRH-------------------SSALWQLLN--SMMTVDPHQRPHIPL 296
Query: 688 IVQMLEGYLEVPSPPMPPLHSLQL 711
++ LE PP P H+ Q+
Sbjct: 297 LLSQLEALQ----PPAPGQHTTQI 316
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 1e-35
Identities = 66/289 (22%), Positives = 115/289 (39%), Gaps = 58/289 (20%)
Query: 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLG 485
E +G G FG V+K + G +K++ E+ + EV A+ + H N+V G
Sbjct: 17 ELIGSGGFGQVFKAKHRI-DGKTYVIKRVKY---NNEKAER-EVKALAKLDHVNIVHYNG 71
Query: 486 -FCDEGLNRL---------------LVYEFMGNGTLANLL-----FAIPRPD-WSLRVRI 523
+ + + EF GTL + + + +
Sbjct: 72 CWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLAL----EL 127
Query: 524 SLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIR 583
+I +G+ Y+H + +I+ D+KP NI L KI DFGL L +D RTR+
Sbjct: 128 FEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSK-- 182
Query: 584 GTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYV 643
GT Y++PE + +VD+Y+ G++L +++ + E S TD
Sbjct: 183 GTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT-----AFETSKFFTD-----LR 232
Query: 644 EGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQML 692
+G + + + K L+ + + P RP I++ L
Sbjct: 233 DGIISDIF----------DKKEKTLL--QKLLSKKPEDRPNTSEILRTL 269
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 1e-35
Identities = 67/201 (33%), Positives = 106/201 (52%), Gaps = 20/201 (9%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNA---VAVKKLDKLAQERER-EFKTEVSAIGRTHHKN 479
++ +G G FG VYKG+LK++SG VA+K L E++R +F E +G+ H N
Sbjct: 48 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHN 107
Query: 480 LVQLLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLR--VRISLEIARGLLYLHEE 537
+++L G + +++ E+M NG L L ++S+ V + IA G+ YL
Sbjct: 108 IIRLEGVISKYKPMMIITEYMENGALDKFLRE-KDGEFSVLQLVGMLRGIAAGMKYL-AN 165
Query: 538 CNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTV------IRGTRGYVAP 591
N +H D+ +NIL++ + K+SDFGLS++L D T T IR T AP
Sbjct: 166 MNY--VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT----AP 219
Query: 592 EWFKNVPVSAKVDVYSFGVVL 612
E ++ DV+SFG+V+
Sbjct: 220 EAISYRKFTSASDVWSFGIVM 240
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 2e-35
Identities = 59/212 (27%), Positives = 102/212 (48%), Gaps = 21/212 (9%)
Query: 414 LVELNEATNGFEEELGRGSFGIVYKGVLKSASGNA--VAVKKLDKLAQERER-EFKTEVS 470
++ + F E +GRG FG VY G L G AVK L+++ E +F TE
Sbjct: 83 VIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGI 142
Query: 471 AIGRTHHKNLVQLLGFC-DEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLR--VRISLEI 527
+ H N++ LLG C + L+V +M +G L N + + +++ + L++
Sbjct: 143 IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN-ETHNPTVKDLIGFGLQV 201
Query: 528 ARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSD---QSRTRTV--- 581
A+G+ +L +H D+ +N +LD+ FT K++DFGL++ + +T
Sbjct: 202 AKGMKFL-ASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKL 258
Query: 582 -IRGTRGYVAPEWFKNVPVSAKVDVYSFGVVL 612
++ A E + + K DV+SFGV+L
Sbjct: 259 PVKWM----ALESLQTQKFTTKSDVWSFGVLL 286
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 2e-35
Identities = 83/309 (26%), Positives = 142/309 (45%), Gaps = 51/309 (16%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGN----AVAVKKLDKLAQERER-EFKTEVSAIGRTHHK 478
ELG+GSFG+VY+GV K + VA+K +++ A RER EF E S + +
Sbjct: 29 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 88
Query: 479 NLVQLLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLR-----------VRISLEI 527
++V+LLG +G L++ E M G L + L ++ RP + ++++ EI
Sbjct: 89 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSL-RPAMANNPVLAPPSLSKMIQMAGEI 147
Query: 528 ARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSD-----QSRTRTVI 582
A G+ YL+ +H D+ +N ++ +DFT KI DFG+++ + + +
Sbjct: 148 ADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 204
Query: 583 RGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDW-AYDC 641
R +PE K+ + DV+SFGVVL +I L E+ L++
Sbjct: 205 RWM----SPESLKDGVFTTYSDVWSFGVVLWEI--------ATLAEQPYQGLSNEQVLRF 252
Query: 642 YVEGKLDVLVDNDKAAMADKSRACKWLM--IALWCIQEDPLKRPAMKMIVQMLEGYLEVP 699
+EG L + DK C ++ + C Q +P RP+ I+ ++ +E
Sbjct: 253 VMEGGL----------L-DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPG 301
Query: 700 SPPMPPLHS 708
+ +S
Sbjct: 302 FREVSFYYS 310
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 142 bits (358), Expect = 2e-35
Identities = 70/290 (24%), Positives = 109/290 (37%), Gaps = 33/290 (11%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQERERE-FKTEVSAIGRTHHKNLVQ 482
+E LG G FG V + + + +G VA+K+ + + RE + E+ + + +H N+V
Sbjct: 18 MKERLGTGGFGYVLRWIHQD-TGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVS 76
Query: 483 LLGFCDE------GLNRLLVYEFMGNGTLANLLFAIPRPDWSLR---VRISL-EIARGLL 532
D LL E+ G L L L+ +R L +I+ L
Sbjct: 77 AREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQ-FENCCGLKEGPIRTLLSDISSALR 135
Query: 533 YLHEECNVPIIHCDIKPQNILLD---QDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYV 589
YLHE IIH D+KP+NI+L Q KI D G +K L + GT Y+
Sbjct: 136 YLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL-DQGELCTEFV-GTLQYL 190
Query: 590 APEWFKNVPVSAKVDVYSFGVVLLKIIC------CKRSVEMELGEERSAILTDWAYDCYV 643
APE + + VD +SFG + + I G+ R +
Sbjct: 191 APELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDL 250
Query: 644 EGKLD---VLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690
G + VL + + + +WL L +R
Sbjct: 251 TGAVKFSSVLPTPNHLSGILAGKLERWLQCML---MWHQRQRGTDPQNPN 297
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 2e-35
Identities = 61/200 (30%), Positives = 101/200 (50%), Gaps = 19/200 (9%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGN--AVAVKKLDKLAQERER-EFKTEVSAIGRTHHKNL 480
++ +G G FG V G LK S +VA+K L E++R +F E S +G+ H N+
Sbjct: 49 IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNI 108
Query: 481 VQLLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLR--VRISLEIARGLLYLHEEC 538
++L G + ++V E+M NG+L + L +++ V + IA G+ YL +
Sbjct: 109 IRLEGVVTKSKPVMIVTEYMENGSLDSFLRK-HDAQFTVIQLVGMLRGIASGMKYL-SDM 166
Query: 539 NVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTV------IRGTRGYVAPE 592
+H D+ +NIL++ + K+SDFGL ++L D T IR T +PE
Sbjct: 167 GY--VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWT----SPE 220
Query: 593 WFKNVPVSAKVDVYSFGVVL 612
++ DV+S+G+VL
Sbjct: 221 AIAYRKFTSASDVWSYGIVL 240
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 3e-35
Identities = 58/193 (30%), Positives = 92/193 (47%), Gaps = 14/193 (7%)
Query: 428 LGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFC 487
LG+G++GIVY G ++ +A+K++ + + E++ HKN+VQ LG
Sbjct: 30 LGKGTYGIVYAG-RDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 488 DEGLNRLLVYEFMGNGTLANLLF----AIPRPDWSLRVRISLEIARGLLYLHEECNVPII 543
E + E + G+L+ LL + + ++ + +I GL YLH+ I+
Sbjct: 89 SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGF-YTKQILEGLKYLHDNQ---IV 144
Query: 544 HCDIKPQNILLDQ-DFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPV--S 600
H DIK N+L++ KISDFG SK L T T GT Y+APE P
Sbjct: 145 HRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETF-TGTLQYMAPEIIDKGPRGYG 203
Query: 601 AKVDVYSFG-VVL 612
D++S G ++
Sbjct: 204 KAADIWSLGCTII 216
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 3e-35
Identities = 60/202 (29%), Positives = 99/202 (49%), Gaps = 21/202 (10%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNA--VAVKKLDKLAQERER-EFKTEVSAIGRTHHKNL 480
F E +GRG FG VY G L G AVK L+++ E +F TE + H N+
Sbjct: 29 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 88
Query: 481 VQLLGFC-DEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLR--VRISLEIARGLLYLHEE 537
+ LLG C + L+V +M +G L N + + +++ + L++A+G+ YL
Sbjct: 89 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKYL-AS 146
Query: 538 CNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSD---QSRTRTV----IRGTRGYVA 590
+H D+ +N +LD+ FT K++DFGL++ + +T ++ A
Sbjct: 147 KK--FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM----A 200
Query: 591 PEWFKNVPVSAKVDVYSFGVVL 612
E + + K DV+SFGV+L
Sbjct: 201 LESLQTQKFTTKSDVWSFGVLL 222
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 3e-35
Identities = 78/314 (24%), Positives = 126/314 (40%), Gaps = 58/314 (18%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNA----VAVKKLDKLAQERER-EFKTEVSAIGRTHHK 478
LG G+FG VY+G + + VAVK L ++ E++ +F E I + +H+
Sbjct: 34 LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 93
Query: 479 NLVQLLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLR--------VRISLEIARG 530
N+V+ +G + L R ++ E M G L + L RP S + ++ +IA G
Sbjct: 94 NIVRCIGVSLQSLPRFILMELMAGGDLKSFLRET-RPRPSQPSSLAMLDLLHVARDIACG 152
Query: 531 LLYLHEECNVPIIHCDIKPQNILLD---QDFTAKISDFGLSKLLLSD-----QSRTRTVI 582
YL EE + IH DI +N LL AKI DFG+++ + +
Sbjct: 153 CQYL-EENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPV 209
Query: 583 RGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDW-AYDC 641
+ PE F ++K D +SFGV+L +I LG ++ +
Sbjct: 210 KWM----PPEAFMEGIFTSKTDTWSFGVLLWEI--------FSLGYMPYPSKSNQEVLEF 257
Query: 642 YVEGKLDVLVDNDKAAMADKSRACKW----LMIALWCIQEDPLKRPAMKMIVQMLEGYLE 697
G M D + C +M W Q P RP +I++ +E +
Sbjct: 258 VTSGGR----------M-DPPKNCPGPVYRIMTQCW--QHQPEDRPNFAIILERIEYCTQ 304
Query: 698 VPS---PPMPPLHS 708
P +P +
Sbjct: 305 DPDVINTALPIEYG 318
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 4e-35
Identities = 55/203 (27%), Positives = 96/203 (47%), Gaps = 17/203 (8%)
Query: 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQ-EREREF-KTEVSAIGRTHHKNLVQL 483
+++G GSFG V + G +K+++ +ERE + EV+ + H N+VQ
Sbjct: 30 QKIGEGSFGKAIL-VKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQY 88
Query: 484 LGFCDEGLNRLLVYEFMGNGTLANLL-----FAIPRPD-WSLRVRISLEIARGLLYLHEE 537
+E + +V ++ G L + ++I L ++H+
Sbjct: 89 RESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQIL----DWFVQICLALKHVHDR 144
Query: 538 CNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNV 597
I+H DIK QNI L +D T ++ DFG++++L S R I GT Y++PE +N
Sbjct: 145 ---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI-GTPYYLSPEICENK 200
Query: 598 PVSAKVDVYSFGVVLLKIICCKR 620
P + K D+++ G VL ++ K
Sbjct: 201 PYNNKSDIWALGCVLYELCTLKH 223
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 6e-35
Identities = 49/198 (24%), Positives = 86/198 (43%), Gaps = 18/198 (9%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGN--AVAVKKLDKLAQERER-EFKTEVSAIGRTHHKNL 480
+G G FG V++G+ S AVA+K + R +F E + + H ++
Sbjct: 19 LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 78
Query: 481 VQLLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLR--VRISLEIARGLLYLHEEC 538
V+L+G E ++ E G L + L + L + + +++ L YL E
Sbjct: 79 VKLIGVITEN-PVWIIMELCTLGELRSFLQV-RKYSLDLASLILYAYQLSTALAYL-ESK 135
Query: 539 NVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSD----QSRTRTVIRGTRGYVAPEWF 594
+H DI +N+L+ + K+ DFGLS+ + S+ + I+ APE
Sbjct: 136 R--FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM----APESI 189
Query: 595 KNVPVSAKVDVYSFGVVL 612
++ DV+ FGV +
Sbjct: 190 NFRRFTSASDVWMFGVCM 207
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 7e-35
Identities = 68/195 (34%), Positives = 99/195 (50%), Gaps = 15/195 (7%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQL 483
+ +LG G +G VY+GV K S VAVK L + E E EF E + + H NLVQL
Sbjct: 17 MKHKLGGGQYGEVYEGVWKKYS-LTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQL 74
Query: 484 LGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLR--VRISLEIARGLLYLHEECNVP 541
LG C ++ EFM G L + L R + S + ++ +I+ + YL E+ N
Sbjct: 75 LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL-EKKNF- 132
Query: 542 IIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTV----IRGTRGYVAPEWFKNV 597
IH D+ +N L+ ++ K++DFGLS+L+ D I+ T APE
Sbjct: 133 -IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT----APESLAYN 187
Query: 598 PVSAKVDVYSFGVVL 612
S K DV++FGV+L
Sbjct: 188 KFSIKSDVWAFGVLL 202
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 7e-35
Identities = 56/198 (28%), Positives = 87/198 (43%), Gaps = 18/198 (9%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGN--AVAVKKLDKLAQERER-EFKTEVSAIGRTHHKNL 480
LG G FG VY+GV + G VAVK K + +F +E + H ++
Sbjct: 16 LNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHI 75
Query: 481 VQLLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLR--VRISLEIARGLLYLHEEC 538
V+L+G +E ++ E G L + L + + V SL+I + + YL E
Sbjct: 76 VKLIGIIEEE-PTWIIMELYPYGELGHYLER-NKNSLKVLTLVLYSLQICKAMAYL-ESI 132
Query: 539 NVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSD----QSRTRTVIRGTRGYVAPEWF 594
N +H DI +NIL+ K+ DFGLS+ + + S TR I+ +PE
Sbjct: 133 NC--VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWM----SPESI 186
Query: 595 KNVPVSAKVDVYSFGVVL 612
+ DV+ F V +
Sbjct: 187 NFRRFTTASDVWMFAVCM 204
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 1e-34
Identities = 68/309 (22%), Positives = 120/309 (38%), Gaps = 45/309 (14%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNA---VAVKKLDKLAQEREREFKTEVSAIGRTHHKNL 480
+ +LG+G+FG V N VAVK+L +++R+F+ E+ + H +
Sbjct: 27 YISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFI 86
Query: 481 VQLLGFCDEGLNR--LLVYEFMGNGTLANLLFAIPRPDWSLR--VRISLEIARGLLYLHE 536
V+ G + LV E++ +G L + L R + S +I +G+ YL
Sbjct: 87 VKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQR-HRARLDASRLLLYSSQICKGMEYL-G 144
Query: 537 ECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSD------QSRTRTVIRGTRGYVA 590
+H D+ +NIL++ + KI+DFGL+KLL D + ++ I A
Sbjct: 145 SRR--CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWY----A 198
Query: 591 PEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVL 650
PE + S + DV+SFGVVL ++ ++ + ++ + G +
Sbjct: 199 PESLSDNIFSRQSDVWSFGVVLYEL--------FTYCDKSCSPSAEFL---RMMGCERDV 247
Query: 651 VDNDKAAMADKS-------RACKW----LMIALWCIQEDPLKRPAMKMIVQMLEGYLEVP 699
+ + AC LM W P RP+ + L+
Sbjct: 248 PALSRLLELLEEGQRLPAPPACPAEVHELMKLCW--APSPQDRPSFSALGPQLDMLWSGS 305
Query: 700 SPPMPPLHS 708
+
Sbjct: 306 RGCETHAFT 314
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 1e-34
Identities = 75/313 (23%), Positives = 125/313 (39%), Gaps = 56/313 (17%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNA----VAVKKLDKLAQERER-EFKTEVSAIGRTHHK 478
LG G+FG VY+G + + VAVK L ++ E++ +F E I + +H+
Sbjct: 75 LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 134
Query: 479 NLVQLLGFCDEGLNRLLVYEFMGNGTLANLL-----FAIPRPDWSLR--VRISLEIARGL 531
N+V+ +G + L R ++ E M G L + L ++ + ++ +IA G
Sbjct: 135 NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 194
Query: 532 LYLHEECNVPIIHCDIKPQNILLD---QDFTAKISDFGLSKLLLSD-----QSRTRTVIR 583
YL EE + IH DI +N LL AKI DFG+++ + ++
Sbjct: 195 QYL-EENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVK 251
Query: 584 GTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDW-AYDCY 642
PE F ++K D +SFGV+L +I LG ++ +
Sbjct: 252 WM----PPEAFMEGIFTSKTDTWSFGVLLWEI--------FSLGYMPYPSKSNQEVLEFV 299
Query: 643 VEGKLDVLVDNDKAAMADKSRACKW----LMIALWCIQEDPLKRPAMKMIVQMLEGYLEV 698
G M D + C +M W Q P RP +I++ +E +
Sbjct: 300 TSGGR----------M-DPPKNCPGPVYRIMTQCW--QHQPEDRPNFAIILERIEYCTQD 346
Query: 699 PS---PPMPPLHS 708
P +P +
Sbjct: 347 PDVINTALPIEYG 359
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 1e-34
Identities = 55/195 (28%), Positives = 94/195 (48%), Gaps = 17/195 (8%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQL 483
F +ELG G FG+V G + VA+K + + + + EF E + H+ LVQL
Sbjct: 28 FLKELGTGQFGVVKYGKWRGQ--YDVAIKMIKEGSMSED-EFIEEAKVMMNLSHEKLVQL 84
Query: 484 LGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLR--VRISLEIARGLLYLHEECNVP 541
G C + ++ E+M NG L N L R + + + + ++ + YL E
Sbjct: 85 YGVCTKQRPIFIITEYMANGCLLNYLRE-MRHRFQTQQLLEMCKDVCEAMEYL-ESKQF- 141
Query: 542 IIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTV----IRGTRGYVAPEWFKNV 597
+H D+ +N L++ K+SDFGLS+ +L D+ + +R + PE
Sbjct: 142 -LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWS----PPEVLMYS 196
Query: 598 PVSAKVDVYSFGVVL 612
S+K D+++FGV++
Sbjct: 197 KFSSKSDIWAFGVLM 211
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 1e-34
Identities = 68/286 (23%), Positives = 119/286 (41%), Gaps = 37/286 (12%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQL 483
E++LG G FG V+ + VAVK + + E F E + + H LV+L
Sbjct: 192 LEKKLGAGQFGEVWMATYNKHT--KVAVKTMKPGSMSVE-AFLAEANVMKTLQHDKLVKL 248
Query: 484 LGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLR--VRISLEIARGLLYLHEECNVP 541
+ ++ EFM G+L + L + L + S +IA G+ ++ E+ N
Sbjct: 249 HAVVTKE-PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI-EQRN-- 304
Query: 542 IIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTV----IRGTRGYVAPEWFKNV 597
IH D++ NIL+ KI+DFGL++++ ++ R I+ T APE
Sbjct: 305 YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWT----APEAINFG 360
Query: 598 PVSAKVDVYSFGVVLLKIICCKRSV--EMELGEERSAILTDWAYDCYVEGKLDVLVDNDK 655
+ K DV+SFG++L++I+ R M E A+ ++
Sbjct: 361 SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG--------YRMP------- 405
Query: 656 AAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLEVPSP 701
+ +M+ W + P +RP + I +L+ +
Sbjct: 406 -RPENCPEELYNIMMRCW--KNRPEERPTFEYIQSVLDDFYTATES 448
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-34
Identities = 53/230 (23%), Positives = 100/230 (43%), Gaps = 33/230 (14%)
Query: 394 KDGNKVQRSSISETNLRFFSLVELNEATNGFEEELGRGSFGIVYKGVLKSASGNA---VA 450
+ N+ + ET + + LG G+FG VYKG+ VA
Sbjct: 2 EAPNQALLRILKETEFKK-------------IKVLGSGAFGTVYKGLWIPEGEKVKIPVA 48
Query: 451 VKKLDKLAQERER-EFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEFMGNGTLANLL 509
+K+L + + E E + + ++ +LLG C L+ + M G L + +
Sbjct: 49 IKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYV 107
Query: 510 FAIPRPDWSLR--VRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGL 567
+ + + + ++IA+G+ YL E+ ++H D+ +N+L+ KI+DFGL
Sbjct: 108 RE-HKDNIGSQYLLNWCVQIAKGMNYL-EDRR--LVHRDLAARNVLVKTPQHVKITDFGL 163
Query: 568 SKLLLSDQSRTRTV-----IRGTRGYVAPEWFKNVPVSAKVDVYSFGVVL 612
+KLL +++ I+ A E + + + DV+S+GV +
Sbjct: 164 AKLLGAEEKEYHAEGGKVPIKWM----ALESILHRIYTHQSDVWSYGVTV 209
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 2e-34
Identities = 58/203 (28%), Positives = 98/203 (48%), Gaps = 15/203 (7%)
Query: 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLG 485
++G GS GIV K SG VAVK +D Q+R EV + H N+V++
Sbjct: 51 VKIGEGSTGIVCLAREK-HSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYK 109
Query: 486 FCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHC 545
G ++ EF+ G L +++ + + + + + + L YLH + +IH
Sbjct: 110 SYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIAT-VCEAVLQALAYLHAQ---GVIHR 165
Query: 546 DIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPVSAKVDV 605
DIK +ILL D K+SDFG + D + ++++ GT ++APE + +VD+
Sbjct: 166 DIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVISRSLYATEVDI 224
Query: 606 YSFGVVLLKIICCKRSVEMELGE 628
+S G++++ EM GE
Sbjct: 225 WSLGIMVI---------EMVDGE 238
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 2e-34
Identities = 57/194 (29%), Positives = 97/194 (50%), Gaps = 15/194 (7%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQL 483
+ELG G FG+V G K VAVK + + + + EF E + + H LV+
Sbjct: 12 LLKELGSGQFGVVKLGKWKGQY--DVAVKMIKEGSMSED-EFFQEAQTMMKLSHPKLVKF 68
Query: 484 LGFCDEGLNRLLVYEFMGNGTLANLLFA-IPRPDWSLRVRISLEIARGLLYLHEECNVPI 542
G C + +V E++ NG L N L + + S + + ++ G+ +L E
Sbjct: 69 YGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFL-ESHQF-- 125
Query: 543 IHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTV----IRGTRGYVAPEWFKNVP 598
IH D+ +N L+D+D K+SDFG+++ +L DQ + ++ + APE F
Sbjct: 126 IHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWS----APEVFHYFK 181
Query: 599 VSAKVDVYSFGVVL 612
S+K DV++FG+++
Sbjct: 182 YSSKSDVWAFGILM 195
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-34
Identities = 57/193 (29%), Positives = 82/193 (42%), Gaps = 14/193 (7%)
Query: 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLG 485
+GRGSFG V++ +G AVKK+ E E+ A +V L G
Sbjct: 64 PRVGRGSFGEVHRM-KDKQTGFQCAVKKVRLEVFRVE-----ELVACAGLSSPRIVPLYG 117
Query: 486 FCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHC 545
EG + E + G+L L+ + + + GL YLH I+H
Sbjct: 118 AVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRR---ILHG 174
Query: 546 DIKPQNILLDQD-FTAKISDFGLSKLLLSDQS----RTRTVIRGTRGYVAPEWFKNVPVS 600
D+K N+LL D A + DFG + L D T I GT ++APE P
Sbjct: 175 DVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCD 234
Query: 601 AKVDVYSFGVVLL 613
AKVD++S ++L
Sbjct: 235 AKVDIWSSCCMML 247
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 2e-34
Identities = 52/202 (25%), Positives = 100/202 (49%), Gaps = 21/202 (10%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNA--VAVKKLDKLAQERER-EFKTEVSAIGRTHHKNL 480
+ +G+G FG+VY G + N A+K L ++ + ++ F E + +H N+
Sbjct: 25 SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84
Query: 481 VQLLGFC-DEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLR--VRISLEIARGLLYLHEE 537
+ L+G ++ +M +G L + + P+ + +++ + L++ARG+ YL E
Sbjct: 85 LALIGIMLPPEGLPHVLLPYMCHGDLLQFIRS-PQRNPTVKDLISFGLQVARGMEYL-AE 142
Query: 538 CNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSD---QSRTRTV----IRGTRGYVA 590
+H D+ +N +LD+ FT K++DFGL++ +L + ++ T A
Sbjct: 143 QK--FVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWT----A 196
Query: 591 PEWFKNVPVSAKVDVYSFGVVL 612
E + + K DV+SFGV+L
Sbjct: 197 LESLQTYRFTTKSDVWSFGVLL 218
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 3e-34
Identities = 64/195 (32%), Positives = 104/195 (53%), Gaps = 17/195 (8%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQL 483
F +E+G G FG+V+ G + + VA+K + + A E +F E + + H LVQL
Sbjct: 12 FVQEIGSGQFGLVHLGYWLNK--DKVAIKTIREGAMSEE-DFIEEAEVMMKLSHPKLVQL 68
Query: 484 LGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLR--VRISLEIARGLLYLHEECNVP 541
G C E LV EFM +G L++ L R ++ + + L++ G+ YL EE V
Sbjct: 69 YGVCLEQAPICLVTEFMEHGCLSDYLRT-QRGLFAAETLLGMCLDVCEGMAYL-EEACV- 125
Query: 542 IIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTV----IRGTRGYVAPEWFKNV 597
IH D+ +N L+ ++ K+SDFG+++ +L DQ + T ++ +PE F
Sbjct: 126 -IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWA----SPEVFSFS 180
Query: 598 PVSAKVDVYSFGVVL 612
S+K DV+SFGV++
Sbjct: 181 RYSSKSDVWSFGVLM 195
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 3e-34
Identities = 75/308 (24%), Positives = 131/308 (42%), Gaps = 62/308 (20%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGN----AVAVKKLDKLAQERER-EFKTEVSAIGRTHHK 478
+ ELG G+FG V+ + S VAVK L K R +F+ E + H+
Sbjct: 19 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKAL-KDPTLAARKDFQREAELLTNLQHE 77
Query: 479 NLVQLLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLR-----------------V 521
++V+ G C +G ++V+E+M +G L L A PD + +
Sbjct: 78 HIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAH-GPDAMILVDGQPRQAKGELGLSQML 136
Query: 522 RISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSD-----QS 576
I+ +IA G++YL + +H D+ +N L+ + KI DFG+S+ + S
Sbjct: 137 HIASQIASGMVYL-ASQH--FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGG 193
Query: 577 RTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTD 636
T IR PE + + DV+SFGV+L +I G++ L++
Sbjct: 194 HTMLPIRWM----PPESIMYRKFTTESDVWSFGVILWEI--------FTYGKQPWFQLSN 241
Query: 637 W-AYDCYVEGKLDVLVDNDKAAMADKSRACKW----LMIALWCIQEDPLKRPAMKMIVQM 691
+C +G++ + ++ R C +M+ W Q +P +R +K I ++
Sbjct: 242 TEVIECITQGRV----------L-ERPRVCPKEVYDVMLGCW--QREPQQRLNIKEIYKI 288
Query: 692 LEGYLEVP 699
L +
Sbjct: 289 LHALGKAT 296
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 4e-34
Identities = 66/192 (34%), Positives = 99/192 (51%), Gaps = 15/192 (7%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQL 483
+ +G+G FG V G + GN VAVK + A + F E S + + H NLVQL
Sbjct: 197 LLQTIGKGEFGDVMLGDYR---GNKVAVKCIKNDATAQA--FLAEASVMTQLRHSNLVQL 251
Query: 484 LGFCDEGLNRL-LVYEFMGNGTLANLLFAIPRPDWSLR--VRISLEIARGLLYLHEECNV 540
LG E L +V E+M G+L + L + R ++ SL++ + YL E N
Sbjct: 252 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL-EGNN- 309
Query: 541 PIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPVS 600
+H D+ +N+L+ +D AK+SDFGL+K S Q + ++ T APE + S
Sbjct: 310 -FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKKFS 364
Query: 601 AKVDVYSFGVVL 612
K DV+SFG++L
Sbjct: 365 TKSDVWSFGILL 376
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 4e-34
Identities = 53/199 (26%), Positives = 79/199 (39%), Gaps = 14/199 (7%)
Query: 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDK-LAQERERE-FKTEVSAIGR-THHKNLVQ 482
LG GS+G V+K V G AVK+ ++R EV + + H V+
Sbjct: 63 SRLGHGSYGEVFK-VRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVR 121
Query: 483 LLGFCDEGLNRLLVYEFMGNGTLANLLFAIPR--PDWSLRVRISLEIARGLLYLHEECNV 540
L +EG L E G +L A P+ + + L +LH +
Sbjct: 122 LEQAWEEGGILYLQTELCG-PSLQQHCEAWGASLPEAQVW-GYLRDTLLALAHLHSQ--- 176
Query: 541 PIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPVS 600
++H D+KP NI L K+ DFGL L G Y+APE +
Sbjct: 177 GLVHLDVKPANIFLGPRGRCKLGDFGLLV-ELGTAGAGEVQE-GDPRYMAPELLQG-SYG 233
Query: 601 AKVDVYSFGVVLLKIICCK 619
DV+S G+ +L++ C
Sbjct: 234 TAADVFSLGLTILEVACNM 252
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 7e-34
Identities = 29/250 (11%), Positives = 60/250 (24%), Gaps = 45/250 (18%)
Query: 405 SETNLRFFSLVELNEATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQERERE 464
SL+ E E L G +V+ A+K A+ E
Sbjct: 47 QNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVE-RLEDFALKVFTMGAENSRSE 105
Query: 465 ---FKTEVSAIGRTHHKNLVQLLGFC--------------------------DEGLNRLL 495
A R ++ + N LL
Sbjct: 106 LERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLL 165
Query: 496 VYEFMG--NGTLANLLFAIPRPDWSL----RVRISLEIARGLLYLHEECNVPIIHCDIKP 549
+ L + L + ++ ++ R L + ++H P
Sbjct: 166 LMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG---LVHGHFTP 222
Query: 550 QNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWF--KNVPVSAKVDVYS 607
N+ + D + D + Y E+ + ++ +
Sbjct: 223 DNLFIMPDGRLMLGDVSALWKV----GTRGPASSVPVTYAPREFLNASTATFTHALNAWQ 278
Query: 608 FGVVLLKIIC 617
G+ + ++ C
Sbjct: 279 LGLSIYRVWC 288
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 7e-34
Identities = 55/203 (27%), Positives = 100/203 (49%), Gaps = 15/203 (7%)
Query: 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLG 485
E++G+G+ G VY + A+G VA+++++ Q ++ E+ + + N+V L
Sbjct: 26 EKIGQGASGTVYTAMDV-ATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLD 84
Query: 486 FCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHC 545
G +V E++ G+L +++ + + + E + L +LH +IH
Sbjct: 85 SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA-VCRECLQALEFLHSN---QVIHR 140
Query: 546 DIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPVSAKVDV 605
DIK NILL D + K++DFG + +QS+ T++ GT ++APE KVD+
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDI 199
Query: 606 YSFGVVLLKIICCKRSVEMELGE 628
+S G++ + EM GE
Sbjct: 200 WSLGIMAI---------EMIEGE 213
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 8e-34
Identities = 64/215 (29%), Positives = 98/215 (45%), Gaps = 35/215 (16%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGN----AVAVKKLDKLAQERER-EFKTEVSAIGRTHHK 478
+ ELG G+FG V+ + VAVK L K A E R +F+ E + H+
Sbjct: 45 LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL-KEASESARQDFQREAELLTMLQHQ 103
Query: 479 NLVQLLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLR----------------VR 522
++V+ G C EG L+V+E+M +G L L + PD L +
Sbjct: 104 HIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSH-GPDAKLLAGGEDVAPGPLGLGQLLA 162
Query: 523 ISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSD-----QSR 577
++ ++A G++YL + +H D+ +N L+ Q KI DFG+S+ + S R
Sbjct: 163 VASQVAAGMVYL-AGLH--FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGR 219
Query: 578 TRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVL 612
T IR PE + + DV+SFGVVL
Sbjct: 220 TMLPIRWM----PPESILYRKFTTESDVWSFGVVL 250
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 8e-34
Identities = 59/197 (29%), Positives = 96/197 (48%), Gaps = 17/197 (8%)
Query: 425 EEELGRGSFGIVYKGVLKSASGN-AVAVK--KLDKLAQEREREFKTEVSAIGRTHHKNLV 481
++ELG G+FG V KG + VAVK K + + E E + + + + +V
Sbjct: 22 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 81
Query: 482 QLLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVP 541
+++G C+ + +LV E G L L + + +++ G+ YL EE N
Sbjct: 82 RMIGICEAE-SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYL-EESN-- 137
Query: 542 IIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTV------IRGTRGYVAPEWFK 595
+H D+ +N+LL AKISDFGLSK L +D++ + ++ APE
Sbjct: 138 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY----APECIN 193
Query: 596 NVPVSAKVDVYSFGVVL 612
S+K DV+SFGV++
Sbjct: 194 YYKFSSKSDVWSFGVLM 210
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 9e-34
Identities = 67/296 (22%), Positives = 116/296 (39%), Gaps = 34/296 (11%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNA---VAVKKLDKLAQEREREFKTEVSAIGRTHHKNL 480
F ++LG+G+FG V N VAVKKL +E R+F+ E+ + H N+
Sbjct: 14 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 73
Query: 481 VQLLGFCDEGLNR--LLVYEFMGNGTLANLLFAIPRPDWSLR--VRISLEIARGLLYLHE 536
V+ G C R L+ E++ G+L + L + ++ + +I +G+ YL
Sbjct: 74 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK-HKERIDHIKLLQYTSQICKGMEYL-G 131
Query: 537 ECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSD------QSRTRTVIRGTRGYVA 590
IH D+ +NIL++ + KI DFGL+K+L D + + I A
Sbjct: 132 TKR--YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWY----A 185
Query: 591 PEWFKNVPVSAKVDVYSFGVVLLKII--CCKRSVEMELGEERSAILTDWAYDCYVEGKLD 648
PE S DV+SFGVVL ++ K +
Sbjct: 186 PESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF-----H 240
Query: 649 VLVDNDKAAMADKSRACKW----LMIALWCIQEDPLKRPAMKMIVQMLEGYLEVPS 700
++ + C +M W + +RP+ + + ++ + +
Sbjct: 241 LIELLKNNGRLPRPDGCPDEIYMIMTECW--NNNVNQRPSFRDLALRVDQIRDNMA 294
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 1e-33
Identities = 67/293 (22%), Positives = 115/293 (39%), Gaps = 34/293 (11%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNA---VAVKKLDKLAQEREREFKTEVSAIGRTHHKNL 480
F ++LG+G+FG V N VAVKKL +E R+F+ E+ + H N+
Sbjct: 45 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 104
Query: 481 VQLLGFCDEGLNR--LLVYEFMGNGTLANLLFAIPRPDWSLR--VRISLEIARGLLYLHE 536
V+ G C R L+ E++ G+L + L + ++ + +I +G+ YL
Sbjct: 105 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK-HKERIDHIKLLQYTSQICKGMEYL-G 162
Query: 537 ECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSD------QSRTRTVIRGTRGYVA 590
IH D+ +NIL++ + KI DFGL+K+L D + + I A
Sbjct: 163 TKR--YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWY----A 216
Query: 591 PEWFKNVPVSAKVDVYSFGVVLLKII--CCKRSVEMELGEERSAILTDWAYDCYVEGKLD 648
PE S DV+SFGVVL ++ K +
Sbjct: 217 PESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF-----H 271
Query: 649 VLVDNDKAAMADKSRACKW----LMIALWCIQEDPLKRPAMKMIVQMLEGYLE 697
++ + C +M W + +RP+ + + ++ +
Sbjct: 272 LIELLKNNGRLPRPDGCPDEIYMIMTECW--NNNVNQRPSFRDLALRVDQIRD 322
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 1e-33
Identities = 58/196 (29%), Positives = 97/196 (49%), Gaps = 19/196 (9%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQL 483
E LG G FG V+ G VAVK L + + + F E + + + H+ LV+L
Sbjct: 17 LVERLGAGQFGEVWMGYYNGH--TKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRL 73
Query: 484 LGFC-DEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLR--VRISLEIARGLLYLHEECNV 540
E + ++ E+M NG+L + L ++ + ++ +IA G+ ++ EE N
Sbjct: 74 YAVVTQEPI--YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI-EERNY 130
Query: 541 PIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTV----IRGTRGYVAPEWFKN 596
IH D++ NIL+ + KI+DFGL++L+ ++ R I+ T APE
Sbjct: 131 --IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWT----APEAINY 184
Query: 597 VPVSAKVDVYSFGVVL 612
+ K DV+SFG++L
Sbjct: 185 GTFTIKSDVWSFGILL 200
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-33
Identities = 66/192 (34%), Positives = 99/192 (51%), Gaps = 15/192 (7%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQL 483
+ +G+G FG V G + GN VAVK + A + F E S + + H NLVQL
Sbjct: 25 LLQTIGKGEFGDVMLGDYR---GNKVAVKCIKNDATAQA--FLAEASVMTQLRHSNLVQL 79
Query: 484 LGFCDEGLNRL-LVYEFMGNGTLANLLFAIPRPDWSLR--VRISLEIARGLLYLHEECNV 540
LG E L +V E+M G+L + L + R ++ SL++ + YL E N
Sbjct: 80 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL-EGNNF 138
Query: 541 PIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPVS 600
+H D+ +N+L+ +D AK+SDFGL+K S Q + ++ T APE + S
Sbjct: 139 --VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKKFS 192
Query: 601 AKVDVYSFGVVL 612
K DV+SFG++L
Sbjct: 193 TKSDVWSFGILL 204
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 53/213 (24%), Positives = 98/213 (46%), Gaps = 26/213 (12%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQERERE-FKTEVSAIGRTHHKNLVQ 482
+ LG+G+ V++G K +G+ A+K + ++ R + E + + +HKN+V+
Sbjct: 13 LSDILGQGATANVFRGRHKK-TGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVK 71
Query: 483 LLGFCDEGLNRL--LVYEFMGNGTLANLLFAIPRPDWSLR----VRISLEIARGLLYLHE 536
L +E R L+ EF G+L +L P + L + + ++ G+ +L E
Sbjct: 72 LFAIEEETTTRHKVLIMEFCPCGSLYTVLEE-PSNAYGLPESEFLIVLRDVVGGMNHLRE 130
Query: 537 ECNVPIIHCDIKPQNILL----DQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPE 592
I+H +IKP NI+ D K++DFG ++ L D + ++ GT Y+ P+
Sbjct: 131 NG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR-ELEDDEQFVSLY-GTEEYLHPD 185
Query: 593 WFKNVPV--------SAKVDVYSFGVVLLKIIC 617
++ + A VD++S GV
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT 218
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 65/301 (21%), Positives = 116/301 (38%), Gaps = 38/301 (12%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNA---VAVKKLDKLAQERER-EFKTEVSAIGRTHHKN 479
+LG G FG V + VAVK L A + R +K E+ + +H++
Sbjct: 35 KIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEH 94
Query: 480 LVQLLGFCDEGLNR--LLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEE 537
+++ G C++ LV E++ G+L + L + + + +I G+ YL
Sbjct: 95 IIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPR-HSIGLAQLLLFAQQICEGMAYL-HA 152
Query: 538 CNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSD------QSRTRTVIRGTRGYVAP 591
+ IH D+ +N+LLD D KI DFGL+K + + + + AP
Sbjct: 153 QH--YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY----AP 206
Query: 592 EWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGK----L 647
E K DV+SFGV L ++ + + + T + + L
Sbjct: 207 ECLKEYKFYYASDVWSFGVTLYEL--------LTHCDSSQSPPTKFLELIGIAQGQMTVL 258
Query: 648 DVLVDNDKAAMADKSRACKW----LMIALWCIQEDPLKRPAMKMIVQMLEGYLEVPSPPM 703
+ ++ + C LM W + + RP + ++ +L+ E
Sbjct: 259 RLTELLERGERLPRPDKCPAEVYHLMKNCW--ETEASFRPTFENLIPILKTVHEKYQGQA 316
Query: 704 P 704
P
Sbjct: 317 P 317
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 3e-33
Identities = 61/215 (28%), Positives = 90/215 (41%), Gaps = 33/215 (15%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGN----AVAVKKLDKLAQERER-EFKTEVSAIGRTHHK 478
F EELG FG VYKG L + AVA+K L A+ R EF+ E R H
Sbjct: 13 FMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHP 72
Query: 479 NLVQLLGFCDEGLNRLLVYEFMGNGTLANLL------------FAIPRPDWSLR----VR 522
N+V LLG + +++ + +G L L +L V
Sbjct: 73 NVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVH 132
Query: 523 ISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSD-----QSR 577
+ +IA G+ YL + ++H D+ +N+L+ KISD GL + + +
Sbjct: 133 LVAQIAAGMEYL-SSHH--VVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGN 189
Query: 578 TRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVL 612
+ IR APE S D++S+GVVL
Sbjct: 190 SLLPIRWM----APEAIMYGKFSIDSDIWSYGVVL 220
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 3e-33
Identities = 60/198 (30%), Positives = 97/198 (48%), Gaps = 19/198 (9%)
Query: 425 EEELGRGSFGIVYKGVLKSASGN-AVAVKKLDKLAQERER-EFKTEVSAIGRTHHKNLVQ 482
+ ELG G+FG V +GV + VA+K L + ++ + E E + + + +V+
Sbjct: 15 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74
Query: 483 LLGFCDEGLNRLLVYEFMGNGTLANLLFAIPR--PDWSLRVRISLEIARGLLYLHEECNV 540
L+G C +LV E G G L L P ++ + +++ G+ YL EE N
Sbjct: 75 LIGVCQAE-ALMLVMEMAGGGPLHKFLVGKREEIPVSNV-AELLHQVSMGMKYL-EEKN- 130
Query: 541 PIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSD------QSRTRTVIRGTRGYVAPEWF 594
+H D+ +N+LL AKISDFGLSK L +D +S + ++ APE
Sbjct: 131 -FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY----APECI 185
Query: 595 KNVPVSAKVDVYSFGVVL 612
S++ DV+S+GV +
Sbjct: 186 NFRKFSSRSDVWSYGVTM 203
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 4e-33
Identities = 68/316 (21%), Positives = 120/316 (37%), Gaps = 61/316 (19%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQERERE-FKTEVSAIGRTHHKNLVQ 482
+ LG+G+ V++G K +G+ A+K + ++ R + E + + +HKN+V+
Sbjct: 13 LSDILGQGATANVFRGRHKK-TGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVK 71
Query: 483 LLGFCDEGLNRL--LVYEFMGNGTLANLLFAIPRPDWSLR----VRISLEIARGLLYLHE 536
L +E R L+ EF G+L +L P + L + + ++ G+ +L E
Sbjct: 72 LFAIEEETTTRHKVLIMEFCPCGSLYTVLEE-PSNAYGLPESEFLIVLRDVVGGMNHLRE 130
Query: 537 ECNVPIIHCDIKPQNILL----DQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPE 592
I+H +IKP NI+ D K++DFG ++ L D + ++ GT Y+ P+
Sbjct: 131 NG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR-ELEDDEQFVSLY-GTEEYLHPD 185
Query: 593 WFKNVPV--------SAKVDVYSFGVVL-----------------------LKIICCKRS 621
++ + A VD++S GV KII K S
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPS 245
Query: 622 VEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLK 681
+ ++ DW+ D V L + + L L + D K
Sbjct: 246 GAISGVQKAENGPIDWSGDMPVSCSLSRGL---------QVLLTPVLANIL---EADQEK 293
Query: 682 RPAMKMIVQMLEGYLE 697
L
Sbjct: 294 CWGFDQFFAETSDILH 309
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 4e-33
Identities = 60/226 (26%), Positives = 101/226 (44%), Gaps = 18/226 (7%)
Query: 397 NKVQRSSISETNLRFFSLVELNEATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDK 456
+ + NL F S+ N +ELGRG F +V + + KS +G A K L K
Sbjct: 6 HHSSGVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKS-TGQEYAAKFLKK 64
Query: 457 --LAQEREREFKTEVSAIGR-THHKNLVQLLGFCDEGLNRLLVYEFMGNGTLANLLFAIP 513
Q+ E E++ + ++ L + +L+ E+ G + +L +P
Sbjct: 65 RRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLC--LP 122
Query: 514 RPDWSLR----VRISLEIARGLLYLHEECNVPIIHCDIKPQNILL---DQDFTAKISDFG 566
+ +R+ +I G+ YLH+ I+H D+KPQNILL KI DFG
Sbjct: 123 ELAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFG 179
Query: 567 LSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVL 612
+S+ + + I GT Y+APE P++ D+++ G++
Sbjct: 180 MSRKI--GHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIA 223
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 4e-33
Identities = 49/198 (24%), Positives = 86/198 (43%), Gaps = 18/198 (9%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNA--VAVKKLDKLAQERER-EFKTEVSAIGRTHHKNL 480
+G G FG V++G+ S A VA+K + R +F E + + H ++
Sbjct: 394 LGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 453
Query: 481 VQLLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLR--VRISLEIARGLLYLHEEC 538
V+L+G E ++ E G L + L + L + + +++ L YL E
Sbjct: 454 VKLIGVITEN-PVWIIMELCTLGELRSFLQV-RKFSLDLASLILYAYQLSTALAYL-ESK 510
Query: 539 NVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSD----QSRTRTVIRGTRGYVAPEWF 594
+H DI +N+L+ + K+ DFGLS+ + S+ + I+ APE
Sbjct: 511 R--FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM----APESI 564
Query: 595 KNVPVSAKVDVYSFGVVL 612
++ DV+ FGV +
Sbjct: 565 NFRRFTSASDVWMFGVCM 582
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 5e-33
Identities = 63/203 (31%), Positives = 91/203 (44%), Gaps = 24/203 (11%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNA--VAVK--KLDKLAQERER-EFKTEVSAIGRTHHK 478
E+LG GSFG+V +G + SG VAVK K D L+Q +F EV+A+ H+
Sbjct: 22 LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHR 81
Query: 479 NLVQLLGFC-DEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLR--VRISLEIARGLLYLH 535
NL++L G + +V E G+L + L + + L R ++++A G+ YL
Sbjct: 82 NLIRLYGVVLTPPM--KMVTELAPLGSLLDRLRK-HQGHFLLGTLSRYAVQVAEGMGYL- 137
Query: 536 EECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTV------IRGTRGYV 589
E IH D+ +N+LL KI DFGL + L +
Sbjct: 138 ESKR--FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC---- 191
Query: 590 APEWFKNVPVSAKVDVYSFGVVL 612
APE K S D + FGV L
Sbjct: 192 APESLKTRTFSHASDTWMFGVTL 214
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 6e-33
Identities = 37/215 (17%), Positives = 67/215 (31%), Gaps = 24/215 (11%)
Query: 424 FEEELGRGSFGIVYKGVLKSA----SGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKN 479
LG G+F VY+ + +K + + +
Sbjct: 69 VHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHM 128
Query: 480 LVQLLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDW-----SLRVRISLEIARGLLYL 534
++ +LV E GTL N + L + ++ + + +
Sbjct: 129 FMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQV 188
Query: 535 HEECNVPIIHCDIKPQNILL-----------DQDFTAKISDFGLSK-LLLSDQSRTRTVI 582
H+ IIH DIKP N +L D + D G S + L + T
Sbjct: 189 HD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAK 245
Query: 583 RGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC 617
T G+ E N P + ++D + + ++
Sbjct: 246 CETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLF 280
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 8e-33
Identities = 53/205 (25%), Positives = 88/205 (42%), Gaps = 26/205 (12%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNA---VAVKKLDKLAQERER-EFKTEVSAIGRTHHKN 479
+LG G FG V N VAVK L + + K E+ + +H+N
Sbjct: 25 RIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHEN 84
Query: 480 LVQLLGFCDEGLNR--LLVYEFMGNGTLANLLFAIPRPDWSLR----VRISLEIARGLLY 533
+V+ G C E L+ EF+ +G+L L P+ + ++ +++I +G+ Y
Sbjct: 85 IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL---PKNKNKINLKQQLKYAVQICKGMDY 141
Query: 534 LHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTV------IRGTRG 587
L +H D+ +N+L++ + KI DFGL+K + +D+ +
Sbjct: 142 L-GSRQ--YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWY-- 196
Query: 588 YVAPEWFKNVPVSAKVDVYSFGVVL 612
APE DV+SFGV L
Sbjct: 197 --APECLMQSKFYIASDVWSFGVTL 219
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 9e-33
Identities = 50/199 (25%), Positives = 93/199 (46%), Gaps = 18/199 (9%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNA---VAVKKLDKLAQERER-EFKTEVSAIGRTHHKN 479
+ LG G FG V+KGV + V +K ++ + + + AIG H +
Sbjct: 17 KLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAH 76
Query: 480 LVQLLGFC-DEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLR--VRISLEIARGLLYLHE 536
+V+LLG C L LV +++ G+L + + R + + ++IA+G+ YL E
Sbjct: 77 IVRLLGLCPGSSL--QLVTQYLPLGSLLDHVRQ-HRGALGPQLLLNWGVQIAKGMYYL-E 132
Query: 537 ECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYV---APEW 593
E ++H ++ +N+LL +++DFG++ LL D + + + A E
Sbjct: 133 EHG--MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLY--SEAKTPIKWMALES 188
Query: 594 FKNVPVSAKVDVYSFGVVL 612
+ + DV+S+GV +
Sbjct: 189 IHFGKYTHQSDVWSYGVTV 207
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 9e-33
Identities = 71/298 (23%), Positives = 111/298 (37%), Gaps = 52/298 (17%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRT-HHKNLVQ 482
E+ LG GS G V G VAVK++ + E+ + + H N+++
Sbjct: 19 SEKILGYGSSGTVVFQGSFQ--GRPVAVKRMLI---DFCDIALMEIKLLTESDDHPNVIR 73
Query: 483 LLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLE-------IARGLLYLH 535
+ E L +L+ + D +L+++ IA G+ +LH
Sbjct: 74 YYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH 132
Query: 536 EECNVPIIHCDIKPQNILLD-------------QDFTAKISDFGLSKLLLSDQSRTRTVI 582
IIH D+KPQNIL+ ++ ISDFGL K L S QS RT +
Sbjct: 133 SLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNL 189
Query: 583 R---GTRGYVAPE-------WFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSA 632
GT G+ APE ++ +D++S G V I+ + + S
Sbjct: 190 NNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESN 249
Query: 633 ILTDWAYDCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690
I+ G L + L+ I DPLKRP +++
Sbjct: 250 II---------RGIFS-LDEMKCLHDRSLIAEATDLI--SQMIDHDPLKRPTAMKVLR 295
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-32
Identities = 43/210 (20%), Positives = 84/210 (40%), Gaps = 23/210 (10%)
Query: 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDK--LAQEREREFKTEVSAIGRTHHKNL--V 481
+++G G V++ + A+K ++ + ++ E++ + + + +
Sbjct: 34 KQIGSGGSSKVFQV--LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKII 91
Query: 482 QLLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVP 541
+L + +V E GN L + L D R + + +H+
Sbjct: 92 RLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG--- 147
Query: 542 IIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQ-SRTRTVIRGTRGYVAPEWFKNVP-- 598
I+H D+KP N L+ K+ DFG++ + D S + GT Y+ PE K++
Sbjct: 148 IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSS 206
Query: 599 ---------VSAKVDVYSFGVVLLKIICCK 619
+S K DV+S G +L + K
Sbjct: 207 RENGKSKSKISPKSDVWSLGCILYYMTYGK 236
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-32
Identities = 50/196 (25%), Positives = 87/196 (44%), Gaps = 18/196 (9%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQL 483
E+LGRG FGIV++ V S S K + ++ K E+S + H+N++ L
Sbjct: 9 IAEDLGRGEFGIVHRCVETS-SKKTYMAKFVKVKGTDQV-LVKKEISILNIARHRNILHL 66
Query: 484 LGFCDEGLNRLLVYEFMGNGTLANLLF-AIPRPDWSLR----VRISLEIARGLLYLHEEC 538
+ ++++EF+ + F I + L V ++ L +LH
Sbjct: 67 HESFESMEELVMIFEFISGLDI----FERINTSAFELNEREIVSYVHQVCEALQFLHSH- 121
Query: 539 NVPIIHCDIKPQNILL--DQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKN 596
I H DI+P+NI+ + T KI +FG ++ L ++ Y APE ++
Sbjct: 122 --NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL--KPGDNFRLLFTAPEYYAPEVHQH 177
Query: 597 VPVSAKVDVYSFGVVL 612
VS D++S G ++
Sbjct: 178 DVVSTATDMWSLGTLV 193
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 2e-32
Identities = 82/313 (26%), Positives = 122/313 (38%), Gaps = 65/313 (20%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNA----VAVKKLDKLAQERER-EFKTEV---SAIGRT 475
F + LG G+FG V + + VAVK L A ER +E+ S +G
Sbjct: 27 FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN- 85
Query: 476 HHKNLVQLLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLR--------------- 520
H N+V LLG C G L++ E+ G L N L R +
Sbjct: 86 -HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRK-RDSFICSKTSPAIMEDDELALD 143
Query: 521 ----VRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSD-- 574
+ S ++A+G+ +L N IH D+ +NILL KI DFGL++ + +D
Sbjct: 144 LEDLLSFSYQVAKGMAFL-ASKN--CIHRDLAARNILLTHGRITKICDFGLARDIKNDSN 200
Query: 575 ---QSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRS--VEMELGEE 629
+ R ++ APE N + + DV+S+G+ L ++ S M + +
Sbjct: 201 YVVKGNARLPVKWM----APESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 256
Query: 630 RSAILTDWAYDCYVEGKLDVLVDNDKAAMADKSRACKWLM--IALWCIQEDPLKRPAMKM 687
Y EG M M I C DPLKRP K
Sbjct: 257 --------FYKMIKEGFR----------M-LSPEHAPAEMYDIMKTCWDADPLKRPTFKQ 297
Query: 688 IVQMLEGYLEVPS 700
IVQ++E + +
Sbjct: 298 IVQLIEKQISEST 310
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-32
Identities = 56/210 (26%), Positives = 90/210 (42%), Gaps = 29/210 (13%)
Query: 424 FEEELGRGSFG-IVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGR-THHKNLV 481
++ LG G+ G IVY+G+ VAVK++ E EV + H N++
Sbjct: 28 PKDVLGHGAEGTIVYRGMFD---NRDVAVKRILP---ECFSFADREVQLLRESDEHPNVI 81
Query: 482 QLLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLR----VRISLEIARGLLYLHEE 537
+ + + + E TL + + D++ + + + GL +LH
Sbjct: 82 RYFCTEKDRQFQYIAIELCA-ATLQEY---VEQKDFAHLGLEPITLLQQTTSGLAHLHS- 136
Query: 538 CNVPIIHCDIKPQNILL-----DQDFTAKISDFGLSKLLLSDQS--RTRTVIRGTRGYVA 590
N I+H D+KP NIL+ A ISDFGL K L + R+ + GT G++A
Sbjct: 137 LN--IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIA 194
Query: 591 PEWFK---NVPVSAKVDVYSFGVVLLKIIC 617
PE + VD++S G V +I
Sbjct: 195 PEMLSEDCKENPTYTVDIFSAGCVFYYVIS 224
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-32
Identities = 59/191 (30%), Positives = 87/191 (45%), Gaps = 16/191 (8%)
Query: 428 LGRGSFGIVYKGVLKSASGNAVAVKKLDK---LAQEREREFKTEVSAIGRTHHKNLVQLL 484
LG+G FG VY K + +A+K L K + E + + E+ H N++++
Sbjct: 22 LGKGKFGNVYLAREKQ-NKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80
Query: 485 G-FCDEGLNRL-LVYEFMGNGTLANLLFAIPR-PDWSLRVRISLEIARGLLYLHEECNVP 541
F D R+ L+ EF G L L R + E+A L Y HE
Sbjct: 81 NYFHDR--KRIYLMLEFAPRGELYKELQKHGRFDEQRSA-TFMEELADALHYCHERK--- 134
Query: 542 IIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPVSA 601
+IH DIKP+N+L+ KI+DFG S + R RT+ GT Y+ PE +
Sbjct: 135 VIHRDIKPENLLMGYKGELKIADFGWSV--HAPSLRRRTMC-GTLDYLPPEMIEGKTHDE 191
Query: 602 KVDVYSFGVVL 612
KVD++ GV+
Sbjct: 192 KVDLWCAGVLC 202
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 2e-32
Identities = 58/210 (27%), Positives = 94/210 (44%), Gaps = 28/210 (13%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNA--VAVK--KLDKLAQEREREFKTEVSAIGRTHHKN 479
LG+G FG V + LK G+ VAVK K D +A EF E + + H +
Sbjct: 27 LGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPH 86
Query: 480 LVQLLGFC------DEGLNRLLVYEFMGNGTLANLLFA--IPRPDWSLR----VRISLEI 527
+ +L+G +++ FM +G L L A I ++L VR ++I
Sbjct: 87 VAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDI 146
Query: 528 ARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSD-----QSRTRTVI 582
A G+ YL N IH D+ +N +L +D T ++DFGLS+ + S ++ +
Sbjct: 147 ACGMEYL-SSRN--FIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPV 203
Query: 583 RGTRGYVAPEWFKNVPVSAKVDVYSFGVVL 612
+ A E + + DV++FGV +
Sbjct: 204 KWL----ALESLADNLYTVHSDVWAFGVTM 229
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 3e-32
Identities = 61/210 (29%), Positives = 97/210 (46%), Gaps = 29/210 (13%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNA--VAVK--KLDKLAQEREREFKTEVSAIGRTHHKN 479
+ LG G FG V +G LK G + VAVK KLD +Q EF +E + + H N
Sbjct: 38 LGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPN 97
Query: 480 LVQLLGFCDEG-----LNRLLVYEFMGNGTLANLLFAIPRPDWSLR-------VRISLEI 527
+++LLG C E +++ FM G L L R + + ++ ++I
Sbjct: 98 VIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLY-SRLETGPKHIPLQTLLKFMVDI 156
Query: 528 ARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSD-----QSRTRTVI 582
A G+ YL N +H D+ +N +L D T ++DFGLSK + S + +
Sbjct: 157 ALGMEYL-SNRN--FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV 213
Query: 583 RGTRGYVAPEWFKNVPVSAKVDVYSFGVVL 612
+ A E + ++K DV++FGV +
Sbjct: 214 KWI----AIESLADRVYTSKSDVWAFGVTM 239
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 3e-32
Identities = 54/204 (26%), Positives = 83/204 (40%), Gaps = 23/204 (11%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNAVAVK-----KLDKLAQEREREFKTEVSAIGRTHHK 478
E +G+G F +V + + + +G AVK K + K E S H
Sbjct: 28 LCEVIGKGPFSVVRRCINRE-TGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHP 86
Query: 479 NLVQLLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRV-------RISLEIARGL 531
++V+LL +V+EFM +L F I + + V +I L
Sbjct: 87 HIVELLETYSSDGMLYMVFEFMDGA---DLCFEIVKRADAGFVYSEAVASHYMRQILEAL 143
Query: 532 LYLHEECNVPIIHCDIKPQNILL---DQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGY 588
Y H+ IIH D+KP +LL + K+ FG++ L + GT +
Sbjct: 144 RYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV-GTPHF 199
Query: 589 VAPEWFKNVPVSAKVDVYSFGVVL 612
+APE K P VDV+ GV+L
Sbjct: 200 MAPEVVKREPYGKPVDVWGCGVIL 223
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 3e-32
Identities = 61/191 (31%), Positives = 89/191 (46%), Gaps = 16/191 (8%)
Query: 428 LGRGSFGIVYKGVLKSASGNAVAVKKLDK---LAQEREREFKTEVSAIGRTHHKNLVQLL 484
LG+G FG VY K S +A+K L K E + + EV H N+++L
Sbjct: 17 LGKGKFGNVYLAREKQ-SKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 75
Query: 485 G-FCDEGLNRL-LVYEFMGNGTLANLLFAIPR-PDWSLRVRISLEIARGLLYLHEECNVP 541
G F D R+ L+ E+ GT+ L + + + E+A L Y H +
Sbjct: 76 GYFHDA--TRVYLILEYAPLGTVYRELQKLSKFDEQRTA-TYITELANALSYCHSKR--- 129
Query: 542 IIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPVSA 601
+IH DIKP+N+LL KI+DFG S + SR + GT Y+ PE +
Sbjct: 130 VIHRDIKPENLLLGSAGELKIADFGWSV--HAPSSRRTDLC-GTLDYLPPEMIEGRMHDE 186
Query: 602 KVDVYSFGVVL 612
KVD++S GV+
Sbjct: 187 KVDLWSLGVLC 197
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 3e-32
Identities = 58/201 (28%), Positives = 91/201 (45%), Gaps = 28/201 (13%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQL 483
F E LG G+F V+ + +G A+K + K R+ + E++ + + H+N+V L
Sbjct: 13 FMEVLGSGAFSEVFLVKQRL-TGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTL 71
Query: 484 LGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLR---------VRISLEIARGLLYL 534
+ + LV + + G L F D L + ++ + YL
Sbjct: 72 EDIYESTTHYYLVMQLVSGGEL----F-----DRILERGVYTEKDASLVIQQVLSAVKYL 122
Query: 535 HEECNVPIIHCDIKPQNILL---DQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAP 591
HE I+H D+KP+N+L +++ I+DFGLSK+ T GT GYVAP
Sbjct: 123 HENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKME--QNGIMSTAC-GTPGYVAP 176
Query: 592 EWFKNVPVSAKVDVYSFGVVL 612
E P S VD +S GV+
Sbjct: 177 EVLAQKPYSKAVDCWSIGVIT 197
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 3e-32
Identities = 57/196 (29%), Positives = 92/196 (46%), Gaps = 17/196 (8%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQL 483
EELG G+FG+V++ V K+ +G K ++ + K E+S + + HH L+ L
Sbjct: 55 ILEELGSGAFGVVHRCVEKA-TGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINL 113
Query: 484 LGFCDEGLNRLLVYEFMGNGTLANLLF-AIPRPDWSLRVRISLEIAR----GLLYLHEEC 538
++ +L+ EF+ G LF I D+ + + R GL ++HE
Sbjct: 114 HDAFEDKYEMVLILEFLSGGE----LFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH- 168
Query: 539 NVPIIHCDIKPQNILL--DQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKN 596
I+H DIKP+NI+ + + KI DFGL+ L + V T + APE
Sbjct: 169 --SIVHLDIKPENIMCETKKASSVKIIDFGLATKL--NPDEIVKVTTATAEFAAPEIVDR 224
Query: 597 VPVSAKVDVYSFGVVL 612
PV D+++ GV+
Sbjct: 225 EPVGFYTDMWAIGVLG 240
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 3e-32
Identities = 53/229 (23%), Positives = 100/229 (43%), Gaps = 33/229 (14%)
Query: 395 DGNKVQRSSISETNLRFFSLVELNEATNGFEEELGRGSFGIVYKGVLKSASGNA---VAV 451
N+ + ET + + LG G+FG VYKG+ VA+
Sbjct: 3 APNQALLRILKETEFKK-------------IKVLGSGAFGTVYKGLWIPEGEKVKIPVAI 49
Query: 452 KKLDKLAQERER-EFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEFMGNGTLANLLF 510
K+L + + E E + + ++ +LLG C L+ + M G L + +
Sbjct: 50 KELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVR 108
Query: 511 AIPRPDWSLR--VRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLS 568
+ + + + ++IA+G+ YL E+ ++H D+ +N+L+ KI+DFGL+
Sbjct: 109 E-HKDNIGSQYLLNWCVQIAKGMNYL-EDRR--LVHRDLAARNVLVKTPQHVKITDFGLA 164
Query: 569 KLLLSDQ-----SRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVL 612
KLL +++ + I+ A E + + + DV+S+GV +
Sbjct: 165 KLLGAEEKEYHAEGGKVPIKWM----ALESILHRIYTHQSDVWSYGVTV 209
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 4e-32
Identities = 76/316 (24%), Positives = 125/316 (39%), Gaps = 68/316 (21%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNA------VAVKKLDKLAQERER-EFKTEVS---AIG 473
+ LG G+FG V + VAVK L A E++ + +E+ IG
Sbjct: 39 LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 98
Query: 474 RTHHKNLVQLLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLR------------- 520
+ HKN++ LLG C + ++ E+ G L L A RP
Sbjct: 99 K--HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRAR-RPPGMEYSYDINRVPEEQMT 155
Query: 521 ----VRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSD-- 574
V + ++ARG+ YL IH D+ +N+L+ ++ KI+DFGL++ + +
Sbjct: 156 FKDLVSCTYQLARGMEYL-ASQK--CIHRDLAARNVLVTENNVMKIADFGLARDINNIDY 212
Query: 575 ---QSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEE-R 630
+ R ++ APE + + + DV+SFGV++ +I LG
Sbjct: 213 YKKTTNGRLPVKWM----APEALFDRVYTHQSDVWSFGVLMWEI--------FTLGGSPY 260
Query: 631 SAILTDWAYDCYVEGKLDVLVDNDKAAMADKSRACKW----LMIALWCIQEDPLKRPAMK 686
I + + EG M DK C +M W P +RP K
Sbjct: 261 PGIPVEELFKLLKEGHR----------M-DKPANCTNELYMMMRDCW--HAVPSQRPTFK 307
Query: 687 MIVQMLEGYLEVPSPP 702
+V+ L+ L + +
Sbjct: 308 QLVEDLDRILTLTTNE 323
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 5e-32
Identities = 43/210 (20%), Positives = 84/210 (40%), Gaps = 23/210 (10%)
Query: 426 EELGRGSFGIVYKGVLKSASGNAVAVK--KLDKLAQEREREFKTEVSAIGRTHHKNL--V 481
+++G G V++ + A+K L++ + ++ E++ + + + +
Sbjct: 62 KQIGSGGSSKVFQV--LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKII 119
Query: 482 QLLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVP 541
+L + +V E GN L + L D R + + +H+
Sbjct: 120 RLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG--- 175
Query: 542 IIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQ-SRTRTVIRGTRGYVAPEWFKNVP-- 598
I+H D+KP N L+ K+ DFG++ + D S + G Y+ PE K++
Sbjct: 176 IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSS 234
Query: 599 ---------VSAKVDVYSFGVVLLKIICCK 619
+S K DV+S G +L + K
Sbjct: 235 RENGKSKSKISPKSDVWSLGCILYYMTYGK 264
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 6e-32
Identities = 76/313 (24%), Positives = 124/313 (39%), Gaps = 66/313 (21%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNA------VAVKKLDKLAQERER-EFKTEVS---AIG 473
+ LG G+FG V + VAVK L A E++ + +E+ IG
Sbjct: 73 LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 132
Query: 474 RTHHKNLVQLLGFCDEGLNRLLVYEFMGNGTLANLL------------FAIPRPDWSLR- 520
+ HKN++ LLG C + ++ E+ G L L P+ L
Sbjct: 133 K--HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSS 190
Query: 521 ---VRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSD--- 574
V + ++ARG+ YL IH D+ +N+L+ +D KI+DFGL++ +
Sbjct: 191 KDLVSCAYQVARGMEYL-ASKK--CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 247
Query: 575 --QSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEE-RS 631
+ R ++ APE + + + DV+SFGV+L +I LG
Sbjct: 248 KKTTNGRLPVKWM----APEALFDRIYTHQSDVWSFGVLLWEI--------FTLGGSPYP 295
Query: 632 AILTDWAYDCYVEGKLDVLVDNDKAAMADKSRACKW----LMIALWCIQEDPLKRPAMKM 687
+ + + EG M DK C +M W P +RP K
Sbjct: 296 GVPVEELFKLLKEGHR----------M-DKPSNCTNELYMMMRDCW--HAVPSQRPTFKQ 342
Query: 688 IVQMLEGYLEVPS 700
+V+ L+ + + S
Sbjct: 343 LVEDLDRIVALTS 355
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 7e-32
Identities = 43/210 (20%), Positives = 85/210 (40%), Gaps = 23/210 (10%)
Query: 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDK--LAQEREREFKTEVSAIG--RTHHKNLV 481
+++G G V++ + A+K ++ + ++ E++ + + H ++
Sbjct: 15 KQIGSGGSSKVFQV--LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKII 72
Query: 482 QLLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVP 541
+L + +V E GN L + L D R + + +H+
Sbjct: 73 RLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG--- 128
Query: 542 IIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRT-RTVIRGTRGYVAPEWFKNVP-- 598
I+H D+KP N L+ K+ DFG++ + D + + GT Y+ PE K++
Sbjct: 129 IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSS 187
Query: 599 ---------VSAKVDVYSFGVVLLKIICCK 619
+S K DV+S G +L + K
Sbjct: 188 RENGKSKSKISPKSDVWSLGCILYYMTYGK 217
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 9e-32
Identities = 72/318 (22%), Positives = 119/318 (37%), Gaps = 70/318 (22%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNA----VAVKKLDKLAQERER-EFKTEV---SAIGRT 475
F + LG G+FG V S VAVK L + A ER +E+ + +G
Sbjct: 49 FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGS- 107
Query: 476 HHKNLVQLLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLR--------------- 520
H+N+V LLG C L++E+ G L N L + R +S
Sbjct: 108 -HENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSK-REKFSEDEIEYENQKRLEEEED 165
Query: 521 ---------VRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLL 571
+ + ++A+G+ +L E + +H D+ +N+L+ KI DFGL++ +
Sbjct: 166 LNVLTFEDLLCFAYQVAKGMEFL-EFKS--CVHRDLAARNVLVTHGKVVKICDFGLARDI 222
Query: 572 LSD-----QSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRS--VEM 624
+SD + R ++ APE + K DV+S+G++L +I + +
Sbjct: 223 MSDSNYVVRGNARLPVKWM----APESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 278
Query: 625 ELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMADKSRACKWLM--IALWCIQEDPLKR 682
+ Y G M D+ + I C D KR
Sbjct: 279 PVDAN--------FYKLIQNGFK----------M-DQPFYATEEIYIIMQSCWAFDSRKR 319
Query: 683 PAMKMIVQMLEGYLEVPS 700
P+ + L L
Sbjct: 320 PSFPNLTSFLGCQLADAE 337
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 1e-31
Identities = 55/224 (24%), Positives = 94/224 (41%), Gaps = 43/224 (19%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGN----AVAVKKLDKLAQERER-EFKTEVSAIGRTHHK 478
+ ++G G+FG V++ VAVK L + A + +F+ E + + +
Sbjct: 51 YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNP 110
Query: 479 NLVQLLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLR------------------ 520
N+V+LLG C G L++E+M G L L ++ P
Sbjct: 111 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSM-SPHTVCSLSHSDLSTRARVSSPGPP 169
Query: 521 -------VRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLS 573
+ I+ ++A G+ YL E +H D+ +N L+ ++ KI+DFGLS+ + S
Sbjct: 170 PLSCAEQLCIARQVAAGMAYL-SERK--FVHRDLATRNCLVGENMVVKIADFGLSRNIYS 226
Query: 574 D-----QSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVL 612
IR PE + + DV+++GVVL
Sbjct: 227 ADYYKADGNDAIPIRWM----PPESIFYNRYTTESDVWAYGVVL 266
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-31
Identities = 71/305 (23%), Positives = 121/305 (39%), Gaps = 59/305 (19%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNA----VAVKKLDKLAQERER-EFKTEV---SAIGRT 475
F + LG G+FG V + VAVK L A E+ +E+ S +G
Sbjct: 50 FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLG-- 107
Query: 476 HHKNLVQLLGFCDEGLNRLLVYEFMGNGTLANLL----------FAIPRPDWSLR----V 521
H+N+V LLG C G L++ E+ G L N L A + + +
Sbjct: 108 QHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLL 167
Query: 522 RISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSD-----QS 576
S ++A+G+ +L N IH D+ +N+LL AKI DFGL++ +++D +
Sbjct: 168 HFSSQVAQGMAFL-ASKN--CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKG 224
Query: 577 RTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRS--VEMELGEERSAIL 634
R ++ APE + + + DV+S+G++L +I + + + +
Sbjct: 225 NARLPVKWM----APESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK----- 275
Query: 635 TDWAYDCYVEGKLDVLVDNDKAAMADKSRACKWLM--IALWCIQEDPLKRPAMKMIVQML 692
Y +G M + + I C +P RP + I L
Sbjct: 276 ---FYKLVKDGYQ----------M-AQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFL 321
Query: 693 EGYLE 697
+ +
Sbjct: 322 QEQAQ 326
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 1e-31
Identities = 75/309 (24%), Positives = 122/309 (39%), Gaps = 64/309 (20%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGN------AVAVKKLDKLAQERER-EFKTEV---SAIG 473
+ LG G FG V + VAVK L A E++ + +E+ IG
Sbjct: 85 LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 144
Query: 474 RTHHKNLVQLLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLR------------- 520
+ HKN++ LLG C + ++ E+ G L L A RP
Sbjct: 145 K--HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRAR-RPPGMEYSYDINRVPEEQMT 201
Query: 521 ----VRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSD-- 574
V + ++ARG+ YL IH D+ +N+L+ ++ KI+DFGL++ + +
Sbjct: 202 FKDLVSCTYQLARGMEYL-ASQK--CIHRDLAARNVLVTENNVMKIADFGLARDINNIDY 258
Query: 575 ---QSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEE-R 630
+ R ++ APE + + + DV+SFGV++ +I LG
Sbjct: 259 YKKTTNGRLPVKWM----APEALFDRVYTHQSDVWSFGVLMWEI--------FTLGGSPY 306
Query: 631 SAILTDWAYDCYVEGKLDVLVDNDKAAMADKSRACKWLM--IALWCIQEDPLKRPAMKMI 688
I + + EG M DK C + + C P +RP K +
Sbjct: 307 PGIPVEELFKLLKEGHR----------M-DKPANCTNELYMMMRDCWHAVPSQRPTFKQL 355
Query: 689 VQMLEGYLE 697
V+ L+ L
Sbjct: 356 VEDLDRILT 364
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 1e-31
Identities = 56/196 (28%), Positives = 96/196 (48%), Gaps = 15/196 (7%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNAVAVKKLDK--LAQEREREFKTEVSAIGRTHHKNLV 481
+EELG+G+F +V + V K+ +G A K ++ L+ ++ + E + H N+V
Sbjct: 10 VKEELGKGAFSVVRRCVHKT-TGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIV 68
Query: 482 QLLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRV--RISLEIARGLLYLHEECN 539
+L E LV++ + G L + A R +S +I + Y H
Sbjct: 69 RLHDSIQEESFHYLVFDLVTGGELFEDIVA--REFYSEADASHCIQQILESIAYCHSNG- 125
Query: 540 VPIIHCDIKPQNILL---DQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKN 596
I+H ++KP+N+LL + K++DFGL+ ++D GT GY++PE K
Sbjct: 126 --IVHRNLKPENLLLASKAKGAAVKLADFGLAI-EVNDSEAWHGFA-GTPGYLSPEVLKK 181
Query: 597 VPVSAKVDVYSFGVVL 612
P S VD+++ GV+L
Sbjct: 182 DPYSKPVDIWACGVIL 197
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 77/311 (24%), Positives = 121/311 (38%), Gaps = 62/311 (19%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNA----VAVKKLDKLAQERER-EFKTEVS---AIGRT 475
+ LGRG+FG V + A VAVK L + A E +E+ IG
Sbjct: 31 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH- 89
Query: 476 HHKNLVQLLGFC-DEGLNRLLVYEFMGNGTLANLL--------------FAIPRPDWSLR 520
H N+V LLG C G +++ EF G L+ L + + +L
Sbjct: 90 -HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 148
Query: 521 --VRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSD---- 574
+ S ++A+G+ +L IH D+ +NILL + KI DFGL++ + D
Sbjct: 149 HLICYSFQVAKGMEFL-ASRK--CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 205
Query: 575 -QSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRS--VEMELGEERS 631
+ R ++ APE + + + DV+SFGV+L +I S +++ EE
Sbjct: 206 RKGDARLPLKWM----APETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-- 259
Query: 632 AILTDWAYDCYVEGKLDVLVDNDKAAMADKSRACKWLM--IALWCIQEDPLKRPAMKMIV 689
EG M M L C +P +RP +V
Sbjct: 260 ------FCRRLKEGTR----------M-RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELV 302
Query: 690 QMLEGYLEVPS 700
+ L L+ +
Sbjct: 303 EHLGNLLQANA 313
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 2e-31
Identities = 55/190 (28%), Positives = 93/190 (48%), Gaps = 9/190 (4%)
Query: 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREF-KTEVSAIGRTHHKNLVQLL 484
ELG G+ G+V+K K SG +A K + + R E+ + + +V
Sbjct: 39 SELGAGNGGVVFKVSHKP-SGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFY 97
Query: 485 G-FCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPII 543
G F +G + E M G+L +L R + ++S+ + +GL YL E+ I+
Sbjct: 98 GAFYSDG-EISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--IM 154
Query: 544 HCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPVSAKV 603
H D+KP NIL++ K+ DFG+S L+ + + GTR Y++PE + S +
Sbjct: 155 HRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV---GTRSYMSPERLQGTHYSVQS 211
Query: 604 DVYSFGVVLL 613
D++S G+ L+
Sbjct: 212 DIWSMGLSLV 221
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-31
Identities = 53/189 (28%), Positives = 84/189 (44%), Gaps = 10/189 (5%)
Query: 428 LGRGSFGIVYKGVLKSASGNAVAVKKLDK--LAQERERE-FKTEVSAIGRTHHKNLVQLL 484
LG+G F ++ + A K + K L + +RE E+S H+++V
Sbjct: 49 LGKGGFAKCFEISDAD-TKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107
Query: 485 GFCDEGLNRLLVYEFMGNGTLANLLFAIPR-PDWSLRVRISLEIARGLLYLHEECNVPII 543
GF ++ +V E +L L + R +I G YLH +I
Sbjct: 108 GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR-YYLRQIVLGCQYLHRNR---VI 163
Query: 544 HCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPVSAKV 603
H D+K N+ L++D KI DFGL+ + D R + + GT Y+APE S +V
Sbjct: 164 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC-GTPNYIAPEVLSKKGHSFEV 222
Query: 604 DVYSFGVVL 612
DV+S G ++
Sbjct: 223 DVWSIGCIM 231
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 2e-31
Identities = 53/190 (27%), Positives = 89/190 (46%), Gaps = 11/190 (5%)
Query: 428 LGRGSFGIVYKGVLKSASGNAVAVKKLDK--LAQERERE-FKTEVSAIGRTHHKNLVQLL 484
LG+GSF VY+ +G VA+K +DK + + + + EV + H ++++L
Sbjct: 19 LGKGSFAGVYRAESIH-TGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77
Query: 485 GFCDEGLNRLLVYEFMGNGTLANLLFAIPR--PDWSLRVRISLEIARGLLYLHEECNVPI 542
+ ++ LV E NG + L + + R +I G+LYLH I
Sbjct: 78 NYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEAR-HFMHQIITGMLYLHSHG---I 133
Query: 543 IHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPVSAK 602
+H D+ N+LL ++ KI+DFGL+ L + T+ GT Y++PE +
Sbjct: 134 LHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC-GTPNYISPEIATRSAHGLE 192
Query: 603 VDVYSFGVVL 612
DV+S G +
Sbjct: 193 SDVWSLGCMF 202
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 3e-31
Identities = 53/189 (28%), Positives = 84/189 (44%), Gaps = 10/189 (5%)
Query: 428 LGRGSFGIVYKGVLKSASGNAVAVKKLDK--LAQERERE-FKTEVSAIGRTHHKNLVQLL 484
LG+G F ++ + A K + K L + +RE E+S H+++V
Sbjct: 23 LGKGGFAKCFEISDAD-TKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81
Query: 485 GFCDEGLNRLLVYEFMGNGTLANLLFAIPR-PDWSLRVRISLEIARGLLYLHEECNVPII 543
GF ++ +V E +L L + R +I G YLH +I
Sbjct: 82 GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR-YYLRQIVLGCQYLHRNR---VI 137
Query: 544 HCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPVSAKV 603
H D+K N+ L++D KI DFGL+ + D R + + GT Y+APE S +V
Sbjct: 138 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC-GTPNYIAPEVLSKKGHSFEV 196
Query: 604 DVYSFGVVL 612
DV+S G ++
Sbjct: 197 DVWSIGCIM 205
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 3e-31
Identities = 51/191 (26%), Positives = 93/191 (48%), Gaps = 11/191 (5%)
Query: 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLG 485
ELG G+FG VYK K +G A K ++ ++E ++ E+ + H +V+LLG
Sbjct: 25 GELGDGAFGKVYKAKNKE-TGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLG 83
Query: 486 FCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVR-ISLEIARGLLYLHEECNVPIIH 544
++ EF G + ++ + R +++ + ++ L +LH + IIH
Sbjct: 84 AYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK---RIIH 140
Query: 545 CDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPE-----WFKNVPV 599
D+K N+L+ + +++DFG+S L + + I GT ++APE K+ P
Sbjct: 141 RDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-GTPYWMAPEVVMCETMKDTPY 199
Query: 600 SAKVDVYSFGV 610
K D++S G+
Sbjct: 200 DYKADIWSLGI 210
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 4e-31
Identities = 60/213 (28%), Positives = 94/213 (44%), Gaps = 38/213 (17%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNAVAVKKLDK---------LAQEREREFKTEVSAIGR 474
+E LGRG +V + + K + AVK +D QE EV + +
Sbjct: 21 PKEILGRGVSSVVRRCIHKP-TCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRK 79
Query: 475 -THHKNLVQLLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLL- 532
+ H N++QL + LV++ M G L + L +V +S + R ++
Sbjct: 80 VSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE--------KVTLSEKETRKIMR 131
Query: 533 -------YLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGT 585
LH+ I+H D+KP+NILLD D K++DFG S L + R V GT
Sbjct: 132 ALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSC-QLDPGEKLREVC-GT 186
Query: 586 RGYVAPEWFKNVPVSA------KVDVYSFGVVL 612
Y+APE + +VD++S GV++
Sbjct: 187 PSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 4e-31
Identities = 57/197 (28%), Positives = 91/197 (46%), Gaps = 17/197 (8%)
Query: 423 GFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQ 482
E LG G FG V+K + +G +A K + + + E K E+S + + H NL+Q
Sbjct: 92 SKTEILGGGRFGQVHKCEETA-TGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQ 150
Query: 483 LLGFCDEGLNRLLVYEFMGNGTLANLLF-AIPRPDWSLR----VRISLEIARGLLYLHEE 537
L + + +LV E++ G LF I ++L + +I G+ ++H +
Sbjct: 151 LYDAFESKNDIVLVMEYVDGGE----LFDRIIDESYNLTELDTILFMKQICEGIRHMH-Q 205
Query: 538 CNVPIIHCDIKPQNILLDQDFTA--KISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFK 595
I+H D+KP+NIL KI DFGL++ V GT ++APE
Sbjct: 206 MY--ILHLDLKPENILCVNRDAKQIKIIDFGLARRY--KPREKLKVNFGTPEFLAPEVVN 261
Query: 596 NVPVSAKVDVYSFGVVL 612
VS D++S GV+
Sbjct: 262 YDFVSFPTDMWSVGVIA 278
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 128 bits (322), Expect = 5e-31
Identities = 59/198 (29%), Positives = 97/198 (48%), Gaps = 19/198 (9%)
Query: 425 EEELGRGSFGIVYKGVLKSASGN-AVAVKKLDKLAQERER-EFKTEVSAIGRTHHKNLVQ 482
+ ELG G+FG V +GV + VA+K L + ++ + E E + + + +V+
Sbjct: 341 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 400
Query: 483 LLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLR--VRISLEIARGLLYLHEECNV 540
L+G C +LV E G G L L R + + + +++ G+ YL EE N
Sbjct: 401 LIGVCQAE-ALMLVMEMAGGGPLHKFLVG-KREEIPVSNVAELLHQVSMGMKYL-EEKN- 456
Query: 541 PIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSD------QSRTRTVIRGTRGYVAPEWF 594
+H ++ +N+LL AKISDFGLSK L +D +S + ++ APE
Sbjct: 457 -FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY----APECI 511
Query: 595 KNVPVSAKVDVYSFGVVL 612
S++ DV+S+GV +
Sbjct: 512 NFRKFSSRSDVWSYGVTM 529
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 5e-31
Identities = 60/198 (30%), Positives = 96/198 (48%), Gaps = 21/198 (10%)
Query: 425 EEELGRGSFGIVYKG---VLKSASGNAVAVKKL------DKLAQEREREFKTEVSAIGRT 475
++LG G VY +L VA+K + + +R F+ EV +
Sbjct: 16 VDKLGGGGMSTVYLAEDTIL----NIKVAIKAIFIPPREKEETLKR---FEREVHNSSQL 68
Query: 476 HHKNLVQLLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLH 535
H+N+V ++ +E LV E++ TL+ + + + + +I G+ + H
Sbjct: 69 SHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAH 128
Query: 536 EECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRT-VIRGTRGYVAPEWF 594
+ I+H DIKPQNIL+D + T KI DFG++K LS+ S T+T + GT Y +PE
Sbjct: 129 DM---RIVHRDIKPQNILIDSNKTLKIFDFGIAK-ALSETSLTQTNHVLGTVQYFSPEQA 184
Query: 595 KNVPVSAKVDVYSFGVVL 612
K D+YS G+VL
Sbjct: 185 KGEATDECTDIYSIGIVL 202
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 6e-31
Identities = 43/260 (16%), Positives = 83/260 (31%), Gaps = 56/260 (21%)
Query: 405 SETNLRFFSLVELNEATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQERERE 464
+ R S + T LG+ + +G + V +
Sbjct: 58 TGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEAT-DQETGESFEVHVPYFTERPPSNA 116
Query: 465 ---FKTEVSAIGR-------------------------THHKNLVQLLGFCDEG--LNRL 494
K EV + K ++++ + L+R
Sbjct: 117 IKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRF 176
Query: 495 LVYEFMG--NGTLANLLFAIPRPDWSL----RVRISLEIARGLLYLHEECNVPIIHCDIK 548
+Y M T +L + SL R++++L++ R L LH ++H ++
Sbjct: 177 FLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLR 233
Query: 549 PQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFK-----------NV 597
P +I+LDQ ++ F + R V +RG+ PE
Sbjct: 234 PVDIVLDQRGGVFLTGFEHLV-----RDGARVVSSVSRGFEPPELEARRATISYHRDRRT 288
Query: 598 PVSAKVDVYSFGVVLLKIIC 617
++ D ++ G+V+ I C
Sbjct: 289 LMTFSFDAWALGLVIYWIWC 308
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 6e-31
Identities = 56/195 (28%), Positives = 94/195 (48%), Gaps = 15/195 (7%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQL 483
EELG G+FG+V++ + A+GN A K + + + + E+ + H LV L
Sbjct: 161 IHEELGTGAFGVVHRVTER-ATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNL 219
Query: 484 LGFCDEGLNRLLVYEFMGNGTL----ANLLFAIPRPDWSLRVRISLEIARGLLYLHEECN 539
++ +++YEFM G L A+ + + +R + GL ++H E N
Sbjct: 220 HDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCK---GLCHMH-ENN 275
Query: 540 VPIIHCDIKPQNILL--DQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNV 597
+H D+KP+NI+ + K+ DFGL+ L D ++ V GT + APE +
Sbjct: 276 --YVHLDLKPENIMFTTKRSNELKLIDFGLTAHL--DPKQSVKVTTGTAEFAAPEVAEGK 331
Query: 598 PVSAKVDVYSFGVVL 612
PV D++S GV+
Sbjct: 332 PVGYYTDMWSVGVLS 346
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 9e-31
Identities = 50/196 (25%), Positives = 93/196 (47%), Gaps = 14/196 (7%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNAVAVKKLDK--LAQEREREFKTEVSAIGRTHHKNLV 481
EELG+G+F +V + V +G A ++ L+ ++ + E H N+V
Sbjct: 15 LFEELGKGAFSVVRRCVKVL-AGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIV 73
Query: 482 QLLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLR--VRISLEIARGLLYLHEECN 539
+L E + L+++ + G L + A R +S +I +L+ H+
Sbjct: 74 RLHDSISEEGHHYLIFDLVTGGELFEDIVA--REYYSEADASHCIQQILEAVLHCHQMG- 130
Query: 540 VPIIHCDIKPQNILL---DQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKN 596
++H ++KP+N+LL + K++DFGL+ + +Q GT GY++PE +
Sbjct: 131 --VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA-GTPGYLSPEVLRK 187
Query: 597 VPVSAKVDVYSFGVVL 612
P VD+++ GV+L
Sbjct: 188 DPYGKPVDLWACGVIL 203
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 1e-30
Identities = 54/196 (27%), Positives = 92/196 (46%), Gaps = 18/196 (9%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGR-THHKNLVQ 482
+E++G GS+ + + + K+ + AVK +DK +R+ E+ + R H N++
Sbjct: 26 VKEDIGVGSYSVCKRCIHKA-TNMEFAVKIIDK----SKRDPTEEIEILLRYGQHPNIIT 80
Query: 483 LLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLR--VRISLEIARGLLYLHEECNV 540
L D+G +V E M G L + + + +S R + I + + YLH
Sbjct: 81 LKDVYDDGKYVYVVTELMKGGELLDKILR--QKFFSEREASAVLFTITKTVEYLHA-QG- 136
Query: 541 PIIHCDIKPQNILL----DQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKN 596
++H D+KP NIL + +I DFG +K L ++ T T +VAPE +
Sbjct: 137 -VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPC-YTANFVAPEVLER 194
Query: 597 VPVSAKVDVYSFGVVL 612
A D++S GV+L
Sbjct: 195 QGYDAACDIWSLGVLL 210
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 1e-30
Identities = 56/196 (28%), Positives = 96/196 (48%), Gaps = 15/196 (7%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNAVAVKKLDK--LAQEREREFKTEVSAIGRTHHKNLV 481
+EELG+G+F +V + V K+ +G A K ++ L+ ++ + E + H N+V
Sbjct: 33 VKEELGKGAFSVVRRCVHKT-TGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIV 91
Query: 482 QLLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRV--RISLEIARGLLYLHEECN 539
+L E LV++ + G L + A R +S +I + Y H
Sbjct: 92 RLHDSIQEESFHYLVFDLVTGGELFEDIVA--REFYSEADASHCIQQILESIAYCHSNG- 148
Query: 540 VPIIHCDIKPQNILL---DQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKN 596
I+H ++KP+N+LL + K++DFGL+ ++D GT GY++PE K
Sbjct: 149 --IVHRNLKPENLLLASKAKGAAVKLADFGLAI-EVNDSEAWHGFA-GTPGYLSPEVLKK 204
Query: 597 VPVSAKVDVYSFGVVL 612
P S VD+++ GV+L
Sbjct: 205 DPYSKPVDIWACGVIL 220
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-30
Identities = 61/293 (20%), Positives = 108/293 (36%), Gaps = 58/293 (19%)
Query: 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDK-LAQEREREFK-TEVSAIGR-THHKNLVQ 482
E++G G FG V+K +K G A+K+ K LA + + EV A H ++V+
Sbjct: 17 EKIGSGEFGSVFK-CVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVR 75
Query: 483 LLGFCDEGLNRLLVY-EFMGNGTLANLLFAIPRPDWSLR----VRISLEIARGLLYLHEE 537
E + +L+ E+ G+LA+ + R + + L++ RGL Y+H
Sbjct: 76 YFSAWAED-DHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM 134
Query: 538 CNVPIIHCDIKPQNILLDQD-------------------FTAKISDFGLSKLLLSDQSRT 578
++H DIKP NI + + KI D G + S Q
Sbjct: 135 ---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEE 191
Query: 579 RTVIRGTRGYVAPE-WFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDW 637
G ++A E +N K D+++ + ++ E W
Sbjct: 192 -----GDSRFLANEVLQENYTHLPKADIFALALTVV---------CAAGAEPLPRNGDQW 237
Query: 638 AYDCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690
+G+L + + ++ I DP +RP+ +V+
Sbjct: 238 HE--IRQGRLPRIPQVLSQEFTE--------LLK-VMIHPDPERRPSAMALVK 279
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-30
Identities = 55/196 (28%), Positives = 90/196 (45%), Gaps = 20/196 (10%)
Query: 425 EEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGR-THHKNLVQL 483
++ LG GSF I K V K S A AVK + K + ++ E++A+ H N+V+L
Sbjct: 16 DKPLGEGSFSICRKCVHKK-SNQAFAVKIISKRMEANTQK---EITALKLCEGHPNIVKL 71
Query: 484 LGFCDEGLNRLLVYEFMGNGTLANLLFA--IPRPDWSLR--VRISLEIARGLLYLHEECN 539
+ L+ LV E + G L F + +S I ++ + ++H+
Sbjct: 72 HEVFHDQLHTFLVMELLNGGEL----FERIKKKKHFSETEASYIMRKLVSAVSHMHDVG- 126
Query: 540 VPIIHCDIKPQNILL---DQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKN 596
++H D+KP+N+L + + KI DFG ++L D +T T Y APE
Sbjct: 127 --VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC-FTLHYAAPELLNQ 183
Query: 597 VPVSAKVDVYSFGVVL 612
D++S GV+L
Sbjct: 184 NGYDESCDLWSLGVIL 199
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 74/320 (23%), Positives = 126/320 (39%), Gaps = 81/320 (25%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNA----VAVKKLDKLAQERER-EFKTEVSAIGRTHHK 478
+ LG G FG V K G A VAVK L + A E + +E + + + +H
Sbjct: 27 LGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHP 86
Query: 479 NLVQLLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLR------------------ 520
++++L G C + LL+ E+ G+L L R
Sbjct: 87 HVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRES-RKVGPGYLGSGGSRNSSSLDHPDER 145
Query: 521 -------VRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLS 573
+ + +I++G+ YL E ++H D+ +NIL+ + KISDFGLS+ +
Sbjct: 146 ALTMGDLISFAWQISQGMQYL-AEMK--LVHRDLAARNILVAEGRKMKISDFGLSRDVYE 202
Query: 574 D-----QSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELG- 627
+ +S+ R ++ A E + + + DV+SFGV+L +I + LG
Sbjct: 203 EDSYVKRSQGRIPVKWM----AIESLFDHIYTTQSDVWSFGVLLWEI--------VTLGG 250
Query: 628 --------EERSAILTDWAYDCYVEGKLDVLVDNDKAAMADKSRACKWLM--IALWCIQE 677
E ++ G M ++ C M + L C ++
Sbjct: 251 NPYPGIPPER--------LFNLLKTGHR----------M-ERPDNCSEEMYRLMLQCWKQ 291
Query: 678 DPLKRPAMKMIVQMLEGYLE 697
+P KRP I + LE +
Sbjct: 292 EPDKRPVFADISKDLEKMMV 311
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-30
Identities = 55/199 (27%), Positives = 96/199 (48%), Gaps = 12/199 (6%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNAVAVKKLDK--LAQEREREFKTEVSAIGRTHHKNLV 481
++LG G++G V K + A+K + K ++ + EV+ + H N++
Sbjct: 41 RVKKLGSGAYGEVLLCRDKV-THVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIM 99
Query: 482 QLLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVP 541
+L F ++ N LV E G L + + + + I ++ G+ YLH+
Sbjct: 100 KLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN--- 156
Query: 542 IIHCDIKPQNILL---DQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVP 598
I+H D+KP+N+LL ++D KI DFGLS + + + + GT Y+APE +
Sbjct: 157 IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERL--GTAYYIAPEVLRK-K 213
Query: 599 VSAKVDVYSFGVVLLKIIC 617
K DV+S GV+L ++
Sbjct: 214 YDEKCDVWSIGVILFILLA 232
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 3e-30
Identities = 61/199 (30%), Positives = 93/199 (46%), Gaps = 17/199 (8%)
Query: 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQERERE-FKTEVSAIGRT-HHKNLVQL 483
E+GRG++G V K V K SG +AVK++ E+E++ ++ + R+ +VQ
Sbjct: 28 GEIGRGAYGSVNKMVHKP-SGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQF 86
Query: 484 LG-FCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRV----RISLEIARGLLYLHEEC 538
G EG + + E M + D + +I+L + L +L E
Sbjct: 87 YGALFREG-DCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL 145
Query: 539 NVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVP 598
IIH DIKP NILLD+ K+ DFG+S L+ ++TR G R Y+APE
Sbjct: 146 K--IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDA--GCRPYMAPERIDPSA 201
Query: 599 V----SAKVDVYSFGVVLL 613
+ DV+S G+ L
Sbjct: 202 SRQGYDVRSDVWSLGITLY 220
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 3e-30
Identities = 62/305 (20%), Positives = 109/305 (35%), Gaps = 47/305 (15%)
Query: 425 EEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGR-THHKNLVQL 483
L G F VY+ SG A+K+L +E+ R EV + + + H N+VQ
Sbjct: 33 RRVLAEGGFAFVYE-AQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQF 91
Query: 484 LGFCDEGLNR--------LLVYEFMGNGTLANLLFAIPRPDWSLR--VRISLEIARGLLY 533
G LL+ E + L R S ++I + R + +
Sbjct: 92 CSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQH 151
Query: 534 LHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVI----------- 582
+H PIIH D+K +N+LL T K+ DFG + + + +
Sbjct: 152 MHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITR 210
Query: 583 RGTRGYVAPE---WFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAY 639
T Y PE + N P+ K D+++ G +L + + E + I+
Sbjct: 211 NTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFE---DGAKLRIV----- 262
Query: 640 DCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLEVP 699
GK + + + L+ +Q +P +R ++ +V L+
Sbjct: 263 ----NGKYSIPPHD------TQYTVFHSLIR--AMLQVNPEERLSIAEVVHQLQEIAAAR 310
Query: 700 SPPMP 704
+
Sbjct: 311 NVNPK 315
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 3e-30
Identities = 61/201 (30%), Positives = 93/201 (46%), Gaps = 20/201 (9%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQERER------EFKTEVSAIGRTHH 477
EELG G F IV K KS +G A K + K R E + EVS + + H
Sbjct: 16 IGEELGSGQFAIVKKCREKS-TGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLH 74
Query: 478 KNLVQLLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISL--EIARGLLYLH 535
N++ L + + +L+ E + G L + L + S S +I G+ YLH
Sbjct: 75 HNVITLHDVYENRTDVVLILELVSGGELFDFL--AQKESLSEEEATSFIKQILDGVNYLH 132
Query: 536 EECNVPIIHCDIKPQNILL-DQDFTA---KISDFGLSKLLLSDQSRTRTVIRGTRGYVAP 591
+ I H D+KP+NI+L D++ K+ DFGL+ + + I GT +VAP
Sbjct: 133 TKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGVEFKNIFGTPEFVAP 187
Query: 592 EWFKNVPVSAKVDVYSFGVVL 612
E P+ + D++S GV+
Sbjct: 188 EIVNYEPLGLEADMWSIGVIT 208
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 4e-30
Identities = 55/201 (27%), Positives = 89/201 (44%), Gaps = 20/201 (9%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQERER------EFKTEVSAIGRTHH 477
EELG G F IV K K +G A K + K R E + EV+ + H
Sbjct: 9 MGEELGSGQFAIVRKCRQKG-TGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRH 67
Query: 478 KNLVQLLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLR--VRISLEIARGLLYLH 535
N++ L + + +L+ E + G L + L + + + +I G+ YLH
Sbjct: 68 PNIITLHDIFENKTDVVLILELVSGGELFDFL--AEKESLTEDEATQFLKQILDGVHYLH 125
Query: 536 EECNVPIIHCDIKPQNILL----DQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAP 591
+ I H D+KP+NI+L + K+ DFG++ + + I GT +VAP
Sbjct: 126 SKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI--EAGNEFKNIFGTPEFVAP 180
Query: 592 EWFKNVPVSAKVDVYSFGVVL 612
E P+ + D++S GV+
Sbjct: 181 EIVNYEPLGLEADMWSIGVIT 201
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 4e-30
Identities = 59/196 (30%), Positives = 93/196 (47%), Gaps = 16/196 (8%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNAVAVKKLDK--LAQEREREFKTEVSAIGRTHHKNLV 481
LG+GSFG V K + + AVK ++K + EV + + H N++
Sbjct: 26 IVCMLGKGSFGEVLKCKDRI-TQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIM 84
Query: 482 QLLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLR--VRISLEIARGLLYLHEECN 539
+L ++ + +V E G L + + I R +S RI ++ G+ Y+H+
Sbjct: 85 KLFEILEDSSSFYIVGELYTGGELFDEI--IKRKRFSEHDAARIIKQVFSGITYMHKHN- 141
Query: 540 VPIIHCDIKPQNILL---DQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKN 596
I+H D+KP+NILL ++D KI DFGLS + + GT Y+APE +
Sbjct: 142 --IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI--GTAYYIAPEVLRG 197
Query: 597 VPVSAKVDVYSFGVVL 612
K DV+S GV+L
Sbjct: 198 -TYDEKCDVWSAGVIL 212
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 4e-30
Identities = 52/199 (26%), Positives = 93/199 (46%), Gaps = 18/199 (9%)
Query: 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQERERE-FKTEVSAIGRT-HHKNLVQL 483
ELGRG++G+V K SG +AVK++ +E++ ++ RT V
Sbjct: 13 MELGRGAYGVVEKMRHVP-SGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTF 71
Query: 484 LG-FCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRV----RISLEIARGLLYLHEEC 538
G EG + + E M +L + ++ +I++ I + L +LH +
Sbjct: 72 YGALFREG-DVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL 129
Query: 539 NVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPE----WF 594
+ +IH D+KP N+L++ K+ DFG+S L+ D ++ G + Y+APE
Sbjct: 130 S--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDA--GCKPYMAPERINPEL 185
Query: 595 KNVPVSAKVDVYSFGVVLL 613
S K D++S G+ ++
Sbjct: 186 NQKGYSVKSDIWSLGITMI 204
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 5e-30
Identities = 56/186 (30%), Positives = 99/186 (53%), Gaps = 7/186 (3%)
Query: 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLD-KLAQEREREFKTEVSAIGRTHHKNLVQLL 484
E++G+GSFG V+KG+ + VA+K +D + A++ + + E++ + + + +
Sbjct: 28 EKIGKGSFGEVFKGIDN-RTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYY 86
Query: 485 GFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIH 544
G + ++ E++G G+ +LL P + + I EI +GL YLH E IH
Sbjct: 87 GSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIAT-ILREILKGLDYLHSE---KKIH 142
Query: 545 CDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPVSAKVD 604
DIK N+LL + K++DFG++ L Q + T + GT ++APE K +K D
Sbjct: 143 RDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAYDSKAD 201
Query: 605 VYSFGV 610
++S G+
Sbjct: 202 IWSLGI 207
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 6e-30
Identities = 57/197 (28%), Positives = 96/197 (48%), Gaps = 15/197 (7%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNAVAVKKLDK-LAQEREREFKTEVSAIGRTHHKNLVQ 482
F+ +LG G+FG V+ +S SG +K ++K +Q + + E+ + H N+++
Sbjct: 26 FKRKLGSGAFGDVHLVEERS-SGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIK 84
Query: 483 LLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLR----VRISLEIARGLLYLHEEC 538
+ ++ N +V E G L + + +L + ++ L Y H +
Sbjct: 85 IFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ- 143
Query: 539 NVPIIHCDIKPQNILL---DQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFK 595
++H D+KP+NIL KI DFGL++L SD+ T GT Y+APE FK
Sbjct: 144 --HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAA--GTALYMAPEVFK 199
Query: 596 NVPVSAKVDVYSFGVVL 612
V+ K D++S GVV+
Sbjct: 200 R-DVTFKCDIWSAGVVM 215
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 6e-30
Identities = 58/200 (29%), Positives = 93/200 (46%), Gaps = 13/200 (6%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNAVAVKKLDK---LAQEREREFKTEVSAIGRTHHKNL 480
+ LG+GSFG V K +G AVK + K + + EV + + H N+
Sbjct: 30 GQRVLGKGSFGEVILCKDKI-TGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNI 88
Query: 481 VQLLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNV 540
++L F ++ LV E G L + + + R RI ++ G+ Y+H+
Sbjct: 89 MKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK-- 146
Query: 541 PIIHCDIKPQNILL---DQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNV 597
I+H D+KP+N+LL +D +I DFGLS + + + GT Y+APE
Sbjct: 147 -IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI--GTAYYIAPEVLHG- 202
Query: 598 PVSAKVDVYSFGVVLLKIIC 617
K DV+S GV+L ++
Sbjct: 203 TYDEKCDVWSTGVILYILLS 222
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 8e-30
Identities = 57/194 (29%), Positives = 90/194 (46%), Gaps = 12/194 (6%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNAVAVKKLDK--LAQEREREFKTEVSAIGRTHHKNLV 481
LG+GSFG V K + + AVK ++K + EV + + H N++
Sbjct: 26 IVCMLGKGSFGEVLKCKDRI-TQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIM 84
Query: 482 QLLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVP 541
+L ++ + +V E G L + + R RI ++ G+ Y+H+
Sbjct: 85 KLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN--- 141
Query: 542 IIHCDIKPQNILL---DQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVP 598
I+H D+KP+NILL ++D KI DFGLS + + GT Y+APE +
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI--GTAYYIAPEVLRG-T 198
Query: 599 VSAKVDVYSFGVVL 612
K DV+S GV+L
Sbjct: 199 YDEKCDVWSAGVIL 212
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-29
Identities = 56/213 (26%), Positives = 97/213 (45%), Gaps = 39/213 (18%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNAVAVKKLDK--------LAQEREREFKTEVSAIGR- 474
++ +GRG +V + V ++ +G+ AVK ++ +E + E I R
Sbjct: 98 PKDVIGRGVSSVVRRCVHRA-TGHEFAVKIMEVTAERLSPEQLEEVREATRRET-HILRQ 155
Query: 475 -THHKNLVQLLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLL- 532
H +++ L+ + LV++ M G L + L +V +S + R ++
Sbjct: 156 VAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTE--------KVALSEKETRSIMR 207
Query: 533 -------YLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGT 585
+LH I+H D+KP+NILLD + ++SDFG S L + R + GT
Sbjct: 208 SLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSC-HLEPGEKLRELC-GT 262
Query: 586 RGYVAPEWFKNVPVSA------KVDVYSFGVVL 612
GY+APE K +VD+++ GV+L
Sbjct: 263 PGYLAPEILKCSMDETHPGYGKEVDLWACGVIL 295
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-29
Identities = 59/201 (29%), Positives = 89/201 (44%), Gaps = 20/201 (9%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQERER------EFKTEVSAIGRTHH 477
EELG G F IV K KS +G A K + K R E + EVS + + H
Sbjct: 16 IGEELGSGQFAIVKKCREKS-TGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLH 74
Query: 478 KNLVQLLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLR--VRISLEIARGLLYLH 535
N++ L + + +L+ E + G L + L + S +I G+ YLH
Sbjct: 75 PNIITLHDVYENRTDVVLILELVSGGELFDFL--AQKESLSEEEATSFIKQILDGVNYLH 132
Query: 536 EECNVPIIHCDIKPQNILL----DQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAP 591
+ I H D+KP+NI+L K+ DFGL+ + + I GT +VAP
Sbjct: 133 TKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGVEFKNIFGTPEFVAP 187
Query: 592 EWFKNVPVSAKVDVYSFGVVL 612
E P+ + D++S GV+
Sbjct: 188 EIVNYEPLGLEADMWSIGVIT 208
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 1e-29
Identities = 58/217 (26%), Positives = 94/217 (43%), Gaps = 49/217 (22%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNAVAVKKLDK--------LAQEREREFKTEVSAIGRT 475
+ LG G+ G V + + VA++ + K + +TE+ + +
Sbjct: 139 MSKTLGSGACGEVKLAFERK-TCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKL 197
Query: 476 HHKNLVQLLGFCDEGLNRLLVYEFMGNGTL--------------ANLLFAIPRPDWSLRV 521
+H ++++ F D + +V E M G L L F
Sbjct: 198 NHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYF----------- 245
Query: 522 RISLEIARGLLYLHEECNVPIIHCDIKPQNILL---DQDFTAKISDFGLSKLLLSDQSRT 578
++ + YLHE IIH D+KP+N+LL ++D KI+DFG SK +L + S
Sbjct: 246 ---YQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSK-ILGETSLM 298
Query: 579 RTVIRGTRGYVAPEWFKNVPV---SAKVDVYSFGVVL 612
RT+ GT Y+APE +V + VD +S GV+L
Sbjct: 299 RTLC-GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 334
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-29
Identities = 59/195 (30%), Positives = 92/195 (47%), Gaps = 17/195 (8%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQL 483
E ELGRG+ IVY+ K + A+K L K ++ +TE+ + R H N+++L
Sbjct: 57 VESELGRGATSIVYRCKQKG-TQKPYALKVLKK--TVDKKIVRTEIGVLLRLSHPNIIKL 113
Query: 484 LGFCDEGLNRLLVYEFMGNGTLANLLFAIPR---PDWSLRVRISLEIARGLLYLHEECNV 540
+ LV E + G L + + D + V+ +I + YLHE
Sbjct: 114 KEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVK---QILEAVAYLHENG-- 168
Query: 541 PIIHCDIKPQNILL---DQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNV 597
I+H D+KP+N+L D KI+DFGLSK++ GT GY APE +
Sbjct: 169 -IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVC--GTPGYCAPEILRGC 225
Query: 598 PVSAKVDVYSFGVVL 612
+VD++S G++
Sbjct: 226 AYGPEVDMWSVGIIT 240
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 2e-29
Identities = 54/212 (25%), Positives = 92/212 (43%), Gaps = 35/212 (16%)
Query: 428 LGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREF-----------------KTEVS 470
L +G F + L A+KK +K E++R+F K E+
Sbjct: 39 LNQGKFNKII---LCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQ 95
Query: 471 AIGRTHHKNLVQLLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIAR- 529
I ++ + G ++YE+M N ++ D + I +++ +
Sbjct: 96 IITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKC 155
Query: 530 -------GLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVI 582
Y+H E N I H D+KP NIL+D++ K+SDFG S+ ++ + +
Sbjct: 156 IIKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKG---S 210
Query: 583 RGTRGYVAPEWFKNVPV--SAKVDVYSFGVVL 612
RGT ++ PE+F N AKVD++S G+ L
Sbjct: 211 RGTYEFMPPEFFSNESSYNGAKVDIWSLGICL 242
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 3e-29
Identities = 51/196 (26%), Positives = 80/196 (40%), Gaps = 17/196 (8%)
Query: 425 EEELGRGSFGIVYKG---VLKSASGNAVAVKKLD-KLAQE---REREFKTEVSAIGRTHH 477
+GRG G VY+ V VA+K + L+ + R R + E GR
Sbjct: 39 RRLVGRGGMGDVYEAEDTVR----ERIVALKLMSETLSSDPVFRTR-MQREARTAGRLQE 93
Query: 478 KNLVQLLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEE 537
++V + F + + + LA +L V I +I L H
Sbjct: 94 PHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAA 153
Query: 538 CNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRT-VIRGTRGYVAPEWFKN 596
H D+KP+NIL+ D A + DFG++ +D+ T+ GT Y+APE F
Sbjct: 154 ---GATHRDVKPENILVSADDFAYLVDFGIAS-ATTDEKLTQLGNTVGTLYYMAPERFSE 209
Query: 597 VPVSAKVDVYSFGVVL 612
+ + D+Y+ VL
Sbjct: 210 SHATYRADIYALTCVL 225
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 4e-29
Identities = 57/201 (28%), Positives = 86/201 (42%), Gaps = 20/201 (9%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNAVAVKKLDK------LAQEREREFKTEVSAIGRTHH 477
EELG G F +V K KS +G A K + K + + EVS + H
Sbjct: 15 TGEELGSGQFAVVKKCREKS-TGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQH 73
Query: 478 KNLVQLLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLR--VRISLEIARGLLYLH 535
N++ L + + +L+ E + G L + L + + +I G+ YLH
Sbjct: 74 PNVITLHEVYENKTDVILILELVAGGELFDFL--AEKESLTEEEATEFLKQILNGVYYLH 131
Query: 536 EECNVPIIHCDIKPQNILL----DQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAP 591
I H D+KP+NI+L KI DFGL+ + D I GT +VAP
Sbjct: 132 SLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKNIFGTPEFVAP 186
Query: 592 EWFKNVPVSAKVDVYSFGVVL 612
E P+ + D++S GV+
Sbjct: 187 EIVNYEPLGLEADMWSIGVIT 207
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 4e-29
Identities = 55/187 (29%), Positives = 98/187 (52%), Gaps = 8/187 (4%)
Query: 425 EEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLL 484
E+LG GS+G VYK + K +G VA+K++ + +E E+S + + ++V+
Sbjct: 34 LEKLGEGSYGSVYKAIHKE-TGQIVAIKQVP--VESDLQEIIKEISIMQQCDSPHVVKYY 90
Query: 485 GFCDEGLNRLLVYEFMGNGTLANLLFAIPRP-DWSLRVRISLEIARGLLYLHEECNVPII 543
G + + +V E+ G G++++++ + I +GL YLH I
Sbjct: 91 GSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFM---RKI 147
Query: 544 HCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPVSAKV 603
H DIK NILL+ + AK++DFG++ L ++ TVI GT ++APE + + +
Sbjct: 148 HRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-GTPFWMAPEVIQEIGYNCVA 206
Query: 604 DVYSFGV 610
D++S G+
Sbjct: 207 DIWSLGI 213
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 6e-29
Identities = 59/205 (28%), Positives = 89/205 (43%), Gaps = 23/205 (11%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNAVAVKKLDK-------------LAQEREREFKTEVS 470
+LG G++G V K+ + A+K + K ++ E E+S
Sbjct: 40 KVRKLGSGAYGEVLLCKEKN-GHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEIS 98
Query: 471 AIGRTHHKNLVQLLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARG 530
+ H N+++L ++ LV EF G L + + D I +I G
Sbjct: 99 LLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSG 158
Query: 531 LLYLHEECNVPIIHCDIKPQNILL---DQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRG 587
+ YLH+ I+H DIKP+NILL + KI DFGLS D + GT
Sbjct: 159 ICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRL--GTAY 213
Query: 588 YVAPEWFKNVPVSAKVDVYSFGVVL 612
Y+APE K + K DV+S GV++
Sbjct: 214 YIAPEVLKK-KYNEKCDVWSCGVIM 237
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 7e-29
Identities = 69/220 (31%), Positives = 106/220 (48%), Gaps = 26/220 (11%)
Query: 409 LRFFSLVELNEATNGFE--EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFK 466
L L L + FE E +G G++G VYKG +G A+K +D + + E E K
Sbjct: 11 LDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVK-TGQLAAIKVMD-VTGDEEEEIK 68
Query: 467 TEVSAIGRT-HHKNLVQLLG-----FCDEGLNRL-LVYEFMGNGTLANLLFAIPRPDWSL 519
E++ + + HH+N+ G ++L LV EF G G++ +L+ +L
Sbjct: 69 QEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI--KNTKGNTL 126
Query: 520 RVR----ISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQ 575
+ I EI RGL +LH+ +IH DIK QN+LL ++ K+ DFG+S L
Sbjct: 127 KEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV 183
Query: 576 SRTRTVIRGTRGYVAPE-----WFKNVPVSAKVDVYSFGV 610
R T I GT ++APE + K D++S G+
Sbjct: 184 GRRNTFI-GTPYWMAPEVIACDENPDATYDFKSDLWSLGI 222
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-28
Identities = 55/212 (25%), Positives = 99/212 (46%), Gaps = 32/212 (15%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGN-AVAVKKLDKLAQERER-EFKTEVSAIGR-THHKNL 480
F++ +G G+FG V K +K A+K++ + A + + +F E+ + + HH N+
Sbjct: 29 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 88
Query: 481 VQLLGFCDEGLNRLLVYEFMGNGTLANLL------------FAIPRPDWSLR----VRIS 524
+ LLG C+ L E+ +G L + L +L + +
Sbjct: 89 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 148
Query: 525 LEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTV--- 581
++ARG+ YL + IH D+ +NIL+ +++ AKI+DFGLS+ + +T+
Sbjct: 149 ADVARGMDYL-SQKQ--FIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMGRL 203
Query: 582 -IRGTRGYVAPEWFKNVPVSAKVDVYSFGVVL 612
+R A E + DV+S+GV+L
Sbjct: 204 PVRWM----AIESLNYSVYTTNSDVWSYGVLL 231
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-28
Identities = 52/196 (26%), Positives = 94/196 (47%), Gaps = 14/196 (7%)
Query: 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQERERE-FKTEVSAIGRTH-HKNLVQL 483
E+G G+ G V+K + +G+ +AVK++ + + E + ++ + ++H +VQ
Sbjct: 31 GEMGSGTCGQVWKMRFRK-TGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQC 89
Query: 484 LG-FCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPI 542
G F + + E MG + ++++ I + L YL E+ +
Sbjct: 90 FGTFITNT-DVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHG--V 146
Query: 543 IHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPE-----WFKNV 597
IH D+KP NILLD+ K+ DFG+S L+ D+++ R+ G Y+APE
Sbjct: 147 IHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSA--GCAAYMAPERIDPPDPTKP 204
Query: 598 PVSAKVDVYSFGVVLL 613
+ DV+S G+ L+
Sbjct: 205 DYDIRADVWSLGISLV 220
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 1e-28
Identities = 55/324 (16%), Positives = 100/324 (30%), Gaps = 50/324 (15%)
Query: 405 SETNLRFFSLVELNEATNGFE--EELGRG--SFGIVYKGVLKSASGNAVAVKK--LDKLA 458
NL F + +E +G+G V K +G V V++ L+ +
Sbjct: 8 HMENLYFQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKP-TGEYVTVRRINLEACS 66
Query: 459 QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEFMGNGTLANLL-FAIPRP-D 516
E + E+ +H N+V +V FM G+ +L+ +
Sbjct: 67 NEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMN 126
Query: 517 WSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQS 576
I + + L Y+H +H +K +IL+ D +S + ++S
Sbjct: 127 ELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQ 183
Query: 577 RTRTVIRGTRGYV------APEWFK--NVPVSAKVDVYSFGV------------------ 610
R R V + V +PE + AK D+YS G+
Sbjct: 184 RQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPAT 243
Query: 611 -VLLKII-----CCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMADKSRA 664
+LL+ + C + + E + A +
Sbjct: 244 QMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYH 303
Query: 665 CKW-----LMIALWCIQEDPLKRP 683
+ + C+Q +P RP
Sbjct: 304 RTFSPHFHHFVEQ-CLQRNPDARP 326
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-28
Identities = 58/217 (26%), Positives = 92/217 (42%), Gaps = 49/217 (22%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNAVAVKKLDK--------LAQEREREFKTEVSAIGRT 475
+ LG G+ G V + + VA+K + K + +TE+ + +
Sbjct: 14 MSKTLGSGACGEVKLAFERK-TCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKL 72
Query: 476 HHKNLVQLLGFCDEGLNRLLVYEFMGNGTL--------------ANLLFAIPRPDWSLRV 521
+H ++++ F D + +V E M G L L F
Sbjct: 73 NHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYF----------- 120
Query: 522 RISLEIARGLLYLHEECNVPIIHCDIKPQNILL---DQDFTAKISDFGLSKLLLSDQSRT 578
++ + YLHE IIH D+KP+N+LL ++D KI+DFG SK +L + S
Sbjct: 121 ---YQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSK-ILGETSLM 173
Query: 579 RTVIRGTRGYVAPE---WFKNVPVSAKVDVYSFGVVL 612
RT+ GT Y+APE + VD +S GV+L
Sbjct: 174 RTLC-GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 52/192 (27%), Positives = 82/192 (42%), Gaps = 10/192 (5%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQL 483
E +GRGS+G V V K + A KK+ K E FK E+ + H N+++L
Sbjct: 13 LENTIGRGSWGEVKIAVQKG-TRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRL 71
Query: 484 LGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPII 543
++ + LV E G L + S RI ++ + Y H+ +
Sbjct: 72 YETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKL---NVA 128
Query: 544 HCDIKPQNILL---DQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPVS 600
H D+KP+N L D K+ DFGL+ + V GT YV+P+ +
Sbjct: 129 HRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKV--GTPYYVSPQVLEG-LYG 185
Query: 601 AKVDVYSFGVVL 612
+ D +S GV++
Sbjct: 186 PECDEWSAGVMM 197
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 54/205 (26%), Positives = 84/205 (40%), Gaps = 29/205 (14%)
Query: 425 EEELGRGSFGIVYKG---VLKSASGNAVAVKKL------DKLAQEREREFKTEVSAIGRT 475
E LG G V+ VAVK L D R F+ E
Sbjct: 17 GEILGFGGMSEVHLARDLRD----HRDVAVKVLRADLARDPSFYLR---FRREAQNAAAL 69
Query: 476 HHKNLVQLL--GFCDEGLNRLLVY---EFMGNGTLANLLFAIPRPDWSLRVRISLEIARG 530
+H +V + G E L Y E++ TL +++ + + + +
Sbjct: 70 NHPAIVAVYDTG-EAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQA 128
Query: 531 LLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQS---RTRTVIRGTRG 587
L + H+ IIH D+KP NI++ K+ DFG+++ + + +T VI GT
Sbjct: 129 LNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVI-GTAQ 184
Query: 588 YVAPEWFKNVPVSAKVDVYSFGVVL 612
Y++PE + V A+ DVYS G VL
Sbjct: 185 YLSPEQARGDSVDARSDVYSLGCVL 209
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 7e-28
Identities = 54/241 (22%), Positives = 85/241 (35%), Gaps = 56/241 (23%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNAVAVK-----KLDKLAQEREREFKTEVSAIGRTHHK 478
+ +G+GS+G+V + + A+K K+ ++ + KTEV + + HH
Sbjct: 30 LKGAIGQGSYGVVRVAIENQ-TRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHP 88
Query: 479 NLVQLLGFCDEGLNRLLVYEFMGNGTL------------------------------ANL 508
N+ +L ++ LV E G L
Sbjct: 89 NIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEE 148
Query: 509 LFAIPRPDWSLRVRISL----------EIARGLLYLHEECNVPIIHCDIKPQNILL--DQ 556
+ + +I L YLH + I H DIKP+N L ++
Sbjct: 149 AINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNK 205
Query: 557 DFTAKISDFGLSKLLLSDQSRTRTVIR---GTRGYVAPEWFKNV--PVSAKVDVYSFGVV 611
F K+ DFGLSK + + GT +VAPE K D +S GV+
Sbjct: 206 SFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVL 265
Query: 612 L 612
L
Sbjct: 266 L 266
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 8e-28
Identities = 45/208 (21%), Positives = 82/208 (39%), Gaps = 36/208 (17%)
Query: 498 EFMGNGTLANLL---FAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILL 554
+ L + + ++ + + + I ++IA + +LH + ++H D+KP NI
Sbjct: 141 QLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFF 197
Query: 555 DQDFTAKISDFGLSKLLLSDQSRTRTVIR-----------GTRGYVAPEWFKNVPVSAKV 603
D K+ DFGL + D+ + GT+ Y++PE S KV
Sbjct: 198 TMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKV 257
Query: 604 DVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMADKSR 663
D++S G++L + + S +M ER I+TD K +L
Sbjct: 258 DIFSLGLILFE-LLYSFSTQM----ERVRIITD-----VRNLKFPLLFTQKYPQEHM--- 304
Query: 664 ACKWLMIALWCIQEDPLKRPAMKMIVQM 691
M+ + P +RP I++
Sbjct: 305 -----MV-QDMLSPSPTERPEATDIIEN 326
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 44.5 bits (105), Expect = 7e-05
Identities = 18/62 (29%), Positives = 30/62 (48%), Gaps = 4/62 (6%)
Query: 424 FEEE--LGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQERERE-FKTEVSAIGRTHHKNL 480
FE +GRG FG+V++ A+K++ +E RE EV A+ + H +
Sbjct: 8 FEPIQCMGRGGFGVVFE-AKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI 66
Query: 481 VQ 482
V+
Sbjct: 67 VR 68
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 49/198 (24%), Positives = 87/198 (43%), Gaps = 22/198 (11%)
Query: 425 EEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGR-THHKNLVQL 483
++ LG G G V + + +G A+K L + R+ EV + + ++V +
Sbjct: 34 KQVLGLGVNGKVLECFHRR-TGQKCALKLLYDSPKARQ-----EVDHHWQASGGPHIVCI 87
Query: 484 LGFCDEGLNR----LLVYEFMGNGTLANLLFAIPRPDWSLR--VRISLEIARGLLYLHEE 537
L + + L++ E M G L + + ++ R I +I + +LH
Sbjct: 88 LDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH 147
Query: 538 CNVPIIHCDIKPQNILL---DQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWF 594
I H D+KP+N+L ++D K++DFG +K Q+ +T T YVAPE
Sbjct: 148 N---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET--TQNALQTPC-YTPYYVAPEVL 201
Query: 595 KNVPVSAKVDVYSFGVVL 612
D++S GV++
Sbjct: 202 GPEKYDKSCDMWSLGVIM 219
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 3e-27
Identities = 34/233 (14%), Positives = 72/233 (30%), Gaps = 45/233 (19%)
Query: 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQERE---REFKTEVSAIGR-------- 474
LG+ + +G + V + ++ K EV +
Sbjct: 84 TVLGQEDPYAYLEAT-DQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQK 142
Query: 475 -----------------THHKNLVQLLGFCDEG--LNRLLVYEFMG--NGTLANLLFAIP 513
K ++++ + L+R +Y M T +L +
Sbjct: 143 QAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHS 202
Query: 514 RPDWSL----RVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSK 569
SL R++++L++ R L LH ++H ++P +I+LDQ ++ F
Sbjct: 203 STHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLV 259
Query: 570 LLLSDQSRTRTVIRGTRGYVAPEWFK-----NVPVSAKVDVYSFGVVLLKIIC 617
+ A ++ D ++ G+ + I C
Sbjct: 260 RDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWC 312
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 6e-27
Identities = 51/205 (24%), Positives = 89/205 (43%), Gaps = 23/205 (11%)
Query: 425 EEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGR-THHKNLVQL 483
E+ LG G+ V + + AVK ++K EV + + H+N+++L
Sbjct: 18 EDVLGEGAHARVQTCINLI-TSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLEL 76
Query: 484 LGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLR--VRISLEIARGLLYLHEECNVP 541
+ F +E LV+E M G++ + + R ++ + ++A L +LH +
Sbjct: 77 IEFFEEEDRFYLVFEKMRGGSILSHI--HKRRHFNELEASVVVQDVASALDFLHNKG--- 131
Query: 542 IIHCDIKPQNILL---DQDFTAKISDFGLSKLLLSDQSRTRTVIR------GTRGYVAPE 592
I H D+KP+NIL +Q KI DF L + + + G+ Y+APE
Sbjct: 132 IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPE 191
Query: 593 WFKNVPVSAK-----VDVYSFGVVL 612
+ A D++S GV+L
Sbjct: 192 VVEAFSEEASIYDKRCDLWSLGVIL 216
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 7e-27
Identities = 47/197 (23%), Positives = 84/197 (42%), Gaps = 24/197 (12%)
Query: 425 EEELGRGSFGIVYKGVLKSASGNAVAVKKL----DKLAQEREREFKTEVSAIGRTHHKNL 480
+ + G G +Y + ++ +G V +K L D AQ E + H ++
Sbjct: 85 KGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAM---AMAERQFLAEVVHPSI 141
Query: 481 VQLLGFCDEGLNRL-----LVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLH 535
VQ+ F + +V E++G +L + + + LEI L YLH
Sbjct: 142 VQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLH 199
Query: 536 EECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFK 595
+ +++ D+KP+NI+L ++ K+ D G + + + GT G+ APE +
Sbjct: 200 S---IGLVYNDLKPENIMLTEE-QLKLIDLGAVSRI----NSFGYLY-GTPGFQAPEIVR 250
Query: 596 NVPVSAKVDVYSFGVVL 612
P A D+Y+ G L
Sbjct: 251 TGPTVAT-DIYTVGRTL 266
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-26
Identities = 51/199 (25%), Positives = 81/199 (40%), Gaps = 21/199 (10%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGR-THHKNLVQ 482
+ LG G G V + K + A+K L + R EV R + ++V+
Sbjct: 66 TSQVLGLGINGKVLQIFNKR-TQEKFALKMLQDCPKARR-----EVELHWRASQCPHIVR 119
Query: 483 LLGFCDEGLNR----LLVYEFMGNGTLANLLFAIPRPDWSLR--VRISLEIARGLLYLHE 536
++ + L+V E + G L + + ++ R I I + YLH
Sbjct: 120 IVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS 179
Query: 537 ECNVPIIHCDIKPQNILL---DQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEW 593
N I H D+KP+N+L + K++DFG +K S S T T YVAPE
Sbjct: 180 -IN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPC--YTPYYVAPEV 234
Query: 594 FKNVPVSAKVDVYSFGVVL 612
D++S GV++
Sbjct: 235 LGPEKYDKSCDMWSLGVIM 253
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 57/201 (28%), Positives = 94/201 (46%), Gaps = 22/201 (10%)
Query: 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLD-KLAQEREREFKTEVSAIGRTHHKNLVQLL 484
E +G G+ +V VA+K+++ + Q E E+ A+ + HH N+V
Sbjct: 21 EVIGSGATAVVQAAYCAP-KKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYY 79
Query: 485 G-FCDEGLNRL-LVYEFMGNGTLANLLFAIPRPDWSLRVR--------ISLEIARGLLYL 534
F + + L LV + + G++ +++ I I E+ GL YL
Sbjct: 80 TSFVVK--DELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYL 137
Query: 535 HEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIR----GTRGYVA 590
H+ IH D+K NILL +D + +I+DFG+S L + TR +R GT ++A
Sbjct: 138 HKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMA 194
Query: 591 PEWFKNV-PVSAKVDVYSFGV 610
PE + V K D++SFG+
Sbjct: 195 PEVMEQVRGYDFKADIWSFGI 215
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-25
Identities = 53/192 (27%), Positives = 87/192 (45%), Gaps = 17/192 (8%)
Query: 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKT---EVSAIGRTHHKNLVQ 482
E+G GSFG VY + VA+KK+ ++ +++ EV + + H N +Q
Sbjct: 60 REIGHGSFGAVYFARDVR-NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQ 118
Query: 483 LLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRP-DWSLRVRISLEIARGLLYLHEECNVP 541
G LV E+ G+ ++LL +P ++ +GL YLH
Sbjct: 119 YRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---N 174
Query: 542 IIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPE---WFKNVP 598
+IH D+K NILL + K+ DFG + ++ + + + GT ++APE
Sbjct: 175 MIHRDVKAGNILLSEPGLVKLGDFGSASIM----APANSFV-GTPYWMAPEVILAMDEGQ 229
Query: 599 VSAKVDVYSFGV 610
KVDV+S G+
Sbjct: 230 YDGKVDVWSLGI 241
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-25
Identities = 60/198 (30%), Positives = 96/198 (48%), Gaps = 14/198 (7%)
Query: 428 LGRGSFGIVYKGVLKSASGNAVAVKKLDK---LAQEREREFKTEVSAIGRTHHKNLVQLL 484
LGRG FG V+ A+G A KKL+K ++ + E + + H + +V L
Sbjct: 193 LGRGGFGEVF-ACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA 251
Query: 485 GFCDEGLNRL-LVYEFMGNGTLANLLFAIPRPDWSL---RVRI-SLEIARGLLYLHEECN 539
+ E L LV M G + ++ + + R + +I GL +LH+
Sbjct: 252 -YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN- 309
Query: 540 VPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPV 599
II+ D+KP+N+LLD D +ISD GL+ L + Q++T+ GT G++APE
Sbjct: 310 --IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA-GTPGFMAPELLLGEEY 366
Query: 600 SAKVDVYSFGVVLLKIIC 617
VD ++ GV L ++I
Sbjct: 367 DFSVDYFALGVTLYEMIA 384
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 4e-25
Identities = 57/203 (28%), Positives = 91/203 (44%), Gaps = 16/203 (7%)
Query: 425 EEELGRGSFGIVYKGVLKSASGNAVAVKKLDK--------LAQEREREFKTEVSAIGRTH 476
LG G+FG V+ V K V VK + K + + + E++ + R
Sbjct: 29 MSPLGSGAFGFVWTAVDKE-KNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVE 87
Query: 477 HKNLVQLLGFCDEGLNRLLVYEFMGNGT-LANLLFAIPRPDWSLRVRISLEIARGLLYLH 535
H N++++L + LV E G+G L + PR D L I ++ + YL
Sbjct: 88 HANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLR 147
Query: 536 EECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFK 595
+ IIH DIK +NI++ +DFT K+ DFG + L + GT Y APE
Sbjct: 148 LKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFC--GTIEYCAPEVLM 202
Query: 596 NVP-VSAKVDVYSFGVVLLKIIC 617
P +++++S GV L ++
Sbjct: 203 GNPYRGPELEMWSLGVTLYTLVF 225
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-24
Identities = 61/206 (29%), Positives = 99/206 (48%), Gaps = 35/206 (16%)
Query: 425 EEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLL 484
+ +G GSFG+VY+ L SG VA+KK+ Q++ + + E+ + + H N+V+L
Sbjct: 59 TKVIGNGSFGVVYQAKLC-DSGELVAIKKV---LQDKRFKNR-ELQIMRKLDHCNIVRLR 113
Query: 485 GF--------CDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLE--------IA 528
F + LN LV +++ T+ + R + + + +
Sbjct: 114 YFFYSSGEKKDEVYLN--LVLDYVPE-TVYRVA----RHYSRAKQTLPVIYVKLYMYQLF 166
Query: 529 RGLLYLHEECNVPIIHCDIKPQNILLDQD-FTAKISDFGLSKLLLSDQSRTRTVIRGTRG 587
R L Y+H + I H DIKPQN+LLD D K+ DFG +K L+ + + +R
Sbjct: 167 RSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC--SRY 221
Query: 588 YVAPEW-FKNVPVSAKVDVYSFGVVL 612
Y APE F ++ +DV+S G VL
Sbjct: 222 YRAPELIFGATDYTSSIDVWSAGCVL 247
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 62/210 (29%), Positives = 93/210 (44%), Gaps = 37/210 (17%)
Query: 425 EEELGRGSFGIVYKGVLKSASGNAVAVKK--LDKLAQERE-REFKTEVSAIGRTHHKNLV 481
E G+G+FG V G KS +G +VA+KK D + RE + + + HH N+V
Sbjct: 28 ERMAGQGTFGTVQLGKEKS-TGMSVAIKKVIQDPRFRNRELQIMQD----LAVLHHPNIV 82
Query: 482 QLL---------GFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLE------ 526
QL D LN +V E++ + TL R + +V
Sbjct: 83 QLQSYFYTLGERDRRDIYLN--VVMEYVPD-TLHRCC----RNYYRRQVAPPPILIKVFL 135
Query: 527 --IARGLLYLHEECNVPIIHCDIKPQNILLD-QDFTAKISDFGLSKLLLSDQSRTRTVIR 583
+ R + LH V + H DIKP N+L++ D T K+ DFG +K L + +
Sbjct: 136 FQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYIC- 193
Query: 584 GTRGYVAPEW-FKNVPVSAKVDVYSFGVVL 612
+R Y APE F N + VD++S G +
Sbjct: 194 -SRYYRAPELIFGNQHYTTAVDIWSVGCIF 222
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 67/311 (21%), Positives = 108/311 (34%), Gaps = 58/311 (18%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNAVAVKKLDK------LAQEREREFKTEVSAIGRTHH 477
LG G FG VY G+ + + VA+K ++K EV + +
Sbjct: 47 VGPLLGSGGFGSVYSGI-RVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 105
Query: 478 K--NLVQLLGFCDEGLNRLLVYEF-MGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYL 534
+++LL + + + +L+ E L + + L ++ + +
Sbjct: 106 GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC 165
Query: 535 HEECNVPIIHCDIKPQNILLDQD-FTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEW 593
H ++H DIK +NIL+D + K+ DFG LL GTR Y PEW
Sbjct: 166 HNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD---GTRVYSPPEW 219
Query: 594 FKNVP-VSAKVDVYSFGVVLLKIICCKRSVEMELG----EERSAILTDWAYDC--YVEGK 646
+ V+S G++L ++C G E I+ V
Sbjct: 220 IRYHRYHGRSAAVWSLGILLYDMVC---------GDIPFEHDEEII-RGQVFFRQRV--- 266
Query: 647 LDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ---MLEGYLEVPSPPM 703
S C+ L+ WC+ P RP + I M + L +
Sbjct: 267 ---------------SSECQHLI--RWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAE- 308
Query: 704 PPLHSLQLTES 714
LHSL S
Sbjct: 309 IHLHSLSPGPS 319
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 69/314 (21%), Positives = 111/314 (35%), Gaps = 75/314 (23%)
Query: 425 EEELGRGSFGIVYKGVLKSASGNAVAVKKLDK------LAQEREREFKTEVS----AIGR 474
LG+G FG V+ G + VA+K + + EV+
Sbjct: 36 GPLLGKGGFGTVFAGH-RLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAG 94
Query: 475 THHKNLVQLLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDW-SLRVRISLEIAR---- 529
H +++LL + + +LV E LF D+ + + + +R
Sbjct: 95 GGHPGVIRLLDWFETQEGFMLVLERPLPA---QDLF-----DYITEKGPLGEGPSRCFFG 146
Query: 530 ----GLLYLHEECNVPIIHCDIKPQNILLDQD-FTAKISDFGLSKLLLSDQSRTRTVIRG 584
+ + H ++H DIK +NIL+D AK+ DFG LL D+ T G
Sbjct: 147 QVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGA-LLHDEPYTDFD--G 200
Query: 585 TRGYVAPEWFKNVP-VSAKVDVYSFGVVLLKIICCKRSVEMELG----EERSAILTDWAY 639
TR Y PEW + V+S G++L ++C G E IL +
Sbjct: 201 TRVYSPPEWISRHQYHALPATVWSLGILLYDMVC---------GDIPFERDQEIL-EAEL 250
Query: 640 DC--YVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ---MLEG 694
+V S C L+ C+ P RP+++ I+ M
Sbjct: 251 HFPAHV------------------SPDCCALI--RRCLAPKPSSRPSLEEILLDPWMQTP 290
Query: 695 YLEVPSPPMPPLHS 708
+VP P +
Sbjct: 291 AEDVPLNPSKGGPA 304
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 1e-23
Identities = 54/197 (27%), Positives = 87/197 (44%), Gaps = 9/197 (4%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNAVAVKKLDK--LAQEREREFKTEVSAIGRTHHKNLV 481
+ +G+G+F V +G VA+K +DK L ++ EV + +H N+V
Sbjct: 19 LLKTIGKGNFAKVKLAR-HILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIV 77
Query: 482 QLLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVP 541
+L + L+ E+ G + + L A R +I + Y H++
Sbjct: 78 KLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR--- 134
Query: 542 IIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVP-VS 600
I+H D+K +N+LLD D KI+DFG S G Y APE F+
Sbjct: 135 IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFC--GAPPYAAPELFQGKKYDG 192
Query: 601 AKVDVYSFGVVLLKIIC 617
+VDV+S GV+L ++
Sbjct: 193 PEVDVWSLGVILYTLVS 209
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-23
Identities = 59/196 (30%), Positives = 94/196 (47%), Gaps = 13/196 (6%)
Query: 428 LGRGSFGIVYKGVLKSASGNAVAVKKLDK---LAQEREREFKTEVSAIGRTHHKNLVQLL 484
LG+G FG V A+G A KKL+K ++ E E + + + + +V L
Sbjct: 192 LGKGGFGEVC-ACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL- 249
Query: 485 GFCDEGLNRL-LVYEFMGNGTLANLLFAIPRPDWSL-RVRI-SLEIARGLLYLHEECNVP 541
+ E + L LV M G L ++ + + + R + EI GL LH E
Sbjct: 250 AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER--- 306
Query: 542 IIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPVSA 601
I++ D+KP+NILLD +ISD GL+ + + + + GT GY+APE KN +
Sbjct: 307 IVYRDLKPENILLDDHGHIRISDLGLAV-HVPEGQTIKGRV-GTVGYMAPEVVKNERYTF 364
Query: 602 KVDVYSFGVVLLKIIC 617
D ++ G +L ++I
Sbjct: 365 SPDWWALGCLLYEMIA 380
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-23
Identities = 57/199 (28%), Positives = 91/199 (45%), Gaps = 18/199 (9%)
Query: 428 LGRGSFGIVYKGVLKSASGNAVAVKKLDK---LAQEREREFKTE---VSAIGRTHHKNLV 481
+GRG FG VY G K+ +G A+K LDK ++ E E +S + +V
Sbjct: 197 IGRGGFGEVY-GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 255
Query: 482 QLLGFCDEGLNRL-LVYEFMGNGTLANLLFAIPRPDWSLRVRI-SLEIARGLLYLHEECN 539
+ + ++L + + M G L L + +R + EI GL ++H
Sbjct: 256 CM-SYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA-DMRFYAAEIILGLEHMHNRF- 312
Query: 540 VPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPE-WFKNVP 598
+++ D+KP NILLD+ +ISD GL+ + GT GY+APE K V
Sbjct: 313 --VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQKGVA 367
Query: 599 VSAKVDVYSFGVVLLKIIC 617
+ D +S G +L K++
Sbjct: 368 YDSSADWFSLGCMLFKLLR 386
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 4e-23
Identities = 49/173 (28%), Positives = 83/173 (47%), Gaps = 15/173 (8%)
Query: 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKT---EVSAIGRTHHKNLVQ 482
++G GS+G+V+K + +G VA+KK +++ K E+ + + H NLV
Sbjct: 9 GKIGEGSYGVVFKCRNRD-TGQIVAIKKF-LESEDDPVIKKIALREIRMLKQLKHPNLVN 66
Query: 483 LLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRP-DWSLRVRISLEIARGLLYLHEECNVP 541
LL LV+E+ + T+ + L R L I+ + + + + H+
Sbjct: 67 LLEVFRRKRRLHLVFEYC-DHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHN--- 122
Query: 542 IIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRT--VIRGTRGYVAPE 592
IH D+KP+NIL+ + K+ DFG ++ LL+ S V TR Y +PE
Sbjct: 123 CIHRDVKPENILITKHSVIKLCDFGFAR-LLTGPSDYYDDEVA--TRWYRSPE 172
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 5e-23
Identities = 60/209 (28%), Positives = 87/209 (41%), Gaps = 32/209 (15%)
Query: 428 LGRGSFGIVYKGVLKSASGNAVAVKKLDK----LAQEREREFKTEVSAIGRTHHKNLVQL 483
LG GS+G V + + S + AVK L K E K E+ + R HKN++QL
Sbjct: 13 LGEGSYGKVKEVL-DSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 484 LG-FCDEGLNRL-LVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIAR--------GLLY 533
+ +E ++ +V E+ G + D R + A GL Y
Sbjct: 72 VDVLYNEEKQKMYMVMEYCVCGMQE--ML-----DSVPEKRFPVCQAHGYFCQLIDGLEY 124
Query: 534 LHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIR---GTRGYVA 590
LH + I+H DIKP N+LL T KIS G+++ L R G+ +
Sbjct: 125 LHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEAL--HPFAADDTCRTSQGSPAFQP 179
Query: 591 PEWFKNVPV--SAKVDVYSFGVVLLKIIC 617
PE + KVD++S GV L I
Sbjct: 180 PEIANGLDTFSGFKVDIWSAGVTLYNITT 208
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 5e-23
Identities = 55/204 (26%), Positives = 96/204 (47%), Gaps = 32/204 (15%)
Query: 425 EEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLL 484
+ +G GSFG+V++ L + VA+KK+ Q++ + + E+ + H N+V L
Sbjct: 45 CKVIGNGSFGVVFQAKLVE--SDEVAIKKV---LQDKRFKNR-ELQIMRIVKHPNVVDLK 98
Query: 485 GFCDEGLNRL------LVYEFMGNGTLANLLFAIPRPDWSLRVRISLE--------IARG 530
F ++ LV E++ T+ R L+ + + + R
Sbjct: 99 AFFYSNGDKKDEVFLNLVLEYVPE-TVYRAS----RHYAKLKQTMPMLLIKLYMYQLLRS 153
Query: 531 LLYLHEECNVPIIHCDIKPQNILLDQD-FTAKISDFGLSKLLLSDQSRTRTVIRGTRGYV 589
L Y+H ++ I H DIKPQN+LLD K+ DFG +K+L++ + + +R Y
Sbjct: 154 LAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYIC--SRYYR 208
Query: 590 APEW-FKNVPVSAKVDVYSFGVVL 612
APE F + +D++S G V+
Sbjct: 209 APELIFGATNYTTNIDIWSTGCVM 232
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 7e-23
Identities = 59/198 (29%), Positives = 92/198 (46%), Gaps = 26/198 (13%)
Query: 428 LGRGSFGIVYKGVLKSASGNAVAVKKLDK--LAQEREREF-KTEVSAIGRTHHKNLVQLL 484
LG GSF V + A+ A+K L+K + +E + + E + R H V+L
Sbjct: 38 LGEGSFSTVVL-ARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY 96
Query: 485 G-FCDEGLNRL-LVYEFMGNGTLANLL-----FAIPRPDWSLRVRI-SLEIARGLLYLHE 536
F D+ +L + NG L + F R + EI L YLH
Sbjct: 97 FTFQDD--EKLYFGLSYAKNGELLKYIRKIGSFDETC------TRFYTAEIVSALEYLHG 148
Query: 537 ECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLL--LSDQSRTRTVIRGTRGYVAPEWF 594
+ IIH D+KP+NILL++D +I+DFG +K+L S Q+R + + GT YV+PE
Sbjct: 149 K---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV-GTAQYVSPELL 204
Query: 595 KNVPVSAKVDVYSFGVVL 612
D+++ G ++
Sbjct: 205 TEKSACKSSDLWALGCII 222
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 9e-23
Identities = 56/226 (24%), Positives = 91/226 (40%), Gaps = 53/226 (23%)
Query: 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREF-------------------- 465
+E+G+GS+G+V A+K L K R+ F
Sbjct: 19 DEIGKGSYGVVKLAY-NENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPR 77
Query: 466 ------KTEVSAIGRTHHKNLVQLLGFCDEGLNRLL--VYEFMGNGTLANLLFAIPRPDW 517
E++ + + H N+V+L+ D+ L V+E + G + +P
Sbjct: 78 GPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV----MEVPT--- 130
Query: 518 SLRVRISLEIAR--------GLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSK 569
+S + AR G+ YLH + IIH DIKP N+L+ +D KI+DFG+S
Sbjct: 131 --LKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSN 185
Query: 570 LLLSDQSRTRTVIRGTRGYVAPEWFKNVPVS---AKVDVYSFGVVL 612
+ + GT ++APE +DV++ GV L
Sbjct: 186 EFKGSDALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTL 230
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 1e-22
Identities = 55/173 (31%), Positives = 85/173 (49%), Gaps = 15/173 (8%)
Query: 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKT---EVSAIGRTHHKNLVQ 482
+G GS+G+V K K +G VA+KK + + + K E+ + + H+NLV
Sbjct: 31 GLVGEGSYGMVMKCRNK-DTGRIVAIKKF-LESDDDKMVKKIAMREIKLLKQLRHENLVN 88
Query: 483 LLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRP-DWSLRVRISLEIARGLLYLHEECNVP 541
LL C + LV+EF+ + T+ + L P D+ + + +I G+ + H
Sbjct: 89 LLEVCKKKKRWYLVFEFV-DHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHN--- 144
Query: 542 IIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRT--VIRGTRGYVAPE 592
IIH DIKP+NIL+ Q K+ DFG ++ L+ V TR Y APE
Sbjct: 145 IIHRDIKPENILVSQSGVVKLCDFGFAR-TLAAPGEVYDDEVA--TRWYRAPE 194
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 3e-22
Identities = 62/204 (30%), Positives = 93/204 (45%), Gaps = 29/204 (14%)
Query: 428 LGRGSFGIVYKGVLKSASGNAVAVKKLDK--LAQEREREFKTEVSAIGRTHHKNLVQLLG 485
LG G++G V V + AVAVK +D E K E+ +H+N+V+ G
Sbjct: 15 LGEGAYGEVQLAV-NRVTEEAVAVKIVDMKRAVDCPEN-IKKEICINKMLNHENVVKFYG 72
Query: 486 FCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIAR--------GLLYLHEE 537
EG + L E+ G L + + + + A+ G++YLH
Sbjct: 73 HRREGNIQYLFLEYCSGGELFDRIEP--------DIGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 538 CNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIR---GTRGYVAPEWF 594
I H DIKP+N+LLD+ KISDFGL+ + + ++ GT YVAPE
Sbjct: 125 G---ITHRDIKPENLLLDERDNLKISDFGLAT--VFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 595 KNVP-VSAKVDVYSFGVVLLKIIC 617
K + VDV+S G+VL ++
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLA 203
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 8e-22
Identities = 64/202 (31%), Positives = 100/202 (49%), Gaps = 21/202 (10%)
Query: 428 LGRGSFGIVYKGVLKSASGNAVAVKKLDK---LAQEREREFKTEVSAIGRTHHKNLVQLL 484
LG+G+FG V V + A+G A+K L K +A++ TE + + H L L
Sbjct: 156 LGKGTFGKVIL-VKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 214
Query: 485 GFCDEGLNRL-LVYEFMGNGTLANLL-----FAIPRPDWSLRVRI-SLEIARGLLYLHEE 537
+ + +RL V E+ G L L F+ R R EI L YLH E
Sbjct: 215 -YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDR------ARFYGAEIVSALDYLHSE 267
Query: 538 CNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNV 597
N +++ D+K +N++LD+D KI+DFGL K + D + +T GT Y+APE ++
Sbjct: 268 KN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC-GTPEYLAPEVLEDN 324
Query: 598 PVSAKVDVYSFGVVLLKIICCK 619
VD + GVV+ +++C +
Sbjct: 325 DYGRAVDWWGLGVVMYEMMCGR 346
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 8e-22
Identities = 54/198 (27%), Positives = 91/198 (45%), Gaps = 22/198 (11%)
Query: 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQERE-------REFKTEVSAIGRTHHK 478
E+G G++G V+K G VA+K++ ++ E RE + + H
Sbjct: 17 AEIGEGAYGKVFKARDLKNGGRFVALKRV-RVQTGEEGMPLSTIREVAV-LRHLETFEHP 74
Query: 479 NLVQLL----GFCDEGLNRL-LVYEFMGNGTLANLLFAIPRPDWSLRV--RISLEIARGL 531
N+V+L + +L LV+E + + L L +P P + ++ RGL
Sbjct: 75 NVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQLLRGL 133
Query: 532 LYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAP 591
+LH ++H D+KPQNIL+ K++DFGL+++ + T V+ T Y AP
Sbjct: 134 DFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV--TLWYRAP 188
Query: 592 EWFKNVPVSAKVDVYSFG 609
E + VD++S G
Sbjct: 189 EVLLQSSYATPVDLWSVG 206
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 1e-21
Identities = 62/203 (30%), Positives = 94/203 (46%), Gaps = 27/203 (13%)
Query: 428 LGRGSFGIVYKGVLKSASGNAVAVKKLDK-LAQEREREFKTEVSAIGRTHHKNLVQLLGF 486
LG G++G V V + AVAVK +D A + K E+ +H+N+V+ G
Sbjct: 15 LGEGAYGEVQLAV-NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 487 CDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIAR--------GLLYLHEEC 538
EG + L E+ G L + + + + A+ G++YLH
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIEP--------DIGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 539 NVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIR---GTRGYVAPEWFK 595
I H DIKP+N+LLD+ KISDFGL+ + + ++ GT YVAPE K
Sbjct: 126 ---ITHRDIKPENLLLDERDNLKISDFGLAT--VFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 596 NVP-VSAKVDVYSFGVVLLKIIC 617
+ VDV+S G+VL ++
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLA 203
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 2e-21
Identities = 55/200 (27%), Positives = 91/200 (45%), Gaps = 24/200 (12%)
Query: 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAI---------GRTH 476
E+G G++G VYK SG+ VA+K + ++ +S +
Sbjct: 15 AEIGVGAYGTVYKARDPH-SGHFVALKSV-RVPNGGGGGGGLPISTVREVALLRRLEAFE 72
Query: 477 HKNLVQLL----GFCDEGLNRL-LVYEFMGNGTLANLLFAIPRPDWSLRV--RISLEIAR 529
H N+V+L+ + ++ LV+E + + L L P P + + R
Sbjct: 73 HPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDLMRQFLR 131
Query: 530 GLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYV 589
GL +LH C I+H D+KP+NIL+ T K++DFGL+++ + T V+ T Y
Sbjct: 132 GLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVV--TLWYR 186
Query: 590 APEWFKNVPVSAKVDVYSFG 609
APE + VD++S G
Sbjct: 187 APEVLLQSTYATPVDMWSVG 206
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 6e-21
Identities = 58/194 (29%), Positives = 97/194 (50%), Gaps = 10/194 (5%)
Query: 428 LGRGSFGIVYKGVLKSASGNAVAVKKLDK---LAQEREREFKTEVSAIGRTHHKNLVQLL 484
LG G+FG V G +G+ VAVK L++ + + + K E+ + H ++++L
Sbjct: 19 LGVGTFGKVKIGE-HQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLY 77
Query: 485 GFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIH 544
+ +V E++ G L + + R + R+ +I + Y H ++H
Sbjct: 78 QVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM---VVH 134
Query: 545 CDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVP-VSAKV 603
D+KP+N+LLD AKI+DFGLS ++SD RT G+ Y APE +V
Sbjct: 135 RDLKPENVLLDAHMNAKIADFGLSN-MMSDGEFLRTSC-GSPNYAAPEVISGRLYAGPEV 192
Query: 604 DVYSFGVVLLKIIC 617
D++S GV+L ++C
Sbjct: 193 DIWSCGVILYALLC 206
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 6e-21
Identities = 55/178 (30%), Positives = 90/178 (50%), Gaps = 24/178 (13%)
Query: 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQERE-------REFKTEVSAIGRTHHK 478
E++G G++G+VYK K +G VA+KK+ +L E E RE +S + +H
Sbjct: 9 EKIGEGTYGVVYKARNKL-TGEVVALKKI-RLDTETEGVPSTAIRE----ISLLKELNHP 62
Query: 479 NLVQLLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRV--RISLEIARGLLYLHE 536
N+V+LL LV+EF+ + L + A L + ++ +GL + H
Sbjct: 63 NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 537 ECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRT--VIRGTRGYVAPE 592
++H D+KPQN+L++ + K++DFGL++ RT T V+ T Y APE
Sbjct: 122 HR---VLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYTHEVV--TLWYRAPE 173
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 7e-21
Identities = 60/205 (29%), Positives = 99/205 (48%), Gaps = 32/205 (15%)
Query: 400 QRSSISETNLRFFSLVELNEATNGFE--EELGRGSFGIVYKGVLKSASGNAVAVKKLDKL 457
S NL F L+E ++ E++G G++G+VYK K + G VA+K++ +L
Sbjct: 5 HHHSSGRENLYFQGLME------KYQKLEKVGEGTYGVVYKA--KDSQGRIVALKRI-RL 55
Query: 458 AQERE-------REFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEFMGNGTLANLLF 510
E E RE +S + HH N+V L+ LV+EFM L +L
Sbjct: 56 DAEDEGIPSTAIRE----ISLLKELHHPNIVSLIDVIHSERCLTLVFEFM-EKDLKKVLD 110
Query: 511 AIPRPDWSLRVR-ISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSK 569
+++ ++ RG+ + H+ I+H D+KPQN+L++ D K++DFGL++
Sbjct: 111 ENKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLAR 167
Query: 570 LLLSDQSRTRT--VIRGTRGYVAPE 592
R+ T V+ T Y AP+
Sbjct: 168 -AFGIPVRSYTHEVV--TLWYRAPD 189
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 92.6 bits (231), Expect = 7e-21
Identities = 51/177 (28%), Positives = 90/177 (50%), Gaps = 24/177 (13%)
Query: 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQERE-------REFKTEVSAIGRTHHK 478
E++G G++G+VYK ++ G A+KK+ +L +E E RE +S + H
Sbjct: 8 EKIGEGTYGVVYKA--QNNYGETFALKKI-RLEKEDEGIPSTTIRE----ISILKELKHS 60
Query: 479 NLVQLLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVR-ISLEIARGLLYLHEE 537
N+V+L +LV+E + + L LL S+ + L++ G+ Y H+
Sbjct: 61 NIVKLYDVIHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR 119
Query: 538 CNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRT--VIRGTRGYVAPE 592
++H D+KPQN+L++++ KI+DFGL++ R T ++ T Y AP+
Sbjct: 120 R---VLHRDLKPQNLLINREGELKIADFGLAR-AFGIPVRKYTHEIV--TLWYRAPD 170
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 1e-20
Identities = 54/199 (27%), Positives = 90/199 (45%), Gaps = 23/199 (11%)
Query: 428 LGRGSFGIVYKGVLKSASGNAVAVKKLDK--LAQERERE-FKTEVSAIGRTHHKNLVQLL 484
+GRG+FG V V + A+K L+K + + E F+ E + K + L
Sbjct: 82 IGRGAFGEVAV-VKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLH 140
Query: 485 G-FCDEGLNRL-LVYEFMGNGTLANLLFAIPRPDWSL---RVRISL-EIARGLLYLHEEC 538
F D+ N L LV ++ G +LL + + + L R L E+ + +H+
Sbjct: 141 YAFQDD--NNLYLVMDYYVGG---DLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH 195
Query: 539 NVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVP 598
+H DIKP NIL+D + +++DFG L+ D + +V GT Y++PE + +
Sbjct: 196 ---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAME 252
Query: 599 VSAK-----VDVYSFGVVL 612
D +S GV +
Sbjct: 253 GGKGRYGPECDWWSLGVCM 271
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 92.2 bits (230), Expect = 2e-20
Identities = 60/196 (30%), Positives = 94/196 (47%), Gaps = 22/196 (11%)
Query: 428 LGRGSFGIVY--KGVLKSASGNAVAVKKLDK--LAQEREREFKTEVSAIGRTHHKNLVQL 483
LG+GSFG V+ K + S + A+K L K L K E + +H +V+L
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91
Query: 484 LGFCDEGLNRL-LVYEFMGNGTLANLL-----FAIPRPDWSLRVRI-SLEIARGLLYLHE 536
+ + +L L+ +F+ G L L F V+ E+A L +LH
Sbjct: 92 H-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEED------VKFYLAELALALDHLHS 144
Query: 537 ECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKN 596
II+ D+KP+NILLD++ K++DFGLSK + + + + GT Y+APE
Sbjct: 145 LG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC-GTVEYMAPEVVNR 200
Query: 597 VPVSAKVDVYSFGVVL 612
+ D +SFGV++
Sbjct: 201 RGHTQSADWWSFGVLM 216
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 91.4 bits (228), Expect = 2e-20
Identities = 43/177 (24%), Positives = 83/177 (46%), Gaps = 23/177 (12%)
Query: 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQERE-------REFKTEVSAIGRTHHK 478
E++G G++G V+K + + VA+K++ +L + E RE + + HK
Sbjct: 8 EKIGEGTYGTVFKAKNRE-THEIVALKRV-RLDDDDEGVPSSALRE----ICLLKELKHK 61
Query: 479 NLVQLLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRP-DWSLRVRISLEIARGLLYLHEE 537
N+V+L LV+EF + L + D + ++ +GL + H
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFC-DQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR 120
Query: 538 CNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRT--VIRGTRGYVAPE 592
++H D+KPQN+L++++ K+++FGL++ R + V+ T Y P+
Sbjct: 121 N---VLHRDLKPQNLLINRNGELKLANFGLAR-AFGIPVRCYSAEVV--TLWYRPPD 171
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 92.2 bits (230), Expect = 2e-20
Identities = 55/199 (27%), Positives = 92/199 (46%), Gaps = 26/199 (13%)
Query: 428 LGRGSFGIVY---KGVLKSASGNAVAVKKLDK---LAQEREREF-KTEVSAIGRTHHKNL 480
LG+G +G V+ K + +G A+K L K + ++ K E + + H +
Sbjct: 25 LGKGGYGKVFQVRKVTGAN-TGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 481 VQLLGFCDEGLNRL-LVYEFMGNGTLANLL-----FAIPRPDWSLRVRI-SLEIARGLLY 533
V L+ + + +L L+ E++ G L L F EI+ L +
Sbjct: 84 VDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDT------ACFYLAEISMALGH 136
Query: 534 LHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEW 593
LH++ II+ D+KP+NI+L+ K++DFGL K + D + T T GT Y+APE
Sbjct: 137 LHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFC-GTIEYMAPEI 192
Query: 594 FKNVPVSAKVDVYSFGVVL 612
+ VD +S G ++
Sbjct: 193 LMRSGHNRAVDWWSLGALM 211
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 2e-20
Identities = 53/236 (22%), Positives = 93/236 (39%), Gaps = 63/236 (26%)
Query: 425 EEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLL 484
+ LG GSFGIV + SG A+KK+ + + + RE + H N+++L+
Sbjct: 12 GKTLGTGSFGIVCEVFDI-ESGKRFALKKVLQDPRYKNRELDI----MKVLDHVNIIKLV 66
Query: 485 -GFCDEGLNRL-------------------------------------LVYEFMGNGTLA 506
F G ++ E++ + TL
Sbjct: 67 DYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLH 125
Query: 507 NLLFAIPRPDWSLRVRISLE--------IARGLLYLHEECNVPIIHCDIKPQNILLD-QD 557
+L + I + + R + ++H ++ I H DIKPQN+L++ +D
Sbjct: 126 KVL----KSFIRSGRSIPMNLISIYIYQLFRAVGFIH---SLGICHRDIKPQNLLVNSKD 178
Query: 558 FTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPE-WFKNVPVSAKVDVYSFGVVL 612
T K+ DFG +K L+ + + +R Y APE + +D++S G V
Sbjct: 179 NTLKLCDFGSAKKLIPSEPSVAYIC--SRFYRAPELMLGATEYTPSIDLWSIGCVF 232
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 2e-20
Identities = 65/202 (32%), Positives = 97/202 (48%), Gaps = 22/202 (10%)
Query: 428 LGRGSFGIVYKGVLKSASGNAVAVKKLDK--LAQEREREF-KTEVSAIGRTHHKNLVQLL 484
LG+G+FG V V + A+G A+K L K + + E TE + T H L L
Sbjct: 13 LGKGTFGKVIL-VREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71
Query: 485 GFCDEGLNRL-LVYEFMGNGTLANLL-----FAIPRPDWSLRVRI-SLEIARGLLYLHEE 537
+ + +RL V E+ G L L F R R EI L YLH
Sbjct: 72 -YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEER------ARFYGAEIVSALEYLHSR 124
Query: 538 CNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNV 597
+++ DIK +N++LD+D KI+DFGL K +SD + +T GT Y+APE ++
Sbjct: 125 ---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPEVLEDN 180
Query: 598 PVSAKVDVYSFGVVLLKIICCK 619
VD + GVV+ +++C +
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGR 202
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 3e-20
Identities = 24/194 (12%), Positives = 52/194 (26%), Gaps = 43/194 (22%)
Query: 425 EEELGRGSFGIVYKG---VLKSASGNAVAVKKLD---KLAQEREREFKTEVSAIGRTHHK 478
G ++ L VA+ +D L + +E + + R
Sbjct: 36 LIFHGGVPPLQFWQALDTAL----DRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKP 91
Query: 479 NLVQLLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEEC 538
+ ++L L+V E++ G+L + P P + +R +A H
Sbjct: 92 GVARVLDVVHTRAGGLVVAEWIRGGSLQEVADTSPSPVGA--IRAMQSLAAAADAAHRA- 148
Query: 539 NVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVP 598
+ P + + D ++ +
Sbjct: 149 --GVALSIDHPSRVRVSIDGDVVLAYP---------------------ATMP-------D 178
Query: 599 VSAKVDVYSFGVVL 612
+ + D+ G L
Sbjct: 179 ANPQDDIRGIGASL 192
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 3e-20
Identities = 43/199 (21%), Positives = 73/199 (36%), Gaps = 42/199 (21%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGR-THHKNLVQ 482
+ LG G G V + K + A+K L + R EV R + ++V+
Sbjct: 22 TSQVLGLGINGKVLQIFNKR-TQEKFALKMLQDCPKARR-----EVELHWRASQCPHIVR 75
Query: 483 LLGFCDEGLNR----LLVYEFMGNGTLANLLFAIPRPDWSLR--VRISLEIARGLLYLHE 536
++ + L+V E + G L + + ++ R I I + YLH
Sbjct: 76 IVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH- 134
Query: 537 ECNVPIIHCDIKPQNILL---DQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEW 593
N I H D+KP+N+L + K++DFG +K Y
Sbjct: 135 SIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTG------------EKY----- 175
Query: 594 FKNVPVSAKVDVYSFGVVL 612
D++S GV++
Sbjct: 176 ------DKSCDMWSLGVIM 188
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 4e-20
Identities = 52/201 (25%), Positives = 81/201 (40%), Gaps = 26/201 (12%)
Query: 428 LGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFC 487
+G G+FG+ + VAVK +++ A E + E+ H N+V+
Sbjct: 28 IGSGNFGVARLMR-DKLTKELVAVKYIERGAAIDEN-VQREIINHRSLRHPNIVRFKEVI 85
Query: 488 DEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIAR--------GLLYLHEECN 539
+ ++ E+ G L + R S + AR G+ Y H
Sbjct: 86 LTPTHLAIIMEYASGGELYERICN--------AGRFSEDEARFFFQQLLSGVSYCHSMQ- 136
Query: 540 VPIIHCDIKPQNILLDQDFTA--KISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNV 597
I H D+K +N LLD KI DFG SK + S+ ++ + GT Y+APE
Sbjct: 137 --ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTV-GTPAYIAPEVLLRQ 192
Query: 598 P-VSAKVDVYSFGVVLLKIIC 617
DV+S GV L ++
Sbjct: 193 EYDGKIADVWSCGVTLYVMLV 213
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 6e-20
Identities = 59/199 (29%), Positives = 93/199 (46%), Gaps = 28/199 (14%)
Query: 428 LGRGSFGIVYKGVLKSASGNAVAVKKLDK---LAQEREREFKTEVSAIGRTHHKNLVQLL 484
+G+GSFG V V K+ + A+K ++K + + R E+ + H LV L
Sbjct: 23 IGKGSFGKVCI-VQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLW 81
Query: 485 G-FCDEGLNRL-LVYEFMGNGTLANLL-----FAIPRPDWSLRVRISL-EIARGLLYLHE 536
F DE + +V + + G L L F V++ + E+ L YL
Sbjct: 82 YSFQDEE--DMFMVVDLLLGGDLRYHLQQNVHFKEET------VKLFICELVMALDYLQN 133
Query: 537 ECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKN 596
+ IIH D+KP NILLD+ I+DF ++ +L +++ T+ GT+ Y+APE F +
Sbjct: 134 Q---RIIHRDMKPDNILLDEHGHVHITDFNIAA-MLPRETQITTMA-GTKPYMAPEMFSS 188
Query: 597 VPV---SAKVDVYSFGVVL 612
S VD +S GV
Sbjct: 189 RKGAGYSFAVDWWSLGVTA 207
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 8e-20
Identities = 54/194 (27%), Positives = 91/194 (46%), Gaps = 11/194 (5%)
Query: 428 LGRGSFGIVYKGVLKSASGNAVAVKKLDK---LAQEREREFKTEVSAIGRTHHKNLVQLL 484
LG GSFG V + VA+K + + + + E+S + H ++++L
Sbjct: 17 LGEGSFGKVKLAT-HYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLY 75
Query: 485 GFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIH 544
+ ++V E+ G G L + + R R +I + Y H I+H
Sbjct: 76 DVITTPTDIVMVIEYAG-GELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHK---IVH 131
Query: 545 CDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVP-VSAKV 603
D+KP+N+LLD + KI+DFGLS +++D + +T G+ Y APE +V
Sbjct: 132 RDLKPENLLLDDNLNVKIADFGLSN-IMTDGNFLKTSC-GSPNYAAPEVINGKLYAGPEV 189
Query: 604 DVYSFGVVLLKIIC 617
DV+S G+VL ++
Sbjct: 190 DVWSCGIVLYVMLV 203
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 2e-19
Identities = 57/198 (28%), Positives = 88/198 (44%), Gaps = 24/198 (12%)
Query: 428 LGRGSFGIVYKGVLKSASGNAVAVKKLDK---LAQEREREFKTEVSAIGRTHHKNLVQLL 484
+GRG+FG V V ++ A+K L K + + F E + + +VQL
Sbjct: 77 IGRGAFGEVQL-VRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 135
Query: 485 G-FCDEGLNRL-LVYEFMGNGTLANLL--FAIPRPDWSLRVRI-SLEIARGLLYLHEECN 539
F D+ L +V E+M G L NL+ + +P R + E+ L +H
Sbjct: 136 YAFQDD--RYLYMVMEYMPGGDLVNLMSNYDVPEK----WARFYTAEVVLALDAIHS--- 186
Query: 540 VPIIHCDIKPQNILLDQDFTAKISDFGLSK-LLLSDQSRTRTVIRGTRGYVAPEWFKNVP 598
+ IH D+KP N+LLD+ K++DFG + R T + GT Y++PE K+
Sbjct: 187 MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQG 245
Query: 599 VSAK----VDVYSFGVVL 612
D +S GV L
Sbjct: 246 GDGYYGRECDWWSVGVFL 263
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 91.0 bits (226), Expect = 2e-19
Identities = 59/194 (30%), Positives = 98/194 (50%), Gaps = 10/194 (5%)
Query: 428 LGRGSFGIVYKGVLKSASGNAVAVKKLDK---LAQEREREFKTEVSAIGRTHHKNLVQLL 484
LG G+FG V G +G+ VAVK L++ + + + + E+ + H ++++L
Sbjct: 24 LGVGTFGKVKVGK-HELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLY 82
Query: 485 GFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIH 544
+ +V E++ G L + + R D R+ +I G+ Y H ++H
Sbjct: 83 QVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHM---VVH 139
Query: 545 CDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVP-VSAKV 603
D+KP+N+LLD AKI+DFGLS ++SD RT G+ Y APE +V
Sbjct: 140 RDLKPENVLLDAHMNAKIADFGLSN-MMSDGEFLRTSC-GSPNYAAPEVISGRLYAGPEV 197
Query: 604 DVYSFGVVLLKIIC 617
D++S GV+L ++C
Sbjct: 198 DIWSSGVILYALLC 211
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 2e-19
Identities = 47/181 (25%), Positives = 77/181 (42%), Gaps = 27/181 (14%)
Query: 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQERE-------REFKTEVSAIGRTHHK 478
+LG G++G VYK + + VA+K++ +L E E RE VS + H+
Sbjct: 40 TKLGEGTYGEVYKAIDTV-TNETVAIKRI-RLEHEEEGVPGTAIRE----VSLLKELQHR 93
Query: 479 NLVQLLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEEC 538
N+++L L++E+ L + P + ++ G+ + H
Sbjct: 94 NIIELKSVIHHNHRLHLIFEYA-ENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRR 152
Query: 539 NVPIIHCDIKPQNILLDQDFTA-----KISDFGLSKLLLSDQSRTRT--VIRGTRGYVAP 591
+H D+KPQN+LL + KI DFGL++ R T +I T Y P
Sbjct: 153 ---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR-AFGIPIRQFTHEII--TLWYRPP 206
Query: 592 E 592
E
Sbjct: 207 E 207
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 2e-19
Identities = 56/201 (27%), Positives = 85/201 (42%), Gaps = 25/201 (12%)
Query: 428 LGRGSFGIVYKGVLKSASGNAVAVKKLDK---LAQEREREFKTEVSAIGRTHHKNLVQLL 484
+GRG+F V V +G A+K ++K L + F+ E + + + QL
Sbjct: 69 IGRGAFSEVAV-VKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH 127
Query: 485 -GFCDEGLNRL-LVYEFMGNGTLANLLFAIPRPDWSL---RVRISL-EIARGLLYLHEEC 538
F DE N L LV E+ G +LL + + + R L EI + +H
Sbjct: 128 FAFQDE--NYLYLVMEYYVGG---DLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLG 182
Query: 539 NVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVP 598
+H DIKP NILLD+ +++DFG L +D + V GT Y++PE + V
Sbjct: 183 ---YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVG 239
Query: 599 VSAKVDVY-------SFGVVL 612
Y + GV
Sbjct: 240 GGPGTGSYGPECDWWALGVFA 260
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 3e-19
Identities = 54/212 (25%), Positives = 84/212 (39%), Gaps = 40/212 (18%)
Query: 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQERE--REFKTEVSAIGRT-------- 475
+ GS+G V GV G VA+K++ + R
Sbjct: 28 RFISSGSYGAVCAGVDSE--GIPVAIKRVFNTVSDGRTVNILSDSFLCK-RVLREIRLLN 84
Query: 476 --HHKNLVQLLG----FCDEGLNRL-LVYEFMGNGTLANLLFAIPRPDWSL---RVRISL 525
HH N++ L F + +++L LV E M +L I + ++ +
Sbjct: 85 HFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR----TDLAQVIHDQRIVISPQHIQYFM 140
Query: 526 -EIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRG 584
I GL LHE V +H D+ P NILL + I DF L++ +D ++T V
Sbjct: 141 YHILLGLHVLHE-AGV--VHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVT-- 195
Query: 585 TRGYVAPE----WFKNVPVSAKVDVYSFGVVL 612
R Y APE + + VD++S G V+
Sbjct: 196 HRWYRAPELVMQFKGF---TKLVDMWSAGCVM 224
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 3e-19
Identities = 60/202 (29%), Positives = 89/202 (44%), Gaps = 35/202 (17%)
Query: 428 LGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRT----------HH 477
+G G+ GIV + VA+KKL R F+ + A R +H
Sbjct: 33 IGSGAQGIVCA-AYDAILERNVAIKKL-------SRPFQNQTHAK-RAYRELVLMKCVNH 83
Query: 478 KNLVQLL-----GFCDEGLNRL-LVYEFMGNGTLANLLFAIPRPDWSLRVRISL-EIARG 530
KN++ LL E + +V E M ANL I R+ L ++ G
Sbjct: 84 KNIIGLLNVFTPQKSLEEFQDVYIVMELMD----ANLCQVIQMELDHERMSYLLYQMLCG 139
Query: 531 LLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVA 590
+ +LH + IIH D+KP NI++ D T KI DFGL++ + T V+ TR Y A
Sbjct: 140 IKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRYYRA 194
Query: 591 PEWFKNVPVSAKVDVYSFGVVL 612
PE + VD++S G ++
Sbjct: 195 PEVILGMGYKENVDIWSVGCIM 216
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 9e-19
Identities = 64/196 (32%), Positives = 91/196 (46%), Gaps = 23/196 (11%)
Query: 428 LGRGSFGIVYKGVLKSASGNAVAVKKLDK--LAQEREREF-KTEVSAIGR-THHKNLVQL 483
+G+GSFG V A AVK L K + +++E + +E + + + H LV L
Sbjct: 46 IGKGSFGKVLL-ARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 104
Query: 484 LGFCDEGLNRL-LVYEFMGNGTLANLL-----FAIPRPDWSLRVRI-SLEIARGLLYLHE 536
F + ++L V +++ G L L F PR R + EIA L YLH
Sbjct: 105 H-FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPR------ARFYAAEIASALGYLHS 157
Query: 537 ECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKN 596
I++ D+KP+NILLD ++DFGL K + S T T GT Y+APE
Sbjct: 158 L---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFC-GTPEYLAPEVLHK 213
Query: 597 VPVSAKVDVYSFGVVL 612
P VD + G VL
Sbjct: 214 QPYDRTVDWWCLGAVL 229
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 89.7 bits (222), Expect = 9e-19
Identities = 61/193 (31%), Positives = 93/193 (48%), Gaps = 17/193 (8%)
Query: 428 LGRGSFGIVYKGVLKSASGNAVAVKKLDK--LAQEREREF-KTEVSAIGR-THHKNLVQL 483
LG+GSFG V + + AVK L K + Q+ + E E + L QL
Sbjct: 349 LGKGSFGKVML-SERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 407
Query: 484 LGFCDEGLNRL-LVYEFMGNGTLANLLFAIPRPDWSL--RVRI-SLEIARGLLYLHEECN 539
C + ++RL V E++ G +L++ I + + EIA GL +L +
Sbjct: 408 H-SCFQTMDRLYFVMEYVNGG---DLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK-- 461
Query: 540 VPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPV 599
II+ D+K N++LD + KI+DFG+ K + D T+T GT Y+APE P
Sbjct: 462 -GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFC-GTPDYIAPEIIAYQPY 519
Query: 600 SAKVDVYSFGVVL 612
VD ++FGV+L
Sbjct: 520 GKSVDWWAFGVLL 532
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 1e-18
Identities = 58/193 (30%), Positives = 94/193 (48%), Gaps = 17/193 (8%)
Query: 428 LGRGSFGIVYKGVLKSASGNAVAVKKLDK--LAQEREREF-KTEVSAIGR-THHKNLVQL 483
+GRGS+ V V + A+K + K + + + ++ +TE + ++H LV L
Sbjct: 17 IGRGSYAKVLL-VRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 75
Query: 484 LGFCDEGLNRL-LVYEFMGNGTLANLLFAIPRPDW--SLRVRI-SLEIARGLLYLHEECN 539
C + +RL V E++ G +L+F + R R S EI+ L YLHE
Sbjct: 76 H-SCFQTESRLFFVIEYVNGG---DLMFHMQRQRKLPEEHARFYSAEISLALNYLHER-- 129
Query: 540 VPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPV 599
II+ D+K N+LLD + K++D+G+ K L T T GT Y+APE +
Sbjct: 130 -GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC-GTPNYIAPEILRGEDY 187
Query: 600 SAKVDVYSFGVVL 612
VD ++ GV++
Sbjct: 188 GFSVDWWALGVLM 200
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 1e-18
Identities = 57/193 (29%), Positives = 94/193 (48%), Gaps = 17/193 (8%)
Query: 428 LGRGSFGIVYKGVLKSASGNAVAVKKLDK--LAQEREREF-KTEVSAIGR-THHKNLVQL 483
+GRGS+ V V + A++ + K + + + ++ +TE + ++H LV L
Sbjct: 60 IGRGSYAKVLL-VRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 118
Query: 484 LGFCDEGLNRL-LVYEFMGNGTLANLLFAIPRPDW--SLRVRI-SLEIARGLLYLHEECN 539
C + +RL V E++ G +L+F + R R S EI+ L YLHE
Sbjct: 119 H-SCFQTESRLFFVIEYVNGG---DLMFHMQRQRKLPEEHARFYSAEISLALNYLHER-- 172
Query: 540 VPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPV 599
II+ D+K N+LLD + K++D+G+ K L T T GT Y+APE +
Sbjct: 173 -GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC-GTPNYIAPEILRGEDY 230
Query: 600 SAKVDVYSFGVVL 612
VD ++ GV++
Sbjct: 231 GFSVDWWALGVLM 243
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 1e-18
Identities = 62/196 (31%), Positives = 91/196 (46%), Gaps = 23/196 (11%)
Query: 428 LGRGSFGIVYKGVLKSASGNAVAVKKLDK--LAQEREREF-KTEVSAIGR-THHKNLVQL 483
LG+GSFG V + + AVK L K + Q+ + E E + L QL
Sbjct: 28 LGKGSFGKVML-SERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 86
Query: 484 LGFCDEGLNRL-LVYEFMGNGTLANLL-----FAIPRPDWSLRVRI-SLEIARGLLYLHE 536
C + ++RL V E++ G L + F P + EIA GL +L
Sbjct: 87 H-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPH------AVFYAAEIAIGLFFLQS 139
Query: 537 ECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKN 596
+ II+ D+K N++LD + KI+DFG+ K + D T+T GT Y+APE
Sbjct: 140 K---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFC-GTPDYIAPEIIAY 195
Query: 597 VPVSAKVDVYSFGVVL 612
P VD ++FGV+L
Sbjct: 196 QPYGKSVDWWAFGVLL 211
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 2e-18
Identities = 55/183 (30%), Positives = 89/183 (48%), Gaps = 31/183 (16%)
Query: 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQE--------REREFKTEVSAIGRTHH 477
E+LG G++ VYKG+ K+ +G VA+K++ KL E RE +S + H
Sbjct: 11 EKLGNGTYATVYKGLNKT-TGVYVALKEV-KLDSEEGTPSTAIRE------ISLMKELKH 62
Query: 478 KNLVQLLGFCDEGLNRLLVYEFMGNGTLANLL-----FAIPRPDWSLRVR-ISLEIARGL 531
+N+V+L LV+EFM + L + PR V+ ++ +GL
Sbjct: 63 ENIVRLYDVIHTENKLTLVFEFM-DNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGL 121
Query: 532 LYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRT--VIRGTRGYV 589
+ HE I+H D+KPQN+L+++ K+ DFGL++ T + V+ T Y
Sbjct: 122 AFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLAR-AFGIPVNTFSSEVV--TLWYR 175
Query: 590 APE 592
AP+
Sbjct: 176 APD 178
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 3e-18
Identities = 58/178 (32%), Positives = 83/178 (46%), Gaps = 22/178 (12%)
Query: 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKT--------EVSAIGRTHH 477
+ LG G F VYK K+ + VA+KK+ KL E K E+ + H
Sbjct: 16 DFLGEGQFATVYKARDKN-TNQIVAIKKI-KL--GHRSEAKDGINRTALREIKLLQELSH 71
Query: 478 KNLVQLLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRP-DWSLRVRISLEIARGLLYLHE 536
N++ LL N LV++FM L ++ S L +GL YLH+
Sbjct: 72 PNIIGLLDAFGHKSNISLVFDFM-ETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQ 130
Query: 537 ECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRT--VIRGTRGYVAPE 592
I+H D+KP N+LLD++ K++DFGL+K +R T V+ TR Y APE
Sbjct: 131 HW---ILHRDLKPNNLLLDENGVLKLADFGLAK-SFGSPNRAYTHQVV--TRWYRAPE 182
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 86.8 bits (215), Expect = 4e-18
Identities = 60/200 (30%), Positives = 90/200 (45%), Gaps = 27/200 (13%)
Query: 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDK------LAQEREREFKTEVSAIGRTHHKN 479
+ +G G+ GIV + VA+KKL + A+ RE + +HKN
Sbjct: 68 KPIGSGAQGIVCA-AYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVL----MKCVNHKN 122
Query: 480 LVQLL-----GFCDEGLNRL-LVYEFMGNGTLANLLFAIPRPDWSLRVRISL-EIARGLL 532
++ LL E + LV E M ANL I R+ L ++ G+
Sbjct: 123 IISLLNVFTPQKTLEEFQDVYLVMELMD----ANLCQVIQMELDHERMSYLLYQMLCGIK 178
Query: 533 YLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPE 592
+LH + IIH D+KP NI++ D T KI DFGL++ + T V+ TR Y APE
Sbjct: 179 HLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRYYRAPE 233
Query: 593 WFKNVPVSAKVDVYSFGVVL 612
+ VD++S G ++
Sbjct: 234 VILGMGYKENVDIWSVGCIM 253
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 5e-18
Identities = 50/178 (28%), Positives = 85/178 (47%), Gaps = 26/178 (14%)
Query: 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQE--------REREFKTEVSAIGRTHH 477
++LG G++ VYKG K + N VA+K++ +L E RE VS + H
Sbjct: 8 DKLGEGTYATVYKGKSKL-TDNLVALKEI-RLEHEEGAPCTAIRE------VSLLKDLKH 59
Query: 478 KNLVQLLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRP-DWSLRVRISLEIARGLLYLHE 536
N+V L + LV+E++ + L L + ++ RGL Y H
Sbjct: 60 ANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHR 118
Query: 537 ECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRT--VIRGTRGYVAPE 592
+ ++H D+KPQN+L+++ K++DFGL++ S ++T V+ T Y P+
Sbjct: 119 QK---VLHRDLKPQNLLINERGELKLADFGLAR-AKSIPTKTYDNEVV--TLWYRPPD 170
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 7e-18
Identities = 63/197 (31%), Positives = 97/197 (49%), Gaps = 25/197 (12%)
Query: 428 LGRGSFGIVYKGVLKSASGNAVAVKKLDK--LAQEREREF-KTE--VSAIGRTHHKNLVQ 482
LG+GSFG V +G+ AVK L K + Q+ + E TE + ++ +H L Q
Sbjct: 31 LGKGSFGKVML-ARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLA-RNHPFLTQ 88
Query: 483 LLGFCDEGLNRL-LVYEFMGNGTLANLL-----FAIPRPDWSLRVRI-SLEIARGLLYLH 535
L C + +RL V EF+ G L + F R R + EI L++LH
Sbjct: 89 LF-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEAR------ARFYAAEIISALMFLH 141
Query: 536 EECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFK 595
++ II+ D+K N+LLD + K++DFG+ K + + T T GT Y+APE +
Sbjct: 142 DK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFC-GTPDYIAPEILQ 197
Query: 596 NVPVSAKVDVYSFGVVL 612
+ VD ++ GV+L
Sbjct: 198 EMLYGPAVDWWAMGVLL 214
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 7e-18
Identities = 59/197 (29%), Positives = 90/197 (45%), Gaps = 25/197 (12%)
Query: 428 LGRGSFGIVYKGVLKSASGNAVAVKKLDK--LAQERERE-FKTE--VSAIGRTHHKNLVQ 482
LG+GSFG V+ + A+K L K + + + E E V ++ H L
Sbjct: 25 LGKGSFGKVFL-AEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA-WEHPFLTH 82
Query: 483 LLGFCDEGLNRL-LVYEFMGNGTLANLL-----FAIPRPDWSLRVRI-SLEIARGLLYLH 535
+ + L V E++ G L + F + R + EI GL +LH
Sbjct: 83 MF-CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSR------ATFYAAEIILGLQFLH 135
Query: 536 EECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFK 595
+ I++ D+K NILLD+D KI+DFG+ K + ++T T GT Y+APE
Sbjct: 136 SK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDYIAPEILL 191
Query: 596 NVPVSAKVDVYSFGVVL 612
+ VD +SFGV+L
Sbjct: 192 GQKYNHSVDWWSFGVLL 208
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 7e-18
Identities = 58/196 (29%), Positives = 93/196 (47%), Gaps = 27/196 (13%)
Query: 428 LGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREF---KTEVSAIGRTHHKNLVQLL 484
LG GSFG V V SGN A+K LDK + ++ E + + LV+L
Sbjct: 49 LGTGSFGRVML-VKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 485 G-FCDEGLNRL-LVYEFMGNGTLANLL-----FAIPRPDWSLRVRI-SLEIARGLLYLHE 536
F D + L +V E++ G + + L F+ P R + +I YLH
Sbjct: 108 FSFKDN--SNLYMVMEYVAGGEMFSHLRRIGRFSEPH------ARFYAAQIVLTFEYLHS 159
Query: 537 ECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKN 596
+I+ D+KP+N+L+DQ +++DFG +K + RT T + GT +APE +
Sbjct: 160 LD---LIYRDLKPENLLIDQQGYIQVTDFGFAK---RVKGRTWT-LCGTPEALAPEIILS 212
Query: 597 VPVSAKVDVYSFGVVL 612
+ VD ++ GV++
Sbjct: 213 KGYNKAVDWWALGVLI 228
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 83.7 bits (208), Expect = 1e-17
Identities = 58/196 (29%), Positives = 96/196 (48%), Gaps = 27/196 (13%)
Query: 428 LGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREF---KTEVSAIGRTHHKNLVQLL 484
LG GSFG V+ + +G A+K L K R ++ E + H ++++
Sbjct: 14 LGTGSFGRVHL-IRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMW 72
Query: 485 G-FCDEGLNRL-LVYEFMGNGTLANLL-----FAIPRPDWSLRVRI-SLEIARGLLYLHE 536
G F D ++ ++ +++ G L +LL F P + + E+ L YLH
Sbjct: 73 GTFQDA--QQIFMIMDYIEGGELFSLLRKSQRFPNPV------AKFYAAEVCLALEYLHS 124
Query: 537 ECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKN 596
+ II+ D+KP+NILLD++ KI+DFG +K T T + GT Y+APE
Sbjct: 125 -KD--IIYRDLKPENILLDKNGHIKITDFGFAKY---VPDVTYT-LCGTPDYIAPEVVST 177
Query: 597 VPVSAKVDVYSFGVVL 612
P + +D +SFG+++
Sbjct: 178 KPYNKSIDWWSFGILI 193
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 2e-17
Identities = 48/199 (24%), Positives = 87/199 (43%), Gaps = 23/199 (11%)
Query: 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQER-EREFKTEVSAIGR--THHKNLVQ 482
+LGRG + V++ + + V VK L + +++ +RE K I N++
Sbjct: 42 RKLGRGKYSEVFEAI-NITNNEKVVVKILKPVKKKKIKREIK-----ILENLRGGPNIIT 95
Query: 483 LLG-FCDEGLNRL-LVYEFMGNGTLANLLFAIPRPDWSLRVRISL-EIARGLLYLHEECN 539
L D LV+E + N L + D +R + EI + L Y H
Sbjct: 96 LADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYD----IRFYMYEILKALDYCHSMG- 150
Query: 540 VPIIHCDIKPQNILLDQDFTA-KISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVP 598
I+H D+KP N+++D + ++ D+GL++ Q V +R + PE +
Sbjct: 151 --IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRV--ASRYFKGPELLVDYQ 206
Query: 599 V-SAKVDVYSFGVVLLKII 616
+ +D++S G +L +I
Sbjct: 207 MYDYSLDMWSLGCMLASMI 225
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 8e-17
Identities = 58/202 (28%), Positives = 93/202 (46%), Gaps = 28/202 (13%)
Query: 428 LGRGSFGIVY--KGVLKSASGNAVAVKKLDK---LAQEREREF-KTEVSAIGRT-HHKNL 480
LG G++G V+ + + +G A+K L K + + + E +TE + L
Sbjct: 62 LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 121
Query: 481 VQLLG-FCDEGLNRL-LVYEFMGNGTLANLL-----FAIPRPDWSLRVRI-SLEIARGLL 532
V L F E +L L+ +++ G L L F V+I EI L
Sbjct: 122 VTLHYAFQTET--KLHLILDYINGGELFTHLSQRERFTEHE------VQIYVGEIVLALE 173
Query: 533 YLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPE 592
+LH+ II+ DIK +NILLD + ++DFGLSK ++D++ GT Y+AP+
Sbjct: 174 HLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPD 230
Query: 593 --WFKNVPVSAKVDVYSFGVVL 612
+ VD +S GV++
Sbjct: 231 IVRGGDSGHDKAVDWWSLGVLM 252
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 2e-16
Identities = 53/215 (24%), Positives = 84/215 (39%), Gaps = 42/215 (19%)
Query: 426 EELGRGSFGIVYKGVLKSASGNAVAVK-----KLDKLAQEREREF-----KTEVSAIGRT 475
+LG G F V+ + VA+K K+ A E E + + +
Sbjct: 25 RKLGWGHFSTVWL-AKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSM 83
Query: 476 HHKNLVQLLG-FCDEGLNRL---LVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIAR-- 529
++++LL F +G N + +V+E +G NLL I + I L +
Sbjct: 84 GANHILKLLDHFNHKGPNGVHVVMVFEVLG----ENLLALIKK---YEHRGIPLIYVKQI 136
Query: 530 ------GLLYLHEECNVPIIHCDIKPQNILLD------QDFTAKISDFGLSKLLLSDQSR 577
GL Y+H C IIH DIKP+N+L++ KI+D G +
Sbjct: 137 SKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNA----CWYDE 190
Query: 578 TRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVL 612
T TR Y +PE P D++S ++
Sbjct: 191 HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLI 225
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 2e-16
Identities = 52/188 (27%), Positives = 87/188 (46%), Gaps = 33/188 (17%)
Query: 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQERE-------REFKTEVSAIGRTHHK 478
++G+G+FG V+K + +G VA+KK+ + E+E RE + + H+
Sbjct: 23 AKIGQGTFGEVFKARHRK-TGQKVALKKV-LMENEKEGFPITALRE----IKILQLLKHE 76
Query: 479 NLVQLLGFCDEGLNRL--------LVYEFMGNGTLANLLFAIPRP-DWSLRVRISLEIAR 529
N+V L+ C + LV++F + LA LL + S R+ +
Sbjct: 77 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLN 135
Query: 530 GLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLL---LSDQSR--TRTVIRG 584
GL Y+H I+H D+K N+L+ +D K++DFGL++ + Q T V+
Sbjct: 136 GLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV-- 190
Query: 585 TRGYVAPE 592
T Y PE
Sbjct: 191 TLWYRPPE 198
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 3e-16
Identities = 55/204 (26%), Positives = 92/204 (45%), Gaps = 36/204 (17%)
Query: 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDK------LAQEREREFKTEVSAIGRTHHKN 479
+G G++G V + K SG VA+KKL + A+ RE + H+N
Sbjct: 30 THVGSGAYGSVCSAIDKR-SGEKVAIKKLSRPFQSEIFAKRAYRELLL----LKHMQHEN 84
Query: 480 LVQLL-----GFCDEGLNRL-LVYEFMGNGTLANLLFAIPRPDWSLRVRISL-EIARGLL 532
++ LL LV FM L ++ + +++ + ++ +GL
Sbjct: 85 VIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGLKFSEE---KIQYLVYQMLKGLK 140
Query: 533 YLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPE 592
Y+H V +H D+KP N+ +++D KI DFGL++ +D T V+ TR Y APE
Sbjct: 141 YIHS-AGV--VHRDLKPGNLAVNEDCELKILDFGLAR--HADAEMTGYVV--TRWYRAPE 193
Query: 593 ----WFKNVPVSAKVDVYSFGVVL 612
W + VD++S G ++
Sbjct: 194 VILSWMHY---NQTVDIWSVGCIM 214
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 80.2 bits (198), Expect = 4e-16
Identities = 52/233 (22%), Positives = 86/233 (36%), Gaps = 74/233 (31%)
Query: 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRT---------- 475
+GRGS+G VY K+ + VA+KK+ R F+ + R
Sbjct: 32 HLIGRGSYGYVYLAYDKN-TEKNVAIKKV-------NRMFEDLIDCK-RILREITILNRL 82
Query: 476 HHKNLVQLLG-FCDEGLNRL----LVYEFMGNGTLANLLFAIPRPDWSLRVRISLE---- 526
+++L + L + +V E + L L + I L
Sbjct: 83 KSDYIIRLYDLIIPDDLLKFDELYIVLEIADS-DLKKLF----------KTPIFLTEEHI 131
Query: 527 ------IARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRT 580
+ G ++HE + IH D+KP N LL+QD + K+ DFGL++ + S++
Sbjct: 132 KTILYNLLLGENFIHE-SGI--IHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIV 188
Query: 581 VIRG---------------------TRGYVAPE---WFKNVPVSAKVDVYSFG 609
TR Y APE +N + +D++S G
Sbjct: 189 NDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQEN--YTKSIDIWSTG 239
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 79.9 bits (197), Expect = 6e-16
Identities = 51/232 (21%), Positives = 90/232 (38%), Gaps = 67/232 (28%)
Query: 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKT---EVSAIGRTHHKNLVQ 482
+G GS+G V + K VA+KK+ + E + K E++ + R +H ++V+
Sbjct: 59 HLIGTGSYGHVCEAYDKL-EKRVVAIKKILR-VFEDLIDCKRILREIAILNRLNHDHVVK 116
Query: 483 LLGFC----DEGLNRL-LVYEFMGNGT-LANLLFAIPRPDWSLRVRISLE---------- 526
+L E + L +V E + L R + L
Sbjct: 117 VLDIVIPKDVEKFDELYVVLEIAD--SDFKKLF----------RTPVYLTELHIKTLLYN 164
Query: 527 IARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRG-- 584
+ G+ Y+H + +H D+KP N L++QD + K+ DFGL++ + ++ +
Sbjct: 165 LLVGVKYVHS-AGI--LHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPR 221
Query: 585 ------------------------TRGYVAPE---WFKNVPVSAKVDVYSFG 609
TR Y APE +N + +DV+S G
Sbjct: 222 EDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQEN--YTEAIDVWSIG 271
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 4e-15
Identities = 55/202 (27%), Positives = 88/202 (43%), Gaps = 27/202 (13%)
Query: 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLD-----KLAQEREREFKTEVSAIGRTHHKNL 480
+G G++G+V + VA+KK+ Q RE K + R H+N+
Sbjct: 33 SYIGEGAYGMVCSAYDNL-NKVRVAIKKISPFEHQTYCQRTLREIKI----LLRFRHENI 87
Query: 481 VQLLG-FCDEGLNRL----LVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLH 535
+ + + ++ +V + M L LL + + +I RGL Y+H
Sbjct: 88 IGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICY-FLYQILRGLKYIH 145
Query: 536 EECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSR----TRTVIRGTRGYVAP 591
NV +H D+KP N+LL+ KI DFGL+++ D T V TR Y AP
Sbjct: 146 S-ANV--LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA--TRWYRAP 200
Query: 592 EWFKNVPV-SAKVDVYSFGVVL 612
E N + +D++S G +L
Sbjct: 201 EIMLNSKGYTKSIDIWSVGCIL 222
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 8e-15
Identities = 49/206 (23%), Positives = 83/206 (40%), Gaps = 34/206 (16%)
Query: 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLD-----KLAQEREREFKTEVSAIGRTHHKNL 480
LG G++G+V K +G VA+KK++ A RE K + H+N+
Sbjct: 17 SLLGEGAYGVVCSATHKP-TGEIVAIKKIEPFDKPLFALRTLREIKI----LKHFKHENI 71
Query: 481 VQLLG-FCDEGLNRL----LVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLH 535
+ + + ++ E M L ++ D ++ + R + LH
Sbjct: 72 ITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVISTQMLSDDHIQY-FIYQTLRAVKVLH 129
Query: 536 EECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRG---------TR 586
NV IH D+KP N+L++ + K+ DFGL++++ + TR
Sbjct: 130 G-SNV--IHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATR 186
Query: 587 GYVAPE---WFKNVPVSAKVDVYSFG 609
Y APE S +DV+S G
Sbjct: 187 WYRAPEVMLTSAK--YSRAMDVWSCG 210
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 8e-15
Identities = 55/203 (27%), Positives = 95/203 (46%), Gaps = 33/203 (16%)
Query: 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDK------LAQEREREFKTEVSAIGRTHHKN 479
+ +G G++G V + +G VA+KKL + A+ RE + + H+N
Sbjct: 31 QPVGSGAYGAVCS-AVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRL----LKHMRHEN 85
Query: 480 LVQLL-----GFCDEGLNRL-LVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLY 533
++ LL + LV FMG L L+ + ++ + ++ +GL Y
Sbjct: 86 VIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKHEKLGEDRIQF-LVYQMLKGLRY 143
Query: 534 LHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPE- 592
+H + IH D+KP N+ +++D KI DFGL++ +D T V+ TR Y APE
Sbjct: 144 IHA-AGI--IHRDLKPGNLAVNEDCELKILDFGLAR--QADSEMTGYVV--TRWYRAPEV 196
Query: 593 ---WFKNVPVSAKVDVYSFGVVL 612
W + + VD++S G ++
Sbjct: 197 ILNWMRY---TQTVDIWSVGCIM 216
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 2e-14
Identities = 52/201 (25%), Positives = 88/201 (43%), Gaps = 49/201 (24%)
Query: 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDK------LAQE--RE----REFKTEVSAIG 473
++LG+G++GIV+K + +G VAVKK+ AQ RE E
Sbjct: 15 KKLGKGAYGIVWK-SIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELS------- 66
Query: 474 RTHHKNLVQLLG-FCDEGLNRL-LVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGL 531
H+N+V LL + + LV+++M L ++ A + + ++ + +
Sbjct: 67 --GHENIVNLLNVLRADNDRDVYLVFDYMET-DLHAVIRANILEPVHKQY-VVYQLIKVI 122
Query: 532 LYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRG------- 584
YLH + +H D+KP NILL+ + K++DFGLS+ ++ + T +
Sbjct: 123 KYLHS-GGL--LHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTEN 179
Query: 585 -------------TRGYVAPE 592
TR Y APE
Sbjct: 180 FDDDQPILTDYVATRWYRAPE 200
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 2e-14
Identities = 60/203 (29%), Positives = 94/203 (46%), Gaps = 33/203 (16%)
Query: 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDK------LAQEREREFKTEVSAIGRTHHKN 479
+G G++G V + +G VAVKKL + A+ RE + + H+N
Sbjct: 35 SPVGSGAYGSVCA-AFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL----LKHMKHEN 89
Query: 480 LVQLL-----GFCDEGLNRL-LVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLY 533
++ LL E N + LV MG L N++ D ++ + +I RGL Y
Sbjct: 90 VIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQKLTDDHVQF-LIYQILRGLKY 147
Query: 534 LHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPE- 592
+H + IIH D+KP N+ +++D KI DFGL++ + T V TR Y APE
Sbjct: 148 IH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTADEMTGYVA--TRWYRAPEI 200
Query: 593 ---WFKNVPVSAKVDVYSFGVVL 612
W + VD++S G ++
Sbjct: 201 MLNWMHY---NQTVDIWSVGCIM 220
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 2e-14
Identities = 55/212 (25%), Positives = 97/212 (45%), Gaps = 38/212 (17%)
Query: 426 EELGRGSFGIVYKGVLKSASGNAVAVKKL----DKLAQEREREFKTEVSAIGRTHHKNLV 481
+ LG G G+V+ V + VA+KK+ + + RE K I R H N+V
Sbjct: 17 KPLGCGGNGLVFSAV-DNDCDKRVAIKKIVLTDPQSVKHALREIKI----IRRLDHDNIV 71
Query: 482 QLL-------------GFCDEGLNRL-LVYEFMGNGT-LANLLFAIPRPDWSLRVRISLE 526
++ LN + +V E+M T LAN+L P + R+ +
Sbjct: 72 KVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME--TDLANVLEQGPLLEEHARL-FMYQ 128
Query: 527 IARGLLYLHEECNVPIIHCDIKPQNILLD-QDFTAKISDFGLSKLLLSDQSR----TRTV 581
+ RGL Y+H NV +H D+KP N+ ++ +D KI DFGL++++ S + +
Sbjct: 129 LLRGLKYIHS-ANV--LHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGL 185
Query: 582 IRGTRGYVAPEWFKNVPV-SAKVDVYSFGVVL 612
+ T+ Y +P + + +D+++ G +
Sbjct: 186 V--TKWYRSPRLLLSPNNYTKAIDMWAAGCIF 215
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 2e-14
Identities = 42/195 (21%), Positives = 74/195 (37%), Gaps = 44/195 (22%)
Query: 426 EELGRGSFGIVYKGVLKS-ASGNAVAVKKLDKLAQEREREFKTEVSAIGRT------HHK 478
++GRG++G VYK K A+K++ +SA H
Sbjct: 27 CKVGRGTYGHVYKAKRKDGKDDKDYALKQI--------EGTGISMSACREIALLRELKHP 78
Query: 479 NLVQLLG-FCDEGLNRL-LVYEFM-----------GNGTLANLLFAIPRPDWSLRVR-IS 524
N++ L F ++ L++++ +PR V+ +
Sbjct: 79 NVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGM----VKSLL 134
Query: 525 LEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTA----KISDFGLSKLLLSDQSRTRT 580
+I G+ YLH ++H D+KP NIL+ + KI+D G ++ L + +
Sbjct: 135 YQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR-LFNSPLKPLA 190
Query: 581 VIRG---TRGYVAPE 592
+ T Y APE
Sbjct: 191 DLDPVVVTFWYRAPE 205
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 7e-14
Identities = 51/221 (23%), Positives = 81/221 (36%), Gaps = 45/221 (20%)
Query: 426 EELGRGSFGIVYKGVLKSASGNAVAVK-----KLDKLAQEREREFKTEVSAIGRTHHKNL 480
+ +G+GSFG V K VA+K K E + + + N+
Sbjct: 103 KVIGKGSFGQVVK-AYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNV 161
Query: 481 VQLLGFCD---------E--GLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIAR 529
+ +L E +N +YE + + R + + I +
Sbjct: 162 IHMLENFTFRNHICMTFELLSMN---LYELIKKNKFQGFSLPLVR-------KFAHSILQ 211
Query: 530 GLLYLHEECNVPIIHCDIKPQNILLDQDFTA--KISDFGLSKLLLSDQSRTRTVIRGTRG 587
L LH+ IIHCD+KP+NILL Q + K+ DFG S + + +R
Sbjct: 212 CLDALHK-NR--IIHCDLKPENILLKQQGRSGIKVIDFGSS----CYEHQRVYTYIQSRF 264
Query: 588 YVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGE 628
Y APE +D++S G +L E+ G
Sbjct: 265 YRAPEVILGARYGMPIDMWSLGCIL---------AELLTGY 296
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 3e-13
Identities = 58/220 (26%), Positives = 86/220 (39%), Gaps = 41/220 (18%)
Query: 426 EELGRGSFGIVYKGVLKSASGNAVAVK-----KLDKLAQEREREFKTEVSAIGRTHHKNL 480
+G+GSFG V K VA+K K + E ++ +
Sbjct: 60 SLIGKGSFGQVVK-AYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYI 118
Query: 481 VQLLGF-------CDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRV--RISLEIARGL 531
V L C LV+E + L +LL SL + + + ++ L
Sbjct: 119 VHLKRHFMFRNHLC-------LVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTAL 170
Query: 532 LYLH-EECNVPIIHCDIKPQNILLDQDFTA--KISDFGLSKLLLSDQSRTRTVIRGTRGY 588
L+L E + IIHCD+KP+NILL + KI DFG S + +R Y
Sbjct: 171 LFLATPELS--IIHCDLKPENILLCNPKRSAIKIVDFGSS----CQLGQRIYQYIQSRFY 224
Query: 589 VAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGE 628
+PE +P +D++S G +L VEM GE
Sbjct: 225 RSPEVLLGMPYDLAIDMWSLGCIL---------VEMHTGE 255
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 67.3 bits (164), Expect = 4e-12
Identities = 30/101 (29%), Positives = 50/101 (49%), Gaps = 12/101 (11%)
Query: 521 VRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRT 580
+ S ++A+G+ +L IH D+ +NILL + KI DFGL++ + D
Sbjct: 196 ICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP----D 248
Query: 581 VIRGTRGYV-----APEWFKNVPVSAKVDVYSFGVVLLKII 616
+R + APE + + + DV+SFGV+L +I
Sbjct: 249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 289
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 64.2 bits (156), Expect = 5e-11
Identities = 42/153 (27%), Positives = 63/153 (41%), Gaps = 14/153 (9%)
Query: 424 FEEELGRGSFGIVYKGVL----KSASGNAVAVKKLDKLAQERER-EFKTEVS-AIGRTHH 477
+ LGRG+FG V + K+A+ VAVK L + A E +E+ I HH
Sbjct: 26 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 85
Query: 478 KNLVQLLGFC-DEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHE 536
N+V LLG C G +++ EF G L+ L S R +G +
Sbjct: 86 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL-------RSKRNEFVPYKTKGARFRQG 138
Query: 537 ECNVPIIHCDIKPQNILLDQDFTAKISDFGLSK 569
+ V I D+K + + ++ S F K
Sbjct: 139 KDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 9e-12
Identities = 46/205 (22%), Positives = 90/205 (43%), Gaps = 24/205 (11%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNAVAVK--KLDKLAQEREREFKTEVSAIGRTHHKNLV 481
+G GSFG++++G + VA+K A + E++T G T +
Sbjct: 14 VGRRIGEGSFGVIFEGT-NLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTG---IP 69
Query: 482 QLLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLR--VRISLEIARGLLYLHEECN 539
+ F EGL+ +LV + +G +L +LL R +S++ + ++ + +HE+
Sbjct: 70 NVYYFGQEGLHNVLVIDLLGP-SLEDLLDLCGRK-FSVKTVAMAAKQMLARVQSIHEKS- 126
Query: 540 VPIIHCDIKPQNILLDQDFTAK-----ISDFGLSKLLLSDQS------RTRTVIRGTRGY 588
+++ DIKP N L+ + + + DFG+ K + R + + GT Y
Sbjct: 127 --LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARY 184
Query: 589 VAPEWFKNVPVSAKVDVYSFGVVLL 613
++ S + D+ + G V +
Sbjct: 185 MSINTHLGREQSRRDDLEALGHVFM 209
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 2e-11
Identities = 35/154 (22%), Positives = 69/154 (44%), Gaps = 18/154 (11%)
Query: 425 EEELGRGSFGIVYKGVLKSASGNAVAVK--KLDKLAQEREREFKTEVSAIGRTHHKNLVQ 482
+++G G+FG + G + VA+K + A + E++ + Q
Sbjct: 14 GKKIGCGNFGELRLGK-NLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDG---IPQ 69
Query: 483 LLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLR--VRISLEIARGLLYLHEECNV 540
+ F G +V E +G +L +L R +SL+ + I++++ + Y+H +
Sbjct: 70 VYYFGPCGKYNAMVLELLGP-SLEDLFDLCDRT-FSLKTVLMIAIQLISRMEYVHSKN-- 125
Query: 541 PIIHCDIKPQNILLDQDFTAK-----ISDFGLSK 569
+I+ D+KP+N L+ + I DF L+K
Sbjct: 126 -LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 63.7 bits (154), Expect = 5e-11
Identities = 25/190 (13%), Positives = 48/190 (25%), Gaps = 51/190 (26%)
Query: 426 EELGRGSFGIVYKGVLKSASGNAVAVKKL--------DKLAQEREREFKTEV-------- 469
E++G G FG V++ + VA+K + + Q+ E E+
Sbjct: 26 EKIGEGVFGEVFQTIAD---HTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSL 82
Query: 470 -SAIGRTHHKNLVQLLGFC-----------------------------DEGLNRLLVYEF 499
S + + L ++L +
Sbjct: 83 LSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLE 142
Query: 500 MGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFT 559
G + + I ++ L H D+ N+LL +
Sbjct: 143 FEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLR--FEHRDLHWGNVLLKKTSL 200
Query: 560 AKISDFGLSK 569
K+ K
Sbjct: 201 KKLHYTLNGK 210
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 3e-10
Identities = 29/167 (17%), Positives = 64/167 (38%), Gaps = 26/167 (15%)
Query: 425 EEELGRGSFGIVYKGV------LKSASGNA-VAVK------KLDKLAQEREREFKTEVSA 471
+ R + GI+Y+ S ++K +L +R K
Sbjct: 47 KSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVN 106
Query: 472 IGRTHHKNLV----QLLGF-CDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLR--VRIS 524
+ + + +GF + R LV +G +L + L P+ S R ++++
Sbjct: 107 KWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGR-SLQSALDVSPKHVLSERSVLQVA 165
Query: 525 LEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKI--SDFGLSK 569
+ L +LHE +H ++ +NI +D + +++ + +G +
Sbjct: 166 CRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 5e-10
Identities = 49/202 (24%), Positives = 85/202 (42%), Gaps = 22/202 (10%)
Query: 425 EEELGRGSFGIVYKGVLKSASGNAVAVK--KLDKLAQEREREFKTEVSAIGRTHHKNLVQ 482
++G GSFG +Y G A+G VA+K + + E K + +
Sbjct: 14 GRKIGSGSFGDIYLGT-DIAAGEEVAIKLECVKTKHPQLHIESKI-YKMMQGGVG--IPT 69
Query: 483 LLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLR--VRISLEIARGLLYLHEECNV 540
+ EG ++V E +G +L +L R +SL+ + ++ ++ + Y+H +
Sbjct: 70 IRWCGAEGDYNVMVMELLGP-SLEDLFNFCSR-KFSLKTVLLLADQMISRIEYIHSKN-- 125
Query: 541 PIIHCDIKPQNILLDQDFTAK---ISDFGLSKLLLSDQS------RTRTVIRGTRGYVAP 591
IH D+KP N L+ I DFGL+K ++ R + GT Y +
Sbjct: 126 -FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASI 184
Query: 592 EWFKNVPVSAKVDVYSFGVVLL 613
+ S + D+ S G VL+
Sbjct: 185 NTHLGIEQSRRDDLESLGYVLM 206
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 61.6 bits (149), Expect = 5e-10
Identities = 50/202 (24%), Positives = 84/202 (41%), Gaps = 22/202 (10%)
Query: 425 EEELGRGSFGIVYKGVLKSASGNAVAVK--KLDKLAQEREREFKTEVSAIGRTHHKNLVQ 482
++G GSFG +Y G + VA+K + + E K G T +
Sbjct: 12 GRKIGSGSFGEIYLGT-NIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTG---IPN 67
Query: 483 LLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLR--VRISLEIARGLLYLHEECNV 540
+ F EG +LV + +G +L +L R SL+ + ++ ++ + ++H +
Sbjct: 68 VRWFGVEGDYNVLVMDLLGP-SLEDLFNFCSRK-LSLKTVLMLADQMINRVEFVHSKS-- 123
Query: 541 PIIHCDIKPQNILLDQDFTAK---ISDFGLSKLLLSDQS------RTRTVIRGTRGYVAP 591
+H DIKP N L+ A I DFGL+K + R + GT Y +
Sbjct: 124 -FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASV 182
Query: 592 EWFKNVPVSAKVDVYSFGVVLL 613
+ S + D+ S G VL+
Sbjct: 183 NTHLGIEQSRRDDLESLGYVLM 204
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 1e-09
Identities = 46/238 (19%), Positives = 80/238 (33%), Gaps = 61/238 (25%)
Query: 426 EELGRGSFGIVYKGVLKSASGNAVAVK---KLDKLAQEREREFK--TEVSAIGRTHHKNL 480
LG G+FG V + + + + VA+K + K + E ++ + +
Sbjct: 25 GNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLC 84
Query: 481 VQLLGFCD---------E--GLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIAR 529
V + + + E G N +EF+ R ++ ++
Sbjct: 85 VLMSDWFNFHGHMCIAFELLGKN---TFEFLKENNFQPYPLPHVR-------HMAYQLCH 134
Query: 530 GLLYLHEECNVPIIHCDIKPQNILLDQDFTA-------------------KISDFGLSKL 570
L +LHE + H D+KP+NIL +++DFG +
Sbjct: 135 ALRFLHE-NQ--LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA-- 189
Query: 571 LLSDQSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGE 628
+ T I TR Y PE + + DV+S G +L E G
Sbjct: 190 --TFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCIL---------FEYYRGF 236
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 58.8 bits (142), Expect = 3e-09
Identities = 51/251 (20%), Positives = 79/251 (31%), Gaps = 70/251 (27%)
Query: 428 LGRGSFGIVYKGVLKSASGNAVAVK-----KLDKLAQEREREFKTEVSAIGRTH--HKNL 480
LG G F V+ VA+K + E V + +
Sbjct: 45 LGWGHFSTVWL-SWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMV 103
Query: 481 VQLLG-FCDEGLN---RLLVYEFMGNGTLANLLFAIPRPDWSLRV--RISLEIARGLLYL 534
VQLL F G+N +V+E +G+ L + L +I ++ +GL YL
Sbjct: 104 VQLLDDFKISGVNGTHICMVFEVLGH-HLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYL 162
Query: 535 HEECNVPIIHCDIKPQNILL---------------------------------------- 554
H +C IIH DIKP+NILL
Sbjct: 163 HTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNF 220
Query: 555 ---------DQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPVSAKVDV 605
+ KI+D G + + T TR Y + E + D+
Sbjct: 221 LVNPLEPKNAEKLKVKIADLGNA----CWVHKHFTEDIQTRQYRSLEVLIGSGYNTPADI 276
Query: 606 YSFGVVLLKII 616
+S + ++
Sbjct: 277 WSTACMAFELA 287
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 4e-09
Identities = 53/250 (21%), Positives = 84/250 (33%), Gaps = 81/250 (32%)
Query: 426 EELGRGSFGIVYKGVLKSASGNAVAVK-----------------KLDKLAQEREREFKTE 468
++G G+FG V + AVK L K+ +
Sbjct: 41 RKMGDGTFGRVLL-CQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNI- 98
Query: 469 VSAIGRTHHKN---LV-QLLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVR-I 523
V G+ + + L+ + LG +YE + N ++
Sbjct: 99 VKYHGKFMYYDHMCLIFEPLGPS--------LYEIITR----NNYNGFHIE----DIKLY 142
Query: 524 SLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTA----------------------- 560
+EI + L YL + + + H D+KP+NILLD +
Sbjct: 143 CIEILKALNYLRK-MS--LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKST 199
Query: 561 --KISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICC 618
K+ DFG + + +S I TR Y APE N+ D++SFG VL
Sbjct: 200 GIKLIDFGCA----TFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVL------ 249
Query: 619 KRSVEMELGE 628
E+ G
Sbjct: 250 ---AELYTGS 256
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 4e-09
Identities = 34/164 (20%), Positives = 60/164 (36%), Gaps = 23/164 (14%)
Query: 425 EEELGRGSFGIVYKGV-LKSASGNAVAVKKLDKLAQER-EREFKTE-----VSAIGRTHH 477
+++G G FG++Y +A V K++ E K I +
Sbjct: 42 GKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIE 101
Query: 478 KNLVQLLGF----------CDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEI 527
+ + LG R +V E +G L + S +++ + +
Sbjct: 102 RKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGI-DLQKISGQNGTFKKSTVLQLGIRM 160
Query: 528 ARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKI--SDFGLSK 569
L Y+HE +H DIK N+LL ++ +D+GLS
Sbjct: 161 LDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 9e-09
Identities = 54/239 (22%), Positives = 89/239 (37%), Gaps = 63/239 (26%)
Query: 426 EELGRGSFGIVYKGVLKSASGNAVAVK---KLDKLAQEREREFK--TEVSAIGRTHHKNL 480
+ LG G+FG V + + A G VAVK +D+ + E + ++
Sbjct: 20 DTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRC 79
Query: 481 VQLLGFCD---------E--GLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVR-ISLEIA 528
VQ+L + + E GL+ Y+F+ N +R ++ +I
Sbjct: 80 VQMLEWFEHHGHICIVFELLGLS---TYDFIKE----NGFLPFRLD----HIRKMAYQIC 128
Query: 529 RGLLYLHEECNVPIIHCDIKPQNILLDQDFTA-------------------KISDFGLSK 569
+ + +LH + H D+KP+NIL Q K+ DFG +
Sbjct: 129 KSVNFLHS-NK--LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA- 184
Query: 570 LLLSDQSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGE 628
+ + + TR Y APE + S DV+S G +L +E LG
Sbjct: 185 ---TYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCIL---------IEYYLGF 231
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 55.2 bits (133), Expect = 3e-08
Identities = 42/219 (19%), Positives = 81/219 (36%), Gaps = 34/219 (15%)
Query: 428 LGRGSFGIVYKGVLKS----ASGNAVAVKKLDKLAQEREREFKT-----EVSAIGRTHHK 478
+G+G FG +Y + S S VK E K + I +
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102
Query: 479 NLVQLLGFC----------DEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLR--VRISLE 526
++ LG + R ++ + G+ L + A + +S + +++SL
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGS-DLQKIYEANAKR-FSRKTVLQLSLR 160
Query: 527 IARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKI--SDFGLSKLLLSDQS------RT 578
I L Y+HE +H DIK N+LL+ ++ D+GL+ +
Sbjct: 161 ILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADP 217
Query: 579 RTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC 617
+ GT + + + V S + D+ G +++ +
Sbjct: 218 KRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLT 256
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* Length = 276 | Back alignment and structure |
|---|
Score = 42.3 bits (98), Expect = 3e-04
Identities = 22/117 (18%), Positives = 36/117 (30%), Gaps = 20/117 (17%)
Query: 16 LLPFLSAAN--IPLGSTLSSTSNNSSWISPSRDFAFGFRQLNNNSDLFLLAIWFNKMPER 73
+PF +P TLS+ +SP++ F + N L I N
Sbjct: 6 RIPFNGVGTSVLPAYQTLSA---GQYLLSPNQRFKLLLQGDGN------LVIQDNGAT-- 54
Query: 74 TIIWHANEDNH-----PVLAPRGSTLELTATGLLLKDPGGQAIWDEKPNKISFKSPT 125
+W ANE P+ + G L D + +W + +
Sbjct: 55 --VWVANEQQPFSSTIPLRNKKAPLAFYVQYGAFLDDYSRRRVWLTDNSTFTSNDQW 109
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 714 | |||
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 99.96 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.91 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 99.88 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.86 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.74 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 99.73 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.61 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 99.51 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 99.51 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 99.47 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 99.26 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.23 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 99.15 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.02 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.97 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 98.96 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 98.89 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.85 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 98.55 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.44 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 98.4 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.38 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.36 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.3 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.2 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.1 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.91 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.78 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.73 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.66 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.42 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 97.36 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.12 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.12 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 97.12 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.1 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.05 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.03 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 97.0 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 96.92 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.84 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.82 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 96.78 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.71 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 96.56 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.51 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.4 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 96.35 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.28 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 96.14 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 95.16 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.58 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 92.7 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 92.56 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 92.36 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 91.59 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 88.72 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 84.23 | |
| 1edm_B | 39 | Factor IX; epidermal growth factor, EGF, calcium- | 83.54 |
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-53 Score=439.77 Aligned_cols=263 Identities=25% Similarity=0.344 Sum_probs=215.1
Q ss_pred HHHHHHhhhhhhhhCcccceeEEEeEee----CCCCcEEEEEEecccc-hhhHHHHHHHHHHHhccCcccccceeceEec
Q 041576 415 VELNEATNGFEEELGRGSFGIVYKGVLK----SASGNAVAVKKLDKLA-QEREREFKTEVSAIGRTHHKNLVQLLGFCDE 489 (714)
Q Consensus 415 ~el~~at~~~~~~ig~G~~g~Vy~~~~~----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~ 489 (714)
.|+..++..|.++||+|+||+||+|.+. ..+++.||||+++... ....++|.+|+.++++++|||||+++|+|.+
T Consensus 21 ~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~ 100 (308)
T 4gt4_A 21 KEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTK 100 (308)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEE
Confidence 3455567788999999999999999873 2356789999997533 3446789999999999999999999999999
Q ss_pred CCeeeEEEeecCCCchhhhhhcC----------------CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEE
Q 041576 490 GLNRLLVYEFMGNGTLANLLFAI----------------PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNIL 553 (714)
Q Consensus 490 ~~~~~lv~E~~~~gsL~~~l~~~----------------~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIl 553 (714)
++..+|||||+++|+|.++|... ..+++.++++|+.|||+||+|||+++ ||||||||+|||
T Consensus 101 ~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NIL 177 (308)
T 4gt4_A 101 DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVL 177 (308)
T ss_dssp SSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred CCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceE
Confidence 99999999999999999999643 24789999999999999999999998 999999999999
Q ss_pred ECCCCceEEecCCCccccccCcc-cceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccchhh
Q 041576 554 LDQDFTAKISDFGLSKLLLSDQS-RTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEERS 631 (714)
Q Consensus 554 l~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~ 631 (714)
|++++.+||+|||+++.+..... .......||+.|+|||++.+..++.++|||||||+||||+| |+.||......+.
T Consensus 178 l~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~- 256 (308)
T 4gt4_A 178 VYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV- 256 (308)
T ss_dssp ECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHH-
T ss_pred ECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHH-
Confidence 99999999999999987654332 23344578999999999999999999999999999999998 8999975543321
Q ss_pred hhhhHHHhhhhhcCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccC
Q 041576 632 AILTDWAYDCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLE 697 (714)
Q Consensus 632 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 697 (714)
+ .....+.... .+...+..+.+++.+||+.||++||||+||++.|+.+..
T Consensus 257 --~-----~~i~~~~~~~---------~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~n 306 (308)
T 4gt4_A 257 --V-----EMIRNRQVLP---------CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWGN 306 (308)
T ss_dssp --H-----HHHHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCC
T ss_pred --H-----HHHHcCCCCC---------CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhccC
Confidence 1 1112221111 122344578889999999999999999999999997654
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-53 Score=438.90 Aligned_cols=259 Identities=26% Similarity=0.413 Sum_probs=213.8
Q ss_pred HhhhhhhhhCcccceeEEEeEeeC----CCCcEEEEEEecccchhhHHHHHHHHHHHhccCcccccceeceEecCCeeeE
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKS----ASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLL 495 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 495 (714)
..+.+.++||+|+||+||+|++.. .+++.||||+++.......++|.+|+++|++++|||||+++|+|.+++..+|
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 445677899999999999998752 3577899999988777777899999999999999999999999999999999
Q ss_pred EEeecCCCchhhhhhcC-------------CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEE
Q 041576 496 VYEFMGNGTLANLLFAI-------------PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKI 562 (714)
Q Consensus 496 v~E~~~~gsL~~~l~~~-------------~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl 562 (714)
||||+++|+|.++|+.. ..+++.+++.|+.||++||+|||+++ |+||||||+||||++++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEE
Confidence 99999999999999753 36899999999999999999999998 999999999999999999999
Q ss_pred ecCCCccccccCcccc-eeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccchhhhhhhHHHhh
Q 041576 563 SDFGLSKLLLSDQSRT-RTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEERSAILTDWAYD 640 (714)
Q Consensus 563 ~Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~l~~~~~~ 640 (714)
+|||+++......... .....||+.|+|||++.+..++.++|||||||+||||+| |+.||......+. +.
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~---~~----- 241 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEV---IE----- 241 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH---HH-----
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH---HH-----
Confidence 9999998764433222 223468999999999999999999999999999999999 8999976543321 11
Q ss_pred hhhcCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCC
Q 041576 641 CYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLEV 698 (714)
Q Consensus 641 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 698 (714)
....+.... .+...+.++.+++.+||+.||++||||+||++.|+++.+.
T Consensus 242 ~i~~~~~~~---------~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 242 CITQGRVLQ---------RPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp HHHHTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHcCCCCC---------CCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 111221111 1223445788899999999999999999999999987653
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-52 Score=440.18 Aligned_cols=258 Identities=26% Similarity=0.413 Sum_probs=207.7
Q ss_pred hhhhhhhhCcccceeEEEeEeeC----CCCcEEEEEEecccchhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEE
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKS----ASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLV 496 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 496 (714)
...+.++||+|+||+||+|+++. .+++.||||+++.......++|.+|+++|++++|||||+++|+|.+++..+||
T Consensus 42 d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV 121 (329)
T 4aoj_A 42 DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMV 121 (329)
T ss_dssp GEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEE
T ss_pred HeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 34566899999999999998752 35789999999887777778999999999999999999999999999999999
Q ss_pred EeecCCCchhhhhhcC---------------CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceE
Q 041576 497 YEFMGNGTLANLLFAI---------------PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAK 561 (714)
Q Consensus 497 ~E~~~~gsL~~~l~~~---------------~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~k 561 (714)
|||+++|+|.++++.. ..+++.+++.|+.||++||+|||+++ ||||||||+||||++++.+|
T Consensus 122 ~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~K 198 (329)
T 4aoj_A 122 FEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVVK 198 (329)
T ss_dssp EECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEE
T ss_pred EEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcEE
Confidence 9999999999999753 34789999999999999999999998 99999999999999999999
Q ss_pred EecCCCccccccCcc-cceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccchhhhhhhHHHh
Q 041576 562 ISDFGLSKLLLSDQS-RTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEERSAILTDWAY 639 (714)
Q Consensus 562 l~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~l~~~~~ 639 (714)
|+|||+++....... .......||+.|||||++.+..++.++|||||||+||||+| |+.||......+. +
T Consensus 199 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~---~----- 270 (329)
T 4aoj_A 199 IGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEA---I----- 270 (329)
T ss_dssp ECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHH---H-----
T ss_pred EcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHH---H-----
Confidence 999999987654332 23344679999999999999999999999999999999999 8999975443221 1
Q ss_pred hhhhcCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCC
Q 041576 640 DCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLEV 698 (714)
Q Consensus 640 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 698 (714)
.....+... ..+...+.++.+|+.+||+.||++||||+||++.|+.+.+.
T Consensus 271 ~~i~~g~~~---------~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 271 DCITQGREL---------ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp HHHHHTCCC---------CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred HHHHcCCCC---------CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 111111111 11223345788899999999999999999999999998765
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-51 Score=427.54 Aligned_cols=264 Identities=27% Similarity=0.385 Sum_probs=204.4
Q ss_pred HHhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecc--cchhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEE
Q 041576 419 EATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDK--LAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLV 496 (714)
Q Consensus 419 ~at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 496 (714)
.....+.++||+|+||+||+|+++ ..||||+++. ......+.|.+|++++++++|||||++++++.+ +..+||
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~----~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iV 109 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWH----GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIV 109 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESS----SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEEC----CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEE
Confidence 344567789999999999999874 3699999864 334556789999999999999999999999865 568999
Q ss_pred EeecCCCchhhhhhcC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCc
Q 041576 497 YEFMGNGTLANLLFAI-PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQ 575 (714)
Q Consensus 497 ~E~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 575 (714)
|||+++|+|.++|+.. ..+++.+++.|+.|||+||+|||+++ ||||||||+||||++++.+||+|||+|+......
T Consensus 110 mEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~ 186 (307)
T 3omv_A 110 TQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWS 186 (307)
T ss_dssp EECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC-----
T ss_pred EEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccCC
Confidence 9999999999999754 57999999999999999999999998 9999999999999999999999999998764432
Q ss_pred -ccceeeecCCCCccCcccccC---CCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceee
Q 041576 576 -SRTRTVIRGTRGYVAPEWFKN---VPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLV 651 (714)
Q Consensus 576 -~~~~~~~~gt~~y~aPE~~~~---~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 651 (714)
........||+.|||||++.+ ..++.++|||||||+||||+||+.||........ +... ...+...
T Consensus 187 ~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~---~~~~----~~~~~~~--- 256 (307)
T 3omv_A 187 GSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQ---IIFM----VGRGYAS--- 256 (307)
T ss_dssp -------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH---HHHH----HHTTCCC---
T ss_pred cceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHH---HHHH----HhcCCCC---
Confidence 223345679999999999963 4689999999999999999999999975432221 1111 1111110
Q ss_pred cchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCCCCCCC
Q 041576 652 DNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLEVPSPPM 703 (714)
Q Consensus 652 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~pp~ 703 (714)
+.. ...+...+..+.+++.+||+.||++||||.||++.|+.+ +.+.|+.
T Consensus 257 -p~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l-~~~lpk~ 305 (307)
T 3omv_A 257 -PDL-SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELL-QHSLPKI 305 (307)
T ss_dssp -CCS-TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHH-HTTCCC-
T ss_pred -CCc-ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH-hccCCCC
Confidence 000 011223445788899999999999999999999999754 4444543
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-50 Score=422.35 Aligned_cols=251 Identities=25% Similarity=0.247 Sum_probs=205.8
Q ss_pred hhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEeecC
Q 041576 422 NGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEFMG 501 (714)
Q Consensus 422 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~ 501 (714)
+.+.++||+|+||.||+|+++ .+|+.||||+++... ...+|+.++++++|||||++++++.+++..||||||++
T Consensus 60 ~~~~~~lG~G~fG~Vy~a~~~-~~g~~vAiK~i~~~~-----~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~ 133 (336)
T 4g3f_A 60 MTHQPRVGRGSFGEVHRMKDK-QTGFQCAVKKVRLEV-----FRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLE 133 (336)
T ss_dssp EEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEETTT-----CCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred eEeCcEeccCCCeEEEEEEEC-CCCCEEEEEEECHHH-----hHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccC
Confidence 455678999999999999976 578999999996532 22579999999999999999999999999999999999
Q ss_pred CCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCC-ceEEecCCCccccccCccc---
Q 041576 502 NGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDF-TAKISDFGLSKLLLSDQSR--- 577 (714)
Q Consensus 502 ~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~-~~kl~Dfg~~~~~~~~~~~--- 577 (714)
+|+|.++|.....+++.++..++.||+.||+|||+++ |+||||||+||||+.++ ++||+|||+++.+..+...
T Consensus 134 gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~ 210 (336)
T 4g3f_A 134 GGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSL 210 (336)
T ss_dssp TCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC---------
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccce
Confidence 9999999998888999999999999999999999998 99999999999999987 6999999999977543321
Q ss_pred -ceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhh
Q 041576 578 -TRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKA 656 (714)
Q Consensus 578 -~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 656 (714)
......||+.|||||++.+..++.++|||||||+||||+||+.||...........+. .+.. ..
T Consensus 211 ~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~--------~~~~-------~~ 275 (336)
T 4g3f_A 211 LTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIA--------SEPP-------PI 275 (336)
T ss_dssp ---CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHH--------HSCC-------GG
T ss_pred ecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHH--------cCCC-------Cc
Confidence 2233579999999999999999999999999999999999999997554332111110 1100 00
Q ss_pred hccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 041576 657 AMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYL 696 (714)
Q Consensus 657 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 696 (714)
...+...+..+.+++.+||+.||++|||+.|+++.|...+
T Consensus 276 ~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l 315 (336)
T 4g3f_A 276 REIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKAL 315 (336)
T ss_dssp GGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence 1122334567888999999999999999999999887654
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-50 Score=424.96 Aligned_cols=250 Identities=25% Similarity=0.343 Sum_probs=209.6
Q ss_pred hhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEeec
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEFM 500 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~ 500 (714)
.|.+.++||+|+||+||+|+++ .+|+.||||+++.......+.+.+|+++|++++|||||++++++.+++..||||||+
T Consensus 75 ~y~~~~~iG~G~fG~V~~a~~~-~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 75 YLDNFIKIGEGSTGIVCIATVR-SSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp TEEEEEEEEECSSCEEEEEEET-TTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hcEEeEEeecCcCeEEEEEEEC-CCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 4667789999999999999976 578999999997655555667899999999999999999999999999999999999
Q ss_pred CCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCccccee
Q 041576 501 GNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRT 580 (714)
Q Consensus 501 ~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 580 (714)
++|+|.+++.. ..+++.++..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.+..... ...
T Consensus 154 ~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~-~~~ 228 (346)
T 4fih_A 154 EGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRK 228 (346)
T ss_dssp TTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-CBC
T ss_pred CCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCCC-ccc
Confidence 99999999976 56899999999999999999999998 99999999999999999999999999987654332 234
Q ss_pred eecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhhccc
Q 041576 581 VIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMAD 660 (714)
Q Consensus 581 ~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 660 (714)
...||+.|+|||++.+..|+.++|||||||++|||++|+.||......+....+ .......+ ...
T Consensus 229 ~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i--------~~~~~~~~-------~~~ 293 (346)
T 4fih_A 229 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI--------RDNLPPRL-------KNL 293 (346)
T ss_dssp CCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH--------HHSSCCCC-------SCG
T ss_pred ccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHH--------HcCCCCCC-------Ccc
Confidence 567999999999999999999999999999999999999999755333211111 11110000 011
Q ss_pred hHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 661 KSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 661 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
...+..+.+|+.+||+.||++|||++|+++.
T Consensus 294 ~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 294 HKVSPSLKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 2234577889999999999999999999873
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=411.96 Aligned_cols=247 Identities=28% Similarity=0.397 Sum_probs=200.5
Q ss_pred hhhhhhCcccceeEEEeEeeCCCCcEEEEEEeccc--chhhHHHHHHHHHHHhccCcccccceeceEec----CCeeeEE
Q 041576 423 GFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKL--AQEREREFKTEVSAIGRTHHKNLVQLLGFCDE----GLNRLLV 496 (714)
Q Consensus 423 ~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~----~~~~~lv 496 (714)
.+.++||+|+||+||+|.+. .+++.||+|++... .....+.|.+|++++++++|||||++++++.+ +...+||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~-~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDT-ETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEEC-CCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 56778999999999999976 57899999999643 34456789999999999999999999999864 3557999
Q ss_pred EeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECC-CCceEEecCCCccccccCc
Q 041576 497 YEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQ-DFTAKISDFGLSKLLLSDQ 575 (714)
Q Consensus 497 ~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~-~~~~kl~Dfg~~~~~~~~~ 575 (714)
|||+++|+|.+++.....+++..+..++.||+.||+|||+++ ++|+||||||+||||+. ++.+||+|||+|+....
T Consensus 108 mEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~-- 184 (290)
T 3fpq_A 108 TELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA-- 184 (290)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT--
T ss_pred EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCCC--
Confidence 999999999999998888999999999999999999999985 46999999999999984 79999999999985432
Q ss_pred ccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchh
Q 041576 576 SRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDK 655 (714)
Q Consensus 576 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 655 (714)
.......||+.|||||++.+ .++.++|||||||+||||+||+.||....... .+ ......+....
T Consensus 185 -~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~---~~----~~~i~~~~~~~------ 249 (290)
T 3fpq_A 185 -SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA---QI----YRRVTSGVKPA------ 249 (290)
T ss_dssp -TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH---HH----HHHHTTTCCCG------
T ss_pred -CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHH---HH----HHHHHcCCCCC------
Confidence 23345679999999999875 69999999999999999999999996432221 11 11111111110
Q ss_pred hhccchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 656 AAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 656 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
..+...+.++.+|+.+||+.||++|||++|+++
T Consensus 250 --~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 250 --SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp --GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred --CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111222346788999999999999999999986
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-50 Score=422.92 Aligned_cols=248 Identities=23% Similarity=0.331 Sum_probs=201.7
Q ss_pred hhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEeccc--chhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEe
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKL--AQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYE 498 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E 498 (714)
+|.+.++||+|+||+||+|+++ .+|+.||||+++.. .....+.+.+|++++++++|||||++++++.+++..|||||
T Consensus 25 ~Y~~~~~lG~G~fg~V~~a~~~-~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 25 KYVRLQKIGEGSFGKAILVKST-EDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CEEEEEEC------CEEEEEET-TTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ceEEeEEEecCCCeEEEEEEEC-CCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 5778899999999999999976 57899999999643 34456789999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcC--CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcc
Q 041576 499 FMGNGTLANLLFAI--PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQS 576 (714)
Q Consensus 499 ~~~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 576 (714)
|+++|+|.++|... ..+++.+++.|+.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.+.....
T Consensus 104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~ 180 (350)
T 4b9d_A 104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVE 180 (350)
T ss_dssp CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHHHH
T ss_pred CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCCcc
Confidence 99999999999754 34688899999999999999999998 99999999999999999999999999987643221
Q ss_pred cceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhh
Q 041576 577 RTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKA 656 (714)
Q Consensus 577 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 656 (714)
......||+.|+|||++.+..++.++|||||||+||||++|+.||......+. +.. ...+....
T Consensus 181 -~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~---~~~-----i~~~~~~~------- 244 (350)
T 4b9d_A 181 -LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNL---VLK-----IISGSFPP------- 244 (350)
T ss_dssp -HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHH-----HHHTCCCC-------
T ss_pred -cccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH---HHH-----HHcCCCCC-------
Confidence 22345799999999999999999999999999999999999999976543321 111 11111111
Q ss_pred hccchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 657 AMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 657 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
.+...+..+.+|+.+||+.||++|||++|+++
T Consensus 245 --~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 245 --VSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp --CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --CCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11223456888999999999999999999986
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-50 Score=416.79 Aligned_cols=247 Identities=24% Similarity=0.289 Sum_probs=210.3
Q ss_pred hhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEeccc---chhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEE
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKL---AQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVY 497 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 497 (714)
.|.+.+.||+|+||+||+|+.+ .+++.||||++.+. .....+.+.+|+++|++++|||||++++++.+++..||||
T Consensus 33 dy~i~~~lG~G~fg~V~~a~~~-~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 33 DFKFGKILGEGSFSTVVLAREL-ATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEEEecccCeEEEEEEEC-CCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 4888899999999999999976 57899999999753 2344678999999999999999999999999999999999
Q ss_pred eecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcc-
Q 041576 498 EFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQS- 576 (714)
Q Consensus 498 E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~- 576 (714)
||+++|+|.+++...+.+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.+.....
T Consensus 112 Ey~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~ 188 (311)
T 4aw0_A 112 SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 188 (311)
T ss_dssp CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTC
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCc
Confidence 99999999999998889999999999999999999999998 99999999999999999999999999998754433
Q ss_pred cceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhh
Q 041576 577 RTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKA 656 (714)
Q Consensus 577 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 656 (714)
......+||+.|+|||++.+..++.++||||+||+||||++|+.||......+.... ...+...
T Consensus 189 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~--------i~~~~~~-------- 252 (311)
T 4aw0_A 189 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAK--------IIKLEYD-------- 252 (311)
T ss_dssp CCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH--------HHHTCCC--------
T ss_pred ccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH--------HHcCCCC--------
Confidence 334456899999999999999999999999999999999999999976543321111 1111111
Q ss_pred hccchHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 041576 657 AMADKSRACKWLMIALWCIQEDPLKRPAMKMIV 689 (714)
Q Consensus 657 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl 689 (714)
.+...+.++.+|+.+||+.||++|||++|++
T Consensus 253 --~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 253 --FPEKFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp --CCTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred --CCcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 1112345678899999999999999999863
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-49 Score=403.55 Aligned_cols=246 Identities=24% Similarity=0.357 Sum_probs=193.9
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEeccc---chhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEE
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKL---AQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLV 496 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 496 (714)
..|.+.+.||+|+||+||+|+.+ .+++.||||++++. .......+.+|++++++++||||+++++++.+++..|+|
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~-~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHT-TTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV 91 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECT-TTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEEC-CCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 36888899999999999999876 57899999999653 233456799999999999999999999999999999999
Q ss_pred EeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcc
Q 041576 497 YEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQS 576 (714)
Q Consensus 497 ~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 576 (714)
|||+ +|+|.+++.....+++.++..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++......
T Consensus 92 mEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~- 166 (275)
T 3hyh_A 92 IEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN- 166 (275)
T ss_dssp EECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC--------
T ss_pred EeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCCC-
Confidence 9999 6799999998889999999999999999999999998 9999999999999999999999999998654322
Q ss_pred cceeeecCCCCccCcccccCCCC-CchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchh
Q 041576 577 RTRTVIRGTRGYVAPEWFKNVPV-SAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDK 655 (714)
Q Consensus 577 ~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 655 (714)
......||+.|+|||++.+..+ +.++||||+||++|||+||+.||........ +. ....+...
T Consensus 167 -~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~---~~-----~i~~~~~~------- 230 (275)
T 3hyh_A 167 -FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVL---FK-----NISNGVYT------- 230 (275)
T ss_dssp ---------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HH-----HHHHTCCC-------
T ss_pred -ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHH---HH-----HHHcCCCC-------
Confidence 2334679999999999998876 5799999999999999999999975433221 11 11111111
Q ss_pred hhccchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 656 AAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 656 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
.+...+..+.+++.+||+.||++|||++|+++
T Consensus 231 ---~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 231 ---LPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp ---CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ---CCCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 11123456788999999999999999999987
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-49 Score=425.51 Aligned_cols=250 Identities=25% Similarity=0.338 Sum_probs=209.5
Q ss_pred hhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEeec
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEFM 500 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~ 500 (714)
.|.+.++||+|+||.||+|+++ .+|+.||||++........+.+.+|+++|++++|||||++++++.+++..|||||||
T Consensus 152 ~y~~~~~iG~G~fG~V~~a~~~-~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 152 YLDNFIKIGEGSTGIVCIATVR-SSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp TEEEEEEEEECSSCEEEEEEET-TTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hcEeeeEeccCcCcEEEEEEEC-CCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 4677789999999999999976 578999999997655555667899999999999999999999999999999999999
Q ss_pred CCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCccccee
Q 041576 501 GNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRT 580 (714)
Q Consensus 501 ~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 580 (714)
++|+|.+++.. ..+++.++..++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+++.+..... ...
T Consensus 231 ~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~-~~~ 305 (423)
T 4fie_A 231 EGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRK 305 (423)
T ss_dssp TTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC-CBC
T ss_pred CCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCCc-ccc
Confidence 99999999976 56899999999999999999999998 99999999999999999999999999987654332 234
Q ss_pred eecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhhccc
Q 041576 581 VIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMAD 660 (714)
Q Consensus 581 ~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 660 (714)
..+||+.|||||++.+..|+.++|||||||++|||++|+.||........... +.......+ ...
T Consensus 306 ~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~--------i~~~~~~~~-------~~~ 370 (423)
T 4fie_A 306 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKM--------IRDNLPPRL-------KNL 370 (423)
T ss_dssp CCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH--------HHHSCCCCC-------SCT
T ss_pred ccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHH--------HHcCCCCCC-------ccc
Confidence 56799999999999999999999999999999999999999975433321111 111110000 011
Q ss_pred hHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 661 KSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 661 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
...+..+.+|+.+||+.||++|||++|+++.
T Consensus 371 ~~~s~~~~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 371 HKVSPSLKGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp TSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1234567889999999999999999999873
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=423.45 Aligned_cols=265 Identities=26% Similarity=0.352 Sum_probs=214.4
Q ss_pred HHHHHhhhhhhhhCcccceeEEEeEeeCC----CCcEEEEEEecccc-hhhHHHHHHHHHHHhccCc-ccccceeceEec
Q 041576 416 ELNEATNGFEEELGRGSFGIVYKGVLKSA----SGNAVAVKKLDKLA-QEREREFKTEVSAIGRTHH-KNLVQLLGFCDE 489 (714)
Q Consensus 416 el~~at~~~~~~ig~G~~g~Vy~~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h-~nIv~l~~~~~~ 489 (714)
|+....+.+.++||+|+||+||+|.+... .++.||||+++... ....+.|.+|+++|.+++| ||||+++|+|.+
T Consensus 60 Ei~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~ 139 (353)
T 4ase_A 60 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK 139 (353)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred EecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEe
Confidence 45566788889999999999999987632 34689999997643 3445789999999999955 999999999966
Q ss_pred C-CeeeEEEeecCCCchhhhhhcC----------------CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeE
Q 041576 490 G-LNRLLVYEFMGNGTLANLLFAI----------------PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNI 552 (714)
Q Consensus 490 ~-~~~~lv~E~~~~gsL~~~l~~~----------------~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NI 552 (714)
. +..+||||||++|+|.++|+.. ..+++.+++.++.|||+||+|||+++ ||||||||+||
T Consensus 140 ~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDLK~~NI 216 (353)
T 4ase_A 140 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNI 216 (353)
T ss_dssp TTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGE
T ss_pred cCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCccCccce
Confidence 4 5689999999999999999753 24789999999999999999999998 99999999999
Q ss_pred EECCCCceEEecCCCccccccCccc-ceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccchh
Q 041576 553 LLDQDFTAKISDFGLSKLLLSDQSR-TRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEER 630 (714)
Q Consensus 553 ll~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~ 630 (714)
|+++++.+||+|||+++.+..+... ......||+.|||||++.+..++.++|||||||+||||+| |+.||........
T Consensus 217 Ll~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~ 296 (353)
T 4ase_A 217 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 296 (353)
T ss_dssp EECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH
T ss_pred eeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHH
Confidence 9999999999999999977554433 2334578999999999999999999999999999999998 8999975432221
Q ss_pred hhhhhHHHhhhhhcCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCCC
Q 041576 631 SAILTDWAYDCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLEVP 699 (714)
Q Consensus 631 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 699 (714)
+. ....++.... .+...+.++.+++.+||+.||++|||+.||++.|+.+++..
T Consensus 297 ---~~----~~i~~g~~~~---------~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~ 349 (353)
T 4ase_A 297 ---FC----RRLKEGTRMR---------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 349 (353)
T ss_dssp ---HH----HHHHHTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred ---HH----HHHHcCCCCC---------CCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHh
Confidence 11 1111211111 12223457888999999999999999999999999887643
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-49 Score=410.33 Aligned_cols=268 Identities=22% Similarity=0.263 Sum_probs=201.9
Q ss_pred hhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCcccccceeceEecCC----eeeEE
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGL----NRLLV 496 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~----~~~lv 496 (714)
++.+.++||+|+||+||+|++ +|+.||||+++.... ....++.|+..+.+++|||||+++++|.+++ ..+||
T Consensus 4 ~i~L~~~iG~G~fG~Vy~~~~---~g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV 79 (303)
T 3hmm_A 4 TIVLQESIGKGRFGEVWRGKW---RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GEEEEEEEEECSSSEEEEEEE---TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEE---CCEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence 355678999999999999987 488999999975432 2233456777778899999999999997654 57999
Q ss_pred EeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcC-----CCCeEecCCCcCeEEECCCCceEEecCCCcccc
Q 041576 497 YEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEEC-----NVPIIHCDIKPQNILLDQDFTAKISDFGLSKLL 571 (714)
Q Consensus 497 ~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~-----~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~ 571 (714)
|||+++|+|.++|+. ..++++.+.+++.|+++||+|||+++ .++|+||||||+||||++++++||+|||+++..
T Consensus 80 ~Ey~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~ 158 (303)
T 3hmm_A 80 SDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 158 (303)
T ss_dssp EECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred ecCCCCCcHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccc
Confidence 999999999999986 46899999999999999999999872 235999999999999999999999999999876
Q ss_pred ccCccc---ceeeecCCCCccCcccccCC------CCCchhhhHHHHHHHHHHHhcCCCCcccccchh-hh-------hh
Q 041576 572 LSDQSR---TRTVIRGTRGYVAPEWFKNV------PVSAKVDVYSFGVVLLKIICCKRSVEMELGEER-SA-------IL 634 (714)
Q Consensus 572 ~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~-~~-------~l 634 (714)
...... ......||+.|+|||++.+. .++.++|||||||+||||+||+.|+........ .. ..
T Consensus 159 ~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~ 238 (303)
T 3hmm_A 159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 238 (303)
T ss_dssp ETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred cCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchH
Confidence 543322 22345799999999999764 367899999999999999999988754322110 00 00
Q ss_pred hHHHhhhhhcCccceeecchhh-hccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCC
Q 041576 635 TDWAYDCYVEGKLDVLVDNDKA-AMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLEV 698 (714)
Q Consensus 635 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 698 (714)
.. ......++. .++... .....+....+.+++.+||+.||++||||.||++.|+++.+.
T Consensus 239 ~~-~~~~~~~~~----~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~ 298 (303)
T 3hmm_A 239 EE-MRKVVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp HH-HHHHHTTSC----CCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HH-HHHHHhccc----CCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence 00 001111111 111111 112334566788999999999999999999999999987654
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-49 Score=407.03 Aligned_cols=248 Identities=25% Similarity=0.259 Sum_probs=199.0
Q ss_pred hhhhhhhhCcccceeEEEeEee--CCCCcEEEEEEecccc--hhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEE
Q 041576 421 TNGFEEELGRGSFGIVYKGVLK--SASGNAVAVKKLDKLA--QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLV 496 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~--~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 496 (714)
.|.+.+.||+|+||+||+|+.. ..+++.||||++++.. ......+.+|++++++++|||||++++++.+++..|+|
T Consensus 25 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv 104 (304)
T 3ubd_A 25 QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLI 104 (304)
T ss_dssp GEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEEE
T ss_pred ccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 5888899999999999999864 2357899999996532 22334688999999999999999999999999999999
Q ss_pred EeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcc
Q 041576 497 YEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQS 576 (714)
Q Consensus 497 ~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 576 (714)
|||+++|+|.+++.....+++.++..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++.......
T Consensus 105 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~ 181 (304)
T 3ubd_A 105 LDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK 181 (304)
T ss_dssp ECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC-----C
T ss_pred EEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceeccCCCc
Confidence 999999999999998889999999999999999999999998 99999999999999999999999999986543322
Q ss_pred cceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhh
Q 041576 577 RTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKA 656 (714)
Q Consensus 577 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 656 (714)
......||+.|+|||++.+..++.++||||+||+||||+||+.||......+.... ...+...
T Consensus 182 -~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~--------i~~~~~~-------- 244 (304)
T 3ubd_A 182 -KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTM--------ILKAKLG-------- 244 (304)
T ss_dssp -CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH--------HHHCCCC--------
T ss_pred -cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHH--------HHcCCCC--------
Confidence 23346799999999999999999999999999999999999999986543321111 1111111
Q ss_pred hccchHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 041576 657 AMADKSRACKWLMIALWCIQEDPLKRPA-----MKMIVQ 690 (714)
Q Consensus 657 ~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 690 (714)
.+...+.++.+++.+||+.||++||| ++|+++
T Consensus 245 --~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 245 --MPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp --CCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred --CCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 11223456788999999999999998 467765
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-47 Score=395.34 Aligned_cols=247 Identities=23% Similarity=0.339 Sum_probs=187.4
Q ss_pred hhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc-hhhHHHHHHHHHHHhccCcccccceeceEecCC--------
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA-QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGL-------- 491 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-------- 491 (714)
.|.+.+.||+|+||+||+|+.+ .+++.||||+++... ....+.+.+|+++|++++|||||++++++.+.+
T Consensus 6 dy~~~~~lG~G~fg~V~~a~~~-~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 6 DFEPIQCLGRGGFGVVFEAKNK-VDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HEEEEEEEEECC--EEEEEEET-TTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hCEEeeEEecCCCeEEEEEEEC-CCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 3677899999999999999976 578999999996533 344568999999999999999999999986544
Q ss_pred ----eeeEEEeecCCCchhhhhhcCCCC---ChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEec
Q 041576 492 ----NRLLVYEFMGNGTLANLLFAIPRP---DWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISD 564 (714)
Q Consensus 492 ----~~~lv~E~~~~gsL~~~l~~~~~~---~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D 564 (714)
..|+||||+++|+|.+++.....+ ++..++.++.||++||+|||+++ |+||||||+||||+.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEcc
Confidence 368999999999999999876544 44568899999999999999998 99999999999999999999999
Q ss_pred CCCccccccCccc-----------ceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhh
Q 041576 565 FGLSKLLLSDQSR-----------TRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAI 633 (714)
Q Consensus 565 fg~~~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~ 633 (714)
||+++.+...... ......||+.|||||++.+..++.++|||||||++|||++ ||...... ...
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~--~~~ 236 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMER--VRT 236 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHH--HHH
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHH--HHH
Confidence 9999877543221 1233569999999999999999999999999999999996 76532211 111
Q ss_pred hhHHHhhhhhcCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 634 LTDWAYDCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 634 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
+. ........ + ........+.+++.+||+.||++|||+.|+++
T Consensus 237 ~~-----~~~~~~~p----~-----~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 237 LT-----DVRNLKFP----P-----LFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HH-----HHHTTCCC----H-----HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HH-----HHhcCCCC----C-----CCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11 11111111 0 11122345667999999999999999999987
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-45 Score=395.01 Aligned_cols=266 Identities=18% Similarity=0.256 Sum_probs=204.5
Q ss_pred hhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEeccc--chhhHHHHHHHHHHHhccCcccccceeceEec------CCe
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKL--AQEREREFKTEVSAIGRTHHKNLVQLLGFCDE------GLN 492 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~------~~~ 492 (714)
.|.+.+.||+|+||+||+|+++ .+|+.||||+++.. .....+.+.+|+++|++++|||||++++++.. .+.
T Consensus 55 ~Y~~~~~lG~G~fG~V~~a~~~-~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 55 EYEIIETIGNGAYGVVSSARRR-LTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SEEEEEEEEECSSCEEEEEEET-TTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CeEEEEEEecccCeEEEEEEEC-CCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 4778899999999999999976 57999999999653 23445678899999999999999999998754 367
Q ss_pred eeEEEeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccc
Q 041576 493 RLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLL 572 (714)
Q Consensus 493 ~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~ 572 (714)
.||||||++ |+|.+++.....+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 134 ~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~ 209 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMARGLC 209 (398)
T ss_dssp EEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBCC-
T ss_pred EEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecceeeecc
Confidence 899999996 689999998889999999999999999999999998 9999999999999999999999999998764
Q ss_pred cCc---ccceeeecCCCCccCcccccCC-CCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhh-----
Q 041576 573 SDQ---SRTRTVIRGTRGYVAPEWFKNV-PVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYV----- 643 (714)
Q Consensus 573 ~~~---~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~----- 643 (714)
... ........||+.|+|||++.+. .++.++||||+||++|||++|+.||......+....+.........
T Consensus 210 ~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~ 289 (398)
T 4b99_A 210 TSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQA 289 (398)
T ss_dssp ------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-
T ss_pred cCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhh
Confidence 332 2233456799999999998875 5699999999999999999999999865443322222111000000
Q ss_pred --cCccc----eeec--chhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 644 --EGKLD----VLVD--NDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 644 --~~~~~----~~~~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
..... .+.. +..........+..+.+|+.+||+.||++|||++|+++.
T Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 290 VGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp ----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred hhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00000 0000 000000011224567889999999999999999999873
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=379.93 Aligned_cols=198 Identities=19% Similarity=0.323 Sum_probs=169.7
Q ss_pred HhhhhhhhhCcccceeEEEeEeeC--CCCcEEEEEEecccchhhHHHHHHHHHHHhcc-CcccccceeceEecCCeeeEE
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKS--ASGNAVAVKKLDKLAQEREREFKTEVSAIGRT-HHKNLVQLLGFCDEGLNRLLV 496 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv 496 (714)
..|.+.++||+|+||+||+|+.+. .+++.||||++.... ....+.+|+++|+++ +||||+++++++.+.++.++|
T Consensus 21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lv 98 (361)
T 4f9c_A 21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIA 98 (361)
T ss_dssp GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEE
T ss_pred CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEE
Confidence 357788999999999999998652 357899999986532 345688999999998 799999999999999999999
Q ss_pred EeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCC-CceEEecCCCccccccCc
Q 041576 497 YEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQD-FTAKISDFGLSKLLLSDQ 575 (714)
Q Consensus 497 ~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~-~~~kl~Dfg~~~~~~~~~ 575 (714)
|||+++|+|.+++. .+++.++..++.||+.||+|||++| |+||||||+|||++.+ +.+||+|||+|+......
T Consensus 99 mE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~ 172 (361)
T 4f9c_A 99 MPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTK 172 (361)
T ss_dssp EECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEECTTCS
T ss_pred EeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCcc
Confidence 99999999999984 5899999999999999999999998 9999999999999877 799999999998653321
Q ss_pred c---------------------------cceeeecCCCCccCcccccCC-CCCchhhhHHHHHHHHHHHhcCCCCccc
Q 041576 576 S---------------------------RTRTVIRGTRGYVAPEWFKNV-PVSAKVDVYSFGVVLLKIICCKRSVEME 625 (714)
Q Consensus 576 ~---------------------------~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~p~~~~ 625 (714)
. .......||+.|+|||++.+. .++.++||||+||++|||++|+.||...
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~ 250 (361)
T 4f9c_A 173 IELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKA 250 (361)
T ss_dssp CGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCC
Confidence 1 112335699999999999775 5899999999999999999999999644
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=401.69 Aligned_cols=250 Identities=24% Similarity=0.340 Sum_probs=209.6
Q ss_pred hhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEeec
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEFM 500 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~ 500 (714)
.|.+.+.||+|+||.||+|+.+ .+|+.||+|++........+.+.+|+++|++++||||+++++++.++...+|||||+
T Consensus 158 ~Y~i~~~lG~G~fg~V~~~~~~-~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~ 236 (573)
T 3uto_A 158 HYDIHEELGTGAFGVVHRVTER-ATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 236 (573)
T ss_dssp TEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred ccEEEEEEeeccCeEEEEEEEC-CCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence 5778899999999999999976 578999999998766666778999999999999999999999999999999999999
Q ss_pred CCCchhhhhhcC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCC--CceEEecCCCccccccCccc
Q 041576 501 GNGTLANLLFAI-PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQD--FTAKISDFGLSKLLLSDQSR 577 (714)
Q Consensus 501 ~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~--~~~kl~Dfg~~~~~~~~~~~ 577 (714)
++|+|.++|... ..+++.++..++.||++||+|||+++ |+||||||+|||++.+ +.+||+|||+++.+... .
T Consensus 237 ~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~--~ 311 (573)
T 3uto_A 237 SGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK--Q 311 (573)
T ss_dssp CCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT--S
T ss_pred CCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCC--C
Confidence 999999998654 57899999999999999999999998 9999999999999854 89999999999877443 2
Q ss_pred ceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhh
Q 041576 578 TRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAA 657 (714)
Q Consensus 578 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 657 (714)
......||+.|+|||++.+..++.++||||+||++|||++|+.||......+....+ ...... +..
T Consensus 312 ~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i--------~~~~~~--~~~---- 377 (573)
T 3uto_A 312 SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNV--------KSCDWN--MDD---- 377 (573)
T ss_dssp EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH--------HTTCCC--CCS----
T ss_pred ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHH--------HhCCCC--CCc----
Confidence 334567999999999999999999999999999999999999999765433221111 111110 000
Q ss_pred ccchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 658 MADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 658 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
......+..+.+|+.+||+.||++|||+.|+++
T Consensus 378 ~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 378 SAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 011123456778999999999999999999987
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-43 Score=369.17 Aligned_cols=274 Identities=37% Similarity=0.630 Sum_probs=229.1
Q ss_pred hhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEeec
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEFM 500 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~ 500 (714)
.|.+.+.||+|+||.||+|.++ +++.||||++........+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 40 ~y~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 117 (321)
T 2qkw_B 40 NFDHKFLIGHGVFGKVYKGVLR--DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYM 117 (321)
T ss_dssp CCSCCCCSCBCSSSEEEEEECT--TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECC
T ss_pred ccCccceeecCCCeeEEEEEEC--CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcC
Confidence 3555688999999999999864 68899999998766666788999999999999999999999999999999999999
Q ss_pred CCCchhhhhhcCC----CCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCc-
Q 041576 501 GNGTLANLLFAIP----RPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQ- 575 (714)
Q Consensus 501 ~~gsL~~~l~~~~----~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~- 575 (714)
++++|.+++.... .+++..++.++.||++||+|||+++ |+||||||+||+++.++.+||+|||++.......
T Consensus 118 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 194 (321)
T 2qkw_B 118 ENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQ 194 (321)
T ss_dssp TTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTTCEECSSSSC
T ss_pred CCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeecccccccccccc
Confidence 9999999997643 4789999999999999999999998 9999999999999999999999999998654322
Q ss_pred ccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchh
Q 041576 576 SRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDK 655 (714)
Q Consensus 576 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 655 (714)
........|+..|+|||.+.+..++.++||||||+++|||++|+.||......... ....+.......+.+...+++..
T Consensus 195 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 273 (321)
T 2qkw_B 195 THLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMV-NLAEWAVESHNNGQLEQIVDPNL 273 (321)
T ss_dssp CCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCC-CHHHHTHHHHTTTCCCSSSSSSC
T ss_pred cccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHH-HHHHHhhhccccccHHHhcChhh
Confidence 22233445899999999999889999999999999999999999999765433321 12233333344445555555555
Q ss_pred hhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCCCC
Q 041576 656 AAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLEVPS 700 (714)
Q Consensus 656 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 700 (714)
...........+.+++.+||+.||++|||+.||++.|+.+++...
T Consensus 274 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~~ 318 (321)
T 2qkw_B 274 ADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQE 318 (321)
T ss_dssp TTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSC
T ss_pred ccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhccc
Confidence 555667788899999999999999999999999999999887644
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=395.96 Aligned_cols=248 Identities=23% Similarity=0.251 Sum_probs=201.6
Q ss_pred hhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc---hhhHHH---HHHHHHHHhccCcccccceeceEecCCeee
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA---QERERE---FKTEVSAIGRTHHKNLVQLLGFCDEGLNRL 494 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~---~~~~~~---~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 494 (714)
.|.+.++||+|+||.||+|+.+ .+|+.||||++++.. ...... ...++.+++.++|||||++++++.+.+..|
T Consensus 190 df~i~k~LG~G~fG~V~la~~~-~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 190 DFSVHRIIGRGGFGEVYGCRKA-DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HeEEEEEEecccCeEEEEEEEC-CCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 3667789999999999999976 579999999996522 122223 344567778889999999999999999999
Q ss_pred EEEeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccC
Q 041576 495 LVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSD 574 (714)
Q Consensus 495 lv~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 574 (714)
|||||++||+|.++|.....+++..+..++.||+.||+|||+++ ||||||||+||||+.+|++||+|||+|+.+...
T Consensus 269 lVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~ 345 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK 345 (689)
T ss_dssp EEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeeecCCC
Confidence 99999999999999998889999999999999999999999998 999999999999999999999999999876443
Q ss_pred cccceeeecCCCCccCcccccC-CCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecc
Q 041576 575 QSRTRTVIRGTRGYVAPEWFKN-VPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDN 653 (714)
Q Consensus 575 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 653 (714)
. ....+||+.|||||++.+ ..++.++|||||||+||||++|+.||............. .......
T Consensus 346 ~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~-----~i~~~~~------ 411 (689)
T 3v5w_A 346 K---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR-----MTLTMAV------ 411 (689)
T ss_dssp C---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHH-----HHHHCCC------
T ss_pred C---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH-----hhcCCCC------
Confidence 2 234579999999999964 579999999999999999999999997654332211111 1111111
Q ss_pred hhhhccchHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 041576 654 DKAAMADKSRACKWLMIALWCIQEDPLKRPA-----MKMIVQ 690 (714)
Q Consensus 654 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 690 (714)
..+...+.++.+|+.+||+.||++|++ ++||++
T Consensus 412 ----~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 412 ----ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp ----CCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred ----CCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 012223456788999999999999998 788865
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-43 Score=371.47 Aligned_cols=288 Identities=42% Similarity=0.701 Sum_probs=236.8
Q ss_pred CCccccCHHHHHHHhhhh--hhhhCcccceeEEEeEeeCCCCcEEEEEEecccch-hhHHHHHHHHHHHhccCcccccce
Q 041576 407 TNLRFFSLVELNEATNGF--EEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQ-EREREFKTEVSAIGRTHHKNLVQL 483 (714)
Q Consensus 407 ~~~~~~~~~el~~at~~~--~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l 483 (714)
...+.+++.++.....++ .+.||+|+||.||+|... +++.||||++..... .....+.+|++++++++||||+++
T Consensus 15 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~ 92 (326)
T 3uim_A 15 GQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA--DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRL 92 (326)
T ss_dssp CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCS--SSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCC
T ss_pred CccceecHHHHHHHhhccccceeEecCCCcEEEEEEec--CCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccce
Confidence 345677888887766555 578999999999999854 688999999976432 223478999999999999999999
Q ss_pred eceEecCCeeeEEEeecCCCchhhhhhcCC----CCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCc
Q 041576 484 LGFCDEGLNRLLVYEFMGNGTLANLLFAIP----RPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFT 559 (714)
Q Consensus 484 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~----~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~ 559 (714)
++++.+....++||||+++++|.+++.... .+++..+..++.||+.||+|||++...+|+||||||+||+++.++.
T Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~ 172 (326)
T 3uim_A 93 RGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFE 172 (326)
T ss_dssp CEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCC
T ss_pred EEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCC
Confidence 999999999999999999999999998653 4889999999999999999999992223999999999999999999
Q ss_pred eEEecCCCccccccCcccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccc-hhhhhhhHHH
Q 041576 560 AKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGE-ERSAILTDWA 638 (714)
Q Consensus 560 ~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~-~~~~~l~~~~ 638 (714)
+||+|||++...............||+.|+|||.+.+..++.++||||||+++|||++|+.||...... .....+..+.
T Consensus 173 ~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 252 (326)
T 3uim_A 173 AVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV 252 (326)
T ss_dssp EEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHH
T ss_pred EEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHH
Confidence 999999999877655554555566999999999998888999999999999999999999999743221 1222334444
Q ss_pred hhhhhcCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 041576 639 YDCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYL 696 (714)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 696 (714)
.............+..............+.+++.+||+.||++|||+.||++.|++..
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~ 310 (326)
T 3uim_A 253 KGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG 310 (326)
T ss_dssp TTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSS
T ss_pred HHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcc
Confidence 4445555566666666666667778889999999999999999999999999998743
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=362.24 Aligned_cols=259 Identities=27% Similarity=0.437 Sum_probs=212.9
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEee
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEF 499 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~ 499 (714)
..+.+.+.||+|+||+||+|.+. .+++.||+|++........+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHR-ETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEET-TTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hHeeccceecCCCCEEEEEEEEC-CCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 35667789999999999999976 57899999999877777788999999999999999999999999999999999999
Q ss_pred cCCCchhhhhhc-CCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcccc
Q 041576 500 MGNGTLANLLFA-IPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRT 578 (714)
Q Consensus 500 ~~~gsL~~~l~~-~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 578 (714)
+++++|.+++.. ...+++.++..++.||++||+|||+++ |+||||||+||+++.++.+||+|||++..........
T Consensus 89 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 165 (310)
T 3s95_A 89 IKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQP 165 (310)
T ss_dssp CTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC------
T ss_pred cCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceecccccccc
Confidence 999999999987 467899999999999999999999998 9999999999999999999999999998764332211
Q ss_pred -------------eeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcC
Q 041576 579 -------------RTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEG 645 (714)
Q Consensus 579 -------------~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~ 645 (714)
.....||+.|+|||.+.+..++.++||||||+++|||++|..|+.............
T Consensus 166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~---------- 235 (310)
T 3s95_A 166 EGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLN---------- 235 (310)
T ss_dssp --------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBC----------
T ss_pred cccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhh----------
Confidence 114568999999999999999999999999999999999999986543222110000
Q ss_pred ccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccC
Q 041576 646 KLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLE 697 (714)
Q Consensus 646 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 697 (714)
.........+...+..+.+++.+||+.||++|||+.|+++.|+.+..
T Consensus 236 -----~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~ 282 (310)
T 3s95_A 236 -----VRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRM 282 (310)
T ss_dssp -----HHHHHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----hhccccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 00000111122233467789999999999999999999999988654
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=363.22 Aligned_cols=266 Identities=30% Similarity=0.468 Sum_probs=204.1
Q ss_pred HHhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEeccc--chhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEE
Q 041576 419 EATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKL--AQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLV 496 (714)
Q Consensus 419 ~at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 496 (714)
...|.+.+.||+|+||+||+|.. .++.||||++... .....+.+.+|++++++++||||+++++++.+....++|
T Consensus 36 ~~~y~i~~~lG~G~~g~V~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 3p86_A 36 WCDLNIKEKIGAGSFGTVHRAEW---HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIV 112 (309)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEE---TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEE
T ss_pred hhHceeeeEeecCCCeEEEEEEE---CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEE
Confidence 34567788999999999999976 4789999998653 344456899999999999999999999999999999999
Q ss_pred EeecCCCchhhhhhcCCC---CChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCcccccc
Q 041576 497 YEFMGNGTLANLLFAIPR---PDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLS 573 (714)
Q Consensus 497 ~E~~~~gsL~~~l~~~~~---~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~ 573 (714)
|||+++++|.+++..... +++..++.++.||++||+|||+++ .+|+||||||+||+++.++.+||+|||+++....
T Consensus 113 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~ 191 (309)
T 3p86_A 113 TEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAS 191 (309)
T ss_dssp EECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC-------
T ss_pred EecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCccccc
Confidence 999999999999987653 899999999999999999999985 4599999999999999999999999999975433
Q ss_pred CcccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecc
Q 041576 574 DQSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDN 653 (714)
Q Consensus 574 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 653 (714)
.. .......||+.|+|||.+.+..++.++||||||+++|||++|+.||...........+ . .....
T Consensus 192 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~------~-~~~~~------ 257 (309)
T 3p86_A 192 TF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAV------G-FKCKR------ 257 (309)
T ss_dssp -----------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHH------H-HSCCC------
T ss_pred cc-cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH------H-hcCCC------
Confidence 22 2233456899999999999999999999999999999999999999755333211110 0 00000
Q ss_pred hhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCCCCCCCCC
Q 041576 654 DKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLEVPSPPMPP 705 (714)
Q Consensus 654 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~pp~p~ 705 (714)
...+...+..+.+++.+||+.||++|||++||++.|+.+++...||.++
T Consensus 258 ---~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~~~~ 306 (309)
T 3p86_A 258 ---LEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPPNR 306 (309)
T ss_dssp ---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--------
T ss_pred ---CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCCCCc
Confidence 0112223456788999999999999999999999999998876666544
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=355.99 Aligned_cols=251 Identities=25% Similarity=0.362 Sum_probs=208.7
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEee
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEF 499 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~ 499 (714)
..|.+.+.||+|+||+||+|... .+++.||||++........+.+.+|+.++++++||||+++++++..++..++||||
T Consensus 20 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 20 KKYTRFEKIGQGASGTVYTAMDV-ATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GTBCCCEEEEEETTEEEEEEEBT-TTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hceeeeeeeccCCCeEEEEEEEC-CCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 35677789999999999999865 57899999999766666677899999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcccce
Q 041576 500 MGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTR 579 (714)
Q Consensus 500 ~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 579 (714)
+++++|.+++... .+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||++........ ..
T Consensus 99 ~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~ 173 (297)
T 3fxz_A 99 LAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KR 173 (297)
T ss_dssp CTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-CB
T ss_pred CCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc-cc
Confidence 9999999999764 6899999999999999999999998 99999999999999999999999999987644332 23
Q ss_pred eeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhhcc
Q 041576 580 TVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMA 659 (714)
Q Consensus 580 ~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 659 (714)
....||+.|+|||.+.+..++.++||||||+++|||++|+.||...........+ ....... . ..
T Consensus 174 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~-------~~~~~~~-~-------~~ 238 (297)
T 3fxz_A 174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI-------ATNGTPE-L-------QN 238 (297)
T ss_dssp CCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH-------HHHCSCC-C-------SC
T ss_pred CCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-------HhCCCCC-C-------CC
Confidence 3456999999999999999999999999999999999999999754332211111 0000000 0 01
Q ss_pred chHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 660 DKSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 660 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
+...+..+.+++.+||+.||++|||++|+++.
T Consensus 239 ~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 239 PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 22234567889999999999999999999873
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=354.08 Aligned_cols=267 Identities=23% Similarity=0.299 Sum_probs=213.2
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecc---cchhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEE
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDK---LAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLV 496 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 496 (714)
.+|.+.+.||+|+||.||+|... .+++.||+|.+.. ......+.+.+|+.++++++||||+++++++.+++..++|
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 11 ERYKIVDKLGGGGMSTVYLAEDT-ILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp TTEEEEEEEEEETTEEEEEEEET-TTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccEEEEEEEccCCCEEEEEEEEC-CCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 45778899999999999999875 5788999999853 2334457899999999999999999999999999999999
Q ss_pred EeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcc
Q 041576 497 YEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQS 576 (714)
Q Consensus 497 ~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 576 (714)
|||+++++|.+++.....+++..++.++.||+.||+|||+++ |+||||||+||+++.++.+||+|||++........
T Consensus 90 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 166 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL 166 (294)
T ss_dssp EECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC-----
T ss_pred EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCccccccccc
Confidence 999999999999988888999999999999999999999998 99999999999999999999999999987654443
Q ss_pred cceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhh
Q 041576 577 RTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKA 656 (714)
Q Consensus 577 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 656 (714)
.......||+.|+|||.+.+..++.++||||||+++|||++|+.||......... ...... ... ...
T Consensus 167 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~-------~~~~~~-~~~-----~~~ 233 (294)
T 4eqm_A 167 TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIA-------IKHIQD-SVP-----NVT 233 (294)
T ss_dssp --------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHH-------HHHHSS-CCC-----CHH
T ss_pred cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH-------HHHhhc-cCC-----Ccc
Confidence 4444566999999999999999999999999999999999999999755332210 000111 110 011
Q ss_pred hccchHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHhcccCCCCCCC
Q 041576 657 AMADKSRACKWLMIALWCIQEDPLKRP-AMKMIVQMLEGYLEVPSPPM 703 (714)
Q Consensus 657 ~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~~~~~~~pp~ 703 (714)
.......+..+.+++.+||+.||++|| +++++.+.|+.++.......
T Consensus 234 ~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~~~~ 281 (294)
T 4eqm_A 234 TDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENRANE 281 (294)
T ss_dssp HHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSSTTC
T ss_pred hhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhccCCc
Confidence 112223345788899999999999998 99999999999876654443
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-42 Score=362.93 Aligned_cols=264 Identities=27% Similarity=0.394 Sum_probs=212.0
Q ss_pred HHHhhhhhhhhCcccceeEEEeEeeCC--CCcEEEEEEeccc-chhhHHHHHHHHHHHhccCcccccceeceEecCCeee
Q 041576 418 NEATNGFEEELGRGSFGIVYKGVLKSA--SGNAVAVKKLDKL-AQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRL 494 (714)
Q Consensus 418 ~~at~~~~~~ig~G~~g~Vy~~~~~~~--~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 494 (714)
...+|.+.+.||+|+||.||+|.+... .+..||||+++.. .....+.+.+|++++++++||||+++++++.+++..+
T Consensus 47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 126 (325)
T 3kul_A 47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAM 126 (325)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCE
T ss_pred ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccE
Confidence 345677778999999999999997532 2346999999764 4445678999999999999999999999999999999
Q ss_pred EEEeecCCCchhhhhhcC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCcccccc
Q 041576 495 LVYEFMGNGTLANLLFAI-PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLS 573 (714)
Q Consensus 495 lv~E~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~ 573 (714)
+||||+++++|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 127 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 203 (325)
T 3kul_A 127 IVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLED 203 (325)
T ss_dssp EEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC-
T ss_pred EEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCccccccc
Confidence 999999999999999754 57899999999999999999999998 99999999999999999999999999987654
Q ss_pred Ccccc--eeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccchhhhhhhHHHhhhhhcCcccee
Q 041576 574 DQSRT--RTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEERSAILTDWAYDCYVEGKLDVL 650 (714)
Q Consensus 574 ~~~~~--~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 650 (714)
..... .....+|..|+|||.+.+..++.++||||||+++|||++ |+.||........... ...+..
T Consensus 204 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~--------~~~~~~--- 272 (325)
T 3kul_A 204 DPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISS--------VEEGYR--- 272 (325)
T ss_dssp ---CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHH--------HHTTCC---
T ss_pred CccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHH--------HHcCCC---
Confidence 33222 222346778999999998899999999999999999999 9999975433321111 111100
Q ss_pred ecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCCCCC
Q 041576 651 VDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLEVPSP 701 (714)
Q Consensus 651 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~p 701 (714)
...+...+..+.+++.+||+.||++|||+.||++.|+.+++.+..
T Consensus 273 ------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~~ 317 (325)
T 3kul_A 273 ------LPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPES 317 (325)
T ss_dssp ------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC-
T ss_pred ------CCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCccc
Confidence 011223345788899999999999999999999999998876543
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=365.92 Aligned_cols=259 Identities=25% Similarity=0.344 Sum_probs=211.3
Q ss_pred HhhhhhhhhCcccceeEEEeEeeC------CCCcEEEEEEeccc-chhhHHHHHHHHHHHhcc-CcccccceeceEecCC
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKS------ASGNAVAVKKLDKL-AQEREREFKTEVSAIGRT-HHKNLVQLLGFCDEGL 491 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~ 491 (714)
..|.+.+.||+|+||.||+|.+.. ..+..||||+++.. .....+.+.+|+++++++ +||||+++++++.+.+
T Consensus 81 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~ 160 (370)
T 2psq_A 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 160 (370)
T ss_dssp GGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSS
T ss_pred HHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCC
Confidence 456778899999999999998642 34568999999764 334557899999999999 8999999999999999
Q ss_pred eeeEEEeecCCCchhhhhhcCC----------------CCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEEC
Q 041576 492 NRLLVYEFMGNGTLANLLFAIP----------------RPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLD 555 (714)
Q Consensus 492 ~~~lv~E~~~~gsL~~~l~~~~----------------~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~ 555 (714)
..++||||+++|+|.+++.... .+++.+++.++.||++||+|||+++ |+||||||+|||++
T Consensus 161 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~ 237 (370)
T 2psq_A 161 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLVT 237 (370)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEC
T ss_pred CEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEEC
Confidence 9999999999999999997643 4688999999999999999999998 99999999999999
Q ss_pred CCCceEEecCCCccccccCcc-cceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccchhhhh
Q 041576 556 QDFTAKISDFGLSKLLLSDQS-RTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEERSAI 633 (714)
Q Consensus 556 ~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~ 633 (714)
.++.+||+|||+++....... .......+++.|+|||++.+..++.++|||||||++|||++ |+.||......+...
T Consensus 238 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~- 316 (370)
T 2psq_A 238 ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK- 316 (370)
T ss_dssp TTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH-
T ss_pred CCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH-
Confidence 999999999999986644332 22223456789999999999999999999999999999999 999997543322111
Q ss_pred hhHHHhhhhhcCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCC
Q 041576 634 LTDWAYDCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLEV 698 (714)
Q Consensus 634 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 698 (714)
....+... ..+......+.+++.+||+.||++||++.|+++.|++++..
T Consensus 317 -------~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~ 365 (370)
T 2psq_A 317 -------LLKEGHRM---------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 365 (370)
T ss_dssp -------HHHTTCCC---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -------HHhcCCCC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 11111111 11223345788899999999999999999999999987754
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-41 Score=353.83 Aligned_cols=261 Identities=23% Similarity=0.300 Sum_probs=213.6
Q ss_pred cccCHHHHHHHhhh------------hhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCc
Q 041576 410 RFFSLVELNEATNG------------FEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHH 477 (714)
Q Consensus 410 ~~~~~~el~~at~~------------~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h 477 (714)
..++++++..++.. ..+.||+|+||.||+|... .+|+.||||++........+.+.+|+.++++++|
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h 101 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREK-HSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQH 101 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCC
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEEC-CCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCC
Confidence 45788888887753 3457999999999999875 4789999999976666667789999999999999
Q ss_pred ccccceeceEecCCeeeEEEeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCC
Q 041576 478 KNLVQLLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQD 557 (714)
Q Consensus 478 ~nIv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~ 557 (714)
|||+++++++...+..++||||+++++|.+++.. ..+++..+..++.||++||+|||+.+ |+||||||+||+++.+
T Consensus 102 ~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~ 177 (321)
T 2c30_A 102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLD 177 (321)
T ss_dssp TTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTT
T ss_pred CCcceEEEEEEECCEEEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCC
Confidence 9999999999999999999999999999999875 56899999999999999999999998 9999999999999999
Q ss_pred CceEEecCCCccccccCcccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHH
Q 041576 558 FTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDW 637 (714)
Q Consensus 558 ~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~ 637 (714)
+.+||+|||++........ ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...........
T Consensus 178 ~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~---- 252 (321)
T 2c30_A 178 GRVKLSDFGFCAQISKDVP-KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKR---- 252 (321)
T ss_dssp CCEEECCCTTCEECCSSSC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH----
T ss_pred CcEEEeeeeeeeecccCcc-ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH----
Confidence 9999999999987644322 22345689999999999999999999999999999999999999975433221111
Q ss_pred HhhhhhcCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 638 AYDCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
......... ......+..+.+++.+||+.||++|||++|+++.
T Consensus 253 ----~~~~~~~~~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 253 ----LRDSPPPKL-------KNSHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp ----HHHSSCCCC-------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ----HhcCCCCCc-------CccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111110000 0111233467889999999999999999999874
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=358.20 Aligned_cols=247 Identities=24% Similarity=0.346 Sum_probs=207.0
Q ss_pred hhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEeccc--chhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEe
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKL--AQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYE 498 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E 498 (714)
.|.+.+.||+|+||.||+|.+. .+++.||||++... .....+.+.+|++++++++||||+++++++...+..++|||
T Consensus 16 ~y~~~~~lG~G~~g~V~~a~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e 94 (328)
T 3fe3_A 16 NYRLLKTIGKGNFAKVKLARHI-LTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIME 94 (328)
T ss_dssp TEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred CEEEEEEEeeCCCEEEEEEEEC-CCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEE
Confidence 4677899999999999999875 57899999999653 34456678999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcccc
Q 041576 499 FMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRT 578 (714)
Q Consensus 499 ~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 578 (714)
|+++++|.+++.....+++.++..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||++....... .
T Consensus 95 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~--~ 169 (328)
T 3fe3_A 95 YASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG--K 169 (328)
T ss_dssp CCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC--G
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCCC--c
Confidence 9999999999988888999999999999999999999998 9999999999999999999999999998654332 2
Q ss_pred eeeecCCCCccCcccccCCCCC-chhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhh
Q 041576 579 RTVIRGTRGYVAPEWFKNVPVS-AKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAA 657 (714)
Q Consensus 579 ~~~~~gt~~y~aPE~~~~~~~s-~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 657 (714)
.....||+.|+|||.+.+..++ .++|||||||++|||++|+.||........... ...+...
T Consensus 170 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~--------i~~~~~~--------- 232 (328)
T 3fe3_A 170 LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRER--------VLRGKYR--------- 232 (328)
T ss_dssp GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH--------HHHCCCC---------
T ss_pred cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHH--------HHhCCCC---------
Confidence 3345699999999999888765 799999999999999999999976543321111 1111110
Q ss_pred ccchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 658 MADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 658 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
.+...+..+.+++.+||+.||.+|||++|+++.
T Consensus 233 -~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 233 -IPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp -CCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred -CCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 111233467789999999999999999999874
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=361.09 Aligned_cols=270 Identities=26% Similarity=0.389 Sum_probs=210.6
Q ss_pred HHHHHhhhhhhhhCcccceeEEEeEe---eCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCcccccceeceEec--C
Q 041576 416 ELNEATNGFEEELGRGSFGIVYKGVL---KSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCDE--G 490 (714)
Q Consensus 416 el~~at~~~~~~ig~G~~g~Vy~~~~---~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--~ 490 (714)
++....|.+.+.||+|+||+||+|++ ...+++.||||++........+.+.+|++++++++||||+++++++.. .
T Consensus 6 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 85 (295)
T 3ugc_A 6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR 85 (295)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHH
T ss_pred cCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 34456788889999999999999985 335788999999987777777889999999999999999999999854 3
Q ss_pred CeeeEEEeecCCCchhhhhhcCC-CCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCcc
Q 041576 491 LNRLLVYEFMGNGTLANLLFAIP-RPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSK 569 (714)
Q Consensus 491 ~~~~lv~E~~~~gsL~~~l~~~~-~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~ 569 (714)
...++||||+++++|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+||+++.++.+||+|||++.
T Consensus 86 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~ 162 (295)
T 3ugc_A 86 RNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTK 162 (295)
T ss_dssp TSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred CceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCcccc
Confidence 56899999999999999998754 4899999999999999999999998 9999999999999999999999999998
Q ss_pred ccccCcc--cceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhh--------hhhhHHHh
Q 041576 570 LLLSDQS--RTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERS--------AILTDWAY 639 (714)
Q Consensus 570 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~--------~~l~~~~~ 639 (714)
....... .......++..|+|||.+.+..++.++||||||+++|||++|..|+......... ........
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (295)
T 3ugc_A 163 VLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 242 (295)
T ss_dssp -------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHH
T ss_pred cccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHH
Confidence 7654332 1222334677899999999999999999999999999999999998654322100 00000000
Q ss_pred hhhhcCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccC
Q 041576 640 DCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLE 697 (714)
Q Consensus 640 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 697 (714)
.....+ .....+...+..+.+++.+||+.||++|||++|+++.|+.+.+
T Consensus 243 ~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~ 291 (295)
T 3ugc_A 243 ELLKNN---------GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 291 (295)
T ss_dssp HHHHTT---------CCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHhcc---------CcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence 011111 0111123344678889999999999999999999999998754
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=346.75 Aligned_cols=280 Identities=38% Similarity=0.604 Sum_probs=223.3
Q ss_pred CCccccCHHHHHHHhhhhhh--------hhCcccceeEEEeEeeCCCCcEEEEEEeccc----chhhHHHHHHHHHHHhc
Q 041576 407 TNLRFFSLVELNEATNGFEE--------ELGRGSFGIVYKGVLKSASGNAVAVKKLDKL----AQEREREFKTEVSAIGR 474 (714)
Q Consensus 407 ~~~~~~~~~el~~at~~~~~--------~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~ 474 (714)
.....|++.++..++.+|.+ .||+|+||.||+|.. +++.||||++... .....+.+.+|+.++++
T Consensus 10 ~~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~ 86 (307)
T 2nru_A 10 TRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV---NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAK 86 (307)
T ss_dssp -CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES---SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHH
T ss_pred CCCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE---CCceEEEEEEecccCcchHHHHHHHHHHHHHHHh
Confidence 35678999999999998864 599999999999986 4789999998642 23446789999999999
Q ss_pred cCcccccceeceEecCCeeeEEEeecCCCchhhhhhc---CCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCe
Q 041576 475 THHKNLVQLLGFCDEGLNRLLVYEFMGNGTLANLLFA---IPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQN 551 (714)
Q Consensus 475 l~h~nIv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~---~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~N 551 (714)
++||||+++++++.+.+..++||||+++++|.+++.. ...+++..++.++.||++||+|||+++ |+||||||+|
T Consensus 87 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~N 163 (307)
T 2nru_A 87 CQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSAN 163 (307)
T ss_dssp CCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGG
T ss_pred cCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHH
Confidence 9999999999999999999999999999999999873 346899999999999999999999998 9999999999
Q ss_pred EEECCCCceEEecCCCccccccCccc-ceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchh
Q 041576 552 ILLDQDFTAKISDFGLSKLLLSDQSR-TRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEER 630 (714)
Q Consensus 552 Ill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~ 630 (714)
|+++.++.+||+|||++......... ......|+..|+|||.+.+ .++.++||||||+++|||++|+.||........
T Consensus 164 ili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~ 242 (307)
T 2nru_A 164 ILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQL 242 (307)
T ss_dssp EEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSB
T ss_pred EEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHH
Confidence 99999999999999999866443222 2233468999999998875 588999999999999999999999976543322
Q ss_pred hhhhhHHHhhhhhcCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 041576 631 SAILTDWAYDCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYL 696 (714)
Q Consensus 631 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 696 (714)
...+.... ......+...++... ..........+.+++.+||+.||++|||++||++.|+++.
T Consensus 243 ~~~~~~~~--~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 243 LLDIKEEI--EDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp TTHHHHHH--HTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred HHHHHHHh--hhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 11111100 001111112222211 1234556778999999999999999999999999999864
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=349.12 Aligned_cols=257 Identities=27% Similarity=0.412 Sum_probs=211.5
Q ss_pred HHhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEe
Q 041576 419 EATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYE 498 (714)
Q Consensus 419 ~at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E 498 (714)
...|.+.+.||+|+||.||+|.++ ++..||+|+++... ...+++.+|++++++++||||+++++++.++...++|||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWK--GQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTE 83 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET--TTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred hhheeeeeeeccCCCceEEEEEec--CceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEE
Confidence 456778899999999999999775 57789999997543 234678999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcCC-CCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCccc
Q 041576 499 FMGNGTLANLLFAIP-RPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSR 577 (714)
Q Consensus 499 ~~~~gsL~~~l~~~~-~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 577 (714)
|+++++|.+++.... .+++..++.++.||++||+|||+.+ |+||||||+||+++.++.+||+|||++.........
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 160 (268)
T 3sxs_A 84 YISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV 160 (268)
T ss_dssp CCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE
T ss_pred ccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhhhh
Confidence 999999999997653 5899999999999999999999998 999999999999999999999999999876554433
Q ss_pred ceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhh
Q 041576 578 TRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKA 656 (714)
Q Consensus 578 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 656 (714)
......++..|+|||.+.+..++.++||||||+++|||++ |+.||........... ...+...
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~--------~~~~~~~-------- 224 (268)
T 3sxs_A 161 SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLK--------VSQGHRL-------- 224 (268)
T ss_dssp ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH--------HHTTCCC--------
T ss_pred cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHH--------HHcCCCC--------
Confidence 3334456778999999998889999999999999999999 9999975443321111 1111100
Q ss_pred hccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCC
Q 041576 657 AMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLEV 698 (714)
Q Consensus 657 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 698 (714)
..+...+..+.+++.+||+.||++|||+.|+++.|+.+.+.
T Consensus 225 -~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 225 -YRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp -CCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred -CCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 01111234678899999999999999999999999988654
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=359.92 Aligned_cols=266 Identities=26% Similarity=0.359 Sum_probs=206.5
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCcccccceeceEecCC----eeeE
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGL----NRLL 495 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~----~~~l 495 (714)
..|.+.+.||+|+||+||+|.+. ++.||||++.... ........|+.++++++||||+++++++.... ..++
T Consensus 24 ~~y~~~~~lg~G~~g~Vy~~~~~---~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~l 99 (322)
T 3soc_A 24 MPLQLLEVKARGRFGCVWKAQLL---NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWL 99 (322)
T ss_dssp EEEEEEEEEECSTTCEEEEEEET---TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred hhchhhheecccCceEEEEEEEC---CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEE
Confidence 45677899999999999999864 7899999997543 33445677999999999999999999997754 3699
Q ss_pred EEeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhc----------CCCCeEecCCCcCeEEECCCCceEEecC
Q 041576 496 VYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEE----------CNVPIIHCDIKPQNILLDQDFTAKISDF 565 (714)
Q Consensus 496 v~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~----------~~~~ivH~Dlk~~NIll~~~~~~kl~Df 565 (714)
||||+++|+|.+++.. ..+++..++.++.||++||+|||+. + |+||||||+||+++.++.+||+||
T Consensus 100 v~e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~kL~DF 175 (322)
T 3soc_A 100 ITAFHEKGSLSDFLKA-NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTACIADF 175 (322)
T ss_dssp EEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEEECCC
T ss_pred EEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEEEccC
Confidence 9999999999999977 4589999999999999999999998 7 999999999999999999999999
Q ss_pred CCccccccCccc-ceeeecCCCCccCcccccCC-----CCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhh-----
Q 041576 566 GLSKLLLSDQSR-TRTVIRGTRGYVAPEWFKNV-----PVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAIL----- 634 (714)
Q Consensus 566 g~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-----~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l----- 634 (714)
|+++........ ......||+.|+|||.+.+. .++.++|||||||++|||++|+.||............
T Consensus 176 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~ 255 (322)
T 3soc_A 176 GLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQ 255 (322)
T ss_dssp TTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCS
T ss_pred CcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhcc
Confidence 999876543322 22335689999999999863 4567899999999999999999999754332211110
Q ss_pred ----hHHHhhhhhcCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccC
Q 041576 635 ----TDWAYDCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLE 697 (714)
Q Consensus 635 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 697 (714)
..... ............ ...........+.+++.+||+.||++|||+.||++.|+++.+
T Consensus 256 ~~~~~~~~~-~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~ 318 (322)
T 3soc_A 256 HPSLEDMQE-VVVHKKKRPVLR---DYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQR 318 (322)
T ss_dssp SCCHHHHHH-HHTTSCCCCCCC---GGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCchhhhhh-hhhcccCCCCcc---ccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 00000 001111111111 111223455678999999999999999999999999998754
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=349.28 Aligned_cols=256 Identities=29% Similarity=0.446 Sum_probs=211.3
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEee
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEF 499 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~ 499 (714)
..|.+.+.||+|+||.||+|.+. +++.||+|++.... ...+.+.+|++++++++||||+++++++.++...++||||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWL--NKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF 86 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET--TTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred hhceeeheecCCCccEEEEEEec--CCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEe
Confidence 45677889999999999999875 57789999997543 2346789999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcccc
Q 041576 500 MGNGTLANLLFAI-PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRT 578 (714)
Q Consensus 500 ~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 578 (714)
+++++|.+++... ..+++..++.++.|+++||+|||+++ |+||||||+||+++.++.+||+|||++..........
T Consensus 87 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 163 (269)
T 4hcu_A 87 MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 163 (269)
T ss_dssp CTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHS
T ss_pred CCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEecccccccccccccccc
Confidence 9999999999754 45899999999999999999999998 9999999999999999999999999998765443333
Q ss_pred eeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhh
Q 041576 579 RTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAA 657 (714)
Q Consensus 579 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 657 (714)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||........... ...+.. .
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~--------~~~~~~---------~ 226 (269)
T 4hcu_A 164 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVED--------ISTGFR---------L 226 (269)
T ss_dssp TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH--------HHTTCC---------C
T ss_pred ccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHH--------HhcCcc---------C
Confidence 334456788999999998999999999999999999999 9999975443321111 111100 0
Q ss_pred ccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCC
Q 041576 658 MADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLEV 698 (714)
Q Consensus 658 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 698 (714)
..+...+..+.+++.+||+.||++|||++|+++.|+++.+.
T Consensus 227 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 227 YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 11122245678899999999999999999999999987653
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=357.07 Aligned_cols=251 Identities=25% Similarity=0.312 Sum_probs=207.3
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchh------hHHHHHHHHHHHhccCcccccceeceEecCCee
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQE------REREFKTEVSAIGRTHHKNLVQLLGFCDEGLNR 493 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 493 (714)
..|.+.+.||+|+||.||+|..+ .+++.||+|.++..... ..+.+.+|+.++++++||||+++++++.+....
T Consensus 12 ~~y~~~~~LG~G~fg~V~~~~~~-~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 12 DFYDIGEELGSGQFAIVKKCREK-STGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GTEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hceEEeeEEeeCcCEEEEEEEEC-CCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 35778899999999999999876 57899999999753321 356899999999999999999999999999999
Q ss_pred eEEEeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCC----ceEEecCCCcc
Q 041576 494 LLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDF----TAKISDFGLSK 569 (714)
Q Consensus 494 ~lv~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~----~~kl~Dfg~~~ 569 (714)
++||||+++|+|.+++.....+++..+..++.||+.||+|||+++ |+||||||+||++++++ .+||+|||++.
T Consensus 91 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DFG~a~ 167 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167 (361)
T ss_dssp EEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCSSCE
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEecCCce
Confidence 999999999999999998888999999999999999999999998 99999999999998877 79999999998
Q ss_pred ccccCcccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccce
Q 041576 570 LLLSDQSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDV 649 (714)
Q Consensus 570 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 649 (714)
...... ......||+.|+|||++.+..++.++|||||||++|||++|..||......+....+ ..+...
T Consensus 168 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i--------~~~~~~- 236 (361)
T 2yab_A 168 EIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANI--------TAVSYD- 236 (361)
T ss_dssp ECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH--------HTTCCC-
T ss_pred EcCCCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--------HhcCCC-
Confidence 764432 223456999999999999999999999999999999999999999765433211111 111110
Q ss_pred eecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 650 LVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 650 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
++.. .....+..+.+++.+||+.||++|||+.|+++
T Consensus 237 -~~~~----~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 237 -FDEE----FFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp -CCHH----HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred -CCch----hccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0100 01122346788999999999999999999985
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=353.66 Aligned_cols=248 Identities=26% Similarity=0.287 Sum_probs=207.1
Q ss_pred hhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEeccc---chhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEE
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKL---AQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVY 497 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 497 (714)
.|.+.+.||+|+||.||+|+.+ .+++.||+|++++. .......+.+|++++++++||||+++++++.+.+..++||
T Consensus 6 ~y~~~~~lG~G~fg~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 6 DFDYLKLLGKGTFGKVILVREK-ATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HeEEEEEEecCCCeEEEEEEEC-CCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 4667789999999999999876 57899999999753 2344567899999999999999999999999999999999
Q ss_pred eecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCccc
Q 041576 498 EFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSR 577 (714)
Q Consensus 498 E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 577 (714)
||+++|+|.+++.....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...... .
T Consensus 85 E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~-~ 160 (337)
T 1o6l_A 85 EYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-A 160 (337)
T ss_dssp ECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT-C
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhcccCC-C
Confidence 99999999999988788999999999999999999999998 9999999999999999999999999998643322 2
Q ss_pred ceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhh
Q 041576 578 TRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAA 657 (714)
Q Consensus 578 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 657 (714)
......||+.|+|||++.+..++.++|||||||++|||++|+.||........... ...+...
T Consensus 161 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~--------i~~~~~~--------- 223 (337)
T 1o6l_A 161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL--------ILMEEIR--------- 223 (337)
T ss_dssp CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH--------HHHCCCC---------
T ss_pred cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHH--------HHcCCCC---------
Confidence 23345689999999999999999999999999999999999999975433221111 1111110
Q ss_pred ccchHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 041576 658 MADKSRACKWLMIALWCIQEDPLKRP-----AMKMIVQM 691 (714)
Q Consensus 658 ~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 691 (714)
.+...+..+.+++.+||+.||++|| +++||++.
T Consensus 224 -~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 224 -FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp -CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred -CCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 1122345678899999999999999 89999763
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=367.34 Aligned_cols=260 Identities=26% Similarity=0.387 Sum_probs=200.1
Q ss_pred HHhhhhhhhhCcccceeEEEeEeeC--CCCcEEEEEEeccc-chhhHHHHHHHHHHHhccCcccccceeceEecCCeeeE
Q 041576 419 EATNGFEEELGRGSFGIVYKGVLKS--ASGNAVAVKKLDKL-AQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLL 495 (714)
Q Consensus 419 ~at~~~~~~ig~G~~g~Vy~~~~~~--~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 495 (714)
...+.+.+.||+|+||.||+|++.. ..+..||||.++.. .....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 3466778899999999999998752 35678999999754 34456789999999999999999999999999999999
Q ss_pred EEeecCCCchhhhhhcCC-CCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccC
Q 041576 496 VYEFMGNGTLANLLFAIP-RPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSD 574 (714)
Q Consensus 496 v~E~~~~gsL~~~l~~~~-~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 574 (714)
||||+++++|.+++.... .+++.+++.++.||++||+|||+++ |+||||||+||+++.++.+||+|||+++.....
T Consensus 124 v~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 200 (373)
T 2qol_A 124 VTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLEDD 200 (373)
T ss_dssp EEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccccccccC
Confidence 999999999999998654 6899999999999999999999998 999999999999999999999999999876543
Q ss_pred cccc--eeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccchhhhhhhHHHhhhhhcCccceee
Q 041576 575 QSRT--RTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEERSAILTDWAYDCYVEGKLDVLV 651 (714)
Q Consensus 575 ~~~~--~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 651 (714)
.... .....++..|+|||.+.+..++.++||||||+++|||++ |+.||.......... ....+..
T Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~--------~i~~~~~---- 268 (373)
T 2qol_A 201 PEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIK--------AVDEGYR---- 268 (373)
T ss_dssp -------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHH--------HHHTTEE----
T ss_pred CccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHH--------HHHcCCC----
Confidence 3221 122235678999999999999999999999999999998 999997543322111 1111100
Q ss_pred cchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCC
Q 041576 652 DNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLEV 698 (714)
Q Consensus 652 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 698 (714)
...+...+..+.+++.+||+.||++||++.||++.|+.+++.
T Consensus 269 -----~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 310 (373)
T 2qol_A 269 -----LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310 (373)
T ss_dssp -----CCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred -----CCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence 011223345688899999999999999999999999887644
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=350.99 Aligned_cols=252 Identities=25% Similarity=0.318 Sum_probs=207.6
Q ss_pred HHhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccch------hhHHHHHHHHHHHhccCcccccceeceEecCCe
Q 041576 419 EATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQ------EREREFKTEVSAIGRTHHKNLVQLLGFCDEGLN 492 (714)
Q Consensus 419 ~at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 492 (714)
...|.+.+.||+|+||.||+|... .+++.||+|.+..... ...+.+.+|+.++++++||||+++++++.+...
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 88 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREK-STGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 88 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEET-TTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred ccceEeceEEeeCCCeEEEEEEEC-CCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 356788899999999999999876 5789999999865322 135789999999999999999999999999999
Q ss_pred eeEEEeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCC----ceEEecCCCc
Q 041576 493 RLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDF----TAKISDFGLS 568 (714)
Q Consensus 493 ~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~----~~kl~Dfg~~ 568 (714)
.++||||+++++|.+++.....+++..+..++.||+.||+|||+.+ |+||||||+||+++.++ .+||+|||++
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a 165 (326)
T 2y0a_A 89 VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165 (326)
T ss_dssp EEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECCCC
Confidence 9999999999999999988888999999999999999999999998 99999999999999887 8999999999
Q ss_pred cccccCcccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccc
Q 041576 569 KLLLSDQSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLD 648 (714)
Q Consensus 569 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 648 (714)
....... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...........+. .....
T Consensus 166 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~--------~~~~~ 235 (326)
T 2y0a_A 166 HKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS--------AVNYE 235 (326)
T ss_dssp EECCTTS--CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH--------HTCCC
T ss_pred eECCCCC--ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHH--------hcCCC
Confidence 8764332 2234568999999999999999999999999999999999999997543322111110 00000
Q ss_pred eeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 649 VLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 649 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
... ......+..+.+++.+||+.||++|||+.|+++
T Consensus 236 --~~~----~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 236 --FED----EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp --CCH----HHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred --cCc----cccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 000 011122346778999999999999999999987
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-41 Score=348.05 Aligned_cols=257 Identities=26% Similarity=0.396 Sum_probs=209.1
Q ss_pred HHHhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEE
Q 041576 418 NEATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVY 497 (714)
Q Consensus 418 ~~at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 497 (714)
....|.+.+.||+|+||.||+|.++ ++..||+|+++... ...+++.+|++++++++||||+++++++.+.+..++||
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWR--GQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIIT 98 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEET--TTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEc--CCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEE
Confidence 3456777899999999999999875 57789999997543 23467899999999999999999999999999999999
Q ss_pred eecCCCchhhhhhc-CCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcc
Q 041576 498 EFMGNGTLANLLFA-IPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQS 576 (714)
Q Consensus 498 E~~~~gsL~~~l~~-~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 576 (714)
||+++++|.+++.. ...+++..++.++.||++||+|||+++ |+||||||+||+++.++.+||+|||++........
T Consensus 99 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 175 (283)
T 3gen_A 99 EYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY 175 (283)
T ss_dssp CCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH
T ss_pred eccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEcccccccccccccc
Confidence 99999999999986 467899999999999999999999998 99999999999999999999999999987654433
Q ss_pred cceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccchhhhhhhHHHhhhhhcCccceeecchh
Q 041576 577 RTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDK 655 (714)
Q Consensus 577 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 655 (714)
.......++..|+|||.+.+..++.++||||||+++|||++ |+.||...........+ ..+..
T Consensus 176 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~--------~~~~~-------- 239 (283)
T 3gen_A 176 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI--------AQGLR-------- 239 (283)
T ss_dssp HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH--------HTTCC--------
T ss_pred ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHH--------hcccC--------
Confidence 33333456788999999998899999999999999999998 99999755433211111 11100
Q ss_pred hhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccC
Q 041576 656 AAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLE 697 (714)
Q Consensus 656 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 697 (714)
...+...+..+.+++.+||+.||++|||++|+++.|+++++
T Consensus 240 -~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~ 280 (283)
T 3gen_A 240 -LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD 280 (283)
T ss_dssp -CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -CCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhh
Confidence 00111223567889999999999999999999999998764
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-40 Score=346.53 Aligned_cols=271 Identities=21% Similarity=0.272 Sum_probs=211.9
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc-hhhHHHHHHHHHHHhccCcccccceeceEecCC--eeeEE
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA-QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGL--NRLLV 496 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~--~~~lv 496 (714)
.+|.+.+.||+|+||+||+|... .+++.||||+++... ....+.+.+|++++++++||||+++++++.... ..++|
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHK-KTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEEC-CCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 35777899999999999999976 468999999997543 344567889999999999999999999997665 77999
Q ss_pred EeecCCCchhhhhhcCC---CCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEE----CCCCceEEecCCCcc
Q 041576 497 YEFMGNGTLANLLFAIP---RPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILL----DQDFTAKISDFGLSK 569 (714)
Q Consensus 497 ~E~~~~gsL~~~l~~~~---~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll----~~~~~~kl~Dfg~~~ 569 (714)
|||+++++|.+++.... .+++..++.++.||++||+|||+++ |+||||||+||++ +.++.+||+|||+++
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 99999999999998653 3899999999999999999999998 9999999999999 788889999999998
Q ss_pred ccccCcccceeeecCCCCccCccccc--------CCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhh
Q 041576 570 LLLSDQSRTRTVIRGTRGYVAPEWFK--------NVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDC 641 (714)
Q Consensus 570 ~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~ 641 (714)
....... .....||..|+|||++. +..++.++|||||||++|||++|+.||...........+.......
T Consensus 165 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 242 (319)
T 4euu_A 165 ELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242 (319)
T ss_dssp ECCTTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHH
T ss_pred ecCCCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcC
Confidence 7644332 23346899999999986 5678999999999999999999999997543322211111111111
Q ss_pred hhcCccceee-----------cchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 041576 642 YVEGKLDVLV-----------DNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYL 696 (714)
Q Consensus 642 ~~~~~~~~~~-----------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 696 (714)
.......... ...............+.+++.+||+.||++|||++|+++...+..
T Consensus 243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred CCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence 1111111100 001111234566778889999999999999999999999987654
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=361.29 Aligned_cols=262 Identities=27% Similarity=0.371 Sum_probs=210.2
Q ss_pred HHHHhhhhhhhhCcccceeEEEeEee----CCCCcEEEEEEeccc-chhhHHHHHHHHHHHhcc-CcccccceeceEecC
Q 041576 417 LNEATNGFEEELGRGSFGIVYKGVLK----SASGNAVAVKKLDKL-AQEREREFKTEVSAIGRT-HHKNLVQLLGFCDEG 490 (714)
Q Consensus 417 l~~at~~~~~~ig~G~~g~Vy~~~~~----~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~ 490 (714)
+....|.+.+.||+|+||.||+|.+. ..+++.||||+++.. .....+.+.+|++++.++ +||||+++++++.+.
T Consensus 19 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~ 98 (359)
T 3vhe_A 19 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 98 (359)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred ccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecC
Confidence 34456777899999999999999853 245689999999763 334456899999999999 899999999999776
Q ss_pred Ce-eeEEEeecCCCchhhhhhcCCC-------------------------------------------------------
Q 041576 491 LN-RLLVYEFMGNGTLANLLFAIPR------------------------------------------------------- 514 (714)
Q Consensus 491 ~~-~~lv~E~~~~gsL~~~l~~~~~------------------------------------------------------- 514 (714)
+. .++||||+++|+|.+++.....
T Consensus 99 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (359)
T 3vhe_A 99 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 178 (359)
T ss_dssp TSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------------
T ss_pred CCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhh
Confidence 54 8999999999999999976532
Q ss_pred -----------CChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcc-cceeee
Q 041576 515 -----------PDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQS-RTRTVI 582 (714)
Q Consensus 515 -----------~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~ 582 (714)
+++..++.++.||++||+|||+++ |+||||||+||+++.++.+||+|||++........ ......
T Consensus 179 ~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 255 (359)
T 3vhe_A 179 EEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 255 (359)
T ss_dssp -----CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--C
T ss_pred cccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecccccchhcccc
Confidence 788899999999999999999998 99999999999999999999999999986644332 223345
Q ss_pred cCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhhccch
Q 041576 583 RGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMADK 661 (714)
Q Consensus 583 ~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 661 (714)
.+|..|+|||++.+..++.++||||||+++|||++ |+.||........ +. .....+.... .+.
T Consensus 256 ~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~---~~----~~~~~~~~~~---------~~~ 319 (359)
T 3vhe_A 256 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---FC----RRLKEGTRMR---------APD 319 (359)
T ss_dssp EECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH---HH----HHHHHTCCCC---------CCT
T ss_pred CCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHH---HH----HHHHcCCCCC---------CCC
Confidence 67889999999999999999999999999999998 9999975433221 10 1111111110 112
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccC
Q 041576 662 SRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLE 697 (714)
Q Consensus 662 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 697 (714)
.....+.+++.+||+.||++|||++||++.|+.+++
T Consensus 320 ~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 355 (359)
T 3vhe_A 320 YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 355 (359)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 233567889999999999999999999999998764
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=349.64 Aligned_cols=251 Identities=21% Similarity=0.280 Sum_probs=206.5
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEee
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEF 499 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~ 499 (714)
..|.+.+.||+|+||.||+|... .+++.||+|.+... ......+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 5 EKYMIAEDLGRGEFGIVHRCVET-SSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hceEeeeEEecCCCeEEEEEEEC-CCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 35677899999999999999876 57889999998753 33456789999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCC-CCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECC--CCceEEecCCCccccccCcc
Q 041576 500 MGNGTLANLLFAIP-RPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQ--DFTAKISDFGLSKLLLSDQS 576 (714)
Q Consensus 500 ~~~gsL~~~l~~~~-~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~--~~~~kl~Dfg~~~~~~~~~~ 576 (714)
+++++|.+++.... .+++.++..++.||+.||+|||+++ |+||||||+||+++. ++.+||+|||++.......
T Consensus 83 ~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~- 158 (321)
T 1tki_A 83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD- 158 (321)
T ss_dssp CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC-
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC-
Confidence 99999999998653 6899999999999999999999998 999999999999987 7899999999998764432
Q ss_pred cceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhh
Q 041576 577 RTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKA 656 (714)
Q Consensus 577 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 656 (714)
......|++.|+|||.+.+..++.++||||||+++|||++|+.||...........+ ..+... ....
T Consensus 159 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i--------~~~~~~--~~~~-- 225 (321)
T 1tki_A 159 -NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENI--------MNAEYT--FDEE-- 225 (321)
T ss_dssp -EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH--------HHTCCC--CCHH--
T ss_pred -ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHH--------HcCCCC--CChh--
Confidence 234456899999999999988999999999999999999999999765433211111 111110 0000
Q ss_pred hccchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 657 AMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 657 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
.....+..+.+++.+||+.||++|||+.|+++.
T Consensus 226 --~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 226 --AFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp --HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred --hhccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 011234567889999999999999999999983
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-41 Score=363.67 Aligned_cols=268 Identities=26% Similarity=0.328 Sum_probs=216.3
Q ss_pred HHHHHhhhhhhhhCcccceeEEEeEeeC------CCCcEEEEEEeccc-chhhHHHHHHHHHHHhcc-CcccccceeceE
Q 041576 416 ELNEATNGFEEELGRGSFGIVYKGVLKS------ASGNAVAVKKLDKL-AQEREREFKTEVSAIGRT-HHKNLVQLLGFC 487 (714)
Q Consensus 416 el~~at~~~~~~ig~G~~g~Vy~~~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~ 487 (714)
++...++.+.+.||+|+||.||+|.... ..+..||||+++.. .....+.+.+|+++++++ +||||+++++++
T Consensus 65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~ 144 (382)
T 3tt0_A 65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 144 (382)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence 3444677888999999999999998642 23457999999754 344457899999999999 999999999999
Q ss_pred ecCCeeeEEEeecCCCchhhhhhcCC----------------CCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCe
Q 041576 488 DEGLNRLLVYEFMGNGTLANLLFAIP----------------RPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQN 551 (714)
Q Consensus 488 ~~~~~~~lv~E~~~~gsL~~~l~~~~----------------~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~N 551 (714)
.+++..++||||+++|+|.+++.... .+++.+++.++.||+.||+|||+++ |+||||||+|
T Consensus 145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~N 221 (382)
T 3tt0_A 145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARN 221 (382)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGG
T ss_pred ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcce
Confidence 99999999999999999999997643 4889999999999999999999998 9999999999
Q ss_pred EEECCCCceEEecCCCccccccCcc-cceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccch
Q 041576 552 ILLDQDFTAKISDFGLSKLLLSDQS-RTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEE 629 (714)
Q Consensus 552 Ill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~ 629 (714)
||++.++.+||+|||+++....... .......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+
T Consensus 222 Ill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~ 301 (382)
T 3tt0_A 222 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 301 (382)
T ss_dssp EEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred EEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999999987644332 22233457889999999999999999999999999999999 999997543332
Q ss_pred hhhhhhHHHhhhhhcCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCCCCCCC
Q 041576 630 RSAILTDWAYDCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLEVPSPPM 703 (714)
Q Consensus 630 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~pp~ 703 (714)
... ....+.... .+......+.+++.+||+.||++|||++||++.|++++.......
T Consensus 302 ~~~--------~~~~~~~~~---------~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~ 358 (382)
T 3tt0_A 302 LFK--------LLKEGHRMD---------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQE 358 (382)
T ss_dssp HHH--------HHHTTCCCC---------CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC
T ss_pred HHH--------HHHcCCCCC---------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCC
Confidence 111 111111110 112234568889999999999999999999999999876544333
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=356.48 Aligned_cols=259 Identities=24% Similarity=0.394 Sum_probs=211.6
Q ss_pred HhhhhhhhhCcccceeEEEeEeeC----CCCcEEEEEEeccc-chhhHHHHHHHHHHHhccCcccccceeceEecCCeee
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKS----ASGNAVAVKKLDKL-AQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRL 494 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~----~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 494 (714)
..|.+.+.||+|+||.||+|.+.. .+++.||||.++.. .....+.+.+|++++++++||||+++++++.+++..+
T Consensus 47 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 126 (343)
T 1luf_A 47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMC 126 (343)
T ss_dssp GGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceE
Confidence 456677899999999999999863 34589999999764 3344678999999999999999999999999999999
Q ss_pred EEEeecCCCchhhhhhcC------------------------CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcC
Q 041576 495 LVYEFMGNGTLANLLFAI------------------------PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQ 550 (714)
Q Consensus 495 lv~E~~~~gsL~~~l~~~------------------------~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~ 550 (714)
+||||+++++|.+++... ..+++.+++.++.||++||+|||+++ |+||||||+
T Consensus 127 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~ 203 (343)
T 1luf_A 127 LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATR 203 (343)
T ss_dssp EEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGG
T ss_pred EEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcc
Confidence 999999999999999763 46789999999999999999999998 999999999
Q ss_pred eEEECCCCceEEecCCCccccccCcc-cceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccc
Q 041576 551 NILLDQDFTAKISDFGLSKLLLSDQS-RTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGE 628 (714)
Q Consensus 551 NIll~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~ 628 (714)
||+++.++.+||+|||++........ .......++..|+|||.+.+..++.++||||||+++|||++ |+.||......
T Consensus 204 NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~ 283 (343)
T 1luf_A 204 NCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE 283 (343)
T ss_dssp GEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH
T ss_pred eEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCChH
Confidence 99999999999999999986643322 22334557889999999998899999999999999999999 99999754332
Q ss_pred hhhhhhhHHHhhhhhcCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCC
Q 041576 629 ERSAILTDWAYDCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLEV 698 (714)
Q Consensus 629 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 698 (714)
... .....+.... .+...+..+.+++.+||+.||++|||+.||++.|+++.+.
T Consensus 284 ~~~--------~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~ 336 (343)
T 1luf_A 284 EVI--------YYVRDGNILA---------CPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCER 336 (343)
T ss_dssp HHH--------HHHHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-
T ss_pred HHH--------HHHhCCCcCC---------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhh
Confidence 211 1111121111 1122345688899999999999999999999999998754
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=373.85 Aligned_cols=259 Identities=23% Similarity=0.382 Sum_probs=211.6
Q ss_pred HHHHhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEE
Q 041576 417 LNEATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLV 496 (714)
Q Consensus 417 l~~at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 496 (714)
+....+.+.+.||+|+||.||+|.+. .+..||||+++... ...+.+.+|++++++++||||+++++++. .+..++|
T Consensus 185 i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv 260 (454)
T 1qcf_A 185 IPRESLKLEKKLGAGQFGEVWMATYN--KHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYII 260 (454)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEET--TTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred echHHeEEEEEcccCCceEEEEEEEC--CccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEE
Confidence 33456777899999999999999875 57789999997643 34678999999999999999999999986 5678999
Q ss_pred EeecCCCchhhhhhcC--CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccC
Q 041576 497 YEFMGNGTLANLLFAI--PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSD 574 (714)
Q Consensus 497 ~E~~~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 574 (714)
|||+++|+|.+++... ..+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~ 337 (454)
T 1qcf_A 261 TEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDN 337 (454)
T ss_dssp ECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCH
T ss_pred EeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCC
Confidence 9999999999999854 36788999999999999999999998 999999999999999999999999999876443
Q ss_pred cccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccchhhhhhhHHHhhhhhcCccceeecc
Q 041576 575 QSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDN 653 (714)
Q Consensus 575 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 653 (714)
.........++..|+|||.+....++.++||||||+++|||++ |+.||......+.... ...+..
T Consensus 338 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~--------i~~~~~------ 403 (454)
T 1qcf_A 338 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRA--------LERGYR------ 403 (454)
T ss_dssp HHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH--------HHHTCC------
T ss_pred ceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHH--------HHcCCC------
Confidence 3222333446788999999998899999999999999999999 9999975433221111 111100
Q ss_pred hhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCCC
Q 041576 654 DKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLEVP 699 (714)
Q Consensus 654 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 699 (714)
...+...+..+.+++.+||+.||++|||+++|++.|+.+....
T Consensus 404 ---~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~ 446 (454)
T 1qcf_A 404 ---MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTAT 446 (454)
T ss_dssp ---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSS
T ss_pred ---CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcc
Confidence 0012233457888999999999999999999999999987543
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=377.40 Aligned_cols=259 Identities=26% Similarity=0.361 Sum_probs=213.4
Q ss_pred HHHhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEE
Q 041576 418 NEATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVY 497 (714)
Q Consensus 418 ~~at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 497 (714)
....+.+.+.||+|+||.||+|.++ .++..||||.++... ...+.+.+|++++++++||||+++++++.+....++||
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 295 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWK-KYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 295 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEG-GGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred CHHHceeeeEecCCCCeEEEEEEEc-CCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEE
Confidence 3455777899999999999999986 357899999997643 34678999999999999999999999999999999999
Q ss_pred eecCCCchhhhhhcC--CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCc
Q 041576 498 EFMGNGTLANLLFAI--PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQ 575 (714)
Q Consensus 498 E~~~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 575 (714)
||+++|+|.+++... ..+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 296 E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 372 (495)
T 1opk_A 296 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT 372 (495)
T ss_dssp ECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTCC
T ss_pred EccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCCc
Confidence 999999999999753 45889999999999999999999998 9999999999999999999999999998765433
Q ss_pred ccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccchhhhhhhHHHhhhhhcCccceeecch
Q 041576 576 SRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDND 654 (714)
Q Consensus 576 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 654 (714)
........++..|+|||.+.+..++.++||||||++||||++ |+.||........... ...+.
T Consensus 373 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~--------~~~~~-------- 436 (495)
T 1opk_A 373 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL--------LEKDY-------- 436 (495)
T ss_dssp EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH--------HHTTC--------
T ss_pred eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHH--------HHcCC--------
Confidence 333333446778999999998899999999999999999999 9999975433221111 11110
Q ss_pred hhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCC
Q 041576 655 KAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLEV 698 (714)
Q Consensus 655 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 698 (714)
....+...+..+.+++.+||+.||++|||+.||++.|+.+++.
T Consensus 437 -~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~ 479 (495)
T 1opk_A 437 -RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 479 (495)
T ss_dssp -CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSS
T ss_pred -CCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhc
Confidence 0111223345788899999999999999999999999998654
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=365.92 Aligned_cols=254 Identities=21% Similarity=0.233 Sum_probs=205.7
Q ss_pred hhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccch---hhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEE
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQ---EREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVY 497 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 497 (714)
.+.+.++||+|+||+||+|+++ .+++.||+|++++... .....+.+|..++.+++||||+++++++.+++..++||
T Consensus 75 ~y~~~~~LG~G~fG~V~~~~~~-~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~ 153 (437)
T 4aw2_A 75 DFEILKVIGRGAFGEVAVVKLK-NADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVM 153 (437)
T ss_dssp GEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEE
T ss_pred heEEEEEEEeCCCEEEEEEEEc-CCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEE
Confidence 4556689999999999999986 4688999999975322 22334889999999999999999999999999999999
Q ss_pred eecCCCchhhhhhc-CCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcc
Q 041576 498 EFMGNGTLANLLFA-IPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQS 576 (714)
Q Consensus 498 E~~~~gsL~~~l~~-~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 576 (714)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.......
T Consensus 154 Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 230 (437)
T 4aw2_A 154 DYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT 230 (437)
T ss_dssp CCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTTSC
T ss_pred ecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcchhhhhhcccCCC
Confidence 99999999999987 467899999999999999999999998 99999999999999999999999999987655444
Q ss_pred cceeeecCCCCccCccccc-----CCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceee
Q 041576 577 RTRTVIRGTRGYVAPEWFK-----NVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLV 651 (714)
Q Consensus 577 ~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 651 (714)
.......||+.|+|||++. ...++.++|||||||++|||++|+.||......+....+...... -....
T Consensus 231 ~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~----~~~p~-- 304 (437)
T 4aw2_A 231 VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKER----FQFPT-- 304 (437)
T ss_dssp EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH----CCCCS--
T ss_pred cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhcccc----ccCCc--
Confidence 4444567999999999997 567899999999999999999999999865443322222111000 00000
Q ss_pred cchhhhccchHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 041576 652 DNDKAAMADKSRACKWLMIALWCIQEDPLK--RPAMKMIVQM 691 (714)
Q Consensus 652 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~ 691 (714)
.....+..+.+++.+||+.+|++ ||+++|+++.
T Consensus 305 -------~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 305 -------QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp -------SCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred -------ccccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 00113446778999999888888 9999999873
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=365.39 Aligned_cols=256 Identities=24% Similarity=0.354 Sum_probs=208.1
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc-hhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEe
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA-QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYE 498 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E 498 (714)
..+.+.+.||+|+||.||+|.+. .+++.||||.++... ......+.+|++++++++||||+++++++.+++..++|||
T Consensus 114 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 192 (377)
T 3cbl_A 114 EDLVLGEQIGRGNFGEVFSGRLR-ADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192 (377)
T ss_dssp GGEEEEEEEEEETTEEEEEEEET-TTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred HHeEEeeEeccCCCCeEEEEEEe-cCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence 45667889999999999999986 468899999997542 3344578999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCccc
Q 041576 499 FMGNGTLANLLFAI-PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSR 577 (714)
Q Consensus 499 ~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 577 (714)
|+++|+|.+++... ..+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++........
T Consensus 193 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~ 269 (377)
T 3cbl_A 193 LVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYA 269 (377)
T ss_dssp CCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEE
T ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCCCcee
Confidence 99999999999764 35899999999999999999999998 999999999999999999999999999864332211
Q ss_pred ce-eeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccchhhhhhhHHHhhhhhcCccceeecchh
Q 041576 578 TR-TVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDK 655 (714)
Q Consensus 578 ~~-~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 655 (714)
.. ....++..|+|||.+.+..++.++||||||+++|||++ |+.||........... ...+...
T Consensus 270 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~--------~~~~~~~------- 334 (377)
T 3cbl_A 270 ASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREF--------VEKGGRL------- 334 (377)
T ss_dssp CCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHH--------HHTTCCC-------
T ss_pred ecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH--------HHcCCCC-------
Confidence 11 11235678999999998889999999999999999998 9999975433221111 1111100
Q ss_pred hhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 041576 656 AAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYL 696 (714)
Q Consensus 656 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 696 (714)
..+...+..+.+++.+||+.||++|||+++|++.|+.+.
T Consensus 335 --~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~ 373 (377)
T 3cbl_A 335 --PCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373 (377)
T ss_dssp --CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 112223456788999999999999999999999998764
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=348.87 Aligned_cols=259 Identities=21% Similarity=0.301 Sum_probs=198.6
Q ss_pred HHHhhhhhhhhCcccceeEEEeEeeCC--CCcEEEEEEeccc-chhhHHHHHHHHHHHhccCcccccceeceEecCCeee
Q 041576 418 NEATNGFEEELGRGSFGIVYKGVLKSA--SGNAVAVKKLDKL-AQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRL 494 (714)
Q Consensus 418 ~~at~~~~~~ig~G~~g~Vy~~~~~~~--~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 494 (714)
...+|.+.+.||+|+||.||+|.+... .+..||+|.++.. .....+.+.+|+.++++++||||+++++++. ++..+
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 91 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 91 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccE
Confidence 345677889999999999999987532 3457999998753 3344568999999999999999999999984 46789
Q ss_pred EEEeecCCCchhhhhhcCC-CCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCcccccc
Q 041576 495 LVYEFMGNGTLANLLFAIP-RPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLS 573 (714)
Q Consensus 495 lv~E~~~~gsL~~~l~~~~-~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~ 573 (714)
+||||+++++|.+++.... .+++..++.++.||++||+|||+++ |+||||||+||+++.++.+||+|||++.....
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 168 (281)
T 1mp8_A 92 IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 168 (281)
T ss_dssp EEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC---------
T ss_pred EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccccccCc
Confidence 9999999999999998654 6899999999999999999999998 99999999999999999999999999987654
Q ss_pred CcccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccchhhhhhhHHHhhhhhcCccceeec
Q 041576 574 DQSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVD 652 (714)
Q Consensus 574 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 652 (714)
..........+++.|+|||.+.+..++.++||||||+++|||++ |..||......+.... ...+...
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~--------i~~~~~~---- 236 (281)
T 1mp8_A 169 STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR--------IENGERL---- 236 (281)
T ss_dssp ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH--------HHTTCCC----
T ss_pred ccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHH--------HHcCCCC----
Confidence 44333344456789999999998899999999999999999997 9999975543321111 1111110
Q ss_pred chhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccC
Q 041576 653 NDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLE 697 (714)
Q Consensus 653 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 697 (714)
..+...+..+.+++.+||+.||++|||+.|+++.|+.+++
T Consensus 237 -----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 276 (281)
T 1mp8_A 237 -----PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 276 (281)
T ss_dssp -----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 0112234567889999999999999999999999988754
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=353.92 Aligned_cols=253 Identities=23% Similarity=0.313 Sum_probs=207.8
Q ss_pred HHhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEeccc--chhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEE
Q 041576 419 EATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKL--AQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLV 496 (714)
Q Consensus 419 ~at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 496 (714)
...|.+.+.||+|+||.||+|..+ .+++.||+|++... .....+.+.+|++++++++||||+++++++.+++..++|
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHK-TTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEEC-CCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 456888899999999999999876 57899999999643 334556889999999999999999999999999999999
Q ss_pred EeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCC---ceEEecCCCcccccc
Q 041576 497 YEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDF---TAKISDFGLSKLLLS 573 (714)
Q Consensus 497 ~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~---~~kl~Dfg~~~~~~~ 573 (714)
|||+++++|.+.+.....+++..+..++.||++||+|||+++ |+||||||+||+++.++ .+||+|||++.....
T Consensus 107 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~ 183 (362)
T 2bdw_A 107 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 183 (362)
T ss_dssp ECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTT
T ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceEecC
Confidence 999999999999988888999999999999999999999998 99999999999998654 599999999987643
Q ss_pred CcccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecc
Q 041576 574 DQSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDN 653 (714)
Q Consensus 574 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 653 (714)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......... ....+.... ...
T Consensus 184 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~--------~i~~~~~~~-~~~ 252 (362)
T 2bdw_A 184 SE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYA--------QIKAGAYDY-PSP 252 (362)
T ss_dssp CC--SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH--------HHHHTCCCC-CTT
T ss_pred Cc--ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHH--------HHHhCCCCC-Ccc
Confidence 32 2234569999999999999999999999999999999999999997543322111 111111110 000
Q ss_pred hhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 654 DKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 654 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
.....+..+.+++.+||+.||++|||+.|+++.
T Consensus 253 -----~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 253 -----EWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp -----GGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred -----cccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 011234567889999999999999999999763
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=352.50 Aligned_cols=273 Identities=22% Similarity=0.340 Sum_probs=211.4
Q ss_pred CHHHHHHHhhhhhhhhCcccceeEEEeEe---eCCCCcEEEEEEeccc-chhhHHHHHHHHHHHhccCcccccceeceEe
Q 041576 413 SLVELNEATNGFEEELGRGSFGIVYKGVL---KSASGNAVAVKKLDKL-AQEREREFKTEVSAIGRTHHKNLVQLLGFCD 488 (714)
Q Consensus 413 ~~~el~~at~~~~~~ig~G~~g~Vy~~~~---~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~ 488 (714)
....+....+.+.+.||+|+||.||+|++ ...+++.||||+++.. .....+.+.+|++++++++||||+++++++.
T Consensus 14 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 93 (302)
T 4e5w_A 14 DPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICT 93 (302)
T ss_dssp CTTBCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred ChhhhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEe
Confidence 33444456678889999999999999984 2357889999999753 3344578999999999999999999999998
Q ss_pred cC--CeeeEEEeecCCCchhhhhhc-CCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecC
Q 041576 489 EG--LNRLLVYEFMGNGTLANLLFA-IPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDF 565 (714)
Q Consensus 489 ~~--~~~~lv~E~~~~gsL~~~l~~-~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Df 565 (714)
+. ...++||||+++++|.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+||+++.++.+||+||
T Consensus 94 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Df 170 (302)
T 4e5w_A 94 EDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDF 170 (302)
T ss_dssp C---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCC
T ss_pred cCCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECcc
Confidence 76 668999999999999999954 457899999999999999999999998 999999999999999999999999
Q ss_pred CCccccccCcc--cceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhh-------hhhhH
Q 041576 566 GLSKLLLSDQS--RTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERS-------AILTD 636 (714)
Q Consensus 566 g~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~-------~~l~~ 636 (714)
|++........ .......++..|+|||.+.+..++.++||||||+++|||++|+.|+......... .....
T Consensus 171 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 250 (302)
T 4e5w_A 171 GLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVT 250 (302)
T ss_dssp TTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHH
T ss_pred cccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHH
Confidence 99987654432 2223345788899999999989999999999999999999999987533211000 00000
Q ss_pred HHhhhhhcCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccC
Q 041576 637 WAYDCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLE 697 (714)
Q Consensus 637 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 697 (714)
........+ .....+...+..+.+++.+||+.||++|||+.|+++.|+.+++
T Consensus 251 ~~~~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll~ 302 (302)
T 4e5w_A 251 RLVNTLKEG---------KRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK 302 (302)
T ss_dssp HHHHHHHTT---------CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred HHHHHHhcc---------CCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhC
Confidence 000001111 0111122344678889999999999999999999999998753
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=350.92 Aligned_cols=269 Identities=20% Similarity=0.279 Sum_probs=204.4
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEeccc---chhhHHHHHHHHHHHhccCcccccceeceEecCCee---
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKL---AQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNR--- 493 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~--- 493 (714)
..|.+.+.||+|+||.||+|.+. .+++.||||+++.. .......+.+|++++++++||||+++++++......
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 12 DRYELGEILGFGGMSEVHLARDL-RDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred CcEEEEEEEccCCCEEEEEEEEC-CCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 45778899999999999999875 57899999999753 233456789999999999999999999998765543
Q ss_pred -eEEEeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccc
Q 041576 494 -LLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLL 572 (714)
Q Consensus 494 -~lv~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~ 572 (714)
++||||+++++|.+++.....+++.+++.++.||++||+|||+++ |+||||||+||+++.++.+||+|||++....
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 167 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIA 167 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC----
T ss_pred cEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCccccc
Confidence 999999999999999988788999999999999999999999998 9999999999999999999999999998764
Q ss_pred cCcc--cceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCcccee
Q 041576 573 SDQS--RTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVL 650 (714)
Q Consensus 573 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 650 (714)
.... .......|++.|+|||.+.+..++.++||||||+++|||++|+.||......... .........
T Consensus 168 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~-------~~~~~~~~~--- 237 (311)
T 3ork_A 168 DSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVA-------YQHVREDPI--- 237 (311)
T ss_dssp --------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-------HHHHHCCCC---
T ss_pred ccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH-------HHHhcCCCC---
Confidence 4322 2223356899999999999999999999999999999999999999754332211 111111100
Q ss_pred ecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHH-HHHHHhcccCCCCCCCCCC
Q 041576 651 VDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKM-IVQMLEGYLEVPSPPMPPL 706 (714)
Q Consensus 651 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e-vl~~L~~~~~~~~pp~p~~ 706 (714)
.........+..+.+++.+||+.||++||++.+ +...+........|+.|..
T Consensus 238 ----~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~~~~~~~~~ 290 (311)
T 3ork_A 238 ----PPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEPPEAPKV 290 (311)
T ss_dssp ----CHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTTCCCSSCCC
T ss_pred ----CcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcCCCCCCCcc
Confidence 001111223456788999999999999996555 4556666655554444443
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=350.51 Aligned_cols=256 Identities=25% Similarity=0.405 Sum_probs=205.8
Q ss_pred HHHhhhhhhhhCcccceeEEEeEeeCCCC------cEEEEEEecccchhhHHHHHHHHHHHhccCcccccceeceEecCC
Q 041576 418 NEATNGFEEELGRGSFGIVYKGVLKSASG------NAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGL 491 (714)
Q Consensus 418 ~~at~~~~~~ig~G~~g~Vy~~~~~~~~~------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 491 (714)
....|.+.+.||+|+||.||+|....... ..||+|.+........+.+.+|++++++++||||+++++++.+++
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (289)
T 4fvq_A 6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGD 85 (289)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTT
T ss_pred chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCC
Confidence 34567788999999999999998764321 579999998777777788999999999999999999999999999
Q ss_pred eeeEEEeecCCCchhhhhhcCCC-CChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCc--------eEE
Q 041576 492 NRLLVYEFMGNGTLANLLFAIPR-PDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFT--------AKI 562 (714)
Q Consensus 492 ~~~lv~E~~~~gsL~~~l~~~~~-~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~--------~kl 562 (714)
..++||||+++++|.+++..... +++..++.++.||++||+|||+++ |+||||||+||+++.++. +||
T Consensus 86 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~kl 162 (289)
T 4fvq_A 86 ENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKL 162 (289)
T ss_dssp CCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEEE
T ss_pred CCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceeee
Confidence 99999999999999999987654 899999999999999999999998 999999999999998887 999
Q ss_pred ecCCCccccccCcccceeeecCCCCccCcccccC-CCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhh
Q 041576 563 SDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKN-VPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDC 641 (714)
Q Consensus 563 ~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~ 641 (714)
+|||++...... ....++..|+|||.+.+ ..++.++||||||+++|||++|..|+............ .
T Consensus 163 ~Dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~--~---- 231 (289)
T 4fvq_A 163 SDPGISITVLPK-----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQF--Y---- 231 (289)
T ss_dssp CCCCSCTTTSCH-----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH--H----
T ss_pred ccCcccccccCc-----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHH--h----
Confidence 999998754322 22347889999999987 67999999999999999999965554432221110000 0
Q ss_pred hhcCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCCC
Q 041576 642 YVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLEVP 699 (714)
Q Consensus 642 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 699 (714)
...... +...+..+.+++.+||+.||++|||++|+++.|++++...
T Consensus 232 ~~~~~~------------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~ 277 (289)
T 4fvq_A 232 EDRHQL------------PAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPD 277 (289)
T ss_dssp HTTCCC------------CCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC---
T ss_pred hccCCC------------CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence 000000 0111234677999999999999999999999999987643
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=350.26 Aligned_cols=252 Identities=29% Similarity=0.355 Sum_probs=203.6
Q ss_pred hhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc-hhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEee
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA-QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEF 499 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~ 499 (714)
.|.+.+.||+|+||.||+|... .+++.||||++.... ....+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus 8 ~y~i~~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 86 (323)
T 3tki_A 8 DWDLVQTLGEGAYGEVQLAVNR-VTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (323)
T ss_dssp CEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hceeeeEEecCCCEEEEEEEEC-CCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEc
Confidence 4677889999999999999876 578999999986432 23346788999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCc-ccc
Q 041576 500 MGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQ-SRT 578 (714)
Q Consensus 500 ~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~ 578 (714)
+++++|.+++.....+++.++..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++....... ...
T Consensus 87 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 163 (323)
T 3tki_A 87 CSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 163 (323)
T ss_dssp CTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred CCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCCcccc
Confidence 999999999998888999999999999999999999998 9999999999999999999999999998664332 222
Q ss_pred eeeecCCCCccCcccccCCCC-CchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhh
Q 041576 579 RTVIRGTRGYVAPEWFKNVPV-SAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAA 657 (714)
Q Consensus 579 ~~~~~gt~~y~aPE~~~~~~~-s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 657 (714)
.....||+.|+|||++.+..+ +.++||||||+++|||++|+.||........ ....+ ...... .
T Consensus 164 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--~~~~~-----~~~~~~--------~ 228 (323)
T 3tki_A 164 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ--EYSDW-----KEKKTY--------L 228 (323)
T ss_dssp BCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH--HHHHH-----HTTCTT--------S
T ss_pred cCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH--HHHHH-----hccccc--------C
Confidence 334578999999999987765 7899999999999999999999975433221 11111 110000 0
Q ss_pred ccchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 658 MADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 658 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
.........+.+++.+||+.||++|||++|+++.
T Consensus 229 ~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 229 NPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 0012234567789999999999999999999874
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=361.41 Aligned_cols=254 Identities=21% Similarity=0.273 Sum_probs=207.4
Q ss_pred HHhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEeccc--chhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEE
Q 041576 419 EATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKL--AQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLV 496 (714)
Q Consensus 419 ~at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 496 (714)
...|.+.+.||+|+||.||+|... .+++.+|+|++... .....+.+.+|++++++++||||+++++++.+++..++|
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~-~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKV-LAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEET-TTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEEC-CCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 456888899999999999999876 57899999998653 334456789999999999999999999999999999999
Q ss_pred EeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEEC---CCCceEEecCCCcccccc
Q 041576 497 YEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLD---QDFTAKISDFGLSKLLLS 573 (714)
Q Consensus 497 ~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~---~~~~~kl~Dfg~~~~~~~ 573 (714)
|||+++|+|.+.+.....+++..+..++.||++||+|||+++ |+||||||+|||++ .++.+||+|||++.....
T Consensus 89 ~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~ 165 (444)
T 3soa_A 89 FDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG 165 (444)
T ss_dssp ECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCT
T ss_pred EEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeEEecC
Confidence 999999999999998888999999999999999999999998 99999999999998 567899999999987644
Q ss_pred CcccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecc
Q 041576 574 DQSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDN 653 (714)
Q Consensus 574 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 653 (714)
... ......||+.|+|||++.+..++.++||||+||++|+|++|+.||.......... ....+.... ..+
T Consensus 166 ~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~--------~i~~~~~~~-~~~ 235 (444)
T 3soa_A 166 EQQ-AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQ--------QIKAGAYDF-PSP 235 (444)
T ss_dssp TCC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH--------HHHHTCCCC-CTT
T ss_pred CCc-eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHH--------HHHhCCCCC-Ccc
Confidence 322 2234569999999999999999999999999999999999999997554332111 111111110 000
Q ss_pred hhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 654 DKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 654 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
.....+..+.+++.+||+.||++|||+.|+++.
T Consensus 236 -----~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 236 -----EWDTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp -----TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred -----ccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 011234567889999999999999999999873
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=350.19 Aligned_cols=259 Identities=26% Similarity=0.356 Sum_probs=211.6
Q ss_pred HHhhhhhhhhCcccceeEEEeEeeC----CCCcEEEEEEeccc-chhhHHHHHHHHHHHhccCcccccceeceEecCCee
Q 041576 419 EATNGFEEELGRGSFGIVYKGVLKS----ASGNAVAVKKLDKL-AQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNR 493 (714)
Q Consensus 419 ~at~~~~~~ig~G~~g~Vy~~~~~~----~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 493 (714)
...|.+.+.||+|+||.||+|.... .+++.||||+++.. .....+.+.+|++++++++||||+++++++.+.+..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 101 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL 101 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence 3557778999999999999998742 34578999999753 344567899999999999999999999999999999
Q ss_pred eEEEeecCCCchhhhhhcCCC------------------------CChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCc
Q 041576 494 LLVYEFMGNGTLANLLFAIPR------------------------PDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKP 549 (714)
Q Consensus 494 ~lv~E~~~~gsL~~~l~~~~~------------------------~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~ 549 (714)
++||||+++++|.+++..... +++.+++.++.||++||+|||+++ |+||||||
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dikp 178 (314)
T 2ivs_A 102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLAA 178 (314)
T ss_dssp EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCSG
T ss_pred EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccccch
Confidence 999999999999999986533 788899999999999999999998 99999999
Q ss_pred CeEEECCCCceEEecCCCccccccCccc-ceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCccccc
Q 041576 550 QNILLDQDFTAKISDFGLSKLLLSDQSR-TRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELG 627 (714)
Q Consensus 550 ~NIll~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~ 627 (714)
+||+++.++.+||+|||++......... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||.....
T Consensus 179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 258 (314)
T 2ivs_A 179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP 258 (314)
T ss_dssp GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 9999999999999999999876443321 2233456788999999998889999999999999999999 9999975543
Q ss_pred chhhhhhhHHHhhhhhcCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccC
Q 041576 628 EERSAILTDWAYDCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLE 697 (714)
Q Consensus 628 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 697 (714)
...... ...+... ..+...+..+.+++.+||+.||++|||+.|+++.|++++.
T Consensus 259 ~~~~~~--------~~~~~~~---------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 311 (314)
T 2ivs_A 259 ERLFNL--------LKTGHRM---------ERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV 311 (314)
T ss_dssp GGHHHH--------HHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHH--------hhcCCcC---------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 321111 1111110 1112234578889999999999999999999999998764
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-40 Score=345.14 Aligned_cols=264 Identities=23% Similarity=0.254 Sum_probs=201.0
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc--hhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEE
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA--QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVY 497 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 497 (714)
..|.+.+.||+|+||+||+|... +++.||+|++.... ......+.+|++++++++||||+++++++.++...++||
T Consensus 21 ~~y~~~~~lG~G~~g~V~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 98 (311)
T 3niz_A 21 EKYQKLEKVGEGTYGVVYKAKDS--QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF 98 (311)
T ss_dssp CEEEEEEEEEECSSCEEEEEEET--TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred hhhHhhhhccCCCCeEEEEEEEC--CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence 45777899999999999999875 58999999996532 223467889999999999999999999999999999999
Q ss_pred eecCCCchhhhhhcC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcc
Q 041576 498 EFMGNGTLANLLFAI-PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQS 576 (714)
Q Consensus 498 E~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 576 (714)
||+++ +|.+++... ..+++..+..++.||++||+|||+++ |+||||||+||+++.++.+||+|||++.......
T Consensus 99 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~- 173 (311)
T 3niz_A 99 EFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPV- 173 (311)
T ss_dssp ECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSCC-
T ss_pred cCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCCc-
Confidence 99985 777777654 45899999999999999999999998 9999999999999999999999999998764322
Q ss_pred cceeeecCCCCccCcccccC-CCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhc-----------
Q 041576 577 RTRTVIRGTRGYVAPEWFKN-VPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVE----------- 644 (714)
Q Consensus 577 ~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~----------- 644 (714)
.......+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||......+....+..........
T Consensus 174 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 253 (311)
T 3niz_A 174 RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLW 253 (311)
T ss_dssp C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHH
T ss_pred ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchh
Confidence 22233468999999999876 568999999999999999999999997654443222211110000000
Q ss_pred -CccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 645 -GKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 645 -~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
.....................++.+++.+||+.||++|||++|+++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 254 KQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp HSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 0000001111111111223457788999999999999999999987
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-41 Score=348.79 Aligned_cols=259 Identities=27% Similarity=0.375 Sum_probs=214.6
Q ss_pred HHHHhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEE
Q 041576 417 LNEATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLV 496 (714)
Q Consensus 417 l~~at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 496 (714)
+....+.+.+.||+|+||.||+|.+. .+++.||+|.+.... ...+.+.+|++++++++||||+++++++.++...++|
T Consensus 10 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v 87 (288)
T 3kfa_A 10 MERTDITMKHKLGGGQYGEVYEGVWK-KYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 87 (288)
T ss_dssp CCGGGEEEEEESGGGTTCSEEEEEEG-GGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEE
T ss_pred ccccceeEEeecCCCCceeEEEeEec-CCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEE
Confidence 44566778899999999999999986 467899999997543 3456889999999999999999999999999999999
Q ss_pred EeecCCCchhhhhhcC--CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccC
Q 041576 497 YEFMGNGTLANLLFAI--PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSD 574 (714)
Q Consensus 497 ~E~~~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 574 (714)
|||+++++|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+||+++.++.+||+|||++......
T Consensus 88 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 164 (288)
T 3kfa_A 88 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 164 (288)
T ss_dssp EECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSS
T ss_pred EEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCC
Confidence 9999999999999864 45889999999999999999999998 999999999999999999999999999877554
Q ss_pred cccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccchhhhhhhHHHhhhhhcCccceeecc
Q 041576 575 QSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDN 653 (714)
Q Consensus 575 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 653 (714)
.........++..|+|||.+.+..++.++||||||+++|+|++ |..||...........+ ....
T Consensus 165 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~--------~~~~------- 229 (288)
T 3kfa_A 165 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL--------EKDY------- 229 (288)
T ss_dssp SSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH--------HTTC-------
T ss_pred ccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH--------hccC-------
Confidence 4444444557889999999998899999999999999999999 99998754433211111 1110
Q ss_pred hhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccC
Q 041576 654 DKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLE 697 (714)
Q Consensus 654 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 697 (714)
....+...+..+.+++.+||+.||++|||++|+++.|+.+.+
T Consensus 230 --~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~ 271 (288)
T 3kfa_A 230 --RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 271 (288)
T ss_dssp --CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --CCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHH
Confidence 001112234568889999999999999999999999987653
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=356.10 Aligned_cols=251 Identities=26% Similarity=0.339 Sum_probs=203.4
Q ss_pred HHHHhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEeccc---chhhHHHHHHHHHHHhcc-CcccccceeceEecCCe
Q 041576 417 LNEATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKL---AQEREREFKTEVSAIGRT-HHKNLVQLLGFCDEGLN 492 (714)
Q Consensus 417 l~~at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~ 492 (714)
+....|.+.+.||+|+||.||+|+.+ .+++.||||++++. .......+.+|.+++.++ +||||+++++++.+.+.
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~-~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~ 98 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVK-ETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDR 98 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEc-CCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCE
Confidence 44456778899999999999999976 57899999999753 233456788999999988 79999999999999999
Q ss_pred eeEEEeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccc
Q 041576 493 RLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLL 572 (714)
Q Consensus 493 ~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~ 572 (714)
.++||||+++|+|.+++.....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 99 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~~ 175 (353)
T 3txo_A 99 LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGI 175 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeecc
Confidence 9999999999999999998888999999999999999999999998 9999999999999999999999999998543
Q ss_pred cCcccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeec
Q 041576 573 SDQSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVD 652 (714)
Q Consensus 573 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 652 (714)
.. ........||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+ ..+...
T Consensus 176 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i--------~~~~~~---- 242 (353)
T 3txo_A 176 CN-GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAI--------LNDEVV---- 242 (353)
T ss_dssp C----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--------HHCCCC----
T ss_pred cC-CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHH--------HcCCCC----
Confidence 22 22334457999999999999888999999999999999999999999765433221111 111110
Q ss_pred chhhhccchHHHHHHHHHHHHccccCCCCCCCH------HHHHH
Q 041576 653 NDKAAMADKSRACKWLMIALWCIQEDPLKRPAM------KMIVQ 690 (714)
Q Consensus 653 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~------~evl~ 690 (714)
.+......+.+++.+||+.||++||++ +||++
T Consensus 243 ------~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 243 ------YPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp ------CCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred ------CCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 111233467789999999999999998 77765
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=369.73 Aligned_cols=261 Identities=25% Similarity=0.384 Sum_probs=206.5
Q ss_pred HHHhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEE
Q 041576 418 NEATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVY 497 (714)
Q Consensus 418 ~~at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 497 (714)
....+.+.+.||+|+||.||+|.+. .+..||||.++... ...+.+.+|++++++++||||+++++++.+ +..++||
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~ 257 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWN--GTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT 257 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET--TTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred ChhHceeeeeecCCCCeEEEEEEEC--CCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEe
Confidence 3455677889999999999999986 45689999997643 235689999999999999999999999876 6789999
Q ss_pred eecCCCchhhhhhcC--CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCc
Q 041576 498 EFMGNGTLANLLFAI--PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQ 575 (714)
Q Consensus 498 E~~~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 575 (714)
||+++|+|.+++... ..+++..++.++.||++||+|||+++ |+||||||+|||+++++.+||+|||+++......
T Consensus 258 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 334 (452)
T 1fmk_A 258 EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE 334 (452)
T ss_dssp CCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred hhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCCc
Confidence 999999999999743 46899999999999999999999998 9999999999999999999999999998765443
Q ss_pred ccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccchhhhhhhHHHhhhhhcCccceeecch
Q 041576 576 SRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDND 654 (714)
Q Consensus 576 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 654 (714)
........++..|+|||.+.+..++.++||||||+++|||++ |+.||......+. +. ....+..
T Consensus 335 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~---~~-----~i~~~~~------- 399 (452)
T 1fmk_A 335 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV---LD-----QVERGYR------- 399 (452)
T ss_dssp --------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH---HH-----HHHTTCC-------
T ss_pred eecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHH---HH-----HHHcCCC-------
Confidence 333334457789999999998899999999999999999999 9999975433221 11 1111110
Q ss_pred hhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCCCCCC
Q 041576 655 KAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLEVPSPP 702 (714)
Q Consensus 655 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~pp 702 (714)
...+...+..+.+++.+||+.||++|||+++|++.|+.+.....|+
T Consensus 400 --~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~~ 445 (452)
T 1fmk_A 400 --MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 445 (452)
T ss_dssp --CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCC
T ss_pred --CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCcc
Confidence 0112233457888999999999999999999999999987665443
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=343.50 Aligned_cols=253 Identities=30% Similarity=0.423 Sum_probs=196.2
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccch----hhHHHHHHHHHHHhccCcccccceeceEecCCeeeE
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQ----EREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLL 495 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 495 (714)
..|.+.+.||+|+||.||+|.+. ++.||||+++.... ...+.+.+|++++++++||||+++++++.+++..++
T Consensus 7 ~~~~~~~~lg~G~~g~V~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (271)
T 3dtc_A 7 AELTLEEIIGIGGFGKVYRAFWI---GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCL 83 (271)
T ss_dssp TSEEEEEEEEEETTEEEEEEEET---TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEE
T ss_pred hheeeeeeeccCCCeEEEEEEEc---CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEE
Confidence 45677889999999999999863 78999999865322 234678999999999999999999999999999999
Q ss_pred EEeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECC--------CCceEEecCCC
Q 041576 496 VYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQ--------DFTAKISDFGL 567 (714)
Q Consensus 496 v~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~--------~~~~kl~Dfg~ 567 (714)
||||+++++|.+++.. ..+++..++.++.|+++||+|||+++..+|+||||||+||+++. ++.+||+|||+
T Consensus 84 v~e~~~~~~L~~~~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~ 162 (271)
T 3dtc_A 84 VMEFARGGPLNRVLSG-KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGL 162 (271)
T ss_dssp EEECCTTEEHHHHHTS-SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC
T ss_pred EEEcCCCCCHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCc
Confidence 9999999999999864 57899999999999999999999997666999999999999986 77899999999
Q ss_pred ccccccCcccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCcc
Q 041576 568 SKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKL 647 (714)
Q Consensus 568 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~ 647 (714)
+........ ....|+..|+|||.+.+..++.++||||||+++|||++|+.||.......... . ......
T Consensus 163 ~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~-------~-~~~~~~ 231 (271)
T 3dtc_A 163 AREWHRTTK---MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAY-------G-VAMNKL 231 (271)
T ss_dssp ----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHH-------H-HHTSCC
T ss_pred ccccccccc---cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-------h-hhcCCC
Confidence 986543222 23468999999999999999999999999999999999999997543322110 0 001110
Q ss_pred ceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 041576 648 DVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGY 695 (714)
Q Consensus 648 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 695 (714)
. ...+...+..+.+++.+||+.||++|||+.|+++.|+.+
T Consensus 232 ~--------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 232 A--------LPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp C--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred C--------CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 0 011222345688899999999999999999999999864
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-41 Score=360.55 Aligned_cols=260 Identities=27% Similarity=0.377 Sum_probs=208.9
Q ss_pred HHHhhhhhhhhCcccceeEEEeEee----CCCCcEEEEEEeccc-chhhHHHHHHHHHHHhccCcccccceeceEecCCe
Q 041576 418 NEATNGFEEELGRGSFGIVYKGVLK----SASGNAVAVKKLDKL-AQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLN 492 (714)
Q Consensus 418 ~~at~~~~~~ig~G~~g~Vy~~~~~----~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 492 (714)
....+.+.+.||+|+||.||+|.+. ..+++.||||+++.. .......+.+|+.++++++||||+++++++.+...
T Consensus 69 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 148 (367)
T 3l9p_A 69 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 148 (367)
T ss_dssp CGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred CHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 3456778899999999999999853 235678999999653 34555678999999999999999999999999999
Q ss_pred eeEEEeecCCCchhhhhhcC-------CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCC---ceEE
Q 041576 493 RLLVYEFMGNGTLANLLFAI-------PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDF---TAKI 562 (714)
Q Consensus 493 ~~lv~E~~~~gsL~~~l~~~-------~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~---~~kl 562 (714)
.++||||+++|+|.+++... ..+++..++.++.||++||+|||+++ |+||||||+|||++.++ .+||
T Consensus 149 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL 225 (367)
T 3l9p_A 149 RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKI 225 (367)
T ss_dssp CEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEE
T ss_pred CEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEE
Confidence 99999999999999999753 34788999999999999999999998 99999999999999555 5999
Q ss_pred ecCCCccccccCcc-cceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccchhhhhhhHHHhh
Q 041576 563 SDFGLSKLLLSDQS-RTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEERSAILTDWAYD 640 (714)
Q Consensus 563 ~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~l~~~~~~ 640 (714)
+|||+++....... .......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||...........
T Consensus 226 ~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~------- 298 (367)
T 3l9p_A 226 GDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEF------- 298 (367)
T ss_dssp CCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH-------
T ss_pred CCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-------
Confidence 99999986533222 22333457889999999999999999999999999999998 9999975543321111
Q ss_pred hhhcCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccC
Q 041576 641 CYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLE 697 (714)
Q Consensus 641 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 697 (714)
...+... ..+...+..+.+++.+||+.||++|||+.||++.|+.+.+
T Consensus 299 -i~~~~~~---------~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~ 345 (367)
T 3l9p_A 299 -VTSGGRM---------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 345 (367)
T ss_dssp -HHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -HHcCCCC---------CCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhh
Confidence 1111100 0112233467889999999999999999999999987654
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-40 Score=345.21 Aligned_cols=245 Identities=23% Similarity=0.286 Sum_probs=206.0
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEE
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA---QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLV 496 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 496 (714)
..|.+.+.||+|+||.||+|+.+ .+++.||+|++++.. ....+.+.+|+.+++.++||||+++++++.+....++|
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSR-HNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEEC-CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 35677889999999999999876 578999999997532 23456788999999999999999999999999999999
Q ss_pred EeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcc
Q 041576 497 YEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQS 576 (714)
Q Consensus 497 ~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 576 (714)
|||+++|+|.+++.....+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+++.....
T Consensus 85 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~-- 159 (318)
T 1fot_A 85 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-- 159 (318)
T ss_dssp ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC--
T ss_pred EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCCc--
Confidence 999999999999998888999999999999999999999998 999999999999999999999999999865332
Q ss_pred cceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhh
Q 041576 577 RTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKA 656 (714)
Q Consensus 577 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 656 (714)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.......... ........
T Consensus 160 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~--------~i~~~~~~-------- 221 (318)
T 1fot_A 160 --TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYE--------KILNAELR-------- 221 (318)
T ss_dssp --BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH--------HHHHCCCC--------
T ss_pred --cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHH--------HHHhCCCC--------
Confidence 234568999999999999999999999999999999999999997543322111 11111110
Q ss_pred hccchHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 041576 657 AMADKSRACKWLMIALWCIQEDPLKRP-----AMKMIVQ 690 (714)
Q Consensus 657 ~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 690 (714)
.+......+.+++.+||+.||++|| +++||++
T Consensus 222 --~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 222 --FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp --CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred --CCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 1122345678899999999999999 8999985
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=352.54 Aligned_cols=253 Identities=23% Similarity=0.280 Sum_probs=204.1
Q ss_pred HHHhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccch-----hhHHHHHHHHHHHhccCcccccceeceEecCCe
Q 041576 418 NEATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQ-----EREREFKTEVSAIGRTHHKNLVQLLGFCDEGLN 492 (714)
Q Consensus 418 ~~at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 492 (714)
....|.+.+.||+|+||.||+|..+ .+++.||||+++.... ...+.+.+|++++++++||||+++++++.+++.
T Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 100 (351)
T 3c0i_A 22 FEDVYELCEVIGKGPFSVVRRCINR-ETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGM 100 (351)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred cccceEEeeEEeeCCCEEEEEEEEC-CCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 3457888999999999999999876 5789999999864221 235789999999999999999999999999999
Q ss_pred eeEEEeecCCCchhhhhhcC----CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCc---eEEecC
Q 041576 493 RLLVYEFMGNGTLANLLFAI----PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFT---AKISDF 565 (714)
Q Consensus 493 ~~lv~E~~~~gsL~~~l~~~----~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~---~kl~Df 565 (714)
.++||||+++++|.+.+... ..+++..+..++.||++||+|||+++ |+||||||+||+++.++. +||+||
T Consensus 101 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Df 177 (351)
T 3c0i_A 101 LYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGF 177 (351)
T ss_dssp EEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCC
T ss_pred EEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecC
Confidence 99999999999998887542 35789999999999999999999998 999999999999987654 999999
Q ss_pred CCccccccCcccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcC
Q 041576 566 GLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEG 645 (714)
Q Consensus 566 g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~ 645 (714)
|++........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ... ....+
T Consensus 178 g~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~----~~~-----~i~~~ 247 (351)
T 3c0i_A 178 GVAIQLGESGL-VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKER----LFE-----GIIKG 247 (351)
T ss_dssp TTCEECCTTSC-BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHH----HHH-----HHHHT
T ss_pred cceeEecCCCe-eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHH----HHH-----HHHcC
Confidence 99987654322 223456999999999999999999999999999999999999999754221 111 11111
Q ss_pred ccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 646 KLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 646 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
.... .... ....+..+.+++.+||+.||++|||+.|+++
T Consensus 248 ~~~~--~~~~----~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 248 KYKM--NPRQ----WSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp CCCC--CHHH----HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCC--Cccc----cccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 1100 0000 0122456788999999999999999999986
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=351.44 Aligned_cols=263 Identities=28% Similarity=0.405 Sum_probs=213.7
Q ss_pred HHHHhhhhhhhhCcccceeEEEeEe----eCCCCcEEEEEEecccc-hhhHHHHHHHHHHHhcc-CcccccceeceEecC
Q 041576 417 LNEATNGFEEELGRGSFGIVYKGVL----KSASGNAVAVKKLDKLA-QEREREFKTEVSAIGRT-HHKNLVQLLGFCDEG 490 (714)
Q Consensus 417 l~~at~~~~~~ig~G~~g~Vy~~~~----~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~ 490 (714)
+....|.+.+.||+|+||.||+|.+ +..+++.||||+++... ....+.+.+|+.+++++ +||||+++++++.++
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 99 (313)
T 1t46_A 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (313)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecC
Confidence 3445678889999999999999986 33567899999997543 34457899999999999 999999999999999
Q ss_pred CeeeEEEeecCCCchhhhhhcCC------------------CCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeE
Q 041576 491 LNRLLVYEFMGNGTLANLLFAIP------------------RPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNI 552 (714)
Q Consensus 491 ~~~~lv~E~~~~gsL~~~l~~~~------------------~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NI 552 (714)
+..++||||+++++|.+++.... .+++..++.++.||++||+|||+++ |+||||||+||
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Ni 176 (313)
T 1t46_A 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNI 176 (313)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGE
T ss_pred CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceE
Confidence 99999999999999999997643 3789999999999999999999998 99999999999
Q ss_pred EECCCCceEEecCCCccccccCcccc-eeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccchh
Q 041576 553 LLDQDFTAKISDFGLSKLLLSDQSRT-RTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEER 630 (714)
Q Consensus 553 ll~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~ 630 (714)
+++.++.+||+|||++.......... .....++..|+|||.+.+..++.++||||||+++|||++ |+.||........
T Consensus 177 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~ 256 (313)
T 1t46_A 177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 256 (313)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH
T ss_pred EEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH
Confidence 99999999999999998765443322 223446788999999999999999999999999999999 9999975433221
Q ss_pred hhhhhHHHhhhhhcCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCC
Q 041576 631 SAILTDWAYDCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLEV 698 (714)
Q Consensus 631 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 698 (714)
. ... ...+. . ...+...+..+.+++.+||+.||.+|||+.|+++.|+++++.
T Consensus 257 ~---~~~----~~~~~-~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 308 (313)
T 1t46_A 257 F---YKM----IKEGF-R--------MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (313)
T ss_dssp H---HHH----HHHTC-C--------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred H---HHH----hccCC-C--------CCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 1 110 11110 0 011122345678899999999999999999999999987643
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=345.86 Aligned_cols=264 Identities=18% Similarity=0.208 Sum_probs=202.9
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEE
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA---QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLV 496 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 496 (714)
..|.+.+.||+|+||.||+|... .+++.||+|++.... ....+.+.+|+.++++++||||+++++++..++..++|
T Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 34 GPYRLRRLVGRGGMGDVYEAEDT-VRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp CCEEEEEEEEECSSSEEEEEEET-TTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccEEEEEEEcCCCCeeEEEEEEc-CCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 45778899999999999999875 468899999997543 23347889999999999999999999999999999999
Q ss_pred EeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcc
Q 041576 497 YEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQS 576 (714)
Q Consensus 497 ~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 576 (714)
|||+++++|.+++.....+++..++.++.||++||+|||+.+ |+||||||+||+++.++.+||+|||++........
T Consensus 113 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 189 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTDEKL 189 (309)
T ss_dssp EECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC---------
T ss_pred EEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCcccccccc
Confidence 999999999999988788999999999999999999999998 99999999999999999999999999987654433
Q ss_pred cceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhh
Q 041576 577 RTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKA 656 (714)
Q Consensus 577 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 656 (714)
.......++..|+|||.+.+..++.++||||||+++|||++|+.||........ .. ..... ... .
T Consensus 190 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~----~~----~~~~~-~~~------~ 254 (309)
T 2h34_A 190 TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVM----GA----HINQA-IPR------P 254 (309)
T ss_dssp -------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHH----HH----HHHSC-CCC------G
T ss_pred ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHH----HH----HhccC-CCC------c
Confidence 333445689999999999999999999999999999999999999975433211 00 00010 000 0
Q ss_pred hccchHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHhcccCCCCCC
Q 041576 657 AMADKSRACKWLMIALWCIQEDPLKRP-AMKMIVQMLEGYLEVPSPP 702 (714)
Q Consensus 657 ~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~~~~~~~pp 702 (714)
.......+..+.+++.+||+.||++|| +++++++.|+.++....+.
T Consensus 255 ~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~~~ 301 (309)
T 2h34_A 255 STVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATADQD 301 (309)
T ss_dssp GGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC-----
T ss_pred cccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhccc
Confidence 011222334677899999999999999 9999999999987665443
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=355.20 Aligned_cols=268 Identities=25% Similarity=0.343 Sum_probs=213.6
Q ss_pred HHHHHhhhhhhhhCcccceeEEEeEeeC------CCCcEEEEEEeccc-chhhHHHHHHHHHHHhcc-CcccccceeceE
Q 041576 416 ELNEATNGFEEELGRGSFGIVYKGVLKS------ASGNAVAVKKLDKL-AQEREREFKTEVSAIGRT-HHKNLVQLLGFC 487 (714)
Q Consensus 416 el~~at~~~~~~ig~G~~g~Vy~~~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~ 487 (714)
++....|.+.+.||+|+||.||+|.+.. .+++.||||+++.. .....+.+.+|+++++++ +||||+++++++
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 110 (334)
T 2pvf_A 31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 110 (334)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEE
Confidence 4445678888999999999999998642 35678999999754 334557899999999999 999999999999
Q ss_pred ecCCeeeEEEeecCCCchhhhhhcCC----------------CCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCe
Q 041576 488 DEGLNRLLVYEFMGNGTLANLLFAIP----------------RPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQN 551 (714)
Q Consensus 488 ~~~~~~~lv~E~~~~gsL~~~l~~~~----------------~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~N 551 (714)
.+.+..++||||+++++|.+++.... .+++..++.++.||++||+|||+++ |+||||||+|
T Consensus 111 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~N 187 (334)
T 2pvf_A 111 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARN 187 (334)
T ss_dssp CSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGG
T ss_pred ccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccce
Confidence 99999999999999999999998653 3788999999999999999999998 9999999999
Q ss_pred EEECCCCceEEecCCCccccccCcc-cceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccch
Q 041576 552 ILLDQDFTAKISDFGLSKLLLSDQS-RTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEE 629 (714)
Q Consensus 552 Ill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~ 629 (714)
|+++.++.+||+|||++........ .......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+
T Consensus 188 Ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~ 267 (334)
T 2pvf_A 188 VLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 267 (334)
T ss_dssp EEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred EEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHH
Confidence 9999999999999999987654332 12223456788999999988889999999999999999999 999997543322
Q ss_pred hhhhhhHHHhhhhhcCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCCCCCCC
Q 041576 630 RSAILTDWAYDCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLEVPSPPM 703 (714)
Q Consensus 630 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~pp~ 703 (714)
.... ...+... ..+......+.+++.+||+.||.+|||+.|+++.|++++.......
T Consensus 268 ~~~~--------~~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~~~~ 324 (334)
T 2pvf_A 268 LFKL--------LKEGHRM---------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNEE 324 (334)
T ss_dssp HHHH--------HHHTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC---
T ss_pred HHHH--------HhcCCCC---------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccccCc
Confidence 1111 1111100 0112234567889999999999999999999999999886644433
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-40 Score=341.37 Aligned_cols=264 Identities=18% Similarity=0.221 Sum_probs=200.1
Q ss_pred hhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEeccc--chhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEe
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKL--AQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYE 498 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E 498 (714)
+|.+.+.||+|+||+||+|... .+++.||||+++.. .......+.+|+.++++++||||+++++++.+++..++|||
T Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 3 KYEKLEKIGEGTYGTVFKAKNR-ETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp SEEEEEEEEECSSSEEEEEEET-TTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CceeeeEecCCCCeEEEEEEEC-CCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 4667889999999999999876 57899999999643 23345678899999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcccc
Q 041576 499 FMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRT 578 (714)
Q Consensus 499 ~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 578 (714)
|++++.+..+......+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||++....... ..
T Consensus 82 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~ 157 (292)
T 3o0g_A 82 FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV-RC 157 (292)
T ss_dssp CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSCC-SC
T ss_pred cCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCcc-cc
Confidence 9987555555555678999999999999999999999998 9999999999999999999999999998764322 22
Q ss_pred eeeecCCCCccCcccccCCC-CCchhhhHHHHHHHHHHHhcCCCCcccccc-hhhhhhhHHHhhhhhcCcc---ceee--
Q 041576 579 RTVIRGTRGYVAPEWFKNVP-VSAKVDVYSFGVVLLKIICCKRSVEMELGE-ERSAILTDWAYDCYVEGKL---DVLV-- 651 (714)
Q Consensus 579 ~~~~~gt~~y~aPE~~~~~~-~s~ksDVwSlGvil~elltG~~p~~~~~~~-~~~~~l~~~~~~~~~~~~~---~~~~-- 651 (714)
.....+|..|+|||.+.+.. ++.++||||||+++|||++|+.|+...... .....+..... ....... ....
T Consensus 158 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~~~~~ 236 (292)
T 3o0g_A 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLG-TPTEEQWPSMTKLPDY 236 (292)
T ss_dssp CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHC-CCCTTTCTTGGGSTTC
T ss_pred ccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhC-CCChhhhhhhcccccc
Confidence 23446899999999998765 799999999999999999998886433221 11111100000 0000000 0000
Q ss_pred -------cchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 652 -------DNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 652 -------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
...............+.+++.+||+.||++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp CCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 000000111234457788999999999999999999987
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=352.29 Aligned_cols=257 Identities=24% Similarity=0.355 Sum_probs=201.9
Q ss_pred HHhhhhhhhhCcccceeEEEeEeeCCCCc----EEEEEEeccc-chhhHHHHHHHHHHHhccCcccccceeceEecCCee
Q 041576 419 EATNGFEEELGRGSFGIVYKGVLKSASGN----AVAVKKLDKL-AQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNR 493 (714)
Q Consensus 419 ~at~~~~~~ig~G~~g~Vy~~~~~~~~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 493 (714)
...|.+.+.||+|+||+||+|++.. +++ +||+|.++.. .....+.+.+|+.++++++||||+++++++.++. .
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~-~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~ 91 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIP-EGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-V 91 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC-----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-E
T ss_pred HHHcccceEEeeCCCeEEEEEEEcC-CCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-e
Confidence 3457778899999999999998753 343 4688888643 3345678999999999999999999999998765 7
Q ss_pred eEEEeecCCCchhhhhhcC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccc
Q 041576 494 LLVYEFMGNGTLANLLFAI-PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLL 572 (714)
Q Consensus 494 ~lv~E~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~ 572 (714)
++|+||+++|+|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 92 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 168 (327)
T 3poz_A 92 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp EEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred EEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence 8999999999999999864 56899999999999999999999998 9999999999999999999999999998765
Q ss_pred cCcc-cceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccchhhhhhhHHHhhhhhcCcccee
Q 041576 573 SDQS-RTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEERSAILTDWAYDCYVEGKLDVL 650 (714)
Q Consensus 573 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 650 (714)
.... .......+|..|+|||.+.+..++.++||||||+++|||++ |+.||...........+ ..+..
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~--------~~~~~--- 237 (327)
T 3poz_A 169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL--------EKGER--- 237 (327)
T ss_dssp TTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH--------HTTCC---
T ss_pred CCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHH--------HcCCC---
Confidence 4332 22233456889999999999999999999999999999999 99999755433221111 11110
Q ss_pred ecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccC
Q 041576 651 VDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLE 697 (714)
Q Consensus 651 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 697 (714)
...+......+.+++.+||+.||++||++.|+++.|+.+..
T Consensus 238 ------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 278 (327)
T 3poz_A 238 ------LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp ------CCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred ------CCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 01122234467889999999999999999999999987654
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=353.70 Aligned_cols=251 Identities=27% Similarity=0.357 Sum_probs=207.3
Q ss_pred hhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEeec
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEFM 500 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~ 500 (714)
.|.+.+.||+|+||.||+|... .+++.||+|.+..........+.+|++++++++||||+++++++.+....++||||+
T Consensus 52 ~y~i~~~LG~G~~g~Vy~~~~~-~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~ 130 (387)
T 1kob_A 52 YYDILEELGSGAFGVVHRCVEK-ATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 130 (387)
T ss_dssp TEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred ceEEEEEEecCCCEEEEEEEEC-CCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcC
Confidence 5778899999999999999876 578899999997765556678999999999999999999999999999999999999
Q ss_pred CCCchhhhhhcCC-CCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECC--CCceEEecCCCccccccCccc
Q 041576 501 GNGTLANLLFAIP-RPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQ--DFTAKISDFGLSKLLLSDQSR 577 (714)
Q Consensus 501 ~~gsL~~~l~~~~-~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~--~~~~kl~Dfg~~~~~~~~~~~ 577 (714)
++++|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+|||++. ++.+||+|||++.......
T Consensus 131 ~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~-- 205 (387)
T 1kob_A 131 SGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE-- 205 (387)
T ss_dssp CCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS--
T ss_pred CCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCCc--
Confidence 9999999998654 6899999999999999999999998 999999999999974 5789999999998764432
Q ss_pred ceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhh
Q 041576 578 TRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAA 657 (714)
Q Consensus 578 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 657 (714)
......||+.|+|||++.+..++.++|||||||++|||++|+.||........ +... ...... .+..
T Consensus 206 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~---~~~i-----~~~~~~--~~~~--- 272 (387)
T 1kob_A 206 IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET---LQNV-----KRCDWE--FDED--- 272 (387)
T ss_dssp CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH---HHHH-----HHCCCC--CCSS---
T ss_pred ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHH---HHHH-----HhCCCC--CCcc---
Confidence 23345689999999999999999999999999999999999999976433221 1111 111100 0000
Q ss_pred ccchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 658 MADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 658 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
.....+..+.+++.+||+.||++|||+.|+++.
T Consensus 273 -~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 273 -AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp -TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred -ccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 111234567889999999999999999999874
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-41 Score=354.77 Aligned_cols=274 Identities=26% Similarity=0.348 Sum_probs=212.9
Q ss_pred HHhhhhhhhhCcccceeEEEeEe---eCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCcccccceeceEe--cCCee
Q 041576 419 EATNGFEEELGRGSFGIVYKGVL---KSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCD--EGLNR 493 (714)
Q Consensus 419 ~at~~~~~~ig~G~~g~Vy~~~~---~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~--~~~~~ 493 (714)
...|.+.+.||+|+||.||+|.+ ...+++.||||++........+.+.+|++++++++||||+++++++. +....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 35677889999999999999985 33578899999998777777788999999999999999999999886 45668
Q ss_pred eEEEeecCCCchhhhhhcC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccc
Q 041576 494 LLVYEFMGNGTLANLLFAI-PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLL 572 (714)
Q Consensus 494 ~lv~E~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~ 572 (714)
++||||+++++|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++....
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 178 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLLP 178 (327)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEECC
T ss_pred EEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccceecc
Confidence 8999999999999999763 56899999999999999999999998 9999999999999999999999999998764
Q ss_pred cCccc--ceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCcccee
Q 041576 573 SDQSR--TRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVL 650 (714)
Q Consensus 573 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 650 (714)
..... ......++..|+|||.+.+..++.++||||||+++|||++|+.||............... ...........
T Consensus 179 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 256 (327)
T 3lxl_A 179 LDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCER--DVPALSRLLEL 256 (327)
T ss_dssp TTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC------CCHHHHHHHH
T ss_pred cCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhccccc--ccccHHHHHHH
Confidence 43321 223345788899999999888999999999999999999999998754332110000000 00000000000
Q ss_pred ecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccC
Q 041576 651 VDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLE 697 (714)
Q Consensus 651 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 697 (714)
.........+...+..+.+++.+||+.||++|||++|+++.|+.+..
T Consensus 257 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 303 (327)
T 3lxl_A 257 LEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWS 303 (327)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--
T ss_pred hhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 00111111223345678889999999999999999999999998764
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=355.57 Aligned_cols=264 Identities=24% Similarity=0.328 Sum_probs=210.3
Q ss_pred HHHHHhhhhhhhhCcccceeEEEeEee----CCCCcEEEEEEeccc-chhhHHHHHHHHHHHhcc-CcccccceeceEec
Q 041576 416 ELNEATNGFEEELGRGSFGIVYKGVLK----SASGNAVAVKKLDKL-AQEREREFKTEVSAIGRT-HHKNLVQLLGFCDE 489 (714)
Q Consensus 416 el~~at~~~~~~ig~G~~g~Vy~~~~~----~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~ 489 (714)
++....+.+.+.||+|+||.||+|.+. ..+++.||||.+... .....+.+.+|+.+++++ +||||+++++++..
T Consensus 41 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 120 (344)
T 1rjb_A 41 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL 120 (344)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee
Confidence 344566778899999999999999973 345678999999753 233456899999999999 99999999999999
Q ss_pred CCeeeEEEeecCCCchhhhhhcCC-----------------------CCChhhHHHHHHHHHHHHHHHHhcCCCCeEecC
Q 041576 490 GLNRLLVYEFMGNGTLANLLFAIP-----------------------RPDWSLRVRISLEIARGLLYLHEECNVPIIHCD 546 (714)
Q Consensus 490 ~~~~~lv~E~~~~gsL~~~l~~~~-----------------------~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~D 546 (714)
.+..++||||+++|+|.+++.... .+++..++.++.||++||+|||+++ |+|||
T Consensus 121 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~D 197 (344)
T 1rjb_A 121 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRD 197 (344)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETT
T ss_pred CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCC
Confidence 999999999999999999997653 2688999999999999999999998 99999
Q ss_pred CCcCeEEECCCCceEEecCCCccccccCccc-ceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcc
Q 041576 547 IKPQNILLDQDFTAKISDFGLSKLLLSDQSR-TRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEM 624 (714)
Q Consensus 547 lk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~ 624 (714)
|||+||+++.++.+||+|||++......... ......+++.|+|||.+.+..++.++||||||+++|||+| |+.||..
T Consensus 198 ikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 277 (344)
T 1rjb_A 198 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 277 (344)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred CChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCccc
Confidence 9999999999999999999999876543322 2223457889999999998899999999999999999998 9999975
Q ss_pred cccchhhhhhhHHHhhhhhcCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCC
Q 041576 625 ELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLEV 698 (714)
Q Consensus 625 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 698 (714)
...... +.. ....+.. ...+...+..+.+++.+||+.||.+|||+.||++.|+.++..
T Consensus 278 ~~~~~~---~~~----~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 335 (344)
T 1rjb_A 278 IPVDAN---FYK----LIQNGFK---------MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD 335 (344)
T ss_dssp CCCSHH---HHH----HHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred CCcHHH---HHH----HHhcCCC---------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 533221 111 1111100 001122345688899999999999999999999999987654
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=344.58 Aligned_cols=261 Identities=23% Similarity=0.322 Sum_probs=199.0
Q ss_pred HHhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhc--cCcccccceeceEec----CCe
Q 041576 419 EATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGR--THHKNLVQLLGFCDE----GLN 492 (714)
Q Consensus 419 ~at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~nIv~l~~~~~~----~~~ 492 (714)
...|.+.+.||+|+||+||+|.+ +++.||||++... ....+..|.+++.. ++||||+++++++.. ...
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~---~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~ 80 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW---QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQ 80 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE---TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE---CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCce
Confidence 34677789999999999999986 4889999999653 23445556665555 899999999998644 345
Q ss_pred eeEEEeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHH--------hcCCCCeEecCCCcCeEEECCCCceEEec
Q 041576 493 RLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLH--------EECNVPIIHCDIKPQNILLDQDFTAKISD 564 (714)
Q Consensus 493 ~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH--------~~~~~~ivH~Dlk~~NIll~~~~~~kl~D 564 (714)
.++||||+++|+|.++++. ..+++..++.++.||++||+||| +.+ |+||||||+|||++.++.+||+|
T Consensus 81 ~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~D 156 (301)
T 3q4u_A 81 LWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCIAD 156 (301)
T ss_dssp EEEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEECC
T ss_pred eEEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEEee
Confidence 7899999999999999965 57899999999999999999999 776 99999999999999999999999
Q ss_pred CCCccccccCcccc---eeeecCCCCccCcccccCC------CCCchhhhHHHHHHHHHHHhc----------CCCCccc
Q 041576 565 FGLSKLLLSDQSRT---RTVIRGTRGYVAPEWFKNV------PVSAKVDVYSFGVVLLKIICC----------KRSVEME 625 (714)
Q Consensus 565 fg~~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~s~ksDVwSlGvil~elltG----------~~p~~~~ 625 (714)
||+++......... .....||+.|+|||.+.+. .++.++||||||+++|||++| +.||...
T Consensus 157 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~ 236 (301)
T 3q4u_A 157 LGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDV 236 (301)
T ss_dssp CTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccccc
Confidence 99998654433221 2234689999999999876 455799999999999999999 7777543
Q ss_pred ccchhhhhhhHHHhhhhhcCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 041576 626 LGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGY 695 (714)
Q Consensus 626 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 695 (714)
...... ................. ............+.+++.+||+.||++|||+.||++.|+++
T Consensus 237 ~~~~~~--~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 237 VPNDPS--FEDMRKVVCVDQQRPNI----PNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp SCSSCC--HHHHHHHHTTSCCCCCC----CGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCcc--hhhhhHHHhccCCCCCC----ChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 222111 00110101111111111 11122345667899999999999999999999999999864
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=351.02 Aligned_cols=261 Identities=26% Similarity=0.363 Sum_probs=196.0
Q ss_pred HHhhhhhhhhCcccceeEEEeEeeCCCC--cEEEEEEeccc--chhhHHHHHHHHHHHhccCcccccceeceEecCCee-
Q 041576 419 EATNGFEEELGRGSFGIVYKGVLKSASG--NAVAVKKLDKL--AQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNR- 493 (714)
Q Consensus 419 ~at~~~~~~ig~G~~g~Vy~~~~~~~~~--~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~- 493 (714)
...|.+.+.||+|+||.||+|.+...++ ..||||.++.. .....+.+.+|++++++++||||+++++++......
T Consensus 22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (323)
T 3qup_A 22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKG 101 (323)
T ss_dssp ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC----
T ss_pred hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccccc
Confidence 3467788999999999999998763322 37999999753 344567899999999999999999999999887665
Q ss_pred -----eEEEeecCCCchhhhhhcCC------CCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEE
Q 041576 494 -----LLVYEFMGNGTLANLLFAIP------RPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKI 562 (714)
Q Consensus 494 -----~lv~E~~~~gsL~~~l~~~~------~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl 562 (714)
++||||+++++|.+++.... .+++..++.++.||++||+|||+++ |+||||||+||+++.++.+||
T Consensus 102 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~kl 178 (323)
T 3qup_A 102 RLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVCV 178 (323)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEE
T ss_pred CCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCEEE
Confidence 99999999999999996432 5889999999999999999999998 999999999999999999999
Q ss_pred ecCCCccccccCcc-cceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccchhhhhhhHHHhh
Q 041576 563 SDFGLSKLLLSDQS-RTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEERSAILTDWAYD 640 (714)
Q Consensus 563 ~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~l~~~~~~ 640 (714)
+|||++........ .......++..|+|||.+.+..++.++||||||+++|||++ |+.||...........+
T Consensus 179 ~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~------ 252 (323)
T 3qup_A 179 ADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYL------ 252 (323)
T ss_dssp CCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH------
T ss_pred eeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHH------
Confidence 99999987644332 22233456788999999999999999999999999999999 89999755433211111
Q ss_pred hhhcCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCCC
Q 041576 641 CYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLEVP 699 (714)
Q Consensus 641 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 699 (714)
..+... ..+...+..+.+++.+||+.||++|||+.|+++.|++++..+
T Consensus 253 --~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~ 300 (323)
T 3qup_A 253 --IGGNRL---------KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL 300 (323)
T ss_dssp --HTTCCC---------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred --hcCCCC---------CCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 111100 011223456888999999999999999999999999987654
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-40 Score=347.26 Aligned_cols=259 Identities=15% Similarity=0.191 Sum_probs=207.9
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhcc-CcccccceeceEecCCeeeEEEe
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRT-HHKNLVQLLGFCDEGLNRLLVYE 498 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~E 498 (714)
..|.+.+.||+|+||.||+|... .+++.||||.+.... ....+.+|+++++++ +||||+++++++..++..++|||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 9 PNFRVGKKIGCGNFGELRLGKNL-YTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTEEEEEECCC-CTTSEEEEEET-TTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred CCeEEEEEeeccCCceEEEEEEC-CCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 34667889999999999999865 578999999986532 234688999999999 99999999999999999999999
Q ss_pred ecCCCchhhhhhcC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCc-----eEEecCCCccccc
Q 041576 499 FMGNGTLANLLFAI-PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFT-----AKISDFGLSKLLL 572 (714)
Q Consensus 499 ~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~-----~kl~Dfg~~~~~~ 572 (714)
|+ +++|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++. +||+|||+++...
T Consensus 86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~ 161 (330)
T 2izr_A 86 LL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYI 161 (330)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESB
T ss_pred eC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEcccceeee
Confidence 99 89999999864 67899999999999999999999998 999999999999999887 9999999998764
Q ss_pred cCccc------ceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCc
Q 041576 573 SDQSR------TRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGK 646 (714)
Q Consensus 573 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~ 646 (714)
..... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...........+..........
T Consensus 162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~-- 239 (330)
T 2izr_A 162 DPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRAT-- 239 (330)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHS--
T ss_pred cCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccC--
Confidence 43321 1235679999999999999999999999999999999999999998654333222221111100000
Q ss_pred cceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 041576 647 LDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYL 696 (714)
Q Consensus 647 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 696 (714)
. ........+ .+.+++.+||+.||.+||++++|++.|+++.
T Consensus 240 ---~-----~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~ 280 (330)
T 2izr_A 240 ---P-----IEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLF 280 (330)
T ss_dssp ---C-----HHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred ---C-----HHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHH
Confidence 0 000001122 7888999999999999999999999998754
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=339.88 Aligned_cols=255 Identities=29% Similarity=0.438 Sum_probs=210.0
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEee
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEF 499 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~ 499 (714)
..|.+.+.||+|+||.||+|... +++.||+|.+..... ..+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~--~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWL--NKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEF 84 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEET--TTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECC
T ss_pred hheeeeeEecCCCceeEEEEEec--CCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeC
Confidence 45677889999999999999875 577999999976432 346789999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcccc
Q 041576 500 MGNGTLANLLFAI-PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRT 578 (714)
Q Consensus 500 ~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 578 (714)
+++++|.+++... ..+++..+..++.||++||+|||+++ ++||||||+||+++.++.+||+|||++..........
T Consensus 85 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~ 161 (267)
T 3t9t_A 85 MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 161 (267)
T ss_dssp CTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHS
T ss_pred CCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEcccccccccccccccc
Confidence 9999999999865 46899999999999999999999998 9999999999999999999999999998764433222
Q ss_pred eeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhh
Q 041576 579 RTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAA 657 (714)
Q Consensus 579 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 657 (714)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||.......... ....+...
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~--------~i~~~~~~--------- 224 (267)
T 3t9t_A 162 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVE--------DISTGFRL--------- 224 (267)
T ss_dssp TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH--------HHHTTCCC---------
T ss_pred cccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHH--------HHhcCCcC---------
Confidence 233456788999999998899999999999999999999 899987543322111 11111000
Q ss_pred ccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccC
Q 041576 658 MADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLE 697 (714)
Q Consensus 658 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 697 (714)
..+...+..+.+++.+||+.||++|||++|+++.|+++.+
T Consensus 225 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 225 YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 0111234567889999999999999999999999998765
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=350.87 Aligned_cols=246 Identities=24% Similarity=0.321 Sum_probs=203.4
Q ss_pred hhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEE
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA---QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVY 497 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 497 (714)
.|.+.+.||+|+||.||+|.+. .+++.||||++.... ......+.+|++++++++||||+++++++..+...++||
T Consensus 10 ~Y~i~~~lG~G~~g~V~~a~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 88 (336)
T 3h4j_B 10 PYIIRETLGEGSFGKVKLATHY-KTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI 88 (336)
T ss_dssp TEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CEEEEEEEecCCCeEEEEEEEC-CCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 5777899999999999999975 578999999996532 223457899999999999999999999999999999999
Q ss_pred eecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCccc
Q 041576 498 EFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSR 577 (714)
Q Consensus 498 E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 577 (714)
||+ +|+|.+++.....+++.++..++.||+.||+|||+.+ |+||||||+||++++++.+||+|||++.......
T Consensus 89 E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~-- 162 (336)
T 3h4j_B 89 EYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN-- 162 (336)
T ss_dssp CCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB--
T ss_pred ECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccCCc--
Confidence 999 6899999988788999999999999999999999998 9999999999999999999999999998664332
Q ss_pred ceeeecCCCCccCcccccCCCC-CchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhh
Q 041576 578 TRTVIRGTRGYVAPEWFKNVPV-SAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKA 656 (714)
Q Consensus 578 ~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 656 (714)
......||+.|+|||.+.+..+ +.++||||||+++|||++|+.||...........+ ..+.
T Consensus 163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i--------~~~~---------- 224 (336)
T 3h4j_B 163 FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV--------NSCV---------- 224 (336)
T ss_dssp TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCC--------CSSC----------
T ss_pred ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHH--------HcCC----------
Confidence 2234569999999999988776 78999999999999999999999754322211000 0000
Q ss_pred hccchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 657 AMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 657 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
...+...+..+.+++.+||+.||.+|||++|+++.
T Consensus 225 ~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 225 YVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp CCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred CCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 00122234567889999999999999999999873
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=351.77 Aligned_cols=250 Identities=22% Similarity=0.299 Sum_probs=206.3
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEeccc---chhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEE
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKL---AQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLV 496 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 496 (714)
..|.+.+.||+|+||.||+|... .+++.||+|.+... .....+.+.+|++++++++||||+++++++.+....++|
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~-~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKN-DTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEET-TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEEC-CCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 45777899999999999999876 57889999999653 233456889999999999999999999999999999999
Q ss_pred EeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcc
Q 041576 497 YEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQS 576 (714)
Q Consensus 497 ~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 576 (714)
|||+.+|+|.+++.....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 94 ~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~-- 168 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE-- 168 (384)
T ss_dssp ECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTT--
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccCC--
Confidence 999999999999998888999999999999999999999998 999999999999999999999999999876432
Q ss_pred cceeeecCCCCccCcccccC---CCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecc
Q 041576 577 RTRTVIRGTRGYVAPEWFKN---VPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDN 653 (714)
Q Consensus 577 ~~~~~~~gt~~y~aPE~~~~---~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 653 (714)
.......||+.|+|||++.. ..++.++|||||||++|||++|+.||............... .....
T Consensus 169 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~-----~~~~~------ 237 (384)
T 4fr4_A 169 TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTF-----ETTVV------ 237 (384)
T ss_dssp CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHH-----HHCCC------
T ss_pred CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHH-----hhccc------
Confidence 22344579999999999964 45899999999999999999999999754433222111111 11100
Q ss_pred hhhhccchHHHHHHHHHHHHccccCCCCCCC-HHHHHH
Q 041576 654 DKAAMADKSRACKWLMIALWCIQEDPLKRPA-MKMIVQ 690 (714)
Q Consensus 654 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~ 690 (714)
..+...+..+.+++.+||+.||++||+ +++|++
T Consensus 238 ----~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 238 ----TYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp ----CCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred ----CCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 012223457888999999999999998 777764
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=340.03 Aligned_cols=262 Identities=16% Similarity=0.203 Sum_probs=210.8
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhcc-CcccccceeceEecCCeeeEEEe
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRT-HHKNLVQLLGFCDEGLNRLLVYE 498 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~E 498 (714)
..|.+.+.||+|+||.||+|... .+++.||||++.... ....+.+|+++++++ +|+|++++++++.++...++|||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 10 VHYKVGRRIGEGSFGVIFEGTNL-LNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTEEEEEEEEECSSCEEEEEEET-TTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred cceEEEEEEeecCCEEEEEEEEC-CCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 45777899999999999999865 578999999986432 234678899999999 89999999999999999999999
Q ss_pred ecCCCchhhhhhcC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCc-----eEEecCCCccccc
Q 041576 499 FMGNGTLANLLFAI-PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFT-----AKISDFGLSKLLL 572 (714)
Q Consensus 499 ~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~-----~kl~Dfg~~~~~~ 572 (714)
|+ +++|.+++... ..+++..+..++.||++||+|||+++ |+||||||+||+++.++. +||+|||++....
T Consensus 87 ~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~ 162 (298)
T 1csn_A 87 LL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 162 (298)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred ec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECccccccc
Confidence 99 99999999865 45899999999999999999999998 999999999999987776 9999999998765
Q ss_pred cCcc------cceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCc
Q 041576 573 SDQS------RTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGK 646 (714)
Q Consensus 573 ~~~~------~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~ 646 (714)
.... .......||..|+|||.+.+..++.++||||||+++|||++|+.||...........+.......... .
T Consensus 163 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~ 241 (298)
T 1csn_A 163 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST-P 241 (298)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS-C
T ss_pred cccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCc-c
Confidence 4332 12344569999999999999999999999999999999999999998654332222111111000000 0
Q ss_pred cceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCC
Q 041576 647 LDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLEV 698 (714)
Q Consensus 647 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 698 (714)
........+..+.+++.+||+.||++||++++|++.|+++++.
T Consensus 242 ---------~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~ 284 (298)
T 1csn_A 242 ---------LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLER 284 (298)
T ss_dssp ---------HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred ---------HHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHh
Confidence 0001112345788899999999999999999999999997753
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=351.40 Aligned_cols=276 Identities=24% Similarity=0.337 Sum_probs=209.3
Q ss_pred hhhhhhCcccceeEEEeEee---CCCCcEEEEEEecccc-hhhHHHHHHHHHHHhccCcccccceeceEec--CCeeeEE
Q 041576 423 GFEEELGRGSFGIVYKGVLK---SASGNAVAVKKLDKLA-QEREREFKTEVSAIGRTHHKNLVQLLGFCDE--GLNRLLV 496 (714)
Q Consensus 423 ~~~~~ig~G~~g~Vy~~~~~---~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--~~~~~lv 496 (714)
.+.+.||+|+||+||++.++ ..+++.||||+++... ....+.+.+|++++++++||||+++++++.+ ....++|
T Consensus 34 ~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 113 (318)
T 3lxp_A 34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLV 113 (318)
T ss_dssp EEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEE
T ss_pred hhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEE
Confidence 77899999999999888653 2367899999997643 3446789999999999999999999999977 4678999
Q ss_pred EeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcc
Q 041576 497 YEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQS 576 (714)
Q Consensus 497 ~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 576 (714)
|||+++++|.+++... .+++..++.++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++........
T Consensus 114 ~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 189 (318)
T 3lxp_A 114 MEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE 189 (318)
T ss_dssp ECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECCTTCS
T ss_pred EecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCcccccccccccc
Confidence 9999999999999774 4899999999999999999999998 99999999999999999999999999987654332
Q ss_pred --cceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecch
Q 041576 577 --RTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDND 654 (714)
Q Consensus 577 --~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 654 (714)
.......++..|+|||.+.+..++.++||||||+++|||++|+.||.......... ..+.............+...
T Consensus 190 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 267 (318)
T 3lxp_A 190 YYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLEL--IGIAQGQMTVLRLTELLERG 267 (318)
T ss_dssp EEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHH--HCSCCHHHHHHHHHHHHHTT
T ss_pred ccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhh--hcccccchhHHHHHHHHhcc
Confidence 12233457888999999999889999999999999999999999987543221000 00000000000000111111
Q ss_pred hhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCCCCCCCC
Q 041576 655 KAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLEVPSPPMP 704 (714)
Q Consensus 655 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~pp~p 704 (714)
.....+...+..+.+++.+||+.||++|||++|+++.|+.+.+.-..+.|
T Consensus 268 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~~p 317 (318)
T 3lxp_A 268 ERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQAP 317 (318)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC---
T ss_pred cCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhccCCC
Confidence 11112233446788899999999999999999999999988765444433
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=359.32 Aligned_cols=252 Identities=21% Similarity=0.242 Sum_probs=204.8
Q ss_pred hhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEE
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA---QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVY 497 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 497 (714)
.|.+.+.||+|+||.||+|+++ .+++.||+|++++.. ......+.+|+.+++.++||||+++++++.++...++||
T Consensus 70 ~y~~~~~LG~G~fG~V~~~~~~-~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~ 148 (410)
T 3v8s_A 70 DYEVVKVIGRGAFGEVQLVRHK-STRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVM 148 (410)
T ss_dssp GEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEEEEcCCCEEEEEEEEC-CCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence 4566789999999999999976 578899999996532 222345889999999999999999999999999999999
Q ss_pred eecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCccc
Q 041576 498 EFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSR 577 (714)
Q Consensus 498 E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 577 (714)
||+++|+|.+++.. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++........
T Consensus 149 E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~ 224 (410)
T 3v8s_A 149 EYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV 224 (410)
T ss_dssp CCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTTSEE
T ss_pred eCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccceeEeeccCCcc
Confidence 99999999999976 46899999999999999999999998 999999999999999999999999999876554433
Q ss_pred ceeeecCCCCccCcccccCCC----CCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecc
Q 041576 578 TRTVIRGTRGYVAPEWFKNVP----VSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDN 653 (714)
Q Consensus 578 ~~~~~~gt~~y~aPE~~~~~~----~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 653 (714)
......||+.|+|||++.+.. ++.++|||||||++|||++|+.||...........+..... ....
T Consensus 225 ~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~--------~~~~-- 294 (410)
T 3v8s_A 225 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKN--------SLTF-- 294 (410)
T ss_dssp ECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH--------HCCC--
T ss_pred cccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccc--------cccC--
Confidence 344567999999999997665 78999999999999999999999986543332221111100 0000
Q ss_pred hhhhccchHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 041576 654 DKAAMADKSRACKWLMIALWCIQEDPLK--RPAMKMIVQM 691 (714)
Q Consensus 654 ~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~ 691 (714)
......+..+.+++.+||+.+|.+ ||+++||++.
T Consensus 295 ----p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 295 ----PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp ----CTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred ----CCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 001123356778999999999988 9999999974
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=340.81 Aligned_cols=249 Identities=22% Similarity=0.294 Sum_probs=196.0
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccch--------------------------hhHHHHHHHHHHHh
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQ--------------------------EREREFKTEVSAIG 473 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~--------------------------~~~~~~~~E~~~l~ 473 (714)
..|.+.+.||+|+||.||+|... .+++.||||++..... ...+.+.+|+++++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~a~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 13 NQYTLKDEIGKGSYGVVKLAYNE-NDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp TTEEEEEEEEC--CCEEEEEEET-TTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred cceEEEeEEeecCCEEEEEEEEC-CCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 35777899999999999999875 5788999999864321 12356889999999
Q ss_pred ccCcccccceeceEec--CCeeeEEEeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCe
Q 041576 474 RTHHKNLVQLLGFCDE--GLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQN 551 (714)
Q Consensus 474 ~l~h~nIv~l~~~~~~--~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~N 551 (714)
+++||||+++++++.+ ....++||||+++++|.+++.. ..+++.++..++.||++||+|||+++ |+||||||+|
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~N 167 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL-KPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKPSN 167 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGG
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHH
Confidence 9999999999999986 5678999999999999987654 57899999999999999999999998 9999999999
Q ss_pred EEECCCCceEEecCCCccccccCcccceeeecCCCCccCcccccCCC---CCchhhhHHHHHHHHHHHhcCCCCcccccc
Q 041576 552 ILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVP---VSAKVDVYSFGVVLLKIICCKRSVEMELGE 628 (714)
Q Consensus 552 Ill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~s~ksDVwSlGvil~elltG~~p~~~~~~~ 628 (714)
|+++.++.+||+|||++........ ......||+.|+|||.+.+.. .+.++||||||+++|||++|+.||......
T Consensus 168 il~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 246 (298)
T 2zv2_A 168 LLVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIM 246 (298)
T ss_dssp EEECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred EEECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHH
Confidence 9999999999999999987644322 223456899999999998765 378999999999999999999999754322
Q ss_pred hhhhhhhHHHhhhhhcCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 629 ERSAILTDWAYDCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 629 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
.... ......... ......+..+.+++.+||+.||++|||+.|+++
T Consensus 247 ~~~~--------~~~~~~~~~--------~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 247 CLHS--------KIKSQALEF--------PDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp HHHH--------HHHHCCCCC--------CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred HHHH--------HHhcccCCC--------CCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 1110 111111100 001123356788999999999999999999875
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=343.94 Aligned_cols=266 Identities=23% Similarity=0.298 Sum_probs=191.9
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc-hhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEe
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA-QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYE 498 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E 498 (714)
..|.+.+.||+|+||.||+|..+ .+++.||+|+++... ....+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 5 SQFKQLEKLGNGTYATVYKGLNK-TTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp --------------CEEEEEECS-SSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred cceeEeeEECCCCCEEEEEEEEC-CCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 35677899999999999999876 578999999996533 2334678899999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcC------CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccc
Q 041576 499 FMGNGTLANLLFAI------PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLL 572 (714)
Q Consensus 499 ~~~~gsL~~~l~~~------~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~ 572 (714)
|++ ++|.+++... ..+++..+..++.||++||+|||+++ |+||||||+||+++.++.+||+|||++....
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 5999988643 35789999999999999999999998 9999999999999999999999999998764
Q ss_pred cCcccceeeecCCCCccCcccccC-CCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhh----hhhc---
Q 041576 573 SDQSRTRTVIRGTRGYVAPEWFKN-VPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYD----CYVE--- 644 (714)
Q Consensus 573 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~----~~~~--- 644 (714)
.... ......+|+.|+|||.+.+ ..++.++|||||||++|||++|+.||......+....+...... .+..
T Consensus 160 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 238 (317)
T 2pmi_A 160 IPVN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTK 238 (317)
T ss_dssp SCCC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGG
T ss_pred CCcc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhh
Confidence 3222 2233468999999999976 46899999999999999999999999765443322211111000 0000
Q ss_pred -----Ccccee----ecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 645 -----GKLDVL----VDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 645 -----~~~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
...... +...............+.+++.+||+.||++|||++|+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 239 LPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp CTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 000000 00000011111234578899999999999999999999873
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=335.57 Aligned_cols=251 Identities=23% Similarity=0.294 Sum_probs=207.7
Q ss_pred HHhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEe
Q 041576 419 EATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYE 498 (714)
Q Consensus 419 ~at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E 498 (714)
...|.+.+.||+|+||.||+|... .++..||+|++........+.+.+|++++++++||||+++++++.++...++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQK-GTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhEEeeeEEeecCCEEEEEEEeC-CCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 346778899999999999999876 5678999999987666667889999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEE---CCCCceEEecCCCccccccCc
Q 041576 499 FMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILL---DQDFTAKISDFGLSKLLLSDQ 575 (714)
Q Consensus 499 ~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll---~~~~~~kl~Dfg~~~~~~~~~ 575 (714)
|+++++|.+++.....+++..+..++.|++.||+|||+++ |+||||||+||++ +.++.+||+|||++.......
T Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~ 163 (277)
T 3f3z_A 87 LCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK 163 (277)
T ss_dssp CCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS
T ss_pred ccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc
Confidence 9999999999988888999999999999999999999998 9999999999999 788999999999998664332
Q ss_pred ccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchh
Q 041576 576 SRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDK 655 (714)
Q Consensus 576 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 655 (714)
......+++.|+|||.+.+. ++.++||||||+++|||++|+.||........... ...+.... +
T Consensus 164 --~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~--------~~~~~~~~---~-- 227 (277)
T 3f3z_A 164 --MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLK--------IREGTFTF---P-- 227 (277)
T ss_dssp --CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH--------HHHCCCCC---C--
T ss_pred --chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHH--------HHhCCCCC---C--
Confidence 22334689999999998764 89999999999999999999999976443321111 11111100 0
Q ss_pred hhccchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 656 AAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 656 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
.......+..+.+++.+||+.||++|||+.|+++
T Consensus 228 -~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 228 -EKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp -HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred -chhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000122456788999999999999999999986
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=344.31 Aligned_cols=256 Identities=25% Similarity=0.411 Sum_probs=208.5
Q ss_pred HHhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEe
Q 041576 419 EATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYE 498 (714)
Q Consensus 419 ~at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E 498 (714)
..+|.+.+.||+|+||.||+|... +++.||||.+.... ...+.+.+|++++++++||||+++++++.+ +..++|||
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e 87 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYN--GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITE 87 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET--TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred HHhhhheeeecCCCCeEEEEEEEc--CCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEe
Confidence 356778899999999999999865 56789999997543 345688999999999999999999999864 46899999
Q ss_pred ecCCCchhhhhhcCC--CCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcc
Q 041576 499 FMGNGTLANLLFAIP--RPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQS 576 (714)
Q Consensus 499 ~~~~gsL~~~l~~~~--~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 576 (714)
|+++++|.+++.... .+++..++.++.||++||+|||+++ |+||||||+||++++++.+||+|||++........
T Consensus 88 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 164 (279)
T 1qpc_A 88 YMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY 164 (279)
T ss_dssp CCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred cCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCccc
Confidence 999999999997643 6899999999999999999999998 99999999999999999999999999987654433
Q ss_pred cceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccchhhhhhhHHHhhhhhcCccceeecchh
Q 041576 577 RTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDK 655 (714)
Q Consensus 577 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 655 (714)
.......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+. +. ....+..
T Consensus 165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~---~~-----~~~~~~~-------- 228 (279)
T 1qpc_A 165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV---IQ-----NLERGYR-------- 228 (279)
T ss_dssp ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH---HH-----HHHTTCC--------
T ss_pred ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHH---HH-----HHhcccC--------
Confidence 33333456788999999998889999999999999999999 8999875433221 11 1111100
Q ss_pred hhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCC
Q 041576 656 AAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLEV 698 (714)
Q Consensus 656 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 698 (714)
...+...+..+.+++.+||+.||++|||+.++++.|+++...
T Consensus 229 -~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 270 (279)
T 1qpc_A 229 -MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (279)
T ss_dssp -CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -CCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHh
Confidence 001122345788899999999999999999999999987644
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=348.58 Aligned_cols=245 Identities=24% Similarity=0.235 Sum_probs=206.1
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEE
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA---QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLV 496 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 496 (714)
..|.+.+.||+|+||.||+|+.. .+++.||||++.... ....+.+.+|++++++++||||+++++++.+....++|
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHK-ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEEC-CCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 35667789999999999999876 578999999996532 23456789999999999999999999999999999999
Q ss_pred EeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcc
Q 041576 497 YEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQS 576 (714)
Q Consensus 497 ~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 576 (714)
|||+++|+|.+++.....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 120 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~-- 194 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-- 194 (350)
T ss_dssp EECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC--
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccCC--
Confidence 999999999999998788999999999999999999999998 999999999999999999999999999866432
Q ss_pred cceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhh
Q 041576 577 RTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKA 656 (714)
Q Consensus 577 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 656 (714)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.......... ....+...
T Consensus 195 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~--------~i~~~~~~-------- 256 (350)
T 1rdq_E 195 --TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE--------KIVSGKVR-------- 256 (350)
T ss_dssp --BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH--------HHHHCCCC--------
T ss_pred --cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHH--------HHHcCCCC--------
Confidence 223468999999999999999999999999999999999999997553322111 11111111
Q ss_pred hccchHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 041576 657 AMADKSRACKWLMIALWCIQEDPLKRPA-----MKMIVQ 690 (714)
Q Consensus 657 ~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 690 (714)
.+...+..+.+++.+||+.||++||+ ++||++
T Consensus 257 --~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 257 --FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp --CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred --CCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 11223456788999999999999998 888875
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-40 Score=363.26 Aligned_cols=250 Identities=28% Similarity=0.358 Sum_probs=204.5
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCcccccceeceEecCC-eeeEEEe
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGL-NRLLVYE 498 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-~~~lv~E 498 (714)
..+.+.+.||+|+||.||+|.+. ++.||||.++... ..+.+.+|++++++++||||+++++++.+.. ..++|||
T Consensus 193 ~~~~~~~~lG~G~fg~V~~~~~~---~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e 267 (450)
T 1k9a_A 193 KELKLLQTIGKGEFGDVMLGDYR---GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 267 (450)
T ss_dssp GGEEEEEEEEECSSEEEEEEEET---TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEE
T ss_pred HHeEEEeeecCcCCeeEEEEEec---CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEE
Confidence 45667789999999999999874 7799999997643 4568999999999999999999999987665 7899999
Q ss_pred ecCCCchhhhhhcCC--CCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcc
Q 041576 499 FMGNGTLANLLFAIP--RPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQS 576 (714)
Q Consensus 499 ~~~~gsL~~~l~~~~--~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 576 (714)
|+++|+|.+++.... .+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 268 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-- 342 (450)
T 1k9a_A 268 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-- 342 (450)
T ss_dssp CCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC----
T ss_pred ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccccccc--
Confidence 999999999998654 3689999999999999999999998 999999999999999999999999999854322
Q ss_pred cceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccchhhhhhhHHHhhhhhcCccceeecchh
Q 041576 577 RTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDK 655 (714)
Q Consensus 577 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 655 (714)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+... ....+..
T Consensus 343 --~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~--------~i~~~~~-------- 404 (450)
T 1k9a_A 343 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP--------RVEKGYK-------- 404 (450)
T ss_dssp ------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHH--------HHHTTCC--------
T ss_pred --ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH--------HHHcCCC--------
Confidence 122357889999999999999999999999999999998 999997543322111 1111110
Q ss_pred hhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCC
Q 041576 656 AAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLEV 698 (714)
Q Consensus 656 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 698 (714)
...+...+..+.+++.+||+.||++|||+.+|++.|+.+...
T Consensus 405 -~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 405 -MDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp -CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred -CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 011223345788899999999999999999999999987543
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=349.99 Aligned_cols=246 Identities=24% Similarity=0.281 Sum_probs=198.2
Q ss_pred hhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEeecCCCc
Q 041576 425 EEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEFMGNGT 504 (714)
Q Consensus 425 ~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~gs 504 (714)
.+.||+|+||.||+|... .+++.||+|+++.......+.+.+|++++++++||||+++++++.+.+..++||||+++++
T Consensus 94 ~~~lG~G~~g~Vy~a~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~ 172 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEET-ATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE 172 (373)
T ss_dssp EEECC-----CEEEEEET-TTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred ceEEecCcCEEEEEEEEc-CCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence 467999999999999876 4789999999987665667789999999999999999999999999999999999999999
Q ss_pred hhhhhhcC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEE--CCCCceEEecCCCccccccCcccceee
Q 041576 505 LANLLFAI-PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILL--DQDFTAKISDFGLSKLLLSDQSRTRTV 581 (714)
Q Consensus 505 L~~~l~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll--~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 581 (714)
|.+++... ..+++..++.++.||++||+|||+.+ |+||||||+|||+ +.++.+||+|||+++....... ...
T Consensus 173 L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~--~~~ 247 (373)
T 2x4f_A 173 LFDRIIDESYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK--LKV 247 (373)
T ss_dssp EHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB--CCC
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc--ccc
Confidence 99988754 46899999999999999999999998 9999999999999 6778999999999987644322 223
Q ss_pred ecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhhccch
Q 041576 582 IRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMADK 661 (714)
Q Consensus 582 ~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 661 (714)
..||+.|+|||++.+..++.++|||||||++|||++|+.||...........+. ..... . .. ....
T Consensus 248 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~--------~~~~~-~-~~----~~~~ 313 (373)
T 2x4f_A 248 NFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNIL--------ACRWD-L-ED----EEFQ 313 (373)
T ss_dssp CCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH--------HTCCC-S-CS----GGGT
T ss_pred ccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--------hccCC-C-Ch----hhhc
Confidence 458999999999999899999999999999999999999997654332111111 11000 0 00 0011
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 662 SRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 662 ~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
.....+.+++.+||+.||++|||+.|+++
T Consensus 314 ~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 314 DISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred cCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 23457888999999999999999999987
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=352.03 Aligned_cols=269 Identities=18% Similarity=0.178 Sum_probs=205.6
Q ss_pred HHhhhhhhhhCcccceeEEEeEeeCC----CCcEEEEEEecccchhh-----------HHHHHHHHHHHhccCcccccce
Q 041576 419 EATNGFEEELGRGSFGIVYKGVLKSA----SGNAVAVKKLDKLAQER-----------EREFKTEVSAIGRTHHKNLVQL 483 (714)
Q Consensus 419 ~at~~~~~~ig~G~~g~Vy~~~~~~~----~~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~h~nIv~l 483 (714)
...|.+.+.||+|+||.||+|.+... .++.||||++....... ...+..|+..+..++||||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 34678889999999999999988643 25789999986533211 1234456777888899999999
Q ss_pred eceEecC----CeeeEEEeecCCCchhhhhhcC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEEC--C
Q 041576 484 LGFCDEG----LNRLLVYEFMGNGTLANLLFAI-PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLD--Q 556 (714)
Q Consensus 484 ~~~~~~~----~~~~lv~E~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~--~ 556 (714)
++++... ...++||||+ +++|.+++... ..+++..++.|+.||+.||+|||+++ |+||||||+|||++ .
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~~~~ 189 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKN 189 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEESSC
T ss_pred EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEecCC
Confidence 9998764 4579999999 99999999875 67899999999999999999999998 99999999999999 8
Q ss_pred CCceEEecCCCccccccCccc------ceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchh
Q 041576 557 DFTAKISDFGLSKLLLSDQSR------TRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEER 630 (714)
Q Consensus 557 ~~~~kl~Dfg~~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~ 630 (714)
++.+||+|||+++.+...... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||........
T Consensus 190 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~ 269 (364)
T 3op5_A 190 PDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPK 269 (364)
T ss_dssp TTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHH
T ss_pred CCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHH
Confidence 899999999999876443221 11334599999999999999999999999999999999999999985433221
Q ss_pred hhhhhHHHhhhhhcCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCC
Q 041576 631 SAILTDWAYDCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLEV 698 (714)
Q Consensus 631 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 698 (714)
... ........ .+..+.+... .....+..+.+++.+||+.||++||++.+|++.|+++++.
T Consensus 270 ~~~---~~~~~~~~-~~~~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~ 330 (364)
T 3op5_A 270 YVR---DSKIRYRE-NIASLMDKCF---PAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKA 330 (364)
T ss_dssp HHH---HHHHHHHH-CHHHHHHHHS---CTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred HHH---HHHHHhhh-hHHHHHHHhc---ccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Confidence 111 01111111 1111111111 0122345788899999999999999999999999887643
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=343.94 Aligned_cols=260 Identities=23% Similarity=0.286 Sum_probs=205.9
Q ss_pred HHhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCcccccceeceEe----cCCeee
Q 041576 419 EATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCD----EGLNRL 494 (714)
Q Consensus 419 ~at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~----~~~~~~ 494 (714)
..+|.+.+.||+|+||.||+|... .+++.||||++........+.+.+|++++++++||||+++++++. .....+
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 106 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGL-HDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW 106 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEET-TTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEec-CCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence 346778899999999999999875 478999999997766667788999999999999999999999986 345789
Q ss_pred EEEeecCCCchhhhhhc----CCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccc
Q 041576 495 LVYEFMGNGTLANLLFA----IPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKL 570 (714)
Q Consensus 495 lv~E~~~~gsL~~~l~~----~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~ 570 (714)
+||||+++++|.+++.. ...+++.+++.++.||++||+|||+++ |+||||||+||+++.++.+||+|||++..
T Consensus 107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~ 183 (317)
T 2buj_A 107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQ 183 (317)
T ss_dssp EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence 99999999999999875 467899999999999999999999998 99999999999999999999999999876
Q ss_pred cccCccc--------ceeeecCCCCccCcccccCCC---CCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHh
Q 041576 571 LLSDQSR--------TRTVIRGTRGYVAPEWFKNVP---VSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAY 639 (714)
Q Consensus 571 ~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~---~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~ 639 (714)
....... ......|+..|+|||.+.+.. ++.++||||||+++|||++|+.||......... +...
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~--~~~~-- 259 (317)
T 2buj_A 184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDS--VALA-- 259 (317)
T ss_dssp SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSC--HHHH--
T ss_pred cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccch--hhHH--
Confidence 5322111 112234799999999987654 689999999999999999999999643221110 0000
Q ss_pred hhhhcCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccC
Q 041576 640 DCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLE 697 (714)
Q Consensus 640 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 697 (714)
... .. ........+..+.+++.+||+.||++|||++|+++.|+.+..
T Consensus 260 --~~~-~~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 306 (317)
T 2buj_A 260 --VQN-QL--------SIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306 (317)
T ss_dssp --HHC-C----------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred --hhc-cC--------CCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence 000 00 000112234578889999999999999999999999998753
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=352.56 Aligned_cols=256 Identities=23% Similarity=0.305 Sum_probs=203.4
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHHhcc-CcccccceeceEecCCeeeE
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA---QEREREFKTEVSAIGRT-HHKNLVQLLGFCDEGLNRLL 495 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~l 495 (714)
..+.+.+.||+|+||.||+|+.+ .+++.||+|++++.. ......+.+|..++.++ +||||+++++++.++...++
T Consensus 52 ~~y~~~~~LG~G~fG~V~~~~~~-~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 52 QDFDLLRVIGRGSYAKVLLVRLK-KTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hHcEEEEEEeeCCCeEEEEEEEC-CCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 45677899999999999999976 578899999997542 22334678899999887 89999999999999999999
Q ss_pred EEeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCc
Q 041576 496 VYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQ 575 (714)
Q Consensus 496 v~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 575 (714)
||||+++|+|.+++.....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 131 V~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~ 207 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG 207 (396)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred EEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeecccCC
Confidence 9999999999999998888999999999999999999999998 9999999999999999999999999998533222
Q ss_pred ccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchh-hhhhhHHHhhhhhcCccceeecch
Q 041576 576 SRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEER-SAILTDWAYDCYVEGKLDVLVDND 654 (714)
Q Consensus 576 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~-~~~l~~~~~~~~~~~~~~~~~~~~ 654 (714)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ..................
T Consensus 208 -~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~------ 280 (396)
T 4dc2_A 208 -DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR------ 280 (396)
T ss_dssp -CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCC------
T ss_pred -CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccC------
Confidence 223446799999999999999999999999999999999999999964322111 000001111111111111
Q ss_pred hhhccchHHHHHHHHHHHHccccCCCCCCCH------HHHHH
Q 041576 655 KAAMADKSRACKWLMIALWCIQEDPLKRPAM------KMIVQ 690 (714)
Q Consensus 655 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~------~evl~ 690 (714)
.+...+..+.+++.+||+.||++||++ +||++
T Consensus 281 ----~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~ 318 (396)
T 4dc2_A 281 ----IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 318 (396)
T ss_dssp ----CCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHH
T ss_pred ----CCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhc
Confidence 122234567889999999999999985 56654
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=336.18 Aligned_cols=254 Identities=29% Similarity=0.445 Sum_probs=202.1
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhh-------HHHHHHHHHHHhccCcccccceeceEecCCe
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQER-------EREFKTEVSAIGRTHHKNLVQLLGFCDEGLN 492 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 492 (714)
.+|.+.+.||+|+||.||+|.+. .+++.||+|++....... .+.+.+|++++++++||||+++++++.+..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 19 NEIEYEKQIGKGGFGLVHKGRLV-KDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp TTEEEEEECCCCSSSCEEEEEET-TTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred ccceehhccccCCceeEEEEEEc-CCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 46777899999999999999876 478999999986432211 167899999999999999999999997665
Q ss_pred eeEEEeecCCCchhhhhhcC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCc-----eEEecCC
Q 041576 493 RLLVYEFMGNGTLANLLFAI-PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFT-----AKISDFG 566 (714)
Q Consensus 493 ~~lv~E~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~-----~kl~Dfg 566 (714)
++||||+++++|.+++... ..+++..++.++.|++.||+|||+++ .+|+||||||+||+++.++. +||+|||
T Consensus 97 -~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg 174 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFG 174 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECCCT
T ss_pred -eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCCCC
Confidence 6999999999998888654 46899999999999999999999985 45999999999999988776 9999999
Q ss_pred CccccccCcccceeeecCCCCccCcccc--cCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhc
Q 041576 567 LSKLLLSDQSRTRTVIRGTRGYVAPEWF--KNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVE 644 (714)
Q Consensus 567 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~ 644 (714)
+++.... ......|++.|+|||.+ ....++.++||||||+++|||++|+.||.......... .. ....
T Consensus 175 ~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~-~~-----~~~~ 244 (287)
T 4f0f_A 175 LSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKF-IN-----MIRE 244 (287)
T ss_dssp TCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHH-HH-----HHHH
T ss_pred ccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHH-HH-----HHhc
Confidence 9975432 23345689999999998 45567899999999999999999999997543332110 00 0011
Q ss_pred CccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 041576 645 GKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGY 695 (714)
Q Consensus 645 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 695 (714)
.... ...+...+..+.+++.+||+.||++|||++|+++.|+++
T Consensus 245 ~~~~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 245 EGLR--------PTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp SCCC--------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred cCCC--------CCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 1110 011223345788899999999999999999999999864
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=340.76 Aligned_cols=257 Identities=24% Similarity=0.328 Sum_probs=204.6
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCC--CcEEEEEEeccc-chhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEE
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSAS--GNAVAVKKLDKL-AQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLV 496 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~--~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 496 (714)
..|.+.+.||+|+||.||+|.+.... +..||+|.+... .....+.+.+|+.++++++||||+++++++.++ ..++|
T Consensus 12 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~v 90 (281)
T 3cc6_A 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWII 90 (281)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCEEE
T ss_pred cceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCEEE
Confidence 45677889999999999999876433 346999999764 344567899999999999999999999998654 56899
Q ss_pred EeecCCCchhhhhhcC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCc
Q 041576 497 YEFMGNGTLANLLFAI-PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQ 575 (714)
Q Consensus 497 ~E~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 575 (714)
|||+++++|.+++... ..+++..+..++.||++||+|||+++ |+||||||+||+++.++.+||+|||++.......
T Consensus 91 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 167 (281)
T 3cc6_A 91 MELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYIEDED 167 (281)
T ss_dssp EECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC----
T ss_pred EecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCccccccc
Confidence 9999999999999764 45899999999999999999999998 9999999999999999999999999998765544
Q ss_pred ccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccchhhhhhhHHHhhhhhcCccceeecch
Q 041576 576 SRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDND 654 (714)
Q Consensus 576 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 654 (714)
........++..|+|||.+.+..++.++||||||+++|||++ |+.||...........+ ..+...
T Consensus 168 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~--------~~~~~~------ 233 (281)
T 3cc6_A 168 YYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVL--------EKGDRL------ 233 (281)
T ss_dssp -----CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHH--------HHTCCC------
T ss_pred ccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHH--------hcCCCC------
Confidence 333344557889999999998899999999999999999998 99999754333211111 111000
Q ss_pred hhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccC
Q 041576 655 KAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLE 697 (714)
Q Consensus 655 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 697 (714)
..+...+..+.+++.+||+.||++|||+.|+++.|+.+.+
T Consensus 234 ---~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 273 (281)
T 3cc6_A 234 ---PKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ 273 (281)
T ss_dssp ---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---CCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHH
Confidence 0111233567889999999999999999999999988754
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=340.72 Aligned_cols=266 Identities=21% Similarity=0.283 Sum_probs=202.4
Q ss_pred hhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc--hhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEe
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA--QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYE 498 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E 498 (714)
+|.+.+.||+|+||+||+|... .+++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 4 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 4 KYEKIGKIGEGSYGVVFKCRNR-DTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEeeEEeecCCeEEEEEEeC-CCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 4677889999999999999976 468999999986532 3345678899999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcccc
Q 041576 499 FMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRT 578 (714)
Q Consensus 499 ~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 578 (714)
|+++++|.+++.....+++..+..++.|+++||+|||+++ |+||||||+||+++.++.+||+|||++........ .
T Consensus 83 ~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~ 158 (311)
T 4agu_A 83 YCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD-Y 158 (311)
T ss_dssp CCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred eCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc-c
Confidence 9999999999988888999999999999999999999998 99999999999999999999999999987643322 2
Q ss_pred eeeecCCCCccCcccccC-CCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHh-------hhhhcC-----
Q 041576 579 RTVIRGTRGYVAPEWFKN-VPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAY-------DCYVEG----- 645 (714)
Q Consensus 579 ~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~-------~~~~~~----- 645 (714)
.....++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+....+..... ..+...
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (311)
T 4agu_A 159 YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSG 238 (311)
T ss_dssp -------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTT
T ss_pred cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccccc
Confidence 233468999999999976 6689999999999999999999999976544332211111000 000000
Q ss_pred -ccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 646 -KLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 646 -~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
..................+..+.+++.+||+.||++|||++|+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 239 VKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp CCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred CcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0000000000000112234568889999999999999999999863
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=342.19 Aligned_cols=252 Identities=25% Similarity=0.315 Sum_probs=207.7
Q ss_pred HHhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccch------hhHHHHHHHHHHHhccCcccccceeceEecCCe
Q 041576 419 EATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQ------EREREFKTEVSAIGRTHHKNLVQLLGFCDEGLN 492 (714)
Q Consensus 419 ~at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 492 (714)
...|.+.+.||+|+||.||+|... .+++.||+|.+..... ...+.+.+|+.++++++||||+++++++.+...
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 89 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREK-STGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD 89 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hccEEEeeEeeecCCEEEEEEEEC-CCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence 456888899999999999999876 5789999999865322 135789999999999999999999999999999
Q ss_pred eeEEEeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCC----ceEEecCCCc
Q 041576 493 RLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDF----TAKISDFGLS 568 (714)
Q Consensus 493 ~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~----~~kl~Dfg~~ 568 (714)
.++||||+++++|.+++.....+++..+..++.||++||+|||+++ |+||||||+||+++.++ .+||+|||++
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~ 166 (321)
T 2a2a_A 90 VVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (321)
T ss_dssp EEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCTTC
T ss_pred EEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCccc
Confidence 9999999999999999998888999999999999999999999998 99999999999999888 7999999999
Q ss_pred cccccCcccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccc
Q 041576 569 KLLLSDQSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLD 648 (714)
Q Consensus 569 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 648 (714)
....... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||...........+ ......
T Consensus 167 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i--------~~~~~~ 236 (321)
T 2a2a_A 167 HEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANI--------TSVSYD 236 (321)
T ss_dssp EECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH--------HTTCCC
T ss_pred eecCccc--cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHH--------Hhcccc
Confidence 8764432 223446899999999999999999999999999999999999999754333211111 111000
Q ss_pred eeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 649 VLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 649 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
.+.. .....+..+.+++.+||+.||++|||+.|+++
T Consensus 237 --~~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 237 --FDEE----FFSHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp --CCHH----HHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred --cChh----hhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0000 11123346788999999999999999999987
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=350.92 Aligned_cols=249 Identities=25% Similarity=0.295 Sum_probs=205.7
Q ss_pred HHhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHHhcc-CcccccceeceEecCCeee
Q 041576 419 EATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA---QEREREFKTEVSAIGRT-HHKNLVQLLGFCDEGLNRL 494 (714)
Q Consensus 419 ~at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~ 494 (714)
...|.+.+.||+|+||.||+|+.+ .+++.||||++++.. ......+..|.+++.++ +||||+++++++.+.+..+
T Consensus 16 ~~~y~~~~~lG~G~fg~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~ 94 (345)
T 1xjd_A 16 IEDFILHKMLGKGSFGKVFLAEFK-KTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLF 94 (345)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEET-TTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEEC-CCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEE
Confidence 345777899999999999999976 578999999997632 33456788899999887 9999999999999999999
Q ss_pred EEEeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccC
Q 041576 495 LVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSD 574 (714)
Q Consensus 495 lv~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 574 (714)
+||||+++|+|.+++.....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 95 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 171 (345)
T 1xjd_A 95 FVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 171 (345)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhhcccC
Confidence 99999999999999988788999999999999999999999998 999999999999999999999999999854322
Q ss_pred cccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecch
Q 041576 575 QSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDND 654 (714)
Q Consensus 575 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 654 (714)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+ ..+...
T Consensus 172 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i--------~~~~~~------ 236 (345)
T 1xjd_A 172 D-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI--------RMDNPF------ 236 (345)
T ss_dssp T-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--------HHCCCC------
T ss_pred C-CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHH--------HhCCCC------
Confidence 2 2233457999999999999999999999999999999999999999755433211111 111100
Q ss_pred hhhccchHHHHHHHHHHHHccccCCCCCCCHH-HHHH
Q 041576 655 KAAMADKSRACKWLMIALWCIQEDPLKRPAMK-MIVQ 690 (714)
Q Consensus 655 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl~ 690 (714)
.+...+..+.+++.+||+.||++||++. ||++
T Consensus 237 ----~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~ 269 (345)
T 1xjd_A 237 ----YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 269 (345)
T ss_dssp ----CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred ----CCcccCHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence 1112345678899999999999999997 6653
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=351.93 Aligned_cols=268 Identities=16% Similarity=0.202 Sum_probs=204.3
Q ss_pred HhhhhhhhhCcc--cceeEEEeEeeCCCCcEEEEEEecccc--hhhHHHHHHHHHHHhccCcccccceeceEecCCeeeE
Q 041576 420 ATNGFEEELGRG--SFGIVYKGVLKSASGNAVAVKKLDKLA--QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLL 495 (714)
Q Consensus 420 at~~~~~~ig~G--~~g~Vy~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 495 (714)
..|.+.+.||+| +||.||+|+.. .+++.||||+++... ....+.+.+|+.++++++||||+++++++.+++..++
T Consensus 25 ~~y~~~~~lG~G~~~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 25 GCYELLTVIGKGFEDLMTVNLARYK-PTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGEEEEEEEEEETTTTEEEEEEEET-TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CcEEEEecccCCcCCceEEEEEEEc-CCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 467788999999 99999999976 578999999997532 3445778899999999999999999999999999999
Q ss_pred EEeecCCCchhhhhhcC--CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCcccccc
Q 041576 496 VYEFMGNGTLANLLFAI--PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLS 573 (714)
Q Consensus 496 v~E~~~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~ 573 (714)
||||+++++|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||.+.....
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~ 180 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMIS 180 (389)
T ss_dssp EEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred EEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence 99999999999999865 67899999999999999999999998 99999999999999999999999999875432
Q ss_pred Ccc------cceeeecCCCCccCcccccC--CCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhc-
Q 041576 574 DQS------RTRTVIRGTRGYVAPEWFKN--VPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVE- 644 (714)
Q Consensus 574 ~~~------~~~~~~~gt~~y~aPE~~~~--~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~- 644 (714)
... .......||..|+|||.+.+ ..++.++|||||||++|||++|+.||......................
T Consensus 181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 260 (389)
T 3gni_B 181 HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDT 260 (389)
T ss_dssp TTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-----------
T ss_pred ccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccc
Confidence 211 11122368899999999987 578999999999999999999999997543322111000000000000
Q ss_pred -----Cc-------------cceee---------cchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 645 -----GK-------------LDVLV---------DNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 645 -----~~-------------~~~~~---------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
.. ..... ...............+.+|+.+||+.||++|||++|+++.
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 261 STIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp ---------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred cccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 00 00000 0000001122234568889999999999999999999864
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=342.02 Aligned_cols=251 Identities=23% Similarity=0.257 Sum_probs=197.4
Q ss_pred CHHHHHHHhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEeccc--chhhHHHHHHHHHHHhcc-CcccccceeceEec
Q 041576 413 SLVELNEATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKL--AQEREREFKTEVSAIGRT-HHKNLVQLLGFCDE 489 (714)
Q Consensus 413 ~~~el~~at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~ 489 (714)
...++....|.+.++||+|+||+||+|.+. .+++.||||++... .......+..|+..+.++ +||||+++++++.+
T Consensus 50 ~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~ 128 (311)
T 3p1a_A 50 RPESFFQQSFQRLSRLGHGSYGEVFKVRSK-EDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEE 128 (311)
T ss_dssp SSSCHHHHHEEEEEEEEEETTEEEEEEEET-TTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred CccchhhhheeeeheeccCCCeEEEEEEEC-CCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEe
Confidence 344566678888999999999999999976 47899999998642 223344555666666555 99999999999999
Q ss_pred CCeeeEEEeecCCCchhhhhhcC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCc
Q 041576 490 GLNRLLVYEFMGNGTLANLLFAI-PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLS 568 (714)
Q Consensus 490 ~~~~~lv~E~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~ 568 (714)
++..++||||+ +++|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 129 ~~~~~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a 204 (311)
T 3p1a_A 129 GGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLL 204 (311)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTC
T ss_pred CCEEEEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceee
Confidence 99999999999 56888887654 46899999999999999999999998 999999999999999999999999998
Q ss_pred cccccCcccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccc
Q 041576 569 KLLLSDQSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLD 648 (714)
Q Consensus 569 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 648 (714)
....... ......||+.|+|||++.+ .++.++||||||+++|||++|..|+...... .....+..
T Consensus 205 ~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~-----------~~~~~~~~- 269 (311)
T 3p1a_A 205 VELGTAG--AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGW-----------QQLRQGYL- 269 (311)
T ss_dssp EECC--------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHH-----------HHHTTTCC-
T ss_pred eecccCC--CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHH-----------HHHhccCC-
Confidence 7654322 2234458999999999876 7899999999999999999997776532111 01111111
Q ss_pred eeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 649 VLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 649 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
. .......+..+.+++.+||+.||++|||++|+++
T Consensus 270 ---~----~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 270 ---P----PEFTAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp ---C----HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ---C----cccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 0 0111223457888999999999999999999986
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=348.67 Aligned_cols=249 Identities=28% Similarity=0.307 Sum_probs=205.9
Q ss_pred HHhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHHhcc-CcccccceeceEecCCeee
Q 041576 419 EATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA---QEREREFKTEVSAIGRT-HHKNLVQLLGFCDEGLNRL 494 (714)
Q Consensus 419 ~at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~ 494 (714)
...|.+.+.||+|+||.||+|+.+ .+++.||||++++.. ....+.+..|.+++..+ +||||+++++++.+.+..+
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~-~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERK-GTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEET-TEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEEC-CCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 345777899999999999999876 468899999997632 33456788999999988 8999999999999999999
Q ss_pred EEEeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccC
Q 041576 495 LVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSD 574 (714)
Q Consensus 495 lv~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 574 (714)
+||||+++|+|.+++.....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 98 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 174 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD 174 (353)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCcccccccC
Confidence 99999999999999988788999999999999999999999998 999999999999999999999999999854322
Q ss_pred cccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecch
Q 041576 575 QSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDND 654 (714)
Q Consensus 575 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 654 (714)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||........... .......
T Consensus 175 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~--------i~~~~~~------ 239 (353)
T 2i0e_A 175 G-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQS--------IMEHNVA------ 239 (353)
T ss_dssp T-CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH--------HHHCCCC------
T ss_pred C-cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHH--------HHhCCCC------
Confidence 2 223345699999999999999999999999999999999999999976543321111 1111111
Q ss_pred hhhccchHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 041576 655 KAAMADKSRACKWLMIALWCIQEDPLKRPA-----MKMIVQ 690 (714)
Q Consensus 655 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 690 (714)
.+...+..+.+++.+||+.||++||+ ++||++
T Consensus 240 ----~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 240 ----YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp ----CCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred ----CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 11223456788999999999999995 577765
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=345.75 Aligned_cols=256 Identities=24% Similarity=0.306 Sum_probs=204.4
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEeccc---chhhHHHHHHHHHHHhcc-CcccccceeceEecCCeeeE
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKL---AQEREREFKTEVSAIGRT-HHKNLVQLLGFCDEGLNRLL 495 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~l 495 (714)
..|.+.+.||+|+||.||+|+.+ .+++.||+|++++. .....+.+.+|..++.++ +||||+++++++.+....++
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLK-KTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEEC-CCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 34677789999999999999976 57899999999753 234456788999999988 89999999999999999999
Q ss_pred EEeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCc
Q 041576 496 VYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQ 575 (714)
Q Consensus 496 v~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 575 (714)
||||+++|+|.+++.....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 88 v~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~ 164 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG 164 (345)
T ss_dssp EECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccccCCC
Confidence 9999999999999988788999999999999999999999998 9999999999999999999999999998543222
Q ss_pred ccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhh-hhhhHHHhhhhhcCccceeecch
Q 041576 576 SRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERS-AILTDWAYDCYVEGKLDVLVDND 654 (714)
Q Consensus 576 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~-~~l~~~~~~~~~~~~~~~~~~~~ 654 (714)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||......... .................
T Consensus 165 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~------ 237 (345)
T 3a8x_A 165 -DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR------ 237 (345)
T ss_dssp -CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCC------
T ss_pred -CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCC------
Confidence 2233457999999999999999999999999999999999999999643211100 00001111111111111
Q ss_pred hhhccchHHHHHHHHHHHHccccCCCCCCCH------HHHHH
Q 041576 655 KAAMADKSRACKWLMIALWCIQEDPLKRPAM------KMIVQ 690 (714)
Q Consensus 655 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~------~evl~ 690 (714)
.+...+..+.+++.+||+.||++||++ .|+++
T Consensus 238 ----~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~ 275 (345)
T 3a8x_A 238 ----IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 275 (345)
T ss_dssp ----CCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHT
T ss_pred ----CCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhc
Confidence 112234567889999999999999995 66664
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=344.89 Aligned_cols=251 Identities=24% Similarity=0.302 Sum_probs=182.6
Q ss_pred hhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccC-cccccceeceEecCCeeeEEEeecCCCc
Q 041576 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTH-HKNLVQLLGFCDEGLNRLLVYEFMGNGT 504 (714)
Q Consensus 426 ~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~E~~~~gs 504 (714)
+.||+|+||.||+|.+. .+++.||||++... ....+.+|+.+++++. ||||+++++++.++...++||||+++++
T Consensus 17 ~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHK-KSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp CCSEEETTEEEEEEEET-TTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CccccCCCeEEEEEEEC-CCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 67999999999999976 57899999999643 3457789999999996 9999999999999999999999999999
Q ss_pred hhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCC---ceEEecCCCccccccCcccceee
Q 041576 505 LANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDF---TAKISDFGLSKLLLSDQSRTRTV 581 (714)
Q Consensus 505 L~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~---~~kl~Dfg~~~~~~~~~~~~~~~ 581 (714)
|.+++.....+++.++..++.||+.||+|||+++ |+||||||+||+++.++ .+||+|||++........ ....
T Consensus 93 L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~-~~~~ 168 (325)
T 3kn6_A 93 LFERIKKKKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ-PLKT 168 (325)
T ss_dssp HHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC--------
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC-cccc
Confidence 9999998888999999999999999999999998 99999999999997765 899999999986543322 2234
Q ss_pred ecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhhccch
Q 041576 582 IRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMADK 661 (714)
Q Consensus 582 ~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 661 (714)
..+|+.|+|||.+.+..++.++||||||+++|||++|+.||.............. .......+.... .. ....
T Consensus 169 ~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~-~~~~i~~~~~~~--~~----~~~~ 241 (325)
T 3kn6_A 169 PCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVE-IMKKIKKGDFSF--EG----EAWK 241 (325)
T ss_dssp ---------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHH-HHHHHTTTCCCC--CS----HHHH
T ss_pred cCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHH-HHHHHHcCCCCC--Cc----cccc
Confidence 4589999999999999999999999999999999999999976433211111111 111111211110 00 0011
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 662 SRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 662 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
..+..+.+++.+||+.||++|||++|+++.
T Consensus 242 ~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 242 NVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp TSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred CCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 234578889999999999999999999854
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=337.68 Aligned_cols=263 Identities=22% Similarity=0.266 Sum_probs=198.5
Q ss_pred hhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc--hhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEe
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA--QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYE 498 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E 498 (714)
.|.+.+.||+|+||+||+|.. .+++.||+|++.... ......+.+|++++++++||||+++++++.+++..++|||
T Consensus 3 ~y~~~~~lg~G~~g~V~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (288)
T 1ob3_A 3 KYHGLEKIGEGTYGVVYKAQN--NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80 (288)
T ss_dssp SEEEEEEEEEETTEEEEEEEE--TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred cchhhhhcccCCCEEEEEEEc--CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEE
Confidence 466788999999999999987 368999999986532 2234678899999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCccc
Q 041576 499 FMGNGTLANLLFAI-PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSR 577 (714)
Q Consensus 499 ~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 577 (714)
|+++ +|.+++... ..+++..+..++.||++||+|||+++ |+||||||+||+++.++.+||+|||++....... .
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~ 155 (288)
T 1ob3_A 81 HLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPV-R 155 (288)
T ss_dssp CCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred ecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCccc-c
Confidence 9986 999988764 57899999999999999999999998 9999999999999999999999999998654322 1
Q ss_pred ceeeecCCCCccCcccccCC-CCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhh----hhhc----Cccc
Q 041576 578 TRTVIRGTRGYVAPEWFKNV-PVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYD----CYVE----GKLD 648 (714)
Q Consensus 578 ~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~----~~~~----~~~~ 648 (714)
......+|+.|+|||.+.+. .++.++||||||+++|||++|+.||...........+...... .+.. ....
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T 1ob3_A 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235 (288)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccc
Confidence 22334689999999999764 5899999999999999999999999765433221111110000 0000 0000
Q ss_pred ---eeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 649 ---VLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 649 ---~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
....+..........+..+.+++.+||+.||++|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 000000001111223457788999999999999999999986
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-40 Score=348.50 Aligned_cols=259 Identities=26% Similarity=0.392 Sum_probs=202.4
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCC---CcEEEEEEeccc-chhhHHHHHHHHHHHhccCcccccceeceEecCCeeeE
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSAS---GNAVAVKKLDKL-AQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLL 495 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~---~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 495 (714)
..+.+.+.||+|+||.||+|.+...+ +..||||.++.. .......+.+|++++++++||||+++++++.+.+..++
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 123 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence 45566789999999999999876433 346999999754 33445679999999999999999999999999999999
Q ss_pred EEeecCCCchhhhhhcC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccC
Q 041576 496 VYEFMGNGTLANLLFAI-PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSD 574 (714)
Q Consensus 496 v~E~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 574 (714)
||||+++++|.+++... ..+++..++.++.||++||+|||+++ |+||||||+||+++.++.+||+|||++......
T Consensus 124 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~ 200 (333)
T 1mqb_A 124 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 200 (333)
T ss_dssp EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred EEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhhccc
Confidence 99999999999999765 57899999999999999999999998 999999999999999999999999999876543
Q ss_pred ccc--ceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccchhhhhhhHHHhhhhhcCccceee
Q 041576 575 QSR--TRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEERSAILTDWAYDCYVEGKLDVLV 651 (714)
Q Consensus 575 ~~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 651 (714)
... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+... ....+...
T Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~--------~~~~~~~~--- 269 (333)
T 1mqb_A 201 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMK--------AINDGFRL--- 269 (333)
T ss_dssp ----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH--------HHHTTCCC---
T ss_pred cccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHH--------HHHCCCcC---
Confidence 221 1222346778999999999999999999999999999999 999996543322111 11111000
Q ss_pred cchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCC
Q 041576 652 DNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLEV 698 (714)
Q Consensus 652 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 698 (714)
..+...+..+.+++.+||+.||++||++.|+++.|++++..
T Consensus 270 ------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 310 (333)
T 1mqb_A 270 ------PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 310 (333)
T ss_dssp ------CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred ------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 01122345678899999999999999999999999886643
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=350.02 Aligned_cols=256 Identities=23% Similarity=0.349 Sum_probs=202.2
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCc----EEEEEEecccc-hhhHHHHHHHHHHHhccCcccccceeceEecCCeee
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGN----AVAVKKLDKLA-QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRL 494 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 494 (714)
..|.+.+.||+|+||.||+|.+.. +++ +|++|.+.... ......+.+|+.++++++||||+++++++. +...+
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~-~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 90 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIP-EGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ 90 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECC-TTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred hHceeeeeeeecCCceEEEEEEcC-CCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence 346677899999999999999763 444 37888875432 233456788999999999999999999986 45688
Q ss_pred EEEeecCCCchhhhhhcC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCcccccc
Q 041576 495 LVYEFMGNGTLANLLFAI-PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLS 573 (714)
Q Consensus 495 lv~E~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~ 573 (714)
+||||+++|+|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 91 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 167 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPP 167 (325)
T ss_dssp EEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGSCC
T ss_pred EEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccccCc
Confidence 999999999999999875 57899999999999999999999998 99999999999999999999999999987754
Q ss_pred Ccc-cceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccchhhhhhhHHHhhhhhcCccceee
Q 041576 574 DQS-RTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEERSAILTDWAYDCYVEGKLDVLV 651 (714)
Q Consensus 574 ~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 651 (714)
... .......++..|+|||.+.+..++.++||||||+++|||++ |+.||...........+ ..+....
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~--------~~~~~~~-- 237 (325)
T 3kex_A 168 DDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLL--------EKGERLA-- 237 (325)
T ss_dssp CTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHH--------HTTCBCC--
T ss_pred ccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHH--------HcCCCCC--
Confidence 432 23344567889999999998999999999999999999999 99999765433211111 1111100
Q ss_pred cchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccC
Q 041576 652 DNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLE 697 (714)
Q Consensus 652 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 697 (714)
.+......+.+++.+||+.||++|||+.|+++.|+.+..
T Consensus 238 -------~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 238 -------QPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp -------CCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred -------CCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 011122346679999999999999999999999988764
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=351.00 Aligned_cols=253 Identities=23% Similarity=0.242 Sum_probs=195.1
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEee
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEF 499 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~ 499 (714)
.+|.+.+.||+|+||+||+++.. .+++.||||++..... ..+.+.+|+.++++++||||+++++++.+....++||||
T Consensus 20 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 20 DRYDFVKDIGSGNFGVARLMRDK-LTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTEEEEEEESSSTTSSEEEEEET-TTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CcEEEEEEeccCCCEEEEEEEEC-CCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 46788899999999999999976 5789999999975332 335688999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCc--eEEecCCCccccccCccc
Q 041576 500 MGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFT--AKISDFGLSKLLLSDQSR 577 (714)
Q Consensus 500 ~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~--~kl~Dfg~~~~~~~~~~~ 577 (714)
+++|+|.+++.....+++..+..++.||+.||+|||+++ |+||||||+||+++.++. +||+|||+++..... .
T Consensus 98 ~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~--~ 172 (361)
T 3uc3_A 98 ASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH--S 172 (361)
T ss_dssp CCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC---------
T ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCcccccccc--C
Confidence 999999999988788999999999999999999999998 999999999999987765 999999999743222 2
Q ss_pred ceeeecCCCCccCcccccCCCCCch-hhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhh
Q 041576 578 TRTVIRGTRGYVAPEWFKNVPVSAK-VDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKA 656 (714)
Q Consensus 578 ~~~~~~gt~~y~aPE~~~~~~~s~k-sDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 656 (714)
......||+.|+|||.+.+..++.+ +|||||||++|||++|+.||.............. ........
T Consensus 173 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~----~~~~~~~~-------- 240 (361)
T 3uc3_A 173 QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQ----RILSVKYS-------- 240 (361)
T ss_dssp --------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHH----HHHTTCCC--------
T ss_pred CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHH----HHhcCCCC--------
Confidence 2233468999999999988887665 8999999999999999999976543221111111 01111000
Q ss_pred hccchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 657 AMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 657 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
.......+..+.+++.+||+.||++|||+.|+++.
T Consensus 241 ~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 241 IPDDIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp CCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred CCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 00011223567789999999999999999999874
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=345.71 Aligned_cols=248 Identities=22% Similarity=0.334 Sum_probs=195.8
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc-hhhHHHHHHHHHHHhccCcccccceeceEecCC-------
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA-QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGL------- 491 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~------- 491 (714)
..|.+.+.||+|+||.||+|+++ .+++.||||+++... ....+.+.+|++++++++||||+++++++.+..
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNK-VDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEET-TTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEc-CCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 45677889999999999999976 578999999996533 345678999999999999999999999985543
Q ss_pred --------------------------------------------------eeeEEEeecCCCchhhhhhcCCC---CChh
Q 041576 492 --------------------------------------------------NRLLVYEFMGNGTLANLLFAIPR---PDWS 518 (714)
Q Consensus 492 --------------------------------------------------~~~lv~E~~~~gsL~~~l~~~~~---~~~~ 518 (714)
..++||||+++++|.+++..... .++.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 27899999999999999987644 3455
Q ss_pred hHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcc-----------cceeeecCCCC
Q 041576 519 LRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQS-----------RTRTVIRGTRG 587 (714)
Q Consensus 519 ~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~-----------~~~~~~~gt~~ 587 (714)
.++.++.||+.||+|||+++ |+||||||+||+++.++.+||+|||++........ .......||+.
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 68999999999999999998 99999999999999999999999999987654321 12233468999
Q ss_pred ccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhhccchHHHHHH
Q 041576 588 YVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMADKSRACKW 667 (714)
Q Consensus 588 y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 667 (714)
|+|||.+.+..++.++||||||+++|||++|..|+..... .. ......... .........+
T Consensus 242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~~-----~~-----~~~~~~~~~---------~~~~~~~~~~ 302 (332)
T 3qd2_B 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVR-----II-----TDVRNLKFP---------LLFTQKYPQE 302 (332)
T ss_dssp GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHHH-----HH-----HHHHTTCCC---------HHHHHHCHHH
T ss_pred ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHHH-----HH-----HHhhccCCC---------cccccCChhH
Confidence 9999999999999999999999999999998776532110 00 001111110 0112233466
Q ss_pred HHHHHHccccCCCCCCCHHHHHH
Q 041576 668 LMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 668 ~~li~~cl~~dP~~RPs~~evl~ 690 (714)
.+++.+||+.||++|||++|+++
T Consensus 303 ~~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 303 HMMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HHHHHHHHCSSGGGSCCHHHHHH
T ss_pred HHHHHHHccCCCCcCCCHHHHhh
Confidence 78999999999999999999986
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=340.07 Aligned_cols=257 Identities=28% Similarity=0.377 Sum_probs=206.8
Q ss_pred Hhhhhhh-hhCcccceeEEEeEee-CCCCcEEEEEEecccc--hhhHHHHHHHHHHHhccCcccccceeceEecCCeeeE
Q 041576 420 ATNGFEE-ELGRGSFGIVYKGVLK-SASGNAVAVKKLDKLA--QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLL 495 (714)
Q Consensus 420 at~~~~~-~ig~G~~g~Vy~~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 495 (714)
.+|.+.+ .||+|+||.||+|.+. ...++.||||+++... ....+.+.+|++++++++||||+++++++ ..+..++
T Consensus 16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~l 94 (291)
T 1xbb_A 16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWML 94 (291)
T ss_dssp GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEE
T ss_pred hhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEE
Confidence 4556666 8999999999999654 2356899999997543 23357899999999999999999999999 5667899
Q ss_pred EEeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCc
Q 041576 496 VYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQ 575 (714)
Q Consensus 496 v~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 575 (714)
||||+++++|.+++.....+++..++.++.||++||+|||+++ |+||||||+||+++.++.+||+|||++.......
T Consensus 95 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 171 (291)
T 1xbb_A 95 VMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 171 (291)
T ss_dssp EEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTC
T ss_pred EEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcceeeccCC
Confidence 9999999999999998888999999999999999999999998 9999999999999999999999999998765443
Q ss_pred ccc--eeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccchhhhhhhHHHhhhhhcCccceeec
Q 041576 576 SRT--RTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVD 652 (714)
Q Consensus 576 ~~~--~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 652 (714)
... .....++..|+|||.+.+..++.++||||||+++|||++ |+.||........... ...+...
T Consensus 172 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~--------~~~~~~~---- 239 (291)
T 1xbb_A 172 NYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM--------LEKGERM---- 239 (291)
T ss_dssp SEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH--------HHTTCCC----
T ss_pred CcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH--------HHcCCCC----
Confidence 321 222346788999999998889999999999999999999 9999976543321111 1111111
Q ss_pred chhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccC
Q 041576 653 NDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLE 697 (714)
Q Consensus 653 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 697 (714)
..+...+..+.+++.+||+.||++||++.||++.|+++..
T Consensus 240 -----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 279 (291)
T 1xbb_A 240 -----GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 279 (291)
T ss_dssp -----CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred -----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 0122334578889999999999999999999999998763
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=345.39 Aligned_cols=254 Identities=24% Similarity=0.264 Sum_probs=199.3
Q ss_pred HHhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEeccc-----chhhHHHHHHHHHHHhccCcccccceeceEecCCee
Q 041576 419 EATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKL-----AQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNR 493 (714)
Q Consensus 419 ~at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 493 (714)
..+|.+.+.||+|+||.||+|... .+++.||+|++... .....+.+.+|++++++++||||+++++++.+.+..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 103 (345)
T 3hko_A 25 QKKYHLKGAIGQGSYGVVRVAIEN-QTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYI 103 (345)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEET-TTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhheeecceeeecCCeEEEEEEEC-CCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeE
Confidence 456888899999999999999875 57889999998653 234557899999999999999999999999999999
Q ss_pred eEEEeecCCCchhhhhhcC----------------------------------------CCCChhhHHHHHHHHHHHHHH
Q 041576 494 LLVYEFMGNGTLANLLFAI----------------------------------------PRPDWSLRVRISLEIARGLLY 533 (714)
Q Consensus 494 ~lv~E~~~~gsL~~~l~~~----------------------------------------~~~~~~~~~~i~~qi~~~L~y 533 (714)
++||||+++|+|.+++... ..+++..+..++.||++||+|
T Consensus 104 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~ 183 (345)
T 3hko_A 104 CLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHY 183 (345)
T ss_dssp EEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHH
Confidence 9999999999999998521 112466788899999999999
Q ss_pred HHhcCCCCeEecCCCcCeEEECCCC--ceEEecCCCccccccCcc---cceeeecCCCCccCcccccC--CCCCchhhhH
Q 041576 534 LHEECNVPIIHCDIKPQNILLDQDF--TAKISDFGLSKLLLSDQS---RTRTVIRGTRGYVAPEWFKN--VPVSAKVDVY 606 (714)
Q Consensus 534 LH~~~~~~ivH~Dlk~~NIll~~~~--~~kl~Dfg~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~--~~~s~ksDVw 606 (714)
||+++ |+||||||+||+++.++ .+||+|||++........ .......||+.|+|||.+.+ ..++.++|||
T Consensus 184 LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diw 260 (345)
T 3hko_A 184 LHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAW 260 (345)
T ss_dssp HHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHH
T ss_pred HHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHH
Confidence 99998 99999999999998776 899999999986643221 22344568999999999975 6789999999
Q ss_pred HHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHH
Q 041576 607 SFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMK 686 (714)
Q Consensus 607 SlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 686 (714)
|||+++|||++|+.||......+....+ ...... ............+.+++.+||+.||.+||++.
T Consensus 261 slG~il~el~~g~~pf~~~~~~~~~~~~--------~~~~~~------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 326 (345)
T 3hko_A 261 SAGVLLHLLLMGAVPFPGVNDADTISQV--------LNKKLC------FENPNYNVLSPLARDLLSNLLNRNVDERFDAM 326 (345)
T ss_dssp HHHHHHHHHHHSSCSSCCSSHHHHHHHH--------HHCCCC------TTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHH
T ss_pred HHHHHHHHHHHCCCCCCCCChHHHHHHH--------Hhcccc------cCCcccccCCHHHHHHHHHHcCCChhHCCCHH
Confidence 9999999999999999755433211111 111100 00001112345678899999999999999999
Q ss_pred HHHH
Q 041576 687 MIVQ 690 (714)
Q Consensus 687 evl~ 690 (714)
|+++
T Consensus 327 ~~l~ 330 (345)
T 3hko_A 327 RALQ 330 (345)
T ss_dssp HHHH
T ss_pred HHhc
Confidence 9987
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-40 Score=336.55 Aligned_cols=252 Identities=26% Similarity=0.382 Sum_probs=204.2
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEeccc--chhhHHHHHHHHHHHhccCcccccceeceEecC--CeeeE
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKL--AQEREREFKTEVSAIGRTHHKNLVQLLGFCDEG--LNRLL 495 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~l 495 (714)
..|.+.+.||+|+||.||+|+++ ++.||||+++.. .....+.+.+|+.++++++||||+++++++.+. ...++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~---~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQ---GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTL 86 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEET---TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEE
T ss_pred HHhHHHHHhcCCCcceEEEEEEC---CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEe
Confidence 45677889999999999999974 789999999753 344557899999999999999999999999887 77899
Q ss_pred EEeecCCCchhhhhhcCC--CCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCcccccc
Q 041576 496 VYEFMGNGTLANLLFAIP--RPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLS 573 (714)
Q Consensus 496 v~E~~~~gsL~~~l~~~~--~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~ 573 (714)
||||+++++|.+++.... .+++..++.++.||++||+|||+++ .+++||||||+||+++.++.++|+|||+......
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~ 165 (271)
T 3kmu_A 87 ITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQS 165 (271)
T ss_dssp EEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC
T ss_pred eecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeecc
Confidence 999999999999998765 4899999999999999999999975 4599999999999999999999999888754322
Q ss_pred CcccceeeecCCCCccCcccccCCCCC---chhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCcccee
Q 041576 574 DQSRTRTVIRGTRGYVAPEWFKNVPVS---AKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVL 650 (714)
Q Consensus 574 ~~~~~~~~~~gt~~y~aPE~~~~~~~s---~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 650 (714)
....+|+.|+|||.+.+...+ .++||||||+++|||++|+.||.......... .....+...
T Consensus 166 ------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~-------~~~~~~~~~-- 230 (271)
T 3kmu_A 166 ------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGM-------KVALEGLRP-- 230 (271)
T ss_dssp ------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHH-------HHHHSCCCC--
T ss_pred ------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHH-------HHHhcCCCC--
Confidence 223578999999999876544 48999999999999999999997543322111 011111111
Q ss_pred ecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccC
Q 041576 651 VDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLE 697 (714)
Q Consensus 651 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 697 (714)
..+...+..+.+++.+||+.||++|||++|+++.|+.+.+
T Consensus 231 -------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 231 -------TIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp -------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred -------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 1112234568889999999999999999999999998754
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-39 Score=355.77 Aligned_cols=252 Identities=25% Similarity=0.390 Sum_probs=208.6
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEE
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA---QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLV 496 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 496 (714)
..|.+.+.||+|+||.||+|.+. .+|+.||||++.... ......+.+|+.++++++||||+++++++......++|
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~-~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHE-LTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEET-TTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEEC-CCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 35677899999999999999876 578999999997532 23356789999999999999999999999999999999
Q ss_pred EeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcc
Q 041576 497 YEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQS 576 (714)
Q Consensus 497 ~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 576 (714)
|||+++++|.+++.....+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||++.......
T Consensus 95 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~- 170 (476)
T 2y94_A 95 MEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE- 170 (476)
T ss_dssp EECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCTTC-
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhccccc-
Confidence 999999999999998888999999999999999999999998 9999999999999999999999999998764332
Q ss_pred cceeeecCCCCccCcccccCCCC-CchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchh
Q 041576 577 RTRTVIRGTRGYVAPEWFKNVPV-SAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDK 655 (714)
Q Consensus 577 ~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 655 (714)
......||+.|+|||.+.+..+ +.++|||||||++|||++|+.||......... .....+...
T Consensus 171 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~--------~~i~~~~~~------- 234 (476)
T 2y94_A 171 -FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLF--------KKICDGIFY------- 234 (476)
T ss_dssp -CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHH--------HHHHTTCCC-------
T ss_pred -cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHH--------HHHhcCCcC-------
Confidence 2234569999999999988765 78999999999999999999999754332211 111111110
Q ss_pred hhccchHHHHHHHHHHHHccccCCCCCCCHHHHHH--HHhcc
Q 041576 656 AAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ--MLEGY 695 (714)
Q Consensus 656 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~ 695 (714)
.+......+.+++.+||+.||++|||++||++ .+.+.
T Consensus 235 ---~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 235 ---TPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp ---CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred ---CCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence 01122346788999999999999999999997 45543
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=340.13 Aligned_cols=253 Identities=29% Similarity=0.478 Sum_probs=196.6
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEee
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEF 499 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~ 499 (714)
..+.+.+.||+|+||.||+|.+. ++.||||++... ...+.+.+|++++++++||||+++++++.+ ..++||||
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~---~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~ 80 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR---AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEY 80 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET---TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEEC
T ss_pred hHeeeeeEeecCCCceEEEEEEC---CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEc
Confidence 45667889999999999999874 789999999643 345688999999999999999999998874 47899999
Q ss_pred cCCCchhhhhhcCC---CCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCc-eEEecCCCccccccCc
Q 041576 500 MGNGTLANLLFAIP---RPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFT-AKISDFGLSKLLLSDQ 575 (714)
Q Consensus 500 ~~~gsL~~~l~~~~---~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~-~kl~Dfg~~~~~~~~~ 575 (714)
+++++|.+++.... .+++..++.++.||++||+|||+.+..+|+||||||+||+++.++. +||+|||++......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~- 159 (307)
T 2eva_A 81 AEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH- 159 (307)
T ss_dssp CTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--------
T ss_pred CCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc-
Confidence 99999999998654 3678899999999999999999932234999999999999998886 799999999755322
Q ss_pred ccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchh
Q 041576 576 SRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDK 655 (714)
Q Consensus 576 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 655 (714)
.....|+..|+|||.+.+..++.++||||||+++|||++|+.||......... .. + ....+....
T Consensus 160 ---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-~~--~---~~~~~~~~~------ 224 (307)
T 2eva_A 160 ---MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR-IM--W---AVHNGTRPP------ 224 (307)
T ss_dssp --------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHH-HH--H---HHHTTCCCC------
T ss_pred ---cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHH-HH--H---HHhcCCCCC------
Confidence 22345899999999999999999999999999999999999999754322110 00 0 011111111
Q ss_pred hhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCC
Q 041576 656 AAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLEV 698 (714)
Q Consensus 656 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 698 (714)
.....+..+.+++.+||+.||++|||++|+++.|+.+.+.
T Consensus 225 ---~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 264 (307)
T 2eva_A 225 ---LIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRY 264 (307)
T ss_dssp ---CBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGG
T ss_pred ---cccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence 1112334677899999999999999999999999886643
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=338.54 Aligned_cols=258 Identities=24% Similarity=0.400 Sum_probs=203.7
Q ss_pred hhhhhhhCcccceeEEEeEeeCC--CCcEEEEEEecccc-hhhHHHHHHHHHHHhccCcccccceeceEecCCee-eEEE
Q 041576 422 NGFEEELGRGSFGIVYKGVLKSA--SGNAVAVKKLDKLA-QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNR-LLVY 497 (714)
Q Consensus 422 ~~~~~~ig~G~~g~Vy~~~~~~~--~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~-~lv~ 497 (714)
+...+.||+|+||+||+|.+... ++..||+|.+.... ....+.+.+|+.++++++||||+++++++.+.+.. ++||
T Consensus 23 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~ 102 (298)
T 3pls_A 23 THSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLL 102 (298)
T ss_dssp EEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEE
T ss_pred EccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEE
Confidence 33457899999999999987532 23379999997533 34567899999999999999999999999776665 9999
Q ss_pred eecCCCchhhhhhcC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcc
Q 041576 498 EFMGNGTLANLLFAI-PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQS 576 (714)
Q Consensus 498 E~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 576 (714)
||+.+++|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||++........
T Consensus 103 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 179 (298)
T 3pls_A 103 PYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILDREY 179 (298)
T ss_dssp CCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGG
T ss_pred ecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccCCcc
Confidence 999999999999873 56889999999999999999999998 99999999999999999999999999986543321
Q ss_pred ---cceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecc
Q 041576 577 ---RTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDN 653 (714)
Q Consensus 577 ---~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 653 (714)
.......++..|+|||.+.+..++.++||||||+++|||++|..|+........ +.. ....+..
T Consensus 180 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~---~~~----~~~~~~~------ 246 (298)
T 3pls_A 180 YSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD---LTH----FLAQGRR------ 246 (298)
T ss_dssp GCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGG---HHH----HHHTTCC------
T ss_pred cccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHH---HHH----HhhcCCC------
Confidence 222334578899999999999999999999999999999996666543222111 101 0011110
Q ss_pred hhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCC
Q 041576 654 DKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLEV 698 (714)
Q Consensus 654 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 698 (714)
...+...+..+.+++.+||+.||.+|||++|+++.|+++++.
T Consensus 247 ---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~ 288 (298)
T 3pls_A 247 ---LPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSA 288 (298)
T ss_dssp ---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---CCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 001122335678899999999999999999999999987644
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=334.35 Aligned_cols=246 Identities=27% Similarity=0.361 Sum_probs=202.5
Q ss_pred hhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEE
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA---QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVY 497 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 497 (714)
.|.+.+.||+|+||.||+|... .+++.||+|++.... ......+.+|+.++++++||||+++++++.+....++||
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 88 (279)
T 3fdn_A 10 DFEIGRPLGKGKFGNVYLAREK-QSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 88 (279)
T ss_dssp GEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cEEEeeEEecCCCeEEEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEE
Confidence 4667789999999999999876 568899999986532 223567899999999999999999999999999999999
Q ss_pred eecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCccc
Q 041576 498 EFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSR 577 (714)
Q Consensus 498 E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 577 (714)
||+++++|.+++.....+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 89 e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~--- 162 (279)
T 3fdn_A 89 EYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--- 162 (279)
T ss_dssp CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC------
T ss_pred ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCCcc---
Confidence 99999999999988788999999999999999999999998 999999999999999999999999988654322
Q ss_pred ceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhh
Q 041576 578 TRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAA 657 (714)
Q Consensus 578 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 657 (714)
......++..|+|||.+.+..++.++||||||+++|||++|+.||...........+. ....
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~--------~~~~---------- 224 (279)
T 3fdn_A 163 RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS--------RVEF---------- 224 (279)
T ss_dssp -----CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH--------HTCC----------
T ss_pred cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHH--------hCCC----------
Confidence 2233468999999999999999999999999999999999999997543332111110 1000
Q ss_pred ccchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 658 MADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 658 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
..+......+.+++.+||+.||++|||++|+++.
T Consensus 225 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 225 TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp CCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred CCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0111233467789999999999999999999974
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=333.92 Aligned_cols=251 Identities=24% Similarity=0.318 Sum_probs=205.9
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEeccc--chhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEE
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKL--AQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVY 497 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 497 (714)
..|.+.+.||+|+||.||+|... .+++.||+|++... .....+.+.+|++++++++||||+++++++.++...++||
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 6 DNYDVKEELGKGAFSVVRRCVHK-TTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhcCcCCeEEEEEEEc-CCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 35677899999999999999876 56889999998653 3344577899999999999999999999999999999999
Q ss_pred eecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCc---eEEecCCCccccccC
Q 041576 498 EFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFT---AKISDFGLSKLLLSD 574 (714)
Q Consensus 498 E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~---~kl~Dfg~~~~~~~~ 574 (714)
||+++++|.+.+.....+++..+..++.||+.||+|||+.+ |+||||||+||+++.++. +||+|||++......
T Consensus 85 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (284)
T 3kk8_A 85 DLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 161 (284)
T ss_dssp CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSS
T ss_pred ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccC
Confidence 99999999999988888999999999999999999999998 999999999999987655 999999999766433
Q ss_pred cccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecch
Q 041576 575 QSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDND 654 (714)
Q Consensus 575 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 654 (714)
.. .....|++.|+|||.+.+..++.++||||||+++|+|++|+.||...........+ ..+.... ..+
T Consensus 162 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~--------~~~~~~~-~~~- 229 (284)
T 3kk8_A 162 EA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI--------KAGAYDY-PSP- 229 (284)
T ss_dssp CB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--------HHTCCCC-CTT-
T ss_pred cc--ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHH--------HhccccC-Cch-
Confidence 22 23356899999999999999999999999999999999999999754333211111 1111110 000
Q ss_pred hhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 655 KAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 655 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
.....+..+.+++.+||+.||++|||++|+++
T Consensus 230 ----~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 230 ----EWDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp ----TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ----hhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 01123356788999999999999999999987
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=347.29 Aligned_cols=251 Identities=26% Similarity=0.352 Sum_probs=190.9
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEee
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEF 499 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~ 499 (714)
..|.+.+.||+|+||.||+|... .+++.||||+++... ..+.+.+|++++++++||||+++++++.+....++||||
T Consensus 53 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 129 (349)
T 2w4o_A 53 DFFEVESELGRGATSIVYRCKQK-GTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLEL 129 (349)
T ss_dssp GTEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred CcEEEeeEEeeCCCEEEEEEEEC-CCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEe
Confidence 34677789999999999999976 468899999997532 346788999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECC---CCceEEecCCCccccccCcc
Q 041576 500 MGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQ---DFTAKISDFGLSKLLLSDQS 576 (714)
Q Consensus 500 ~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~---~~~~kl~Dfg~~~~~~~~~~ 576 (714)
+++++|.+++.....+++.++..++.||++||+|||+.+ |+||||||+||+++. ++.+||+|||+++......
T Consensus 130 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~- 205 (349)
T 2w4o_A 130 VTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV- 205 (349)
T ss_dssp CCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC----------
T ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccCccc-
Confidence 999999999998888999999999999999999999998 999999999999975 8899999999998654322
Q ss_pred cceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhh
Q 041576 577 RTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKA 656 (714)
Q Consensus 577 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 656 (714)
......||+.|+|||.+.+..++.++|||||||++|||++|+.||........ .+ .......... ..+
T Consensus 206 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~~-----~~i~~~~~~~-~~~--- 273 (349)
T 2w4o_A 206 -LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF--MF-----RRILNCEYYF-ISP--- 273 (349)
T ss_dssp --------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHH--HH-----HHHHTTCCCC-CTT---
T ss_pred -ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHH--HH-----HHHHhCCCcc-CCc---
Confidence 22345689999999999999999999999999999999999999975433221 11 1111111110 000
Q ss_pred hccchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 657 AMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 657 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
.....+..+.+++.+||+.||++|||+.|+++.
T Consensus 274 --~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 274 --WWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp --TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred --hhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 112234567889999999999999999999873
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=352.77 Aligned_cols=273 Identities=21% Similarity=0.268 Sum_probs=212.5
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc-hhhHHHHHHHHHHHhccCcccccceeceEecCC--eeeEE
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA-QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGL--NRLLV 496 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~--~~~lv 496 (714)
..|.+.+.||+|+||+||+|.+. .+++.||||+++... ....+.+.+|++++++++||||+++++++.... ..++|
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHK-KTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEEC-CCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 35777899999999999999976 568999999997543 334567889999999999999999999997765 67999
Q ss_pred EeecCCCchhhhhhcCC---CCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEE----CCCCceEEecCCCcc
Q 041576 497 YEFMGNGTLANLLFAIP---RPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILL----DQDFTAKISDFGLSK 569 (714)
Q Consensus 497 ~E~~~~gsL~~~l~~~~---~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll----~~~~~~kl~Dfg~~~ 569 (714)
|||+++++|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+||++ +.++.+||+|||+++
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 99999999999998643 3899999999999999999999998 9999999999999 778889999999998
Q ss_pred ccccCcccceeeecCCCCccCcccccC--------CCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhh
Q 041576 570 LLLSDQSRTRTVIRGTRGYVAPEWFKN--------VPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDC 641 (714)
Q Consensus 570 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~ 641 (714)
....... .....||..|+|||.+.+ ..++.++|||||||++|||++|+.||...................
T Consensus 165 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~ 242 (396)
T 4eut_A 165 ELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242 (396)
T ss_dssp ECCCGGG--SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHS
T ss_pred EccCCCc--cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcC
Confidence 7644322 233568999999999864 467889999999999999999999997543322111111111111
Q ss_pred hhcCccceee-----------cchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCC
Q 041576 642 YVEGKLDVLV-----------DNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLEV 698 (714)
Q Consensus 642 ~~~~~~~~~~-----------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 698 (714)
.......... +..............+.+++.+||+.||++||+++|+++.++.+++.
T Consensus 243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred CCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 1111110000 00111123356677888999999999999999999999999888764
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=346.82 Aligned_cols=269 Identities=17% Similarity=0.199 Sum_probs=202.5
Q ss_pred HHHHhhhhhhhhCcccceeEEEeEeeC--CCCcEEEEEEecccchh-----------hHHHHHHHHHHHhccCcccccce
Q 041576 417 LNEATNGFEEELGRGSFGIVYKGVLKS--ASGNAVAVKKLDKLAQE-----------REREFKTEVSAIGRTHHKNLVQL 483 (714)
Q Consensus 417 l~~at~~~~~~ig~G~~g~Vy~~~~~~--~~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~nIv~l 483 (714)
+....|.+.+.||+|+||.||+|.... .++..+|||++...... ....+.+|+..++.++||||+++
T Consensus 34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~ 113 (345)
T 2v62_A 34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLF 113 (345)
T ss_dssp TTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCE
T ss_pred ccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCccee
Confidence 334567888999999999999999763 15678999998653221 12346788899999999999999
Q ss_pred eceEec----CCeeeEEEeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCC-
Q 041576 484 LGFCDE----GLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDF- 558 (714)
Q Consensus 484 ~~~~~~----~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~- 558 (714)
++++.. ....++||||+ +++|.+++.....+++.+++.++.||+.||+|||+++ |+||||||+||+++.++
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~ 189 (345)
T 2v62_A 114 YGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNP 189 (345)
T ss_dssp EEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSST
T ss_pred ecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCCC
Confidence 999977 77889999999 9999999988778999999999999999999999998 99999999999999887
Q ss_pred -ceEEecCCCccccccCcc------cceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhh
Q 041576 559 -TAKISDFGLSKLLLSDQS------RTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERS 631 (714)
Q Consensus 559 -~~kl~Dfg~~~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~ 631 (714)
.+||+|||+++.+..... .......|+..|+|||.+.+..++.++||||||+++|||++|+.||.........
T Consensus 190 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~ 269 (345)
T 2v62_A 190 DQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVA 269 (345)
T ss_dssp TSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHH
T ss_pred CcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHH
Confidence 999999999987643321 1123456899999999999999999999999999999999999999643222111
Q ss_pred hhhhHHHhhhhhcCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 041576 632 AILTDWAYDCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYL 696 (714)
Q Consensus 632 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 696 (714)
.. .. ....... +. ............+..+.+++.+||+.||++||++++|++.|+.+.
T Consensus 270 ~~--~~-~~~~~~~-~~---~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 327 (345)
T 2v62_A 270 VQ--TA-KTNLLDE-LP---QSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG 327 (345)
T ss_dssp HH--HH-HHHHHHT-TT---HHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred HH--HH-HHhhccc-cc---HHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence 00 00 0000000 00 000000001134457888999999999999999999999998754
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-40 Score=349.15 Aligned_cols=262 Identities=25% Similarity=0.379 Sum_probs=209.6
Q ss_pred HHHHHhhhhhhhhCcccceeEEEeEeeCC----CCcEEEEEEecccc-hhhHHHHHHHHHHHhcc-CcccccceeceEec
Q 041576 416 ELNEATNGFEEELGRGSFGIVYKGVLKSA----SGNAVAVKKLDKLA-QEREREFKTEVSAIGRT-HHKNLVQLLGFCDE 489 (714)
Q Consensus 416 el~~at~~~~~~ig~G~~g~Vy~~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~ 489 (714)
++....+.+.+.||+|+||.||+|..... ....||+|.+.... ....+.+.+|+.+++++ +||||+++++++.+
T Consensus 42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 121 (333)
T 2i1m_A 42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTH 121 (333)
T ss_dssp BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec
Confidence 44455677788999999999999987532 22489999997543 34557899999999999 89999999999999
Q ss_pred CCeeeEEEeecCCCchhhhhhcC--------------CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEEC
Q 041576 490 GLNRLLVYEFMGNGTLANLLFAI--------------PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLD 555 (714)
Q Consensus 490 ~~~~~lv~E~~~~gsL~~~l~~~--------------~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~ 555 (714)
++..++||||+++|+|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+||+++
T Consensus 122 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~ 198 (333)
T 2i1m_A 122 GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLT 198 (333)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEE
T ss_pred CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEEC
Confidence 99999999999999999999742 35789999999999999999999998 99999999999999
Q ss_pred CCCceEEecCCCccccccCccc-ceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccchhhhh
Q 041576 556 QDFTAKISDFGLSKLLLSDQSR-TRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEERSAI 633 (714)
Q Consensus 556 ~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~ 633 (714)
.++.+||+|||++......... ......++..|+|||.+.+..++.++||||||+++|||++ |..||........
T Consensus 199 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~--- 275 (333)
T 2i1m_A 199 NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK--- 275 (333)
T ss_dssp GGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH---
T ss_pred CCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH---
Confidence 9999999999999866443322 2223456788999999998899999999999999999998 8999875433221
Q ss_pred hhHHHhhhhhcCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 041576 634 LTDWAYDCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYL 696 (714)
Q Consensus 634 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 696 (714)
+.... ..+.. ...+...+..+.+++.+||+.||.+|||+.||++.|+++.
T Consensus 276 ~~~~~----~~~~~---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~ 325 (333)
T 2i1m_A 276 FYKLV----KDGYQ---------MAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQA 325 (333)
T ss_dssp HHHHH----HHTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHH----hcCCC---------CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHH
Confidence 11110 11100 0011122356788999999999999999999999998765
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=338.67 Aligned_cols=266 Identities=27% Similarity=0.411 Sum_probs=199.8
Q ss_pred cCHHHHHHHhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEeccc--chhhHHHHHHHHHHHhccCcccccceeceEec
Q 041576 412 FSLVELNEATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKL--AQEREREFKTEVSAIGRTHHKNLVQLLGFCDE 489 (714)
Q Consensus 412 ~~~~el~~at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~ 489 (714)
+...|+...+|.+.+.||+|+||.||+|.+. ..||||+++.. .....+.+.+|++++++++||||+++++++ .
T Consensus 16 ~~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~ 90 (289)
T 3og7_A 16 ADDWEIPDGQITVGQRIGSGSFGTVYKGKWH----GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-T 90 (289)
T ss_dssp --CCBCCTTSCEEEEEEEECSSEEEEEEESS----SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-C
T ss_pred CCCCccCccceeeeeEecCCCCeEEEEEEEc----CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-c
Confidence 3444666677888999999999999999864 36999998643 344567899999999999999999999965 4
Q ss_pred CCeeeEEEeecCCCchhhhhhcC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCc
Q 041576 490 GLNRLLVYEFMGNGTLANLLFAI-PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLS 568 (714)
Q Consensus 490 ~~~~~lv~E~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~ 568 (714)
....++||||+++++|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+||+++.++.+||+|||++
T Consensus 91 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~ 167 (289)
T 3og7_A 91 APQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLA 167 (289)
T ss_dssp SSSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC--
T ss_pred CCccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceec
Confidence 55689999999999999999654 56899999999999999999999998 999999999999999999999999999
Q ss_pred cccccCc-ccceeeecCCCCccCccccc---CCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhc
Q 041576 569 KLLLSDQ-SRTRTVIRGTRGYVAPEWFK---NVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVE 644 (714)
Q Consensus 569 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~ 644 (714)
....... ........|+..|+|||.+. +..++.++||||||+++|||++|+.||........ +... ...
T Consensus 168 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~---~~~~----~~~ 240 (289)
T 3og7_A 168 TEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ---IIEM----VGR 240 (289)
T ss_dssp ----------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHH---HHHH----HHH
T ss_pred cccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHH---HHHH----hcc
Confidence 7654322 22233456899999999986 66789999999999999999999999975433221 1111 111
Q ss_pred CccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccC
Q 041576 645 GKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLE 697 (714)
Q Consensus 645 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 697 (714)
+....... ......+..+.+++.+||+.||++|||+.|+++.|+++.+
T Consensus 241 ~~~~~~~~-----~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 241 GSLSPDLS-----KVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp TSCCCCTT-----SSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred cccCcchh-----hccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 11111000 0112234578889999999999999999999999998764
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=342.77 Aligned_cols=250 Identities=22% Similarity=0.252 Sum_probs=196.7
Q ss_pred HHhhhhhhhhCcccceeEEEeEee--CCCCcEEEEEEecccc----hhhHHHHHHHHHHHhccCcccccceeceEecCCe
Q 041576 419 EATNGFEEELGRGSFGIVYKGVLK--SASGNAVAVKKLDKLA----QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLN 492 (714)
Q Consensus 419 ~at~~~~~~ig~G~~g~Vy~~~~~--~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 492 (714)
...|.+.+.||+|+||.||+|... ..+++.||+|+++... ......+.+|++++++++||||+++++++..++.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 356788899999999999999864 2478899999997532 2334568899999999999999999999999999
Q ss_pred eeEEEeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccc
Q 041576 493 RLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLL 572 (714)
Q Consensus 493 ~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~ 572 (714)
.++||||+++++|.+++.....+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+++...
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 172 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESI 172 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC----
T ss_pred EEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCcccccc
Confidence 9999999999999999988788999999999999999999999998 9999999999999999999999999997543
Q ss_pred cCcccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeec
Q 041576 573 SDQSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVD 652 (714)
Q Consensus 573 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 652 (714)
.... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...........+ ......
T Consensus 173 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i--------~~~~~~---- 239 (327)
T 3a62_A 173 HDGT-VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKI--------LKCKLN---- 239 (327)
T ss_dssp -------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH--------HHTCCC----
T ss_pred cCCc-cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHH--------HhCCCC----
Confidence 2221 223346899999999999999999999999999999999999999755332211111 111110
Q ss_pred chhhhccchHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 041576 653 NDKAAMADKSRACKWLMIALWCIQEDPLKRP-----AMKMIVQ 690 (714)
Q Consensus 653 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 690 (714)
.+......+.+++.+||+.||++|| ++.|+++
T Consensus 240 ------~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 240 ------LPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp ------CCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred ------CCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 1122345678899999999999999 7888876
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=372.54 Aligned_cols=261 Identities=25% Similarity=0.385 Sum_probs=212.1
Q ss_pred HHHHhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEE
Q 041576 417 LNEATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLV 496 (714)
Q Consensus 417 l~~at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 496 (714)
+....+.+.+.||+|+||.||+|.+. .+..||||+++... ...+.|.+|++++++++||||+++++++.+ +..++|
T Consensus 264 i~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv 339 (535)
T 2h8h_A 264 IPRESLRLEVKLGQGCFGEVWMGTWN--GTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV 339 (535)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEET--TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred cchhhhhhheecccCCCeEEEEEEEC--CCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEe
Confidence 44456778899999999999999986 45689999997643 235689999999999999999999999876 678999
Q ss_pred EeecCCCchhhhhhcC--CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccC
Q 041576 497 YEFMGNGTLANLLFAI--PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSD 574 (714)
Q Consensus 497 ~E~~~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 574 (714)
|||+++|+|.+++... ..+++.+++.|+.||++||+|||+++ |+||||||+||||++++.+||+|||+++.....
T Consensus 340 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 416 (535)
T 2h8h_A 340 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDN 416 (535)
T ss_dssp ECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCH
T ss_pred eehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCC
Confidence 9999999999999753 46899999999999999999999998 999999999999999999999999999876543
Q ss_pred cccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccchhhhhhhHHHhhhhhcCccceeecc
Q 041576 575 QSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDN 653 (714)
Q Consensus 575 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 653 (714)
.........++..|+|||.+....++.++||||||++||||++ |+.||......+. +. ....+...
T Consensus 417 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~---~~-----~i~~~~~~----- 483 (535)
T 2h8h_A 417 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV---LD-----QVERGYRM----- 483 (535)
T ss_dssp HHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHH---HH-----HHHTTCCC-----
T ss_pred ceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH---HH-----HHHcCCCC-----
Confidence 3222233446788999999998899999999999999999999 8999975433221 11 11111100
Q ss_pred hhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCCCCC
Q 041576 654 DKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLEVPSP 701 (714)
Q Consensus 654 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~p 701 (714)
..+...+..+.+++.+||+.||++|||+++|++.|+.+.....|
T Consensus 484 ----~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~ 527 (535)
T 2h8h_A 484 ----PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 527 (535)
T ss_dssp ----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCSC
T ss_pred ----CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccCc
Confidence 11223345688899999999999999999999999998765444
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=360.29 Aligned_cols=248 Identities=26% Similarity=0.288 Sum_probs=196.7
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEeccc---chhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEE
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKL---AQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLV 496 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 496 (714)
..|.+.+.||+|+||.||+|... .+++.||||+++.. .......+.+|++++++++||||+++++++.+.+..++|
T Consensus 148 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 148 NEFEYLKLLGKGTFGKVILVKEK-ATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred HHcEEeEEEeeCcCEEEEEEEEc-CCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 35677889999999999999876 57899999999753 233446778999999999999999999999999999999
Q ss_pred EeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHh-cCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCc
Q 041576 497 YEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHE-ECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQ 575 (714)
Q Consensus 497 ~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~-~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 575 (714)
|||+++++|.+++.....+++..+..++.||+.||+|||+ .+ |+||||||+||||+.++.+||+|||+++......
T Consensus 227 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 303 (446)
T 4ejn_A 227 MEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG 303 (446)
T ss_dssp ECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTCC--
T ss_pred EeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceeccCCC
Confidence 9999999999999888889999999999999999999998 77 9999999999999999999999999998643322
Q ss_pred ccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchh
Q 041576 576 SRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDK 655 (714)
Q Consensus 576 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 655 (714)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+ ......
T Consensus 304 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i--------~~~~~~------- 367 (446)
T 4ejn_A 304 -ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI--------LMEEIR------- 367 (446)
T ss_dssp ----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--------HHCCCC-------
T ss_pred -cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHH--------HhCCCC-------
Confidence 2233467999999999999999999999999999999999999999755433211111 111110
Q ss_pred hhccchHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 041576 656 AAMADKSRACKWLMIALWCIQEDPLKRP-----AMKMIVQ 690 (714)
Q Consensus 656 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 690 (714)
.+......+.+++.+||+.||++|| +++|+++
T Consensus 368 ---~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 368 ---FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp ---CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ---CCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 1122345678899999999999999 9999986
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=333.52 Aligned_cols=252 Identities=25% Similarity=0.334 Sum_probs=204.4
Q ss_pred HHhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccch------hhHHHHHHHHHHHhccCcccccceeceEecCCe
Q 041576 419 EATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQ------EREREFKTEVSAIGRTHHKNLVQLLGFCDEGLN 492 (714)
Q Consensus 419 ~at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 492 (714)
...|.+.+.||+|+||.||+|... .+++.||+|.++.... ...+.+.+|+.++++++||||+++++++.+...
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 82 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQK-GTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTD 82 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhhhhhHHhhcccCceEEEEEEEc-CCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCe
Confidence 456888899999999999999876 4688999999865321 136789999999999999999999999999999
Q ss_pred eeEEEeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCC----ceEEecCCCc
Q 041576 493 RLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDF----TAKISDFGLS 568 (714)
Q Consensus 493 ~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~----~~kl~Dfg~~ 568 (714)
.++||||+++++|.+++.....+++..+..++.||++||+|||+++ ++||||||+||+++.++ .+||+|||++
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~ 159 (283)
T 3bhy_A 83 VVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIA 159 (283)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEecccc
Confidence 9999999999999999988788999999999999999999999998 99999999999998877 8999999999
Q ss_pred cccccCcccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccc
Q 041576 569 KLLLSDQSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLD 648 (714)
Q Consensus 569 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 648 (714)
........ .....+++.|+|||.+.+..++.++||||||+++|||++|+.||...........+ ......
T Consensus 160 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~--------~~~~~~ 229 (283)
T 3bhy_A 160 HKIEAGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNI--------SAVNYD 229 (283)
T ss_dssp EECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH--------HTTCCC
T ss_pred eeccCCCc--ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHh--------HhcccC
Confidence 86643222 23345899999999999999999999999999999999999999755432211111 111000
Q ss_pred eeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 649 VLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 649 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
... ......+..+.+++.+||+.||++|||+.|+++
T Consensus 230 --~~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 230 --FDE----EYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp --CCH----HHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred --Ccc----hhcccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 000 011122346788999999999999999999997
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=344.11 Aligned_cols=260 Identities=28% Similarity=0.444 Sum_probs=210.3
Q ss_pred HHHhhhhhhhhCcccceeEEEeEeeC----CCCcEEEEEEecccc-hhhHHHHHHHHHHHhccCcccccceeceEecCCe
Q 041576 418 NEATNGFEEELGRGSFGIVYKGVLKS----ASGNAVAVKKLDKLA-QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLN 492 (714)
Q Consensus 418 ~~at~~~~~~ig~G~~g~Vy~~~~~~----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 492 (714)
....|.+.+.||+|+||.||+|++.. .+++.||||.+.... ......+.+|++++++++||||+++++++.+++.
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 102 (322)
T 1p4o_A 23 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 102 (322)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSS
T ss_pred hhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCc
Confidence 34567788999999999999998752 346789999997533 3445678999999999999999999999999999
Q ss_pred eeEEEeecCCCchhhhhhcC----------CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEE
Q 041576 493 RLLVYEFMGNGTLANLLFAI----------PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKI 562 (714)
Q Consensus 493 ~~lv~E~~~~gsL~~~l~~~----------~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl 562 (714)
.++||||+++++|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+||+++.++.+||
T Consensus 103 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~~~~kl 179 (322)
T 1p4o_A 103 TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 179 (322)
T ss_dssp CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEE
T ss_pred cEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCCCeEEE
Confidence 99999999999999999742 35688999999999999999999998 999999999999999999999
Q ss_pred ecCCCccccccCcc-cceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccchhhhhhhHHHhh
Q 041576 563 SDFGLSKLLLSDQS-RTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEERSAILTDWAYD 640 (714)
Q Consensus 563 ~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~l~~~~~~ 640 (714)
+|||++........ .......++..|+|||.+.+..++.++||||||+++|||++ |+.||..........
T Consensus 180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~-------- 251 (322)
T 1p4o_A 180 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR-------- 251 (322)
T ss_dssp CCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHH--------
T ss_pred CcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHH--------
Confidence 99999986643322 11223346788999999999899999999999999999999 889987543322111
Q ss_pred hhhcCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccC
Q 041576 641 CYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLE 697 (714)
Q Consensus 641 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 697 (714)
....+.... .+...+..+.+++.+||+.||++|||+.|+++.|+++++
T Consensus 252 ~~~~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 252 FVMEGGLLD---------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp HHHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HHHcCCcCC---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 111111111 112234567889999999999999999999999998754
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=342.54 Aligned_cols=261 Identities=21% Similarity=0.282 Sum_probs=199.7
Q ss_pred hhhhh-hhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhcc-CcccccceeceEecCCeeeEEEe
Q 041576 421 TNGFE-EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRT-HHKNLVQLLGFCDEGLNRLLVYE 498 (714)
Q Consensus 421 t~~~~-~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~E 498 (714)
.|.+. +.||+|+||.||+|... .+++.||||++..........+.+|++++.++ +||||+++++++.+++..++|||
T Consensus 13 ~y~i~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 91 (316)
T 2ac3_A 13 VYQLQEDVLGEGAHARVQTCINL-ITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE 91 (316)
T ss_dssp SCEECCCCCCCCSSEEEEEEECS-SSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eEEecCceecCCceEEEEEEEEc-CCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence 35553 67999999999999865 57899999999776556677899999999985 79999999999999999999999
Q ss_pred ecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCc---eEEecCCCccccccCc
Q 041576 499 FMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFT---AKISDFGLSKLLLSDQ 575 (714)
Q Consensus 499 ~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~---~kl~Dfg~~~~~~~~~ 575 (714)
|+++++|.+++.....+++..+..++.||++||+|||+++ |+||||||+||+++.++. +||+|||++.......
T Consensus 92 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~ 168 (316)
T 2ac3_A 92 KMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNG 168 (316)
T ss_dssp CCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC------
T ss_pred cCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCccccccCC
Confidence 9999999999988788999999999999999999999998 999999999999998776 9999999998654321
Q ss_pred c------cceeeecCCCCccCcccccC-----CCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhh-------hHH
Q 041576 576 S------RTRTVIRGTRGYVAPEWFKN-----VPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAIL-------TDW 637 (714)
Q Consensus 576 ~------~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l-------~~~ 637 (714)
. .......||..|+|||.+.+ ..++.++||||||+++|||++|+.||............ ...
T Consensus 169 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 248 (316)
T 2ac3_A 169 DCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNM 248 (316)
T ss_dssp -------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHH
T ss_pred ccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHH
Confidence 1 11223458999999999875 45789999999999999999999999765322100000 000
Q ss_pred HhhhhhcCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 638 AYDCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
.......+... ... ......+..+.+++.+||+.||++|||++|+++.
T Consensus 249 ~~~~i~~~~~~-~~~-----~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 249 LFESIQEGKYE-FPD-----KDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp HHHHHHHCCCC-CCH-----HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHhccCcc-cCc-----hhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 01111111110 000 0001234568889999999999999999999984
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=339.97 Aligned_cols=267 Identities=24% Similarity=0.277 Sum_probs=199.8
Q ss_pred HHHHHhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc-----hhhHHHHHHHHHHHhcc---CcccccceeceE
Q 041576 416 ELNEATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA-----QEREREFKTEVSAIGRT---HHKNLVQLLGFC 487 (714)
Q Consensus 416 el~~at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l---~h~nIv~l~~~~ 487 (714)
++...+|.+.+.||+|+||+||+|++. .+++.||||+++... ......+.+|+++++++ +||||+++++++
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~ 83 (308)
T 3g33_A 5 SMATSRYEPVAEIGVGAYGTVYKARDP-HSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVC 83 (308)
T ss_dssp -----CCEEEEEECCSSSCCEEEEECT-TTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEE
T ss_pred cccccceEEEEEEecCCCeEEEEEEEC-CCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeee
Confidence 445567888999999999999999875 578999999986422 11234566777777666 499999999999
Q ss_pred ecCC-----eeeEEEeecCCCchhhhhhcCCC--CChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCce
Q 041576 488 DEGL-----NRLLVYEFMGNGTLANLLFAIPR--PDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTA 560 (714)
Q Consensus 488 ~~~~-----~~~lv~E~~~~gsL~~~l~~~~~--~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ 560 (714)
.... ..++||||+. ++|.+++..... +++..+..++.||+.||+|||+++ |+||||||+||+++.++.+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~ 159 (308)
T 3g33_A 84 ATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTV 159 (308)
T ss_dssp EECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCE
T ss_pred eccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCE
Confidence 7655 4789999998 599999987654 899999999999999999999998 9999999999999999999
Q ss_pred EEecCCCccccccCcccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhh
Q 041576 561 KISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYD 640 (714)
Q Consensus 561 kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~ 640 (714)
||+|||++....... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||...........+.....
T Consensus 160 kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~- 236 (308)
T 3g33_A 160 KLADFGLARIYSYQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIG- 236 (308)
T ss_dssp EECSCSCTTTSTTCC--CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHC-
T ss_pred EEeeCccccccCCCc--ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC-
Confidence 999999998654322 22345689999999999999999999999999999999999999976544332221111100
Q ss_pred hhhcCcccee-------e---cchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 641 CYVEGKLDVL-------V---DNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 641 ~~~~~~~~~~-------~---~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
.......... + ...............+.+++.+||+.||++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 237 LPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp CCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 0000000000 0 000001111234457888999999999999999999986
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=338.37 Aligned_cols=258 Identities=25% Similarity=0.412 Sum_probs=201.7
Q ss_pred hhhhhhhhCcccceeEEEeEeeCCC--CcEEEEEEeccc-chhhHHHHHHHHHHHhccCcccccceeceE-ecCCeeeEE
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSAS--GNAVAVKKLDKL-AQEREREFKTEVSAIGRTHHKNLVQLLGFC-DEGLNRLLV 496 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~~--~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~-~~~~~~~lv 496 (714)
+|.+.+.||+|+||.||+|.+...+ ...||+|.+... .....+.+.+|+.++++++||||+++++++ ..++..++|
T Consensus 26 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 105 (298)
T 3f66_A 26 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 105 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred ehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEE
Confidence 4566789999999999999875333 236899998753 334557899999999999999999999986 455678999
Q ss_pred EeecCCCchhhhhhcC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCc
Q 041576 497 YEFMGNGTLANLLFAI-PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQ 575 (714)
Q Consensus 497 ~E~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 575 (714)
|||+++++|.+++... ..+++..++.++.||++||+|||+++ |+||||||+||+++.++.+||+|||++.......
T Consensus 106 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 182 (298)
T 3f66_A 106 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 182 (298)
T ss_dssp EECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGG
T ss_pred EeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECcccccccccccc
Confidence 9999999999999764 46789999999999999999999998 9999999999999999999999999998764433
Q ss_pred c---cceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhc-CCCCcccccchhhhhhhHHHhhhhhcCccceee
Q 041576 576 S---RTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICC-KRSVEMELGEERSAILTDWAYDCYVEGKLDVLV 651 (714)
Q Consensus 576 ~---~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG-~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 651 (714)
. .......+++.|+|||.+.+..++.++||||||+++|||++| .+||........... ...+...
T Consensus 183 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~--------~~~~~~~--- 251 (298)
T 3f66_A 183 YYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY--------LLQGRRL--- 251 (298)
T ss_dssp GCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHH--------HHTTCCC---
T ss_pred hhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHH--------HhcCCCC---
Confidence 2 222334577889999999999999999999999999999995 555543322221110 0111100
Q ss_pred cchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCC
Q 041576 652 DNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLEV 698 (714)
Q Consensus 652 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 698 (714)
..+...+..+.+++.+||+.||++|||++|+++.|++++..
T Consensus 252 ------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 292 (298)
T 3f66_A 252 ------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 292 (298)
T ss_dssp ------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 01112234688899999999999999999999999987654
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=344.14 Aligned_cols=261 Identities=27% Similarity=0.371 Sum_probs=209.8
Q ss_pred HHHhhhhhhhhCcccceeEEEeEee----CCCCcEEEEEEecccc-hhhHHHHHHHHHHHhcc-CcccccceeceEecCC
Q 041576 418 NEATNGFEEELGRGSFGIVYKGVLK----SASGNAVAVKKLDKLA-QEREREFKTEVSAIGRT-HHKNLVQLLGFCDEGL 491 (714)
Q Consensus 418 ~~at~~~~~~ig~G~~g~Vy~~~~~----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~ 491 (714)
....|.+.+.||+|+||.||+|.+. ..+++.||||.++... ....+.+.+|++++.++ +||||+++++++...+
T Consensus 25 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 104 (316)
T 2xir_A 25 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 104 (316)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred chhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCC
Confidence 3456778899999999999999863 2466899999997643 34456899999999999 7999999999987654
Q ss_pred -eeeEEEeecCCCchhhhhhcCCC----------------CChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEE
Q 041576 492 -NRLLVYEFMGNGTLANLLFAIPR----------------PDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILL 554 (714)
Q Consensus 492 -~~~lv~E~~~~gsL~~~l~~~~~----------------~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll 554 (714)
..++||||+++++|.+++..... +++..++.++.||++||+|||+++ |+||||||+||++
T Consensus 105 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~ 181 (316)
T 2xir_A 105 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILL 181 (316)
T ss_dssp SCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred CceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEE
Confidence 48999999999999999987543 788999999999999999999998 9999999999999
Q ss_pred CCCCceEEecCCCccccccCccc-ceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccchhhh
Q 041576 555 DQDFTAKISDFGLSKLLLSDQSR-TRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEERSA 632 (714)
Q Consensus 555 ~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~ 632 (714)
+.++.+||+|||++......... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||........
T Consensus 182 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~-- 259 (316)
T 2xir_A 182 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-- 259 (316)
T ss_dssp CGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH--
T ss_pred CCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHH--
Confidence 99999999999999876443322 2233457889999999999999999999999999999998 9999975432221
Q ss_pred hhhHHHhhhhhcCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccC
Q 041576 633 ILTDWAYDCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLE 697 (714)
Q Consensus 633 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 697 (714)
+. .....+.... .+......+.+++.+||+.||.+|||+.||++.|+.+++
T Consensus 260 -~~----~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 310 (316)
T 2xir_A 260 -FC----RRLKEGTRMR---------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 310 (316)
T ss_dssp -HH----HHHHHTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -HH----HHhccCccCC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 10 0111111100 111234567889999999999999999999999998764
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=344.48 Aligned_cols=243 Identities=26% Similarity=0.348 Sum_probs=203.5
Q ss_pred HHhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc--------hhhHHHHHHHHHHHhccCcccccceeceEecC
Q 041576 419 EATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA--------QEREREFKTEVSAIGRTHHKNLVQLLGFCDEG 490 (714)
Q Consensus 419 ~at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 490 (714)
...|.+.+.||+|+||.||+|+.. .+++.||||+++... ......+.+|++++++++||||+++++++.+.
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDK-EKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEET-TTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred ccceEEEeEEEecCCEEEEEEEEC-CCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 356777889999999999999876 578999999986532 11334678899999999999999999999999
Q ss_pred CeeeEEEeecCCC-chhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCcc
Q 041576 491 LNRLLVYEFMGNG-TLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSK 569 (714)
Q Consensus 491 ~~~~lv~E~~~~g-sL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~ 569 (714)
+..++||||+.+| +|.+++.....+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||++.
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~a~ 178 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAA 178 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred CEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeecccce
Confidence 9999999999777 99999998888999999999999999999999998 9999999999999999999999999998
Q ss_pred ccccCcccceeeecCCCCccCcccccCCCC-CchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccc
Q 041576 570 LLLSDQSRTRTVIRGTRGYVAPEWFKNVPV-SAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLD 648 (714)
Q Consensus 570 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 648 (714)
...... ......||+.|+|||.+.+..+ +.++||||||+++|||++|+.||....... ....
T Consensus 179 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--------------~~~~- 241 (335)
T 3dls_A 179 YLERGK--LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETV--------------EAAI- 241 (335)
T ss_dssp ECCTTC--CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGT--------------TTCC-
T ss_pred ECCCCC--ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHH--------------hhcc-
Confidence 764432 2234568999999999988876 889999999999999999999996422110 0000
Q ss_pred eeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 649 VLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 649 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
. .+...+..+.+++.+||+.||++|||++|+++.
T Consensus 242 ---~------~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 242 ---H------PPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp ---C------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred ---C------CCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 011123467889999999999999999999985
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=334.81 Aligned_cols=258 Identities=25% Similarity=0.305 Sum_probs=210.8
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEE
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA---QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLV 496 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 496 (714)
..|.+.+.||+|+||.||+|... .+++.||+|.+.... ......+.+|++++++++||||+++++++.+.+..++|
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREK-QNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEc-CCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 45777889999999999999876 467899999996532 22356789999999999999999999999999999999
Q ss_pred EeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcc
Q 041576 497 YEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQS 576 (714)
Q Consensus 497 ~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 576 (714)
|||+++++|.+++.....+++..+..++.||++||+|||+++ |+||||||+||+++.++.+||+|||++.......
T Consensus 93 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~- 168 (284)
T 2vgo_A 93 LEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR- 168 (284)
T ss_dssp ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSSSC-
T ss_pred EEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCcccc-
Confidence 999999999999988788999999999999999999999998 9999999999999999999999999987553322
Q ss_pred cceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhh
Q 041576 577 RTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKA 656 (714)
Q Consensus 577 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 656 (714)
.....|+..|+|||.+.+..++.++||||||+++|||++|+.||........... .......
T Consensus 169 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~--------~~~~~~~-------- 230 (284)
T 2vgo_A 169 --RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRR--------IVNVDLK-------- 230 (284)
T ss_dssp --BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH--------HHTTCCC--------
T ss_pred --cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHH--------HhccccC--------
Confidence 2334689999999999999999999999999999999999999975433221111 1111110
Q ss_pred hccchHHHHHHHHHHHHccccCCCCCCCHHHHHH--HHhcccCCCCCC
Q 041576 657 AMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ--MLEGYLEVPSPP 702 (714)
Q Consensus 657 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~~~~~~pp 702 (714)
.+...+..+.+++.+||+.||++|||++|+++ .++.......||
T Consensus 231 --~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~~~~~p~ 276 (284)
T 2vgo_A 231 --FPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSRRVLPP 276 (284)
T ss_dssp --CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHCCCCCCC
T ss_pred --CCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhccccCCC
Confidence 11223356778999999999999999999987 455544443333
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=344.83 Aligned_cols=257 Identities=23% Similarity=0.342 Sum_probs=200.5
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCc----EEEEEEeccc-chhhHHHHHHHHHHHhccCcccccceeceEecCCeee
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGN----AVAVKKLDKL-AQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRL 494 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 494 (714)
..|.+.+.||+|+||.||+|.+.. +++ +|++|.+... .....+.+.+|+.++++++||||+++++++..+. .+
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~-~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 15 TEFKKIKVLGSGAFGTVYKGLWIP-EGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC-TTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred hHceEEEEeeeCCCeEEEEEEEcC-CCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 456778999999999999999763 344 3577877543 3445678999999999999999999999998765 78
Q ss_pred EEEeecCCCchhhhhhcC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCcccccc
Q 041576 495 LVYEFMGNGTLANLLFAI-PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLS 573 (714)
Q Consensus 495 lv~E~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~ 573 (714)
+|+||+++|+|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+||+++.++.+||+|||++.....
T Consensus 93 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~ 169 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp EEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC------
T ss_pred EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEccC
Confidence 999999999999999864 56899999999999999999999998 99999999999999999999999999987644
Q ss_pred Ccc-cceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccchhhhhhhHHHhhhhhcCccceee
Q 041576 574 DQS-RTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEERSAILTDWAYDCYVEGKLDVLV 651 (714)
Q Consensus 574 ~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 651 (714)
... .......++..|+|||.+.+..++.++||||||+++|||++ |+.||...........+ ..+..
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~--------~~~~~---- 237 (327)
T 3lzb_A 170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL--------EKGER---- 237 (327)
T ss_dssp ----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH--------HTTCC----
T ss_pred ccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHH--------HcCCC----
Confidence 332 22233456788999999999999999999999999999999 99999765433321111 11110
Q ss_pred cchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCC
Q 041576 652 DNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLEV 698 (714)
Q Consensus 652 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 698 (714)
...+...+..+.+++.+||+.||.+|||+.|+++.|+.+...
T Consensus 238 -----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 238 -----LPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp -----CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred -----CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 011122344678899999999999999999999999987644
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=343.57 Aligned_cols=258 Identities=26% Similarity=0.390 Sum_probs=205.7
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcE--EEEEEeccc-chhhHHHHHHHHHHHhcc-CcccccceeceEecCCeeeE
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNA--VAVKKLDKL-AQEREREFKTEVSAIGRT-HHKNLVQLLGFCDEGLNRLL 495 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~--vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~l 495 (714)
..|.+.+.||+|+||.||+|.... ++.. +++|.++.. .....+.+.+|+++++++ +||||+++++++.+.+..++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~-~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 103 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKK-DGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 103 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEE-TTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHccceeeeecCCCceEEEEEEcc-CCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence 467788999999999999999763 4554 599988653 334456789999999999 99999999999999999999
Q ss_pred EEeecCCCchhhhhhcCC----------------CCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCc
Q 041576 496 VYEFMGNGTLANLLFAIP----------------RPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFT 559 (714)
Q Consensus 496 v~E~~~~gsL~~~l~~~~----------------~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~ 559 (714)
||||+++++|.+++.... .+++..++.++.||++||+|||+++ |+||||||+||+++.++.
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~ 180 (327)
T 1fvr_A 104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV 180 (327)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGC
T ss_pred EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCe
Confidence 999999999999997654 6899999999999999999999998 999999999999999999
Q ss_pred eEEecCCCccccccCcccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccchhhhhhhHHH
Q 041576 560 AKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEERSAILTDWA 638 (714)
Q Consensus 560 ~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~l~~~~ 638 (714)
+||+|||++...... .......++..|+|||.+.+..++.++||||||+++|||++ |+.||..........
T Consensus 181 ~kL~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~------ 252 (327)
T 1fvr_A 181 AKIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE------ 252 (327)
T ss_dssp EEECCTTCEESSCEE--CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH------
T ss_pred EEEcccCcCcccccc--ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHH------
Confidence 999999998743221 12223446889999999998889999999999999999998 999997543322111
Q ss_pred hhhhhcCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCCCC
Q 041576 639 YDCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLEVPS 700 (714)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 700 (714)
....+... ..+...+..+.+++.+||+.||++|||++|+++.|+.+++...
T Consensus 253 --~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 303 (327)
T 1fvr_A 253 --KLPQGYRL---------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 303 (327)
T ss_dssp --HGGGTCCC---------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred --HhhcCCCC---------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhc
Confidence 11111000 0112234568889999999999999999999999998776543
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=329.82 Aligned_cols=252 Identities=29% Similarity=0.363 Sum_probs=206.1
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc-hhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEe
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA-QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYE 498 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E 498 (714)
..|.+.+.||+|+||.||+|... .+++.||||.+.... ....+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNR-VTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEET-TTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEEEEeecCCCcEEEEEEEC-CCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 46778899999999999999876 468899999986432 3445788999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcc-c
Q 041576 499 FMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQS-R 577 (714)
Q Consensus 499 ~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~-~ 577 (714)
|+++++|.+++.....+++..+..++.||++||+|||+++ ++|+||||+||+++.++.+||+|||++........ .
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~ 162 (276)
T 2yex_A 86 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162 (276)
T ss_dssp CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred ecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCCcchh
Confidence 9999999999988788999999999999999999999998 99999999999999999999999999986543321 2
Q ss_pred ceeeecCCCCccCcccccCCCC-CchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhh
Q 041576 578 TRTVIRGTRGYVAPEWFKNVPV-SAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKA 656 (714)
Q Consensus 578 ~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 656 (714)
......|+..|+|||.+.+..+ +.++||||||+++|||++|+.||........ ....+ ...... .
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~~~~-----~~~~~~--~----- 228 (276)
T 2yex_A 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ--EYSDW-----KEKKTY--L----- 228 (276)
T ss_dssp CBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH--HHHHH-----HTTCTT--S-----
T ss_pred cccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH--HHHHh-----hhcccc--c-----
Confidence 2334568999999999987765 7899999999999999999999975433221 11111 111000 0
Q ss_pred hccchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 657 AMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 657 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
......+..+.+++.+||+.||++|||++|+++
T Consensus 229 -~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 229 -NPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp -TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -CchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 001123446778999999999999999999987
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=352.38 Aligned_cols=254 Identities=21% Similarity=0.224 Sum_probs=203.9
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEE
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA---QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLV 496 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 496 (714)
..+.+.+.||+|+||.||+|+.+ .+++.||||++++.. ......+.+|..++.+++||||+++++++.+.+..++|
T Consensus 61 ~~f~~~~~lG~G~fG~V~~~~~~-~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV 139 (412)
T 2vd5_A 61 DDFEILKVIGRGAFSEVAVVKMK-QTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLV 139 (412)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEE
T ss_pred hhEEEEEEEeeCCCeEEEEEEEC-CCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEE
Confidence 34556689999999999999976 578999999997532 22334588999999999999999999999999999999
Q ss_pred EeecCCCchhhhhhcC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCc
Q 041576 497 YEFMGNGTLANLLFAI-PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQ 575 (714)
Q Consensus 497 ~E~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 575 (714)
|||+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++++||+|||+++......
T Consensus 140 mE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~ 216 (412)
T 2vd5_A 140 MEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADG 216 (412)
T ss_dssp ECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred EcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeechhheeccCCC
Confidence 9999999999999864 47899999999999999999999998 9999999999999999999999999998765544
Q ss_pred ccceeeecCCCCccCccccc-------CCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccc
Q 041576 576 SRTRTVIRGTRGYVAPEWFK-------NVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLD 648 (714)
Q Consensus 576 ~~~~~~~~gt~~y~aPE~~~-------~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 648 (714)
........||+.|+|||++. ...++.++|||||||++|||++|+.||......+....+...... ....
T Consensus 217 ~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~----~~~p 292 (412)
T 2vd5_A 217 TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEH----LSLP 292 (412)
T ss_dssp CEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH----CCCC
T ss_pred ccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC----cCCC
Confidence 33334457999999999997 456899999999999999999999999765443322111111000 0000
Q ss_pred eeecchhhhccchHHHHHHHHHHHHccccCCCCC---CCHHHHHHH
Q 041576 649 VLVDNDKAAMADKSRACKWLMIALWCIQEDPLKR---PAMKMIVQM 691 (714)
Q Consensus 649 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R---Ps~~evl~~ 691 (714)
. .....+..+.+++.+||+ +|.+| |+++||++.
T Consensus 293 -----~----~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 293 -----L----VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp -------------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred -----c----cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 0 011234567889999999 99998 699999863
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=340.48 Aligned_cols=261 Identities=20% Similarity=0.310 Sum_probs=200.0
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecc---cchhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEE
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDK---LAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLV 496 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 496 (714)
..|.+.+.||+|+||.||+|... .+++.||||+++. ........+.+|+.++++++||||+++++++.+.+..++|
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACL-LDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEET-TTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cceEEEEeecCCCCceEEEEEEc-CCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 35778899999999999999875 4689999999974 2344567889999999999999999999999999999999
Q ss_pred EeecCCCchhhhhhc----CCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccc
Q 041576 497 YEFMGNGTLANLLFA----IPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLL 572 (714)
Q Consensus 497 ~E~~~~gsL~~~l~~----~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~ 572 (714)
|||+++++|.+++.. ...+++..++.++.||++||+|||+.+ ++||||||+||+++.++.+||+|||++....
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 999999999999864 456899999999999999999999998 9999999999999999999999999998654
Q ss_pred cCcccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeec
Q 041576 573 SDQSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVD 652 (714)
Q Consensus 573 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 652 (714)
.... ......++..|+|||.+.+..++.++||||||+++|||++|+.||........ ... ...........
T Consensus 188 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~~-----~~~~~~~~~~~-- 258 (310)
T 2wqm_A 188 SKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY-SLC-----KKIEQCDYPPL-- 258 (310)
T ss_dssp ------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHH-HHH-----HHHHTTCSCCC--
T ss_pred CCCc-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHH-HHH-----HHhhcccCCCC--
Confidence 3322 22234589999999999999999999999999999999999999975432211 000 01111111111
Q ss_pred chhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCCC
Q 041576 653 NDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLEVP 699 (714)
Q Consensus 653 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 699 (714)
.....+..+.+++.+||+.||++|||+.||++.|+++....
T Consensus 259 ------~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~ 299 (310)
T 2wqm_A 259 ------PSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACT 299 (310)
T ss_dssp ------CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ------cccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhh
Confidence 11223456888999999999999999999999999986554
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=340.02 Aligned_cols=260 Identities=27% Similarity=0.396 Sum_probs=198.5
Q ss_pred HHHhhhhhhhhCcccceeEEEeEeeCC--CCcEEEEEEeccc--chhhHHHHHHHHHHHhccCcccccceeceEecCCe-
Q 041576 418 NEATNGFEEELGRGSFGIVYKGVLKSA--SGNAVAVKKLDKL--AQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLN- 492 (714)
Q Consensus 418 ~~at~~~~~~ig~G~~g~Vy~~~~~~~--~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~- 492 (714)
....|.+.+.||+|+||.||+|.+... +++.||+|.++.. .....+.+.+|+.++++++||||+++++++.+...
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 111 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ 111 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence 345677788999999999999987643 4458999998653 34445789999999999999999999999977653
Q ss_pred ----eeEEEeecCCCchhhhhh------cCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEE
Q 041576 493 ----RLLVYEFMGNGTLANLLF------AIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKI 562 (714)
Q Consensus 493 ----~~lv~E~~~~gsL~~~l~------~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl 562 (714)
.++||||+++++|.+++. ....+++..++.++.||++||+|||+++ |+||||||+||+++.++.+||
T Consensus 112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kl 188 (313)
T 3brb_A 112 GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTVCV 188 (313)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSCEEE
T ss_pred CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEE
Confidence 499999999999999984 3356899999999999999999999998 999999999999999999999
Q ss_pred ecCCCccccccCcc-cceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccchhhhhhhHHHhh
Q 041576 563 SDFGLSKLLLSDQS-RTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEERSAILTDWAYD 640 (714)
Q Consensus 563 ~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~l~~~~~~ 640 (714)
+|||++........ .......++..|+|||.+.+..++.++||||||+++|||++ |..||...........
T Consensus 189 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~------- 261 (313)
T 3brb_A 189 ADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDY------- 261 (313)
T ss_dssp CSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH-------
T ss_pred eecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHH-------
Confidence 99999987644322 22233457889999999999999999999999999999999 8889875433321111
Q ss_pred hhhcCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccC
Q 041576 641 CYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLE 697 (714)
Q Consensus 641 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 697 (714)
...+... ..+...+..+.+++.+||+.||++|||+.++++.|+++++
T Consensus 262 -~~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~ 308 (313)
T 3brb_A 262 -LLHGHRL---------KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLE 308 (313)
T ss_dssp -HHTTCCC---------CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -HHcCCCC---------CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 1111111 0112234568889999999999999999999999998764
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=343.49 Aligned_cols=265 Identities=20% Similarity=0.243 Sum_probs=196.9
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccch--hhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEE
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQ--EREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVY 497 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 497 (714)
..|.+.+.||+|+||+||+|... .+++.||||+++.... ...+.+.+|++++++++||||+++++++.+++..++||
T Consensus 34 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 112 (329)
T 3gbz_A 34 DRYRRITKLGEGTYGEVYKAIDT-VTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIF 112 (329)
T ss_dssp GGEEEEEEEEECSSSEEEEEEET-TTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhEEEEEEEEecCCeEEEEEEEC-CCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEE
Confidence 46778899999999999999865 5789999999965332 23457789999999999999999999999999999999
Q ss_pred eecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEE-----CCCCceEEecCCCccccc
Q 041576 498 EFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILL-----DQDFTAKISDFGLSKLLL 572 (714)
Q Consensus 498 E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll-----~~~~~~kl~Dfg~~~~~~ 572 (714)
||+++ +|.+++.....+++..+..++.||+.||+|||+++ |+||||||+||++ +.++.+||+|||++....
T Consensus 113 e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~ 188 (329)
T 3gbz_A 113 EYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG 188 (329)
T ss_dssp ECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC
T ss_pred ecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCCccccC
Confidence 99985 99999998888999999999999999999999998 9999999999999 455569999999998664
Q ss_pred cCcccceeeecCCCCccCcccccCC-CCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhh----hh-----
Q 041576 573 SDQSRTRTVIRGTRGYVAPEWFKNV-PVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYD----CY----- 642 (714)
Q Consensus 573 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~----~~----- 642 (714)
... .......+|..|+|||++.+. .++.++|||||||++|||++|+.||...........+...... .+
T Consensus 189 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (329)
T 3gbz_A 189 IPI-RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTA 267 (329)
T ss_dssp ------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred Ccc-cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhh
Confidence 322 222334579999999999875 4899999999999999999999999765433221111110000 00
Q ss_pred ---hcCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 643 ---VEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 643 ---~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
........................+.+++.+||+.||++|||++|+++
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 268 LPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp STTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 000000111111111122223457889999999999999999999987
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=337.82 Aligned_cols=273 Identities=22% Similarity=0.306 Sum_probs=203.0
Q ss_pred HHHHHHHhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhc--cCcccccceeceEecC-
Q 041576 414 LVELNEATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGR--THHKNLVQLLGFCDEG- 490 (714)
Q Consensus 414 ~~el~~at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~nIv~l~~~~~~~- 490 (714)
..+.....|.+.+.||+|+||.||+|.+. ++.||||++.... ...+..|.+++.. ++||||+++++++...
T Consensus 31 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~---~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~ 104 (337)
T 3mdy_A 31 VQRTIAKQIQMVKQIGKGRYGEVWMGKWR---GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGT 104 (337)
T ss_dssp HHTTHHHHCEEEEEEEEETTEEEEEEEET---TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESC
T ss_pred cccccccceEEEeEeecCCCeEEEEEEEC---CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCC
Confidence 34455567888999999999999999864 8899999986432 2344455555554 4999999999999877
Q ss_pred ---CeeeEEEeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcC-----CCCeEecCCCcCeEEECCCCceEE
Q 041576 491 ---LNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEEC-----NVPIIHCDIKPQNILLDQDFTAKI 562 (714)
Q Consensus 491 ---~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~-----~~~ivH~Dlk~~NIll~~~~~~kl 562 (714)
...++||||+++|+|.+++.. ..+++..++.++.|++.||+|||+++ ..+|+||||||+||+++.++.+||
T Consensus 105 ~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl 183 (337)
T 3mdy_A 105 GSWTQLYLITDYHENGSLYDYLKS-TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCI 183 (337)
T ss_dssp GGGCEEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEE
T ss_pred CCCCceEEEEeccCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEE
Confidence 678999999999999999976 46899999999999999999999981 112999999999999999999999
Q ss_pred ecCCCccccccCcccc---eeeecCCCCccCcccccCCCCCch------hhhHHHHHHHHHHHhc----------CCCCc
Q 041576 563 SDFGLSKLLLSDQSRT---RTVIRGTRGYVAPEWFKNVPVSAK------VDVYSFGVVLLKIICC----------KRSVE 623 (714)
Q Consensus 563 ~Dfg~~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~s~k------sDVwSlGvil~elltG----------~~p~~ 623 (714)
+|||++.......... .....||..|+|||.+.+...+.+ +|||||||++|||++| +.||.
T Consensus 184 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~ 263 (337)
T 3mdy_A 184 ADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYH 263 (337)
T ss_dssp CCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred EeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHh
Confidence 9999997664433221 223468999999999987766654 9999999999999999 45554
Q ss_pred ccccchhhhhhhHHHhhhhhcCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCCC
Q 041576 624 MELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLEVP 699 (714)
Q Consensus 624 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 699 (714)
........ .... .......... ...............+.+++.+||+.||++|||+.||++.|+.+.+..
T Consensus 264 ~~~~~~~~--~~~~-~~~~~~~~~~---~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 333 (337)
T 3mdy_A 264 DLVPSDPS--YEDM-REIVCIKKLR---PSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ 333 (337)
T ss_dssp TTSCSSCC--HHHH-HHHHTTSCCC---CCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred hhcCCCCc--hhhh-HHHHhhhccC---ccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence 32211110 0000 0000011111 111111223356778999999999999999999999999999987654
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=342.58 Aligned_cols=265 Identities=24% Similarity=0.332 Sum_probs=203.1
Q ss_pred hhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEeccc--chhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEe
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKL--AQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYE 498 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E 498 (714)
.|.+.+.||+|+||.||+|... .+++.||||++... .....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 26 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 104 (331)
T 4aaa_A 26 KYENLGLVGEGSYGMVMKCRNK-DTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE 104 (331)
T ss_dssp GEEEEEEGGGGTTSSEEEEEET-TTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hheeeeEEeecCCEEEEEEEEC-CCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence 5677789999999999999876 56899999998543 23345678899999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcccc
Q 041576 499 FMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRT 578 (714)
Q Consensus 499 ~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 578 (714)
|+++++|.+++.....+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++........ .
T Consensus 105 ~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~ 180 (331)
T 4aaa_A 105 FVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE-V 180 (331)
T ss_dssp CCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC----------
T ss_pred cCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCCcc-c
Confidence 9999999999888788999999999999999999999998 99999999999999999999999999986543322 2
Q ss_pred eeeecCCCCccCcccccCC-CCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHH------------Hhhh-hhc
Q 041576 579 RTVIRGTRGYVAPEWFKNV-PVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDW------------AYDC-YVE 644 (714)
Q Consensus 579 ~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~------------~~~~-~~~ 644 (714)
.....++..|+|||.+.+. .++.++||||||+++|||++|+.||...........+... .... ...
T Consensus 181 ~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (331)
T 4aaa_A 181 YDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAG 260 (331)
T ss_dssp ---CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTT
T ss_pred cCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcccccc
Confidence 2334589999999999875 7899999999999999999999999765433221111100 0000 000
Q ss_pred CccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 645 GKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 645 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
...................+..+.+++.+||+.||++|||++|+++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 261 VRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp CCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 1111111111111112234567889999999999999999999876
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=336.64 Aligned_cols=257 Identities=26% Similarity=0.357 Sum_probs=206.8
Q ss_pred hhhhhh-hhCcccceeEEEeEee-CCCCcEEEEEEeccc-chhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEE
Q 041576 421 TNGFEE-ELGRGSFGIVYKGVLK-SASGNAVAVKKLDKL-AQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVY 497 (714)
Q Consensus 421 t~~~~~-~ig~G~~g~Vy~~~~~-~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 497 (714)
.+.+.+ .||+|+||.||+|.+. ..+++.||||.++.. .....+.+.+|++++++++||||+++++++ ..+..++||
T Consensus 10 ~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~ 88 (287)
T 1u59_A 10 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVM 88 (287)
T ss_dssp GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEE
T ss_pred HhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEE
Confidence 344445 8999999999999864 235778999999764 344567899999999999999999999999 456689999
Q ss_pred eecCCCchhhhhhcC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcc
Q 041576 498 EFMGNGTLANLLFAI-PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQS 576 (714)
Q Consensus 498 E~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 576 (714)
||+++++|.+++... ..+++..++.++.||++||+|||+.+ |+||||||+||+++.++.+||+|||++........
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 165 (287)
T 1u59_A 89 EMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS 165 (287)
T ss_dssp ECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTCSC
T ss_pred EeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeeccCcc
Confidence 999999999999754 56899999999999999999999998 99999999999999999999999999987644332
Q ss_pred c--ceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccchhhhhhhHHHhhhhhcCccceeecc
Q 041576 577 R--TRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDN 653 (714)
Q Consensus 577 ~--~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 653 (714)
. ......++..|+|||.+.+..++.++||||||+++|||++ |+.||........... ...+...
T Consensus 166 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~--------i~~~~~~----- 232 (287)
T 1u59_A 166 YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF--------IEQGKRM----- 232 (287)
T ss_dssp EECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHH--------HHTTCCC-----
T ss_pred eeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHH--------HhcCCcC-----
Confidence 1 1223346789999999988889999999999999999998 9999975443321111 1111111
Q ss_pred hhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCC
Q 041576 654 DKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLEV 698 (714)
Q Consensus 654 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 698 (714)
..+...+..+.+++.+||+.||++||++.|+++.|+.+...
T Consensus 233 ----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 273 (287)
T 1u59_A 233 ----ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 273 (287)
T ss_dssp ----CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----CCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 11223345788899999999999999999999999987643
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-39 Score=337.06 Aligned_cols=256 Identities=25% Similarity=0.354 Sum_probs=206.8
Q ss_pred HHhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEe
Q 041576 419 EATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYE 498 (714)
Q Consensus 419 ~at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E 498 (714)
..+|.+.+.||+|+||.||+|... .+++.||+|.++.........+.+|+.++++++||||+++++++.+....++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQR-LTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hccceeeeeccCCCCceEEEEEEC-CCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 456788899999999999999876 4789999999986555556678999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEE---CCCCceEEecCCCccccccCc
Q 041576 499 FMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILL---DQDFTAKISDFGLSKLLLSDQ 575 (714)
Q Consensus 499 ~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll---~~~~~~kl~Dfg~~~~~~~~~ 575 (714)
|+++++|.+++.....+++..+..++.||+.||+|||+.+ |+||||||+||++ +.++.+||+|||++......
T Consensus 87 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~- 162 (304)
T 2jam_A 87 LVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG- 162 (304)
T ss_dssp CCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB-
T ss_pred cCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC-
Confidence 9999999999988788999999999999999999999998 9999999999999 78899999999998754322
Q ss_pred ccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchh
Q 041576 576 SRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDK 655 (714)
Q Consensus 576 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 655 (714)
......|++.|+|||.+.+..++.++||||||+++|||++|+.||.......... ....+.... .
T Consensus 163 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~--------~i~~~~~~~--~--- 227 (304)
T 2jam_A 163 --IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFE--------KIKEGYYEF--E--- 227 (304)
T ss_dssp --TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH--------HHHHCCCCC--C---
T ss_pred --ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHH--------HHHcCCCCC--C---
Confidence 1223458999999999999999999999999999999999999997543322111 111111100 0
Q ss_pred hhccchHHHHHHHHHHHHccccCCCCCCCHHHHHH--HHhcc
Q 041576 656 AAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ--MLEGY 695 (714)
Q Consensus 656 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~ 695 (714)
.......+..+.+++.+||+.||++|||++|+++ .+++.
T Consensus 228 -~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (304)
T 2jam_A 228 -SPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGN 268 (304)
T ss_dssp -TTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred -ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCC
Confidence 0011223456888999999999999999999987 35443
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-40 Score=348.10 Aligned_cols=268 Identities=26% Similarity=0.381 Sum_probs=211.0
Q ss_pred HHHHhhhhhhhhCcccceeEEEeEe---eCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCcccccceeceEecCC--
Q 041576 417 LNEATNGFEEELGRGSFGIVYKGVL---KSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGL-- 491 (714)
Q Consensus 417 l~~at~~~~~~ig~G~~g~Vy~~~~---~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-- 491 (714)
+....+.+.+.||+|+||.||+|.+ ...+++.||||++........+.+.+|++++++++||||+++++++...+
T Consensus 38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 117 (326)
T 2w1i_A 38 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 117 (326)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----
T ss_pred cCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCC
Confidence 3445677889999999999999985 23578899999998776667788999999999999999999999986654
Q ss_pred eeeEEEeecCCCchhhhhhcC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccc
Q 041576 492 NRLLVYEFMGNGTLANLLFAI-PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKL 570 (714)
Q Consensus 492 ~~~lv~E~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~ 570 (714)
..++||||+++++|.+++... ..+++..++.++.||++||+|||+.+ |+||||||+||+++.++.+||+|||++..
T Consensus 118 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~ 194 (326)
T 2w1i_A 118 NLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV 194 (326)
T ss_dssp CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred ceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhh
Confidence 679999999999999999875 45899999999999999999999998 99999999999999999999999999987
Q ss_pred cccCccc--ceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhh--------hhhhHHHhh
Q 041576 571 LLSDQSR--TRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERS--------AILTDWAYD 640 (714)
Q Consensus 571 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~--------~~l~~~~~~ 640 (714)
....... ......++..|+|||.+.+..++.++||||||+++|||++|..|+......... .........
T Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (326)
T 2w1i_A 195 LPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 274 (326)
T ss_dssp CCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred ccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHH
Confidence 6544321 122334677899999999888999999999999999999999998643211100 000000000
Q ss_pred hhhcCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 041576 641 CYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYL 696 (714)
Q Consensus 641 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 696 (714)
....+. ....+...+..+.+++.+||+.||++|||+.||++.|+.+.
T Consensus 275 ~~~~~~---------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~ 321 (326)
T 2w1i_A 275 LLKNNG---------RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 321 (326)
T ss_dssp HHHTTC---------CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred HhhcCC---------CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 011100 01112233457888999999999999999999999998764
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=349.09 Aligned_cols=245 Identities=27% Similarity=0.279 Sum_probs=193.8
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc---hhhHHHHHHHHHH-HhccCcccccceeceEecCCeeeE
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA---QEREREFKTEVSA-IGRTHHKNLVQLLGFCDEGLNRLL 495 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~-l~~l~h~nIv~l~~~~~~~~~~~l 495 (714)
..|.+.+.||+|+||.||+|+.+ .+++.||||++++.. ......+.+|..+ ++.++||||+++++++.+.+..++
T Consensus 38 ~~y~~~~~lG~G~fg~V~~~~~~-~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 38 SDFHFLKVIGKGSFGKVLLARHK-AEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGEEEEEEEECCTTCEEEEEEET-TTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEEc-CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 45778899999999999999976 578899999997543 2334566777776 567899999999999999999999
Q ss_pred EEeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCc
Q 041576 496 VYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQ 575 (714)
Q Consensus 496 v~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 575 (714)
||||+++|+|.+++.....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 117 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~ 193 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN 193 (373)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCC
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccccccCC
Confidence 9999999999999988788999999999999999999999998 9999999999999999999999999998643222
Q ss_pred ccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchh
Q 041576 576 SRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDK 655 (714)
Q Consensus 576 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 655 (714)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+ ......
T Consensus 194 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i--------~~~~~~------- 257 (373)
T 2r5t_A 194 -STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNI--------LNKPLQ------- 257 (373)
T ss_dssp -CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHH--------HHSCCC-------
T ss_pred -CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHH--------HhcccC-------
Confidence 2234457999999999999999999999999999999999999999765433221111 111110
Q ss_pred hhccchHHHHHHHHHHHHccccCCCCCCCHHH
Q 041576 656 AAMADKSRACKWLMIALWCIQEDPLKRPAMKM 687 (714)
Q Consensus 656 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e 687 (714)
.+......+.+++.+||+.||.+||++.+
T Consensus 258 ---~~~~~~~~~~~li~~lL~~dp~~R~~~~~ 286 (373)
T 2r5t_A 258 ---LKPNITNSARHLLEGLLQKDRTKRLGAKD 286 (373)
T ss_dssp ---CCSSSCHHHHHHHHHHTCSSGGGSTTTTT
T ss_pred ---CCCCCCHHHHHHHHHHcccCHHhCCCCCC
Confidence 11123346778999999999999999853
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-39 Score=332.60 Aligned_cols=249 Identities=26% Similarity=0.355 Sum_probs=197.7
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc-hhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEe
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA-QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYE 498 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E 498 (714)
..|.+.+.||+|+||.||+|..+ .+++.||+|++.... ....+.+.+|++++++++||||+++++++.+....++|||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEER-SSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEET-TTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hheeecceeccCCCeEEEEEEEc-cCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 46788899999999999999876 568899999986543 3346789999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhc----CCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEE---CCCCceEEecCCCcccc
Q 041576 499 FMGNGTLANLLFA----IPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILL---DQDFTAKISDFGLSKLL 571 (714)
Q Consensus 499 ~~~~gsL~~~l~~----~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll---~~~~~~kl~Dfg~~~~~ 571 (714)
|+++++|.+++.. ...+++..++.++.||++||+|||+++ |+||||||+||++ +.++.+||+|||++...
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 9999999999854 367899999999999999999999998 9999999999999 45688999999999865
Q ss_pred ccCcccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceee
Q 041576 572 LSDQSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLV 651 (714)
Q Consensus 572 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 651 (714)
.... ......++..|+|||.+. ..++.++||||||+++|||++|+.||............ ........ .
T Consensus 178 ~~~~--~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~------~~~~~~~~--~ 246 (285)
T 3is5_A 178 KSDE--HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKA------TYKEPNYA--V 246 (285)
T ss_dssp -----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------HHCCCCCC--C
T ss_pred CCcc--cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhh------ccCCcccc--c
Confidence 4332 223456899999999986 46899999999999999999999999754332211100 00000000 0
Q ss_pred cchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 652 DNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 652 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
........+.+++.+||+.||++|||+.||++
T Consensus 247 -------~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 247 -------ECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp ---------CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred -------ccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00112346778999999999999999999986
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=349.56 Aligned_cols=268 Identities=22% Similarity=0.296 Sum_probs=194.4
Q ss_pred HHHhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEeccc--chhhHHHHHHHHHHHhccC-cccccceeceEecCC--e
Q 041576 418 NEATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKL--AQEREREFKTEVSAIGRTH-HKNLVQLLGFCDEGL--N 492 (714)
Q Consensus 418 ~~at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~--~ 492 (714)
....|.+.+.||+|+||.||+|.+. .+++.||||++... .....+.+.+|+.++.++. ||||+++++++...+ .
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~-~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDR-RTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEET-TTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred ccCceEEEEEeeeCCCeEEEEEEEC-CCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 3456788899999999999999876 57899999998642 3445567889999999997 999999999997544 6
Q ss_pred eeEEEeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccc
Q 041576 493 RLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLL 572 (714)
Q Consensus 493 ~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~ 572 (714)
.++||||++ ++|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 86 ~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 160 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFV 160 (388)
T ss_dssp EEEEEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEESS
T ss_pred EEEEecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCccccccc
Confidence 899999998 589999876 57889999999999999999999998 9999999999999999999999999998653
Q ss_pred cCc--------------------ccceeeecCCCCccCcccccC-CCCCchhhhHHHHHHHHHHHhcCCCCcccccchhh
Q 041576 573 SDQ--------------------SRTRTVIRGTRGYVAPEWFKN-VPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERS 631 (714)
Q Consensus 573 ~~~--------------------~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~ 631 (714)
... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||.........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~ 240 (388)
T 3oz6_A 161 NIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQL 240 (388)
T ss_dssp SCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred ccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 211 112234579999999999976 67899999999999999999999999765433322
Q ss_pred hhhhHHHhh-------hhh------------------cCccceeecch----hhhccchHHHHHHHHHHHHccccCCCCC
Q 041576 632 AILTDWAYD-------CYV------------------EGKLDVLVDND----KAAMADKSRACKWLMIALWCIQEDPLKR 682 (714)
Q Consensus 632 ~~l~~~~~~-------~~~------------------~~~~~~~~~~~----~~~~~~~~~~~~l~~li~~cl~~dP~~R 682 (714)
..+...... ... .......+... ............+.+++.+||+.||++|
T Consensus 241 ~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R 320 (388)
T 3oz6_A 241 ERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKR 320 (388)
T ss_dssp HHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGS
T ss_pred HHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccC
Confidence 111110000 000 00000000000 0000001224578899999999999999
Q ss_pred CCHHHHHHH
Q 041576 683 PAMKMIVQM 691 (714)
Q Consensus 683 Ps~~evl~~ 691 (714)
||++|+++.
T Consensus 321 ~t~~e~l~H 329 (388)
T 3oz6_A 321 ISANDALKH 329 (388)
T ss_dssp CCHHHHTTS
T ss_pred CCHHHHhCC
Confidence 999999875
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=345.10 Aligned_cols=250 Identities=19% Similarity=0.296 Sum_probs=195.6
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEeccc--chhhHHHHHHHHHHHhccCc--ccccceeceEecCCeeeE
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKL--AQEREREFKTEVSAIGRTHH--KNLVQLLGFCDEGLNRLL 495 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h--~nIv~l~~~~~~~~~~~l 495 (714)
..|.+.+.||+|+||.||+|... +++.||||++... .....+.+.+|++++.+++| |||+++++++.++...++
T Consensus 9 ~~y~i~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 86 (343)
T 3dbq_A 9 RIYSILKQIGSGGSSKVFQVLNE--KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 86 (343)
T ss_dssp CEEEEEEEESCCSSEEEEEEECT--TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred CEEEEEEEEecCCCeEEEEEEeC--CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence 35777899999999999999874 6889999998643 34445789999999999976 999999999999999999
Q ss_pred EEeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCc
Q 041576 496 VYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQ 575 (714)
Q Consensus 496 v~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 575 (714)
||| +.+++|.+++.....+++.++..++.||++||+|||+++ |+||||||+|||++ ++.+||+|||++.......
T Consensus 87 v~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~ 161 (343)
T 3dbq_A 87 VME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 161 (343)
T ss_dssp EEC-CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC----
T ss_pred EEe-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccCccc
Confidence 999 567899999999888999999999999999999999998 99999999999997 5789999999998765433
Q ss_pred cc-ceeeecCCCCccCcccccC-----------CCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhh
Q 041576 576 SR-TRTVIRGTRGYVAPEWFKN-----------VPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYV 643 (714)
Q Consensus 576 ~~-~~~~~~gt~~y~aPE~~~~-----------~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~ 643 (714)
.. ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ .+.. ..
T Consensus 162 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~~~~-----~~ 234 (343)
T 3dbq_A 162 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS--KLHA-----II 234 (343)
T ss_dssp --------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHH--HHHH-----HH
T ss_pred ccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHH--HHHH-----Hh
Confidence 22 2334569999999999864 6789999999999999999999999974322110 0100 00
Q ss_pred cCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 644 EGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 644 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
... .....+......+.+++.+||+.||++|||+.|+++.
T Consensus 235 ~~~--------~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 235 DPN--------HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp CTT--------SCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cCC--------cccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 100 0011111123467789999999999999999999864
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=350.68 Aligned_cols=258 Identities=25% Similarity=0.413 Sum_probs=196.3
Q ss_pred hhhhhhhhCcccceeEEEeEeeCCCC--cEEEEEEeccc-chhhHHHHHHHHHHHhccCcccccceeceEec-CCeeeEE
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSASG--NAVAVKKLDKL-AQEREREFKTEVSAIGRTHHKNLVQLLGFCDE-GLNRLLV 496 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~~~--~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-~~~~~lv 496 (714)
.+.+.+.||+|+||.||+|.+...++ ..||||.++.. .....+.+.+|+.++++++||||+++++++.. ++..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 35567899999999999998764333 46899998653 33456789999999999999999999998754 5678999
Q ss_pred EeecCCCchhhhhhcC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCc
Q 041576 497 YEFMGNGTLANLLFAI-PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQ 575 (714)
Q Consensus 497 ~E~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 575 (714)
|||+++++|.+++... ..+++..++.++.||++||+|||+++ |+||||||+||+++.++.+||+|||+++......
T Consensus 170 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 246 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 246 (373)
T ss_dssp EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeeccccccccccc
Confidence 9999999999999865 45789999999999999999999998 9999999999999999999999999998664332
Q ss_pred c---cceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccchhhhhhhHHHhhhhhcCccceee
Q 041576 576 S---RTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEERSAILTDWAYDCYVEGKLDVLV 651 (714)
Q Consensus 576 ~---~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 651 (714)
. .......++..|+|||.+.+..++.++||||||+++|||++ |..||......+.... ...+...
T Consensus 247 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~--------~~~~~~~--- 315 (373)
T 3c1x_A 247 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY--------LLQGRRL--- 315 (373)
T ss_dssp -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHH--------HHTTCCC---
T ss_pred cccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHH--------HHcCCCC---
Confidence 1 12233457788999999999999999999999999999999 6667754432221111 1111110
Q ss_pred cchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCC
Q 041576 652 DNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLEV 698 (714)
Q Consensus 652 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 698 (714)
..+...+..+.+++.+||+.||++|||+.|+++.|+.++..
T Consensus 316 ------~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~ 356 (373)
T 3c1x_A 316 ------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 356 (373)
T ss_dssp ------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 01122335678899999999999999999999999987654
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=331.26 Aligned_cols=263 Identities=18% Similarity=0.246 Sum_probs=207.0
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCcccccceeceE-ecCCeeeEEEe
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFC-DEGLNRLLVYE 498 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~-~~~~~~~lv~E 498 (714)
..|.+.+.||+|+||.||+|+.. .+++.||||++..... ...+.+|+.++++++|++++..+..+ ..+...++|||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 9 NRYRLGRKIGSGSFGDIYLGTDI-AAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTEEEEEEEEEETTEEEEEEEET-TTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred cEEEEEEEEccCCCeEEEEEEEc-CCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 35677889999999999999875 5789999999865332 34688999999999988877666665 66777899999
Q ss_pred ecCCCchhhhhhc-CCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEE---CCCCceEEecCCCccccccC
Q 041576 499 FMGNGTLANLLFA-IPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILL---DQDFTAKISDFGLSKLLLSD 574 (714)
Q Consensus 499 ~~~~gsL~~~l~~-~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll---~~~~~~kl~Dfg~~~~~~~~ 574 (714)
|+ +++|.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+||++ ++++.+||+|||++......
T Consensus 86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (296)
T 3uzp_A 86 LL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred ec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccc
Confidence 99 8999999974 457899999999999999999999998 9999999999999 48899999999999876543
Q ss_pred ccc------ceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccc
Q 041576 575 QSR------TRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLD 648 (714)
Q Consensus 575 ~~~------~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 648 (714)
... ......|+..|+|||.+.+..++.++||||||+++|||++|+.||...........+...........
T Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--- 238 (296)
T 3uzp_A 162 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP--- 238 (296)
T ss_dssp TTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC---
T ss_pred ccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc---
Confidence 321 22345689999999999999999999999999999999999999986433322222211111100000
Q ss_pred eeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCCC
Q 041576 649 VLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLEVP 699 (714)
Q Consensus 649 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 699 (714)
........+..+.+++.+||+.||++|||+++|++.|+.+....
T Consensus 239 -------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~ 282 (296)
T 3uzp_A 239 -------IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 282 (296)
T ss_dssp -------HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHT
T ss_pred -------hHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhc
Confidence 00011223456888999999999999999999999999876543
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-39 Score=332.00 Aligned_cols=247 Identities=22% Similarity=0.331 Sum_probs=182.9
Q ss_pred hhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEE
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA---QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVY 497 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 497 (714)
.|.+.+.||+|+||.||+|... .+++.||||.+.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 12 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (278)
T 3cok_A 12 DFKVGNLLGKGSFAGVYRAESI-HTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL 90 (278)
T ss_dssp GEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceeeeeecCCCceEEEEEEEc-cCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence 4667789999999999999875 468999999996532 223467899999999999999999999999999999999
Q ss_pred eecCCCchhhhhhcC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcc
Q 041576 498 EFMGNGTLANLLFAI-PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQS 576 (714)
Q Consensus 498 E~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 576 (714)
||+++++|.+++... ..+++..+..++.||++||+|||+++ |+||||||+||+++.++.+||+|||++........
T Consensus 91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 167 (278)
T 3cok_A 91 EMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE 167 (278)
T ss_dssp ECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC----
T ss_pred ecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccCCCC
Confidence 999999999999875 56899999999999999999999998 99999999999999999999999999986643222
Q ss_pred cceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhh
Q 041576 577 RTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKA 656 (714)
Q Consensus 577 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 656 (714)
......+++.|+|||.+.+..++.++||||||+++|||++|+.||.......... . ......
T Consensus 168 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~---~-----~~~~~~--------- 229 (278)
T 3cok_A 168 -KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLN---K-----VVLADY--------- 229 (278)
T ss_dssp -------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-------------CCSSCC---------
T ss_pred -cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHH---H-----Hhhccc---------
Confidence 1223468999999999999889999999999999999999999997543221100 0 000000
Q ss_pred hccchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 657 AMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 657 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
..+...+..+.+++.+||+.||++|||++|+++
T Consensus 230 -~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 230 -EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp -CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred -CCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 011223456788999999999999999999986
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=333.23 Aligned_cols=263 Identities=19% Similarity=0.252 Sum_probs=205.1
Q ss_pred HHhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCcccccceeceE-ecCCeeeEEE
Q 041576 419 EATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFC-DEGLNRLLVY 497 (714)
Q Consensus 419 ~at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~-~~~~~~~lv~ 497 (714)
..+|.+.+.||+|+||.||+|... .+++.||||++.... ....+.+|++++++++|++++..+..+ ......++||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDI-AAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEET-TTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred CCceEEeeeecCCCCeEEEEEEEc-CCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 356778899999999999999865 478899999875432 223578899999999988877776665 6677889999
Q ss_pred eecCCCchhhhhhc-CCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEE---CCCCceEEecCCCcccccc
Q 041576 498 EFMGNGTLANLLFA-IPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILL---DQDFTAKISDFGLSKLLLS 573 (714)
Q Consensus 498 E~~~~gsL~~~l~~-~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll---~~~~~~kl~Dfg~~~~~~~ 573 (714)
||+ +++|.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+||++ ++++.+||+|||++.....
T Consensus 85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~ 160 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp ECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred Ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceeccC
Confidence 999 8999999984 457899999999999999999999998 9999999999999 7889999999999987654
Q ss_pred Ccc------cceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCcc
Q 041576 574 DQS------RTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKL 647 (714)
Q Consensus 574 ~~~------~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~ 647 (714)
... .......|+..|+|||.+.+..++.++||||||+++|||++|+.||...........+...........
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-- 238 (296)
T 4hgt_A 161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP-- 238 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC--
T ss_pred cccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch--
Confidence 332 122345689999999999999999999999999999999999999976543322222211111100000
Q ss_pred ceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCC
Q 041576 648 DVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLEV 698 (714)
Q Consensus 648 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 698 (714)
........+..+.+++.+||+.||++|||+++|++.|+.+++.
T Consensus 239 --------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~ 281 (296)
T 4hgt_A 239 --------IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 281 (296)
T ss_dssp --------HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHH
T ss_pred --------hhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHH
Confidence 0001112245788899999999999999999999999987653
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=349.52 Aligned_cols=265 Identities=23% Similarity=0.338 Sum_probs=206.0
Q ss_pred HHhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEeccc-chhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEE
Q 041576 419 EATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKL-AQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVY 497 (714)
Q Consensus 419 ~at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 497 (714)
...|.+.+.||+|+||.||+|.+. .+++.||+|++... .....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 110 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHK-PSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 110 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceeeeeecCCCCeEEEEEEEC-CCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEE
Confidence 345677789999999999999976 57899999999754 3445678999999999999999999999999999999999
Q ss_pred eecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhc-CCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcc
Q 041576 498 EFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEE-CNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQS 576 (714)
Q Consensus 498 E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~-~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 576 (714)
||+++++|.+++.....+++..+..++.|++.||+|||+. + |+||||||+||+++.++.+||+|||++......
T Consensus 111 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 185 (360)
T 3eqc_A 111 EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 185 (360)
T ss_dssp CCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--
T ss_pred ECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCcccccc--
Confidence 9999999999999888899999999999999999999996 7 999999999999999999999999999755322
Q ss_pred cceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHh-----------------
Q 041576 577 RTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAY----------------- 639 (714)
Q Consensus 577 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~----------------- 639 (714)
......|++.|+|||.+.+..++.++||||||+++|||++|+.||...........+.....
T Consensus 186 -~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (360)
T 3eqc_A 186 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 264 (360)
T ss_dssp -C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---------------------
T ss_pred -cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcc
Confidence 22334689999999999999999999999999999999999999976443321111100000
Q ss_pred -----hhhhcCcc----ceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 640 -----DCYVEGKL----DVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 640 -----~~~~~~~~----~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
........ ..+.............+..+.+++.+||+.||++|||++|+++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 324 (360)
T 3eqc_A 265 NKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324 (360)
T ss_dssp ---------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred cccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 00000000 0000000000111123457888999999999999999999986
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=344.12 Aligned_cols=252 Identities=23% Similarity=0.334 Sum_probs=201.9
Q ss_pred HHhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhcc-CcccccceeceEecCCeeeEEE
Q 041576 419 EATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRT-HHKNLVQLLGFCDEGLNRLLVY 497 (714)
Q Consensus 419 ~at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~ 497 (714)
...|.+.+.||+|+||.||+|..+ .+++.||||+++.... ...+|++++.++ +||||+++++++.++...++||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHK-ATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEEeeCCCEEEEEEEEC-CCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 346778899999999999999876 5789999999965432 245688888887 7999999999999999999999
Q ss_pred eecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCC----CceEEecCCCcccccc
Q 041576 498 EFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQD----FTAKISDFGLSKLLLS 573 (714)
Q Consensus 498 E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~----~~~kl~Dfg~~~~~~~ 573 (714)
||+++|+|.+++.....+++..+..++.||+.||+|||+++ |+||||||+||++.++ +.+||+|||++.....
T Consensus 96 E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~ 172 (342)
T 2qr7_A 96 ELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA 172 (342)
T ss_dssp CCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBC
T ss_pred eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcC
Confidence 99999999999998888999999999999999999999998 9999999999998543 3599999999987644
Q ss_pred CcccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecc
Q 041576 574 DQSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDN 653 (714)
Q Consensus 574 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 653 (714)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+.. ...+.... ..
T Consensus 173 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~-----i~~~~~~~--~~ 244 (342)
T 2qr7_A 173 ENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILAR-----IGSGKFSL--SG 244 (342)
T ss_dssp TTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHH-----HHHCCCCC--CS
T ss_pred CCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHH-----HccCCccc--Cc
Confidence 332 22345689999999999888889999999999999999999999975432222222111 11111110 00
Q ss_pred hhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 654 DKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 654 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
......+..+.+++.+||+.||++|||+.|+++
T Consensus 245 ----~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 245 ----GYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp ----TTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ----cccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 011223456788999999999999999999986
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=333.52 Aligned_cols=249 Identities=23% Similarity=0.292 Sum_probs=207.1
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEeccc---chhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEE
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKL---AQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLV 496 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 496 (714)
..|.+.+.||+|+||.||+|... .+++.||+|.+... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 15 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 15 RRYVRGRFLGKGGFAKCFEISDA-DTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp EEEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cceEEEEEEeecCCEEEEEEEEC-CCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 35667889999999999999876 56889999998653 234556789999999999999999999999999999999
Q ss_pred EeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcc
Q 041576 497 YEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQS 576 (714)
Q Consensus 497 ~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 576 (714)
|||+++++|.+++.....+++.++..++.||++||+|||+++ |+||||||+||+++.++.+||+|||++........
T Consensus 94 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 170 (294)
T 2rku_A 94 LELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE 170 (294)
T ss_dssp EECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceecccCcc
Confidence 999999999999988788999999999999999999999998 99999999999999999999999999987643222
Q ss_pred cceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhh
Q 041576 577 RTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKA 656 (714)
Q Consensus 577 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 656 (714)
......|+..|+|||.+.+..++.++||||||+++|||++|+.||......+... ........
T Consensus 171 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~--------~~~~~~~~-------- 233 (294)
T 2rku_A 171 -RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYL--------RIKKNEYS-------- 233 (294)
T ss_dssp -CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH--------HHHTTCCC--------
T ss_pred -ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH--------HHhhccCC--------
Confidence 2233568999999999999899999999999999999999999997543322111 11111100
Q ss_pred hccchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 657 AMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 657 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
.+......+.+++.+||+.||++|||++|+++.
T Consensus 234 --~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 234 --IPKHINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp --CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred --CccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 111223467789999999999999999999974
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=343.04 Aligned_cols=256 Identities=23% Similarity=0.321 Sum_probs=189.5
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccC-cccccceeceEe--------cC
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTH-HKNLVQLLGFCD--------EG 490 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~--------~~ 490 (714)
.+|.+.+.||+|+||.||+|.+. .+++.||||++........+.+.+|+.++.++. ||||+++++++. ..
T Consensus 28 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 106 (337)
T 3ll6_A 28 LRLRVRRVLAEGGFAFVYEAQDV-GSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106 (337)
T ss_dssp EEEEEEEEEECCSSEEEEEEEET-TTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred ceEEEEEEEccCCceEEEEEEEC-CCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence 46778899999999999999975 478999999997766667778999999999995 999999999983 34
Q ss_pred CeeeEEEeecCCCchhhhhhc---CCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCC
Q 041576 491 LNRLLVYEFMGNGTLANLLFA---IPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGL 567 (714)
Q Consensus 491 ~~~~lv~E~~~~gsL~~~l~~---~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~ 567 (714)
...++||||+. |+|.+++.. ...+++..++.++.||+.||+|||+++ ++|+||||||+||+++.++.+||+|||+
T Consensus 107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 184 (337)
T 3ll6_A 107 AEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFGS 184 (337)
T ss_dssp EEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCCTT
T ss_pred ceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecCcc
Confidence 45789999996 699888864 456899999999999999999999975 4599999999999999999999999999
Q ss_pred ccccccCccc-----------ceeeecCCCCccCcccc---cCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhh
Q 041576 568 SKLLLSDQSR-----------TRTVIRGTRGYVAPEWF---KNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAI 633 (714)
Q Consensus 568 ~~~~~~~~~~-----------~~~~~~gt~~y~aPE~~---~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~ 633 (714)
+......... ......+++.|+|||.+ .+..++.++||||||+++|||++|+.||........
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~--- 261 (337)
T 3ll6_A 185 ATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRI--- 261 (337)
T ss_dssp CBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----------
T ss_pred ceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHh---
Confidence 9876543221 11134589999999998 566789999999999999999999999964322110
Q ss_pred hhHHHhhhhhcCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCC
Q 041576 634 LTDWAYDCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLEV 698 (714)
Q Consensus 634 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 698 (714)
..+.... .........+.+++.+||+.||++|||+.|+++.|+.+...
T Consensus 262 ---------~~~~~~~--------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~ 309 (337)
T 3ll6_A 262 ---------VNGKYSI--------PPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAA 309 (337)
T ss_dssp -------------CCC--------CTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---------hcCcccC--------CcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 0000000 00111122366799999999999999999999999887643
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=370.89 Aligned_cols=250 Identities=28% Similarity=0.390 Sum_probs=202.0
Q ss_pred hhhCcccceeEEEeEeeC-CCCcEEEEEEecccc--hhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEeecCC
Q 041576 426 EELGRGSFGIVYKGVLKS-ASGNAVAVKKLDKLA--QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEFMGN 502 (714)
Q Consensus 426 ~~ig~G~~g~Vy~~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~ 502 (714)
++||+|+||.||+|.+.. ..++.||||+++... ....+++.+|++++++++||||+++++++.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 479999999999997643 346789999997643 3346789999999999999999999999965 457899999999
Q ss_pred CchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcc--ccee
Q 041576 503 GTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQS--RTRT 580 (714)
Q Consensus 503 gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~--~~~~ 580 (714)
|+|.+++.....+++..++.|+.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.+..... ....
T Consensus 454 g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 530 (635)
T 4fl3_A 454 GPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT 530 (635)
T ss_dssp EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC---------
T ss_pred CCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccccccc
Confidence 999999998888999999999999999999999998 99999999999999999999999999987654332 2223
Q ss_pred eecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhhcc
Q 041576 581 VIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMA 659 (714)
Q Consensus 581 ~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 659 (714)
...++..|+|||++.+..++.++|||||||++|||++ |+.||......+... ....+... ..
T Consensus 531 ~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~--------~i~~~~~~---------~~ 593 (635)
T 4fl3_A 531 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTA--------MLEKGERM---------GC 593 (635)
T ss_dssp ----CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH--------HHHTTCCC---------CC
T ss_pred CCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH--------HHHcCCCC---------CC
Confidence 3456788999999999999999999999999999998 999997654332111 11111111 11
Q ss_pred chHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 041576 660 DKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYL 696 (714)
Q Consensus 660 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 696 (714)
+...+..+.+++.+||+.||++||++++|++.|+.+.
T Consensus 594 p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~ 630 (635)
T 4fl3_A 594 PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 630 (635)
T ss_dssp CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 2233457888999999999999999999999998754
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-39 Score=343.34 Aligned_cols=246 Identities=25% Similarity=0.317 Sum_probs=199.6
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEeccc---chhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEE
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKL---AQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLV 496 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 496 (714)
..|...+.||+|+||.||+|... .+++.||||++... .....+.+.+|++++++++||||+++++++..++..++|
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDV-RNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEc-cCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 44667789999999999999865 47899999998642 233456789999999999999999999999999999999
Q ss_pred EeecCCCchhhhhh-cCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCc
Q 041576 497 YEFMGNGTLANLLF-AIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQ 575 (714)
Q Consensus 497 ~E~~~~gsL~~~l~-~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 575 (714)
|||+. |+|.+++. ....+++..+..++.||++||+|||+++ |+||||||+||+++.++.+||+|||++......
T Consensus 133 ~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~- 207 (348)
T 1u5q_A 133 MEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA- 207 (348)
T ss_dssp EECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-
T ss_pred EecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCCC-
Confidence 99998 57877775 4567899999999999999999999998 999999999999999999999999999765432
Q ss_pred ccceeeecCCCCccCccccc---CCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeec
Q 041576 576 SRTRTVIRGTRGYVAPEWFK---NVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVD 652 (714)
Q Consensus 576 ~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 652 (714)
....||+.|+|||.+. ...++.++||||||+++|||++|+.||........ +.. ...+.....
T Consensus 208 ----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~---~~~-----~~~~~~~~~-- 273 (348)
T 1u5q_A 208 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA---LYH-----IAQNESPAL-- 273 (348)
T ss_dssp ----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH---HHH-----HHHSCCCCC--
T ss_pred ----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH---HHH-----HHhcCCCCC--
Confidence 2346899999999984 56789999999999999999999999975432221 111 111111111
Q ss_pred chhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 653 NDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 653 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
.....+..+.+++.+||+.||++|||++++++.
T Consensus 274 ------~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 274 ------QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp ------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred ------CCCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 111234567789999999999999999999864
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=334.34 Aligned_cols=254 Identities=25% Similarity=0.363 Sum_probs=206.3
Q ss_pred HHHHHHhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCcccccceeceEec-----
Q 041576 415 VELNEATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCDE----- 489 (714)
Q Consensus 415 ~el~~at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~----- 489 (714)
.......|.+.+.||+|+||.||+|.+. .+++.||+|++.... ..+.+|++++++++||||+++++++..
T Consensus 6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 80 (284)
T 2a19_B 6 DKRFGMDFKEIELIGSGGFGQVFKAKHR-IDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDP 80 (284)
T ss_dssp CHHHHHHEEEEEEEECSSSCCEEEEEET-TTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-
T ss_pred cchhccccceeeeeccCCceEEEEEEEc-CCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCc
Confidence 3445567888899999999999999876 468999999996543 356789999999999999999998854
Q ss_pred -----------CCeeeEEEeecCCCchhhhhhcC--CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECC
Q 041576 490 -----------GLNRLLVYEFMGNGTLANLLFAI--PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQ 556 (714)
Q Consensus 490 -----------~~~~~lv~E~~~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~ 556 (714)
....++||||+++++|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+||++++
T Consensus 81 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~ 157 (284)
T 2a19_B 81 ETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVD 157 (284)
T ss_dssp --------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEE
T ss_pred ccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcC
Confidence 44578999999999999999754 57899999999999999999999998 999999999999999
Q ss_pred CCceEEecCCCccccccCcccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhH
Q 041576 557 DFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTD 636 (714)
Q Consensus 557 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~ 636 (714)
++.+||+|||++........ .....+++.|+|||.+.+..++.++||||||+++|||++|..|+..... .
T Consensus 158 ~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~-----~--- 227 (284)
T 2a19_B 158 TKQVKIGDFGLVTSLKNDGK--RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSK-----F--- 227 (284)
T ss_dssp TTEEEECCCTTCEESSCCSC--CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHH-----H---
T ss_pred CCCEEECcchhheecccccc--ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHH-----H---
Confidence 99999999999987644322 2334589999999999999999999999999999999999988753211 0
Q ss_pred HHhhhhhcCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCCCC
Q 041576 637 WAYDCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLEVPS 700 (714)
Q Consensus 637 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 700 (714)
......+.. +...+..+.+++.+||+.||++|||+.|+++.|+.+...+.
T Consensus 228 --~~~~~~~~~------------~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~ 277 (284)
T 2a19_B 228 --FTDLRDGII------------SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE 277 (284)
T ss_dssp --HHHHHTTCC------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC---
T ss_pred --HHHhhcccc------------cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCC
Confidence 011111111 11123457789999999999999999999999988765543
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=344.89 Aligned_cols=263 Identities=17% Similarity=0.168 Sum_probs=205.1
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCC-------CCcEEEEEEecccchhhHHHHHHHHHHHhccCcccccc----------
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSA-------SGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQ---------- 482 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~---------- 482 (714)
..|.+.+.||+|+||.||+|..... .++.||||.+... +.+.+|++++++++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 116 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL 116 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence 4677889999999999999998642 4789999998653 36789999999999999998
Q ss_pred -----eeceEec-CCeeeEEEeecCCCchhhhhhcC--CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEE
Q 041576 483 -----LLGFCDE-GLNRLLVYEFMGNGTLANLLFAI--PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILL 554 (714)
Q Consensus 483 -----l~~~~~~-~~~~~lv~E~~~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll 554 (714)
+++++.. +...++||||+ +++|.+++... ..+++..++.++.||++||+|||+++ |+||||||+||++
T Consensus 117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIl~ 192 (352)
T 2jii_A 117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENIFV 192 (352)
T ss_dssp CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGEEE
T ss_pred cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEE
Confidence 5666655 77889999999 99999999876 67999999999999999999999998 9999999999999
Q ss_pred CCCC--ceEEecCCCccccccCccc------ceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccc
Q 041576 555 DQDF--TAKISDFGLSKLLLSDQSR------TRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMEL 626 (714)
Q Consensus 555 ~~~~--~~kl~Dfg~~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~ 626 (714)
+.++ .+||+|||+++........ ......|++.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 193 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 272 (352)
T 2jii_A 193 DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCL 272 (352)
T ss_dssp ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence 9998 9999999999876543221 1233468999999999999999999999999999999999999998654
Q ss_pred cchhhhhhhHHHhhhhhcCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCC
Q 041576 627 GEERSAILTDWAYDCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLEV 698 (714)
Q Consensus 627 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 698 (714)
.... .+.... ..+.. ....+..... .....+..+.+++.+||+.||++|||++||++.|+++++.
T Consensus 273 ~~~~--~~~~~~-~~~~~-~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~ 337 (352)
T 2jii_A 273 PNTE--DIMKQK-QKFVD-KPGPFVGPCG---HWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQD 337 (352)
T ss_dssp TCHH--HHHHHH-HHHHH-SCCCEECTTS---CEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred cCHH--HHHHHH-HhccC-Chhhhhhhcc---ccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHh
Confidence 2211 111111 11111 1111111100 0112235788899999999999999999999999997644
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=340.17 Aligned_cols=248 Identities=23% Similarity=0.297 Sum_probs=206.8
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEeccc---chhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEE
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKL---AQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLV 496 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 496 (714)
.+|.+.+.||+|+||.||++... .+++.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 41 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 41 RRYVRGRFLGKGGFAKCFEISDA-DTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp EEEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEEC-CCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 35667889999999999999876 56889999998653 234566889999999999999999999999999999999
Q ss_pred EeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcc
Q 041576 497 YEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQS 576 (714)
Q Consensus 497 ~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 576 (714)
|||+++++|.+++.....+++.+++.++.||++||+|||+++ |+||||||+||+++.++.+||+|||++........
T Consensus 120 ~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 196 (335)
T 2owb_A 120 LELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE 196 (335)
T ss_dssp ECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred EecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceecccCcc
Confidence 999999999999988788999999999999999999999998 99999999999999999999999999987643322
Q ss_pred cceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhh
Q 041576 577 RTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKA 656 (714)
Q Consensus 577 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 656 (714)
......|+..|+|||.+.+..++.++||||||+++|||++|+.||......+.... .......
T Consensus 197 -~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~--------~~~~~~~-------- 259 (335)
T 2owb_A 197 -RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLR--------IKKNEYS-------- 259 (335)
T ss_dssp -CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH--------HHHTCCC--------
T ss_pred -cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHH--------HhcCCCC--------
Confidence 22345689999999999998999999999999999999999999975433221111 1111100
Q ss_pred hccchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 657 AMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 657 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
.+......+.+++.+||+.||++|||++|+++
T Consensus 260 --~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 260 --IPKHINPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp --CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred --CCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11122346778999999999999999999987
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=342.24 Aligned_cols=268 Identities=25% Similarity=0.328 Sum_probs=195.5
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCcccccceeceEe-----cCCeee
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCD-----EGLNRL 494 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~-----~~~~~~ 494 (714)
..|.+.+.||+|+||.||+|.. +++.||||++...... ....+.|+..+..++||||+++++.+. .....+
T Consensus 13 ~~y~~~~~lg~G~~g~Vy~~~~---~~~~vavK~~~~~~~~-~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 88 (336)
T 3g2f_A 13 DNLKLLELIGRGRYGAVYKGSL---DERPVAVKVFSFANRQ-NFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYL 88 (336)
T ss_dssp TSEEEEEEEEECSSEEEEEEEE---TTEEEEEEEEEGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEE
T ss_pred HHhheeeecccCCCeEEEEEEE---CCeEEEEEEeeccchh-hHHHHHHHHHHHhccCcchhhheecccccccCCCceEE
Confidence 4567789999999999999976 5789999999653322 122234444455689999999998552 233568
Q ss_pred EEEeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhc---------CCCCeEecCCCcCeEEECCCCceEEecC
Q 041576 495 LVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEE---------CNVPIIHCDIKPQNILLDQDFTAKISDF 565 (714)
Q Consensus 495 lv~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~---------~~~~ivH~Dlk~~NIll~~~~~~kl~Df 565 (714)
+||||+++|+|.+++... ..++..+..++.||++||+|||+. + |+||||||+|||++.++.+||+||
T Consensus 89 lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~kL~DF 164 (336)
T 3g2f_A 89 LVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTCVISDF 164 (336)
T ss_dssp EEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCEEECCC
T ss_pred EEEecCCCCcHHHHHhhc-ccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcEEEeec
Confidence 999999999999999764 448889999999999999999998 7 999999999999999999999999
Q ss_pred CCccccccCcc-------cceeeecCCCCccCcccccC-------CCCCchhhhHHHHHHHHHHHhcCCCCcccccchhh
Q 041576 566 GLSKLLLSDQS-------RTRTVIRGTRGYVAPEWFKN-------VPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERS 631 (714)
Q Consensus 566 g~~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~-------~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~ 631 (714)
|++..+..... .......||..|+|||.+.+ ..++.++|||||||++|||++|..|+.........
T Consensus 165 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~ 244 (336)
T 3g2f_A 165 GLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEY 244 (336)
T ss_dssp TTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCC
T ss_pred cceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHH
Confidence 99987643321 12223468999999999987 35677999999999999999998776543221110
Q ss_pred -hhhh----------HHHhhhhhcCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCC
Q 041576 632 -AILT----------DWAYDCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLEV 698 (714)
Q Consensus 632 -~~l~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 698 (714)
..+. ..............+ .. ........+..+.+++.+||+.||++|||++|+++.|++++..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~--~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~ 319 (336)
T 3g2f_A 245 QMAFQTEVGNHPTFEDMQVLVSREKQRPKF-PE--AWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMI 319 (336)
T ss_dssp CCTTHHHHCSSCCHHHHHHHHTTSCCCCCC-CT--TCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHhhhcccCCCchHHHHHhhhcccccCCCC-Cc--ccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHH
Confidence 0000 000000000000000 00 0111234566799999999999999999999999999987744
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=329.25 Aligned_cols=248 Identities=28% Similarity=0.401 Sum_probs=199.7
Q ss_pred hhhhhhhCcccceeEEEeEeeCCCCcEEEEEEeccc--chhhHHHHHHHHHHHhccCcccccceeceEec----CCeeeE
Q 041576 422 NGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKL--AQEREREFKTEVSAIGRTHHKNLVQLLGFCDE----GLNRLL 495 (714)
Q Consensus 422 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~----~~~~~l 495 (714)
+.+.+.||+|+||.||+|... .++..||+|.+... .....+.+.+|+.++++++||||+++++++.. ....++
T Consensus 28 ~~~~~~lg~G~~g~Vy~~~~~-~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 106 (290)
T 1t4h_A 28 LKFDIEIGRGSFKTVYKGLDT-ETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred EEeeeeccCCCCeEEEEeEec-CCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence 556778999999999999876 57889999998653 34456789999999999999999999998865 456799
Q ss_pred EEeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEEC-CCCceEEecCCCccccccC
Q 041576 496 VYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLD-QDFTAKISDFGLSKLLLSD 574 (714)
Q Consensus 496 v~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~-~~~~~kl~Dfg~~~~~~~~ 574 (714)
||||+++++|.+++.....+++..++.++.||+.||+|||+.+ .+|+||||||+||+++ +++.+||+|||++......
T Consensus 107 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~ 185 (290)
T 1t4h_A 107 VTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS 185 (290)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT
T ss_pred EEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCccccccc
Confidence 9999999999999988788999999999999999999999985 4599999999999998 7899999999999754332
Q ss_pred cccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecch
Q 041576 575 QSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDND 654 (714)
Q Consensus 575 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 654 (714)
......|++.|+|||.+.+ .++.++||||||+++|+|++|+.||........ . ......+...
T Consensus 186 ---~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~---~----~~~~~~~~~~------ 248 (290)
T 1t4h_A 186 ---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ---I----YRRVTSGVKP------ 248 (290)
T ss_dssp ---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH---H----HHHHTTTCCC------
T ss_pred ---ccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHH---H----HHHHhccCCc------
Confidence 2234568999999998875 589999999999999999999999975332211 0 0111111110
Q ss_pred hhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 655 KAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 655 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
...+......+.+++.+||+.||++|||++|+++
T Consensus 249 --~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 249 --ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp --GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred --cccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 0111122346788999999999999999999986
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=358.66 Aligned_cols=251 Identities=25% Similarity=0.276 Sum_probs=205.6
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEE
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA---QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLV 496 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 496 (714)
..+.+.+.||+|+||.||+|..+ .+++.||||++.... ......+.+|++++++++||||+++++++.+.+..++|
T Consensus 184 ~~f~~~~~LG~G~fG~Vy~a~~~-~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 184 NTFRQYRVLGKGGFGEVCACQVR-ATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cceEEEEEEeeCCCEEEEEEEEC-CCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 34666789999999999999976 578999999996532 23456789999999999999999999999999999999
Q ss_pred EeecCCCchhhhhhcCC--CCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccC
Q 041576 497 YEFMGNGTLANLLFAIP--RPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSD 574 (714)
Q Consensus 497 ~E~~~~gsL~~~l~~~~--~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 574 (714)
|||+++|+|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.....
T Consensus 263 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~~~ 339 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 339 (576)
T ss_dssp ECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceecccC
Confidence 99999999999998654 4899999999999999999999998 999999999999999999999999999876433
Q ss_pred cccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecch
Q 041576 575 QSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDND 654 (714)
Q Consensus 575 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 654 (714)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+... ......
T Consensus 340 ~--~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~----i~~~~~------- 406 (576)
T 2acx_A 340 Q--TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERL----VKEVPE------- 406 (576)
T ss_dssp C--CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHH----HHHCCC-------
T ss_pred c--cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHH----hhcccc-------
Confidence 2 233457999999999999989999999999999999999999999865332211111111 111100
Q ss_pred hhhccchHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 041576 655 KAAMADKSRACKWLMIALWCIQEDPLKRP-----AMKMIVQ 690 (714)
Q Consensus 655 ~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 690 (714)
..+...+..+.+++.+||+.||++|| +++||++
T Consensus 407 ---~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 407 ---EYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp ---CCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred ---cCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 01122345778899999999999999 7899975
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=342.13 Aligned_cols=251 Identities=18% Similarity=0.199 Sum_probs=202.3
Q ss_pred HhhhhhhhhCcccceeEEEeEe----eCCCCcEEEEEEecccchhhHHHHHHHHHHHhccC---cccccceeceEecCCe
Q 041576 420 ATNGFEEELGRGSFGIVYKGVL----KSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTH---HKNLVQLLGFCDEGLN 492 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~nIv~l~~~~~~~~~ 492 (714)
..|.+.+.||+|+||+||+|++ ...+++.||||+++... ..++..|++++.+++ |+||+++++++...+.
T Consensus 65 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~ 141 (365)
T 3e7e_A 65 KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNG 141 (365)
T ss_dssp SEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSC
T ss_pred EEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCC
Confidence 4567788999999999999952 23468899999997643 345667777777765 9999999999999999
Q ss_pred eeEEEeecCCCchhhhhhc-----CCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECC-----------
Q 041576 493 RLLVYEFMGNGTLANLLFA-----IPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQ----------- 556 (714)
Q Consensus 493 ~~lv~E~~~~gsL~~~l~~-----~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~----------- 556 (714)
.++||||+++|+|.+++.. ...+++..++.|+.||++||+|||+++ |+||||||+|||++.
T Consensus 142 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~~~~ 218 (365)
T 3e7e_A 142 SVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDEDDL 218 (365)
T ss_dssp EEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC------
T ss_pred cEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCccccccc
Confidence 9999999999999999973 456899999999999999999999998 999999999999998
Q ss_pred CCceEEecCCCccccccC-cccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhh
Q 041576 557 DFTAKISDFGLSKLLLSD-QSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILT 635 (714)
Q Consensus 557 ~~~~kl~Dfg~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~ 635 (714)
++.+||+|||+++.+... .........||..|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus 219 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~----- 293 (365)
T 3e7e_A 219 SAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC----- 293 (365)
T ss_dssp CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE-----
T ss_pred cCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce-----
Confidence 899999999999765422 22333446799999999999999999999999999999999999999964432210
Q ss_pred HHHhhhhhcCccceeecchhhhccchHHHHHHHHHHHHccccCCCCC-CCHHHHHHHHhcccCC
Q 041576 636 DWAYDCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKR-PAMKMIVQMLEGYLEV 698 (714)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R-Ps~~evl~~L~~~~~~ 698 (714)
.+...+ ... .....+.+++..||+.+|.+| |+++++.+.|++.++.
T Consensus 294 ----------~~~~~~----~~~---~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~ 340 (365)
T 3e7e_A 294 ----------KPEGLF----RRL---PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ 340 (365)
T ss_dssp ----------EECSCC----TTC---SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHH
T ss_pred ----------eechhc----ccc---CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHH
Confidence 000000 000 123456678999999999999 6899999999887654
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=345.73 Aligned_cols=256 Identities=23% Similarity=0.258 Sum_probs=205.6
Q ss_pred HhhhhhhhhCcccceeEEEeEeeC--CCCcEEEEEEecccc----hhhHHHHHHHHHHHhcc-CcccccceeceEecCCe
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKS--ASGNAVAVKKLDKLA----QEREREFKTEVSAIGRT-HHKNLVQLLGFCDEGLN 492 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~--~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~ 492 (714)
..|.+.+.||+|+||.||+|.... .+++.||||+++... ......+.+|+++++++ +||||+++++++..+..
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 357778999999999999998742 468899999997532 23345677899999999 69999999999999999
Q ss_pred eeEEEeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccc
Q 041576 493 RLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLL 572 (714)
Q Consensus 493 ~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~ 572 (714)
.++||||+++++|.+++.....+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 134 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 210 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFV 210 (355)
T ss_dssp EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred EEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCCeecc
Confidence 9999999999999999988788999999999999999999999998 9999999999999999999999999998765
Q ss_pred cCcccceeeecCCCCccCcccccC--CCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCcccee
Q 041576 573 SDQSRTRTVIRGTRGYVAPEWFKN--VPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVL 650 (714)
Q Consensus 573 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 650 (714)
...........||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+... .....
T Consensus 211 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~----~~~~~---- 282 (355)
T 1vzo_A 211 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRR----ILKSE---- 282 (355)
T ss_dssp GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHH----HHHCC----
T ss_pred cCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHH----HhccC----
Confidence 444444445679999999999985 34789999999999999999999999754332221111111 00000
Q ss_pred ecchhhhccchHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHH
Q 041576 651 VDNDKAAMADKSRACKWLMIALWCIQEDPLKRP-----AMKMIVQML 692 (714)
Q Consensus 651 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~L 692 (714)
...+......+.+++.+||+.||++|| +++|+++..
T Consensus 283 ------~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 283 ------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp ------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred ------CCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 001222345677899999999999999 999998753
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-39 Score=347.52 Aligned_cols=249 Identities=19% Similarity=0.300 Sum_probs=196.3
Q ss_pred hhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEeccc--chhhHHHHHHHHHHHhccC--cccccceeceEecCCeeeEE
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKL--AQEREREFKTEVSAIGRTH--HKNLVQLLGFCDEGLNRLLV 496 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~--h~nIv~l~~~~~~~~~~~lv 496 (714)
.|.+.+.||+|+||.||+|... .++.||||++... .....+.+.+|++++++++ ||||+++++++..++..++|
T Consensus 57 ~y~~~~~LG~G~fg~Vy~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 134 (390)
T 2zmd_A 57 IYSILKQIGSGGSSKVFQVLNE--KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 134 (390)
T ss_dssp EEEEEEEEECCSSEEEEEEECT--TCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred ceEEEEEEccCCCeEEEEEEcC--CCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence 4777899999999999999875 4889999998642 3445678999999999996 59999999999999999999
Q ss_pred EeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcc
Q 041576 497 YEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQS 576 (714)
Q Consensus 497 ~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 576 (714)
|| +.+++|.+++.....+++.++..++.||+.||+|||+++ |+||||||+|||++ ++.+||+|||+++.......
T Consensus 135 ~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~ 209 (390)
T 2zmd_A 135 ME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT 209 (390)
T ss_dssp EE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC-----
T ss_pred Ee-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccCCCc
Confidence 99 678899999998888999999999999999999999998 99999999999995 57999999999987654332
Q ss_pred c-ceeeecCCCCccCcccccC-----------CCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhc
Q 041576 577 R-TRTVIRGTRGYVAPEWFKN-----------VPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVE 644 (714)
Q Consensus 577 ~-~~~~~~gt~~y~aPE~~~~-----------~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~ 644 (714)
. ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... ..+.. ...
T Consensus 210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~--~~~~~-----~~~ 282 (390)
T 2zmd_A 210 SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI--SKLHA-----IID 282 (390)
T ss_dssp ----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH--HHHHH-----HHC
T ss_pred cccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHH--HHHHH-----HhC
Confidence 2 2334569999999999865 468999999999999999999999997432211 01110 111
Q ss_pred CccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 645 GKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 645 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
..... ..+......+.+++.+||+.||++|||+.|+++.
T Consensus 283 ~~~~~--------~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 283 PNHEI--------EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp TTSCC--------CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccC--------CCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 11100 0111113467789999999999999999999864
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=352.32 Aligned_cols=238 Identities=16% Similarity=0.156 Sum_probs=186.7
Q ss_pred hhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecc---cchhhHHHHHHHH---HHHhccCccccccee-------ceE
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDK---LAQEREREFKTEV---SAIGRTHHKNLVQLL-------GFC 487 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~---~~~~~~~~~~~E~---~~l~~l~h~nIv~l~-------~~~ 487 (714)
.|.+.+.||+|+||.||+|.+. .+++.||||++.. ......+.+.+|+ +.+++++||||++++ +++
T Consensus 74 ~y~~~~~lG~G~~g~V~~a~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~ 152 (377)
T 3byv_A 74 TLVRGTVLGQEDPYAYLEATDQ-ETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 152 (377)
T ss_dssp EEEEEEEEEEETTEEEEEEEC--CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEE
T ss_pred eEEEcceeecCCCEEEEEEEEC-CCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhh
Confidence 4566789999999999999975 4689999999963 3344567899999 555666899999998 555
Q ss_pred ecCC-----------------eeeEEEeecCCCchhhhhhcCCCCCh-------hhHHHHHHHHHHHHHHHHhcCCCCeE
Q 041576 488 DEGL-----------------NRLLVYEFMGNGTLANLLFAIPRPDW-------SLRVRISLEIARGLLYLHEECNVPII 543 (714)
Q Consensus 488 ~~~~-----------------~~~lv~E~~~~gsL~~~l~~~~~~~~-------~~~~~i~~qi~~~L~yLH~~~~~~iv 543 (714)
.+.+ ..++||||+ +|+|.+++.....+++ ..++.|+.||++||+|||+++ |+
T Consensus 153 ~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---iv 228 (377)
T 3byv_A 153 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LV 228 (377)
T ss_dssp ECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred hccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence 5443 278999999 5799999986544444 788889999999999999998 99
Q ss_pred ecCCCcCeEEECCCCceEEecCCCccccccCcccceeeecCCCCccCcccccCC-----------CCCchhhhHHHHHHH
Q 041576 544 HCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNV-----------PVSAKVDVYSFGVVL 612 (714)
Q Consensus 544 H~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~s~ksDVwSlGvil 612 (714)
||||||+|||++.++.+||+|||+++.... ......| ..|+|||.+.+. .++.++|||||||++
T Consensus 229 HrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il 303 (377)
T 3byv_A 229 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVI 303 (377)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHH
T ss_pred cCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHH
Confidence 999999999999999999999999985322 2334457 999999999877 899999999999999
Q ss_pred HHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 613 LKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 613 ~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
|||++|+.||...........+ ... ....+..+.+++.+||+.||++|||+.|+++
T Consensus 304 ~elltg~~Pf~~~~~~~~~~~~----------------~~~------~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 304 YWIWCADLPITKDAALGGSEWI----------------FRS------CKNIPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHSSCCC------CCSGGG----------------GSS------CCCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHCCCCCcccccccchhhh----------------hhh------ccCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 9999999999754322211100 000 0112346788999999999999999999986
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=333.53 Aligned_cols=249 Identities=29% Similarity=0.370 Sum_probs=197.2
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCcccccceeceEecC-CeeeEEEe
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEG-LNRLLVYE 498 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-~~~~lv~E 498 (714)
..|.+.+.||+|+||.||+|... ++.||||.++... ..+.+.+|++++++++||||+++++++.+. +..++|||
T Consensus 21 ~~y~~~~~lg~G~~g~V~~~~~~---~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e 95 (278)
T 1byg_A 21 KELKLLQTIGKGEFGDVMLGDYR---GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 95 (278)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET---TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred hhceEEeEEecCCCceEEEEEEc---CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEe
Confidence 45777899999999999999863 7899999997543 456789999999999999999999997554 47899999
Q ss_pred ecCCCchhhhhhcCCC--CChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcc
Q 041576 499 FMGNGTLANLLFAIPR--PDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQS 576 (714)
Q Consensus 499 ~~~~gsL~~~l~~~~~--~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 576 (714)
|+++++|.+++..... +++..++.++.|+++||+|||+++ ++||||||+||+++.++.+||+|||++.......
T Consensus 96 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 171 (278)
T 1byg_A 96 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ- 171 (278)
T ss_dssp CCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred cCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeeccccccccccc-
Confidence 9999999999976533 788999999999999999999998 9999999999999999999999999987543321
Q ss_pred cceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccchhhhhhhHHHhhhhhcCccceeecchh
Q 041576 577 RTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDK 655 (714)
Q Consensus 577 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 655 (714)
....++..|+|||.+.+..++.++||||||+++|||++ |+.||.......... ....+..
T Consensus 172 ---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~--------~~~~~~~-------- 232 (278)
T 1byg_A 172 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP--------RVEKGYK-------- 232 (278)
T ss_dssp -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHH--------HHTTTCC--------
T ss_pred ---cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHH--------HHhcCCC--------
Confidence 22347889999999998899999999999999999998 999997543322111 1111100
Q ss_pred hhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccC
Q 041576 656 AAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLE 697 (714)
Q Consensus 656 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 697 (714)
...+...+..+.+++.+||+.||++|||+.|+++.|+.+..
T Consensus 233 -~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~ 273 (278)
T 1byg_A 233 -MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 273 (278)
T ss_dssp -CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -CCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHh
Confidence 01122234578889999999999999999999999988653
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=336.11 Aligned_cols=259 Identities=24% Similarity=0.336 Sum_probs=205.2
Q ss_pred CHHHHHHHhhhhh-hhhCcccceeEEEeEeeCCCCcEEEEEEecccc--hhhHHHHHHHHHHHhcc-CcccccceeceEe
Q 041576 413 SLVELNEATNGFE-EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA--QEREREFKTEVSAIGRT-HHKNLVQLLGFCD 488 (714)
Q Consensus 413 ~~~el~~at~~~~-~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~ 488 (714)
...+.....|.+. +.||+|+||.||+|... .+++.||+|++.... ......+.+|+.++.++ +||||+++++++.
T Consensus 21 ~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~ 99 (327)
T 3lm5_A 21 QSMENFNNFYILTSKELGRGKFAVVRQCISK-STGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYE 99 (327)
T ss_dssp BCHHHHHHHEEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred HHHHhhhhEEeeccceeCCCCCeEEEEEEEC-CCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEE
Confidence 3344455566665 88999999999999876 578999999987533 23467889999999999 5699999999999
Q ss_pred cCCeeeEEEeecCCCchhhhhhcC--CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECC---CCceEEe
Q 041576 489 EGLNRLLVYEFMGNGTLANLLFAI--PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQ---DFTAKIS 563 (714)
Q Consensus 489 ~~~~~~lv~E~~~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~---~~~~kl~ 563 (714)
+....++||||+++++|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+||+++. ++.+||+
T Consensus 100 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~kL~ 176 (327)
T 3lm5_A 100 NTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIV 176 (327)
T ss_dssp CSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEEEC
T ss_pred eCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEEEe
Confidence 999999999999999999999654 67899999999999999999999998 999999999999998 7899999
Q ss_pred cCCCccccccCcccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhh
Q 041576 564 DFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYV 643 (714)
Q Consensus 564 Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~ 643 (714)
|||++....... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||...........+.
T Consensus 177 Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~-------- 246 (327)
T 3lm5_A 177 DFGMSRKIGHAC--ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNIS-------- 246 (327)
T ss_dssp CGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--------
T ss_pred eCccccccCCcc--ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHH--------
Confidence 999998764332 2233568999999999999999999999999999999999999997654332211111
Q ss_pred cCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 644 EGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 644 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
...... ...........+.+++.+||+.||++|||++|+++.
T Consensus 247 ~~~~~~------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 247 QVNVDY------SEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp HTCCCC------CTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred hccccc------CchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 000000 000112234567789999999999999999999874
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=341.36 Aligned_cols=264 Identities=22% Similarity=0.239 Sum_probs=202.5
Q ss_pred HHHHhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccC-----cccccceeceEecCC
Q 041576 417 LNEATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTH-----HKNLVQLLGFCDEGL 491 (714)
Q Consensus 417 l~~at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h~nIv~l~~~~~~~~ 491 (714)
+....|.+.++||+|+||.||+|... .+++.||||+++.. ......+..|++++++++ ||||+++++++...+
T Consensus 32 ~~~~~y~~~~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~ 109 (360)
T 3llt_A 32 LLNNAFLVIRKMGDGTFGRVLLCQHI-DNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYD 109 (360)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETT
T ss_pred EecCEEEEEEEEcccCCeEEEEEEEC-CCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECC
Confidence 34456778899999999999999976 46889999999753 334556788999999886 999999999999999
Q ss_pred eeeEEEeecCCCchhhhhhcCC--CCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECC-------------
Q 041576 492 NRLLVYEFMGNGTLANLLFAIP--RPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQ------------- 556 (714)
Q Consensus 492 ~~~lv~E~~~~gsL~~~l~~~~--~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~------------- 556 (714)
..++||||+ +++|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+|||++.
T Consensus 110 ~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~~~~~~~ 185 (360)
T 3llt_A 110 HMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEKSLITVRRV 185 (360)
T ss_dssp EEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTCCEEEEEEECT
T ss_pred eeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEccccccccccchhcc
Confidence 999999999 889999998654 5889999999999999999999998 999999999999976
Q ss_pred ------------CCceEEecCCCccccccCcccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcc
Q 041576 557 ------------DFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEM 624 (714)
Q Consensus 557 ------------~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~ 624 (714)
++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 186 ~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 261 (360)
T 3llt_A 186 TDGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRT 261 (360)
T ss_dssp TTCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCC
Confidence 789999999999864332 2345689999999999999999999999999999999999999976
Q ss_pred cccchhhhhhhHHHh-------hhhhcCccceeecc-hh-----hh---------------ccchHHHHHHHHHHHHccc
Q 041576 625 ELGEERSAILTDWAY-------DCYVEGKLDVLVDN-DK-----AA---------------MADKSRACKWLMIALWCIQ 676 (714)
Q Consensus 625 ~~~~~~~~~l~~~~~-------~~~~~~~~~~~~~~-~~-----~~---------------~~~~~~~~~l~~li~~cl~ 676 (714)
....+....+..... .............. .. .. .........+.+++.+||+
T Consensus 262 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 341 (360)
T 3llt_A 262 HEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQ 341 (360)
T ss_dssp SSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCC
T ss_pred CcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhc
Confidence 543322111111000 00000000000000 00 00 0000112567789999999
Q ss_pred cCCCCCCCHHHHHH
Q 041576 677 EDPLKRPAMKMIVQ 690 (714)
Q Consensus 677 ~dP~~RPs~~evl~ 690 (714)
.||++|||++|+++
T Consensus 342 ~dP~~Rpta~elL~ 355 (360)
T 3llt_A 342 IDPTLRPSPAELLK 355 (360)
T ss_dssp SSGGGSCCHHHHTT
T ss_pred CChhhCCCHHHHhc
Confidence 99999999999975
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=350.60 Aligned_cols=262 Identities=25% Similarity=0.282 Sum_probs=195.7
Q ss_pred hhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEeccc--chhhHHHHHHHHHHHhccCcccccceeceEecC------Ce
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKL--AQEREREFKTEVSAIGRTHHKNLVQLLGFCDEG------LN 492 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~------~~ 492 (714)
+|.+.+.||+|+||+||+|... .+++.||||++... .....+.+.+|+.++++++||||+++++++... ..
T Consensus 63 ~y~~~~~lG~G~~g~V~~a~~~-~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~ 141 (464)
T 3ttj_A 63 RYQNLKPIGSGAQGIVCAAYDA-VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 141 (464)
T ss_dssp TEEEEEEEEECSSCEEEEEEET-TTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CeEEEEEeecCCCeEEEEEEEC-CCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCe
Confidence 5677889999999999999876 57899999999753 344567889999999999999999999999654 45
Q ss_pred eeEEEeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccc
Q 041576 493 RLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLL 572 (714)
Q Consensus 493 ~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~ 572 (714)
.++||||++++ |.+.+.. .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 142 ~~lv~E~~~~~-l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 215 (464)
T 3ttj_A 142 VYLVMELMDAN-LCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG 215 (464)
T ss_dssp EEEEEECCSEE-HHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC----
T ss_pred EEEEEeCCCCC-HHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEeeeecC
Confidence 69999999874 6666543 4889999999999999999999998 9999999999999999999999999998654
Q ss_pred cCcccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHH--------------
Q 041576 573 SDQSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWA-------------- 638 (714)
Q Consensus 573 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~-------------- 638 (714)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+....
T Consensus 216 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~ 293 (464)
T 3ttj_A 216 TS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 293 (464)
T ss_dssp -C--CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHH
T ss_pred CC--cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchh
Confidence 32 22344578999999999999999999999999999999999999997654332211111100
Q ss_pred hhhhhcCc-------cceeecchh---hhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 639 YDCYVEGK-------LDVLVDNDK---AAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 639 ~~~~~~~~-------~~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
...+.+.. ....+.... ...........+.+|+.+||+.||++|||++|+++.
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 294 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp HHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000000 000000000 000112235678899999999999999999999874
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=344.63 Aligned_cols=263 Identities=27% Similarity=0.377 Sum_probs=206.0
Q ss_pred HHHHHhhhhhhhhCcccceeEEEeEee----CCCCcEEEEEEeccc-chhhHHHHHHHHHHHhccCcccccceeceEecC
Q 041576 416 ELNEATNGFEEELGRGSFGIVYKGVLK----SASGNAVAVKKLDKL-AQEREREFKTEVSAIGRTHHKNLVQLLGFCDEG 490 (714)
Q Consensus 416 el~~at~~~~~~ig~G~~g~Vy~~~~~----~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 490 (714)
++....|.+.+.||+|+||.||+|.+. ..+++.||||.+... .......+.+|+.++++++||||+++++++.+.
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 105 (327)
T 2yfx_A 26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS 105 (327)
T ss_dssp BCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCC
Confidence 345567888899999999999999853 246779999999653 344566899999999999999999999999999
Q ss_pred CeeeEEEeecCCCchhhhhhcCC-------CCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECC---CCce
Q 041576 491 LNRLLVYEFMGNGTLANLLFAIP-------RPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQ---DFTA 560 (714)
Q Consensus 491 ~~~~lv~E~~~~gsL~~~l~~~~-------~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~---~~~~ 560 (714)
...++||||+++++|.+++.... .+++..++.++.||++||+|||+++ |+||||||+||+++. +..+
T Consensus 106 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~ 182 (327)
T 2yfx_A 106 LPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVA 182 (327)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCE
T ss_pred CCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceE
Confidence 99999999999999999998653 4788899999999999999999998 999999999999984 4569
Q ss_pred EEecCCCccccccCcc-cceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccchhhhhhhHHH
Q 041576 561 KISDFGLSKLLLSDQS-RTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEERSAILTDWA 638 (714)
Q Consensus 561 kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~l~~~~ 638 (714)
||+|||++........ .......++..|+|||.+.+..++.++||||||+++|||++ |+.||..........
T Consensus 183 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~------ 256 (327)
T 2yfx_A 183 KIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLE------ 256 (327)
T ss_dssp EECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH------
T ss_pred EECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHH------
Confidence 9999999976543322 22233457889999999998899999999999999999998 999987543322111
Q ss_pred hhhhhcCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCC
Q 041576 639 YDCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLEV 698 (714)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 698 (714)
....+.... .+...+..+.+++.+||+.||.+||++.||++.|+.+...
T Consensus 257 --~~~~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 305 (327)
T 2yfx_A 257 --FVTSGGRMD---------PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 305 (327)
T ss_dssp --HHHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred --HHhcCCCCC---------CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence 111111100 1122345678899999999999999999999999876543
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=366.26 Aligned_cols=249 Identities=27% Similarity=0.366 Sum_probs=200.3
Q ss_pred hhCcccceeEEEeEeeC-CCCcEEEEEEecccc-hhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEeecCCCc
Q 041576 427 ELGRGSFGIVYKGVLKS-ASGNAVAVKKLDKLA-QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEFMGNGT 504 (714)
Q Consensus 427 ~ig~G~~g~Vy~~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~gs 504 (714)
.||+|+||.||+|.++. .++..||||+++... ....+.+.+|++++++++||||+++++++.. +..++||||+++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 79999999999998763 245689999997643 3456789999999999999999999999976 56899999999999
Q ss_pred hhhhhhcC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcccc--eee
Q 041576 505 LANLLFAI-PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRT--RTV 581 (714)
Q Consensus 505 L~~~l~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~--~~~ 581 (714)
|.+++... ..+++..++.++.||++||+|||+++ |+||||||+||||+.++.+||+|||+++......... ...
T Consensus 422 L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~ 498 (613)
T 2ozo_A 422 LHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSA 498 (613)
T ss_dssp HHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC-----------
T ss_pred HHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccC
Confidence 99999754 45899999999999999999999998 9999999999999999999999999998764433221 122
Q ss_pred ecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhhccc
Q 041576 582 IRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMAD 660 (714)
Q Consensus 582 ~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 660 (714)
..++..|+|||++.+..++.++|||||||++|||++ |+.||......+... .+..+... ..+
T Consensus 499 ~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~--------~i~~~~~~---------~~p 561 (613)
T 2ozo_A 499 GKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMA--------FIEQGKRM---------ECP 561 (613)
T ss_dssp ---CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHH--------HHHTTCCC---------CCC
T ss_pred CCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH--------HHHcCCCC---------CCC
Confidence 345689999999998999999999999999999998 999997654332111 11111111 112
Q ss_pred hHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 041576 661 KSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYL 696 (714)
Q Consensus 661 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 696 (714)
...+..+.+++.+||+.||++||++.+|++.|+.+.
T Consensus 562 ~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~ 597 (613)
T 2ozo_A 562 PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 597 (613)
T ss_dssp TTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHH
T ss_pred CcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 234467888999999999999999999999998864
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=353.40 Aligned_cols=253 Identities=25% Similarity=0.305 Sum_probs=205.9
Q ss_pred HHHhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc--hhhHHHHHHHHHHHhccCcccccceeceEecCCeeeE
Q 041576 418 NEATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA--QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLL 495 (714)
Q Consensus 418 ~~at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 495 (714)
....|.+.+.||+|+||+||+|..+ .+++.||||++.... ......+.+|++++++++||||+++++++.+....++
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 98 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDR-ITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEET-TTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEEC-CCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEE
Confidence 3467888999999999999999876 578999999996432 3346788999999999999999999999999999999
Q ss_pred EEeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEEC---CCCceEEecCCCccccc
Q 041576 496 VYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLD---QDFTAKISDFGLSKLLL 572 (714)
Q Consensus 496 v~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~---~~~~~kl~Dfg~~~~~~ 572 (714)
||||+++++|.+.+.....+++..+..++.||+.||+|||+++ |+||||||+||+++ .++.+||+|||++....
T Consensus 99 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 175 (486)
T 3mwu_A 99 VGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (486)
T ss_dssp EECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBC
T ss_pred EEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeECC
Confidence 9999999999999988788999999999999999999999998 99999999999995 45679999999998664
Q ss_pred cCcccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeec
Q 041576 573 SDQSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVD 652 (714)
Q Consensus 573 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 652 (714)
... ......||+.|+|||++.+ .++.++||||+||++|+|++|+.||......+. +.. ...+......
T Consensus 176 ~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---~~~-----i~~~~~~~~~- 243 (486)
T 3mwu_A 176 QNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDI---LKR-----VETGKYAFDL- 243 (486)
T ss_dssp CC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHH-----HHHTCCCSCS-
T ss_pred CCC--ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHH-----HHhCCCCCCC-
Confidence 332 2234568999999999976 599999999999999999999999976543321 111 1111111000
Q ss_pred chhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 653 NDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 653 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
......+..+.+++.+||+.||++|||+.|+++.
T Consensus 244 -----~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 244 -----PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp -----GGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred -----cccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0112234567889999999999999999999984
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-38 Score=349.34 Aligned_cols=194 Identities=24% Similarity=0.340 Sum_probs=156.3
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEeccc--chhhHHHHHHHHHHHhccCcccccceeceEec-----CCe
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKL--AQEREREFKTEVSAIGRTHHKNLVQLLGFCDE-----GLN 492 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-----~~~ 492 (714)
..|.+.+.||+|+||.||+|++. .+++.||||++... .....+.+.+|++++++++||||+++++++.. ...
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDK-LEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp TTEEECCC-------CEEEEEEC-C--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCeEEeeEeeecCCeEEEEEEEC-CCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 35778899999999999999876 57899999999652 33455789999999999999999999999943 356
Q ss_pred eeEEEeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccc
Q 041576 493 RLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLL 572 (714)
Q Consensus 493 ~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~ 572 (714)
.|+||||+. ++|.+++.....+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++...
T Consensus 132 ~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~~~~ 207 (458)
T 3rp9_A 132 LYVVLEIAD-SDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVD 207 (458)
T ss_dssp EEEEECCCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBCTT
T ss_pred EEEEEeccc-cchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccchhcc
Confidence 899999985 699999998888999999999999999999999998 9999999999999999999999999998764
Q ss_pred cCcc--------------------------cceeeecCCCCccCcccc-cCCCCCchhhhHHHHHHHHHHHhc
Q 041576 573 SDQS--------------------------RTRTVIRGTRGYVAPEWF-KNVPVSAKVDVYSFGVVLLKIICC 618 (714)
Q Consensus 573 ~~~~--------------------------~~~~~~~gt~~y~aPE~~-~~~~~s~ksDVwSlGvil~elltG 618 (714)
.... .......||+.|+|||++ ....++.++|||||||+||||++|
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 208 YPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp SCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred CccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 3221 122345689999999976 566799999999999999999993
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=327.24 Aligned_cols=248 Identities=26% Similarity=0.385 Sum_probs=197.4
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEE
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA---QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLV 496 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 496 (714)
..|.+.+.||+|+||.||+|.+. .+++.||||.+.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 11 GHYVLGDTLGVGTFGKVKIGEHQ-LTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp TTEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccEEEEeeecCCCCeEEEEEEEC-CCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 35677889999999999999876 468899999996532 23356889999999999999999999999999999999
Q ss_pred EeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcc
Q 041576 497 YEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQS 576 (714)
Q Consensus 497 ~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 576 (714)
|||+++++|.+++.....+++..+..++.||++||+|||+++ ++|+||||+||+++.++.+||+|||++.......
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~- 165 (276)
T 2h6d_A 90 MEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE- 165 (276)
T ss_dssp EECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC---
T ss_pred EeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCCCc-
Confidence 999999999999988788999999999999999999999998 9999999999999999999999999998664332
Q ss_pred cceeeecCCCCccCcccccCCCC-CchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchh
Q 041576 577 RTRTVIRGTRGYVAPEWFKNVPV-SAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDK 655 (714)
Q Consensus 577 ~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 655 (714)
......+++.|+|||.+.+..+ +.++||||||+++|||++|+.||.......... ....+...
T Consensus 166 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~--------~~~~~~~~------- 229 (276)
T 2h6d_A 166 -FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFK--------KIRGGVFY------- 229 (276)
T ss_dssp ------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH--------HHHHCCCC-------
T ss_pred -ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHH--------HhhcCccc-------
Confidence 1223458899999999988765 689999999999999999999997543222111 11111100
Q ss_pred hhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 656 AAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 656 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
.+......+.+++.+||+.||++|||++|+++.
T Consensus 230 ---~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 230 ---IPEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp ---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred ---CchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 111223467789999999999999999999984
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=348.17 Aligned_cols=254 Identities=24% Similarity=0.316 Sum_probs=194.7
Q ss_pred HHHHhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc--------hhhHHHHHHHHHHHhccCcccccceeceEe
Q 041576 417 LNEATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA--------QEREREFKTEVSAIGRTHHKNLVQLLGFCD 488 (714)
Q Consensus 417 l~~at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~ 488 (714)
.....|.+.+.||+|+||.||+|... .+++.||||++.... ......+.+|++++++++||||+++++++.
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~ 210 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFER-KTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD 210 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEET-TTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEEC-CCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 34567888899999999999999876 578999999986532 112235889999999999999999999986
Q ss_pred cCCeeeEEEeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCC---CceEEecC
Q 041576 489 EGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQD---FTAKISDF 565 (714)
Q Consensus 489 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~---~~~kl~Df 565 (714)
. +..++||||+++++|.+++.....+++.++..++.||++||+|||+++ |+||||||+|||++.+ +.+||+||
T Consensus 211 ~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~DF 286 (419)
T 3i6u_A 211 A-EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDF 286 (419)
T ss_dssp S-SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEECCS
T ss_pred c-CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEeec
Confidence 5 457999999999999999998888999999999999999999999998 9999999999999754 45999999
Q ss_pred CCccccccCcccceeeecCCCCccCcccccC---CCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhh
Q 041576 566 GLSKLLLSDQSRTRTVIRGTRGYVAPEWFKN---VPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCY 642 (714)
Q Consensus 566 g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~ 642 (714)
|+++..... .......||+.|+|||++.+ ..++.++||||||+++|||++|+.||........ +.. ..
T Consensus 287 G~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~---~~~----~i 357 (419)
T 3i6u_A 287 GHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS---LKD----QI 357 (419)
T ss_dssp STTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC---HHH----HH
T ss_pred ccceecCCC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH---HHH----HH
Confidence 999876432 22234568999999999853 5688999999999999999999999975432211 100 11
Q ss_pred hcCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 643 VEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 643 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
..+..... + ......+..+.+++.+||+.||++|||++|+++
T Consensus 358 ~~~~~~~~--~----~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 358 TSGKYNFI--P----EVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp HTTCCCCC--H----HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hcCCCCCC--c----hhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 11111100 0 001123456788999999999999999999987
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=339.77 Aligned_cols=268 Identities=24% Similarity=0.263 Sum_probs=198.6
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEeccc--chhhHHHHHHHHHHHhccCcccccceeceEecCC------
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKL--AQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGL------ 491 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~------ 491 (714)
..|.+.+.||+|+||.||+|... .+|+.||||++... .....+.+.+|++++++++||||+++++++....
T Consensus 25 ~~y~~~~~lG~G~~g~V~~a~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 25 AVYRDLQPVGSGAYGAVCSAVDG-RTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp SSEEEEEEC------CEEEEEET-TTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred ceEEEeEEeeecCCeEEEEEEEC-CCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 35677889999999999999875 57899999999542 3344567899999999999999999999997663
Q ss_pred eeeEEEeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCcccc
Q 041576 492 NRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLL 571 (714)
Q Consensus 492 ~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~ 571 (714)
..++||||+ +++|.+++.. ..+++..+..++.||++||+|||+++ |+||||||+||+++.++.+||+|||+++..
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 178 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQA 178 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred eEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeeccccc
Confidence 459999999 7899999976 56899999999999999999999998 999999999999999999999999999865
Q ss_pred ccCcccceeeecCCCCccCcccccC-CCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHh-------hhhh
Q 041576 572 LSDQSRTRTVIRGTRGYVAPEWFKN-VPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAY-------DCYV 643 (714)
Q Consensus 572 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~-------~~~~ 643 (714)
... .....+|..|+|||.+.+ ..++.++||||+||++|||++|+.||...........+..... ....
T Consensus 179 ~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~ 254 (367)
T 1cm8_A 179 DSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQ 254 (367)
T ss_dssp CSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCS
T ss_pred ccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhh
Confidence 432 234568999999999877 6799999999999999999999999976543322111111000 0000
Q ss_pred cC-------ccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HhcccCC
Q 041576 644 EG-------KLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM--LEGYLEV 698 (714)
Q Consensus 644 ~~-------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~~~~ 698 (714)
.. .+......... .........+.+++.+||+.||++|||++|+++. ++.+.+.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~~ 317 (367)
T 1cm8_A 255 SDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDT 317 (367)
T ss_dssp CHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC--
T ss_pred hHHHHHHHHhCCCCCCCCHH-HHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcCC
Confidence 00 00000000000 1112234578889999999999999999999983 5554443
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=334.77 Aligned_cols=259 Identities=26% Similarity=0.332 Sum_probs=198.9
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCc--EEEEEEeccc---chhhHHHHHHHHHHHhccCcccccceeceEecCCeee
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGN--AVAVKKLDKL---AQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRL 494 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~--~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 494 (714)
..|.+.+.||+|+||+||+|.+...+++ .||||.++.. .....+.+.+|++++++++||||+++++++..+. .+
T Consensus 18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~ 96 (291)
T 1u46_A 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MK 96 (291)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CE
T ss_pred hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ce
Confidence 4677889999999999999987644444 6899998653 2345678999999999999999999999998765 88
Q ss_pred EEEeecCCCchhhhhhcC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCcccccc
Q 041576 495 LVYEFMGNGTLANLLFAI-PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLS 573 (714)
Q Consensus 495 lv~E~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~ 573 (714)
+|+||+++++|.+++... ..+++..+..++.||++||+|||+++ ++|+||||+||+++.++.+||+|||++.....
T Consensus 97 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 173 (291)
T 1u46_A 97 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 173 (291)
T ss_dssp EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred eeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEccccccccccc
Confidence 999999999999999764 56889999999999999999999998 99999999999999999999999999987654
Q ss_pred Cccc--ceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccchhhhhhhHHHhhhhhcCcccee
Q 041576 574 DQSR--TRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEERSAILTDWAYDCYVEGKLDVL 650 (714)
Q Consensus 574 ~~~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 650 (714)
.... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||........ +... ......
T Consensus 174 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~---~~~~----~~~~~~--- 243 (291)
T 1u46_A 174 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI---LHKI----DKEGER--- 243 (291)
T ss_dssp -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH---HHHH----HTSCCC---
T ss_pred cccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHH---HHHH----HccCCC---
Confidence 3321 2223457788999999998889999999999999999999 9999975533221 1110 001000
Q ss_pred ecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCC
Q 041576 651 VDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLEV 698 (714)
Q Consensus 651 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 698 (714)
...+...+..+.+++.+||+.||++|||+.++++.|+++...
T Consensus 244 ------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 285 (291)
T 1u46_A 244 ------LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT 285 (291)
T ss_dssp ------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred ------CCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence 001122345788899999999999999999999999887543
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-38 Score=335.30 Aligned_cols=271 Identities=23% Similarity=0.283 Sum_probs=210.5
Q ss_pred cCHHHHHHHhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhc--cCcccccceeceEec
Q 041576 412 FSLVELNEATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGR--THHKNLVQLLGFCDE 489 (714)
Q Consensus 412 ~~~~el~~at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~nIv~l~~~~~~ 489 (714)
+...+.....|.+.+.||+|+||.||+|.. +++.||||.+... ....+.+|++++.. ++||||+++++++..
T Consensus 34 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~---~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~ 107 (342)
T 1b6c_B 34 LLVQRTIARTIVLQESIGKGRFGEVWRGKW---RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNK 107 (342)
T ss_dssp HHHHHHHHHHCEEEEEEEEETTEEEEEEEE---TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEEC
T ss_pred eeecccccccEEEEeeecCCCCcEEEEEEE---cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecc
Confidence 345566778899999999999999999986 4889999999643 34567788888877 799999999999988
Q ss_pred CC----eeeEEEeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHH--------hcCCCCeEecCCCcCeEEECCC
Q 041576 490 GL----NRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLH--------EECNVPIIHCDIKPQNILLDQD 557 (714)
Q Consensus 490 ~~----~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH--------~~~~~~ivH~Dlk~~NIll~~~ 557 (714)
.. ..++||||+++|+|.+++.. ..+++..++.++.||+.||+||| +.+ |+||||||+||+++.+
T Consensus 108 ~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~~ 183 (342)
T 1b6c_B 108 DNGTWTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKN 183 (342)
T ss_dssp CCSSCCCEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECTT
T ss_pred cCCccceeEEEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECCC
Confidence 76 78999999999999999976 46899999999999999999999 666 9999999999999999
Q ss_pred CceEEecCCCccccccCccc---ceeeecCCCCccCcccccCCC------CCchhhhHHHHHHHHHHHhc----------
Q 041576 558 FTAKISDFGLSKLLLSDQSR---TRTVIRGTRGYVAPEWFKNVP------VSAKVDVYSFGVVLLKIICC---------- 618 (714)
Q Consensus 558 ~~~kl~Dfg~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~s~ksDVwSlGvil~elltG---------- 618 (714)
+.+||+|||++......... ......|+..|+|||.+.+.. ++.++||||||+++|||++|
T Consensus 184 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~ 263 (342)
T 1b6c_B 184 GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDY 263 (342)
T ss_dssp SCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCC
T ss_pred CCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccccc
Confidence 99999999999876543322 223446899999999997652 34789999999999999999
Q ss_pred CCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCC
Q 041576 619 KRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLEV 698 (714)
Q Consensus 619 ~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 698 (714)
+.||......... ...+ ............+. ...........+.+++.+||+.||++|||+.||++.|+++.+.
T Consensus 264 ~~p~~~~~~~~~~--~~~~-~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~ 337 (342)
T 1b6c_B 264 QLPYYDLVPSDPS--VEEM-RKVVCEQKLRPNIP---NRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 337 (342)
T ss_dssp CCTTTTTSCSSCC--HHHH-HHHHTTSCCCCCCC---GGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ccCccccCcCccc--HHHH-HHHHHHHHhCCCCc---ccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHH
Confidence 6677543221110 0011 11111111111111 1112345667889999999999999999999999999987654
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=339.59 Aligned_cols=252 Identities=24% Similarity=0.348 Sum_probs=203.5
Q ss_pred HHhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc--------hhhHHHHHHHHHHHhcc-CcccccceeceEec
Q 041576 419 EATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA--------QEREREFKTEVSAIGRT-HHKNLVQLLGFCDE 489 (714)
Q Consensus 419 ~at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~ 489 (714)
...|.+.+.||+|+||.||+|.+. .+|+.||||+++... ....+.+.+|+.+++++ +||||+++++++..
T Consensus 93 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 171 (365)
T 2y7j_A 93 YQKYDPKDVIGRGVSSVVRRCVHR-ATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYES 171 (365)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEB
T ss_pred hhhcccceEEecCCCEEEEEEEEC-CCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEee
Confidence 345677789999999999999875 468999999986432 12245788999999999 89999999999999
Q ss_pred CCeeeEEEeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCcc
Q 041576 490 GLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSK 569 (714)
Q Consensus 490 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~ 569 (714)
....++||||+++++|.+++.....+++..+..++.||+.||+|||+.+ |+|+||||+||+++.++.+||+|||++.
T Consensus 172 ~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ikl~DfG~~~ 248 (365)
T 2y7j_A 172 SSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSC 248 (365)
T ss_dssp SSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred CCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEEecCccc
Confidence 9999999999999999999988788999999999999999999999998 9999999999999999999999999998
Q ss_pred ccccCcccceeeecCCCCccCcccccC------CCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhh
Q 041576 570 LLLSDQSRTRTVIRGTRGYVAPEWFKN------VPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYV 643 (714)
Q Consensus 570 ~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~ 643 (714)
.+.... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||........... ..
T Consensus 249 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~--------i~ 318 (365)
T 2y7j_A 249 HLEPGE--KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRM--------IM 318 (365)
T ss_dssp ECCTTC--CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH--------HH
T ss_pred ccCCCc--ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHH--------HH
Confidence 764432 2234568999999999863 3588999999999999999999999975432221111 11
Q ss_pred cCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 644 EGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 644 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
.+..... .+ .....+..+.+++.+||+.||++|||+.|+++
T Consensus 319 ~~~~~~~-~~-----~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 319 EGQYQFS-SP-----EWDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp HTCCCCC-HH-----HHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hCCCCCC-Cc-----ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1111000 00 00112346788999999999999999999987
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=337.80 Aligned_cols=269 Identities=21% Similarity=0.237 Sum_probs=197.9
Q ss_pred hhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhh-HHHHHHHHHHHhccCcccccceeceEecCCeeeEEEee
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQER-EREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEF 499 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~ 499 (714)
+|.+.+.||+|+||+||+|... .+++.||||+++...... ...+.+|++++++++||||+++++++.+++..++||||
T Consensus 3 ~y~~~~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 3 TYIKLDKLGEGTYATVYKGKSK-LTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp SEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ceEEEEEEcCCCCEEEEEEEEC-CCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 4667789999999999999876 578899999996533222 22456799999999999999999999999999999999
Q ss_pred cCCCchhhhhhcC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcccc
Q 041576 500 MGNGTLANLLFAI-PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRT 578 (714)
Q Consensus 500 ~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 578 (714)
+++ +|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++....... ..
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~-~~ 156 (324)
T 3mtl_A 82 LDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT-KT 156 (324)
T ss_dssp CSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred ccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCCc-cc
Confidence 985 888888765 45899999999999999999999998 9999999999999999999999999997653322 22
Q ss_pred eeeecCCCCccCcccccC-CCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecc----
Q 041576 579 RTVIRGTRGYVAPEWFKN-VPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDN---- 653 (714)
Q Consensus 579 ~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~---- 653 (714)
.....+|..|+|||.+.+ ..++.++||||||+++|||++|+.||......+....+....... ...........
T Consensus 157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~-~~~~~~~~~~~~~~~ 235 (324)
T 3mtl_A 157 YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTP-TEETWPGILSNEEFK 235 (324)
T ss_dssp ------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC-CTTTSTTGGGCHHHH
T ss_pred cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC-ChHhchhhhcchhhc
Confidence 233457999999999876 568999999999999999999999998654433222221110000 00000000000
Q ss_pred ---------hhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHH--HHhccc
Q 041576 654 ---------DKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ--MLEGYL 696 (714)
Q Consensus 654 ---------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~~ 696 (714)
.............+.+++.+||+.||++|||++|+++ .+.++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 289 (324)
T 3mtl_A 236 TYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLG 289 (324)
T ss_dssp HTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred ccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcc
Confidence 0000111223456788999999999999999999987 344443
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=329.24 Aligned_cols=244 Identities=23% Similarity=0.317 Sum_probs=198.5
Q ss_pred HHhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEeccc--chhhHHHHHHHHHHHhcc-CcccccceeceEecCCeeeE
Q 041576 419 EATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKL--AQEREREFKTEVSAIGRT-HHKNLVQLLGFCDEGLNRLL 495 (714)
Q Consensus 419 ~at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~l 495 (714)
...|.+.+.||+|+||.||+|... .+++.||+|.++.. .......+.+|+..+.++ +||||+++++++.+++..++
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKR-LDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEc-CCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 356778899999999999999876 47899999998753 334566788999999999 99999999999999999999
Q ss_pred EEeecCCCchhhhhhcC----CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCC--------------
Q 041576 496 VYEFMGNGTLANLLFAI----PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQD-------------- 557 (714)
Q Consensus 496 v~E~~~~gsL~~~l~~~----~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~-------------- 557 (714)
||||+++++|.+++... ..+++..++.++.||++||+|||+++ |+||||||+||+++.+
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC----------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCccccccccccc
Confidence 99999999999999764 56899999999999999999999998 9999999999999844
Q ss_pred -----CceEEecCCCccccccCcccceeeecCCCCccCcccccCC-CCCchhhhHHHHHHHHHHHhcCCCCcccccchhh
Q 041576 558 -----FTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNV-PVSAKVDVYSFGVVLLKIICCKRSVEMELGEERS 631 (714)
Q Consensus 558 -----~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~ 631 (714)
..+||+|||.+....... ...|+..|+|||.+.+. .++.++||||||+++|||++|..++......
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~--- 237 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQW--- 237 (289)
T ss_dssp ----CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHH---
T ss_pred ccCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHH---
Confidence 479999999998764432 23489999999999866 5678999999999999999999876432111
Q ss_pred hhhhHHHhhhhhcCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 632 AILTDWAYDCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 632 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
.....+....+ +...+..+.+++.+||+.||++|||+.|+++.
T Consensus 238 --------~~~~~~~~~~~---------~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 238 --------HEIRQGRLPRI---------PQVLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp --------HHHHTTCCCCC---------SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred --------HHHHcCCCCCC---------CcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 11111111111 11233567889999999999999999999863
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=344.33 Aligned_cols=245 Identities=22% Similarity=0.261 Sum_probs=189.1
Q ss_pred hhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhc-cCcccccceeceEec----CCeeeEEEeec
Q 041576 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGR-THHKNLVQLLGFCDE----GLNRLLVYEFM 500 (714)
Q Consensus 426 ~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~h~nIv~l~~~~~~----~~~~~lv~E~~ 500 (714)
+.||+|+||+||+|.+. .+++.||||+++.. ..+.+|++++.+ .+||||+++++++.. ....++||||+
T Consensus 68 ~~LG~G~~g~V~~~~~~-~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~ 141 (400)
T 1nxk_A 68 QVLGLGINGKVLQIFNK-RTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECL 141 (400)
T ss_dssp EEEEEETTEEEEEEEET-TTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECC
T ss_pred ceeeeccCeEEEEEEEC-CCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeC
Confidence 68999999999999876 57899999999642 356778888755 489999999999865 66789999999
Q ss_pred CCCchhhhhhcCC--CCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECC---CCceEEecCCCccccccCc
Q 041576 501 GNGTLANLLFAIP--RPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQ---DFTAKISDFGLSKLLLSDQ 575 (714)
Q Consensus 501 ~~gsL~~~l~~~~--~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~---~~~~kl~Dfg~~~~~~~~~ 575 (714)
++|+|.+++.... .+++.++..|+.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||+++......
T Consensus 142 ~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~ 218 (400)
T 1nxk_A 142 DGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN 218 (400)
T ss_dssp CSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTTCEECC---
T ss_pred CCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEecccccccCCCC
Confidence 9999999998753 5899999999999999999999998 999999999999998 7899999999998654322
Q ss_pred ccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchh
Q 041576 576 SRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDK 655 (714)
Q Consensus 576 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 655 (714)
......||+.|+|||++.+..++.++|||||||++|||++|+.||.............. ....+.... ..
T Consensus 219 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~----~i~~~~~~~-~~--- 288 (400)
T 1nxk_A 219 --SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT----RIRMGQYEF-PN--- 288 (400)
T ss_dssp ----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHH----HHHHTCCCC-CT---
T ss_pred --ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHH----HHHcCcccC-CC---
Confidence 22345689999999999999999999999999999999999999975543221110100 111111100 00
Q ss_pred hhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 656 AAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 656 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
......+..+.+++.+||+.||++|||+.|+++.
T Consensus 289 --~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 289 --PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp --TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred --cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0011234567889999999999999999999974
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=352.92 Aligned_cols=251 Identities=24% Similarity=0.303 Sum_probs=201.0
Q ss_pred HHhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc--hhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEE
Q 041576 419 EATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA--QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLV 496 (714)
Q Consensus 419 ~at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 496 (714)
...|.+.+.||+|+||+||+|+.+ .+++.||+|++.... ......+.+|+.++++++||||+++++++.+....++|
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 114 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDK-VTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV 114 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEET-TTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEEC-CCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 456888899999999999999976 578899999997532 33456789999999999999999999999999999999
Q ss_pred EeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCC---CceEEecCCCcccccc
Q 041576 497 YEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQD---FTAKISDFGLSKLLLS 573 (714)
Q Consensus 497 ~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~---~~~kl~Dfg~~~~~~~ 573 (714)
|||+++|+|.+.+.....+++..+..++.||+.||+|||+++ |+||||||+|||++.. +.+||+|||++.....
T Consensus 115 ~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~ 191 (494)
T 3lij_A 115 MECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN 191 (494)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEECBT
T ss_pred EecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeECCC
Confidence 999999999999988788999999999999999999999998 9999999999999764 5599999999987644
Q ss_pred CcccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecc
Q 041576 574 DQSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDN 653 (714)
Q Consensus 574 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 653 (714)
.. ......||+.|+|||++. ..++.++||||+||++|+|++|+.||......+.... ...+.... ..+
T Consensus 192 ~~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~--------i~~~~~~~-~~~ 259 (494)
T 3lij_A 192 QK--KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRK--------VEKGKYTF-DSP 259 (494)
T ss_dssp TB--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH--------HHHTCCCC-CSG
T ss_pred Cc--cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH--------HHhCCCCC-Cch
Confidence 32 223456999999999986 4689999999999999999999999976543321111 11111110 000
Q ss_pred hhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 654 DKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 654 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
.....+..+.+++.+||+.||.+|||+.|+++
T Consensus 260 -----~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 260 -----EWKNVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp -----GGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -----hcccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 01123356788999999999999999999986
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=338.09 Aligned_cols=266 Identities=21% Similarity=0.279 Sum_probs=200.2
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc--hhhHHHHHHHHHHHhccCcccccceeceEec--------
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA--QEREREFKTEVSAIGRTHHKNLVQLLGFCDE-------- 489 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-------- 489 (714)
.+|.+.+.||+|+||.||+|+.. .+++.||||++.... ......+.+|++++++++||||+++++++..
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHR-KTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEET-TTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred cceeEEEEEecCCCcEEEEEEEC-CCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 46778899999999999999976 578999999985432 2234578899999999999999999999976
Q ss_pred CCeeeEEEeecCCCchhhhhhcC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCc
Q 041576 490 GLNRLLVYEFMGNGTLANLLFAI-PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLS 568 (714)
Q Consensus 490 ~~~~~lv~E~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~ 568 (714)
.+..++||||+++ +|.+.+... ..+++.++..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||++
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 171 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLA 171 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred CceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccchhc
Confidence 4468999999986 666666543 67899999999999999999999998 999999999999999999999999999
Q ss_pred cccccCc---ccceeeecCCCCccCcccccC-CCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhc
Q 041576 569 KLLLSDQ---SRTRTVIRGTRGYVAPEWFKN-VPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVE 644 (714)
Q Consensus 569 ~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~ 644 (714)
....... ........||+.|+|||.+.+ ..++.++|||||||++|||++|+.||...........+....... ..
T Consensus 172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~-~~ 250 (351)
T 3mi9_A 172 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI-TP 250 (351)
T ss_dssp EECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC-CT
T ss_pred ccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC-Ch
Confidence 8764322 222234568999999999876 458999999999999999999999998654433222221110000 00
Q ss_pred Cccce-----------eecch---h-hhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 645 GKLDV-----------LVDND---K-AAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 645 ~~~~~-----------~~~~~---~-~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
..... ..... . ...........+.+++.+||+.||++|||++|+++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 251 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp TTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 00000 00000 0 000001113457889999999999999999999874
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-38 Score=330.75 Aligned_cols=253 Identities=23% Similarity=0.330 Sum_probs=200.3
Q ss_pred HHHHHhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCcccccceeceEecCCeeeE
Q 041576 416 ELNEATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLL 495 (714)
Q Consensus 416 el~~at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 495 (714)
+.....|.+.+.||+|+||.||+|... .+++.||||.+... ...+.+.+|+.++++++||||+++++++......++
T Consensus 25 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 101 (314)
T 3com_A 25 KQPEEVFDVLEKLGEGSYGSVYKAIHK-ETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWI 101 (314)
T ss_dssp -----CEEEEEECC----CEEEEEEET-TTCCEEEEEEEETT--SCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred hcchhhhhhheeeccCCCeEEEEEEEC-CCCCEEEEEecCch--HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEE
Confidence 344566778899999999999999876 56899999999653 234678999999999999999999999999999999
Q ss_pred EEeecCCCchhhhhh-cCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccC
Q 041576 496 VYEFMGNGTLANLLF-AIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSD 574 (714)
Q Consensus 496 v~E~~~~gsL~~~l~-~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 574 (714)
||||+++++|.+++. ....+++..+..++.||+.||+|||+.+ ++|+||||+||+++.++.+||+|||++......
T Consensus 102 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (314)
T 3com_A 102 VMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT 178 (314)
T ss_dssp EEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred EeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence 999999999999997 4567899999999999999999999998 999999999999999999999999999866433
Q ss_pred cccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecch
Q 041576 575 QSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDND 654 (714)
Q Consensus 575 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 654 (714)
.. ......++..|+|||.+.+..++.++||||||+++|||++|+.||........... .........
T Consensus 179 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~--------~~~~~~~~~---- 245 (314)
T 3com_A 179 MA-KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFM--------IPTNPPPTF---- 245 (314)
T ss_dssp BS-CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH--------HHHSCCCCC----
T ss_pred cc-ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHH--------HhcCCCccc----
Confidence 22 22334689999999999999999999999999999999999999975432211100 001100000
Q ss_pred hhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 655 KAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 655 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
..+...+..+.+++.+||+.||++|||+.++++
T Consensus 246 ---~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 246 ---RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp ---SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ---CCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 011223456788999999999999999999986
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=354.53 Aligned_cols=252 Identities=25% Similarity=0.295 Sum_probs=207.9
Q ss_pred HHHhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEeccc---chhhHHHHHHHHHHHhccCcccccceeceEecCCeee
Q 041576 418 NEATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKL---AQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRL 494 (714)
Q Consensus 418 ~~at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 494 (714)
....|.+.+.||+|+||.||+|... .+++.||||++... .......+.+|++++++++||||+++++++.+....+
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 102 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDK-ITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFY 102 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEEC-CCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 4467888899999999999999876 57899999998642 2345678999999999999999999999999999999
Q ss_pred EEEeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEE---CCCCceEEecCCCcccc
Q 041576 495 LVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILL---DQDFTAKISDFGLSKLL 571 (714)
Q Consensus 495 lv~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll---~~~~~~kl~Dfg~~~~~ 571 (714)
+||||+.+++|.+++.....+++..+..++.||+.||+|||+++ |+||||||+||++ +.++.+||+|||++...
T Consensus 103 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 179 (484)
T 3nyv_A 103 LVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHF 179 (484)
T ss_dssp EEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHHHB
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEc
Confidence 99999999999999998889999999999999999999999998 9999999999999 56789999999999866
Q ss_pred ccCcccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceee
Q 041576 572 LSDQSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLV 651 (714)
Q Consensus 572 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 651 (714)
.... ......||+.|+|||.+.+ .++.++||||+||++|+|++|+.||........ +. ....+......
T Consensus 180 ~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---~~-----~i~~~~~~~~~ 248 (484)
T 3nyv_A 180 EASK--KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDI---LK-----KVEKGKYTFEL 248 (484)
T ss_dssp CCCC--SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HH-----HHHHCCCCCCS
T ss_pred cccc--ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHH---HH-----HHHcCCCCCCC
Confidence 4332 2233468999999999876 689999999999999999999999976543321 11 11111111000
Q ss_pred cchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 652 DNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 652 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
......+..+.+++.+||+.||++|||+.|+++
T Consensus 249 ------~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 249 ------PQWKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp ------GGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 011223456788999999999999999999986
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=331.89 Aligned_cols=248 Identities=24% Similarity=0.360 Sum_probs=205.0
Q ss_pred hhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc-hhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEee
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA-QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEF 499 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~ 499 (714)
.|.+.+.||+|+||.||+|... .+++.||||.+.... ....+.+.+|+.++++++||||+++++++.+....++||||
T Consensus 23 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 101 (303)
T 3a7i_A 23 LFTKLEKIGKGSFGEVFKGIDN-RTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 101 (303)
T ss_dssp TEEEEEEEEECSSSEEEEEEET-TTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred HHHHhhhhcccCCeEEEEEEEC-CCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence 4667789999999999999865 578899999996532 34567899999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcccce
Q 041576 500 MGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTR 579 (714)
Q Consensus 500 ~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 579 (714)
+++++|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++........ ..
T Consensus 102 ~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~ 176 (303)
T 3a7i_A 102 LGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-KR 176 (303)
T ss_dssp CTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC-CB
T ss_pred CCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCcccc-cc
Confidence 999999999875 56899999999999999999999998 99999999999999999999999999987644322 22
Q ss_pred eeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhhcc
Q 041576 580 TVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMA 659 (714)
Q Consensus 580 ~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 659 (714)
....|+..|+|||.+.+..++.++||||||+++|||++|+.||........... ........ .
T Consensus 177 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~--------~~~~~~~~---------~ 239 (303)
T 3a7i_A 177 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFL--------IPKNNPPT---------L 239 (303)
T ss_dssp CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH--------HHHSCCCC---------C
T ss_pred CccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHH--------hhcCCCCC---------C
Confidence 345689999999999999999999999999999999999999975432221110 01111110 1
Q ss_pred chHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 660 DKSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 660 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
....+..+.+++.+||+.||++|||+.|+++.
T Consensus 240 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 240 EGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp CSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred ccccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 11223467889999999999999999999874
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=326.18 Aligned_cols=253 Identities=26% Similarity=0.277 Sum_probs=199.5
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc----hhhHHHHHHHHHHHhccCcccccceeceE--ecCCee
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA----QEREREFKTEVSAIGRTHHKNLVQLLGFC--DEGLNR 493 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~nIv~l~~~~--~~~~~~ 493 (714)
..|.+.+.||+|+||.||+|... .+++.||+|+++... ......+.+|++++++++||||+++++++ .+....
T Consensus 5 ~~y~i~~~lg~G~~g~V~~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 5 GKYLMGDLLGEGSYGKVKEVLDS-ETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp CCBCCCCEEEECSSCEEEEEEBT-TTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred cceeEeeEEecCCCeEEEEEEEC-CCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 35778899999999999999875 578899999997532 23457899999999999999999999998 455678
Q ss_pred eEEEeecCCCchhhhhhc--CCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCcccc
Q 041576 494 LLVYEFMGNGTLANLLFA--IPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLL 571 (714)
Q Consensus 494 ~lv~E~~~~gsL~~~l~~--~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~ 571 (714)
++||||++++ |.+++.. ...+++..+..++.||++||+|||+++ |+||||||+||+++.++.+||+|||++...
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~ 159 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEAL 159 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeecccccccc
Confidence 9999999986 7777654 356889999999999999999999998 999999999999999999999999999876
Q ss_pred ccCc-ccceeeecCCCCccCcccccCCC--CCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccc
Q 041576 572 LSDQ-SRTRTVIRGTRGYVAPEWFKNVP--VSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLD 648 (714)
Q Consensus 572 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~--~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 648 (714)
.... ........|+..|+|||.+.+.. .+.++||||||+++|||++|+.||........... ...+...
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~--------i~~~~~~ 231 (305)
T 2wtk_C 160 HPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFEN--------IGKGSYA 231 (305)
T ss_dssp CTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH--------HHHCCCC
T ss_pred CccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHH--------HhcCCCC
Confidence 4322 22233456899999999997654 37899999999999999999999975432221111 1111110
Q ss_pred eeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHH--Hhcc
Q 041576 649 VLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM--LEGY 695 (714)
Q Consensus 649 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~ 695 (714)
.+......+.+++.+||+.||++|||++|+++. +.+.
T Consensus 232 ----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 270 (305)
T 2wtk_C 232 ----------IPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKK 270 (305)
T ss_dssp ----------CCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSC
T ss_pred ----------CCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccC
Confidence 111234567789999999999999999999974 5543
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=333.10 Aligned_cols=256 Identities=22% Similarity=0.297 Sum_probs=202.5
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEeccc--chhhHHHHHHHHHHHhccCcccccceeceEe--cCCeeeE
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKL--AQEREREFKTEVSAIGRTHHKNLVQLLGFCD--EGLNRLL 495 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~--~~~~~~l 495 (714)
..|.+.+.||+|+||.||+|... .+++.||+|.+... .....+.+.+|++++++++||||+++++++. .....++
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 6 EDYEVLYTIGTGSYGRCQKIRRK-SDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGEEEEEEEEECSSSEEEEEEET-TTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hheeeehhccCCCCcEEEEEEEC-CCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 35677889999999999999876 57899999999643 3445678999999999999999999999874 4678899
Q ss_pred EEeecCCCchhhhhhcC----CCCChhhHHHHHHHHHHHHHHHHhcC--CCCeEecCCCcCeEEECCCCceEEecCCCcc
Q 041576 496 VYEFMGNGTLANLLFAI----PRPDWSLRVRISLEIARGLLYLHEEC--NVPIIHCDIKPQNILLDQDFTAKISDFGLSK 569 (714)
Q Consensus 496 v~E~~~~gsL~~~l~~~----~~~~~~~~~~i~~qi~~~L~yLH~~~--~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~ 569 (714)
||||+++++|.+++... ..+++..++.++.||+.||+|||+.+ ..+|+||||||+||+++.++.+||+|||++.
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 99999999999999753 34899999999999999999999986 2349999999999999999999999999998
Q ss_pred ccccCcccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccce
Q 041576 570 LLLSDQSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDV 649 (714)
Q Consensus 570 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 649 (714)
....... ......++..|+|||.+.+..++.++||||||+++|||++|+.||.......... ....+....
T Consensus 165 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~--------~i~~~~~~~ 235 (279)
T 2w5a_A 165 ILNHDTS-FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAG--------KIREGKFRR 235 (279)
T ss_dssp HC---CH-HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH--------HHHHTCCCC
T ss_pred eeccccc-cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHH--------HHhhccccc
Confidence 6543321 1223458999999999999899999999999999999999999997553322111 111111111
Q ss_pred eecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 041576 650 LVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEG 694 (714)
Q Consensus 650 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 694 (714)
.+...+..+.+++.+||+.||++|||+.||++.+..
T Consensus 236 ---------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 236 ---------IPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp ---------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred ---------CCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 112234578889999999999999999999987643
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=332.39 Aligned_cols=251 Identities=22% Similarity=0.351 Sum_probs=199.2
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEee
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEF 499 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~ 499 (714)
..|.+.+.||+|+||.||+|... .+++.||+|.+........+.+.+|++++++++||||+++++++..++..++||||
T Consensus 19 ~~y~i~~~lg~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 97 (302)
T 2j7t_A 19 EVWEIVGELGDGAFGKVYKAKNK-ETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF 97 (302)
T ss_dssp GTEEEEEEEECSTTCCEEEEEET-TTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred cceeecceeccCCCeEEEEEEEc-CCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence 45777889999999999999976 46889999999876666678899999999999999999999999999999999999
Q ss_pred cCCCchhhhhhc-CCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcccc
Q 041576 500 MGNGTLANLLFA-IPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRT 578 (714)
Q Consensus 500 ~~~gsL~~~l~~-~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 578 (714)
+++++|.+++.. ...+++..+..++.||+.||+|||+.+ ++||||||+||+++.++.+||+|||++....... ..
T Consensus 98 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~ 173 (302)
T 2j7t_A 98 CPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL-QK 173 (302)
T ss_dssp CTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH-HC
T ss_pred CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCccccccc-cc
Confidence 999999999875 466899999999999999999999998 9999999999999999999999999876432211 11
Q ss_pred eeeecCCCCccCcccc-----cCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecc
Q 041576 579 RTVIRGTRGYVAPEWF-----KNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDN 653 (714)
Q Consensus 579 ~~~~~gt~~y~aPE~~-----~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 653 (714)
.....|+..|+|||.+ .+..++.++||||||+++|||++|+.||........ +... ........
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~~~-----~~~~~~~~--- 242 (302)
T 2j7t_A 174 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV---LLKI-----AKSDPPTL--- 242 (302)
T ss_dssp -----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH---HHHH-----HHSCCCCC---
T ss_pred cccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHH---HHHH-----hccCCccc---
Confidence 2234589999999998 467789999999999999999999999975433221 1110 11111100
Q ss_pred hhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 654 DKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 654 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
..+...+..+.+++.+||+.||++|||+.|+++
T Consensus 243 ----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 243 ----LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp ----SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred ----CCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 112223456788999999999999999999976
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=346.99 Aligned_cols=199 Identities=26% Similarity=0.364 Sum_probs=169.2
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEeccc--chhhHHHHHHHHHHHhccCcccccceeceEecC-----Ce
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKL--AQEREREFKTEVSAIGRTHHKNLVQLLGFCDEG-----LN 492 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-----~~ 492 (714)
..|.+.+.||+|+||.||+|... .+++.||||++... .....+.+.+|++++++++||||+++++++... ..
T Consensus 26 ~~y~~~~~lG~G~~g~V~~a~~~-~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 26 DNYIIKHLIGRGSYGYVYLAYDK-NTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp TTEEEEEEEEEETTEEEEEEEET-TTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCEEEEEEEeecCCEEEEEEEEC-CCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 36778899999999999999876 57889999999753 334557889999999999999999999999766 57
Q ss_pred eeEEEeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccc
Q 041576 493 RLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLL 572 (714)
Q Consensus 493 ~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~ 572 (714)
.++||||++ ++|.+++.....+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~~~~ 180 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTIN 180 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC-
T ss_pred EEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCccccc
Confidence 899999987 599999998888999999999999999999999998 9999999999999999999999999998764
Q ss_pred cCcc---------------------cceeeecCCCCccCcccc-cCCCCCchhhhHHHHHHHHHHHhcCCCCc
Q 041576 573 SDQS---------------------RTRTVIRGTRGYVAPEWF-KNVPVSAKVDVYSFGVVLLKIICCKRSVE 623 (714)
Q Consensus 573 ~~~~---------------------~~~~~~~gt~~y~aPE~~-~~~~~s~ksDVwSlGvil~elltG~~p~~ 623 (714)
.... .......||+.|+|||++ ....++.++|||||||++|||++|..|+.
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 181 SEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp ------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred ccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 3321 122456789999999986 56679999999999999999998655543
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-38 Score=327.77 Aligned_cols=251 Identities=24% Similarity=0.289 Sum_probs=204.1
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc---------hhhHHHHHHHHHHHhccC-cccccceeceEec
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA---------QEREREFKTEVSAIGRTH-HKNLVQLLGFCDE 489 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~ 489 (714)
..|.+.+.||+|+||.||+|..+ .+++.||||.++... ....+.+.+|+++++++. ||||+++++++..
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 17 ENYEPKEILGRGVSSVVRRCIHK-PTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hccceeeeecCCCceEEEEEEEc-CcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 45677789999999999999876 578899999986432 223457889999999995 9999999999999
Q ss_pred CCeeeEEEeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCcc
Q 041576 490 GLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSK 569 (714)
Q Consensus 490 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~ 569 (714)
+...++||||+++++|.+++.....+++..+..++.||+.||+|||+.+ ++|+||||+||+++.++.+||+|||++.
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 172 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSC 172 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred CCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEecccchh
Confidence 9999999999999999999988788999999999999999999999998 9999999999999999999999999998
Q ss_pred ccccCcccceeeecCCCCccCccccc------CCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhh
Q 041576 570 LLLSDQSRTRTVIRGTRGYVAPEWFK------NVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYV 643 (714)
Q Consensus 570 ~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~ 643 (714)
...... ......++..|+|||.+. ...++.++||||||+++|||++|+.||........... ..
T Consensus 173 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~--------~~ 242 (298)
T 1phk_A 173 QLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRM--------IM 242 (298)
T ss_dssp ECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH--------HH
T ss_pred hcCCCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHH--------Hh
Confidence 764332 223346899999999985 45689999999999999999999999975433221111 11
Q ss_pred cCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 644 EGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 644 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
.+..... . ......+..+.+++.+||+.||++|||+.|+++
T Consensus 243 ~~~~~~~-~-----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 243 SGNYQFG-S-----PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp HTCCCCC-T-----TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred cCCcccC-c-----ccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 1111100 0 011223456888999999999999999999986
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=334.58 Aligned_cols=262 Identities=24% Similarity=0.337 Sum_probs=185.4
Q ss_pred HHHHhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc-hhhHHHHHHHHHHHhccCcccccceeceEecCCeeeE
Q 041576 417 LNEATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA-QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLL 495 (714)
Q Consensus 417 l~~at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 495 (714)
+....|.+.+.||+|+||.||+|... .+++.||||.+.... ....+.+.+|+.++++++||||+++++++...+..++
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 90 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCA-PKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWL 90 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC-----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEE
T ss_pred cchhhhhhhheeccccceEEEEEEEC-CCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEE
Confidence 33456778899999999999999875 468899999986532 3345678899999999999999999999999999999
Q ss_pred EEeecCCCchhhhhhc--------CCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCC
Q 041576 496 VYEFMGNGTLANLLFA--------IPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGL 567 (714)
Q Consensus 496 v~E~~~~gsL~~~l~~--------~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~ 567 (714)
||||+++++|.+++.. ...+++..++.++.||++||+|||+++ ++||||||+||+++.++.+||+|||+
T Consensus 91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~ 167 (303)
T 2vwi_A 91 VMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGV 167 (303)
T ss_dssp EEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred EehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccc
Confidence 9999999999999873 355899999999999999999999998 99999999999999999999999999
Q ss_pred ccccccCcc----cceeeecCCCCccCcccccC-CCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhh
Q 041576 568 SKLLLSDQS----RTRTVIRGTRGYVAPEWFKN-VPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCY 642 (714)
Q Consensus 568 ~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~ 642 (714)
+........ .......|++.|+|||.+.+ ..++.++||||||+++|||++|+.||.......... . .
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~---~----~- 239 (303)
T 2vwi_A 168 SAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLM---L----T- 239 (303)
T ss_dssp HHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHH---H----H-
T ss_pred hheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHH---H----H-
Confidence 876543221 12233568999999999875 568999999999999999999999997543322110 0 0
Q ss_pred hcCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 643 VEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 643 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
........................+.+++.+||+.||.+|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 240 LQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp HTSSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred hccCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 000000000000000111223356788999999999999999999987
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=336.72 Aligned_cols=266 Identities=24% Similarity=0.255 Sum_probs=199.0
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchh-----hHHHHHHHHHHHhccCcccccceeceEecCCeee
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQE-----REREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRL 494 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 494 (714)
..|.+.+.||+|+||.||+|... .+++.||||++...... ..+.+.+|++++++++||||+++++++.+....+
T Consensus 10 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 88 (346)
T 1ua2_A 10 KRYEKLDFLGEGQFATVYKARDK-NTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNIS 88 (346)
T ss_dssp ---CEEEEEEEETTEEEEEEECS-SCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCE
T ss_pred cccEEEeEEeecCCEEEEEEEEC-CCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceE
Confidence 46777899999999999999876 46899999999653221 1246889999999999999999999999999999
Q ss_pred EEEeecCCCchhhhhhcC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCcccccc
Q 041576 495 LVYEFMGNGTLANLLFAI-PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLS 573 (714)
Q Consensus 495 lv~E~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~ 573 (714)
+||||+++ +|.+++... ..+++..+..++.||++||+|||+++ |+||||||+||+++.++.+||+|||++.....
T Consensus 89 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 164 (346)
T 1ua2_A 89 LVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGS 164 (346)
T ss_dssp EEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTS
T ss_pred EEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccceeccC
Confidence 99999986 888888765 46899999999999999999999998 99999999999999999999999999987643
Q ss_pred CcccceeeecCCCCccCcccccCC-CCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhh----hhhcC-cc
Q 041576 574 DQSRTRTVIRGTRGYVAPEWFKNV-PVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYD----CYVEG-KL 647 (714)
Q Consensus 574 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~----~~~~~-~~ 647 (714)
.. .......+|+.|+|||.+.+. .++.++|||||||++|||++|..||...........+...... .+... ..
T Consensus 165 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 243 (346)
T 1ua2_A 165 PN-RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSL 243 (346)
T ss_dssp CC-CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSS
T ss_pred Cc-ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccC
Confidence 32 223345689999999999764 5899999999999999999999999765433221111110000 00000 00
Q ss_pred ceeec-----chhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 648 DVLVD-----NDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 648 ~~~~~-----~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
..... ..............+.+++.+||+.||++|||++|+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 244 PDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp TTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred cccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 00000 000000112234678889999999999999999999985
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-38 Score=327.51 Aligned_cols=246 Identities=26% Similarity=0.336 Sum_probs=195.7
Q ss_pred hhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEeecCCCch
Q 041576 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEFMGNGTL 505 (714)
Q Consensus 426 ~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~gsL 505 (714)
..||+|+||.||+|... .+++.||||.+........+.+.+|+.++++++||||+++++++.+.+..++||||+++++|
T Consensus 28 ~~lg~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 106 (295)
T 2clq_A 28 VVLGKGTYGIVYAGRDL-SNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSL 106 (295)
T ss_dssp CEEEECSSSEEEEEEET-TTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEH
T ss_pred EEEeecCcEEEEEEEEC-CCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCH
Confidence 47999999999999875 57889999999776666677899999999999999999999999999999999999999999
Q ss_pred hhhhhcCC---CCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECC-CCceEEecCCCccccccCcccceee
Q 041576 506 ANLLFAIP---RPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQ-DFTAKISDFGLSKLLLSDQSRTRTV 581 (714)
Q Consensus 506 ~~~l~~~~---~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~-~~~~kl~Dfg~~~~~~~~~~~~~~~ 581 (714)
.+++.... .+++..+..++.||++||+|||+++ |+|+||||+||+++. ++.+||+|||++........ ....
T Consensus 107 ~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~-~~~~ 182 (295)
T 2clq_A 107 SALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP-CTET 182 (295)
T ss_dssp HHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC------CC
T ss_pred HHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCCC-cccc
Confidence 99997652 4568888999999999999999998 999999999999987 89999999999986543221 2234
Q ss_pred ecCCCCccCcccccCCC--CCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhhcc
Q 041576 582 IRGTRGYVAPEWFKNVP--VSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMA 659 (714)
Q Consensus 582 ~~gt~~y~aPE~~~~~~--~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 659 (714)
..|+..|+|||.+.+.. ++.++||||||+++|||++|+.||......... .... . . .... ...
T Consensus 183 ~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~~~--~-~-~~~~---------~~~ 247 (295)
T 2clq_A 183 FTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAA--MFKV--G-M-FKVH---------PEI 247 (295)
T ss_dssp CCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHH--HHHH--H-H-HCCC---------CCC
T ss_pred cCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHH--HHhh--c-c-cccc---------ccc
Confidence 46899999999997643 889999999999999999999999743222110 0000 0 0 0000 011
Q ss_pred chHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 660 DKSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 660 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
+...+..+.+++.+||+.||++||++.|+++.
T Consensus 248 ~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 248 PESMSAEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp CTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred cccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 22234567889999999999999999999863
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-38 Score=351.54 Aligned_cols=251 Identities=26% Similarity=0.326 Sum_probs=202.8
Q ss_pred hhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEE
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA---QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVY 497 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 497 (714)
.+.+.+.||+|+||.||+|+.+ .+++.||+|++.+.. ......+.+|++++++++||||+++++++.+....++||
T Consensus 186 ~f~~~~~LG~G~fG~Vy~a~~~-~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 264 (543)
T 3c4z_A 186 WFLDFRVLGRGGFGEVFACQMK-ATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM 264 (543)
T ss_dssp GEEEEEEEEECSSSEEEEEEET-TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred heEEEEEEeeCCCeEEEEEEEC-CCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence 3445578999999999999976 578999999996532 234567899999999999999999999999999999999
Q ss_pred eecCCCchhhhhhcC----CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCcccccc
Q 041576 498 EFMGNGTLANLLFAI----PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLS 573 (714)
Q Consensus 498 E~~~~gsL~~~l~~~----~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~ 573 (714)
||+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~~ 341 (543)
T 3c4z_A 265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341 (543)
T ss_dssp CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence 999999999998753 36889999999999999999999998 99999999999999999999999999987644
Q ss_pred CcccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecc
Q 041576 574 DQSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDN 653 (714)
Q Consensus 574 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 653 (714)
.... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...........+.. .......
T Consensus 342 ~~~~-~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~----~i~~~~~------ 410 (543)
T 3c4z_A 342 GQTK-TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQ----RVLEQAV------ 410 (543)
T ss_dssp TCCC-BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHH----HHHHCCC------
T ss_pred CCcc-cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHH----HHhhccc------
Confidence 3322 2335799999999999999999999999999999999999999976532211111111 1111111
Q ss_pred hhhhccchHHHHHHHHHHHHccccCCCCCCCH-----HHHHH
Q 041576 654 DKAAMADKSRACKWLMIALWCIQEDPLKRPAM-----KMIVQ 690 (714)
Q Consensus 654 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~ 690 (714)
..+...+..+.+++.+||+.||++||++ ++|++
T Consensus 411 ----~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 411 ----TYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp ----CCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred ----CCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 0112234567889999999999999965 66764
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-38 Score=351.84 Aligned_cols=251 Identities=27% Similarity=0.321 Sum_probs=202.5
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccch-------------hhHHHHHHHHHHHhccCcccccceece
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQ-------------EREREFKTEVSAIGRTHHKNLVQLLGF 486 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~h~nIv~l~~~ 486 (714)
..|.+.+.||+|+||+||+|..+ .+++.||||++..... ...+.+.+|+.++++++||||++++++
T Consensus 36 ~~Y~~~~~lG~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 36 ESYFKVRKLGSGAYGEVLLCKEK-NGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GTEEEEEEEEC--CEEEEEEEET-TTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred cceEEEeEecccCCeEEEEEEEC-CCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 45777899999999999999976 5788999999865321 235678999999999999999999999
Q ss_pred EecCCeeeEEEeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCC---ceEEe
Q 041576 487 CDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDF---TAKIS 563 (714)
Q Consensus 487 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~---~~kl~ 563 (714)
+.++...++||||+++|+|.+++.....+++..+..++.||+.||+|||+++ |+||||||+||+++.++ .+||+
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~ 191 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIV 191 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSSEEEC
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCccEEEE
Confidence 9999999999999999999999988888999999999999999999999998 99999999999998776 69999
Q ss_pred cCCCccccccCcccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhh
Q 041576 564 DFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYV 643 (714)
Q Consensus 564 Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~ 643 (714)
|||++....... ......||+.|+|||++.+ .++.++||||+||++|+|++|+.||........... ..
T Consensus 192 Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~--------i~ 260 (504)
T 3q5i_A 192 DFGLSSFFSKDY--KLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKK--------VE 260 (504)
T ss_dssp CCTTCEECCTTS--CBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH--------HH
T ss_pred ECCCCEEcCCCC--ccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH--------HH
Confidence 999998764432 2234569999999999874 689999999999999999999999986543321111 11
Q ss_pred cCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 644 EGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 644 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
.+.... ... .....+..+.+++.+||+.||.+|||++|+++.
T Consensus 261 ~~~~~~--~~~----~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 261 KGKYYF--DFN----DWKNISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp HCCCCC--CHH----HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cCCCCC--Ccc----ccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 111110 000 011223567889999999999999999999863
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=364.53 Aligned_cols=249 Identities=28% Similarity=0.311 Sum_probs=207.3
Q ss_pred HHhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEeccc---chhhHHHHHHHHHHHhcc-CcccccceeceEecCCeee
Q 041576 419 EATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKL---AQEREREFKTEVSAIGRT-HHKNLVQLLGFCDEGLNRL 494 (714)
Q Consensus 419 ~at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~ 494 (714)
...|.+.+.||+|+||.||+|..+ .+++.||||++++. .....+.+..|.+++..+ +||+|+++++++.+.+..+
T Consensus 340 ~~~f~~~~~LG~G~fG~V~~~~~~-~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 340 LTDFNFLMVLGKGSFGKVMLSERK-GTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp CTTEEEEEESSBTTTBCEEEEEES-SSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred ccceEEEEEEccCCCEEEEEEEEC-CCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 345677789999999999999976 57889999999753 233456788999999988 7999999999999999999
Q ss_pred EEEeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccC
Q 041576 495 LVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSD 574 (714)
Q Consensus 495 lv~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 574 (714)
+||||+++|+|.+++.....+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.....
T Consensus 419 lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~ 495 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD 495 (674)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEECCCT
T ss_pred EEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeeccccC
Confidence 99999999999999998888999999999999999999999998 999999999999999999999999999864332
Q ss_pred cccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecch
Q 041576 575 QSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDND 654 (714)
Q Consensus 575 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 654 (714)
. .......||+.|+|||++.+..++.++|||||||+||||++|+.||......+... .+......
T Consensus 496 ~-~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~--------~i~~~~~~------ 560 (674)
T 3pfq_A 496 G-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQ--------SIMEHNVA------ 560 (674)
T ss_dssp T-CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH--------HHHSSCCC------
T ss_pred C-cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHH--------HHHhCCCC------
Confidence 2 22345679999999999999999999999999999999999999998654332211 11111111
Q ss_pred hhhccchHHHHHHHHHHHHccccCCCCCCCH-----HHHHH
Q 041576 655 KAAMADKSRACKWLMIALWCIQEDPLKRPAM-----KMIVQ 690 (714)
Q Consensus 655 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~ 690 (714)
.+.....++.+|+.+||+.||++||++ +||++
T Consensus 561 ----~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 561 ----YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp ----CCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred ----CCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 122334578889999999999999997 77764
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-38 Score=330.66 Aligned_cols=254 Identities=24% Similarity=0.315 Sum_probs=199.5
Q ss_pred HHHHhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc--------hhhHHHHHHHHHHHhccCcccccceeceEe
Q 041576 417 LNEATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA--------QEREREFKTEVSAIGRTHHKNLVQLLGFCD 488 (714)
Q Consensus 417 l~~at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~ 488 (714)
.....|.+.+.||+|+||.||+|... .+++.||||.+.... ......+.+|++++++++||||+++++++.
T Consensus 7 ~l~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 85 (322)
T 2ycf_A 7 ALRDEYIMSKTLGSGACGEVKLAFER-KTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD 85 (322)
T ss_dssp HHHHHEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hhhhceeEeeEEecCCCEEEEEEEEc-CCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEc
Confidence 34567888999999999999999876 578899999986432 122345889999999999999999999987
Q ss_pred cCCeeeEEEeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCc---eEEecC
Q 041576 489 EGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFT---AKISDF 565 (714)
Q Consensus 489 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~---~kl~Df 565 (714)
.+. .++||||+++++|.+++.....+++..+..++.||++||+|||+++ |+||||||+||+++.++. +||+||
T Consensus 86 ~~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Df 161 (322)
T 2ycf_A 86 AED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDF 161 (322)
T ss_dssp SSS-EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECCC
T ss_pred CCc-eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEccC
Confidence 765 8999999999999999988888999999999999999999999998 999999999999987664 999999
Q ss_pred CCccccccCcccceeeecCCCCccCccccc---CCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhh
Q 041576 566 GLSKLLLSDQSRTRTVIRGTRGYVAPEWFK---NVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCY 642 (714)
Q Consensus 566 g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~ 642 (714)
|++....... ......|+..|+|||.+. ...++.++||||||+++|||++|+.||........ +.. ..
T Consensus 162 g~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~----~~ 232 (322)
T 2ycf_A 162 GHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS---LKD----QI 232 (322)
T ss_dssp TTCEECCCCH--HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC---HHH----HH
T ss_pred ccceeccccc--ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH---HHH----HH
Confidence 9998764322 122345899999999974 56789999999999999999999999975433211 100 01
Q ss_pred hcCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 643 VEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 643 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
..+..... +. .....+..+.+++.+||+.||++|||+.|+++
T Consensus 233 ~~~~~~~~--~~----~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 233 TSGKYNFI--PE----VWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp HHTCCCCC--HH----HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HhCccccC--ch----hhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 11111100 00 01123456788999999999999999999984
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=330.11 Aligned_cols=250 Identities=22% Similarity=0.320 Sum_probs=186.1
Q ss_pred HHhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc--hhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEE
Q 041576 419 EATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA--QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLV 496 (714)
Q Consensus 419 ~at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 496 (714)
...|.+.+.||+|+||.||+|... .+++.||||+++... ....+.+.++...++.++||||+++++++.+++..++|
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv 84 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHV-PSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC 84 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEec-CCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence 345777899999999999999875 478999999997532 22334455566668888999999999999999999999
Q ss_pred EeecCCCchhhhhh----cCCCCChhhHHHHHHHHHHHHHHHHhc-CCCCeEecCCCcCeEEECCCCceEEecCCCcccc
Q 041576 497 YEFMGNGTLANLLF----AIPRPDWSLRVRISLEIARGLLYLHEE-CNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLL 571 (714)
Q Consensus 497 ~E~~~~gsL~~~l~----~~~~~~~~~~~~i~~qi~~~L~yLH~~-~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~ 571 (714)
|||+++ +|.+++. ....+++..++.++.||+.||+|||++ + |+||||||+||+++.++.+||+|||++...
T Consensus 85 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 85 MELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred Eehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 999985 8877765 346789999999999999999999998 8 999999999999999999999999999866
Q ss_pred ccCcccceeeecCCCCccCcccc----cCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCcc
Q 041576 572 LSDQSRTRTVIRGTRGYVAPEWF----KNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKL 647 (714)
Q Consensus 572 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~ 647 (714)
..... .....|++.|+|||.+ .+..++.++||||||+++|||++|+.||........ .+.. ..... .
T Consensus 161 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~~~----~~~~~-~ 231 (290)
T 3fme_A 161 VDDVA--KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQ--QLKQ----VVEEP-S 231 (290)
T ss_dssp -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHH--HHHH----HHHSC-C
T ss_pred ccccc--ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHH--HHHH----HhccC-C
Confidence 44322 2234589999999996 566789999999999999999999999974322211 1111 01111 0
Q ss_pred ceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 648 DVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 648 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
.. ......+..+.+++.+||+.||++|||+.|+++
T Consensus 232 ~~--------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 232 PQ--------LPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp CC--------CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CC--------cccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 00 011123456788999999999999999999987
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-38 Score=339.96 Aligned_cols=260 Identities=23% Similarity=0.276 Sum_probs=196.4
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCcccccceeceEec----------
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCDE---------- 489 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~---------- 489 (714)
.+|.+.+.||+|+||.||+|.+. .+++.||||++..... ...+|++++++++||||+++++++..
T Consensus 7 ~~y~~~~~lG~G~fg~V~~a~~~-~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~ 81 (383)
T 3eb0_A 7 KKYSLGKTLGTGSFGIVCEVFDI-ESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQ 81 (383)
T ss_dssp TTEEEEEEEECC-CEEEEEEEET-TTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC---------
T ss_pred ceEEEEEEEEeccCEEEEEEEEC-CCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCcccccccc
Confidence 46778899999999999999876 5789999999864322 23479999999999999999999843
Q ss_pred ----------------------------CCeeeEEEeecCCCchhhhhh----cCCCCChhhHHHHHHHHHHHHHHHHhc
Q 041576 490 ----------------------------GLNRLLVYEFMGNGTLANLLF----AIPRPDWSLRVRISLEIARGLLYLHEE 537 (714)
Q Consensus 490 ----------------------------~~~~~lv~E~~~~gsL~~~l~----~~~~~~~~~~~~i~~qi~~~L~yLH~~ 537 (714)
....++||||+++ +|.+.+. ....+++..+..++.||++||+|||+.
T Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~ 160 (383)
T 3eb0_A 82 PPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL 160 (383)
T ss_dssp ----------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT
T ss_pred cccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 3347899999985 7766664 456789999999999999999999999
Q ss_pred CCCCeEecCCCcCeEEEC-CCCceEEecCCCccccccCcccceeeecCCCCccCcccccCC-CCCchhhhHHHHHHHHHH
Q 041576 538 CNVPIIHCDIKPQNILLD-QDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNV-PVSAKVDVYSFGVVLLKI 615 (714)
Q Consensus 538 ~~~~ivH~Dlk~~NIll~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvil~el 615 (714)
+ |+||||||+||+++ .++.+||+|||+++...... ......++..|+|||.+.+. .++.++||||+||++|||
T Consensus 161 g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el 235 (383)
T 3eb0_A 161 G---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE--PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGEL 235 (383)
T ss_dssp T---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS--CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHH
T ss_pred c---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC--CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHH
Confidence 8 99999999999997 68899999999998764332 22334579999999998765 489999999999999999
Q ss_pred HhcCCCCcccccchhhhhhhHHHh-----------hhhhcCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCC
Q 041576 616 ICCKRSVEMELGEERSAILTDWAY-----------DCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPA 684 (714)
Q Consensus 616 ltG~~p~~~~~~~~~~~~l~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs 684 (714)
++|+.||......+....+..... ..+.+...............+...+..+.+++.+||+.||++|||
T Consensus 236 l~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t 315 (383)
T 3eb0_A 236 ILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRIN 315 (383)
T ss_dssp HHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCC
T ss_pred HhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCC
Confidence 999999986544332211111000 000000111111111222223334567889999999999999999
Q ss_pred HHHHHH
Q 041576 685 MKMIVQ 690 (714)
Q Consensus 685 ~~evl~ 690 (714)
+.|+++
T Consensus 316 ~~e~l~ 321 (383)
T 3eb0_A 316 PYEAMA 321 (383)
T ss_dssp HHHHHT
T ss_pred HHHHhc
Confidence 999985
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=341.75 Aligned_cols=252 Identities=12% Similarity=0.045 Sum_probs=180.1
Q ss_pred hhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHHhcc--Cccccccee-------ceEe
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA---QEREREFKTEVSAIGRT--HHKNLVQLL-------GFCD 488 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l--~h~nIv~l~-------~~~~ 488 (714)
+|.+.+.||+|+||.||+|.+. .+++.||||++.... ....+.+.+|+.+++.+ +||||++++ +++.
T Consensus 63 ~y~~~~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 63 KLKLVEPLRVGDRSVVFLVRDV-ERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeccCCCCEEEEEEEEC-CCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 3667789999999999999976 468999999997633 34456778885444444 699988755 3443
Q ss_pred cC-----------------CeeeEEEeecCCCchhhhhhcC-CCCChhhH------HHHHHHHHHHHHHHHhcCCCCeEe
Q 041576 489 EG-----------------LNRLLVYEFMGNGTLANLLFAI-PRPDWSLR------VRISLEIARGLLYLHEECNVPIIH 544 (714)
Q Consensus 489 ~~-----------------~~~~lv~E~~~~gsL~~~l~~~-~~~~~~~~------~~i~~qi~~~L~yLH~~~~~~ivH 544 (714)
.. ...++||||++ ++|.+++... ..+.+..+ ..++.||++||+|||+++ |+|
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~---ivH 217 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG---LVH 217 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---EEE
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---Ccc
Confidence 22 34799999999 8999999864 34455555 688899999999999998 999
Q ss_pred cCCCcCeEEECCCCceEEecCCCccccccCcccceeeecCCCCccCcccccC--CCCCchhhhHHHHHHHHHHHhcCCCC
Q 041576 545 CDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKN--VPVSAKVDVYSFGVVLLKIICCKRSV 622 (714)
Q Consensus 545 ~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~ksDVwSlGvil~elltG~~p~ 622 (714)
|||||+|||++.++.+||+|||+++..... .....+++.|+|||.+.+ ..++.++|||||||++|||++|+.||
T Consensus 218 rDikp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf 293 (371)
T 3q60_A 218 GHFTPDNLFIMPDGRLMLGDVSALWKVGTR----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPF 293 (371)
T ss_dssp TTCSGGGEEECTTSCEEECCGGGEEETTCE----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCST
T ss_pred CcCCHHHEEECCCCCEEEEecceeeecCCC----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999999865322 113456799999999987 67999999999999999999999999
Q ss_pred cccccchhhhhhhHHHhhhhhcCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 623 EMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 623 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
........... .....................+..+.+++.+||+.||++|||+.|+++
T Consensus 294 ~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 294 GLVTPGIKGSW---------KRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp TBCCTTCTTCC---------CBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCcCcccccch---------hhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 86533221100 000000000000000111233457888999999999999999999975
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=329.74 Aligned_cols=259 Identities=19% Similarity=0.256 Sum_probs=198.5
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccC-cccccceeceEec--CCeeeEE
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTH-HKNLVQLLGFCDE--GLNRLLV 496 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~--~~~~~lv 496 (714)
..|.+.+.||+|+||.||+|+.. .+++.||||+++.. ..+.+.+|++++++++ ||||+++++++.+ ....++|
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINI-TNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CceEEEEEecccCCeEEEEEEEC-CCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 45677899999999999999875 57899999999743 3467899999999996 9999999999987 6678999
Q ss_pred EeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCC-ceEEecCCCccccccCc
Q 041576 497 YEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDF-TAKISDFGLSKLLLSDQ 575 (714)
Q Consensus 497 ~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~-~~kl~Dfg~~~~~~~~~ 575 (714)
|||+++++|.+++.. +++..+..++.||++||+|||+++ |+||||||+||+++.++ .+||+|||++.......
T Consensus 112 ~e~~~~~~l~~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~ 185 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 185 (330)
T ss_dssp EECCCCCCHHHHGGG---CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC
T ss_pred EeccCchhHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC
Confidence 999999999999854 788999999999999999999998 99999999999999776 89999999998664432
Q ss_pred ccceeeecCCCCccCcccccC-CCCCchhhhHHHHHHHHHHHhcCCCCcccccchhh-hhhhHH-----HhhhhhcCc--
Q 041576 576 SRTRTVIRGTRGYVAPEWFKN-VPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERS-AILTDW-----AYDCYVEGK-- 646 (714)
Q Consensus 576 ~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~-~~l~~~-----~~~~~~~~~-- 646 (714)
. .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||......... ..+... .........
T Consensus 186 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 263 (330)
T 3nsz_A 186 E--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 263 (330)
T ss_dssp C--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCC
T ss_pred c--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccc
Confidence 2 233468899999999977 67899999999999999999999999543221110 000000 000000000
Q ss_pred ------------cceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 647 ------------LDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 647 ------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
....................+.+++.+||+.||++|||++|+++
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 264 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp CCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred cccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00000000001111224567889999999999999999999987
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=342.19 Aligned_cols=199 Identities=25% Similarity=0.292 Sum_probs=171.6
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhcc------CcccccceeceEecCCee
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRT------HHKNLVQLLGFCDEGLNR 493 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~h~nIv~l~~~~~~~~~~ 493 (714)
.+|.+.+.||+|+||.||+|... .+++.||||+++.. ......+.+|+++++.+ +|+||+++++++......
T Consensus 97 ~ry~~~~~LG~G~fg~V~~a~~~-~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 97 YRYEVLKVIGKGSFGQVVKAYDH-KVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp TTEEEEEEEEESSSEEEEEEEET-TTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred CcEEEEEEcccCccEEEEEEEEC-CCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 45778899999999999999876 56899999999753 23345677788877776 577999999999999999
Q ss_pred eEEEeecCCCchhhhhhcCC--CCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCc--eEEecCCCcc
Q 041576 494 LLVYEFMGNGTLANLLFAIP--RPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFT--AKISDFGLSK 569 (714)
Q Consensus 494 ~lv~E~~~~gsL~~~l~~~~--~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~--~kl~Dfg~~~ 569 (714)
++||||+. ++|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++. +||+|||++.
T Consensus 175 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~a~ 250 (429)
T 3kvw_A 175 CMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSSC 250 (429)
T ss_dssp EEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred EEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecccce
Confidence 99999997 58999987653 4899999999999999999999998 999999999999999987 9999999997
Q ss_pred ccccCcccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccc
Q 041576 570 LLLSDQSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGE 628 (714)
Q Consensus 570 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~ 628 (714)
..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 251 ~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~ 305 (429)
T 3kvw_A 251 YEHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEG 305 (429)
T ss_dssp ETTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred ecCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHH
Confidence 54322 22346899999999999999999999999999999999999999765443
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=335.03 Aligned_cols=263 Identities=23% Similarity=0.241 Sum_probs=192.8
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEeccc--chhhHHHHHHHHHHHhccCcccccceeceEecCC------
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKL--AQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGL------ 491 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~------ 491 (714)
..|.+.+.||+|+||.||+|... .+++.||||++... .....+.+.+|+.++++++||||+++++++....
T Consensus 25 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 25 KRYQNLKPIGSGAQGIVCAAYDA-ILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hheeEeeeeEecCCEEEEEEEEC-CCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 35677889999999999999875 57889999999652 3344567899999999999999999999997665
Q ss_pred eeeEEEeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCcccc
Q 041576 492 NRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLL 571 (714)
Q Consensus 492 ~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~ 571 (714)
..++||||+++ +|.+.+. ..+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+++..
T Consensus 104 ~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~ 177 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA 177 (371)
T ss_dssp EEEEEEECCSE-EHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC----
T ss_pred ceEEEEEcCCC-CHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeeccccc
Confidence 67999999985 7888875 35889999999999999999999998 999999999999999999999999999865
Q ss_pred ccCcccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHH--------------
Q 041576 572 LSDQSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDW-------------- 637 (714)
Q Consensus 572 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~-------------- 637 (714)
... .......||..|+|||.+.+..++.++|||||||++|||++|+.||...........+...
T Consensus 178 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 255 (371)
T 2xrw_A 178 GTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP 255 (371)
T ss_dssp --------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCH
T ss_pred ccc--cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhh
Confidence 432 1223456899999999999999999999999999999999999999765432211111000
Q ss_pred -HhhhhhcC-c-----cceeecchh---hhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 638 -AYDCYVEG-K-----LDVLVDNDK---AAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 638 -~~~~~~~~-~-----~~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
........ . ......... ...........+.+++.+||+.||++|||++|+++.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 256 TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp HHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 00000000 0 000000000 000112235678999999999999999999999873
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=332.62 Aligned_cols=269 Identities=20% Similarity=0.260 Sum_probs=201.3
Q ss_pred hhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc-hhhHHHHHHHHHHHhccCcccccceeceEecC-----Ceee
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA-QEREREFKTEVSAIGRTHHKNLVQLLGFCDEG-----LNRL 494 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-----~~~~ 494 (714)
.|.+.+.||+|+||.||+|... .+++.||||++.... ......+.+|++++++++||||+++++++... ...+
T Consensus 12 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 90 (353)
T 2b9h_A 12 DFQLKSLLGEGAYGVVCSATHK-PTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVY 90 (353)
T ss_dssp TEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEE
T ss_pred ceEEeeEEcCCCCeEEEEEEEC-CCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEE
Confidence 5667789999999999999876 568899999997533 34456788999999999999999999988654 6789
Q ss_pred EEEeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccC
Q 041576 495 LVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSD 574 (714)
Q Consensus 495 lv~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 574 (714)
+||||+. ++|.+++.. ..+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||++......
T Consensus 91 lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 165 (353)
T 2b9h_A 91 IIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDES 165 (353)
T ss_dssp EEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred EEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEecccccccccc
Confidence 9999998 599999876 56899999999999999999999998 999999999999999999999999999876432
Q ss_pred ccc---------ceeeecCCCCccCcccccC-CCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhc
Q 041576 575 QSR---------TRTVIRGTRGYVAPEWFKN-VPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVE 644 (714)
Q Consensus 575 ~~~---------~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~ 644 (714)
... ......||..|+|||.+.+ ..++.++||||||+++|||++|+.||...........+..........
T Consensus 166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 245 (353)
T 2b9h_A 166 AADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSD 245 (353)
T ss_dssp --------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCST
T ss_pred cccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchh
Confidence 211 1123468999999998764 678999999999999999999999997654332211111100000000
Q ss_pred Cccceee--------------cchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHH--HHhcc
Q 041576 645 GKLDVLV--------------DNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ--MLEGY 695 (714)
Q Consensus 645 ~~~~~~~--------------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~ 695 (714)
....... ............+..+.+++.+||+.||++|||++|+++ .++..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 312 (353)
T 2b9h_A 246 NDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTY 312 (353)
T ss_dssp TTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred ccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCcccccc
Confidence 0000000 000000011233457788999999999999999999987 35443
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=329.21 Aligned_cols=264 Identities=20% Similarity=0.280 Sum_probs=204.9
Q ss_pred HHhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCccc------ccceeceEecCCe
Q 041576 419 EATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKN------LVQLLGFCDEGLN 492 (714)
Q Consensus 419 ~at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------Iv~l~~~~~~~~~ 492 (714)
..+|.+.+.||+|+||.||+|.....+++.||||+++... ...+.+.+|++++++++|++ |+++++++.+.+.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 3567888999999999999998755678999999997542 34567889999999987765 9999999999999
Q ss_pred eeEEEeecCCCchhhhhhcCC--CCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECC--------------
Q 041576 493 RLLVYEFMGNGTLANLLFAIP--RPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQ-------------- 556 (714)
Q Consensus 493 ~~lv~E~~~~gsL~~~l~~~~--~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~-------------- 556 (714)
.++||||+ +++|.+++.... .+++..+..++.||++||+|||+++ |+||||||+||+++.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~ 167 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKRD 167 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred EEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCccccc
Confidence 99999999 889999998664 5789999999999999999999998 999999999999987
Q ss_pred -----CCceEEecCCCccccccCcccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhh
Q 041576 557 -----DFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERS 631 (714)
Q Consensus 557 -----~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~ 631 (714)
++.+||+|||++...... .....||..|+|||.+.+..++.++||||||+++|||++|+.||......+..
T Consensus 168 ~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 243 (339)
T 1z57_A 168 ERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHL 243 (339)
T ss_dssp EEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHH
T ss_pred cccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 678999999999864332 22346899999999999999999999999999999999999999765433321
Q ss_pred hhhhHHHh----hhhhcCccceee---------------------cc-hhhhccchHHHHHHHHHHHHccccCCCCCCCH
Q 041576 632 AILTDWAY----DCYVEGKLDVLV---------------------DN-DKAAMADKSRACKWLMIALWCIQEDPLKRPAM 685 (714)
Q Consensus 632 ~~l~~~~~----~~~~~~~~~~~~---------------------~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 685 (714)
..+..... ............ .. .............+.+++.+||+.||++|||+
T Consensus 244 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~ 323 (339)
T 1z57_A 244 AMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITL 323 (339)
T ss_dssp HHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCH
T ss_pred HHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCH
Confidence 11111000 000000000000 00 00011223456788999999999999999999
Q ss_pred HHHHHH
Q 041576 686 KMIVQM 691 (714)
Q Consensus 686 ~evl~~ 691 (714)
+|+++.
T Consensus 324 ~ell~h 329 (339)
T 1z57_A 324 REALKH 329 (339)
T ss_dssp HHHTTS
T ss_pred HHHhcC
Confidence 999863
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=338.31 Aligned_cols=264 Identities=23% Similarity=0.250 Sum_probs=200.5
Q ss_pred HHHHhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccC--------cccccceeceEe
Q 041576 417 LNEATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTH--------HKNLVQLLGFCD 488 (714)
Q Consensus 417 l~~at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------h~nIv~l~~~~~ 488 (714)
+...+|.+.+.||+|+||+||+|+.. .+++.||||+++.. ....+.+.+|++++++++ |+||+++++++.
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~ 111 (397)
T 1wak_A 34 LFNGRYHVIRKLGWGHFSTVWLSWDI-QGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFK 111 (397)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEE
T ss_pred hcCCeEEEEEEeeecCCeeEEEEEec-CCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeeccee
Confidence 33466888899999999999999875 57889999999753 344567889999999985 888999999987
Q ss_pred ----cCCeeeEEEeecCCCchhhhhhcC--CCCChhhHHHHHHHHHHHHHHHHhc-CCCCeEecCCCcCeEEECCCC---
Q 041576 489 ----EGLNRLLVYEFMGNGTLANLLFAI--PRPDWSLRVRISLEIARGLLYLHEE-CNVPIIHCDIKPQNILLDQDF--- 558 (714)
Q Consensus 489 ----~~~~~~lv~E~~~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~~L~yLH~~-~~~~ivH~Dlk~~NIll~~~~--- 558 (714)
+....++||||+.+ +|.+.+... ..+++..++.++.||+.||+|||++ + |+||||||+|||++.++
T Consensus 112 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~ 187 (397)
T 1wak_A 112 ISGVNGTHICMVFEVLGH-HLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYI 187 (397)
T ss_dssp EEETTEEEEEEEECCCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHH
T ss_pred ecCCCCceEEEEEeccCc-cHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhh
Confidence 66788999999955 555555433 5689999999999999999999998 7 99999999999999775
Q ss_pred ----------------------------------------------ceEEecCCCccccccCcccceeeecCCCCccCcc
Q 041576 559 ----------------------------------------------TAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPE 592 (714)
Q Consensus 559 ----------------------------------------------~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE 592 (714)
.+||+|||++...... .....||..|+|||
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE 263 (397)
T 1wak_A 188 RRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLE 263 (397)
T ss_dssp HHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHH
T ss_pred hhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCCh
Confidence 7999999999866432 23346899999999
Q ss_pred cccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHH--hhh--------hhc-----------Cccceee
Q 041576 593 WFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWA--YDC--------YVE-----------GKLDVLV 651 (714)
Q Consensus 593 ~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~--~~~--------~~~-----------~~~~~~~ 651 (714)
++.+..++.++|||||||++|||++|+.||................ ... ... +....+.
T Consensus 264 ~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 343 (397)
T 1wak_A 264 VLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHIT 343 (397)
T ss_dssp HHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCC
T ss_pred hhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccc
Confidence 9999999999999999999999999999997544322110000000 000 000 0000000
Q ss_pred cch---------hhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 652 DND---------KAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 652 ~~~---------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
+.. .....+......+.+|+.+||+.||++|||++|+++
T Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 344 KLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred ccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 000 001123456678899999999999999999999986
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-38 Score=334.91 Aligned_cols=255 Identities=21% Similarity=0.325 Sum_probs=202.1
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhh-----------------HHHHHHHHHHHhccCcccccc
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQER-----------------EREFKTEVSAIGRTHHKNLVQ 482 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~E~~~l~~l~h~nIv~ 482 (714)
..|.+.+.||+|+||.||+|.. +++.||||.+....... .+.+.+|++++++++||||++
T Consensus 31 ~~y~~~~~lg~G~~g~V~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 107 (348)
T 2pml_X 31 NDYRIIRTLNQGKFNKIILCEK---DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT 107 (348)
T ss_dssp TTEEEEEEEECCSSCCEEEEEE---TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred CceEEEEEEcCCCCeEEEEEEc---CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence 3577789999999999999987 68999999996532221 178999999999999999999
Q ss_pred eeceEecCCeeeEEEeecCCCchhhh------hhc--CCCCChhhHHHHHHHHHHHHHHHHh-cCCCCeEecCCCcCeEE
Q 041576 483 LLGFCDEGLNRLLVYEFMGNGTLANL------LFA--IPRPDWSLRVRISLEIARGLLYLHE-ECNVPIIHCDIKPQNIL 553 (714)
Q Consensus 483 l~~~~~~~~~~~lv~E~~~~gsL~~~------l~~--~~~~~~~~~~~i~~qi~~~L~yLH~-~~~~~ivH~Dlk~~NIl 553 (714)
+++++.+.+..++||||+++++|.++ +.. ...+++..++.++.||+.||+|||+ .+ |+||||||+||+
T Consensus 108 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil 184 (348)
T 2pml_X 108 CEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNIL 184 (348)
T ss_dssp CSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEE
T ss_pred EEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEE
Confidence 99999999999999999999999999 665 5678999999999999999999999 87 999999999999
Q ss_pred ECCCCceEEecCCCccccccCcccceeeecCCCCccCcccccCC-CCCc-hhhhHHHHHHHHHHHhcCCCCcccccchhh
Q 041576 554 LDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNV-PVSA-KVDVYSFGVVLLKIICCKRSVEMELGEERS 631 (714)
Q Consensus 554 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~-ksDVwSlGvil~elltG~~p~~~~~~~~~~ 631 (714)
++.++.+||+|||.+...... ......++..|+|||.+.+. .++. ++||||||+++|||++|+.||........
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~- 260 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVE- 260 (348)
T ss_dssp ECTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHH-
T ss_pred EcCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHH-
Confidence 999999999999999875433 23345689999999999887 6666 99999999999999999999976543111
Q ss_pred hhhhHHHhhhhhcCccceeec---------chhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 632 AILTDWAYDCYVEGKLDVLVD---------NDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 632 ~~l~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
... ....+....... ...........+..+.+++.+||+.||.+|||+.|+++
T Consensus 261 -~~~-----~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 261 -LFN-----NIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp -HHH-----HHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred -HHH-----HHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 110 111111100000 00000011233457888999999999999999999987
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=343.70 Aligned_cols=260 Identities=17% Similarity=0.235 Sum_probs=205.7
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCc-ccccceeceEecCCeeeEEEe
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHH-KNLVQLLGFCDEGLNRLLVYE 498 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~nIv~l~~~~~~~~~~~lv~E 498 (714)
..|.+.++||+|+||.||+|.+. .+++.||||++..... ...+.+|+++++.++| ++|..+..++...+..++|||
T Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~-~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 7 NKFRLGRKIGSGSFGEIYLGTNI-QTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTEECCCCCEECSSCEEEEEEET-TTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CcEEEEEEEeeCCCEEEEEEEEC-CCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 35677899999999999999875 5789999998764322 2357889999999976 556666667788888999999
Q ss_pred ecCCCchhhhhhc-CCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEE---CCCCceEEecCCCccccccC
Q 041576 499 FMGNGTLANLLFA-IPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILL---DQDFTAKISDFGLSKLLLSD 574 (714)
Q Consensus 499 ~~~~gsL~~~l~~-~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll---~~~~~~kl~Dfg~~~~~~~~ 574 (714)
|+ +++|.+++.. ...+++..++.|+.||+.||+|||+++ |+||||||+|||| +.++.+||+|||+++.....
T Consensus 84 ~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (483)
T 3sv0_A 84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (483)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred CC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceeccCC
Confidence 99 8999999985 467899999999999999999999998 9999999999999 68899999999999876543
Q ss_pred ccc------ceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccc
Q 041576 575 QSR------TRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLD 648 (714)
Q Consensus 575 ~~~------~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 648 (714)
... ......||..|+|||.+.+..++.++|||||||+||||++|+.||...........+........ .
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~-----~ 234 (483)
T 3sv0_A 160 STHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV-----A 234 (483)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHH-----H
T ss_pred ccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccc-----c
Confidence 321 22245799999999999999999999999999999999999999986544332222221111111 0
Q ss_pred eeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 041576 649 VLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYL 696 (714)
Q Consensus 649 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 696 (714)
..+.. .....+.++.+++..||+.||++||++.+|++.|+.++
T Consensus 235 ~~~~~-----l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~ 277 (483)
T 3sv0_A 235 TSIEA-----LCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLF 277 (483)
T ss_dssp SCHHH-----HHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred ccHHH-----HhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 00000 01122457888999999999999999999999998864
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-38 Score=362.69 Aligned_cols=260 Identities=21% Similarity=0.311 Sum_probs=206.3
Q ss_pred HHHHhhhhhhhhCcccceeEEEeEeeCC--CCcEEEEEEeccc-chhhHHHHHHHHHHHhccCcccccceeceEecCCee
Q 041576 417 LNEATNGFEEELGRGSFGIVYKGVLKSA--SGNAVAVKKLDKL-AQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNR 493 (714)
Q Consensus 417 l~~at~~~~~~ig~G~~g~Vy~~~~~~~--~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 493 (714)
+....+.+.+.||+|+||.||+|.+... .+..||||.++.. .....+.+.+|+.++++++||||+++++++.+ +..
T Consensus 387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~ 465 (656)
T 2j0j_A 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPV 465 (656)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-Cce
Confidence 3445677889999999999999987532 3467999998753 33445789999999999999999999999854 568
Q ss_pred eEEEeecCCCchhhhhhcCC-CCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccc
Q 041576 494 LLVYEFMGNGTLANLLFAIP-RPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLL 572 (714)
Q Consensus 494 ~lv~E~~~~gsL~~~l~~~~-~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~ 572 (714)
++||||+++|+|.+++.... .+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 466 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~~~~ 542 (656)
T 2j0j_A 466 WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME 542 (656)
T ss_dssp EEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCCSCC
T ss_pred EEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCeecC
Confidence 99999999999999998654 6899999999999999999999998 9999999999999999999999999998765
Q ss_pred cCcccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccchhhhhhhHHHhhhhhcCccceee
Q 041576 573 SDQSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEERSAILTDWAYDCYVEGKLDVLV 651 (714)
Q Consensus 573 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 651 (714)
...........+++.|+|||.+.+..++.++||||||+++|||++ |..||......+.... ...+....
T Consensus 543 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~--------i~~~~~~~-- 612 (656)
T 2j0j_A 543 DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR--------IENGERLP-- 612 (656)
T ss_dssp C----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH--------HHHTCCCC--
T ss_pred CCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHH--------HHcCCCCC--
Confidence 444333344557789999999998899999999999999999997 9999975433321111 11111100
Q ss_pred cchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccC
Q 041576 652 DNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLE 697 (714)
Q Consensus 652 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 697 (714)
.+...+..+.+++.+||+.||++|||+.||++.|+.+++
T Consensus 613 -------~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~ 651 (656)
T 2j0j_A 613 -------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 651 (656)
T ss_dssp -------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -------CCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 112234577889999999999999999999999988753
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-38 Score=336.68 Aligned_cols=261 Identities=22% Similarity=0.252 Sum_probs=184.2
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEeccc--chhhHHHHHHHHHHHhccCcccccceeceEecC------C
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKL--AQEREREFKTEVSAIGRTHHKNLVQLLGFCDEG------L 491 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~------~ 491 (714)
.+|.+.+.||+|+||.||+|... .+++.||||++... .....+.+.+|++++++++||||+++++++... .
T Consensus 29 ~~y~~~~~lG~G~~g~V~~a~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 29 ERYQNLSPVGSGAYGSVCAAFDT-KTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp TTEEEEEECC----CCEEEEEET-TTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEeeEEeecCCeEEEEEEEC-CCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 45777889999999999999865 57899999999653 334556888999999999999999999998654 5
Q ss_pred eeeEEEeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCcccc
Q 041576 492 NRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLL 571 (714)
Q Consensus 492 ~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~ 571 (714)
..++|+|++ +++|.+++.. ..+++..+..++.||++||+|||+.+ |+||||||+||+++.++.+||+|||+++..
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~ 182 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHT 182 (367)
T ss_dssp CCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC-------
T ss_pred eEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeeccccccc
Confidence 679999999 6799999876 67899999999999999999999998 999999999999999999999999999865
Q ss_pred ccCcccceeeecCCCCccCcccccC-CCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhh-------hhh
Q 041576 572 LSDQSRTRTVIRGTRGYVAPEWFKN-VPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYD-------CYV 643 (714)
Q Consensus 572 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~-------~~~ 643 (714)
... .....+|..|+|||.+.+ ..++.++|||||||++|||++|+.||...........+...... ...
T Consensus 183 ~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~ 258 (367)
T 2fst_X 183 ADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 258 (367)
T ss_dssp ------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCC
T ss_pred ccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhh
Confidence 322 234568999999999877 67899999999999999999999999765433221111110000 000
Q ss_pred cCc-------cceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 644 EGK-------LDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 644 ~~~-------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
... +......... .........+.+|+.+||+.||++|||+.|+++.
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 259 SESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp CHHHHHHHHTSCCCCCCCHH-HHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hHHHHHHHhccCCCCCCCHH-HHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 000 0000000000 0011224567889999999999999999999874
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=333.91 Aligned_cols=265 Identities=21% Similarity=0.250 Sum_probs=202.4
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc-hhhHHHHHHHHHHHhccCcccccceeceEecC-----Cee
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA-QEREREFKTEVSAIGRTHHKNLVQLLGFCDEG-----LNR 493 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-----~~~ 493 (714)
.+|.+.+.||+|+||.||+|... .+++.||||++.... ....+.+.+|++++++++||||+++++++... ...
T Consensus 27 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 27 PRYTNLSYIGEGAYGMVCSAYDN-LNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred ccEEEEEEeecCCCeEEEEEEEC-CCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 35778899999999999999875 578899999997533 34457889999999999999999999999655 367
Q ss_pred eEEEeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCcccccc
Q 041576 494 LLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLS 573 (714)
Q Consensus 494 ~lv~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~ 573 (714)
++||||+++ +|.+++.. ..+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||++.....
T Consensus 106 ~iv~e~~~~-~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 180 (364)
T 3qyz_A 106 YIVQDLMET-DLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADP 180 (364)
T ss_dssp EEEEECCSE-EHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred EEEEcccCc-CHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEecCC
Confidence 999999985 99999876 46899999999999999999999998 99999999999999999999999999987654
Q ss_pred Cccc--ceeeecCCCCccCccccc-CCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccce-
Q 041576 574 DQSR--TRTVIRGTRGYVAPEWFK-NVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDV- 649 (714)
Q Consensus 574 ~~~~--~~~~~~gt~~y~aPE~~~-~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~- 649 (714)
.... ......||+.|+|||.+. ...++.++||||||+++|||++|+.||......+....+......... .....
T Consensus 181 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~-~~~~~~ 259 (364)
T 3qyz_A 181 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ-EDLNCI 259 (364)
T ss_dssp GGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCH-HHHHTC
T ss_pred CCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCH-HHHHHh
Confidence 3322 123457899999999875 445899999999999999999999999765443322221110000000 00000
Q ss_pred -----------eec--chhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 650 -----------LVD--NDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 650 -----------~~~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
... ..............+.+++.+||+.||++|||++|+++.
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 260 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp CCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000 000000112234568889999999999999999999973
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=329.10 Aligned_cols=264 Identities=20% Similarity=0.263 Sum_probs=194.9
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCcccccceeceEe-----------
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCD----------- 488 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~----------- 488 (714)
.+|.+.+.||+|+||.||+|... .+++.||||++........+.+.+|++++++++||||+++++++.
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 11 SRYMDLKPLGCGGNGLVFSAVDN-DCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTEEEEEECC-----CEEEEEET-TTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CceeEEEEeccCCCeEEEEEEEC-CCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 35677789999999999999876 468999999998766667788999999999999999999999873
Q ss_pred ---cCCeeeEEEeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEEC-CCCceEEec
Q 041576 489 ---EGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLD-QDFTAKISD 564 (714)
Q Consensus 489 ---~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~-~~~~~kl~D 564 (714)
+....++||||++ ++|.+++.. ..+++..+..++.||++||+|||+++ |+||||||+||+++ +++.+||+|
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl~D 164 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGD 164 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEEECC
T ss_pred cccccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEEEcc
Confidence 4467899999998 599999875 56889999999999999999999998 99999999999997 567999999
Q ss_pred CCCccccccCcc--cceeeecCCCCccCcccccC-CCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHH---
Q 041576 565 FGLSKLLLSDQS--RTRTVIRGTRGYVAPEWFKN-VPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWA--- 638 (714)
Q Consensus 565 fg~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~--- 638 (714)
||++........ .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...........+....
T Consensus 165 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 244 (320)
T 2i6l_A 165 FGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVV 244 (320)
T ss_dssp CTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCC
T ss_pred CccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 999987643221 12233457889999998865 678999999999999999999999997654332211111000
Q ss_pred ----hhhhhcCccceeecc------hhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 639 ----YDCYVEGKLDVLVDN------DKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 639 ----~~~~~~~~~~~~~~~------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
...... .+...... ..........+..+.+++.+||+.||++|||++|+++
T Consensus 245 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 245 HEEDRQELLS-VIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp CHHHHHHHHT-TSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred chhhhhhhhh-cCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 000000 00000000 0000011223467889999999999999999999987
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=321.24 Aligned_cols=255 Identities=24% Similarity=0.292 Sum_probs=206.0
Q ss_pred HHHHHHhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc--hhhHHHHHHHHHHHhccCcccccceeceEecCCe
Q 041576 415 VELNEATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA--QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLN 492 (714)
Q Consensus 415 ~el~~at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 492 (714)
......+|.+.+.||+|+||.||+|... .+++.||+|++.... ......+.+|++++++++||||+++++++.+...
T Consensus 17 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~-~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 95 (287)
T 2wei_A 17 QGTFAERYNIVCMLGKGSFGEVLKCKDR-ITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSS 95 (287)
T ss_dssp THHHHHHEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred HHHHhhcceeeEEEcCCCCEEEEEEEEc-CCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCe
Confidence 3445567888999999999999999875 468899999986532 3346789999999999999999999999999999
Q ss_pred eeEEEeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCC---CceEEecCCCcc
Q 041576 493 RLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQD---FTAKISDFGLSK 569 (714)
Q Consensus 493 ~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~---~~~kl~Dfg~~~ 569 (714)
.++|+||+++++|.+.+.....+++..++.++.||+.||+|||+++ ++||||||+||+++.+ +.+||+|||++.
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~ 172 (287)
T 2wei_A 96 FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (287)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGG
T ss_pred EEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcce
Confidence 9999999999999999987778999999999999999999999998 9999999999999764 479999999998
Q ss_pred ccccCcccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccce
Q 041576 570 LLLSDQSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDV 649 (714)
Q Consensus 570 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 649 (714)
....... .....++..|+|||.+.+ .++.++||||||+++|+|++|+.||........ +. ....+....
T Consensus 173 ~~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~---~~-----~~~~~~~~~ 241 (287)
T 2wei_A 173 CFQQNTK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDI---LK-----RVETGKYAF 241 (287)
T ss_dssp TBCCCSS--CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HH-----HHHHCCCCC
T ss_pred eecCCCc--cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHH---HH-----HHHcCCCCC
Confidence 6643322 223347889999999876 489999999999999999999999975433221 11 111111110
Q ss_pred eecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 650 LVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 650 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
... .....+..+.+++.+||+.||++|||+.|+++
T Consensus 242 ~~~------~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 242 DLP------QWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp CSG------GGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred Cch------hhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 000 01123456788999999999999999999997
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=329.17 Aligned_cols=265 Identities=22% Similarity=0.292 Sum_probs=199.4
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccch--hhHHHHHHHHHHHhcc---CcccccceeceEe-----c
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQ--EREREFKTEVSAIGRT---HHKNLVQLLGFCD-----E 489 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~nIv~l~~~~~-----~ 489 (714)
..|.+.+.||+|+||.||+|.....+++.||+|+++.... .....+.+|+.+++++ +||||+++++++. .
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~ 90 (326)
T 1blx_A 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 90 (326)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred hceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCC
Confidence 3567789999999999999997545788999999865322 1223556777776666 8999999999987 5
Q ss_pred CCeeeEEEeecCCCchhhhhhcCC--CCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCC
Q 041576 490 GLNRLLVYEFMGNGTLANLLFAIP--RPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGL 567 (714)
Q Consensus 490 ~~~~~lv~E~~~~gsL~~~l~~~~--~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~ 567 (714)
....++||||++ ++|.+++.... .+++..+..++.||++||+|||+++ |+||||||+||+++.++.+||+|||+
T Consensus 91 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~Dfg~ 166 (326)
T 1blx_A 91 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGL 166 (326)
T ss_dssp EEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred CceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEecCcc
Confidence 677899999998 59999997653 4899999999999999999999998 99999999999999999999999999
Q ss_pred ccccccCcccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHh----hhhh
Q 041576 568 SKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAY----DCYV 643 (714)
Q Consensus 568 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~----~~~~ 643 (714)
+....... ......++..|+|||.+.+..++.++||||||+++|||++|+.||...........+..... ..+.
T Consensus 167 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 244 (326)
T 1blx_A 167 ARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 244 (326)
T ss_dssp CCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSC
T ss_pred cccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCc
Confidence 98654322 22345689999999999999999999999999999999999999976543322111111000 0000
Q ss_pred cC-cc-ceee---cchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 644 EG-KL-DVLV---DNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 644 ~~-~~-~~~~---~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
.. .. .... ............+..+.+++.+||+.||++|||+.|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 245 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp TTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00 00 0000 000001112234457788999999999999999999996
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=341.07 Aligned_cols=259 Identities=24% Similarity=0.281 Sum_probs=192.8
Q ss_pred hhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCcccccceeceEecC------Ceee
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEG------LNRL 494 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~------~~~~ 494 (714)
.|.+.+.||+|+||.||+|++. .+++.||||++.... ....+|++++++++||||+++++++... ...+
T Consensus 55 ~y~~~~~lG~G~fg~Vy~~~~~-~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 55 SYTDTKVIGNGSFGVVYQAKLC-DSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred eEEeeeEEeeCCCEEEEEEEEC-CCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 4667789999999999999986 468999999986532 2235799999999999999999998432 2357
Q ss_pred EEEeecCCCchhhhhh----cCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCC-CceEEecCCCcc
Q 041576 495 LVYEFMGNGTLANLLF----AIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQD-FTAKISDFGLSK 569 (714)
Q Consensus 495 lv~E~~~~gsL~~~l~----~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~-~~~kl~Dfg~~~ 569 (714)
+||||+++ +|.+.+. ....+++..+..++.||++||+|||+++ |+||||||+||||+.+ +.+||+|||+++
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 99999986 5655543 3467899999999999999999999998 9999999999999965 578999999998
Q ss_pred ccccCcccceeeecCCCCccCcccccCC-CCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHH-------hhh
Q 041576 570 LLLSDQSRTRTVIRGTRGYVAPEWFKNV-PVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWA-------YDC 641 (714)
Q Consensus 570 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~-------~~~ 641 (714)
....... .....+|..|+|||++.+. .++.++|||||||++|||++|+.||......+....+.... ...
T Consensus 206 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~ 283 (420)
T 1j1b_A 206 QLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 283 (420)
T ss_dssp ECCTTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHH
T ss_pred hcccCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 7643322 2335689999999998765 78999999999999999999999998654332211111100 000
Q ss_pred h----hcCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 642 Y----VEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 642 ~----~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
. .+.....+................+.+|+.+||+.||++|||+.|+++
T Consensus 284 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 284 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp HCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 0 000000110111111122233467889999999999999999999986
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=334.36 Aligned_cols=256 Identities=25% Similarity=0.359 Sum_probs=198.1
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEeccc--chhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEE
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKL--AQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVY 497 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 497 (714)
..|.+.+.||+|+||.||+|... ..+|+|.++.. .....+.+.+|+.++++++||||+++++++.+....++||
T Consensus 33 ~~~~~~~~lg~G~~g~V~~~~~~----~~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~ 108 (319)
T 2y4i_B 33 EQLEIGELIGKGRFGQVYHGRWH----GEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIIT 108 (319)
T ss_dssp SCEECCCBCCCSSSSEEEEEEES----SSEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEEC
T ss_pred HHeEEeeEeccCCceEEEEEEEc----CeEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEe
Confidence 45677899999999999999874 25999998643 2233456788999999999999999999999999999999
Q ss_pred eecCCCchhhhhhcCC-CCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCc-
Q 041576 498 EFMGNGTLANLLFAIP-RPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQ- 575 (714)
Q Consensus 498 E~~~~gsL~~~l~~~~-~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~- 575 (714)
||+++++|.+++...+ .+++..++.++.||++||+|||+++ |+||||||+||+++ ++.+||+|||++.......
T Consensus 109 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~ 184 (319)
T 2y4i_B 109 SLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQA 184 (319)
T ss_dssp BCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC-------
T ss_pred ecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCccccccccc
Confidence 9999999999998754 6899999999999999999999998 99999999999998 6799999999987653211
Q ss_pred ---ccceeeecCCCCccCcccccC---------CCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhh
Q 041576 576 ---SRTRTVIRGTRGYVAPEWFKN---------VPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYV 643 (714)
Q Consensus 576 ---~~~~~~~~gt~~y~aPE~~~~---------~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~ 643 (714)
........|+..|+|||.+.+ ..++.++||||||+++|||++|+.||.......... ...
T Consensus 185 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~--------~~~ 256 (319)
T 2y4i_B 185 GRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIW--------QMG 256 (319)
T ss_dssp ---CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHH--------HHH
T ss_pred cccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH--------Hhc
Confidence 122233458899999999864 457899999999999999999999997544332111 111
Q ss_pred cCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCCC
Q 041576 644 EGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLEVP 699 (714)
Q Consensus 644 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 699 (714)
.+....... ...+..+.+++.+||+.||++|||+.+++++|+.+.+..
T Consensus 257 ~~~~~~~~~--------~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~ 304 (319)
T 2y4i_B 257 TGMKPNLSQ--------IGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN 304 (319)
T ss_dssp TTCCCCCCC--------SSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred cCCCCCCCc--------CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence 111111111 112235778999999999999999999999999987654
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=334.13 Aligned_cols=263 Identities=21% Similarity=0.219 Sum_probs=192.0
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc-----------hhhHHHHHHHHHHHhccCcccccceeceEe
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA-----------QEREREFKTEVSAIGRTHHKNLVQLLGFCD 488 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~-----------~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~ 488 (714)
..|.+.+.||+|+||.||+|... .++.||||++.... ....+.+.+|++++++++||||+++++++.
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 99 (362)
T 3pg1_A 22 SPYTVQRFISSGSYGAVCAGVDS--EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFV 99 (362)
T ss_dssp CSCEEEEEEEEETTEEEEEEECT--TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEE
T ss_pred cceEEeEEeccCCCEEEEEEECC--CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEE
Confidence 45666789999999999999875 58999999985422 122478999999999999999999999984
Q ss_pred c-----CCeeeEEEeecCCCchhhhhhcC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEE
Q 041576 489 E-----GLNRLLVYEFMGNGTLANLLFAI-PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKI 562 (714)
Q Consensus 489 ~-----~~~~~lv~E~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl 562 (714)
. ....++||||++ ++|.+.+... ..+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||
T Consensus 100 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl 175 (362)
T 3pg1_A 100 HFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITI 175 (362)
T ss_dssp ECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEE
T ss_pred eccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEEEcCCCCEEE
Confidence 3 346799999998 5787777654 46899999999999999999999998 999999999999999999999
Q ss_pred ecCCCccccccCcccceeeecCCCCccCcccccC-CCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHh--
Q 041576 563 SDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKN-VPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAY-- 639 (714)
Q Consensus 563 ~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~-- 639 (714)
+|||++....... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...........+.....
T Consensus 176 ~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~ 253 (362)
T 3pg1_A 176 CDFNLAREDTADA--NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTP 253 (362)
T ss_dssp CCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred EecCccccccccc--ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCC
Confidence 9999997543322 2234568899999999876 6789999999999999999999999976543322111111000
Q ss_pred -------------hhhhcCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 640 -------------DCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 640 -------------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
............. .............+.+++.+||+.||++|||+.|+++.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 254 KIEDVVMFSSPSARDYLRNSLSNVPA-RAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp CHHHHHHTSCHHHHHHTTTCCCCCCC-CCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ChHHhhhccchhhhHHHHhhcccCCh-hhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 0000000000000 01111122334568889999999999999999999874
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-37 Score=330.04 Aligned_cols=271 Identities=22% Similarity=0.272 Sum_probs=202.5
Q ss_pred HHhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccC-----------cccccceeceE
Q 041576 419 EATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTH-----------HKNLVQLLGFC 487 (714)
Q Consensus 419 ~at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~nIv~l~~~~ 487 (714)
...|.+.+.||+|+||.||+|... .+++.||||++... ......+.+|+.++++++ ||||+++++++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~ 95 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDM-VNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 95 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEec-CCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHh
Confidence 356788899999999999999875 57899999999753 334567889999999886 89999999999
Q ss_pred ecCC----eeeEEEeecCCCchhhhhhcC--CCCChhhHHHHHHHHHHHHHHHHhc-CCCCeEecCCCcCeEEEC-----
Q 041576 488 DEGL----NRLLVYEFMGNGTLANLLFAI--PRPDWSLRVRISLEIARGLLYLHEE-CNVPIIHCDIKPQNILLD----- 555 (714)
Q Consensus 488 ~~~~----~~~lv~E~~~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~~L~yLH~~-~~~~ivH~Dlk~~NIll~----- 555 (714)
.... ..++||||+ +++|.+++... ..+++..+..++.||+.||+|||++ + |+||||||+|||++
T Consensus 96 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 96 NHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp EEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETT
T ss_pred hccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCC
Confidence 7654 789999999 88999999764 4589999999999999999999998 8 99999999999994
Q ss_pred -CCCceEEecCCCccccccCcccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhh---
Q 041576 556 -QDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERS--- 631 (714)
Q Consensus 556 -~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~--- 631 (714)
..+.+||+|||++...... .....+|+.|+|||.+.+..++.++||||||+++|||++|+.||.........
T Consensus 172 ~~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 247 (373)
T 1q8y_A 172 ENLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 247 (373)
T ss_dssp TTEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred cCcceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChH
Confidence 4458999999999865432 22346899999999999999999999999999999999999999754322110
Q ss_pred hhhhHHHh-------hh----------hhc-Cccceeec-------c--hhhhccchHHHHHHHHHHHHccccCCCCCCC
Q 041576 632 AILTDWAY-------DC----------YVE-GKLDVLVD-------N--DKAAMADKSRACKWLMIALWCIQEDPLKRPA 684 (714)
Q Consensus 632 ~~l~~~~~-------~~----------~~~-~~~~~~~~-------~--~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs 684 (714)
..+..... .. +.. +....+.. . ......+......+.+++.+||+.||++|||
T Consensus 248 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 327 (373)
T 1q8y_A 248 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD 327 (373)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred HHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCC
Confidence 00100000 00 000 00000000 0 0011233556778999999999999999999
Q ss_pred HHHHHH--HHhcccCCC
Q 041576 685 MKMIVQ--MLEGYLEVP 699 (714)
Q Consensus 685 ~~evl~--~L~~~~~~~ 699 (714)
++|+++ .+.+.....
T Consensus 328 ~~ell~hp~f~~~~~~~ 344 (373)
T 1q8y_A 328 AGGLVNHPWLKDTLGME 344 (373)
T ss_dssp HHHHHTCGGGTTCTTCT
T ss_pred HHHHhhChhhhcccCcc
Confidence 999998 456554443
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=335.52 Aligned_cols=261 Identities=22% Similarity=0.251 Sum_probs=194.0
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCcccccceeceEecCC------ee
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGL------NR 493 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~------~~ 493 (714)
.+|.+.+.||+|+||.||+|.+. .+..||+|++..... ...+|++++++++||||+++++++.... ..
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~--~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 113 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLV--ESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFL 113 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEET--TTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEEC--CCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEE
Confidence 35778899999999999999875 344588888854322 2246999999999999999999995443 37
Q ss_pred eEEEeecCCCchhhhh---hcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEEC-CCCceEEecCCCcc
Q 041576 494 LLVYEFMGNGTLANLL---FAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLD-QDFTAKISDFGLSK 569 (714)
Q Consensus 494 ~lv~E~~~~gsL~~~l---~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~-~~~~~kl~Dfg~~~ 569 (714)
++||||++++.+.... .....+++..+..++.||++||+|||+++ |+||||||+|||++ .++.+||+|||+++
T Consensus 114 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~ 190 (394)
T 4e7w_A 114 NLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAK 190 (394)
T ss_dssp EEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCcc
Confidence 8999999985444333 23567899999999999999999999998 99999999999999 79999999999998
Q ss_pred ccccCcccceeeecCCCCccCcccccCC-CCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHH----------
Q 041576 570 LLLSDQSRTRTVIRGTRGYVAPEWFKNV-PVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWA---------- 638 (714)
Q Consensus 570 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~---------- 638 (714)
....... .....+|+.|+|||.+.+. .++.++|||||||++|||++|+.||......+....+....
T Consensus 191 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~ 268 (394)
T 4e7w_A 191 ILIAGEP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKT 268 (394)
T ss_dssp ECCTTCC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred cccCCCC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 7643322 2334689999999998765 58999999999999999999999998654433221111100
Q ss_pred -hhhhhcCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 639 -YDCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 639 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
...+.....................+..+.+++.+||+.||++|||+.|+++.
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 269 MNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp HCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred hChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 00011111111111111112222345678899999999999999999999874
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=328.99 Aligned_cols=249 Identities=27% Similarity=0.374 Sum_probs=193.4
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhcc-CcccccceeceEec------CCe
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRT-HHKNLVQLLGFCDE------GLN 492 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~------~~~ 492 (714)
..|.+.+.||+|+||.||+|.+. .+++.||||++.... .....+.+|+.+++++ +||||+++++++.. ...
T Consensus 24 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~ 101 (326)
T 2x7f_A 24 GIFELVELVGNGTYGQVYKGRHV-KTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ 101 (326)
T ss_dssp TTEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCE
T ss_pred CcEEEEEEeccCCCEEEEEEEEC-CCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccce
Confidence 34667789999999999999875 468899999986532 3446788999999999 89999999999976 467
Q ss_pred eeEEEeecCCCchhhhhhcC--CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccc
Q 041576 493 RLLVYEFMGNGTLANLLFAI--PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKL 570 (714)
Q Consensus 493 ~~lv~E~~~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~ 570 (714)
.++||||+++++|.+++... ..+++..+..++.||+.||+|||+++ |+|+||||+||+++.++.+||+|||++..
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~ 178 (326)
T 2x7f_A 102 LWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQ 178 (326)
T ss_dssp EEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCTTTC-
T ss_pred EEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEEEeeCcCcee
Confidence 89999999999999999864 46889999999999999999999998 99999999999999999999999999986
Q ss_pred cccCcccceeeecCCCCccCccccc-----CCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcC
Q 041576 571 LLSDQSRTRTVIRGTRGYVAPEWFK-----NVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEG 645 (714)
Q Consensus 571 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~ 645 (714)
...... ......|+..|+|||.+. +..++.++||||||+++|||++|+.||.......... . ....
T Consensus 179 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~---~-----~~~~ 249 (326)
T 2x7f_A 179 LDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF---L-----IPRN 249 (326)
T ss_dssp -------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH---H-----HHHS
T ss_pred cCcCcc-ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHH---H-----hhcC
Confidence 543221 223346899999999987 5678999999999999999999999996543222110 0 0111
Q ss_pred ccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 646 KLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 646 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
..... .....+..+.+++.+||+.||++||++.|+++
T Consensus 250 ~~~~~--------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 250 PAPRL--------KSKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp CCCCC--------SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ccccC--------CccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 11111 11122356788999999999999999999987
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=338.62 Aligned_cols=199 Identities=21% Similarity=0.350 Sum_probs=154.5
Q ss_pred hhh-hhhhCcccceeEEEeEeeC-CCCcEEEEEEecccchhhHHHHHHHHHHHhccCcccccceeceEe--cCCeeeEEE
Q 041576 422 NGF-EEELGRGSFGIVYKGVLKS-ASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCD--EGLNRLLVY 497 (714)
Q Consensus 422 ~~~-~~~ig~G~~g~Vy~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~--~~~~~~lv~ 497 (714)
|.+ .++||+|+||+||+|+++. .+++.||||++.... ....+.+|++++++++||||+++++++. .....++||
T Consensus 22 y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~ 99 (405)
T 3rgf_A 22 FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLF 99 (405)
T ss_dssp EECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEE
T ss_pred hhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEE
Confidence 444 3579999999999998753 357899999997532 2346789999999999999999999994 477889999
Q ss_pred eecCCCchhhhhhcC---------CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEE----CCCCceEEec
Q 041576 498 EFMGNGTLANLLFAI---------PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILL----DQDFTAKISD 564 (714)
Q Consensus 498 E~~~~gsL~~~l~~~---------~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll----~~~~~~kl~D 564 (714)
||+++ +|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+|||| +.++.+||+|
T Consensus 100 e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~D 175 (405)
T 3rgf_A 100 DYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIAD 175 (405)
T ss_dssp ECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEECC
T ss_pred eCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEEEE
Confidence 99975 787777521 24889999999999999999999998 9999999999999 7788999999
Q ss_pred CCCccccccCcc--cceeeecCCCCccCcccccCC-CCCchhhhHHHHHHHHHHHhcCCCCcccc
Q 041576 565 FGLSKLLLSDQS--RTRTVIRGTRGYVAPEWFKNV-PVSAKVDVYSFGVVLLKIICCKRSVEMEL 626 (714)
Q Consensus 565 fg~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~ 626 (714)
||+++....... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||....
T Consensus 176 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 240 (405)
T 3rgf_A 176 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 240 (405)
T ss_dssp TTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred CCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcc
Confidence 999987643321 223345789999999999874 58999999999999999999999997543
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-37 Score=319.80 Aligned_cols=251 Identities=27% Similarity=0.359 Sum_probs=191.4
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCcccccceeceEec----------
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCDE---------- 489 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~---------- 489 (714)
..|.+.+.||+|+||.||+|+.. .+++.||||++... ....+.+.+|+.++++++||||+++++++.+
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNA-LDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred ccchhhheeccCCcEEEEEEEEc-CCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 45777899999999999999875 47899999999653 3455788999999999999999999998854
Q ss_pred ---CCeeeEEEeecCCCchhhhhhcC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecC
Q 041576 490 ---GLNRLLVYEFMGNGTLANLLFAI-PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDF 565 (714)
Q Consensus 490 ---~~~~~lv~E~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Df 565 (714)
....++||||+++++|.+++... ..+++..++.++.||++||+|||+++ |+||||||+||+++.++.+||+||
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~df 160 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDF 160 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCC
T ss_pred cccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEeeC
Confidence 45678999999999999999854 35678899999999999999999998 999999999999999999999999
Q ss_pred CCccccccCc-------------ccceeeecCCCCccCcccccCC-CCCchhhhHHHHHHHHHHHhcCCCCcccccchhh
Q 041576 566 GLSKLLLSDQ-------------SRTRTVIRGTRGYVAPEWFKNV-PVSAKVDVYSFGVVLLKIICCKRSVEMELGEERS 631 (714)
Q Consensus 566 g~~~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~ 631 (714)
|++....... ........|+..|+|||.+.+. .++.++||||||+++|||++ |+.......
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~-- 235 (303)
T 1zy4_A 161 GLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERV-- 235 (303)
T ss_dssp CCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHH--
T ss_pred cchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHH--
Confidence 9998664321 1122344689999999999864 68999999999999999998 443221111
Q ss_pred hhhhHHHhhhhhcCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 632 AILTDWAYDCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 632 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
.... ....... .............+.+++.+||+.||++|||+.|+++.
T Consensus 236 ~~~~-----~~~~~~~------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 236 NILK-----KLRSVSI------EFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp HHHH-----HHHSTTC------CCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred HHHH-----hcccccc------ccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 1111 1111100 00111222334567889999999999999999999873
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-37 Score=331.21 Aligned_cols=259 Identities=22% Similarity=0.259 Sum_probs=196.4
Q ss_pred hhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEeccc--chhhHHHHHHHHHHHhccCcccccceeceEecCCee-----
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKL--AQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNR----- 493 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~----- 493 (714)
+|.+.+.||+|+||.||+|... .+++.||||++... .....+.+.+|+.++++++||||+++++++......
T Consensus 43 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 121 (371)
T 4exu_A 43 TYVSPTHVGSGAYGSVCSAIDK-RSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 121 (371)
T ss_dssp TEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCC
T ss_pred cEEEEeEEecCCCeEEEEEEEC-CCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccccee
Confidence 5667789999999999999876 57899999999753 334457889999999999999999999999877765
Q ss_pred -eEEEeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccc
Q 041576 494 -LLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLL 572 (714)
Q Consensus 494 -~lv~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~ 572 (714)
++||||+. ++|.+++.. .+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+++...
T Consensus 122 ~~lv~e~~~-~~l~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~ 195 (371)
T 4exu_A 122 FYLVMPFMQ-TDLQKIMGM--EFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHAD 195 (371)
T ss_dssp CEEEEECCC-EEHHHHTTS--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC----
T ss_pred EEEEEcccc-ccHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCcccccc
Confidence 99999998 588888743 4899999999999999999999998 9999999999999999999999999998653
Q ss_pred cCcccceeeecCCCCccCcccccC-CCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHh---hhhhcC---
Q 041576 573 SDQSRTRTVIRGTRGYVAPEWFKN-VPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAY---DCYVEG--- 645 (714)
Q Consensus 573 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~---~~~~~~--- 645 (714)
.. .....+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||......+....+..... ......
T Consensus 196 ~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 271 (371)
T 4exu_A 196 AE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLND 271 (371)
T ss_dssp --------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSC
T ss_pred cC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhh
Confidence 32 233468999999999987 6789999999999999999999999976543322111111000 000000
Q ss_pred --------ccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 646 --------KLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 646 --------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
.......... ..........+.+++.+||+.||++|||++|+++.
T Consensus 272 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 272 KAAKSYIQSLPQTPRKDF-TQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp HHHHHHHHHSCCCCCCCH-HHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hhhhhhhhccCCCcchhH-HHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 0000000000 00112234678899999999999999999999874
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-37 Score=324.33 Aligned_cols=251 Identities=19% Similarity=0.289 Sum_probs=195.3
Q ss_pred HHhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecc--cchhhHHHHHHHHHHHhccC--cccccceeceEecCCeee
Q 041576 419 EATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDK--LAQEREREFKTEVSAIGRTH--HKNLVQLLGFCDEGLNRL 494 (714)
Q Consensus 419 ~at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~--h~nIv~l~~~~~~~~~~~ 494 (714)
...|.+.+.||+|+||.||+|... +++.||||++.. ......+.+.+|++++.+++ ||||+++++++.+++..+
T Consensus 27 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~ 104 (313)
T 3cek_A 27 GRIYSILKQIGSGGSSKVFQVLNE--KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 104 (313)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECT--TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEE
T ss_pred cceEEEEEEecCCCCEEEEEEEcC--CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEE
Confidence 345777899999999999999875 588999999864 23445678999999999997 599999999999999999
Q ss_pred EEEeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccC
Q 041576 495 LVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSD 574 (714)
Q Consensus 495 lv~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 574 (714)
+||| +.+++|.+++.....+++..+..++.||++||+|||+++ |+||||||+||++++ +.+||+|||++......
T Consensus 105 lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~ 179 (313)
T 3cek_A 105 MVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFGIANQMQPD 179 (313)
T ss_dssp EEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCSSSCC----
T ss_pred EEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeeccccccccCc
Confidence 9999 678899999998888999999999999999999999998 999999999999965 89999999999876443
Q ss_pred ccc-ceeeecCCCCccCcccccC-----------CCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhh
Q 041576 575 QSR-TRTVIRGTRGYVAPEWFKN-----------VPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCY 642 (714)
Q Consensus 575 ~~~-~~~~~~gt~~y~aPE~~~~-----------~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~ 642 (714)
... ......|+..|+|||.+.+ ..++.++||||||+++|||++|+.||........ .+.. .
T Consensus 180 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~--~~~~-----~ 252 (313)
T 3cek_A 180 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS--KLHA-----I 252 (313)
T ss_dssp ----------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHH--HHHH-----H
T ss_pred cccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHH--HHHH-----H
Confidence 321 2234468999999999875 4688999999999999999999999964322110 0100 0
Q ss_pred hcCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 643 VEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 643 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
...... ...+......+.+++.+||+.||++||++.|+++.
T Consensus 253 ~~~~~~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 253 IDPNHE--------IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp HCTTSC--------CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred Hhcccc--------cCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 111000 00111123467789999999999999999999874
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-37 Score=329.12 Aligned_cols=273 Identities=21% Similarity=0.193 Sum_probs=189.5
Q ss_pred HHHHhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCcccccceeceEecCCe----
Q 041576 417 LNEATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLN---- 492 (714)
Q Consensus 417 l~~at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~---- 492 (714)
..-..|.+.+.||+|+||.||+|.+. .+++.||||++.... .....+.+|++.+..++||||+++++++.....
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~ 97 (360)
T 3e3p_A 20 KEMDRFQVERMAGQGTFGTVQLGKEK-STGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRR 97 (360)
T ss_dssp HHHTTEEEC----------CEEEEET-TTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTT
T ss_pred hhccceEEEEEEecCCCeEEEEEEEC-CCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhcccccccc
Confidence 33456777899999999999999976 468899999985532 223456778888899999999999999965433
Q ss_pred ---eeEEEeecCCCchh---hhhhcCCCCChhhHHHHHHHHHHHHHHHH--hcCCCCeEecCCCcCeEEECC-CCceEEe
Q 041576 493 ---RLLVYEFMGNGTLA---NLLFAIPRPDWSLRVRISLEIARGLLYLH--EECNVPIIHCDIKPQNILLDQ-DFTAKIS 563 (714)
Q Consensus 493 ---~~lv~E~~~~gsL~---~~l~~~~~~~~~~~~~i~~qi~~~L~yLH--~~~~~~ivH~Dlk~~NIll~~-~~~~kl~ 563 (714)
.++||||++++.+. ..+.....+++..+..++.||+.||+||| +.+ |+||||||+|||++. ++.+||+
T Consensus 98 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~kl~ 174 (360)
T 3e3p_A 98 DIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTLKLC 174 (360)
T ss_dssp CEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEEEEC
T ss_pred ceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcEEEe
Confidence 78999999975332 23335567889999999999999999999 877 999999999999997 8999999
Q ss_pred cCCCccccccCcccceeeecCCCCccCcccccCCC-CCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHH----
Q 041576 564 DFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVP-VSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWA---- 638 (714)
Q Consensus 564 Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~---- 638 (714)
|||++....... ......||..|+|||.+.+.. ++.++||||||+++|||++|+.||...........+....
T Consensus 175 Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 252 (360)
T 3e3p_A 175 DFGSAKKLSPSE--PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPS 252 (360)
T ss_dssp CCTTCBCCCTTS--CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred eCCCceecCCCC--CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCC
Confidence 999998764332 223346899999999986654 8999999999999999999999998654333221111100
Q ss_pred ---hhhhhcC--cccee-----ecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHH--Hhccc
Q 041576 639 ---YDCYVEG--KLDVL-----VDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM--LEGYL 696 (714)
Q Consensus 639 ---~~~~~~~--~~~~~-----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~~ 696 (714)
....... ..... .-..............+.+++.+||+.||.+|||+.|+++. +++..
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 322 (360)
T 3e3p_A 253 REVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELH 322 (360)
T ss_dssp HHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGG
T ss_pred HHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccC
Confidence 0000000 00000 00000011122245678899999999999999999999974 55443
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=324.76 Aligned_cols=263 Identities=17% Similarity=0.269 Sum_probs=200.5
Q ss_pred HHhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCccc------ccceeceEecCCe
Q 041576 419 EATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKN------LVQLLGFCDEGLN 492 (714)
Q Consensus 419 ~at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------Iv~l~~~~~~~~~ 492 (714)
...|.+.+.||+|+||.||+|.....+++.||+|+++.. ....+.+.+|++++++++|++ ++.+++++...+.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 356788899999999999999986545579999999753 334567889999999998776 8999999999999
Q ss_pred eeEEEeecCCCchhhhhhcC--CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEE----------------
Q 041576 493 RLLVYEFMGNGTLANLLFAI--PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILL---------------- 554 (714)
Q Consensus 493 ~~lv~E~~~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll---------------- 554 (714)
.++||||+ +++|.+++... ..+++.++..++.||+.||+|||+++ |+||||||+|||+
T Consensus 97 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~~ 172 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSCE 172 (355)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-CCC
T ss_pred EEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeccccccccccccccc
Confidence 99999999 55666666544 36899999999999999999999998 9999999999999
Q ss_pred ---CCCCceEEecCCCccccccCcccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhh
Q 041576 555 ---DQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERS 631 (714)
Q Consensus 555 ---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~ 631 (714)
+.++.+||+|||++...... .....||..|+|||.+.+..++.++||||||+++|||++|+.||.........
T Consensus 173 ~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 248 (355)
T 2eu9_A 173 EKSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHL 248 (355)
T ss_dssp EEEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred ccccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 56789999999999864322 23346899999999999999999999999999999999999999765433221
Q ss_pred hhhhHHHh----hhhhcCcc-ceee------cc---------------hhhhccchHHHHHHHHHHHHccccCCCCCCCH
Q 041576 632 AILTDWAY----DCYVEGKL-DVLV------DN---------------DKAAMADKSRACKWLMIALWCIQEDPLKRPAM 685 (714)
Q Consensus 632 ~~l~~~~~----~~~~~~~~-~~~~------~~---------------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 685 (714)
..+..... ........ .... +. .............+.+++.+||+.||++|||+
T Consensus 249 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~ 328 (355)
T 2eu9_A 249 VMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITL 328 (355)
T ss_dssp HHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCH
T ss_pred HHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCH
Confidence 11111000 00000000 0000 00 00011123345678899999999999999999
Q ss_pred HHHHH
Q 041576 686 KMIVQ 690 (714)
Q Consensus 686 ~evl~ 690 (714)
+|+++
T Consensus 329 ~e~l~ 333 (355)
T 2eu9_A 329 AEALL 333 (355)
T ss_dssp HHHTT
T ss_pred HHHhc
Confidence 99985
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=326.20 Aligned_cols=259 Identities=22% Similarity=0.260 Sum_probs=196.2
Q ss_pred hhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEeccc--chhhHHHHHHHHHHHhccCcccccceeceEecCCe------
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKL--AQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLN------ 492 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~------ 492 (714)
+|.+.+.||+|+||.||+|.+. .+|+.||||++... .....+.+.+|+.++++++||||+++++++.....
T Consensus 25 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 103 (353)
T 3coi_A 25 TYVSPTHVGSGAYGSVCSAIDK-RSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 103 (353)
T ss_dssp TEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred eEEEeeeEecCCCeEEEEEEEC-CCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence 4667789999999999999876 57899999999653 33345678999999999999999999999987654
Q ss_pred eeEEEeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccc
Q 041576 493 RLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLL 572 (714)
Q Consensus 493 ~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~ 572 (714)
.++||||+. ++|.+++.. .+++..+..++.||++||+|||+++ |+||||||+||+++.++.+||+|||++....
T Consensus 104 ~~lv~e~~~-~~l~~~~~~--~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 177 (353)
T 3coi_A 104 FYLVMPFMQ-TDLQKIMGL--KFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHAD 177 (353)
T ss_dssp CEEEEECCS-EEGGGTTTS--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCTTC--
T ss_pred EEEEecccc-CCHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccccCCC
Confidence 499999998 589888754 4899999999999999999999998 9999999999999999999999999998653
Q ss_pred cCcccceeeecCCCCccCcccccC-CCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHh---hhhhcC---
Q 041576 573 SDQSRTRTVIRGTRGYVAPEWFKN-VPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAY---DCYVEG--- 645 (714)
Q Consensus 573 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~---~~~~~~--- 645 (714)
.. .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...........+..... ..+...
T Consensus 178 ~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 253 (353)
T 3coi_A 178 AE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLND 253 (353)
T ss_dssp ----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSC
T ss_pred CC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhh
Confidence 22 233468999999999877 6789999999999999999999999976543221111110000 000000
Q ss_pred --------ccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 646 --------KLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 646 --------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
.+........ .......+..+.+++.+||+.||++|||++|+++.
T Consensus 254 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 254 KAAKSYIQSLPQTPRKDF-TQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp HHHHHHHHTSCBCSSCCT-TTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHHHHHhCcCCCCccH-HHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0000000000 01112345678889999999999999999999874
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-37 Score=323.96 Aligned_cols=252 Identities=25% Similarity=0.349 Sum_probs=177.4
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEeccc-chhhHHHHHHHHH-HHhccCcccccceeceEecCCeeeEEE
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKL-AQEREREFKTEVS-AIGRTHHKNLVQLLGFCDEGLNRLLVY 497 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~-~l~~l~h~nIv~l~~~~~~~~~~~lv~ 497 (714)
..|.+.+.||+|+||.||+|... .+++.||||+++.. .......+..|+. +++.++||||+++++++.+++..++||
T Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 22 EDLKDLGEIGRGAYGSVNKMVHK-PSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp CSEEC-CEEEECSSEEEEEEEET-TTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHhhehheeccCCCEEEEEEEEc-CCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 34566789999999999999876 47899999999653 2333445566665 777789999999999999999999999
Q ss_pred eecCCCchhhhhhc-----CCCCChhhHHHHHHHHHHHHHHHHhc-CCCCeEecCCCcCeEEECCCCceEEecCCCcccc
Q 041576 498 EFMGNGTLANLLFA-----IPRPDWSLRVRISLEIARGLLYLHEE-CNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLL 571 (714)
Q Consensus 498 E~~~~gsL~~~l~~-----~~~~~~~~~~~i~~qi~~~L~yLH~~-~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~ 571 (714)
||+++ +|.+++.. ...+++..+..++.|+++||+|||+. + |+||||||+||+++.++.+||+|||++...
T Consensus 101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 99986 88887763 46789999999999999999999998 8 999999999999999999999999999866
Q ss_pred ccCcccceeeecCCCCccCcccc----cCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCcc
Q 041576 572 LSDQSRTRTVIRGTRGYVAPEWF----KNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKL 647 (714)
Q Consensus 572 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~ 647 (714)
.... ......|+..|+|||.+ .+..++.++||||||+++|||++|+.||........ .+ .....+..
T Consensus 177 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~-----~~~~~~~~ 247 (327)
T 3aln_A 177 VDSI--AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD--QL-----TQVVKGDP 247 (327)
T ss_dssp -------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC--------------CCCCCSCC
T ss_pred cccc--ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH--HH-----HHHhcCCC
Confidence 4332 22233589999999998 456789999999999999999999999975322110 00 00011111
Q ss_pred ceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 648 DVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 648 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
..+ ...........+.+++.+||+.||++|||+.||++
T Consensus 248 ~~~-----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 248 PQL-----SNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp CCC-----CCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCC-----CCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 111 01111223457888999999999999999999965
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=324.44 Aligned_cols=246 Identities=24% Similarity=0.346 Sum_probs=193.0
Q ss_pred HHHHHHhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccch------hhHHHHHHHHHHHhcc----Cccccccee
Q 041576 415 VELNEATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQ------EREREFKTEVSAIGRT----HHKNLVQLL 484 (714)
Q Consensus 415 ~el~~at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l----~h~nIv~l~ 484 (714)
.+.....|.+.+.||+|+||.||+|... .+++.||||+++.... .....+.+|+.++.++ +||||++++
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~ 104 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRL-TDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL 104 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECT-TTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEc-cCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence 4555677888999999999999999875 4688999999965332 1233466789999888 899999999
Q ss_pred ceEecCCeeeEEEee-cCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEEC-CCCceEE
Q 041576 485 GFCDEGLNRLLVYEF-MGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLD-QDFTAKI 562 (714)
Q Consensus 485 ~~~~~~~~~~lv~E~-~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~-~~~~~kl 562 (714)
+++...+..++|+|+ +.+++|.+++.....+++..++.++.||++||+|||+++ |+||||||+||+++ .++.+||
T Consensus 105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl 181 (312)
T 2iwi_A 105 DWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKL 181 (312)
T ss_dssp EEC-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEEEE
T ss_pred EEEecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeEEE
Confidence 999999999999999 789999999988788999999999999999999999998 99999999999999 8899999
Q ss_pred ecCCCccccccCcccceeeecCCCCccCcccccCCCC-CchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhh
Q 041576 563 SDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPV-SAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDC 641 (714)
Q Consensus 563 ~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~ 641 (714)
+|||++....... .....|+..|+|||.+.+..+ +.++||||||+++|||++|+.||...... .
T Consensus 182 ~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~------- 246 (312)
T 2iwi_A 182 IDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEI-----L------- 246 (312)
T ss_dssp CCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH-----H-------
T ss_pred EEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHHH-----h-------
Confidence 9999998764432 233458999999999977665 45999999999999999999999643210 0
Q ss_pred hhcCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 642 YVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 642 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
..... .+......+.+++.+||+.||++|||++|+++.
T Consensus 247 --~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 247 --EAELH----------FPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp --HTCCC----------CCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred --hhccC----------CcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000 111233467789999999999999999999983
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=323.94 Aligned_cols=259 Identities=20% Similarity=0.244 Sum_probs=175.3
Q ss_pred Hhhhhh-hhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCcccccceeceEec----CCeee
Q 041576 420 ATNGFE-EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCDE----GLNRL 494 (714)
Q Consensus 420 at~~~~-~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~----~~~~~ 494 (714)
..|.+. +.||+|+||.||+|.+. .+++.||||++..... ...+....++.++||||+++++++.. +...+
T Consensus 28 ~~y~i~~~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~~~----~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 102 (336)
T 3fhr_A 28 DDYQLSKQVLGLGVNGKVLECFHR-RTGQKCALKLLYDSPK----ARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL 102 (336)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEESSHH----HHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ceeEecceeeeeCCCeEEEEEEEC-CCCCEEEEEEecCcHH----HHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence 346664 46999999999999976 5789999999965321 22223334566799999999999866 45589
Q ss_pred EEEeecCCCchhhhhhcCC--CCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECC---CCceEEecCCCcc
Q 041576 495 LVYEFMGNGTLANLLFAIP--RPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQ---DFTAKISDFGLSK 569 (714)
Q Consensus 495 lv~E~~~~gsL~~~l~~~~--~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~---~~~~kl~Dfg~~~ 569 (714)
+||||+++|+|.+++.... .+++.+++.++.||+.||+|||+++ |+||||||+||+++. ++.+||+|||++.
T Consensus 103 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~ 179 (336)
T 3fhr_A 103 IIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAK 179 (336)
T ss_dssp EEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEeccccce
Confidence 9999999999999998653 6899999999999999999999998 999999999999976 4559999999998
Q ss_pred ccccCcccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccce
Q 041576 570 LLLSDQSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDV 649 (714)
Q Consensus 570 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 649 (714)
..... ......+++.|+|||.+.+..++.++||||||+++|||++|+.||.............. ........
T Consensus 180 ~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~----~~~~~~~~- 251 (336)
T 3fhr_A 180 ETTQN---ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKR----RIRLGQYG- 251 (336)
T ss_dssp EC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------------C-
T ss_pred ecccc---ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHH----hhhccccc-
Confidence 65432 22334579999999999888899999999999999999999999975543321100000 00000000
Q ss_pred eecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHH--HHhcccCCC
Q 041576 650 LVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ--MLEGYLEVP 699 (714)
Q Consensus 650 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~~~~~ 699 (714)
.........+..+.+++.+||+.||++|||++|+++ .+.+....+
T Consensus 252 -----~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~ 298 (336)
T 3fhr_A 252 -----FPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVP 298 (336)
T ss_dssp -----CCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGGGSC
T ss_pred -----cCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccccCC
Confidence 000111223456888999999999999999999998 555544433
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-36 Score=324.12 Aligned_cols=200 Identities=26% Similarity=0.347 Sum_probs=168.9
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccC-cc-----cccceeceEecCCee
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTH-HK-----NLVQLLGFCDEGLNR 493 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~-----nIv~l~~~~~~~~~~ 493 (714)
..|.+.+.||+|+||+||+|... .+++.||||+++.. ......+..|+++++.++ |+ +|+++++++...+..
T Consensus 54 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 131 (382)
T 2vx3_A 54 DRYEIDSLIGKGSFGQVVKAYDR-VEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHL 131 (382)
T ss_dssp TTEEEEEEEEEETTEEEEEEEET-TTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEE
T ss_pred eeEEEEEEEeecCCEEEEEEEEc-CCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCce
Confidence 45777899999999999999876 56889999999753 234556778888888774 44 499999999999999
Q ss_pred eEEEeecCCCchhhhhhcC--CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEEC--CCCceEEecCCCcc
Q 041576 494 LLVYEFMGNGTLANLLFAI--PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLD--QDFTAKISDFGLSK 569 (714)
Q Consensus 494 ~lv~E~~~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~--~~~~~kl~Dfg~~~ 569 (714)
++||||+++ +|.+++... ..+++..+..++.||+.||+|||++. .+|+||||||+|||++ .++.+||+|||++.
T Consensus 132 ~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~-~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~ 209 (382)
T 2vx3_A 132 CLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPE-LSIIHCDLKPENILLCNPKRSAIKIVDFGSSC 209 (382)
T ss_dssp EEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTT-TCEECCCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred EEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCC-CCEEcCCCCcccEEEecCCCCcEEEEeccCce
Confidence 999999975 999999765 45899999999999999999999531 2499999999999994 47889999999998
Q ss_pred ccccCcccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCccccc
Q 041576 570 LLLSDQSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELG 627 (714)
Q Consensus 570 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~ 627 (714)
..... .....+|+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 210 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~ 263 (382)
T 2vx3_A 210 QLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE 263 (382)
T ss_dssp ETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 76432 2335689999999999999999999999999999999999999986543
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=326.96 Aligned_cols=243 Identities=23% Similarity=0.371 Sum_probs=199.8
Q ss_pred HHHhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchh------hHHHHHHHHHHHhccC--cccccceeceEec
Q 041576 418 NEATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQE------REREFKTEVSAIGRTH--HKNLVQLLGFCDE 489 (714)
Q Consensus 418 ~~at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--h~nIv~l~~~~~~ 489 (714)
....|.+.+.||+|+||.||+|... .+++.||||.++..... ....+.+|+.++++++ ||||+++++++..
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~ 119 (320)
T 3a99_A 41 LESQYQVGPLLGSGGFGSVYSGIRV-SDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER 119 (320)
T ss_dssp CTTTEEEEEECSSSSSCEEEEEEET-TTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred ccCceEEEEEEeeCCCeEEEEEEEC-CCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec
Confidence 3456778899999999999999865 57899999999653221 2245678999999995 5999999999999
Q ss_pred CCeeeEEEeecCC-CchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEEC-CCCceEEecCCC
Q 041576 490 GLNRLLVYEFMGN-GTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLD-QDFTAKISDFGL 567 (714)
Q Consensus 490 ~~~~~lv~E~~~~-gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~-~~~~~kl~Dfg~ 567 (714)
++..++|+|++.+ ++|.+++.....+++..++.++.||++||+|||+.+ |+||||||+||+++ +++.+||+|||+
T Consensus 120 ~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~Dfg~ 196 (320)
T 3a99_A 120 PDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGS 196 (320)
T ss_dssp SSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTT
T ss_pred CCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEeeCcc
Confidence 9999999999986 899999988788999999999999999999999998 99999999999999 789999999999
Q ss_pred ccccccCcccceeeecCCCCccCcccccCCCC-CchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCc
Q 041576 568 SKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPV-SAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGK 646 (714)
Q Consensus 568 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~ 646 (714)
+....... .....|+..|+|||.+.+..+ +.++||||||+++|||++|+.||....... .+.
T Consensus 197 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~--------------~~~ 259 (320)
T 3a99_A 197 GALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII--------------RGQ 259 (320)
T ss_dssp CEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHH--------------HCC
T ss_pred cccccccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhhh--------------ccc
Confidence 98764322 223458999999999987665 788999999999999999999996432110 000
Q ss_pred cceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 647 LDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 647 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
. . .....+..+.+++.+||+.||++|||++||++.
T Consensus 260 ~--~--------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 260 V--F--------FRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp C--C--------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred c--c--------ccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 0 011123467789999999999999999999873
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-36 Score=331.41 Aligned_cols=245 Identities=27% Similarity=0.332 Sum_probs=184.5
Q ss_pred hhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhcc-CcccccceeceEecCCeeeEEEeecCC
Q 041576 424 FEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRT-HHKNLVQLLGFCDEGLNRLLVYEFMGN 502 (714)
Q Consensus 424 ~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~E~~~~ 502 (714)
..+.||+|+||+||.+.. .+|+.||||++... ..+.+.+|+++++++ +||||+++++++.+++..++||||+.
T Consensus 19 ~~~~LG~G~~g~V~~~~~--~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~- 92 (434)
T 2rio_A 19 SEKILGYGSSGTVVFQGS--FQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN- 92 (434)
T ss_dssp EEEEEEECSTTCEEEEEE--SSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-
T ss_pred ccCeEeeCCCeEEEEEEE--ECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-
Confidence 457899999999986543 36899999998653 234678899999886 89999999999999999999999996
Q ss_pred CchhhhhhcCCCC-------ChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCC-------------CceEE
Q 041576 503 GTLANLLFAIPRP-------DWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQD-------------FTAKI 562 (714)
Q Consensus 503 gsL~~~l~~~~~~-------~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~-------------~~~kl 562 (714)
|+|.+++...... .+..++.++.||+.||+|||+++ |+||||||+|||++.+ +.+||
T Consensus 93 gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL 169 (434)
T 2rio_A 93 LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILI 169 (434)
T ss_dssp EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEE
T ss_pred CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEEEE
Confidence 5999999865432 33456789999999999999998 9999999999999754 48999
Q ss_pred ecCCCccccccCccc---ceeeecCCCCccCcccccC-------CCCCchhhhHHHHHHHHHHHh-cCCCCcccccchhh
Q 041576 563 SDFGLSKLLLSDQSR---TRTVIRGTRGYVAPEWFKN-------VPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEERS 631 (714)
Q Consensus 563 ~Dfg~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-------~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~ 631 (714)
+|||+++........ ......||+.|+|||++.+ ..++.++|||||||++|||++ |+.||........
T Consensus 170 ~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~- 248 (434)
T 2rio_A 170 SDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES- 248 (434)
T ss_dssp CCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHHH-
T ss_pred cccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhHH-
Confidence 999999877543322 1234569999999999975 578999999999999999999 9999964432211
Q ss_pred hhhhHHHhhhhhcCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 632 AILTDWAYDCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 632 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
. + ..+... ............+..+.+++.+||+.||++|||+.||++
T Consensus 249 ~-i--------~~~~~~---~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 249 N-I--------IRGIFS---LDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp H-H--------HHTCCC---CCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred H-H--------hcCCCC---cccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 0 0 001000 000111223445678889999999999999999999985
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-36 Score=315.08 Aligned_cols=250 Identities=23% Similarity=0.355 Sum_probs=178.4
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc--hhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEE
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA--QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVY 497 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 497 (714)
..|.+.+.||+|+||.||+|.+. .+++.||||++.... ....+.+.++..+++.++||||+++++++.+++..++||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 25 NDLENLGEMGSGTCGQVWKMRFR-KTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGEEEEEEC------CEEEEEET-TTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred ccccccceeeecCCeeEEEEEEe-cCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 34666789999999999999876 468899999996532 222344555566788889999999999999999999999
Q ss_pred eecCCCchhhhhhc-CCCCChhhHHHHHHHHHHHHHHHHhc-CCCCeEecCCCcCeEEECCCCceEEecCCCccccccCc
Q 041576 498 EFMGNGTLANLLFA-IPRPDWSLRVRISLEIARGLLYLHEE-CNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQ 575 (714)
Q Consensus 498 E~~~~gsL~~~l~~-~~~~~~~~~~~i~~qi~~~L~yLH~~-~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 575 (714)
||+ ++.+..+... ...+++..+..++.||++||+|||++ + |+||||||+||+++.++.+||+|||++.......
T Consensus 104 e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (318)
T 2dyl_A 104 ELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK 179 (318)
T ss_dssp CCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred ecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhccCCc
Confidence 999 4455555543 46789999999999999999999995 7 9999999999999999999999999997654322
Q ss_pred ccceeeecCCCCccCccccc-----CCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCcccee
Q 041576 576 SRTRTVIRGTRGYVAPEWFK-----NVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVL 650 (714)
Q Consensus 576 ~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 650 (714)
......++..|+|||.+. ...++.++||||||+++|||++|+.||....... ..+.. ...+.....
T Consensus 180 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~-----~~~~~~~~~ 250 (318)
T 2dyl_A 180 --AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDF--EVLTK-----VLQEEPPLL 250 (318)
T ss_dssp ---------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHH--HHHHH-----HHHSCCCCC
T ss_pred --cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccH--HHHHH-----HhccCCCCC
Confidence 223345899999999994 5568899999999999999999999997532211 11111 111111100
Q ss_pred ecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 651 VDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 651 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
. .....+..+.+++.+||+.||.+||+++|+++
T Consensus 251 ~-------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 251 P-------GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp C-------SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred C-------ccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 0 01122346778999999999999999999976
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-36 Score=341.94 Aligned_cols=273 Identities=23% Similarity=0.269 Sum_probs=203.7
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEeccc-chhhHHHHHHHHHHHhccCcccccceeceEec------CCe
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKL-AQEREREFKTEVSAIGRTHHKNLVQLLGFCDE------GLN 492 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~------~~~ 492 (714)
..|.+.+.||+|+||.||+|.+. .+++.||||+++.. .....+.+.+|++++++++||||+++++++.. ++.
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~-~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQ-DTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCT-TTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCeEEEEEEeeCCCeEEEEEEEC-CCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 56888899999999999999876 57899999998753 44556789999999999999999999999765 677
Q ss_pred eeEEEeecCCCchhhhhhcCC---CCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCc---eEEecCC
Q 041576 493 RLLVYEFMGNGTLANLLFAIP---RPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFT---AKISDFG 566 (714)
Q Consensus 493 ~~lv~E~~~~gsL~~~l~~~~---~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~---~kl~Dfg 566 (714)
.++||||+++++|.+++.... .+++..++.++.||+.||+|||+.+ |+||||||+||+++.++. +||+|||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEcccc
Confidence 899999999999999998654 5889999999999999999999998 999999999999997765 9999999
Q ss_pred CccccccCcccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhh-hhhhH-HHhhhh--
Q 041576 567 LSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERS-AILTD-WAYDCY-- 642 (714)
Q Consensus 567 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~-~~l~~-~~~~~~-- 642 (714)
++....... ......|+..|+|||.+.+..++.++||||||+++|||++|+.||......... ..+.. ......
T Consensus 170 ~a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~ 247 (676)
T 3qa8_A 170 YAKELDQGE--LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVY 247 (676)
T ss_dssp CCCBTTSCC--CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSC
T ss_pred ccccccccc--ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhh
Confidence 998764432 223456899999999999999999999999999999999999999653221100 00000 000000
Q ss_pred --hcCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHH-----HHHHHhcccCC
Q 041576 643 --VEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKM-----IVQMLEGYLEV 698 (714)
Q Consensus 643 --~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e-----vl~~L~~~~~~ 698 (714)
..+..................+..+.+++.+||+.||++|||+.| ..+.++.++..
T Consensus 248 ~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~ 310 (676)
T 3qa8_A 248 DDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSL 310 (676)
T ss_dssp CCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCC
T ss_pred hhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhc
Confidence 000000000000111233446678899999999999999999977 44555555443
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=307.43 Aligned_cols=236 Identities=13% Similarity=0.096 Sum_probs=187.1
Q ss_pred HHHHhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHHhccCcccccceeceEecCCee
Q 041576 417 LNEATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA---QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNR 493 (714)
Q Consensus 417 l~~at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 493 (714)
+...+|.+.+.||+|+||.||+|.+. .+++.||||.+.... ....+.+.+|+..+.+++||||+++++++.+++..
T Consensus 28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~ 106 (286)
T 3uqc_A 28 IANGRYRLLIFHGGVPPLQFWQALDT-ALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGG 106 (286)
T ss_dssp ETTTTEEEEEEEEBSTTCEEEEEEET-TTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred EecCcEEEEEEEcccCCeEEEEEEec-CCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcE
Confidence 34456888899999999999999875 568999999997532 33457899999999999999999999999999999
Q ss_pred eEEEeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCcccccc
Q 041576 494 LLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLS 573 (714)
Q Consensus 494 ~lv~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~ 573 (714)
++||||+++++|.+++... ....++.+|+.||++||+|||+++ |+||||||+||+++.++.+||++++
T Consensus 107 ~lv~e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~------- 174 (286)
T 3uqc_A 107 LVVAEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA------- 174 (286)
T ss_dssp EEEEECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC-------
T ss_pred EEEEEecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc-------
Confidence 9999999999999999653 456678999999999999999998 9999999999999999999998543
Q ss_pred CcccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecc
Q 041576 574 DQSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDN 653 (714)
Q Consensus 574 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 653 (714)
|++ .++.++||||||+++|||++|+.||............. .. ..+..
T Consensus 175 --------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~----~~-~~~~~------ 222 (286)
T 3uqc_A 175 --------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE----RD-TAGQP------ 222 (286)
T ss_dssp --------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECC----BC-TTSCB------
T ss_pred --------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHH----HH-hccCC------
Confidence 333 36899999999999999999999998654322100000 00 00000
Q ss_pred hhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCC
Q 041576 654 DKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLEV 698 (714)
Q Consensus 654 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 698 (714)
..........+..+.+++.+||+.||++| |+.|+++.|+++...
T Consensus 223 ~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~ 266 (286)
T 3uqc_A 223 IEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAV 266 (286)
T ss_dssp CCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC-
T ss_pred CChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhcc
Confidence 00011122334568889999999999999 999999999886644
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=326.28 Aligned_cols=246 Identities=24% Similarity=0.307 Sum_probs=183.9
Q ss_pred hhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhcc-CcccccceeceEecCCeeeEEEee
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRT-HHKNLVQLLGFCDEGLNRLLVYEF 499 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~E~ 499 (714)
++.+.+.||+|+||+|+.... .+++.||||++..... ..+.+|+++++++ +||||+++++++.+....++||||
T Consensus 25 ~y~~~~~LG~G~~G~V~~~~~--~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~ 99 (432)
T 3p23_A 25 SFCPKDVLGHGAEGTIVYRGM--FDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL 99 (432)
T ss_dssp EEEEEEEEEECGGGCEEEEEE--SSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred EEecCCeeecCcCEEEEEEEE--eCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence 455668999999999654332 3689999999965322 2356899999999 899999999999999999999999
Q ss_pred cCCCchhhhhhcCC-CCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECC-----CCceEEecCCCcccccc
Q 041576 500 MGNGTLANLLFAIP-RPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQ-----DFTAKISDFGLSKLLLS 573 (714)
Q Consensus 500 ~~~gsL~~~l~~~~-~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~-----~~~~kl~Dfg~~~~~~~ 573 (714)
+. |+|.+++.... ...+..++.++.||++||+|||+++ |+||||||+||+++. ...+||+|||+++....
T Consensus 100 ~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~ 175 (432)
T 3p23_A 100 CA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV 175 (432)
T ss_dssp CS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC--
T ss_pred CC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceeeccC
Confidence 97 59999997654 4566678899999999999999998 999999999999953 33688999999987654
Q ss_pred Ccc--cceeeecCCCCccCccccc---CCCCCchhhhHHHHHHHHHHHh-cCCCCcccccchhhhhhhHHHhhhhhcCcc
Q 041576 574 DQS--RTRTVIRGTRGYVAPEWFK---NVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEERSAILTDWAYDCYVEGKL 647 (714)
Q Consensus 574 ~~~--~~~~~~~gt~~y~aPE~~~---~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~ 647 (714)
... .......||+.|+|||++. ...++.++|||||||++|||++ |..||.......... .......
T Consensus 176 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~--------~~~~~~~ 247 (432)
T 3p23_A 176 GRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANI--------LLGACSL 247 (432)
T ss_dssp ----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHH--------HTTCCCC
T ss_pred CCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHH--------HhccCCc
Confidence 322 2233456999999999997 4567889999999999999999 899986432221100 0000000
Q ss_pred ceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 648 DVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 648 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
.. ..........+.+++.+||+.||++|||++||++
T Consensus 248 ~~-------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 248 DC-------LHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp TT-------SCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cc-------cCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 00 0112234456778999999999999999999984
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=344.00 Aligned_cols=241 Identities=22% Similarity=0.308 Sum_probs=194.4
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEeccc-chhhHHHHHHHHHHHhccCcccccceeceEecCCe-----e
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKL-AQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLN-----R 493 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~-----~ 493 (714)
.+|.+.+.||+|+||.||+|.+...+++.||||++... .......+.+|++++++++||||+++++++.+.+. .
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~ 159 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG 159 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence 46788899999999999999987556899999998643 34455688999999999999999999999987665 6
Q ss_pred eEEEeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCcccccc
Q 041576 494 LLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLS 573 (714)
Q Consensus 494 ~lv~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~ 573 (714)
++||||+++++|.+++.. .+++.+++.++.||++||+|||+++ |+||||||+||+++.+ .+||+|||+++....
T Consensus 160 ~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~ 233 (681)
T 2pzi_A 160 YIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVSRINS 233 (681)
T ss_dssp EEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCEETTC
T ss_pred EEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccchhccc
Confidence 999999999999998765 7899999999999999999999998 9999999999999986 999999999986643
Q ss_pred CcccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecc
Q 041576 574 DQSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDN 653 (714)
Q Consensus 574 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 653 (714)
. ....||+.|+|||++.+.. +.++|||||||++|||++|..|+....... +..
T Consensus 234 ~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~--------------------~~~- 286 (681)
T 2pzi_A 234 F-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDG--------------------LPE- 286 (681)
T ss_dssp C-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSS--------------------CCT-
T ss_pred C-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccc--------------------ccc-
Confidence 3 3446899999999987654 899999999999999999988876322110 000
Q ss_pred hhhhccchHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHhccc
Q 041576 654 DKAAMADKSRACKWLMIALWCIQEDPLKRP-AMKMIVQMLEGYL 696 (714)
Q Consensus 654 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~~~ 696 (714)
..........+.+++.+||+.||++|| +++++.+.|.+++
T Consensus 287 ---~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 327 (681)
T 2pzi_A 287 ---DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL 327 (681)
T ss_dssp ---TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred ---cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence 001112235678899999999999999 5666766666543
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-34 Score=301.37 Aligned_cols=238 Identities=20% Similarity=0.248 Sum_probs=181.1
Q ss_pred hhhh-hhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHH-hccCcccccceeceEec----CCeeeE
Q 041576 422 NGFE-EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAI-GRTHHKNLVQLLGFCDE----GLNRLL 495 (714)
Q Consensus 422 ~~~~-~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~h~nIv~l~~~~~~----~~~~~l 495 (714)
|.+. +.||+|+||.||+|... .+++.||+|+++.. ..+.+|++++ +..+||||+++++++.. ....++
T Consensus 19 y~~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~l 92 (299)
T 3m2w_A 19 YKVTSQVLGLGINGKVLQIFNK-RTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLI 92 (299)
T ss_dssp EEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred hhhcCcccccCCCeEEEEEEEc-CCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEE
Confidence 4444 67999999999999876 57899999999642 3567888887 55599999999999876 677899
Q ss_pred EEeecCCCchhhhhhcCC--CCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECC---CCceEEecCCCccc
Q 041576 496 VYEFMGNGTLANLLFAIP--RPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQ---DFTAKISDFGLSKL 570 (714)
Q Consensus 496 v~E~~~~gsL~~~l~~~~--~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~---~~~~kl~Dfg~~~~ 570 (714)
||||+++++|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+||+++. ++.+||+|||++..
T Consensus 93 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 169 (299)
T 3m2w_A 93 VMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 169 (299)
T ss_dssp EECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred EEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEeccccccc
Confidence 999999999999998754 6899999999999999999999998 999999999999998 78999999999864
Q ss_pred cccCcccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCcccee
Q 041576 571 LLSDQSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVL 650 (714)
Q Consensus 571 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 650 (714)
.. +..++.++||||||+++|||++|+.||............. .....+..
T Consensus 170 ~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~----~~~~~~~~--- 219 (299)
T 3m2w_A 170 TT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK----TRIRMGQY--- 219 (299)
T ss_dssp CT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSC----CSSCTTCC---
T ss_pred cc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHH----HHHhhccc---
Confidence 32 2346889999999999999999999997543322100000 00000000
Q ss_pred ecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHH--HHhcccCCCCC
Q 041576 651 VDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ--MLEGYLEVPSP 701 (714)
Q Consensus 651 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~~~~~~p 701 (714)
..........+..+.+++.+||+.||++|||+.|+++ .+.+....+.+
T Consensus 220 ---~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~~~~~ 269 (299)
T 3m2w_A 220 ---EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQT 269 (299)
T ss_dssp ---SSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGGSCCC
T ss_pred ---cCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccccCCCC
Confidence 0000001223457888999999999999999999998 45554444333
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-34 Score=306.06 Aligned_cols=244 Identities=16% Similarity=0.100 Sum_probs=184.1
Q ss_pred HHHHhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc--------hhhHHHHHHHHHHHhccC------------
Q 041576 417 LNEATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA--------QEREREFKTEVSAIGRTH------------ 476 (714)
Q Consensus 417 l~~at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~------------ 476 (714)
+....|.+.+.||+|+||+||+|+. +++.||||+++... ....+.+.+|+.++++++
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~---~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~n 93 (336)
T 2vuw_A 17 LPTEKLQRCEKIGEGVFGEVFQTIA---DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEG 93 (336)
T ss_dssp SCHHHHHTCEEEEEETTEEEEEEEE---TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCC
T ss_pred cccccchheeeecccCceEEEEEEe---CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCc
Confidence 3456788899999999999999986 47999999997532 223467888999888886
Q ss_pred --------------cccccceeceEec-------------CCeeeEEEeecCCCchhhhhhcCCCCChhhHHHHHHHHHH
Q 041576 477 --------------HKNLVQLLGFCDE-------------GLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIAR 529 (714)
Q Consensus 477 --------------h~nIv~l~~~~~~-------------~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~ 529 (714)
||||+++++++.+ ....++||||+++|++.+.+.. ..+++..+..++.||+.
T Consensus 94 iv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~ 172 (336)
T 2vuw_A 94 FIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTA 172 (336)
T ss_dssp BCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHH
T ss_pred hhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHH
Confidence 5555555555544 7889999999999977666644 56799999999999999
Q ss_pred HHHHHH-hcCCCCeEecCCCcCeEEECCCC--------------------ceEEecCCCccccccCcccceeeecCCCCc
Q 041576 530 GLLYLH-EECNVPIIHCDIKPQNILLDQDF--------------------TAKISDFGLSKLLLSDQSRTRTVIRGTRGY 588 (714)
Q Consensus 530 ~L~yLH-~~~~~~ivH~Dlk~~NIll~~~~--------------------~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y 588 (714)
||+||| +.+ |+||||||+|||++.++ .+||+|||+++..... ...||+.|
T Consensus 173 aL~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y 243 (336)
T 2vuw_A 173 SLAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVS 243 (336)
T ss_dssp HHHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCT
T ss_pred HHHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeecc
Confidence 999999 888 99999999999999887 8999999999866432 34689999
Q ss_pred cCcccccCCCCCchhhhHHHHHH-HHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhhccchHHHHHH
Q 041576 589 VAPEWFKNVPVSAKVDVYSFGVV-LLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMADKSRACKW 667 (714)
Q Consensus 589 ~aPE~~~~~~~s~ksDVwSlGvi-l~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 667 (714)
+|||++.+.. +.++||||+|++ .+++++|..||....... .+.. ........ ............+..+
T Consensus 244 ~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~---~~~~---~~~~~~~~----~~~~~~~~~~~~s~~~ 312 (336)
T 2vuw_A 244 MDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLH---YLTD---KMLKQMTF----KTKCNTPAMKQIKRKI 312 (336)
T ss_dssp TCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHH---HHHH---HHHHTCCC----SSCCCSHHHHHHHHHH
T ss_pred cChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhh---HHHH---hhhhhhcc----CcccchhhhhhcCHHH
Confidence 9999998766 899999998776 778899999985321000 0000 00000000 0011111234566789
Q ss_pred HHHHHHccccCCCCCCCHHHHH
Q 041576 668 LMIALWCIQEDPLKRPAMKMIV 689 (714)
Q Consensus 668 ~~li~~cl~~dP~~RPs~~evl 689 (714)
.+|+.+||+.| |++|++
T Consensus 313 ~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 313 QEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHHGGGSS-----SHHHHH
T ss_pred HHHHHHHhccC-----CHHHHH
Confidence 99999999976 999988
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-34 Score=314.71 Aligned_cols=236 Identities=17% Similarity=0.126 Sum_probs=175.0
Q ss_pred hhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHHhccCc-ccccceece-----------
Q 041576 422 NGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA---QEREREFKTEVSAIGRTHH-KNLVQLLGF----------- 486 (714)
Q Consensus 422 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h-~nIv~l~~~----------- 486 (714)
+.+.+.||+|+||.||+|.+. .+++.||||+++... ....+.+.+|+.+++.++| +|......+
T Consensus 80 ~~~~~~LG~G~fG~Vy~a~~~-~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 158 (413)
T 3dzo_A 80 LVRGTVLGQEDPYAYLEATDQ-ETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVK 158 (413)
T ss_dssp EEEEEEEEEETTEEEEEEEET-TTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEE
T ss_pred EEEecccccCCCEEEEEEEec-CCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcc
Confidence 344578999999999999976 578899999987322 2335789999999999976 332211111
Q ss_pred ----------Eec-----CCeeeEEEeecCCCchhhhhhc-------CCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEe
Q 041576 487 ----------CDE-----GLNRLLVYEFMGNGTLANLLFA-------IPRPDWSLRVRISLEIARGLLYLHEECNVPIIH 544 (714)
Q Consensus 487 ----------~~~-----~~~~~lv~E~~~~gsL~~~l~~-------~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH 544 (714)
+.. ....+++|+++ +++|.+++.. ...+++..++.++.||++||+|||+++ |+|
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---iiH 234 (413)
T 3dzo_A 159 DPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVH 234 (413)
T ss_dssp CCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEC
T ss_pred cCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccc
Confidence 111 12345666654 5799998841 234677889999999999999999998 999
Q ss_pred cCCCcCeEEECCCCceEEecCCCccccccCcccceeeecCCCCccCcccc----------cCCCCCchhhhHHHHHHHHH
Q 041576 545 CDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWF----------KNVPVSAKVDVYSFGVVLLK 614 (714)
Q Consensus 545 ~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~s~ksDVwSlGvil~e 614 (714)
|||||+||||+.++.+||+|||+++..... .....| +.|+|||++ ....++.++|||||||++||
T Consensus 235 rDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~e 309 (413)
T 3dzo_A 235 TYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYW 309 (413)
T ss_dssp SCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHH
T ss_pred CCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHH
Confidence 999999999999999999999998765332 333457 999999999 55568899999999999999
Q ss_pred HHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 041576 615 IICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIV 689 (714)
Q Consensus 615 lltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl 689 (714)
|++|+.||........... ++.. ....+..+.+++.+||+.||++||++.|++
T Consensus 310 lltg~~Pf~~~~~~~~~~~----------------~~~~------~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l 362 (413)
T 3dzo_A 310 IWCADLPNTDDAALGGSEW----------------IFRS------CKNIPQPVRALLEGFLRYPKEDRLLPLQAM 362 (413)
T ss_dssp HHHSSCCCCTTGGGSCSGG----------------GGSS------CCCCCHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred HHHCCCCCCCcchhhhHHH----------------HHhh------cccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 9999999975433221110 0000 001225688899999999999999977664
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=9e-31 Score=267.15 Aligned_cols=184 Identities=17% Similarity=0.215 Sum_probs=140.6
Q ss_pred ccccccccCCCCeeecCCCCCeEeeCCCeeeeeeecCCCCCCceEEEEEeecCCCCeeEEeeCCCCCCcccCC----ccE
Q 041576 18 PFLSAANIPLGSTLSSTSNNSSWISPSRDFAFGFRQLNNNSDLFLLAIWFNKMPERTIIWHANEDNHPVLAPR----GST 93 (714)
Q Consensus 18 ~~~~~~~~~~~~~~~~~~~~~~l~S~~g~F~lgFf~~~~~~~~~ylgIw~~~~~~~t~vW~Anr~~p~~~~~~----~~~ 93 (714)
+.++.++|++|++|++ +++|+|++|+|+||||+++ ++|| |+ +++ +|||||||+|+ .++ +++
T Consensus 10 ~~~~~~~l~~g~~l~~---~~~l~S~~g~F~lgf~~~~----~~~l---y~--~~~-vvW~Anr~~p~--~~~~~~~~~~ 74 (276)
T 3m7h_A 10 NGVGTSVLPAYQTLSA---GQYLLSPNQRFKLLLQGDG----NLVI---QD--NGA-TVWVANEQQPF--SSTIPLRNKK 74 (276)
T ss_dssp CCTTSSEECTTEEBCT---TCEEECTTSSEEEEECTTS----CEEE---EE--TTE-EEEECSTTSTT--EEEEECCCTT
T ss_pred ccccCCEecCCCEecC---CCEEEcCCCcEEEEEECCC----CeEE---EC--CCC-eEEECCCCCCc--CCcccccceE
Confidence 3457899999999984 7899999999999999432 3788 87 778 99999999984 333 778
Q ss_pred EEEcccc-eEE--eCCCCCeEEecCC-----------------------------CcccccCCCCCcCCcce----eccC
Q 041576 94 LELTATG-LLL--KDPGGQAIWDEKP-----------------------------NKISFKSPTDTILPTQI----FDLG 137 (714)
Q Consensus 94 l~~~~~g-lvl--~d~~~~~vWst~~-----------------------------~~qSFd~PtDTlLp~~~----l~~~ 137 (714)
|+|+.|| ||| .|++|++||+|+. .||| ||||||||||| |..+
T Consensus 75 l~l~~~G~Lvl~~~~~~~~~vWst~~~~~~~~~~~~~~~a~L~d~GNlVl~~~~~lWqS--~ptdtlLpg~~~~~~l~~g 152 (276)
T 3m7h_A 75 APLAFYVQYGAFLDDYSRRRVWLTDNSTFTSNDQWNRTHLVLQDDGNIVLVDSLALWNG--TPAIPLVPGAIDSLLLAPG 152 (276)
T ss_dssp CCSEEEESSSEEEEEGGGTEEEEECCCCCCCTTHHHHEEEEECTTSCEEEEEEEEEEES--CTTSCCCCSCTTCEEECSS
T ss_pred EEEeCCCcEEEEEeCCCCCEEEEeCCCcccccccCCceEEEEeCCCCEEecCCceeeCc--ccccccccccccccccccC
Confidence 9999999 999 7888999999863 1999 99999999999 7777
Q ss_pred ceEEecCCCCCCCCCceEEEee-CCCeeeeeccCCCcCcccccccccccccCC----------------Cccee--eE--
Q 041576 138 SVLVSRLTETNLSKGRFELHFS-NGSLQLIPVAWPTPSQYKSYYTSNTCSANS----------------SESGI--NY-- 196 (714)
Q Consensus 138 ~~l~S~~s~~dps~G~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------------~~~~~--~~-- 196 (714)
+.| ++.+||++|.|++.++ +|+++++ +.+ ...||+++++..+. .+... +.
T Consensus 153 ~~L---~S~~dps~G~fsl~l~~dGnlvLy---~~~---~~~yW~Sgt~~~~~~~l~l~~dGnLvl~d~~~~~vWsS~t~ 223 (276)
T 3m7h_A 153 SEL---VQGVVYGAGASKLVFQGDGNLVAY---GPN---GAATWNAGTQGKGAVRAVFQGDGNLVVYGAGNAVLWHSHTG 223 (276)
T ss_dssp EEE---CTTCEEEETTEEEEECTTSCEEEE---CTT---SSEEEECCCTTTTCCEEEECTTSCEEEECTTSCEEEECSCT
T ss_pred ccc---ccCCCCCCceEEEeecCCceEEEE---eCC---CeEEEECCCCCCccEEEEEcCCCeEEEEeCCCcEEEEecCC
Confidence 888 5678999999999999 7776653 221 24678766543211 00000 00
Q ss_pred --EEEeeeeeccceEEEEeecCCCCCCCCeEEEeecCcc
Q 041576 197 --LLFRATLDFDGVFTEYAYPKNSAPNQSWFTIQRLPNN 233 (714)
Q Consensus 197 --~~~~~~~~~~G~~~~~~~~~~~~~~~~w~~~~~~p~d 233 (714)
...+++++.||++++|.| . ..|..++..|..
T Consensus 224 ~~~~~rl~Ld~dGnLvly~~---~---~~Wqsf~~~P~~ 256 (276)
T 3m7h_A 224 GHASAVLRLQANGSIAILDE---K---PVWARFGFQPTY 256 (276)
T ss_dssp TCTTCEEEECTTSCEEEEEE---E---EEEESSSCCTTS
T ss_pred CCCCEEEEEcCCccEEEEcC---C---CeEEccCccCCc
Confidence 014789999999999999 2 478888877754
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=5.1e-29 Score=282.51 Aligned_cols=186 Identities=19% Similarity=0.091 Sum_probs=133.3
Q ss_pred hhCcccceeEEEeEeeCCCCcEEEEEEeccc----------chhhHHHHHHHHHHHhcc-CcccccceeceEecCCeeeE
Q 041576 427 ELGRGSFGIVYKGVLKSASGNAVAVKKLDKL----------AQEREREFKTEVSAIGRT-HHKNLVQLLGFCDEGLNRLL 495 (714)
Q Consensus 427 ~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~----------~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~l 495 (714)
..+.|+.|.+..++.. ..|+.+++|.+... .+...++|.+|+++|+++ +|+||+++++++++++..||
T Consensus 241 ~~~~~~~~~h~~~rr~-~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL 319 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRY-FFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL 319 (569)
T ss_dssp C-C--------CCEEE-EECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred ccccCCcccccccccc-cccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence 4667777766655433 35789999998542 223346799999999999 79999999999999999999
Q ss_pred EEeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCc
Q 041576 496 VYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQ 575 (714)
Q Consensus 496 v~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 575 (714)
||||++|++|.++|.....++.. +|+.||+.||+|||++| ||||||||+||||++++.+||+|||+++....+.
T Consensus 320 VMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~ 393 (569)
T 4azs_A 320 VMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC 393 (569)
T ss_dssp EEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC---
T ss_pred EEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCCCC
Confidence 99999999999999988777654 58999999999999999 9999999999999999999999999998765433
Q ss_pred ccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCC
Q 041576 576 SRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRS 621 (714)
Q Consensus 576 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p 621 (714)
. ......||+.|+|||++.+ .+..++|+||+|++++++.++..+
T Consensus 394 ~-~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 394 S-WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp C-CSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred c-cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 2 2334569999999999976 467789999999999888766544
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=3.2e-25 Score=250.00 Aligned_cols=182 Identities=17% Similarity=0.204 Sum_probs=146.1
Q ss_pred hhhhCcccceeEEEeEeeCCCCcEEEEEEecccc--------hhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEE
Q 041576 425 EEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA--------QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLV 496 (714)
Q Consensus 425 ~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 496 (714)
.+.||+|+||.||+|.. .++.+++|+..... ....+.+.+|++++++++||||+++..++...+..++|
T Consensus 341 ~~~LG~G~fg~Vy~~~~---~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 341 EHLIGKGAEADIKRDSY---LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp -------CCEEEEEEEC---SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCEEeeCCCEEEEEEEE---CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 46899999999999954 47889999864311 11245689999999999999999777777777888999
Q ss_pred EeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcc
Q 041576 497 YEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQS 576 (714)
Q Consensus 497 ~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 576 (714)
|||+++++|.+++.. +..++.||++||+|||+++ |+||||||+|||+++ .+||+|||+++.......
T Consensus 418 mE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~ 484 (540)
T 3en9_A 418 MSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDED 484 (540)
T ss_dssp EECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCCHHH
T ss_pred EECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCCccc
Confidence 999999999999976 6689999999999999998 999999999999999 999999999998754332
Q ss_pred cc------eeeecCCCCccCcccccC--CCCCchhhhHHHHHHHHHHHhcCCCC
Q 041576 577 RT------RTVIRGTRGYVAPEWFKN--VPVSAKVDVYSFGVVLLKIICCKRSV 622 (714)
Q Consensus 577 ~~------~~~~~gt~~y~aPE~~~~--~~~s~ksDVwSlGvil~elltG~~p~ 622 (714)
.. .....||+.|+|||++.. ..|+.++|+|+..+-.++-+.++.++
T Consensus 485 ~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 485 KAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred cccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 21 234579999999999986 56888999999998888887766654
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=99.88 E-value=8.5e-23 Score=204.90 Aligned_cols=158 Identities=20% Similarity=0.249 Sum_probs=117.8
Q ss_pred cccccccCCCCeeecCCCCCeEeeCCCeeeeeeecCCCCCCceEEEEEeecCCCCeeEEeeCCCCCCcccCCccEEEEcc
Q 041576 19 FLSAANIPLGSTLSSTSNNSSWISPSRDFAFGFRQLNNNSDLFLLAIWFNKMPERTIIWHANEDNHPVLAPRGSTLELTA 98 (714)
Q Consensus 19 ~~~~~~~~~~~~~~~~~~~~~l~S~~g~F~lgFf~~~~~~~~~ylgIw~~~~~~~t~vW~Anr~~p~~~~~~~~~l~~~~ 98 (714)
+++.++|++|++|++ +++| ++|.|+|||+.+++ +. +|.. +|+||+|||+.| +++.|+|++
T Consensus 5 ~~~~~~i~~g~~L~~---g~~l--~~g~f~l~f~~~gn------l~-ly~~---~~~vW~an~~~~-----~~~~l~l~~ 64 (236)
T 1dlp_A 5 FGLSHEGSHPQTLHA---AQSL--ELSSFRFTMQSDCN------LV-LFDS---DVRVWASNTAGA-----TGCRAVLQS 64 (236)
T ss_dssp BCSSSSSCSCSCCCT---TCEE--CSTTEEEEECTTSC------EE-EEES---SSEEECCCCCSC-----SCCBCCBCS
T ss_pred eeccceeCCCCEECC---CCEE--EcCCEEEEECCCCc------EE-EEEC---CEEEEECCCCCC-----CCeEEEEcC
Confidence 367899999999984 6788 59999999986543 22 4443 899999999975 567899999
Q ss_pred cc-eEEeCCCCCeEEecCC-----------------------CcccccCCCCCc----------CCcceeccC-ceEEec
Q 041576 99 TG-LLLKDPGGQAIWDEKP-----------------------NKISFKSPTDTI----------LPTQIFDLG-SVLVSR 143 (714)
Q Consensus 99 ~g-lvl~d~~~~~vWst~~-----------------------~~qSFd~PtDTl----------Lp~~~l~~~-~~l~S~ 143 (714)
|| |||.|++|.+||+|+. -||||||||||+ +||||++.+ ++|+|
T Consensus 65 dGnLvl~d~~~~~vW~s~~~~~~~~~~~~l~d~Gnlvl~~~~~W~S~~~p~~t~~lp~~g~d~L~~gq~~~~~~~~L~s- 143 (236)
T 1dlp_A 65 DGLLVILTAQNTIRWSSGTKGSIGNYVLVLQPDRTVTIYGPGLWDSGTSNKGSVVVANNGNSILYSTQGNDNHPQTLHA- 143 (236)
T ss_dssp SSCBCCBCTTTCCSCCCCCCCCSSCCEEEECSSSCEEEECSEEEECSCCCSSCCCCSSCCCEECCCC--CCCCCCEECS-
T ss_pred CCcEEEEcCCCcEEEeCCccccCCcEEEEEeCCCCEEEecCCEEECCCCCCcccccCCccceEEecCCcCCCccceEEc-
Confidence 99 9999999999999974 199999998665 777776654 46764
Q ss_pred CCCCCCCCCceEEEee-CCCeeeeeccCCCcCcccccccccccccCCCcceeeEEEEeeeeeccceEEEEee
Q 041576 144 LTETNLSKGRFELHFS-NGSLQLIPVAWPTPSQYKSYYTSNTCSANSSESGINYLLFRATLDFDGVFTEYAY 214 (714)
Q Consensus 144 ~s~~dps~G~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~G~~~~~~~ 214 (714)
..||++|.|++.++ +|+++++ ... ..||+++++... .. .++.++.+|++.+|..
T Consensus 144 --~~d~s~G~~~l~l~~dG~LvL~--~~~-----~~~W~s~~~~~~-----~~---~~~~L~~~Gnl~ly~~ 198 (236)
T 1dlp_A 144 --TQSLQLSPYRLSMETDCNLVLF--DRD-----DRVWSTNTAGKG-----TG---CRAVLQPNGRMDVLTN 198 (236)
T ss_dssp --SCCCBCSSCEEEEETTTEEEEE--BTT-----BCCSCCCCCSSC-----SS---CEEEEETTTEEEEEET
T ss_pred --CcEeecCcEEEEECCCCcEEEE--cCC-----EeEEeCCCcCCC-----Cc---eEEEECCCCcEEEEeC
Confidence 78999999999999 6655443 322 367888775221 11 1456778898887753
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=5.4e-22 Score=205.08 Aligned_cols=141 Identities=15% Similarity=0.070 Sum_probs=116.6
Q ss_pred hhhhhCcccceeEEEeEeeCCCCcEEEEEEecccch------------------hhHHHHHHHHHHHhccCcccccceec
Q 041576 424 FEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQ------------------EREREFKTEVSAIGRTHHKNLVQLLG 485 (714)
Q Consensus 424 ~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~h~nIv~l~~ 485 (714)
+.+.||+|+||.||+|.+ .+++.||||.++.... .....+.+|++++++++ | +++.+
T Consensus 94 ~~~~iG~G~~g~Vy~~~~--~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~ 168 (282)
T 1zar_A 94 IGKLMGEGKESAVFNCYS--EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPK 168 (282)
T ss_dssp EEEEEEECSSEEEEEEEE--TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCC
T ss_pred ecCEeccCCCceEEEEEe--CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCe
Confidence 458899999999999997 4789999999964221 13467899999999999 5 66666
Q ss_pred eEecCCeeeEEEeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecC
Q 041576 486 FCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDF 565 (714)
Q Consensus 486 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Df 565 (714)
++.. +..++||||+++++|.+ +. ......++.||++||+|||+.+ |+||||||+|||++ ++.+||+||
T Consensus 169 ~~~~-~~~~lvmE~~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl~-~~~vkl~DF 236 (282)
T 1zar_A 169 VYAW-EGNAVLMELIDAKELYR-VR------VENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVS-EEGIWIIDF 236 (282)
T ss_dssp EEEE-ETTEEEEECCCCEEGGG-CC------CSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE-TTEEEECCC
T ss_pred EEec-cceEEEEEecCCCcHHH-cc------hhhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEEE-CCcEEEEEC
Confidence 5544 55699999999999998 42 2345679999999999999998 99999999999999 999999999
Q ss_pred CCccccccCcccceeeecCCCCccCccccc
Q 041576 566 GLSKLLLSDQSRTRTVIRGTRGYVAPEWFK 595 (714)
Q Consensus 566 g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 595 (714)
|+++. +..+.|||++.
T Consensus 237 G~a~~--------------~~~~~a~e~l~ 252 (282)
T 1zar_A 237 PQSVE--------------VGEEGWREILE 252 (282)
T ss_dssp TTCEE--------------TTSTTHHHHHH
T ss_pred CCCeE--------------CCCCCHHHHHH
Confidence 99963 44578999874
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.74 E-value=4.8e-18 Score=173.19 Aligned_cols=137 Identities=19% Similarity=0.181 Sum_probs=106.3
Q ss_pred hhhhhhhCcccceeEEEeEeeCCCCcE--EEEEEecccch------------------------hhHHHHHHHHHHHhcc
Q 041576 422 NGFEEELGRGSFGIVYKGVLKSASGNA--VAVKKLDKLAQ------------------------EREREFKTEVSAIGRT 475 (714)
Q Consensus 422 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~--vavK~~~~~~~------------------------~~~~~~~~E~~~l~~l 475 (714)
+.+.+.||+|+||.||+|... .+|+. ||||+++.... .....+.+|++.+.++
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~-~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGV-FDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEE-ETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEc-CCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 345678999999999999873 25778 99998754211 1123688999999999
Q ss_pred Ccccc--cceeceEecCCeeeEEEeecCC-C----chhhhhhcCCCCChhhHHHHHHHHHHHHHHHH-hcCCCCeEecCC
Q 041576 476 HHKNL--VQLLGFCDEGLNRLLVYEFMGN-G----TLANLLFAIPRPDWSLRVRISLEIARGLLYLH-EECNVPIIHCDI 547 (714)
Q Consensus 476 ~h~nI--v~l~~~~~~~~~~~lv~E~~~~-g----sL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH-~~~~~~ivH~Dl 547 (714)
+|+++ ..++++ ...+|||||+.+ | +|.++... .++..+..++.||+.||.||| +.+ |+||||
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~g---ivHrDl 197 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAE---LVHADL 197 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSC---EECSSC
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCC---EEeCCC
Confidence 88864 344432 356899999942 4 66665432 235678899999999999999 887 999999
Q ss_pred CcCeEEECCCCceEEecCCCcccc
Q 041576 548 KPQNILLDQDFTAKISDFGLSKLL 571 (714)
Q Consensus 548 k~~NIll~~~~~~kl~Dfg~~~~~ 571 (714)
||+|||+++ .++|+|||++...
T Consensus 198 kp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 198 SEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp STTSEEESS--SEEECCCTTCEET
T ss_pred CHHHEEEcC--cEEEEECcccccC
Confidence 999999998 9999999999754
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=99.73 E-value=2.8e-17 Score=145.26 Aligned_cols=109 Identities=16% Similarity=0.283 Sum_probs=91.1
Q ss_pred cccccccCCCCeeecCCCCCeEe--eCCCeeeeeeecCCCCCCceEEEEEeecCCCCeeEEeeCCCCCCcccCCccEEEE
Q 041576 19 FLSAANIPLGSTLSSTSNNSSWI--SPSRDFAFGFRQLNNNSDLFLLAIWFNKMPERTIIWHANEDNHPVLAPRGSTLEL 96 (714)
Q Consensus 19 ~~~~~~~~~~~~~~~~~~~~~l~--S~~g~F~lgFf~~~~~~~~~ylgIw~~~~~~~t~vW~Anr~~p~~~~~~~~~l~~ 96 (714)
+.+.++|.+|++|. .|++|+ |++|.|+|+|+++++ . +||++ +++||+|||+.| +.++.|+|
T Consensus 5 ~~~~~~l~~g~~L~---~g~~l~~~S~~g~~~L~~~~dgn----l---vly~~---~~~vW~sn~~~~----~~~~~l~l 67 (119)
T 1b2p_A 5 FSKQPDDNHPQILH---ATESLEILFGTHVYRFIMQTDCN----L---VLYDN---NNPIWATNTGGL----GNGCRAVL 67 (119)
T ss_dssp ECSCSSSCCCCEEE---TTCEEEEEETTEEEEEEECTTSC----E---EEEET---TEEEEECCCTTS----CSSCEEEE
T ss_pred eecCcccCCCCEEc---CCCEEEEeCCCCCEEEEEecCCC----E---EEEEC---CEEEEeCCCccC----CCceEEEE
Confidence 36789999999999 478999 999999999998654 3 68975 899999999975 45678999
Q ss_pred cccc-eEEeCCCCCeEEecCCCcccccCCCCCcCCcceeccCceEEecCCCCCCCCCceEEEee-CCCeeeeeccCCCcC
Q 041576 97 TATG-LLLKDPGGQAIWDEKPNKISFKSPTDTILPTQIFDLGSVLVSRLTETNLSKGRFELHFS-NGSLQLIPVAWPTPS 174 (714)
Q Consensus 97 ~~~g-lvl~d~~~~~vWst~~~~qSFd~PtDTlLp~~~l~~~~~l~S~~s~~dps~G~~~~~~~-~~~~~~~~~~~~~~~ 174 (714)
.+|| |||.|.+|.+||+ || +||++|.|++.++ +|+++++-
T Consensus 68 ~~dGNLVl~d~~~~~lW~------S~-------------------------~~~~~g~~~l~l~~~Gnlvl~~------- 109 (119)
T 1b2p_A 68 QPDGVLVVITNENVTVWQ------SP-------------------------VAGKAGHYVLVLQPDRNVVIYG------- 109 (119)
T ss_dssp CTTSCEEEECTTCCEEEE------CS-------------------------CCCCSSCEEEEECTTSCEEEEE-------
T ss_pred ccCCEEEEEeCCCcEEEc------CC-------------------------CCCCCCCEEEEEECCCcEEEEC-------
Confidence 9999 9999999999999 66 4677899999998 78877642
Q ss_pred cccccccccc
Q 041576 175 QYKSYYTSNT 184 (714)
Q Consensus 175 ~~~~~~~~~~ 184 (714)
..||.+++
T Consensus 110 --~~~W~Sg~ 117 (119)
T 1b2p_A 110 --DALWATQT 117 (119)
T ss_dssp --SEEEECCC
T ss_pred --ccEeCCCC
Confidence 15788775
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.61 E-value=5.2e-16 Score=164.64 Aligned_cols=137 Identities=12% Similarity=0.080 Sum_probs=97.6
Q ss_pred hhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccch--------------hhHHHH--------HHHHHHHhccCccc
Q 041576 422 NGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQ--------------EREREF--------KTEVSAIGRTHHKN 479 (714)
Q Consensus 422 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~--------------~~~~~~--------~~E~~~l~~l~h~n 479 (714)
|.+...||+|++|.||+|... +|+.||||+++.... ...... .+|...|.++.+.+
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~--~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADE--KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECT--TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEecCEeeeCCceEEEEEECC--CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 567788999999999999874 689999998753110 011122 34555555554333
Q ss_pred ccceeceEecCCeeeEEEeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCC-
Q 041576 480 LVQLLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDF- 558 (714)
Q Consensus 480 Iv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~- 558 (714)
+.-..-+.. ...+|||||+++++|.++.. ......++.||+.+|.|||+.| ||||||||.|||+++++
T Consensus 175 v~vp~p~~~--~~~~LVME~i~G~~L~~l~~------~~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~~dgd 243 (397)
T 4gyi_A 175 FPVPEPIAQ--SRHTIVMSLVDALPMRQVSS------VPDPASLYADLIALILRLAKHG---LIHGDFNEFNILIREEKD 243 (397)
T ss_dssp CSCCCEEEE--ETTEEEEECCSCEEGGGCCC------CSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEEEEEC
T ss_pred CCCCeeeec--cCceEEEEecCCccHhhhcc------cHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeCCCC
Confidence 321111111 12379999999998876643 2345678999999999999998 99999999999998876
Q ss_pred ---------ceEEecCCCcccc
Q 041576 559 ---------TAKISDFGLSKLL 571 (714)
Q Consensus 559 ---------~~kl~Dfg~~~~~ 571 (714)
.+.|+||+-+...
T Consensus 244 ~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 244 AEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp SSCTTSEEEEEEECCCTTCEET
T ss_pred cccccccccceEEEEeCCcccC
Confidence 3899999988754
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=99.51 E-value=7.3e-14 Score=122.90 Aligned_cols=106 Identities=19% Similarity=0.386 Sum_probs=84.9
Q ss_pred ccccCCCCeeecCCCCCeEeeCCCeeeeeeecCCCCCCceEEEEEeecCCCCeeEEeeCCCCCCcccCCccEEEEcccc-
Q 041576 22 AANIPLGSTLSSTSNNSSWISPSRDFAFGFRQLNNNSDLFLLAIWFNKMPERTIIWHANEDNHPVLAPRGSTLELTATG- 100 (714)
Q Consensus 22 ~~~~~~~~~~~~~~~~~~l~S~~g~F~lgFf~~~~~~~~~ylgIw~~~~~~~t~vW~Anr~~p~~~~~~~~~l~~~~~g- 100 (714)
.|+|.+|++|.+ +++|+ +|.|+|+|++.++ . ++|+ ..++||+|||+.| ..++.|+|.++|
T Consensus 2 ~dtl~~gq~L~~---g~~L~--~g~~~L~~~~dgn----l---vly~---~~~~vW~sn~~~~----~~~~~l~l~~~Gn 62 (115)
T 2dpf_A 2 DNVLLSGQTLHA---DHSLQ--AGAYTLTIQNKCN----L---VKYQ---NGRQIWASNTDRR----GSGCRLTLLSDGN 62 (115)
T ss_dssp CCEEETTCEEET---TEEEE--ETTEEEEECTTSC----E---EEEE---TTEEEEECSCTTS----CSSCEEEECTTSC
T ss_pred CCEeCCCCEECC---CCEEE--CCCEEEEEcCCCc----E---EEEe---CCEEEEeCCCCCC----CCceEEEECCCCc
Confidence 367889999984 77898 7999999987643 3 2465 3899999999986 346789999999
Q ss_pred eEEeCCCCCeEEecCCCcccccCCCCCcCCcceeccCceEEecCCCCCCCCCceEEEee-CCCeeeeeccCCCcCccccc
Q 041576 101 LLLKDPGGQAIWDEKPNKISFKSPTDTILPTQIFDLGSVLVSRLTETNLSKGRFELHFS-NGSLQLIPVAWPTPSQYKSY 179 (714)
Q Consensus 101 lvl~d~~~~~vWst~~~~qSFd~PtDTlLp~~~l~~~~~l~S~~s~~dps~G~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 179 (714)
|||.|.+|.+||+ ||++ |++|.|++.++ +|+++++- . .|
T Consensus 63 Lvl~d~~~~~vW~------S~~~-------------------------~~~g~~~l~l~~dGnlvl~~----~-----~~ 102 (115)
T 2dpf_A 63 LVIYDHNNNDVWG------SACW-------------------------GDNGKYALVLQKDGRFVIYG----P-----VL 102 (115)
T ss_dssp EEEECTTCCEEEE------CCCC-------------------------CSSSCCEEEECTTSCEEEEC----S-----EE
T ss_pred EEEECCCceEEEE------cCCC-------------------------CCCCCEEEEEeCCCeEEEEC----C-----CE
Confidence 9999998999999 8876 45689999998 78877651 1 57
Q ss_pred ccccccc
Q 041576 180 YTSNTCS 186 (714)
Q Consensus 180 ~~~~~~~ 186 (714)
|.++++.
T Consensus 103 W~S~~~~ 109 (115)
T 2dpf_A 103 WSLGPNG 109 (115)
T ss_dssp ECSSTTC
T ss_pred EECCCCC
Confidence 8888764
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=99.51 E-value=9.7e-14 Score=120.92 Aligned_cols=106 Identities=17% Similarity=0.355 Sum_probs=85.5
Q ss_pred ccccCCCCeeecCCCCCeEeeCCCeeeeeeecCCCCCCceEEEEEeecCCCCeeEEeeCCCCCCcccCCccEEEEcccc-
Q 041576 22 AANIPLGSTLSSTSNNSSWISPSRDFAFGFRQLNNNSDLFLLAIWFNKMPERTIIWHANEDNHPVLAPRGSTLELTATG- 100 (714)
Q Consensus 22 ~~~~~~~~~~~~~~~~~~l~S~~g~F~lgFf~~~~~~~~~ylgIw~~~~~~~t~vW~Anr~~p~~~~~~~~~l~~~~~g- 100 (714)
+|+|.+|++|. .+++|+ ++|.|+|+|+..++ . |||+ ..++||.||++.| ..+..|+|.+||
T Consensus 1 ~d~l~~g~~L~---~g~~l~-~~~~~~l~~~~dGn----l---vl~~---~~~~vW~sn~~~~----~~~~~l~l~~dGN 62 (110)
T 3a0c_A 1 VNSLSSPNSLF---TGHSLE-VGPSYRLIMQGDCN----F---VLYD---SGKPVWASNTGGL----GSGCRLTLHNNGN 62 (110)
T ss_dssp CCEEETTCEEC---TTCEEE-ETTTEEEEECTTSC----E---EEEE---TTEEEEECCCTTS----CSSCEEEECTTSC
T ss_pred CCEeCCCCEEC---CCCEEE-ECCCEEEEEcCCCc----E---EEEE---CCEEEEECCCCCC----CCcEEEEEeCCCC
Confidence 36788899998 478999 99999999987643 3 7786 3799999999975 346789999999
Q ss_pred eEEeCCCCCeEEecCCCcccccCCCCCcCCcceeccCceEEecCCCCCCCCCceEEEee-CCCeeeeeccCCCcCccccc
Q 041576 101 LLLKDPGGQAIWDEKPNKISFKSPTDTILPTQIFDLGSVLVSRLTETNLSKGRFELHFS-NGSLQLIPVAWPTPSQYKSY 179 (714)
Q Consensus 101 lvl~d~~~~~vWst~~~~qSFd~PtDTlLp~~~l~~~~~l~S~~s~~dps~G~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 179 (714)
|||.|.+|.+||+ || +++++|.|++.++ +|+++++- . .|
T Consensus 63 LVl~~~~~~~~W~------S~-------------------------t~~~~g~~~l~l~~dGnlvl~~---~------~~ 102 (110)
T 3a0c_A 63 LVIYDQSNRVIWQ------TK-------------------------TNGKEDHYVLVLQQDRNVVIYG---P------VV 102 (110)
T ss_dssp EEEECTTCCEEEE------CC-------------------------CCCSSSCCEEEECTTSCEEEEC---S------EE
T ss_pred EEEECCCCcEEEe------cC-------------------------CCCCCCCEEEEEeCCccEEEEC---C------CE
Confidence 9999999999999 66 3567899999998 78877642 1 58
Q ss_pred cccccc
Q 041576 180 YTSNTC 185 (714)
Q Consensus 180 ~~~~~~ 185 (714)
|.+++.
T Consensus 103 W~S~~~ 108 (110)
T 3a0c_A 103 WATGSG 108 (110)
T ss_dssp EECSCC
T ss_pred ecCCCc
Confidence 887654
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=99.47 E-value=1.6e-13 Score=120.17 Aligned_cols=109 Identities=17% Similarity=0.425 Sum_probs=85.0
Q ss_pred ccccCCCCeeecCCCCCeEeeCCCeeeeeeecCCCCCCceEEEEEeecCCCCeeEEeeCCCCCCcccCCccEEEEcccc-
Q 041576 22 AANIPLGSTLSSTSNNSSWISPSRDFAFGFRQLNNNSDLFLLAIWFNKMPERTIIWHANEDNHPVLAPRGSTLELTATG- 100 (714)
Q Consensus 22 ~~~~~~~~~~~~~~~~~~l~S~~g~F~lgFf~~~~~~~~~ylgIw~~~~~~~t~vW~Anr~~p~~~~~~~~~l~~~~~g- 100 (714)
.|+|.+|++|. .+++| ++|.|+|+|+++++ . +||++ +++||+||++.+ ..++.|+|.++|
T Consensus 1 tdtl~~gq~L~---~g~~L--~~~~~~L~~~~dgn----l---vl~~~---~~~vW~sn~~~~----~~~~~l~l~~~GN 61 (112)
T 1xd5_A 1 SDRLNSGHQLD---TGGSL--AEGGYLFIIQNDCN----L---VLYDN---NRAVWASGTNGK----ASGCVLKMQNDGN 61 (112)
T ss_dssp CCEEETTEEEC---TTCEE--EETTEEEEECTTSC----E---EEEET---TEEEEECCCTTS----CSSEEEEECTTSC
T ss_pred CCCCCCCCEEC---CCCEE--eCCCEEEEEcCCCc----E---EEEEC---CEEEEeCCCcCC----CCCEEEEEeCCCC
Confidence 36788999998 47788 58999999998754 3 46765 799999999863 456789999999
Q ss_pred eEEeCCCCCeEEecCCCcccccCCCCCcCCcceeccCceEEecCCCCCCCCCceEEEee-CCCeeeeeccCCCcCccccc
Q 041576 101 LLLKDPGGQAIWDEKPNKISFKSPTDTILPTQIFDLGSVLVSRLTETNLSKGRFELHFS-NGSLQLIPVAWPTPSQYKSY 179 (714)
Q Consensus 101 lvl~d~~~~~vWst~~~~qSFd~PtDTlLp~~~l~~~~~l~S~~s~~dps~G~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 179 (714)
|||.| ++.+||+ ||+ +|++|.|++.++ +|+++++. .. ...|
T Consensus 62 Lvl~d-~~~~~W~------S~~-------------------------~~~~g~~~l~l~~dGnlvl~~---~~---~~~~ 103 (112)
T 1xd5_A 62 LVIYS-GSRAIWA------SNT-------------------------NRQNGNYYLILQRDRNVVIYD---NS---NNAI 103 (112)
T ss_dssp EEEEE-TTEEEEE------CCC-------------------------CCSCCCCEEEECTTSCEEEEC---TT---SCEE
T ss_pred EEEEc-CCEEEEE------CCc-------------------------cCCCCCEEEEEeCCCcEEEEC---CC---CceE
Confidence 99999 8889999 773 567799999999 78877652 11 2468
Q ss_pred cccccccc
Q 041576 180 YTSNTCSA 187 (714)
Q Consensus 180 ~~~~~~~~ 187 (714)
|.++++..
T Consensus 104 W~S~~~~g 111 (112)
T 1xd5_A 104 WATHTNVG 111 (112)
T ss_dssp EECCCCCC
T ss_pred EECCCccC
Confidence 98887643
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=99.26 E-value=4.5e-11 Score=102.82 Aligned_cols=95 Identities=18% Similarity=0.368 Sum_probs=74.9
Q ss_pred cccCCCCeeecCCCCCeEeeCCCeeeeeeecCCCCCCceEEEEEeecCCCCeeEEeeCCCCCCcccCCccEEEEcccc-e
Q 041576 23 ANIPLGSTLSSTSNNSSWISPSRDFAFGFRQLNNNSDLFLLAIWFNKMPERTIIWHANEDNHPVLAPRGSTLELTATG-L 101 (714)
Q Consensus 23 ~~~~~~~~~~~~~~~~~l~S~~g~F~lgFf~~~~~~~~~ylgIw~~~~~~~t~vW~Anr~~p~~~~~~~~~l~~~~~g-l 101 (714)
+++.+|+.|.+ |++|+| |.|.|.|...++ |.++. ..++||+|||++| ....+.|+|+.|| |
T Consensus 2 n~L~~g~~L~~---g~~L~s--g~y~l~~q~DgN------Lvly~----~~~~vW~ant~~~---~~~~~~L~l~~dGnL 63 (105)
T 4h3o_A 2 NILDNNEGLYA---GQSLDV--EPYHFIMQDDCN------LVLYD----HSTSTWASNTEIG---GKSGCSAVLQSDGNF 63 (105)
T ss_dssp CEECTTEEECT---TCEEEE--TTEEEEECTTSC------EEEEE----TTEEEEECCCCCT---TCCSCEEEECTTSCE
T ss_pred CCcCCCCEEcC---CCEEEE--CCEEEEECCCCe------EEEEE----CCEEEEEecCCCC---CCccEEEEEeCCccE
Confidence 56788999984 789988 789999876533 55644 3689999999997 2456789999999 9
Q ss_pred EEeCCCCCeEEecCCCcccccCCCCCcCCcceeccCceEEecCCCCCCCCCceEEEee-CCCeeee
Q 041576 102 LLKDPGGQAIWDEKPNKISFKSPTDTILPTQIFDLGSVLVSRLTETNLSKGRFELHFS-NGSLQLI 166 (714)
Q Consensus 102 vl~d~~~~~vWst~~~~qSFd~PtDTlLp~~~l~~~~~l~S~~s~~dps~G~~~~~~~-~~~~~~~ 166 (714)
||.|++|++||+|+.. ...|.+.+.++ +|++++|
T Consensus 64 vL~d~~~~~vWss~t~-------------------------------~~~~~~~l~L~ddGNlVly 98 (105)
T 4h3o_A 64 VVYDSSGRSLWASHST-------------------------------RGSGNYILILQDDGNVIIY 98 (105)
T ss_dssp EEECTTCCEEEECCCC-------------------------------CCSSCEEEEECTTSCEEEE
T ss_pred EEECCCcEEEEEecCC-------------------------------CCCCCEEEEEeCCCeEEEE
Confidence 9999999999996531 13467888887 8999886
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.23 E-value=2.8e-11 Score=123.16 Aligned_cols=140 Identities=16% Similarity=0.041 Sum_probs=111.0
Q ss_pred hhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhcc-CcccccceeceEecCCeeeEEEeec
Q 041576 422 NGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRT-HHKNLVQLLGFCDEGLNRLLVYEFM 500 (714)
Q Consensus 422 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~E~~ 500 (714)
+.+...++.|+.+.||++.. .++.+++|............+.+|+++++.+ .|..+.++++++.+.+..++||||+
T Consensus 16 ~~~~~~~~g~s~~~v~~~~~---~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i 92 (263)
T 3tm0_A 16 YRCVKDTEGMSPAKVYKLVG---ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEA 92 (263)
T ss_dssp SEEEECCSCCSSSEEEEEEC---SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECC
T ss_pred ceeEeeccCCCCCeEEEEEC---CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEec
Confidence 45567788888899999864 3689999998753223334688999999988 4677889999999888999999999
Q ss_pred CCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhc-------------------------------------------
Q 041576 501 GNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEE------------------------------------------- 537 (714)
Q Consensus 501 ~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~------------------------------------------- 537 (714)
+|.+|.+.+. +......++.+++++|+.||+.
T Consensus 93 ~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (263)
T 3tm0_A 93 DGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDP 167 (263)
T ss_dssp SSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSH
T ss_pred CCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCH
Confidence 9999987642 2334568899999999999981
Q ss_pred -------------CCCCeEecCCCcCeEEECCCCceEEecCCCcc
Q 041576 538 -------------CNVPIIHCDIKPQNILLDQDFTAKISDFGLSK 569 (714)
Q Consensus 538 -------------~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~ 569 (714)
....++|+|++|.||+++++..+.|+||+.+.
T Consensus 168 ~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 168 RELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 01348999999999999876667799999875
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=99.15 E-value=2.5e-10 Score=99.12 Aligned_cols=95 Identities=19% Similarity=0.365 Sum_probs=74.0
Q ss_pred cccCCCCeeecCCCCCeEeeCCCeeeeeeecCCCCCCceEEEEEeecCCCCeeEEeeCCCCCCcccCCccEEEEcccc-e
Q 041576 23 ANIPLGSTLSSTSNNSSWISPSRDFAFGFRQLNNNSDLFLLAIWFNKMPERTIIWHANEDNHPVLAPRGSTLELTATG-L 101 (714)
Q Consensus 23 ~~~~~~~~~~~~~~~~~l~S~~g~F~lgFf~~~~~~~~~ylgIw~~~~~~~t~vW~Anr~~p~~~~~~~~~l~~~~~g-l 101 (714)
++|.+|++|. .|++|+ +|.|+|+|...++ .+| |.. .++||+||++.+ +.+..|.|.+|| |
T Consensus 2 ntL~~gq~L~---~g~~L~--~g~~~L~~q~dGn----Lvl---y~~---~~~vW~snt~~~----~~~~~l~l~~dGNL 62 (109)
T 3dzw_A 2 NILYSGETLS---PGEFLN--NGRYVFIMQEDCN----LVL---YDV---DKPIWATNTGGL----DRRCHLSMQSDGNL 62 (109)
T ss_dssp CEEETTEEEC---TTCEEE--ETTEEEEECTTSC----EEE---EET---TEEEEECCCTTS----SSSCEEEECTTSCE
T ss_pred CCcCCCCEeC---CCCEEE--CCCEEEEEcCCCc----EEE---EeC---CEEEEECCcccC----CCCEEEEEeCCCCE
Confidence 4678899997 477886 7999999987654 433 764 699999999975 346789999999 9
Q ss_pred EEeCCCCCeEEecCCCcccccCCCCCcCCcceeccCceEEecCCCCCCCCCceEEEee-CCCeeeee
Q 041576 102 LLKDPGGQAIWDEKPNKISFKSPTDTILPTQIFDLGSVLVSRLTETNLSKGRFELHFS-NGSLQLIP 167 (714)
Q Consensus 102 vl~d~~~~~vWst~~~~qSFd~PtDTlLp~~~l~~~~~l~S~~s~~dps~G~~~~~~~-~~~~~~~~ 167 (714)
||.|.+|.++|+|+.. ...+.|.+.++ +|++++|-
T Consensus 63 vl~~~~~~~~W~S~t~-------------------------------~~~~~~~~~L~ddGNlvly~ 98 (109)
T 3dzw_A 63 VVYSPRNNPIWASNTG-------------------------------GENGNYVCVLQKDRNVVIYG 98 (109)
T ss_dssp EEECTTSCEEEECCCC-------------------------------CSSSCEEEEECTTSCEEEEE
T ss_pred EEECCCCCEEEECCCC-------------------------------CCCCCEEEEEeCCCEEEEEC
Confidence 9999999999996431 02356888888 89999873
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.02 E-value=4.4e-10 Score=113.83 Aligned_cols=128 Identities=15% Similarity=0.039 Sum_probs=97.5
Q ss_pred CcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCccc--ccceeceEecCCeeeEEEeecCCCchh
Q 041576 429 GRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKN--LVQLLGFCDEGLNRLLVYEFMGNGTLA 506 (714)
Q Consensus 429 g~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--Iv~l~~~~~~~~~~~lv~E~~~~gsL~ 506 (714)
+.|..+.||++.. .+|+.+++|..... ....+.+|+++++.+.+.+ +.+++++...++..++||||++|.+|.
T Consensus 29 ~gg~~~~v~~~~~--~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~ 103 (264)
T 1nd4_A 29 IGCSDAAVFRLSA--QGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL 103 (264)
T ss_dssp CTTSSCEEEEEEC--TTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred cCCCCceEEEEec--CCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC
Confidence 4566699999864 35778999997653 2245788999998885444 566888888888899999999998884
Q ss_pred hhhhcCCCCChhhHHHHHHHHHHHHHHHHhcC------------------------------------------------
Q 041576 507 NLLFAIPRPDWSLRVRISLEIARGLLYLHEEC------------------------------------------------ 538 (714)
Q Consensus 507 ~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~------------------------------------------------ 538 (714)
... .....++.++++.|+.||+..
T Consensus 104 --~~~------~~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 175 (264)
T 1nd4_A 104 --SSH------LAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLK 175 (264)
T ss_dssp --TSC------CCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHH
T ss_pred --cCc------CCHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHH
Confidence 211 123467888888899998743
Q ss_pred -------CCCeEecCCCcCeEEECCCCceEEecCCCcc
Q 041576 539 -------NVPIIHCDIKPQNILLDQDFTAKISDFGLSK 569 (714)
Q Consensus 539 -------~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~ 569 (714)
...++|+|++|.||+++++..+.|+||+.+.
T Consensus 176 ~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 176 ARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp HTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1129999999999999887667799999875
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.97 E-value=2.1e-09 Score=114.55 Aligned_cols=141 Identities=18% Similarity=0.248 Sum_probs=106.4
Q ss_pred hhhCcccceeEEEeEeeCCCCcEEEEEEec--ccc-hhhHHHHHHHHHHHhccC--cccccceeceEecC---CeeeEEE
Q 041576 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLD--KLA-QEREREFKTEVSAIGRTH--HKNLVQLLGFCDEG---LNRLLVY 497 (714)
Q Consensus 426 ~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~--~~~-~~~~~~~~~E~~~l~~l~--h~nIv~l~~~~~~~---~~~~lv~ 497 (714)
+.|+.|.++.||+.... +..+++|+.. ... ......+.+|+++++.+. +..+.+++.++.+. +..++||
T Consensus 44 ~~l~~G~sn~~y~v~~~---~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 44 EQFKGGQSNPTFKLVTP---GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EECCC-CCSCEEEEECS---SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred EEcCCcccceEEEEEEC---CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 56899999999998753 4688888876 322 122457888999999986 45688899988776 4479999
Q ss_pred eecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcC---------------------------------------
Q 041576 498 EFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEEC--------------------------------------- 538 (714)
Q Consensus 498 E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~--------------------------------------- 538 (714)
||++|..+.+... ..++..++..++.++++.|+.||+..
T Consensus 121 e~v~G~~l~~~~~--~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (359)
T 3dxp_A 121 EFVSGRVLWDQSL--PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMD 198 (359)
T ss_dssp ECCCCBCCCCTTC--TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHH
T ss_pred EecCCeecCCCcc--ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHH
Confidence 9999988854221 34677888899999999999999831
Q ss_pred ----------------CCCeEecCCCcCeEEECCCCc--eEEecCCCcccc
Q 041576 539 ----------------NVPIIHCDIKPQNILLDQDFT--AKISDFGLSKLL 571 (714)
Q Consensus 539 ----------------~~~ivH~Dlk~~NIll~~~~~--~kl~Dfg~~~~~ 571 (714)
...++|||+++.||+++.++. +.|+||+.+..-
T Consensus 199 ~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 199 SLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp HHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred HHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 245999999999999997753 689999988753
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=98.96 E-value=3.2e-09 Score=92.07 Aligned_cols=98 Identities=18% Similarity=0.335 Sum_probs=73.4
Q ss_pred cccccccCCCCeeecCCCCCeEeeCCCeeeeeeecCCCCCCceEEEEEeecCCCCeeEEeeCCCCCCcccCCccEEEEcc
Q 041576 19 FLSAANIPLGSTLSSTSNNSSWISPSRDFAFGFRQLNNNSDLFLLAIWFNKMPERTIIWHANEDNHPVLAPRGSTLELTA 98 (714)
Q Consensus 19 ~~~~~~~~~~~~~~~~~~~~~l~S~~g~F~lgFf~~~~~~~~~ylgIw~~~~~~~t~vW~Anr~~p~~~~~~~~~l~~~~ 98 (714)
+.+.++|.+|++|.. +++|+|. .|.|-| +..++ |.+ |.. ++||.+|++.. ..+..|+|.+
T Consensus 3 ~~~~dtL~~gq~L~~---g~~L~sg--~~~L~~-q~dGn-----Lvl-~~~----~~vW~snt~~~----~~~~~l~l~~ 62 (110)
T 3r0e_B 3 PFTNNLLFSGQVLYG---DGRLTAK--NHQLVM-QGDCN-----LVL-YGG----KYGWQSNTHGN----GEHCFLRLNH 62 (110)
T ss_dssp CCBTTEEETTCEEET---TEEEECS--SCEEEE-CTTSC-----EEE-ECS----SSCEECCCTTS----SSSCEEEECT
T ss_pred ccccCEECCCCEecC---CCEEEeC--CEEEEE-cCCCe-----EEE-ECC----eEEEECCCcCC----CcCEEEEEeC
Confidence 457899999999984 7799984 588855 33221 334 654 48999999863 3457899999
Q ss_pred cc-eEEeCCCCCeEEecCCCcccccCCCCCcCCcceeccCceEEecCCCCCCCCCceEEEee-CCCeeeee
Q 041576 99 TG-LLLKDPGGQAIWDEKPNKISFKSPTDTILPTQIFDLGSVLVSRLTETNLSKGRFELHFS-NGSLQLIP 167 (714)
Q Consensus 99 ~g-lvl~d~~~~~vWst~~~~qSFd~PtDTlLp~~~l~~~~~l~S~~s~~dps~G~~~~~~~-~~~~~~~~ 167 (714)
+| |||.|.+|.++|+|+.. -..|.|.+.++ +|++++|-
T Consensus 63 dGNLvl~d~~~~~iW~S~t~-------------------------------~~~~~~~~~L~~dGNlvly~ 102 (110)
T 3r0e_B 63 KGELIIKDDDFKTIWSSRSS-------------------------------SKQGEYVLILQDDGFGVIYG 102 (110)
T ss_dssp TSCEEEECTTCCEEEECCCC-------------------------------CSSSCCEEEECTTSCEEEEC
T ss_pred CCcEEEEeCCCCEEEEcCCc-------------------------------CCCCCEEEEEcCCccEEEec
Confidence 99 99999999999996431 02356888888 89999873
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=98.89 E-value=2e-08 Score=87.49 Aligned_cols=100 Identities=16% Similarity=0.265 Sum_probs=75.5
Q ss_pred cccccccCCCCeeecCCCCCeEeeCCCeeeeeeecCCCCCCceEEEEEeecCCCCeeEEeeCCCCCCcccCCccEEEEcc
Q 041576 19 FLSAANIPLGSTLSSTSNNSSWISPSRDFAFGFRQLNNNSDLFLLAIWFNKMPERTIIWHANEDNHPVLAPRGSTLELTA 98 (714)
Q Consensus 19 ~~~~~~~~~~~~~~~~~~~~~l~S~~g~F~lgFf~~~~~~~~~ylgIw~~~~~~~t~vW~Anr~~p~~~~~~~~~l~~~~ 98 (714)
+.+.++|.+|+.|.+ ++.|.+ |.|.|-|...++ |.+ |.. ...++||.+|+..+ ..+..|.|.+
T Consensus 3 ~~~~~tL~~gq~L~~---g~~L~~--g~~~L~~q~dGN------LvL-~~~-~~~~~vWssnt~~~----~~~~~l~l~~ 65 (113)
T 3mez_B 3 PRVRNVLFSSQVMYD---NAQLAT--RDYSLVMRDDCN------LVL-TKG-SKTNIVWESGTSGR----GQHCFMRLGH 65 (113)
T ss_dssp CCCSSEEETTCEEET---TCEEEE--TTEEEEECTTSC------EEE-EET-TTTEEEEECCCTTS----CSSCEEEECT
T ss_pred cccCCEeCCCCEECC---CCEeEc--CCEEEEEcCCCE------EEE-EEC-CCCEEEEECCcccC----CcCEEEEEeC
Confidence 346789999999984 668864 788888865432 455 332 14789999999875 3457899999
Q ss_pred cc-eEEeCCCCCeEEecCCCcccccCCCCCcCCcceeccCceEEecCCCCCCCCCceEEEee-CCCeeee
Q 041576 99 TG-LLLKDPGGQAIWDEKPNKISFKSPTDTILPTQIFDLGSVLVSRLTETNLSKGRFELHFS-NGSLQLI 166 (714)
Q Consensus 99 ~g-lvl~d~~~~~vWst~~~~qSFd~PtDTlLp~~~l~~~~~l~S~~s~~dps~G~~~~~~~-~~~~~~~ 166 (714)
+| |||.|.+|.++|+|+.. -..|.|.+.++ +|++++|
T Consensus 66 dGNLVl~d~~~~~iW~S~t~-------------------------------~~~~~~~~~L~~dGnlvly 104 (113)
T 3mez_B 66 SGELDITDDRLNTVFVSNTV-------------------------------GQEGDYVLILQINGQAVVY 104 (113)
T ss_dssp TSCEEEECTTSCEEEECSCC-------------------------------CSSSCCEEEECTTSCEEEE
T ss_pred CCcEEEECCCCCEEEECCCc-------------------------------CCCCCEEEEEcCCceEEEe
Confidence 99 99999999999996531 01356889998 8999987
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.85 E-value=2e-09 Score=112.01 Aligned_cols=186 Identities=18% Similarity=0.124 Sum_probs=123.4
Q ss_pred hhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhcc-Cccc--ccceeceEecCC---eeeEEEee
Q 041576 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRT-HHKN--LVQLLGFCDEGL---NRLLVYEF 499 (714)
Q Consensus 426 ~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~n--Iv~l~~~~~~~~---~~~lv~E~ 499 (714)
+.++.|....||+.. ..+++|..... .....+.+|+++++.+ .+.. +.+++....... ..|+|||+
T Consensus 26 ~~~~~G~~n~v~~v~------~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~ 97 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN------RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTK 97 (304)
T ss_dssp CEEEECSSEEEEEST------TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEEC
T ss_pred EecCCCCcceEEEEC------CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcc
Confidence 458899999999852 46888986543 3456788999999887 3333 345555443333 34899999
Q ss_pred cCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcC-----------------------------------------
Q 041576 500 MGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEEC----------------------------------------- 538 (714)
Q Consensus 500 ~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~----------------------------------------- 538 (714)
++|.+|.+... ..++..++..++.++++.|+.||+..
T Consensus 98 i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 175 (304)
T 3sg8_A 98 IKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDD 175 (304)
T ss_dssp CCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHH
T ss_pred cCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHH
Confidence 99998876433 34667778889999999999999611
Q ss_pred --------------CCCeEecCCCcCeEEECC--CCceEEecCCCccccccCcccceee-------------ecCCCCcc
Q 041576 539 --------------NVPIIHCDIKPQNILLDQ--DFTAKISDFGLSKLLLSDQSRTRTV-------------IRGTRGYV 589 (714)
Q Consensus 539 --------------~~~ivH~Dlk~~NIll~~--~~~~kl~Dfg~~~~~~~~~~~~~~~-------------~~gt~~y~ 589 (714)
...++|+|++|.||++++ ...+.|+||+.+............. .....+..
T Consensus 176 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~ 255 (304)
T 3sg8_A 176 FYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHK 255 (304)
T ss_dssp HHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCS
T ss_pred HHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCC
Confidence 134899999999999998 5568899999886542211100000 00000111
Q ss_pred C-cccccCCCCCchhhhHHHHHHHHHHHhcCCCCc
Q 041576 590 A-PEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVE 623 (714)
Q Consensus 590 a-PE~~~~~~~s~ksDVwSlGvil~elltG~~p~~ 623 (714)
. |+.... .....+.|+++.++|++.+|..++.
T Consensus 256 ~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 256 DIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp CHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred CcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 1 222111 1223689999999999999988764
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=98.55 E-value=2.8e-07 Score=79.60 Aligned_cols=103 Identities=23% Similarity=0.459 Sum_probs=76.3
Q ss_pred cccccCCCCeeecCCCCCeEeeCCCeeeeeeecCCCCCCceEEEEEeecCCCCeeEEeeCCCCCCcccCCccEEEEcccc
Q 041576 21 SAANIPLGSTLSSTSNNSSWISPSRDFAFGFRQLNNNSDLFLLAIWFNKMPERTIIWHANEDNHPVLAPRGSTLELTATG 100 (714)
Q Consensus 21 ~~~~~~~~~~~~~~~~~~~l~S~~g~F~lgFf~~~~~~~~~ylgIw~~~~~~~t~vW~Anr~~p~~~~~~~~~l~~~~~g 100 (714)
+.++|.+||.|.+ +++| .+|.|.|.|...++ . +.|.. +|.+|+..+ ..+..|+|.+||
T Consensus 2 ~~dtL~~gq~L~~---g~~L--~~g~~~L~~q~dGN----L---vl~~~------~Wssnt~~~----~~~~~l~l~~dG 59 (109)
T 3r0e_A 2 GTNYLLSGQTLDT---EGHL--KNGDFDLVMQDDCN----L---VLYNG------NWQSNTANN----GRDCKLTLTDYG 59 (109)
T ss_dssp CCSEEETTCEECT---TCEE--EETTEEEEECTTSC----E---EEETT------TEECCCTTS----CSSCEEEECTTS
T ss_pred ccCCcCCCCCcCC---CCEe--ECCCEEEEEecCCe----E---EEEeC------eEEcCCCCC----CCcEEEEEcCCC
Confidence 5688999999984 6778 46999999865443 2 23542 699999864 346789999999
Q ss_pred -eEEeCCCCCeEEecCCCcccccCCCCCcCCcceeccCceEEecCCCCCCCCCceEEEee-CCCeeeeeccCCCcCcccc
Q 041576 101 -LLLKDPGGQAIWDEKPNKISFKSPTDTILPTQIFDLGSVLVSRLTETNLSKGRFELHFS-NGSLQLIPVAWPTPSQYKS 178 (714)
Q Consensus 101 -lvl~d~~~~~vWst~~~~qSFd~PtDTlLp~~~l~~~~~l~S~~s~~dps~G~~~~~~~-~~~~~~~~~~~~~~~~~~~ 178 (714)
|||.|.++.++|+|+.. -..+.|.+.++ +|++++|. ..
T Consensus 60 nLvl~d~~~~~vWss~t~-------------------------------~~~~~~~~~L~~dGNlvly~---------~~ 99 (109)
T 3r0e_A 60 ELVIKNGDGSTVWKSGAQ-------------------------------SVKGNYAAVVHPDGRLVVFG---------PS 99 (109)
T ss_dssp CEEEECTTSCEEEECCCC-------------------------------CSSSCCEEEEETTTEEEEEC---------SE
T ss_pred eEEEEeCCCCEEEcCCCc-------------------------------CCCcCEEEEEcCCCeEEEEe---------cC
Confidence 99999999999996421 02367888988 89998873 24
Q ss_pred ccccccc
Q 041576 179 YYTSNTC 185 (714)
Q Consensus 179 ~~~~~~~ 185 (714)
.|.++++
T Consensus 100 ~W~s~t~ 106 (109)
T 3r0e_A 100 VFKIDPW 106 (109)
T ss_dssp EEEECTT
T ss_pred EECCCCc
Confidence 5777664
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=98.40 E-value=1.3e-06 Score=75.60 Aligned_cols=104 Identities=13% Similarity=0.298 Sum_probs=74.1
Q ss_pred cccCCCCeeecCCCCCeEeeCCCeeeeeeecCCCCCCceEEEEEeecCCCCeeEEeeCCCCCCcccCCccEEEEcccc-e
Q 041576 23 ANIPLGSTLSSTSNNSSWISPSRDFAFGFRQLNNNSDLFLLAIWFNKMPERTIIWHANEDNHPVLAPRGSTLELTATG-L 101 (714)
Q Consensus 23 ~~~~~~~~~~~~~~~~~l~S~~g~F~lgFf~~~~~~~~~ylgIw~~~~~~~t~vW~Anr~~p~~~~~~~~~l~~~~~g-l 101 (714)
++|.+|+.|.+ |+.| .+|.|.|-|...++ . +.|.. .. ||.+|+..+ ..+..|.|.++| |
T Consensus 3 ~~l~~gq~L~~---g~~L--~~g~~~L~~q~dGn----L---vl~~~---~~-vW~snt~~~----~~~~~l~l~~dGNL 62 (111)
T 3mez_A 3 NVLLTGDVIHT---DNQL--SYESAAFVMQGDCN----L---VLYNE---AG-GFQSNTHGR----GVDCTLRLNNRGQL 62 (111)
T ss_dssp TEEETTCEECT---TCEE--EETTEEEEECTTSC----E---EEECS---SC-CEECCCTTS----CSSCEEEECTTSCE
T ss_pred CEeCCCCEeCC---CCEE--ecCCEEEEEccCCe----E---EEECC---CC-EEECCcccC----CcCEEEEEcCCCcE
Confidence 56788999984 6678 36889999865432 3 22543 23 999999875 345789999999 9
Q ss_pred EEeCCCCC-eEEecCCCcccccCCCCCcCCcceeccCceEEecCCCCCCCCCceEEEee-CCCeeeeeccCCCcCccccc
Q 041576 102 LLKDPGGQ-AIWDEKPNKISFKSPTDTILPTQIFDLGSVLVSRLTETNLSKGRFELHFS-NGSLQLIPVAWPTPSQYKSY 179 (714)
Q Consensus 102 vl~d~~~~-~vWst~~~~qSFd~PtDTlLp~~~l~~~~~l~S~~s~~dps~G~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 179 (714)
||.|.++. ++|+|+.. .....|.|.+.++ +|++++|- ..+
T Consensus 63 Vl~~~~~~~~vW~S~t~-----------------------------~~~~~~~~~l~Lq~dGNlvly~---------~~~ 104 (111)
T 3mez_A 63 EIHSANSNTPVWVYPRS-----------------------------VNTVRGNYAATLGPDQHVTIYG---------PAI 104 (111)
T ss_dssp EEECSSCSSCSEEESSS-----------------------------CCCCSSCCEEEECTTSCEEEEC---------SEE
T ss_pred EEEeCCCCEEEEEeccc-----------------------------cCCCCcCEEEEECCCCeEEEec---------cCE
Confidence 99998876 59995410 1113478999998 89999873 356
Q ss_pred ccccc
Q 041576 180 YTSNT 184 (714)
Q Consensus 180 ~~~~~ 184 (714)
|.+++
T Consensus 105 W~s~t 109 (111)
T 3mez_A 105 WSTPA 109 (111)
T ss_dssp EECCC
T ss_pred EccCC
Confidence 76654
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.38 E-value=1.9e-06 Score=87.53 Aligned_cols=136 Identities=16% Similarity=0.092 Sum_probs=100.4
Q ss_pred hhCcccce-eEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccC-cccccceeceEecCCeeeEEEeecCCCc
Q 041576 427 ELGRGSFG-IVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTH-HKNLVQLLGFCDEGLNRLLVYEFMGNGT 504 (714)
Q Consensus 427 ~ig~G~~g-~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~E~~~~gs 504 (714)
.+..|..+ .||+.... ..+..+++|+-... ....+..|...|+.+. +--+.++++++.+++..++|||++++.+
T Consensus 31 ~~~~G~S~~~v~rl~~~-~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~ 106 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGK-PNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKT 106 (272)
T ss_dssp EEECSSSSCEEEEEECC-TTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEE
T ss_pred EccCCCcCCeEEEEEec-CCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcc
Confidence 34445444 68886544 34668899986543 3456788999888873 4447788999999999999999999988
Q ss_pred hhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcC----------------------------------------------
Q 041576 505 LANLLFAIPRPDWSLRVRISLEIARGLLYLHEEC---------------------------------------------- 538 (714)
Q Consensus 505 L~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~---------------------------------------------- 538 (714)
+.+.... .......+..++++.|+.||...
T Consensus 107 ~~~~~~~----~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 182 (272)
T 4gkh_A 107 AFQVLEE----YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKE 182 (272)
T ss_dssp HHHHHHH----CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHH
T ss_pred ccccccC----CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHH
Confidence 8776543 23345567778888888888521
Q ss_pred ---------CCCeEecCCCcCeEEECCCCceEEecCCCccc
Q 041576 539 ---------NVPIIHCDIKPQNILLDQDFTAKISDFGLSKL 570 (714)
Q Consensus 539 ---------~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~ 570 (714)
...++|+|+++.||++++++.+-|+||+.+..
T Consensus 183 l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 183 MHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 12379999999999999887778999998753
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.30 E-value=4.7e-06 Score=86.44 Aligned_cols=135 Identities=19% Similarity=0.163 Sum_probs=97.0
Q ss_pred hhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCcc---cccceeceEe-cCCeeeEEEeecC
Q 041576 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHK---NLVQLLGFCD-EGLNRLLVYEFMG 501 (714)
Q Consensus 426 ~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---nIv~l~~~~~-~~~~~~lv~E~~~ 501 (714)
+.++.|....||+. +..+++|+-.. ......+..|.++|+.+.+. .+.+++.+.. ..+..++|||+++
T Consensus 25 ~~l~~G~~n~v~~v------g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~ 96 (306)
T 3tdw_A 25 ESLGEGFRNYAILV------NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQ 96 (306)
T ss_dssp EEEEECSSEEEEEE------TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCC
T ss_pred eecCCCcceeEEEE------CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccC
Confidence 45788888899985 45788888543 23456789999999998642 3566677664 4556789999999
Q ss_pred CCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcC-------------------------------------------
Q 041576 502 NGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEEC------------------------------------------- 538 (714)
Q Consensus 502 ~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~------------------------------------------- 538 (714)
|.+|.+... ..++..+...++.++++.|+.||+..
T Consensus 97 G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ 174 (306)
T 3tdw_A 97 GQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTL 174 (306)
T ss_dssp SEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHH
T ss_pred CeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHH
Confidence 988876422 23355566667777777777776532
Q ss_pred --------------CCCeEecCCCcCeEEECC---CCc-eEEecCCCccc
Q 041576 539 --------------NVPIIHCDIKPQNILLDQ---DFT-AKISDFGLSKL 570 (714)
Q Consensus 539 --------------~~~ivH~Dlk~~NIll~~---~~~-~kl~Dfg~~~~ 570 (714)
...++|+|+++.||+++. ++. ..|+||+.+..
T Consensus 175 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 175 RFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 224699999999999987 455 48999998764
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.10 E-value=5.6e-06 Score=87.77 Aligned_cols=145 Identities=7% Similarity=0.042 Sum_probs=89.7
Q ss_pred hhh-CcccceeEEEeEee---CC--CCcEEEEEEecccc---hhhHHHHHHHHHHHhccC-c--ccccceeceEecC---
Q 041576 426 EEL-GRGSFGIVYKGVLK---SA--SGNAVAVKKLDKLA---QEREREFKTEVSAIGRTH-H--KNLVQLLGFCDEG--- 490 (714)
Q Consensus 426 ~~i-g~G~~g~Vy~~~~~---~~--~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h--~nIv~l~~~~~~~--- 490 (714)
+.| +.|....+|+.... +. +++.+++|...... ......+.+|+.+++.+. + ..+.+++.++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 456 88889999987643 00 15678898875432 101245778888888884 3 3567788887665
Q ss_pred CeeeEEEeecCCCchhhhhhc------CCCCChhhHHHHHHHHHHHH---------------------------------
Q 041576 491 LNRLLVYEFMGNGTLANLLFA------IPRPDWSLRVRISLEIARGL--------------------------------- 531 (714)
Q Consensus 491 ~~~~lv~E~~~~gsL~~~l~~------~~~~~~~~~~~i~~qi~~~L--------------------------------- 531 (714)
...++|||+++|..+.+.+.. ...++..++..++.++++.|
T Consensus 106 g~~~~v~e~l~G~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~La~LH~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 185 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPPDVMPYTFGDNWFADAPAERQRQLQDATVAALATLHSIPNAQNTFSFLTQGRTSDTTLHRHFNWV 185 (357)
T ss_dssp SSCEEEEECCCCBCCCBTTBGGGSCSTTTTSCHHHHHHHHHHHHHHHHHHTTCSSHHHHTGGGC-----CCHHHHHHHHH
T ss_pred CCceEEEEecCCCChhhcCcccccccccCCCCHHHHHHHHHHHHHHHHHHhCCCCccCChhhccCCCCCCchHHHHHHHH
Confidence 356899999998877643200 00112222222233333333
Q ss_pred ---------------------HHHHhc-------CCCCeEecCCCcCeEEECCCCceEEecCCCccc
Q 041576 532 ---------------------LYLHEE-------CNVPIIHCDIKPQNILLDQDFTAKISDFGLSKL 570 (714)
Q Consensus 532 ---------------------~yLH~~-------~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~ 570 (714)
.+|.+. ....++|+|+++.||+++++..+.|+||+.+..
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~l~HgDl~~~Nil~~~~~~~~vIDwe~a~~ 252 (357)
T 3ats_A 186 RSWYDFAVEGIGRSPLLERTFEWLQSHWPDDAAAREPVLLWGDARVGNVLYRDFQPVAVLDWEMVAL 252 (357)
T ss_dssp HHHHHHHHHHHCCCHHHHHHHHHHHHTCCHHHHHSCCEEECSSCSGGGEEEETTEEEEECCGGGCEE
T ss_pred HHHHHhhccCCCCChHHHHHHHHHHHhCCCcccCCCceEEeCCCCCCeEEEeCCcEEEEEccccccc
Confidence 333221 134599999999999999655579999998753
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.91 E-value=3.1e-05 Score=83.33 Aligned_cols=75 Identities=17% Similarity=0.164 Sum_probs=48.3
Q ss_pred hhhCcccceeEEEeEeeCCCCcEEEEEEecccch-------hhHHHHHHHHHHHhccCc--cc-ccceeceEecCCeeeE
Q 041576 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQ-------EREREFKTEVSAIGRTHH--KN-LVQLLGFCDEGLNRLL 495 (714)
Q Consensus 426 ~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h--~n-Iv~l~~~~~~~~~~~l 495 (714)
+.||.|..+.||++... .+++.++||....... .....+..|.++++.+.. +. +.+++.+ +.+..++
T Consensus 36 ~~lg~G~~n~vyrv~~~-~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 36 QEIGDGNLNYVFHIYDQ-EHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EECCSSSSEEEEEEEC-----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EECCCCceEEEEEEEEC-CCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 57899999999999754 2467899998653221 122356778888887732 33 3455543 3445689
Q ss_pred EEeecCCC
Q 041576 496 VYEFMGNG 503 (714)
Q Consensus 496 v~E~~~~g 503 (714)
|||++++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999864
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.78 E-value=0.00013 Score=75.53 Aligned_cols=74 Identities=16% Similarity=0.159 Sum_probs=59.1
Q ss_pred hhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccC---cccccceeceEecCCeeeEEEeecCC
Q 041576 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTH---HKNLVQLLGFCDEGLNRLLVYEFMGN 502 (714)
Q Consensus 426 ~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~nIv~l~~~~~~~~~~~lv~E~~~~ 502 (714)
+.|+.|....+|+... ++..+++|..... ....+..|.+.|+.+. ...+.+++.+....+..++||||+++
T Consensus 42 ~~l~gG~~n~~y~v~~---~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G 115 (312)
T 3jr1_A 42 EKLYSGEMNEIWLIND---EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK 115 (312)
T ss_dssp EEECCSSSSEEEEEES---SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred EEeCCccceeeeEEEE---CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence 4688999999999764 4678999987542 3567888999888883 35688899988888889999999998
Q ss_pred Cch
Q 041576 503 GTL 505 (714)
Q Consensus 503 gsL 505 (714)
..+
T Consensus 116 ~~~ 118 (312)
T 3jr1_A 116 SKN 118 (312)
T ss_dssp CCC
T ss_pred CCC
Confidence 765
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.73 E-value=7.8e-05 Score=80.85 Aligned_cols=79 Identities=11% Similarity=-0.001 Sum_probs=48.7
Q ss_pred CCeEecCCCcCeEEECCCCceEEecCCCccccccCcccceeeecCCCCccCcccccCC---CCCchhhhHHHHHHHHHHH
Q 041576 540 VPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNV---PVSAKVDVYSFGVVLLKII 616 (714)
Q Consensus 540 ~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~s~ksDVwSlGvil~ell 616 (714)
..++|||+++.||+++.++ ++|+||+.+..-............-...|.+|+..... .-....++......+|+.+
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y 310 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNLF 310 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHHH
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHHH
Confidence 4599999999999999876 99999998875432111100000011346666655321 1122456668888888887
Q ss_pred hcC
Q 041576 617 CCK 619 (714)
Q Consensus 617 tG~ 619 (714)
+++
T Consensus 311 ~~~ 313 (420)
T 2pyw_A 311 NKR 313 (420)
T ss_dssp HHH
T ss_pred HHH
Confidence 653
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.66 E-value=0.00019 Score=75.12 Aligned_cols=136 Identities=15% Similarity=0.181 Sum_probs=77.6
Q ss_pred hhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCc--ccccceec------eEecCCeeeEEEe
Q 041576 427 ELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHH--KNLVQLLG------FCDEGLNRLLVYE 498 (714)
Q Consensus 427 ~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~nIv~l~~------~~~~~~~~~lv~E 498 (714)
.|+.|..+.||+.... +..+++|+.... ...+..|+++++.+.. -.+.+++. +....+..+++||
T Consensus 39 ~l~gG~~n~~~~v~~~---~~~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~ 111 (346)
T 2q83_A 39 VIQGNQMALVWKVHTD---SGAVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD 111 (346)
T ss_dssp ECC----CEEEEEEET---TEEEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred eccccccCcEEEEEeC---CCCEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence 4566778899997653 345899998752 1233445555555431 12333333 1234567789999
Q ss_pred ecCCCchh-----------h---hhhc----CC-C---------CChhhH------------------------------
Q 041576 499 FMGNGTLA-----------N---LLFA----IP-R---------PDWSLR------------------------------ 520 (714)
Q Consensus 499 ~~~~gsL~-----------~---~l~~----~~-~---------~~~~~~------------------------------ 520 (714)
|++|..+. . .++. .. . ..|...
T Consensus 112 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 191 (346)
T 2q83_A 112 WIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQE 191 (346)
T ss_dssp CCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHH
T ss_pred eecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHH
Confidence 99986543 0 1111 00 0 012110
Q ss_pred -HHHHHHHHHHHHHHHh--------c--CCCCeEecCCCcCeEEECCCCceEEecCCCcc
Q 041576 521 -VRISLEIARGLLYLHE--------E--CNVPIIHCDIKPQNILLDQDFTAKISDFGLSK 569 (714)
Q Consensus 521 -~~i~~qi~~~L~yLH~--------~--~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~ 569 (714)
..+..++.+++++|+. . ....++|+|+++.||+++.++.+.|+||+.+.
T Consensus 192 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 192 IDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 0111224446677763 1 23569999999999999888899999999875
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.42 E-value=0.00042 Score=70.76 Aligned_cols=74 Identities=22% Similarity=0.267 Sum_probs=52.8
Q ss_pred hhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccC-c--ccccceeceEecCCeeeEEEeecCC
Q 041576 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTH-H--KNLVQLLGFCDEGLNRLLVYEFMGN 502 (714)
Q Consensus 426 ~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h--~nIv~l~~~~~~~~~~~lv~E~~~~ 502 (714)
+.+|.|..+.||+..+. +|+.++||+...........|..|++.|+.+. . --+.+++++. ..++||||++.
T Consensus 21 ~~~g~G~~~~vyrv~l~--DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~l~~ 94 (288)
T 3f7w_A 21 AERGHSHRWHLYRVELA--DGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEWVDE 94 (288)
T ss_dssp EEEEEETTEEEEEEEET--TSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEECCCC
T ss_pred EecCCCCCeEEEEEEEC--CCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEeecc
Confidence 56899999999998875 68999999876544333456788999888874 2 2244555442 34789999987
Q ss_pred Cch
Q 041576 503 GTL 505 (714)
Q Consensus 503 gsL 505 (714)
+..
T Consensus 95 ~~~ 97 (288)
T 3f7w_A 95 RPP 97 (288)
T ss_dssp CCC
T ss_pred cCC
Confidence 643
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=97.36 E-value=0.00095 Score=67.45 Aligned_cols=80 Identities=15% Similarity=0.323 Sum_probs=56.4
Q ss_pred cccccCCCCe----eecCCCCCeEeeCCCeeeeeeecCCC-CCCceEEEEEeecCCCCeeEEeeCCCCCCcccCCccEEE
Q 041576 21 SAANIPLGST----LSSTSNNSSWISPSRDFAFGFRQLNN-NSDLFLLAIWFNKMPERTIIWHANEDNHPVLAPRGSTLE 95 (714)
Q Consensus 21 ~~~~~~~~~~----~~~~~~~~~l~S~~g~F~lgFf~~~~-~~~~~ylgIw~~~~~~~t~vW~Anr~~p~~~~~~~~~l~ 95 (714)
..|++-+|+. +. .+++|+| +..++.|+|+..- .....+| |++ ..+++|.+++.++ .. ..|.
T Consensus 135 ptdtlLpg~~~~~~l~---~g~~L~S-~~dps~G~fsl~l~~dGnlvL---y~~--~~~~yW~Sgt~~~----~~-~~l~ 200 (276)
T 3m7h_A 135 PAIPLVPGAIDSLLLA---PGSELVQ-GVVYGAGASKLVFQGDGNLVA---YGP--NGAATWNAGTQGK----GA-VRAV 200 (276)
T ss_dssp TTSCCCCSCTTCEEEC---SSEEECT-TCEEEETTEEEEECTTSCEEE---ECT--TSSEEEECCCTTT----TC-CEEE
T ss_pred cccccccccccccccc---cCccccc-CCCCCCceEEEeecCCceEEE---EeC--CCeEEEECCCCCC----cc-EEEE
Confidence 4577777777 54 3667755 4678888876531 1112443 432 2689999999975 22 6899
Q ss_pred Ecccc-eEEeCCCCCeEEec
Q 041576 96 LTATG-LLLKDPGGQAIWDE 114 (714)
Q Consensus 96 ~~~~g-lvl~d~~~~~vWst 114 (714)
+..+| |++.|.++.++|++
T Consensus 201 l~~dGnLvl~d~~~~~vWsS 220 (276)
T 3m7h_A 201 FQGDGNLVVYGAGNAVLWHS 220 (276)
T ss_dssp ECTTSCEEEECTTSCEEEEC
T ss_pred EcCCCeEEEEeCCCcEEEEe
Confidence 99999 99999988999994
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.12 E-value=0.0012 Score=67.92 Aligned_cols=128 Identities=19% Similarity=0.227 Sum_probs=74.7
Q ss_pred hhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCcccc-cceeceEecCCeeeEEEeec-CC
Q 041576 425 EEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNL-VQLLGFCDEGLNRLLVYEFM-GN 502 (714)
Q Consensus 425 ~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~l~~~~~~~~~~~lv~E~~-~~ 502 (714)
.+.|+.|....+|+. ..+++|+....... .....+|+.+++.+....+ .+++++ +.+.-++++||+ ++
T Consensus 23 i~~l~gG~tN~~~~~-------~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g 92 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-------GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGA 92 (301)
T ss_dssp CEEEESCSSEEEEEE-------TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTC
T ss_pred eeEcCCcccccccee-------eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCC
Confidence 366888999999987 46888887643211 1123567777777643333 355544 344457899999 66
Q ss_pred CchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhc---------------------------------------------
Q 041576 503 GTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEE--------------------------------------------- 537 (714)
Q Consensus 503 gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~--------------------------------------------- 537 (714)
.+|....... +..++.++++.|+-||+.
T Consensus 93 ~~l~~~~~~~-------~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~ 165 (301)
T 3dxq_A 93 QTMSPEKFKT-------RPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSA 165 (301)
T ss_dssp EECCHHHHHH-------STTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHH
T ss_pred ccCCHhhHhh-------hHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHH
Confidence 5553210000 001222222222222221
Q ss_pred -----CCCCeEecCCCcCeEEECCCCceEEecCCCccc
Q 041576 538 -----CNVPIIHCDIKPQNILLDQDFTAKISDFGLSKL 570 (714)
Q Consensus 538 -----~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~ 570 (714)
....++|+|+.+.||+ .+++.+.|+||..+..
T Consensus 166 l~~~~~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 166 LAAHPLPLAACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp HHSSCCCCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHhcCCCceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 1234899999999999 5667889999998764
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.12 E-value=0.0029 Score=60.58 Aligned_cols=101 Identities=13% Similarity=0.037 Sum_probs=66.7
Q ss_pred CchhhhhhcC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcccceee
Q 041576 503 GTLANLLFAI-PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTV 581 (714)
Q Consensus 503 gsL~~~l~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 581 (714)
-+|.++|... .++++++++.++.|.+++|.-+-.+.. + ..+=+.|..|++..+|.+.+.+ ..+.
T Consensus 33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~-~-~~~i~~~~~i~l~~dG~V~f~~-~~s~------------ 97 (229)
T 2yle_A 33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQ-P-RHRVRSAAQIRVWRDGAVTLAP-AADD------------ 97 (229)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTC-C-CCCCCSGGGEEEETTSCEEECC-C---------------
T ss_pred ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhccc-C-CceecCCcceEEecCCceeccc-cccc------------
Confidence 3789999754 678999999999999999877632111 1 1233457999999999998874 1110
Q ss_pred ecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCC
Q 041576 582 IRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKR 620 (714)
Q Consensus 582 ~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~ 620 (714)
.....+.|||... ...+.+.=|||+|++||.-+--..
T Consensus 98 -~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL 134 (229)
T 2yle_A 98 -AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGL 134 (229)
T ss_dssp ----------CCSS-SSSCHHHHHHHHHHHHHHHHTTTC
T ss_pred -ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCC
Confidence 1233567888764 355789999999999999875333
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=97.12 E-value=0.00049 Score=59.05 Aligned_cols=61 Identities=26% Similarity=0.331 Sum_probs=44.2
Q ss_pred CCCcCCcceeccCceEEecCCCCCCCCCceEEEee-CCCeeeeeccCCCcCcccccccccccccCCCcceeeEEEEeeee
Q 041576 125 TDTILPTQIFDLGSVLVSRLTETNLSKGRFELHFS-NGSLQLIPVAWPTPSQYKSYYTSNTCSANSSESGINYLLFRATL 203 (714)
Q Consensus 125 tDTlLp~~~l~~~~~l~S~~s~~dps~G~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 203 (714)
+|||+|||.|..+..| +.|.|.|.++ +|+++++. .+|.+++... .. . ..+++
T Consensus 3 ~dtL~~gq~L~~g~~L---------~~g~~~L~~q~dGNLvl~~----------~~Wssnt~~~---~~--~---~~l~l 55 (109)
T 3r0e_A 3 TNYLLSGQTLDTEGHL---------KNGDFDLVMQDDCNLVLYN----------GNWQSNTANN---GR--D---CKLTL 55 (109)
T ss_dssp CSEEETTCEECTTCEE---------EETTEEEEECTTSCEEEET----------TTEECCCTTS---CS--S---CEEEE
T ss_pred cCCcCCCCCcCCCCEe---------ECCCEEEEEecCCeEEEEe----------CeEEcCCCCC---CC--c---EEEEE
Confidence 6999999999999999 3499999999 89998863 2576654311 11 1 14566
Q ss_pred eccceEEEE
Q 041576 204 DFDGVFTEY 212 (714)
Q Consensus 204 ~~~G~~~~~ 212 (714)
+.||++.+|
T Consensus 56 ~~dGnLvl~ 64 (109)
T 3r0e_A 56 TDYGELVIK 64 (109)
T ss_dssp CTTSCEEEE
T ss_pred cCCCeEEEE
Confidence 778888765
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.10 E-value=0.0019 Score=68.52 Aligned_cols=140 Identities=18% Similarity=0.230 Sum_probs=81.6
Q ss_pred hhhCcccceeEEEeEeeC------CCCcEEEEEEecccchhhHHHHHHHHHHHhccCccc-ccceeceEecCCeeeEEEe
Q 041576 426 EELGRGSFGIVYKGVLKS------ASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKN-LVQLLGFCDEGLNRLLVYE 498 (714)
Q Consensus 426 ~~ig~G~~g~Vy~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-Iv~l~~~~~~~~~~~lv~E 498 (714)
+.|..|-...+|+..... ..++.+++|+.... ......+.+|.++++.+.-.+ ..++++.+.++ +|||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~g----~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPEG----RLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETTE----EEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCCc----cEEE
Confidence 456678888899877531 13468999986432 123456678999988884322 35666666542 9999
Q ss_pred ecCCCchhhh-----------------hhcCC-----CCC--hhhHHHHHHHHHH-------------------HHHHHH
Q 041576 499 FMGNGTLANL-----------------LFAIP-----RPD--WSLRVRISLEIAR-------------------GLLYLH 535 (714)
Q Consensus 499 ~~~~gsL~~~-----------------l~~~~-----~~~--~~~~~~i~~qi~~-------------------~L~yLH 535 (714)
|++|.+|..- |+... ... +.++.++..++.. .+..|.
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 9998765421 11111 111 2334444433321 223332
Q ss_pred ----hc-CCCCeEecCCCcCeEEECCC----CceEEecCCCccc
Q 041576 536 ----EE-CNVPIIHCDIKPQNILLDQD----FTAKISDFGLSKL 570 (714)
Q Consensus 536 ----~~-~~~~ivH~Dlk~~NIll~~~----~~~kl~Dfg~~~~ 570 (714)
.. ....++|+|+.+.||+++.+ +.+.|+||..+..
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 22 23458999999999999876 7899999998853
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.05 E-value=0.0018 Score=70.13 Aligned_cols=74 Identities=15% Similarity=0.177 Sum_probs=49.3
Q ss_pred hhhCcccceeEEEeEeeCC------CCcEEEEEEecccchhhHHHHHHHHHHHhccCcccc-cceeceEecCCeeeEEEe
Q 041576 426 EELGRGSFGIVYKGVLKSA------SGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNL-VQLLGFCDEGLNRLLVYE 498 (714)
Q Consensus 426 ~~ig~G~~g~Vy~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~l~~~~~~~~~~~lv~E 498 (714)
+.|+.|....+|+...... .++.+++|+..... ....+..|..+++.+...++ .++++.+.+ .+|+|
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e 152 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 152 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEE
Confidence 4678888899999876421 24789999884321 11345578888888854444 566665543 28999
Q ss_pred ecCCCch
Q 041576 499 FMGNGTL 505 (714)
Q Consensus 499 ~~~~gsL 505 (714)
|+++.+|
T Consensus 153 ~l~G~~l 159 (429)
T 1nw1_A 153 YIPSRPL 159 (429)
T ss_dssp CCCEEEC
T ss_pred EeCCccc
Confidence 9987554
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.03 E-value=0.0013 Score=68.25 Aligned_cols=139 Identities=14% Similarity=0.124 Sum_probs=77.4
Q ss_pred hhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCccc--ccceece------EecCCeeeEEE
Q 041576 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKN--LVQLLGF------CDEGLNRLLVY 497 (714)
Q Consensus 426 ~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--Iv~l~~~------~~~~~~~~lv~ 497 (714)
+.|+.|....+|+.... ++ .+++|..... .....+..|+.++..+.... +.+++.. ....+..++++
T Consensus 28 ~~i~~G~~n~~~~v~~~--~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~ 102 (322)
T 2ppq_A 28 KGIAEGVENSNFLLHTT--KD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALI 102 (322)
T ss_dssp EEECC---EEEEEEEES--SC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEE
T ss_pred eccCCCcccceEEEEeC--Cc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEE
Confidence 34677888899997653 33 6889988652 11234556777776663222 2333321 12235678999
Q ss_pred eecCCCchhhh--------------hhcC------CC---C---ChhhHHH------------HHHHHHHHHHHHHhc--
Q 041576 498 EFMGNGTLANL--------------LFAI------PR---P---DWSLRVR------------ISLEIARGLLYLHEE-- 537 (714)
Q Consensus 498 E~~~~gsL~~~--------------l~~~------~~---~---~~~~~~~------------i~~qi~~~L~yLH~~-- 537 (714)
||++|..+... ++.. .. . .|..... +...+.+.++.+++.
T Consensus 103 ~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~ 182 (322)
T 2ppq_A 103 SFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWP 182 (322)
T ss_dssp ECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCC
T ss_pred EeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCc
Confidence 99998654210 1110 00 0 1111000 111244555666542
Q ss_pred --CCCCeEecCCCcCeEEECCCCceEEecCCCcc
Q 041576 538 --CNVPIIHCDIKPQNILLDQDFTAKISDFGLSK 569 (714)
Q Consensus 538 --~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~ 569 (714)
....++|+|+++.||+++++..+.|+||+.+.
T Consensus 183 ~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 183 KDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp CSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 12459999999999999987666899998875
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=97.00 E-value=0.0018 Score=55.89 Aligned_cols=81 Identities=19% Similarity=0.359 Sum_probs=53.8
Q ss_pred cCCccEEEEcccc-eEEeCC-CCCeEEecCCCcccccCCCCCcCCcceeccCceEEecCCCCCCCCCceEEEee-CCCee
Q 041576 88 APRGSTLELTATG-LLLKDP-GGQAIWDEKPNKISFKSPTDTILPTQIFDLGSVLVSRLTETNLSKGRFELHFS-NGSLQ 164 (714)
Q Consensus 88 ~~~~~~l~~~~~g-lvl~d~-~~~~vWst~~~~qSFd~PtDTlLp~~~l~~~~~l~S~~s~~dps~G~~~~~~~-~~~~~ 164 (714)
.+...+|.+..|| |||.+. .++++|+++.. .+.. ..++.++ +|+++
T Consensus 22 ~~g~~~L~~q~dGNLvL~~~~~~~~vWssnt~------------------------------~~~~-~~~l~l~~dGNLV 70 (113)
T 3mez_B 22 ATRDYSLVMRDDCNLVLTKGSKTNIVWESGTS------------------------------GRGQ-HCFMRLGHSGELD 70 (113)
T ss_dssp EETTEEEEECTTSCEEEEETTTTEEEEECCCT------------------------------TSCS-SCEEEECTTSCEE
T ss_pred EcCCEEEEEcCCCEEEEEECCCCEEEEECCcc------------------------------cCCc-CEEEEEeCCCcEE
Confidence 3466799999999 999987 48899997531 0111 2566777 78888
Q ss_pred eeeccCCCcCcccccccccccccCCCcceeeEEEEeeeeeccceEEEEe
Q 041576 165 LIPVAWPTPSQYKSYYTSNTCSANSSESGINYLLFRATLDFDGVFTEYA 213 (714)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~G~~~~~~ 213 (714)
++- ..+ ...|.+++... .+ . .+++++.||++++|.
T Consensus 71 l~d--~~~----~~iW~S~t~~~----~~-~---~~~~L~~dGnlvly~ 105 (113)
T 3mez_B 71 ITD--DRL----NTVFVSNTVGQ----EG-D---YVLILQINGQAVVYG 105 (113)
T ss_dssp EEC--TTS----CEEEECSCCCS----SS-C---CEEEECTTSCEEEEC
T ss_pred EEC--CCC----CEEEECCCcCC----CC-C---EEEEEcCCceEEEec
Confidence 763 221 24577665321 11 1 267899999999984
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=96.92 E-value=0.0012 Score=56.70 Aligned_cols=64 Identities=17% Similarity=0.130 Sum_probs=47.6
Q ss_pred CCCcCCcceeccCceEEecCCCCCCCCCceEEEee-CCCeeeeeccCCCcCcccccccccccccCCCcceeeEEEEeeee
Q 041576 125 TDTILPTQIFDLGSVLVSRLTETNLSKGRFELHFS-NGSLQLIPVAWPTPSQYKSYYTSNTCSANSSESGINYLLFRATL 203 (714)
Q Consensus 125 tDTlLp~~~l~~~~~l~S~~s~~dps~G~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 203 (714)
+|||+|||.|..+..|+| |.|+|.++ +|+++++- . ..+|.+++... ... .++++
T Consensus 6 ~dtL~~gq~L~~g~~L~s---------g~~~L~~q~dGnLvl~~--~------~~vW~snt~~~---~~~-----~~l~l 60 (110)
T 3r0e_B 6 NNLLFSGQVLYGDGRLTA---------KNHQLVMQGDCNLVLYG--G------KYGWQSNTHGN---GEH-----CFLRL 60 (110)
T ss_dssp TTEEETTCEEETTEEEEC---------SSCEEEECTTSCEEEEC--S------SSCEECCCTTS---SSS-----CEEEE
T ss_pred cCEECCCCEecCCCEEEe---------CCEEEEEcCCCeEEEEC--C------eEEEECCCcCC---CcC-----EEEEE
Confidence 799999999999999986 78999999 88988852 1 25787665421 111 14667
Q ss_pred eccceEEEEe
Q 041576 204 DFDGVFTEYA 213 (714)
Q Consensus 204 ~~~G~~~~~~ 213 (714)
..||+|.+|.
T Consensus 61 ~~dGNLvl~d 70 (110)
T 3r0e_B 61 NHKGELIIKD 70 (110)
T ss_dssp CTTSCEEEEC
T ss_pred eCCCcEEEEe
Confidence 8899998774
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.84 E-value=0.0069 Score=62.74 Aligned_cols=138 Identities=13% Similarity=0.068 Sum_probs=77.7
Q ss_pred hhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCcc--cccceece-----EecCCeeeEEEee
Q 041576 427 ELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHK--NLVQLLGF-----CDEGLNRLLVYEF 499 (714)
Q Consensus 427 ~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--nIv~l~~~-----~~~~~~~~lv~E~ 499 (714)
.++ |....||+.... +|+.+++|...... .....+..|..++..+... .+.+++.. ...++..+++||+
T Consensus 33 ~l~-g~~n~~y~v~~~--~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~ 108 (328)
T 1zyl_A 33 PLN-SYENRVYQFQDE--DRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPS 108 (328)
T ss_dssp EEC-CSSSEEEEECCT--TCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEEC
T ss_pred eec-CcccceEEEEcC--CCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEe
Confidence 355 777889986543 46689999986321 1234566777777777422 24444443 1223456789999
Q ss_pred cCCCchhh-----h---------hhc----C-----CCCChhhH----HHH---------------HHHHHHHHHHHHhc
Q 041576 500 MGNGTLAN-----L---------LFA----I-----PRPDWSLR----VRI---------------SLEIARGLLYLHEE 537 (714)
Q Consensus 500 ~~~gsL~~-----~---------l~~----~-----~~~~~~~~----~~i---------------~~qi~~~L~yLH~~ 537 (714)
++|..+.. . ++. . ...++... ..+ ...+.+.++.+...
T Consensus 109 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 188 (328)
T 1zyl_A 109 VGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAH 188 (328)
T ss_dssp CCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHH
T ss_pred cCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHH
Confidence 99865431 0 110 0 01111110 000 11111223333321
Q ss_pred ----CCCCeEecCCCcCeEEECCCCceEEecCCCccc
Q 041576 538 ----CNVPIIHCDIKPQNILLDQDFTAKISDFGLSKL 570 (714)
Q Consensus 538 ----~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~ 570 (714)
....++|||+++.||+++ + .+.|+||+.+..
T Consensus 189 ~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 189 WREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 233489999999999999 4 899999988753
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.82 E-value=0.0045 Score=64.43 Aligned_cols=32 Identities=28% Similarity=0.353 Sum_probs=27.5
Q ss_pred CCeEecCCCcCeEEECCC----CceEEecCCCcccc
Q 041576 540 VPIIHCDIKPQNILLDQD----FTAKISDFGLSKLL 571 (714)
Q Consensus 540 ~~ivH~Dlk~~NIll~~~----~~~kl~Dfg~~~~~ 571 (714)
..++|||+++.||+++.+ +.+.|+||+.+..-
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 459999999999999875 68999999988653
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=96.78 E-value=0.0046 Score=53.09 Aligned_cols=81 Identities=16% Similarity=0.214 Sum_probs=51.0
Q ss_pred CCccEEEEcccc-eEEeCCCCCeEEecCCCcccccCCCCCcCCcceeccCceEEecCCCCCCCCCceEEEee-CCCeeee
Q 041576 89 PRGSTLELTATG-LLLKDPGGQAIWDEKPNKISFKSPTDTILPTQIFDLGSVLVSRLTETNLSKGRFELHFS-NGSLQLI 166 (714)
Q Consensus 89 ~~~~~l~~~~~g-lvl~d~~~~~vWst~~~~qSFd~PtDTlLp~~~l~~~~~l~S~~s~~dps~G~~~~~~~-~~~~~~~ 166 (714)
....+|.+..|| |||.+.++ +|+++.. .+. ....+.++ +|+++++
T Consensus 19 ~g~~~L~~q~dGnLvl~~~~~--vW~snt~------------------------------~~~-~~~~l~l~~dGNLVl~ 65 (111)
T 3mez_A 19 YESAAFVMQGDCNLVLYNEAG--GFQSNTH------------------------------GRG-VDCTLRLNNRGQLEIH 65 (111)
T ss_dssp ETTEEEEECTTSCEEEECSSC--CEECCCT------------------------------TSC-SSCEEEECTTSCEEEE
T ss_pred cCCEEEEEccCCeEEEECCCC--EEECCcc------------------------------cCC-cCEEEEEcCCCcEEEE
Confidence 445789999999 99998876 9996531 011 12567777 8888876
Q ss_pred eccCCCcCcccccccccccccCCCcceeeEEEEeeeeeccceEEEEe
Q 041576 167 PVAWPTPSQYKSYYTSNTCSANSSESGINYLLFRATLDFDGVFTEYA 213 (714)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~G~~~~~~ 213 (714)
- ..+ ....|.+...... ..+ ..+++++.||++++|.
T Consensus 66 ~--~~~---~~~vW~S~t~~~~--~~~----~~~l~Lq~dGNlvly~ 101 (111)
T 3mez_A 66 S--ANS---NTPVWVYPRSVNT--VRG----NYAATLGPDQHVTIYG 101 (111)
T ss_dssp C--SSC---SSCSEEESSSCCC--CSS----CCEEEECTTSCEEEEC
T ss_pred e--CCC---CEEEEEeccccCC--CCc----CEEEEECCCCeEEEec
Confidence 3 211 1125765542111 111 1267899999999985
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.71 E-value=0.0049 Score=67.15 Aligned_cols=75 Identities=17% Similarity=0.091 Sum_probs=46.6
Q ss_pred hhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCcccc-cceeceEecCCeeeEEEeecCCCc
Q 041576 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNL-VQLLGFCDEGLNRLLVYEFMGNGT 504 (714)
Q Consensus 426 ~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~l~~~~~~~~~~~lv~E~~~~gs 504 (714)
+.|+.|-...+|+..... .+..+++|+....... .-....|..++..+...++ .++++.+.. .+|+||+++.+
T Consensus 114 ~~lsgG~tN~~y~v~~~~-~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I~G~~ 187 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMS-KQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFFTN----GRIEEFMDGYA 187 (458)
T ss_dssp EEECC--CEEEEEEEETT-TTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEETT----EEEEECCCSEE
T ss_pred EEcCCCeEeEEEEEEECC-CCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEeeCCcc
Confidence 568888889999987641 2468888887432211 1112578888888854444 567766632 25999999865
Q ss_pred hh
Q 041576 505 LA 506 (714)
Q Consensus 505 L~ 506 (714)
|.
T Consensus 188 l~ 189 (458)
T 2qg7_A 188 LS 189 (458)
T ss_dssp CC
T ss_pred CC
Confidence 53
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=96.56 E-value=0.0043 Score=52.68 Aligned_cols=65 Identities=23% Similarity=0.258 Sum_probs=47.6
Q ss_pred CCcCCcceeccCceEEecCCCCCCCCCceEEEee-CCCeeeeeccCCCcCcccccccccccccCCCcceeeEEEEeeeee
Q 041576 126 DTILPTQIFDLGSVLVSRLTETNLSKGRFELHFS-NGSLQLIPVAWPTPSQYKSYYTSNTCSANSSESGINYLLFRATLD 204 (714)
Q Consensus 126 DTlLp~~~l~~~~~l~S~~s~~dps~G~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 204 (714)
|||+|||.|..+..|+| |.|+|.|+ +|++++|- .. ...|.+++..... . . .++++.
T Consensus 2 n~L~~g~~L~~g~~L~s---------g~y~l~~q~DgNLvly~--~~-----~~vW~ant~~~~~--~--~---~~L~l~ 58 (105)
T 4h3o_A 2 NILDNNEGLYAGQSLDV---------EPYHFIMQDDCNLVLYD--HS-----TSTWASNTEIGGK--S--G---CSAVLQ 58 (105)
T ss_dssp CEECTTEEECTTCEEEE---------TTEEEEECTTSCEEEEE--TT-----EEEEECCCCCTTC--C--S---CEEEEC
T ss_pred CCcCCCCEEcCCCEEEE---------CCEEEEECCCCeEEEEE--CC-----EEEEEecCCCCCC--c--c---EEEEEe
Confidence 89999999999999987 99999999 89999873 21 3467665432111 1 1 146778
Q ss_pred ccceEEEEe
Q 041576 205 FDGVFTEYA 213 (714)
Q Consensus 205 ~~G~~~~~~ 213 (714)
.||+|.+|.
T Consensus 59 ~dGnLvL~d 67 (105)
T 4h3o_A 59 SDGNFVVYD 67 (105)
T ss_dssp TTSCEEEEC
T ss_pred CCccEEEEC
Confidence 899998874
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.51 E-value=0.0073 Score=63.87 Aligned_cols=75 Identities=16% Similarity=0.090 Sum_probs=43.6
Q ss_pred hhhCcccceeEEEeEeeCC-------CCcEEEEEEecccchhhHHHHHHHHHHHhccCccc-ccceeceEecCCeeeEEE
Q 041576 426 EELGRGSFGIVYKGVLKSA-------SGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKN-LVQLLGFCDEGLNRLLVY 497 (714)
Q Consensus 426 ~~ig~G~~g~Vy~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-Iv~l~~~~~~~~~~~lv~ 497 (714)
+.|+.|....+|+...... .++.+++|+....... ......|.++++.+...+ ..++++.. . -++||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~ 113 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIE 113 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEE
Confidence 4577788889999875420 1268888887543221 112467788887774333 34666544 1 36899
Q ss_pred eecCCCch
Q 041576 498 EFMGNGTL 505 (714)
Q Consensus 498 E~~~~gsL 505 (714)
||++|..+
T Consensus 114 e~i~G~~l 121 (369)
T 3c5i_A 114 EWLYGDPL 121 (369)
T ss_dssp ECCCSEEC
T ss_pred EEecCCcC
Confidence 99998654
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.40 E-value=0.024 Score=59.19 Aligned_cols=31 Identities=26% Similarity=0.380 Sum_probs=27.6
Q ss_pred CCeEecCCCcCeEEECCCCceEEecCCCccc
Q 041576 540 VPIIHCDIKPQNILLDQDFTAKISDFGLSKL 570 (714)
Q Consensus 540 ~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~ 570 (714)
..++|+|+.+.||++++++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 4599999999999999888999999987764
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=96.35 E-value=0.0086 Score=59.03 Aligned_cols=78 Identities=19% Similarity=0.351 Sum_probs=54.8
Q ss_pred CCeeeeeeecCCCCCCceEEEEEeecCCCCeeEEeeCCCCCCcccCCccEEEEcccc-eEEeCCCCCeEEecCCCccccc
Q 041576 44 SRDFAFGFRQLNNNSDLFLLAIWFNKMPERTIIWHANEDNHPVLAPRGSTLELTATG-LLLKDPGGQAIWDEKPNKISFK 122 (714)
Q Consensus 44 ~g~F~lgFf~~~~~~~~~ylgIw~~~~~~~t~vW~Anr~~p~~~~~~~~~l~~~~~g-lvl~d~~~~~vWst~~~~qSFd 122 (714)
.|.|.|.|-+. + -|-+|.. .+++|.++..+. ..+..+++.++| |++.+.++.++|+ ||.
T Consensus 149 ~G~~~l~l~~d-G-----~LvL~~~----~~~~W~s~~~~~----~~~~~~~L~~~Gnl~ly~~~~~~vw~------s~~ 208 (236)
T 1dlp_A 149 LSPYRLSMETD-C-----NLVLFDR----DDRVWSTNTAGK----GTGCRAVLQPNGRMDVLTNQNIAVWT------SGN 208 (236)
T ss_dssp CSSCEEEEETT-T-----EEEEEBT----TBCCSCCCCCSS----CSSCEEEEETTTEEEEEETTTEEEEE------CCC
T ss_pred cCcEEEEECCC-C-----cEEEEcC----CEeEEeCCCcCC----CCceEEEECCCCcEEEEeCCCcEEEE------eCC
Confidence 58899987432 2 1344533 258898876542 234678899999 9999888889999 663
Q ss_pred CCCCCcCCcceeccCceEEecCCCCCCCCCceEEEee-CCCeeee
Q 041576 123 SPTDTILPTQIFDLGSVLVSRLTETNLSKGRFELHFS-NGSLQLI 166 (714)
Q Consensus 123 ~PtDTlLp~~~l~~~~~l~S~~s~~dps~G~~~~~~~-~~~~~~~ 166 (714)
+ | ++|.|++.++ +|++++|
T Consensus 209 ~-------------------~------~~~~~rl~Ld~dG~l~ly 228 (236)
T 1dlp_A 209 S-------------------R------SAGRYVFVLQPDRNLAIY 228 (236)
T ss_dssp C-------------------C------SSSCCEEEECSSSCEEEE
T ss_pred C-------------------C------CCCCEEEEEcCCCcEEEe
Confidence 2 1 2378999999 7888887
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=96.14 E-value=0.0086 Score=51.17 Aligned_cols=64 Identities=20% Similarity=0.351 Sum_probs=47.0
Q ss_pred CCcCCcceeccCceEEecCCCCCCCCCceEEEee-CCCeeeeeccCCCcCcccccccccccccCCCcceeeEEEEeeeee
Q 041576 126 DTILPTQIFDLGSVLVSRLTETNLSKGRFELHFS-NGSLQLIPVAWPTPSQYKSYYTSNTCSANSSESGINYLLFRATLD 204 (714)
Q Consensus 126 DTlLp~~~l~~~~~l~S~~s~~dps~G~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 204 (714)
+||+|||.|..+..|+ .|.|.|.++ +|++++|-. ...+|.+++... ... ..+++.
T Consensus 2 ntL~~gq~L~~g~~L~---------~g~~~L~~q~dGnLvly~~-------~~~vW~snt~~~-----~~~---~~l~l~ 57 (109)
T 3dzw_A 2 NILYSGETLSPGEFLN---------NGRYVFIMQEDCNLVLYDV-------DKPIWATNTGGL-----DRR---CHLSMQ 57 (109)
T ss_dssp CEEETTEEECTTCEEE---------ETTEEEEECTTSCEEEEET-------TEEEEECCCTTS-----SSS---CEEEEC
T ss_pred CCcCCCCEeCCCCEEE---------CCCEEEEEcCCCcEEEEeC-------CEEEEECCcccC-----CCC---EEEEEe
Confidence 7999999999999995 499999999 899888631 146787765421 111 146778
Q ss_pred ccceEEEEe
Q 041576 205 FDGVFTEYA 213 (714)
Q Consensus 205 ~~G~~~~~~ 213 (714)
.||+|.+|.
T Consensus 58 ~dGNLvl~~ 66 (109)
T 3dzw_A 58 SDGNLVVYS 66 (109)
T ss_dssp TTSCEEEEC
T ss_pred CCCCEEEEC
Confidence 899998764
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=95.16 E-value=0.027 Score=48.50 Aligned_cols=65 Identities=25% Similarity=0.297 Sum_probs=47.8
Q ss_pred CCCcCCcceeccCceEEecCCCCCCCCCceEEEee-CCCeeeeeccCCCcCcccccccccccccCCCcceeeEEEEeeee
Q 041576 125 TDTILPTQIFDLGSVLVSRLTETNLSKGRFELHFS-NGSLQLIPVAWPTPSQYKSYYTSNTCSANSSESGINYLLFRATL 203 (714)
Q Consensus 125 tDTlLp~~~l~~~~~l~S~~s~~dps~G~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 203 (714)
.|||+|||.|..+..|+ .|.|.|.++ +|+++++- . ...+|.+++... ... ..+++
T Consensus 2 ~dtl~~gq~L~~g~~L~---------~g~~~L~~~~dgnlvly~---~----~~~vW~sn~~~~-----~~~---~~l~l 57 (115)
T 2dpf_A 2 DNVLLSGQTLHADHSLQ---------AGAYTLTIQNKCNLVKYQ---N----GRQIWASNTDRR-----GSG---CRLTL 57 (115)
T ss_dssp CCEEETTCEEETTEEEE---------ETTEEEEECTTSCEEEEE---T----TEEEEECSCTTS-----CSS---CEEEE
T ss_pred CCEeCCCCEECCCCEEE---------CCCEEEEEcCCCcEEEEe---C----CEEEEeCCCCCC-----CCc---eEEEE
Confidence 59999999999999987 499999998 88888752 1 246787765311 111 14667
Q ss_pred eccceEEEEe
Q 041576 204 DFDGVFTEYA 213 (714)
Q Consensus 204 ~~~G~~~~~~ 213 (714)
..||+|.++.
T Consensus 58 ~~~GnLvl~d 67 (115)
T 2dpf_A 58 LSDGNLVIYD 67 (115)
T ss_dssp CTTSCEEEEC
T ss_pred CCCCcEEEEC
Confidence 8899998874
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.58 E-value=0.051 Score=58.32 Aligned_cols=75 Identities=12% Similarity=0.095 Sum_probs=46.5
Q ss_pred hhhCcccceeEEEeEeeCCC------CcEEEEEEecccchhhHHHHHHHHHHHhccCccc-ccceeceEecCCeeeEEEe
Q 041576 426 EELGRGSFGIVYKGVLKSAS------GNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKN-LVQLLGFCDEGLNRLLVYE 498 (714)
Q Consensus 426 ~~ig~G~~g~Vy~~~~~~~~------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-Iv~l~~~~~~~~~~~lv~E 498 (714)
+.+..|-...+|+......+ ++.+++|+...... ..-...+|.++++.+...+ ..++++.+. -++|+|
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~-~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~e 150 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVG-KFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIEE 150 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEEE
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcc-hhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEEE
Confidence 45677888889988764211 57889988654321 1123357888887774323 345554332 278999
Q ss_pred ecCCCch
Q 041576 499 FMGNGTL 505 (714)
Q Consensus 499 ~~~~gsL 505 (714)
|++|.+|
T Consensus 151 fI~G~~l 157 (424)
T 3mes_A 151 FIDGEPL 157 (424)
T ss_dssp CCCSEEC
T ss_pred EeCCccC
Confidence 9998765
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=92.70 E-value=0.24 Score=42.79 Aligned_cols=68 Identities=21% Similarity=0.189 Sum_probs=49.4
Q ss_pred CCCCcCCcceeccCceEE--ecCCCCCCCCCceEEEee-CCCeeeeeccCCCcCcccccccccccccCCCcceeeEEEEe
Q 041576 124 PTDTILPTQIFDLGSVLV--SRLTETNLSKGRFELHFS-NGSLQLIPVAWPTPSQYKSYYTSNTCSANSSESGINYLLFR 200 (714)
Q Consensus 124 PtDTlLp~~~l~~~~~l~--S~~s~~dps~G~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (714)
=+|||.||+.|..+..|+ | ..|.|.|.++ +|++++|- . ....|..+.... ... ..
T Consensus 7 ~~~~l~~g~~L~~g~~l~~~S-------~~g~~~L~~~~dgnlvly~--~-----~~~vW~sn~~~~-----~~~---~~ 64 (119)
T 1b2p_A 7 KQPDDNHPQILHATESLEILF-------GTHVYRFIMQTDCNLVLYD--N-----NNPIWATNTGGL-----GNG---CR 64 (119)
T ss_dssp SCSSSCCCCEEETTCEEEEEE-------TTEEEEEEECTTSCEEEEE--T-----TEEEEECCCTTS-----CSS---CE
T ss_pred cCcccCCCCEEcCCCEEEEeC-------CCCCEEEEEecCCCEEEEE--C-----CEEEEeCCCccC-----CCc---eE
Confidence 378999999999999998 6 5699999998 88887652 1 245687665311 111 14
Q ss_pred eeeeccceEEEEe
Q 041576 201 ATLDFDGVFTEYA 213 (714)
Q Consensus 201 ~~~~~~G~~~~~~ 213 (714)
+++..||+|.+|.
T Consensus 65 l~l~~dGNLVl~d 77 (119)
T 1b2p_A 65 AVLQPDGVLVVIT 77 (119)
T ss_dssp EEECTTSCEEEEC
T ss_pred EEEccCCEEEEEe
Confidence 6778899998874
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=92.56 E-value=0.17 Score=43.09 Aligned_cols=40 Identities=18% Similarity=0.514 Sum_probs=31.2
Q ss_pred CCeeEEeeCCCCCCcccCCccEEEEcccc-eEEeCCCCCeEEecCCCcccccCC
Q 041576 72 ERTIIWHANEDNHPVLAPRGSTLELTATG-LLLKDPGGQAIWDEKPNKISFKSP 124 (714)
Q Consensus 72 ~~t~vW~Anr~~p~~~~~~~~~l~~~~~g-lvl~d~~~~~vWst~~~~qSFd~P 124 (714)
..++||..+.+.. +..-.|.+.++| |||.+. ++|+ ||+||
T Consensus 69 ~~~~~W~S~t~~~----~g~~~l~l~~dGnlvl~~~---~~W~------S~~~~ 109 (110)
T 3a0c_A 69 SNRVIWQTKTNGK----EDHYVLVLQQDRNVVIYGP---VVWA------TGSGP 109 (110)
T ss_dssp TCCEEEECCCCCS----SSCCEEEECTTSCEEEECS---EEEE------CSCCC
T ss_pred CCcEEEecCCCCC----CCCEEEEEeCCccEEEECC---CEec------CCCcC
Confidence 4679999987632 334579999999 999874 7888 99988
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=92.36 E-value=0.27 Score=41.88 Aligned_cols=43 Identities=21% Similarity=0.410 Sum_probs=33.2
Q ss_pred CCeeEEeeCCCCCCcccCCccEEEEcccc-eEEeCCCCCeEEecCCCcccccCC
Q 041576 72 ERTIIWHANEDNHPVLAPRGSTLELTATG-LLLKDPGGQAIWDEKPNKISFKSP 124 (714)
Q Consensus 72 ~~t~vW~Anr~~p~~~~~~~~~l~~~~~g-lvl~d~~~~~vWst~~~~qSFd~P 124 (714)
..++||..+.+.. +..-.|.|.+|| |||.+.++.++|+ ||++.
T Consensus 67 ~~~~~W~S~~~~~----~g~~~l~l~~dGnlvl~~~~~~~~W~------S~~~~ 110 (112)
T 1xd5_A 67 GSRAIWASNTNRQ----NGNYYLILQRDRNVVIYDNSNNAIWA------THTNV 110 (112)
T ss_dssp TTEEEEECCCCCS----CCCCEEEECTTSCEEEECTTSCEEEE------CCCCC
T ss_pred CCEEEEECCccCC----CCCEEEEEeCCCcEEEECCCCceEEE------CCCcc
Confidence 3579999986632 334579999999 9999877889999 77663
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=91.59 E-value=0.75 Score=48.84 Aligned_cols=29 Identities=31% Similarity=0.407 Sum_probs=25.0
Q ss_pred eEecCCCcCeEEE------CCCCceEEecCCCccc
Q 041576 542 IIHCDIKPQNILL------DQDFTAKISDFGLSKL 570 (714)
Q Consensus 542 ivH~Dlk~~NIll------~~~~~~kl~Dfg~~~~ 570 (714)
++|+|+.+.||++ +++..++++||..+..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 6799999999999 4567899999998864
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=88.72 E-value=1.6 Score=41.61 Aligned_cols=116 Identities=15% Similarity=0.165 Sum_probs=82.4
Q ss_pred CcccccceeceEecCCeeeEEEeecCC-CchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEE
Q 041576 476 HHKNLVQLLGFCDEGLNRLLVYEFMGN-GTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILL 554 (714)
Q Consensus 476 ~h~nIv~l~~~~~~~~~~~lv~E~~~~-gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll 554 (714)
.||+++.. .+-.+++...+.++.-+. -++.. + +..+...+++++.+|+....+++. -+|--|+|+||++
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-i---k~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~NL~f 112 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-I---KSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDELFF 112 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-G---GGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGGEEE
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-H---HhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecceEEE
Confidence 68888876 456666766666665442 23333 2 456788999999999998866665 4688999999999
Q ss_pred CCCCceEEecCCCccccccCcccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcc
Q 041576 555 DQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEM 624 (714)
Q Consensus 555 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~ 624 (714)
+.++.+++.--|+...+ +|. ..++..=.-.+=+++..+++++..|+.
T Consensus 113 ~~~~~p~i~~RGik~~l------------------~P~-----~~~ee~fL~qyKAliiall~~K~~Fe~ 159 (215)
T 4ann_A 113 TRDGLPIAKTRGLQNVV------------------DPL-----PVSEAEFLTRYKALVICAFNEKQSFDA 159 (215)
T ss_dssp CTTSCEEESCCEETTTB------------------SCC-----CCCHHHHHHHHHHHHHHHHCTTCCHHH
T ss_pred cCCCCEEEEEccCccCC------------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCCHHH
Confidence 99999999877764332 222 123333344678899999999998863
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=84.23 E-value=2 Score=41.03 Aligned_cols=115 Identities=9% Similarity=0.080 Sum_probs=80.5
Q ss_pred CcccccceeceEecCCeeeEEEeecCCC-chhhhhhcCCCCChhhHHHHHHHHHHHHH-HHHhcCCCCeEecCCCcCeEE
Q 041576 476 HHKNLVQLLGFCDEGLNRLLVYEFMGNG-TLANLLFAIPRPDWSLRVRISLEIARGLL-YLHEECNVPIIHCDIKPQNIL 553 (714)
Q Consensus 476 ~h~nIv~l~~~~~~~~~~~lv~E~~~~g-sL~~~l~~~~~~~~~~~~~i~~qi~~~L~-yLH~~~~~~ivH~Dlk~~NIl 553 (714)
.||++ -..+-.+++...+.++.-+++ ++..+ +..+...+++++.+|+.... +++. -+|--|+|+||+
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i----~~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~NL~ 116 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI----RKTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPENLM 116 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH----HTSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGGGEE
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH----HhcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCceEE
Confidence 67887 444456777777777765433 33332 45788899999999988777 6655 578889999999
Q ss_pred ECCCCceEEecCCCccccccCcccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcc
Q 041576 554 LDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEM 624 (714)
Q Consensus 554 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~ 624 (714)
++.++.++|.-.|+-.. ++|.- .++.-=.-++=+++..++.++..|+.
T Consensus 117 f~~~~~p~i~hRGi~~~------------------lpP~e-----~~ee~fl~qyKali~all~~K~~Fe~ 164 (219)
T 4ano_A 117 FNRALEPFFLHVGVKES------------------LPPDE-----WDDERLLREVKATVLALTEGEYRFDE 164 (219)
T ss_dssp ECTTCCEEESCCEETTT------------------BSSCS-----CCHHHHHHHHHHHHHHHTTCSSCHHH
T ss_pred EeCCCcEEEEEcCCccc------------------CCCCC-----CCHHHHHHHHHHHHHHHHcCCCCHHH
Confidence 99999999988776543 23321 12222234677888899999888863
|
| >1edm_B Factor IX; epidermal growth factor, EGF, calcium- binding, EGF-like domain, structure and function, coagulation factor; 1.50A {Homo sapiens} SCOP: g.3.11.1 PDB: 1ixa_A | Back alignment and structure |
|---|
Probab=83.54 E-value=0.3 Score=32.60 Aligned_cols=30 Identities=23% Similarity=0.426 Sum_probs=23.9
Q ss_pred ccccccccCCCcCccCCCcccccCCCCCcccCCCCCc
Q 041576 233 NICTSISDEFGSGACGFNSYCLLQNGRPFCECPPEYL 269 (714)
Q Consensus 233 d~Cd~y~~~~~~~~CG~~g~C~~~~~~~~C~C~~gf~ 269 (714)
|.|.. ..|...|.|.....+..|.|++||+
T Consensus 4 d~C~~-------~pC~ngg~C~~~~~~~~C~C~~G~~ 33 (39)
T 1edm_B 4 DQCES-------NPCLNGGSCKDDINSYECWCPFGFE 33 (39)
T ss_dssp CTTTT-------CCCCTTCEEEEETTEEEEECCTTCC
T ss_pred ccCCC-------CCCCCCCEeEcCCCceEeECCCCCc
Confidence 56765 6798899997655567899999996
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 714 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-68 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 4e-64 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 4e-64 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-63 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-63 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 8e-62 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-61 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-61 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 7e-61 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-60 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 5e-60 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 6e-60 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-59 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 4e-59 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 6e-59 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 4e-58 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 6e-58 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-57 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 4e-57 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-56 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 4e-56 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-55 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-55 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-55 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 4e-55 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-54 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 5e-54 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-53 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-53 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-50 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-50 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-49 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 6e-48 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 9e-48 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-47 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-44 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-44 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-44 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 9e-44 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-43 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-43 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-42 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 8e-42 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-41 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-41 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 3e-41 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 4e-41 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 5e-41 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-40 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-39 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-38 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-38 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-37 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 7e-37 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 3e-36 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 4e-36 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-35 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 5e-34 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-32 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-32 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 7e-30 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-27 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 9e-20 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 223 bits (569), Expect = 3e-68
Identities = 69/275 (25%), Positives = 120/275 (43%), Gaps = 23/275 (8%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQL 483
+ +G GSFG VYKG AV + + ++ + FK EV + +T H N++
Sbjct: 12 VGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 69
Query: 484 LGFCDEGLNRLLVYEFMGNGTLANLLFAIPRP-DWSLRVRISLEIARGLLYLHEECNVPI 542
+G+ +V ++ +L + L I + + I+ + A+G+ YLH + I
Sbjct: 70 MGYSTAP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK---SI 125
Query: 543 IHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQ-SRTRTVIRGTRGYVAPEWFK---NVP 598
IH D+K NI L +D T KI DFGL+ + S + G+ ++APE + P
Sbjct: 126 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 185
Query: 599 VSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAM 658
S + DVY+FG+VL +++ + + Y+ L + N AM
Sbjct: 186 YSFQSDVYAFGIVLYELMTGQLPYS---NINNRDQIIFMVGRGYLSPDLSKVRSNCPKAM 242
Query: 659 ADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLE 693
+ C+++ +RP I+ +E
Sbjct: 243 KR---------LMAECLKKKRDERPLFPQILASIE 268
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (540), Expect = 4e-64
Identities = 66/275 (24%), Positives = 114/275 (41%), Gaps = 25/275 (9%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQL 483
E LG G FG V+ G VAVK L + + + F E + + + H+ LV+L
Sbjct: 17 LVERLGAGQFGEVWMGYYNG--HTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRL 73
Query: 484 LGFCDEGLNRLLVYEFMGNGTLANLLFAIPRP--DWSLRVRISLEIARGLLYLHEECNVP 541
+ ++ E+M NG+L + L + + ++ +IA G+ ++ E
Sbjct: 74 YAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--- 129
Query: 542 IIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPVSA 601
IH D++ NIL+ + KI+DFGL++L+ ++ R + + APE +
Sbjct: 130 YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTI 189
Query: 602 KVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMADK 661
K DV+SFG++L +I+ R + G V DN +
Sbjct: 190 KSDVWSFGILLTEIVTHGRIPYPGMTNP-------EVIQNLERGYRMVRPDNCPEELYQ- 241
Query: 662 SRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYL 696
+ C +E P RP + +LE +
Sbjct: 242 --------LMRLCWKERPEDRPTFDYLRSVLEDFF 268
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 213 bits (542), Expect = 4e-64
Identities = 75/308 (24%), Positives = 128/308 (41%), Gaps = 38/308 (12%)
Query: 412 FSLVELNEATNGFEEE-----------LGRGSFGIVYKGVLKSASGN--AVAVKKLDK-L 457
F+ + NEA F +E +G G FG V G LK VA+K L
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 458 AQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEFMGNGTLANLLFA-IPRPD 516
+++ R+F +E S +G+ H N++ L G + +++ EFM NG+L + L +
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFT 126
Query: 517 WSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQS 576
V + IA G+ YL + +H D+ +NIL++ + K+SDFGLS+ L D S
Sbjct: 127 VIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 183
Query: 577 ----RTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSA 632
+ + + APE + ++ DV+S+G+V+ +++
Sbjct: 184 DPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE------------ 231
Query: 633 ILTDWAYDCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQML 692
Y + ++ D + L C Q+D RP IV L
Sbjct: 232 ----RPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTL 287
Query: 693 EGYLEVPS 700
+ + P+
Sbjct: 288 DKMIRNPN 295
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (536), Expect = 2e-63
Identities = 67/284 (23%), Positives = 114/284 (40%), Gaps = 25/284 (8%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQL 483
E +LG+G FG V+ G VA+K L E F E + + H+ LVQL
Sbjct: 21 LEVKLGQGCFGEVWMGTWNG--TTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQL 77
Query: 484 LGFCDEGLNRLLVYEFMGNGTLANLLFA--IPRPDWSLRVRISLEIARGLLYLHEECNVP 541
E +V E+M G+L + L V ++ +IA G+ Y+
Sbjct: 78 YAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--- 133
Query: 542 IIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPVSA 601
+H D++ NIL+ ++ K++DFGL++L+ ++ R + + APE +
Sbjct: 134 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 193
Query: 602 KVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMADK 661
K DV+SFG++L ++ R + D G ++ D
Sbjct: 194 KSDVWSFGILLTELTTKGRVPYPGMVNR-------EVLDQVERGYRMPCPPECPESLHD- 245
Query: 662 SRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLEVPSPPMPP 705
+ C +++P +RP + + LE Y P P
Sbjct: 246 --------LMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQP 281
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (534), Expect = 2e-63
Identities = 72/275 (26%), Positives = 121/275 (44%), Gaps = 23/275 (8%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQL 483
F +E+G G FG+V+ G + + VA+K + + A E +F E + + H LVQL
Sbjct: 9 FVQEIGSGQFGLVHLGYWLN--KDKVAIKTIREGAMSEE-DFIEEAEVMMKLSHPKLVQL 65
Query: 484 LGFCDEGLNRLLVYEFMGNGTLANLLFA-IPRPDWSLRVRISLEIARGLLYLHEECNVPI 542
G C E LV+EFM +G L++ L + + L++ G+ YL E C +
Sbjct: 66 YGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---V 122
Query: 543 IHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPVSAK 602
IH D+ +N L+ ++ K+SDFG+++ +L DQ + T + + +PE F S+K
Sbjct: 123 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK 182
Query: 603 VDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMADKS 662
DV+SFGV++ ++ + + G +
Sbjct: 183 SDVWSFGVLMWEVFSEGKIPYENRSNS-------EVVEDISTGFRLYKPRLASTHVYQ-- 233
Query: 663 RACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLE 697
I C +E P RPA +++ L E
Sbjct: 234 -------IMNHCWKERPEDRPAFSRLLRQLAEIAE 261
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (523), Expect = 8e-62
Identities = 63/271 (23%), Positives = 111/271 (40%), Gaps = 23/271 (8%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQL 483
F +ELG G FG+V G + VA+K + + E EF E + H+ LVQL
Sbjct: 8 FLKELGTGQFGVVKYGKWRG--QYDVAIKMIKE-GSMSEDEFIEEAKVMMNLSHEKLVQL 64
Query: 484 LGFCDEGLNRLLVYEFMGNGTLANLLF-AIPRPDWSLRVRISLEIARGLLYLHEECNVPI 542
G C + ++ E+M NG L N L R + + ++ + YL +
Sbjct: 65 YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ---F 121
Query: 543 IHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPVSAK 602
+H D+ +N L++ K+SDFGLS+ +L D+ + + + PE S+K
Sbjct: 122 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSK 181
Query: 603 VDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMADKS 662
D+++FGV++ +I + Y+ + + +
Sbjct: 182 SDIWAFGVLMWEIYSLGK----------------MPYERFTNSETAEHIAQGLRLYRPHL 225
Query: 663 RACKWLMIALWCIQEDPLKRPAMKMIVQMLE 693
+ K I C E +RP K+++ +
Sbjct: 226 ASEKVYTIMYSCWHEKADERPTFKILLSNIL 256
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (522), Expect = 1e-61
Identities = 73/273 (26%), Positives = 116/273 (42%), Gaps = 31/273 (11%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQL 483
+ +G+G FG V G + GN VAVK + + F E S + + H NLVQL
Sbjct: 11 LLQTIGKGEFGDVMLGDYR---GNKVAVKCIKN--DATAQAFLAEASVMTQLRHSNLVQL 65
Query: 484 LGFCDEGLNRL-LVYEFMGNGTLANLLFAIPRP--DWSLRVRISLEIARGLLYLHEECNV 540
LG E L +V E+M G+L + L + R ++ SL++ + YL
Sbjct: 66 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN--- 122
Query: 541 PIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPVS 600
+H D+ +N+L+ +D AK+SDFGL+K S T+ + + APE + S
Sbjct: 123 NFVHRDLAARNVLVSEDNVAKVSDFGLTKEA----SSTQDTGKLPVKWTAPEALREKKFS 178
Query: 601 AKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMAD 660
K DV+SFG++L +I R + + +G D A+ +
Sbjct: 179 TKSDVWSFGILLWEIYSFGRVPYPRIPLK-------DVVPRVEKGYKMDAPDGCPPAVYE 231
Query: 661 KSRACKWLMIALWCIQEDPLKRPAMKMIVQMLE 693
+ C D RP+ + + LE
Sbjct: 232 ---------VMKNCWHLDAAMRPSFLQLREQLE 255
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (524), Expect = 2e-61
Identities = 61/292 (20%), Positives = 115/292 (39%), Gaps = 27/292 (9%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQL 483
+E +G+G FG V++G + G VAVK +ER + E+ H+N++
Sbjct: 7 LQESIGKGRFGEVWRGKWR---GEEVAVKIFSS-REERSWFREAEIYQTVMLRHENILGF 62
Query: 484 LGFCDEG----LNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEEC- 538
+ ++ LV ++ +G+L + L ++++L A GL +LH E
Sbjct: 63 IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIV 121
Query: 539 ----NVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQ---SRTRTVIRGTRGYVAP 591
I H D+K +NIL+ ++ T I+D GL+ S GT+ Y+AP
Sbjct: 122 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 181
Query: 592 EWF------KNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEE---RSAILTDWAYDCY 642
E K+ + D+Y+ G+V +I + + + +D + +
Sbjct: 182 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 241
Query: 643 VEGKLDVLVDNDKAAMADKSRACKWLM-IALWCIQEDPLKRPAMKMIVQMLE 693
+ + + + A + + I C + R I + L
Sbjct: 242 RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (518), Expect = 7e-61
Identities = 65/274 (23%), Positives = 111/274 (40%), Gaps = 25/274 (9%)
Query: 425 EEELGRGSFGIVYKGVLKSA-SGNAVAVKKLDKLAQERERE-FKTEVSAIGRTHHKNLVQ 482
+ ELG G+FG V +GV + VA+K L + ++ + E E + + + +V+
Sbjct: 14 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 73
Query: 483 LLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRP-DWSLRVRISLEIARGLLYLHEECNVP 541
L+G C + +LV E G G L L S + +++ G+ YL E+
Sbjct: 74 LIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---N 129
Query: 542 IIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQS--RTRTVIRGTRGYVAPEWFKNVPV 599
+H D+ +N+LL AKISDFGLSK L +D S R+ + + APE
Sbjct: 130 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF 189
Query: 600 SAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMA 659
S++ DV+S+GV + + + + ++ +GK +
Sbjct: 190 SSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-------VMAFIEQGKRMECPPECPPELY 242
Query: 660 DKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLE 693
+ C RP + Q +
Sbjct: 243 A---------LMSDCWIYKWEDRPDFLTVEQRMR 267
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (518), Expect = 2e-60
Identities = 63/300 (21%), Positives = 119/300 (39%), Gaps = 35/300 (11%)
Query: 420 ATNGFE--EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQERERE-FKTEVSAIGRTH 476
+ FE ELG G+ G+V+K K SG +A K + + R E+ + +
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKP-SGLVMARKLIHLEIKPAIRNQIIRELQVLHECN 62
Query: 477 HKNLVQLLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHE 536
+V G + E M G+L +L R + ++S+ + +GL YL E
Sbjct: 63 SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 122
Query: 537 ECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKN 596
+ I+H D+KP NIL++ K+ DFG+S L+ + + GTR Y++PE +
Sbjct: 123 KHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV---GTRSYMSPERLQG 177
Query: 597 VPVSAKVDVYSFGVVLLKIICCKR--------SVEMELGEERSAILTDWAYDCYVEGKLD 648
S + D++S G+ L+++ + +E+ G + + G+
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 237
Query: 649 VLVDNDKAAMADKSRACKWLMIALW------------------CIQEDPLKRPAMKMIVQ 690
D +++ C+ ++P +R +K ++
Sbjct: 238 SSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (512), Expect = 5e-60
Identities = 67/274 (24%), Positives = 111/274 (40%), Gaps = 25/274 (9%)
Query: 425 EEELGRGSFGIVYKGVLK-SASGNAVAVKKLDKLAQERE--REFKTEVSAIGRTHHKNLV 481
++ELG G+FG V KG + VAVK L A + E E + + + + +V
Sbjct: 12 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 71
Query: 482 QLLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVP 541
+++G C+ + +LV E G L L + + +++ G+ YL E
Sbjct: 72 RMIGICEAE-SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN--- 127
Query: 542 IIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQS--RTRTVIRGTRGYVAPEWFKNVPV 599
+H D+ +N+LL AKISDFGLSK L +D++ + +T + + APE
Sbjct: 128 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKF 187
Query: 600 SAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMA 659
S+K DV+SFGV++ + + + +G+ M
Sbjct: 188 SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-------VTAMLEKGERMGCPAGCPREMY 240
Query: 660 DKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLE 693
D + C D RP + L
Sbjct: 241 D---------LMNLCWTYDVENRPGFAAVELRLR 265
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 201 bits (512), Expect = 6e-60
Identities = 76/279 (27%), Positives = 119/279 (42%), Gaps = 23/279 (8%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQL 483
+ +LG G +G VY+GV K VAVK L + E E EF E + + H NLVQL
Sbjct: 21 MKHKLGGGQYGEVYEGVWKK-YSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQL 78
Query: 484 LGFCDEGLNRLLVYEFMGNGTLANLLFAIPRP--DWSLRVRISLEIARGLLYLHEECNVP 541
LG C ++ EFM G L + L R + + ++ +I+ + YL ++
Sbjct: 79 LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---N 135
Query: 542 IIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPVSA 601
IH D+ +N L+ ++ K++DFGLS+L+ D + + APE S
Sbjct: 136 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 195
Query: 602 KVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMADK 661
K DV++FGV+L +I Y ++ L++ D +
Sbjct: 196 KSDVWAFGVLLWEIATYGM----------------SPYPGIDLSQVYELLEKDYRMERPE 239
Query: 662 SRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLEVPS 700
K + C Q +P RP+ I Q E + S
Sbjct: 240 GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESS 278
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (510), Expect = 3e-59
Identities = 66/299 (22%), Positives = 123/299 (41%), Gaps = 31/299 (10%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGN--AVAVKKLDKLAQERE-REFKTEVSAIGRTHHKNL 480
F E +GRG FG VY G L G AVK L+++ E +F TE + H N+
Sbjct: 31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 90
Query: 481 VQLLGFCDEGLNR-LLVYEFMGNGTLANLLF-AIPRPDWSLRVRISLEIARGLLYLHEEC 538
+ LLG C L+V +M +G L N + P + L++A+G+
Sbjct: 91 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGM---KFLA 147
Query: 539 NVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRT---RTVIRGTRGYVAPEWFK 595
+ +H D+ +N +LD+ FT K++DFGL++ + + + +T + ++A E +
Sbjct: 148 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 207
Query: 596 NVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDK 655
+ K DV+SFGV+L +++ ++ ++G+ + +
Sbjct: 208 TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-------ITVYLLQGRRLLQPEYCP 260
Query: 656 AAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLEVPSPPMPPLHSLQLTES 714
+ + + L C RP+ +V + H + + +
Sbjct: 261 DPLYE---------VMLKCWHPKAEMRPSFSELVSRISAIFS----TFIGEHYVHVNAT 306
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (505), Expect = 4e-59
Identities = 69/274 (25%), Positives = 117/274 (42%), Gaps = 28/274 (10%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNAVAVKKLDK--LAQEREREFKTEVSAIGRTHHKNLV 481
F+ E+GRGSF VYKG+ + VA +L L + + FK E + H N+V
Sbjct: 13 FDIEIGRGSFKTVYKGLDTE-TTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIV 71
Query: 482 QLLGFCDEGLNR----LLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEE 537
+ + + +LV E M +GTL L + +I +GL +LH
Sbjct: 72 RFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH-T 130
Query: 538 CNVPIIHCDIKPQNILL-DQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKN 596
PIIH D+K NI + + KI D GL+ L + ++ + GT ++APE ++
Sbjct: 131 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA---VIGTPEFMAPEMYEE 187
Query: 597 VPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKA 656
VDVY+FG+ +L++ + ++ + K
Sbjct: 188 -KYDESVDVYAFGMCMLEMATSEY---------------PYSECQNAAQIYRRVTSGVKP 231
Query: 657 AMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690
A DK + I CI+++ +R ++K ++
Sbjct: 232 ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 199 bits (506), Expect = 6e-59
Identities = 63/304 (20%), Positives = 122/304 (40%), Gaps = 49/304 (16%)
Query: 424 FEEELGRGSFGIVYKGVLKSA----SGNAVAVKKLDK-LAQEREREFKTEVSAIGRTHHK 478
+ ++G G+FG V++ VAVK L + + + + +F+ E + + +
Sbjct: 17 YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNP 76
Query: 479 NLVQLLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRP----------------------- 515
N+V+LLG C G L++E+M G L L ++
Sbjct: 77 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 136
Query: 516 -DWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLS- 573
+ ++ I+ ++A G+ YL E +H D+ +N L+ ++ KI+DFGLS+ + S
Sbjct: 137 LSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSA 193
Query: 574 DQSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAI 633
D + ++ PE + + DV+++GVVL +I + E
Sbjct: 194 DYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE---- 249
Query: 634 LTDWAYDCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLE 693
+G + +N + + + C + P RP+ I ++L+
Sbjct: 250 ---EVIYYVRDGNILACPENCPLELYN---------LMRLCWSKLPADRPSFCSIHRILQ 297
Query: 694 GYLE 697
E
Sbjct: 298 RMCE 301
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (499), Expect = 4e-58
Identities = 73/284 (25%), Positives = 127/284 (44%), Gaps = 26/284 (9%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGN---AVAVKKLDKLAQERER-EFKTEVSAIGRTHHKN 479
++ +G G FG VYKG+LK++SG VA+K L E++R +F E +G+ H N
Sbjct: 11 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHN 70
Query: 480 LVQLLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRP-DWSLRVRISLEIARGLLYLHEEC 538
+++L G + +++ E+M NG L L V + IA G+ YL
Sbjct: 71 IIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN 130
Query: 539 NVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSR--TRTVIRGTRGYVAPEWFKN 596
+H D+ +NIL++ + K+SDFGLS++L D T + + + APE
Sbjct: 131 ---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISY 187
Query: 597 VPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKA 656
++ DV+SFG+V+ +++ EL +G + +
Sbjct: 188 RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE-------VMKAINDGFRLPTPMDCPS 240
Query: 657 AMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLEVPS 700
A+ + + C Q++ +RP IV +L+ + P
Sbjct: 241 AIYQ---------LMMQCWQQERARRPKFADIVSILDKLIRAPD 275
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (497), Expect = 6e-58
Identities = 58/278 (20%), Positives = 105/278 (37%), Gaps = 24/278 (8%)
Query: 424 FEEELGRGSFGIVYKGVLKSA--SGNAVAVKKLDKLAQERERE-FKTEVSAIGRTHHKNL 480
+G G FG V++G+ S AVA+K + RE F E + + H ++
Sbjct: 11 LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 70
Query: 481 VQLLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRP-DWSLRVRISLEIARGLLYLHEECN 539
V+L+G E ++ E G L + L D + + + +++ L YL +
Sbjct: 71 VKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR- 128
Query: 540 VPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPV 599
+H DI +N+L+ + K+ DFGLS+ + + + ++APE
Sbjct: 129 --FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 186
Query: 600 SAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMA 659
++ DV+ FGV + +I+ + G+ + N +
Sbjct: 187 TSASDVWMFGVCMWEILMHGVKPFQGVKNN-------DVIGRIENGERLPMPPNCPPTLY 239
Query: 660 DKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLE 697
+ C DP +RP + L LE
Sbjct: 240 S---------LMTKCWAYDPSRRPRFTELKAQLSTILE 268
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (496), Expect = 2e-57
Identities = 78/302 (25%), Positives = 125/302 (41%), Gaps = 43/302 (14%)
Query: 424 FEEELGRGSFGIVYKGVL----KSASGNAVAVKKLDKLAQERERE-FKTEVSAIGR-THH 477
F + LG G+FG V + KS + VAVK L A ERE +E+ + +H
Sbjct: 27 FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 86
Query: 478 KNLVQLLGFCDEGLNRLLVYEFMGNGTLANLLF------------------AIPRPDWSL 519
N+V LLG C G L++ E+ G L N L D
Sbjct: 87 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146
Query: 520 RVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRT- 578
+ S ++A+G+ +L + IH D+ +NILL KI DFGL++ + +D +
Sbjct: 147 LLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 203
Query: 579 RTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWA 638
+ R ++APE N + + DV+S+G+ L ++ S
Sbjct: 204 KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS---------------PY 248
Query: 639 YDCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLEV 698
V+ K ++ ++ + + I C DPLKRP K IVQ++E +
Sbjct: 249 PGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308
Query: 699 PS 700
+
Sbjct: 309 ST 310
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 4e-57
Identities = 58/277 (20%), Positives = 112/277 (40%), Gaps = 29/277 (10%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNAVAVKKLDK--LAQEREREFKTEVSAIGRTHHKNLV 481
+G GS+G K KS G + K+LD + + ++ +EV+ + H N+V
Sbjct: 8 VLYTIGTGSYGRCQKIRRKS-DGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIV 66
Query: 482 QLLGFCDEGLNRLL--VYEFMGNGTLANLLFAIPRP----DWSLRVRISLEIARGLLYLH 535
+ + N L V E+ G LA+++ + D +R+ ++ L H
Sbjct: 67 RYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH 126
Query: 536 E--ECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEW 593
+ ++H D+KP N+ LD K+ DFGL+++L D S + + T Y++PE
Sbjct: 127 RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVG-TPYYMSPEQ 185
Query: 594 FKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDN 653
+ + K D++S G +L ++ + + EGK +
Sbjct: 186 MNRMSYNEKSDIWSLGCLLYELCALMPPFT---AFSQKEL-----AGKIREGKFRRIPYR 237
Query: 654 DKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690
+ + I + RP+++ I++
Sbjct: 238 YSDELNE---------IITRMLNLKDYHRPSVEEILE 265
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 2e-56
Identities = 67/273 (24%), Positives = 112/273 (41%), Gaps = 26/273 (9%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQL 483
ELG G+FG VYK K + A K +D ++E ++ E+ + H N+V+L
Sbjct: 16 IIGELGDGAFGKVYKAQNKE-TSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKL 74
Query: 484 LGFCDEGLNRLLVYEFMGNGTLANLLFAIPRP-DWSLRVRISLEIARGLLYLHEECNVPI 542
L N ++ EF G + ++ + RP S + + L YLH+ I
Sbjct: 75 LDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN---KI 131
Query: 543 IHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWF-----KNV 597
IH D+K NIL D K++DFG+S R + I GT ++APE K+
Sbjct: 132 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPEVVMCETSKDR 190
Query: 598 PVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAA 657
P K DV+S G+ L+++ + +L + + L +
Sbjct: 191 PYDYKADVWSLGITLIEMAEIEPPHH---ELNPMRVLLKI-----AKSEPPTLAQPSRW- 241
Query: 658 MADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690
S K + C++++ R ++Q
Sbjct: 242 ----SSNFKDFL--KKCLEKNVDARWTTSQLLQ 268
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 4e-56
Identities = 68/270 (25%), Positives = 113/270 (41%), Gaps = 28/270 (10%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQER---EREFKTEVSAIGRTHHKNL 480
LG+G FG VY K S +A+K L K E+ E + + EV H N+
Sbjct: 10 IGRPLGKGKFGNVYLAREKQ-SKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 68
Query: 481 VQLLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNV 540
++L G+ + L+ E+ GT+ L + + D E+A L Y H +
Sbjct: 69 LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK--- 125
Query: 541 PIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPVS 600
+IH DIKP+N+LL KI+DFG S S + T + GT Y+ PE +
Sbjct: 126 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT---LCGTLDYLPPEMIEGRMHD 182
Query: 601 AKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMAD 660
KVD++S GV+ + + K E +E Y +
Sbjct: 183 EKVDLWSLGVLCYEFLVGKPPFEANTYQE--------TYKRISRVEFTF--------PDF 226
Query: 661 KSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690
+ + L+ ++ +P +RP ++ +++
Sbjct: 227 VTEGARDLI--SRLLKHNPSQRPMLREVLE 254
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 1e-55
Identities = 69/301 (22%), Positives = 127/301 (42%), Gaps = 40/301 (13%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGN-AVAVKKLDKLA-QEREREFKTEVSAIGR-THHKNL 480
F++ +G G+FG V K +K A+K++ + A ++ R+F E+ + + HH N+
Sbjct: 14 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 73
Query: 481 VQLLGFCDEGLNRLLVYEFMGNGTLANLLF----------------AIPRPDWSLRVRIS 524
+ LLG C+ L E+ +G L + L + +
Sbjct: 74 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 133
Query: 525 LEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRG 584
++ARG+ YL ++ IH D+ +NIL+ +++ AKI+DFGLS+ + +T+ R
Sbjct: 134 ADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMGRL 188
Query: 585 TRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVE 644
++A E + DV+S+GV+L +I+ + + Y+ +
Sbjct: 189 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-------LYEKLPQ 241
Query: 645 GKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLEVPSPPMP 704
G N + D + C +E P +RP+ I+ L LE +
Sbjct: 242 GYRLEKPLNCDDEVYD---------LMRQCWREKPYERPSFAQILVSLNRMLEERKTYVN 292
Query: 705 P 705
Sbjct: 293 T 293
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (483), Expect = 2e-55
Identities = 67/300 (22%), Positives = 115/300 (38%), Gaps = 48/300 (16%)
Query: 424 FEEELGRGSFGIVYKGVL----KSASGNAVAVKKLDKLAQERERE-FKTEVSAIGR-THH 477
F + LG G+FG V K+ VAVK L + A ERE +E+ + + H
Sbjct: 41 FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSH 100
Query: 478 KNLVQLLGFCDEGLNRLLVYEFMGNGTLANLLF-----------------------AIPR 514
+N+V LLG C L++E+ G L N L +
Sbjct: 101 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 160
Query: 515 PDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSD 574
+ + + ++A+G+ +L + +H D+ +N+L+ KI DFGL++ ++SD
Sbjct: 161 LTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD 217
Query: 575 QSRTR-TVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAI 633
+ R ++APE + K DV+S+G++L +I +
Sbjct: 218 SNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN------------ 265
Query: 634 LTDWAYDCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLE 693
V+ L+ N + +I C D KRP+ + L
Sbjct: 266 ---PYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (477), Expect = 3e-55
Identities = 71/270 (26%), Positives = 115/270 (42%), Gaps = 22/270 (8%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNAVAVKKLDK-LAQEREREFKTEVSAIGRTHHKNLVQ 482
+ LG G++G V V + + AVAVK +D A + K E+ +H+N+V+
Sbjct: 9 LVQTLGEGAYGEVQLAVNRV-TEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVK 67
Query: 483 LLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPI 542
G EG + L E+ G L + + R ++ G++YLH I
Sbjct: 68 FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---I 124
Query: 543 IHCDIKPQNILLDQDFTAKISDFGLSKLL-LSDQSRTRTVIRGTRGYVAPEWFKNVPV-S 600
H DIKP+N+LLD+ KISDFGL+ + +++ R + GT YVAPE K +
Sbjct: 125 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 184
Query: 601 AKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMAD 660
VDV+S G+VL ++ + + + +DW +
Sbjct: 185 EPVDVWSCGIVLTAMLAGELPWDQP--SDSCQEYSDWKEKKTYLNPWKKI---------- 232
Query: 661 KSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690
A L+ + E+P R + I +
Sbjct: 233 -DSAPLALL--HKILVENPSARITIPDIKK 259
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 4e-55
Identities = 69/299 (23%), Positives = 133/299 (44%), Gaps = 29/299 (9%)
Query: 413 SLVELNEATNGFE--EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVS 470
S+V + + + E++G+G+ G VY + + +G VA+++++ Q ++ E+
Sbjct: 11 SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVA-TGQEVAIRQMNLQQQPKKELIINEIL 69
Query: 471 AIGRTHHKNLVQLLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARG 530
+ + N+V L G +V E++ G+L +++ D + E +
Sbjct: 70 VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQA 128
Query: 531 LLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVA 590
L +LH +IH DIK NILL D + K++DFG + +QS+ T++ GT ++A
Sbjct: 129 LEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMA 184
Query: 591 PEWFKNVPVSAKVDVYSFGVVLLKIICCKRS-VEMELGEERSAILTDWAYDCYVEGKLDV 649
PE KVD++S G++ +++I + + I T+ + KL
Sbjct: 185 PEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKL-- 242
Query: 650 LVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLEV--PSPPMPPL 706
S + + C+ D KR + K ++Q +L++ P + PL
Sbjct: 243 ------------SAIFRDFL--NRCLDMDVEKRGSAKELLQH--QFLKIAKPLSSLTPL 285
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 3e-54
Identities = 68/278 (24%), Positives = 109/278 (39%), Gaps = 27/278 (9%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGN--AVAVKKLDKLA---QEREREFKTEVSAIGRTHHK 478
E+LG GSFG+V +G + SG +VAVK L E +F EV+A+ H+
Sbjct: 12 LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHR 71
Query: 479 NLVQLLGFCDEGLNRLLVYEFMGNGTLANLLFA-IPRPDWSLRVRISLEIARGLLYLHEE 537
NL++L G +V E G+L + L R ++++A G+ YL +
Sbjct: 72 NLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK 130
Query: 538 CNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLS--DQSRTRTVIRGTRGYVAPEWFK 595
IH D+ +N+LL KI DFGL + L D + + + APE K
Sbjct: 131 R---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 187
Query: 596 NVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDK 655
S D + FGV L ++ + + L + EG+ ++
Sbjct: 188 TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS------QILHKIDKEGERLPRPEDCP 241
Query: 656 AAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLE 693
+ + + + C P RP + L
Sbjct: 242 QDIYN---------VMVQCWAHKPEDRPTFVALRDFLL 270
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 5e-54
Identities = 55/282 (19%), Positives = 110/282 (39%), Gaps = 24/282 (8%)
Query: 424 FEEELGRGSFGIVYKGVLKS---ASGNAVAVKKLDKLAQER-EREFKTEVSAIGRTHHKN 479
+ LG G+FG VYKG+ VA+K+L + + +E E + + +
Sbjct: 13 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPH 72
Query: 480 LVQLLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECN 539
+ +LLG C +L+ L + + ++IA+G+ YL +
Sbjct: 73 VCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR-- 130
Query: 540 VPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRT-VIRGTRGYVAPEWFKNVP 598
++H D+ +N+L+ KI+DFGL+KLL +++ + ++A E +
Sbjct: 131 -RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 189
Query: 599 VSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAM 658
+ + DV+S+GV + +++ YD ++ +++ +
Sbjct: 190 YTHQSDVWSYGVTVWELMTFGS----------------KPYDGIPASEISSILEKGERLP 233
Query: 659 ADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLEVPS 700
MI + C D RP + ++ P
Sbjct: 234 QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQ 275
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 185 bits (470), Expect = 1e-53
Identities = 66/297 (22%), Positives = 115/297 (38%), Gaps = 37/297 (12%)
Query: 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDK---LAQEREREFKTEVSAIGRTHHKNLVQ 482
E+G GSFG VY + VA+KK+ + E+ ++ EV + + H N +Q
Sbjct: 21 REIGHGSFGAVYFARDVR-NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQ 79
Query: 483 LLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPI 542
G LV E+ L ++ +GL YLH +
Sbjct: 80 YRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NM 136
Query: 543 IHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNV---PV 599
IH D+K NILL + K+ DFG + ++ S GT ++APE +
Sbjct: 137 IHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS-----FVGTPYWMAPEVILAMDEGQY 191
Query: 600 SAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMA 659
KVDV+S G+ +++ K ++ L + N+ A+
Sbjct: 192 DGKVDVWSLGITCIELAERKP----------------PLFNMNAMSALYHIAQNESPALQ 235
Query: 660 DK--SRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLEVPSPPMPPLHSLQLTES 714
S + + C+Q+ P RP +++++ ++ PP + +Q T+
Sbjct: 236 SGHWSEYFRNFV--DSCLQKIPQDRPTSEVLLKH--RFVLRERPPTVIMDLIQRTKD 288
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (468), Expect = 2e-53
Identities = 81/290 (27%), Positives = 131/290 (45%), Gaps = 35/290 (12%)
Query: 424 FEEELGRGSFGIVYKGVLKSA----SGNAVAVKKLDKLAQERER-EFKTEVSAIGRTHHK 478
ELG+GSFG+VY+GV K VA+K +++ A RER EF E S + +
Sbjct: 24 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 83
Query: 479 NLVQLLGFCDEGLNRLLVYEFMGNGTLANLLF----------AIPRPDWSLRVRISLEIA 528
++V+LLG +G L++ E M G L + L + P S ++++ EIA
Sbjct: 84 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 143
Query: 529 RGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLS-DQSRTRTVIRGTRG 587
G+ YL+ +H D+ +N ++ +DFT KI DFG+++ + D R
Sbjct: 144 DGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 200
Query: 588 YVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKL 647
+++PE K+ + DV+SFGVVL +I L E +EG L
Sbjct: 201 WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE-------QVLRFVMEGGL 253
Query: 648 DVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLE 697
DN + + + C Q +P RP+ I+ ++ +E
Sbjct: 254 LDKPDNCPDMLFE---------LMRMCWQYNPKMRPSFLEIISSIKEEME 294
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (446), Expect = 1e-50
Identities = 74/301 (24%), Positives = 118/301 (39%), Gaps = 42/301 (13%)
Query: 424 FEEELGRGSFGIVYKGVL----KSASGNAVAVKKLDK-LAQEREREFKTEVSAIGRT-HH 477
+ LGRG+FG V + K+A+ VAVK L + R +E+ + HH
Sbjct: 17 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 76
Query: 478 KNLVQLLGFC-DEGLNRLLVYEFMGNGTLANLLFAIPRP----------------DWSLR 520
N+V LLG C G +++ EF G L+ L +
Sbjct: 77 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 136
Query: 521 VRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTR- 579
+ S ++A+G+ +L IH D+ +NILL + KI DFGL++ + D R
Sbjct: 137 ICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 193
Query: 580 TVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAY 639
R ++APE + + + DV+SFGV+L +I S + + +
Sbjct: 194 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID------EEFC 247
Query: 640 DCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLEVP 699
EG D M L C +P +RP +V+ L L+
Sbjct: 248 RRLKEGTRMRAPDYTTPEMYQ---------TMLDCWHGEPSQRPTFSELVEHLGNLLQAN 298
Query: 700 S 700
+
Sbjct: 299 A 299
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (444), Expect = 3e-50
Identities = 71/302 (23%), Positives = 118/302 (39%), Gaps = 44/302 (14%)
Query: 424 FEEELGRGSFGIVYKGVLKS------ASGNAVAVKKLDKLAQERE-REFKTEVSAIGR-T 475
+ LG G+FG V VAVK L A E++ + +E+ +
Sbjct: 17 LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 76
Query: 476 HHKNLVQLLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRP----------------DWSL 519
HKN++ LLG C + ++ E+ G L L A P
Sbjct: 77 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 136
Query: 520 RVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTR 579
V + ++ARG+ YL + IH D+ +N+L+ +D KI+DFGL++ + +
Sbjct: 137 LVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 193
Query: 580 T-VIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWA 638
T R ++APE + + + DV+SFGV+L +I S + E
Sbjct: 194 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE-------EL 246
Query: 639 YDCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLEV 698
+ EG N + + C P +RP K +V+ L+ + +
Sbjct: 247 FKLLKEGHRMDKPSNCTNELYM---------MMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297
Query: 699 PS 700
S
Sbjct: 298 TS 299
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 174 bits (442), Expect = 2e-49
Identities = 66/297 (22%), Positives = 120/297 (40%), Gaps = 26/297 (8%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQL 483
EELG G+FG+V++ ++ +GN A K + + + + E+ + H LV L
Sbjct: 30 IHEELGTGAFGVVHRVTERA-TGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNL 88
Query: 484 LGFCDEGLNRLLVYEFMGNGTLANLLFAIPRP-DWSLRVRISLEIARGLLYLHEECNVPI 542
++ +++YEFM G L + V ++ +GL ++HE
Sbjct: 89 HDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---Y 145
Query: 543 IHCDIKPQNILL--DQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPVS 600
+H D+KP+NI+ + K+ DFGL+ L D ++ V GT + APE + PV
Sbjct: 146 VHLDLKPENIMFTTKRSNELKLIDFGLTAHL--DPKQSVKVTTGTAEFAAPEVAEGKPVG 203
Query: 601 AKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMAD 660
D++S GV+ ++ GE L + + D +A +
Sbjct: 204 YYTDMWSVGVLSYILLSGLSPFG---GENDDETLRNV---------KSCDWNMDDSAFSG 251
Query: 661 KSRACKWLMIALWCIQEDPLKRPAMKMIVQ---MLEGYLEVPSPPMPPLHSLQLTES 714
S K + + DP R + ++ + G +P ++ +S
Sbjct: 252 ISEDGKDFI--RKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDS 306
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 6e-48
Identities = 59/274 (21%), Positives = 103/274 (37%), Gaps = 26/274 (9%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNAVAVKKLDK---LAQEREREFKTEVSAIGRTHHKNL 480
F + LG GSF V + + A+K L+K + + + E + R H
Sbjct: 12 FGKILGEGSFSTVVLARELA-TSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 70
Query: 481 VQLLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNV 540
V+L + + NG L + I D + + EI L YLH +
Sbjct: 71 VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG-- 128
Query: 541 PIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTR-TVIRGTRGYVAPEWFKNVPV 599
IIH D+KP+NILL++D +I+DFG +K+L + + R GT YV+PE
Sbjct: 129 -IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSA 187
Query: 600 SAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMA 659
D+++ G ++ +++ I + ++ + D
Sbjct: 188 CKSSDLWALGCIIYQLVAGLPPFR---AGNEYLI-----FQKIIKLEYDFP--------E 231
Query: 660 DKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLE 693
+ L+ + D KR + +
Sbjct: 232 KFFPKARDLV--EKLLVLDATKRLGCEEMEGYGP 263
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 169 bits (428), Expect = 9e-48
Identities = 66/268 (24%), Positives = 108/268 (40%), Gaps = 18/268 (6%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNAVAVKKLDK-LAQEREREFKTEVSAIGRTHHKNLVQ 482
F + LG G+F V K + VA+K + K + +E + E++ + + H N+V
Sbjct: 13 FRDVLGTGAFSEVILAEDKR-TQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVA 71
Query: 483 LLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPI 542
L + G + L+ + + G L + + R+ ++ + YLH+ V
Sbjct: 72 LDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHR 131
Query: 543 IHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPVSAK 602
LD+D ISDFGLSK+ D + GT GYVAPE P S
Sbjct: 132 DLKPENLLYYSLDEDSKIMISDFGLSKME--DPGSVLSTACGTPGYVAPEVLAQKPYSKA 189
Query: 603 VDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMADKS 662
VD +S GV+ ++C E + + E L + D D S
Sbjct: 190 VDCWSIGVIAYILLCGYPPFY---DENDAKLF---------EQILKAEYEFDSPYWDDIS 237
Query: 663 RACKWLMIALWCIQEDPLKRPAMKMIVQ 690
+ K + +++DP KR + +Q
Sbjct: 238 DSAKDFI--RHLMEKDPEKRFTCEQALQ 263
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 169 bits (430), Expect = 1e-47
Identities = 69/287 (24%), Positives = 124/287 (43%), Gaps = 25/287 (8%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQL 483
EELG G+FG+V++ V K+ +G K ++ + K E+S + + HH L+ L
Sbjct: 33 ILEELGSGAFGVVHRCVEKA-TGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINL 91
Query: 484 LGFCDEGLNRLLVYEFMGNGTLANLLFAIPRP-DWSLRVRISLEIARGLLYLHEECNVPI 542
++ +L+ EF+ G L + + A + + + GL ++HE I
Sbjct: 92 HDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH---SI 148
Query: 543 IHCDIKPQNILLD--QDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPVS 600
+H DIKP+NI+ + + + KI DFGL+ L D+ T T + APE PV
Sbjct: 149 VHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT--ATAEFAAPEIVDREPVG 206
Query: 601 AKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMAD 660
D+++ GV+ ++ GE+ L + + D+ A +
Sbjct: 207 FYTDMWAIGVLGYVLLSGLSPFA---GEDDLETL---------QNVKRCDWEFDEDAFSS 254
Query: 661 KSRACKWLMIALWCIQEDPLKRPAMKMIVQM--LEGYLEVPSPPMPP 705
S K + +Q++P KR + ++ L+G + +P
Sbjct: 255 VSPEAKDFI--KNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPS 299
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (407), Expect = 1e-44
Identities = 56/287 (19%), Positives = 110/287 (38%), Gaps = 26/287 (9%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQL 483
E+LGRG FGIV++ V S S K + ++ K E+S + H+N++ L
Sbjct: 9 IAEDLGRGEFGIVHRCVETS-SKKTYMAKFVKVKGTDQVL-VKKEISILNIARHRNILHL 66
Query: 484 LGFCDEGLNRLLVYEFMGNGTLANLLFAIPRP-DWSLRVRISLEIARGLLYLHEECNVPI 542
+ ++++EF+ + + + V ++ L +LH I
Sbjct: 67 HESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH---NI 123
Query: 543 IHCDIKPQNILLDQD--FTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPVS 600
H DI+P+NI+ T KI +FG ++ L ++ Y APE ++ VS
Sbjct: 124 GHFDIRPENIIYQTRRSSTIKIIEFGQARQL--KPGDNFRLLFTAPEYYAPEVHQHDVVS 181
Query: 601 AKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMAD 660
D++S G ++ ++ E ++ + + + D+ A +
Sbjct: 182 TATDMWSLGTLVYVLLSGINPFLAETNQQ--------IIENIMNAEYTF----DEEAFKE 229
Query: 661 KSRACKWLMIALWCIQEDPLKRPAMKMIVQM--LEGYLEVPSPPMPP 705
S + + ++ R +Q L+ +E S +
Sbjct: 230 ISIEAMDFV--DRLLVKERKSRMTASEALQHPWLKQKIERVSTKVIR 274
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (404), Expect = 2e-44
Identities = 66/267 (24%), Positives = 109/267 (40%), Gaps = 27/267 (10%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNAVAVKKLDK---LAQEREREFKTEVSAIGRT-HHKN 479
+ LG+GSFG V+ K + A+K L K L + E + H
Sbjct: 6 LHKMLGKGSFGKVFLAEFKK-TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPF 64
Query: 480 LVQLLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECN 539
L + N V E++ G L + + + D S + EI GL +LH +
Sbjct: 65 LTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG- 123
Query: 540 VPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPV 599
I++ D+K NILLD+D KI+DFG+ K + ++T T GT Y+APE
Sbjct: 124 --IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDYIAPEILLGQKY 180
Query: 600 SAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMA 659
+ VD +SFGV+L +++ + G++ + D +
Sbjct: 181 NHSVDWWSFGVLLYEMLIGQSPFH---GQDEEELFHSIRMDNPFYPR------------- 224
Query: 660 DKSRACKWLMIALWCIQEDPLKRPAMK 686
+ K L+ + +P KR ++
Sbjct: 225 WLEKEAKDLL--VKLFVREPEKRLGVR 249
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 158 bits (400), Expect = 3e-44
Identities = 66/283 (23%), Positives = 107/283 (37%), Gaps = 36/283 (12%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNAVAVKKLDK---------LAQEREREFKTEVSAIGR 474
+E LGRG +V + + K + AVK +D QE EV + +
Sbjct: 7 PKEILGRGVSSVVRRCIHKP-TCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRK 65
Query: 475 TH-HKNLVQLLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLY 533
H N++QL + LV++ M G L + L +I + +
Sbjct: 66 VSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICA 125
Query: 534 LHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEW 593
LH+ I+H D+KP+NILLD D K++DFG S L D + GT Y+APE
Sbjct: 126 LHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQL--DPGEKLREVCGTPSYLAPEI 180
Query: 594 F------KNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKL 647
+ +VD++S GV++ ++ ++ +L + G
Sbjct: 181 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFW---HRKQMLML-----RMIMSGNY 232
Query: 648 DVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690
D S K L+ + P KR + +
Sbjct: 233 QFGSPEWD----DYSDTVKDLV--SRFLVVQPQKRYTAEEALA 269
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 157 bits (398), Expect = 9e-44
Identities = 47/280 (16%), Positives = 90/280 (32%), Gaps = 26/280 (9%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQL 483
++G GSFG +Y G + +G VA+K + + + E +
Sbjct: 11 LGRKIGSGSFGDIYLGTDIA-AGEEVAIKLECV--KTKHPQLHIESKIYKMMQGGVGIPT 67
Query: 484 LGFC-DEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPI 542
+ +C EG ++V E +G F + + ++ ++ + Y+H +
Sbjct: 68 IRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---F 124
Query: 543 IHCDIKPQNIL---LDQDFTAKISDFGLSKLLLSDQSRT------RTVIRGTRGYVAPEW 593
IH D+KP N L + I DFGL+K ++ + GT Y +
Sbjct: 125 IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINT 184
Query: 594 FKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDN 653
+ S + D+ S G VL+ + Y +
Sbjct: 185 HLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAAT--------KRQKYERISEKKMSTP 236
Query: 654 DKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLE 693
+ + +C +P + Q+
Sbjct: 237 IEVLCKGYPSEFATYL--NFCRSLRFDDKPDYSYLRQLFR 274
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 159 bits (402), Expect = 1e-43
Identities = 57/267 (21%), Positives = 93/267 (34%), Gaps = 29/267 (10%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNAVAVKKLDK------LAQEREREFKTEVSAIGRTHH 477
+GRG FG VY +G A+K LDK + + +S +
Sbjct: 8 VHRIIGRGGFGEVYGCRKAD-TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDC 66
Query: 478 KNLVQLLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEE 537
+V + + + M G L L + + EI GL ++H
Sbjct: 67 PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNR 126
Query: 538 CNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWF-KN 596
+++ D+KP NILLD+ +ISD GL+ + GT GY+APE K
Sbjct: 127 F---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP---HASVGTHGYMAPEVLQKG 180
Query: 597 VPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKA 656
V + D +S G +L K++ +++ I
Sbjct: 181 VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPD---------- 230
Query: 657 AMADKSRACKWLMIALWCIQEDPLKRP 683
S + L+ +Q D +R
Sbjct: 231 ---SFSPELRSLL--EGLLQRDVNRRL 252
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 155 bits (393), Expect = 3e-43
Identities = 54/280 (19%), Positives = 100/280 (35%), Gaps = 28/280 (10%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNAVAVKKLDK---LAQEREREFKTEVSAIGRTHHKNL 480
E LG G V+ VAVK L F+ E +H +
Sbjct: 11 LGEILGFGGMSEVHLARDLR-LHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAI 69
Query: 481 VQLLGFC----DEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHE 536
V + G +V E++ TL +++ + + + + L + H+
Sbjct: 70 VAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQ 129
Query: 537 ECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSR--TRTVIRGTRGYVAPEWF 594
IIH D+KP NI++ K+ DFG+++ + + + GT Y++PE
Sbjct: 130 NG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 186
Query: 595 KNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDND 654
+ V A+ DVYS G VL +++ + G+ ++ + +
Sbjct: 187 RGDSVDARSDVYSLGCVLYEVLTGEPPFT---GDSPVSVAYQHVREDPIP---------P 234
Query: 655 KAAMADKSRACKWLMIALWCIQEDPLKRP-AMKMIVQMLE 693
A S ++ L + ++P R + L
Sbjct: 235 SARHEGLSADLDAVV--LKALAKNPENRYQTAAEMRADLV 272
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 154 bits (389), Expect = 2e-42
Identities = 52/200 (26%), Positives = 94/200 (47%), Gaps = 11/200 (5%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNAVAVKKLDK---LAQEREREFKTEVSAIGRTHHKNL 480
LG GSFG V+ + +G A+K L K + ++ E + H +
Sbjct: 8 ILRTLGTGSFGRVHLIRSRH-NGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFI 66
Query: 481 VQLLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNV 540
+++ G + ++ +++ G L +LL R + + E+ L YLH +
Sbjct: 67 IRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD-- 124
Query: 541 PIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPVS 600
II+ D+KP+NILLD++ KI+DFG +K + + GT Y+APE P +
Sbjct: 125 -IIYRDLKPENILLDKNGHIKITDFGFAKYV----PDVTYTLCGTPDYIAPEVVSTKPYN 179
Query: 601 AKVDVYSFGVVLLKIICCKR 620
+D +SFG+++ +++
Sbjct: 180 KSIDWWSFGILIYEMLAGYT 199
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 8e-42
Identities = 67/300 (22%), Positives = 103/300 (34%), Gaps = 28/300 (9%)
Query: 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDK-----LAQEREREFKTEVSAIGRTHHKNL 480
+ LG G F VYK K+ + VA+KK+ R E+ + H N+
Sbjct: 4 DFLGEGQFATVYKARDKN-TNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNI 62
Query: 481 VQLLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNV 540
+ LL N LV++FM + S L +GL YLH+
Sbjct: 63 IGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW-- 120
Query: 541 PIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNV-PV 599
I+H D+KP N+LLD++ K++DFGL+K S R T TR Y APE
Sbjct: 121 -ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN-RAYTHQVVTRWYRAPELLFGARMY 178
Query: 600 SAKVDVYSFGVVLLKIICCK------------RSVEMELGEERSAILTDWAYDCYVEGKL 647
VD+++ G +L +++ + LG D
Sbjct: 179 GVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 238
Query: 648 DVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM---LEGYLEVPSPPMP 704
+ L+ +P R ++M P +P
Sbjct: 239 SFPGIPLHHIFSAAGDDLLDLI--QGLFLFNPCARITATQALKMKYFSNRPGPTPGCQLP 296
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 1e-41
Identities = 69/287 (24%), Positives = 113/287 (39%), Gaps = 29/287 (10%)
Query: 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDK--LAQEREREFKTEV---SAIGRTHHKNL 480
E+G G++G V+K G VA+K++ + EV + H N+
Sbjct: 13 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72
Query: 481 VQLLGFC-----DEGLNRLLVYEFMGNGTLANLLFAI-PRPDWSLRVRISLEIARGLLYL 534
V+L C D LV+E + L P + ++ RGL +L
Sbjct: 73 VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 132
Query: 535 HEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWF 594
H ++H D+KPQNIL+ K++DFGL+++ + T V T Y APE
Sbjct: 133 HSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVV--VTLWYRAPEVL 187
Query: 595 KNVPVSAKVDVYSFGVVLLKIICCKR-----SVEMELGEERSAILTDWAYDCYVEGKLDV 649
+ VD++S G + ++ K S +LG+ I D + L
Sbjct: 188 LQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPR 247
Query: 650 LVDNDKAA------MADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690
+ K+A + D K L+ L C+ +P KR + +
Sbjct: 248 QAFHSKSAQPIEKFVTDIDELGKDLL--LKCLTFNPAKRISAYSALS 292
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 150 bits (379), Expect = 3e-41
Identities = 42/286 (14%), Positives = 91/286 (31%), Gaps = 28/286 (9%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGR-THHKNLVQ 482
+G GSFG++++G + VA+K + + + + E +
Sbjct: 9 VGRRIGEGSFGVIFEGTNLL-NNQQVAIKFEPR--RSDAPQLRDEYRTYKLLAGCTGIPN 65
Query: 483 LLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPI 542
+ F EGL+ +LV + +G L + + ++ + +HE+ +
Sbjct: 66 VYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---L 122
Query: 543 IHCDIKPQNILLDQDFT-----AKISDFGLSKLLLSDQSRT------RTVIRGTRGYVAP 591
++ DIKP N L+ + + + DFG+ K ++ + + GT Y++
Sbjct: 123 VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSI 182
Query: 592 EWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLV 651
S + D+ + G V + + + + + L L
Sbjct: 183 NTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKY-ERIGEKKQSTPLRELC 241
Query: 652 DNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLE 697
+ P + + LE
Sbjct: 242 AGFPEEFYK---------YMHYARNLAFDATPDYDYLQGLFSKVLE 278
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 3e-41
Identities = 68/277 (24%), Positives = 112/277 (40%), Gaps = 30/277 (10%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQERER------EFKTEVSAIGRTHH 477
EELG G F +V K KS +G A K + K + R + + EVS + H
Sbjct: 14 TGEELGSGQFAVVKKCREKS-TGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQH 72
Query: 478 KNLVQLLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEE 537
N++ L + + +L+ E + G L + L +I G+ YLH
Sbjct: 73 PNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSL 132
Query: 538 CNVPIIHCDIKPQNILLDQD----FTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEW 593
I H D+KP+NI+L KI DFGL+ + D I GT +VAPE
Sbjct: 133 Q---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKNIFGTPEFVAPEI 187
Query: 594 FKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDN 653
P+ + D++S GV+ ++ + +E A ++ Y+
Sbjct: 188 VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEF------------ 235
Query: 654 DKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690
+ ++ S K + + +DP KR ++ +Q
Sbjct: 236 EDEYFSNTSALAKDFI--RRLLVKDPKKRMTIQDSLQ 270
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 4e-41
Identities = 55/314 (17%), Positives = 111/314 (35%), Gaps = 32/314 (10%)
Query: 419 EATNGFE--EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQERERE-FKTEVSAIGRT 475
+ + +G G++G+V + VA+KK+ + + E+ + R
Sbjct: 5 DVGPRYTNLSYIGEGAYGMVCSAYDNV-NKVRVAIKKISPFEHQTYCQRTLREIKILLRF 63
Query: 476 HHKNLVQLLGFCDEGLNRLLVYEFMGNGTLANLLFAI---PRPDWSLRVRISLEIARGLL 532
H+N++ + + ++ + L+ + +I RGL
Sbjct: 64 RHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLK 123
Query: 533 YLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSR--TRTVIRGTRGYVA 590
Y+H ++H D+KP N+LL+ KI DFGL+++ D T TR Y A
Sbjct: 124 YIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 180
Query: 591 PEWFKN-VPVSAKVDVYSFGVVLLKIICCK---------------RSVEMELGEERSAIL 634
PE N + +D++S G +L +++ + + +E +
Sbjct: 181 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 240
Query: 635 TDWAYDCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM--L 692
+ Y+ + L+ + +P KR ++ + L
Sbjct: 241 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLL--DKMLTFNPHKRIEVEQALAHPYL 298
Query: 693 EGYLEVPSPPMPPL 706
E Y + P+
Sbjct: 299 EQYYDPSDEPIAEA 312
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 149 bits (377), Expect = 5e-41
Identities = 54/278 (19%), Positives = 105/278 (37%), Gaps = 18/278 (6%)
Query: 426 EELGRGSFGIVYKGVLKSASGNAVAVKKL--DKLAQEREREFKTEVSAIGRTHHKNLVQL 483
E++G G++G+VYK G A+KK+ +K + E+S + H N+V+L
Sbjct: 8 EKIGEGTYGVVYKAQNN--YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKL 65
Query: 484 LGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPII 543
+LV+E + L + L++ G+ Y H+ ++
Sbjct: 66 YDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD---RRVL 122
Query: 544 HCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPVSAKV 603
H D+KPQN+L++++ KI+DFGL++ + I + S +
Sbjct: 123 HRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTI 182
Query: 604 DVYSFGVVLLKIICCKR----SVEMELGEERSAIL-----TDWAYDCYVEGKLDVLVDND 654
D++S G + +++ E + IL +W + +
Sbjct: 183 DIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYE 242
Query: 655 KAAMADKSRACKWLMIAL--WCIQEDPLKRPAMKMIVQ 690
+ I L ++ DP +R K ++
Sbjct: 243 PLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 1e-40
Identities = 61/297 (20%), Positives = 108/297 (36%), Gaps = 31/297 (10%)
Query: 425 EEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLL 484
+ LG G G V + K + A+K L + R RE + A ++V+++
Sbjct: 17 SQVLGLGINGKVLQIFNKR-TQEKFALKMLQDCPKAR-REVELHWRAS---QCPHIVRIV 71
Query: 485 GFCD----EGLNRLLVYEFMGNGTLANLLFAIPRP--DWSLRVRISLEIARGLLYLHEEC 538
+ L+V E + G L + + I I + YLH
Sbjct: 72 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN 131
Query: 539 NVPIIHCDIKPQNILLD---QDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFK 595
I H D+KP+N+L + K++DFG +K S S T T YVAPE
Sbjct: 132 ---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY--TPYYVAPEVLG 186
Query: 596 NVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDK 655
D++S GV++ ++C G ++ G+ +
Sbjct: 187 PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA----ISPGMKTRIRMGQYEF----PN 238
Query: 656 AAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM--LEGYLEVPSPPMPPLHSLQ 710
++ S K L+ ++ +P +R + + + +VP P+ L+
Sbjct: 239 PEWSEVSEEVKMLI--RNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLK 293
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 1e-39
Identities = 57/298 (19%), Positives = 111/298 (37%), Gaps = 24/298 (8%)
Query: 426 EELGRGSFGIVYKGVLKSASGNAVAVKKL--DKLAQEREREFKTEVSAIGRTHHKNLVQL 483
E++G G++G+VYK K +G VA+KK+ D + E+S + +H N+V+L
Sbjct: 8 EKIGEGTYGVVYKARNKL-TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 66
Query: 484 LGFCDEGLNRLLVYEFMGNGTLANLLFAIPRP-DWSLRVRISLEIARGLLYLHEECNVPI 542
L LV+EF+ + + L ++ +GL + H +
Sbjct: 67 LDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR---V 123
Query: 543 IHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPVSAK 602
+H D+KPQN+L++ + K++DFGL++ + S
Sbjct: 124 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTA 183
Query: 603 VDVYSFGVVLLKIICCK-------------RSVEMELGEERSAILTDWAYDCYVEGKLDV 649
VD++S G + +++ + R + + Y
Sbjct: 184 VDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKW 243
Query: 650 LVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLEVPSPPMPPLH 707
+ + + L+ + DP KR + K + + + + P+P L
Sbjct: 244 ARQDFSKVVPPLDEDGRSLL--SQMLHYDPNKRISAKAALAH--PFFQDVTKPVPHLR 297
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 1e-38
Identities = 59/278 (21%), Positives = 101/278 (36%), Gaps = 42/278 (15%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNAVAVKKLDK------LAQEREREFKTEVSAIGR--T 475
LG G FG VY G+ S VA+K ++K EV + + +
Sbjct: 8 VGPLLGSGGFGSVYSGIRVS-DNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 66
Query: 476 HHKNLVQLLGFCDEGLNRLLVYEFM-GNGTLANLLFAIPRPDWSLRVRISLEIARGLLYL 534
+++LL + + + +L+ E L + + L ++ + +
Sbjct: 67 GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC 126
Query: 535 HEECNVPIIHCDIKPQNILLDQD-FTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEW 593
H ++H DIK +NIL+D + K+ DFG LL + T GTR Y PEW
Sbjct: 127 HNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEW 180
Query: 594 FKNVPV-SAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVD 652
+ V+S G++L ++C E + + ++
Sbjct: 181 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD----------------------EEIIR 218
Query: 653 NDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690
S C+ L+ WC+ P RP + I
Sbjct: 219 GQVFFRQRVSSECQHLI--RWCLALRPSDRPTFEEIQN 254
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (360), Expect = 3e-38
Identities = 59/200 (29%), Positives = 91/200 (45%), Gaps = 8/200 (4%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNAVAVKKLDK---LAQEREREFKTEVSAIGRTHHKNL 480
+ + LG+G+FG V K+ +G A+K L K +A++ TE + T H L
Sbjct: 9 YLKLLGKGTFGKVILVREKA-TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFL 67
Query: 481 VQLLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNV 540
L V E+ G L L EI L YLH
Sbjct: 68 TALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR--- 124
Query: 541 PIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPVS 600
+++ DIK +N++LD+D KI+DFGL K +SD + +T GT Y+APE ++
Sbjct: 125 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPEVLEDNDYG 183
Query: 601 AKVDVYSFGVVLLKIICCKR 620
VD + GVV+ +++C +
Sbjct: 184 RAVDWWGLGVVMYEMMCGRL 203
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 3e-37
Identities = 66/317 (20%), Positives = 114/317 (35%), Gaps = 43/317 (13%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQL 483
+ +G GSFG+VY+ L SG VA+KK+ + +R E+ + + H N+V+L
Sbjct: 24 DTKVIGNGSFGVVYQAKLCD-SGELVAIKKVLQ----DKRFKNRELQIMRKLDHCNIVRL 78
Query: 484 LGFCDEGLNR------LLVYEFMGNGTLANLLFAIPRP---DWSLRVRISLEIARGLLYL 534
F + LV +++ ++ R L Y+
Sbjct: 79 RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 138
Query: 535 HEECNVPIIHCDIKPQNILLDQD-FTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAP-E 592
H I H DIKPQN+LLD D K+ DFG +K L+ + + R Y AP
Sbjct: 139 HSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICS--RYYRAPEL 193
Query: 593 WFKNVPVSAKVDVYSFGVVLLKIICCKR----SVEMELGEERSAILTDWAYDCYVEGKLD 648
F ++ +DV+S G VL +++ + ++ E +L + E +
Sbjct: 194 IFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN 253
Query: 649 VL---------VDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ------MLE 693
K L ++ P R + +
Sbjct: 254 YTEFKFPQIKAHPWTKVFRPRTPPEAIALC--SRLLEYTPTARLTPLEACAHSFFDELRD 311
Query: 694 GYLEVPS-PPMPPLHSL 709
+++P+ P L +
Sbjct: 312 PNVKLPNGRDTPALFNF 328
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 7e-37
Identities = 46/281 (16%), Positives = 103/281 (36%), Gaps = 22/281 (7%)
Query: 426 EELGRGSFGIVYKGVLKSASGNAVAVKKL--DKLAQEREREFKTEVSAIGRTHHKNLVQL 483
E++G G++G V+K + + VA+K++ D + E+ + HKN+V+L
Sbjct: 8 EKIGEGTYGTVFKAKNRE-THEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRL 66
Query: 484 LGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPII 543
LV+EF D + ++ +GL + H ++
Sbjct: 67 HDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN---VL 123
Query: 544 HCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPVSAKV 603
H D+KPQN+L++++ K+++FGL++ + F S +
Sbjct: 124 HRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSI 183
Query: 604 DVYSFGVVLLKIICCKRS--------------VEMELGEERSAILTDWAYDCYVEGKLDV 649
D++S G + ++ R + + Y +
Sbjct: 184 DMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYP 243
Query: 650 LVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690
+ + + + L+ ++ +P++R + + +Q
Sbjct: 244 ATTSLVNVVPKLNATGRDLL--QNLLKCNPVQRISAEEALQ 282
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 137 bits (346), Expect = 3e-36
Identities = 60/262 (22%), Positives = 101/262 (38%), Gaps = 29/262 (11%)
Query: 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDK---LAQEREREFKTEVSAIGRTHHKNLVQ 482
+ LG GSFG V K SGN A+K LDK + ++ E + + LV+
Sbjct: 47 KTLGTGSFGRVMLVKHKE-SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK 105
Query: 483 LLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPI 542
L + N +V E++ G + + L I R + +I YLH +
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---L 162
Query: 543 IHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPVSAK 602
I+ D+KP+N+L+DQ +++DFG +K + GT +APE + +
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWTLCGTPEALAPEIILSKGYNKA 218
Query: 603 VDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMADKS 662
VD ++ GV++ ++ ++ I + S
Sbjct: 219 VDWWALGVLIYEMAAGYPPFF---ADQPIQIYEKIVSGKVRF-------------PSHFS 262
Query: 663 RACKWLMIALWCIQEDPLKRPA 684
K L+ +Q D KR
Sbjct: 263 SDLKDLL--RNLLQVDLTKRFG 282
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 4e-36
Identities = 52/293 (17%), Positives = 105/293 (35%), Gaps = 32/293 (10%)
Query: 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDK--LAQEREREFKTEVSAIGRTHHKNLVQL 483
++G+G+FG V+K + +G VA+KK+ + E+ + H+N+V L
Sbjct: 16 AKIGQGTFGEVFKARHRK-TGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNL 74
Query: 484 LGFCDEGLNR--------LLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLH 535
+ C + LV++F + L + + S R+ + GL +
Sbjct: 75 IEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGL---Y 131
Query: 536 EECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQS---RTRTVIRGTRGYVAPE 592
I+H D+K N+L+ +D K++DFGL++ ++ T T Y PE
Sbjct: 132 YIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPE 191
Query: 593 WFKN-VPVSAKVDVYSFGVVLLKIICCKR----SVEMELGEERSAILTDWAYDCYVEGKL 647
+D++ G ++ ++ + E S + + +
Sbjct: 192 LLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDN 251
Query: 648 DVLVDNDKAAMADKSRACKWLMIALW----------CIQEDPLKRPAMKMIVQ 690
L + + K + L + + DP +R +
Sbjct: 252 YELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (342), Expect = 1e-35
Identities = 66/309 (21%), Positives = 116/309 (37%), Gaps = 42/309 (13%)
Query: 412 FSLVELNEATNGFE------EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQERE--R 463
F E+ + + +G G++G V V +G VA+KKL + Q +
Sbjct: 4 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGR-TGAKVAIKKLYRPFQSELFAK 62
Query: 464 EFKTEVSAIGRTHHKNLVQLLGFC------DEGLNRLLVYEFMGNGTLANLLFAIPRPDW 517
E+ + H+N++ LL D+ + LV FMG L +
Sbjct: 63 RAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGT--DLGKLMKHEKLGE 120
Query: 518 SLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSR 577
+ ++ +GL Y+H IH D+KP N+ +++D KI DFGL++
Sbjct: 121 DRIQFLVYQMLKGLRYIHAAGI---IHRDLKPGNLAVNEDCELKILDFGLARQA----DS 173
Query: 578 TRTVIRGTRGYVAPEWFKN-VPVSAKVDVYSFGVVLLKIICCK---------------RS 621
T TR Y APE N + + VD++S G ++ ++I K
Sbjct: 174 EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMK 233
Query: 622 VEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLK 681
V E L Y++G ++ + + + + S L+ + D +
Sbjct: 234 VTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLL--EKMLVLDAEQ 291
Query: 682 RPAMKMIVQ 690
R +
Sbjct: 292 RVTAGEALA 300
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (329), Expect = 5e-34
Identities = 75/339 (22%), Positives = 127/339 (37%), Gaps = 55/339 (16%)
Query: 410 RFFSLVELNEAT----NGFE--EELGRGSFGIVYKGVLKSASGNAVAVKKLDK--LAQER 461
+F+S VE+ ++T ++ + +G G+ GIV VA+KKL + Q
Sbjct: 2 QFYS-VEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAV-LDRNVAIKKLSRPFQNQTH 59
Query: 462 EREFKTEVSAIGRTHHKNLVQLLGFC------DEGLNRLLVYEFMGNGTLANLLFAIPRP 515
+ E+ + +HKN++ LL +E + LV E M +
Sbjct: 60 AKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM---EL 116
Query: 516 DWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQ 575
D + ++ G+ +LH IH D+KP NI++ D T KI DFGL++ +
Sbjct: 117 DHERMSYLLYQMLCGIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 173
Query: 576 SRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVV-------------------LLKII 616
T V TR Y APE + VD++S G + K+I
Sbjct: 174 MMTPYV--VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI 231
Query: 617 CCKRSVEMELGEERSAILTDWAYDCYVEGKL-------DVLVDNDKAAMADKSRACKWLM 669
+ E ++ + ++ + L D L D K+ + L+
Sbjct: 232 EQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLL 291
Query: 670 IALWCIQEDPLKRPAMKMIVQ---MLEGYLEVPSPPMPP 705
+ DP KR ++ +Q + Y PP
Sbjct: 292 --SKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPP 328
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 126 bits (317), Expect = 1e-32
Identities = 55/292 (18%), Positives = 111/292 (38%), Gaps = 37/292 (12%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGR-THHKNLVQ 482
+LGRG + V++ + + + V VK L ++++ K E+ + N++
Sbjct: 39 LVRKLGRGKYSEVFEAINIT-NNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIIT 94
Query: 483 LLGFCDEGLNRL--LVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNV 540
L + ++R LV+E + N L + D EI + L Y H
Sbjct: 95 LADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYD---IRFYMYEILKALDYCHSMG-- 149
Query: 541 PIIHCDIKPQNILLDQDF-TAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPE-WFKNVP 598
I+H D+KP N+++D + ++ D+GL++ Q V +R + PE
Sbjct: 150 -IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRV--ASRYFKGPELLVDYQM 206
Query: 599 VSAKVDVYSFGVVLLKIICCK------RSVEMELGEERSAILTDWAYDCYVEGKLDVLVD 652
+D++S G +L +I K +L + T+ YD + +++
Sbjct: 207 YDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPR 266
Query: 653 -NDKAAMADKSRACKWLMIALW-------------CIQEDPLKRPAMKMIVQ 690
ND + R +++ ++ D R + ++
Sbjct: 267 FNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (317), Expect = 1e-32
Identities = 63/308 (20%), Positives = 116/308 (37%), Gaps = 40/308 (12%)
Query: 424 FEEELGRGSFGIVYKGVLKSA--SGNAVAVKKLDKLAQERE----REFKTEVSAIGR-TH 476
+ LG G++G V+ S +G A+K L K ++ +TE +
Sbjct: 28 LLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQ 87
Query: 477 HKNLVQLLGFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHE 536
LV L L+ +++ G L L R + + + +L L
Sbjct: 88 SPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEH---EVQIYVGEIVLALEH 144
Query: 537 ECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWF-- 594
+ II+ DIK +NILLD + ++DFGLSK ++D++ GT Y+AP+
Sbjct: 145 LHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRG 204
Query: 595 KNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDND 654
+ VD +S GV++ +++ ++ + A ++ ++
Sbjct: 205 GDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEM----- 259
Query: 655 KAAMADKSRACKWLMIALWCIQEDPLKRP--AMKMIVQMLE------------GYLEVPS 700
S K L+ + +DP KR + ++ E +VP+
Sbjct: 260 -------SALAKDLI--QRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPA 310
Query: 701 PPMPPLHS 708
P P +
Sbjct: 311 PFKPVIRD 318
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (298), Expect = 7e-30
Identities = 66/328 (20%), Positives = 118/328 (35%), Gaps = 42/328 (12%)
Query: 412 FSLVELN----EATNGFE--EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQERE--R 463
F ELN E ++ +G G++G V +G VAVKKL + Q +
Sbjct: 4 FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTK-TGLRVAVKKLSRPFQSIIHAK 62
Query: 464 EFKTEVSAIGRTHHKNLVQLLGFCDEG-----LNRLLVYEFMGNGTLANLLFAIPRPDWS 518
E+ + H+N++ LL N + + + G N + +
Sbjct: 63 RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL-MGADLNNIVKCQKLTDD 121
Query: 519 LRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRT 578
+ +I RGL Y+H IH D+KP N+ +++D KI DFGL++
Sbjct: 122 HVQFLIYQILRGLKYIHSADI---IHRDLKPSNLAVNEDCELKILDFGLAR----HTDDE 174
Query: 579 RTVIRGTRGYVAPEWFKN-VPVSAKVDVYSFGVVLLKIICCKR---------------SV 622
T TR Y APE N + + VD++S G ++ +++ + +
Sbjct: 175 MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 234
Query: 623 EMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKR 682
G E ++ + Y++ + N + L+ + D KR
Sbjct: 235 VGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLL--EKMLVLDSDKR 292
Query: 683 PAMKMIVQM--LEGYLEVPSPPMPPLHS 708
+ Y + P+ +
Sbjct: 293 ITAAQALAHAYFAQYHDPDDEPVADPYD 320
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 112 bits (281), Expect = 1e-27
Identities = 47/243 (19%), Positives = 85/243 (34%), Gaps = 22/243 (9%)
Query: 424 FEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQL 483
+LG G F V+ + VA+K + E + E+ + R + + +
Sbjct: 17 LVRKLGWGHFSTVWLAKDMV-NNTHVAMKIVRGDKVYTEA-AEDEIKLLQRVNDADNTKE 74
Query: 484 LGFCDEGLNRLLVY----------------EFMGNGTLANLLFAIPRPDWSLRVRISLEI 527
+ +LL + N + +IS ++
Sbjct: 75 DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQL 134
Query: 528 ARGLLYLHEECNVPIIHCDIKPQNILLDQ-DFTAKISDFGLSKLLLSDQSRTR-TVIRGT 585
GL Y+H C IIH DIKP+N+L++ D + ++ L + T T
Sbjct: 135 LLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQT 192
Query: 586 RGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEG 645
R Y +PE P D++S ++ ++I E + G + A + G
Sbjct: 193 REYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLG 252
Query: 646 KLD 648
+L
Sbjct: 253 ELP 255
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 85.6 bits (211), Expect = 9e-20
Identities = 29/208 (13%), Positives = 56/208 (26%), Gaps = 40/208 (19%)
Query: 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQE----------REREFKTEVSAIGRT 475
+ +G G V+ + VK + F R
Sbjct: 6 KLMGEGKESAVFNCYSE--KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARN 63
Query: 476 HHKNLVQLLGFCD----EGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGL 531
+ L +L G ++ E + + R + I +
Sbjct: 64 EFRALQKLQGLAVPKVYAWEGNAVLMELIDAKE-------LYRVRVENPDEVLDMILEEV 116
Query: 532 LYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRT---RTVIRGTRGY 588
+ I+H D+ N+L+ + I DF S + + R R V
Sbjct: 117 AKFYHRG---IVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGWREILERDVRNIIT-- 170
Query: 589 VAPEWFKNVPVSAKVDVYSFGVVLLKII 616
+F + D+ S + +I+
Sbjct: 171 ----YFSR-TYRTEKDINS---AIDRIL 190
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 714 | |||
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.85 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 99.22 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 99.12 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 99.07 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 98.69 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 98.59 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 98.55 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.29 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.87 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 97.77 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.74 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 97.7 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 97.67 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 97.09 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 96.75 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.67 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 96.5 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.5 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 94.85 | |
| d1emoa2 | 39 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 93.86 | |
| d1lmja2 | 42 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 93.37 | |
| d2vj3a1 | 42 | Neurogenic locus notch homolog protein 1, Notch1 { | 93.01 | |
| d1emoa1 | 43 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 92.88 | |
| d1xkba1 | 39 | Factor X, N-terminal module {Human (Homo sapiens) | 91.48 | |
| d1uzka2 | 43 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 91.09 | |
| d2vj3a2 | 39 | Neurogenic locus notch homolog protein 1, Notch1 { | 90.43 | |
| d1lmja1 | 44 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 89.38 | |
| d1edmb_ | 39 | Factor IX (IXa) {Human (Homo sapiens) [TaxId: 9606 | 89.19 | |
| d2vj3a3 | 35 | Neurogenic locus notch homolog protein 1, Notch1 { | 88.34 | |
| d1uzka1 | 43 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 87.99 | |
| d1gl4a2 | 40 | EGF-like domain of nidogen-1 {Mouse (Mus musculus) | 87.15 | |
| d1i0ua2 | 41 | Low density lipoprotein (LDL) receptor, different | 87.08 | |
| d2c4fl1 | 37 | Factor IX (IXa) {Pig (Sus scrofa) [TaxId: 9823]} | 86.62 | |
| d1autl1 | 48 | Activated protein c (autoprothrombin IIa) {Human ( | 84.95 | |
| d1nt0a3 | 45 | Mannose-binding protein associated serine protease | 84.12 | |
| d1g1ta2 | 39 | E-selectin, EGF-domain {Human (Homo sapiens) [TaxI | 83.23 | |
| d1apqa_ | 53 | Complement protease C1R {Human (Homo sapiens) [Tax | 83.15 | |
| d1g1sa2 | 40 | E-selectin, EGF-domain {Human (Homo sapiens) [TaxI | 82.97 | |
| d1q4ga2 | 42 | Prostaglandin H2 synthase-1, EGF-like module {Shee | 82.87 |
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7.7e-50 Score=415.26 Aligned_cols=255 Identities=27% Similarity=0.392 Sum_probs=198.0
Q ss_pred hhhhhCcccceeEEEeEeeCCCC--cEEEEEEeccc-chhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEeec
Q 041576 424 FEEELGRGSFGIVYKGVLKSASG--NAVAVKKLDKL-AQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEFM 500 (714)
Q Consensus 424 ~~~~ig~G~~g~Vy~~~~~~~~~--~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~ 500 (714)
+.+.||+|+||+||+|.++..++ ..||||.+... .....+.|.+|+++|++++|||||++++++.+++..++||||+
T Consensus 30 ~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~Ey~ 109 (299)
T d1jpaa_ 30 IEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFM 109 (299)
T ss_dssp EEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred EeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEec
Confidence 34679999999999999864322 36889988653 4445678999999999999999999999999999999999999
Q ss_pred CCCchhhhhhcC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcccc-
Q 041576 501 GNGTLANLLFAI-PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRT- 578 (714)
Q Consensus 501 ~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~- 578 (714)
++|+|.+++... +.+++.+++.++.||++||+|||+++ |+||||||+||||+.++.+||+|||+++.+.......
T Consensus 110 ~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~ 186 (299)
T d1jpaa_ 110 ENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPT 186 (299)
T ss_dssp TTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------------
T ss_pred CCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccCCCCcce
Confidence 999999988764 56899999999999999999999998 9999999999999999999999999998765433221
Q ss_pred ---eeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccchhhhhhhHHHhhhhhcCccceeecch
Q 041576 579 ---RTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDND 654 (714)
Q Consensus 579 ---~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 654 (714)
.....+|+.|+|||.+.+..++.++|||||||++|||+| |+.||......+. +. ....+..
T Consensus 187 ~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~---~~-----~i~~~~~------- 251 (299)
T d1jpaa_ 187 YTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDV---IN-----AIEQDYR------- 251 (299)
T ss_dssp ---------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH---HH-----HHHTTCC-------
T ss_pred eeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHH---HH-----HHHcCCC-------
Confidence 122457899999999999999999999999999999998 8999975443321 11 1111110
Q ss_pred hhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCC
Q 041576 655 KAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLEV 698 (714)
Q Consensus 655 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 698 (714)
...+...+..+.+++.+||+.||++||||+||++.|+++++.
T Consensus 252 --~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 252 --LPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp --CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred --CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence 111223445788899999999999999999999999998764
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-50 Score=408.68 Aligned_cols=254 Identities=30% Similarity=0.457 Sum_probs=198.3
Q ss_pred hhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEeec
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEFM 500 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~ 500 (714)
.+.+.++||+|+||+||+|+++ +++.||||+++... ...++|.+|++++++++||||++++|+|.+++..++||||+
T Consensus 6 ~~~~~~~iG~G~fg~Vy~~~~~--~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~ 82 (263)
T d1sm2a_ 6 ELTFVQEIGSGQFGLVHLGYWL--NKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 82 (263)
T ss_dssp CEEEEEEEECCSSCCEEEEEET--TTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HcEEEEEEeeCCCeEEEEEEEC--CCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEec
Confidence 3567789999999999999975 57789999997633 34568999999999999999999999999999999999999
Q ss_pred CCCchhhhhhcC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcccce
Q 041576 501 GNGTLANLLFAI-PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTR 579 (714)
Q Consensus 501 ~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 579 (714)
++|+|.+++... ..+++..++.++.||++||+|||+++ |+||||||+|||+++++.+||+|||+++..........
T Consensus 83 ~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~ 159 (263)
T d1sm2a_ 83 EHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS 159 (263)
T ss_dssp TTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC-------------
T ss_pred CCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCceee
Confidence 999999998755 56789999999999999999999998 99999999999999999999999999987755544444
Q ss_pred eeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCC-CcccccchhhhhhhHHHhhhhhcCccceeecchhhhc
Q 041576 580 TVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRS-VEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAM 658 (714)
Q Consensus 580 ~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p-~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 658 (714)
....||..|+|||++.+..++.++|||||||++|||+|+..| +......+. +.. ...+... .
T Consensus 160 ~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~---~~~-----i~~~~~~---------~ 222 (263)
T d1sm2a_ 160 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV---VED-----ISTGFRL---------Y 222 (263)
T ss_dssp -----CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHH---HHH-----HHHTCCC---------C
T ss_pred cceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHH---HHH-----HHhcCCC---------C
Confidence 456789999999999999999999999999999999996544 443222211 111 1111100 0
Q ss_pred cchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccC
Q 041576 659 ADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLE 697 (714)
Q Consensus 659 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 697 (714)
.+...+.++.+++.+||+.||++||||+||++.|+++++
T Consensus 223 ~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 223 KPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 112234577889999999999999999999999998764
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7.3e-50 Score=412.93 Aligned_cols=262 Identities=27% Similarity=0.382 Sum_probs=216.3
Q ss_pred HHHHHhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCcccccceeceEecCCeeeE
Q 041576 416 ELNEATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLL 495 (714)
Q Consensus 416 el~~at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 495 (714)
|+....+.+.++||+|+||+||+|+++ .+++.||||+++... ...++|.+|++++++++||||+++++++.+++..++
T Consensus 13 ei~~~~~~~~~~iG~G~fg~Vy~a~~~-~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 90 (287)
T d1opja_ 13 EMERTDITMKHKLGGGQYGEVYEGVWK-KYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 90 (287)
T ss_dssp BCCGGGEEEEEETTTTTTSSEEEEEEG-GGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred EecHHHeEEeeEEeeCCCeEEEEEEEC-CCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEE
Confidence 455566778899999999999999986 468899999997543 345689999999999999999999999999999999
Q ss_pred EEeecCCCchhhhhhcC--CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCcccccc
Q 041576 496 VYEFMGNGTLANLLFAI--PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLS 573 (714)
Q Consensus 496 v~E~~~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~ 573 (714)
||||+++|+|.+++... ..+++..++.|+.||++||+|||+++ |+||||||+||||++++.+||+|||+++....
T Consensus 91 v~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (287)
T d1opja_ 91 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTG 167 (287)
T ss_dssp EEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCS
T ss_pred EeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCC
Confidence 99999999999999754 56799999999999999999999998 99999999999999999999999999997765
Q ss_pred CcccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecc
Q 041576 574 DQSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDN 653 (714)
Q Consensus 574 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 653 (714)
+.........|+..|+|||++.+..++.++|||||||++|||++|+.|+........ +.. ....+..
T Consensus 168 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~---~~~----~i~~~~~------ 234 (287)
T d1opja_ 168 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---VYE----LLEKDYR------ 234 (287)
T ss_dssp SSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---HHH----HHHTTCC------
T ss_pred CCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHH---HHH----HHhcCCC------
Confidence 554444455688999999999999999999999999999999998777653322211 111 1111110
Q ss_pred hhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCC
Q 041576 654 DKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLEV 698 (714)
Q Consensus 654 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 698 (714)
...+...+..+.+|+.+||+.||++||||+||++.|+.+.+.
T Consensus 235 ---~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~ 276 (287)
T d1opja_ 235 ---MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 276 (287)
T ss_dssp ---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred ---CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 111223345788899999999999999999999999987643
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-49 Score=403.59 Aligned_cols=251 Identities=29% Similarity=0.365 Sum_probs=204.6
Q ss_pred hhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc-hhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEee
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA-QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEF 499 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~ 499 (714)
.|.+.+.||+|+||+||+|+++ .+++.||||+++... ....+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 6 dy~~~~~lG~G~fg~V~~~~~~-~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 6 DWDLVQTLGEGAYGEVQLAVNR-VTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp EEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ceEEEEEEecCcCeEEEEEEEC-CCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 4677899999999999999976 578999999986532 23446789999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCc-ccc
Q 041576 500 MGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQ-SRT 578 (714)
Q Consensus 500 ~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~ 578 (714)
+++|+|.+++.....+++.++..++.||++||+|||+++ |+||||||+|||+++++.+||+|||+++...... ...
T Consensus 85 ~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~ 161 (271)
T d1nvra_ 85 CSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 161 (271)
T ss_dssp CTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred cCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCCcccc
Confidence 999999999998888999999999999999999999998 9999999999999999999999999998765433 233
Q ss_pred eeeecCCCCccCcccccCCCC-CchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhh
Q 041576 579 RTVIRGTRGYVAPEWFKNVPV-SAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAA 657 (714)
Q Consensus 579 ~~~~~gt~~y~aPE~~~~~~~-s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 657 (714)
.....||+.|+|||++.+..+ +.++|||||||++|||++|+.||......... .... ...... .
T Consensus 162 ~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~--~~~~-----~~~~~~--------~ 226 (271)
T d1nvra_ 162 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE--YSDW-----KEKKTY--------L 226 (271)
T ss_dssp BCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHH--HHHH-----HTTCTT--------S
T ss_pred ccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHH--HHHH-----hcCCCC--------C
Confidence 445679999999999988776 67899999999999999999999754332211 1110 010000 0
Q ss_pred ccchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 658 MADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 658 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
......+..+.+++.+||+.||++|||++|+++
T Consensus 227 ~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 227 NPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 011223456778999999999999999999976
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-49 Score=400.82 Aligned_cols=245 Identities=27% Similarity=0.360 Sum_probs=207.9
Q ss_pred hhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEeccc---chhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEE
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKL---AQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVY 497 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 497 (714)
.|.+.+.||+|+||+||+|+++ .+++.||+|++.+. .....+.+.+|++++++++||||+++++++.+++..++||
T Consensus 7 dy~i~~~iG~G~fg~Vy~~~~~-~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 7 DFEIGRPLGKGKFGNVYLAREK-QSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HeEEEEEEecCCCcEEEEEEEC-CCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 4778899999999999999976 57899999998653 2334568899999999999999999999999999999999
Q ss_pred eecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCccc
Q 041576 498 EFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSR 577 (714)
Q Consensus 498 E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 577 (714)
||+++|+|.+++.....+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 86 Ey~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~--- 159 (263)
T d2j4za1 86 EYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--- 159 (263)
T ss_dssp ECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC---
T ss_pred eecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCC---
Confidence 99999999999998888999999999999999999999998 999999999999999999999999999865432
Q ss_pred ceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhh
Q 041576 578 TRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAA 657 (714)
Q Consensus 578 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 657 (714)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.... .......
T Consensus 160 ~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~--------i~~~~~~--------- 222 (263)
T d2j4za1 160 RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKR--------ISRVEFT--------- 222 (263)
T ss_dssp CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH--------HHTTCCC---------
T ss_pred cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHH--------HHcCCCC---------
Confidence 23345799999999999999999999999999999999999999975543321111 1111110
Q ss_pred ccchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 658 MADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 658 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
.+...+.++.+++.+||+.||++|||++|+++
T Consensus 223 -~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 223 -FPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp -CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -CCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 11223456788999999999999999999986
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-48 Score=403.51 Aligned_cols=249 Identities=25% Similarity=0.360 Sum_probs=208.8
Q ss_pred hhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEeec
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEFM 500 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~ 500 (714)
+|.+.++||+|+||+||+|+.+ .+|+.||||+++.......+.+.+|++++++++||||+++++++.+++..++||||+
T Consensus 21 ~Y~~~~~iG~G~fg~Vy~a~~~-~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 21 KYTRFEKIGQGASGTVYTAMDV-ATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TBCSCEECCCSSSCEEEEEEBT-TTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred ccEEEEEEecCcCcEEEEEEEC-CCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 5777899999999999999876 578999999997665566778999999999999999999999999999999999999
Q ss_pred CCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCccccee
Q 041576 501 GNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRT 580 (714)
Q Consensus 501 ~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 580 (714)
++|+|.+++.. ..+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.+..... ...
T Consensus 100 ~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~-~~~ 174 (293)
T d1yhwa1 100 AGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRS 174 (293)
T ss_dssp TTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-CBC
T ss_pred CCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeeccccc-ccc
Confidence 99999998876 56899999999999999999999998 99999999999999999999999999987654332 234
Q ss_pred eecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhhccc
Q 041576 581 VIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMAD 660 (714)
Q Consensus 581 ~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 660 (714)
...||+.|+|||++.+..++.++|||||||++|||++|+.||........ +... ...+... . ..+
T Consensus 175 ~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~---~~~~----~~~~~~~-~-------~~~ 239 (293)
T d1yhwa1 175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA---LYLI----ATNGTPE-L-------QNP 239 (293)
T ss_dssp CCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH---HHHH----HHHCSCC-C-------SSG
T ss_pred ccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHH---HHHH----HhCCCCC-C-------CCc
Confidence 45699999999999999999999999999999999999999975433221 1111 0111100 0 111
Q ss_pred hHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 661 KSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 661 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
...+..+.+++.+||+.||++|||++|+++
T Consensus 240 ~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 240 EKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp GGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 223456788999999999999999999986
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-49 Score=404.04 Aligned_cols=258 Identities=27% Similarity=0.414 Sum_probs=202.5
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEeccc--chhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEE
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKL--AQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVY 497 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 497 (714)
..+.+.+.||+|+||+||+|+++ ..||||+++.. .....+.|++|++++++++||||+++++++.+ +..++||
T Consensus 8 ~~~~~~~~lG~G~fg~Vy~~~~~----~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~ 82 (276)
T d1uwha_ 8 GQITVGQRIGSGSFGTVYKGKWH----GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVT 82 (276)
T ss_dssp TCCCCCSEEEECSSCEEEEEESS----SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred ccEEEEEEEeeCCCcEEEEEEEC----CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEE
Confidence 45667899999999999999864 36999998643 34556789999999999999999999998865 5679999
Q ss_pred eecCCCchhhhhhcC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcc
Q 041576 498 EFMGNGTLANLLFAI-PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQS 576 (714)
Q Consensus 498 E~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 576 (714)
||+++|+|.+++... ..+++..++.++.||++||+|||+++ |+||||||+||||+.++.+||+|||+++.......
T Consensus 83 Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~ 159 (276)
T d1uwha_ 83 QWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG 159 (276)
T ss_dssp ECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC------
T ss_pred ecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccccCC
Confidence 999999999999754 56899999999999999999999998 99999999999999999999999999987654332
Q ss_pred -cceeeecCCCCccCcccccC---CCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeec
Q 041576 577 -RTRTVIRGTRGYVAPEWFKN---VPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVD 652 (714)
Q Consensus 577 -~~~~~~~gt~~y~aPE~~~~---~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 652 (714)
.......||+.|+|||++.+ ..++.++|||||||+||||+||+.||........ +.... ..+...
T Consensus 160 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~---~~~~~----~~~~~~---- 228 (276)
T d1uwha_ 160 SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ---IIFMV----GRGYLS---- 228 (276)
T ss_dssp ------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH---HHHHH----HHTSCC----
T ss_pred cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHH---HHHHH----hcCCCC----
Confidence 33345679999999999864 3589999999999999999999999975433221 11111 111110
Q ss_pred chhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccC
Q 041576 653 NDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLE 697 (714)
Q Consensus 653 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 697 (714)
+.. .......+..+.+++.+||+.||++||||+||++.|+.+.+
T Consensus 229 p~~-~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~ 272 (276)
T d1uwha_ 229 PDL-SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272 (276)
T ss_dssp CCG-GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred Ccc-hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 000 11122334578889999999999999999999999998765
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-49 Score=406.40 Aligned_cols=256 Identities=25% Similarity=0.411 Sum_probs=207.8
Q ss_pred HHHhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEE
Q 041576 418 NEATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVY 497 (714)
Q Consensus 418 ~~at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 497 (714)
....+.+.+.||+|+||+||+|+++ +++.||||+++... ...+.|.+|++++++++|||||++++++.+ +..++||
T Consensus 11 ~~~~~~~~~~iG~G~fg~Vy~~~~~--~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~ 86 (272)
T d1qpca_ 11 PRETLKLVERLGAGQFGEVWMGYYN--GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIIT 86 (272)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET--TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred CHHHeEEeEEEecCCCcEEEEEEEC--CCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEE
Confidence 3456778899999999999999975 57889999997543 345689999999999999999999998865 5679999
Q ss_pred eecCCCchhhhhhcC--CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCc
Q 041576 498 EFMGNGTLANLLFAI--PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQ 575 (714)
Q Consensus 498 E~~~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 575 (714)
||+++|+|.+++... ..+++..+++|+.||++||+|||+++ |+||||||+||||++++.+||+|||+++.+....
T Consensus 87 Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~ 163 (272)
T d1qpca_ 87 EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163 (272)
T ss_dssp ECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred EeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCc
Confidence 999999999987654 35899999999999999999999998 9999999999999999999999999999876555
Q ss_pred ccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchh
Q 041576 576 SRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDK 655 (714)
Q Consensus 576 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 655 (714)
........|++.|+|||++.+..++.++|||||||++|||+||..|+....... ..+. ....+...
T Consensus 164 ~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~--~~~~-----~i~~~~~~------- 229 (272)
T d1qpca_ 164 YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP--EVIQ-----NLERGYRM------- 229 (272)
T ss_dssp EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHH-----HHHTTCCC-------
T ss_pred cccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHH--HHHH-----HHHhcCCC-------
Confidence 444455678999999999998899999999999999999999766654322211 1111 11111111
Q ss_pred hhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 041576 656 AAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYL 696 (714)
Q Consensus 656 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 696 (714)
..+...+..+.+++.+||+.||++||||+||+++|+.+.
T Consensus 230 --~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~f 268 (272)
T d1qpca_ 230 --VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (272)
T ss_dssp --CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --CCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhh
Confidence 111223456888999999999999999999999998753
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-48 Score=394.78 Aligned_cols=251 Identities=26% Similarity=0.395 Sum_probs=211.6
Q ss_pred hhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEeecC
Q 041576 422 NGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEFMG 501 (714)
Q Consensus 422 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~ 501 (714)
+.+.++||+|+||+||+|+++ +++.||||+++... ...++|.+|++++++++||||++++|+|.+++..++||||++
T Consensus 6 ~~~~~~iG~G~fg~Vy~~~~~--~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 6 LTFLKELGTGQFGVVKYGKWR--GQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCEETTEEEEEEEET--TTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred CEEeEEEecCCCeEEEEEEEC--CCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 457789999999999999985 67899999997643 345689999999999999999999999999999999999999
Q ss_pred CCchhhhhhcC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCccccee
Q 041576 502 NGTLANLLFAI-PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTRT 580 (714)
Q Consensus 502 ~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 580 (714)
+|+|.+++... ..+++..+.+++.||++||+|||+.+ |+||||||+||++++++.+||+|||+++...........
T Consensus 83 ~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~ 159 (258)
T d1k2pa_ 83 NGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV 159 (258)
T ss_dssp TEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCC
T ss_pred CCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCceeec
Confidence 99999997654 56889999999999999999999998 999999999999999999999999999877665555555
Q ss_pred eecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhhcc
Q 041576 581 VIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMA 659 (714)
Q Consensus 581 ~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 659 (714)
...+|..|+|||.+.+..++.|+|||||||++|||+| |+.||......+... ....+... ..
T Consensus 160 ~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~--------~i~~~~~~---------~~ 222 (258)
T d1k2pa_ 160 GSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAE--------HIAQGLRL---------YR 222 (258)
T ss_dssp CSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHH--------HHHTTCCC---------CC
T ss_pred ccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHH--------HHHhCCCC---------CC
Confidence 5678999999999999999999999999999999998 899997654433211 11111111 11
Q ss_pred chHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 041576 660 DKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGY 695 (714)
Q Consensus 660 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 695 (714)
+...+..+.+++.+||+.||++|||++||++.|.++
T Consensus 223 p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 223 PHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred cccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 222335788899999999999999999999998653
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-48 Score=394.79 Aligned_cols=247 Identities=28% Similarity=0.404 Sum_probs=199.9
Q ss_pred hhhhhhCcccceeEEEeEeeCCCCcEEEEEEeccc--chhhHHHHHHHHHHHhccCcccccceeceEec----CCeeeEE
Q 041576 423 GFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKL--AQEREREFKTEVSAIGRTHHKNLVQLLGFCDE----GLNRLLV 496 (714)
Q Consensus 423 ~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~----~~~~~lv 496 (714)
.|.++||+|+||+||+|++. .+++.||+|++... .....+.+.+|++++++++||||+++++++.+ +...++|
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~-~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDT-ETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEEC-CCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 56778999999999999976 57889999998653 34455689999999999999999999999854 3457899
Q ss_pred EeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEEC-CCCceEEecCCCccccccCc
Q 041576 497 YEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLD-QDFTAKISDFGLSKLLLSDQ 575 (714)
Q Consensus 497 ~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~-~~~~~kl~Dfg~~~~~~~~~ 575 (714)
|||+++|+|.+++.....+++.++..++.||++||+|||+++ .+|+||||||+|||++ +++.+||+|||+++.....
T Consensus 91 mE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~- 168 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS- 168 (270)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT-
T ss_pred EeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC-
Confidence 999999999999998888999999999999999999999975 5699999999999996 5789999999999764332
Q ss_pred ccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchh
Q 041576 576 SRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDK 655 (714)
Q Consensus 576 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 655 (714)
......||+.|+|||++.+ .++.++|||||||++|||++|+.||........ + ......+....
T Consensus 169 --~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~---~----~~~i~~~~~~~------ 232 (270)
T d1t4ha_ 169 --FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ---I----YRRVTSGVKPA------ 232 (270)
T ss_dssp --SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH---H----HHHHTTTCCCG------
T ss_pred --ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHH---H----HHHHHcCCCCc------
Confidence 2335679999999999876 599999999999999999999999964322211 1 11111111110
Q ss_pred hhccchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 656 AAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 656 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
..+.....++.+++.+||++||++|||++|+++
T Consensus 233 --~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 233 --SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp --GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred --ccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 111222345788999999999999999999986
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-48 Score=399.64 Aligned_cols=249 Identities=27% Similarity=0.385 Sum_probs=202.5
Q ss_pred hhhCcccceeEEEeEeeC-CCCcEEEEEEeccc--chhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEeecCC
Q 041576 426 EELGRGSFGIVYKGVLKS-ASGNAVAVKKLDKL--AQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEFMGN 502 (714)
Q Consensus 426 ~~ig~G~~g~Vy~~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~ 502 (714)
++||+|+||+||+|.++. ..++.||||+++.. .....++|.+|++++++++||||++++++|..+ ..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCCC
Confidence 469999999999998763 34578999999653 233456899999999999999999999999654 57899999999
Q ss_pred CchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCccc--cee
Q 041576 503 GTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSR--TRT 580 (714)
Q Consensus 503 gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~--~~~ 580 (714)
|+|.+++.....+++.+++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.+...... ...
T Consensus 92 g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~ 168 (277)
T d1xbba_ 92 GPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT 168 (277)
T ss_dssp EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC--
T ss_pred CcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhcccccccccccc
Confidence 999999999889999999999999999999999998 999999999999999999999999999876544332 223
Q ss_pred eecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhhcc
Q 041576 581 VIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMA 659 (714)
Q Consensus 581 ~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 659 (714)
...||+.|+|||.+.+..++.++|||||||++|||+| |+.||......+... .+..+.... .
T Consensus 169 ~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~--------~i~~~~~~~---------~ 231 (277)
T d1xbba_ 169 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTA--------MLEKGERMG---------C 231 (277)
T ss_dssp --CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH--------HHHTTCCCC---------C
T ss_pred ccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHH--------HHHcCCCCC---------C
Confidence 4568999999999999999999999999999999998 899997543322111 111221111 1
Q ss_pred chHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 041576 660 DKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGY 695 (714)
Q Consensus 660 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 695 (714)
+...+.++.+++.+||+.||++|||+++|+++|+..
T Consensus 232 p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~ 267 (277)
T d1xbba_ 232 PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267 (277)
T ss_dssp CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence 222345788899999999999999999999988763
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-48 Score=401.23 Aligned_cols=247 Identities=23% Similarity=0.282 Sum_probs=205.3
Q ss_pred hhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEeccc---chhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEE
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKL---AQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVY 497 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 497 (714)
.|.+.+.||+|+||+||+|+.+ .+++.||||+++.. .....+.+.+|++++++++||||+++++++.+++..|+||
T Consensus 9 dy~i~~~lG~G~fg~Vy~a~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 9 DFKFGKILGEGSFSTVVLAREL-ATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GEEEEEEEEECSSCEEEEEEET-TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEeeCCCeEEEEEEEC-CCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 4788899999999999999976 57899999999653 2334568999999999999999999999999999999999
Q ss_pred eecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcc-
Q 041576 498 EFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQS- 576 (714)
Q Consensus 498 E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~- 576 (714)
||+++|+|.+++...+.+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++.+.....
T Consensus 88 Ey~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~ 164 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 164 (288)
T ss_dssp CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred EccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccCCcc
Confidence 99999999999998889999999999999999999999998 99999999999999999999999999987754332
Q ss_pred cceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhh
Q 041576 577 RTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKA 656 (714)
Q Consensus 577 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 656 (714)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||.......... ....+...
T Consensus 165 ~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~--------~i~~~~~~-------- 228 (288)
T d1uu3a_ 165 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQ--------KIIKLEYD-------- 228 (288)
T ss_dssp -----CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH--------HHHTTCCC--------
T ss_pred cccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHH--------HHHcCCCC--------
Confidence 23344579999999999999999999999999999999999999998553332111 11111111
Q ss_pred hccchHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 041576 657 AMADKSRACKWLMIALWCIQEDPLKRPAMKMIV 689 (714)
Q Consensus 657 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl 689 (714)
.+...+.++.+++.+||+.||++|||++|++
T Consensus 229 --~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~ 259 (288)
T d1uu3a_ 229 --FPEKFFPKARDLVEKLLVLDATKRLGCEEME 259 (288)
T ss_dssp --CCTTCCHHHHHHHHTTSCSSGGGSTTSGGGT
T ss_pred --CCccCCHHHHHHHHHHccCCHhHCcCHHHHc
Confidence 1112345678899999999999999999864
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-48 Score=401.31 Aligned_cols=250 Identities=24% Similarity=0.309 Sum_probs=206.4
Q ss_pred hhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEeec
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEFM 500 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~ 500 (714)
.|.+.+.||+|+||+||+|+++ .+++.||||+++.......+.+.+|++++++++||||+++++++.+++..++||||+
T Consensus 13 ~Y~i~~~iG~G~fg~Vy~~~~~-~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 13 FWEIIGELGDGAFGKVYKAQNK-ETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp TEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred CeEEeEEEeeCCCcEEEEEEEC-CCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 3677889999999999999976 578999999997766666778999999999999999999999999999999999999
Q ss_pred CCCchhhhhhc-CCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcccce
Q 041576 501 GNGTLANLLFA-IPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTR 579 (714)
Q Consensus 501 ~~gsL~~~l~~-~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 579 (714)
++|+|.+++.. ...+++.++..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++....... ..
T Consensus 92 ~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~-~~ 167 (288)
T d2jfla1 92 AGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-RR 167 (288)
T ss_dssp TTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHHHH-HH
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCCcc-cc
Confidence 99999999765 456899999999999999999999998 99999999999999999999999999976533221 22
Q ss_pred eeecCCCCccCccccc-----CCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecch
Q 041576 580 TVIRGTRGYVAPEWFK-----NVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDND 654 (714)
Q Consensus 580 ~~~~gt~~y~aPE~~~-----~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 654 (714)
....||+.|+|||++. +..++.++|||||||++|||++|+.||......+. +... ..+....+
T Consensus 168 ~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~---~~~i-----~~~~~~~~---- 235 (288)
T d2jfla1 168 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV---LLKI-----AKSEPPTL---- 235 (288)
T ss_dssp TCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH---HHHH-----HHSCCCCC----
T ss_pred cccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHH---HHHH-----HcCCCCCC----
Confidence 3456999999999984 45689999999999999999999999975543321 1111 11111111
Q ss_pred hhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 655 KAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 655 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
..+...+..+.+++.+||+.||++|||++|+++
T Consensus 236 ---~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 236 ---AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp ---SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ---CccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 011233457888999999999999999999976
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-48 Score=401.37 Aligned_cols=263 Identities=25% Similarity=0.395 Sum_probs=207.0
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEee
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEF 499 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~ 499 (714)
..+.+.+.||+|+||+||+|+++ +++.||||+++... ...+.|.+|+.++++++|||||++++++.+ +..++||||
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~--~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey 92 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWN--GTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 92 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET--TTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred HHEEEeeEEeeCCCeEEEEEEEC--CCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEe
Confidence 46788899999999999999886 45689999997543 345789999999999999999999999855 567999999
Q ss_pred cCCCchhhhhhcC--CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCccc
Q 041576 500 MGNGTLANLLFAI--PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSR 577 (714)
Q Consensus 500 ~~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 577 (714)
+++|+|..++... ..+++.+++.++.||++||+|||+++ |+||||||+||||++++.+||+|||+++........
T Consensus 93 ~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~ 169 (285)
T d1fmka3 93 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 169 (285)
T ss_dssp CTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred cCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCCce
Confidence 9999999998753 56899999999999999999999998 999999999999999999999999999877555544
Q ss_pred ceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhh
Q 041576 578 TRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAA 657 (714)
Q Consensus 578 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 657 (714)
......||+.|+|||++.+..++.++|||||||++|||++|..|+........ .+.. ...+.. .
T Consensus 170 ~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~--~~~~-----i~~~~~---------~ 233 (285)
T d1fmka3 170 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--VLDQ-----VERGYR---------M 233 (285)
T ss_dssp ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HHHH-----HHTTCC---------C
T ss_pred eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHH--HHHH-----HHhcCC---------C
Confidence 55556789999999999999999999999999999999997776654322211 1111 111110 1
Q ss_pred ccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCCCCCCCCC
Q 041576 658 MADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLEVPSPPMPP 705 (714)
Q Consensus 658 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~pp~p~ 705 (714)
..+...+.++.+++.+||+.||++||||++|+++|+.......|+-+|
T Consensus 234 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p~~~p 281 (285)
T d1fmka3 234 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQP 281 (285)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCCCCC
T ss_pred CCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCCCCCCC
Confidence 112233457888999999999999999999999999988776555444
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-48 Score=411.47 Aligned_cols=265 Identities=23% Similarity=0.332 Sum_probs=206.8
Q ss_pred HHhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEeccc-chhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEE
Q 041576 419 EATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKL-AQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVY 497 (714)
Q Consensus 419 ~at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 497 (714)
...|.+.+.||+|+||+||+|+++ .+|+.||+|+++.. .......+.+|+.+|++++|||||++++++.++...++||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~-~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHK-PSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEET-TTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEEC-CCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 345777899999999999999876 57899999999653 3344568899999999999999999999999999999999
Q ss_pred eecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhc-CCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcc
Q 041576 498 EFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEE-CNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQS 576 (714)
Q Consensus 498 E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~-~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 576 (714)
||+++|+|.+++.....+++..+..++.||++||+|||++ + |+||||||+||||++++.+||+|||+|+......
T Consensus 84 Ey~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~- 159 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM- 159 (322)
T ss_dssp ECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHT-
T ss_pred EcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCCCc-
Confidence 9999999999999888899999999999999999999974 7 9999999999999999999999999998664322
Q ss_pred cceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhh--------cC---
Q 041576 577 RTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYV--------EG--- 645 (714)
Q Consensus 577 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~--------~~--- 645 (714)
.....||+.|+|||++.+..++.++||||+||++|||++|+.||..................... ..
T Consensus 160 --~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (322)
T d1s9ja_ 160 --ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 237 (322)
T ss_dssp --C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC----------------------
T ss_pred --cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccc
Confidence 23457999999999999999999999999999999999999999765432211100000000000 00
Q ss_pred -----------cccee----ecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 646 -----------KLDVL----VDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 646 -----------~~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
..... .............+.++.+++.+||+.||++|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~ 297 (322)
T d1s9ja_ 238 SSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297 (322)
T ss_dssp --------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 00000 0000000011123457888999999999999999999987
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-48 Score=397.85 Aligned_cols=251 Identities=23% Similarity=0.321 Sum_probs=194.2
Q ss_pred hhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEeccc--chhhHHHHHHHHHHHhccCcccccceeceEec--CCeeeEE
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKL--AQEREREFKTEVSAIGRTHHKNLVQLLGFCDE--GLNRLLV 496 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--~~~~~lv 496 (714)
.|.+.+.||+|+||+||+|+.+ .+|+.||||.++.. .+...+.+.+|++++++++||||+++++++.+ ++..++|
T Consensus 5 dy~~~~~iG~G~fg~Vy~~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 5 DYEVLYTIGTGSYGRCQKIRRK-SDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hCEEeEEEecCCCeEEEEEEEC-CCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 4677899999999999999876 57899999998653 34455679999999999999999999999865 4567999
Q ss_pred EeecCCCchhhhhhc----CCCCChhhHHHHHHHHHHHHHHHHhcC--CCCeEecCCCcCeEEECCCCceEEecCCCccc
Q 041576 497 YEFMGNGTLANLLFA----IPRPDWSLRVRISLEIARGLLYLHEEC--NVPIIHCDIKPQNILLDQDFTAKISDFGLSKL 570 (714)
Q Consensus 497 ~E~~~~gsL~~~l~~----~~~~~~~~~~~i~~qi~~~L~yLH~~~--~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~ 570 (714)
|||+++|+|.+++.. ...+++..++.++.||+.||+|||+++ ..+|+||||||+||||+.++.+||+|||+++.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 999999999999863 457899999999999999999999975 23599999999999999999999999999987
Q ss_pred cccCcccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCcccee
Q 041576 571 LLSDQSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVL 650 (714)
Q Consensus 571 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 650 (714)
+..... ......||+.|+|||++.+..++.++|||||||++|||+||+.||......+. . .....+....
T Consensus 164 ~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~---~-----~~i~~~~~~~- 233 (269)
T d2java1 164 LNHDTS-FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL---A-----GKIREGKFRR- 233 (269)
T ss_dssp C------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---H-----HHHHHTCCCC-
T ss_pred cccCCC-ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHH---H-----HHHHcCCCCC-
Confidence 654332 23346799999999999999999999999999999999999999975433321 1 1111222111
Q ss_pred ecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 651 VDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 651 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
.+...+.++.+++.+||+.||++|||++|+++
T Consensus 234 --------~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 234 --------IPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp --------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --------CCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 11223456888999999999999999999975
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-48 Score=400.85 Aligned_cols=260 Identities=27% Similarity=0.431 Sum_probs=202.5
Q ss_pred hhhhhhhhCcccceeEEEeEeeCCCC---cEEEEEEeccc-chhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEE
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSASG---NAVAVKKLDKL-AQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLV 496 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~~~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 496 (714)
.+.+.+.||+|+||+||+|.++..++ ..||||+++.. ......+|.+|++++++++|||||+++|++.+.+..++|
T Consensus 8 ~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v 87 (283)
T d1mqba_ 8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMII 87 (283)
T ss_dssp TEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEE
T ss_pred HeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEE
Confidence 35567889999999999999874333 47999999653 344456799999999999999999999999999999999
Q ss_pred EeecCCCchhhhhhcC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCc
Q 041576 497 YEFMGNGTLANLLFAI-PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQ 575 (714)
Q Consensus 497 ~E~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 575 (714)
|||+.+++|.+++... ..+++.+++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.+....
T Consensus 88 ~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~ 164 (283)
T d1mqba_ 88 TEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 164 (283)
T ss_dssp EECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC--------
T ss_pred EEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhcccCCC
Confidence 9999999999988755 57899999999999999999999998 9999999999999999999999999998765433
Q ss_pred c--cceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecc
Q 041576 576 S--RTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDN 653 (714)
Q Consensus 576 ~--~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 653 (714)
. .......||..|+|||++.+..++.++|||||||++|||++|..|+....... ..+ .....+..
T Consensus 165 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~--~~~-----~~i~~~~~------ 231 (283)
T d1mqba_ 165 EATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH--EVM-----KAINDGFR------ 231 (283)
T ss_dssp ---------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHH-----HHHHTTCC------
T ss_pred ccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHH--HHH-----HHHhccCC------
Confidence 2 22334568999999999999999999999999999999999776665332221 111 11111111
Q ss_pred hhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCCC
Q 041576 654 DKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLEVP 699 (714)
Q Consensus 654 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 699 (714)
...+...+..+.+++.+||+.||++||||.||++.|+.+++.+
T Consensus 232 ---~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~p 274 (283)
T d1mqba_ 232 ---LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 274 (283)
T ss_dssp ---CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred ---CCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhCc
Confidence 1112223456888999999999999999999999999987753
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.4e-47 Score=399.19 Aligned_cols=252 Identities=26% Similarity=0.348 Sum_probs=193.2
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc-hhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEe
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA-QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYE 498 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E 498 (714)
..|.+.+.||+|+||+||+|+++ .+++.||||++.... ......+.+|++++++++||||+++++++.+++..++|||
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDK-RTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEET-TTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cceEEEEEEeeccCeEEEEEEEC-CCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 35788899999999999999876 578999999996533 2334578899999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEEC---CCCceEEecCCCccccccCc
Q 041576 499 FMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLD---QDFTAKISDFGLSKLLLSDQ 575 (714)
Q Consensus 499 ~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~---~~~~~kl~Dfg~~~~~~~~~ 575 (714)
|+++|+|.+++.....+++.++..++.||+.||+|||+++ |+||||||+||++. +++.+||+|||+++......
T Consensus 88 ~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~ 164 (307)
T d1a06a_ 88 LVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS 164 (307)
T ss_dssp CCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC----------
T ss_pred ccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEccCCC
Confidence 9999999999998889999999999999999999999998 99999999999994 57899999999998654322
Q ss_pred ccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchh
Q 041576 576 SRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDK 655 (714)
Q Consensus 576 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 655 (714)
......||+.|+|||++.+..++.++|||||||++|||++|+.||........... ...+.... .
T Consensus 165 --~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~--------i~~~~~~~--~--- 229 (307)
T d1a06a_ 165 --VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQ--------ILKAEYEF--D--- 229 (307)
T ss_dssp ----------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH--------HHTTCCCC--C---
T ss_pred --eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHH--------HhccCCCC--C---
Confidence 22345699999999999999999999999999999999999999975443321111 11111110 0
Q ss_pred hhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 656 AAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 656 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
.......+..+.+++.+||+.||++|||++|+++.
T Consensus 230 -~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 230 -SPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp -TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred -CccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 01112234568889999999999999999999883
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-48 Score=396.17 Aligned_cols=252 Identities=27% Similarity=0.370 Sum_probs=204.5
Q ss_pred hhhh-hhCcccceeEEEeEeeCC-CCcEEEEEEeccc-chhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEee
Q 041576 423 GFEE-ELGRGSFGIVYKGVLKSA-SGNAVAVKKLDKL-AQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEF 499 (714)
Q Consensus 423 ~~~~-~ig~G~~g~Vy~~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~ 499 (714)
.+.+ +||+|+||+||+|.++.. ++..||||+++.. .....++|.+|++++++++|||||++++++.+ +..++||||
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~ 89 (285)
T d1u59a_ 11 LIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEM 89 (285)
T ss_dssp EEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEEC
T ss_pred EECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEe
Confidence 3445 499999999999987532 3557999999753 34456789999999999999999999999975 467999999
Q ss_pred cCCCchhhhhhcC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcc--
Q 041576 500 MGNGTLANLLFAI-PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQS-- 576 (714)
Q Consensus 500 ~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~-- 576 (714)
+++|+|.+++... ..+++.+++.++.||++||+|||+++ |+||||||+||+++.++.+||+|||+++.+.....
T Consensus 90 ~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~ 166 (285)
T d1u59a_ 90 AGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYY 166 (285)
T ss_dssp CTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEE
T ss_pred CCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhccccccccc
Confidence 9999999997654 57899999999999999999999998 99999999999999999999999999987754332
Q ss_pred cceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccchhhhhhhHHHhhhhhcCccceeecchh
Q 041576 577 RTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDK 655 (714)
Q Consensus 577 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 655 (714)
.......||+.|+|||++.+..++.++|||||||++|||+| |+.||......+. . ..+..+....
T Consensus 167 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~---~-----~~i~~~~~~~------ 232 (285)
T d1u59a_ 167 TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV---M-----AFIEQGKRME------ 232 (285)
T ss_dssp CCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHH---H-----HHHHTTCCCC------
T ss_pred ccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHH---H-----HHHHcCCCCC------
Confidence 22233468899999999999999999999999999999998 8999975433221 1 1112221111
Q ss_pred hhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 041576 656 AAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGY 695 (714)
Q Consensus 656 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 695 (714)
.+...+.++.+++.+||+.||++|||+.+|++.|+..
T Consensus 233 ---~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~ 269 (285)
T d1u59a_ 233 ---CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269 (285)
T ss_dssp ---CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 1223345788899999999999999999999999764
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-48 Score=404.93 Aligned_cols=258 Identities=24% Similarity=0.336 Sum_probs=207.0
Q ss_pred HHHHhhhhhhhhCcccceeEEEeEeeCCC----CcEEEEEEeccc-chhhHHHHHHHHHHHhcc-CcccccceeceEecC
Q 041576 417 LNEATNGFEEELGRGSFGIVYKGVLKSAS----GNAVAVKKLDKL-AQEREREFKTEVSAIGRT-HHKNLVQLLGFCDEG 490 (714)
Q Consensus 417 l~~at~~~~~~ig~G~~g~Vy~~~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~ 490 (714)
+....+.+.++||+|+||+||+|++...+ ...||+|.+... .......+.+|+.++.++ +|||||++++++.+.
T Consensus 34 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~ 113 (325)
T d1rjba_ 34 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS 113 (325)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC
Confidence 44456778899999999999999986322 237999998653 334456789999999998 899999999999999
Q ss_pred CeeeEEEeecCCCchhhhhhcCC-----------------------CCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCC
Q 041576 491 LNRLLVYEFMGNGTLANLLFAIP-----------------------RPDWSLRVRISLEIARGLLYLHEECNVPIIHCDI 547 (714)
Q Consensus 491 ~~~~lv~E~~~~gsL~~~l~~~~-----------------------~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dl 547 (714)
+..++||||+++|+|.++|+... .+++..++.++.||++||+|||+++ |+||||
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDl 190 (325)
T d1rjba_ 114 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDL 190 (325)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTC
T ss_pred CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccC
Confidence 99999999999999999997542 3788999999999999999999998 999999
Q ss_pred CcCeEEECCCCceEEecCCCccccccCccc-ceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCccc
Q 041576 548 KPQNILLDQDFTAKISDFGLSKLLLSDQSR-TRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEME 625 (714)
Q Consensus 548 k~~NIll~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~ 625 (714)
||+||+++.++.+||+|||+++........ ......||+.|+|||.+.+..++.++|||||||++|||+| |+.||...
T Consensus 191 Kp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~ 270 (325)
T d1rjba_ 191 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 270 (325)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred chhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCC
Confidence 999999999999999999999876554432 2234568999999999999999999999999999999998 89999754
Q ss_pred ccchhhhhhhHHHhhhhhcCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 041576 626 LGEERSAILTDWAYDCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLE 693 (714)
Q Consensus 626 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 693 (714)
..... +... ...+.. ...+...+..+.+|+.+||+.||++|||++||++.|.
T Consensus 271 ~~~~~---~~~~----~~~~~~---------~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 271 PVDAN---FYKL----IQNGFK---------MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp CCSHH---HHHH----HHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CHHHH---HHHH----HhcCCC---------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 33221 1111 111100 0112223457888999999999999999999999985
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.1e-47 Score=398.01 Aligned_cols=246 Identities=24% Similarity=0.294 Sum_probs=204.3
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEeccc---chhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEE
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKL---AQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLV 496 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 496 (714)
..|...++||+|+||+||+|+.. .+++.||||+++.. .....+.+.+|++++++++|||||++++++.+++..++|
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 93 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDV-RNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 93 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEET-TTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEEC-CCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEE
Confidence 45777889999999999999876 57899999998653 234456799999999999999999999999999999999
Q ss_pred EeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcc
Q 041576 497 YEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQS 576 (714)
Q Consensus 497 ~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 576 (714)
|||+++|+|..++.....+++.++..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||++......
T Consensus 94 ~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~-- 168 (309)
T d1u5ra_ 94 MEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-- 168 (309)
T ss_dssp EECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB--
T ss_pred EEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCCC--
Confidence 999999999888888888999999999999999999999998 999999999999999999999999999865332
Q ss_pred cceeeecCCCCccCcccccC---CCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecc
Q 041576 577 RTRTVIRGTRGYVAPEWFKN---VPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDN 653 (714)
Q Consensus 577 ~~~~~~~gt~~y~aPE~~~~---~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 653 (714)
....||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ +.. ...+.....
T Consensus 169 ---~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~---~~~-----i~~~~~~~~--- 234 (309)
T d1u5ra_ 169 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA---LYH-----IAQNESPAL--- 234 (309)
T ss_dssp ---CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH---HHH-----HHHSCCCCC---
T ss_pred ---CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHH---HHH-----HHhCCCCCC---
Confidence 23569999999999864 4689999999999999999999999975432221 111 111111111
Q ss_pred hhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 654 DKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 654 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
.+...+..+.+++.+||+.||++|||++|+++
T Consensus 235 -----~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 235 -----QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp -----SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -----CCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 11223457888999999999999999999976
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=8e-47 Score=400.27 Aligned_cols=251 Identities=24% Similarity=0.338 Sum_probs=209.4
Q ss_pred hhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEeec
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEFM 500 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~ 500 (714)
.|.+.+.||+|+||.||+|+.+ .+|+.||||++........+.+.+|+++|++++||||+++++++.+++..++||||+
T Consensus 27 ~Y~i~~~lG~G~fg~Vy~~~~~-~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 105 (350)
T d1koaa2 27 HYDIHEELGTGAFGVVHRVTER-ATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 105 (350)
T ss_dssp TEEEEEEEEEETTEEEEEEEET-TTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred CeEEEEEEecCcCeEEEEEEEC-CCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 5788899999999999999876 578999999998766666788999999999999999999999999999999999999
Q ss_pred CCCchhhhhhc-CCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECC--CCceEEecCCCccccccCccc
Q 041576 501 GNGTLANLLFA-IPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQ--DFTAKISDFGLSKLLLSDQSR 577 (714)
Q Consensus 501 ~~gsL~~~l~~-~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~--~~~~kl~Dfg~~~~~~~~~~~ 577 (714)
++|+|.+++.. ...+++.++..++.||+.||+|||+++ |+||||||+|||++. ++.+||+|||+++.+... .
T Consensus 106 ~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~--~ 180 (350)
T d1koaa2 106 SGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK--Q 180 (350)
T ss_dssp CSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT--S
T ss_pred CCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheecccc--c
Confidence 99999999864 457899999999999999999999998 999999999999964 678999999999876433 2
Q ss_pred ceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhh
Q 041576 578 TRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAA 657 (714)
Q Consensus 578 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 657 (714)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+ ...... ...
T Consensus 181 ~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i--------~~~~~~--~~~---- 246 (350)
T d1koaa2 181 SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNV--------KSCDWN--MDD---- 246 (350)
T ss_dssp CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--------HHTCCC--SCC----
T ss_pred ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHH--------HhCCCC--CCc----
Confidence 334567999999999999999999999999999999999999999755433221111 111100 000
Q ss_pred ccchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 658 MADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 658 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
......+..+.+++.+||+.||++|||++|+++.
T Consensus 247 ~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 247 SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp GGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0111233567889999999999999999999884
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-46 Score=390.52 Aligned_cols=251 Identities=25% Similarity=0.300 Sum_probs=207.8
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc------hhhHHHHHHHHHHHhccCcccccceeceEecCCee
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA------QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNR 493 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 493 (714)
..|.+.++||+|+||+||+|+++ .+|+.||||++++.. ....+.+.+|+++|++++||||+++++++.+++..
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~-~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREK-STGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred cCEEEeEEEecCCCeEEEEEEEC-CCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 35788899999999999999976 578999999986421 12357899999999999999999999999999999
Q ss_pred eEEEeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCC----ceEEecCCCcc
Q 041576 494 LLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDF----TAKISDFGLSK 569 (714)
Q Consensus 494 ~lv~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~----~~kl~Dfg~~~ 569 (714)
++||||+++|+|.+++.....+++..++.++.||+.||+|||+++ |+||||||+||+++.++ .+||+|||++.
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~ 165 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 165 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchhhhh
Confidence 999999999999999988888999999999999999999999998 99999999999998876 59999999998
Q ss_pred ccccCcccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccce
Q 041576 570 LLLSDQSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDV 649 (714)
Q Consensus 570 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 649 (714)
...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+ ......
T Consensus 166 ~~~~~~--~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i--------~~~~~~- 234 (293)
T d1jksa_ 166 KIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV--------SAVNYE- 234 (293)
T ss_dssp ECTTSC--BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--------HTTCCC-
T ss_pred hcCCCc--cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHH--------HhcCCC-
Confidence 764432 223456899999999999999999999999999999999999999865433211111 111110
Q ss_pred eecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 650 LVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 650 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
.........+..+.+++.+||+.||++|||++|+++
T Consensus 235 -----~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 235 -----FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp -----CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -----CCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000111223456788999999999999999999987
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.2e-46 Score=397.24 Aligned_cols=251 Identities=26% Similarity=0.346 Sum_probs=209.2
Q ss_pred hhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEeec
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEFM 500 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~ 500 (714)
.|.+.+.||+|+||.||+|+.+ .+|+.||||+++.......+.+.+|++++++++||||+++++++.+++..++||||+
T Consensus 30 ~Y~i~~~lG~G~fg~V~~a~~~-~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 30 YYDILEELGSGAFGVVHRCVEK-ATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp TEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred ceEEEEEEecCCCeEEEEEEEC-CCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 4788899999999999999976 578999999998766666678899999999999999999999999999999999999
Q ss_pred CCCchhhhhhcC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEEC--CCCceEEecCCCccccccCccc
Q 041576 501 GNGTLANLLFAI-PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLD--QDFTAKISDFGLSKLLLSDQSR 577 (714)
Q Consensus 501 ~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~--~~~~~kl~Dfg~~~~~~~~~~~ 577 (714)
++|+|.+++... ..+++.++..|+.||+.||+|||+++ |+||||||+||||+ .++.+||+|||++..+....
T Consensus 109 ~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~-- 183 (352)
T d1koba_ 109 SGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE-- 183 (352)
T ss_dssp CCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS--
T ss_pred CCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCCC--
Confidence 999999887655 46899999999999999999999998 99999999999998 67899999999998775432
Q ss_pred ceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhh
Q 041576 578 TRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAA 657 (714)
Q Consensus 578 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 657 (714)
......||+.|+|||++.+..++.++|||||||++|||+||+.||........ +.. ...+... .. .
T Consensus 184 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~---~~~-----i~~~~~~--~~----~ 249 (352)
T d1koba_ 184 IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET---LQN-----VKRCDWE--FD----E 249 (352)
T ss_dssp CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH---HHH-----HHHCCCC--CC----S
T ss_pred ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH---HHH-----HHhCCCC--CC----c
Confidence 33456799999999999999999999999999999999999999975443321 111 1111110 00 0
Q ss_pred ccchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 658 MADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 658 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
......+..+.+|+.+||+.||.+|||++|+++.
T Consensus 250 ~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 250 DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1112234567889999999999999999999873
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-47 Score=391.23 Aligned_cols=258 Identities=21% Similarity=0.299 Sum_probs=198.9
Q ss_pred HHhhhhhhhhCcccceeEEEeEeeCCC--CcEEEEEEeccc-chhhHHHHHHHHHHHhccCcccccceeceEecCCeeeE
Q 041576 419 EATNGFEEELGRGSFGIVYKGVLKSAS--GNAVAVKKLDKL-AQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLL 495 (714)
Q Consensus 419 ~at~~~~~~ig~G~~g~Vy~~~~~~~~--~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 495 (714)
...|.+.+.||+|+||.||+|++.... +..||||.++.. .....+.+.+|++++++++||||+++++++. ++..++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence 456778899999999999999876433 357899998653 3344568999999999999999999999996 467899
Q ss_pred EEeecCCCchhhhhhcC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccC
Q 041576 496 VYEFMGNGTLANLLFAI-PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSD 574 (714)
Q Consensus 496 v~E~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 574 (714)
||||+++|+|.+++... ..+++..++.++.||++||+|||+++ |+||||||+||++++++.+||+|||+++.....
T Consensus 85 v~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~ 161 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 161 (273)
T ss_dssp EEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC----------
T ss_pred EEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheeccCC
Confidence 99999999999987654 56899999999999999999999998 999999999999999999999999999877655
Q ss_pred cccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccchhhhhhhHHHhhhhhcCccceeecc
Q 041576 575 QSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDN 653 (714)
Q Consensus 575 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 653 (714)
.........||+.|+|||.+.+..++.++|||||||++|||++ |..||......+... ....+....
T Consensus 162 ~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~--------~i~~~~~~~---- 229 (273)
T d1mp8a_ 162 TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIG--------RIENGERLP---- 229 (273)
T ss_dssp ---------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH--------HHHTTCCCC----
T ss_pred cceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHH--------HHHcCCCCC----
Confidence 4444455678999999999999999999999999999999998 888987654432111 111221111
Q ss_pred hhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccC
Q 041576 654 DKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLE 697 (714)
Q Consensus 654 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 697 (714)
.+...+..+.+++.+||+.||++|||++||++.|+.+++
T Consensus 230 -----~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~ 268 (273)
T d1mp8a_ 230 -----MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 268 (273)
T ss_dssp -----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 122334578889999999999999999999999988754
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.9e-47 Score=394.54 Aligned_cols=258 Identities=24% Similarity=0.400 Sum_probs=209.6
Q ss_pred HhhhhhhhhCcccceeEEEeEeeC----CCCcEEEEEEecccc-hhhHHHHHHHHHHHhccCcccccceeceEecCCeee
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKS----ASGNAVAVKKLDKLA-QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRL 494 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 494 (714)
..+.+.+.||+|+||+||+|+++. .+++.||||+++... ....++|.+|++++++++||||+++++++......+
T Consensus 13 ~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~ 92 (301)
T d1lufa_ 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMC 92 (301)
T ss_dssp GGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCE
T ss_pred HHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceE
Confidence 346678899999999999998753 345789999997533 344568999999999999999999999999999999
Q ss_pred EEEeecCCCchhhhhhcCC------------------------CCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcC
Q 041576 495 LVYEFMGNGTLANLLFAIP------------------------RPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQ 550 (714)
Q Consensus 495 lv~E~~~~gsL~~~l~~~~------------------------~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~ 550 (714)
+||||+++|+|.+++.... .+++..++.|+.||++||+|||+++ |+||||||+
T Consensus 93 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHrDlKp~ 169 (301)
T d1lufa_ 93 LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATR 169 (301)
T ss_dssp EEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGG
T ss_pred EEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEeeEEccc
Confidence 9999999999999996432 3688899999999999999999998 999999999
Q ss_pred eEEECCCCceEEecCCCccccccCcc-cceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcC-CCCcccccc
Q 041576 551 NILLDQDFTAKISDFGLSKLLLSDQS-RTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCK-RSVEMELGE 628 (714)
Q Consensus 551 NIll~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~-~p~~~~~~~ 628 (714)
||||+.++.+||+|||+++....... .......+++.|+|||.+.+..++.++|||||||++|||++|. +||......
T Consensus 170 NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~ 249 (301)
T d1lufa_ 170 NCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE 249 (301)
T ss_dssp GEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH
T ss_pred ceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCHH
Confidence 99999999999999999987654433 2333456889999999999999999999999999999999996 566544332
Q ss_pred hhhhhhhHHHhhhhhcCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccC
Q 041576 629 ERSAILTDWAYDCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLE 697 (714)
Q Consensus 629 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 697 (714)
+. + ....++.... .+...+.++.+|+.+||+.||++||||.||+++|+++.+
T Consensus 250 e~---~-----~~v~~~~~~~---------~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~~ 301 (301)
T d1lufa_ 250 EV---I-----YYVRDGNILA---------CPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 301 (301)
T ss_dssp HH---H-----HHHHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred HH---H-----HHHHcCCCCC---------CCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 21 1 1122222211 122233568889999999999999999999999998864
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-45 Score=388.92 Aligned_cols=247 Identities=26% Similarity=0.287 Sum_probs=208.9
Q ss_pred hhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEeccc---chhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEE
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKL---AQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVY 497 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 497 (714)
.|.+.+.||+|+||.||+|+.+ .+++.||||++++. .....+.+.+|+.+|++++||||+++++++.+++..++||
T Consensus 6 dy~~~~~lG~G~fg~V~~~~~~-~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 6 DFDYLKLLGKGTFGKVILVREK-ATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcEEEEEEecCcCeEEEEEEEC-CCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 3677899999999999999976 57899999999753 2344677899999999999999999999999999999999
Q ss_pred eecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCccc
Q 041576 498 EFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSR 577 (714)
Q Consensus 498 E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 577 (714)
||+++|+|.+++.....+++..++.++.||+.||+|||+++ |+||||||+|||++.+|.+||+|||+++.......
T Consensus 85 ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~- 160 (337)
T d1o6la_ 85 EYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA- 160 (337)
T ss_dssp ECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC-
T ss_pred eccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccccCCc-
Confidence 99999999999998889999999999999999999999998 99999999999999999999999999986543322
Q ss_pred ceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhh
Q 041576 578 TRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAA 657 (714)
Q Consensus 578 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 657 (714)
......||+.|+|||++.+..++.++||||+||++|||++|+.||.......... ....+...
T Consensus 161 ~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~--------~i~~~~~~--------- 223 (337)
T d1o6la_ 161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFE--------LILMEEIR--------- 223 (337)
T ss_dssp CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH--------HHHHCCCC---------
T ss_pred ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHH--------HHhcCCCC---------
Confidence 3344679999999999999999999999999999999999999998654432111 11111111
Q ss_pred ccchHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 041576 658 MADKSRACKWLMIALWCIQEDPLKRPA-----MKMIVQ 690 (714)
Q Consensus 658 ~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 690 (714)
.+...+.++.+|+.+||++||++||+ ++|+++
T Consensus 224 -~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 224 -FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp -CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred -CCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 11223456788999999999999995 888876
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=6.2e-46 Score=382.25 Aligned_cols=259 Identities=20% Similarity=0.248 Sum_probs=204.2
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEeccc---chhhHHHHHHHHHHHhccCcccccceeceEecCC----e
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKL---AQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGL----N 492 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~----~ 492 (714)
.+|.+.+.||+|+||+||+|++. .+++.||||+++.. .....+.+.+|++++++++||||+++++++...+ .
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~-~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDL-RLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred ceeEEeEEEeeCCCeEEEEEEEC-CCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 35778899999999999999876 57899999999753 2344567999999999999999999999986654 3
Q ss_pred eeEEEeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccc
Q 041576 493 RLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLL 572 (714)
Q Consensus 493 ~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~ 572 (714)
.|+||||+++++|.+++...+.+++.+++.++.||++||+|||+++ |+||||||+|||++.++..+|+|||.+....
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~ 162 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIA 162 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCEECC
T ss_pred EEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhhhhc
Confidence 7899999999999999988889999999999999999999999998 9999999999999999999999999987654
Q ss_pred cCc--ccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCcccee
Q 041576 573 SDQ--SRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVL 650 (714)
Q Consensus 573 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 650 (714)
... ........||+.|+|||++.+..++.++|||||||++|||+||+.||......+. +. ........
T Consensus 163 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~---~~----~~~~~~~~--- 232 (277)
T d1o6ya_ 163 DSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV---AY----QHVREDPI--- 232 (277)
T ss_dssp ----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HH----HHHHCCCC---
T ss_pred cccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHH---HH----HHHhcCCC---
Confidence 332 2233445799999999999999999999999999999999999999975433221 11 11111111
Q ss_pred ecchhhhccchHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHhccc
Q 041576 651 VDNDKAAMADKSRACKWLMIALWCIQEDPLKRP-AMKMIVQMLEGYL 696 (714)
Q Consensus 651 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~~~ 696 (714)
.........+..+.+++.+||++||++|| |++++++.|.++.
T Consensus 233 ----~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 233 ----PPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp ----CGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred ----CCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 00111222345788899999999999999 8999999987653
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-46 Score=383.61 Aligned_cols=247 Identities=28% Similarity=0.358 Sum_probs=195.5
Q ss_pred hhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCcccccceeceEec-CCeeeEEEee
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCDE-GLNRLLVYEF 499 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-~~~~~lv~E~ 499 (714)
.+.+.+.||+|+||.||+|.++ |+.||||+++.. ...+.+.+|++++++++||||++++|+|.+ .+..++||||
T Consensus 8 ~~~~~~~lG~G~fg~Vy~~~~~---~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey 82 (262)
T d1byga_ 8 ELKLLQTIGKGEFGDVMLGDYR---GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 82 (262)
T ss_dssp GEEEEEEEEECSSCEEEEEEET---TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred HeEEeEEEecCCCeEEEEEEEC---CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence 4567789999999999999974 779999999753 345679999999999999999999999865 4567999999
Q ss_pred cCCCchhhhhhcC--CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCccc
Q 041576 500 MGNGTLANLLFAI--PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSR 577 (714)
Q Consensus 500 ~~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 577 (714)
+++|+|.+++... ..+++..+++|+.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 83 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~--- 156 (262)
T d1byga_ 83 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--- 156 (262)
T ss_dssp CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCC---
Confidence 9999999999754 34899999999999999999999998 999999999999999999999999999865332
Q ss_pred ceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhh
Q 041576 578 TRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKA 656 (714)
Q Consensus 578 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 656 (714)
.....++..|+|||.+.+..++.++||||||+++|||+| |+.|+......+.. . ....+....
T Consensus 157 -~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~----~----~i~~~~~~~------- 220 (262)
T d1byga_ 157 -QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV----P----RVEKGYKMD------- 220 (262)
T ss_dssp ------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHH----H----HHTTTCCCC-------
T ss_pred -CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHH----H----HHHcCCCCC-------
Confidence 223457899999999999999999999999999999998 67777654333211 1 111111111
Q ss_pred hccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 041576 657 AMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYL 696 (714)
Q Consensus 657 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 696 (714)
.+...+.++.+++.+||+.||++||||.||+++|+++.
T Consensus 221 --~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~ 258 (262)
T d1byga_ 221 --APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258 (262)
T ss_dssp --CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --CCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 12223357788999999999999999999999998764
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.7e-45 Score=384.94 Aligned_cols=244 Identities=23% Similarity=0.288 Sum_probs=206.9
Q ss_pred hhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEeccc---chhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEE
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKL---AQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVY 497 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 497 (714)
.|.+.+.||+|+||+||+|+++ .+|+.||||++++. .....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 5 dy~i~~~lG~G~fg~Vy~a~~~-~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 5 DFQILRTLGTGSFGRVHLIRSR-HNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GEEEEEEEEECSSCEEEEEEET-TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HeEEEEEEecCcCcEEEEEEEC-CCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 3677899999999999999976 57899999999753 2334578999999999999999999999999999999999
Q ss_pred eecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCccc
Q 041576 498 EFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSR 577 (714)
Q Consensus 498 E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 577 (714)
||+++|+|..++.....+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.....
T Consensus 84 E~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~--- 157 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--- 157 (316)
T ss_dssp CCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC---
T ss_pred eecCCccccccccccccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccc---
Confidence 99999999999999889999999999999999999999998 999999999999999999999999999876432
Q ss_pred ceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhh
Q 041576 578 TRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAA 657 (714)
Q Consensus 578 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 657 (714)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......+... ....+...
T Consensus 158 -~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~--------~i~~~~~~--------- 219 (316)
T d1fota_ 158 -TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYE--------KILNAELR--------- 219 (316)
T ss_dssp -BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH--------HHHHCCCC---------
T ss_pred -cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHH--------HHHcCCCC---------
Confidence 234579999999999999999999999999999999999999997654332111 11111110
Q ss_pred ccchHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 041576 658 MADKSRACKWLMIALWCIQEDPLKRP-----AMKMIVQ 690 (714)
Q Consensus 658 ~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 690 (714)
.+...+..+.+++.+||+.||.+|| |++|+++
T Consensus 220 -~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 220 -FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp -CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred -CCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 1112334677899999999999996 8999986
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-46 Score=386.46 Aligned_cols=257 Identities=26% Similarity=0.422 Sum_probs=204.9
Q ss_pred hhhhhhCcccceeEEEeEeeCCCC--cEEEEEEecc-cchhhHHHHHHHHHHHhccCcccccceeceEec-CCeeeEEEe
Q 041576 423 GFEEELGRGSFGIVYKGVLKSASG--NAVAVKKLDK-LAQEREREFKTEVSAIGRTHHKNLVQLLGFCDE-GLNRLLVYE 498 (714)
Q Consensus 423 ~~~~~ig~G~~g~Vy~~~~~~~~~--~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-~~~~~lv~E 498 (714)
+|.++||+|+||+||+|++...++ ..||||+++. ......++|.+|++++++++||||++++|++.+ +...++|||
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E 109 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP 109 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEE
Confidence 456789999999999999864433 3689999975 344556789999999999999999999999865 568899999
Q ss_pred ecCCCchhhhhhcC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcc-
Q 041576 499 FMGNGTLANLLFAI-PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQS- 576 (714)
Q Consensus 499 ~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~- 576 (714)
|+++|+|.+++... ...++..+++++.|+++||.|||+.+ |+||||||+||||++++.+||+|||+++.......
T Consensus 110 ~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~ 186 (311)
T d1r0pa_ 110 YMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186 (311)
T ss_dssp CCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred EeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence 99999999998865 45678889999999999999999998 99999999999999999999999999987654332
Q ss_pred --cceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecch
Q 041576 577 --RTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDND 654 (714)
Q Consensus 577 --~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 654 (714)
.......||..|+|||.+.+..++.++||||||+++|||+||+.||........ +.. ....+....
T Consensus 187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~---~~~----~i~~g~~~~----- 254 (311)
T d1r0pa_ 187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITV----YLLQGRRLL----- 254 (311)
T ss_dssp CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC---------CHH----HHHTTCCCC-----
T ss_pred cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHH---HHH----HHHcCCCCC-----
Confidence 222335689999999999999999999999999999999998888864432211 111 111121111
Q ss_pred hhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCC
Q 041576 655 KAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLEV 698 (714)
Q Consensus 655 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 698 (714)
.+...+..+.+++.+||+.||++||+|.||++.|+.++..
T Consensus 255 ----~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~ 294 (311)
T d1r0pa_ 255 ----QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294 (311)
T ss_dssp ----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ----CcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 1122335678899999999999999999999999988653
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2.5e-45 Score=376.38 Aligned_cols=251 Identities=24% Similarity=0.290 Sum_probs=205.9
Q ss_pred hhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc---------hhhHHHHHHHHHHHhccC-cccccceeceEecC
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA---------QEREREFKTEVSAIGRTH-HKNLVQLLGFCDEG 490 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~ 490 (714)
.|.+.+.||+|+||+||+|+.. .+++.||||+++... ....+.+.+|+.++++++ ||||+++++++.++
T Consensus 4 ~y~~~~~iG~G~~g~V~~~~~~-~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 4 NYEPKEILGRGVSSVVRRCIHK-PTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred cCEEceEEecCcCeEEEEEEEC-CCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 4677899999999999999875 578999999986422 122346889999999996 99999999999999
Q ss_pred CeeeEEEeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccc
Q 041576 491 LNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKL 570 (714)
Q Consensus 491 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~ 570 (714)
+..|+||||+++|+|.+++.....+++.+++.++.||++||+|||+++ |+||||||+||+++.++.+||+|||+++.
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~ 159 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQ 159 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred cceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccchheeE
Confidence 999999999999999999998889999999999999999999999998 99999999999999999999999999987
Q ss_pred cccCcccceeeecCCCCccCccccc------CCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhc
Q 041576 571 LLSDQSRTRTVIRGTRGYVAPEWFK------NVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVE 644 (714)
Q Consensus 571 ~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~ 644 (714)
+.... ......||..|+|||.+. ...++.++||||+||++|||++|+.||.......... ....
T Consensus 160 ~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~--------~i~~ 229 (277)
T d1phka_ 160 LDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLR--------MIMS 229 (277)
T ss_dssp CCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH--------HHHH
T ss_pred ccCCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHH--------HHHh
Confidence 65432 233456999999999985 3457889999999999999999999998654332111 1111
Q ss_pred CccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 645 GKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 645 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
+.... ........++++.+++.+||++||++|||++||++.
T Consensus 230 ~~~~~------~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 230 GNYQF------GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp TCCCC------CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred CCCCC------CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 11110 011112344578889999999999999999999763
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-46 Score=383.18 Aligned_cols=256 Identities=26% Similarity=0.330 Sum_probs=197.6
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCc--EEEEEEeccc---chhhHHHHHHHHHHHhccCcccccceeceEecCCeee
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGN--AVAVKKLDKL---AQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRL 494 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~--~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 494 (714)
..+.+.+.||+|+||+||+|++...+++ .||||+++.. .....++|.+|++++++++||||++++|++.+ ...+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 3467789999999999999987654444 7899998653 33445689999999999999999999999976 4678
Q ss_pred EEEeecCCCchhhhhhcC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCcccccc
Q 041576 495 LVYEFMGNGTLANLLFAI-PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLS 573 (714)
Q Consensus 495 lv~E~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~ 573 (714)
+||||+++|+|.+.+... ..+++..++.++.||++||+|||+++ |+||||||+||+++.++.+||+|||+++....
T Consensus 87 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~ 163 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 163 (273)
T ss_dssp EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred eeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhccc
Confidence 999999999999887654 46899999999999999999999998 99999999999999999999999999998754
Q ss_pred Cccc--ceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccchhhhhhhHHHhhhhhcCcccee
Q 041576 574 DQSR--TRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEERSAILTDWAYDCYVEGKLDVL 650 (714)
Q Consensus 574 ~~~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 650 (714)
.... ......++..|+|||.+.+..++.++|||||||++|||+| |+.||......+....+ ...+...
T Consensus 164 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i-------~~~~~~~-- 234 (273)
T d1u46a_ 164 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI-------DKEGERL-- 234 (273)
T ss_dssp -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH-------HTSCCCC--
T ss_pred CCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHH-------HhCCCCC--
Confidence 4332 2233457889999999999999999999999999999998 89999755433211111 1111110
Q ss_pred ecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 041576 651 VDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGY 695 (714)
Q Consensus 651 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 695 (714)
..+...+..+.+++.+||+.||++||||+||++.|+++
T Consensus 235 -------~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 235 -------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp -------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -------CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 11122335688899999999999999999999999764
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-46 Score=389.34 Aligned_cols=262 Identities=27% Similarity=0.364 Sum_probs=200.3
Q ss_pred HHHHhhhhhhhhCcccceeEEEeEeeC----CCCcEEEEEEeccc-chhhHHHHHHHHHHHhcc-CcccccceeceEecC
Q 041576 417 LNEATNGFEEELGRGSFGIVYKGVLKS----ASGNAVAVKKLDKL-AQEREREFKTEVSAIGRT-HHKNLVQLLGFCDEG 490 (714)
Q Consensus 417 l~~at~~~~~~ig~G~~g~Vy~~~~~~----~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~ 490 (714)
+....|.+.++||+|+||.||+|.+.. .+++.||||+++.. .....+.+.+|...+.++ +|+||+++++++.+.
T Consensus 10 i~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~ 89 (299)
T d1ywna1 10 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 89 (299)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred ccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC
Confidence 344567888999999999999998753 23468999999753 344556788888888887 789999999998654
Q ss_pred -CeeeEEEeecCCCchhhhhhcC----------------CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEE
Q 041576 491 -LNRLLVYEFMGNGTLANLLFAI----------------PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNIL 553 (714)
Q Consensus 491 -~~~~lv~E~~~~gsL~~~l~~~----------------~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIl 553 (714)
...++||||+++|+|.++++.. ..+++.+++.++.||++||+|||+++ |+||||||+|||
T Consensus 90 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NIL 166 (299)
T d1ywna1 90 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNIL 166 (299)
T ss_dssp TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEE
T ss_pred CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCcccee
Confidence 4679999999999999999743 24788999999999999999999998 999999999999
Q ss_pred ECCCCceEEecCCCccccccCccc-ceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcC-CCCcccccchhh
Q 041576 554 LDQDFTAKISDFGLSKLLLSDQSR-TRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCK-RSVEMELGEERS 631 (714)
Q Consensus 554 l~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~-~p~~~~~~~~~~ 631 (714)
|++++.+||+|||+++........ ......||+.|+|||.+.+..++.++|||||||++|||+||. .||........
T Consensus 167 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~- 245 (299)
T d1ywna1 167 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE- 245 (299)
T ss_dssp ECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH-
T ss_pred ECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHH-
Confidence 999999999999999876544332 333457999999999999999999999999999999999975 56654332221
Q ss_pred hhhhHHHhhhhhcCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccC
Q 041576 632 AILTDWAYDCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLE 697 (714)
Q Consensus 632 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 697 (714)
+. .....+.... .+...+.++.+++.+||+.||++|||++||++.|+.+++
T Consensus 246 --~~----~~~~~~~~~~---------~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq 296 (299)
T d1ywna1 246 --FC----RRLKEGTRMR---------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296 (299)
T ss_dssp --HH----HHHHHTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --HH----HHHhcCCCCC---------CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 11 1111111111 112234568889999999999999999999999998765
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-45 Score=384.59 Aligned_cols=256 Identities=26% Similarity=0.400 Sum_probs=203.6
Q ss_pred hhhhhhhhCcccceeEEEeEeeCCCCc--EEEEEEeccc-chhhHHHHHHHHHHHhcc-CcccccceeceEecCCeeeEE
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSASGN--AVAVKKLDKL-AQEREREFKTEVSAIGRT-HHKNLVQLLGFCDEGLNRLLV 496 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv 496 (714)
.+.+.++||+|+||+||+|+++. ++. .||||+++.. .....+.+.+|+++|+++ +||||+++++++.+++..++|
T Consensus 11 ~~~~~~~iG~G~fg~Vy~~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 11 DIKFQDVIGEGNFGQVLKARIKK-DGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GCEEEEEEECGGGCEEEEEEEEE-TTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HcEEEEEEeeCCCcEEEEEEECC-CCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 45667899999999999999874 343 5788888643 334556899999999999 799999999999999999999
Q ss_pred EeecCCCchhhhhhcC----------------CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCce
Q 041576 497 YEFMGNGTLANLLFAI----------------PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTA 560 (714)
Q Consensus 497 ~E~~~~gsL~~~l~~~----------------~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ 560 (714)
|||+++|+|.++|+.. ..+++..+..++.||++||.|||+++ |+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence 9999999999999754 56899999999999999999999998 9999999999999999999
Q ss_pred EEecCCCccccccCcccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCC-CCcccccchhhhhhhHHHh
Q 041576 561 KISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKR-SVEMELGEERSAILTDWAY 639 (714)
Q Consensus 561 kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~-p~~~~~~~~~~~~l~~~~~ 639 (714)
||+|||+++...... ......||..|+|||.+.+..++.++|||||||++|||++|.. ||......+..
T Consensus 167 kl~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~-------- 236 (309)
T d1fvra_ 167 KIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY-------- 236 (309)
T ss_dssp EECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH--------
T ss_pred EEccccccccccccc--cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHH--------
Confidence 999999997653322 2233458999999999999999999999999999999999765 56543322211
Q ss_pred hhhhcCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCCC
Q 041576 640 DCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLEVP 699 (714)
Q Consensus 640 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 699 (714)
.....+... ..+...+.++.+|+.+||+.||++||||+||++.|+++++..
T Consensus 237 ~~i~~~~~~---------~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~ 287 (309)
T d1fvra_ 237 EKLPQGYRL---------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 287 (309)
T ss_dssp HHGGGTCCC---------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred HHHHhcCCC---------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence 111111111 112223457888999999999999999999999999987543
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-45 Score=387.20 Aligned_cols=253 Identities=24% Similarity=0.356 Sum_probs=200.7
Q ss_pred hhhhhhhCcccceeEEEeEeeCCCCc----EEEEEEeccc-chhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEE
Q 041576 422 NGFEEELGRGSFGIVYKGVLKSASGN----AVAVKKLDKL-AQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLV 496 (714)
Q Consensus 422 ~~~~~~ig~G~~g~Vy~~~~~~~~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 496 (714)
|.+.+.||+|+||+||+|.+.. +|+ +||+|+++.. .....+++.+|++++++++||||++++++|.++ ..+++
T Consensus 11 y~~~~~lG~G~fG~Vy~~~~~~-~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v 88 (317)
T d1xkka_ 11 FKKIKVLGSGAFGTVYKGLWIP-EGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLI 88 (317)
T ss_dssp EEEEEEEEECSSEEEEEEEECC-----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEE
T ss_pred CEEeeEEecCCCeEEEEEEEcC-CCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEE
Confidence 6778999999999999998763 343 6899998653 344567899999999999999999999999875 56788
Q ss_pred EeecCCCchhhhhhcC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCc
Q 041576 497 YEFMGNGTLANLLFAI-PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQ 575 (714)
Q Consensus 497 ~E~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 575 (714)
+||+.+++|.+++... ..+++..+++++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 89 ~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~ 165 (317)
T d1xkka_ 89 TQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 165 (317)
T ss_dssp EECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTC
T ss_pred EEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceeccccc
Confidence 8999999999888754 57899999999999999999999998 9999999999999999999999999998775544
Q ss_pred cc-ceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccchhhhhhhHHHhhhhhcCccceeecc
Q 041576 576 SR-TRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDN 653 (714)
Q Consensus 576 ~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 653 (714)
.. ......||..|+|||.+.+..++.++|||||||++|||+| |+.||......+....+ ..+...
T Consensus 166 ~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i--------~~~~~~----- 232 (317)
T d1xkka_ 166 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL--------EKGERL----- 232 (317)
T ss_dssp C--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHH--------HHTCCC-----
T ss_pred ccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHH--------HcCCCC-----
Confidence 32 2334568999999999999999999999999999999998 78888754433211111 111100
Q ss_pred hhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 041576 654 DKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYL 696 (714)
Q Consensus 654 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 696 (714)
..+...+..+.+++.+||+.||++|||+.||++.|+.+.
T Consensus 233 ----~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~ 271 (317)
T d1xkka_ 233 ----PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 271 (317)
T ss_dssp ----CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHH
Confidence 112223456888999999999999999999999987653
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-45 Score=380.51 Aligned_cols=249 Identities=21% Similarity=0.284 Sum_probs=205.5
Q ss_pred hhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEeec
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEFM 500 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~ 500 (714)
+|.+.+.||+|+||+||+|+++ .+++.||||.++... .....+.+|+++|++++||||+++++++.+++..|+||||+
T Consensus 6 rY~i~~~lG~G~fg~Vy~~~~~-~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~ 83 (321)
T d1tkia_ 6 KYMIAEDLGRGEFGIVHRCVET-SSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI 83 (321)
T ss_dssp TEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred ceEEEEEEecCCCeEEEEEEEC-CCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecC
Confidence 4778899999999999999876 578999999997643 33456889999999999999999999999999999999999
Q ss_pred CCCchhhhhhcCC-CCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCC--CceEEecCCCccccccCccc
Q 041576 501 GNGTLANLLFAIP-RPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQD--FTAKISDFGLSKLLLSDQSR 577 (714)
Q Consensus 501 ~~gsL~~~l~~~~-~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~--~~~kl~Dfg~~~~~~~~~~~ 577 (714)
++|+|.+++...+ .+++.++..++.||++||+|||+++ |+||||||+|||++.+ ..+||+|||+++..... .
T Consensus 84 ~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~--~ 158 (321)
T d1tkia_ 84 SGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG--D 158 (321)
T ss_dssp CCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT--C
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccC--C
Confidence 9999999998765 6899999999999999999999998 9999999999999854 58999999999876432 2
Q ss_pred ceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhh
Q 041576 578 TRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAA 657 (714)
Q Consensus 578 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 657 (714)
......+++.|+|||.+.+..++.++||||+||++|||++|+.||......+....+ ..+... ++..
T Consensus 159 ~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i--------~~~~~~--~~~~--- 225 (321)
T d1tkia_ 159 NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENI--------MNAEYT--FDEE--- 225 (321)
T ss_dssp EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH--------HHTCCC--CCHH---
T ss_pred cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHH--------HhCCCC--CChh---
Confidence 234456899999999999999999999999999999999999999865433221111 111110 0000
Q ss_pred ccchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 658 MADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 658 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
.....+.++.+++.+||+.||++|||++|+++
T Consensus 226 -~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 226 -AFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp -HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -hccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 01122346788999999999999999999987
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-46 Score=387.59 Aligned_cols=263 Identities=28% Similarity=0.408 Sum_probs=212.3
Q ss_pred HHHHHhhhhhhhhCcccceeEEEeEee----CCCCcEEEEEEeccc-chhhHHHHHHHHHHHhcc-CcccccceeceEec
Q 041576 416 ELNEATNGFEEELGRGSFGIVYKGVLK----SASGNAVAVKKLDKL-AQEREREFKTEVSAIGRT-HHKNLVQLLGFCDE 489 (714)
Q Consensus 416 el~~at~~~~~~ig~G~~g~Vy~~~~~----~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~ 489 (714)
|+....+.+.++||+|+||.||+|++. ..+++.||||+++.. .......+.+|+.+++++ +||||+++++++.+
T Consensus 19 ~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~ 98 (311)
T d1t46a_ 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI 98 (311)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEee
Confidence 344567788899999999999999864 245679999999753 334556899999999999 79999999999999
Q ss_pred CCeeeEEEeecCCCchhhhhhcCC------------------CCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCe
Q 041576 490 GLNRLLVYEFMGNGTLANLLFAIP------------------RPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQN 551 (714)
Q Consensus 490 ~~~~~lv~E~~~~gsL~~~l~~~~------------------~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~N 551 (714)
++..++||||+++|+|.++++... .+++..++.++.||++||+|||+++ ++||||||+|
T Consensus 99 ~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~N 175 (311)
T d1t46a_ 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARN 175 (311)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGG
T ss_pred CCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccccccc
Confidence 999999999999999999997542 5789999999999999999999998 9999999999
Q ss_pred EEECCCCceEEecCCCccccccCcc-cceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhc-CCCCcccccch
Q 041576 552 ILLDQDFTAKISDFGLSKLLLSDQS-RTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICC-KRSVEMELGEE 629 (714)
Q Consensus 552 Ill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG-~~p~~~~~~~~ 629 (714)
|+++.++.+||+|||+++....... .......||+.|+|||.+.+..++.++|||||||++|||+|+ .+|+......+
T Consensus 176 Il~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~ 255 (311)
T d1t46a_ 176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS 255 (311)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH
T ss_pred ccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999999997754433 333345789999999999999999999999999999999995 55554433222
Q ss_pred hhhhhhHHHhhhhhcCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccC
Q 041576 630 RSAILTDWAYDCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLE 697 (714)
Q Consensus 630 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 697 (714)
. +... ...+. ....+...+..+.+|+.+||+.||++||||+||+++|++++.
T Consensus 256 ~---~~~~----i~~~~---------~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~ 307 (311)
T d1t46a_ 256 K---FYKM----IKEGF---------RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (311)
T ss_dssp H---HHHH----HHHTC---------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred H---HHHH----HhcCC---------CCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhc
Confidence 1 1111 11111 011122234578889999999999999999999999988653
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.1e-44 Score=384.05 Aligned_cols=244 Identities=25% Similarity=0.244 Sum_probs=206.4
Q ss_pred hhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEeccc---chhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEE
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKL---AQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVY 497 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 497 (714)
.|.+.+.||+|+||.||+|+++ .+|+.||||++.+. .....+.+.+|+++|++++||||+++++++.+....++||
T Consensus 42 ~y~i~~~lG~G~fg~Vy~a~~~-~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 42 QFDRIKTLGTGSFGRVMLVKHK-ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GEEEEEEEEECSSCEEEEEEET-TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CeEEEEEeecCcCcEEEEEEEC-CCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 5777899999999999999976 57899999999642 2234567899999999999999999999999999999999
Q ss_pred eecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCccc
Q 041576 498 EFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSR 577 (714)
Q Consensus 498 E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 577 (714)
||+.+|+|.+++.....+++..+..++.||+.||.|||+++ ||||||||+|||++.++.+||+|||+++.+...
T Consensus 121 e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~--- 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--- 194 (350)
T ss_dssp ECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC---
T ss_pred ccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccc---
Confidence 99999999999998889999999999999999999999998 999999999999999999999999999876432
Q ss_pred ceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhhh
Q 041576 578 TRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKAA 657 (714)
Q Consensus 578 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 657 (714)
.....||+.|+|||++.+..++.++|||||||++|||+||+.||........ +.. ...+...
T Consensus 195 -~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~---~~~-----i~~~~~~--------- 256 (350)
T d1rdqe_ 195 -TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI---YEK-----IVSGKVR--------- 256 (350)
T ss_dssp -BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHH-----HHHCCCC---------
T ss_pred -cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHH---HHH-----HhcCCCC---------
Confidence 2345699999999999999999999999999999999999999975433221 111 1111110
Q ss_pred ccchHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 041576 658 MADKSRACKWLMIALWCIQEDPLKRP-----AMKMIVQ 690 (714)
Q Consensus 658 ~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 690 (714)
.+...+..+.+++.+||+.||.+|+ |++|+++
T Consensus 257 -~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 257 -FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp -CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred -CCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 1122345678899999999999994 8999986
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-45 Score=377.76 Aligned_cols=260 Identities=23% Similarity=0.240 Sum_probs=199.8
Q ss_pred hhhhCcccceeEEEeEeeCCCCcEEEEEEecccchh-----hHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEee
Q 041576 425 EEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQE-----REREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYEF 499 (714)
Q Consensus 425 ~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~ 499 (714)
.+.||+|+||+||+|+++ .+|+.||||+++..... ..+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 3 l~~lG~G~fg~Vy~~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDK-NTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEETTEEEEEEECS-SCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred ceEeccCcCeEEEEEEEC-CCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 368999999999999976 57899999999653222 124688999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcccce
Q 041576 500 MGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRTR 579 (714)
Q Consensus 500 ~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 579 (714)
+.++++..++.....+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....... ..
T Consensus 82 ~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~-~~ 157 (299)
T d1ua2a_ 82 METDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR-AY 157 (299)
T ss_dssp CSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC-CC
T ss_pred hcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCcc-cc
Confidence 999988888887788999999999999999999999998 99999999999999999999999999987644332 22
Q ss_pred eeecCCCCccCcccccCC-CCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHh----hhhhcC-------cc
Q 041576 580 TVIRGTRGYVAPEWFKNV-PVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAY----DCYVEG-------KL 647 (714)
Q Consensus 580 ~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~----~~~~~~-------~~ 647 (714)
....||+.|+|||++... .++.++|||||||++|||++|+.||......+....+..... ..+... ..
T Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (299)
T d1ua2a_ 158 THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF 237 (299)
T ss_dssp CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCC
T ss_pred cceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhh
Confidence 335689999999998654 579999999999999999999999976544332111111000 000000 00
Q ss_pred ceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 648 DVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 648 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
.... ..............+.+|+.+||+.||++|||++|+++
T Consensus 238 ~~~~-~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 238 KSFP-GIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp CCCC-CCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred ccCC-CCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 0000 00000111123457889999999999999999999987
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-45 Score=383.11 Aligned_cols=262 Identities=26% Similarity=0.339 Sum_probs=207.5
Q ss_pred HHHHhhhhhhhhCcccceeEEEeEeeCC------CCcEEEEEEecccc-hhhHHHHHHHHHHHhcc-CcccccceeceEe
Q 041576 417 LNEATNGFEEELGRGSFGIVYKGVLKSA------SGNAVAVKKLDKLA-QEREREFKTEVSAIGRT-HHKNLVQLLGFCD 488 (714)
Q Consensus 417 l~~at~~~~~~ig~G~~g~Vy~~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~ 488 (714)
+....|.+.+.||+|+||.||+|+.... .+..||||+++... .....++.+|+..+.++ +||||++++++|.
T Consensus 10 i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~ 89 (299)
T d1fgka_ 10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 89 (299)
T ss_dssp CCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccc
Confidence 3345677889999999999999986532 23479999997643 34457889999999888 8999999999999
Q ss_pred cCCeeeEEEeecCCCchhhhhhcC----------------CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeE
Q 041576 489 EGLNRLLVYEFMGNGTLANLLFAI----------------PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNI 552 (714)
Q Consensus 489 ~~~~~~lv~E~~~~gsL~~~l~~~----------------~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NI 552 (714)
+++..++||||+++|+|.+++... ..+++.+++.++.||+.||+|||+++ ||||||||+||
T Consensus 90 ~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~Ni 166 (299)
T d1fgka_ 90 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNV 166 (299)
T ss_dssp SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGE
T ss_pred cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccce
Confidence 999999999999999999999754 24789999999999999999999998 99999999999
Q ss_pred EECCCCceEEecCCCccccccCccc-ceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHh-cCCCCcccccchh
Q 041576 553 LLDQDFTAKISDFGLSKLLLSDQSR-TRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIIC-CKRSVEMELGEER 630 (714)
Q Consensus 553 ll~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~ 630 (714)
|++.++.+||+|||+++........ ......+++.|+|||.+.+..++.++|||||||++|||++ |..||........
T Consensus 167 Ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~ 246 (299)
T d1fgka_ 167 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 246 (299)
T ss_dssp EECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred eecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHH
Confidence 9999999999999999877554332 2334568899999999999999999999999999999998 6778764433221
Q ss_pred hhhhhHHHhhhhhcCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCC
Q 041576 631 SAILTDWAYDCYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLEV 698 (714)
Q Consensus 631 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 698 (714)
...+..+.... .+...+..+.+++.+||+.||++||||.||++.|++++.+
T Consensus 247 --------~~~i~~~~~~~---------~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~ 297 (299)
T d1fgka_ 247 --------FKLLKEGHRMD---------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297 (299)
T ss_dssp --------HHHHHTTCCCC---------CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --------HHHHHcCCCCC---------CCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhhc
Confidence 11111221111 1122345688899999999999999999999999988654
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.6e-44 Score=384.95 Aligned_cols=248 Identities=23% Similarity=0.253 Sum_probs=200.2
Q ss_pred hhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc---hhhHHHH---HHHHHHHhccCcccccceeceEecCCeee
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA---QEREREF---KTEVSAIGRTHHKNLVQLLGFCDEGLNRL 494 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~---~~~~~~~---~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 494 (714)
.|.+.+.||+|+||.||+|+.. .+|+.||||++.+.. ......+ .+|+++++.++||||+++++++.+++..|
T Consensus 5 dy~i~~~lG~G~fg~Vy~~~~~-~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 5 DFSVHRIIGRGGFGEVYGCRKA-DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TEEEEEEEEECSSCEEEEEEET-TTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred hCeeeeEEecCCCeEEEEEEEC-CCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 3677899999999999999976 578999999986421 1222333 34577788889999999999999999999
Q ss_pred EEEeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccC
Q 041576 495 LVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSD 574 (714)
Q Consensus 495 lv~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 574 (714)
+||||+++|+|.+++.....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 84 ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~ 160 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK 160 (364)
T ss_dssp EEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEECSSS
T ss_pred EEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeecCCC
Confidence 99999999999999998888999999999999999999999998 999999999999999999999999999876443
Q ss_pred cccceeeecCCCCccCcccccC-CCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecc
Q 041576 575 QSRTRTVIRGTRGYVAPEWFKN-VPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDN 653 (714)
Q Consensus 575 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 653 (714)
. .....||+.|+|||++.. ..++.++|||||||+||||+||+.||............ ........
T Consensus 161 ~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~-----~~~~~~~~------ 226 (364)
T d1omwa3 161 K---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID-----RMTLTMAV------ 226 (364)
T ss_dssp C---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHH-----HHSSSCCC------
T ss_pred c---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHH-----HhcccCCC------
Confidence 2 234569999999999964 56899999999999999999999999765433221111 00001000
Q ss_pred hhhhccchHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 041576 654 DKAAMADKSRACKWLMIALWCIQEDPLKRPA-----MKMIVQ 690 (714)
Q Consensus 654 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 690 (714)
..+...+..+.+++.+||+.||++||| ++|+++
T Consensus 227 ----~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 227 ----ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp ----CCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred ----CCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 011123456788999999999999999 788875
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-45 Score=378.68 Aligned_cols=269 Identities=22% Similarity=0.247 Sum_probs=200.8
Q ss_pred hhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCcccccceeceEecCC----eeeEE
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGL----NRLLV 496 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~----~~~lv 496 (714)
++-+.++||+|+||.||+|++ +|+.||||+++.... .....+.|+..+.+++||||+++++++.+.+ ..++|
T Consensus 4 ~~~l~~~iG~G~fg~Vy~~~~---~g~~vAvK~~~~~~~-~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv 79 (303)
T d1vjya_ 4 TIVLQESIGKGRFGEVWRGKW---RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GEEEEEEEECCSSSEEEEEEE---TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEE---CCEEEEEEEECccch-hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence 455678999999999999986 478999999965332 2233445666677889999999999997654 57899
Q ss_pred EeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcC-----CCCeEecCCCcCeEEECCCCceEEecCCCcccc
Q 041576 497 YEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEEC-----NVPIIHCDIKPQNILLDQDFTAKISDFGLSKLL 571 (714)
Q Consensus 497 ~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~-----~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~ 571 (714)
|||+++|+|.++++. ..+++..+++++.|++.||+|||+.+ .++|+||||||+||||+.++.+||+|||+++..
T Consensus 80 ~Ey~~~g~L~~~l~~-~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~ 158 (303)
T d1vjya_ 80 SDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 158 (303)
T ss_dssp EECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred EecccCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccc
Confidence 999999999999987 46889999999999999999999741 235999999999999999999999999999877
Q ss_pred ccCcc---cceeeecCCCCccCcccccCCC------CCchhhhHHHHHHHHHHHhcCCCCcccccchhhh-h------hh
Q 041576 572 LSDQS---RTRTVIRGTRGYVAPEWFKNVP------VSAKVDVYSFGVVLLKIICCKRSVEMELGEERSA-I------LT 635 (714)
Q Consensus 572 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~------~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~-~------l~ 635 (714)
..... .......||+.|+|||++.+.. ++.|+|||||||+||||+||..|+.......... . ..
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~ 238 (303)
T d1vjya_ 159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 238 (303)
T ss_dssp ETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred cCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchH
Confidence 54332 2233467999999999987643 5779999999999999999998875432221100 0 00
Q ss_pred HHHhhhhhcCccceeecchh-hhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCC
Q 041576 636 DWAYDCYVEGKLDVLVDNDK-AAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLEV 698 (714)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 698 (714)
.........+. .++.. ......+....+.+++.+||+.||++|||+.||++.|+++.+-
T Consensus 239 ~~~~~~~~~~~----~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 298 (303)
T d1vjya_ 239 EEMRKVVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp HHHHHHHTTSC----CCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHhccc----cCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence 00011111111 11111 1112334556788999999999999999999999999887643
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-45 Score=381.29 Aligned_cols=247 Identities=26% Similarity=0.300 Sum_probs=204.4
Q ss_pred hhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEeccc---chhhHHHHHHHHHHHh-ccCcccccceeceEecCCeeeEE
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKL---AQEREREFKTEVSAIG-RTHHKNLVQLLGFCDEGLNRLLV 496 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~-~l~h~nIv~l~~~~~~~~~~~lv 496 (714)
.|.+.++||+|+||+||+|+++ .+++.||||++++. .....+.+..|..++. .++||||+++++++.+++..|+|
T Consensus 3 dy~i~~~iG~G~fg~Vy~~~~~-~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 3 DFILHKMLGKGSFGKVFLAEFK-KTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TEEEEEEEEECSSSEEEEEEET-TTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CeEEeeEEecCCCcEEEEEEEC-CCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 3677899999999999999976 57899999999753 2333456677777665 68999999999999999999999
Q ss_pred EeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcc
Q 041576 497 YEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQS 576 (714)
Q Consensus 497 ~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 576 (714)
|||+++|+|.+++.....+++.++..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++......
T Consensus 82 mEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~- 157 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD- 157 (320)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT-
T ss_pred EeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccccc-
Confidence 999999999999998888999999999999999999999998 9999999999999999999999999998654332
Q ss_pred cceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceeecchhh
Q 041576 577 RTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLVDNDKA 656 (714)
Q Consensus 577 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 656 (714)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||........... ...+..
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~--------i~~~~~--------- 220 (320)
T d1xjda_ 158 AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHS--------IRMDNP--------- 220 (320)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH--------HHHCCC---------
T ss_pred ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHH--------HHcCCC---------
Confidence 233345699999999999999999999999999999999999999986543321111 111111
Q ss_pred hccchHHHHHHHHHHHHccccCCCCCCCHH-HHHH
Q 041576 657 AMADKSRACKWLMIALWCIQEDPLKRPAMK-MIVQ 690 (714)
Q Consensus 657 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl~ 690 (714)
..+...+..+.+|+.+||+.||++|||+. |+++
T Consensus 221 -~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 221 -FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp -CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred -CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 01122345678899999999999999995 7754
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-45 Score=380.86 Aligned_cols=260 Identities=28% Similarity=0.446 Sum_probs=210.0
Q ss_pred HHHhhhhhhhhCcccceeEEEeEeeC----CCCcEEEEEEeccc-chhhHHHHHHHHHHHhccCcccccceeceEecCCe
Q 041576 418 NEATNGFEEELGRGSFGIVYKGVLKS----ASGNAVAVKKLDKL-AQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLN 492 (714)
Q Consensus 418 ~~at~~~~~~ig~G~~g~Vy~~~~~~----~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 492 (714)
....+.+.++||+|+||+||+|.+.. .+++.||||+++.. .......|.+|++++++++||||+++++++..++.
T Consensus 18 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~ 97 (308)
T d1p4oa_ 18 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 97 (308)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSS
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCc
Confidence 33566778999999999999998742 23578999999753 33445679999999999999999999999999999
Q ss_pred eeEEEeecCCCchhhhhhcC----------CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEE
Q 041576 493 RLLVYEFMGNGTLANLLFAI----------PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKI 562 (714)
Q Consensus 493 ~~lv~E~~~~gsL~~~l~~~----------~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl 562 (714)
.++||||+++|+|.+++... ..+++..+.+++.|+++||+|||+++ |+||||||+|||+++++++||
T Consensus 98 ~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl 174 (308)
T d1p4oa_ 98 TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 174 (308)
T ss_dssp CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEE
T ss_pred eeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEE
Confidence 99999999999999998632 34688899999999999999999998 999999999999999999999
Q ss_pred ecCCCccccccCcc-cceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcC-CCCcccccchhhhhhhHHHhh
Q 041576 563 SDFGLSKLLLSDQS-RTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCK-RSVEMELGEERSAILTDWAYD 640 (714)
Q Consensus 563 ~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~-~p~~~~~~~~~~~~l~~~~~~ 640 (714)
+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||+||. .|+......+. + .
T Consensus 175 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~---~-----~ 246 (308)
T d1p4oa_ 175 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV---L-----R 246 (308)
T ss_dssp CCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHH---H-----H
T ss_pred eecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHH---H-----H
Confidence 99999987654333 2223345899999999999999999999999999999999985 56654332221 1 1
Q ss_pred hhhcCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccC
Q 041576 641 CYVEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLE 697 (714)
Q Consensus 641 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 697 (714)
....+.... .+...+..+.+++.+||+.||++||||+||+++|++.++
T Consensus 247 ~i~~~~~~~---------~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 247 FVMEGGLLD---------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp HHHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HHHhCCCCC---------CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 111221111 112233578889999999999999999999999998765
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-44 Score=378.06 Aligned_cols=249 Identities=22% Similarity=0.252 Sum_probs=196.5
Q ss_pred hhhhh-hhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhcc-CcccccceeceEec----CCeee
Q 041576 421 TNGFE-EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRT-HHKNLVQLLGFCDE----GLNRL 494 (714)
Q Consensus 421 t~~~~-~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~----~~~~~ 494 (714)
.|.+. +.||+|+||+||+|++. .+++.||||++++. ..+.+|++++.++ +||||+++++++.+ ....|
T Consensus 12 ~y~i~~~~lG~G~fg~Vy~a~~~-~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ 85 (335)
T d2ozaa1 12 DYKVTSQVLGLGINGKVLQIFNK-RTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 85 (335)
T ss_dssp TEEEEEEEEEECSSCEEEEEEET-TTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred CEEEeeEEeeeccCeEEEEEEEC-CCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence 45555 46999999999999976 47899999999642 3567899887665 89999999999865 46689
Q ss_pred EEEeecCCCchhhhhhcC--CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECC---CCceEEecCCCcc
Q 041576 495 LVYEFMGNGTLANLLFAI--PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQ---DFTAKISDFGLSK 569 (714)
Q Consensus 495 lv~E~~~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~---~~~~kl~Dfg~~~ 569 (714)
+||||+++|+|.+++... ..+++.++..++.||+.||+|||+++ |+||||||+|||+++ ++.+||+|||+++
T Consensus 86 ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~ 162 (335)
T d2ozaa1 86 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAK 162 (335)
T ss_dssp EEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccccccceee
Confidence 999999999999999764 46899999999999999999999998 999999999999985 5679999999998
Q ss_pred ccccCcccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccce
Q 041576 570 LLLSDQSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDV 649 (714)
Q Consensus 570 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 649 (714)
....... .....||+.|+|||++.+..++.++|||||||++|||+||+.||...........+. .....+...
T Consensus 163 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~----~~i~~~~~~- 235 (335)
T d2ozaa1 163 ETTSHNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK----TRIRMGQYE- 235 (335)
T ss_dssp ECCCCCC--CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC------------CCCSCSSS-
T ss_pred eccCCCc--cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHH----HHHhcCCCC-
Confidence 7654332 334569999999999999999999999999999999999999997654332111110 000111100
Q ss_pred eecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 650 LVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 650 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
.........+.++.+|+.+||+.||++|||+.|+++
T Consensus 236 -----~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 236 -----FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp -----CCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred -----CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 001111233457888999999999999999999988
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-43 Score=368.31 Aligned_cols=265 Identities=22% Similarity=0.264 Sum_probs=199.4
Q ss_pred hhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc--hhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEe
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA--QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYE 498 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E 498 (714)
.|.+.++||+|+||+||+|++. .+++.||||+++... ....+.+.+|++++++++||||+++++++.++...++|||
T Consensus 3 ~Y~~~~~lG~G~fg~Vy~~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 3 NFQKVEKIGEGTYGVVYKARNK-LTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TEEEEEEEEECSSSEEEEEEET-TTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCEeccEEecCcCeEEEEEEEC-CCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 4667789999999999999976 578999999996532 2335688999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhc-CCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCccc
Q 041576 499 FMGNGTLANLLFA-IPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSR 577 (714)
Q Consensus 499 ~~~~gsL~~~l~~-~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 577 (714)
|+.++.+...... ...+++..+..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~- 157 (298)
T d1gz8a_ 82 FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR- 157 (298)
T ss_dssp CCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB-
T ss_pred ecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCcc-
Confidence 9987555544333 456899999999999999999999998 99999999999999999999999999987644332
Q ss_pred ceeeecCCCCccCcccccCCC-CCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHh-------hhhhc--C--
Q 041576 578 TRTVIRGTRGYVAPEWFKNVP-VSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAY-------DCYVE--G-- 645 (714)
Q Consensus 578 ~~~~~~gt~~y~aPE~~~~~~-~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~-------~~~~~--~-- 645 (714)
......||+.|+|||.+.... ++.++||||+||++|||++|+.||......+....+..... ..... .
T Consensus 158 ~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 237 (298)
T d1gz8a_ 158 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 237 (298)
T ss_dssp CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccc
Confidence 233446899999999887665 58899999999999999999999975543321111100000 00000 0
Q ss_pred -ccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 646 -KLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 646 -~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
.......... .......+..+.+++.+||+.||++|||++|+++.
T Consensus 238 ~~~~~~~~~~~-~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 238 PSFPKWARQDF-SKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp TTSCCCCCCCH-HHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccch-hhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 0000000000 00111233577889999999999999999999985
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.9e-43 Score=364.05 Aligned_cols=264 Identities=20% Similarity=0.225 Sum_probs=202.0
Q ss_pred hhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEeccc--chhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEe
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKL--AQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYE 498 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E 498 (714)
+|.+.++||+|+||+||+|+++ +++.||||+++.. .....+.+.+|+.++++++||||+++++++.+++..++++|
T Consensus 3 ~Y~~~~~iG~G~fg~Vy~~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e 80 (286)
T d1ob3a_ 3 KYHGLEKIGEGTYGVVYKAQNN--YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80 (286)
T ss_dssp SEEEEEEEEEETTEEEEEEEET--TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred CceeccEEecCCCcEEEEEEeC--CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEE
Confidence 4667789999999999999875 6899999999653 23335789999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcccc
Q 041576 499 FMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRT 578 (714)
Q Consensus 499 ~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 578 (714)
++.++.+..+......+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||.+........ .
T Consensus 81 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~-~ 156 (286)
T d1ob3a_ 81 HLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-K 156 (286)
T ss_dssp CCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred eehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCcc-c
Confidence 9999888888888888999999999999999999999998 99999999999999999999999999987644322 2
Q ss_pred eeeecCCCCccCcccccCC-CCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhh----hh----hcCcc--
Q 041576 579 RTVIRGTRGYVAPEWFKNV-PVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYD----CY----VEGKL-- 647 (714)
Q Consensus 579 ~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~----~~----~~~~~-- 647 (714)
.....+++.|+|||.+.+. .++.++|||||||++|||++|+.||......+....+...... .+ .....
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T d1ob3a_ 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236 (286)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhccc
Confidence 2334589999999998754 5699999999999999999999999754332211111000000 00 00000
Q ss_pred -ceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 648 -DVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 648 -~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
................+..+.+++.+||+.||++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp TCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000011111112223457788999999999999999999985
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-44 Score=368.59 Aligned_cols=240 Identities=23% Similarity=0.385 Sum_probs=197.4
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccch------hhHHHHHHHHHHHhccC--cccccceeceEecCC
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQ------EREREFKTEVSAIGRTH--HKNLVQLLGFCDEGL 491 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--h~nIv~l~~~~~~~~ 491 (714)
.+|.+.+.||+|+||+||+|+.. .+++.||||+++.... .....+.+|+.++++++ ||||+++++++.+++
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRV-SDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CeEEEeEEEeeCCCeEEEEEEEC-CCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 35788899999999999999976 5789999999864221 12234678999999986 899999999999999
Q ss_pred eeeEEEeecCC-CchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECC-CCceEEecCCCcc
Q 041576 492 NRLLVYEFMGN-GTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQ-DFTAKISDFGLSK 569 (714)
Q Consensus 492 ~~~lv~E~~~~-gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~-~~~~kl~Dfg~~~ 569 (714)
..++||||+.+ +++.+++.....+++.++..++.||++||+|||+++ |+||||||+|||++. ++.+||+|||+++
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG~a~ 159 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGA 159 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECccccce
Confidence 99999999976 688888888888999999999999999999999998 999999999999985 4799999999998
Q ss_pred ccccCcccceeeecCCCCccCcccccCCCC-CchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccc
Q 041576 570 LLLSDQSRTRTVIRGTRGYVAPEWFKNVPV-SAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLD 648 (714)
Q Consensus 570 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 648 (714)
..... ......||+.|+|||++.+..+ +.++||||+||++|||++|+.||...... ..+..
T Consensus 160 ~~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~i--------------~~~~~- 221 (273)
T d1xwsa_ 160 LLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI--------------IRGQV- 221 (273)
T ss_dssp ECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH--------------HHCCC-
T ss_pred ecccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchHH--------------hhccc-
Confidence 65332 2334579999999999987665 67799999999999999999999743210 00100
Q ss_pred eeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 649 VLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 649 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
.+ +...+.++.+++.+||+.||++|||++|+++
T Consensus 222 -~~--------~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 222 -FF--------RQRVSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp -CC--------SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -CC--------CCCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 01 1112356788999999999999999999987
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-43 Score=368.35 Aligned_cols=267 Identities=21% Similarity=0.256 Sum_probs=198.2
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc--hhhHHHHHHHHHHHhcc---CcccccceeceEec-----
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA--QEREREFKTEVSAIGRT---HHKNLVQLLGFCDE----- 489 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~nIv~l~~~~~~----- 489 (714)
.+|++.++||+|+||+||+|++...+++.||||+++... ......+.+|+++++.+ +||||+++++++..
T Consensus 7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~ 86 (305)
T d1blxa_ 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 86 (305)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccccc
Confidence 457788999999999999999764557789999986532 22233456777776665 79999999999853
Q ss_pred CCeeeEEEeecCCCchhhhhh-cCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCc
Q 041576 490 GLNRLLVYEFMGNGTLANLLF-AIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLS 568 (714)
Q Consensus 490 ~~~~~lv~E~~~~gsL~~~l~-~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~ 568 (714)
....+++|||++++.+..... ....+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||++
T Consensus 87 ~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~dfg~~ 163 (305)
T d1blxa_ 87 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLA 163 (305)
T ss_dssp EEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSCCSC
T ss_pred CceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecchhhh
Confidence 356789999999988765554 3456889999999999999999999998 999999999999999999999999998
Q ss_pred cccccCcccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHh----hhhhc
Q 041576 569 KLLLSDQSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAY----DCYVE 644 (714)
Q Consensus 569 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~----~~~~~ 644 (714)
+..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||......+....+..... ..+..
T Consensus 164 ~~~~~~--~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 241 (305)
T d1blxa_ 164 RIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR 241 (305)
T ss_dssp CCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCT
T ss_pred hhhccc--ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccc
Confidence 865332 233456799999999999999999999999999999999999999986544332111111000 00000
Q ss_pred C-----ccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 645 G-----KLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 645 ~-----~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
. ..................+..+.+|+.+||+.||++|||++|+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 242 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp TCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0 0000000000111122234567889999999999999999999863
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-42 Score=359.57 Aligned_cols=268 Identities=21% Similarity=0.251 Sum_probs=200.5
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEeccc--chhhHHHHHHHHHHHhccCcccccceeceEec--------
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKL--AQEREREFKTEVSAIGRTHHKNLVQLLGFCDE-------- 489 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-------- 489 (714)
.+|.+.++||+|+||+||+|++. .+|+.||||++... .....+.+.+|+++|++++||||+++++++..
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHR-KTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEET-TTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred CCEEEEEEEecCcCeEEEEEEEC-CCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 46778899999999999999976 57899999998543 33345678999999999999999999999855
Q ss_pred CCeeeEEEeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCcc
Q 041576 490 GLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSK 569 (714)
Q Consensus 490 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~ 569 (714)
+...++||||+.++.+.........+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||++.
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg~~~ 165 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLAR 165 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred CceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecceee
Confidence 3467899999999888877777788999999999999999999999998 9999999999999999999999999998
Q ss_pred ccccCcc---cceeeecCCCCccCcccccCC-CCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhc-
Q 041576 570 LLLSDQS---RTRTVIRGTRGYVAPEWFKNV-PVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVE- 644 (714)
Q Consensus 570 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~- 644 (714)
....... .......||+.|+|||.+.+. .++.++||||+||++|||++|+.||...........+.........+
T Consensus 166 ~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 245 (318)
T d3blha1 166 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV 245 (318)
T ss_dssp ECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred ecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhh
Confidence 7653322 222334689999999998765 68999999999999999999999997654333222221111000000
Q ss_pred ------Cccceeecchhh-------hccchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 645 ------GKLDVLVDNDKA-------AMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 645 ------~~~~~~~~~~~~-------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
............ ..........+.+|+.+||+.||++|||++|+++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 246 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp STTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 000000000000 00011123466789999999999999999999875
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-41 Score=360.21 Aligned_cols=269 Identities=23% Similarity=0.251 Sum_probs=196.4
Q ss_pred hhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEeccc--chhhHHHHHHHHHHHhccCcccccceeceEecCC------e
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKL--AQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGL------N 492 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~------~ 492 (714)
+|.+.++||+|+||+||+|+++ .+|+.||||+++.. .....+.+.+|+++|++++||||+++++++...+ .
T Consensus 19 ~Y~~i~~lG~G~fg~V~~~~~~-~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~ 97 (346)
T d1cm8a_ 19 VYRDLQPVGSGAYGAVCSAVDG-RTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD 97 (346)
T ss_dssp SEEEEEEC------CEEEEEET-TTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred cEEEEEEEecCCCeEEEEEEEC-CCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccce
Confidence 5777889999999999999976 57899999999753 3344568899999999999999999999997655 4
Q ss_pred eeEEEeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccc
Q 041576 493 RLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLL 572 (714)
Q Consensus 493 ~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~ 572 (714)
.++||||+ +.+|..+++. ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 98 ~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~ 172 (346)
T d1cm8a_ 98 FYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQAD 172 (346)
T ss_dssp CEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEEecc-cccHHHHHHh-ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccceeccC
Confidence 69999999 5577777654 57999999999999999999999998 9999999999999999999999999998654
Q ss_pred cCcccceeeecCCCCccCcccccCC-CCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHh----hhhhcC--
Q 041576 573 SDQSRTRTVIRGTRGYVAPEWFKNV-PVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAY----DCYVEG-- 645 (714)
Q Consensus 573 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~----~~~~~~-- 645 (714)
.. .....||+.|+|||.+.+. .++.++||||+||++|||++|+.||................. ......
T Consensus 173 ~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (346)
T d1cm8a_ 173 SE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS 248 (346)
T ss_dssp SS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSC
T ss_pred Cc----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcc
Confidence 32 2345689999999998764 578999999999999999999999976533221111100000 000000
Q ss_pred --------ccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HhcccCCCC
Q 041576 646 --------KLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM--LEGYLEVPS 700 (714)
Q Consensus 646 --------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~~~~~~ 700 (714)
.......... ..........+.+|+.+||+.||++|||++|+++. ++++.+...
T Consensus 249 ~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~~~ 312 (346)
T d1cm8a_ 249 DEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTED 312 (346)
T ss_dssp HHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC----
T ss_pred hhhhhhhccCCcccccch-HHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCccc
Confidence 0000000000 01112233567789999999999999999999985 666554433
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-41 Score=361.29 Aligned_cols=265 Identities=23% Similarity=0.260 Sum_probs=196.9
Q ss_pred hhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCcccccceeceEec------CCeee
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQLLGFCDE------GLNRL 494 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~------~~~~~ 494 (714)
+|...++||+|+||+||+|++. .+++.||||+++.... ...+|+++|++++||||+++++++.. ..+.+
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~-~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~ 95 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLC-DSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 95 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEEC-CCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEE
Confidence 5667789999999999999976 5789999999965332 23579999999999999999999843 33468
Q ss_pred EEEeecCCCchhhhh---hcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCC-ceEEecCCCccc
Q 041576 495 LVYEFMGNGTLANLL---FAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDF-TAKISDFGLSKL 570 (714)
Q Consensus 495 lv~E~~~~gsL~~~l---~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~-~~kl~Dfg~~~~ 570 (714)
+||||++++.+..+. .....+++.++..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||++..
T Consensus 96 lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~ 172 (350)
T d1q5ka_ 96 LVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172 (350)
T ss_dssp EEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred EEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhh
Confidence 999999876544433 34567899999999999999999999998 99999999999999775 899999999987
Q ss_pred cccCcccceeeecCCCCccCcccccC-CCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHH-------Hhhhh
Q 041576 571 LLSDQSRTRTVIRGTRGYVAPEWFKN-VPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDW-------AYDCY 642 (714)
Q Consensus 571 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~-------~~~~~ 642 (714)
...... .....|+..|+|||.+.+ ..++.++||||+||++|||++|+.||......+....+... .....
T Consensus 173 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~ 250 (350)
T d1q5ka_ 173 LVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 250 (350)
T ss_dssp CCTTSC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred ccCCcc--cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhh
Confidence 644332 233568999999998765 56899999999999999999999999765433221111100 00000
Q ss_pred ----hcCccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHH--Hhcc
Q 041576 643 ----VEGKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM--LEGY 695 (714)
Q Consensus 643 ----~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~ 695 (714)
.....................+..+.+|+.+||+.||++|||++|+++. ++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 309 (350)
T d1q5ka_ 251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309 (350)
T ss_dssp CC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred ccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence 0001111111111111222344578889999999999999999999963 5444
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-42 Score=360.26 Aligned_cols=253 Identities=23% Similarity=0.248 Sum_probs=206.6
Q ss_pred hhhhhhhhCcccceeEEEeEee--CCCCcEEEEEEeccc----chhhHHHHHHHHHHHhccCc-ccccceeceEecCCee
Q 041576 421 TNGFEEELGRGSFGIVYKGVLK--SASGNAVAVKKLDKL----AQEREREFKTEVSAIGRTHH-KNLVQLLGFCDEGLNR 493 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~--~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h-~nIv~l~~~~~~~~~~ 493 (714)
.|.+.++||+|+||+||+|+.. ..+|+.||||.++.. .....+.+.+|++++++++| |||+++++++.+....
T Consensus 25 ~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~ 104 (322)
T d1vzoa_ 25 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKL 104 (322)
T ss_dssp GEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEE
T ss_pred ceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCce
Confidence 4888899999999999999863 236889999998642 22334678899999999966 8999999999999999
Q ss_pred eEEEeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCcccccc
Q 041576 494 LLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLS 573 (714)
Q Consensus 494 ~lv~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~ 573 (714)
+++|||+.+|+|.+++.....+.+..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 105 ~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~ 181 (322)
T d1vzoa_ 105 HLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVA 181 (322)
T ss_dssp EEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEEECCG
T ss_pred eeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchhhhcc
Confidence 999999999999999998888899999999999999999999998 99999999999999999999999999987755
Q ss_pred CcccceeeecCCCCccCcccccCC--CCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccceee
Q 041576 574 DQSRTRTVIRGTRGYVAPEWFKNV--PVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDVLV 651 (714)
Q Consensus 574 ~~~~~~~~~~gt~~y~aPE~~~~~--~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 651 (714)
..........|++.|+|||.+.+. .++.++|||||||+||||++|+.||...........+.... .....
T Consensus 182 ~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~----~~~~~---- 253 (322)
T d1vzoa_ 182 DETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI----LKSEP---- 253 (322)
T ss_dssp GGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHH----HHCCC----
T ss_pred cccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc----ccCCC----
Confidence 555445556799999999999754 46889999999999999999999997654443222221110 01000
Q ss_pred cchhhhccchHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 041576 652 DNDKAAMADKSRACKWLMIALWCIQEDPLKRP-----AMKMIVQ 690 (714)
Q Consensus 652 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 690 (714)
..+...+.++.+++.+||++||++|| |++|+++
T Consensus 254 ------~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 254 ------PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp ------CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred ------CCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 11223456788899999999999999 4889986
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-41 Score=359.47 Aligned_cols=265 Identities=20% Similarity=0.230 Sum_probs=197.0
Q ss_pred hhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc-hhhHHHHHHHHHHHhccCcccccceeceEecCC----eeeE
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA-QEREREFKTEVSAIGRTHHKNLVQLLGFCDEGL----NRLL 495 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~----~~~l 495 (714)
+|.+.+.||+|+||+||+|+.. .+|+.||||+++... ....+.+++|+++|++++||||+++++++.... ..++
T Consensus 9 rY~~~~~LG~G~fg~Vy~~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~ 87 (345)
T d1pmea_ 9 RYTNLSYIGEGAYGMVCSAYDN-VNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 87 (345)
T ss_dssp TEEEEEECC---CCCEEEEEET-TTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred CeEEEEEEeeccCeEEEEEEEC-CCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEE
Confidence 4777899999999999999865 578999999997543 344568899999999999999999999996653 2355
Q ss_pred EEeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCc
Q 041576 496 VYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQ 575 (714)
Q Consensus 496 v~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 575 (714)
++||+.+|+|.+++.. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 88 l~~~~~~g~L~~~l~~-~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~ 163 (345)
T d1pmea_ 88 LVTHLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 163 (345)
T ss_dssp EEEECCCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred EEEeecCCchhhhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeeccCCC
Confidence 6677789999999976 46899999999999999999999998 9999999999999999999999999998764432
Q ss_pred c--cceeeecCCCCccCccccc-CCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhh---hhhcC----
Q 041576 576 S--RTRTVIRGTRGYVAPEWFK-NVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYD---CYVEG---- 645 (714)
Q Consensus 576 ~--~~~~~~~gt~~y~aPE~~~-~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~---~~~~~---- 645 (714)
. .......|++.|+|||.+. ...++.++||||+||++|||++|+.||......+........... .....
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (345)
T d1pmea_ 164 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243 (345)
T ss_dssp CBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCH
T ss_pred ccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhh
Confidence 2 2234456899999999985 456789999999999999999999999765432211111000000 00000
Q ss_pred -------ccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 646 -------KLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 646 -------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
..... ..............++.+++.+||+.||++|||++|+++.
T Consensus 244 ~~~~~~~~~~~~-~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 244 KARNYLLSLPHK-NKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp HHHHHHHTSCCC-CCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhcccccCCcc-CCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00000 0000000111223467889999999999999999999974
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-41 Score=350.06 Aligned_cols=265 Identities=17% Similarity=0.206 Sum_probs=205.5
Q ss_pred hhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEeccc--chhhHHHHHHHHHHHhccCcccccceeceEecCCeeeEEEe
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKL--AQEREREFKTEVSAIGRTHHKNLVQLLGFCDEGLNRLLVYE 498 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E 498 (714)
+|++.++||+|+||+||+|++. .+++.||||+++.. .......+++|+.++++++||||+++++++.+....++|+|
T Consensus 3 ry~~i~~LG~G~fg~V~~~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 3 KYEKLEKIGEGTYGTVFKAKNR-ETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp SEEEEEEEEECSSSEEEEEEET-TTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCEeeeEEecCcCeEEEEEEEC-CCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 4677899999999999999976 57899999998543 33456789999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccccCcccc
Q 041576 499 FMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLSDQSRT 578 (714)
Q Consensus 499 ~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 578 (714)
++.+++|..++...+.+++..+..++.|+++||+|||+++ |+||||||+|||++.++.+||+|||.++....... .
T Consensus 82 ~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~-~ 157 (292)
T d1unla_ 82 FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR-C 157 (292)
T ss_dssp CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS-C
T ss_pred eccccccccccccccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCCc-c
Confidence 9999999999988889999999999999999999999998 99999999999999999999999999987644332 2
Q ss_pred eeeecCCCCccCcccccCCC-CCchhhhHHHHHHHHHHHhcCCCCcccccchh-hhhhhHHHhh----------hhhc-C
Q 041576 579 RTVIRGTRGYVAPEWFKNVP-VSAKVDVYSFGVVLLKIICCKRSVEMELGEER-SAILTDWAYD----------CYVE-G 645 (714)
Q Consensus 579 ~~~~~gt~~y~aPE~~~~~~-~s~ksDVwSlGvil~elltG~~p~~~~~~~~~-~~~l~~~~~~----------~~~~-~ 645 (714)
.....++..|+|||.+.... ++.++||||+||++|||++|+.||........ ...+...... ...+ .
T Consensus 158 ~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (292)
T d1unla_ 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237 (292)
T ss_dssp CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCC
T ss_pred ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccccc
Confidence 22345778899999987665 69999999999999999999999754322211 1111110000 0000 0
Q ss_pred ccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 646 KLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 646 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
.....................+.+|+.+||+.||++|||++||++
T Consensus 238 ~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp CCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000000000011112233456788999999999999999999987
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.4e-41 Score=350.73 Aligned_cols=259 Identities=19% Similarity=0.253 Sum_probs=197.1
Q ss_pred hhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCcccccc-eeceEecCCeeeEEEee
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNLVQ-LLGFCDEGLNRLLVYEF 499 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~-l~~~~~~~~~~~lv~E~ 499 (714)
+|.+.+.||+|+||.||+|++. .+++.||||++.... ...++..|++++++++|+|++. +.++..+++..++||||
T Consensus 8 rY~l~~~iG~G~fG~Vy~a~~~-~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 8 RYRLGRKIGSGSFGDIYLGTDI-AAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TEEEEEEEEECSSSEEEEEEET-TTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred EEEEeEEEeeCCCcEEEEEEEC-CCCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 5788899999999999999876 568899999886532 2345788999999998766554 55556788888999999
Q ss_pred cCCCchhhhh-hcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECC---CCceEEecCCCccccccCc
Q 041576 500 MGNGTLANLL-FAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQ---DFTAKISDFGLSKLLLSDQ 575 (714)
Q Consensus 500 ~~~gsL~~~l-~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~---~~~~kl~Dfg~~~~~~~~~ 575 (714)
+.+ +|.+.+ .....+++..+..++.|++.||+|||+++ |+||||||+|||++. +..+||+|||+++......
T Consensus 85 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~ 160 (299)
T d1ckia_ 85 LGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 160 (299)
T ss_dssp CCC-BHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTT
T ss_pred cCC-chhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceeccccc
Confidence 965 555544 45568999999999999999999999998 999999999999864 5579999999999775433
Q ss_pred c------cceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCccce
Q 041576 576 S------RTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGKLDV 649 (714)
Q Consensus 576 ~------~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 649 (714)
. .......||+.|+|||.+.+..++.++|||||||++|||++|+.||...................... .
T Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~-~--- 236 (299)
T d1ckia_ 161 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST-P--- 236 (299)
T ss_dssp TCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHS-C---
T ss_pred cccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCC-C---
Confidence 2 22334579999999999999999999999999999999999999997654333221111111000000 0
Q ss_pred eecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 041576 650 LVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYL 696 (714)
Q Consensus 650 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 696 (714)
........+.++.+++..||+.||++||+++++.+.|+.+.
T Consensus 237 ------~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~ 277 (299)
T d1ckia_ 237 ------IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 277 (299)
T ss_dssp ------HHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHH
T ss_pred ------hhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence 00011123456888999999999999999999999888754
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.4e-40 Score=349.03 Aligned_cols=258 Identities=19% Similarity=0.273 Sum_probs=196.6
Q ss_pred hhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccC-cccccceeceEec--CCeeeEEE
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTH-HKNLVQLLGFCDE--GLNRLLVY 497 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~--~~~~~lv~ 497 (714)
.|.+.++||+|+||+||+|+.. .+++.||||+++.. ..+.+.+|+++|++++ ||||+++++++.. ....++||
T Consensus 36 ~y~i~~~LG~G~fg~V~~a~~~-~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 36 DYQLVRKLGRGKYSEVFEAINI-TNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred CeEEEEEEecCcCeEEEEEEEC-CCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 5778899999999999999976 57899999999753 3457889999999995 9999999999974 45689999
Q ss_pred eecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCC-ceEEecCCCccccccCcc
Q 041576 498 EFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDF-TAKISDFGLSKLLLSDQS 576 (714)
Q Consensus 498 E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~-~~kl~Dfg~~~~~~~~~~ 576 (714)
||+++++|..+. +.+++..+..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||++........
T Consensus 112 e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~ 185 (328)
T d3bqca1 112 EHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE 185 (328)
T ss_dssp ECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCC
T ss_pred eecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccCCCc
Confidence 999999998775 46899999999999999999999998 99999999999998655 699999999987644332
Q ss_pred cceeeecCCCCccCcccccCC-CCCchhhhHHHHHHHHHHHhcCCCCcccccchhhh-hhhH---------HHhhhhhcC
Q 041576 577 RTRTVIRGTRGYVAPEWFKNV-PVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSA-ILTD---------WAYDCYVEG 645 (714)
Q Consensus 577 ~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~-~l~~---------~~~~~~~~~ 645 (714)
.....+|..|+|||.+.+. .++.++||||+||++|||++|+.||.......... .+.. +........
T Consensus 186 --~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 263 (328)
T d3bqca1 186 --YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 263 (328)
T ss_dssp --CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCC
T ss_pred --ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhccccc
Confidence 3345689999999998765 47999999999999999999999997543221110 0000 000000000
Q ss_pred --cccee--------ecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041576 646 --KLDVL--------VDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ 690 (714)
Q Consensus 646 --~~~~~--------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 690 (714)
..... ...............++.+|+.+||+.||++|||++|+++
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 264 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp CGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000 0000111111233457888999999999999999999986
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.5e-40 Score=344.28 Aligned_cols=261 Identities=16% Similarity=0.212 Sum_probs=205.8
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCc-ccccceeceEecCCeeeEEEe
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHH-KNLVQLLGFCDEGLNRLLVYE 498 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~nIv~l~~~~~~~~~~~lv~E 498 (714)
.+|.+.+.||+|+||+||+|++. .+++.||||.+.... ....+.+|++.++.++| +|++.+++++.++...++|||
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~-~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNL-LNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEET-TTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CceEEEEEEecCCCeEEEEEEEC-CCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 46788899999999999999976 578999999885432 23457788999999965 899999999999999999999
Q ss_pred ecCCCchhhhhhcC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECC-----CCceEEecCCCccccc
Q 041576 499 FMGNGTLANLLFAI-PRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQ-----DFTAKISDFGLSKLLL 572 (714)
Q Consensus 499 ~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~-----~~~~kl~Dfg~~~~~~ 572 (714)
|+ +++|.+++... ..+++..+..++.|++.||+|||+++ |+||||||+|||++. ++.+||+|||+++...
T Consensus 82 ~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~ 157 (293)
T d1csna_ 82 LL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 157 (293)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred ec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence 98 67999998765 46899999999999999999999998 999999999999974 5789999999998764
Q ss_pred cCcc------cceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhhhhhcCc
Q 041576 573 SDQS------RTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYDCYVEGK 646 (714)
Q Consensus 573 ~~~~------~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~ 646 (714)
.... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||.................... ...
T Consensus 158 ~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~-~~~ 236 (293)
T d1csna_ 158 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ-STP 236 (293)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH-HSC
T ss_pred cCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccC-CCC
Confidence 4321 123345799999999999999999999999999999999999999975543332211111110000 000
Q ss_pred cceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccC
Q 041576 647 LDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQMLEGYLE 697 (714)
Q Consensus 647 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 697 (714)
. .......+.++.+++..|++.+|++||+++.+.+.|+++++
T Consensus 237 ~---------~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~ 278 (293)
T d1csna_ 237 L---------RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE 278 (293)
T ss_dssp H---------HHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred h---------HHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHH
Confidence 0 00111223567889999999999999999999998887653
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-40 Score=351.37 Aligned_cols=262 Identities=24% Similarity=0.256 Sum_probs=190.5
Q ss_pred hhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEeccc--chhhHHHHHHHHHHHhccCcccccceeceEec------CCe
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKL--AQEREREFKTEVSAIGRTHHKNLVQLLGFCDE------GLN 492 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~------~~~ 492 (714)
+|.+.++||+|+||+||+|++. .+|+.||||++... .....+.+.+|+.++++++||||+++++++.. ...
T Consensus 18 ~Y~i~~~LG~G~fg~V~~~~d~-~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 18 RYQNLKPIGSGAQGIVCAAYDA-VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TEEEEEECSCC--CEEEEEEET-TTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CeEEEEEeecCcCeEEEEEEEC-CCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 4667789999999999999876 57899999999643 34445678999999999999999999999953 467
Q ss_pred eeEEEeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCccccc
Q 041576 493 RLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLL 572 (714)
Q Consensus 493 ~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~ 572 (714)
.|+||||+.++.+... . ..+++..+..++.||+.||+|||++| |+||||||+|||++.++.+|++|||+++...
T Consensus 97 ~~iv~Ey~~~~l~~~~-~--~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~~~~ 170 (355)
T d2b1pa1 97 VYLVMELMDANLCQVI-Q--MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG 170 (355)
T ss_dssp EEEEEECCSEEHHHHH-T--SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred eEEEEeccchHHHHhh-h--cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhhccc
Confidence 8999999987655544 2 46889999999999999999999998 9999999999999999999999999988654
Q ss_pred cCcccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHH--------------
Q 041576 573 SDQSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWA-------------- 638 (714)
Q Consensus 573 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~-------------- 638 (714)
.. .......+|+.|+|||.+.+..++.++||||+||+++||++|+.||...........+....
T Consensus 171 ~~--~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 248 (355)
T d2b1pa1 171 TS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 248 (355)
T ss_dssp ------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHH
T ss_pred cc--cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhh
Confidence 32 23344568999999999999999999999999999999999999997543222111110000
Q ss_pred hhhhhcCcc-------ceeecch---hhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041576 639 YDCYVEGKL-------DVLVDND---KAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQM 691 (714)
Q Consensus 639 ~~~~~~~~~-------~~~~~~~---~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 691 (714)
......... ....... .........+..+.+|+.+||+.||++|||++||++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp HHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000000000 0000000 0011123356678899999999999999999999864
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-40 Score=351.36 Aligned_cols=268 Identities=21% Similarity=0.244 Sum_probs=199.1
Q ss_pred hhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEeccc--chhhHHHHHHHHHHHhccCcccccceeceEecC-----Cee
Q 041576 421 TNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKL--AQEREREFKTEVSAIGRTHHKNLVQLLGFCDEG-----LNR 493 (714)
Q Consensus 421 t~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-----~~~ 493 (714)
+|.+.+.||+|+||+||+|++. .+|+.||||+++.. .....+.+.+|+++|++++||||+++++++... ...
T Consensus 19 rY~i~~~LG~G~fg~Vy~a~~~-~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~ 97 (348)
T d2gfsa1 19 RYQNLSPVGSGAYGSVCAAFDT-KTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 97 (348)
T ss_dssp TEEEEEECGGGTTSSEEEEEET-TTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCC
T ss_pred CeEEEEEEecCCCeEEEEEEEC-CCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCce
Confidence 4777899999999999999875 57899999999753 334456789999999999999999999998643 345
Q ss_pred eEEEeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEecCCCcccccc
Q 041576 494 LLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISDFGLSKLLLS 573 (714)
Q Consensus 494 ~lv~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~~~~ 573 (714)
++++||+.+|+|.+++.. +.+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+|++|||++.....
T Consensus 98 ~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~ 173 (348)
T d2gfsa1 98 VYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDD 173 (348)
T ss_dssp CEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----CCTG
T ss_pred EEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhcccCc
Confidence 777888899999999965 57999999999999999999999998 99999999999999999999999999975432
Q ss_pred CcccceeeecCCCCccCcccccCC-CCCchhhhHHHHHHHHHHHhcCCCCcccccchhhhhhhHHHhh----hhhc----
Q 041576 574 DQSRTRTVIRGTRGYVAPEWFKNV-PVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSAILTDWAYD----CYVE---- 644 (714)
Q Consensus 574 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~l~~~~~~----~~~~---- 644 (714)
......|+..|+|||.+.+. .++.++|||||||++|||++|+.||...........+...... ....
T Consensus 174 ----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 249 (348)
T d2gfsa1 174 ----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 249 (348)
T ss_dssp ----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCH
T ss_pred ----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccch
Confidence 22334688999999987665 4689999999999999999999999755433221111110000 0000
Q ss_pred ------CccceeecchhhhccchHHHHHHHHHHHHccccCCCCCCCHHHHHH--HHhcccCC
Q 041576 645 ------GKLDVLVDNDKAAMADKSRACKWLMIALWCIQEDPLKRPAMKMIVQ--MLEGYLEV 698 (714)
Q Consensus 645 ------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~~~~ 698 (714)
............ .........+.+|+.+||+.||++|||++|+++ .+.++...
T Consensus 250 ~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~~ 310 (348)
T d2gfsa1 250 SARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 310 (348)
T ss_dssp HHHHHHTTSCCCCCCCHH-HHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCT
T ss_pred hhhhhhhhcccCCCcchh-hhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCCC
Confidence 000000000000 001123456788999999999999999999998 46655443
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.2e-35 Score=315.24 Aligned_cols=267 Identities=21% Similarity=0.200 Sum_probs=190.2
Q ss_pred HhhhhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccC-----------cccccceeceEe
Q 041576 420 ATNGFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTH-----------HKNLVQLLGFCD 488 (714)
Q Consensus 420 at~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~nIv~l~~~~~ 488 (714)
.+|.+.++||+|+||+||+|+.. .+|+.||||+++... ...+.+.+|+.++++++ |+||+++++++.
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~-~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~ 90 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDM-VNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 90 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEEC-CCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEee
Confidence 45888999999999999999976 578999999997643 23457788898888775 578999998885
Q ss_pred c--CCeeeEEEeecCCCchhhh-h--hcCCCCChhhHHHHHHHHHHHHHHHHh-cCCCCeEecCCCcCeEEECCCC----
Q 041576 489 E--GLNRLLVYEFMGNGTLANL-L--FAIPRPDWSLRVRISLEIARGLLYLHE-ECNVPIIHCDIKPQNILLDQDF---- 558 (714)
Q Consensus 489 ~--~~~~~lv~E~~~~gsL~~~-l--~~~~~~~~~~~~~i~~qi~~~L~yLH~-~~~~~ivH~Dlk~~NIll~~~~---- 558 (714)
. ....+++++++..+..... . .....+++..+..++.||+.||+|||+ .+ |+||||||+||||+.++
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~ 167 (362)
T d1q8ya_ 91 HKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPEN 167 (362)
T ss_dssp EEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTT
T ss_pred eccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCcccc
Confidence 4 3455667776655433222 2 233567889999999999999999998 66 99999999999998665
Q ss_pred --ceEEecCCCccccccCcccceeeecCCCCccCcccccCCCCCchhhhHHHHHHHHHHHhcCCCCcccccchhhh---h
Q 041576 559 --TAKISDFGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVVLLKIICCKRSVEMELGEERSA---I 633 (714)
Q Consensus 559 --~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~---~ 633 (714)
.++++|||.+..... ......||+.|+|||.+....++.++||||+||+++||++|+.||.......... .
T Consensus 168 ~~~~kl~dfg~s~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~ 243 (362)
T d1q8ya_ 168 LIQIKIADLGNACWYDE----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 243 (362)
T ss_dssp EEEEEECCCTTCEETTB----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred cceeeEeeccccccccc----ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHH
Confidence 399999999975432 2234568999999999999999999999999999999999999997543221110 0
Q ss_pred hhHHHh-------hhh----------hcC----ccceeecc------hhhhccchHHHHHHHHHHHHccccCCCCCCCHH
Q 041576 634 LTDWAY-------DCY----------VEG----KLDVLVDN------DKAAMADKSRACKWLMIALWCIQEDPLKRPAMK 686 (714)
Q Consensus 634 l~~~~~-------~~~----------~~~----~~~~~~~~------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 686 (714)
+..... ... ... .+...... .............+.+|+.+||+.||.+|||++
T Consensus 244 ~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~ 323 (362)
T d1q8ya_ 244 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG 323 (362)
T ss_dssp HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred HHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHH
Confidence 000000 000 000 00000000 001122345677899999999999999999999
Q ss_pred HHHHH--Hhcc
Q 041576 687 MIVQM--LEGY 695 (714)
Q Consensus 687 evl~~--L~~~ 695 (714)
|+++. +++.
T Consensus 324 e~L~Hp~f~~~ 334 (362)
T d1q8ya_ 324 GLVNHPWLKDT 334 (362)
T ss_dssp HHHTCGGGTTC
T ss_pred HHhcCcccCCC
Confidence 99984 5543
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.85 E-value=6.4e-22 Score=190.10 Aligned_cols=168 Identities=14% Similarity=0.082 Sum_probs=120.2
Q ss_pred hhhhhhCcccceeEEEeEeeCCCCcEEEEEEecccc------------------hhhHHHHHHHHHHHhccCccccccee
Q 041576 423 GFEEELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA------------------QEREREFKTEVSAIGRTHHKNLVQLL 484 (714)
Q Consensus 423 ~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~------------------~~~~~~~~~E~~~l~~l~h~nIv~l~ 484 (714)
.+.++||+|+||+||+|+.. +|+.||||+++... .........|+..+.++.|++++..+
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~--~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSE--KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp EEEEEEEECSSEEEEEEEET--TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred hhCCEeeeCcceEEEEEECC--CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 45689999999999999874 68899999875311 11123456788999999999999887
Q ss_pred ceEecCCeeeEEEeecCCCchhhhhhcCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeEecCCCcCeEEECCCCceEEec
Q 041576 485 GFCDEGLNRLLVYEFMGNGTLANLLFAIPRPDWSLRVRISLEIARGLLYLHEECNVPIIHCDIKPQNILLDQDFTAKISD 564 (714)
Q Consensus 485 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D 564 (714)
++.. .+++|||+++..+.+ ++......++.|++++|+|||+++ |+||||||+|||++++ .++|+|
T Consensus 81 ~~~~----~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~liD 145 (191)
T d1zara2 81 AWEG----NAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWIID 145 (191)
T ss_dssp EEET----TEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEECC
T ss_pred EecC----CEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEEEEE
Confidence 6532 379999999866543 345667789999999999999998 9999999999999965 589999
Q ss_pred CCCccccccCcccceeeecCCCCccCcccccCCCCCchhhhHHHHHH
Q 041576 565 FGLSKLLLSDQSRTRTVIRGTRGYVAPEWFKNVPVSAKVDVYSFGVV 611 (714)
Q Consensus 565 fg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvi 611 (714)
||.+............. .+... -.|.+ ...++.++|+||..--
T Consensus 146 FG~a~~~~~~~~~~~l~--rd~~~-~~~~f-~r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 146 FPQSVEVGEEGWREILE--RDVRN-IITYF-SRTYRTEKDINSAIDR 188 (191)
T ss_dssp CTTCEETTSTTHHHHHH--HHHHH-HHHHH-HHHHCCCCCHHHHHHH
T ss_pred CCCcccCCCCCcHHHHH--HHHHH-HHHHH-cCCCCCcccHHHHHHH
Confidence 99997654322111000 00000 01111 2457788999997543
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=99.22 E-value=5.2e-11 Score=100.98 Aligned_cols=95 Identities=19% Similarity=0.395 Sum_probs=74.2
Q ss_pred cccCCCCeeecCCCCCeEeeCCCeeeeeeecCCCCCCceEEEEEeecCCCCeeEEeeCCCCCCcccCCccEEEEcccc-e
Q 041576 23 ANIPLGSTLSSTSNNSSWISPSRDFAFGFRQLNNNSDLFLLAIWFNKMPERTIIWHANEDNHPVLAPRGSTLELTATG-L 101 (714)
Q Consensus 23 ~~~~~~~~~~~~~~~~~l~S~~g~F~lgFf~~~~~~~~~ylgIw~~~~~~~t~vW~Anr~~p~~~~~~~~~l~~~~~g-l 101 (714)
++|.+|++|.+ |++|++ |.|.|+|...++ |.++. ..++||+||++.| ....+.|.|..|| |
T Consensus 2 ~~L~~g~~L~~---g~~l~~--g~~~l~~q~dgn------Lvl~~----~~~~vW~ant~~~---~~~~~~l~l~~dGnL 63 (109)
T d1kj1a_ 2 NLLTNGEGLYA---GQSLDV--EPYHFIMQEDCN------LVLYD----HSTSVWASNTGIL---GKKGCKAVLQSDGNF 63 (109)
T ss_dssp CEEETTCEEET---TCEEEE--TTEEEEECTTSC------EEEEE----TTEEEEECCCCCT---TCCCCEEEECTTSCE
T ss_pred CCccCCCEEeC---CCEEEe--CCEEEEecCCCe------EEEEe----CCEEEEEeCCCCC---CceeEEEEEcCCceE
Confidence 56788999984 778864 889999976433 44543 3689999999987 3556789999999 9
Q ss_pred EEeCCCCCeEEecCCCcccccCCCCCcCCcceeccCceEEecCCCCCCCCCceEEEee-CCCeeee
Q 041576 102 LLKDPGGQAIWDEKPNKISFKSPTDTILPTQIFDLGSVLVSRLTETNLSKGRFELHFS-NGSLQLI 166 (714)
Q Consensus 102 vl~d~~~~~vWst~~~~qSFd~PtDTlLp~~~l~~~~~l~S~~s~~dps~G~~~~~~~-~~~~~~~ 166 (714)
||.|++|.+||+|+++ -..|.|.+.++ +|++++|
T Consensus 64 vl~~~~g~~vW~s~t~-------------------------------~~~~~~~l~L~ddGNlvly 98 (109)
T d1kj1a_ 64 VVYDAEGRSLWASHSV-------------------------------RGNGNYVLVLQEDGNVVIY 98 (109)
T ss_dssp EEECSSSCEEEECCCC-------------------------------CCSSCCEEEECTTSCEEEE
T ss_pred EEEeCCCcEEEEEeeE-------------------------------CCCCCEEEEEeCCCcEEEE
Confidence 9999999999996431 13477889987 8999886
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=99.12 E-value=2.6e-10 Score=96.47 Aligned_cols=94 Identities=20% Similarity=0.360 Sum_probs=74.4
Q ss_pred cccCCCCeeecCCCCCeEeeCCCeeeeeeecCCCCCCceEEEEEeecCCCCeeEEeeCCCCCCcccCCccEEEEcccc-e
Q 041576 23 ANIPLGSTLSSTSNNSSWISPSRDFAFGFRQLNNNSDLFLLAIWFNKMPERTIIWHANEDNHPVLAPRGSTLELTATG-L 101 (714)
Q Consensus 23 ~~~~~~~~~~~~~~~~~l~S~~g~F~lgFf~~~~~~~~~ylgIw~~~~~~~t~vW~Anr~~p~~~~~~~~~l~~~~~g-l 101 (714)
++|.+|++|. .|+.|. +|.|.|.|...++ |.||.. .++||.||++.| .....|.+..+| |
T Consensus 2 ~~L~~g~~L~---~G~~l~--ng~~~l~~q~DGN------Lvly~~----~~~vW~s~~~~~----~~~~~l~l~~~Gnl 62 (108)
T d1jpca_ 2 NILYSGETLS---TGEFLN--YGSFVFIMQEDCN------LVLYDV----DKPIWATNTGGL----SRSCFLSMQTDGNL 62 (108)
T ss_dssp CEEETTEEEC---TTCEEE--ETTEEEEECTTSC------EEEEET----TEEEEECCCTTS----CSSCEEEECTTSCE
T ss_pred CCccCCCEec---CCCEEE--cCCEEEEECCCCe------EEEEeC----CceeeEeCCCCC----CCccEEEEeccceE
Confidence 4667888887 477885 5999999998754 566653 688999999976 456689999999 9
Q ss_pred EEeCCCCCeEEecCCCcccccCCCCCcCCcceeccCceEEecCCCCCCCCCceEEEee-CCCeeee
Q 041576 102 LLKDPGGQAIWDEKPNKISFKSPTDTILPTQIFDLGSVLVSRLTETNLSKGRFELHFS-NGSLQLI 166 (714)
Q Consensus 102 vl~d~~~~~vWst~~~~qSFd~PtDTlLp~~~l~~~~~l~S~~s~~dps~G~~~~~~~-~~~~~~~ 166 (714)
||.|++|.+||+|+. .-+.+.|.+.++ +|++++|
T Consensus 63 vl~~~~g~~vWsS~t-------------------------------~~~~~~~~l~L~ddGNlVly 97 (108)
T d1jpca_ 63 VVYNPSNKPIWASNT-------------------------------GGQNGNYVCILQKDRNVVIY 97 (108)
T ss_dssp EEECTTCCEEEECCC-------------------------------CCSCSCEEEEECTTSCEEEE
T ss_pred EEECCCccceEEccc-------------------------------cCCCCcEEEEEcCCCCEEEe
Confidence 999999999999532 114578888888 8999987
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=99.07 E-value=1.8e-10 Score=98.43 Aligned_cols=75 Identities=19% Similarity=0.442 Sum_probs=58.9
Q ss_pred ccccCCCCeeecCCCCCeEeeCCCeeeeeeecCCCCCCceEEEEEeecCCCCeeEEeeCCCCCCcccCCccEEEEcccc-
Q 041576 22 AANIPLGSTLSSTSNNSSWISPSRDFAFGFRQLNNNSDLFLLAIWFNKMPERTIIWHANEDNHPVLAPRGSTLELTATG- 100 (714)
Q Consensus 22 ~~~~~~~~~~~~~~~~~~l~S~~g~F~lgFf~~~~~~~~~ylgIw~~~~~~~t~vW~Anr~~p~~~~~~~~~l~~~~~g- 100 (714)
+|+|.+|+.|.+ |++|+| |.|+|+|...++ |.|++ ..++||.||++.| ..+..|.|..||
T Consensus 1 tDtL~~gq~L~~---g~~l~~--g~~~l~~q~DGN------Lvly~----~~~~vW~s~~~~~----~~~~~l~l~~dGn 61 (112)
T d1xd5a_ 1 SDRLNSGHQLDT---GGSLAE--GGYLFIIQNDCN------LVLYD----NNRAVWASGTNGK----ASGCVLKMQNDGN 61 (112)
T ss_dssp CCEEETTEEECT---TCEEEE--TTEEEEECTTSC------EEEEE----TTEEEEECCCTTS----CSSEEEEECTTSC
T ss_pred CCEecCCCEecC---CCEEEE--CCEEEEEcCCCC------EEEEc----CCcEEEEccCccC----CCCcEEEEecccc
Confidence 478889999984 788975 899999987654 45544 3789999999986 456789999999
Q ss_pred eEEeCCCCCeEEecCC
Q 041576 101 LLLKDPGGQAIWDEKP 116 (714)
Q Consensus 101 lvl~d~~~~~vWst~~ 116 (714)
|||.|. +..+|+++.
T Consensus 62 Lvl~~~-~~~~w~s~t 76 (112)
T d1xd5a_ 62 LVIYSG-SRAIWASNT 76 (112)
T ss_dssp EEEEET-TEEEEECCC
T ss_pred EEEEec-CCeEEEEee
Confidence 999986 556777654
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=98.69 E-value=1.3e-07 Score=80.67 Aligned_cols=99 Identities=16% Similarity=0.344 Sum_probs=73.1
Q ss_pred CeeecCCCCCeE--eeCCCeeeeeeecCCCCCCceEEEEEeecCCCCeeEEeeCCCCCCcccCCccEEEEcccc-eEEeC
Q 041576 29 STLSSTSNNSSW--ISPSRDFAFGFRQLNNNSDLFLLAIWFNKMPERTIIWHANEDNHPVLAPRGSTLELTATG-LLLKD 105 (714)
Q Consensus 29 ~~~~~~~~~~~l--~S~~g~F~lgFf~~~~~~~~~ylgIw~~~~~~~t~vW~Anr~~p~~~~~~~~~l~~~~~g-lvl~d 105 (714)
++|.+ +++| .+..|.|.|.|-..++ |-+ |. ..++||.||+..+ .....|.+..+| |+|.|
T Consensus 15 ~~l~~---~q~l~~~~~~~~y~l~mQ~DGN------LVL-y~---~~~~vWssnt~~~----~~~~~l~l~~dGnLvL~d 77 (119)
T d1b2pa_ 15 QILHA---TESLEILFGTHVYRFIMQTDCN------LVL-YD---NNNPIWATNTGGL----GNGCRAVLQPDGVLVVIT 77 (119)
T ss_dssp CEEET---TCEEEEEETTEEEEEEECTTSC------EEE-EE---TTEEEEECCCTTS----CSSCEEEECTTSCEEEEC
T ss_pred CEEeC---CCeEEEecCCceEEEEECCCCc------EEE-EE---CCeEEEEecCCCC----CcceEEEEEeCCCEEEEC
Confidence 55553 3344 6678999999987654 333 53 3789999999875 456789999999 99999
Q ss_pred CCCCeEEecCCCcccccCCCCCcCCcceeccCceEEecCCCCCCCCCceEEEee-CCCeeeeeccCCCcCcccccccccc
Q 041576 106 PGGQAIWDEKPNKISFKSPTDTILPTQIFDLGSVLVSRLTETNLSKGRFELHFS-NGSLQLIPVAWPTPSQYKSYYTSNT 184 (714)
Q Consensus 106 ~~~~~vWst~~~~qSFd~PtDTlLp~~~l~~~~~l~S~~s~~dps~G~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 184 (714)
++|.+||++++ .-+.|.|.+.++ +|++++|- ...|.+++
T Consensus 78 ~~g~~vWsS~t-------------------------------~~~~~~~~l~Lq~DGNlvlYg---------~~~W~S~T 117 (119)
T d1b2pa_ 78 NENVTVWQSPV-------------------------------AGKAGHYVLVLQPDRNVVIYG---------DALWATQT 117 (119)
T ss_dssp TTCCEEEECSC-------------------------------CCCSSCEEEEECTTSCEEEEE---------SEEEECCC
T ss_pred CCCcEEEECCC-------------------------------cCCCCceEEEEcCCCCEEEEC---------CCEeccCC
Confidence 99999999542 114578889998 89998862 24577665
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=98.59 E-value=4.1e-08 Score=84.10 Aligned_cols=98 Identities=13% Similarity=0.222 Sum_probs=67.7
Q ss_pred EEeecCCCCeeEEeeCCCCCCcccCCccEEEEcccc-eEEeCCCCCeEEecCCCcccccCCCCCcCCcceecc--CceEE
Q 041576 65 IWFNKMPERTIIWHANEDNHPVLAPRGSTLELTATG-LLLKDPGGQAIWDEKPNKISFKSPTDTILPTQIFDL--GSVLV 141 (714)
Q Consensus 65 Iw~~~~~~~t~vW~Anr~~p~~~~~~~~~l~~~~~g-lvl~d~~~~~vWst~~~~qSFd~PtDTlLp~~~l~~--~~~l~ 141 (714)
|||.++++++.+|++|++.| +.....+|.+..|| |||.+. |.++|+++....+ ....=.|...=.|.. ...-+
T Consensus 12 il~~~~~~~~~~~~l~~~q~--l~~g~y~L~~q~DGNLvL~~~-~~~vW~s~t~~~~-~~~~~~l~~~GnLvl~d~~~~~ 87 (120)
T d1dlpa2 12 ILYSTQGNDNHPQTLHATQS--LQLSPYRLSMETDCNLVLFDR-DDRVWSTNTAGKG-TGCRAVLQPNGRMDVLTNQNIA 87 (120)
T ss_dssp ECCCC--CCCCCCEECSSCC--CBCSSCEEEEETTTEEEEEBT-TBCCSCCCCCSSC-SSCEEEEETTTEEEEEETTTEE
T ss_pred EEEcCCCCCCcccEEcCCCe--eEcCCEEEEEcCCCcEEEecC-CcEEEEEccccCC-CcEEEEEeCCeeEEEEcCCCCE
Confidence 99999999999999999998 34566789999999 999885 6789998754221 111111111111111 11123
Q ss_pred ecCCCCCCCCCceEEEee-CCCeeee
Q 041576 142 SRLTETNLSKGRFELHFS-NGSLQLI 166 (714)
Q Consensus 142 S~~s~~dps~G~~~~~~~-~~~~~~~ 166 (714)
=|.|.++.++|.|.+.++ +|++++|
T Consensus 88 lW~S~t~~~~~~~~l~Lq~DGnlvlY 113 (120)
T d1dlpa2 88 VWTSGNSRSAGRYVFVLQPDRNLAIY 113 (120)
T ss_dssp EEECCCCCSSSCCEEEECSSSCEEEE
T ss_pred EEEeCCCCCCCcEEEEECCCCcEEEe
Confidence 388999999999999998 8999987
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=98.55 E-value=8e-08 Score=81.42 Aligned_cols=91 Identities=20% Similarity=0.337 Sum_probs=67.9
Q ss_pred CCeEeeCCCeeeeeeecCCCCCCceEEEEEeecCCCCeeEEeeCCCCCCcccCCccEEEEcccc-eEEeCCCCCeEEecC
Q 041576 37 NSSWISPSRDFAFGFRQLNNNSDLFLLAIWFNKMPERTIIWHANEDNHPVLAPRGSTLELTATG-LLLKDPGGQAIWDEK 115 (714)
Q Consensus 37 ~~~l~S~~g~F~lgFf~~~~~~~~~ylgIw~~~~~~~t~vW~Anr~~p~~~~~~~~~l~~~~~g-lvl~d~~~~~vWst~ 115 (714)
++.| .+|.|.|.|...++ |.++. ..++||.+|...+ ..+.|.|.++| |||.|.+|.+||++
T Consensus 20 ~~~l--~~g~~~l~~q~DGN------LvL~~----~~~~vW~s~t~~~-----~~~~l~l~~dGNLvl~d~~~~~vWsS- 81 (115)
T d1dlpa1 20 AQSL--ELSSFRFTMQSDCN------LVLFD----SDVRVWASNTAGA-----TGCRAVLQSDGLLVILTAQNTIRWSS- 81 (115)
T ss_dssp TCEE--CSTTEEEEECTTSC------EEEEE----SSSEEECCCCCSC-----SCCBCCBCSSSCBCCBCTTTCCSCCC-
T ss_pred CCcE--EcCCEEEEECCCCe------EEEEc----CCeeEEEcccCCC-----CceEEEEeccCCEEEEccCCCEEEEc-
Confidence 4455 35779999887654 55643 2578999997653 45788999999 99999999999993
Q ss_pred CCcccccCCCCCcCCcceeccCceEEecCCCCCCCCCceEEEee-CCCeeeeeccCCCcCcccccccccc
Q 041576 116 PNKISFKSPTDTILPTQIFDLGSVLVSRLTETNLSKGRFELHFS-NGSLQLIPVAWPTPSQYKSYYTSNT 184 (714)
Q Consensus 116 ~~~qSFd~PtDTlLp~~~l~~~~~l~S~~s~~dps~G~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 184 (714)
+ ++.++|.|.+.++ +|++++|- ..+|.+++
T Consensus 82 -----~-------------------------t~~~~g~y~l~Lq~DGNlvlY~---------~~~Wssgt 112 (115)
T d1dlpa1 82 -----G-------------------------TKGSIGNYVLVLQPDRTVTIYG---------PGLWDSGT 112 (115)
T ss_dssp -----C-------------------------CCCCSSCCEEEECSSSCEEEEC---------SEEEECSC
T ss_pred -----C-------------------------CCCCCCCEEEEECCCCcEEEeC---------CCeecCCC
Confidence 2 2346899999998 89998761 25787765
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.29 E-value=1.1e-06 Score=86.24 Aligned_cols=131 Identities=16% Similarity=0.046 Sum_probs=96.1
Q ss_pred ccceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccC-cccccceeceEecCCeeeEEEeecCCCchhhhh
Q 041576 431 GSFGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTH-HKNLVQLLGFCDEGLNRLLVYEFMGNGTLANLL 509 (714)
Q Consensus 431 G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~E~~~~gsL~~~l 509 (714)
++.+.||+... +++.+++|+...........+.+|...+..+. +--+.+++.+..+++..++|||++++.++.+..
T Consensus 25 ~s~~~v~rv~~---~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~ 101 (263)
T d1j7la_ 25 MSPAKVYKLVG---ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEY 101 (263)
T ss_dssp CSSSEEEEEEC---SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHT
T ss_pred CCCCcEEEEEe---CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEecccccccccc
Confidence 34468998653 46778899887655444556778888877763 444678888888888999999999998886654
Q ss_pred hcCCCCChhhHHHHHHHHHHHHHHHHhcC---------------------------------------------------
Q 041576 510 FAIPRPDWSLRVRISLEIARGLLYLHEEC--------------------------------------------------- 538 (714)
Q Consensus 510 ~~~~~~~~~~~~~i~~qi~~~L~yLH~~~--------------------------------------------------- 538 (714)
.. ......++.++++.++.||+..
T Consensus 102 ~~-----~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 176 (263)
T d1j7la_ 102 ED-----EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKT 176 (263)
T ss_dssp TT-----CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHH
T ss_pred cc-----cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHHh
Confidence 32 2234456677777777777521
Q ss_pred -----CCCeEecCCCcCeEEECCCCceEEecCCCcc
Q 041576 539 -----NVPIIHCDIKPQNILLDQDFTAKISDFGLSK 569 (714)
Q Consensus 539 -----~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~ 569 (714)
...++|+|+.|.||++++++..-|+||+.+.
T Consensus 177 ~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 177 EKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp SCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred cCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 1127999999999999987777899999875
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.87 E-value=3.6e-05 Score=74.65 Aligned_cols=129 Identities=16% Similarity=0.092 Sum_probs=85.0
Q ss_pred hCccc-ceeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccC--cccccceeceEecCCeeeEEEeecCCCc
Q 041576 428 LGRGS-FGIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTH--HKNLVQLLGFCDEGLNRLLVYEFMGNGT 504 (714)
Q Consensus 428 ig~G~-~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--h~nIv~l~~~~~~~~~~~lv~E~~~~gs 504 (714)
+..|. .+.||+...+ .+..+++|....... ..+..|.+.++.+. .-.+.+++.+..+++..++|||++++.+
T Consensus 18 ~~~G~s~~~v~r~~~~--~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~ 92 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQ--GRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQD 92 (255)
T ss_dssp CSCTTSSCEEEEEECT--TSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEE
T ss_pred cCCcccCCeEEEEEeC--CCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccc
Confidence 44444 3678987653 566788898754332 24567777777663 3336778888888889999999999876
Q ss_pred hhhhhhcCCCCChhhHHHHHHHHHHHHHHHHh------------------------------------------------
Q 041576 505 LANLLFAIPRPDWSLRVRISLEIARGLLYLHE------------------------------------------------ 536 (714)
Q Consensus 505 L~~~l~~~~~~~~~~~~~i~~qi~~~L~yLH~------------------------------------------------ 536 (714)
+.+... ....++.++++.|+-||+
T Consensus 93 ~~~~~~--------~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (255)
T d1nd4a_ 93 LLSSHL--------APAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFAR 164 (255)
T ss_dssp TTTSCC--------CHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHH
T ss_pred cccccc--------cHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHH
Confidence 644210 011223344444444442
Q ss_pred ---cC----CCCeEecCCCcCeEEECCCCceEEecCCCcc
Q 041576 537 ---EC----NVPIIHCDIKPQNILLDQDFTAKISDFGLSK 569 (714)
Q Consensus 537 ---~~----~~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~ 569 (714)
.. ...++|+|+.|.||+++++..+-|+||+.+.
T Consensus 165 l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 165 LKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 11 1237999999999999988777899999875
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=97.77 E-value=1.2e-05 Score=67.62 Aligned_cols=99 Identities=18% Similarity=0.194 Sum_probs=66.9
Q ss_pred EEeecCCCCeeEEeeCCCCCCcccCCccEEEEcccc-eEEeCCCCCeEEecCCCcccccCCCCCcCCcceeccCceEEec
Q 041576 65 IWFNKMPERTIIWHANEDNHPVLAPRGSTLELTATG-LLLKDPGGQAIWDEKPNKISFKSPTDTILPTQIFDLGSVLVSR 143 (714)
Q Consensus 65 Iw~~~~~~~t~vW~Anr~~p~~~~~~~~~l~~~~~g-lvl~d~~~~~vWst~~~~qSFd~PtDTlLp~~~l~~~~~l~S~ 143 (714)
|||.-.++.+..|+.+.+.+ +.....+|.+..|| |||.+ ++.++|+++..
T Consensus 3 ~~~~~~~~~~~~~tl~~~~~--l~~g~~~l~~q~DGNLvL~~-~~~~vW~s~t~-------------------------- 53 (115)
T d1dlpa1 3 ILFGLSHEGSHPQTLHAAQS--LELSSFRFTMQSDCNLVLFD-SDVRVWASNTA-------------------------- 53 (115)
T ss_dssp CCBCSSSSSCSCSCCCTTCE--ECSTTEEEEECTTSCEEEEE-SSSEEECCCCC--------------------------
T ss_pred EEEecCCCCCCcceecCCCc--EEcCCEEEEECCCCeEEEEc-CCeeEEEcccC--------------------------
Confidence 78887788889999999997 45666799999999 99987 57899996431
Q ss_pred CCCCCCCCCceEEEee-CCCeeeeeccCCCcCcccccccccccccCCCcceeeEEEEeeeeeccceEEEE
Q 041576 144 LTETNLSKGRFELHFS-NGSLQLIPVAWPTPSQYKSYYTSNTCSANSSESGINYLLFRATLDFDGVFTEY 212 (714)
Q Consensus 144 ~s~~dps~G~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~G~~~~~ 212 (714)
..+...+.++ +|+++++- ..+ ...|.+.... .... ..++++.||++++|
T Consensus 54 ------~~~~~~l~l~~dGNLvl~d--~~~----~~vWsS~t~~-----~~g~---y~l~Lq~DGNlvlY 103 (115)
T d1dlpa1 54 ------GATGCRAVLQSDGLLVILT--AQN----TIRWSSGTKG-----SIGN---YVLVLQPDRTVTIY 103 (115)
T ss_dssp ------SCSCCBCCBCSSSCBCCBC--TTT----CCSCCCCCCC-----CSSC---CEEEECSSSCEEEE
T ss_pred ------CCCceEEEEeccCCEEEEc--cCC----CEEEEcCCCC-----CCCC---EEEEECCCCcEEEe
Confidence 1122345555 78877652 221 3456554321 1111 14678999999988
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.74 E-value=5.4e-05 Score=78.68 Aligned_cols=76 Identities=18% Similarity=0.174 Sum_probs=47.2
Q ss_pred hhhCcccceeEEEeEeeCCCCcEEEEEEecccc-------hhhHHHHHHHHHHHhcc-Cc--ccccceeceEecCCeeeE
Q 041576 426 EELGRGSFGIVYKGVLKSASGNAVAVKKLDKLA-------QEREREFKTEVSAIGRT-HH--KNLVQLLGFCDEGLNRLL 495 (714)
Q Consensus 426 ~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~E~~~l~~l-~h--~nIv~l~~~~~~~~~~~l 495 (714)
+.||.|....||+.... .+++.++||.-.... .....+...|.+.|+.+ .+ ..+.+++.+ ++...++
T Consensus 32 ~eig~G~~N~vfrV~~~-~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQ-EHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EECCSSSSEEEEEEEC-----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEeCCCceEeEEEEEeC-CCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 56899999999998765 356789999754211 11123345677777765 22 335555544 4456689
Q ss_pred EEeecCCCc
Q 041576 496 VYEFMGNGT 504 (714)
Q Consensus 496 v~E~~~~gs 504 (714)
|||++++..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999998754
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=97.70 E-value=3.8e-05 Score=64.43 Aligned_cols=34 Identities=21% Similarity=0.346 Sum_probs=31.2
Q ss_pred CCCcCCcceeccCceEEecCCCCCCCCCceEEEee-CCCeeeee
Q 041576 125 TDTILPTQIFDLGSVLVSRLTETNLSKGRFELHFS-NGSLQLIP 167 (714)
Q Consensus 125 tDTlLp~~~l~~~~~l~S~~s~~dps~G~~~~~~~-~~~~~~~~ 167 (714)
||||+|||.|..+..|++ |.|+|.++ +|+++++.
T Consensus 1 tDtL~~gq~L~~g~~l~~---------g~~~l~~q~DGNLvly~ 35 (112)
T d1xd5a_ 1 SDRLNSGHQLDTGGSLAE---------GGYLFIIQNDCNLVLYD 35 (112)
T ss_dssp CCEEETTEEECTTCEEEE---------TTEEEEECTTSCEEEEE
T ss_pred CCEecCCCEecCCCEEEE---------CCEEEEEcCCCCEEEEc
Confidence 899999999999999976 99999999 89998863
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=97.67 E-value=1.9e-05 Score=66.98 Aligned_cols=48 Identities=17% Similarity=0.351 Sum_probs=36.5
Q ss_pred c-eEEeCCCCCeEEecCCCcccccCCCCCcCCcceeccCceEEecCCCCCCCCCceEEEee-CCCeeee
Q 041576 100 G-LLLKDPGGQAIWDEKPNKISFKSPTDTILPTQIFDLGSVLVSRLTETNLSKGRFELHFS-NGSLQLI 166 (714)
Q Consensus 100 g-lvl~d~~~~~vWst~~~~qSFd~PtDTlLp~~~l~~~~~l~S~~s~~dps~G~~~~~~~-~~~~~~~ 166 (714)
| +|+.+..+.++|++ +|+|.|++||.++|.|. .|.|+|.++ +|+++++
T Consensus 1 g~~v~~~~~n~il~~~----~~~~~~~~~l~~~q~l~---------------~g~y~L~~q~DGNLvL~ 50 (120)
T d1dlpa2 1 GSVVVANNGNSILYST----QGNDNHPQTLHATQSLQ---------------LSPYRLSMETDCNLVLF 50 (120)
T ss_dssp SCCCCSSCCCEECCCC------CCCCCCEECSSCCCB---------------CSSCEEEEETTTEEEEE
T ss_pred CcEEEEeCCCeEEEcC----CCCCCcccEEcCCCeeE---------------cCCEEEEEcCCCcEEEe
Confidence 5 77778777888874 48999999999999984 466777777 7777665
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=97.09 E-value=0.00032 Score=58.99 Aligned_cols=38 Identities=11% Similarity=0.157 Sum_probs=32.1
Q ss_pred cccccCCCCCcCCcceeccCceEEecCCCCCCCCCceEEEee-CCCeeee
Q 041576 118 KISFKSPTDTILPTQIFDLGSVLVSRLTETNLSKGRFELHFS-NGSLQLI 166 (714)
Q Consensus 118 ~qSFd~PtDTlLp~~~l~~~~~l~S~~s~~dps~G~~~~~~~-~~~~~~~ 166 (714)
||++|.|.+||-++|.|..+ .+.|+|+|.|+ +|+++++
T Consensus 7 ~~~~~~~~~~l~~~q~l~~~-----------~~~~~y~l~mQ~DGNLVLy 45 (119)
T d1b2pa_ 7 KQPDDNHPQILHATESLEIL-----------FGTHVYRFIMQTDCNLVLY 45 (119)
T ss_dssp SCSSSCCCCEEETTCEEEEE-----------ETTEEEEEEECTTSCEEEE
T ss_pred eecCCCCCCEEeCCCeEEEe-----------cCCceEEEEECCCCcEEEE
Confidence 68999999999999998422 25799999999 8999885
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=96.75 E-value=0.0011 Score=54.57 Aligned_cols=32 Identities=19% Similarity=0.343 Sum_probs=29.0
Q ss_pred CCcCCcceeccCceEEecCCCCCCCCCceEEEee-CCCeeee
Q 041576 126 DTILPTQIFDLGSVLVSRLTETNLSKGRFELHFS-NGSLQLI 166 (714)
Q Consensus 126 DTlLp~~~l~~~~~l~S~~s~~dps~G~~~~~~~-~~~~~~~ 166 (714)
|||+|||.|..+..|.+ |+|+|.|+ +|+++++
T Consensus 2 ~~L~~g~~L~~G~~l~n---------g~~~l~~q~DGNLvly 34 (108)
T d1jpca_ 2 NILYSGETLSTGEFLNY---------GSFVFIMQEDCNLVLY 34 (108)
T ss_dssp CEEETTEEECTTCEEEE---------TTEEEEECTTSCEEEE
T ss_pred CCccCCCEecCCCEEEc---------CCEEEEECCCCeEEEE
Confidence 89999999999998853 99999999 8999886
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.67 E-value=0.0029 Score=63.30 Aligned_cols=132 Identities=13% Similarity=0.081 Sum_probs=75.6
Q ss_pred eeEEEeEeeCCCCcEEEEEEecccchhhHHHHHHHHHHHhccCcccc--cceec-----eEecCCeeeEEEeecCCCchh
Q 041576 434 GIVYKGVLKSASGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNL--VQLLG-----FCDEGLNRLLVYEFMGNGTLA 506 (714)
Q Consensus 434 g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nI--v~l~~-----~~~~~~~~~lv~E~~~~gsL~ 506 (714)
-.||++..+ +|+.+++|..+.. ....+++..|...+..|....| +..+. ....+...+.++++++|..+.
T Consensus 36 N~vy~v~~~--dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~ 112 (325)
T d1zyla1 36 NRVYQFQDE--DRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFE 112 (325)
T ss_dssp SEEEEECCT--TCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECC
T ss_pred ceeEEEEcC--CCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCC
Confidence 479998764 6889999998653 2345667788888877743222 11111 223455678899998875432
Q ss_pred h-----h------h---h----cC-----CCCC-------------------hhhHHHHHHHHHHHHHHHHhc----CCC
Q 041576 507 N-----L------L---F----AI-----PRPD-------------------WSLRVRISLEIARGLLYLHEE----CNV 540 (714)
Q Consensus 507 ~-----~------l---~----~~-----~~~~-------------------~~~~~~i~~qi~~~L~yLH~~----~~~ 540 (714)
. + + + .. ...+ ......+...+.+.++.+... ...
T Consensus 113 ~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~ 192 (325)
T d1zyla1 113 ADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTV 192 (325)
T ss_dssp SSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCC
T ss_pred CCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCc
Confidence 1 0 0 0 00 1111 111112222233333333332 234
Q ss_pred CeEecCCCcCeEEECCCCceEEecCCCccc
Q 041576 541 PIIHCDIKPQNILLDQDFTAKISDFGLSKL 570 (714)
Q Consensus 541 ~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~~ 570 (714)
.++|+|+.+.|||++++ ..++||+-+..
T Consensus 193 ~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 193 LRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp EECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred eeecCCCCcccEEEeCC--ceEEechhccc
Confidence 58999999999999754 45899998763
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=96.50 E-value=0.0017 Score=53.50 Aligned_cols=33 Identities=12% Similarity=0.134 Sum_probs=29.2
Q ss_pred CCcCCcceeccCceEEecCCCCCCCCCceEEEee-CCCeeeee
Q 041576 126 DTILPTQIFDLGSVLVSRLTETNLSKGRFELHFS-NGSLQLIP 167 (714)
Q Consensus 126 DTlLp~~~l~~~~~l~S~~s~~dps~G~~~~~~~-~~~~~~~~ 167 (714)
|||.|||.|..+..|++ |.|+|.|+ +|+++++.
T Consensus 2 ~~L~~g~~L~~g~~l~~---------g~~~l~~q~dgnLvl~~ 35 (109)
T d1kj1a_ 2 NLLTNGEGLYAGQSLDV---------EPYHFIMQEDCNLVLYD 35 (109)
T ss_dssp CEEETTCEEETTCEEEE---------TTEEEEECTTSCEEEEE
T ss_pred CCccCCCEEeCCCEEEe---------CCEEEEecCCCeEEEEe
Confidence 89999999999998865 99999999 89988763
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.50 E-value=0.0044 Score=63.72 Aligned_cols=75 Identities=16% Similarity=0.205 Sum_probs=49.6
Q ss_pred hhhCcccceeEEEeEeeCC------CCcEEEEEEecccchhhHHHHHHHHHHHhccCcccc-cceeceEecCCeeeEEEe
Q 041576 426 EELGRGSFGIVYKGVLKSA------SGNAVAVKKLDKLAQEREREFKTEVSAIGRTHHKNL-VQLLGFCDEGLNRLLVYE 498 (714)
Q Consensus 426 ~~ig~G~~g~Vy~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~l~~~~~~~~~~~lv~E 498 (714)
+.|+.|-.-.+|+...... ..+.|++++... ........+|..+++.+.-.++ .++++++.+ .+|+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~--~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN--PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS--CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC--cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence 5688888899999876531 234677766642 2223456688888888843344 467777654 58999
Q ss_pred ecCCCchh
Q 041576 499 FMGNGTLA 506 (714)
Q Consensus 499 ~~~~gsL~ 506 (714)
|+++.+|.
T Consensus 122 fi~g~~l~ 129 (395)
T d1nw1a_ 122 YIPSRPLS 129 (395)
T ss_dssp CCCEEECC
T ss_pred EeccccCC
Confidence 99876543
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=94.85 E-value=0.073 Score=52.09 Aligned_cols=30 Identities=23% Similarity=0.350 Sum_probs=26.9
Q ss_pred CCeEecCCCcCeEEECCCCceEEecCCCcc
Q 041576 540 VPIIHCDIKPQNILLDQDFTAKISDFGLSK 569 (714)
Q Consensus 540 ~~ivH~Dlk~~NIll~~~~~~kl~Dfg~~~ 569 (714)
.++||+|+.++||+++.+...-|.||+.+.
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccccCCcchhhhhcccccceeEecccccc
Confidence 359999999999999998878899999885
|
| >d1emoa2 g.3.11.1 (A:2167-2205) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=93.86 E-value=0.014 Score=35.72 Aligned_cols=32 Identities=25% Similarity=0.463 Sum_probs=25.1
Q ss_pred ccccccccCCCcCccCCCcccccCCCCCcccCCCCCccc
Q 041576 233 NICTSISDEFGSGACGFNSYCLLQNGRPFCECPPEYLFV 271 (714)
Q Consensus 233 d~Cd~y~~~~~~~~CG~~g~C~~~~~~~~C~C~~gf~~~ 271 (714)
|.|.+- ..|| ||-|++--..-.|.|-+||+|.
T Consensus 2 dECsig------npCG-nGTCtNviGgFec~C~~GFepg 33 (39)
T d1emoa2 2 DECSVG------NPCG-NGTCKNVIGGFECTCEEGFEPG 33 (39)
T ss_dssp CGGGTT------CSSS-SSCEEECSSSEEECCSSSSCCC
T ss_pred CccccC------CccC-CceeeecccceEEeecCCcCCC
Confidence 678883 7888 6889865456689999999974
|
| >d1lmja2 g.3.11.1 (A:47-88) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=93.37 E-value=0.0089 Score=39.45 Aligned_cols=33 Identities=27% Similarity=0.584 Sum_probs=26.4
Q ss_pred ccccccccCCCcCccCCCcccccCCCCCcccCCCCCccc
Q 041576 233 NICTSISDEFGSGACGFNSYCLLQNGRPFCECPPEYLFV 271 (714)
Q Consensus 233 d~Cd~y~~~~~~~~CG~~g~C~~~~~~~~C~C~~gf~~~ 271 (714)
|+|... +..|. ++.|.++.++..|.|.+||++.
T Consensus 3 dEC~~~-----~~~C~-~~~C~Nt~Gsy~C~C~~Gy~l~ 35 (42)
T d1lmja2 3 DECQRD-----PLLCR-GGVCHNTEGSYRCECPPGHQLS 35 (42)
T ss_dssp CHHHHC-----SSTTT-TSEEEEETTEEEEESCTTSCCC
T ss_pred cccCCC-----CCCCC-CCEeECCCCCeEEeCCCCCeEC
Confidence 567654 57885 7899987778899999999864
|
| >d2vj3a1 g.3.11.1 (A:411-452) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=93.01 E-value=0.015 Score=38.33 Aligned_cols=32 Identities=22% Similarity=0.534 Sum_probs=26.3
Q ss_pred ccccccccCCCcCccCCCcccccCCCCCcccCCCCCc
Q 041576 233 NICTSISDEFGSGACGFNSYCLLQNGRPFCECPPEYL 269 (714)
Q Consensus 233 d~Cd~y~~~~~~~~CG~~g~C~~~~~~~~C~C~~gf~ 269 (714)
|.|... +..|..+|.|.+...+..|.|++||+
T Consensus 4 deC~~~-----~~pC~n~g~C~n~~g~y~C~C~~G~~ 35 (42)
T d2vj3a1 4 DECSLG-----ANPCEHAGKCINTLGSFECQCLQGYT 35 (42)
T ss_dssp CTTTSS-----SCSSSTTCEEEECSSSEEEECCTTEE
T ss_pred ccccCC-----CCCCCCCcEeECCCCCEEeECCCCCc
Confidence 567653 46899999998776678999999997
|
| >d1emoa1 g.3.11.1 (A:2124-2166) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=92.88 E-value=0.03 Score=37.00 Aligned_cols=32 Identities=25% Similarity=0.600 Sum_probs=26.1
Q ss_pred cccccccccCCCcCccCCCcccccCCCCCcccCCCCCcc
Q 041576 232 NNICTSISDEFGSGACGFNSYCLLQNGRPFCECPPEYLF 270 (714)
Q Consensus 232 ~d~Cd~y~~~~~~~~CG~~g~C~~~~~~~~C~C~~gf~~ 270 (714)
.|+|.. ..|+.++.|.++.++..|.|++||+.
T Consensus 5 idEC~~-------~~~~~~~~C~Nt~Gsy~C~C~~Gy~~ 36 (43)
T d1emoa1 5 MDECKE-------PDVCKHGQCINTDGSYRCECPFGYIL 36 (43)
T ss_dssp CCSSSS-------TTSCSSSCCCCCSSCCCCCCCTTEEE
T ss_pred eeccCC-------cCCCCCCEeECCCCCeEeECCCCccc
Confidence 367876 45667899998777899999999985
|
| >d1xkba1 g.3.11.1 (A:48-86) Factor X, N-terminal module {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Factor X, N-terminal module species: Human (Homo sapiens) [TaxId: 9606]
Probab=91.48 E-value=0.042 Score=35.35 Aligned_cols=25 Identities=20% Similarity=0.425 Sum_probs=21.9
Q ss_pred CccCCCcccccCCCCCcccCCCCCc
Q 041576 245 GACGFNSYCLLQNGRPFCECPPEYL 269 (714)
Q Consensus 245 ~~CG~~g~C~~~~~~~~C~C~~gf~ 269 (714)
..|...|.|........|.|++||+
T Consensus 6 ~PC~ngg~C~~~~~~y~C~C~~G~~ 30 (39)
T d1xkba1 6 SPCQNQGKCKDGLGEYTCTCLEGFE 30 (39)
T ss_dssp CCCCSSCEECCCSSSCCEECCTTEE
T ss_pred CCCCCCcEEECCCCCEEEECCCCCC
Confidence 6899999998766678999999997
|
| >d1uzka2 g.3.11.1 (A:1605-1647) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=91.09 E-value=0.031 Score=36.96 Aligned_cols=34 Identities=26% Similarity=0.763 Sum_probs=26.7
Q ss_pred ccccccccCCCcCccCCCcccccCCCCCcccCCCCCcccC
Q 041576 233 NICTSISDEFGSGACGFNSYCLLQNGRPFCECPPEYLFVD 272 (714)
Q Consensus 233 d~Cd~y~~~~~~~~CG~~g~C~~~~~~~~C~C~~gf~~~~ 272 (714)
|+|... ++.|. ++.|.++.++..|.|.+||.+..
T Consensus 4 nEC~~~-----~~~c~-~~~C~Nt~Gsy~C~C~~Gy~l~~ 37 (43)
T d1uzka2 4 DECQEL-----PGLCQ-GGKCINTFGSFQCRCPTGYYLNE 37 (43)
T ss_dssp CHHHHC-----GGGGB-TSEEEECSSCEEEECCTTCCBCT
T ss_pred ccccCC-----CCCcC-CCEEECCCCCeEeECCCCCeECc
Confidence 567664 56785 78999877789999999998643
|
| >d2vj3a2 g.3.11.1 (A:453-491) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=90.43 E-value=0.04 Score=35.48 Aligned_cols=30 Identities=40% Similarity=0.733 Sum_probs=25.0
Q ss_pred ccccccccCCCcCccCCCcccccCCCCCcccCCCCCc
Q 041576 233 NICTSISDEFGSGACGFNSYCLLQNGRPFCECPPEYL 269 (714)
Q Consensus 233 d~Cd~y~~~~~~~~CG~~g~C~~~~~~~~C~C~~gf~ 269 (714)
|.|.. ..|...|.|.....+..|.|++||+
T Consensus 2 d~C~~-------~PC~n~g~C~~~~~~y~C~C~~G~~ 31 (39)
T d2vj3a2 2 NECVS-------NPCQNDATCLDQIGEFQCICMPGYE 31 (39)
T ss_dssp CTTTT-------CCCCSSCEEEECSSCEEEECCTTEE
T ss_pred cCCcC-------CCCCCCCEEECCCCCEEEeCCCCCc
Confidence 56766 6899999998766678999999996
|
| >d1lmja1 g.3.11.1 (A:3-46) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=89.38 E-value=0.065 Score=35.42 Aligned_cols=32 Identities=25% Similarity=0.584 Sum_probs=25.4
Q ss_pred ccccccccCCCcCccCCCcccccCCCCCcccCCCCCcc
Q 041576 233 NICTSISDEFGSGACGFNSYCLLQNGRPFCECPPEYLF 270 (714)
Q Consensus 233 d~Cd~y~~~~~~~~CG~~g~C~~~~~~~~C~C~~gf~~ 270 (714)
|+|..- +..|. ++.|.++.++..|.|++||+.
T Consensus 4 dEC~~~-----~~~C~-~~~C~Nt~Gsy~C~C~~Gy~~ 35 (44)
T d1lmja1 4 DECRIS-----PDLCG-RGQCVNTPGDFECKCDEGYES 35 (44)
T ss_dssp CTTTTC-----SSTTT-TSCEEEETTEEEECCCSSEEE
T ss_pred cccCCC-----CCCCC-CCEeEcCCCCeEEeCCCCCcc
Confidence 678663 45675 789998777889999999985
|
| >d1edmb_ g.3.11.1 (B:) Factor IX (IXa) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Factor IX (IXa) species: Human (Homo sapiens) [TaxId: 9606]
Probab=89.19 E-value=0.047 Score=35.13 Aligned_cols=31 Identities=23% Similarity=0.416 Sum_probs=26.1
Q ss_pred cccccccccCCCcCccCCCcccccCCCCCcccCCCCCc
Q 041576 232 NNICTSISDEFGSGACGFNSYCLLQNGRPFCECPPEYL 269 (714)
Q Consensus 232 ~d~Cd~y~~~~~~~~CG~~g~C~~~~~~~~C~C~~gf~ 269 (714)
.|.|.. ..|...|.|........|.|++||+
T Consensus 3 ~d~C~~-------~PC~ngg~C~~~~~~y~C~C~~g~~ 33 (39)
T d1edmb_ 3 GDQCES-------NPCLNGGSCKDDINSYECWCPFGFE 33 (39)
T ss_dssp CCTTTT-------CCCCTTCEEEEETTEEEEECCTTCC
T ss_pred cccCCC-------CCCCCCcEEEcCCCCEEEECCCCCC
Confidence 367877 6899999998766678999999996
|
| >d2vj3a3 g.3.11.1 (A:492-526) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=88.34 E-value=0.072 Score=33.31 Aligned_cols=25 Identities=32% Similarity=0.693 Sum_probs=21.6
Q ss_pred CccCCCcccccCCCCCcccCCCCCc
Q 041576 245 GACGFNSYCLLQNGRPFCECPPEYL 269 (714)
Q Consensus 245 ~~CG~~g~C~~~~~~~~C~C~~gf~ 269 (714)
..|...|.|........|.|++||+
T Consensus 6 ~PC~ngg~C~~~~~~y~C~C~~g~~ 30 (35)
T d2vj3a3 6 SPCLHNGRCLDKINEFQCECPTGFT 30 (35)
T ss_dssp CCSTTTCEEEECSSCEEEECCTTEE
T ss_pred CCCCCCcEEECCCCCeEEECCCCCC
Confidence 6899999998665578999999996
|
| >d1uzka1 g.3.11.1 (A:1486-1528) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=87.99 E-value=0.064 Score=35.34 Aligned_cols=32 Identities=28% Similarity=0.869 Sum_probs=24.5
Q ss_pred ccccccccCCCcCccCCCcccccCCCCCcccCCCCCccc
Q 041576 233 NICTSISDEFGSGACGFNSYCLLQNGRPFCECPPEYLFV 271 (714)
Q Consensus 233 d~Cd~y~~~~~~~~CG~~g~C~~~~~~~~C~C~~gf~~~ 271 (714)
|+|.. +..| -.+.|.++..+..|.|++||++.
T Consensus 4 dEC~~------~~~~-c~~~C~Nt~G~y~C~C~~Gy~l~ 35 (43)
T d1uzka1 4 NECLD------PTTC-ISGNCVNTPGSYICDCPPDFELN 35 (43)
T ss_dssp CGGGS------TTSS-BTSEEEEETTEEEEECCTTCEEC
T ss_pred cccCC------CCcC-cCCEeECCCCCEEEecCCCCEEC
Confidence 67876 2333 57899977778899999999864
|
| >d1gl4a2 g.3.11.5 (A:359-398) EGF-like domain of nidogen-1 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-like domain of nidogen-1 domain: EGF-like domain of nidogen-1 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=87.15 E-value=0.042 Score=35.55 Aligned_cols=26 Identities=19% Similarity=0.459 Sum_probs=22.7
Q ss_pred cCccCCCcccccCCCCCcccCCCCCc
Q 041576 244 SGACGFNSYCLLQNGRPFCECPPEYL 269 (714)
Q Consensus 244 ~~~CG~~g~C~~~~~~~~C~C~~gf~ 269 (714)
...|.+++.|.++..+..|.|.+||.
T Consensus 6 ~~~C~~~A~C~Nt~Gsy~C~C~~Gy~ 31 (40)
T d1gl4a2 6 RHQCSVHAECRDYATGFCCRCVANYT 31 (40)
T ss_dssp GGGSCTTEEEEECSSCEEEEECTTEE
T ss_pred CCCCCCCCEeecCCCCeEeECCCCCc
Confidence 35799999999877788999999997
|
| >d1i0ua2 g.3.11.1 (A:42-82) Low density lipoprotein (LDL) receptor, different EGF domains {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Low density lipoprotein (LDL) receptor, different EGF domains species: Human (Homo sapiens) [TaxId: 9606]
Probab=87.08 E-value=0.16 Score=32.93 Aligned_cols=31 Identities=19% Similarity=0.640 Sum_probs=23.5
Q ss_pred ccccccccCCCcCccCCCcccccCCCCCcccCCCCCccc
Q 041576 233 NICTSISDEFGSGACGFNSYCLLQNGRPFCECPPEYLFV 271 (714)
Q Consensus 233 d~Cd~y~~~~~~~~CG~~g~C~~~~~~~~C~C~~gf~~~ 271 (714)
|+|.. ++.| ...|.++.++..|.|++||++.
T Consensus 2 dEC~~------~~~C--~~~C~n~~Gsy~C~C~~Gy~L~ 32 (41)
T d1i0ua2 2 DECQD------PDTC--SQLCVNLEGGYKCQCEEGFQLD 32 (41)
T ss_dssp CTTTT------TTSC--SSCEECSSSCCEECCCTTEEEC
T ss_pred ccCCC------CCCC--CCEeECCCCCEEeECCCCCeEC
Confidence 56654 3566 4589877778899999999864
|
| >d2c4fl1 g.3.11.1 (L:46-82) Factor IX (IXa) {Pig (Sus scrofa) [TaxId: 9823]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Factor IX (IXa) species: Pig (Sus scrofa) [TaxId: 9823]
Probab=86.62 E-value=0.07 Score=33.84 Aligned_cols=30 Identities=27% Similarity=0.557 Sum_probs=25.2
Q ss_pred ccccccccCCCcCccCCCcccccCCCCCcccCCCCCc
Q 041576 233 NICTSISDEFGSGACGFNSYCLLQNGRPFCECPPEYL 269 (714)
Q Consensus 233 d~Cd~y~~~~~~~~CG~~g~C~~~~~~~~C~C~~gf~ 269 (714)
|.|.. ..|...|.|........|.|++||+
T Consensus 3 d~C~~-------~PC~ngg~C~~~~~~y~C~C~~g~~ 32 (37)
T d2c4fl1 3 DQCAS-------SPCQNGGSCKDQLQSYICFCLPAFE 32 (37)
T ss_dssp CGGGG-------CCCCTTCEEEEETTEEEEECCTTEE
T ss_pred ccCCC-------CCCCCCCEEECCCCCeEEECCCCCc
Confidence 66776 7899999998665678999999996
|
| >d1autl1 g.3.11.1 (L:49-96) Activated protein c (autoprothrombin IIa) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Activated protein c (autoprothrombin IIa) species: Human (Homo sapiens) [TaxId: 9606]
Probab=84.95 E-value=0.16 Score=34.14 Aligned_cols=31 Identities=26% Similarity=0.618 Sum_probs=25.7
Q ss_pred CcccccccccCCCcCccCCCcccccCCCCCcccCCCCCc
Q 041576 231 PNNICTSISDEFGSGACGFNSYCLLQNGRPFCECPPEYL 269 (714)
Q Consensus 231 p~d~Cd~y~~~~~~~~CG~~g~C~~~~~~~~C~C~~gf~ 269 (714)
+.+.|+. ..|+ ||.|.....+..|.|++||+
T Consensus 7 ~~~~C~~-------~PC~-nG~C~~~~~~y~C~C~~G~~ 37 (48)
T d1autl1 7 LEHPCAS-------LCCG-HGTCIDGIGSFSCDCRSGWE 37 (48)
T ss_dssp SCCSSSS-------TTTT-SEEECCCSSCCCEEECTTEE
T ss_pred CCCcccC-------CCCC-CCEEECCCCCCeEeCCCCCc
Confidence 5678988 6897 59998766678999999996
|
| >d1nt0a3 g.3.11.1 (A:120-164) Mannose-binding protein associated serine protease 2, MASP2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Mannose-binding protein associated serine protease 2, MASP2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=84.12 E-value=0.096 Score=34.81 Aligned_cols=26 Identities=23% Similarity=0.617 Sum_probs=20.0
Q ss_pred cCCCcccccCCCCCcccCCCCCcccC
Q 041576 247 CGFNSYCLLQNGRPFCECPPEYLFVD 272 (714)
Q Consensus 247 CG~~g~C~~~~~~~~C~C~~gf~~~~ 272 (714)
++-...|.++..+..|.|++||.+..
T Consensus 12 ~~C~~~C~Nt~gsy~C~C~~Gy~L~~ 37 (45)
T d1nt0a3 12 VPCDHYCHNYLGGYYCSCRVGYILHQ 37 (45)
T ss_dssp -CCSSEEEEETTEEEEECCTTEEECT
T ss_pred CCCCCEeecCCCCEEEeCCCCCEECC
Confidence 34467898777788999999998643
|
| >d1g1ta2 g.3.11.1 (A:119-157) E-selectin, EGF-domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: E-selectin, EGF-domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=83.23 E-value=0.07 Score=34.26 Aligned_cols=25 Identities=20% Similarity=0.561 Sum_probs=21.7
Q ss_pred CccCCCcccccCCCCCcccCCCCCc
Q 041576 245 GACGFNSYCLLQNGRPFCECPPEYL 269 (714)
Q Consensus 245 ~~CG~~g~C~~~~~~~~C~C~~gf~ 269 (714)
..|...|.|........|.|++||+
T Consensus 7 ~pC~ngg~C~~~~~~~~C~C~~g~~ 31 (39)
T d1g1ta2 7 TSCSGHGECVETINNYTCKCDPGFS 31 (39)
T ss_dssp TGGGGSEEEEEETTEEEEEECTTEE
T ss_pred CcCCCCcEEECCCCCEEEeCCCCCc
Confidence 6899999998665678999999996
|
| >d1apqa_ g.3.11.1 (A:) Complement protease C1R {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Complement protease C1R species: Human (Homo sapiens) [TaxId: 9606]
Probab=83.15 E-value=0.18 Score=34.78 Aligned_cols=26 Identities=27% Similarity=0.542 Sum_probs=20.9
Q ss_pred ccCCCcccccCCCCCcccCCCCCccc
Q 041576 246 ACGFNSYCLLQNGRPFCECPPEYLFV 271 (714)
Q Consensus 246 ~CG~~g~C~~~~~~~~C~C~~gf~~~ 271 (714)
.|+...+|.++.++..|+|++||++.
T Consensus 19 ~~~c~~~C~Nt~GsY~C~C~~Gy~l~ 44 (53)
T d1apqa_ 19 QPQCQHLCHNYVGGYFCSCRPGYELQ 44 (53)
T ss_dssp SCTTSSEEEEETTEEEEECSTTCEEC
T ss_pred CCCccCEeEcCCCCeEeECCCCCeEC
Confidence 45556689887778999999999864
|
| >d1g1sa2 g.3.11.1 (A:119-158) E-selectin, EGF-domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: E-selectin, EGF-domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=82.97 E-value=0.11 Score=33.61 Aligned_cols=25 Identities=28% Similarity=0.642 Sum_probs=21.7
Q ss_pred CccCCCcccccCCCCCcccCCCCCc
Q 041576 245 GACGFNSYCLLQNGRPFCECPPEYL 269 (714)
Q Consensus 245 ~~CG~~g~C~~~~~~~~C~C~~gf~ 269 (714)
..|...|.|........|.|++||.
T Consensus 7 ~pC~ngg~C~~~~~~y~C~C~~g~~ 31 (40)
T d1g1sa2 7 MSCSKQGECLETIGNYTCSCYPGFY 31 (40)
T ss_dssp TGGGGSEEEEECSSSEEEEECTTEE
T ss_pred CcCCCCcEEECCCCCeEEeCCCCcc
Confidence 6899999998765678999999996
|
| >d1q4ga2 g.3.11.1 (A:32-73) Prostaglandin H2 synthase-1, EGF-like module {Sheep (Ovis aries) [TaxId: 9940]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Prostaglandin H2 synthase-1, EGF-like module species: Sheep (Ovis aries) [TaxId: 9940]
Probab=82.87 E-value=0.17 Score=32.98 Aligned_cols=32 Identities=28% Similarity=0.596 Sum_probs=25.3
Q ss_pred CcccccccccCCCcCccCCCcccccC-CCCCcccCCC-CCc
Q 041576 231 PNNICTSISDEFGSGACGFNSYCLLQ-NGRPFCECPP-EYL 269 (714)
Q Consensus 231 p~d~Cd~y~~~~~~~~CG~~g~C~~~-~~~~~C~C~~-gf~ 269 (714)
|-|.|+. ..|...|.|... .....|.|+. ||+
T Consensus 1 Pid~C~~-------nPC~ngG~C~~~~~~~y~C~C~~~G~~ 34 (42)
T d1q4ga2 1 PVNPCCY-------YPCQHQGICVRFGLDRYQCDCTRTGYS 34 (42)
T ss_dssp CCCGGGG-------CCCCTTCEEEEETTTEEEEECTTSSEE
T ss_pred CCccCcC-------CCCCCCCEeeeCCCCCEEEECCCCCcC
Confidence 5678888 799999999643 3467999986 896
|